PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kumari, A; Yadav, SK; Ali, S				Kumari, Anju; Yadav, Sandeep Kumar; Ali, Sher			Organizational and Functional Status of the Y-linked Genes and Loci in the Infertile Patients Having Normal Spermiogram	PLOS ONE			English	Article							FACTORS AFFECTING FERTILITY; PARTIAL AZFC DELETIONS; CELL-ONLY-SYNDROME; NUCLEAR-LOCALIZATION; EXPRESSION ANALYSIS; GONADAL-DYSGENESIS; POINT MUTATION; SEX REVERSAL; SRY GENE; CHROMOSOME	Male fertility is an orchestrated interplay of loci on the Y chromosome with a number of genes from across the other chromosomes. In this context, micro-deletions in the Y chromosome have been correlated with spermatogenic failure often leading to infertility. However, causes of infertility in the patients with the normal spermiogram have remained unclear and therefore pose another level of challenge. In the present study, we analyzed 64 STSs, studied different Y-linked genes and loci and conducted single nucleotide variant (SNV) analyses in 31 infertile males with normal spermiogram along with 67 normal fertile males (NFMs) to gain an insight into the organization of their Y chromosome. Further, employing quantitative real-time PCR (qPCR), we studied copy number variation of DYZ1 arrays and three genes and mutational status of SRY by direct sequence analyses. STS analyses of the AZFa, b and c regions in these patients showed known and new mutations. Further, copies of DAZ and BPY2 in the patients were found to be affected (p<0.001) compared to those in NFMs. All the patients had normal copy number of the SRY however its sequence analysis (in silico) showed mutations in eight patients. In four of these eight patients, SRY mutations resulted into truncated proteins. Similarly, DYZ1 analysis showed micro-deletions and it's much reduced copy number (p<0.001) as compared to those in NFMs. Present study in males with unexplained infertility revealed deletions similar to those observed in oligospermic and azoospermic patients. Thus, there are some common but still unknown factors underlying infertility in these patients irrespective of their spermatogenic status. This work is envisaged to augment DNA diagnosis, proving beneficial in the context of in vitro fertilization (IVF) and genetic counselling.	[Kumari, Anju; Yadav, Sandeep Kumar; Ali, Sher] Natl Inst Immunol, Mol Genet Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Kumari, A (corresponding author), Natl Inst Immunol, Mol Genet Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	alisher@nii.ac.in	KUMARI, ANJU/ABH-8502-2020; Yadav, Sandeep Kumar/ABA-8776-2020; Kumar, Vineet/F-2923-2015	Yadav, Sandeep Kumar/0000-0001-6999-040X; Kumar, Vineet/0000-0002-8772-679X; KUMARI, ANJU/0000-0001-5130-4774	Department of Biotechnology (DBT), Government of India [BT/PR11805/MED/12/424/2009, BT/PR14102/AAQ/01/438/2010]; DBT, New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi; Department of Science and Technology, New Delhi, Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); DBT, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, New Delhi, Government of India(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology (DBT), Government of India Grants - BT/PR11805/MED/12/424/2009 and BT/PR14102/AAQ/01/438/2010 to SA and a core grant from DBT, New Delhi, to the National Institute of Immunology, New Delhi. The authors also acknowledge the Council of Scientific and Industrial Research (CSIR), New Delhi, for its financial assistance to SKY and AK as JRF and SRF, respectively. SA is also grateful to Department of Science and Technology, New Delhi, Government of India, for J. C. Bose National Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2003, GENE, V321, P25, DOI 10.1016/j.gene.2003.08.006; Ali S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-35; Alvarez-Nava F, 2001, ANN GENET-PARIS, V44, P155; Blagosklonova O, 2000, MOL HUM REPROD, V6, P795, DOI 10.1093/molehr/6.9.795; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Ferlin A, 2005, CYTOGENET GENOME RES, V111, P310, DOI 10.1159/000086905; Ferlin A, 2004, FERTIL STERIL, V81, P1013, DOI 10.1016/j.fertnstert.2003.08.053; Ferlin A, 2003, J MED GENET, V40, P18, DOI 10.1136/jmg.40.1.18; Ferlin A, 2006, REPROD TOXICOL, V22, P133, DOI 10.1016/j.reprotox.2006.04.016; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Fernandez R, 2002, HUM GENET, V111, P242, DOI 10.1007/s00439-002-0767-6; Fernando L, 2006, ASIAN J ANDROL, V8, P39, DOI 10.1111/j.1745-7262.2006.00100.x; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Foresta C, 2000, J ENDOCRINOL INVEST, V23, P646, DOI 10.1007/BF03343788; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Giachini C, 2007, HUM REPROD, V22, P2398, DOI 10.1093/humrep/dem186; Giachini C, 2005, J MED GENET, V42, P497, DOI 10.1136/jmg.2004.028191; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Hargreave TB, 2000, BRIT MED BULL, V56, P650, DOI 10.1258/0007142001903454; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; Kamp C, 2001, MOL HUM REPROD, V7, P987, DOI 10.1093/molehr/7.10.987; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kleiman SE, 2003, HUM GENET, V113, P486, DOI 10.1007/s00439-003-0990-9; Krausz C, 2006, HUM MOL GENET, V15, P2673, DOI 10.1093/hmg/ddl198; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lee KH, 2003, REPROD FERT DEVELOP, V15, P129, DOI 10.1071/RD03002; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; Luddi A, 2009, NEW ENGL J MED, V360, P881, DOI 10.1056/NEJMoa0806218; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; Marchina E, 2009, FERTIL STERIL, V91, DOI 10.1016/j.fertnstert.2008.07.1722; MOGHISSI KS, 1983, FERTIL STERIL, V39, P5; Moro E, 2000, J CLIN ENDOCR METAB, V85, P4069, DOI 10.1210/jc.85.11.4069; Navarro-Costa P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-342; NEGROVILAR A, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431377; NELSON CMK, 1974, FERTIL STERIL, V25, P503; Paliwal P, 2011, MOL HUM REPROD, V17, P372, DOI 10.1093/molehr/gar002; Pathak D, 2006, DNA RES, V13, P103, DOI 10.1093/dnares/dsl002; Phillips NB, 2006, J MOL BIOL, V358, P172, DOI 10.1016/j.jmb.2006.01.060; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Shahid M, 2004, MOL HUM REPROD, V10, P521, DOI 10.1093/molehr/gah071; Shahid M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-131; Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9; Sharpe RM, 2002, NAT MED, V8, P33; Sinclair A, 2001, GENOME BIOL, V2, P40171; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stouffs K, 2008, HUM REPROD, V23, P1193, DOI 10.1093/humrep/den069; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; VanWaeleghem K, 1996, HUM REPROD, V11, P325, DOI 10.1093/HUMREP/11.2.325; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Vogt PH, 2004, MOL CELL ENDOCRINOL, V224, P1, DOI 10.1016/j.mce.2004.06.008; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499; Younglai EV, 2005, HUM REPROD UPDATE, V11, P43, DOI 10.1093/humupd/dmh055	66	69	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41488	10.1371/journal.pone.0041488	http://dx.doi.org/10.1371/journal.pone.0041488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844483	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700094
J	Takahashi, R; Giannini, C; Sarkaria, JN; Schroeder, M; Rogers, J; Mastroeni, D; Scrable, H				Takahashi, R.; Giannini, C.; Sarkaria, J. N.; Schroeder, M.; Rogers, J.; Mastroeni, D.; Scrable, H.			p53 isoform profiling in glioblastoma and injured brain	ONCOGENE			English	Article						gliosis; regeneration; astrocytoma	NEURAL STEM-CELLS; ADULT MAMMALIAN BRAIN; HUMAN CANCERS; SPINAL-CORD; MUTANT P53; EXPRESSION; ASTROCYTES; TUMORS; ZONE; GENE	The tumor suppressor p53 has been found to be the most commonly mutated gene in human cancers; however, the frequency of p53 mutations varies from 10 to 70% across different cancer types. This variability can partly be explained by inactivating mechanisms aside from direct genomic polymorphisms. The p53 gene encodes 12 isoforms, some of which can modulate full-length p53 activity in cancer. In this study, we characterized p53 isoform expression patterns in glioblastoma, gliosis, non-tumor brain and neural progenitor cells by SDS-PAGE, immunoblot, mass spectrometry and reverse transcription-PCR. We found that the most consistently expressed isoform in glioblastoma, Delta 40p53, was uniquely expressed in regenerative processes, such as those involving neural progenitor cells and gliosis compared with tumor samples. Isoform profiling of glioblastoma tissues revealed the presence of both Delta 40p53 and full-length p53, neither of which were detected in non-tumor cerebral cortex. Upon xenograft propagation of tumors, p53 levels increased. The variability of overall p53 expression and relative levels of isoforms suggest fluctuations in subpopulations of cells with greater or lesser capacity for proliferation, which can change as the tumor evolves under different growth conditions.	[Takahashi, R.] Mayo Clin, Med Scientist Training Program, Rochester, MN 55905 USA; [Takahashi, R.; Scrable, H.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Giannini, C.] Mayo Clin, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN 55905 USA; [Sarkaria, J. N.; Schroeder, M.] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA; [Rogers, J.; Mastroeni, D.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Scrable, H.] Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN 55905 USA; [Scrable, H.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Banner Research; Banner Health; Banner Sun Health Research Institute; Mayo Clinic; Mayo Clinic	Scrable, H (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol, 200 1st St SW, Rochester, MN 55905 USA.	Scrable.Heidi@mayo.edu	Giannini, Caterina/AAB-7551-2022		PHS [R01AG026094]; Ellison Medical Research Foundation; NCI Cancer Center support grant; Robert and Arlene Kogod Center on Aging at Mayo Clinic; Mayo Brain Tumors SPORE; Mayo Clinic Medical Scientist Training Program; NATIONAL INSTITUTE ON AGING [R01AG026094] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Ellison Medical Research Foundation(Lawrence Ellison Foundation); NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert and Arlene Kogod Center on Aging at Mayo Clinic; Mayo Brain Tumors SPORE; Mayo Clinic Medical Scientist Training Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank our Mayo Clinic colleagues for their contributions, in particular, Dr Robert Jenkins for seminal discussions on the etiology of GBM and xenograft biology; Alissa Caron for preparing GBM patient tumor specimens; Dr John Black for CTX samples; Guido Gonzalez for obtaining LNZ308 cells; and Benjamin Madden and the Mayo Clinic Protein Chemistry and Proteomics Shared Resource core for mass spectrometry analysis. We are grateful to past and current members of the Scrable lab for their enduring enthusiasm and abilities, in particular Dr Erica Ungewitter for her invaluable help with p53 antibodies and the work she did as a graduate student that laid the foundation for subsequent studies on p53 in ESCs, and Dr Silvia Medrano, for passing on her expertise with mouse NSC culture and the role of p53 in adult stem cells. This work was supported by PHS award R01AG026094 and a Senior Scholar in Aging award from the Ellison Medical Research Foundation to HS Additional support came from an NCI Cancer Center support grant to the Mayo Clinic Cancer Center, the Robert and Arlene Kogod Center on Aging at Mayo Clinic, the Mayo Brain Tumors SPORE, and the Mayo Clinic Medical Scientist Training Program (RT).	Anensen N, 2006, CLIN CANCER RES, V12, P3985, DOI 10.1158/1078-0432.CCR-05-1970; Avery-Kiejda KA, 2008, CLIN CANCER RES, V14, P1659, DOI 10.1158/1078-0432.CCR-07-1422; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boldrup L, 2007, EUR J CANCER, V43, P617, DOI 10.1016/j.ejca.2006.10.019; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Butler T, 2010, BLOOD REV, V24, P135, DOI 10.1016/j.blre.2010.03.004; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Carlson BL, 2011, CURR PROTOC PHARM, V52, P1; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Globus J.H., 1944, J NEUROPATH EXP NEUR, V3, P1; Globus JH, 1942, ARCH PATHOL, V34, P674; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; GRITTI A, 2001, PROTOCOLS NEURAL CEL; Grover R, 2009, ONCOGENE, V28, P2766, DOI 10.1038/onc.2009.138; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Imura T, 2003, J NEUROSCI, V23, P2824; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Laywell ED, 1999, EXP NEUROL, V156, P430, DOI 10.1006/exnr.1999.7029; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li W, 2006, PATHOLOGY, V38, P287, DOI 10.1080/00313020600817951; Machado-Silva A, 2010, SEMIN CANCER BIOL, V20, P57, DOI 10.1016/j.semcancer.2010.02.005; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; MATLASHEWSKI G, 1987, ONCOGENE RES, V1, P77; Medrano S, 2009, NEUROBIOL AGING, V30, P483, DOI 10.1016/j.neurobiolaging.2007.07.016; Mills AA, 2005, GENE DEV, V19, P2091, DOI 10.1101/gad.1362905; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Philipova T, 2011, INT J ONCOL, V38, P843, DOI 10.3892/ijo.2010.884; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Robles AI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001016; ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Shoshan Y, 1999, P NATL ACAD SCI USA, V96, P10361, DOI 10.1073/pnas.96.18.10361; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Ungewitter E, 2010, GENE DEV, V24, P2408, DOI 10.1101/gad.1987810; VAN MEIR EG, 1994, CANCER RES, V54, P649; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801	59	27	29	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 27	2013	32	26					3165	3174		10.1038/onc.2012.322	http://dx.doi.org/10.1038/onc.2012.322			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22824800	Green Accepted			2022-12-25	WOS:000321004600007
J	Wejda, M; Impens, F; Takahashi, N; Van Damme, P; Gevaert, K; Vandenabeele, P				Wejda, Magdalena; Impens, Francis; Takahashi, Nozomi; Van Damme, Petra; Gevaert, Kris; Vandenabeele, Peter			Degradomics Reveals That Cleavage Specificity Profiles of Caspase-2 and Effector Caspases Are Alike	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL PEPTIDES; FRACTIONAL DIAGONAL CHROMATOGRAPHY; CYTOSOLIC PHOSPHOLIPASE A(2); FAS-INDUCED APOPTOSIS; CELL-DEATH; QUANTITATIVE PROTEOMICS; INFLAMMATORY CASPASES; GENOTOXIC STRESS; STRUCTURAL BASIS; DNA-DAMAGE	Caspase-2 is considered an initiator caspase because its long prodomain contains a CARD domain that allows its recruitment and activation in several complexes by homotypic death domain-fold interactions. Because little is known about the function and specificity of caspase-2 and its physiological substrates, we compared the cleavage specificity profile of recombinant human caspase-2 with those of caspase-3 and -7 by analyzing cell lysates using N-terminal COmbined FRActional DIagonal Chromatography (COFRADIC). Substrate analysis of the 68 cleavage sites identified in 61 proteins revealed that the protease specificities of human caspases-2, -3, and -7 largely overlap, revealing the DEVD down arrow G consensus cleavage sequence. We confirmed that Asp(563) in eukaryotic translation initiation factor 4B (eIF4B) is a cleavage site preferred by caspase-2 not only in COFRADIC setup but also upon co-expression in HEK 293T cells. These results demonstrate that activated human caspase-2 shares remarkably overlapping protease specificity with the prototype apoptotic executioner caspases-3 and -7, suggesting that caspase-2 could function as a proapoptotic caspase once released from the activating complex.	[Wejda, Magdalena; Takahashi, Nozomi; Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Zwijnaarde, Belgium; [Wejda, Magdalena; Takahashi, Nozomi; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Zwijnaarde, Belgium; [Impens, Francis; Van Damme, Petra; Gevaert, Kris] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Impens, Francis; Van Damme, Petra; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Vandenabeele, P (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, Technol Pk 927, B-9052 Ghent, Zwijnaarde, Belgium.	peter.vandenabeele@dmbr.UGent.be	Van Damme, Petra/C-7269-2008; Gevaert, Kris/H-3637-2013; Gevaert, Kris/AAE-4212-2019; Gevaert, Kris/D-6489-2017; Vandenabeele, Peter/C-8597-2009; Vandenabeele, Peter/AAD-5793-2022	Van Damme, Petra/0000-0001-9090-027X; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Vandenabeele, Peter/0000-0002-6669-8822; Takahashi, Nozomi/0000-0002-3751-4203; Impens, Francis/0000-0003-2886-9616	European grants [MRTN-CT-035624, FP7-200767]; Belgian grants (Interuniversity Attraction Poles) [IAP 6/18]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11]; Ghent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Fund for Scientific Research-Flanders (Belgium) [G.0048.08]; Flemish Government [BOF09/01M00709]	European grants; Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grants (Research Foundation Flanders)(FWO); Ghent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Fund for Scientific Research-Flanders (Belgium)(FWO); Flemish Government(European Commission)	This work was supported by European grants (FP6 ApopTrain, MRTN-CT-035624; FP7 EC RTD Integrated Project, Apo-Sys, FP7-200767; Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 6/18), Flemish grants (Research Foundation Flanders, FWO G.0875.11 and FWO G.0973.11), Ghent University grants (MRP, GROUP-ID consortium), and grants from Flanders Institute for Biotechnology (VIB).; Recipient of a research grant from the Fund for Scientific Research-Flanders (Belgium) (project number G.0048.08).; Holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. To whom correspondence should be addressed: Dept. for Molecular Biomedical Research, VIB and Ghent University, Technologiepark 927, Ghent 9052, Belgium. Tel.: 32-93313760; Fax: 32-92217673; E-mail: peter.vandenabeele@dmbr.UGent.be.	Adam-Klages S, 1998, J IMMUNOL, V161, P5687; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bushell M, 2000, EUR J BIOCHEM, V267, P1083, DOI 10.1046/j.1432-1327.2000.01101.x; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cuenin S, 2008, ONCOGENE, V27, P387, DOI 10.1038/sj.onc.1210635; Demon D, 2009, MOL CELL PROTEOMICS, V8, P2700, DOI 10.1074/mcp.M900310-MCP200; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Enoksson M, 2007, J PROTEOME RES, V6, P2850, DOI 10.1021/pr0701052; Fang B, 2006, J MOL BIOL, V360, P654, DOI 10.1016/j.jmb.2006.05.041; Fu GX, 2008, APOPTOSIS, V13, P1291, DOI 10.1007/s10495-008-0259-9; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Ghesquiere B, 2006, J PROTEOME RES, V5, P2438, DOI 10.1021/pr060186m; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Helsens K, 2010, PROTEOMICS, V10, P1261, DOI 10.1002/pmic.200900409; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Impens F, 2010, MOL CELL PROTEOMICS, V9, P2327, DOI 10.1074/mcp.M110.001271; Ju WJ, 2007, P NATL ACAD SCI USA, V104, P14294, DOI 10.1073/pnas.0702251104; Karki P, 2008, PROTEIN PEPTIDE LETT, V15, P1044, DOI 10.2174/092986608786071193; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Luschen S, 1998, BIOCHEM BIOPH RES CO, V253, P92, DOI 10.1006/bbrc.1998.9754; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Oliver TG, 2011, MOL CELL, V43, P57, DOI 10.1016/j.molcel.2011.06.012; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pereira NA, 2008, BIOCHEM BIOPH RES CO, V377, P873, DOI 10.1016/j.bbrc.2008.10.101; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Saelens X, 2005, J CELL BIOL, V168, P545, DOI 10.1083/jcb.200407162; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schweizer A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/jbc.M304895200; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Shahbazian D, 2010, CELL CYCLE, V9, P4106, DOI 10.4161/cc.9.20.13630; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Staes A, 2008, PROTEOMICS, V8, P1362, DOI 10.1002/pmic.200700950; Staes A, 2011, NAT PROTOC, V6, P1130, DOI 10.1038/nprot.2011.355; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Troy CM, 2000, J NEUROSCI, V20, P1386; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	76	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33983	33995		10.1074/jbc.M112.384552	http://dx.doi.org/10.1074/jbc.M112.384552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22825847	Green Published, hybrid			2022-12-25	WOS:000309654200006
J	Narayanan, A; Kehn-Hall, K; Senina, S; Lundberg, L; Van Duyne, R; Guendel, I; Das, R; Baer, A; Bethel, L; Turell, M; Hartman, AL; Das, B; Bailey, C; Kashanchi, F				Narayanan, Aarthi; Kehn-Hall, Kylene; Senina, Svetlana; Lundberg, Lindsay; Van Duyne, Rachel; Guendel, Irene; Das, Ravi; Baer, Alan; Bethel, Laura; Turell, Michael; Hartman, Amy Lynn; Das, Bhaskar; Bailey, Charles; Kashanchi, Fatah			Curcumin Inhibits Rift Valley Fever Virus Replication in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NSS PROTEIN; PROTEASOME EXPRESSION; P65 PHOSPHORYLATION; MEDIATED ACTIVATION; DOWN-REGULATION; IKK-BETA; KINASE; TRANSCRIPTION; INDUCTION	Rift Valley fever virus (RVFV) is an arbovirus that is classified as a select agent, an emerging infectious virus, and an agricultural pathogen. Understanding RVFV-host interactions is imperative to the design of novel therapeutics. Here, we report that an infection by the MP-12 strain of RVFV induces phosphorylation of the p65 component of the NF kappa B cascade. We demonstrate that phosphorylation of p65 (serine 536) involves phosphorylation of I kappa B alpha and occurs through the classical NF kappa B cascade. A unique, low molecular weight complex of the IKK-beta subunit can be observed in MP-12-infected cells, which we have labeled IKK-beta 2. The IKK-beta 2 complex retains kinase activity and phosphorylates an I kappa B alpha substrate. Inhibition of the IKK complex using inhibitors impairs viral replication, thus alluding to the requirement of an active IKK complex to the viral life cycle. Curcumin strongly down-regulates levels of extracellular infectious virus. Our data demonstrated that curcumin binds to and inhibits kinase activity of the IKK-beta 2 complex in infected cells. Curcumin partially exerts its inhibitory influence on RVFV replication by interfering with IKK-beta 2-mediated phosphorylation of the viral protein NSs and by altering the cell cycle of treated cells. Curcumin also demonstrated efficacy against ZH501, the fully virulent version of RVFV. Curcumin treatment down-regulated viral replication in the liver of infected animals. Our data point to the possibility that RVFV infection may result in the generation of novel versions of host components (such as IKK-beta 2) that, by virtue of altered protein interaction and function, qualify as unique therapeutic targets.	[Narayanan, Aarthi; Kehn-Hall, Kylene; Senina, Svetlana; Lundberg, Lindsay; Van Duyne, Rachel; Guendel, Irene; Das, Ravi; Baer, Alan; Bailey, Charles; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Van Duyne, Rachel] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Turell, Michael] USA, Div Virol, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Das, Bhaskar] Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10461 USA; [Bethel, Laura; Hartman, Amy Lynn] Univ Pittsburgh, Reg Biocontainment Lab, Ctr Vaccine Res, Pittsburgh, PA 15261 USA	George Mason University; George Washington University; Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashanchi, F (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Discovery Hall,Rm 182,10900 Univ Blvd,MS 1H8, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Turell, Michael/ABE-1826-2020; Van Duyne, Rachel/ABI-2429-2020; Kehn-Hall, Kylene/I-5752-2013; Van Duyne, Rachel/I-7365-2019	Turell, Michael/0000-0003-1902-7740; Van Duyne, Rachel/0000-0003-2914-6874; Hartman, Amy/0000-0002-0857-2973	United States Department of Energy [DE-FC52-04NA25455]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FC52-04NA25455 (to C.B. and F.K.).	Agbottah Emmanuel, 2008, AIDS Res Ther, V5, P12, DOI 10.1186/1742-6405-5-12; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Ahmed KM, 2007, CURR CANCER DRUG TAR, V7, P335; Baer A, 2012, J BIOL CHEM, V287, P7399, DOI 10.1074/jbc.M111.296608; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy M, 2009, ANTIVIR RES, V84, P101, DOI 10.1016/j.antiviral.2009.08.002; Caselli E, 2007, BLOOD, V109, P2718, DOI 10.1182/blood-2006-03-012500; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Dasgupta A, 2004, MOL CELL, V13, P456, DOI 10.1016/S1097-2765(04)00092-9; Dattani JJ, 2010, ENVIRON TOXICOL PHAR, V30, P103, DOI 10.1016/j.etap.2010.04.001; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Dong XN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002336; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10; Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Haddad JJ, 2002, CELL SIGNAL, V14, P211, DOI 10.1016/S0898-6568(01)00233-9; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Jin HL, 2011, J VIROL, V85, P3397, DOI 10.1128/JVI.02373-10; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Kazi A, 2003, BIOCHEM PHARMACOL, V66, P965, DOI 10.1016/S0006-2952(03)00414-3; LaBeaud AD, 2010, CURR OPIN INFECT DIS, V23, P403, DOI 10.1097/QCO.0b013e32833c3da6; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lorenzo G, 2010, VACCINE, V28, P2937, DOI 10.1016/j.vaccine.2010.02.018; Milacic V, 2008, CANCER RES, V68, P7283, DOI 10.1158/0008-5472.CAN-07-6246; Narayanan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020354; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh SW, 2011, J ETHNOPHARMACOL, V136, P414, DOI 10.1016/j.jep.2010.07.026; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Panchal RG, 2012, ANTIVIR RES, V93, P23, DOI 10.1016/j.antiviral.2011.10.011; Pasquini LA, 2003, J NEUROSCI, V23, P4635; Pise-Masison CA, 2000, AIDS RES HUM RETROV, V16, P1669, DOI 10.1089/08892220050193128; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Sgarbanti M, 2004, ONCOGENE, V23, P5770, DOI 10.1038/sj.onc.1207707; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Smith HJ, 2003, BRIT J CANCER, V89, P1783, DOI 10.1038/sj.bjc.6601328; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Tu CT, 2011, MOL CELL BIOCHEM, V358, P53, DOI [10.1007/s11010-011-0920-4, 10.1007/s11010-011-0978-z]; Tu CT, 2012, INT IMMUNOPHARMACOL, V12, P151, DOI 10.1016/j.intimp.2011.11.005; Valentine R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-1; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wan SB, 2010, INT J MOL MED, V26, P447, DOI 10.3892/ijmm_00000484; Wang J, 2010, VIROLOGY, V400, P215, DOI 10.1016/j.virol.2010.01.035; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; Yu Wen-Guang, 2011, Indian J Med Res, V134, P717, DOI 10.4103/0971-5916.91009; Zheng ZH, 2011, J IMMUNOL, V187, P2202, DOI 10.4049/jimmunol.1100285; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	63	53	55	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33198	33214		10.1074/jbc.M112.356535	http://dx.doi.org/10.1074/jbc.M112.356535			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22847000	Green Published, hybrid			2022-12-25	WOS:000309602100011
J	Zamocky, M; Garcia-Fernandez, Q; Gasselhuber, B; Jakopitsch, C; Furtmuller, PG; Loewen, PC; Fita, I; Obinger, C; Carpena, X				Zamocky, Marcel; Garcia-Fernandez, Queralt; Gasselhuber, Bernhard; Jakopitsch, Christa; Furtmueller, Paul G.; Loewen, Peter C.; Fita, Ignacio; Obinger, Christian; Carpena, Xavi			High Conformational Stability of Secreted Eukaryotic Catalase-peroxidases ANSWERS FROM FIRST CRYSTAL STRUCTURE AND UNFOLDING STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICE BLAST FUNGUS; MAGNAPORTHE-GRISEA; BURKHOLDERIA-PSEUDOMALLEI; CRYSTAL-STRUCTURE; KATG; EVOLUTION; CATALASE/PEROXIDASE; SEQUENCE; CELLS	Catalase-peroxidases (KatGs) are bifunctional heme enzymes widely spread in archaea, bacteria, and lower eukaryotes. Here we present the first crystal structure (1.55 angstrom resolution) of an eukaryotic KatG, the extracellular or secreted enzyme from the phytopathogenic fungus Magnaporthe grisea. The heme cavity of the homodimeric enzyme is similar to prokaryotic KatGs including the unique distal (+)Met-Tyr-Trp adduct (where the Trp is further modified by peroxidation) and its associated mobile arginine. The structure also revealed several conspicuous peculiarities that are fully conserved in all secreted eukaryotic KatGs. Peculiarities include the wrapping at the dimer interface of the N-terminal elongations from the two subunits and cysteine residues that cross-link the two subunits. Differential scanning calorimetry and temperature- and urea-mediated unfolding followed by UV-visible, circular dichroism, and fluorescence spectroscopy combined with site-directed mutagenesis demonstrated that secreted eukaryotic KatGs have a significantly higher conformational stability as well as a different unfolding pattern when compared with intracellular eukaryotic and prokaryotic catalase-peroxidases. We discuss these properties with respect to the structure as well as the postulated roles of this metalloenzyme in host-pathogen interactions.	[Garcia-Fernandez, Queralt; Fita, Ignacio; Carpena, Xavi] CSIC, Inst Res Biomed IRB Barcelona, E-08028 Barcelona, Spain; [Garcia-Fernandez, Queralt; Fita, Ignacio; Carpena, Xavi] CSIC, IBMB, E-08028 Barcelona, Spain; [Zamocky, Marcel] Slovak Acad Sci, Inst Mol Biol, Mol Microbiol Lab, SK-84551 Bratislava, Slovakia; [Obinger, Christian] Univ Nat Resources & Life Sci, BOKU, Div Biochem, Dept Chem, A-1190 Vienna, Austria; [Loewen, Peter C.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Slovak Academy of Sciences; University of Natural Resources & Life Sciences, Vienna; University of Manitoba	Carpena, X (corresponding author), CSIC, Inst Res Biomed IRB Barcelona, Parc Cient Barcelona,Baldiri Reixac 10, E-08028 Barcelona, Spain.	xcvcri@ibmb.csic.es	Furtmüller, Paul G./Y-5819-2018; Fita, Ignasi/R-4515-2019; Carpena, Xavi/J-5877-2017; Obinger, Christian/AAV-3173-2021; Zamocky, Marcel/AAC-2882-2019	Furtmüller, Paul G./0000-0002-1199-2469; Fita, Ignasi/0000-0002-7521-2679; Carpena, Xavi/0000-0002-8646-0440; Zamocky, Marcel/0000-0002-2443-2823; Obinger, Christian/0000-0002-7133-3430; Jakopitsch, Christa/0000-0002-5855-2057	Ministerio de Ciencia y Tecnologia [BFU2009-09268]; Natural Sciences and Engineering Research Council of Canada [DG 9600]; Canada Research Chair Program; Austrian Science Foundation - Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) [W1224, P20996, P23855]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); Austrian Science Foundation - Fonds zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	This work was supported by Grants BFU2009-09268 from Ministerio de Ciencia y Tecnologia (to I. F.), by Grant DG 9600 from the Natural Sciences and Engineering Research Council of Canada (to P. C. L.), and by the Canada Research Chair Program (to P. C. L.). The work was also supported by the Austrian Science Foundation - Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) with doctoral program BioToP, Biomolecular Technology of Proteins, W1224 and the projects P20996 and P23855.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee S, 2010, BBA-PROTEINS PROTEOM, V1804, P2136, DOI 10.1016/j.bbapap.2010.07.013; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2005, EMBO REP, V6, P1156, DOI 10.1038/sj.embor.7400550; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passardi F, 2007, GENE, V397, P101, DOI 10.1016/j.gene.2007.04.016; Peraza L, 2002, BIOL CHEM, V383, P569, DOI 10.1515/BC.2002.058; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe S, 2008, BIOSCI BIOTECH BIOCH, V72, P889, DOI 10.1271/bbb.70684; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Tanabe S, 2009, PHYSIOL PLANTARUM, V137, P148, DOI 10.1111/j.1399-3054.2009.01272.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vidossich P, 2007, J AM CHEM SOC, V129, P13436, DOI 10.1021/ja072245i; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Wiseman B, 2010, J BIOL CHEM, V285, P26662, DOI 10.1074/jbc.M110.139428; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Zamocky M, 2009, BIOCHEM J, V418, P443, DOI 10.1042/BJ20081478; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zamocky M, 2012, BIOCHIMIE, V94, P673, DOI 10.1016/j.biochi.2011.09.020; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2; Zamocky M, 2010, ARCH BIOCHEM BIOPHYS, V500, P45, DOI 10.1016/j.abb.2010.03.024; Zamocky M, 2009, BIOCHEM SOC T, V37, P772, DOI 10.1042/BST0370772; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhao XB, 2010, J AM CHEM SOC, V132, P8268, DOI 10.1021/ja103311e	34	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32254	32262		10.1074/jbc.M112.384271	http://dx.doi.org/10.1074/jbc.M112.384271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822072	hybrid, Green Published			2022-12-25	WOS:000309059400062
J	Lin, CH; Wang, LH; Fan, TY; Kuo, W				Lin, Chiahsin; Wang, Li-Hsueh; Fan, Tung-Yung; Kuo, Wen			Lipid Content and Composition during the Oocyte Development of Two Gorgonian Coral Species in Relation to Low Temperature Preservation	PLOS ONE			English	Article							UNSATURATED FATTY-ACIDS; CHILLING SENSITIVITY; LARVAL DEVELOPMENT; ZOOXANTHELLAE; EMBRYOS; CRYOPRESERVATION; BIOSYNTHESIS; METABOLISM; INDICATORS; RECOVERY	Our previous studies have suggested that chilling sensitivity of coral oocytes may relate to their relatively high lipid intracellular content and lipid composition. The distribution of lipids during the oocyte development was determined here for the first time in two gorgonian species (Junceella juncea and Junceella fragilis). The main lipid classes in the two gorgonian oocytes were total lipid, wax ester, triacylglycerol, total fatty acid, phosphatidylethanolamine and phosphatidylcholine. The results indicated that early stage oocytes of J. juncea and J. fragilis were found to have increased lipid content than late stage oocytes. The content of wax ester was significantly higher in the early stage oocytes of two gorgonian corals (51.0 +/- 2.5 and 41.7 +/- 2.9 mg/mm(3)/oocyte) than those of late stage oocytes (24.0 +/- 1.4 and 30.4 +/- 1.2 mg/mm(3)/oocyte, respectively). A substantial amount of phosphatidylethanolamine and total fatty acid was detected at each stage of oocyte development in two gorgonian ranges from 107 to 42 mg/mm(3)/oocyte and 106 to 48 mg/mm(3)/oocyte, whilst low levels of phosphatidylcholine were found in two gorgonian oocytes. The levels of total lipid in the late stage oocytes of J. juncea were significantly higher than those of J. fragilis. The observed differences may partially be related to different habitat preferences as higher lipid levels in J. juncea, a deeper-water coral species exposed to lower temperature seawater, might relate to adjustments of cell membranes in order to increase membrane fluidity.	[Lin, Chiahsin; Wang, Li-Hsueh; Fan, Tung-Yung; Kuo, Wen] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Lin, Chiahsin; Wang, Li-Hsueh] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Checheng, Pingtung, Taiwan; [Fan, Tung-Yung] Natl Dong Hwa Univ, Grad Inst Marine Biodivers & Evolut, Checheng, Pingtung, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Dong Hwa University	Lin, CH (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	chiahsin@nmmba.gov.tw			National Museum of Marine Biology & Aquarium and National Science Council	National Museum of Marine Biology & Aquarium and National Science Council	Funding was provided by the National Museum of Marine Biology & Aquarium and National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAVA VR, 1993, NIPPON SUISAN GAKK, V59, P345, DOI 10.2331/suisan.59.345; ARAI T, 1993, CORAL REEFS, V12, P71; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; BATTEY JF, 1984, MAR BIOL, V79, P27, DOI 10.1007/BF00404982; Bell MV, 2007, J PLANKTON RES, V29, P417, DOI 10.1093/plankt/fbm025; Blair AC, 2003, THESIS COLL CHARLEST; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Christie WW, 1998, PHYTOCHEM ANALYSIS, V9, P53, DOI 10.1002/(SICI)1099-1565(199803/04)9:2&lt;53::AID-PCA391&gt;3.0.CO;2-U; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; Dobrinsky JR, 2001, THERIOGENOLOGY, V56, P1333, DOI 10.1016/S0093-691X(01)00634-3; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hagedorn M, 2006, CRYOBIOLOGY, V52, P454, DOI 10.1016/j.cryobiol.2006.03.001; Hagedorn M, 2006, CRYOBIOLOGY, V52, P33, DOI 10.1016/j.cryobiol.2005.09.008; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; HARLAND AD, 1993, MAR BIOL, V117, P113, DOI 10.1007/BF00346432; HEYWARD AJ, 1985, AUST J MAR FRESH RES, V36, P441; Holmer L.E., 1989, Fossils and Strata, P1; Imbs AB, 2007, LIPIDS, V42, P1035, DOI 10.1007/s11745-007-3109-6; Imbs AB, 2006, LIPIDS, V41, P721, DOI 10.1007/s11745-006-5023-8; JOBLING M, 1995, J THERM BIOL, V20, P157, DOI 10.1016/0306-4565(94)00044-J; LATYSHEV NA, 1991, MAR ECOL PROG SER, V76, P295, DOI 10.3354/meps076295; Leibo SP, 1995, THERIOGENOLOGY, V43, P265, DOI [DOI 10.1016/0093-691X(95)92419-A, 10. 1016/0093-691X(95)92419-A]; Lin C, 2011, CRYOLETTERS, V32, P141; Lin C, 2011, THERIOGENOL IN PRESS; Martino A, 1996, MOL REPROD DEV, V45, P503, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;503::AID-MRD13&gt;3.0.CO;2-X; MEYERS PA, 1979, MAR BIOL LETT, V1, P69; Moran AL, 2004, J EXP MAR BIOL ECOL, V306, P17, DOI 10.1016/j.jembe.2003.12.021; Moran AL, 2003, BIOL BULL-US, V204, P270, DOI 10.2307/1543598; MOURENTE G, 1990, FISH PHYSIOL BIOCHEM, V8, P93, DOI 10.1007/BF00004436; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; Oku H, 2003, FISHERIES SCI, V69, P625, DOI 10.1046/j.1444-2906.2003.00665.x; Oku H, 2003, CORAL REEFS, V22, P83, DOI 10.1007/s00338-003-0279-4; Oku H, 2002, FISHERIES SCI, V68, P517, DOI 10.1046/j.1444-2906.2002.00456.x; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; PEARSE VB, 1971, BIOL BULL, V141, P350, DOI 10.2307/1540123; Ravid T, 1999, J EXP BIOL, V202, P1819; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Schafer W.G., 1980, P47; Seidel GE, 2006, THERIOGENOLOGY, V65, P228, DOI 10.1016/j.theriogenology.2005.09.025; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; STIMSON JS, 1987, B MAR SCI, V41, P889; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Tsai S, 2011, CRYOLETTERS, V32, P1; Tsai S, 2010, THERIOGENOLOGY, V73, P605, DOI 10.1016/j.theriogenology.2009.10.016; Tsai S, 2009, CRYOBIOLOGY, V58, P279, DOI 10.1016/j.cryobiol.2009.02.002; Ulrich K, 1994, COMP ANIMAL BIOCH; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Yamashiro H, 1999, COMP BIOCHEM PHYS B, V122, P397, DOI 10.1016/S0305-0491(99)00014-0; Zhang TT, 2003, THERIOGENOLOGY, V59, P1545, DOI 10.1016/S0093-691X(02)01199-8; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	52	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e38689	10.1371/journal.pone.0038689	http://dx.doi.org/10.1371/journal.pone.0038689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848343	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950200005
J	Cano, PG; Santacruz, A; Moya, A; Sanz, Y				Gauffin Cano, Paola; Santacruz, Arlette; Moya, Angela; Sanz, Yolanda			Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced Obesity	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; GROUP-SPECIFIC PRIMERS; REAL-TIME PCR; INSULIN-RESISTANCE; WEIGHT-LOSS; IMMUNE-RESPONSES; ENERGY-BALANCE; ADIPOSE-TISSUE; HUMAN FECES; PREDOMINANT BACTERIA	Background: Associations have been made between obesity and reduced intestinal numbers of members of the phylum Bacteroidetes, but there is no direct evidence of the role these bacteria play in obesity. Herein, the effects of Bacteroides uniformis CECT 7771 on obesity-related metabolic and immune alterations have been evaluated. Methods and Findings: Adult (6-8 week) male wild-type C57BL-6 mice were fed a standard diet or a high-fat-diet HFD to induce obesity, supplemented or not with B. uniformis CECT 7771 for seven weeks. Animal weight was monitored and histologic, biochemical, immunocompetent cell functions, and features of the faecal microbiota were analysed after intervention. The oral administration of B. uniformis CECT 7771 reduced body weight gain, liver steatosis and liver cholesterol and triglyceride concentrations and increased small adipocyte numbers in HFD-fed mice. The strain also reduced serum cholesterol, triglyceride, glucose, insulin and leptin levels, and improved oral tolerance to glucose in HFD fed mice. The bacterial strain also reduced dietary fat absorption, as indicated by the reduced number of fat micelles detected in enterocytes. Moreover, B. uniformis CECT 7771 improved immune defence mechanisms, impaired in obesity. HFD-induced obesity led to a decrease in TNF-alpha production by peritoneal macrophages stimulated with LPS, conversely, the administration of B. uniformis CECT 7771 increased TNF-alpha production and phagocytosis. Administering this strain also increased TNF-alpha production by dendritic cells (DCs) in response to LPS stimulation, which was significantly reduced by HFD. B. uniformis CECT 7771 also restored the capacity of DCs to induce a T-cell proliferation response, which was impaired in obese mice. HFD induced marked changes in gut microbiota composition, which were partially restored by the intervention. Conclusions: Altogether, the findings indicate that administration of B. uniformis CECT 7771 ameliorates HFD-induced metabolic and immune dysfunction associated with intestinal dysbiosis in obese mice.	[Gauffin Cano, Paola; Santacruz, Arlette; Moya, Angela; Sanz, Yolanda] Natl Res Council CSIC, Microbial Ecol & Nutr Res Grp, Inst Agrochem & Food Technol IATA, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Sanz, Y (corresponding author), Natl Res Council CSIC, Microbial Ecol & Nutr Res Grp, Inst Agrochem & Food Technol IATA, Valencia, Spain.	yolsanz@iata.csic.es	Gauffin Cano, Paola/ABG-2631-2021; Sanz, Yolanda/H-5498-2012	Sanz, Yolanda/0000-0002-1615-1976; Santacruz, Arlette/0000-0001-5580-3108; Gauffin-Cano, Paola/0000-0001-9397-6034; MOYA PEREZ, ANGELA/0000-0002-2265-3630	Spanish Ministry of Science and Innovation (MICINN, Spain) [AGL2011-25169, Consolider Fun-C-Food CSD2007-00063]; CONACYT (Mexico); CONICET (Argentina); MICINN	Spanish Ministry of Science and Innovation (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This study was supported by public grants AGL2011-25169 and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation (MICINN, Spain) The scholarships of AS from CONACYT (Mexico), PGC from CONICET (Argentina) and AM from MICINN are fully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Ciccocioppo R, 2008, DIGEST LIVER DIS, V40, P927, DOI 10.1016/j.dld.2008.05.005; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hoyles L, 2009, FEMS MICROBIOL LETT, V299, P175, DOI 10.1111/j.1574-6968.2009.01741.x; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Misra A, 2000, J CARDIOVASC RISK, V7, P215; Moreno LA, 2006, EUR J CLIN NUTR, V60, P191, DOI 10.1038/sj.ejcn.1602285; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Parnell JA, 2011, BR J NUTR, V18, P1; Porkka KVK, 1996, CURR OPIN LIPIDOL, V7, P183, DOI 10.1097/00041433-199608000-00002; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Sanchez E, 2011, APPL ENVIRON MICROB, V77, P5316, DOI 10.1128/AEM.00365-11; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Sanz Y, 2010, P NUTR SOC, V69, P434, DOI 10.1017/S0029665110001813; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Solga SF, 2003, J HEPATOL, V38, P681, DOI 10.1016/S0168-8278(03)00097-7; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Verwaerde C, 2006, SCAND J IMMUNOL, V64, P457, DOI 10.1111/j.1365-3083.2006.01791.x; Vieira JMBD, 2009, BIOCHEM BIOPH RES CO, V387, P627, DOI 10.1016/j.bbrc.2009.05.124; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; WHO, 2007, WHO TECH REP SER, V935, P1; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	57	234	244	6	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41079	10.1371/journal.pone.0041079	http://dx.doi.org/10.1371/journal.pone.0041079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844426	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600014
J	Reimer, JM; Karlsson, KH; Lovgren-Bengtsson, K; Magnusson, SE; Fuentes, A; Stertman, L				Reimer, Jenny M.; Karlsson, Karin H.; Lovgren-Bengtsson, Karin; Magnusson, Sofia E.; Fuentes, Alexis; Stertman, Linda			Matrix-M (TM) Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen	PLOS ONE			English	Article							QUILLAJA-SAPONARIA MOLINA; DENDRITIC CELLS; NALP3 INFLAMMASOME; LYMPH-NODES; POLYMORPHONUCLEAR NEUTROPHILS; T-CELLS; RESPONSES; INDUCTION; INFLUENZA; VACCINE	Saponin-based adjuvants are widely used to enhance humoral and cellular immune responses towards vaccine antigens, although it is not yet completely known how they mediate their stimulatory effects. The aim of this study was to elucidate the mechanism of action of adjuvant Matrix-M (TM) without antigen and Alum was used as reference adjuvant. Adjuvant Matrix-M (TM) is comprised of 40 nm nanoparticles composed of Quillaja saponins, cholesterol and phospholipid. BALB/c mice were subcutaneously injected once with, 3, 12 or 30 mu g of Matrix-M (TM), resulting in recruitment of leukocytes to draining lymph nodes (dLNs) and spleen 48 h post treatment. Flow cytometry analysis identified CD11b(+) Gr-1(high) granulocytes as the cell population increasing most in dLNs and spleen. Additionally, dendritic cells, F4/80(int) cells, T-, B- and NK-cells were recruited to dLNs and in spleen the number of F4/80(int) cells, and to some extent, B cells and dendritic cells, increased. Elevated levels of early activation marker CD69 were detected on T-, B-and NK-cells, CD11b(+) Gr-1(high) cells, F4/80(int) cells and dendritic cells in dLNs. In spleen CD69 was mainly up-regulated on NK cells. B cells and dendritic cells in dLNs and spleen showed an increased expression of the co-stimulatory molecule CD86 and dendritic cells in dLNs expressed elevated levels of MHC class II. The high-dose (30 mu g) of Matrix-M (TM) induced detectable serum levels of IL-6 and MIP-1 beta 4 h post administration, most likely representing spillover of locally produced cytokines. A lesser increase of IL-6 in serum after administration of 12 mu g Matrix-M (TM) was also observed. In conclusion, early immunostimulatory properties were demonstrated by Matrix-M (TM) alone, as therapeutic doses resulted in a local transient immune response with recruitment and activation of central immune cells to dLNs. These effects may play a role in enhancing uptake and presentation of vaccine antigens to elicit a competent immune response.	[Reimer, Jenny M.; Karlsson, Karin H.; Lovgren-Bengtsson, Karin; Magnusson, Sofia E.; Fuentes, Alexis; Stertman, Linda] Isconova AB, Uppsala, Sweden		Reimer, JM (corresponding author), Isconova AB, Uppsala, Sweden.	jenny.reimer@isconova.com			U.S. Department of Defense, Defense Threat Reduction Agency (DTRA) [HDTRA 1-06-C-0029]	U.S. Department of Defense, Defense Threat Reduction Agency (DTRA)	This work has been supported in part by the U.S. Department of Defense, Defense Threat Reduction Agency (DTRA) under the contract number HDTRA 1-06-C-0029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Behboudi S, 1997, CYTOKINE, V9, P682, DOI 10.1006/cyto.1997.0219; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cloete M, 2008, ONDERSTEPOORT J VET, V75, P17; DALSGAARD K, 1974, ARCH GES VIRUSFORSCH, V44, P243, DOI 10.1007/BF01240612; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Drane D, 2007, EXPERT REV VACCINES, V6, P761, DOI 10.1586/14760584.6.5.761; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Heldens JGM, 2010, VACCINE, V28, P6989, DOI 10.1016/j.vaccine.2010.08.043; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; LOVGREN K, 1988, BIOTECHNOL APPL BIOC, V10, P161; Madhun AS, 2009, VACCINE, V27, P7367, DOI 10.1016/j.vaccine.2009.09.044; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Marzio R, 1999, IMMUNOPHARM IMMUNOT, V21, P565, DOI 10.3109/08923979909007126; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; McKenzie A, 2010, HUMAN VACCINES, P6; Megiovanni AM, 2006, J LEUKOCYTE BIOL, V79, P977, DOI 10.1189/jlb.0905526; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; MOREIN B, 1984, NATURE, V308, P457, DOI 10.1038/308457a0; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Radosevic K, 2008, VACCINE, V26, P3640, DOI 10.1016/j.vaccine.2008.04.071; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Schnurr M, 2009, J IMMUNOL, V182, P1253, DOI 10.4049/jimmunol.182.3.1253; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Sjolander A, 1997, CELL IMMUNOL, V177, P69, DOI 10.1006/cimm.1997.1088; TAKAHASHI H, 1990, NATURE, V344, P873, DOI 10.1038/344873a0; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Windon RG, 2000, VACCINE, V19, P572, DOI 10.1016/S0264-410X(00)00148-1; Windon RG, 2001, VACCINE, V20, P490, DOI 10.1016/S0264-410X(01)00332-2; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Zanoni I, 2005, J IMMUNOL, V175, P286, DOI 10.4049/jimmunol.175.1.286	40	70	72	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41451	10.1371/journal.pone.0041451	http://dx.doi.org/10.1371/journal.pone.0041451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844480	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700092
J	Szebeni, GJ; Kriston-Pal, E; Blazso, P; Katona, RL; Novak, J; Szabo, E; Czibula, A; Fajka-Boja, R; Hegyi, B; Uher, F; Krenacs, L; Joo, G; Monostori, E				Szebeni, Gabor Janos; Kriston-Pal, Eva; Blazso, Peter; Katona, Robert Laszlo; Novak, Julianna; Szabo, Eniko; Czibula, Agnes; Fajka-Boja, Roberta; Hegyi, Beata; Uher, Ferenc; Krenacs, Laszlo; Joo, Gabriella; Monostori, Eva			Identification of Galectin-1 as a Critical Factor in Function of Mouse Mesenchymal Stromal Cell-Mediated Tumor Promotion	PLOS ONE			English	Article							STEM-CELLS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH; ANGIOGENESIS; MICE; DIFFERENTIATION; MYOFIBROBLASTS; RECRUITMENT; METASTASIS	Bone marrow derived mesenchymal stromal cells (MSCs) have recently been implicated as one source of the tumor-associated stroma, which plays essential role in regulating tumor progression. In spite of the intensive research, the individual factors in MSCs controlling tumor progression have not been adequately defined. In the present study we have examined the role of galectin-1 (Gal-1), a protein highly expressed in tumors with poor prognosis, in MSCs in the course of tumor development. Co-transplantation of wild type MSCs with 4T1 mouse breast carcinoma cells enhances the incidence of palpable tumors, growth, vascularization and metastasis. It also reduces survival compared to animals treated with tumor cells alone or in combination with Gal-1 knockout MSCs. In vitro studies show that the absence of Gal-1 in MSCs does not affect the number of migrating MSCs toward the tumor cells, which is supported by the in vivo migration of intravenously injected MSCs into the tumor. Moreover, differentiation of endothelial cells into blood vessel-like structures strongly depends on the expression of Gal-1 in MSCs. Vital role of Gal-1 in MSCs has been further verified in Gal-1 knockout mice. By administering B16F10 melanoma cells into Gal-1 deficient animals, tumor growth is highly reduced compared to wild type animals. Nevertheless, co-injection of wild type but not Gal-1 deficient MSCs results in dramatic tumor growth and development. These results confirm that galectin-1 is one of the critical factors in MSCs regulating tumor progression.	[Szebeni, Gabor Janos; Kriston-Pal, Eva; Blazso, Peter; Katona, Robert Laszlo; Novak, Julianna; Szabo, Eniko; Czibula, Agnes; Fajka-Boja, Roberta] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Joo, Gabriella; Monostori, Eva] Univ Szeged, Fac Hlth Sci & Social Studies, Szeged, Hungary; [Hegyi, Beata; Uher, Ferenc] Natl Blood Serv, Budapest, Hungary; [Krenacs, Laszlo] Tumor Pathol & Mol Diagnost Lab, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Szebeni, GJ (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	monos@brc.hu	Krenács, László/L-8063-2014	Krenács, László/0000-0001-6541-3031; Blazso, Peter/0000-0003-4404-8068; Szebeni, Gabor J./0000-0002-6998-5632	Bastyai-Holczer Foundation; Hungarian Scientific Research Fund [OTKA PD 75938, NKTH-OTKA CK 78007, NKTH-OTKA CK 78188, OTKA K 69047]	Bastyai-Holczer Foundation; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Bastyai-Holczer Foundation and by grants from the Hungarian Scientific Research Fund: OTKA PD 75938 (http://www.otka.hu/), NKTH-OTKA CK 78007 (http://www.otka.hu/), NKTH-OTKA CK 78188 (http://www.otka.hu/), and OTKA K 69047 (http://www.otka.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157; Bektas S, 2010, PATHOL ONCOL RES, V16, P569, DOI 10.1007/s12253-010-9248-8; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Burns JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021888; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dwyer RM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt25; FIDLER IJ, 1975, CANCER RES, V35, P218; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gieseke F, 2010, BLOOD, V116, P3770, DOI 10.1182/blood-2010-02-270777; Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254; Gong ZD, 2011, METHODS MOL BIOL, V698, P279, DOI 10.1007/978-1-60761-999-4_21; Hartmann MC, 2011, EUR J CANCER, V47, P1669, DOI 10.1016/j.ejca.2011.05.001; Hegyi B, 2012, BIOCHEM BIOPH RES CO, V419, P215, DOI 10.1016/j.bbrc.2012.01.150; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Kovacs-Solyom F, 2010, IMMUNOL LETT, V127, P108, DOI 10.1016/j.imlet.2009.10.003; Le Mercier M, 2008, J NEUROPATH EXP NEUR, V67, P456, DOI 10.1097/NEN.0b013e318170f892; Le Mercier M, 2009, NEOPLASIA, V11, P485, DOI 10.1593/neo.81526; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Placencio VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012920; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; Rabinovich GA, 2009, IMMUNOL REV, V230, P144, DOI 10.1111/j.1600-065X.2009.00787.x; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Roorda BD, 2009, CRIT REV ONCOL HEMAT, V69, P187, DOI 10.1016/j.critrevonc.2008.06.004; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Stannard KA, 2010, CANCER LETT, V299, P95, DOI 10.1016/j.canlet.2010.08.005; Sun B, 2005, STEM CELLS DEV, V14, P292, DOI 10.1089/scd.2005.14.292; Suzuki K, 2011, MOL MED, V17, P579, DOI 10.2119/molmed.2010.00157; Teven CM, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/201371; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Tsunoda S, 2009, AM J PATHOL, V174, P671, DOI 10.2353/ajpath.2009.080471; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; van den Brule FA, 2001, AIDPATH73030CO22; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116	50	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41372	10.1371/journal.pone.0041372	http://dx.doi.org/10.1371/journal.pone.0041372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844466	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700077
J	Via, LE; Tsytsykova, AV; Rajsbaum, R; Falvo, JV; Goldfeld, AE				Via, Laura E.; Tsytsykova, Alla V.; Rajsbaum, Ricardo; Falvo, James V.; Goldfeld, Anne E.			The Transcription Factor NFATp Plays a Key Role in Susceptibility to TB in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA GENE; MYCOBACTERIUM-TUBERCULOSIS INFECTION; CREB-BINDING-PROTEIN; IFN-GAMMA PRODUCTION; HUMAN B-CELLS; INTERFERON-GAMMA; TNF GENE; IN-VIVO; NUCLEAR FACTOR	In T cells, the transcription factor nuclear factor of activated T cells p (NFATp) is a key regulator of the cytokine genes tumor necrosis factor (TNF) and interferon-gamma (IFN-gamma). Here, we show that NFATp-deficient (NFATp(-/-)) mice have a dramatic and highly significant increase in mortality after Mycobacterium tuberculosis (MTb) infection as compared to mortality of control animals after MTb infection. Animals deficient in NFATp have significantly impaired levels of TNF and IFN-gamma transcription and protein expression in naive or total CD4(+) T cells, but display wild-type levels of TNF mRNA or protein from MTb-stimulated dendritic cells (DC). The rapid mortality and disease severity observed in MTb-infected NFATp(-/-) mice is associated with dysregulated production of TNF and IFN-gamma in the lungs, as well as with increased levels of TNF, in their serum. Furthermore, global blocking of TNF production by injection of a TNF neutralizaing agent at 6 weeks, but not 12 weeks, post-MTb-infection further decreased the survival rate of both wild-type and NFATp(-/-) mice, indicating an early role for TNF derived from cells from the monocyte lineage in containment of infection. These results thus demonstrate that NFATp plays a critical role in immune containment of TB disease in vivo, through the NFATp-dependent expression of TNF and IFN-gamma in T cells.	[Via, Laura E.] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Tsytsykova, Alla V.; Rajsbaum, Ricardo; Falvo, James V.; Goldfeld, Anne E.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA USA; [Tsytsykova, Alla V.; Rajsbaum, Ricardo; Falvo, James V.; Goldfeld, Anne E.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Via, LE (corresponding author), NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	goldfeld@idi.harvard.edu	Rajsbaum, Ricardo/F-2046-2014; Goldfeld, Anne/AAF-1818-2019; Rajsbaum, Ricardo/AAD-4775-2020; Via, Laura/AAD-3917-2021	Via, Laura/0000-0001-6074-9521	NIH [HL-059838, GM076685]; NIH, NIAID; Comparative Medicine Branch of NIAID; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Comparative Medicine Branch of NIAID; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH to A. E. G. (HL-059838 and GM076685). In addition, the work was partly supported by the Intramural Research Program of the NIH, NIAID and the Comparative Medicine Branch of NIAID is thankfully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1995, J INFECT DIS, V171, P400, DOI 10.1093/infdis/171.2.400; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Barczak AK, 2005, J INFECT DIS, V192, P600, DOI 10.1086/432006; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Barthel R, 2003, J IMMUNOL, V171, P3612, DOI 10.4049/jimmunol.171.7.3612; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Bean AGD, 1999, J IMMUNOL, V162, P3504; BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006; Biglione S, 2011, J BIOL CHEM, V286, P44126, DOI 10.1074/jbc.M111.272476; Boom WH, 1996, INFECT AGENT DIS, V5, P73; BOUSSIOTIS VA, 1994, P NATL ACAD SCI USA, V91, P7007, DOI 10.1073/pnas.91.15.7007; Broderick A, 1996, AIDSLINK, V1, P3; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Cockerill PN, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe15; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Doffinger R, 2000, MICROBES INFECT, V2, P1553, DOI 10.1016/S1286-4579(00)01311-3; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Erb KJ, 2003, INFECT IMMUN, V71, P6641, DOI 10.1128/IAI.71.11.6641-6647.2003; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Falvo JV, 2008, P NATL ACAD SCI USA, V105, P19637, DOI 10.1073/pnas.0810648105; Falvo JV, 2000, P NATL ACAD SCI USA, V97, P3925, DOI 10.1073/pnas.97.8.3925; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Falvo JV, 2011, AM J RESP CELL  0603; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Goffe B, 2003, J AM ACAD DERMATOL, V49, pS105, DOI 10.1016/mjd.2003.554; GOLDFELD AE, 1992, P NATL ACAD SCI USA, V89, P12198, DOI 10.1073/pnas.89.24.12198; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Goldfeld AE, 2008, HDB TUBERCULOSIS IMM; Goldfeld AE, 2009, AIDS AND TUBERCULOSIS: A DEADLY LIAISON, P209, DOI 10.1002/9783527627905.ch9; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Hernandez-Pando R, 2004, EUR J IMMUNOL, V34, P174, DOI 10.1002/eji.200324253; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MCCAFFREY PG, 1994, J BIOL CHEM, V269, P30445; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; Orme I, 2004, CURR OPIN MICROBIOL, V7, P58, DOI 10.1016/j.mib.2003.11.002; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; Pedroza-Gonzalez A, 2004, INT J EXP PATHOL, V85, P135, DOI 10.1111/j.0959-9673.2004.00381.x; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Prieschl EE, 1996, J IMMUNOL, V157, P2645; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Ranjbar S, 2006, J IMMUNOL, V176, P4182, DOI 10.4049/jimmunol.176.7.4182; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Remus N, 2001, PEDIATR RES, V50, P8, DOI 10.1203/00006450-200107000-00005; Rivas-Santiago Bruno, 2005, Invest. clín, V46, P391; Rosenzweig S, 2002, CLIN IMMUNOL, V102, P25, DOI 10.1006/clim.2001.5135; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Salgame P, 2005, CURR OPIN IMMUNOL, V17, P374, DOI 10.1016/j.coi.2005.06.006; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Serfling Edgar, 2007, Sci STKE, V2007, ppe42, DOI 10.1126/stke.3982007pe42; Smith S, 2002, INFECT IMMUN, V70, P2082, DOI 10.1128/IAI.70.4.2082-2089.2002; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tascon RE, 2000, IMMUNOLOGY, V99, P473, DOI 10.1046/j.1365-2567.2000.00963.x; Taylor JM, 2008, NUCLEIC ACIDS RES, V36, P4845, DOI 10.1093/nar/gkn444; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Tsytsykova AV, 2000, J EXP MED, V192, P581, DOI 10.1084/jem.192.4.581; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230; WHO, 2011, WHO GLOBAL TUBERCULO	90	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41427	10.1371/journal.pone.0041427	http://dx.doi.org/10.1371/journal.pone.0041427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844476	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700088
J	Pilfold, NW; Derocher, AE; Stirling, I; Richardson, E; Andriashek, D				Pilfold, Nicholas W.; Derocher, Andrew E.; Stirling, Ian; Richardson, Evan; Andriashek, Dennis			Age and Sex Composition of Seals Killed by Polar Bears in the Eastern Beaufort Sea	PLOS ONE			English	Article							PHOCA-HISPIDA PUPS; RINGED SEAL; URSUS-MARITIMUS; BREEDING HABITAT; PREDATION RISK; HUDSON-BAY; SERUM UREA; BEHAVIOR; ECOLOGY; SVALBARD	Background: Polar bears (Ursus maritimus) of the Beaufort Sea enter hyperphagia in spring and gain fat reserves to survive periods of low prey availability. We collected information on seals killed by polar bears (n = 650) and hunting attempts on ringed seal (Pusa hispida) lairs (n = 1396) observed from a helicopter during polar bear mark-recapture studies in the eastern Beaufort Sea in spring in 1985-2011. We investigated how temporal shifts in ringed seal reproduction affect kill composition and the intraspecific vulnerabilities of ringed seals to polar bear predation. Principal Findings: Polar bears primarily preyed on ringed seals (90.2%) while bearded seals (Erignathus barbatus) only comprised 9.8% of the kills, but 33% of the biomass. Adults comprised 43.6% (150/344) of the ringed seals killed, while their pups comprised 38.4% (132/344). Juvenile ringed seals were killed at the lowest proportion, comprising 18.0% (62/344) of the ringed seal kills. The proportion of ringed seal pups was highest between 2007-2011, in association with high ringed seal productivity. Half of the adult ringed seal kills were >= 21 years (60/121), and kill rates of adults increased following the peak of parturition. Determination of sex from DNA revealed that polar bears killed adult male and adult female ringed seals equally (0.50, n = 78). The number of hunting attempts at ringed seal subnivean lair sites was positively correlated with the number of pup kills (r(2) = 0.30, P = 0.04), but was not correlated with the number of adult kills (P = 0.37). Conclusions/Significance: Results are consistent with decadal trends in ringed seal productivity, with low numbers of pups killed by polar bears in spring in years of low pup productivity, and conversely when pup productivity was high. Vulnerability of adult ringed seals to predation increased in relation to reproductive activities and age, but not gender.	[Pilfold, Nicholas W.; Derocher, Andrew E.; Stirling, Ian; Richardson, Evan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stirling, Ian; Richardson, Evan; Andriashek, Dennis] Environm Canada, Sci & Technol Branch, Wildlife Res Div, Edmonton, AB, Canada	University of Alberta; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada	Pilfold, NW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	pilfold@ualberta.ca	Pilfold, Nick/J-1376-2012; Derocher, Andrew/J-4469-2012	Derocher, Andrew/0000-0002-1104-7774; Chiaradia, Andre/0000-0002-6178-4211; Pilfold, Nicholas/0000-0001-5324-5499	ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Circumpolar/Boreal Alberta Research; Environment Canada; Inuvialuit Game Council; Natural Sciences and Engineering Research Council of Canada; Northern Scientific Training Program; Northwest Territories Department of Environment and Natural Resources; Polar Continental Shelf Project; Polar Bears International; Quark Expeditions; United States Geological Survey; United States Department of the Interior; World Wildlife Fund (Canada)	ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Circumpolar/Boreal Alberta Research; Environment Canada(CGIAR); Inuvialuit Game Council; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Northern Scientific Training Program; Northwest Territories Department of Environment and Natural Resources; Polar Continental Shelf Project(Natural Resources Canada); Polar Bears International; Quark Expeditions; United States Geological Survey(United States Geological Survey); United States Department of the Interior; World Wildlife Fund (Canada)	The authors gratefully acknowledge the financial and logistic support from ArcticNet, Canadian Association of Zoos and Aquariums, Canadian Wildlife Federation, Circumpolar/Boreal Alberta Research, Environment Canada, Inuvialuit Game Council, Natural Sciences and Engineering Research Council of Canada (A.E.D.), Northern Scientific Training Program, Northwest Territories Department of Environment and Natural Resources, Polar Continental Shelf Project, Polar Bears International, Quark Expeditions, United States Geological Survey, United States Department of the Interior, and World Wildlife Fund (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA L, 1995, ANIM BEHAV, V49, P1461, DOI 10.1016/0003-3472(95)90067-5; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chambellant M, 2012, J MAMMAL, V93, P267, DOI 10.1644/10-MAMM-A-253.1; Cherry SG, 2009, POLAR BIOL, V32, P383, DOI 10.1007/s00300-008-0530-0; Crawford JA, 2012, POLAR BIOL, V35, P241, DOI 10.1007/s00300-011-1067-1; Curio E., 1976, ETHOLOGY PREDATION; Derocher AE, 2002, POLAR BIOL, V25, P448, DOI 10.1007/s00300-002-0364-0; Derocher AE, 1999, ARCTIC, V52, P307; DEROCHER AE, 1990, CAN J ZOOL, V68, P1395, DOI 10.1139/z90-208; DEROCHER AE, 1990, MAR MAMMAL SCI, V6, P196, DOI 10.1111/j.1748-7692.1990.tb00243.x; FETTERER F, 2009, SEA ICE INDEX; Furgal CM, 1996, CAN J ZOOL, V74, P858, DOI 10.1139/z96-100; FURNELL DJ, 1980, CAN FIELD NAT, V94, P88; GJERTZ I, 1986, Polar Research, V4, P65; HAMMILL MO, 1991, MAR MAMMAL SCI, V7, P123, DOI 10.1111/j.1748-7692.1991.tb00559.x; HARDY MH, 1991, CAN J ZOOL, V69, P189, DOI 10.1139/z91-029; Harwood LA, 2000, ARCTIC, V53, P422, DOI 10.14430/arctic872; Harwood LA, 2012, RINGED SEALS SEA ICE; Hindle AG, 2009, J EXP BIOL, V212, P790, DOI 10.1242/jeb.025387; HURST RJ, 1982, CAN J ZOOL, V60, P40, DOI 10.1139/z82-005; IMS RA, 1990, AM NAT, V136, P485, DOI 10.1086/285109; KELLY BP, 1990, CAN J ZOOL, V68, P2503, DOI 10.1139/z90-350; Kelly BP, 1996, CAN J ZOOL, V74, P1547, DOI 10.1139/z96-169; Kelly BP, 2010, POLAR BIOL, V33, P1095, DOI 10.1007/s00300-010-0796-x; Kingsley M. C. S., 1998, RINGED SEALS N ATLAN, P197; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; Krafft BA, 2007, MAR ECOL PROG SER, V335, P199, DOI 10.3354/meps335199; LYDERSEN C, 1987, CAN J ZOOL, V65, P1021, DOI 10.1139/z87-162; LYDERSEN C, 1993, CAN J ZOOL, V71, P991, DOI 10.1139/z93-131; Lydersen C, 1995, DEV MAR BIO, V4, P319; Lydersen C, 1999, MAR ECOL PROG SER, V187, P265, DOI 10.3354/meps187265; LYDERSEN C, 1993, J COMP PHYSIOL B, V163, P433; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MARASCUILO LA, 1966, PSYCHOL BULL, V65, P280, DOI 10.1037/h0023189; McLaren IA, 1958, B FISH RES BOARD CAN, V118, P1; Mech L. David, 1970, WOLF ECOLOGY BEHAV E; MESSIER F, 1992, J ZOOL, V226, P219, DOI 10.1111/j.1469-7998.1992.tb03835.x; MESSIER F, 1994, J MAMMAL, V75, P420, DOI 10.2307/1382563; NELSON RA, 1987, MAYO CLIN PROC, V62, P850, DOI 10.1016/S0025-6196(12)62341-6; Quinn TP, 1999, OECOLOGIA, V121, P273, DOI 10.1007/s004420050929; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; RAMSAY MA, 1991, CAN J ZOOL, V69, P298, DOI 10.1139/z91-048; RYG M, 1992, J ZOOL, V226, P681, DOI 10.1111/j.1469-7998.1992.tb07509.x; Schafer JL., 1997, ANAL INCOMPLETE MULT, V1st, P430; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Smith T., 1987, CANADIAN B FISHERIES, V216, P1; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; SMITH TG, 1991, ARCTIC, V44, P124; SMITH TG, 1975, CAN J ZOOL, V53, P1297, DOI 10.1139/z75-155; Sommer S, 2000, ANIM BEHAV, V59, P1087, DOI 10.1006/anbe.2000.1381; Stewart REA, 1996, MAR MAMMAL SCI, V12, P383, DOI 10.1111/j.1748-7692.1996.tb00591.x; STIRLING I, 1977, J FISH RES BOARD CAN, V34, P1126, DOI 10.1139/f77-169; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; STIRLING I, 1975, CAN J ZOOL, V53, P1021, DOI 10.1139/z75-117; Stirling I, 2002, ARCTIC, V55, P59; STIRLING I, 1990, INT C BEAR, V8, P189; STIRLING I, 1982, DISTRIBUTION ABUNDAN; STIRLING I, 1997, ECOLOGY ARCTIC ENV, P167; Stirling Ian, 1993, Polar Record, V29, P13; TAYLOR M, 1985, ARCTIC, V38, P303; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Thiemann GW, 2011, OIKOS, V120, P1469, DOI 10.1111/j.1600-0706.2011.19277.x; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	63	41	42	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41429	10.1371/journal.pone.0041429	http://dx.doi.org/10.1371/journal.pone.0041429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829949	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300089
J	Qin, W; Zhang, M; Piao, YS; Guo, DY; Zhu, ZX; Tian, X; Li, KC; Yu, CS				Qin, Wen; Zhang, Min; Piao, Yueshan; Guo, Deyu; Zhu, Zixin; Tian, Xin; Li, Kuncheng; Yu, Chunshui			Wallerian Degeneration in Central Nervous System: Dynamic Associations between Diffusion Indices and Their Underlying Pathology	PLOS ONE			English	Article							TENSOR IMAGING DETECTS; WHITE-MATTER DAMAGE; SPONTANEOUS REGENERATION; PYRAMIDAL TRACT; CORTICOSPINAL TRACT; MULTIPLE-SCLEROSIS; SPINAL-CORD; AXONAL DEGENERATION; FUNCTIONAL RECOVERY; WATER DIFFUSION	Background: Although diffusion tensor imaging has been used to monitor Wallerian degeneration, the exact relationship between the evolution of diffusion indices and its underlying pathology, especially in central nervous system, remains largely unknown. Here we aimed to address this question using a cat Wallerian degeneration model of corticospinal tract. Methodology/Principal Findings: Twenty-five domestic mature Felis catus were included in the present study. The evolution of diffusion indices, including mean diffusivity (MD), fractional anisotropy (FA), primary (lambda 1) and transverse eigenvalues (lambda 23) of the degenerated corticospinal tract, were observed at baseline (before modeling) and at 2, 4, 6, 8, 10, 15, 20, 25, 30, 45 and 60 days after modeling in 4 cats. Pathological examinations were performed at eight time points mentioned above. Wallerian degeneration can be detected as early as the 2nd day after modeling by both diffusion tensor imaging and pathology. According to the evolution of diffusion indices, Wallerian degeneration can be classified into 2 stages. During the early stage (within 8 days after modeling), progressive disintegration of axons and myelin sheaths underlies the decreases in FA and lambda 1 and the increase in lambda 23. However, during the late stage (after 8 days), the gradual increases in FA, MD and lambda 1 and the unchanged lambda 23 seem to be a comprehensive reflection of the pathological processes including microglia activation, myelin clearance, and astrocytosis. Conclusions/Significance: Our findings help the understanding of the altered diffusion indices in the context of pathology and suggest that diffusion tensor imaging has the potential to monitor the processes of Wallerian degeneration in the central nervous system in vivo after acute damage.	[Qin, Wen; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Qin, Wen; Zhang, Min; Li, Kuncheng; Yu, Chunshui] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Piao, Yueshan] Capital Med Univ, Xuanwu Hosp, Dept Pathol, Beijing, Peoples R China; [Guo, Deyu; Zhu, Zixin; Tian, Xin] Capital Med Univ, Xuanwu Hosp, Dept Expt Anim, Beijing, Peoples R China	Tianjin Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Qin, W (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	kunchengli1955@yahoo.com.cn; chunshuiyu@yahoo.cn	QIN, WEN/F-3783-2015	QIN, WEN/0000-0002-9121-8296; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [30670601]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (no. 30670601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Buss A, 2005, BRAIN, V128, P356, DOI 10.1093/brain/awh355; Buss A, 2003, GLIA, V42, P424, DOI 10.1002/glia.10220; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Ciccarelli O, 2003, J NEUROL, V250, P287, DOI 10.1007/s00415-003-0992-5; DeVetten G, 2010, STROKE, V41, P751, DOI 10.1161/STROKEAHA.109.573287; Dziedzic T, 2010, BRAIN PATHOL, V20, P976, DOI 10.1111/j.1750-3639.2010.00401.x; Foerster AP, 1999, EUR J NEUROSCI, V11, P3151, DOI 10.1046/j.1460-9568.1999.00735.x; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Hunsche S, 2001, RADIOLOGY, V221, P550, DOI 10.1148/radiol.2212001823; Inoue T, 1998, NEUROSCI LETT, V247, P151, DOI 10.1016/S0304-3940(98)00297-3; Iseda T, 2004, NEUROSCIENCE, V126, P365, DOI 10.1016/j.neuroscience.2004.03.056; Iseda T, 2003, J COMP NEUROL, V464, P343, DOI 10.1002/cne.10786; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Kim H, 2008, EPILEPSY RES, V81, P136, DOI 10.1016/j.eplepsyres.2008.05.005; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lehmann HC, 2010, EXP NEUROL, V223, P238, DOI 10.1016/j.expneurol.2009.10.012; Liang ZJ, 2008, CEREBROVASC DIS, V25, P209, DOI 10.1159/000113858; Liang ZJ, 2007, J NEUROL NEUROSUR PS, V78, P581, DOI 10.1136/jnnp.2006.099077; Lin F, 2007, AM J NEURORADIOL, V28, P278; MacLullich AMJ, 2009, STROKE, V40, P3869, DOI 10.1161/STROKEAHA.109.547877; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Qin W, 2009, MAGN RESON MED, V61, P755, DOI 10.1002/mrm.21920; Radlinska BA, 2009, ANN NEUROL, V66, P825, DOI 10.1002/ana.21796; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stoll G, 1999, BRAIN PATHOL, V9, P313; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; VAN CREVEL, 1963, J Anat, V97, P495; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Waller A, 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Weigel M, 2006, MAGN RESON MED, V55, P826, DOI 10.1002/mrm.20816; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066; Yuan WH, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-19; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010	53	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41441	10.1371/journal.pone.0041441	http://dx.doi.org/10.1371/journal.pone.0041441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829950	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300090
J	Qu, B; Han, X; Tang, YJ; Shen, N				Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan			A Novel Vector-Based Method for Exclusive Overexpression of Star-Form MicroRNAs	PLOS ONE			English	Article							SHORT-INTERFERING RNAS; EXPRESSION; BIOGENESIS; MECHANISMS; SYSTEM; SUPPRESSION; SIRNAS	The roles of microRNAs (miRNAs) as important regulators of gene expression have been studied intensively. Although most of these investigations have involved the highly expressed form of the two mature miRNA species, increasing evidence points to essential roles for star-form microRNAs (miRNA*), which are usually expressed at much lower levels. Owing to the nature of miRNA biogenesis, it is challenging to use plasmids containing miRNA coding sequences for gain-of-function experiments concerning the roles of microRNA* species. Synthetic microRNA mimics could introduce specific miRNA* species into cells, but this transient overexpression system has many shortcomings. Here, we report that specific miRNA* species can be overexpressed by introducing artificially designed stem-loop sequences into short hairpin RNA (shRNA) overexpression vectors. By our prototypic plasmid, designed to overexpress hsa-miR-146b-3p, we successfully expressed high levels of hsa-miR-146b-3p without detectable change of hsa-miR-146b-5p. Functional analysis involving luciferase reporter assays showed that, like natural miRNAs, the overexpressed hsa-miR-146b-3p inhibited target gene expression by 3'UTR seed pairing. Our demonstration that this method could overexpress two other miRNAs suggests that the approach should be broadly applicable. Our novel strategy opens the way for exclusively stable overexpression of miRNA* species and analyzing their unique functions both in vitro and in vivo.	[Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan] Chinese Acad Sci, Inst Hlth Sci, Joint Mol Rheumatol Lab, Shanghai, Peoples R China; [Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Renji Hosp, Shanghai, Peoples R China; [Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Qu, Bo; Han, Xiao; Tang, Yuanjia; Shen, Nan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Shen, Nan] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH USA; [Shen, Nan] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Qu, B (corresponding author), Chinese Acad Sci, Inst Hlth Sci, Joint Mol Rheumatol Lab, Shanghai, Peoples R China.	nanshensibs@gmail.com	Qu, Bo/V-6675-2019; Shen, Nan/AGK-6807-2022	Han, Xiao/0000-0003-1707-5079; tang, yuan jia/0000-0002-2044-5424; Shen, Nan/0000-0002-5875-4417	National Natural Science Foundation of China [30971632, 81025016]; Program of the Shanghai Commission of Science and Technology [10JC1409300, 09411951800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of the Shanghai Commission of Science and Technology	This work was supported by the National Natural Science Foundation of China (No. 30971632, No. 81025016) and the Program of the Shanghai Commission of Science and Technology (No. 10JC1409300, No. 09411951800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Broderick JA, 2011, GENE THER; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Tsang WP, 2009, CARCINOGENESIS, V30, P953, DOI 10.1093/carcin/bgp094; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	48	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41504	10.1371/journal.pone.0041504	http://dx.doi.org/10.1371/journal.pone.0041504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829954	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300094
J	Huettl, RE; Haehl, T; Huber, AB				Huettl, Rosa-Eva; Haehl, Teresa; Huber, Andrea B.			Fasciculation and Guidance of Spinal Motor Axons in the Absence of FGFR2 Signaling	PLOS ONE			English	Article							FACTOR RECEPTOR 2; GROWTH-FACTOR RECEPTORS; MESODERM FORMATION; NEURON POOL; EXPRESSION; LIMB; MAINTENANCE; SEMAPHORIN; FGF10; GENERATION	During development, fibroblast growth factors (FGF) are essential for early patterning events along the anterior-posterior axis, conferring positional identity to spinal motor neurons by activation of different Hox codes. In the periphery, signaling through one of four fibroblast growth factor receptors supports the development of the skeleton, as well as induction and maintenance of extremities. In previous studies, FGF receptor 2 (FGFR2) was found to interact with axon bound molecules involved in axon fasciculation and extension, thus rendering this receptor an interesting candidate for the promotion of proper peripheral innervation. However, while the involvement of FGFR2 in limb bud induction has been extensively studied, its role during axon elongation and formation of distinct nervous projections has not been addressed so far. We show here that motor neurons in the spinal cord express FGFR2 and other family members during the establishment of motor connections to the forelimb and axial musculature. Employing a conditional genetic approach to selectively ablate FGFR2 from motor neurons we found that the patterning of motor columns and the expression patterns of other FGF receptors and Sema3A in the motor columns of mutant embryos are not altered. In the absence of FGFR2 signaling, pathfinding of motor axons is intact, and also fasciculation, distal advancement of motor nerves and gross morphology and positioning of axonal projections are not altered. Our findings therefore show that FGFR2 is not required cell-autonomously in motor neurons during the formation of initial motor projections towards limb and axial musculature.	[Huettl, Rosa-Eva; Haehl, Teresa; Huber, Andrea B.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Huber, AB (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	andrea.huber@helmholtz-muenchen.de		Huettl, Rosa-Eva/0000-0001-8196-9865	Deutsche Forschungsgemeinschaft (DFG); Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany	The authors gratefully acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG, to ABH) and the Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge K, 2010, DEV DYNAM, V239, P987, DOI 10.1002/dvdy.22218; Altmann CR, 2001, INT REV CYTOL, V203, P447; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Belluardo N, 1997, J COMP NEUROL, V379, P226; Blak AA, 2005, DEV DYNAM, V233, P1023, DOI 10.1002/dvdy.20386; Blak AA, 2007, DEV BIOL, V303, P231, DOI 10.1016/j.ydbio.2006.11.008; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Ferhat L, 1997, EUR J NEUROSCI, V9, P1282, DOI 10.1111/j.1460-9568.1997.tb01483.x; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Furusho M, 2011, J NEUROSCI, V31, P5055, DOI 10.1523/JNEUROSCI.4800-10.2011; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465; Haupt C, 2008, FRONT BIOSCI-LANDMRK, V13, P3136, DOI 10.2741/2915; Hebert JM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00133; Hehr U, 1999, MOL GENET METAB, V68, P139, DOI 10.1006/mgme.1999.2915; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Huettl RE, 2011, DEV BIOL; Huettl RE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001020; ISAACS HV, 1992, DEVELOPMENT, V114, P711; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kettunen P, 2007, MECH DEVELOP, V124, P868, DOI 10.1016/j.mod.2007.09.003; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lizarraga G, 1999, DEV GENET, V25, P331, DOI 10.1002/(SICI)1520-6408(1999)25:4<331::AID-DVG7>3.0.CO;2-U; Lom B, 1998, J NEUROBIOL, V37, P633, DOI 10.1002/(SICI)1097-4695(199812)37:4<633::AID-NEU11>3.0.CO;2-L; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Moret F, 2007, DEVELOPMENT, V134, P4491, DOI 10.1242/dev.011452; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Ornitz DM, 2001, GENOME BIOL, V2; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Sahay A, 2003, J NEUROSCI, V23, P6671; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shi P, 2010, LAB CHIP, V10, P1005, DOI 10.1039/b922143c; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; SuterCrazzolara C, 1996, MOL BRAIN RES, V41, P175, DOI 10.1016/0169-328X(96)00089-7; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; THISSE B, 1995, DEV DYNAM, V203, P377, DOI 10.1002/aja.1002030309; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Vesterlund L, 2011, INT J DEV BIOL, V55, P313, DOI 10.1387/ijdb.103240lv; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xu XL, 1998, DEVELOPMENT, V125, P753; Zhang F, 2002, NEUROSCIENCE, V114, P837, DOI 10.1016/S0306-4522(02)00321-4; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	66	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41095	10.1371/journal.pone.0041095	http://dx.doi.org/10.1371/journal.pone.0041095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815929	Green Published, gold, Green Submitted			2022-12-25	WOS:000306507000065
J	Alvarez-Cubero, MJ; Guinaldo, MS; Martinez-Gonzalez, LJ; Merino, JCA; Olmo, JMC; Acosta, JAL				Jesus Alvarez-Cubero, Maria; Saiz Guinaldo, Maria; Javier Martinez-Gonzalez, Luis; Alvarez Merino, Juan Carlos; Cozar Olmo, Jose Manuel; Lorente Acosta, Jose Antonio			Mitochondrial Haplogroups and Polymorphisms Reveal No Association with Sporadic Prostate Cancer in a Southern European Population	PLOS ONE			English	Article							CONTROL-REGION SEQUENCES; DNA MUTATIONS; SOMATIC MUTATIONS; SUSCEPTIBILITY GENES; BREAST-CANCER; LINKAGE SCAN; GENOME; GENETICS; RISK; TUMORS	Background: It is known that mitochondria play an important role in certain cancers (prostate, renal, breast, or colorectal) and coronary disease. These organelles play an essential role in apoptosis and the production of reactive oxygen species; in addition, mtDNA also reveals the history of populations and ancient human migration. All these events and variations in the mitochondrial genome are thought to cause some cancers, including prostate cancer, and also help us to group individuals into common origin groups. The aim of the present study is to analyze the different haplogroups and variations in the sequence in the mitochondrial genome of a southern European population consisting of subjects affected (n = 239) and non-affected (n = 150) by sporadic prostate cancer. Methodology and Principal Findings: Using primer extension analysis and DNA sequencing, we identified the nine major European haplogroups and CR polymorphisms. The frequencies of the haplogroups did not differ between patients and control cohorts, whereas the CR polymorphism T16356C was significantly higher in patients with PC compared to the controls (p = 0.029). PSA, staging, and Gleason score were associated with none of the nine major European haplogroups. The CR polymorphisms G16129A (p = 0.007) and T16224C (p = 0.022) were significantly associated with Gleason score, whereas T16311C (p = 0.046) was linked with T-stage. Conclusions and Significance: Our results do not suggest that mtDNA haplogroups could be involved in sporadic prostate cancer etiology and pathogenesis as previous studies performed in middle Europe population. Although some significant associations have been obtained in studying CR polymorphisms, further studies should be performed to validate these results.	[Jesus Alvarez-Cubero, Maria; Saiz Guinaldo, Maria; Alvarez Merino, Juan Carlos; Lorente Acosta, Jose Antonio] Univ Granada, Fac Med, Legal Med & Toxicol Dept, Lab Genet Identificat, Granada, Spain; [Javier Martinez-Gonzalez, Luis; Alvarez Merino, Juan Carlos; Lorente Acosta, Jose Antonio] Univ Granada, Pfizer, Andalusian Govt Ctr Genom & Oncol Res, GENYO, Granada, Spain; [Cozar Olmo, Jose Manuel] Univ Hosp Virgen Nieves, Serv Urol, Granada, Spain	University of Granada; Pfizer; University of Granada; Hospital Universitario Virgen de las Nieves	Alvarez-Cubero, MJ (corresponding author), Univ Granada, Fac Med, Legal Med & Toxicol Dept, Lab Genet Identificat, Granada, Spain.	luisjavier.martinez@genyo.es	Martinez-Gonzalez, Luis Javier/L-6136-2014; Alvarez, Juan/GSD-7155-2022; Alvarez, J. Carlos/R-9722-2019; Cubero, Maria Jesus Alvarez/M-2892-2015; LORENTE, JOSE A./B-8372-2008	Martinez-Gonzalez, Luis Javier/0000-0003-2202-0662; Alvarez, J. Carlos/0000-0002-5884-9918; Cubero, Maria Jesus Alvarez/0000-0002-5492-9355; LORENTE, JOSE A./0000-0002-9892-7386				Akouchekian M, 2009, DIS COLON RECTUM, V52, P526, DOI 10.1007/DCR.0b013e31819acb99; Alberti C, 2010, EUR REV MED PHARMACO, V14, P31; Alvarez J. Carlos, 2007, Legal Medicine, V9, P293, DOI 10.1016/j.legalmed.2007.05.005; Alvarez-Cubero MJ, 2011, PROSTATE CANC PROSTA; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], MANUAL UROLOGIA ESEN; Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Bailar J C 3rd, 1966, Cancer Chemother Rep, V50, P129; Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Chang BL, 2006, HUM GENET, V118, P716, DOI 10.1007/s00439-005-0099-4; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen JJZ, 2004, J ENVIRON SCI HEAL C, V22, P1, DOI 10.1081/GNC-120037931; Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Ferlay J, 2001, IARC CANCERBASE; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Gomez-Zaera M, 2006, MUTAT RES-FUND MOL M, V595, P42, DOI 10.1016/j.mrfmmm.2005.10.012; Griffiths A.J.F., 2000, INTRO GENETIC ANAL; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Hulgan T, 2011, AIDS, V25, P37, DOI 10.1097/QAD.0b013e32833f9d02; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Isaacs WB, 2007, LINKAGE STUDIES PROS; Jeronimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646; Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X; Kim W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002211; Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375; Kloss-Brandstatter A, 2010, AM J HUM GENET, V87, P802, DOI 10.1016/j.ajhg.2010.11.001; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Kumar V, 2010, CHEMOSPHERE, V81, P464, DOI 10.1016/j.chemosphere.2010.07.067; Kurtz A, 2004, MOL CANCER RES, V2, P433; Lee HY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-483; Liu S., 2011, EUR ARCH OTO-RHINO-L, P1; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; O'Dowd GJ, 2001, PCRI INSIGHTS, V4; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Quaglia A, 2003, EUR J CANCER, V39, P654, DOI 10.1016/S0959-8049(02)00872-9; Ray Katrina, 2011, Nat Rev Urol, V8, P119, DOI 10.1038/nrurol.2011.14; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Shaik NA, 2011, GENET TEST MOL BIOMA, V15, P537, DOI 10.1089/gtmb.2010.0255; Snall N, 2002, HUM BIOL, V74, P253, DOI 10.1353/hub.2002.0024; Tan DJ, 2002, CANCER RES, V62, P972; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tseng LM, 2011, GENE CHROMOSOME CANC, V50, P800, DOI 10.1002/gcc.20901; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; Wang L, 2007, CANCER EPIDEM BIOMAR, V16, P1455, DOI 10.1158/1055-9965.EPI-07-0119; Wang L, 2008, CANCER EPIDEM BIOMAR, V17, P3558, DOI 10.1158/1055-9965.EPI-08-0434; Wiesbauer M, 2006, MITOCHONDRION, V6, P263; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Yu JJ, 2010, AGING MALE, V13, P159, DOI 10.3109/13685530903536668	56	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41201	10.1371/journal.pone.0041201	http://dx.doi.org/10.1371/journal.pone.0041201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815971	Green Published, Green Submitted, gold			2022-12-25	WOS:000306507000078
J	Notomi, T; Ezura, Y; Noda, M				Notomi, Takuya; Ezura, Yoichi; Noda, Masaki			Identification of Two-pore Channel 2 as a Novel Regulator of Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DIFFERENTIATION; ENDOPLASMIC-RETICULUM; MOBILIZES CALCIUM; BONE-RESORPTION; ACTIVATION; NAADP; CELLS; CD38; INDUCTION; MUSCLE	Osteoclast differentiation is one of the critical steps that control bone mass levels in osteoporosis, but the molecules involved in osteoclastogenesis are still incompletely understood. Here, we show that two-pore channel 2 (TPC2) is expressed in osteoclast precursor cells, and its knockdown (TPC2-KD) in these cells suppressed RANKL-induced key events including multi-nucleation, enhancement of tartrate-resistant acid phosphatase (TRAP) activities, and TRAP mRNA expression levels. With respect to intracellular signaling, TPC2-KD reduced the levels of the RANKL-induced dynamic waving of Ca2+ in RAW cells. The search for the target of TPC2 identified that nuclear localization of NFATc1 is retarded in TPC2-KD cells. Finally, TPC2-KD suppressed osteoclastic pit formation in cultures. We conclude that TPC2 is a novel critical molecule for osteoclastogenesis.	[Notomi, Takuya; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan; [Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence Program Mol Sci Tooth & Bon, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Notomi, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tnotomi.gcoe@tmd.ac.jp; noda.mph@mri.tmd.ac.jp	Ezura, Yoichi/L-9485-2016		Ministry of Education, Science, and Culture; Uehara Memorial Foundation; Nakatomi Foundation; Mochida Memorial Foundation	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Mochida Memorial Foundation	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, and Culture, Uehara Memorial Foundation, Nakatomi Foundation, and Mochida Memorial Foundation.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Henriksen K, 2008, CALCIFIED TISSUE INT, V83, P230, DOI 10.1007/s00223-008-9168-8; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; KUKITA A, 1993, BIOCHEM BIOPH RES CO, V196, P1383, DOI 10.1006/bbrc.1993.2406; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LY IA, 1974, J IMMUNOL METHODS, V5, P239, DOI 10.1016/0022-1759(74)90108-2; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; McClung MR, 2012, J BONE MINER RES, V27, P211, DOI 10.1002/jbmr.536; Mori H, 2003, J BONE MINER RES, V18, P2069, DOI 10.1359/jbmr.2003.18.11.2069; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Razzouk S, 1999, EUR J CELL BIOL, V78, P249, DOI 10.1016/S0171-9335(99)80058-2; Schmid F, 2011, FEBS LETT, V585, P3544, DOI 10.1016/j.febslet.2011.10.017; Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196; SILVERTON S, 1994, J CELL BIOCHEM, V56, P367, DOI 10.1002/jcb.240560313; Sun L, 2003, FASEB J, V17, P369, DOI 10.1096/fj.02-0205com; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takito J, 2012, J CELL SCI, V125, P662, DOI 10.1242/jcs.090886; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Youn MY, 2010, GENES CELLS, V15, P1025, DOI 10.1111/j.1365-2443.2010.01441.x; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028	36	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35057	35064		10.1074/jbc.M111.328930	http://dx.doi.org/10.1074/jbc.M111.328930			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22833668	Green Published, hybrid			2022-12-25	WOS:000309968000017
J	Aikawa, Y				Aikawa, Yoshikatsu			Rabex-5 Protein Regulates the Endocytic Trafficking Pathway of Ubiquitinated Neural Cell Adhesion Molecule L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR RABEX-5; BINDING DOMAINS; GROWTH CONES; RECEPTOR ENDOCYTOSIS; NUCLEOTIDE EXCHANGE; NEURONAL MIGRATION; MEMBRANE-PROTEINS; STRUCTURAL BASIS; EARLY ENDOSOMES; INTERNALIZATION	Ubiquitination of integral membrane proteins is a common posttranslational modification used to mediate endocytosis and endocytic sorting of cell surface proteins in eukaryotic cells. Ubiquitin (Ub)-binding proteins (UBPs) regulate the stability, function, and localization of ubiquitinated cell surface proteins in the endocytic pathway. Here, I report that the immunoglobulin superfamily cell adhesion molecule L1 undergoes ubiquitination and dephosphorylation on the plasma membrane upon L1 antibody-induced clustering, which mimics L1-L1 homophilic binding, and that these modifications are critical for obtaining the maximal rate of internalization and trafficking to the lysosome, but not to the proteasome. Notably, L1 antibody-induced clustering leads to the association of ubiquitinated L1 with Rabex-5, a UBP and guanine nucleotide exchange factor for Rab5, via interaction with the motif interacting with Ub (MIU) domain, but not the A20-type zinc finger domain. This interaction specifically depends on the presence of an Ub moiety on lysine residues in L1. Rabex-5 expression accelerates the internalization rates of L1(WT) and L1(Y1176A), a tyrosine-based motif mutant, but not L1(K11R), an ubiquitination-deficient mutant, leading to the accumulation of ubiquitinated L1 on endosomes. In contrast, RNA interference-mediated knockdown of Rabex-5 impairs the internalizations of L1(WT) and L1(Y1176A), but not L1(K11R) from the plasma membrane. Overall, these results provide a novel mechanistic insight into how Rabex-5 regulates internalization and postendocytic trafficking of ubiquitinated L1 destined for lysosomal degradation.	Doshisha Univ, Grad Sch Brain Sci, Lab Neural Membrane Biol, Kyoto 6100394, Japan	Doshisha University	Aikawa, Y (corresponding author), Doshisha Univ, Grad Sch Brain Sci, Lab Neural Membrane Biol, 1-3 Miyakodani, Kyoto 6100394, Japan.	yaikawa@mail.doshisha.ac.jp			Japan Society for the Promotion of Science [20790085]; Uehara Memorial Foundation; Doshisha University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Doshisha University	This work was supported by Grant-in-aid for Young Scientists (B) (20790085) from the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, and individual research allowances from Doshisha University (to Y. A.). Measurement and data analyses were done at Kagawa School, Tokushima Bunri University.	Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dequidt C, 2007, MOL BIOL CELL, V18, P3131, DOI 10.1091/mbc.E06-12-1101; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Long KE, 2001, J BIOL CHEM, V276, P1285, DOI 10.1074/jbc.M006658200; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sakurai T, 2008, J NEUROSCI RES, V86, P2602, DOI 10.1002/jnr.21705; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schafer MKE, 2010, FEBS LETT, V584, P4475, DOI 10.1016/j.febslet.2010.10.011; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Thelen K, 2008, J BIOL CHEM, V283, P32792, DOI 10.1074/jbc.M805896200; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Volpicelli LA, 2001, J BIOL CHEM, V276, P47590, DOI 10.1074/jbc.M106535200; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Yap CC, 2008, J CELL SCI, V121, P1514, DOI 10.1242/jcs.022442; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143	47	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32312	32323		10.1074/jbc.M112.374322	http://dx.doi.org/10.1074/jbc.M112.374322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846990	hybrid, Green Published			2022-12-25	WOS:000309168300003
J	Hodder, AN; Czabotar, PE; Uboldi, AD; Clarke, OB; Lin, CS; Healer, J; Smith, BJ; Cowman, AF				Hodder, Anthony N.; Czabotar, Peter E.; Uboldi, Alessandro D.; Clarke, Oliver B.; Lin, Clara S.; Healer, Julie; Smith, Brian J.; Cowman, Alan F.			Insights into Duffy Binding-like Domains through the Crystal Structure and Function of the Merozoite Surface Protein MSPDBL2 from Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE INVASION; GLYCOPHORIN-C; MALARIA; RECEPTOR; ANTIGEN; FAMILY; IDENTIFICATION; RECOGNITION; DISRUPTION; SELECTION	Invasion of human red blood cells by Plasmodium falciparum involves interaction of the merozoite form through proteins on the surface coat. The erythrocyte binding-like protein family functions after initial merozoite interaction by binding via the Duffy binding-like (DBL) domain to receptors on the host red blood cell. The merozoite surface proteins DBL1 and -2 (PfMSPDBL1 and PfMSPDBL2) (PF10_0348 and PF10_0355) are extrinsically associated with the merozoite, and both have a DBL domain in each protein. We expressed and refolded recombinant DBL domains for PfMSPDBL1 and -2 and show they are functional. The red cell binding characteristics of these domains were shown to be similar to full-length forms of these proteins isolated from parasite cultures. Futhermore, metal cofactors were found to enhance the binding of both the DBL domains and the parasite-derived full-length proteins to erythrocytes, which has implications for receptor binding of other DBL-containing proteins in Plasmodium spp. We solved the structure of the erythrocyte-binding DBL domain of PfMSPDBL2 to 2.09 angstrom resolution and modeled that of PfMSPDBL1, revealing a canonical DBL fold consisting of a boomerang shaped alpha-helical core formed from three subdomains. PfMSPDBL2 is highly polymorphic, and mapping of these mutations shows they are on the surface, predominantly in the first two domains. For both PfMSPDBL proteins, polymorphic variation spares the cleft separating domains 1 and 2 from domain 3, and the groove between the two major helices of domain 3 extends beyond the cleft, indicating these regions are functionally important and are likely to be associated with the binding of a receptor on the red blood cell.	[Hodder, Anthony N.; Czabotar, Peter E.; Uboldi, Alessandro D.; Clarke, Oliver B.; Lin, Clara S.; Healer, Julie; Smith, Brian J.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Hodder, Anthony N.; Czabotar, Peter E.; Clarke, Oliver B.; Lin, Clara S.; Smith, Brian J.; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia	Walter & Eliza Hall Institute; University of Melbourne; La Trobe University	Hodder, AN (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia.	hodder@wehi.edu.au; cowman@wehi.edu.au	Cowman, Alan F/C-7642-2013; Smith, Brian J/F-8282-2011	Cowman, Alan F/0000-0001-5145-9004; Smith, Brian J/0000-0003-0498-1910; Czabotar, Peter/0000-0002-2594-496X	Victorian State Government; Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme	Victorian State Government; Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auld DS, 2009, BIOMETALS, V22, P141, DOI 10.1007/s10534-008-9184-1; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashford D., 1997, Scientific Computing in Object-Oriented Parallel Environments. First International Conference, ISCOPE 97. Proceedings, P233; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2009, MOL MICROBIOL, V71, P48, DOI 10.1111/j.1365-2958.2008.06508.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Kauth CW, 2003, J BIOL CHEM, V278, P22257, DOI 10.1074/jbc.M302299200; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	51	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32922	32939		10.1074/jbc.M112.350504	http://dx.doi.org/10.1074/jbc.M112.350504			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843685	Green Published, hybrid			2022-12-25	WOS:000309168300057
J	Mondragon-Rodriguez, S; Trillaud-Doppia, E; Dudilot, A; Bourgeois, C; Lauzon, M; Leclerc, N; Boehm, J				Mondragon-Rodriguez, Siddhartha; Trillaud-Doppia, Emilie; Dudilot, Anthony; Bourgeois, Catherine; Lauzon, Michel; Leclerc, Nicole; Boehm, Jannic			Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-D-aspartate Receptor-dependent Tau Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; A-BETA; TRAFFICKING; TRANSMISSION; DEPRESSION; EXPRESSION; PLASTICITY	Amyloid-beta and tau protein are the two most prominent factors in the pathology of Alzheimer disease. Recent studies indicate that phosphorylated tau might affect synaptic function. We now show that endogenous tau is found at postsynaptic sites where it interacts with the PSD95-NMDA receptor complex. NMDA receptor activation leads to a selective phosphorylation of specific sites in tau, regulating the interaction of tau with Fyn and the PSD95-NMDA receptor complex. Based on our results, we propose that the physiologically occurring phosphorylation of tau could serve as a regulatory mechanism to prevent NMDA receptor overexcitation.	[Mondragon-Rodriguez, Siddhartha; Trillaud-Doppia, Emilie; Dudilot, Anthony; Bourgeois, Catherine; Boehm, Jannic] Univ Montreal, Dept Physiol, Montreal, PQ H3T 1J4, Canada; [Lauzon, Michel; Leclerc, Nicole] Univ Montreal, Dept Pathol & Biol Cellulaire, Grp Rech Syst Nerveux Cent, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Universite de Montreal	Boehm, J (corresponding author), Univ Montreal, Dept Physiol, 2960 Chemin Tour, Montreal, PQ H3T 1J4, Canada.	jannic.boehm@umontreal.ca	Mondragon-Rodriguez, Siddhartha/AAA-2452-2019; Boehm, Jannic/AAK-8882-2020		Canadian Institutes of Health Research; Alzheimer Society of Canada; Groupe de Recherche sur le Systeme Nerveux Central; Department of Physiology, Universite de Montreal; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Groupe de Recherche sur le Systeme Nerveux Central; Department of Physiology, Universite de Montreal; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research and the Alzheimer Society of Canada.; Supported by a fellowship from the Groupe de Recherche sur le Systeme Nerveux Central.; Supported by stipends from the Department of Physiology, Universite de Montreal.; Supported by a salary award from the Fonds de la Recherche en Sante du Quebec.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bullmann T, 2007, HIPPOCAMPUS, V17, P98, DOI 10.1002/hipo.20255; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Cheng L, 2009, SYNAPSE, V63, P206, DOI 10.1002/syn.20599; Chittajallu R, 1998, CELL CALCIUM, V24, P377, DOI 10.1016/S0143-4160(98)90061-6; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Galvan M, 2001, J ALZHEIMERS DIS, V3, P417, DOI 10.3233/JAD-2001-3409; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Grey KB, 2010, J NEUROPHYSIOL, V103, P2737, DOI 10.1152/jn.01112.2009; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; Lee G, 1998, J CELL SCI, V111, P3167; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pei JJ, 2006, FEBS LETT, V580, P107, DOI 10.1016/j.febslet.2005.11.059; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Timm T, 2006, NEURODEGENER DIS, V3, P207, DOI 10.1159/000095258; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; Yu JZ, 2006, FASEB J, V20, P1452, DOI 10.1096/fj.05-5206com; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	68	164	166	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32040	32053		10.1074/jbc.M112.401240	http://dx.doi.org/10.1074/jbc.M112.401240			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833681	Green Published, hybrid			2022-12-25	WOS:000309059400042
J	Pan, XC; Yue, JJ; Ding, GF; Li, B; Liu, X; Zheng, XC; Yu, MC; Li, J; Jiang, WW; Wu, C; Zheng, J; Zhou, H				Pan, Xichun; Yue, Junjie; Ding, Guofu; Li, Bin; Liu, Xin; Zheng, Xinchuan; Yu, Mengchen; Li, Jun; Jiang, Weiwei; Wu, Chong; Zheng, Jiang; Zhou, Hong			Leucine-rich Repeat 11 of Toll-like Receptor 9 Can Tightly Bind to CpG-containing Oligodeoxynucleotides, and the Positively Charged Residues Are Critical for the High Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN RECOGNITION; REAL-TIME; DNA; ACTIVATION; PROTEIN; TLR9; ELECTROSTATICS; IDENTIFICATION; RNA	TLR9 is a receptor for sensing bacterial DNA/CpG-containing oligonucleotides (CpG ODN). The extracellular domain (ECD) of human TLR9 (hTLR9) is composed of 25 leucine-rich repeats (LRR) contributing to the binding of CpG ODN. Herein, we showed that among LRR2, -5, -8, and -11, LRR11 of hTLR9 had the highest affinity for CpG ODN followed by LRR2 and -5, whereas LRR8 had almost no affinity. In vitro, preincubation with LRR11 more significantly decreased CpG ODN internalization, subsequent NF-kappa B activation, and cytokine release than with LRR2 and -5 in mouse peritoneal macrophages treated with CpG ODN. The LRR11 deletion mutant of hTLR9 conferred decreased cellular responses to CpG ODN. Single- or multiple-site mutants at five positively charged residues of LRR11 (LRR11m1-9), especially Arg-337 and Lys-367, were shown to contribute to hTLR9 binding of CpG ODN. LRR11m1-9 showed reduced inhibition of CpG ODN internalization and CpG ODN/TLR9 signaling, supporting the above findings. Prediction of whole hTLR9 ECD-CpG ODN interactions revealed that Arg-337 and Lys-338 directly contact CpG ODN through hydrogen bonding, whereas Lys-347, Arg-348, and His-353 contribute to stabilizing the shape of the ligand binding region. These findings suggested that although all five positively charged residues within LRR11 contributed to its high affinity, only Arg-337 and Lys-338 directly interacted with CpG ODN. In conclusion, the results suggested that LRR11 could strongly bind to CpG ODN, whereas mutations at the five positively charge residues reduced this high affinity. LRR11 may be further investigated as an antagonist of hTLR9.	[Liu, Xin; Zheng, Xinchuan; Zheng, Jiang] Third Mil Med Univ, Med Res Ctr, Southwestern Hosp, Chongqing 400038, Peoples R China; [Pan, Xichun; Ding, Guofu; Li, Bin; Yu, Mengchen; Li, Jun; Jiang, Weiwei; Wu, Chong; Zhou, Hong] Third Mil Med Univ, Coll Pharm, Dept Pharmacol, Chongqing 400038, Peoples R China; [Yue, Junjie] Acad Mil Med Sci, Inst Biotechnol, Beijing 100071, Peoples R China	Army Medical University; Army Medical University; Academy of Military Medical Sciences - China	Zheng, J (corresponding author), Third Mil Med Univ, Med Res Ctr, Southwestern Hosp, Gaotanyan St 30, Chongqing 400038, Peoples R China.	zhengj99219@gmail.com; zhouh64@163.com		Yue, Junjie/0000-0002-2549-9261	National Natural Science Foundation of China [30973545]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 30973545.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; Guo YB, 2005, BIOCHEM PHARMACOL, V70, P209, DOI 10.1016/j.bcp.2005.04.040; Jin MS, 2008, CURR OPIN IMMUNOL, V20, P414, DOI 10.1016/j.coi.2008.06.002; Jung I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-298; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Li B, 2008, INT IMMUNOPHARMACOL, V8, P379, DOI 10.1016/j.intimp.2007.10.024; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Liu X, 2011, BRIT J PHARMACOL, V162, P1274, DOI 10.1111/j.1476-5381.2010.01114.x; Liu X, 2009, INT IMMUNOPHARMACOL, V9, P1021, DOI 10.1016/j.intimp.2009.03.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wang J, 2009, ANAL CHEM, V81, P4914, DOI 10.1021/ac900591k; Zhou H, 2004, INT IMMUNOPHARMACOL, V4, P223, DOI 10.1016/j.intimp.2003.12.006	28	17	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30596	30609		10.1074/jbc.M112.396432	http://dx.doi.org/10.1074/jbc.M112.396432			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22822061	Green Published, hybrid			2022-12-25	WOS:000308579800051
J	Gupta, A; Ahmad, FJ; Ahmad, F; Gupta, UD; Natarajan, M; Katoch, V; Bhaskar, S				Gupta, Ankan; Ahmad, Farhan J.; Ahmad, Faiz; Gupta, Umesh D.; Natarajan, Mohan; Katoch, Vishwamohan; Bhaskar, Sangeeta			Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung	PLOS ONE			English	Article							RESISTANT PULMONARY TUBERCULOSIS; GUINEA-PIG LYMPHOCYTES; INTERFERON-GAMMA; BCG VACCINATION; PROTECTIVE EFFICACY; DNA VACCINE; BOVIS BCG; MICE; VACCAE; INFECTION	Background: The 9-month-long chemotherapy of tuberculosis often results in poor compliance and emergence of drug-resistant strains. So, improved therapeutic strategy is urgently needed. Immunotherapy could be beneficial for the effective management of the disease. Previously we showed the protective efficacy of Mycobacterium indicus pranii (MIP) when given as prophylactic vaccine in animal models of tuberculosis. Methods: We sought to investigate whether MIP can be used as an adjunct to the chemotherapy in guinea pig models of tuberculosis. Efficacy of MIP was evaluated when given subcutaneously or by aerosol. Results: MIP-therapy as an adjunct to the chemotherapy was found to be effective in accelerating bacterial killing and improving organ pathology. MIP-immunotherapy resulted in higher numbers of activated antigen-presenting cells and lymphocytes in the infected lungs and also modulated the granulomatous response. Early increase in protective Th1 immune response was observed in the immunotherapy group. Following subsequent doses of MIP, decrease in the inflammatory response and increase in the immunosuppressive response was observed, which resulted in the improvement of lung pathology. Conclusion: MIP immunotherapy is a valuable adjunct to chemotherapy for tuberculosis. Aerosol route of immunotherapy can play a crucial role for inducing immediate local immune response in the lung.	[Gupta, Ankan; Ahmad, Faiz; Bhaskar, Sangeeta] Natl Inst Immunol, Delhi, India; [Ahmad, Farhan J.] Jamia Hamdard, Fac Pharm, Delhi, India; [Gupta, Umesh D.; Natarajan, Mohan; Katoch, Vishwamohan] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Expt Anim Facil, Agra, Uttar Pradesh, India; [Gupta, Umesh D.; Natarajan, Mohan; Katoch, Vishwamohan] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Pathol, Agra, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Hamdard University; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra	Bhaskar, S (corresponding author), Natl Inst Immunol, Delhi, India.	sangeeta@nii.ac.in		Ahmad, Farhan/0000-0002-0740-8573; Bhaskar, Sangeeta/0000-0001-7902-5267; Ahmad, Faiz/0000-0002-0450-042X	National Institute of Immunology from the Department of Biotechnology, Ministry of Science and Technology, Government of India; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PRS340/Med/14/619/2005]	National Institute of Immunology from the Department of Biotechnology, Ministry of Science and Technology, Government of India; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This research work was supported by the core research grant of the National Institute of Immunology and a research grant (BT/PRS340/Med/14/619/2005) from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHR GM, 1990, TUBERCLE, V71, P259, DOI 10.1016/0041-3879(90)90038-A; Barnes PF, 2003, AM J RESP CRIT CARE, V168, P142, DOI 10.1164/rccm.2305001; Cho H, 2005, INFECT IMMUN, V73, P1367, DOI 10.1128/IAI.73.3.1367-1376.2005; Condos R, 1997, LANCET, V349, P1513, DOI 10.1016/S0140-6736(96)12273-X; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dlugovitzky D, 2006, RESP MED, V100, P1079, DOI 10.1016/j.rmed.2005.09.026; Dlugovitzky D, 2011, IMMUNOTHERAPY-UK, V3, P557, DOI [10.2217/IMT.11.6, 10.2217/imt.11.6]; Dlugovitzky D, 2010, IMMUNOTHERAPY-UK, V2, P159, DOI 10.2217/IMT.09.90; Fotedar A, 1978, Lepr India, V50, P520; Garner P, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001166 [doi], DOI 10.1002/14651858.CD001166]; Giosue S, 2000, EUR CYTOKINE NETW, V11, P99; Giri PK, 2006, J INFECTION, V53, P350, DOI 10.1016/j.jinf.2005.12.017; Grahmann PR, 2008, INT J TUBERC LUNG D, V12, P636; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Ha SJ, 2005, GENE THER, V12, P634, DOI 10.1038/sj.gt.3302465; Ha SJ, 2003, GENE THER, V10, P1592, DOI 10.1038/sj.gt.3302057; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Jeyanathan M, 2008, J IMMUNOL, V181, P5618, DOI 10.4049/jimmunol.181.8.5618; Jeyanathan M, 2010, TRENDS IMMUNOL, V31, P247, DOI 10.1016/j.it.2010.05.002; Jeyanathan M, 2010, AM J RESP CRIT CARE, V181, P862, DOI 10.1164/rccm.200910-1583OC; Johnson B, 1998, NOVART FDN SYMP, V217, P99, DOI 10.1002/0470846526.ch7; JOHNSON BJ, 1995, CYTOKINES MOL THER, V1, P185; Johnson BJ, 1998, INFECT IMMUN, V66, P2426, DOI 10.1128/IAI.66.6.2426-2433.1998; Johnson CM, 2005, ANTIMICROB AGENTS CH, V49, P4335, DOI 10.1128/AAC.49.10.4335-4338.2005; Johnson JL, 2003, AM J RESP CRIT CARE, V168, P185, DOI 10.1164/rccm.200211-1359OC; Koh WJ, 2004, J KOREAN MED SCI, V19, P167, DOI 10.3346/jkms.2004.19.2.167; KRAAL G, 1986, EUR J IMMUNOL, V16, P1515, DOI 10.1002/eji.1830161208; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC; Mustafa A S, 1978, Lepr India, V50, P534; Mustafa A S, 1978, Lepr India, V50, P498; Mustafa A S, 1978, Lepr India, V50, P509; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477; Park SK, 2007, INT J INFECT DIS, V11, P434, DOI 10.1016/j.ijid.2006.12.004; Petrofsky M, 1999, CLIN IMMUNOL, V91, P354, DOI 10.1006/clim.1999.4709; REDDI PP, 1994, INT J LEPROSY, V62, P229; Rodriguez-Guell E, 2008, CLIN VACCINE IMMUNOL, V15, P893, DOI 10.1128/CVI.00477-07; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; SCHAFER H, 1991, EUR J IMMUNOL, V21, P701, DOI 10.1002/eji.1830210324; Silva CL, 2005, GENE THER, V12, P281, DOI 10.1038/sj.gt.3302418; Skwor TA, 2006, TUBERCULOSIS, V86, P419, DOI 10.1016/j.tube.2005.12.002; STANFORD JL, 1990, TUBERCLE, V71, P87, DOI 10.1016/0041-3879(90)90002-P; STUCK AE, 1989, REV INFECT DIS, V11, P954; TALWAR GP, 1983, INT J LEPROSY, V51, P550; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Turner J, 2000, INFECT IMMUN, V68, P1706, DOI 10.1128/IAI.68.3.1706-1709.2000; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Xu LJ, 2009, CELL MOL IMMUNOL, V6, P67, DOI 10.1038/cmi.2009.9; YADAVA A, 1991, SCAND J IMMUNOL, V34, P23, DOI 10.1111/j.1365-3083.1991.tb01517.x; Yamada H, 2005, EXP ANIM TOKYO, V54, P163, DOI 10.1538/expanim.54.163; Yu DH, 2008, GENE THER, V15, P652, DOI 10.1038/gt.2008.13; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	58	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e39215	10.1371/journal.pone.0039215	http://dx.doi.org/10.1371/journal.pone.0039215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844392	gold, Green Published, Green Submitted			2022-12-25	WOS:000309240600002
J	Su, YL; Wang, SC; Chiang, PY; Lin, NY; Shen, YF; Chang, GD; Chang, CJ				Su, Yu-Lun; Wang, Shun-Chang; Chiang, Pei-Yu; Lin, Nien-Yi; Shen, Yu-Fang; Chang, Geen-Dong; Chang, Ching-Jin			Tristetraprolin Inhibits Poly(A)-Tail Synthesis in Nuclear mRNA that Contains AU-Rich Elements by Interacting with Poly(A)-Binding Protein Nuclear 1	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; BINDING-PROTEIN; TRANSLATION INITIATION; TAIL LENGTH; DEGRADATION; DECAY; DEADENYLATION; RECRUITMENT; STABILITY; TTP	Background: Tristetraprolin binds mRNA AU-rich elements and thereby facilitates the destabilization of mature mRNA in the cytosol. Methodology/Principal Findings: To understand how tristetraprolin mechanistically functions, we biopanned with a phage-display library for proteins that interact with tristetraprolin and retrieved, among others, a fragment of poly(A)-binding protein nuclear 1, which assists in the 3'-polyadenylation of mRNA by binding to immature poly(A) tails and thereby increases the activity of poly(A) polymerase, which is directly responsible for polyadenylation. The tristetraprolin/poly(A)-binding protein nuclear 1 interaction was characterized using tristetraprolin and poly(A)-binding protein nuclear 1 deletion mutants in pull-down and co-immunoprecipitation assays. Tristetraprolin interacted with the carboxyl-terminal region of poly(A)-binding protein nuclear 1 via its tandem zinc finger domain and another region. Although tristetraprolin and poly(A)-binding protein nuclear 1 are located in both the cytoplasm and the nucleus, they interacted in vivo in only the nucleus. In vitro, tristetraprolin bound both poly(A)-binding protein nuclear 1 and poly(A) polymerase and thereby inhibited polyadenylation of AU-rich element-containing mRNAs encoding tumor necrosis factor alpha, GM-CSF, and interleukin-10. A tandem zinc finger domain-deleted tristetraprolin mutant was a less effective inhibitor. Expression of a tristetraprolin mutant restricted to the nucleus resulted in downregulation of an AU-rich element-containing tumor necrosis factor alpha/luciferase mRNA construct. Conclusion/Significance: In addition to its known cytosolic mRNA-degrading function, tristetraprolin inhibits poly(A) tail synthesis by interacting with poly(A)-binding protein nuclear 1 in the nucleus to regulate expression of AU-rich element-containing mRNA.	[Su, Yu-Lun; Chiang, Pei-Yu; Shen, Yu-Fang; Chang, Geen-Dong; Chang, Ching-Jin] Natl Taiwan Univ, Grad Inst Biochem Sci, Coll Life Sci, Taipei 10764, Taiwan; [Wang, Shun-Chang; Lin, Nien-Yi; Chang, Ching-Jin] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Chang, CJ (corresponding author), Natl Taiwan Univ, Grad Inst Biochem Sci, Coll Life Sci, Taipei 10764, Taiwan.	chingjin@gate.sinica.edu.tw	Chang, Ching-Jin/G-4511-2019	Chang, Ching-Jin/0000-0001-7129-8092	Academia Sinica; National Science Council [NSC97-2311-B-001-019-MY3]; National Taiwan University [98R0066-32]; Department of Medical Research in NTUH (National Taiwan University Hospital)	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Department of Medical Research in NTUH (National Taiwan University Hospital)	This work was supported by grants from Academia Sinica and National Taiwan University (98R0066-32 to G.-D. Chang) and the National Science Council (NSC97-2311-B-001-019-MY3 to C.-J. Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Sheng-Wei Lin of the Institute of Biological Chemistry, Academia Sinica for his technical expertise during protein purification, and Ms Yi-Li Liu and Ms I.-Ching Huang for their technical expertise during DNA sequencing, supported in part by the Department of Medical Research in NTUH (National Taiwan University Hospital).	Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kedar VP, PLOS ONE, V5, pe9588; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Lemieux C, 2009, NUCLEIC ACIDS RES, V37, P3418, DOI 10.1093/nar/gkp207; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Murata T, 2002, BIOCHEM BIOPH RES CO, V293, P1242, DOI 10.1016/S0006-291X(02)00363-7; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Prouteau M, 2008, EMBO J, V27, P2966, DOI 10.1038/emboj.2008.212; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V295, pG421, DOI 10.1152/ajpgi.00508.2007; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; SALLES FJ, 1995, PCR METH APPL, V4, P317; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shim J, 2002, MOL CELLS, V14, P323; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Tan BCM, 2004, J BIOL CHEM, V279, P9321, DOI 10.1074/jbc.M311477200; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41313	10.1371/journal.pone.0041313	http://dx.doi.org/10.1371/journal.pone.0041313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844456	Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600021
J	Thevenin, JM; Rossi, V; Ducamp, M; Doare, F; Condina, V; Lachenaud, P				Thevenin, Jean-Marc; Rossi, Vivien; Ducamp, Michel; Doare, Fabien; Condina, Virgile; Lachenaud, Philippe			Numerous Clones Resistant to Phytophthora palmivora in the "Guiana" Genetic Group of Theobroma cacao L	PLOS ONE			English	Article							FOLIAR RESISTANCE; POD RESISTANCE; FRENCH-GUIANA; FIELD; INDICATOR; ROT	Cocoa black pod rot, a disease caused by Stramenopiles of the genus Phytophthora, and particularly by the pan-tropical species P. palmivora, causes serious production losses worldwide. In order to reduce the impact of these pests and diseases, preference is given to genetic control using resistant varieties and, to that end, breeders seek sources of resistance in wild cocoa trees. For instance, surveys of spontaneous cocoa trees in French Guiana between 1985 and 1995 led to the collection of abundant plant material forming a particular genetic group (the "Guiana" group). Following numerous one-off studies demonstrating the merits of this group as a source of resistance to Phytophthora, this article presents the results of a comprehensive study assessing the resistance of 186 "Guiana" clones in relation to the Guianan strain (GY 27) of P. palmivora. This study, undertaken in French Guiana, using an efficient methodology (ten series of tests and a statistical test adapted to the ordinal nature of the data) confirmed that the "Guiana" genetic group does indeed constitute an important source of resistance to P. palmivora, though with some variations depending on the demes of origin. Numerous clones (59) proved to be as resistant as the SCAVINA 6 resistance control, whilst nine were statistically more resistant. The "Resistant" and "Moderately Resistant" Guianan clones totalled 108 (58% of the total tested). Some of the clones more resistant than SCAVINA 6 could be incorporated into numerous cocoa breeding programmes, particularly those that also display other notable qualities. The same applies for numerous other clones equivalent to SCAVINA 6, especially the "elite"' clones GU 134-B, GU 139-A and GU 285-A.	[Thevenin, Jean-Marc; Doare, Fabien; Condina, Virgile; Lachenaud, Philippe] CIRAD, UPR Bioagresseurs Anal & Maitrise Risque, Kourou, Guyane, France; [Rossi, Vivien] CIRAD, UMR Ecofog, Kourou, Guyane, France; [Ducamp, Michel] CIRAD, UMR BGPI, Montpellier, France	CIRAD; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD	Thevenin, JM (corresponding author), CIRAD, UPR Bioagresseurs Anal & Maitrise Risque, Kourou, Guyane, France.	jean-marc.thevenin@cirad.fr	Rossi, Vivien/C-9721-2009	Rossi, Vivien/0000-0001-5458-1523				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Akaza M. J., 2009, Asian Journal of Plant Pathology, V3, P106; [Anonymous], 2001, CFC ICCO IPGRI PROJE; [Anonymous], 2004, FINAL INDIVIDUAL REP, V1; [Anonymous], 2004, FINAL INDIVIDUAL REP, V2; Bowers J.H., 2001, PLANT HLTH PROG, V2, P12, DOI DOI 10.1094/PHP-2001-0709-01-RV; End MJ, 2010, REVISED FAO IPGRI TE; Eskes AB, 2001, ACT 13 C INT RECH CA, P11; Lachenaud P., 1997, Plantations Recherche Developpement, V4, P25; LACHENAUD P, 1994, CAFE CACAO THE, V38, P91; LACHENAUD P, 1993, CAFE CACAO THE, V37, P101; Lachenaud P, 2007, SCI HORTIC-AMSTERDAM, V113, P313, DOI 10.1016/j.scienta.2007.05.016; McCullagh P, 1989, GEN LINEAR MODELS; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Nyasse S, 1995, CROP PROT, V14, P657, DOI 10.1016/0261-2194(95)00054-2; Paulin D, 2008, CROP PROT, V27, P1143, DOI 10.1016/j.cropro.2008.01.004; Paulin D, 2007, GLOBAL APPROACHES CO, P124; PAULIN D, 2005, C INT RECH CAC 14 20, V1, P85; Paulin D, 2010, 15 C INT RECH CAC SA, V1, P41; Pokou ND, 2008, CROP PROT, V27, P302, DOI 10.1016/j.cropro.2007.07.012; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Tahi GM, 2007, PLANT PATHOL, V56, P219, DOI 10.1111/j.1365-3059.2006.01547.x; Tahi GM, 2006, PLANT PATHOL, V55, P776, DOI 10.1111/j.1365-3059.2006.01453.x; Tahi GM, 2006, EUPHYTICA, V149, P35, DOI 10.1007/s10681-005-9052-9; Tahi GM, 2003, THESIS U COCODY ABID; Tahi M, 2000, EUR J PLANT PATHOL, V106, P87, DOI 10.1023/A:1008747800191	26	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40915	10.1371/journal.pone.0040915	http://dx.doi.org/10.1371/journal.pone.0040915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848411	Green Published, gold			2022-12-25	WOS:000309240600012
J	Johnston-Cox, H; Koupenova, M; Yang, D; Corkey, B; Gokce, N; Farb, MG; LeBrasseur, N; Ravid, K				Johnston-Cox, Hillary; Koupenova, Milka; Yang, Dan; Corkey, Barbara; Gokce, Noyan; Farb, Melissa G.; LeBrasseur, Nathan; Ravid, Katya			The A2b Adenosine Receptor Modulates Glucose Homeostasis and Obesity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; NF-KAPPA-B; CARDIOVASCULAR-DISEASE; A(2B) RECEPTORS; ABDOMINAL FAT; TNF-ALPHA; IKK-BETA; INFLAMMATION; MICE	Background: High fat diet and its induced changes in glucose homeostasis, inflammation and obesity continue to be an epidemic in developed countries. The A2b adenosine receptor (A2bAR) is known to regulate inflammation. We used a diet-induced obesity murine knockout model to investigate the role of this receptor in mediating metabolic homeostasis, and correlated our findings in obese patient samples. Methodology/Principal Findings: Administration of high fat, high cholesterol diet (HFD) for sixteen weeks vastly upregulated the expression of the A2bAR in control mice, while A2bAR knockout ( KO) mice under this diet developed greater obesity and hallmarks of type 2 diabetes (T2D), assessed by delayed glucose clearance and augmented insulin levels compared to matching control mice. We identified a novel link between the expression of A2bAR, insulin receptor substrate 2 (IRS-2), and insulin signaling, determined by Western blotting for IRS-2 and tissue Akt phosphorylation. The latter is impaired in tissues of A2bAR KO mice, along with a greater inflammatory state. Additional mechanisms involved include A2bAR regulation of SREBP-1 expression, a repressor of IRS-2. Importantly, pharmacological activation of the A2bAR by injection of the A2bAR ligand BAY 60-6583 for four weeks post HFD restores IRS-2 levels, and ameliorates T2D. Finally, in obese human subjects A2bAR expression correlates strongly with IRS-2 expression. Conclusions/Significance: Our study identified the A2bAR as a significant regulator of HFD-induced hallmarks of T2D, thereby pointing to its therapeutic potential.	[Johnston-Cox, Hillary; Koupenova, Milka; Yang, Dan; Corkey, Barbara; LeBrasseur, Nathan; Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Koupenova, Milka; Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Johnston-Cox, Hillary; Koupenova, Milka; Gokce, Noyan; Farb, Melissa G.; Ravid, Katya] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Corkey, Barbara; Gokce, Noyan; Farb, Melissa G.; Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Johnston-Cox, H (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	kravid@bu.edu	Koupenova, Milka/L-3576-2019	Ravid, Katya/0000-0002-9918-3024; LeBrasseur, Nathan/0000-0002-2002-0418; Gokce, Noyan/0000-0003-2920-3445	National Heart, Lung and Blood Institute Grant [HL93149]; Boston Nutrition Obesity Research Center [DK046200]; CTSI NIH Grant [UL1-TR000157]; National Institutes of Health [R01 HL084213, P01 HL081587, HL007969, HL007224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, R01HL084213, P01HL081587, T32HL007224, R01HL114675, R01HL093149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, P30DK046200] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Nutrition Obesity Research Center; CTSI NIH Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung and Blood Institute Grant (HL93149) to KR, and by the Boston Nutrition Obesity Research Center (DK046200) to KR, and CTSI NIH Grant (UL1-TR000157) to KR, an established Investigator with the American Heart Association. Dr. Gokce is supported by National Institutes of Health grants R01 HL084213 and P01 HL081587. MK was supported by Cardiovascular pre-doctoral and post-doctoral Training Grants from the National Institutes of Health (HL007969, and HL007224 respectively), and HJC was supported by Cardiovascular Training Grant from the National Institutes of Health (HL007969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; BODEN G, 1995, DIABETES, V44, P1239, DOI 10.2337/diabetes.44.10.1239; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen HJ, 2009, EXP HEMATOL, V37, P533, DOI 10.1016/j.exphem.2009.02.001; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; CRESPIN SR, 1973, J CLIN INVEST, V52, P1979, DOI 10.1172/JCI107382; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; DESPRES JP, 1989, DIABETES, V38, P304, DOI 10.2337/diabetes.38.3.304; Dhaliwal SS, 2009, AM J CARDIOL, V103, P1403, DOI 10.1016/j.amjcard.2008.12.048; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Farb MG, 2011, ARTERIOLAR FUNCTION; Figler RA, 2011, DIABETES, V60, P669, DOI 10.2337/db10-1070; FLATT JP, 1985, J CLIN INVEST, V76, P1019, DOI 10.1172/JCI112054; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Han DH, 1998, DIABETES, V47, P1671, DOI 10.2337/diabetes.47.11.1671; Hilaire CS, 2009, J CELL PHYSIOL, V218, P35, DOI 10.1002/jcp.21579; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hu LP, 2005, AM J PHYSIOL-ENDOC M, V289, pE1085, DOI 10.1152/ajpendo.00210.2005; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Koupenova M, 2011, CIRCULATION; LAW WR, 1988, DIABETES, V37, P842, DOI 10.2337/diabetes.37.6.842; Maeda T, 2009, AM J PHYSIOL-REG I, V296, pR693, DOI 10.1152/ajpregu.90363.2008; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nemeth ZH, 2007, FASEB J, V21, P2379, DOI 10.1096/fj.07-8213com; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olefsky JM, 2009, CELL, V138, P834, DOI 10.1016/j.cell.2009.08.018; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Persaud SJ, 2011, DIABETOLOGIA, V54, P1109, DOI 10.1007/s00125-011-2050-7; Rendell M, 2001, J CLIN ENDOCR METAB, V86, P744, DOI 10.1210/jc.86.2.744; Rusing D, 2006, J PHARM PHARMACOL, V58, P1639, DOI 10.1211/jpp.58.12.0011; Schoelch C, 2004, DIABETES, V53, P1920, DOI 10.2337/diabetes.53.7.1920; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; TUCKER AL, 1993, CARDIOVASC RES, V27, P62, DOI 10.1093/cvr/27.1.62; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008	53	84	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40584	10.1371/journal.pone.0040584	http://dx.doi.org/10.1371/journal.pone.0040584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848385	gold, Green Published, Green Submitted			2022-12-25	WOS:000306806600021
J	Kopfer, DA; Hahn, U; Ohmert, I; Vriend, G; Pongs, O; de Groot, BL; Zachariae, U				Koepfer, David A.; Hahn, Ulrike; Ohmert, Iris; Vriend, Gert; Pongs, Olaf; de Groot, Bert L.; Zachariae, Ulrich			A Molecular Switch Driving Inactivation in the Cardiac K+ Channel hERG	PLOS ONE			English	Article							LONG-QT-SYNDROME; C-TYPE INACTIVATION; GENE POTASSIUM CHANNEL; SELECTIVITY FILTER; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; DYNAMICS SIMULATIONS; VOLTAGE-DEPENDENCE; XENOPUS-OOCYTES; PORE REGION	K+ channels control transmembrane action potentials by gating open or closed in response to external stimuli. Inactivation gating, involving a conformational change at the K+ selectivity filter, has recently been recognized as a major K+ channel regulatory mechanism. In the K+ channel hERG, inactivation controls the length of the human cardiac action potential. Mutations impairing hERG inactivation cause life-threatening cardiac arrhythmia, which also occur as undesired side effects of drugs. In this paper, we report atomistic molecular dynamics simulations, complemented by mutational and electrophysiological studies, which suggest that the selectivity filter adopts a collapsed conformation in the inactivated state of hERG. The selectivity filter is gated by an intricate hydrogen bond network around residues S620 and N629. Mutations of this hydrogen bond network are shown to cause inactivation deficiency in electrophysiological measurements. In addition, drug-related conformational changes around the central cavity and pore helix provide a functional mechanism for newly discovered hERG activators.	[Koepfer, David A.; de Groot, Bert L.; Zachariae, Ulrich] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, Gottingen, Germany; [Hahn, Ulrike; Ohmert, Iris; Pongs, Olaf] Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany; [Vriend, Gert; Zachariae, Ulrich] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Zachariae, Ulrich] Univ Edinburgh, Sch Phys & Astron, Scottish Univ Phys Alliance, Edinburgh, Midlothian, Scotland	Max Planck Society; University of Hamburg; Radboud University Nijmegen; University of Edinburgh	Kopfer, DA (corresponding author), Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, Gottingen, Germany.	uzachari@ph.ed.ac.uk	Vriend, G./H-8112-2014	Zachariae, Ulrich/0000-0003-3287-8494	Dutch TI Pharma project [D2-101]; Deutsche Forschungsgemeinschaft [Po137/39-1]	Dutch TI Pharma project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partially funded by the Dutch TI Pharma project D2-101 (GV, BLdG, UZ; URL: www.ti-pharma.nl) and a grant of the Deutsche Forschungsgemeinschaft to OP (Po137/39-1; URL: www.dfg.de). No additional external funding has been received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader C, 2008, NAT STRUCT MOL BIOL, V15, P605, DOI 10.1038/nsmb.1430; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Bian JS, 2004, CELL BIOCHEM BIOPHYS, V41, P25, DOI 10.1385/CBB:41:1:025; Boukharta L, 2011, BIOCHEMISTRY-US, V50, P6146, DOI 10.1021/bi200173n; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cheng WWL, 2011, P NATL ACAD SCI USA, V108, P5272, DOI 10.1073/pnas.1014186108; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cordeiro JM, 2005, CARDIOVASC RES, V67, P498, DOI 10.1016/j.cardiores.2005.02.018; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durdagi S, 2010, CURR MED CHEM, V17, P3514, DOI 10.2174/092986710792927886; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Garg V, 2011, MOL PHARMACOL, V80, P630, DOI 10.1124/mol.111.073809; Gerlach AC, 2010, MOL PHARMACOL, V77, P58, DOI 10.1124/mol.109.059543; Gomez-Varela D, 2006, FEBS LETT, V580, P5059, DOI 10.1016/j.febslet.2006.08.030; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Lees-Miller JP, 2000, CIRC RES, V86, P507, DOI 10.1161/01.RES.86.5.507; Lemmen C., 2010, FLEXX; Liu J, 2002, J GEN PHYSIOL, V120, P723, DOI 10.1085/jgp.20028687; Mitcheson JS, 2008, CHEM RES TOXICOL, V21, P1005, DOI 10.1021/tx800035b; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Perry M, 2009, P NATL ACAD SCI USA, V106, P20075, DOI 10.1073/pnas.0906597106; Sackin H, 2009, BIOPHYS J, V97, P1058, DOI 10.1016/j.bpj.2009.05.056; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Stary A, 2010, CHEMMEDCHEM, V5, P455, DOI 10.1002/cmdc.200900461; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Torres AM, 2003, J BIOL CHEM, V278, P42136, DOI 10.1074/jbc.M212824200; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Wang HZ, 2002, CANCER RES, V62, P4843; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Witchel HJ, 2007, EXPERT OPIN THER TAR, V11, P321, DOI 10.1517/14728222.11.3.321; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Zachariae U, 2008, STRUCTURE, V16, P747, DOI 10.1016/j.str.2008.01.018; Zachariae U, 2009, J MED CHEM, V52, P4266, DOI 10.1021/jm900002x; Zhang ST, 2003, J PHYSIOL-LONDON, V548, P691, DOI 10.1113/jphysiol.2003.039198; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x	59	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41023	10.1371/journal.pone.0041023	http://dx.doi.org/10.1371/journal.pone.0041023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848423	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300021
J	Zhu, WY; Ventevogel, MS; Knilans, KJ; Anderson, JE; Oldach, LM; McKinnon, KP; Hobbs, MM; Sempowski, GD; Duncan, JA				Zhu, Weiyan; Ventevogel, Melissa S.; Knilans, Kayla J.; Anderson, James E.; Oldach, Laurel M.; McKinnon, Karen P.; Hobbs, Marcia M.; Sempowski, Gregory D.; Duncan, Joseph A.			Neisseria gonorrhoeae Suppresses Dendritic Cell-Induced, Antigen-Dependent CD4 T Cell Proliferation	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; OPACITY PROTEINS; GENITAL-TRACT; RESPONSES; ACTIVATION; RESISTANCE; CHLAMYDIA; PROMOTES; BETA; INTERLEUKIN-10	Neisseria gonorrhoeae is the second most common sexually transmitted bacterial pathogen worldwide. Diseases associated with N. gonorrhoeae cause localized inflammation of the urethra and cervix. Despite this inflammatory response, infected individuals do not develop protective adaptive immune responses to N. gonorrhoeae. N. gonorrhoeae is a highly adapted pathogen that has acquired multiple mechanisms to evade its host's immune system, including the ability to manipulate multiple immune signaling pathways. N. gonorrhoeae has previously been shown to engage immunosuppressive signaling pathways in B and T lymphocytes. We have now found that N. gonorrhoeae also suppresses adaptive immune responses through effects on antigen presenting cells. Using primary, murine bone marrow-derived dendritic cells and lymphocytes, we show that N. gonorrhoeae-exposed dendritic cells fail to elicit antigen-induced CD4+ T lymphocyte proliferation. N. gonorrhoeae exposure leads to upregulation of a number of secreted and dendritic cell surface proteins with immunosuppressive properties, particularly Interleukin 10 (IL-10) and Programmed Death Ligand 1 (PD-L1). We also show that N. gonorrhoeae is able to inhibit dendritic cell-induced proliferation of human T-cells and that human dendritic cells upregulate similar immunosuppressive molecules. Our data suggest that, in addition to being able to directly influence host lymphocytes, N. gonorrhoeae also suppresses development of adaptive immune responses through interactions with host antigen presenting cells. These findings suggest that gonococcal factors involved in host immune suppression may be useful targets in developing vaccines that induce protective adaptive immune responses to this pathogen.	[Zhu, Weiyan; Anderson, James E.; Oldach, Laurel M.; Hobbs, Marcia M.; Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA; [Ventevogel, Melissa S.; Sempowski, Gregory D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Ventevogel, Melissa S.; Sempowski, Gregory D.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA; [Knilans, Kayla J.; McKinnon, Karen P.; Hobbs, Marcia M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [McKinnon, Karen P.; Duncan, Joseph A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhu, WY (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA.	jaduncan@med.unc.edu		Sempowski, Gregory/0000-0003-0391-6594; Oldach, Laurel/0000-0003-1491-608X	Burroughs Wellcome Fund Career Awards for Medical Scientists; NIH [U19-AI031496, UC6-AI058607]; UNC STD; HIV Training Program [T32-AI007001]; American Society for Pharmacology and Experimental Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001, UC6AI058607, U19AI031496] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Awards for Medical Scientists; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC STD; HIV Training Program; American Society for Pharmacology and Experimental Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work reported in this publication was supported by the Burroughs Wellcome Fund Career Awards for Medical Scientists awarded to J.A.D. and the following NIH grants and contracts: U19-AI031496 (Southeastern Sexually Transmitted Infection Cooperative Research Center) to J.A.D., M. M. H., and G. D. S. and UC6-AI058607 (Regional Biocontainment Laboratory at Duke University Medical Center) awarded to G. D. S et al. K.J.K. is an awardee of the UNC STD and HIV Training Program (T32-AI007001). L.M.O. received support from the American Society for Pharmacology and Experimental Therapeutics through a grant to the Carolina Summer Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright CA, 2009, IMMUNOL LETT, V123, P77, DOI 10.1016/j.imlet.2009.02.010; Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bellinghausen I, 2006, CLIN EXP ALLERGY, V36, P1546, DOI 10.1111/j.1365-2222.2006.02601.x; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Cohen CR, 1999, AIDS, V13, P327, DOI 10.1097/00002030-199902250-00004; COHEN IR, 1967, J BACTERIOL, V94, P141, DOI 10.1128/JB.94.1.141-148.1967; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cole JG, 2010, INFECT IMMUN, V78, P1629, DOI 10.1128/IAI.00996-09; COOKSON BT, 1989, BIOCHEMISTRY-US, V28, P1744, DOI 10.1021/bi00430a048; Criss AK, 2009, CELL MICROBIOL, V11, P1074, DOI 10.1111/j.1462-5822.2009.01308.x; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Feinen B, 2010, MUCOSAL IMMUNOL, V3, P312, DOI 10.1038/mi.2009.139; Fields RC, 1998, J IMMUNOTHER, V21, P323, DOI 10.1097/00002371-199809000-00001; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Gagliardi MC, 2011, FEMS IMMUNOL MED MIC, V61, P129, DOI 10.1111/j.1574-695X.2010.00759.x; Geisler WM, 2008, SEX TRANSM DIS, V35, P656, DOI 10.1097/OLQ.0b013e31816b6593; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Goldman W E, 1985, Dev Biol Stand, V61, P103; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Hewitt RE, 2012, CLIN IMMUNOLOGY; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Jounai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032588; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Liu YR, 2011, MBIO, V2, DOI 10.1128/mBio.00095-11; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; MONDINO A, 1994, J LEUKOCYTE BIOL, V55, P805, DOI 10.1002/jlb.55.6.805; Morel C, 2008, EUR J IMMUNOL, V38, P437, DOI 10.1002/eji.200737905; Ohman H, 2009, J INFECT DIS, V199, P1353, DOI 10.1086/597620; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Peng B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-347; Plant LJ, 2006, INFECT IMMUN, V74, P442, DOI 10.1128/IAI.74.1.442-448.2006; Pridmore AC, 2003, INFECT IMMUN, V71, P3901, DOI 10.1128/IAI.71.7.3901-3908.2003; Serre K, 2008, MOL IMMUNOL, V45, P3558, DOI 10.1016/j.molimm.2008.05.010; SINHA RK, 1980, INFECT IMMUN, V29, P914; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Svensson M, 2000, INFECT IMMUN, V68, P6311, DOI 10.1128/IAI.68.11.6311-6320.2000; TAPCHAISRI P, 1976, BRIT J VENER DIS, V52, P374; Tapsall JW, 2005, CLIN INFECT DIS, V41, pS263, DOI 10.1086/430787; van Vliet SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000625; Vlad G, 2010, INT REV IMMUNOL, V29, P119, DOI 10.3109/08830180903281185; Wan YY, 2008, J CLIN IMMUNOL, V28, P647, DOI 10.1007/s10875-008-9251-y; WITT K, 1976, J MED MICROBIOL, V9, P1, DOI 10.1099/00222615-9-1-1; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103	60	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41260	10.1371/journal.pone.0041260	http://dx.doi.org/10.1371/journal.pone.0041260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844448	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700061
J	Le, XF; Almeida, MI; Mao, WQ; Spizzo, R; Rossi, S; Nicoloso, MS; Zhang, S; Wu, Y; Calin, GA; Bast, RC				Le, Xiao-Feng; Almeida, Maria I.; Mao, Weiqun; Spizzo, Riccardo; Rossi, Simona; Nicoloso, Milena S.; Zhang, Shu; Wu, Yun; Calin, George A.; Bast, Robert C., Jr.			Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer	PLOS ONE			English	Article							KINASE INHIBITOR P27(KIP1); MONOCLONAL-ANTIBODY; ANTI-HER2 ANTIBODY; GROWTH-INHIBITION; CYCLE ARREST; HERCEPTIN; HER2; EXPRESSION; TALIN; THERAPY	Trastuzumab, a humanized monoclonal antibody directed against the extracellular domain of the HER2 oncoprotein, can effectively target HER2-positive breast cancer through several mechanisms. Although the effects of trastuzumab on cancer cell proliferation, angiogenesis and apoptosis have been investigated in depth, the effect of trastuzumab on microRNA (miRNA) has not been extensively studied. We have performed miRNA microarray profiling before and after trastuzumab treatment in SKBr3 and BT474 human breast cancer cells that overexpress HER2. We found that trastuzumab treatment of SKBr3 cells significantly decreased five miRNAs and increased three others, whereas treatment of BT474 cells significantly decreased two miRNAs and increased nine. The only change in miRNA expression observed in both cell lines following trastuzumab treatment was upregulation of miRNA-194 (miR-194) that was further validated in vitro and in vivo. Forced expression of miR-194 in breast cancer cells that overexpress HER2 produced no effect on apoptosis, modest inhibition of proliferation, significant inhibition of cell migration/invasion in vitro and significant inhibition of xenograft growth in vivo. Conversely, knockdown of miR-194 promoted cell migration. Increased miR-194 expression markedly reduced levels of the cytoskeletal protein talin2 and specifically inhibited luciferase reporter activity of a talin2 wild-type 39-untranslated region, but not that of a mutant reporter, indicating that talin2 is a direct downstream target of miR-194. Trastuzumab treatment inhibited breast cancer cell migration and reduced talin2 expression in vitro and in vivo. Knockdown of talin2 inhibited cell migration/invasion. Knockdown of trastuzumab-induced miR-194 expression with a miR-194 inhibitor compromised trastuzumab-inhibited cell migration in HER2-overexpressing breast cancer cells. Consequently, trastuzumab treatment upregulates miR-194 expression and may exert its cell migration-inhibitory effect through miR-194-mediated downregulation of cytoskeleton protein talin2 in HER2-overexpressing human breast cancer cells.	[Le, Xiao-Feng; Almeida, Maria I.; Mao, Weiqun; Spizzo, Riccardo; Rossi, Simona; Nicoloso, Milena S.; Zhang, Shu; Calin, George A.; Bast, Robert C., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Almeida, Maria I.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Universidade do Minho; University of Texas System; UTMD Anderson Cancer Center	Le, XF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	xfle@mdanderson.org; rbast@mdanderson.org	Almeida, Maria Ines/AAP-3249-2021; Calin, George/E-9390-2011; Almeida, Maria Ines/N-3196-2013; Nicoloso, Milena S/K-6411-2012; Bast, Robert C/E-6585-2011; Spizzo, Riccardo/V-1057-2019; Zhang, Shuxing/F-9942-2014; Almeida, Maria Ines/AAP-2376-2021	Almeida, Maria Ines/0000-0003-2072-8587; Nicoloso, Milena S/0000-0003-4231-9303; Bast, Robert C/0000-0003-4621-8462; Spizzo, Riccardo/0000-0001-7772-0960; Almeida, Maria Ines/0000-0003-2072-8587; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578; Zhang, Shu/0000-0003-0928-6503	Anne and Henry Zarrow Foundation; Laura and John Arnold Foundation; RGK Foundation; MD Anderson NCI CCSG [P30 CA16672]; CLL Global Research Foundation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Anne and Henry Zarrow Foundation; Laura and John Arnold Foundation; RGK Foundation; MD Anderson NCI CCSG; CLL Global Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Anne and Henry Zarrow Foundation, kind gifts from Stuart and Gaye Lynn Zarrow and from Mrs. Delores Wilkenfeld, the Laura and John Arnold Foundation, the RGK Foundation, and the MD Anderson NCI CCSG P30 CA16672. G.A.C. is supported as a Fellow at the University of Texas MD Anderson Research Trust, as a University of Texas System Regents Research Scholar and by the CLL Global Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arnould L, 2006, BRIT J CANCER, V94, P259, DOI 10.1038/sj.bjc.6602930; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Baselga J, 2001, ANN ONCOL, V12, P35, DOI 10.1023/A:1011163824080; Beano A, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-25; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; BURRIDGE K, 1983, CELL MOTIL CYTOSKEL, V3, P405, DOI 10.1002/cm.970030509; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Burstein HJ, 2001, J CLIN ONCOL, V19, P2722, DOI 10.1200/JCO.2001.19.10.2722; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; CARDOSO F, 2002, CLIN BREAST CANCER, V3, P258; Cardoso Fatima, 2002, Clin Breast Cancer, V3, P247, DOI 10.3816/CBC.2002.n.028; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Franco-Cea A, 2010, DEV BIOL, V345, P64, DOI 10.1016/j.ydbio.2010.06.027; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Guler M, 2009, AM J OPHTHALMOL, V147, P703, DOI 10.1016/j.ajo.2008.09.022; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hino Kimihiro, 2007, Nucleic Acids Symp Ser (Oxf), P415, DOI 10.1093/nass/nrm208; Hortobagyi GN, 2001, SEMIN ONCOL, V28, P41, DOI 10.1053/sonc.2001.28549; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734; Kono K, 2002, CANCER RES, V62, P5813; Kos KS, 2003, CANCER-AM CANCER SOC, V98, P1377, DOI 10.1002/cncr.11656; Koukourakis MI, 2003, ANTICANCER RES, V23, P1673; Lane HA, 2001, ANN ONCOL, V12, P21, DOI 10.1023/A:1011155606333; Le XF, 2005, CELL CYCLE, V4, P87, DOI 10.4161/cc.4.1.1360; Le XF, 2005, J BIOL CHEM, V280, P2092, DOI 10.1074/jbc.M403080200; Le XF, 2003, J BIOL CHEM, V278, P23441, DOI 10.1074/jbc.M300848200; Le XF, 2000, CLIN CANCER RES, V6, P260; Le XF, 2000, CANCER RES, V60, P3522; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Le XF, 2006, CELL CYCLE, V5, P1654, DOI 10.4161/cc.5.15.3007; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Le XF, 2010, CANCER-AM CANCER SOC, V116, P4980, DOI 10.1002/cncr.25426; Le XF, 2008, CELL CYCLE, V7, P3747, DOI 10.4161/cc.7.23.7212; Lee S, 2002, CANCER RES, V62, P5703; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Mohsin SK, 2005, J CLIN ONCOL, V23, P2460, DOI 10.1200/JCO.2005.00.661; Molina MA, 2001, CANCER RES, V61, P4744; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Monkley SJ, 2011, DEV BIOL, V349, P494, DOI 10.1016/j.ydbio.2010.11.010; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pegram MD, 1999, SEMIN ONCOL, V26, P89; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Rukov JL, 2011, TRENDS MOL MED, V17, P412, DOI 10.1016/j.molmed.2011.04.003; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sansing HA, 2011, BIOCHEM BIOPH RES CO, V406, P171, DOI 10.1016/j.bbrc.2011.01.109; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Song Y, 2011, ANN SURG ONCOL; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wen XF, 2006, ONCOGENE, V25, P6986, DOI 10.1038/sj.onc.1209685; Yakes FM, 2002, CANCER RES, V62, P4132; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	70	56	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41170	10.1371/journal.pone.0041170	http://dx.doi.org/10.1371/journal.pone.0041170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829924	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300063
J	Ren, Y; Liu, ZZ; Feng, J; Wan, H; Li, JH; Wang, H; Lin, X				Ren, Yuan; Liu, Zhi-zhong; Feng, Jie; Wan, Hong; Li, Jun-hua; Wang, Hao; Lin, Xin			Association of a BMP9 Haplotype with Ossification of the Posterior Longitudinal Ligament (OPLL) in a Chinese Population	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; BODY-MASS INDEX; CERVICAL-SPINE; GENE-THERAPY; POLYMORPHISMS; RISK; SUSCEPTIBILITY; JAPAN	Direct or ex vivo BMP9 adenoviral gene therapy can induce massive bone formation at the injection sites and clearly promote spinal fusion. A comprehensive analysis of the osteogenic activity indicated that BMP9 was one of the most potent inducers of osteogenic differentiation both in vitro and in vivo among 14 types of human BMPs. However, genetic variations and whether they correlated with OPLL were not considered. We have sequenced the complete BMP9 gene in 450 patients with OPLL and in 550 matched controls. Analyses were performed on single markers and haplotypes. Single marker tests identified 6 SNPs, among which the minor alleles of rs7923671 (T > C; P = 0.0026; OR: 1.33, CI: 1.10-1.60), rs75024165 (C > T, Thr304Met; P < 0.001; OR: 1.76, CI: 1.47-2.12) and rs34379100 (A > C; P < 0.001; OR: 1.52, CI: 1.27-1.82) were associated with OPLL. Logistic regression analysis showed that the additive model of rs75024165 (TT vs. CT vs. CC; P < 0.001; OR: 1.74) and rs34379100 (CC vs. AC vs. AA; P = 0.003; OR: 1.95) retained statistical significance when adjusted for clinical and demographic characteristics. Linkage disequilibrium (LD) analysis identified one 3 kb block of intense LD in BMP9 and one specific haplotype, CTCA (P < 0.001; OR: 2.37), that contained the OPLL-associated risk alleles and was a risk factor for OPLL. This haplotype is associated with increased severity of OPLL, as shown by the distribution of ossified vertebrae in patients with OPLL (P = 0.001). In summary, in the Chinese population studied, SNPs in the BMP9 gene appear to contribute to the risk of OPLL in association with certain clinical and demographic characteristics. The severity of OPLL seems to be mediated predominantly by genetic variations in a 3kb BMP9 locus with the specific haplotype CTCA.	[Ren, Yuan; Wang, Hao; Lin, Xin] Capital Med Univ, Dept Orthopaed, Beijing Tiantan Hosp, Beijing, Peoples R China; [Liu, Zhi-zhong] Capital Med Univ, Dept Clin Lab, Beijing Tiantan Hosp, Beijing, Peoples R China; [Feng, Jie; Wan, Hong; Li, Jun-hua] Capital Med Univ, Dept Inst Neurosurg, Beijing Tiantan Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Ren, Y (corresponding author), Capital Med Univ, Dept Orthopaed, Beijing Tiantan Hosp, Beijing, Peoples R China.	Spine001@hotmail.com		Ren, Yuan/0000-0001-5857-9535	National Natural Science Foundation of China [30872599]; Beijing Natural Science Foundation of China [7092028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This research was supported by grants from the National Natural Science Foundation of China (No. 30872599) and the Beijing Natural Science Foundation of China (No. 7092028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaal MM, 2004, J CRANIOFAC SURG, V15, P736, DOI 10.1097/00001665-200409000-00007; Alden TD, 2000, J CRANIOFAC SURG, V11, P24, DOI 10.1097/00001665-200011010-00005; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Dumont RJ, 2002, NEUROSURGERY, V51, P1239, DOI 10.1097/00006123-200211000-00020; Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191; Inamasu J, 2006, NEUROSURGERY, V58, P1027, DOI 10.1227/01.NEU.0000215867.87770.73; Jiang Biao, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P723; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kawaguchi Y, 2003, SPINE, V28, P1424, DOI 10.1097/00007632-200307010-00013; Kim TJ, 2008, JOINT BONE SPINE, V75, P471, DOI 10.1016/j.jbspin.2007.07.019; Kimelman-Bleich N, 2011, MOL THER, V19, P53, DOI 10.1038/mt.2010.190; Kobashi G, 2004, SPINE, V29, P1006, DOI 10.1097/00007632-200405010-00011; Kong QQ, 2007, SPINE, V32, P2834, DOI 10.1097/BRS.0b013e31815b761c; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Li Z, 1999, CHIN J SPINE SPINAL, V9, P285; Liu K C, 1990, Nihon Seikeigeka Gakkai Zasshi, V64, P401; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Matsunaga S, 1999, SPINE, V24, P937, DOI 10.1097/00007632-199905150-00002; Matsunaga Shunji, 2009, Clin Calcium, V19, P1415, DOI CliCa091014151420; Meng XL, 2010, CHINESE MED J-PEKING, V123, P2537, DOI 10.3760/cma.j.issn.0366-6999.2010.18.008; Nakamura I, 1999, HUM GENET, V104, P492, DOI 10.1007/s004390050993; Okamoto K, 2004, J BONE MINER METAB, V22, P612, DOI 10.1007/s00774-004-0531-1; OSTE C, 1988, BIOTECHNIQUES, V6, P162; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; SAKOU T, 1991, SPINE, V16, P1249, DOI 10.1097/00007632-199111000-00001; Sakou T, 2000, J Orthop Sci, V5, P310, DOI 10.1007/s007760050169; Schmidt MH, 2002, SEMIN NEUROL, V22, P143, DOI 10.1055/s-2002-36537; Shingyouchi Y, 1996, SPINE, V21, P2474, DOI 10.1097/00007632-199611010-00013; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Tahara M, 2005, SPINE, V30, P877, DOI 10.1097/01.brs.0000160686.18321.ad; TAKETOMI E, 1992, SPINE, V17, pS55; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; Wang H, 2008, EUR SPINE J, V17, P956, DOI 10.1007/s00586-008-0651-8; Washio M, 2004, J EPIDEMIOL, V14, P168, DOI 10.2188/jea.14.168; Yamauchi T, 1999, J BONE MINER METAB, V17, P296, DOI 10.1007/s007740050098	38	31	34	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40587	10.1371/journal.pone.0040587	http://dx.doi.org/10.1371/journal.pone.0040587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829878	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300016
J	Akesson, S; Klaassen, R; Holmgren, J; Fox, JW; Hedenstrom, A				Akesson, Susanne; Klaassen, Raymond; Holmgren, Jan; Fox, James W.; Hedenstrom, Anders			Migration Routes and Strategies in a Highly Aerial Migrant, the Common Swift Apus apus, Revealed by Light-Level Geolocators	PLOS ONE			English	Article							SEASONAL DIFFERENCES; FLIGHT; PERFORMANCE; STOPOVER; BEHAVIOR; TRACKING; BIRDS; TIME	The tracking of small avian migrants has only recently become possible by the use of small light-level geolocators, allowing the reconstruction of whole migration routes, as well as timing and speed of migration and identification of wintering areas. Such information is crucial for evaluating theories about migration strategies and pinpointing critical areas for migrants of potential conservation value. Here we report data about migration in the common swift, a highly aerial and long-distance migrating species for which only limited information based on ringing recoveries about migration routes and wintering areas is available. Six individuals were successfully tracked throughout a complete migration cycle from Sweden to Africa and back. The autumn migration followed a similar route in all individuals, with an initial southward movement through Europe followed by a more southwest-bound course through Western Sahara to Sub-Saharan stopovers, before a southeastward approach to the final wintering areas in the Congo basin. After approximately six months at wintering sites, which shifted in three of the individuals, spring migration commenced in late April towards a restricted stopover area in West Africa in all but one individual that migrated directly towards north from the wintering area. The first part of spring migration involved a crossing of the Gulf of Guinea in those individuals that visited West Africa. Spring migration was generally wind assisted within Africa, while through Europe variable or head winds were encountered. The average detour at about 50% could be explained by the existence of key feeding sites and wind patterns. The common swift adopts a mixed fly-and-forage strategy, facilitated by its favourable aerodynamic design allowing for efficient use of fuel. This strategy allowed swifts to reach average migration speeds well above 300 km/day in spring, which is higher than possible for similar sized passerines. This study demonstrates that new technology may drastically change our views about migration routes and strategies in small birds, as well as showing the unexpected use of very limited geographical areas during migration that may have important consequences for conservation strategies for migrants.	[Akesson, Susanne; Klaassen, Raymond; Holmgren, Jan; Hedenstrom, Anders] Lund Univ, Dept Biol, Lund, Sweden; [Fox, James W.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Lund University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Akesson, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	anders.hedenstrom@biol.lu.se	Hedenström, Anders/F-5377-2010; Akesson, Susanne/F-3175-2015; Klaassen, Raymond/K-3027-2013	Hedenström, Anders/0000-0002-1757-0945; Akesson, Susanne/0000-0001-9039-2180; 	Swedish Research Council [349-2007-8690, 621-2007-5930]; Lund University; Carl Tryggers Foundation; Natural Environment Research Council [bas010013] Funding Source: researchfish; NERC [bas010013] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University; Carl Tryggers Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was financed by a Linnaeus grant (349-2007-8690) to the Centre for Animal Movement Research (CAnMove) from the Swedish Research Council and Lund University, and research grants from the Swedish Research Council (621-2007-5930) and the Carl Tryggers Foundation to S. Akesson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Backman J, 2001, P ROY SOC B-BIOL SCI, V268, P1081, DOI 10.1098/rspb.2001.1622; BAS, 2010, GEOL MAN V8; CURRY PJ, 1979, IBIS, V121, P20, DOI 10.1111/j.1474-919X.1979.tb05012.x; De Roo A., 1966, Gerfaut, V56, P113; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Elgood, 1982, BIRDS NIGERIA; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; GATTER W, 1987, Vogelwarte, V34, P80; Gatter W., 1997, BIRDS LIBERIA; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; GLADWIN T. W., 1964, BRIT BIRDS, V57, P344; Grimes L, 1987, BIRDS GHANA; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hall-Karlsson S., 2008, SWEDISH BIRD RINGING, V2; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hedenstrom A, 1998, J AVIAN BIOL, V29, P424, DOI 10.2307/3677161; Hedenstrom A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000362; Henningsson P, 2011, J R SOC INTERFACE, V8, P807, DOI 10.1098/rsif.2010.0533; Henningsson P, 2011, J EXP BIOL, V214, P382, DOI 10.1242/jeb.050609; Henningsson P, 2009, P ROY SOC B-BIOL SCI, V276, P2395, DOI 10.1098/rspb.2009.0195; Holmgren J, 2004, IBIS, V146, P404, DOI 10.1111/j.1474-919X.2004.00274.x; Kemp MU, 2010, J AVIAN BIOL, V41, P672, DOI 10.1111/j.1600-048X.2010.05053.x; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Lack D., 1956, SWIFTS TOWER; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Lockley RM, 1970, OSTRICH S, V8, P265; Magnusson M., 1948, Var Fagelvarld, V7, P129; Moreau R., 1972, PALAEARCTIC AFRICAN; PERRINS C, 1971, BIRD STUDY, V18, P61, DOI 10.1080/00063657109476297; Perrins C, 2005, MIGRATION ATLAS MOVE, P443; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; Putz K, 2002, CONDOR, V104, P528, DOI 10.1650/0010-5422(2002)104[0528:SATVIT]2.0.CO;2; RAPPOLE JH, 1976, OECOLOGIA, V26, P193, DOI 10.1007/BF00345289; SERLE W, 1950, IBIS, V92, P602, DOI 10.1111/j.1474-919X.1950.tb01768.x; Speek BJ, 1984, THIEMES VOGELTREKATL; Strandberg R, 2007, BEHAV ECOL SOCIOBIOL, V61, P1865, DOI 10.1007/s00265-007-0426-y; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; WEITNAUER E, 1975, Ornithologische Beobachter, V72, P87; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	49	111	125	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41195	10.1371/journal.pone.0041195	http://dx.doi.org/10.1371/journal.pone.0041195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815968	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000306548900096
J	Beazley, MJ; Martinez, RJ; Rajan, S; Powell, J; Piceno, YM; Tom, LM; Andersen, GL; Hazen, TC; Van Nostrand, JD; Zhou, JZ; Mortazavi, B; Sobecky, PA				Beazley, Melanie J.; Martinez, Robert J.; Rajan, Suja; Powell, Jessica; Piceno, Yvette M.; Tom, Lauren M.; Andersen, Gary L.; Hazen, Terry C.; Van Nostrand, Joy D.; Zhou, Jizhong; Mortazavi, Behzad; Sobecky, Patricia A.			Microbial Community Analysis of a Coastal Salt Marsh Affected by the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							GULF-OF-MEXICO; POLYCYCLIC AROMATIC-HYDROCARBONS; PETROLEUM-HYDROCARBONS; DEGRADING BACTERIA; RIBOSOMAL-RNA; CRUDE-OIL; SEDIMENTS; DEGRADATION; BIODEGRADATION; PHYTOREMEDIATION	Coastal salt marshes are highly sensitive wetland ecosystems that can sustain long-term impacts from anthropogenic events such as oil spills. In this study, we examined the microbial communities of a Gulf of Mexico coastal salt marsh during and after the influx of petroleum hydrocarbons following the Deepwater Horizon oil spill. Total hydrocarbon concentrations in salt marsh sediments were highest in June and July 2010 and decreased in September 2010. Coupled PhyloChip and GeoChip microarray analyses demonstrated that the microbial community structure and function of the extant salt marsh hydrocarbon-degrading microbial populations changed significantly during the study. The relative richness and abundance of phyla containing previously described hydrocarbon-degrading bacteria (Proteobacteria, Bacteroidetes, and Actinobacteria) increased in hydrocarbon-contaminated sediments and then decreased once hydrocarbons were below detection. Firmicutes, however, continued to increase in relative richness and abundance after hydrocarbon concentrations were below detection. Functional genes involved in hydrocarbon degradation were enriched in hydrocarbon-contaminated sediments then declined significantly (p<0.05) once hydrocarbon concentrations decreased. A greater decrease in hydrocarbon concentrations among marsh grass sediments compared to inlet sediments (lacking marsh grass) suggests that the marsh rhizosphere microbial communities could also be contributing to hydrocarbon degradation. The results of this study provide a comprehensive view of microbial community structural and functional dynamics within perturbed salt marsh ecosystems.	[Beazley, Melanie J.; Martinez, Robert J.; Rajan, Suja; Powell, Jessica; Mortazavi, Behzad; Sobecky, Patricia A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Piceno, Yvette M.; Tom, Lauren M.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Hazen, Terry C.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Mortazavi, Behzad] Dauphin Isl Sea Lab, Dauphin Isl, AL USA	University of Alabama System; University of Alabama Tuscaloosa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tennessee System; University of Tennessee Knoxville; University of Oklahoma System; University of Oklahoma - Norman; Dauphin Island Sea Lab	Beazley, MJ (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	psobecky@as.ua.edu	Piceno, Yvette/I-6738-2016; Hazen, Terry C/C-1076-2012; Beazley, Melanie J./R-5716-2019; Mortazavi, Behzad/D-3864-2013; Andersen, Gary/G-2792-2015; Tom, Lauren/E-9739-2015; 吴, 昊/AAB-1620-2020; Van Nostrand, Joy D/F-1740-2016; Mortazavi, Behzad/ABC-4483-2020	Piceno, Yvette/0000-0002-7915-4699; Hazen, Terry C/0000-0002-2536-9993; Beazley, Melanie J./0000-0001-9973-7798; Mortazavi, Behzad/0000-0002-1912-1940; Andersen, Gary/0000-0002-1618-9827; Van Nostrand, Joy D/0000-0001-9548-6450; Mortazavi, Behzad/0000-0002-1912-1940; Martinez, Robert/0000-0003-0836-4776	National Science Foundation-CBET [RAPID 1042743]; Dauphin Island Sea Lab/Marine Environmental Science Consortium [2423 Jv, T4-005UA]	National Science Foundation-CBET(National Science Foundation (NSF)); Dauphin Island Sea Lab/Marine Environmental Science Consortium	This work was supported by National Science Foundation-CBET (RAPID 1042743) and Dauphin Island Sea Lab/Marine Environmental Science Consortium 2423 Jv, T4-005UA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; AMUND OO, 1991, TRIBOL INT, V24, P235, DOI 10.1016/0301-679X(91)90049-F; Anderson RT, 2000, ENVIRON SCI TECHNOL, V34, P2261, DOI 10.1021/es991211a; Andrade ML, 2004, J ENVIRON QUAL, V33, P2103, DOI 10.2134/jeq2004.2103; Arulazhagan P, 2011, MAR POLLUT BULL, V62, P388, DOI 10.1016/j.marpolbul.2010.09.020; ATLAS RM, 1981, MICROBIOL REV, V45, P180, DOI 10.1128/MMBR.45.1.180-209.1981; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; Bognolo G, 1999, COLLOID SURFACE A, V152, P41, DOI 10.1016/S0927-7757(98)00684-0; BRENDEL PJ, 1995, ENVIRON SCI TECHNOL, V29, P751, DOI 10.1021/es00003a024; Burke DJ, 2002, APPL ENVIRON MICROB, V68, P1157, DOI 10.1128/AEM.68.3.1157-1164.2002; BURNS KA, 1993, MAR POLLUT BULL, V26, P239, DOI 10.1016/0025-326X(93)90062-O; Camilli R, 2012, P NATL ACAD SCI USA, V109, P20235, DOI 10.1073/pnas.1100385108; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Cervantes FJ, 2001, APPL ENVIRON MICROB, V67, P4471, DOI 10.1128/AEM.67.10.4471-4478.2001; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; De la Rosa-Garcia SC, 2007, LETT APPL MICROBIOL, V45, P289, DOI 10.1111/j.1472-765X.2007.02185.x; Deppe U, 2005, EXTREMOPHILES, V9, P461, DOI 10.1007/s00792-005-0463-2; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Edlund A, 2008, FEMS MICROBIOL ECOL, V65, P513, DOI 10.1111/j.1574-6941.2008.00513.x; Edwards BR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035301; Gilfillan ES, 1995, MAR POLLUT BULL, V30, P780, DOI 10.1016/0025-326X(95)00069-Y; Hamann C, 1999, FEMS MICROBIOL LETT, V173, P255, DOI 10.1111/j.1574-6968.1999.tb13510.x; Harvey PJ, 2002, ENVIRON SCI POLLUT R, V9, P29, DOI 10.1007/BF02987315; Hayworth JS, 2011, HYDROL EARTH SYST SC, V15, P3639, DOI 10.5194/hess-15-3639-2011; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He ZL, 2008, T NONFERR METAL SOC, V18, P1319, DOI 10.1016/S1003-6326(09)60004-2; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Hegazi AH, 2004, CHEMOSPHERE, V55, P1053, DOI 10.1016/j.chemosphere.2004.01.019; Heider J, 1998, FEMS MICROBIOL REV, V22, P459, DOI 10.1111/j.1574-6976.1998.tb00381.x; Hoff R. Z., 1995, 961 NOAA HAZMAT; Horel A, 2012, ENVIRON TOXICOL CHEM, V31, P1004, DOI 10.1002/etc.1770; Ilori MO, 2005, CHEMOSPHERE, V61, P985, DOI 10.1016/j.chemosphere.2005.03.066; Juhasz AL, 2000, LETT APPL MICROBIOL, V30, P396, DOI 10.1046/j.1472-765x.2000.00733.x; Kokaly R. F, 2011, 20111022 US GEOL SUR; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Lasher C, 2009, MICROB ECOL, V58, P244, DOI 10.1007/s00248-008-9481-9; Lee RF, 1997, MAR POLLUT BULL, V34, P928, DOI 10.1016/S0025-326X(97)00078-7; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lin QX, 2009, ECOL ENG, V35, P85, DOI 10.1016/j.ecoleng.2008.09.010; Lin QX, 1998, ECOL ENG, V10, P263, DOI 10.1016/S0925-8574(98)00015-9; Lobao MM, 2010, MAR POLLUT BULL, V60, P2263, DOI 10.1016/j.marpolbul.2010.08.008; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Luther GW, 1996, GEOCHIM COSMOCHIM AC, V60, P951, DOI 10.1016/0016-7037(95)00444-0; MacDonald IR, 2002, GEOFLUIDS, V2, P95, DOI 10.1046/j.1468-8123.2002.00023.x; Mann KH, 2000, ECOLOGY COASTAL WATE; Martinez RJ, 2006, ENVIRON MICROBIOL, V8, P1783, DOI 10.1111/j.1462-2920.2006.01063.x; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Oka AR, 2011, ENVIRON SCI TECHNOL, V45, P3407, DOI 10.1021/es103859t; Operational Science Advisory Team II, 2011, SUMM REP FAT EFF REM; Page DS, 1999, MAR POLLUT BULL, V38, P247, DOI 10.1016/S0025-326X(98)00142-8; Pearson A, 2008, APPL ENVIRON MICROB, V74, P1157, DOI 10.1128/AEM.01014-07; Phelps CD, 1999, BIODEGRADATION, V10, P15, DOI 10.1023/A:1008303729431; Prince R, 2005, BIOREMEDIATION: APPLIED MICROBIAL SOLUTIONS FOR REAL-WORLD ENVIRONMENTAL CLEANUP, P269; Prince RC, 2005, PETROLEUM MICROBIOLOGY, P317; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Roberts HH, 1997, ECON GEOL BULL SOC, V92, P863, DOI 10.2113/gsecongeo.92.7-8.863; Ron EZ, 2002, CURR OPIN BIOTECH, V13, P249, DOI 10.1016/S0958-1669(02)00316-6; SASSEN R, 1993, OIL GAS J, V91, P64; SCHNOOR JL, 1995, ENVIRON SCI TECHNOL, V29, pA318, DOI [10.1021/es00007a002, 10.1021/es00007a747]; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Taillefert M, 2007, GEOCHEM T, V8, DOI 10.1186/1467-4866-8-6; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Wang M, 2007, PEDOSPHERE, V17, P545, DOI 10.1016/S1002-0160(07)60065-4; Yumoto I, 2002, INT J SYST EVOL MICR, V52, P85, DOI 10.1099/00207713-52-1-85; Zhu X., 2004, GUIDELINES BIOREMEDI	67	145	151	0	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41305	10.1371/journal.pone.0041305	http://dx.doi.org/10.1371/journal.pone.0041305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815990	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900109
J	Karalija, A; Novikova, LN; Kingham, PJ; Wiberg, M; Novikov, LN				Karalija, Amar; Novikova, Liudmila N.; Kingham, Paul J.; Wiberg, Mikael; Novikov, Lev N.			Neuroprotective Effects of N-Acetyl-Cysteine and Acetyl-L-Carnitine after Spinal Cord Injury in Adult Rats	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; ISCHEMIA-REPERFUSION INJURY; OLFACTORY ENSHEATHING CELLS; AXONAL REGENERATION; FUNCTIONAL RECOVERY; NEURONAL SURVIVAL; GROWTH-FACTOR; NEUROTROPHIC FACTORS; RUBROSPINAL NEURONS; LIPID-PEROXIDATION	Following the initial acute stage of spinal cord injury, a cascade of cellular and inflammatory responses will lead to progressive secondary damage of the nerve tissue surrounding the primary injury site. The degeneration is manifested by loss of neurons and glial cells, demyelination and cyst formation. Injury to the mammalian spinal cord results in nearly complete failure of the severed axons to regenerate. We have previously demonstrated that the antioxidants N-acetyl-cysteine (NAC) and acetyl-L-carnitine (ALC) can attenuate retrograde neuronal degeneration after peripheral nerve and ventral root injury. The present study evaluates the effects of NAC and ALC on neuronal survival, axonal sprouting and glial cell reactions after spinal cord injury in adult rats. Tibial motoneurons in the spinal cord were pre-labeled with fluorescent tracer Fast Blue one week before lumbar L5 hemisection. Continuous intrathecal infusion of NAC (2.4 mg/day) or ALC (0.9 mg/day) was initiated immediately after spinal injury using Alzet 2002 osmotic minipumps. Neuroprotective effects of treatment were assessed by counting surviving motoneurons and by using quantitative immunohistochemistry and Western blotting for neuronal and glial cell markers 4 weeks after hemisection. Spinal cord injury induced significant loss of tibial motoneurons in L4-L6 segments. Neuronal degeneration was associated with decreased immunostaining for microtubular-associated protein-2 (MAP2) in dendritic branches, synaptophysin in presynaptic boutons and neurofilaments in nerve fibers. Immunostaining for the astroglial marker GFAP and microglial marker OX42 was increased. Treatment with NAC and ALC rescued approximately half of the motoneurons destined to die. In addition, antioxidants restored MAP2 and synaptophysin immunoreactivity. However, the perineuronal synaptophysin labeling was not recovered. Although both treatments promoted axonal sprouting, there was no effect on reactive astrocytes. In contrast, the microglial reaction was significantly attenuated. The results indicate a therapeutic potential for NAC and ALC in the early treatment of traumatic spinal cord injury.	[Karalija, Amar; Novikova, Liudmila N.; Kingham, Paul J.; Wiberg, Mikael; Novikov, Lev N.] Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden; [Wiberg, Mikael] Umea Univ, Sect Hand & Plast Surg, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University	Karalija, A (corresponding author), Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden.	lev.novikov@anatomy.umu.se	Novikov, Lev/I-1983-2012	Novikov, Lev/0000-0001-5520-3890; Kingham, Paul/0000-0003-2596-5936	Swedish Medical Research Council; European Union; Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magn. Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Union(European Commission); Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magn. Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	This study was supported by the Swedish Medical Research Council, European Union, Umea University, County of Vasterbotten, Ake Wibergs Stiftelse, Magn. Bergvalls Stiftelse, Clas Groschinskys Minnesfond and the Gunvor and Josef Aner Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELUCCI L, 1988, J NEUROSCI RES, V20, P491, DOI 10.1002/jnr.490200413; Arakawa M, 2007, CEREBELLUM, V6, P308, DOI 10.1080/14734220601142878; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; BERNSTEIN JJ, 1984, EXP NEUROL, V83, P548, DOI 10.1016/0014-4886(84)90122-5; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Brooks J O 3rd, 1998, Int Psychogeriatr, V10, P193, DOI 10.1017/S1041610298005304; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cakir O, 2003, CARDIOVASC SURG, V11, P375, DOI 10.1016/S0967-2109(03)00077-2; Calabrese V, 2005, J NEUROSCI RES, V79, P509, DOI 10.1002/jnr.20386; Cullheim S, 2002, BRAIN RES REV, V40, P309, DOI 10.1016/S0165-0173(02)00213-8; CULLHEIM S, 1978, J COMP NEUROL, V178, P537, DOI 10.1002/cne.901780309; CUMMINGS JP, 1988, EXP NEUROL, V100, P381, DOI 10.1016/0014-4886(88)90116-1; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Diaz-Ruiz A, 2000, NEUROREPORT, V11, P1765, DOI 10.1097/00001756-200006050-00033; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dringen R, 1999, NEUROSCI LETT, V259, P79, DOI 10.1016/S0304-3940(98)00894-5; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Evans JD, 2008, ANN PHARMACOTHER, V42, P1686, DOI 10.1345/aph.1L201; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; FERNANDEZ E, 1995, NEUROL RES, V17, P373, DOI 10.1080/01616412.1995.11740345; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Harkey H Louis 3rd, 2003, Anat Rec B New Anat, V271, P41, DOI 10.1002/ar.b.10012; Hart AM, 2004, NEUROSCIENCE, V125, P91, DOI 10.1016/j.neuroscience.2003.12.040; Hart AM, 2002, EXP BRAIN RES, V145, P182, DOI 10.1007/s00221-002-1100-2; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hawthorne AL, 2011, NEUROTHERAPEUTICS, V8, P252, DOI 10.1007/s13311-011-0032-6; Heard KJ, 2008, NEW ENGL J MED, V359, P285, DOI 10.1056/NEJMct0708278; Hillard VH, 2004, J NEUROTRAUM, V21, P1405, DOI 10.1089/neu.2004.21.1405; Jivan S, 2006, EXP BRAIN RES, V170, P245, DOI 10.1007/s00221-005-0207-7; Kaynar MY, 1998, NEUROSURG REV, V21, P260, DOI 10.1007/BF01105782; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kocogullari CU, 2008, SURG TODAY, V38, P237, DOI 10.1007/s00595-007-3614-5; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; MANFRIDI A, 1992, INT J DEV NEUROSCI, V10, P321, DOI 10.1016/0736-5748(92)90021-Q; McEwen ML, 2011, NEUROTHERAPEUTICS, V8, P168, DOI 10.1007/s13311-011-0031-7; Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27; Muneer PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019258; NACIMIENTO W, 1995, ACTA NEUROPATHOL, V90, P552; Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6; Novikova L, 1997, EUR J NEUROSCI, V9, P2774, DOI 10.1111/j.1460-9568.1997.tb01706.x; Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9; Novikova L, 1996, NEUROSCI LETT, V220, P203, DOI 10.1016/S0304-3940(96)13267-5; Novikova LN, 2011, EXP NEUROL, V229, P132, DOI 10.1016/j.expneurol.2010.09.021; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Novikova LN, 2002, J COMP NEUROL, V452, P255, DOI 10.1002/cne.10381; Park DS, 1996, J BIOL CHEM, V271, P21898, DOI 10.1074/jbc.271.36.21898; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Rahman A, 2001, EUR J CARDIO-THORAC, V20, P65, DOI 10.1016/S1010-7940(01)00756-4; Reid AJ, 2010, BRAIN RES, V1310, P1, DOI 10.1016/j.brainres.2009.11.011; Reid AJ, 2009, NEUROSCI RES, V65, P148, DOI 10.1016/j.neures.2009.06.008; Sasaki M, 2006, GLIA, V53, P352, DOI 10.1002/glia.20285; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Steencken ACC, 2010, NEUROSCIENCE, V170, P971, DOI 10.1016/j.neuroscience.2010.06.064; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SWETT JE, 1986, EXP NEUROL, V93, P227, DOI 10.1016/0014-4886(86)90161-5; TAGLIALATELA G, 1991, DEV BRAIN RES, V59, P221, DOI 10.1016/0165-3806(91)90102-O; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Wang CC, 2009, J CELL BIOCHEM, V107, P933, DOI 10.1002/jcb.22196; Welin D, 2008, EXP BRAIN RES, V186, P315, DOI 10.1007/s00221-007-1232-5; Welin D, 2009, BRAIN RES, V1287, P58, DOI 10.1016/j.brainres.2009.06.038; Wilson ADH, 2007, J PLAST RECONSTR AES, V60, P114, DOI 10.1016/j.bjps.2006.04.017; Woo MS, 2008, J NEUROCHEM, V106, P770, DOI 10.1111/j.1471-4159.2008.05430.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiao M, 2005, EXP NEUROL, V194, P12, DOI 10.1016/j.expneurol.2005.01.021; Yan CYI, 1998, J NEUROSCI, V18, P4042; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Zanelli SA, 2005, ANN NY ACAD SCI, V1053, P153, DOI 10.1196/annals.1344.013; Zhang CG, 2005, BRIT J PLAST SURG, V58, P765, DOI 10.1016/j.bjps.2005.04.012; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	79	63	66	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41086	10.1371/journal.pone.0041086	http://dx.doi.org/10.1371/journal.pone.0041086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815926	Green Submitted, gold, Green Published			2022-12-25	WOS:000306507000063
J	Bhattacharya, A; Schmitz, U; Wolkenhauer, O; Schoenherr, M; Raatz, Y; Kunz, M				Bhattacharya, A.; Schmitz, U.; Wolkenhauer, O.; Schoenherr, M.; Raatz, Y.; Kunz, M.			Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma	ONCOGENE			English	Article						microRNA; melanoma; metastasis; cell cycle	SUPPRESSES TUMORIGENICITY; MICRORNAS; EXPRESSION; GENES; METASTASIS; INHIBITION; MK-1775; PATHWAY; CHK1; P53	WEE1 kinase has been described as a major gate keeper at the G2 cell cycle checkpoint and to be involved in tumour progression in different malignant tumours. Here we analysed the expression levels of WEE1 in a series of melanoma patient samples and melanoma cell lines using immunoblotting, quantitative real-time PCR and immunohistochemistry. WEE1 expression was significantly downregulated in patient samples of metastatic origin as compared with primary melanomas and in melanoma cell lines of high aggressiveness as compared with cell lines of low aggressiveness. Moreover, there was an inverse correlation between the expression of WEE1 and WEE1-targeting microRNA miR-195. Further analyses showed that transfection of melanoma cell lines with miR-195 indeed reduced WEE1 mRNA and protein expression in these cells. Reporter gene analysis confirmed direct targeting of the WEE1 3' untranslated region (3'UTR) by miR-195. Overexpression of miR-195 in SK-Mel-28 melanoma cells was accompanied by WEE1 reduction and significantly reduced stress-induced G2-M cell cycle arrest, which could be restored by stable overexpression of WEE1. Moreover, miR-195 overexpression and WEE1 knockdown, respectively, increased melanoma cell proliferation. miR-195 overexpression also enhanced migration and invasiveness of melanoma cells. Taken together, the present study shows that WEE1 expression in malignant melanoma is directly regulated by miR-195. miR-195-mediated downregulation of WEE1 in metastatic lesions may help to overcome cell cycle arrest under stress conditions in the local tissue microenvironment to allow unrestricted growth of tumour cells.	[Bhattacharya, A.; Schoenherr, M.; Raatz, Y.; Kunz, M.] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04103 Leipzig, Germany; [Schmitz, U.; Wolkenhauer, O.] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany	Leipzig University; University of Rostock	Bhattacharya, A (corresponding author), Univ Leipzig, Dept Dermatol Venereol & Allergol, Philipp Rosenthal St 23-25, D-04103 Leipzig, Germany.	animesh.bhattacharya@medizin.uni-leipzig.de	Schmitz, Ulf/B-5400-2010	Schmitz, Ulf/0000-0001-5806-4662; Wolkenhauer, Olaf/0000-0001-6105-2937	Deutsche Forschungsgemeinschaft [KU 1320/5-1, WO 991/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank T Magin, Translational Centre for Regenerative Medicine (TRM), Division of Cell and Developmental Biology, University of Leipzig, for helpful advice and discussion. This work was supported by the Deutsche Forschungsgemeinschaft, grant number KU 1320/5-1 to MK and grant number WO 991/4-1 to WO.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto O, 2003, MOL CARCINOGEN, V36, P171, DOI 10.1002/mc.10111; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirai H, 2010, CANCER BIOL THER, V9, P514, DOI 10.4161/cbt.9.7.11115; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Jewell R, 2010, CLIN CANCER RES, V16, P5211, DOI 10.1158/1078-0432.CCR-10-1521; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Lee J, 2001, MOL BIOL CELL, V12, P551, DOI 10.1091/mbc.12.3.551; Levati L, 2009, INT J ONCOL, V35, P393, DOI 10.3892/ijo_00000352; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Ujifuku K, 2010, CANCER LETT, V296, P241, DOI 10.1016/j.canlet.2010.04.013; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Wang YL, 2001, CANCER RES, V61, P8211; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	40	77	82	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2013	32	26					3175	3183		10.1038/onc.2012.324	http://dx.doi.org/10.1038/onc.2012.324			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22847610				2022-12-25	WOS:000321004600008
J	Banerjee, P; Basu, A; Wegiel, B; Otterbein, LE; Mizumura, K; Gasser, M; Waaga-Gasser, AM; Choi, AM; Pal, S				Banerjee, Pallavi; Basu, Aninda; Wegiel, Barbara; Otterbein, Leo E.; Mizumura, Kenji; Gasser, Martin; Waaga-Gasser, Ana Maria; Choi, Augustine M.; Pal, Soumitro			Heme Oxygenase-1 Promotes Survival of Renal Cancer Cells through Modulation of Apoptosis- and Autophagy-regulating Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; CARBON-MONOXIDE; TUMOR-GROWTH; INHIBITION; INDUCTION; EXPRESSION; TUMORIGENESIS; ACTIVATION; CROSSTALK; PATHWAYS	The cytoprotective enzyme heme oxygenase-1 (HO-1) is often overexpressed in different types of cancers and promotes cancer progression. We have recently shown that the Ras-Raf-ERK pathway induces HO-1 to promote survival of renal cancer cells. Here, we examined the possible mechanisms underlying HO-1-mediated cell survival. Considering the growing evidence about the significance of apoptosis and autophagy in cancer, we tried to investigate how HO-1 controls these events to regulate survival of cancer cells. Rapamycin (RAPA) and sorafenib, two commonly used drugs for renal cancer treatment, were found to induce HO-1 expression in renal cancer cells Caki-1 and 786-O; and the apoptotic effect of these drugs was markedly enhanced upon HO-1 knockdown. Overexpression of HO-1 protected the cells from RAPA- and sorafenib-induced apoptosis and also averted drug-mediated inhibition of cell proliferation. HO-1 induced the expression of anti-apoptotic Bcl-xL and decreased the expression of autophagic proteins Beclin-1 and LC3B-II; while knockdown of HO-1 down-regulated Bcl-xL and markedly increased LC3B-II. Moreover, HO-1 promoted the association of Beclin-1 with Bcl-xL and Rubicon, a novel negative regulator of autophagy. Drug-induced dissociation of Beclin-1 from Rubicon and the induction of autophagy were also inhibited by HO-1. Together, our data signify that HO-1 is up-regulated in renal cancer cells as a survival strategy against chemotherapeutic drugs and promotes growth of tumor cells by inhibiting both apoptosis and autophagy. Thus, application of chemotherapeutic drugs along with HO-1 inhibitor may elevate therapeutic efficiency by reducing the cytoprotective effects of HO-1 and by simultaneous induction of both apoptosis and autophagy.	[Banerjee, Pallavi; Basu, Aninda; Pal, Soumitro] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Banerjee, Pallavi; Basu, Aninda; Wegiel, Barbara; Otterbein, Leo E.; Mizumura, Kenji; Choi, Augustine M.; Pal, Soumitro] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wegiel, Barbara; Otterbein, Leo E.] Beth Israel Deaconess Med Ctr, Dept Surg, Transplant Inst, Boston, MA 02215 USA; [Mizumura, Kenji] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gasser, Martin; Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97080 Wurzburg, Germany	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; University of Wurzburg	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu		Mizumura, Kenji/0000-0001-8532-9670	National Institutes of Health [R01 CA131145]; American Society of Transplantation; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Transplantation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA131145 (to S. P.) and a Fellowship Grant from American Society of Transplantation (to P. B.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Al-Owais MMA, 2012, J BIOL CHEM, V287, P24754, DOI 10.1074/jbc.M112.357012; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Amundson SA, 2000, CANCER RES, V60, P6101; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Busserolles J, 2006, INT J BIOCHEM CELL B, V38, P1510, DOI 10.1016/j.biocel.2006.03.013; Chen HY, 2011, CANCER PREV RES, V4, P973, DOI 10.1158/1940-6207.CAPR-10-0387; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gobe G, 2002, CANCER INVEST, V20, P324, DOI 10.1081/CNV-120001177; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Hill M, 2005, FASEB J, V19, P1957, DOI 10.1096/fj.05-3875com; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hoare M, 2011, SEMIN CANCER BIOL, V21, P397, DOI 10.1016/j.semcancer.2011.09.004; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kongpetch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034994; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kuroda H, 2010, LUNG CANCER, V67, P31, DOI 10.1016/j.lungcan.2009.03.015; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043; Long J. S., 2012, ONCOGENE IN PRESS; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nishida K, 2008, CIRC RES, V103, P343, DOI 10.1161/CIRCRESAHA.108.175448; Nuhn P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-37; Oh S, 2011, CELL DEATH DIFFER, V18, P452, DOI 10.1038/cdd.2010.116; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Schorr K, 2000, CANCER RES, V60, P5950; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	49	63	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32113	32123		10.1074/jbc.M112.393140	http://dx.doi.org/10.1074/jbc.M112.393140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843690	hybrid, Green Published			2022-12-25	WOS:000309059400049
J	Hoshino, S; Hayashi, I				Hoshino, Shota; Hayashi, Ikuko			Filament Formation of the FtsZ/Tubulin-like Protein TubZ from the Bacillus cereus pXO1 Plasmid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULIN HOMOLOG TUBZ; PROKARYOTIC ACTIN HOMOLOG; BACTERIAL CYTOSKELETON; THURINGIENSIS SUBSP; ATOMIC STRUCTURES; FTSZ; ANTHRACIS; REPLICATION; SOFTWARE; POLYMERIZATION	Stable maintenance of low-copy-number plasmids requires partition (par) systems that consist of a nucleotide hydrolase, a DNA-binding protein, and a cis-acting DNA-binding site. The FtsZ/tubulin-like GTPase TubZ was identified as a partitioning factor of the virulence plasmids pBtoxis and pXO1 in Bacillus thuringiensis and Bacillus anthracis, respectively. TubZ exhibits high GTPase activity and assembles into polymers both in vivo and in vitro, and its "treadmilling" movement is required for plasmid stability in the cell. To investigate the molecular mechanism of pXO1 plasmid segregation by TubZ filaments, we determined the crystal structures of Bacillus cereus TubZ in apo-, GDP-, and guanosine 5'-3-O-(thio)triphosphate (GTP gamma S)-bound forms at resolutions of 2.1, 1.9, and 3.3 angstrom, respectively. Interestingly, the slowly hydrolyzable GTP analog GTP gamma S was hydrolyzed to GDP in the crystal. In the post-GTP hydrolysis state, GDP-bound B. cereus TubZ forms a dimer by the head-to-tail association of individual subunits in the asymmetric unit, which is similar to the protofilament formation of FtsZ and B. thuringiensis TubZ. However, the M loop interacts with the nucleotide-binding site of the adjacent subunit and stabilizes the filament structure in a different manner, which indicates that the molecular assembly of the TubZ-related par systems is not stringently conserved. Furthermore, we show that the C-terminal tail of TubZ is required for association with the DNA-binding protein TubR. Using a combination of crystallography, site-directed mutagenesis, and biochemical analysis, our results provide the structural basis of the TubZ polymer that may drive DNA segregation.	[Hoshino, Shota; Hayashi, Ikuko] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Yokohama, Kanagawa 2300045, Japan	Yokohama City University	Hayashi, I (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan.	ihay@tsurumi.yokohama-cu.ac.jp			Hayashi Memorial Foundation for Female Natural Scientists	Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by the Hayashi Memorial Foundation for Female Natural Scientists (to I. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akhtar P, 2009, J BACTERIOL, V191, P2493, DOI 10.1128/JB.00027-09; Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; Delano W.L, 2002, PYMOL USERS MANUAL; Diaz JF, 2001, J BIOL CHEM, V276, P17307, DOI 10.1074/jbc.M010920200; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; JENSEN RB, 1994, J MOL BIOL, V236, P1299, DOI 10.1016/0022-2836(94)90059-0; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Makarova KS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-33; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2012, P NATL ACAD SCI USA, V109, P7711, DOI 10.1073/pnas.1121546109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Tang M, 2007, J BACTERIOL, V189, P8053, DOI 10.1128/JB.00908-07; Tang MJ, 2006, APPL ENVIRON MICROB, V72, P6948, DOI 10.1128/AEM.00976-06; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; van den Ent F, 2001, CURR OPIN MICROBIOL, V4, P634, DOI 10.1016/S1369-5274(01)00262-4; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WEISENBERG RC, 1976, BIOCHEMISTRY-US, V15, P4248, DOI 10.1021/bi00664a018	37	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32103	32112		10.1074/jbc.M112.373803	http://dx.doi.org/10.1074/jbc.M112.373803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22847006	Green Published, hybrid			2022-12-25	WOS:000309059400048
J	Forgione, N; Tropepe, V				Forgione, Nicole; Tropepe, Vincent			Toll-Like Signaling and the Cytokine IL-6 Regulate Histone Deacetylase Dependent Neuronal Survival	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; CORTICAL-NEURONS; VALPROIC ACID; INHIBITION; BRAIN; INTERLEUKIN-6; ASTROCYTES; DEATH; NEUROPROTECTION; CULTURES	Histone deacetylase (HDAC) proteins have a role in promoting neuronal survival in vitro, but the mechanism underlying this function has not been identified. Here we provide evidence that components of the neuronal microenvironment, including non-neuronal cells and defined culture media, can mitigate midbrain neuronal cell death induced by HDAC inhibitor treatment. Using microarrays we further identified gene expression changes taking place in non-neuronal cells as a result of HDAC inhibition. This analysis demonstrated that HDAC inhibitor treatment results in the down-regulation of immunity related signaling factors, in particular the Toll-like receptors (TLR). TLR signaling is active in cultured midbrain cells, yet blocking TLR receptors is not sufficient to cause neuronal cell death. In contrast, selective activation of this pathway using TLR ligands can modestly block the effects of HDAC inhibition. Furthermore, we observed that the negative effects of HDAC inhibitor treatment on neuronal survival could be more substantially blocked by the cytokine Interleukin-6 (IL-6), which is a major downstream target of TLR signaling. These data suggest that HDACs function to promote neuronal survival by activating a TLR and IL-6 dependent pathway.	[Forgione, Nicole; Tropepe, Vincent] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Tropepe, Vincent] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Forgione, N (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	v.tropepe@utoronto.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; Faraco G, 2009, NEUROBIOL DIS, V36, P269, DOI 10.1016/j.nbd.2009.07.019; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Forgione N, 2011, MOL CELL NEUROSCI, V48, P117, DOI 10.1016/j.mcn.2011.06.012; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; KUSHIMA Y, 1992, NEUROSCI LETT, V143, P110, DOI 10.1016/0304-3940(92)90244-2; LaBonte MJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-67; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; NORRIS JG, 1993, J NEUROIMMUNOL, V45, P137; Okun E, 2011, TRENDS NEUROSCI; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shaked M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002668; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Steelman AJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-89; Sub HS, 2010, J NEUROIMMUNE PHARM, V5, P521, DOI 10.1007/s11481-010-9192-0	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41033	10.1371/journal.pone.0041033	http://dx.doi.org/10.1371/journal.pone.0041033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848425	Green Submitted, gold, Green Published			2022-12-25	WOS:000306950200039
J	Annibali, D; Gioia, U; Savino, M; Laneve, P; Caffarelli, E; Nasi, S				Annibali, Daniela; Gioia, Ubaldo; Savino, Mauro; Laneve, Pietro; Caffarelli, Elisa; Nasi, Sergio			A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and-103, Target the Differentiation Inhibitor ID2	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; HUMAN NEUROBLASTOMA-CELLS; NEURONAL DIFFERENTIATION; RETINOBLASTOMA PROTEIN; CANCER METASTASIS; PROGENITOR CELLS; CODING REGIONS; IN-VIVO; EXPRESSION; RNA	The transcription factor ID2 is an important repressor of neural differentiation strongly implicated in nervous system cancers. MicroRNAs (miRNAs) are increasingly involved in differentiation control and cancer development. Here we show that two miRNAs upregulated on differentiation of neuroblastoma cells - miR-9 and miR-103 - restrain ID2 expression by directly targeting the coding sequence and 39 untranslated region of the ID2 encoding messenger RNA, respectively. Notably, the two miRNAs show an inverse correlation with ID2 during neuroblastoma cell differentiation induced by retinoic acid. Overexpression of miR-9 and miR-103 in neuroblastoma cells reduces proliferation and promotes differentiation, as it was shown to occur upon ID2 inhibition. Conversely, an ID2 mutant that cannot be targeted by either miRNA prevents retinoic acid-induced differentiation more efficient than wild-type ID2. These findings reveal a new regulatory module involving two microRNAs upregulated during neural differentiation that directly target expression of the key differentiation inhibitor ID2, suggesting that its alteration may be involved in neural cancer development.	[Annibali, Daniela; Savino, Mauro; Laneve, Pietro; Caffarelli, Elisa; Nasi, Sergio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, CNR IBPM, Rome, Italy; [Caffarelli, Elisa] Univ Roma La Sapienza, Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome	Annibali, D (corresponding author), Vesalius Res Ctr, Louvain, Belgium.	elisa.caffarelli@uniroma1.it; sergio.nasi@uniroma1.it	Annibali, Daniela/AAE-3004-2019; Annibali, Daniela/AAC-5270-2019; Gioia, Ubaldo/GZL-7436-2022; Gioia, Ubaldo/O-1660-2014; laneve, pietro/ABD-1633-2020; laneve, pietro/M-3386-2014	Annibali, Daniela/0000-0001-8413-7669; Gioia, Ubaldo/0000-0002-4993-5283; Gioia, Ubaldo/0000-0002-4993-5283; laneve, pietro/0000-0002-8865-4038	Agenzia Spaziale Italiana, Fondazione Guido Berlucchi, Associazione Italiana per la Ricerca sul Cancro, European Commission SIROCCO project [LSHGCT-2006-037900]; Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) PRIN project; Istituto Italiano di Tecnologia SEED-project; Epigenomics Flagship Project EPIGEN; MIURCNR; Consiglio Nazionale delle Ricerche	Agenzia Spaziale Italiana, Fondazione Guido Berlucchi, Associazione Italiana per la Ricerca sul Cancro, European Commission SIROCCO project(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) PRIN project; Istituto Italiano di Tecnologia SEED-project(Istituto Italiano di Tecnologia - IIT); Epigenomics Flagship Project EPIGEN; MIURCNR(Ministry of Education, Universities and Research (MIUR)Consiglio Nazionale delle Ricerche (CNR)); Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by grants from Agenzia Spaziale Italiana, Fondazione Guido Berlucchi, Associazione Italiana per la Ricerca sul Cancro, European Commission SIROCCO project (LSHGCT-2006-037900), Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) PRIN project, Istituto Italiano di Tecnologia SEED-project, and Epigenomics Flagship Project EPIGEN, MIURCNR. Funding for open access charge: Consiglio Nazionale delle Ricerche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT REV MOL CELL BIO; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Hamo R, 2011, GENOME MED, V3, DOI 10.1186/gm293; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chassot AA, 2007, ONCOGENE, V26, P5772, DOI 10.1038/sj.onc.1210386; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; CICCARONE V, 1989, CANCER RES, V49, P219; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; DiRocco G, 1997, MOL CELL BIOL, V17, P1244, DOI 10.1128/MCB.17.3.1244; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Hoesel B, 2010, GENE EXPR PATTERNS, V10, P265, DOI 10.1016/j.gep.2010.06.002; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Iavarone A, 2006, TRENDS MOL MED, V12, P588, DOI 10.1016/j.molmed.2006.10.007; Itahana Y, 2003, CANCER RES, V63, P7098; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2006, P NATL ACAD SCI USA, V103, P4976, DOI 10.1073/pnas.0600168103; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012976; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nagasaki K, 1999, NEUROSCI LETT, V267, P177, DOI 10.1016/S0304-3940(99)00359-6; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Paolella BR, 2011, STEM CELLS, V29, P1090, DOI 10.1002/stem.660; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; ROSSI A, 1992, INT J DEV NEUROSCI, V10, P527, DOI 10.1016/0736-5748(92)90053-3; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Tweddle DA, 2001, AM J PATHOL, V158, P2067, DOI 10.1016/S0002-9440(10)64678-0; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; Wu N, 2011, J BIOL CHEM; Yao WL, 2010, NEUROREPORT, V21, P39, DOI 10.1097/WNR.0b013e32833312fe; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zhang CQ, 2010, BRAIN RES, V1315, P1, DOI 10.1016/j.brainres.2009.12.013; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	66	51	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40269	10.1371/journal.pone.0040269	http://dx.doi.org/10.1371/journal.pone.0040269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848373	Green Published, gold, Green Submitted			2022-12-25	WOS:000306806600014
J	Bhati, M; Lee, C; Gadd, MS; Jeffries, CM; Kwan, A; Whitten, AE; Trewhella, J; Mackay, JP; Matthews, JM				Bhati, Mugdha; Lee, Christopher; Gadd, Morgan S.; Jeffries, Cy M.; Kwan, Ann; Whitten, Andrew E.; Trewhella, Jill; Mackay, Joel P.; Matthews, Jacqueline M.			Solution Structure of the LIM-Homeodomain Transcription Factor Complex Lhx3/Ldb1 and the Effects of a Pituitary Mutation on Key Lhx3 Interactions	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; HORMONE DEFICIENCY; MOTOR-NEURONS; TARGET GENES; ACTIVE-SITE; PROTEIN; SPECIFICATION; BINDING; DOMAIN	Lhx3 is a LIM-homeodomain (LIM-HD) transcription factor that regulates neural cell subtype specification and pituitary development in vertebrates, and mutations in this protein cause combined pituitary hormone deficiency syndrome (CPHDS). The recently published structures of Lhx3 in complex with each of two key protein partners, Isl1 and Ldb1, provide an opportunity to understand the effect of mutations and posttranslational modifications on key protein-protein interactions. Here, we use small-angle X-ray scattering of an Ldb1-Lhx3 complex to confirm that in solution the protein is well represented by our previously determined NMR structure as an ensemble of conformers each comprising two well-defined halves (each made up of LIM domain from Lhx3 and the corresponding binding motif in Ldb1) with some flexibility between the two halves. NMR analysis of an Lhx3 mutant that causes CPHDS, Lhx3(Y114C), shows that the mutation does not alter the zinc-ligation properties of Lhx3, but appears to cause a structural rearrangement of the hydrophobic core of the LIM2 domain of Lhx3 that destabilises the domain and/or reduces the affinity of Lhx3 for both Ldb1 and Isl1. Thus the mutation would affect the formation of Lhx3-containing transcription factor complexes, particularly in the pituitary gland where these complexes are required for the production of multiple pituitary cell types and hormones.	[Bhati, Mugdha; Lee, Christopher; Gadd, Morgan S.; Jeffries, Cy M.; Kwan, Ann; Whitten, Andrew E.; Trewhella, Jill; Mackay, Joel P.; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Bhati, M (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	Jacqui.Matthews@sydney.edu.au	Matthews, Jacqueline/A-7322-2013; Mackay, Joel P/D-6834-2011	Mackay, Joel P/0000-0001-7508-8033; Gadd, Morgan/0000-0001-6124-0858; /0000-0002-8718-7343; Kwan, Ann/0000-0002-1506-2226; Matthews, Jacqueline/0000-0001-8518-3472; Whitten, Andrew/0000-0001-8856-3120; Trewhella, Jill/0000-0002-8555-6766	Australian Postgraduate Awards; National Health and Medical Research Council Senior Research Fellowships; Australian Research Council	Australian Postgraduate Awards(Australian Government); National Health and Medical Research Council Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	MB, CL and MG were supported by Australian Postgraduate Awards. JMM and JPM were supported by National Health and Medical Research Council Senior Research Fellowships. JT was supported in part by a Federation Fellowship from the Australian Research Council. This work was supported by grants from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bhati M, 2008, ACTA CRYSTALLOGR F, V64, P297, DOI 10.1107/S174430910800691X; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gadd MS, 2011, J BIOL CHEM, V286, P42971, DOI 10.1074/jbc.M111.248559; Gadd MS, 2009, ACTA CRYSTALLOGR F, V65, P151, DOI 10.1107/S1744309108043431; Goddard TD, 2007, SPARKY NMR ASSIGNMEN; Howard PW, 2000, J BIOL CHEM, V275, P13336, DOI 10.1074/jbc.275.18.13336; Howard PW, 2001, J BIOL CHEM, V276, P19020, DOI 10.1074/jbc.M101782200; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2006, PROTEIN SCI, V15, P2612, DOI 10.1110/ps.062377006; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee C, 2005, J BIOMOL NMR, V33, P198, DOI 10.1007/s10858-005-3209-7; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Meier BC, 1999, MOL CELL ENDOCRINOL, V147, P65, DOI 10.1016/S0303-7207(98)00213-5; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Parker GE, 2005, J CELL BIOCHEM, V94, P67, DOI 10.1002/jcb.20287; PELTON JG, 1993, PROTEIN SCI, V2, P543; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pfaeffle RW, 2007, J CLIN ENDOCR METAB, V92, P1909, DOI 10.1210/jc.2006-2177; Rajab A, 2008, HUM MOL GENET, V17, P2150, DOI 10.1093/hmg/ddn114; Savage JJ, 2007, GENE, V400, P44, DOI 10.1016/j.gene.2007.05.017; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Sloop KW, 1999, MOL ENDOCRINOL, V13, P2212, DOI 10.1210/me.13.12.2212; Sloop KW, 2001, GENE, V265, P61, DOI 10.1016/S0378-1119(01)00369-9; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Trewhella J, 2001, ENCY LIFE SCI; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yarden BC, 2005, MOL BIOL REP, V32, P1	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40719	10.1371/journal.pone.0040719	http://dx.doi.org/10.1371/journal.pone.0040719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848397	Green Published, gold, Green Submitted			2022-12-25	WOS:000306806600024
J	Schaetti, C; Ali, SM; Chaignat, CL; Khatib, AM; Hutubessy, R; Weiss, MG				Schaetti, Christian; Ali, Said M.; Chaignat, Claire-Lise; Khatib, Ahmed M.; Hutubessy, Raymond; Weiss, Mitchell G.			Improving Community Coverage of Oral Cholera Mass Vaccination Campaigns: Lessons Learned in Zanzibar	PLOS ONE			English	Article							SOCIOCULTURAL DETERMINANTS; CULTURAL EPIDEMIOLOGY; RURAL MAHARASHTRA; SOUTHERN GHANA; PRIVATE DEMAND; POLICY-MAKERS; TYPHOID-FEVER; VACCINES; INDIA; GENDER	Background: Recent research in two cholera-endemic communities of Zanzibar has shown that a majority (similar to 94%) of the adult population was willing to receive free oral cholera vaccines (OCVs). Since OCV uptake in the 2009 campaign reached only similar to 50% in these communities, an evaluation of social and cultural factors and of barriers was conducted to understand this difference for future cholera control planning. Methodology/Principal Findings: A random sample of 367 adult peri-urban and rural community residents (46.6% immunized vs. 53.4% unimmunized) was studied with a semi-structured interview that inquired about social and cultural features of cholera depicted in a vignette and barriers to OCV uptake. Symptoms (rectal pain, loose skin only in rural community) and perceived causes (uncovered food, contact with contaminated water) specific for severe diarrhea were associated with uptake. Purchasing drugs from pharmacies to stop diarrhea and vomiting was negatively associated with uptake. Increasing household size, age and previous enteric illness episode were positively related to uptake, the latter only at the rural site. The most prominent barrier to uptake was competing obligations or priorities (reported by 74.5%, identified as most important barrier by 49.5%). Next most prominent barriers were lacking information about the campaign (29.6%, 12.2%), sickness (14.3%, 13.3%) and fear of possible vaccine side effects (15.3%, 5.6%). The majority of unvaccinated respondents requested repetition of the vaccination with free OCVs. Conclusions/Significance: Factors associated with uptake indicated a positive impact of the vaccination campaign and of sensitization activities on vaccine acceptance behavior. Unlike communities opposed to cholera control or settings where public confidence in vaccines is lacking, identified barriers to uptake indicated a good campaign implementation and trust in the health system. Despite prospects and demand for repeating the vaccination, local decision-makers should reconsider how careful logistical arrangements may improve community coverage and thus effectiveness of vaccination campaigns.	[Schaetti, Christian; Weiss, Mitchell G.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Schaetti, Christian; Weiss, Mitchell G.] Univ Basel, Basel, Switzerland; [Ali, Said M.] Publ Hlth Lab Ivo de Carneri, Chake Chake, Pemba, Tanzania; [Chaignat, Claire-Lise] World Hlth Org, Global Task Force Cholera Control, Geneva, Switzerland; [Khatib, Ahmed M.] Minist Hlth Zanzibar, Zanzibar, Tanzania; [Hutubessy, Raymond] World Hlth Org, Initiat Vaccine Res, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; World Health Organization; World Health Organization	Schaetti, C (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	christian.schaetti@unibas.ch			Bill and Melinda Gates Foundation, Seattle, USA	Bill and Melinda Gates Foundation, Seattle, USA(Bill & Melinda Gates Foundation)	This study was supported by a grant from the Bill and Melinda Gates Foundation, Seattle, USA (http://www.gatesfoundation.org), managed by the World Health Organization, Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-47; Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Ali M, 2010, J HEALTH POPUL NUTR, V28, P450, DOI 10.3329/jhpn.v28i5.6153; Ali M, 2010, B WORLD HEALTH ORGAN, V88, P556, DOI 10.2471/BLT.09.070334; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Atre S, 2011, GLOB PUBLIC HEALTH, V6, P56, DOI 10.1080/17441690903334240; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; DeRoeck D, 2004, J HEALTH POPUL NUTR, V22, P322; DeRoeck D, 2005, VACCINE, V23, P2762, DOI 10.1016/j.vaccine.2004.11.044; Dillip A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-144; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kim D, 2008, VALUE HEALTH, V11, P119, DOI 10.1111/j.1524-4733.2007.00220.x; Kleinman A., 1980, PATIENTS HEALERS CON; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Lucas MES, 2007, VACCINE, V25, P2599, DOI 10.1016/j.vaccine.2006.12.027; Nations MK, 1996, SOC SCI MED, V43, P1007, DOI 10.1016/0277-9536(96)00083-4; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Paralikar V, 2011, TRANSCULT PSYCHIATRY, V48, P257, DOI 10.1177/1363461511404623; Renne E, 2006, SOC SCI MED, V63, P1857, DOI 10.1016/j.socscimed.2006.04.025; Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schaetti C, 2011, HUM VACCINES, V7, P1299, DOI 10.4161/hv.7.12.18012; Schaetti C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-339; Schaetti C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-99; Shin S, 2011, CLIN INFECT DIS, V52, P1343, DOI 10.1093/cid/cir141; Stanton BF, 2004, J HEALTH POPUL NUTR, V22, P286; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Sur D, 2009, HUM VACCINES, V5, P614, DOI 10.4161/hv.9313; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Thiem VD, 2003, J HEALTH POPUL NUTR, V21, P304; Weiss, 1997, TRANSCULT PSYCHIATRY, V34, P235, DOI [DOI 10.1177/136346159703400204, 10.1177/136346159703400204]; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P837; Weiss M.G., 2001, ANTHROPOL MED, V8, P5, DOI [10.1080/13648470120070980, DOI 10.1080/13648470120070980]; World Health Organization, 2010, Weekly Epidemiological Record, V85, P293; World Health Organization, 2011, CHOL FACT SHEET 107; World Health Organization Global Task Force on Cholera Control, 2006, CHOL COUNTR PROF ZAN; World Health Organization Global Task Force on Cholera Control, 2006, US 2 DOS CHOL VACC C	43	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41527	10.1371/journal.pone.0041527	http://dx.doi.org/10.1371/journal.pone.0041527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844489	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000306687700101
J	Kuznetsova, IM; Sulatskaya, AI; Povarova, OI; Turoverov, KK				Kuznetsova, Irina M.; Sulatskaya, Anna I.; Povarova, Olga I.; Turoverov, Konstantin K.			Reevaluation of ANS Binding to Human and Bovine Serum Albumins: Key Role of Equilibrium Microdialysis in Ligand - Receptor Binding Characterization	PLOS ONE			English	Article							THIOFLAVINE-T INTERACTION; AMYLOID FIBRILS; MOLTEN GLOBULE; FLUOROMETRIC-DETERMINATION; FLUORESCENCE DECAY; STEADY-STATE; BOUND DYE; PROTEINS; SITES; PROBE	In this work we return to the problem of the determination of ligand-receptor binding stoichiometry and binding constants. In many cases the ligand is a fluorescent dye which has low fluorescence quantum yield in free state but forms highly fluorescent complex with target receptor. That is why many researchers use dye fluorescence for determination of its binding parameters with receptor, but they leave out of account that fluorescence intensity is proportional to the part of the light absorbed by the solution rather than to the concentration of bound dye. We showed how ligand-receptor binding parameters can be determined by spectrophotometry of the solutions prepared by equilibrium microdialysis. We determined the binding parameters of ANS - human serum albumin (HSA) and ANS - bovine serum albumin (BSA) interaction, absorption spectra, concentration and molar extinction coefficient, as well as fluorescence quantum yield of the bound dye. It was found that HSA and BSA have two binding modes with significantly different affinity to ANS. Correct determination of the binding parameters of ligand-receptor interaction is important for fundamental investigations and practical aspects of molecule medicine and pharmaceutics. The data obtained for albumins are important in connection with their role as drugs transporters.	[Kuznetsova, Irina M.; Sulatskaya, Anna I.; Povarova, Olga I.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Kuznetsova, Irina M.] St Petersburg State Polytech Univ, Dept Biophys, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Peter the Great St. Petersburg Polytechnic University	Kuznetsova, IM (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@incras.ru	Sulatskaya, Anna/I-6042-2014; Kuznetsova, Irina M./R-9844-2017; Povarova, Olga I/F-9060-2017; Turoverov, Konstantin/S-2079-2016	Sulatskaya, Anna/0000-0002-1207-3384; Kuznetsova, Irina M./0000-0002-3336-4834; Povarova, Olga/0000-0003-1568-7493; Turoverov, Konstantin/0000-0002-6977-1896	Russian Academy of Sciences; Dmitry Zimin's Russian Charitable Foundation "Dynasty"	Russian Academy of Sciences(Russian Academy of Sciences); Dmitry Zimin's Russian Charitable Foundation "Dynasty"	This work was supported in part by the Program "Molecular and Cell Biology" of the Russian Academy of Sciences and Dmitry Zimin's Russian Charitable Foundation "Dynasty" (A.I.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2009, J AM CHEM SOC, V131, P17068, DOI 10.1021/ja908319m; ANUFRIEVA EV, 1994, VYSOKOMOL SOEDIN, V36, P449; Bagatolli LA, 1996, J PHARM SCI, V85, P1131, DOI 10.1021/js960142k; Bismuto E, 2001, BIOPHYS J, V81, P3510, DOI 10.1016/S0006-3495(01)75982-6; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Collini M, 2000, PROTEIN SCI, V9, P1968, DOI 10.1110/ps.9.10.1968; Dzwolak W, 2005, FEBS LETT, V579, P6601, DOI 10.1016/j.febslet.2005.10.048; Fan YX, 1998, PROTEIN SCI, V7, P2631, DOI 10.1002/pro.5560071217; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Georgiou ME, 1999, ANAL CHEM, V71, P2541, DOI 10.1021/ac981019b; Groenning M, 2009, J CHEM BIOL, DOI [10.1007/s12154-2009-0027-12155, DOI 10.1007/S12154-2009-0027-12155]; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hazra P, 2004, BIOCHEM BIOPH RES CO, V314, P543, DOI 10.1016/j.bbrc.2003.12.118; Ivy MA, 2012, CHEM SCI, V3, P1773, DOI 10.1039/c2sc20083j; JAIN TK, 1989, J PHYS CHEM-US, V93, P7409, DOI 10.1021/j100358a032; Konkoli Z, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-10; Kubarych CJ, 2010, ORG LETT, V12, P4780, DOI 10.1021/ol101906g; Kurganov BI, 2000, BIOPHYS CHEM, V87, P185; LEE AG, 1978, FEBS LETT, V94, P171, DOI 10.1016/0014-5793(78)80930-2; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; NAIK DV, 1975, J PHARM SCI, V64, P1677, DOI 10.1002/jps.2600641020; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Oravcova J, 1996, J CHROMATOGR B, V677, P1, DOI 10.1016/0378-4347(95)00425-4; PANJEHSHAHIN MR, 1989, BIOCHEM PHARMACOL, V38, P155, DOI 10.1016/0006-2952(89)90162-7; Peters T., 1996, ALL ALBUMIN BIOCH GE; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Takehara K, 2009, ANAL SCI, V25, P115, DOI 10.2116/analsci.25.115; Togashi DM, 2008, J FLUORESC, V18, P519, DOI 10.1007/s10895-007-0294-x; Togashi DM, 2010, BIOPHYS CHEM, V152, P55, DOI 10.1016/j.bpc.2010.07.006; Turoverov K K, 1998, Tsitologiia, V40, P806; Uversky VN, 1998, BBA-PROTEIN STRUCT M, V1388, P133, DOI 10.1016/S0167-4838(98)00173-3; Uversky VN, 1996, BIOPHYS CHEM, V60, P79, DOI 10.1016/0301-4622(96)00009-9; VARELA AS, 1992, J PHARM SCI, V81, P842, DOI 10.1002/jps.2600810825; Voropai E. S., 2003, Journal of Applied Spectroscopy, V70, P868, DOI 10.1023/B:JAPS.0000016303.37573.7e; WEBER G, 1964, J BIOL CHEM, V239, P1415; WEBER G, 1952, BIOCHEM J, V51, P155, DOI 10.1042/bj0510155	49	62	65	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40845	10.1371/journal.pone.0040845	http://dx.doi.org/10.1371/journal.pone.0040845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829890	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300028
J	Gautami, B; Fonceka, D; Pandey, MK; Moretzsohn, MC; Sujay, V; Qin, HD; Hong, YB; Faye, I; Chen, XP; BhanuPrakash, A; Shah, TM; Gowda, MVC; Nigam, SN; Liang, XQ; Hoisington, DA; Guo, BZ; Bertioli, DJ; Rami, JF; Varshney, RK				Gautami, Bhimana; Fonceka, Daniel; Pandey, Manish K.; Moretzsohn, Marcio C.; Sujay, Venkataswamy; Qin, Hongde; Hong, Yanbin; Faye, Issa; Chen, Xiaoping; BhanuPrakash, Amindala; Shah, Trushar M.; Gowda, Makanahally V. C.; Nigam, Shyam N.; Liang, Xuanqiang; Hoisington, Dave A.; Guo, Baozhu; Bertioli, David J.; Rami, Jean-Francois; Varshney, Rajeev K.			An International Reference Consensus Genetic Map with 897 Marker Loci Based on 11 Mapping Populations for Tetraploid Groundnut (Arachis hypogaea L.)	PLOS ONE			English	Article							LINKAGE MAP; CULTIVATED PEANUT; RFLP MAP; SSR MARKERS; GENOME; RESISTANCE; BARLEY; MAIZE; TRAIT; QTLS	Only a few genetic maps based on recombinant inbred line (RIL) and backcross (BC) populations have been developed for tetraploid groundnut. The marker density, however, is not very satisfactory especially in the context of large genome size (2800 Mb/1C) and 20 linkage groups (LGs). Therefore, using marker segregation data for 10 RILs and one BC population from the international groundnut community, with the help of common markers across different populations, a reference consensus genetic map has been developed. This map is comprised of 897 marker loci including 895 simple sequence repeat (SSR) and 2 cleaved amplified polymorphic sequence (CAPS) loci distributed on 20 LGs (a01-a10 and b01-b10) spanning a map distance of 3, 863.6 cM with an average map density of 4.4 cM. The highest numbers of markers (70) were integrated on a01 and the least number of markers (21) on b09. The marker density, however, was lowest (6.4 cM) on a08 and highest (2.5 cM) on a01. The reference consensus map has been divided into 20 cM long 203 BINs. These BINs carry 1 (a10_02, a10_08 and a10_09) to 20 (a10_04) loci with an average of 4 marker loci per BIN. Although the polymorphism information content (PIC) value was available for 526 markers in 190 BINs, 36 and 111 BINs have at least one marker with >0.70 and >0.50 PIC values, respectively. This information will be useful for selecting highly informative and uniformly distributed markers for developing new genetic maps, background selection and diversity analysis. Most importantly, this reference consensus map will serve as a reliable reference for aligning new genetic and physical maps, performing QTL analysis in a multi-populations design, evaluating the genetic background effect on QTL expression, and serving other genetic and molecular breeding activities in groundnut.	[Gautami, Bhimana; Pandey, Manish K.; Sujay, Venkataswamy; BhanuPrakash, Amindala; Shah, Trushar M.; Nigam, Shyam N.; Hoisington, Dave A.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom, Patancheru 502324, Andhra Pradesh, India; [Fonceka, Daniel; Rami, Jean-Francois] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR Dev & Ameliorat Plantes, Montpellier, France; [Pandey, Manish K.; Qin, Hongde] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Pandey, Manish K.; Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Moretzsohn, Marcio C.] EMBRAPA Genet Resources & Biotechnol, Plant Genet Lab, Brasilia, DF, Brazil; [Sujay, Venkataswamy; Gowda, Makanahally V. C.] Univ Agr Sci UAS D, Dept Genet & Plant Breeding, Dharwad, Karnataka, India; [Qin, Hongde] HAAS, Cash Crop Res Inst, Wuhan, Hubei, Peoples R China; [Hong, Yanbin; Chen, Xiaoping; Liang, Xuanqiang; Varshney, Rajeev K.] GAAS, Crops Res Inst, Guangzhou, Guangdong, Peoples R China; [Faye, Issa] ISRA, CNRA, Bambey, Senegal; [Bertioli, David J.] Univ Brasilia, Dept Genet, Brasilia, DF, Brazil; [Varshney, Rajeev K.] CIMMYT, CGIAR Generat Challenge Programme GCP, Mexico City 06600, DF, Mexico	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CIRAD; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Guangdong Academy of Agricultural Sciences; Universidade de Brasilia; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Gautami, B (corresponding author), Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom, Patancheru 502324, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014; Moretzsohn, Marcio C/E-5517-2014	Varshney, Rajeev K/0000-0002-4562-9131; Moretzsohn, Marcio C/0000-0003-1708-1508; Amindala, BhanuPrakash/0000-0001-8825-1370; Pandey, Manish/0000-0002-4101-6530; Shah, Trushar/0000-0002-0091-7981	Generation Challenge Programme of Consultative Group on International Agricultural Research (CGIAR)	Generation Challenge Programme of Consultative Group on International Agricultural Research (CGIAR)	Financial support from Generation Challenge Programme (http://www.generationcp.org) of Consultative Group on International Agricultural Research (CGIAR) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Bohra A, 2012, THEOR APPL IN PRESS; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Chu Y, 2009, CROP SCI, V49, P2029, DOI 10.2135/cropsci2009.01.0021; Falque M, 2005, GENETICS, V170, P1957, DOI 10.1534/genetics.104.040204; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Feltus FA, 2006, THEOR APPL GENET, V112, P1295, DOI 10.1007/s00122-006-0232-3; Fonceka D., 2009, BMC PLANT BIOL, V12, P26, DOI [10.1186/1471-2229-12-26, DOI 10.1186/1471-2229-12-26]; Fonceka D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-103; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; GOBBI A, 2006, PLANT AN GEN 14 C SA, P679; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; HALWARD T, 1993, THEOR APPL GENET, V87, P379, DOI 10.1007/BF01184927; HAUGE BM, 1993, PLANT J, V3, P745, DOI 10.1111/j.1365-313X.1993.00745.x; Hong YB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-17; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; KIANIAN SF, 1992, THEOR APPL GENET, V84, P544, DOI 10.1007/BF00224150; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANGRIDGE P, 1995, MOL BREEDING, V1, P389, DOI 10.1007/BF01248416; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; Moretzsohn MC, 2005, THEOR APPL GENET, V111, P1060, DOI 10.1007/s00122-005-0028-x; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pandey MK, 2012, PLANT BREEDING, V131, P139, DOI 10.1111/j.1439-0523.2011.01911.x; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Sewell MM, 1999, GENETICS, V151, P321; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Varshney RK, 2009, THEOR APPL GENET, V118, P729, DOI 10.1007/s00122-008-0933-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wu Y, 2008, P LSS COMP SYST BIOI, P285	42	63	73	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41213	10.1371/journal.pone.0041213	http://dx.doi.org/10.1371/journal.pone.0041213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815973	Green Published, gold, Green Submitted			2022-12-25	WOS:000306548900099
J	Gekonge, B; Giri, MS; Kossenkov, AV; Nebozyhn, M; Yousef, M; Mounzer, K; Showe, L; Montaner, LJ				Gekonge, Bethsebah; Giri, Malavika S.; Kossenkov, Andrew V.; Nebozyhn, Michael; Yousef, Malik; Mounzer, Karam; Showe, Louise; Montaner, Luis J.			Constitutive Gene Expression in Monocytes from Chronic HIV-1 Infection Overlaps with Acute Toll-Like Receptor Induced Monocyte Activation Profiles	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MACROPHAGES; HUMAN MONOCYTE/MACROPHAGES; DENDRITIC CELLS; REPLICATION; INTERFERON; THERAPY; TARGET; RESTRICTION; RESPONSES	Elevated TLR expression/signalling in monocyte/macrophages has been shown to mediate systemic immune activation, a hallmark of progressive HIV-1 infection. Here we show, via differential gene expression comparisons, the presence of a constitutive in vivo TLR-like gene activation signature in steady-state circulating monocytes from chronically HIV-1 infected subjects. The TLR2-like gene signature was defined as an 82 gene subset of the 376 genes constitutively modulated in in vivo HIV-1 monocytes, based on their overlap with de novo TLR2-induced genes in uninfected subjects' monocytes following acute ex vivo stimulation with Staphylococcus Aureus Cowan (SAC). Additional comparison of in vivo gene networks with available datasets from acute TLR activations in M/M expanded the overlap to 151-gene concordance among the 376 differential genes with emphasis on ERK/MAPK, TNF/IL6 (NF kappa B) and p53 gene networks. TLR2 stimulation of monocytes from HIV-1 infected subjects resulted in further upregulation of inflammatory genes indicative of a sustained transcriptional potential upon stimulation. In summary, our data support the presence of a sustained TLR-like gene activation profile in circulating monocyte from steady-state viremia in HIV-1 infected subjects.	[Gekonge, Bethsebah; Giri, Malavika S.; Kossenkov, Andrew V.; Nebozyhn, Michael; Yousef, Malik; Showe, Louise; Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA USA; [Mounzer, Karam] Philadelphia Field Initiating Grp HIV 1 Trials, Philadelphia, PA USA	The Wistar Institute	Gekonge, B (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	montaner@wistar.org			National Institutes of Health [A1047760]; Philadelphia Foundation; Wistar Institute funds from the Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health CURE program; Wistar Cancer Center Support grant (National Cancer Institute) [P30 CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia Foundation; Wistar Institute funds from the Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health CURE program; Wistar Cancer Center Support grant (National Cancer Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grant A1047760, The Philadelphia Foundation, and Wistar Institute funds from the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health CURE program and a Wistar Cancer Center Support grant (National Cancer Institute grant P30 CA010815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Coberley CR, 2004, J VIROL, V78, P11477, DOI 10.1128/JVI.78.21.11477-11486.2004; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; GENDELMAN HE, 1990, J EXP MED, V172, P1433, DOI 10.1084/jem.172.5.1433; GESSANI S, 1994, RES IMMUNOL, V145, P659, DOI 10.1016/S0923-2494(05)80050-1; GESSANI S, 1994, J LEUKOCYTE BIOL, V56, P358, DOI 10.1002/jlb.56.3.358; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Giri MS, 2006, J LEUKOCYTE BIOL, V80, P1031, DOI 10.1189/jlb.0306157; Gorry Paul R, 2005, Methods Mol Biol, V304, P25; Heggelund L, 2004, CLIN EXP IMMUNOL, V138, P116, DOI 10.1111/j.1365-2249.2004.02595.x; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kari L, 2003, J EXP MED, V197, P1477, DOI 10.1084/jem.20021726; MCELRATH MJ, 1989, P NATL ACAD SCI USA, V86, P675, DOI 10.1073/pnas.86.2.675; Meier A, 2007, EXPERT REV ANTI-INFE, V5, P323, DOI 10.1586/14787210.5.3.323; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Olivetta E, 2005, BIOCHEM J, V390, P591, DOI 10.1042/BJ20042139; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Papasavvas E, 2009, AIDS, V23, P369, DOI 10.1097/QAD.0b013e32831e9c76; Remer KA, 2006, J IMMUNOL METHODS, V313, P1, DOI 10.1016/j.jim.2005.07.026; Semnani RT, 2006, INFECT IMMUN, V74, P4409, DOI 10.1128/IAI.01106-05; Storey John D, 2003, Methods Mol Biol, V224, P149; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; SZEBENI J, 1991, J VIROL, V65, P6362, DOI 10.1128/JVI.65.11.6362-6364.1991; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Vazquez N, 2005, J VIROL, V79, P4479, DOI 10.1128/JVI.79.7.4479-4491.2005; Wallet MA, AIDS, V24, P1281; Woelk CH, 2004, AIDS RES HUM RETROV, V20, P1210, DOI 10.1089/aid.2004.20.1210; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	36	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41153	10.1371/journal.pone.0041153	http://dx.doi.org/10.1371/journal.pone.0041153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815948	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900083
J	Daadi, MM; Grueter, BA; Malenka, RC; Redmond, DE; Steinberg, GK				Daadi, Marcel M.; Grueter, Brad A.; Malenka, Robert C.; Redmond, D. Eugene, Jr.; Steinberg, Gary K.			Dopaminergic Neurons from Midbrain-Specified Human Embryonic Stem Cell-Derived Neural Stem Cells Engrafted in a Monkey Model of Parkinson's Disease	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; SERUM-FREE SUSPENSION; IN-VITRO; ES CELLS; FUNCTIONAL ENGRAFTMENT; ADHERENT CULTURE; DIFFERENTIATION; PRECURSORS; GENERATION; GRAFTS	The use of human embryonic stem cells (hESCs) to repair diseased or injured brain is promising technology with significant humanitarian, societal and economic impact. Parkinson's disease (PD) is a neurological disorder characterized by the loss of midbrain dopaminergic (DA) neurons. The generation of this cell type will fulfill a currently unmet therapeutic need. We report on the isolation and perpetuation of a midbrain-specified self-renewable human neural stem cell line (hNSCs) from hESCs. These hNSCs grew as a monolayer and uniformly expressed the neural precursor markers nestin, vimentin and a radial glial phenotype. We describe a process to direct the differentiation of these hNSCs towards the DA lineage. Glial conditioned media acted synergistically with fibroblastic growth factor and leukemia inhibitory factor to induce the expression of the DA marker, tyrosine hydroxylase (TH), in the hNSC progeny. The glial-derived neurotrophic factor did not fully mimic the effects of conditioned media. The hNSCs expressed the midbrain-specific transcription factors Nurr1 and Pitx3. The inductive effects did not modify the level of the glutamic acid decarboxylase (GAD) transcript, a marker for GABAergic neurons, while the TH transcript increased 10-fold. Immunocytochemical analysis demonstrated that the TH-expressing cells did not co-localize with GAD. The transplantation of these DA-induced hNSCs into the non-human primate MPTP model of PD demonstrated that the cells maintain their DA-induced phenotype, extend neurite outgrowths and express synaptic markers.	[Daadi, Marcel M.; Steinberg, Gary K.] Stanford Sch Med, Dept Neurosurg, Stanford, CA USA; [Daadi, Marcel M.; Grueter, Brad A.; Malenka, Robert C.; Steinberg, Gary K.] Stanford Sch Med, Stanford Inst Neuro Innovat & Translat Neurosci, Stanford, CA USA; [Daadi, Marcel M.] Mol Med Res Inst, Sunnyvale, CA USA; [Redmond, D. Eugene, Jr.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Redmond, D. Eugene, Jr.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA	Stanford University; Stanford University; Yale University; Yale University	Daadi, MM (corresponding author), Stanford Sch Med, Dept Neurosurg, Stanford, CA USA.	mdaadi@stanford.edu		Steinberg, Gary/0000-0001-6374-1058; Grueter, Brad/0000-0002-4224-3866	William Randolph Hearst Foundation; Edward G. Hills Fund; Axion Research Foundation; St Kitts Biomedical Research Foundation; State of Connecticut under the Connecticut Stem Cell Research Grants Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS040822] Funding Source: NIH RePORTER	William Randolph Hearst Foundation; Edward G. Hills Fund; Axion Research Foundation; St Kitts Biomedical Research Foundation; State of Connecticut under the Connecticut Stem Cell Research Grants Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Russell and Elizabeth Siegelman, Bernard and Ronni Lacroute, William Randolph Hearst Foundation, Edward G. Hills Fund, Axion Research Foundation, St Kitts Biomedical Research Foundation and by the State of Connecticut under the Connecticut Stem Cell Research Grants Program. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the State of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Buytaert-Hoefen KA, 2004, STEM CELLS, V22, P669, DOI 10.1634/stemcells.22-5-669; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Daadi M, 1998, NEUROSCIENCE, V86, P867, DOI 10.1016/S0306-4522(98)00102-X; Daadi Marcel M, 2002, Methods Mol Biol, V198, P149; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; Daadi Marcel M, 2011, Regen Med, V6, P25, DOI 10.2217/rme.11.85; Daadi MM, 2009, REGEN MED, V4, P251, DOI 10.2217/17460751.4.2.251; Daadi MM, 1999, J NEUROSCI, V19, P4484; Daadi MM, 2002, CONT NEUROS, P203; Dunnett SB, 2001, NAT REV NEUROSCI, V2, P365, DOI 10.1038/35072572; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hayashi H, 2008, EUR J NEUROSCI, V27, P261, DOI 10.1111/j.1460-9568.2008.06027.x; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Iacovitti L, 2007, BRAIN RES, V1127, P19, DOI 10.1016/j.brainres.2006.10.022; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Ko JY, 2009, MOL THER, V17, P1761, DOI 10.1038/mt.2009.148; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindvall O, 2003, PHARMACOL RES, V47, P279, DOI 10.1016/S1043-6618(03)00037-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; REDMOND DE, 1986, LANCET, V1, P1125; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Schulz TC, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-27; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Sladek JR, 2008, CELL TRANSPLANT, V17, P427; SLADEK JR, 1993, EXP NEUROL, V122, P16, DOI 10.1006/exnr.1993.1103; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Taylor JR, 1997, NEUROSCIENCE, V81, P745, DOI 10.1016/S0306-4522(97)00214-5; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	53	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41120	10.1371/journal.pone.0041120	http://dx.doi.org/10.1371/journal.pone.0041120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815935	Green Published, Green Submitted, gold			2022-12-25	WOS:000306507000069
J	Permanyer, M; Ballana, E; Badia, R; Pauls, E; Clotet, B; Este, JA				Permanyer, Marc; Ballana, Ester; Badia, Roger; Pauls, Eduardo; Clotet, Bonaventura; Este, Jose A.			Trans-infection but Not Infection from within Endosomal Compartments after Cell-to-cell HIV-1 Transfer to CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIROLOGICAL SYNAPSES; MEDIATED ENDOCYTOSIS; ENTRY INHIBITORS; MEMBRANE-FUSION; PLASMA-MEMBRANE; SPREAD; REPLICATION; TYPE-1; DEGRADATION	Cellular contacts between HIV-1-infected donor cells and uninfected primary CD4(+) T lymphocytes lead to virus transfer into endosomes. Recent evidence suggests that HIV particles may fuse with endosomal membranes to initiate a productive infection. To explore the role of endocytosis in the entry and replication of HIV, we evaluated the infectivity of transferred HIV particles in a cell-to-cell culture model of virus transmission. Endocytosed virus led to productive infection of cells, except when cells were cultured in the presence of the anti-gp120 mAb IgGb12, an agent that blocks virus attachment to CD4, suggesting that endocytosed virus was recycled to the outer cell surface. Confocal microscopy confirmed the colocalization of internalized virus antigen and the endosomal marker dynamin. Additionally, virus transfer, fusion, or productive infection was not blocked by dynasore, dynamin-dependent endosome-scission inhibitor, at subtoxic concentrations, suggesting that the early capture of virus into intracellular compartments did not depend on endosomal maturation. Our results suggest that endocytosis is not a mechanism of infection of primary CD4 T cells, but may serve as a reservoir capable of inducing trans-infection of cells after the release of HIV particles to the extracellular environment.	[Permanyer, Marc; Ballana, Ester; Badia, Roger; Pauls, Eduardo; Clotet, Bonaventura; Este, Jose A.] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa, Badalona 08916, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Este, JA (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa, Canyet S-N, Badalona 08916, Spain.	jaeste@irsicaixa.es	Este, Jose/B-5509-2008; Guix, Ester Ballana/R-4117-2018; Badia, Roger/T-6929-2017	Este, Jose/0000-0002-1436-5823; Badia, Roger/0000-0003-3982-7577; Pauls, Eduardo/0000-0002-2511-0711; Ballana, Ester/0000-0002-5215-7363	Spanish Ministerio de Economia y Competitividad [BFU2009-06958, SAF2010-21617-C02]; FIPSE [360783-09]; Gala contra la SIDA	Spanish Ministerio de Economia y Competitividad(Spanish Government); FIPSE; Gala contra la SIDA	This work was supported in part by the Spanish Ministerio de Economia y Competitividad Projects BFU2009-06958 and SAF2010-21617-C02, FIPSE 360783-09, and Gala contra la SIDA 2011.	Adamson CS, 2010, ANTIVIR RES, V85, P119, DOI 10.1016/j.antiviral.2009.09.009; Ballana E, 2011, J IMMUNOL, V186, P464, DOI 10.4049/jimmunol.1002693; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Ballana E, 2009, BLOOD, V113, P1278, DOI 10.1182/blood-2008-06-161869; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Bosch B, 2005, ANTIMICROB AGENTS CH, V49, P4296, DOI 10.1128/AAC.49.10.4296-4304.2005; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Clotet-Codina I, 2009, ANTIVIR RES, V83, P94, DOI 10.1016/j.antiviral.2009.03.009; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Izquierdo-Useros N, 2011, TRAFFIC, V12, P1702, DOI 10.1111/j.1600-0854.2011.01281.x; Jolly C, 2004, TRAFFIC, V5, P643, DOI 10.1111/j.1600-0854.2004.00209.X; KIELIAN M, 1990, MOL BIOL MED, V7, P17; Luo TC, 1996, J VIROL, V70, P1527, DOI 10.1128/JVI.70.3.1527-1534.1996; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Massanella M, 2009, AIDS, V23, P183, DOI 10.1097/QAD.0b013e32831ef1a3; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; PAUZA CD, 1988, J CELL BIOL, V107, P959, DOI 10.1083/jcb.107.3.959; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; Permanyer M, 2012, J VIROL, V86, P8773, DOI 10.1128/JVI.01044-12; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sattentau QJ, 2010, VIRUSES-BASEL, V2, P1306, DOI 10.3390/v2061306; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu D., 2009, PLOS PATHOG, V5	42	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32017	32026		10.1074/jbc.M112.343293	http://dx.doi.org/10.1074/jbc.M112.343293			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22846998	Green Published, hybrid			2022-12-25	WOS:000309059400040
J	Buchthal, B; Lau, D; Weiss, U; Weislogel, JM; Bading, H				Buchthal, Bettina; Lau, David; Weiss, Ursula; Weislogel, Jan-Marek; Bading, Hilmar			Nuclear Calcium Signaling Controls Methyl-CpG-binding Protein 2 (MeCP2) Phosphorylation on Serine 421 following Synaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; DNA METHYLATION; RETT-SYNDROME; KINASE-II; BDNF TRANSCRIPTION; MEMORY FORMATION; NMDA RECEPTORS; BRAIN; IDENTIFICATION	The function of MeCP2, a methylated DNA-interacting protein that may act as a global chromatin modifier, is controlled by its phosphorylation on serine 421. Here we show that in hippocampal neurons, nuclear calcium signaling controls synaptic activity-induced phosphorylation of MeCP2 on serine 421. Pharmacological inhibition of calcium/calmodulin-dependent protein (CaM) kinases blocked activity-induced MeCP2 serine 421 phosphorylation. CaM kinase II (CaMKII) but not CaMKIV, the major nuclear CaM kinase in hippocampal neurons, appeared to mediate this phosphorylation event. Biochemical subcellular fractionations and immunolocalization studies revealed that several isoforms of CaMKII (i.e. CaMKII alpha, -beta, -gamma, and -delta) are expressed in the cytosol but are also detectable in the cell nucleus of hippocampal neurons, suggesting that nuclear CaMKII catalyzes MeCP2 serine 421 phosphorylation. Thus, in addition to the classical nuclear calcium-CaMKIV-CREB/CBP (cAMP-response element-binding protein/CREB-binding protein) pathway that regulates transcription of specific target genes, nuclear calcium may also modulate genome-wide the chromatin state in response to synaptic activity via nuclear CaMKII-MeCP2 signaling.	[Bading, Hilmar] Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany; Univ Heidelberg, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de			Deutsche Forschungsgemeinschaft (DFG); Alexander von Humboldt Foundation; European Research Council Advanced Grant; Sonderforschungsbereich (SFB) of the DFG [488, SFB 636]; Graduate Academy (Excellence Initiative) of Heidelberg University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Research Council Advanced Grant(European Research Council (ERC)); Sonderforschungsbereich (SFB) of the DFG(German Research Foundation (DFG)); Graduate Academy (Excellence Initiative) of Heidelberg University	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), the Alexander von Humboldt Foundation (Wolfgang Paul Prize to H. B.), an European Research Council Advanced Grant (to H. B.), the Sonderforschungsbereich (SFB) 488 and SFB 636 of the DFG, and the Graduate Academy (Excellence Initiative) of Heidelberg University.	Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mishra S, 2011, CIRC RES, V109, P1354, DOI 10.1161/CIRCRESAHA.111.248401; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; SIHRA TS, 1995, NEUROPHARMACOLOGY, V34, P731, DOI 10.1016/0028-3908(95)00051-7; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Takeuchi Y, 1999, J NEUROCHEM, V72, P815, DOI 10.1046/j.1471-4159.1999.0720815.x; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	48	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30967	30974		10.1074/jbc.M112.382507	http://dx.doi.org/10.1074/jbc.M112.382507			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822052	Green Published, hybrid			2022-12-25	WOS:000308791300010
J	Giguere, PM; Laroche, G; Oestreich, EA; Duncan, JA; Siderovski, DP				Giguere, Patrick M.; Laroche, Genevieve; Oestreich, Emily A.; Duncan, Joseph A.; Siderovski, David P.			Regulation of the Subcellular Localization of the G-protein Subunit Regulator GPSM3 through Direct Association with 14-3-3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLOCO MOTIF; STRUCTURAL BASIS; PEPTIDE; ALPHA; PHOSPHORYLATION; IDENTIFICATION; SPECIFICITY; ACTIVATION; PARTNERS; BETA	G-protein signaling modulator-3 (GPSM3), also known as G18 or AGS4, is a member of the G alpha(i/o)-Loco (GoLoco) motif containing proteins. GPSM3 acts through its two GoLoco motifs to exert GDP dissociation inhibitor activity over G alpha(i) subunits; recently revealed is the existence of an additional regulatory site within GPSM3 directed toward monomeric G beta subunits during their biosynthesis. Here, using in silico and proteomic approaches, we have found that GPSM3 also interacts directly with numerous members of the 14-3-3 protein family. This interaction is dependent on GPSM3 phosphorylation, creating a mode II consensus 14-3-3 binding site. 14-3-3 binding to the N-terminal disordered region of GPSM3 confers stabilization from protein degradation. The complex of GPSM3 and 14-3-3 is exclusively cytoplasmic, and both moieties mutually control their exclusion from the nucleus. Phosphorylation of GPSM3 by a proline-directed serine/threonine kinase and the resultant association of 14-3-3 is the first description of post-translational regulation of GPSM3 subcellular localization, a process that likely regulates important spatio-temporal aspects of G-protein-coupled receptor signaling modulation by GPSM3.	[Giguere, Patrick M.; Laroche, Genevieve; Oestreich, Emily A.; Duncan, Joseph A.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Duncan, Joseph A.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Siderovski, David P.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; West Virginia University	Siderovski, DP (corresponding author), Robert C Byrd Hlth Sci Ctr, Hlth Sci Ctr 3051, 1 Med Ctr Dr, Morgantown, WV 26506 USA.	dpsiderovski@hsc.wvu.edu	Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210	National Institutes of Health [R01 GM082892, R01 AI088255]; Burroughs Wellcome Fund Career Award for Medical Scientists; NIAMS Postdoctoral Fellowship from the National Institutes of Health [F32 AR057644]; Heart and Stroke Foundation of Canada; Fond de la recherche en sante Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIAMS Postdoctoral Fellowship from the National Institutes of Health; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fond de la recherche en sante Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM082892 (to D. P. S.) and R01 AI088255 (to J. A. D.). This work was also supported by a Burroughs Wellcome Fund Career Award for Medical Scientists (to J. A. D.), NIAMS Postdoctoral Fellowship F32 AR057644 (to E. A. O.) from the National Institutes of Health, and postdoctoral fellowships from the Heart and Stroke Foundation of Canada and Fond de la recherche en sante Quebec (to P. M. G. and G. L.).	Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Diez R., 2010, NEUROPROTEOMICS, P51; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Giguere PM, 2012, J BIOL CHEM, V287, P4863, DOI 10.1074/jbc.M111.311712; Gu YM, 2006, FEBS LETT, V580, P305, DOI 10.1016/j.febslet.2005.12.024; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Sun SY, 2009, J ENDOCRINOL, V202, P327, DOI 10.1677/JOE-09-0041; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zeidner Leigh C, 2011, Int J Biochem Mol Biol, V2, P318	44	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31270	31279		10.1074/jbc.M112.394379	http://dx.doi.org/10.1074/jbc.M112.394379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22843681	Green Published, hybrid			2022-12-25	WOS:000308791300039
J	Fels, J; Jeggle, P; Kusche-Vihrog, K; Oberleithner, H				Fels, Johannes; Jeggle, Pia; Kusche-Vihrog, Kristina; Oberleithner, Hans			Cortical Actin Nanodynamics Determines Nitric Oxide Release in Vascular Endothelium	PLOS ONE			English	Article								The release of the main vasodilator nitric oxide (NO) by the endothelial NO synthase (eNOS) is a hallmark of endothelial function. We aim at elucidating the underlying mechanism how eNOS activity depends on cortical stiffness (K-cortex) of living endothelial cells. It is hypothesized that cortical actin dynamics determines K-cortex and directly influences eNOS activity. By combined atomic force microscopy and fluorescence imaging we generated mechanical and optical sections of single living cells. This approach allows the discrimination between K-cortex and bulk cell stiffness (K-bulk) and, additionally, the simultaneous analysis of submembranous actin web dynamics. We show that K-cortex softens when cortical F-actin depolymerizes and that this shift from a gel-like stiff cortex to a soft G-actin rich layer, triggers the stiffness-sensitive eNOS activity. The results implicate that stiffness changes in the similar to 100 nm phase of the submembranous actin web, without affecting K-bulk, regulate NO release and thus determines endothelial function.	[Fels, Johannes; Jeggle, Pia; Kusche-Vihrog, Kristina; Oberleithner, Hans] Univ Munster, Inst Physiol 2, Munster, Germany	University of Munster	Fels, J (corresponding author), Univ Munster, Inst Physiol 2, Munster, Germany.	felsj@uni-muenster.de			graduate program "Cell Dynamics and Disease" of the University of Muenster; Deutsche Forschungsgemeinschaft [OB 63/17-1, OB 63/18]	graduate program "Cell Dynamics and Disease" of the University of Muenster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work was supported by the graduate program "Cell Dynamics and Disease" of the University of Muenster (international PhD scholarship to first author) and by grants from the Deutsche Forschungsgemeinschaft (OB 63/17-1 and Koselleck Grant OB 63/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 1998, ISOLATION CHARACTERI; Barrera NP, 2008, DETERMINATION ARCHIT; Callies C, 2011, MEMBRANE POTENTIAL D; Callies C, 2009, SIMULTANEOUS MECH ST; Carl P, 2008, ELASTICITY MEASUREME; Cooper JA, 1987, EFFECTS CYTOCHALASIN; Deibler M, 2011, ACTIN FUSION PROTEIN; Fels J, 2010, NITRIC OXIDE RELEASE; Francis LW, 2010, ATOMIC FORCE MICROSC; Franz CM, 2011, METHODS MOL BIOL, V736, P97, DOI 10.1007/978-1-61779-105-5_7; Grinspan JB, 1983, BOVINE ENDOTHELIAL C; Hinterdorfer P, 2006, DETECTION LOCALIZATI; Hofmann UG, 1997, INVESTIGATING CYTOSK; Ju H, 1997, DIRECT INTERACTION E; Kasas S, 2008, PROBING NANOMECHANIC; Kasas S, 2005, SUPERFICIAL DEEP CHA; Kliche K, 2011, ROLE CELLULAR MECH F; Kofuji P, 2004, POTASSIUM BUFFERING; Kojima H, 1999, FLUORESCENT INDICATO; Kondrikov D, 2010, BETA ACTIN ASS ENDOT; Lang F, 2011, STIFF ENDOTHELIAL CE; Laurent VM, 2005, GRADIENT RIGIDITY LA; Martens JC, 2008, SOFTENING ACTIN CYTO; Miranda AF, 1974, ACTION CYTOCHALASIN; Muller DJ, 2009, NEW FRONTIERS ATOMIC; Naseem KM, 2005, ROLE NITRIC OXIDE CA; Nordsborg N, 2003, MUSCLE INTERSTITIAL; Oberleithner H, 2009, POTASSIUM SOFTENS VA; Oberleithner H, 2005, ALDOSTERONE MAKES HU; Oberleithner H, 2007, PLASMA SODIUM STIFFE; Oberleithner H, 2011, SODIUM WOLF SHEEPS C; Oberleithner H, 2006, ALDOSTERONE REMODELS; Oberleithner H, 2010, ENDOTHELIAL CELLS VA; Palmer RM, 1987, NITRIC OXIDE RELEASE; Pedersen SF, 2001, CYTOSKELETON CELL VO; Pesen D, 2005, MICROMECHANICAL ARCH; Riedl J, 2008, LIFEACT VERSATILE MA; Roduit C, 2009, STIFFNESS TOMOGRAPHY; Rotsch C, 1999, DIMENSIONAL MECH DYN; Rotsch C, 2000, DRUG INCUCED CHANGES; Sanchez D, 2008, NONCONTACT MEASUREME; Schillers H, 2010, REAL TIME MONITORING; Sokolov I, 2006, RECOVERY ELASTICITY; Stewart MP, 2011, HYDROSTATIC PRESSURE; Szczygiel AM, 2011, ELASTICITY CHANGES A; Trepat X, 2007, UNIVERSAL PHYS RESPO	46	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41520	10.1371/journal.pone.0041520	http://dx.doi.org/10.1371/journal.pone.0041520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844486	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700098
J	Huber-Keener, KJ; Liu, XP; Wang, Z; Wang, YQ; Freeman, W; Wu, S; Planas-Silva, MD; Ren, XC; Cheng, Y; Zhang, Y; Vrana, K; Liu, CG; Yang, JM; Wu, RL				Huber-Keener, Kathryn J.; Liu, Xiuping; Wang, Zhong; Wang, Yaqun; Freeman, Willard; Wu, Song; Planas-Silva, Maricarmen D.; Ren, Xingcong; Cheng, Yan; Zhang, Yi; Vrana, Kent; Liu, Chang-Gong; Yang, Jin-Ming; Wu, Rongling			Differential Gene Expression in Tamoxifen-Resistant Breast Cancer Cells Revealed by a New Analytical Model of RNA-Seq Data	PLOS ONE			English	Article							MICROARRAY DATA-ANALYSIS; NUCLEAR FACTOR 4-ALPHA; ESTROGEN-RECEPTOR; ENDOCRINE RESISTANCE; GROWTH; PROLIFERATION; PROGRESSION; TARGETS; ENZYMES; ALPHA	Resistance to tamoxifen (Tam), a widely used antagonist of the estrogen receptor (ER), is a common obstacle to successful breast cancer treatment. While adjuvant therapy with Tam has been shown to significantly decrease the rate of disease recurrence and mortality, recurrent disease occurs in one third of patients treated with Tam within 5 years of therapy. A better understanding of gene expression alterations associated with Tam resistance will facilitate circumventing this problem. Using a next generation sequencing approach and a new bioinformatics model, we compared the transcriptomes of Tam-sensitive and Tam-resistant breast cancer cells for identification of genes involved in the development of Tam resistance. We identified differential expression of 1215 mRNA and 513 small RNA transcripts clustered into ER alpha functions, cell cycle regulation, transcription/translation, and mitochondrial dysfunction. The extent of alterations found at multiple levels of gene regulation highlights the ability of the Tam-resistant cells to modulate global gene expression. Alterations of small nucleolar RNA, oxidative phosphorylation, and proliferation processes in Tam-resistant cells present areas for diagnostic and therapeutic tool development for combating resistance to this anti-estrogen agent.	[Huber-Keener, Kathryn J.; Freeman, Willard; Planas-Silva, Maricarmen D.; Ren, Xingcong; Cheng, Yan; Zhang, Yi; Vrana, Kent; Yang, Jin-Ming] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pharmacol,Penn State Canc Inst, Hershey, PA 17033 USA; [Wang, Zhong; Wang, Yaqun; Wu, Rongling] Penn State Univ, Coll Med, Ctr Stat Genet, Hershey, PA 17033 USA; [Liu, Xiuping; Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Wu, Song] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Texas System; UTMD Anderson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Huber-Keener, KJ (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pharmacol,Penn State Canc Inst, Hershey, PA 17033 USA.	cgliu@mdanderson.org; juy16@psu.edu; rwu@hes.hmc.psu.edu	Freeman, Willard/GYQ-5841-2022; Wang, Zhong/C-3737-2014	Huber-Keener, Kathryn/0000-0002-1981-7251; Vrana, Kent/0000-0003-4902-7733; Freeman, Willard/0000-0001-7027-999X	Penn State College of Medicine	Penn State College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study is supported by the Penn State College of Medicine and a gift from the Elsa U. Pardee Foundation: http://www.pardeefoundation.org/ (J. Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; AKAIKE H, 1981, CC/ENG TECH APPL SCI, P22; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Butte A J, 2001, Pac Symp Biocomput, P6; Cardoso CMP, 2001, TOXICOL APPL PHARM, V176, P145, DOI 10.1006/taap.2001.9265; Clarke R, 2001, J STEROID BIOCHEM, V76, P71, DOI 10.1016/S0960-0760(00)00193-X; Clarke R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2870; Cordero Francesca, 2007, Briefings in Functional Genomics & Proteomics, V6, P265, DOI 10.1093/bfgp/elm034; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dorssers LCJ, 2001, DRUGS, V61, P1721, DOI 10.2165/00003495-200161120-00004; Dumont JA, 1996, CELL GROWTH DIFFER, V7, P351; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gao Dexiang, 2010, Human Genomics, V5, P56; Garcia V, 2008, CANCER LETT, V263, P312, DOI 10.1016/j.canlet.2008.01.008; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Honma N, 2008, J CLIN ONCOL, V26, P3727, DOI 10.1200/JCO.2007.14.2968; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Huang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022274; Huang WC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr592; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Jia L, 1996, BLOOD, V87, P2401, DOI 10.1182/blood.V87.6.2401.bloodjournal8762401; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Kilker RL, 2004, J STEROID BIOCHEM, V92, P63, DOI 10.1016/j.jsbmb.2004.05.005; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Liu M, 2011, FEBS LETT, V585, P2998, DOI 10.1016/j.febslet.2011.08.014; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Luo JQ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2616; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Masri S, 2008, CANCER RES, V68, P4910, DOI 10.1158/0008-5472.CAN-08-0303; Mendes-Pereira AM, 2011, P NATL ACAD SCI US; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Omoto Yoko, 2002, Breast Cancer, V9, P308, DOI 10.1007/BF02967609; Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Santen RJ, 2005, ENDOCR-RELAT CANCER, V12, pS61, DOI 10.1677/erc.1.01018; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Sugai M, 2008, PATHOL INT, V58, P681, DOI 10.1111/j.1440-1827.2008.02293.x; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001	54	43	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41333	10.1371/journal.pone.0041333	http://dx.doi.org/10.1371/journal.pone.0041333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844461	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700073
J	Vinzon, SE; Marino-Buslje, C; Rivera, E; Bonino, MBD				Vinzon, Sabrina E.; Marino-Buslje, Cristina; Rivera, Elena; de Jimenez Bonino, Mirtha Biscoglio			A Naturally Occurring Hypoallergenic Variant of Vespid Antigen 5 from Polybia scutellaris Venom as a Candidate for Allergen-Specific Immunotherapy	PLOS ONE			English	Article							CROSS-REACTIVITY; AMINO-ACID; RECOMBINANT ALLERGENS; HYMENOPTERA VENOM; YELLOW JACKET; MODEL; ANTIBODIES; BINDING	Stings by insects from the Hymenoptera order are known to cause life-threatening allergic reactions and impair life quality. Despite the effectiveness of conventional vespid venom immunotherapy, more standardized and safer allergy vaccines are required and recombinant hypoallergenic variants are important clinical tools. Antigen 5 is a major allergen of vespid venoms and it was previously reported that Antigen 5 from Polybia scutellaris (Poly s 5) could be a hypoallergenic variant. In this work we assess the immunological behavior and allergenic activity of Poly s 5 in order to explore its suitability for specific immunotherapy. With this aim, recombinant Poly s 5 was expressed in Pichia pastoris and the presence of cross-reactive epitopes with Pol a 5, a known allergenic Antigen 5, was investigated both at the IgG and IgE levels, by ELISA assays and a basophil-mediator release assay respectively. A molecular model was also built to better understand the relationship between immunological and structural aspects. In mice, Poly s 5 induced IgG antibodies which cross-reacted with Pol a 5. However, Poly s 5 induced only minimal amounts of IgE and was a poor inducer of basophil-mediator release, even when the cells were sensitized with Pol a 5-specific IgE. Moreover, Poly s 5-specific serum showed a specific protective activity and was able to inhibit the Pol a 5-induced basophil degranulation. Structural analysis from the molecular model revealed that a few amino acid substitutions in the N-terminal region of Poly s 5 should lead to an alteration of the surface topography and electrostatic potential of the epitopes which could be responsible for its hypoallergenic behavior. These findings, taken as a whole, show that Poly s 5 is likely a naturally occurring hypoallergenic Antigen 5 variant.	[Vinzon, Sabrina E.; Marino-Buslje, Cristina; de Jimenez Bonino, Mirtha Biscoglio] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Vinzon, Sabrina E.; Marino-Buslje, Cristina; de Jimenez Bonino, Mirtha Biscoglio] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol IQUIFIB, RA-1113 Buenos Aires, DF, Argentina; [Rivera, Elena] Univ Buenos Aires, Fac Farm & Bioquim, Dept Fisicomatemat, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Vinzon, SE (corresponding author), German Canc Res Ctr, Div Viral Transformat Mech, Res Program Infect & Canc, D-6900 Heidelberg, Germany.	s.vinzon@dkfz.de	Vinzon, Sabrina/HFZ-9144-2022; Vinzón, Sabrina/Q-1631-2019; Marino-Buslje, Cristina/J-7438-2019	Vinzón, Sabrina/0000-0002-1330-9125; Marino-Buslje, Cristina/0000-0002-6564-1920	Universidad of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina	Universidad of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was partially supported by grants from the Universidad of Buenos Aires and the Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse R, 2011, ALLERGY, V66, P28, DOI 10.1111/j.1398-9995.2011.02628.x; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Amaral V, 1996, 16 NAT M ALL IMM BUE; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; CASCONE O, 1995, TOXICON, V33, P659, DOI 10.1016/0041-0101(95)00001-3; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Gafvelin G, 2007, J BIOL CHEM, V282, P3778, DOI 10.1074/jbc.M607938200; Gehlhar K, 2006, INT ARCH ALLERGY IMM, V140, P285, DOI 10.1159/000093706; Golden DBK, 2005, J ALLERGY CLIN IMMUN, V115, P439, DOI 10.1016/j.jaci.2005.01.005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V92, P707, DOI 10.1016/0091-6749(93)90014-7; Hoffmann A, 1997, J ALLERGY CLIN IMMUN, V99, P227, DOI 10.1016/S0091-6749(97)70101-5; King TP, 2001, J IMMUNOL, V166, P6057, DOI 10.4049/jimmunol.166.10.6057; King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Muller Ulrich, 2008, Clin Allergy Immunol, V21, P377; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Niederberger V, 2009, IMMUNOL LETT, V122, P131, DOI 10.1016/j.imlet.2008.11.012; Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026; Pirpignani ML, 2002, ARCH BIOCHEM BIOPHYS, V407, P224, DOI 10.1016/S0003-9861(02)00554-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025; VANOSS CJ, 1995, MOL IMMUNOL, V32, P199, DOI 10.1016/0161-5890(94)00124-J; Vinzon SE, 2010, PROTEIN EXPRES PURIF, V73, P23, DOI 10.1016/j.pep.2010.03.029; Wachholz PA, 2004, CURR OPIN ALLERGY CL, V4, P313, DOI 10.1097/01.all.0000136753.35948.c0; Winkler B, 2003, IMMUNOLOGY, V110, P376, DOI 10.1046/j.1365-2567.2003.01751.x	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41351	10.1371/journal.pone.0041351	http://dx.doi.org/10.1371/journal.pone.0041351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844463	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700075
J	Zot, HG; Hasbun, JE; Minh, NV				Zot, Henry G.; Hasbun, Javier E.; Nguyen Van Minh			Second-Chance Signal Transduction Explains Cooperative Flagellar Switching	PLOS ONE			English	Article							TORQUE-GENERATING UNITS; RESPONSE REGULATOR CHEY; BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; CONFORMATIONAL SPREAD; MOTOR; MECHANISM; BINDING; DIRECTION; PROTEINS	The reversal of flagellar motion (switching) results from the interaction between a switch complex of the flagellar rotor and a torque-generating stationary unit, or stator (motor unit). To explain the steeply cooperative ligand-induced switching, present models propose allosteric interactions between subunits of the rotor, but do not address the possibility of a reaction that stimulates a bidirectional motor unit to reverse direction of torque. During flagellar motion, the binding of a ligand-bound switch complex at the dwell site could excite a motor unit. The probability that another switch complex of the rotor, moving according to steady-state rotation, will reach the same dwell site before that motor unit returns to ground state will be determined by the independent decay rate of the excited-state motor unit. Here, we derive an analytical expression for the energy coupling between a switch complex and a motor unit of the stator complex of a flagellum, and demonstrate that this model accounts for the cooperative switching response without the need for allosteric interactions. The analytical result can be reproduced by simulation when (1) the motion of the rotor delivers a subsequent ligand-bound switch to the excited motor unit, thereby providing the excited motor unit with a second chance to remain excited, and (2) the outputs from multiple independent motor units are constrained to a single all-or-none event. In this proposed model, a motor unit and switch complex represent the components of a mathematically defined signal transduction mechanism in which energy coupling is driven by steady-state and is regulated by stochastic ligand binding. Mathematical derivation of the model shows the analytical function to be a general form of the Hill equation (Hill AV (1910) The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 40: iv-vii).	[Zot, Henry G.] Univ W Georgia, Dept Biol, Carrollton, GA 30118 USA; [Hasbun, Javier E.] Univ W Georgia, Dept Phys, Carrollton, GA USA; [Nguyen Van Minh] Univ W Georgia, Dept Math, Carrollton, GA USA	University System of Georgia; University of West Georgia; University System of Georgia; University of West Georgia; University System of Georgia; University of West Georgia	Zot, HG (corresponding author), Univ W Georgia, Dept Biol, Carrollton, GA 30118 USA.	hzot@westga.edu			National Science Foundation (NSF.gov) [MCB-0508203]	National Science Foundation (NSF.gov)(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (NSF.gov) to HGZ (MCB-0508203). The NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Amsler CD., 1995, 2 COMPONENT SIGNAL T, P89; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG HC, 1975, NATURE, V254, P389, DOI 10.1038/254389a0; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bren A, 2001, J MOL BIOL, V312, P699, DOI 10.1006/jmbi.2001.4992; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; Eisenbach M, 1996, MOL MICROBIOL, V20, P903, DOI 10.1111/j.1365-2958.1996.tb02531.x; Fahrner KA, 2003, NATURE, V423, P938, DOI 10.1038/423938a; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Lawrence KL, 2010, NATURE, V466, P996; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Sagi Y, 2003, J BIOL CHEM, V278, P25867, DOI 10.1074/jbc.M303201200; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Tu Y, 2008, P NATL ACAD SCI USA, V105, P11737, DOI 10.1073/pnas.0804641105; Turner L, 1999, BIOPHYS J, V77, P597, DOI 10.1016/S0006-3495(99)76916-X; van Albada SB, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.74; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105; Zot HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008052	30	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41098	10.1371/journal.pone.0041098	http://dx.doi.org/10.1371/journal.pone.0041098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844429	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700043
J	Ardekani, R; Huang, YM; Sancheti, P; Stanciauskas, R; Tavare, S; Tower, J				Ardekani, Reza; Huang, Yichuan Michelle; Sancheti, Prathamesh; Stanciauskas, Ramunas; Tavare, Simon; Tower, John			Using GFP Video to Track 3D Movement and Conditional Gene Expression in Free-Moving Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; FLUORESCENT PROTEINS; FLYING INSECTS; TRANSGENES; BEHAVIOR; SYSTEM; CELLS	Background: In vivo imaging and quantification of fluorescent reporter molecules is increasingly useful in biomedical research. For example, tracking animal movement in 3D with simultaneous quantification of fluorescent transgenic reporters allows for correlations between behavior, aging and gene expression. However implementation has been hindered in the past by the complexity of operating the systems. Results: We report significant technical improvements and user-friendly software (called FluoreScore) that enables tracking of 3D movement and the dynamics of gene expression in adult Drosophila, using two cameras and recorded GFP videos. Expression of a transgenic construct encoding eGFP was induced in free-moving adult flies using the Gene-Switch system and RU486 drug feeding. The time course of induction of eGFP expression was readily quantified from internal tissues including central nervous tissue. Conclusions: FluoreScore should facilitate a variety of future studies involving quantification of movement behaviors and fluorescent molecules in free-moving animals.	[Ardekani, Reza; Huang, Yichuan Michelle; Sancheti, Prathamesh; Stanciauskas, Ramunas; Tavare, Simon; Tower, John] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Ardekani, R (corresponding author), Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	jtower@usc.edu			Department of Health and Human Services [HG02790, AG011833]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011833] Funding Source: NIH RePORTER	Department of Health and Human Services; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Department of Health and Human Services (http://www.hhs.gov/) to ST (HG02790) and to JT (AG011833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Burcin MM, 1999, P NATL ACAD SCI USA, V96, P355, DOI 10.1073/pnas.96.2.355; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Fry SN, 2000, J NEUROSCI METH, V101, P59, DOI 10.1016/S0165-0270(00)00253-3; Frye MA, 2004, J EXP BIOL, V207, P123, DOI 10.1242/jeb.00725; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; Grover Dhruv, 2009, BMC Res Notes, V2, P58, DOI 10.1186/1756-0500-2-58; Grover D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007580; Grover D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-93; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Marden JH, 1997, J EXP BIOL, V200, P2747; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Roman G, 2002, GENESIS, V34, P127, DOI 10.1002/gene.10133; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Shen J, 2009, AGING-US, V1, P191, DOI 10.18632/aging.100018; Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Zisserman A., 2004, MULTIPLE VIEW GEOMET; Zou SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018151	30	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40506	10.1371/journal.pone.0040506	http://dx.doi.org/10.1371/journal.pone.0040506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829875	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300013
J	Gotsman, I; Zwas, D; Lotan, C; Keren, A				Gotsman, Israel; Zwas, Donna; Lotan, Chaim; Keren, Andre			Heart Failure and Preserved Left Ventricular Function: Long Term Clinical Outcome	PLOS ONE			English	Article							NORMAL EJECTION FRACTION; SYSTOLIC FUNCTION; MORTALITY; READMISSION; COMMUNITY; STIFFNESS; REGISTRY	Background: Patients with heart failure (HF) have a poor prognosis. The proportion of patients with HF and preserved left ventricular function (LVF) is increasing. Long term prognosis of HF with preserved LVF may not be so benign. Objectives: To evaluate the long term clinical outcome of patients with HF and preserved LVF and predictors of outcome. Methods: We prospectively evaluated 309 patients hospitalized with a definite clinical diagnosis of HF. Patients were followed for a mean of 6.5 years for clinical outcome. Results: More than a third (36%) of the patients had preserved systolic LVF based on echocardiography. The long term survival rate in this group was poor and not significantly different from patients with reduced LVF (28% vs 23% respectively, P = 0.2). The adjusted survival rate by Cox regression analysis was also not significantly different (hazard ratio 1.16, 95% confidence interval 0.87-1.55, P = 0.31). The event free survival from death or heart failure re-hospitalization was also low in both groups and not significantly different between patients with preserved vs. reduced LVF (12% vs. 10% respectively, P = 0.2). Predictors of mortality in patients with preserved LVF were age, functional capacity and serum urea levels. Conclusions: The long term clinical outcome of patients with heart failure and preserved LVF is poor and not significantly different from patients with reduced LVF.	[Gotsman, Israel; Zwas, Donna; Lotan, Chaim; Keren, Andre] Hadassah Univ Hosp, Inst Heart, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Gotsman, I (corresponding author), Hadassah Univ Hosp, Inst Heart, IL-91120 Jerusalem, Israel.	igotsman@bezeqint.net	Gotsman, Israel/AAH-8833-2021	Gotsman, Israel/0000-0001-9608-2298				[Anonymous], 2011, EUR HEART J     0411; Berry C, 2005, HEART, V91, P907, DOI 10.1136/hrt.2004.041996; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Gotsman I, 2008, AM J MED, V121, P997, DOI 10.1016/j.amjmed.2008.06.031; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Lewis BS, 2007, ISRAEL MED ASSOC J, V9, P234; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; Miyagishima K, 2009, CIRC J, V73, P92, DOI 10.1253/circj.CJ-07-1016; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Orea-Tejeda A, 2007, REV INVEST CLIN, V59, P103; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Tribouilloy C, 2007, EUR HEART J     0411; Tsutsui H, 2001, AM J CARDIOL, V88, P530, DOI 10.1016/S0002-9149(01)01732-5; Varela-Roman A, 2005, HEART, V91, P489, DOI 10.1136/hrt.2003.031922; Westermann D, 2008, CIRCULATION, V117, P2051, DOI 10.1161/CIRCULATIONAHA.107.716886; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	25	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41022	10.1371/journal.pone.0041022	http://dx.doi.org/10.1371/journal.pone.0041022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829907	gold, Green Submitted, Green Published			2022-12-25	WOS:000306956300045
J	Larsson, C; Luna, B; Ammerman, NC; Maiga, M; Agarwal, N; Bishai, WR				Larsson, Christer; Luna, Brian; Ammerman, Nicole C.; Maiga, Mamoudou; Agarwal, Nisheeth; Bishai, William R.			Gene Expression of Mycobacterium tuberculosis Putative Transcription Factors whiB1-7 in Redox Environments	PLOS ONE			English	Article							NITRIC-OXIDE; HYPOXIC RESPONSE; PROTEIN; STREPTOMYCES; HOMOLOG; MODEL; WHMD	The seven WhiB proteins of Mycobacterium tuberculosis (M.tb) are widely believed to be redox-sensing transcription factors due to their binding of iron-sulfur clusters and similarities to DNA binding proteins. Here, we explored the nature of this hypothesized relationship. We exposed M.tb to physiologic conditions such as gradual hypoxia, nitric oxide (NO), cyclic AMP and in vivo conditions, and measured transcription of the whiB genes. We found whiB3 to be induced both by hypoxia and NO, whiB7 to be induced in macrophage-like cells, and whiB4 to be induced in mouse lung. Cyclic AMP induced whiB1,-2, -4, -6 and -7. Our data indicate that the M.tb whiB genes are induced independently by various stimuli which may add versatility to their suggested redox-sensing properties.	[Larsson, Christer; Luna, Brian; Ammerman, Nicole C.; Maiga, Mamoudou; Bishai, William R.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Agarwal, Nisheeth] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, Haryana, India; [Bishai, William R.] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Bishai, William R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Howard Hughes Medical Institute	Larsson, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	wbishai@jhmi.edu		Ammerman, Nicole C./0000-0001-9359-9144; Luna, PhD, Brian/0000-0001-6718-4551; Larsson, Christer/0000-0002-5714-924X	Swedish Research Council (VR); Swedish Society for Medical Research (SSMF); National Institute of Health (NIH) [AI36973, AI37856]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037856, R29AI036973, R01AI036973] Funding Source: NIH RePORTER	Swedish Research Council (VR)(Swedish Research Council); Swedish Society for Medical Research (SSMF); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The Swedish Research Council (VR) www.vr.se, the Swedish Society for Medical Research (SSMF) www.ssmf.se, and the National Institute of Health (NIH) www.nih.gov AI36973 and AI37856. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Swedish Research Council (VR) and Swedish Society for Medical Research (SSMF) are gratefully acknowledged for their support (awarded to CL). This research was also supported by NIH AI36973 and AI37856 (awarded to WRB) and the Howard Hughes Medical Institute (WRB).	Agarwal N, 2007, INFECT IMMUN, V75, P452, DOI 10.1128/IAI.01395-06; Agarwal N, 2006, MICROBIOL-SGM, V152, P2749, DOI 10.1099/mic.0.28924-0; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Banaiee N, 2006, INFECT IMMUN, V74, P6449, DOI 10.1128/IAI.00190-06; Burian J, 2011, J BIOL CHEM; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; DAVIS NK, 1992, MOL GEN GENET, V232, P351, DOI 10.1007/BF00266237; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Drapier JC, 1997, METHODS, V11, P319, DOI 10.1006/meth.1996.0426; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hutter B, 1999, RES MICROBIOL, V150, P295, DOI 10.1016/S0923-2508(99)80055-2; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Kamath AB, 2003, INFECT IMMUN, V71, P4112, DOI 10.1128/IAI.71.7.4112-4118.2003; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Kramnik I, 1998, NOVART FDN SYMP, V217, P120, DOI 10.1002/0470846526.ch9; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Raghunand TR, 2006, MICROBIOL-SGM, V152, P2735, DOI 10.1099/mic.0.28911-0; Raghunand TR, 2006, INT J ANTIMICROB AG, V28, P36, DOI 10.1016/j.ijantimicag.2006.01.012; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WHO, 2011, WHO GLOBAL TUBERCULO	37	47	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e37516	10.1371/journal.pone.0037516	http://dx.doi.org/10.1371/journal.pone.0037516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829866	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300004
J	Maille, A; Engelhart, L; Bourjade, M; Blois-Heulin, C				Maille, Audrey; Engelhart, Lucie; Bourjade, Marie; Blois-Heulin, Catherine			To Beg, or Not to Beg? That Is the Question: Mangabeys Modify Their Production of Requesting Gestures in Response to Human's Attentional States	PLOS ONE			English	Article							CERCOCEBUS-TORQUATUS-TORQUATUS; CHIMPANZEES PAN-TROGLODYTES; SOCIAL VISUAL-ATTENTION; RHESUS-MONKEYS; YOUNG CHIMPANZEES; CONTINGENCY TASK; DIFFERENTIAL USE; GORILLA-GORILLA; PONGO-PYGMAEUS; COMMUNICATION	Background: Although gestural communication is widespread in primates, few studies focused on the cognitive processes underlying gestures produced by monkeys. Methodology/Principal Findings: The present study asked whether red-capped mangabeys (Cercocebus torquatus) trained to produce visually based requesting gestures modify their gestural behavior in response to human's attentional states. The experimenter held a food item and displayed five different attentional states that differed on the basis of body, head and gaze orientation; mangabeys had to request food by extending an arm toward the food item (begging gesture). Mangabeys were sensitive, at least to some extent, to the human's attentional state. They reacted to some postural cues of a human recipient: they gestured more and faster when both the body and the head of the experimenter were oriented toward them than when they were oriented away. However, they did not seem to use gaze cues to recognize an attentive human: monkeys begged at similar levels regardless of the experimenter's eyes state. Conclusions/Significance: These results indicate that mangabeys lowered their production of begging gestures when these could not be perceived by the human who had to respond to it. This finding provides important evidence that acquired begging gestures of monkeys might be used intentionally.	[Maille, Audrey; Engelhart, Lucie; Blois-Heulin, Catherine] Univ Rennes 1, CNRS, UMR Ethos Ethol Anim & Humaine 6552, Biol Stn, Paimpont, France; [Bourjade, Marie] Aix Marseille Univ, Res Ctr Psychol Cognit Language & Emot, Aix En Provence, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; UDICE-French Research Universities; Aix-Marseille Universite	Maille, A (corresponding author), Univ Rennes 1, CNRS, UMR Ethos Ethol Anim & Humaine 6552, Biol Stn, Paimpont, France.	audrey.maille@univ-rennes1.fr		Bourjade, Marie/0000-0002-3216-8284	French National Research Agency [ANR-08-BLAN-0011_01]; French Ministery of Research	French National Research Agency(French National Research Agency (ANR)); French Ministery of Research(Ministry of Research, France)	This research was supported by a grant of the French National Research Agency (ANR-08-BLAN-0011_01) to Catherine Blois-Heulin, and a grant of the French Ministery of Research to Audrey Maille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiach-Serrano A, 2007, ANIM COGN, V10, P387, DOI 10.1007/s10071-007-0076-5; Anderson JR, 2010, AM J PRIMATOL, V72, P707, DOI 10.1002/ajp.20827; Anderson JR, 1996, BEHAV PROCESS, V37, P47, DOI 10.1016/0376-6357(95)00074-7; Anderson JR, 2001, J COMP PSYCHOL, V115, P282, DOI 10.1037/0735-7036.115.3.282; Arbib MA, 2008, CURR ANTHROPOL, V49, P1052, DOI 10.1086/593015; BLASCHKE M, 1987, ANIM BEHAV, V35, P1520, DOI 10.1016/S0003-3472(87)80023-4; Blois-Heulin C, 1999, FOLIA PRIMATOL, V70, P264, DOI 10.1159/000021705; Blois-Heulin C, 1999, FOLIA PRIMATOL, V70, P180, DOI 10.1159/000021695; CALL J, 1994, J COMP PSYCHOL, V108, P307, DOI 10.1037/0735-7036.108.4.307; Call J., 2007, GESTURAL COMMUNICATI; Call Josep, 2007, P197; CAMPBELL R, 1990, NEUROPSYCHOLOGIA, V28, P1123, DOI 10.1016/0028-3932(90)90050-X; COUSSIKORBEL S, 1994, J COMP PSYCHOL, V108, P164, DOI 10.1037/0735-7036.108.2.164; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Gomez J, 2005, GESTURE, V5, P91, DOI [10.1075/gest.5.1-2.08gom, DOI 10.1075/GEST.5.1.08GOM, DOI 10.1075/GEST.5.1-2.08GOM]; Gomez Juan Carlos, 1996, P131; Gomez JC, 2007, CHILD DEV, V78, P729, DOI 10.1111/j.1467-8624.2007.01027.x; Hattori Y, 2007, ANIM COGN, V10, P141, DOI 10.1007/s10071-006-0049-0; Hattori Y, 2010, ANIM COGN, V13, P87, DOI 10.1007/s10071-009-0248-6; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Hostetter AB, 2007, ANIM COGN, V10, P55, DOI 10.1007/s10071-006-0031-x; KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702; Kaminski J, 2004, ANIM COGN, V7, P216, DOI 10.1007/s10071-004-0214-2; Leavens DA, 1996, J COMP PSYCHOL, V110, P346, DOI 10.1037/0735-7036.110.4.346; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens David A., 2004, Interaction Studies, V5, P387, DOI 10.1075/is.5.3.05lea; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal K, 2012, PHILOS T R SOC B, V367, P118, DOI 10.1098/rstb.2011.0044; Liebal Katja, 2007, P69; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Mitchell RW, 1997, J COMP PSYCHOL, V111, P351, DOI 10.1037/0735-7036.111.4.351; Myowa-Yamakoshi M, 2003, COGNITION, V89, pB53, DOI 10.1016/S0010-0277(03)00071-4; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Pika S, 2005, AM J PRIMATOL, V65, P39, DOI 10.1002/ajp.20096; Poss SR, 2006, AM J PRIMATOL, V68, P978, DOI 10.1002/ajp.20304; Povinelli DJ, 1996, J COMP PSYCHOL, V110, P336, DOI 10.1037/0735-7036.110.4.336; Povinelli DJ, 2003, ANIM BEHAV, V66, P71, DOI 10.1006/anbe.2003.2195; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Sankey C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018331; Tempelmann S, 2011, ANIM COGN, V14, P433, DOI 10.1007/s10071-011-0378-5; Theall Laura A., 1999, Animal Cognition, V2, P207, DOI 10.1007/s100710050041; TOMASELLO M, 1994, PRIMATES, V35, P137, DOI 10.1007/BF02382050; TOMASELLO M, 1985, J HUM EVOL, V14, P175, DOI 10.1016/S0047-2484(85)80005-1; Vlamings PHJM, 2006, J EXP PSYCHOL-ANIM B, V32, P60, DOI 10.1037/0097-7403.32.1.60; WOODRUFF G, 1979, COGNITION, V7, P333, DOI 10.1016/0010-0277(79)90021-0	48	34	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41197	10.1371/journal.pone.0041197	http://dx.doi.org/10.1371/journal.pone.0041197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815969	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900097
J	Lu, X; Liu, DP; Xu, Y				Lu, X.; Liu, D. P.; Xu, Y.			The gain of function of p53 cancer mutant in promoting mammary tumorigenesis	ONCOGENE			English	Article						p53 mutant; gain of function; genetic instability	BREAST-CANCER; GENETIC INSTABILITY; EPITHELIAL-CELLS; TRANSGENIC MICE; MOUSE MODEL; DNA-DAMAGE; STEM-CELL; ATM; CARCINOGENESIS; PROTEIN	Tumor suppressor p53 is critical for suppressing all types of human cancers, including breast cancer. The p53 gene is somatically mutated in over half of all human cancers. The majority of the p53 mutations are missense mutations, leading to the expression of the full-length p53 mutants. Several hotspot mutations, including R175H, are frequently detected in human breast cancer. P53 cancer mutants not only lose tumor suppression activity but, more problematically, also gain new oncogenic activities. Despite correlation of the expression of p53 cancer mutants and the poor prognosis of human breast cancer patients, the roles of p53 cancer mutants in promoting breast cancer remain unclear. We used the humanized p53 cancer mutant knock-in (R175H) mice and mouse mammary tumor virus (MMTV)-Wnt-1 transgenic (mWnt-1) mice to specifically address the gain of function of R175H in promoting breast cancer. Although both R175H/R175HmWnt-1(R175HmWnt-1) and p53(-/-) mWnt-1 mice died from mammary tumor at the same kinetics, which was much earlier than mWnt-1 mice, most of the R175HmWnt-1 mice developed multiple mammary tumors per mouse, whereas p53(-/-) mWnt-1 and mWnt-1 mice mostly developed one tumor per mouse. The multiple mammary tumors arose in the same R175HmWnt-1 mouse exhibited different histological characters. Moreover, R175H gain-of-function mutant expands the mammary epithelial stem cells (MESCs) that give rise to the mammary tumors. As ATM suppresses the expansion of MESCs, the inactivation of ATM by R175H in mammary epithelial cells (MECs) could contribute to the expansion of MESCs in R175HmWnt-1 mice. These findings provide the basis for R175H to promote the initiation of breast cancer by expanding MESCs.	[Lu, X.; Liu, D. P.; Xu, Y.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu		Xu, Yang/0000-0001-5574-921X	NIH [R01 CA94254]; DOD Breast Cancer Research Program [W81XWH-08-1-0381]; NATIONAL CANCER INSTITUTE [R01CA094254] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Yi Li for the MMTV-Wnt-1 mice. This work was supported by grants from the NIH (R01 CA94254) and DOD Breast Cancer Research Program (W81XWH-08-1-0381) to YX.	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bowen TJ, 2005, CANCER RES, V65, P8736, DOI 10.1158/0008-5472.CAN-05-1598; Cabioglu N, 2009, J AM COLL SURGEONS, V208, P67, DOI 10.1016/j.jamcollsurg.2008.09.001; DAVIDOFF AM, 1991, P NATL ACAD SCI USA, V88, P5006, DOI 10.1073/pnas.88.11.5006; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; ELLEDGE RM, 1994, BREAST CANCER RES TR, V32, P39, DOI 10.1007/BF00666204; Gallagher WM, 1999, ONCOGENE, V18, P3608, DOI 10.1038/sj.onc.1202937; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Haupt S, 2009, CANCER RES, V69, P4818, DOI 10.1158/0008-5472.CAN-08-4010; Hussain SP, 2000, MUTAT RES-REV MUTAT, V462, P311, DOI 10.1016/S1383-5742(00)00015-6; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kalo E, 2007, MOL CELL BIOL, V27, P8228, DOI 10.1128/MCB.00374-07; Kitamura T, 2009, CANCER RES, V69, P7681, DOI 10.1158/0008-5472.CAN-09-2133; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Lu S, 2006, CARCINOGENESIS, V27, P848, DOI 10.1093/carcin/bgi302; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wang XJ, 1998, MOL CARCINOGEN, V23, P185, DOI 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Weissenbacher TM, 2010, BREAST CANCER RES TR, V122, P27, DOI 10.1007/s10549-010-0917-9; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Xu Y, 2006, NAT REV IMMUNOL, V6, P261, DOI 10.1038/nri1804	36	34	35	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 6	2013	32	23					2900	2906		10.1038/onc.2012.299	http://dx.doi.org/10.1038/onc.2012.299			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	22824795	Green Accepted			2022-12-25	WOS:000320369100010
J	Chollangi, S; Mather, T; Rodgers, KK; Ash, JD				Chollangi, Srinivas; Mather, Timothy; Rodgers, Karla K.; Ash, John D.			A Unique Loop Structure in Oncostatin M Determines Binding Affinity toward Oncostatin M Receptor and Leukemia Inhibitory Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; ACUTE-PHASE PROTEINS; SIGNAL TRANSDUCER; M OSM; CELL-GROWTH; FACTOR LIF; GP130; ACTIVATION; EXPRESSION; CARDIOTROPHIN-1	Oncostatin M (OSM) and leukemia inhibitory factor are pleiotropic cytokines that belong to the interleukin-6 (IL-6) family. These cytokines play a crucial role in diverse biological events like inflammation, neuroprotection, hematopoiesis, metabolism, and development. The family is grouped together based on structural similarities and their ability to activate the transmembrane receptor glycoprotein 130 (gp130). The common structure among these cytokines defines the spacing and the orientation of binding sites for cell surface receptors. OSM is unique in this family as it can signal using heterodimers of gp130 with either leukemia inhibitory factor receptor (LIFR) (type I) or oncostatin M receptor (OSMR) (type II). We have identified a unique helical loop on OSM between its B and C helices that is not found on other IL-6 family cytokines. This loop is located near the "FXXK" motif in active site III, which is essential for OSM's binding to both LIFR and OSMR. In this study, we show that the BC loop does not play a role in OSM's unique ability to bind OSMR. Shortening of the loop enhanced OSM's interaction with OSMR and LIFR as shown by kinetic and equilibrium binding analysis, suggesting the loop may hinder receptor interactions. As a consequence of improved binding, these structurally modified OSMs exhibited enhanced biological activity, including suppressed proliferation of A375 melanoma cells.	[Ash, John D.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Chollangi, Srinivas] Univ Oklahoma, Dept Bioengn, Norman, OK 73019 USA; [Mather, Timothy] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Rodgers, Karla K.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	State University System of Florida; University of Florida; University of Oklahoma System; University of Oklahoma - Norman; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ash, JD (corresponding author), Univ Florida, Dept Ophthalmol, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	jash@ufl.edu		Rodgers, Karla/0000-0002-7338-0281; Ash, John/0000-0002-8330-7301	National Institutes of Health [R01 EY016459]; Research to Prevent Blindness;  [P20 RR017703];  [P30 EY021721]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021721, R01EY016459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY016459 and Core Grants P20 RR017703 and P30 EY021721. This work was also supported by the Research to Prevent Blindness.	Auguste P, 1997, J BIOL CHEM, V272, P15760, DOI 10.1074/jbc.272.25.15760; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Chollangi S, 2009, NEUROBIOL DIS, V34, P535, DOI 10.1016/j.nbd.2009.03.012; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; DiMarco A, 1996, P NATL ACAD SCI USA, V93, P9247, DOI 10.1073/pnas.93.17.9247; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GIOVANNINI M, 1993, CYTOGENET CELL GENET, V62, P32, DOI 10.1159/000133439; GIOVANNINI M, 1993, CYTOGENET CELL GENET, V64, P240, DOI 10.1159/000133586; Grant SL, 2001, GROWTH FACTORS, V19, P153, DOI 10.3109/08977190109001083; Heinrich PC, 1995, ANN NY ACAD SCI, V762, P222; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; Horn D, 1990, GROWTH FACTORS, V2, P157, DOI 10.3109/08977199009071502; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Ichihara M, 1997, BLOOD, V90, P165; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; Liu HY, 2009, INT J MOL MED, V23, P161, DOI 10.3892/ijmm_00000113; Liu JW, 1997, CELL GROWTH DIFFER, V8, P667; Liu JW, 1998, CYTOKINE, V10, P295, DOI 10.1006/cyto.1997.0283; LIU JW, 1992, J BIOL CHEM, V267, P16763; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Modur V, 1997, J CLIN INVEST, V100, P158, DOI 10.1172/JCI119508; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NISHIMOTO N, 1994, J EXP MED, V179, P1343, DOI 10.1084/jem.179.4.1343; RICHARDS CD, 1993, J IMMUNOL, V150, P5596; Richards CD, 1997, J IMMUNOL, V159, P2431; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; ROSE TM, 1993, GENOMICS, V17, P136, DOI 10.1006/geno.1993.1294; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; SPORENO E, 1994, J BIOL CHEM, V269, P10991; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; TAGA T, 1992, CHEM IMMUNOL, V51, P181; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	44	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32848	32859		10.1074/jbc.M112.387324	http://dx.doi.org/10.1074/jbc.M112.387324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22829597	Green Published, hybrid			2022-12-25	WOS:000309168300050
J	Hatano, N; Itoh, Y; Suzuki, H; Muraki, Y; Hayashi, H; Onozaki, K; Wood, IC; Beech, DJ; Muraki, K				Hatano, Noriyuki; Itoh, Yuka; Suzuki, Hiroka; Muraki, Yukiko; Hayashi, Hidetoshi; Onozaki, Kikuo; Wood, Ian C.; Beech, David J.; Muraki, Katsuhiko			Hypoxia-inducible Factor-1 alpha (HIF1 alpha) Switches on Transient Receptor Potential Ankyrin Repeat 1 (TRPA1) Gene Expression via a Hypoxia Response Element-like Motif to Modulate Cytokine Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TNF-ALPHA; FACTOR-I; TRANSCRIPTIONAL REGULATION; INTRACELLULAR CA2+; HUMAN SYNOVIOCYTES; TRPC1 EXPRESSION; SENSORY NEURONS; CATION CHANNELS; HUMAN MONOCYTES	Transient receptor potential ankyrin repeat 1 (TRPA1) forms calcium (Ca2+)- and zinc (Zn2+)-permeable ion channels that sense noxious substances. Despite the biological and clinical importance of TRPA1, there is little knowledge of the mechanisms that lead to transcriptional regulation of TRPA1 and of the functional role of transcriptionally induced TRPA1. Here we show induction of TRPA1 by inflammatory mediators and delineate the underlying molecular mechanisms and functional relevance. In human fibroblast-like synoviocytes, key inflammatory mediators (tumor necrosis factor-alpha and interleukin-1 alpha) induced TRPA1 gene expression via nuclear factor-kappa B signaling and downstream activation of the transcription factor hypoxia-inducible factor-1 alpha (HIF1 alpha). HIF1 alpha unexpectedly acted by binding to a specific hypoxia response element-like motif and its flanking regions in the TRPA1 gene. The induced TRPA1 channels, which were intrinsically activated by endogenous hydrogen peroxide and Zn2+, suppressed secretion of interleukin-6 and interleukin-8. The data suggest a previously unrecognized HIF1 alpha mechanism that links inflammatory mediators to ion channel expression.	[Hatano, Noriyuki; Itoh, Yuka; Suzuki, Hiroka; Muraki, Yukiko; Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Lab Cellular Pharmacol, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Itoh, Yuka; Hayashi, Hidetoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Drug Metab & Disposit, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Onozaki, Kikuo] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Hlth Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Wood, Ian C.; Beech, David J.] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	Aichi Gakuin University; Nagoya City University; Nagoya City University; University of Leeds	Muraki, K (corresponding author), Aichi Gakuin Univ, Sch Pharm, Lab Cellular Pharmacol, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.	kmuraki@dpc.agu.ac.jp	Wood, Ian/AAK-9423-2021	Wood, Ian/0000-0003-1886-2533; Beech, David/0000-0002-7683-9422	Japanese Society of Promotion and Science (JSPS); Cosmetology Research Foundation; Japan Research Foundation for Clinical Pharmacology; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [24590085, 23790966] Funding Source: KAKEN	Japanese Society of Promotion and Science (JSPS); Cosmetology Research Foundation; Japan Research Foundation for Clinical Pharmacology; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (to K. M.) from the Japanese Society of Promotion and Science (JSPS), The Cosmetology Research Foundation, the Japan Research Foundation for Clinical Pharmacology, and the Suzuken Memorial Foundation. Part of this work was supported by the JSPS International Collaboration Program (to K. M. and D. B.).	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Bao B, 2003, AM J PHYSIOL-ENDOC M, V285, pE1095, DOI 10.1152/ajpendo.00545.2002; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Choi JH, 2005, FEBS LETT, V579, P2795, DOI 10.1016/j.febslet.2005.03.097; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Fernandes ES, 2011, ARTHRITIS RHEUM-US, V63, P819, DOI 10.1002/art.30150; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Itoh Y, 2007, J IMMUNOL, V178, P3059, DOI 10.4049/jimmunol.178.5.3059; Itoh Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1082, DOI 10.1152/ajpcell.00204.2009; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kochukov MY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-49; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; Smedlund K, 2010, CIRC RES, V106, P1479, DOI 10.1161/CIRCRESAHA.109.213314; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Ueda T, 2011, AM J PHYSIOL-GASTR L, V301, pG138, DOI 10.1152/ajpgi.00511.2010; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Zhou J, 2003, MOL BIOL CELL, V14, P2216, DOI 10.1091/mbc.E02-09-0598	46	72	74	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31962	31972		10.1074/jbc.M112.361139	http://dx.doi.org/10.1074/jbc.M112.361139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843691	Green Published, hybrid			2022-12-25	WOS:000309059400035
J	He, J; Shi, LDZ; Truong, LN; Lu, CS; Razavian, N; Li, YJ; Negrete, A; Shiloach, J; Berns, MW; Wu, XH				He, Jing; Shi, Linda Z.; Truong, Lan N.; Lu, Chi-Sheng; Razavian, Niema; Li, Yongjiang; Negrete, Alejandro; Shiloach, Joseph; Berns, Michael W.; Wu, Xiaohua			Rad50 Zinc Hook Is Important for the Mre11 Complex to Bind Chromosomal DNA Double-stranded Breaks and Initiate Various DNA Damage Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; MRE11-RAD50-NBS1 COMPLEX; CHROMATIN RETENTION; MAMMALIAN-CELLS; REPAIR COMPLEX; MRN COMPLEX; NBS1; ATM; PHOSPHORYLATION; PROTEIN	The Mre11-Rad50-Nbs1 (MRN) complex plays critical roles in checkpoint activation and double-stranded break (DSB) repair. The Rad50 zinc hook domain mediates zinc-dependent intercomplex associations of MRN, which is important for DNA tethering. Studies in yeast suggest that the Rad50 zinc hook domain is essential for MRN functions, but its role in mammalian cells is not clear. We demonstrated that the human Rad50 hook mutants are severely defective in various DNA damage responses including ATM (Ataxia telangiectasia mutated) activation, homologous recombination, sensitivity to IR, and activation of the ATR pathway. By using live cell imaging, we observed that the Rad50 hook mutants fail to be recruited to chromosomal DSBs, suggesting a novel mechanism underlying the severe defects observed for the Rad50 hook mutants. In vitro analysis showed that Zn2+ promotes wild type but not the hook mutant of MR to bind double-stranded DNA. In vivo, the Rad50 hook mutants are defective in being recruited to chromosomal DSBs in both H2AX-proficient and -deficient cells, suggesting that the Rad50 hook mutants are impaired in direct binding to chromosomal DSB ends. We propose that the Rad50 zinc hook domain is important for the initial binding of MRN to DSBs, leading to ATM activation to phosphorylate H2AX, which recruits more MRN to the DSB-flanking chromosomal regions. Our studies reveal a critical role for the Rad50 zinc hook domain in establishing and maintaining MRN recruitment to chromosomal DSBs and suggest an important mechanism of how the Rad50 zinc hook domain contributes to DNA repair and checkpoint activation.	[He, Jing; Truong, Lan N.; Lu, Chi-Sheng; Razavian, Niema; Li, Yongjiang; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Negrete, Alejandro; Shiloach, Joseph] NIDDK, Biotechnol Core Lab, NIH, Bethesda, MD 20892 USA	Scripps Research Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	HE, JING/J-3099-2014	Razavian, Niema/0000-0001-5746-9860; Berns, Michael/0000-0002-9640-2885	National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1]; Beckman Laser Institute Inc., Foundation; NATIONAL CANCER INSTITUTE [R01CA140972, R01CA102361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK015500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Laser Institute Inc., Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102361, GM080677, CA140972, and CA102361-07S1 (to X. W). This work was also supported by funds from the Beckman Laser Institute Inc., Foundation (to M. W. B.).	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089	38	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31747	31756		10.1074/jbc.M112.384750	http://dx.doi.org/10.1074/jbc.M112.384750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833675	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000309059400016
J	Gao, R; Huang, SYN; Marchand, C; Pommier, Y				Gao, Rui; Huang, Shar-yin N.; Marchand, Christophe; Pommier, Yves			Biochemical Characterization of Human Tyrosyl-DNA Phosphodiesterase 2 (TDP2/TTRAP) A Mg2+/Mn2+-DEPENDENT PHOSPHODIESTERASE SPECIFIC FOR THE REPAIR OF TOPOISOMERASE CLEAVAGE COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; RECEPTOR-ASSOCIATED FACTORS; BODIES-ASSOCIATED PROTEIN; DIVALENT METAL-IONS; VERTEBRATE CELLS; ACTIVE-SITE; I-TASSER; TTRAP; DAMAGE; TDP1	TDP2 is a multifunctional enzyme previously known for its role in signal transduction as TRAF and TNF receptor-associated protein (TTRAP) and ETS1-associated protein 2 (EAPII). The gene has recently been renamed TDP2 because it plays a critical role for the repair of topoisomerase II cleavage complexes (Top2cc) and encodes an enzyme that hydrolyzes 5'-tyrosine-DNA adducts that mimic abortive Top2cc. Here we further elucidate the DNA-processing activities of human recombinant TDP2 and its biochemical characteristics. The preferred substrate for TDP2 is single-stranded DNA or duplex DNA with a four-base pair overhang, which is consistent with the known structure of Top2cc or Top3cc. The k(cat)/K-m of TDP1 and TDP2 was determined. It was found to be 4 x 10(5) s(-1)M(-1) for TDP2 using single-stranded 5'-tyrosyl-DNA. The processing of substrates as short as five nucleotides long suggests that TDP2 can directly bind DNA ends. 5'-Phosphodiesterase activity requires a phosphotyrosyl linkage and tolerates an extended group attached to the tyrosine. TDP2 requires Mg2+ or Mn2+ for efficient catalysis but is weakly active with Ca2+ or Zn2+. Titration with Ca2+ demonstrates a two-metal binding site in TDP2. Sequence alignment suggests that TDP2 contains four conserved catalytic motifs shared by Mg2+-dependent endonucleases, such as APE1. Substitutions at each of the four catalytic motifs identified key residues Asn-120, Glu-152, Asp-262, and His-351, whose mutation to alanine significantly reduced or completely abolished enzymatic activity. Our study characterizes the substrate specificity and kinetic parameters of TDP2. In addition, a two-metal catalytic mechanism is proposed.	[Gao, Rui; Huang, Shar-yin N.; Marchand, Christophe; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov			Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health.	Adhikari Sanjay, 2012, BMC Res Notes, V5, P134, DOI 10.1186/1756-0500-5-134; Adhikari S, 2011, ANAL BIOCHEM, V416, P112, DOI 10.1016/j.ab.2011.05.008; Antony S, 2007, NUCLEIC ACIDS RES, V35, P4474, DOI 10.1093/nar/gkm463; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chou KM, 2003, J BIOL CHEM, V278, P18289, DOI 10.1074/jbc.M212143200; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dexheimer TS, 2008, NUCLEIC ACIDS RES, V36, P4128, DOI 10.1093/nar/gkn334; Dexheimer TS, 2008, ANTI-CANCER AGENT ME, V8, P381, DOI 10.2174/187152008784220357; Dexheimer TS, 2010, NUCLEIC ACIDS RES, V38, P2444, DOI 10.1093/nar/gkp1206; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Kim WC, 2011, J MOL BIOL, V411, P960, DOI 10.1016/j.jmb.2011.06.050; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Li C, 2011, ONCOGENE, V30, P3802, DOI 10.1038/onc.2011.94; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Murai J, 2012, J BIOL CHEM, V287, P12848, DOI 10.1074/jbc.M111.333963; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sabourin M, 2000, NUCLEIC ACIDS RES, V28, P1947, DOI 10.1093/nar/28.9.1947; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Velez-Cruz R, 2005, BIOCHEMISTRY-US, V44, P3972, DOI 10.1021/bi0478289; Vilotti S, 2012, CELL DEATH DIFFER, V19, P488, DOI 10.1038/cdd.2011.118; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; WANG JC, 1991, J BIOL CHEM, V266, P6659; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Xu GL, 2008, BIOCHEM BIOPH RES CO, V375, P395, DOI 10.1016/j.bbrc.2008.08.023; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhang JQ, 2009, BIOCHEM BIOPH RES CO, V387, P256, DOI 10.1016/j.bbrc.2009.06.153; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	44	51	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30842	30852		10.1074/jbc.M112.393983	http://dx.doi.org/10.1074/jbc.M112.393983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22822062	hybrid, Green Published			2022-12-25	WOS:000308579800072
J	Chang, CH; Hinkula, J; Loo, M; Falkeborn, T; Li, RX; Cardillo, TM; Rossi, EA; Goldenberg, DM; Wahren, B				Chang, Chien-Hsing; Hinkula, Jorma; Loo, Meiyu; Falkeborn, Tina; Li, Rongxiu; Cardillo, Thomas M.; Rossi, Edmund A.; Goldenberg, David M.; Wahren, Britta			A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; FUSION-INHIBITOR; LOCK METHOD; MULTIFUNCTIONAL STRUCTURES; ANTIRETROVIRAL ACTIVITY; DEFINED COMPOSITION; ENTRY INHIBITORS; RATIONAL DESIGN; HIGHLY POTENT	We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtide, the first such therapeutic in this class. The three prototypes generated by the Dock-and-Lock (DNL) technology to comprise four copies of enfuvirtide tethered site-specifically to the Fc end of different humanized monoclonal antibodies potently neutralize primary isolates (both R5-tropic and X4-tropic), as well as T-cell-adapted strains of HIV-1 in vitro. All three prototypes show EC50 values in the subnanomolar range, which are 10- to 100-fold lower than enfuvirtide and attainable whether or not the constitutive antibody targets HIV-1. The potential of such conjugates to purge latently infected cells was also demonstrated in a cell-to-cell viral inhibition assay by measuring their efficacy to inhibit the spread of HIV-1(LAI) from infected human peripheral blood mononuclear cells to Jurkat T cells over a period of 30 days following viral activation with 100 nM SAHA (suberoylanilide hydroxamic acid). The IgG-like half-life was not significantly different from that of the parental antibody, as shown by the mean serum concentration of one prototype in mice at 72 h. These encouraging results provide a rationale to develop further novel anti-HIV agents by coupling additional antibodies of interest with alternative HIV-inhibitors via recombinantly-produced, self-assembling, modules.	[Chang, Chien-Hsing; Li, Rongxiu; Cardillo, Thomas M.; Goldenberg, David M.] Immunomedics Inc, Morris Plains, NJ USA; [Chang, Chien-Hsing; Loo, Meiyu; Rossi, Edmund A.; Goldenberg, David M.] IBC Pharmaceut Inc, Morris Plains, NJ USA; [Hinkula, Jorma; Wahren, Britta] Karolinska Inst, Dept Microbiol & Tumor Biol, Stockholm, Sweden; [Hinkula, Jorma; Falkeborn, Tina] Linkoping Univ, Dept Mol Virol, Linkoping, Sweden; [Goldenberg, David M.] Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA	Immunomedics Inc; Karolinska Institutet; Linkoping University	Chang, CH (corresponding author), Immunomedics Inc, Morris Plains, NJ USA.	kchang@immunomedics.com; britta.wahren@ki.se	Hinkula, Jorma/P-6849-2018	Hinkula, Jorma/0000-0003-1908-5609				Asmuth DM, 2010, J INFECT DIS, V201, P1686, DOI 10.1086/652420; Berger EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000803; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; BROLIDEN PA, 1990, J VIROL, V64, P936, DOI 10.1128/JVI.64.2.936-940.1990; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Chang CH, 2007, CLIN CANCER RES, V13, p5586S, DOI 10.1158/1078-0432.CCR-07-1217; Chang CH, 2009, BIOCONJUGATE CHEM, V20, P1899, DOI 10.1021/bc9001773; CHANG SYP, 1993, NATURE, V363, P466, DOI 10.1038/363466a0; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Dadachova E, 2006, PLOS MED, V3, P2094, DOI 10.1371/journal.pmed.0030427; Devito C, 2004, J IMMUNOL, V173, P7078, DOI 10.4049/jimmunol.173.11.7078; Devito C, 2000, J IMMUNOL METHODS, V238, P69, DOI 10.1016/S0022-1759(00)00141-1; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Huet T, 2010, ANTIMICROB AGENTS CH, V54, P134, DOI 10.1128/AAC.00827-09; Ji CH, 2009, J BIOL CHEM, V284, P5175, DOI 10.1074/jbc.M808745200; Johansson S, 2006, AIDS, V20, P1911, DOI 10.1097/01.aids.0000247111.58961.60; Kagiampakis I, 2011, ANTIMICROB AGENTS CH, V55, P264, DOI 10.1128/AAC.00376-10; Kopetzki E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-56; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Luo XM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001225; Makinson A, 2009, CURR OPIN HIV AIDS, V4, P150, DOI 10.1097/COH.0b013e32832498d8; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Nagashima KA, 2001, J INFECT DIS, V183, P1121, DOI 10.1086/319284; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Neff CP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001581; Paulik M, 1999, BIOCHEM PHARMACOL, V58, P1781, DOI 10.1016/S0006-2952(99)00272-5; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rossi EA, 2006, P NATL ACAD SCI USA, V103, P6841, DOI 10.1073/pnas.0600982103; Rossi EA, 2008, CANCER RES, V68, P8384, DOI 10.1158/0008-5472.CAN-08-2033; Rossi EA, 2012, BIOCONJUGATE CHEM, V23, P309, DOI 10.1021/bc2004999; Rossi EA, 2009, BLOOD, V114, P3864, DOI 10.1182/blood-2009-06-228890; Rossi EA, 2009, BLOOD, V113, P6161, DOI 10.1182/blood-2008-10-187138; Rowcliffe E, 2004, SCAND J INFECT DIS, V36, P360, DOI 10.1080/00365540410020208; Schweighardt B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; Stoiber H, 2009, CURR OPIN HIV AIDS, V4, P394, DOI 10.1097/COH.0b013e32832f0108; Vangelista L, 2008, VACCINE, V26, P3008, DOI 10.1016/j.vaccine.2007.12.023; West AP, 2009, J VIROL, V83, P98, DOI 10.1128/JVI.01564-08; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2007, CURR PHARM DESIGN, V13, P203, DOI 10.2174/138161207779313669; Zhang XQ, 2006, ANTIMICROB AGENTS CH, V50, P2231, DOI 10.1128/AAC.00761-05; Zhao B, 2011, J BIOL CHEM, V286, P28370, DOI 10.1074/jbc.M111.234799	51	14	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41235	10.1371/journal.pone.0041235	http://dx.doi.org/10.1371/journal.pone.0041235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844444	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700058
J	Chen, XR; Xiu, FM; Horvath, CN; Damjanovic, D; Thanthrige-Don, N; Jeyanathan, M; Xing, Z				Chen, Xuerong; Xiu, Fangming; Horvath, Carly N.; Damjanovic, Daniela; Thanthrige-Don, Niroshan; Jeyanathan, Mangalakumari; Xing, Zhou			Regulation of TB Vaccine-Induced Airway Luminal T Cells by Respiratory Exposure to Endotoxin	PLOS ONE			English	Article							MUCOSAL IMMUNIZATION; LUNG AIRWAYS; NEUTRALIZING ANTIBODIES; TUBERCULOSIS VACCINES; RECRUITMENT; ADENOVIRUS; MECHANISMS; PROTECTION; IMMUNITY; VECTORS	Tuberculosis (TB) vaccine-induced airway luminal T cells (ALT) have recently been shown to be critical to host defense against pulmonary TB. However, the mechanisms that maintain memory ALT remain poorly understood. In particular, whether respiratory mucosal exposure to environmental agents such as endotoxin may regulate the size of vaccine-induced ALT population is still unclear. Using a murine model of respiratory genetic TB vaccination and respiratory LPS exposure, we have addressed this issue in the current study. We have found that single or repeated LPS exposure increases the number of antigen-specific ALT which are capable of robust secondary responses to pulmonary mycobacterial challenge. To investigate the potential mechanisms by which LPS exposure modulates the ALT population, we have examined the role of ALT proliferation and peripheral T cell recruitment. We have found that LPS exposure-increased ALT is not dependent on increased ALT proliferation as respiratory LPS exposure does not significantly increase the rate of proliferation of ALT. But rather, we find it to be dependent upon the recruitment of peripheral T cells into the airway lumen as blockade of peripheral T cell supplies markedly reduces the initially increased ALT. Thus, our data suggest that environmental exposure to airborne agents such as endotoxin has a profound modulatory effect on TB vaccine-elicited T cells within the respiratory tract. Our study provides a new, M.tb antigen-independent mechanism by which the respiratory mucosal anti-TB memory T cells may be maintained.	[Chen, Xuerong] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University	Chen, XR (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada.	xingz@mcmaster.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study is supported by funds from the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Horvath CN, 2012, MUCOSAL IMMUNOL, V5, P420, DOI 10.1038/mi.2012.19; Jeyanathan M, 2010, TRENDS IMMUNOL, V31, P247, DOI 10.1016/j.it.2010.05.002; Jeyanathan M, 2010, AM J RESP CRIT CARE, V181, P862, DOI 10.1164/rccm.200910-1583OC; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kohlmeier JE, 2006, CURR OPIN IMMUNOL, V18, P357, DOI 10.1016/j.coi.2006.03.012; Larsson L, 2004, INDOOR AIR, V14, P421, DOI 10.1111/j.1600-0668.2004.00290.x; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mu JY, 2010, J GENE MED, V12, P693, DOI 10.1002/jgm.1487; Nilsson A, 2004, INDOOR AIR, V14, P74, DOI 10.1046/j.1600-0668.2003.00178.x; Park JH, 2004, APPL ENVIRON MICROB, V70, P262, DOI 10.1128/aEM.70.1.262-267.2004; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Walrath JR, 2011, AM J RESP CELL MOL, V45, P24, DOI 10.1165/rcmb.2010-0241OC; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; XING Z, 1993, AM J PATHOL, V143, P1009; Xing Z, 2006, TUBERCULOSIS, V86, P211, DOI 10.1016/j.tube.2006.01.017	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41666	10.1371/journal.pone.0041666	http://dx.doi.org/10.1371/journal.pone.0041666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844510	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700136
J	Fatima, N; Schooley, JF; Claycomb, WC; Flagg, TP				Fatima, Naheed; Schooley, James F., Jr.; Claycomb, Willliam C.; Flagg, Thomas P.			Promoter DNA Methylation Regulates Murine SUR1 (Abcc8) and SUR2 (Abcc9) Expression in HL-1 Cardiomyocytes	PLOS ONE			English	Article							K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNEL; SUBUNITS KIR6.2; CPG ISLANDS; CELLS; STOICHIOMETRY; ASSOCIATION; ACTIVATION; DIVERSITY; MUTATION	Two mammalian genes encode the SURx (SUR1, Abcc8 and SUR2, Abcc9) subunits that combine with Kir6.2 (Kcnj11) subunits to form the ATP-sensitive potassium (KATP) channel in cardiac myocytes. Different isoform combinations endow the channel with distinct physiological and pharmacological properties, and we have recently reported that the molecular composition of sarcolemmal KATP channels is chamber specific in the mouse heart. KATP channel composition is determined by what subunits are expressed in a cell or tissue. In the present study, we explore the role of CpG methylation in regulating SUR1 and SUR2 expression. In HL-1 cardiomyocytes, as in atrial myocytes, SUR1 expression is markedly greater than SUR2. Consistent with CpG methylation-dependent silencing of SUR2 expression, bisulfite sequencing of genomic DNA isolated from HL-1 cells demonstrates that 57.6% of the CpGs in the promoter region of the SUR2 gene are methylated, compared with 0.14% of the the CpG residues in the SUR1 sequence. Moreover, treatment with 10 mu M 5-aza-2'-deoxycytidine (Aza-dC) significantly increased both the unmethylated fraction of the SUR2 CpG island and mRNA expression. However, we cannot rule out additional mechanisms of Aza-dC action, as Aza-dC also causes a decrease in SUR1 expression and lower doses of Aza-dC do not alter the unmethylated DNA fraction but do elicit a small increase in SUR2 expression. The conclusion that DNA methylation alone is not the only regulator of SUR subunit expression is also consistent with observations in native myocytes, where the CpG islands of both SUR genes are essentially unmethylated in both atrial and ventricular myocytes. Collectively, these data demonstrate the potential for CpG methylation to regulate SURx subunit expression and raises the possibility that regulated or aberrant CpG methylation might play a role in controlling channel structure and function under different physiological conditions or different species.	[Fatima, Naheed; Schooley, James F., Jr.; Flagg, Thomas P.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Claycomb, Willliam C.] LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA	Uniformed Services University of the Health Sciences - USA; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Fatima, N (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	Thomas.Flagg@usuhs.edu			American Heart Association [11SDG7210070]; Henry M. Jackson Foundation; Department of Defense [R0702O]	American Heart Association(American Heart Association); Henry M. Jackson Foundation; Department of Defense(United States Department of Defense)	This work was supported in part by awards from the American Heart Association Scientist Development Grant (11SDG7210070 to TPF), the Henry M. Jackson Foundation (to TPF), and the Department of Defense (R0702O to TPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Ashfield R, 1998, DIABETES, V47, P1274, DOI 10.2337/diabetes.47.8.1274; Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132; Bao L, 2011, CIRC-ARRHYTHMIA ELEC, V4, P926, DOI 10.1161/CIRCEP.111.964643; Chan KW, 2008, J GEN PHYSIOL, V131, P43, DOI 10.1085/jgp.200709894; Cheng WWL, 2008, RANDOM ASSEMBLY SUR, V2; Chutkow WA, 1999, J BIOL CHEM, V274, P13656, DOI 10.1074/jbc.274.19.13656; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Chutkow WA, 2001, P NATL ACAD SCI USA, V98, P11760, DOI 10.1073/pnas.201390398; Clark RH, 2010, SCIENCE, V329, P458, DOI 10.1126/science.1186146; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Crawford RM, 2003, J BIOL CHEM, V278, P31444, DOI 10.1074/jbc.M303051200; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Flagg TP, 2005, J MOL CELL CARDIOL, V39, P647, DOI 10.1016/j.yjmcc.2005.06.003; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Glukhov AV, 2010, J MOL CELL CARDIOL, V48, P152, DOI 10.1016/j.yjmcc.2009.08.026; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Hernandez-Sanchez C, 1999, J BIOL CHEM, V274, P18261, DOI 10.1074/jbc.274.26.18261; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; INAGAKI N, 1995, GENOMICS, V30, P102, DOI 10.1006/geno.1995.0018; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kao YH, 2010, CRIT CARE MED, V38, P217, DOI 10.1097/CCM.0b013e3181b4a854; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Koster JC, 2001, CIRC RES, V89, P1022, DOI 10.1161/hh2301.100342; Lader JM, 2011, AM J PHYSIOL-HEART C, V301, pH964, DOI 10.1152/ajpheart.00410.2011; Li RA, 2000, CIRC RES, V87, P837, DOI 10.1161/01.RES.87.10.837; Lorenz E, 1999, J MOL CELL CARDIOL, V31, P425, DOI 10.1006/jmcc.1998.0876; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Oki Y, 2007, CRIT REV ONCOL HEMAT, V61, P140, DOI 10.1016/j.critrevonc.2006.07.010; Palbykin B, 2011, CARDIOVASC TOXICOL, V11, P204, DOI 10.1007/s12012-011-9113-3; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Pountney DJ, 2001, J MOL CELL CARDIOL, V33, P1541, DOI 10.1006/jmcc.2001.1407; Remedi MS, 2009, CELL METAB, V9, P140, DOI 10.1016/j.cmet.2008.12.005; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Saegusa N, 2005, CARDIOVASC RES, V67, P60, DOI 10.1016/j.cardiores.2005.03.011; Shi NQ, 2005, J MOL CELL CARDIOL, V39, P51, DOI 10.1016/j.yjmcc.2004.11.024; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570; Takai Daiya, 2003, In Silico Biology, V3, P235; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; Wheeler A, 2008, MOL PHARMACOL, V74, P1333, DOI 10.1124/mol.108.048355; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Zheng ZX, 2012, FASEB J, V26, P449, DOI 10.1096/fj.11-190025; Zingman LV, 2011, J MOL CELL CARDIOL, V51, P72, DOI 10.1016/j.yjmcc.2011.03.010	55	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41533	10.1371/journal.pone.0041533	http://dx.doi.org/10.1371/journal.pone.0041533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844491	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700103
J	Findlay, B; Szelemej, P; Zhanel, GG; Schweizer, F				Findlay, Brandon; Szelemej, Paul; Zhanel, George G.; Schweizer, Frank			Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; PEPTIDE; PATHOGENS; MIMICS	Background: Cationic antimicrobial peptides (CAMPs) are attractive scaffolds for the next generation of antimicrobial compounds, due to their broad spectrum of activity against multi-drug resistant bacteria and the reduced fitness of CAMP-insensitive mutants. Unfortunately, they are limited by poor in vivo performance, including ready cleavage by endogenous serum proteases. Methodology/Principal Findings: To explore the potential for peptoid residues to replace well studied CAMP scaffolds we have produced a series of antimicrobial lipopeptoids, with sequences similar to previously reported lipopeptides. The activity of the peptoids was assessed against a panel of clinically relevant and laboratory reference bacteria, and the potential for non-specific binding was determined through hemolytic testing and repeating the antimicrobial testing in the presence of added bovine serum albumin (BSA). The most active peptoids displayed good to moderate activity against most of the Gram positive strains tested and moderate to limited activity against the Gram negatives. Antimicrobial activity was positively correlated with toxicity towards eukaryotic cells, but was almost completely eliminated by adding BSA. Conclusion/Significance: The lipopeptoids had similar activities to the previously reported lipopeptides, confirming their potential to act as replacement, proteolytically stable scaffolds for CAMPs.	[Findlay, Brandon; Szelemej, Paul; Schweizer, Frank] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Zhanel, George G.; Schweizer, Frank] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Findlay, B (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.	schweize@cc.umanitoba.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding of this work was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Baker TJ, 2000, J ORG CHEM, V65, P9054, DOI 10.1021/jo001142e; Bera S, 2010, J ANTIMICROB CHEMOTH; Chan WC, 2000, FMOC SOLID PHASE PEP; Chongsiriwatana NP, 2011, ANTIMICROB AGENTS CH, V55, P417, DOI 10.1128/AAC.01080-10; Chongsiriwatana NP, 2010, METHODS MOL BIOL, V618, P171, DOI 10.1007/978-1-60761-594-1_12; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; Findlay B, 2012, INT J ANTIMICROB AG, V40, P36, DOI 10.1016/j.ijantimicag.2012.03.013; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Koprivnjak T, 2011, CELL MOL LIFE SCI, V68, P2243, DOI 10.1007/s00018-011-0716-4; Makovitzki A, 2005, BIOCHEMISTRY-US, V44, P9775, DOI 10.1021/bi0502386; MARIS P, 1991, ANN RECH VET, V22, P11; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Rennie RP, 2006, PROTOCOLS EVALUATING, P1; Svenson J, 2008, BIOCHEMISTRY-US, V47, P3777, DOI 10.1021/bi7019904; Svenson J, 2007, J MED CHEM, V50, P3334, DOI 10.1021/jm0703542; Wright GD, 2012, TRENDS MICROBIOL; Yang LH, 2008, P NATL ACAD SCI USA, V105, P20595, DOI 10.1073/pnas.0806456105; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zhanel GG, 2008, ANTIMICROB AGENTS CH, V52, P1430, DOI 10.1128/AAC.01538-07; Zhanel GG, 2011, DIAGN MICR INFEC DIS, V69, P291, DOI 10.1016/j.diagmicrobio.2010.10.025	23	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41141	10.1371/journal.pone.0041141	http://dx.doi.org/10.1371/journal.pone.0041141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844435	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700048
J	Gu, Z; Liu, YH; Zhang, YJ; Jin, SL; Chen, Q; Goltzman, D; Karaplis, A; Miao, DS				Gu, Zhen; Liu, Yahong; Zhang, Yongjie; Jin, Shulei; Chen, Qi; Goltzman, David; Karaplis, Andrew; Miao, Dengshun			Absence of PTHrP Nuclear Localization and Carboxyl Terminus Sequences Leads to Abnormal Brain Development and Function	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; SELF-RENEWAL; CELL-PROLIFERATION; PEPTIDE RECEPTOR; UP-REGULATION; MICE LACKING; GROWTH; SENESCENCE; NEUROGENESIS; INDUCTION	We assessed whether the nuclear localization sequences (NLS) and C terminus of parathyroid hormone-related protein (PTHrP) play critical roles in brain development and function. We used histology, immunohistochemistry, histomorphometry, Western blots and electrophysiological recordings to compare the proliferation and differentiation of neural stem cells, neuronal hippocampal synaptic transmission, and brain phenotypes including shape and structures, in Pthrp knock-in mice, which express PTHrP (1-84), a truncated form of the protein that is missing the NLS and the C-terminal region of the protein, and their wild-type littermates. Results showed that Pthrp knock-in mice display abnormal brain shape and structures; decreased neural cell proliferative capacity and increased apoptosis associated with up-regulation of cyclin dependent kinase inhibitors p16, p21, p27 and p53 and down-regulation of the Bmi-1 oncogene; delayed neural cell differentiation; and impaired hippocampal synaptic transmission and plasticity. These findings provide in vivo experimental evidence that the NLS and C-terminus of PTHrP are essential not only for the regulation of neural cell proliferation and differentiation, but also for the maintenance of normal neuronal synaptic transmission and plasticity.	[Gu, Zhen; Liu, Yahong; Zhang, Yongjie; Jin, Shulei; Miao, Dengshun] Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chen, Qi] Nanjing Med Univ, Dept Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Goltzman, David; Karaplis, Andrew] McGill Univ, Dept Med, Montreal, PQ, Canada	Nanjing Medical University; Nanjing Medical University; McGill University	Gu, Z (corresponding author), Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	dsmiao@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502; Zhang, Yongjie/0000-0002-8674-4566	National Nature and Scientific Foundation of China [30830103]; National Basic Research Program of China [2012CB966902]; Nature and Scientific Basic Research Foundation of Jiangsu Province [07KJB310078]; Scientific Development Foundation of Nanjing Medical University [06NMUZ003]; Canadian Institutes for Health Research; Nature and Scientific Foundation of Jiangsu Province [BK2010539]; Natural Science Foundation for the Youth [81100942]; College of Basic Medicine of Nanjing Medical University [JX1011780114]	National Nature and Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Nature and Scientific Basic Research Foundation of Jiangsu Province; Scientific Development Foundation of Nanjing Medical University; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Nature and Scientific Foundation of Jiangsu Province; Natural Science Foundation for the Youth(National Natural Science Foundation of China (NSFC)); College of Basic Medicine of Nanjing Medical University	This work was supported by the Key Project grant (no. 30830103) from National Nature and Scientific Foundation of China and by the National Basic Research Program of China (2012CB966902) to D.M.; by the grant (07KJB310078) from Nature and Scientific Basic Research Foundation of Jiangsu Province and the Key Project grant (no. 06NMUZ003) from Scientific Development Foundation of Nanjing Medical University to Z.G.; by operating grants from the Canadian Institutes for Health Research to A.C.K. and D.G.; by the Nature and Scientific Foundation of Jiangsu Province (BK2010539), Natural Science Foundation for the Youth (no. 81100942) to Y.Z. and the grant (JX1011780114) from College of Basic Medicine of Nanjing Medical University to Y.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008; Berzhanskaya J, 1998, J NEUROPHYSIOL, V79, P2111, DOI 10.1152/jn.1998.79.4.2111; BURTIS WJ, 1987, J BIOL CHEM, V262, P7151; Chatterjee O, 2002, BRAIN RES, V930, P58, DOI 10.1016/S0006-8993(01)03407-2; Clemens TL, 2001, BRIT J PHARMACOL, V134, P1113, DOI 10.1038/sj.bjp.0704378; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fiaschi-Taesch N, 2009, ENDOCRINOLOGY, V150, P1429, DOI 10.1210/en.2008-0737; Fiaschi-Taesch NM, 2003, ENDOCRINOLOGY, V144, P407, DOI 10.1210/en.2002-220818; FUKAYAMA S, 1995, P NATL ACAD SCI USA, V92, P10182, DOI 10.1073/pnas.92.22.10182; Funk JL, 2001, BRAIN RES, V915, P195, DOI 10.1016/S0006-8993(01)02850-5; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Hildreth BE, 2010, J SURG RES, V162, pE9, DOI 10.1016/j.jss.2010.02.023; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kumari R, 2006, INT J CANCER, V119, P49, DOI 10.1002/ijc.21802; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Macica CM, 2006, GLIA, V53, P637, DOI 10.1002/glia.20319; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; Massa F, 2011, P NATL ACAD SCI USA, V108, P6644, DOI 10.1073/pnas.1016928108; Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105; Miao DS, 2004, ENDOCRINOLOGY, V145, P3554, DOI 10.1210/en.2003-1695; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Qian J, 2003, ENDOCRINOLOGY, V144, P1053, DOI 10.1210/en.2002-220993; Sepulveda VAT, 2002, REGUL PEPTIDES, V105, P109, DOI 10.1016/S0167-0115(02)00007-1; Srivastava RK, 2007, CELL CYCLE, V6, P2953, DOI 10.4161/cc.6.23.4951; URENA P, 1993, ENDOCRINOLOGY, V133, P617, DOI 10.1210/en.133.2.617; WEIR EC, 1990, P NATL ACAD SCI USA, V87, P108, DOI 10.1073/pnas.87.1.108; Wu TL, 1996, J BIOL CHEM, V271, P24371, DOI 10.1074/jbc.271.40.24371; Wysolmerski JJ, 2001, J CLIN ENDOCR METAB, V86, P1788, DOI 10.1210/jc.86.4.1788; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yamamoto S, 2002, ENDOCRINOLOGY, V143, P1521, DOI 10.1210/en.143.4.1521	34	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41542	10.1371/journal.pone.0041542	http://dx.doi.org/10.1371/journal.pone.0041542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844494	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700106
J	Huang, HJ; Chen, YH; Liang, KC; Jheng, YS; Jhao, JJ; Su, MT; Lee-Chen, GJ; Hsieh-Li, HM				Huang, Hei-Jen; Chen, Yen-Hsu; Liang, Keng-Chen; Jheng, Yu-Syuan; Jhao, Jhih-Jhen; Su, Ming-Tsan; Lee-Chen, Guey-Jen; Hsieh-Li, Hsiu Mei			Exendin-4 Protected against Cognitive Dysfunction in Hyperglycemic Mice Receiving an Intrahippocampal Lipopolysaccharide Injection	PLOS ONE			English	Article							NF-KAPPA-B; BETA-INDUCED NEUROTOXICITY; NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE; PEPTIDE-1 RECEPTOR; METABOLIC SYNDROME; CELL APOPTOSIS; BRAIN; EXPRESSION; PATHWAY	Background: Chronic hyperglycemia-associated inflammation plays critical roles in disease initiation and the progression of diabetic complications, including Alzheimer's disease (AD). However, the association of chronic hyperglycemia with acute inflammation of the central nervous system in the progression of AD still needs to be elucidated. In addition, recent evidence suggests that Glucagon-like peptide-1 receptor (GLP-1R) protects against neuronal damage in the brain. Therefore, the neuroprotective effects of the GLP-1R agonist exendin-4 (EX-4) against hyperglycemia/lipopolysaccharides (LPS) damage were also evaluated in this study. Methodology/Principal Findings: Ten days after streptozotocin (STZ) or vehicle (sodium citrate) treatment in mice, EX-4 treatment (10 mu g/kg/day) was applied to the mice before intrahippocampal CA1 injection of LPS or vehicle (saline) and continued for 28 days. This study examined the molecular alterations in these mice after LPS and EX4 application, respectively. The mouse cognitive function was evaluated during the last 6 days of EX-4 treatment. The results showed that the activation of NF-kappa B-related inflammatory responses induced cognitive dysfunction in both the hyperglycemic mice and the mice that received acute intrahippocampal LPS injection. Furthermore, acute intrahippocampal LPS injection exacerbated the impairment of spatial learning and memory through a strong decrease in monoaminergic neurons and increases in astrocytes activation and apoptosis in the hyperglycemic mice. However, EX-4 treatment protected against the cognitive dysfunction resulting from hyperglycemia or/and intrahippocampal LPS injection. Conclusions/Significance: These findings reveal that both hyperglycemia and intrahippocampal LPS injection induced cognitive dysfunction via activation of NF-kappa B-related inflammatory responses. However, acute intrahippocampal LPS injection exacerbated the progression of cognitive dysfunction in the hyperglycemic mice via a large increase in astrocytes activation-related responses. Furthermore, EX-4 might be considered as a potential adjuvant entity to protect against neurodegenerative diseases.	[Huang, Hei-Jen; Jheng, Yu-Syuan; Jhao, Jhih-Jhen] Mackay Med Nursing & Management Coll, Dept Nursing, Taipei, Taiwan; [Chen, Yen-Hsu; Su, Ming-Tsan; Lee-Chen, Guey-Jen; Hsieh-Li, Hsiu Mei] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Liang, Keng-Chen] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan	Mackay Junior College of Medicine, Nursing & Management; National Taiwan Normal University; National Taiwan University	Huang, HJ (corresponding author), Mackay Med Nursing & Management Coll, Dept Nursing, Taipei, Taiwan.	hmhsieh@ntnu.edu.tw	Chen, Chiung-Mei/AAL-6260-2020	Liang, Keng-Chen/0000-0002-3292-6882; Chen, Yen-hsu/0000-0002-8667-4844	National Science Council [NSC100-2325-B-003-002]; National Taiwan Normal University [NTNU100-D-02]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan Normal University	This work was supported in part by research grants from the National Science Council (NSC100-2325-B-003-002) and National Taiwan Normal University (NTNU100-D-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Aid S, 2010, J CEREBR BLOOD F MET, V30, P370, DOI 10.1038/jcbfm.2009.223; Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014; Alvarez E, 1996, J NEUROCHEM, V66, P920; Alvarez EO, 2009, BEHAV BRAIN RES, V198, P224, DOI 10.1016/j.bbr.2008.11.001; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Booz GW, 2011, FREE RADICAL BIO MED, V51, P1054, DOI 10.1016/j.freeradbiomed.2011.01.007; Brown SB, 2010, CARDIOVASC DRUG THER, V24, P197, DOI 10.1007/s10557-010-6242-z; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cai ZY, 2011, PHARMACOL REP, V63, P381, DOI 10.1016/S1734-1140(11)70504-7; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Clouatre DL, 2011, J MED FOOD; Colton CA, 2008, J ALZHEIMERS DIS, V15, P571; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Cunningham C, 2012, J NEUROIMMUNE PHARM, V7, P60, DOI 10.1007/s11481-011-9312-5; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; de Oliveira AC, 2012, ENDOCRINOLOGY; Drucker Thomas B, 2008, Md Med, V9, P5; Elovich R, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-23; Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214; Ferret-Bernard S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013705; Francis P T, 2009, Curr Mol Pharmacol, V2, P77; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hertz L, 2004, CNS NEUROL DISORD-DR, V3, P239, DOI 10.2174/1568007043337535; Hwang J, 2010, NEUROPHARMACOLOGY, V58, P1122, DOI 10.1016/j.neuropharm.2010.02.003; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Jardanhazi-Kurutz D, 2011, NEUROSCIENCE, V176, P396, DOI 10.1016/j.neuroscience.2010.11.052; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kang JH, 2009, J ENDOCRINOL, V202, P65, DOI 10.1677/JOE-08-0507; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; LEE SC, 1993, J IMMUNOL, V150, P2659; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lichtenstein MP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00142; Morley JE, 2002, PEPTIDES, V23, P589, DOI 10.1016/S0196-9781(01)00630-1; Muller N, 1998, PROG NEURO-PSYCHOPH, V22, P1, DOI 10.1016/S0278-5846(97)00179-6; Nareika A, 2008, J ENDOCRINOL, V196, P45, DOI 10.1677/JOE-07-0145; O'Neil JN, 2007, J CHEM NEUROANAT, V34, P102, DOI 10.1016/j.jchemneu.2007.05.008; Pavlovic DM, 2008, SRP ARK CELOK LEK, V136, P170, DOI 10.2298/SARH0804170P; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Perez JL, 2010, EXP NEUROL, V223, P410, DOI 10.1016/j.expneurol.2009.10.013; Potter PE, 2010, J AM OSTEOPATH ASSOC, V110, pS27; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Saravanan R, 2012, J PHYSL BIOCH; Sharifi AM, 2009, NEUROSCI LETT, V459, P47, DOI 10.1016/j.neulet.2009.03.100; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Taepavarapruk P, 2010, J NEUROCHEM, V112, P1054, DOI 10.1111/j.1471-4159.2009.06524.x; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang G, 2012, J BIOL CHEM; Yaffe K, 2007, ALZ DIS ASSOC DIS, V21, P167, DOI 10.1097/WAD.0b013e318065bfd6; Zablocka A, 2010, BIOMED PHARMACOTHER, V64, P16, DOI 10.1016/j.biopha.2009.01.009	60	69	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e39656	10.1371/journal.pone.0039656	http://dx.doi.org/10.1371/journal.pone.0039656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844396	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700006
J	Martin, R; Miana, M; Jurado-Lopez, R; Martinez-Martinez, E; Gomez-Hurtado, N; Delgado, C; Bartolome, MV; San Roman, JA; Cordova, C; Lahera, V; Nieto, ML; Cachofeiro, V				Martin, Ruben; Miana, Maria; Jurado-Lopez, Raquel; Martinez-Martinez, Ernesto; Gomez-Hurtado, Nieves; Delgado, Carmen; Visitacion Bartolome, Maria; Alberto San Roman, Jose; Cordova, Claudia; Lahera, Vicente; Luisa Nieto, Maria; Cachofeiro, Victoria			DIOL Triterpenes Block Profibrotic Effects of Angiotensin II and Protect from Cardiac Hypertrophy	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; OLIVE OIL; EXTRACELLULAR-MATRIX; CARDIOVASCULAR-DISEASES; DIASTOLIC DYSFUNCTION; ALDOSTERONE SYSTEM; HEART-FAILURE; URSOLIC ACIDS; RAT; FIBROBLASTS	Background: The natural triterpenes, erythrodiol and uvaol, exert anti-inflammatory, vasorelaxing and anti-proliferative effects. Angiotensin II is a well-known profibrotic and proliferative agent that participates in the cardiac remodeling associated with different pathological situations through the stimulation and proliferation of cardiac fibroblasts. Therefore, the aim of the study was to investigate the preventive effects of the natural triterpenes erythrodiol and uvaol on the proliferation and collagen production induced by angiotensin II in cardiac myofibroblasts. Their actions on cardiac hypertrophy triggered by angiotensin II were also studied. Methodology/Principal Findings: The effect of erythrodiol and uvaol on angiotensin II-induced proliferation was evaluated in cardiac myofibroblasts from adult rats in the presence or the absence of the inhibitors of PPAR-gamma, GW9662 or JNK, SP600125. The effect on collagen levels induced by angiotensin II was evaluated in cardiac myofibroblasts and mouse heart. The presence of low doses of both triterpenes reduced the proliferation of cardiac myofibroblasts induced by angiotensin II. Pretreatment with GW9662 reversed the effect elicited by both triterpenes while SP600125 did not modify it. Both triterpenes at high doses produced an increase in annexing-V binding in the presence or absence of angiotensin II, which was reduced by either SP600125 or GW9662. Erythrodiol and uvaol decreased collagen I and galectin 3 levels induced by angiotensin II in cardiac myofribroblasts. Finally, cardiac hypertrophy, ventricular remodeling, fibrosis, and increases in myocyte area and brain natriuretic peptide levels observed in angiotensin II-infused mice were reduced in triterpene-treated animals. Conclusions/Significance: Erythrodiol and uvaol reduce cardiac hypertrophy and left ventricle remodeling induced by angiotensin II in mice by diminishing fibrosis and myocyte area. They also modulate growth and survival of cardiac myofibroblasts. They inhibit the angiotensin II-induced proliferation in a PPAR-gamma-dependent manner, while at high doses they activate pathways of programmed cell death that are dependent on JNK and PPAR-gamma.	[Martin, Ruben; Alberto San Roman, Jose] Hosp Clin, Inst Ciencias Corazon ICICOR, Valladolid, Spain; [Miana, Maria; Jurado-Lopez, Raquel; Martinez-Martinez, Ernesto; Lahera, Vicente; Cachofeiro, Victoria] Univ Complutense, Fac Med, Dept Fisiol, E-28040 Madrid, Spain; [Gomez-Hurtado, Nieves; Delgado, Carmen] Univ Complutense, Fac Med, Dept Farmacol, E-28040 Madrid, Spain; [Delgado, Carmen] CSIC, Ctr Invest Biol, Madrid, Spain; [Visitacion Bartolome, Maria] Univ Complutense, Fac Psicol, Dept Oftalmol & Otorrinolaringol, E-28040 Madrid, Spain; [Cordova, Claudia; Luisa Nieto, Maria] CSIC UVA, Inst Biol & Genet Mol, Valladolid, Spain	Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Martin, R (corresponding author), Hosp Clin, Inst Ciencias Corazon ICICOR, Valladolid, Spain.	vcara@med.ucm.es	Martinez-Martinez, Ernesto/M-1376-2017; Velasco, Berta/D-4325-2014; Delgado, Carmen/H-2251-2016; San Roman, Jose A/A-9963-2012; Gomez-Hurtado, Nieves/C-7112-2011; Nieto, Maria L/G-7492-2015	Martinez-Martinez, Ernesto/0000-0002-3011-2041; Velasco, Berta/0000-0002-8390-3867; Delgado, Carmen/0000-0002-0047-4674; Gomez-Hurtado, Nieves/0000-0001-5338-7884; Nieto, Maria L/0000-0001-6842-799X; Lahera, Vicente/0000-0002-9688-4503; Jurado Lopez, Raquel/0000-0002-9149-1073; San Roman Calvar, Jose Alberto/0000-0003-0764-0839; Cordova Marcos, Claudia/0000-0002-2108-2629; Cachofeiro, Victoria/0000-0001-6959-6293; Miana, Maria/0000-0002-0801-8024	Fondo de Investigaciones Sanitarias [PI09/0871]; Red Cardiovascular del FIS [RD06/0014/0007]; La Fundacion General de la Universidad de Valladolid (FGUVa) [060/053186]; FPI Program from the Government of Castilla y Leon; FSE	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Red Cardiovascular del FIS; La Fundacion General de la Universidad de Valladolid (FGUVa); FPI Program from the Government of Castilla y Leon; FSE(European Social Fund (ESF))	This work was supported by grants from Fondo de Investigaciones Sanitarias (PI09/0871). and Junta de Castilla y Leon (CSI11A08). Maria Miana and Raquel Jurado-Lopez were paid with a Grant from Red Cardiovascular del FIS (RD06/0014/0007). Ruben Martin was paid with a Grant from La Fundacion General de la Universidad de Valladolid (FGUVa) (060/053186). Claudia Cordova was funded by the FPI Program from the Government of Castilla y Leon (co-funded by FSE). All the authors are members of the Red Cardiovascular del FIS (RECAVA, RD06/0014/0007 and RD06/0014/0000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007; Bian GX, 2008, BIOL PHARM BULL, V31, P458, DOI 10.1248/bpb.31.458; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Burlew BS, 2002, HERZ, V27, P92, DOI 10.1007/s00059-002-2354-y; CAMPBELL SE, 1995, J MOL CELL CARDIOL, V27, P1545, DOI 10.1016/S0022-2828(95)90359-3; CAPASSO JM, 1990, AM J PHYSIOL, V259, pH1086, DOI 10.1152/ajpheart.1990.259.4.H1086; Carluccioll MA, 2007, MOL NUTR FOOD RES, V51, P1225, DOI 10.1002/mnfr.200600305; Chintharlapalli S, 2007, CARCINOGENESIS, V28, P2337, DOI 10.1093/carcin/bgm189; de las Heras N, 2006, J RENIN-ANGIO-ALDO S, V7, P192, DOI 10.3317/jraas.2006.037; Escrich E, 2006, NUTR REV, V64, pS40, DOI 10.1111/j.1753-4887.2006.tb00262.x; Hao GH, 2008, BRIT J PHARMACOL, V153, P1409, DOI 10.1038/bjp.2008.21; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Kohl P, 2004, CARDIOVASC RES, V64, P195, DOI 10.1016/j.cardiores.2004.08.011; Li J, 2008, J INT MED RES, V36, P329; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lin YH, 2009, CLIN CHIM ACTA, V409, P96, DOI 10.1016/j.cca.2009.09.001; Lopez-Andres N, 2012, EUR J HEART FAIL, V14, P74, DOI 10.1093/eurjhf/hfr151; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; Mair J, 2002, CLIN CHEM, V48, P977; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Martin R, 2010, BIOCHEM PHARMACOL, V79, P198, DOI 10.1016/j.bcp.2009.08.002; Martin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005975; Menendez JA, 2008, INT J MOL MED, V22, P433, DOI 10.3892/ijmm_00000039; Montilla MP, 2003, PLANTA MED, V69, P472, DOI 10.1055/s-2003-39698; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Pellman J, 2010, J MOL CELL CARDIOL, V48, P461, DOI 10.1016/j.yjmcc.2009.09.001; Perez-Camino MC, 1999, J AGR FOOD CHEM, V47, P1558, DOI 10.1021/jf980881h; Perez-Jimenez F, 2007, MOL NUTR FOOD RES, V51, P1199, DOI 10.1002/mnfr.200790023; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Sciarretta S, 2009, CLIN SCI, V116, P467, DOI 10.1042/CS20080390; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007; Smani T, 2010, CARDIOVASC RES, V87, P459, DOI 10.1093/cvr/cvq063; Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Sotiroudis TG, 2008, EUR J NUTR, V47, P69, DOI 10.1007/s00394-008-2008-9; Sudhahar V, 2007, VASC PHARMACOL, V46, P412, DOI 10.1016/j.vph.2006.12.005; Sun Y, 2000, J LAB CLIN MED, V135, P316, DOI 10.1067/mlc.2000.105971; Tsao T, 2010, CANCER RES, V70, P4949, DOI 10.1158/0008-5472.CAN-09-1962; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Bartolome MV, 2009, BRAIN RES REV, V60, P341, DOI 10.1016/j.brainresrev.2009.02.001; Weber KT, 2004, J HYPERTENS, V22, P47, DOI 10.1097/00004872-200401000-00011; Xi SG, 2009, EXP MOL MED, V41, P538, DOI 10.3858/emm.2009.41.8.059; Yamada K, 2008, BIOL PHARM BULL, V31, P651, DOI 10.1248/bpb.31.651; Yamai H, 2009, INT J CANCER, V125, P952, DOI 10.1002/ijc.24433; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	49	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41545	10.1371/journal.pone.0041545	http://dx.doi.org/10.1371/journal.pone.0041545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844495	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700107
J	Narita, R; Kitaura, H; Torii, A; Tashiro, E; Miyazawa, M; Ariga, H; Iguchi-Ariga, SMM				Narita, Rina; Kitaura, Hirotake; Torii, Ayako; Tashiro, Erika; Miyazawa, Makoto; Ariga, Hiroyoshi; Iguchi-Ariga, Sanae M. M.			Rabring7 Degrades c-Myc through Complex Formation with MM-1	PLOS ONE			English	Article							MONO-UBIQUITINATION; TUMOR-SUPPRESSOR; BINDING PROTEIN; DEGRADATION; EXPRESSION; PROTEASOME; REPRESSION; STABILITY; MECHANISM; PREFOLDIN	We have reported that a novel c-Myc-binding protein, MM-1, repressed E-box-dependent transcription and transforming activities of c-Myc and that a mutation of A157R in MM-1, which is often observed in patients with leukemia or lymphoma, abrogated all of the repressive activities of MM-1 toward c-Myc, indicating that MM-1 is a novel tumor suppressor. MM-1 also binds to the ubiquitin-proteasome system, leading to degradation of c-Myc. In this study, we identified Rabring7, a Rab7-binding and RING finger-containing protein, as an MM-1-binding protein, and we found that Rabring7 monoubiquitinated MM-1 in the cytoplasm without degradation of MM-1. Rabring7 was also found to bind to c-Myc and to ubiquitinate c-Myc in a threonine 58-dependent manner. When c-Myc was co-transfected with MM-1 and Rabring7, c-Myc was degraded. Furthermore, it was found that c-Myc was stabilized in MM-1-knockdown cells even when Rabring7 was transfected and that Rabring7 was bound to and co-localized with MM-1 and c-Myc after MM-1 and Rabring7 had been translocated from the cytoplasm to the nucleus. These results suggest that Rabring7 stimulates c-Myc degradation via mono-ubiquitination of MM-1.	[Narita, Rina; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Kitaura, Hirotake; Torii, Ayako; Tashiro, Erika; Miyazawa, Makoto; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Narita, R (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	hiro@pharm.hokudai.ac.jp; myan@res.agr.hokudai.ac.jp	Ariga, Sanae/H-9647-2013; Ariga, Hiroyoshi/B-5895-2013	Ariga, Hiroyoshi/0000-0001-7384-2143	Ministry of Education, Science, Culture and Sports; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research [22300119, 24650191] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Burger AM, 2005, CANCER RES, V65, P10401, DOI 10.1158/0008-5472.CAN-05-2103; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Geissler S, 1998, EMBO J, V145, P265; Hagio Y, 2006, J CELL BIOCHEM, V97, P145, DOI 10.1002/jcb.20619; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kimura Y, 2007, INT J ONCOL, V31, P829; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Miyazawa M, 2011, J BIOL CHEM, V286, P19191, DOI 10.1074/jbc.M110.216259; Mizuno K, 2003, MOL BIOL CELL, V14, P3741, DOI 10.1091/mbc.E02-08-0495; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Ogawa Y, 2005, BIOCHEM BIOPH RES CO, V336, P204, DOI 10.1016/j.bbrc.2005.08.046; Sakane A, 2007, BIOCHEM BIOPH RES CO, V357, P1058, DOI 10.1016/j.bbrc.2007.04.052; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Satou A, 2004, FEBS LETT, V572, P211, DOI 10.1016/j.febslet.2004.07.034; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Taira T, 1999, J BIOL CHEM, V274, P24270, DOI 10.1074/jbc.274.34.24270; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang B, 2008, BIOCHEM BIOPH RES CO, V376, P288, DOI 10.1016/j.bbrc.2008.08.143; Watanabe K, 2002, J BIOL CHEM, V277, P15113, DOI 10.1074/jbc.M111281200; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002	35	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41891	10.1371/journal.pone.0041891	http://dx.doi.org/10.1371/journal.pone.0041891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844532	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700162
J	Noorai, RE; Freese, NH; Wright, LM; Chapman, SC; Clark, LA				Noorai, Rooksana E.; Freese, Nowlan H.; Wright, Lindsay M.; Chapman, Susan C.; Clark, Leigh Anne			Genome-Wide Association Mapping and Identification of Candidate Genes for the Rumpless and Ear-tufted Traits of the Araucana Chicken	PLOS ONE			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; HOMEOBOX GENE; DIGEORGE-SYNDROME; FOWL; MUTATION; MOUSE; TBX1; COMPARTMENT; CAUPOLICAN; PHENOTYPE	Araucana chickens are known for their rounded, tailless rumps and tufted ears. Inheritance studies have shown that the rumpless (Rp) and ear-tufted (Et) loci each act in an autosomal dominant fashion, segregate independently, and are associated with an increased rate of embryonic mortality. To find genomic regions associated with Rp and Et, we generated genome-wide SNP profiles for a diverse population of 60 Araucana chickens using the 60 K chicken SNP BeadChip. Genome-wide association studies using 40 rumpless and 11 tailed birds showed a strong association with rumpless on Gga 2 (P-raw = 2.45x10(-10), P-genome = 0.00575), and analysis of genotypes revealed a 2.14 Mb haplotype shared by all rumpless birds. Within this haplotype, a 0.74 Mb critical interval containing two Iroquois homeobox genes, Irx1 and Irx2, was unique to rumpless Araucana chickens. Irx1 and Irx2 are central for developmental prepatterning, but neither gene is known to have a role in mechanisms leading to caudal development. A second genome-wide association analysis using 30 ear-tufted and 28 non-tufted birds revealed an association with tufted on Gga 15 (P-raw = 6.61x10(-7), P-genome = 0.0981). We identified a 0.58 Mb haplotype common to tufted birds and harboring 7 genes. Because homozygosity for Et is nearly 100% lethal, we employed a heterozygosity mapping approach to prioritize candidate gene selection. A 60 kb region heterozygous in all Araucana chickens contains the complete coding sequence for TBX1 and partial sequence for GNB1L. TBX1 is an important transcriptional regulator of embryonic development and a key genetic determinant of human DiGeorge syndrome. Herein, we describe localization of Rp and Et and identification of positional candidate genes.	[Noorai, Rooksana E.; Wright, Lindsay M.; Clark, Leigh Anne] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29631 USA; [Freese, Nowlan H.; Chapman, Susan C.] Clemson Univ, Dept Biol Sci, Clemson, SC USA	Clemson University; Clemson University	Noorai, RE (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29631 USA.	schapm2@clemson.edu; lclark4@clemson.edu	Chapman, Susan C/J-2688-2013; Noorai, Rooksana E/E-9785-2019	Chapman, Susan C/0000-0002-4314-9193; Noorai, Rooksana E/0000-0002-9992-5198; Piel, Lindsay/0000-0003-0428-6467	NIH/NIDCD [DC009236]; American Recovery and Reinvestment Act; NIFA/USDA [SC-1700374]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009236] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Recovery and Reinvestment Act; NIFA/USDA(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by NIH/NIDCD (DC009236), with supplemental funding from the American Recovery and Reinvestment Act to SCC. Technical Contribution No. 6029 of the Clemson University Experiment Station. This material is based upon work supported by NIFA/USDA, under project number SC-1700374 to SCC. http://www.nidcd.nih.gov/Pages/default.aspx http://www.recovery.gov/Pages/default.aspx http://www.clemson.edu/public/experiment_station/faculty_staff/research_projects.html http://www.csrees.usda.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Browman DL, 1978, ADV ANDEAN ARCHAEOLO, P189; Butts SC, 2009, INT J PEDIATR OTORHI, V73, P343, DOI 10.1016/j.ijporl.2008.10.011; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Cheng CW, 2006, MECH DEVELOP, V123, P252, DOI 10.1016/j.mod.2005.12.001; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Dunn LC, 1934, J GENET, V29, P217, DOI 10.1007/BF02982198; Dunn LC, 1936, J GENET, V33, P401, DOI 10.1007/BF02982895; Ekarius C, 2007, STOREYS ILLUSTRATED, P23; GomezSkarmeta JL, 1996, GENE DEV, V10, P2935, DOI 10.1101/gad.10.22.2935; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Itoh M, 2002, DEVELOPMENT, V129, P2317; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kimura W, 2011, GENESIS, V49, P2, DOI 10.1002/dvg.20688; Lebel M, 2003, MOL CELL BIOL, V23, P8216, DOI 10.1128/MCB.23.22.8216-8225.2003; Li Y, 2011, PSYCHIAT RES, V187, P457, DOI 10.1016/j.psychres.2010.04.019; PABILONIA MS, 1983, POULTRY SCI, V62, P1539, DOI 10.3382/ps.0621539; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; SOMES RG, 1981, J HERED, V72, P121, DOI 10.1093/oxfordjournals.jhered.a109439; SOMES RG, 1978, J HERED, V69, P91, DOI 10.1093/oxfordjournals.jhered.a108911; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Volker M, 2010, GENOME RES, V20, P503, DOI 10.1101/gr.103663.109; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zwilling E, 1942, GENETICS, V27, P641	32	17	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40974	10.1371/journal.pone.0040974	http://dx.doi.org/10.1371/journal.pone.0040974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844420	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700030
J	Noulin, F; Borlon, C; van den Eede, P; Boel, L; Verfaillie, CM; D'Alessandro, U; Erhart, A				Noulin, Florian; Borlon, Celine; van den Eede, Peter; Boel, Luc; Verfaillie, Catherine M.; D'Alessandro, Umberto; Erhart, Annette			Cryopreserved Reticulocytes Derived from Hematopoietic Stem Cells Can Be Invaded by Cryopreserved Plasmodium vivax Isolates	PLOS ONE			English	Article							RED-BLOOD-CELLS; FALCIPARUM; MALARIA; CHLOROQUINE; RESISTANCE; GENERATION; INVASION	The development of a system for the continuous culture of Plasmodium vivax in vitro would benefit from the use of reticulocytes derived from differentiated hematopoietic stem cells (HCS). At present, the need to use both fresh reticulocytes and fresh P. vivax isolates represents a major obstacle towards this goal, particularly for laboratories located in non-endemic countries. Here, we describe a new method for the cryopreservation of HSC-derived reticulocytes to be used for both P. falciparum and P. vivax invasion tests. Cryopreserved P. falciparum and P. vivax isolates could invade both fresh and cryopreserved HSC-derived reticulocytes with similar efficiency. This new technique allows the storage of HSC-derived reticulocytes which can be used for later invasion tests and represents an important step towards the establishment of a continuous P. vivax culture.	[Noulin, Florian; Borlon, Celine; van den Eede, Peter; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med Antwerp, Unit Malariol, Antwerp, Belgium; [Boel, Luc] Inst Trop Med Antwerp, Immunol Unit, Antwerp, Belgium; [Noulin, Florian; Verfaillie, Catherine M.] Katholieke Univ Leuven, Stem Cells Inst, Louvain, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); KU Leuven; University of London; London School of Hygiene & Tropical Medicine	Noulin, F (corresponding author), Inst Trop Med Antwerp, Unit Malariol, Antwerp, Belgium.	fnoulin@itg.be	noulin, florian/J-3809-2013; D'Alessandro, Umberto/D-3457-2015; Verfaillie, Catherine/H-5148-2013	noulin, florian/0000-0001-7430-8073; D'Alessandro, Umberto/0000-0001-6341-5009; Verfaillie, Catherine/0000-0001-7564-4079	ITM Secondary Research Funding (SOFI-B) [755023]	ITM Secondary Research Funding (SOFI-B)	Funding was provided by ITM Secondary Research Funding (SOFI-B), http://www.itg.be/itgtool_v2/Projecten/Project.asp?PNr=755023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; DIGGS C, 1975, AM J TROP MED HYG, V24, P760, DOI 10.4269/ajtmh.1975.24.760; Douay Luc, 2009, V482, P127, DOI 10.1007/978-1-59745-060-7_8; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Giarratana MC, 2011, BLOOD; GOLDMAN JM, 1978, BRIT J HAEMATOL, V40, P185, DOI 10.1111/j.1365-2141.1978.tb03656.x; Golenda CF, 1997, P NATL ACAD SCI USA, V94, P6786, DOI 10.1073/pnas.94.13.6786; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; KLEIHAUER E, 1957, KLIN WOCHENSCHR, V35, P637, DOI 10.1007/BF01481043; Kosaisavee V, 2006, EXP PARASITOL, V114, P34, DOI 10.1016/j.exppara.2006.02.006; LAFOREST J, 1968, Revue Francaise de Transfusion, V11, P23, DOI 10.1016/S0035-2977(68)80078-1; LORETZ LJ, 1989, XENOBIOTICA, V19, P489, DOI 10.3109/00498258909042288; MECHETNER EB, 1991, AM J HEMATOL, V38, P61, DOI 10.1002/ajh.2830380110; MONS B, 1990, BLOOD CELLS, V16, P299; Nienhuis AW, 1979, METHODS CELL SCI, V1, P111; PASVOL G, 1982, LANCET, V2, P947; Prajapati SK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-102; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; RIVADENEIRA EM, 1983, J PROTOZOOL, V30, P367, DOI 10.1111/j.1550-7408.1983.tb02932.x; ROSSAN RN, 1985, AM J TROP MED HYG, V34, P207, DOI 10.4269/ajtmh.1985.34.207; Russell B, 2011, BLOOD; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Tamez PA, 2009, BLOOD, V114, P3652, DOI 10.1182/blood-2009-07-231894; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Udomsangpetch R, 2007, PARASITOL INT, V56, P65, DOI 10.1016/j.parint.2006.12.005; Yohannes AM, 2011, AM J TROP MED HYG, V84, P137, DOI 10.4269/ajtmh.2011.09-0723	31	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40798	10.1371/journal.pone.0040798	http://dx.doi.org/10.1371/journal.pone.0040798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844411	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700018
J	Pansani, MC; Azevedo, PS; Rafacho, BPM; Minicucci, MF; Chiuso-Minicucci, F; Zorzella-Pezavento, SG; Marchini, JS; Padovan, GJ; Fernandes, AAH; Matsubara, BB; Matsubara, LS; Zornoff, LAM; Paiva, SAR				Pansani, Mariele Castilho; Azevedo, Paula S.; Murino Rafacho, Bruna Paola; Minicucci, Marcos F.; Chiuso-Minicucci, Fernanda; Zorzella-Pezavento, Sofia Goncalves; Marchini, Julio Sergio; Padovan, Gilberto Joao; Henrique Fernandes, Ana Angelica; Matsubara, Beatriz B.; Matsubara, Luiz S.; Zornoff, Leonardo A. M.; Paiva, Sergio A. R.			Atrophic Cardiac Remodeling Induced by Taurine Deficiency in Wistar Rats	PLOS ONE			English	Article							PROTEIN-CALORIE MALNUTRITION; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; HEART-FAILURE; AMINO-ACID; DEPLETION; DAMAGE; TISSUE; PURIFICATION; HYPERTENSION	Introduction: Micronutrient deficiency is observed in heart failure patients. Taurine, for example, represents 50% of total free amino acids in the heart, and in vivo studies have linked taurine deficiency with cardiomyopathy. Methods: Thirty-four male Wistar rats (body weight = 100 g) were weighed and randomly assigned to one of two groups: Control (C) or taurine-deficient (T (-)). Beta-alanine at a concentration of 3% was added to the animals' water to induce taurine deficiency in the T (-) group. On day 30, the rats were individually submitted to echocardiography; morphometrical and histopathological evaluation and metalloproteinase activity, oxidative stress and inflammation evaluation were performed. Tissue samples were collected to determine the taurine concentration in the heart. Results: Taurine deficiency led to decreases in: ventricular wall thickness, left ventricle dry weight, myocyte sectional area, left ventricle posterior wall thickness and ventricular geometry. With regard to heart function, the velocity of the A wave, the ratio between the E and A wave, the ejection fraction, fractional shortening and cardiac output values were decreased in T () rats, suggesting abnormal diastolic and systolic function. Increased fibrosis, inflammation and increased activation of metalloproteinases were not observed. Oxidative stress was increased in deficient animals. Conclusions: These data suggest that taurine deficiency promotes structural and functional cardiac alterations with unique characteristics.	[Pansani, Mariele Castilho; Azevedo, Paula S.; Murino Rafacho, Bruna Paola; Minicucci, Marcos F.; Matsubara, Beatriz B.; Matsubara, Luiz S.; Zornoff, Leonardo A. M.; Paiva, Sergio A. R.] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Internal Med, Botucatu, SP, Brazil; [Chiuso-Minicucci, Fernanda; Zorzella-Pezavento, Sofia Goncalves] Univ Estadual Paulista UNESP, Inst Biociencias Botucatu, Dept Microbiol & Immunol, Botucatu, SP, Brazil; [Henrique Fernandes, Ana Angelica] Univ Estadual Paulista UNESP, Inst Biociencias Botucatu, Dept Chem & Biochem, Botucatu, SP, Brazil; [Marchini, Julio Sergio; Padovan, Gilberto Joao] Univ Sao Paulo FMRP USP, Fac Med Ribeirao Preto, Dept Internal Med, Ribeirao Preto, SP, Brazil	Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo	Pansani, MC (corresponding author), Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Internal Med, Botucatu, SP, Brazil.	paiva@fmb.unesp.br	Minicucci, Fernanda C/A-9220-2015; Zorzella-Pezavento, Sofia Fernanda Gonçalves/B-2568-2013; Matsubara, Luiz S/D-5061-2009; Rafacho, Bruna Paola Murino/AGW-5794-2022; Marchini, Julio S/K-1992-2016; Minicucci, Marcos F/A-9094-2008; Azevedo, Paula S/F-2701-2012; Azevedo, Paula Schmidt/S-1597-2019; Fernandes, Ana Angelica Henrique/D-5291-2012; Paiva, Sergio AR/A-5101-2008; Rafacho, Bruna Paola Murino/B-5460-2013; Zornoff, Leonardo/A-5612-2008	Minicucci, Fernanda C/0000-0002-4155-6414; Zorzella-Pezavento, Sofia Fernanda Gonçalves/0000-0001-9030-0768; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Marchini, Julio S/0000-0001-9999-9149; Minicucci, Marcos F/0000-0002-5980-4367; Azevedo, Paula S/0000-0002-5843-6232; Azevedo, Paula Schmidt/0000-0002-5843-6232; Paiva, Sergio AR/0000-0003-4412-1990; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Zornoff, Leonardo/0000-0002-9831-8820	CAPES; Faculdade de Medicina de Botucatu - UNESP	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Faculdade de Medicina de Botucatu - UNESP	This work was supported by the CAPES (MCP scholarship) and Faculdade de Medicina de Botucatu - UNESP (FC-M, SGZ-P, JSM, GJP, AAHF, PSA, BBM, LSM, BPMR, MFM, LAMZ and SARP salaries). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard ML, 2006, HEART FAIL REV, V11, P75, DOI 10.1007/s10741-006-9195-3; Baskin KK, 2011, CARDIOVASC RES, V90, P243, DOI 10.1093/cvr/cvr060; Birdsall T C, 1998, Altern Med Rev, V3, P128; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004; CAMPBELL SE, 1991, CIRC RES, V68, P984, DOI 10.1161/01.RES.68.4.984; Das J, 2012, TOXICOL APPL PHARM, V258, P296, DOI 10.1016/j.taap.2011.11.009; Dawson R, 2002, AMINO ACIDS, V22, P309; de Paiva SAR, 2003, AM J PHYSIOL-HEART C, V284, pH2242, DOI 10.1152/ajpheart.00646.2002; Deminice R, 2009, ANN NUTR METAB, V54, P202, DOI 10.1159/000218707; Denipote F, 2011, CELL PHYSIOL BIOCHEM, V27, P291, DOI 10.1159/000327955; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Fioretto JR, 2002, AM J PHYSIOL-HEART C, V282, pH1327, DOI 10.1152/ajpheart.00431.2001; Ghosh J, 2009, TOXICOL APPL PHARM, V240, P73, DOI 10.1016/j.taap.2009.07.008; Gokce G, 2009, BIOCHEMISTRY-US, V48, P4980, DOI 10.1021/bi900030z; Hobson RM, 2012, AMINO ACIDS, V43, P25, DOI 10.1007/s00726-011-1200-z; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LOSER C, 1988, J CHROMATOGR-BIOMED, V430, P249, DOI 10.1016/S0378-4347(00)83160-6; Metayer S, 2008, J NUTR BIOCHEM, V19, P207, DOI 10.1016/j.jnutbio.2007.05.006; Minicucci MF, 2010, CELL PHYSIOL BIOCHEM, V26, P523, DOI 10.1159/000322320; Mozaffari MS, 2000, AMINO ACIDS, V19, P625, DOI 10.1007/s007260070012; NAKAMURA W, 1974, BIOCHIM BIOPHYS ACTA, V358, P251, DOI 10.1016/0005-2744(74)90455-0; NUTTER DO, 1979, CIRC RES, V45, P144, DOI 10.1161/01.RES.45.1.144; Okoshi MP, 2001, CAN J PHYSIOL PHARM, V79, P754, DOI 10.1139/cjpp-79-9-754; Parildar H, 2008, J NUTR SCI VITAMINOL, V54, P61, DOI 10.3177/jnsv.54.61; PAULETTO P, 1986, J HYPERTENS, V4, pS135; PISSAIA O, 1980, J NUTR, V110, P2035, DOI 10.1093/jn/110.10.2035; Rafacho BPM, 2011, CELL PHYSIOL BIOCHEM, V27, P305, DOI 10.1159/000327957; Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, pC413, DOI 10.1152/ajpcell.00362.2007; Roysommuti S, 2009, ADV EXP MED BIOL, V643, P123, DOI 10.1007/978-0-387-75681-3_13; Schaffer SW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S2; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; Siddiq T, 1996, BIOCHEM MOL MED, V57, P19, DOI 10.1006/bmme.1996.0004; SPAETH DG, 1974, P SOC EXP BIOL MED, V147, P855; Stellingwerff T, 2012, AMINO ACIDS, V43, P57, DOI 10.1007/s00726-012-1245-7; SUSSMAN MR, 1988, ANAL BIOCHEM, V169, P395, DOI 10.1016/0003-2697(88)90302-8; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; TYAGI SC, 1993, CLIN BIOCHEM, V26, P191, DOI 10.1016/0009-9120(93)90025-2; Welsh DC, 2001, AM J PHYSIOL-HEART C, V281, pH1131, DOI 10.1152/ajpheart.2001.281.3.H1131; Witte KKA, 2001, J AM COLL CARDIOL, V37, P1765, DOI 10.1016/S0735-1097(01)01227-X; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; Xu Yan-Jun, 2008, Exp Clin Cardiol, V13, P57; Yndestad Arne, 2007, Curr Cardiol Rep, V9, P236, DOI 10.1007/BF02938356	46	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41439	10.1371/journal.pone.0041439	http://dx.doi.org/10.1371/journal.pone.0041439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844478	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700090
J	Schellenberg, JJ; Dumonceaux, TJ; Hill, JE; Kimani, J; Jaoko, W; Wachihi, C; Mungai, JN; Lane, M; Fowke, KR; Ball, TB; Plummer, FA				Schellenberg, John J.; Dumonceaux, Tim J.; Hill, Janet E.; Kimani, Joshua; Jaoko, Walter; Wachihi, Charles; Mungai, Jane Njeri; Lane, Margo; Fowke, Keith R.; Ball, T. Blake; Plummer, Francis A.			Selection, Phenotyping and Identification of Acid and Hydrogen Peroxide Producing Bacteria from Vaginal Samples of Canadian and East African Women	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEQUENCE DATABASE; GENITAL-TRACT; SEX WORKERS; VAGINOSIS; LACTOBACILLUS; INFECTION; RESISTANCE; ENIGMA; HIV	The common but poorly understood condition known as bacterial vaginosis (BV) increases vulnerability to HIV infection and is associated with the absence of H2O2-producing Lactobacillus. Vaginal lactic acid bacteria (LAB) produce anti-HIV factors such as organic acids and hydrogen peroxide (H2O2), and may bind and inactivate HIV particles during scavenging of mannose. These factors define potential criteria for initial selection of candidate probiotics to block heterosexual transmission of HIV. Therefore, the primary goal of this study was to characterize acid production on mannose and H2O2 production in vaginal isolates from Canadian adolescents (192 isolates, 16 individuals) and commercial sex workers in Nairobi, Kenya (576 isolates, 96 individuals). Selection of isolates from H2O2-detecting media suggested an idiosyncratic individual-level profile and extensive phenotypic diversity, including the identification of a subset of "double-strong" acid- and H2O2-producers with phenotypes similar to well-characterized probiotic strains. Molecular fingerprinting of all isolates by capillary electrophoresis of 16S-23S rRNA interspacer amplicons was coupled with chaperonin-60 universal target (cpn60 UT) sequencing in a subset, tentatively identifying 96% of isolates although only 19% were sequenced. Most isolates belonged to Lactobacillus, Streptococcus, Bifidobacterium or Gardnerella, with a total of 37 species in 15 genera, as well as 5 potentially novel organisms, identified in this study. This sensitivity was likely enhanced by phenotype-based selection on two chromogenic media formulations. Identification of double-strong isolates may provide a rational basis for selection and further characterization of vaginal probiotics, with potential application as part of HIV prevention initiatives in western Canada and East Africa.	[Schellenberg, John J.; Fowke, Keith R.; Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Fowke, Keith R.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Lane, Margo] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Dumonceaux, Tim J.] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Hill, Janet E.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Kimani, Joshua; Jaoko, Walter; Wachihi, Charles; Mungai, Jane Njeri; Fowke, Keith R.; Ball, T. Blake; Plummer, Francis A.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Ball, T. Blake; Plummer, Francis A.] Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Agriculture & Agri Food Canada; University of Saskatchewan; University of Nairobi; Canadian Science Centre for Human & Animal Health	Schellenberg, JJ (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	schellej@cc.umanitoba.ca	Hill, Janet E./B-5001-2011; Jaoko, Walter/AAN-5048-2020; Dumonceaux, Tim/H-4751-2019	Hill, Janet E./0000-0002-2187-6277; Dumonceaux, Tim/0000-0001-5165-0343; Jaoko, Walter/0000-0002-7134-6581; Schellenberg, John/0000-0003-3970-1608; Fowke, Keith/0000-0001-8227-6649	Canadian Institutes of Health Research; National Institutes of Health; Bill & Melinda Gates Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this study was provided by the Canadian Institutes of Health Research, National Institutes of Health and the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mushrif S., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P63; Anukam KC, 2006, SEX TRANSM DIS, V33, P59, DOI 10.1097/01.olq.0000175367.15559.c4; Beigi RH, 2005, J INFECT DIS, V191, P924, DOI 10.1086/428288; Bolton M, 2008, SEX TRANSM DIS, V35, P214, DOI 10.1097/OLQ.0b013e31815b017a; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; FONTAINE EA, 1990, J APPL BACTERIOL, V69, P326, DOI 10.1111/j.1365-2672.1990.tb01523.x; Forsum U, 2005, APMIS, V113, P153, DOI 10.1111/j.1600-0463.2005.apm1130301.x; Forsum U, 2005, APMIS, V113, P81, DOI 10.1111/j.1600-0463.2005.apm1130201.x; Fowke KR, 1998, AIDS RES HUM RETROV, V14, P1521, DOI 10.1089/aid.1998.14.1521; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Hummelen R, 2010, PLOS ONE, V5; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Kilic AO, 2001, CLIN DIAGN LAB IMMUN, V8, P31, DOI 10.1128/CDLI.8.1.31-39.2001; KLEBANOFF SJ, 1991, J EXP MED, V174, P289, DOI 10.1084/jem.174.1.289; Larsson PG, 2005, APMIS, V113, P233, DOI 10.1111/j.1600-0463.2005.apm_01.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Reid G, 2006, PREBIOTICS DEV APPL, P201; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Ronnqvist PDJ, 2006, ACTA OBSTET GYN SCAN, V85, P726, DOI 10.1080/00016340600578357; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schellenberg J, 2008, J MICROBIOL METH, V73, P216, DOI 10.1016/j.mimet.2008.03.004; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Song YL, 1999, J CLIN MICROBIOL, V37, P3062, DOI 10.1128/JCM.37.9.3062-3064.1999; Tao L, 2005, BEN MICR C APR 17 21; Westrom L, 1984, SCAND J UROL NEPHR S, V86, P259	37	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41217	10.1371/journal.pone.0041217	http://dx.doi.org/10.1371/journal.pone.0041217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844440	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700054
J	Zuo, Z; Medeiros, LJ; Chen, Z; Liu, DS; Bueso-Ramos, CE; Luthra, R; Wang, SA				Zuo, Zhuang; Medeiros, L. Jeffrey; Chen, Zhao; Liu, Dingsheng; Bueso-Ramos, Carlos E.; Luthra, Rajyalakshmi; Wang, Sa A.			Acute Myeloid Leukemia (AML) with Erythroid Predominance Exhibits Clinical and Molecular Characteristics that Differ from Other Types of AML	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; WORLD-HEALTH-ORGANIZATION; MYELODYSPLASTIC SYNDROMES; NPM1 MUTATIONS; ACUTE ERYTHROLEUKEMIA; FAVORABLE PROGNOSIS; GENE-MUTATIONS; JAK2 V617F; CLASSIFICATION; RARE	The clinical importance of erythroid predominance in bone marrow of patients with acute myeloid leukemia (AML) is controversial. These cases represent a heterogeneous group of diseases that historically have been classified into different categories. We studied 313 AML patients and specifically compared the clinical, cytogenetic, and molecular features of cases of AML with erythroid predominance, arbitrarily defined as >= 50% erythroid precursors, to AML cases without erythroid predominance. We also assessed 51 patients with a high-grade myelodysplastic syndrome (MDS), refractory anemia with excess blasts (RAEB). All neoplasms were classified according to the World Health Organization classification. With the exception of therapy-related AML/MDS, the presence of erythroid predominance in variously classified categories of AML was associated with a survival advantage. In addition, AML with erythroid predominance had a lower frequency of cytogenetic abnormalities as well as a lower frequency of mutations involving NPM1, NRAS and FLT3 as compared with AML without erythroid predominance. We conclude that the clinical, cytogenetic, and molecular features of AML with erythroid predominance in the non-therapy-related setting are much closer to those of a high-grade myelodysplastic syndrome than they are to other types of AML.	[Zuo, Zhuang; Medeiros, L. Jeffrey; Chen, Zhao; Liu, Dingsheng; Bueso-Ramos, Carlos E.; Luthra, Rajyalakshmi; Wang, Sa A.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Zuo, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	zzuo@mdanderson.org	Medeiros, L. Jeffrey/AAB-1018-2019					Bacher U, 2007, HAEMATOLOGICA, V92, P744, DOI 10.3324/haematol.10869; Bacher U, 2011, HAEMATOL-HEMATOL J, V96, P1284, DOI 10.3324/haematol.2011.043687; Bains A, 2011, AM J CLIN PATHOL, V135, P62, DOI 10.1309/AJCPEI9XU8PYBCIO; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Di Guglielmo G, 1917, FOLIA MEDICA PAVIA, V13, P386; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Ebert BL, 2010, BEST PRACT RES CL HA, V23, P457, DOI 10.1016/j.beha.2010.09.006; Frohling S, 2006, BLOOD, V107, P1242, DOI 10.1182/blood-2005-09-3644; Galton DAGDJ, 1975, BR J HAEMATOL, P31; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hasserjian RP, 2010, BLOOD, V115, P1985, DOI 10.1182/blood-2009-09-243964; Hopfer O, 2012, EUR J HAEMATOL, V88, P144, DOI 10.1111/j.1600-0609.2011.01715.x; Kasyan A, 2010, MODERN PATHOL, V23, P1113, DOI 10.1038/modpathol.2010.96; Lin P, 2006, AM J CLIN PATHOL, V126, P530, DOI 10.1309/JT5BE2L1FGG8P8Y6; OLOPADE OI, 1992, BLOOD, V80, P2873; Ruan GR, 2009, ANN HEMATOL, V88, P159, DOI 10.1007/s00277-008-0591-8; Santos FPS, 2009, LEUKEMIA, V23, P2275, DOI 10.1038/leu.2009.181; Santos FPS, 2010, EXPERT REV HEMATOL, V3, P705, DOI [10.1586/ehm.10.62, 10.1586/EHM.10.62]; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Shimizu R, 2008, NAT REV CANCER, V8, P279, DOI 10.1038/nrc2348; Steensma DP, 2006, LEUKEMIA, V20, P971, DOI 10.1038/sj.leu.2404206; Suzuki T, 2005, BLOOD, V106, P2854, DOI 10.1182/blood-2005-04-1733; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang SA, 2008, MODERN PATHOL, V21, P1394, DOI 10.1038/modpathol.2008.142; Zuo ZA, 2010, ARCH PATHOL LAB MED, V134, P1261, DOI 10.1043/2009-0350-RA.1; Zuo Z, 2009, MODERN PATHOL, V22, P1023, DOI 10.1038/modpathol.2009.59	27	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41485	10.1371/journal.pone.0041485	http://dx.doi.org/10.1371/journal.pone.0041485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844482	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700093
J	Barros, CC; Haro, A; Russo, FJVP; Schadock, I; Almeida, SS; Ribeiro, RA; Vanzela, EC; Lanzoni, VP; Barros, FC; Moraes, MR; Mori, MA; Bacurau, RFP; Wurtele, M; Boschero, AC; Carneiro, EM; Bader, M; Pesquero, JB; Araujo, RC				Barros, Carlos C.; Haro, Anderson; Russo, Fernanda J. V. P.; Schadock, Ines; Almeida, Sandro S.; Ribeiro, Rosane A.; Vanzela, Emerielle C.; Lanzoni, Valeria P.; Barros, Flavio C.; Moraes, Milton R.; Mori, Marcelo A.; Bacurau, Reury F. P.; Wurtele, Martin; Boschero, Antonio C.; Carneiro, Everardo M.; Bader, Michael; Pesquero, Joao B.; Araujo, Ronaldo C.			Altered Glucose Homeostasis and Hepatic Function in Obese Mice Deficient for Both Kinin Receptor Genes	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; GLUT4 TRANSLOCATION; HYPERGLYCEMIC MICE; B-2 RECEPTOR; OB/OB MICE; BRADYKININ; SYSTEM; LEPTIN; EXPRESSION	The Kallikrein-Kinin System (KKS) has been implicated in several aspects of metabolism, including the regulation of glucose homeostasis and adiposity. Kinins and des-Arg-kinins are the major effectors of this system and promote their effects by binding to two different receptors, the kinin B2 and B1 receptors, respectively. To understand the influence of the KKS on the pathophysiology of obesity and type 2 diabetes (T2DM), we generated an animal model deficient for both kinin receptor genes and leptin (obB1B2KO). Six-month-old obB1B2KO mice showed increased blood glucose levels. Isolated islets of the transgenic animals were more responsive to glucose stimulation releasing greater amounts of insulin, mainly in 3-month-old mice, which was corroborated by elevated serum C-peptide concentrations. Furthermore, they presented hepatomegaly, pronounced steatosis, and increased levels of circulating transaminases. This mouse also demonstrated exacerbated gluconeogenesis during the pyruvate challenge test. The hepatic abnormalities were accompanied by changes in the gene expression of factors linked to glucose and lipid metabolisms in the liver. Thus, we conclude that kinin receptors are important for modulation of insulin secretion and for the preservation of normal glucose levels and hepatic functions in obese mice, suggesting a protective role of the KKS regarding complications associated with obesity and T2DM.	[Barros, Carlos C.; Haro, Anderson; Russo, Fernanda J. V. P.; Almeida, Sandro S.; Moraes, Milton R.; Mori, Marcelo A.; Pesquero, Joao B.; Araujo, Ronaldo C.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Schadock, Ines; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Ribeiro, Rosane A.; Vanzela, Emerielle C.; Boschero, Antonio C.; Carneiro, Everardo M.] Univ Estadual Campinas, Campinas, SP, Brazil; [Barros, Flavio C.] Univ Estadual Paulista, Sao Paulo, Brazil; [Bacurau, Reury F. P.] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil; [Wurtele, Martin] Univ Fed Sao Paulo, Dept Sci & Technol, Sao Jose Dos Campos, Brazil; [Lanzoni, Valeria P.] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Barros, CC (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.	araujo.ronaldo@unifesp.br	Boschero, Antonio/O-7525-2014; Barros, Carlos Castilho C/D-5378-2012; Barros, Carlos Castilho/V-8659-2019; Vanzela, Emerielle/AAJ-1679-2021; Bader, Michael/K-2124-2013; Ribeiro, Rosane/C-2180-2013; Carneiro, Everardo/D-4758-2012; Almeida, Sandro Soares/D-9042-2012; Araujo, Ronaldo Carvalho/O-7569-2019; Mori, Marcelo A/R-2881-2018; Würtele, Martin/D-2686-2012; Moraes, Milton Rocha/D-9774-2018; Almeida, Sandro Soares/AAL-2366-2020; Barros, Carlos/D-5378-2012	Boschero, Antonio/0000-0003-3829-8570; Barros, Carlos Castilho C/0000-0002-6926-734X; Barros, Carlos Castilho/0000-0002-6926-734X; Almeida, Sandro Soares/0000-0002-4392-0953; Araujo, Ronaldo Carvalho/0000-0003-0095-4608; Mori, Marcelo A/0000-0001-7112-5263; Almeida, Sandro Soares/0000-0002-4392-0953; Bader, Michael/0000-0003-4780-4164; Vanzela, Emerielle C/0000-0001-8487-9320; Barros, Carlos/0000-0003-3244-7467; Schadock, Ines/0000-0002-6717-6276	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present study was supported by public research grants from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2010, NEUROPEPTIDES, V44, P69, DOI 10.1016/j.npep.2009.09.004; Al Mamun A, 2009, OBESITY, V17, P1255, DOI 10.1038/oby.2008.660; Araujo RC, 2006, BIOL CHEM, V387, P431, DOI 10.1515/BC.2006.057; Barros CC, 2009, INT J OBESITY, V33, P938, DOI 10.1038/ijo.2009.95; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; Carlsson PO, 1998, AM J PHYSIOL-ENDOC M, V275, pE594, DOI 10.1152/ajpendo.1998.275.4.E594; Carvalho CRO, 1997, DIABETES, V46, P1950, DOI 10.2337/diabetes.46.12.1950; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; DUCKWORTH WC, 1988, AM J MED, V85, P71, DOI 10.1016/0002-9343(88)90399-3; Duka I, 2001, HYPERTENSION, V38, P1355, DOI 10.1161/hy1201.096574; Enriquez A, 1999, BIOCHEM BIOPH RES CO, V255, P300, DOI 10.1006/bbrc.1999.0202; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Ginsberg HN, 2009, J CLIN HYPERTENS, V11, P520, DOI 10.1111/j.1559-4572.2009.00060.x; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Ikejima K, 2001, HEPATOLOGY, V34, P288, DOI 10.1053/jhep.2001.26518; Isami S, 1996, DIABETOLOGIA, V39, P412, DOI 10.1007/s001250050460; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lattuada G, 2011, CURR DIABETES REP, V11, P167, DOI 10.1007/s11892-011-0190-2; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Li TG, 2009, BBA-MOL CELL BIOL L, V1791, P991, DOI 10.1016/j.bbalip.2009.05.004; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Miyata T, 1998, EUR J ENDOCRINOL, V138, P344, DOI 10.1530/eje.0.1380344; Mora MEV, 2003, J AM COLL NUTR, V22, P487, DOI 10.1080/07315724.2003.10719326; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Mori MA, 2008, DIABETES, V57, P1491, DOI 10.2337/db07-1508; Mulhall BP, 2002, J GASTROEN HEPATOL, V17, P1136, DOI 10.1046/j.1440-1746.2002.02881.x; Pesquero JB, 1998, BRAZ J MED BIOL RES, V31, P1197, DOI 10.1590/S0100-879X1998000900013; Phillips J, 2009, AUST FAM PHYSICIAN, V38, P699; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P205, DOI 10.1079/PHN2001295; Potter JJ, 1998, BIOCHEM BIOPH RES CO, V244, P178, DOI 10.1006/bbrc.1997.8193; Pruneau D, 2010, CURR OPIN INVEST DR, V11, P507; Riad A, 2007, CURR OPIN NEPHROL HY, V16, P22, DOI 10.1097/MNH.0b013e328011a20c; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Sancho-Bru P, 2007, GASTROENTEROLOGY, V133, P2019, DOI 10.1053/j.gastro.2007.09.023; SATO H, 1991, DIABETOLOGIA, V34, P613, DOI 10.1007/BF00400989; Shiuchi T, 2002, HYPERTENSION, V40, P329, DOI 10.1161/01.HYP.0000028979.98877.0C; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Torsoni MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE216, DOI 10.1152/ajpendo.00031.2003; Tschope C, 2008, BIOL CHEM, V389, P707, DOI 10.1515/BC.2008.082; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wang PHM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003050; Westman S, 1968, Diabetologia, V4, P141, DOI 10.1007/BF01219435	49	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40573	10.1371/journal.pone.0040573	http://dx.doi.org/10.1371/journal.pone.0040573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829877	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000306956300015
J	Brentville, VA; Metheringham, RL; Gunn, B; Durrant, LG				Brentville, Victoria A.; Metheringham, Rachael L.; Gunn, Barbara; Durrant, Lindy G.			High Avidity Cytotoxic T Lymphocytes Can Be Selected into the Memory Pool but They Are Exquisitely Sensitive to Functional Impairment	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; ENHANCED TUMOR-GROWTH; IN-VIVO; PEPTIDE VACCINATION; MELANOMA PATIENTS; CELL RESPONSE; CD8; ANTIGEN; PD-1; ACTIVATION	High avidity cytotoxic T lymphocytes (CTL) are important in viral clearance and anti-tumor immunity, however, mechanisms for their optimal generation and maintenance in vivo remain unclear. Immunizing mice with an antibody-DNA vaccine encoding a single CTL epitope, induces a 100 fold higher avidity response than peptide vaccination with the identical epitope. The high avidity response is retained into memory and can be efficiently reactivated with an antibody-DNA boost. In contrast, reactivation of high avidity CTL with peptide, stimulated responses with a significant drop in avidity, suggesting loss or conversion of the high avidity CTL to lower avidity. Similarly, high avidity T cells maintained ex vivo were exquisitely sensitive to signaling with low doses of peptide (1 ng/ml) giving optimal TCR stimulation and resulting in retained avidity, proliferation and ability to kill specific targets. In contrast, high avidity T cells maintained ex vivo with supraoptimal TCR stimulation (10 mg/ml peptide) resulted in reduced avidity and failure to kill tumor cells. They also failed to proliferate, showed a significant increase in apoptosis and expressed high levels of the exhaustion marker programmed death-1 (PD-1) and low levels of the lymphocyte-activation gene 3 (LAG-3). This suggests high avidity T cells are recruited to the memory pool but can be lost by supraoptimal stimulation in vitro and in vivo. This is characterized by loss of function and an increase in cell death. The remaining CTL, exhibit low functional avidity that is reflected in reduced anti-tumor activity. This could contribute to failure of the immune system to control the growth of tumors and has implications for vaccination strategies and adoptive transfer of T cells.	[Brentville, Victoria A.; Metheringham, Rachael L.; Gunn, Barbara; Durrant, Lindy G.] Univ Nottingham, Acad Dept Clin Oncol, Scancell Holdings Plc, Nottingham NG7 2RD, England	University of Nottingham	Brentville, VA (corresponding author), Univ Nottingham, Acad Dept Clin Oncol, Scancell Holdings Plc, City Hosp Campus, Nottingham NG7 2RD, England.	lindy.durrant@nottingham.ac.uk		Metheringham, Rachael/0000-0002-0594-8189	Scancell Holdings plc	Scancell Holdings plc	The work was funded by Scancell Holdings plc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; Alexander-Miller MA, 1998, J EXP MED, V188, P1391, DOI 10.1084/jem.188.8.1391; AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Ayyoub M, 2003, CANCER RES, V63, P5601; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chapon M, 2011, J INVEST DERMATOL, V131, P1300, DOI 10.1038/jid.2011.30; den Boer AT, 2001, J IMMUNOL, V167, P2522; Derby MA, 2001, EUR J IMMUNOL, V31, P2951, DOI 10.1002/1521-4141(2001010)31:10<2951::AID-IMMU2951>3.0.CO;2-Q; Durrant LG, 2010, EXPERT OPIN BIOL TH, V10, P735, DOI 10.1517/14712591003769790; Dutoit V, 2001, CANCER RES, V61, P5850; Fourcade J, 2009, J IMMUNOL, V182, P5240, DOI 10.4049/jimmunol.0803245; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Goldberg MV, 2007, BLOOD, V110, P186, DOI 10.1182/blood-2006-12-062422; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; HILL AB, 1992, IMMUNOL CELL BIOL, V70, P259, DOI 10.1038/icb.1992.33; Kroger CJ, 2007, IMMUNOLOGY, V122, P167, DOI 10.1111/j.1365-2567.2007.02622.x; LIU YP, 2007, J JISHOU UNIV, V28, P1; Muraoka D, 2010, J IMMUNOL, V185, P3768, DOI 10.4049/jimmunol.0903649; Pudney VA, 2010, EUR J IMMUNOL, V40, P899, DOI 10.1002/eji.200939857; Rezvani K, 2008, BLOOD, V111, P236, DOI 10.1182/blood-2007-08-108241; Rocha B, 2006, IMMUNOL REV, V211, P182, DOI 10.1111/j.0105-2896.2006.00378.x; Sandberg JK, 2000, J IMMUNOL, V165, P25, DOI 10.4049/jimmunol.165.1.25; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Stoklasek TA, 2010, J IMMUNOL, V185, P6857, DOI 10.4049/jimmunol.1001601; Terheyden P, 2003, SCAND J IMMUNOL, V58, P566, DOI 10.1046/j.1365-3083.2003.01324.x; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yee C, 1999, J IMMUNOL, V162, P2227; Zeh HJ, 1999, J IMMUNOL, V162, P989	42	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41112	10.1371/journal.pone.0041112	http://dx.doi.org/10.1371/journal.pone.0041112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829916	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300055
J	Chen, HB; Tian, Y; Shu, WJ; Bo, XC; Wang, SQ				Chen, Hebing; Tian, Yao; Shu, Wenjie; Bo, Xiaochen; Wang, Shengqi			Comprehensive Identification and Annotation of Cell Type-Specific and Ubiquitous CTCF-Binding Sites in the Human Genome	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; C-MYC GENE; CHROMATIN INSULATORS; HISTONE MODIFICATIONS; PROTEIN CTCF; REGULATORY MOTIFS; X-INACTIVATION; CONTROL REGION; H19 GENE; TRANSCRIPTION	Chromatin insulators are DNA elements that regulate the level of gene expression either by preventing gene silencing through the maintenance of heterochromatin boundaries or by preventing gene activation by blocking interactions between enhancers and promoters. CCCTC-binding factor (CTCF), a ubiquitously expressed 11-zinc-finger DNA-binding protein, is the only protein implicated in the establishment of insulators in vertebrates. While CTCF has been implicated in diverse regulatory functions, CTCF has only been studied in a limited number of cell types across human genome. Thus, it is not clear whether the identified cell type-specific differences in CTCF-binding sites are functionally significant. Here, we identify and characterize cell type-specific and ubiquitous CTCF-binding sites in the human genome across 38 cell types designated by the Encyclopedia of DNA Elements (ENCODE) consortium. These cell type-specific and ubiquitous CTCF-binding sites show uniquely versatile transcriptional functions and characteristic chromatin features. In addition, we confirm the insulator barrier function of CTCF-binding and explore the novel function of CTCF in DNA replication. These results represent a critical step toward the comprehensive and systematic understanding of CTCF-dependent insulators and their versatile roles in the human genome.	[Chen, Hebing; Tian, Yao; Shu, Wenjie; Bo, Xiaochen; Wang, Shengqi] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Chen, HB (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	shuwj@bmi.ac.cn; boxc@bmi.ac.cn; sqwang@bmi.ac.cn		Shu, Wenjie/0000-0001-9044-2352; Chen, Hebing/0000-0003-4102-356X; Bo, Xiao-chen/0000-0003-1911-7922	National Nature Science Foundation of China [31070639]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Nature Science Foundation of China (No. 31070639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boden M, 2008, NUCLEIC ACIDS RES, V36, P4108, DOI 10.1093/nar/gkn374; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; Gombert WM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006109; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuhn EJ, 2003, CURR OPIN CELL BIOL, V15, P259, DOI 10.1016/S0955-0674(03)00039-5; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lu L, 1997, MOL CELL BIOL, V17, P2202, DOI 10.1128/MCB.17.4.2202; Lu L, 2001, GENE DEV, V15, P134, DOI 10.1101/gad.822101; Lutz M, 2003, EMBO J, V22, P1579, DOI 10.1093/emboj/cdg147; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Shu WJ, 2011, NUCLEIC ACIDS RES, V39, P7428, DOI 10.1093/nar/gkr443; Simon I, 2001, EMBO J, V20, P6150, DOI 10.1093/emboj/20.21.6150; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Vostrov AA, 2002, J BIOL CHEM, V277, P1619, DOI 10.1074/jbc.M109748200; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	96	96	98	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41374	10.1371/journal.pone.0041374	http://dx.doi.org/10.1371/journal.pone.0041374			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829947	Green Submitted, gold, Green Published			2022-12-25	WOS:000306956300086
J	Schuyler, Q; Hardesty, BD; Wilcox, C; Townsend, K				Schuyler, Qamar; Hardesty, Britta Denise; Wilcox, Chris; Townsend, Kathy			To Eat or Not to Eat? Debris Selectivity by Marine Turtles	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; CARETTA-CARETTA; PLASTIC DEBRIS; FEEDING ECOLOGY; CHELONIA-MYDAS; INGESTION; GREEN; ACCUMULATION; PATTERNS; BEHAVIOR	Marine debris is a growing problem for wildlife, and has been documented to affect more than 267 species worldwide. We investigated the prevalence of marine debris ingestion in 115 sea turtles stranded in Queensland between 2006-2011, and assessed how the ingestion rates differ between species (Eretmochelys imbricata vs. Chelonia mydas) and by turtle size class (smaller oceanic feeders vs. larger benthic feeders). Concurrently, we conducted 25 beach surveys to estimate the composition of the debris present in the marine environment. Based on this proxy measurement of debris availability, we modeled turtles' debris preferences (color and type) using a resource selection function, a method traditionally used for habitat and food selection. We found no significant difference in the overall probability of ingesting debris between the two species studied, both of which have similar life histories. Curved carapace length, however, was inversely correlated with the probability of ingesting debris; 54.5% of pelagic sized turtles had ingested debris, whereas only 25% of benthic feeding turtles were found with debris in their gastrointestinal system. Benthic and pelagic sized turtles also exhibited different selectivity ratios for debris ingestion. Benthic phase turtles had a strong selectivity for soft, clear plastic, lending support to the hypothesis that sea turtles ingest debris because it resembles natural prey items such as jellyfish. Pelagic turtles were much less selective in their feeding, though they showed a trend towards selectivity for rubber items such as balloons. Most ingested items were plastic and were positively buoyant. This study highlights the need to address increasing amounts of plastic in the marine environment, and provides evidence for the disproportionate ingestion of balloons by marine turtles.	[Schuyler, Qamar; Townsend, Kathy] Univ Queensland, Sch Biol Sci, Moreton Bay Res Stn, Dunwich, Qld, Australia; [Hardesty, Britta Denise] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Atherton, Qld, Australia; [Wilcox, Chris] Commonwealth Sci & Ind Res Org, Marine & Atmospher Res, Hobart, Tas, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schuyler, Q (corresponding author), Univ Queensland, Sch Biol Sci, Moreton Bay Res Stn, Dunwich, Qld, Australia.	q.schuyler@uq.edu.au	Hardesty, Britta Denise/A-3189-2011; Wilcox, Chris/A-3585-2010; Schuyler, Qamar A/L-2586-2014; Townsend, Kathy Ann/K-9486-2016	Hardesty, Britta Denise/0000-0003-1948-5098; Wilcox, Chris/0000-0002-5983-657X; Schuyler, Qamar A/0000-0002-2473-4311; Townsend, Kathy Ann/0000-0002-2581-2158	ARC Linkage Grant [LP110200216]; Goldring Marine Emerging Scientist Fellowship (CSIRO Top up fellowship); Earthwatch Institute Australia; Brother Pty Ltd; Australian Postgraduate Award, the Margaret Middleton Fund; Goodman Foundation; Brother, Australia	ARC Linkage Grant(Australian Research Council); Goldring Marine Emerging Scientist Fellowship (CSIRO Top up fellowship); Earthwatch Institute Australia; Brother Pty Ltd; Australian Postgraduate Award, the Margaret Middleton Fund; Goodman Foundation; Brother, Australia	Funding was provided by an ARC Linkage Grant (LP110200216; http://www.arc.gov.au/), a Goldring Marine Emerging Scientist Fellowship (CSIRO Top up fellowship; www.csiro.au), Earthwatch Institute Australia (http://www.earthwatch.org/australia/), Brother Pty Ltd (www.brother.com.au/), an Australian Postgraduate Award, the Margaret Middleton Fund (http://www.science.org.au/awards/awards/conservation.html), and the Goodman Foundation. The funders contributed only financially to the research reported here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partially sponsored by the commercial company Brother, Australia. The authors have no agreements regarding employment, consultancy, patents, products in development or marketed products. This sponsorship does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2011, TRACKING TRASH 25 YE; [Anonymous], 2011, UNDERSTANDING TYPES; Arthur KE, 2007, MAR TECHNOL SOC J, V41, P9, DOI 10.4031/002533207787441953; Balazs G., 1985, P WORKSH FAT IMP MAR, P387; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Bartol SM, 2003, CRC MAR BIOL SER, P79; BJORNDAL KA, 1994, MAR POLLUT BULL, V28, P154, DOI 10.1016/0025-326X(94)90391-3; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bjorndal Karen A., 1997, P199; Bolten AB, 2003, CRC MAR BIOL SER, P243; Boyle MC, 2008, MAR BIOL, V155, P233, DOI 10.1007/s00227-008-1022-z; Boyle MC, 2006, THESIS J COOK U TOWN; Boyle MC, 2006, MARINE POLLUTION B; Bugoni L, 2001, MAR POLLUT BULL, V42, P1330, DOI 10.1016/S0025-326X(01)00147-3; Burchette D, 1989, STUDY EFFECT BALLOON; C?lix M., 2018, EUROPEAN RED LIST SA; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cannon A.C., 1998, NOAA, V143, P81; CARR A, 1987, MAR POLLUT BULL, V18, P352, DOI 10.1016/S0025-326X(87)80025-5; Cheshire A.C., 2009, UNEP REGIONAL SEAS R, V186; Constantino MA, 2003, ZOOLOGY, V106, P173, DOI 10.1078/0944-2006-00114; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; DIXON TR, 1981, MAR POLLUT BULL, V12, P289, DOI 10.1016/0025-326X(81)90078-3; Duguy R., 2000, Annales de la Societe des Sciences Naturelles de la Charente-Maritime, V8, P1035; Duguy R., 1997, Annales de la Societe des Sciences Naturelles de la Charente-Maritime, V8, P633; FEHRING WK, 1972, ANIM BEHAV, V20, P632, DOI 10.1016/S0003-3472(72)80135-0; Frick Michael G., 2010, Endangered Species Research, V9, P91, DOI 10.3354/esr00227; Granda A.M., 1979, P247; HEISEY DM, 1985, ECOLOGY, V66, P1744, DOI 10.2307/2937370; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Kershaw P., 2011, PLASTIC DEBRIS OCEAN; Laist D.W., 1997, SPRINGER SERIES ENV; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lazar B, 2011, MAR POLLUT BULL, V62, P43, DOI 10.1016/j.marpolbul.2010.09.013; Leon YM, 2002, MARINE ECOLOGY PROGR, V245; Limpus C., 2009, BIOL REV AUSTR MARIN; LIMPUS CJ, 1992, WILDLIFE RES, V19, P489, DOI 10.1071/WR9920489; McCauley SJ, 1999, CONSERV BIOL, V13, P925, DOI 10.1046/j.1523-1739.1999.98264.x; Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268; Mrosovsky N, 2009, MAR POLLUT BULL, V58, P287, DOI 10.1016/j.marpolbul.2008.10.018; Mrosovsky N, 1981, MARINE TURTLE NEWSLE, V17; Parker DM, 2005, FISH B-NOAA, V103, P142; PLOTKIN PT, 1993, MAR BIOL, V115, P1, DOI 10.1007/BF00349379; Plotkin PT, 1990, P 2 INT C MAR DEBR, P736; Pritchard PCH, 1973, IUCN MONOGRAPH, V2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; RYAN PG, 1993, NATURE, V361, P23, DOI 10.1038/361023a0; SHAVER DJ, 1991, J HERPETOL, V25, P327, DOI 10.2307/1564592; SHEAVLY S, 2007, NATL MARINE DEBRIS M, DOI DOI 10.1098/RSTB.2008.0207; Stamper MA, 2009, J ZOO WILDLIFE MED, V40, P196, DOI 10.1638/2007-0101.1; Swimmer Y, 2005, MAR ECOL PROG SER, V295, P273, DOI 10.3354/meps295273; Swimmer Y, 2006, SEA TURTLE PELAGIC F; Tomas J, 2002, MAR POLLUT BULL, V44, P211, DOI 10.1016/S0025-326X(01)00236-3; Tourinho PS, 2010, MAR POLLUT BULL, V60, P396, DOI 10.1016/j.marpolbul.2009.10.013; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vorobyev M, 2001, COLOR RES APPL, V26, pS214, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL45>3.0.CO;2-A; Wallace N, 1985, P WORKSH FAT IMP MAR; Windell J. T., 1978, METHODS ASSESSMENT F, P219; Witherington BE, 2002, MAR BIOL, V140, P843, DOI 10.1007/s00227-001-0737-x; Wyneken J., 2001, ANATOMY SEA TURTLES	61	105	112	5	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40884	10.1371/journal.pone.0040884	http://dx.doi.org/10.1371/journal.pone.0040884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829894	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300032
J	Wang, LF; Wang, F; Li, JT; Wen, WH; Zhao, J; Jia, LT; Meng, YL; Cao, YX; Yao, LB; Chen, SY; Xu, YM; Yang, AG				Wang, Li-Feng; Wang, Fang; Li, Jun-Tang; Wen, Wei-Hong; Zhao, Jing; Jia, Lin-Tao; Meng, Yan-Ling; Cao, Yun-Xin; Yao, Li-Bo; Chen, Si-Yi; Xu, Yan-Ming; Yang, An-Gang			Ectopically Expressed Perforin-1 Is Proapoptotic in Tumor Cell Lines by Increasing Caspase-3 Activity and the Nuclear Translocation of Cytochrome c	PLOS ONE			English	Article							GRANZYME-B; TARGET-CELLS; CYTOTOXIC LYMPHOCYTES; DEPENDENT ENDOCYTOSIS; DEFICIENT MICE; T-LYMPHOCYTES; IN-VIVO; APOPTOSIS; ACTIVATION; PATHWAYS	Perforin-1 (PRF), a cytotoxic lymphocyte pore-forming protein, plays an important role in the action of cytotoxic T cells and natural killer cells in that it causes the lysis of abnormal body cells and the elimination of virus-infected cells and tumors. Upon degranulation, PRF inserts itself into the target cell's plasma membrane, forming a pore. The subsequent translocation of pro-apoptotic granzymes (including granzyme B, A, M et al.) into the cytoplasm provides the proteases with access to numerous protein substrates that promote apoptosis after cleavage. These proteases are believed to be the main executioners of target cell apoptosis. Although the PRF and granzyme components are both critical to this process and in some way involved in inducing cell death in target cells, the inhibition of tumor growth could still be efficient in granzyme-deficient mice. It is unclear whether PRF alone can suppress tumors. In this study, we discovered that forced ectopic expression of PRF alone, in the absence of granzymes, could mediate cell death in cancer cells. Notably, transient expression of both full-length and truncated active-form PRF in human Hep G2, SK-BR-3, and HeLa cells was found to induce apparent cell growth inhibition and cell death, as evidenced by chromosome condensation and DNA fragmentation, increased caspase-3 activity, and the release of apoptosis inducing factor (AIF) and cytochrome c from the mitochondria. This PRF-induced cell death could be abrogated by pan-caspase inhibitor (Z-VAD) and mitochondria protector (TAT-BH4). The implication of these results is that ectopically expressed PRF has apoptosis-inducing abilities, and PRF alone is sufficient to induce apoptotic cell death in cells with ectopic expression. Taking this into consideration, our results suggest the possibility of using PRF as a pro-apoptotic gene for tumor therapeutics.	[Wang, Li-Feng; Zhao, Jing; Jia, Lin-Tao; Yao, Li-Bo] Fourth Mil Med Univ, State Key Lab Canc Biol, Sch Basic Med Sci, Dept Biochem, Xian 710032, Peoples R China; [Wang, Li-Feng; Zhao, Jing; Jia, Lin-Tao; Yao, Li-Bo] Fourth Mil Med Univ, State Key Lab Canc Biol, Sch Basic Med Sci, Dept Mol Biol, Xian 710032, Peoples R China; [Li, Jun-Tang; Wen, Wei-Hong; Meng, Yan-Ling; Cao, Yun-Xin; Yang, An-Gang] Fourth Mil Med Univ, Dept Immunol, Sch Basic Med Sci, Xian 710032, Peoples R China; [Wang, Fang] Fourth Mil Med Univ, Dept Microbiol, Sch Basic Med Sci, Xian 710032, Peoples R China; [Chen, Si-Yi] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Xu, Yan-Ming] Shantou Univ, Coll Med, Dept Cell Biol & Genet, Shantou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; University of Southern California; Shantou University	Wang, LF (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Sch Basic Med Sci, Dept Biochem, Xian 710032, Peoples R China.	amyymxu@stu.edu.cn; agyang@fmmu.edu.cn	meng, yan/GSE-2653-2022; Xu, yanming/Q-4931-2019; 温, 家琦/GYV-3177-2022; Meng, Yan/HGC-0394-2022		National High Technology Research and Development Program of China [2007AA021104, 30870497, 30901359, 81001015]; NATIONAL CANCER INSTITUTE [R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084811] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant support: National High Technology Research and Development Program of China grant 2007AA021104 (to A-G Yang), 30870497 (to Y-M Xu), 30901359 (to L-F Wang) and 81001015(to F Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Baran K, 2006, J BIOL CHEM, V281, P30485, DOI 10.1074/jbc.M602007200; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bolitho P, 2007, CURR OPIN IMMUNOL, V19, P339, DOI 10.1016/j.coi.2007.04.007; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan AJ, 2011, IMMUNITY, V34, P879, DOI 10.1016/j.immuni.2011.04.007; Catalfamo M, 2003, CURR OPIN IMMUNOL, V15, P522, DOI 10.1016/S0952-7915(03)00114-6; de Koning PJA, 2009, CRIT REV IMMUNOL, V29, P307, DOI 10.1615/CritRevImmunol.v29.i4.20; FINK TM, 1992, GENOMICS, V13, P1300, DOI 10.1016/0888-7543(92)90050-3; Froelich C, 2011, IMMUNITY, V34, P823, DOI 10.1016/j.immuni.2011.06.008; Guo YM, 2008, MOL IMMUNOL, V45, P2225, DOI 10.1016/j.molimm.2007.11.020; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; MASSON D, 1985, J BIOL CHEM, V260, P9069; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Packard BZ, 2007, J IMMUNOL, V179, P3812, DOI 10.4049/jimmunol.179.6.3812; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; SAUER H, 1991, ANAL BIOCHEM, V194, P418, DOI 10.1016/0003-2697(91)90251-N; Smyth MJ, 2003, J IMMUNOL, V171, P515, DOI 10.4049/jimmunol.171.2.515; Sutton VR, 2007, J CELL BIOL, V176, P425, DOI 10.1083/jcb.200609077; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wowk ME, 2004, MICROBES INFECT, V6, P752, DOI 10.1016/j.micinf.2004.03.008; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429; Zur SU, 2002, PRENAT DIAGN, V22, P80	40	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40639	10.1371/journal.pone.0040639	http://dx.doi.org/10.1371/journal.pone.0040639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829880	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300018
J	Wang, T; Chen, GP; Zan, QJ; Wang, CB; Su, YJ				Wang, Ting; Chen, Guopei; Zan, Qijie; Wang, Chunbo; Su, Ying-Juan			AFLP Genome Scan to Detect Genetic Structure and Candidate Loci under Selection for Local Adaptation of the Invasive Weed Mikania micrantha	PLOS ONE			English	Article							POPULATION-STRUCTURE; DIVERGENT SELECTION; LINKAGE DISEQUILIBRIUM; ADAPTIVE EVOLUTION; BIOLOGICAL-CONTROL; RAPID EVOLUTION; LIFE-HISTORY; DIFFERENTIATION; MARKERS; PLANT	Why some species become successful invaders is an important issue in invasive biology. However, limited genomic resources make it very difficult for identifying candidate genes involved in invasiveness. Mikania micrantha H.B.K. (Asteraceae), one of the world's most invasive weeds, has adapted rapidly in response to novel environments since its introduction to southern China. In its genome, we expect to find outlier loci under selection for local adaptation, critical to dissecting the molecular mechanisms of invasiveness. An explorative amplified fragment length polymorphism (AFLP) genome scan was used to detect candidate loci under selection in 28 M. micrantha populations across its entire introduced range in southern China. We also estimated population genetic parameters, bottleneck signatures, and linkage disequilibrium. In binary characters, such as presence or absence of AFLP bands, if all four character combinations are present, it is referred to as a character incompatibility. Since character incompatibility is deemed to be rare in populations with extensive asexual reproduction, a character incompatibility analysis was also performed in order to infer the predominant mating system in the introduced M. micrantha populations. Out of 483 AFLP loci examined using stringent significance criteria, 14 highly credible outlier loci were identified by Dfdist and Bayescan. Moreover, remarkable genetic variation, multiple introductions, substantial bottlenecks and character compatibility were found to occur in M. micrantha. Thus local adaptation at the genome level indeed exists in M. micrantha, and may represent a major evolutionary mechanism of successful invasion. Interactions between genetic diversity, multiple introductions, and reproductive modes contribute to increase the capacity of adaptive evolution.	[Wang, Ting; Chen, Guopei] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Peoples R China; [Chen, Guopei; Wang, Chunbo; Su, Ying-Juan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zan, Qijie] Shenzhen Wildlife Rescue & Rehabil Ctr, Shenzhen, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Sun Yat Sen University	Wang, T (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Peoples R China.	suyj@mail.sysu.edu.cn			National Natural Science Foundation of China [30970290, 31070594]; Opening Fund of Laboratory Sun Yat-sen University; Guangdong Key Laboratory of Plant Resources [plant01k13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Fund of Laboratory Sun Yat-sen University; Guangdong Key Laboratory of Plant Resources	This work was supported by the National Natural Science Foundation of China (Grant Nos. 30970290, 31070594), the Opening Fund of Laboratory Sun Yat-sen University (2010), and Guangdong Key Laboratory of Plant Resources (plant01k13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Allan E, 2009, OIKOS, V118, P1053, DOI 10.1111/j.1600-0706.2009.17135.x; Amsellem L, 2001, AM J BOT, V88, P2243, DOI 10.2307/3558386; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Baker SA, 2011, CONSERV GENET, V12, P793, DOI 10.1007/s10592-011-0186-0; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Barrett S.C.H., 1986, P21; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BROWN AHD, 1980, GENETICS, V96, P523; BURDON JJ, 1981, J APPL ECOL, V18, P649, DOI 10.2307/2402423; Butlin RK, 2010, GENETICA, V138, P409, DOI 10.1007/s10709-008-9321-3; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Campbell D, 2004, MOL BIOL EVOL, V21, P945, DOI 10.1093/molbev/msh101; Chapman H, 2004, HEREDITY, V92, P182, DOI 10.1038/sj.hdy.6800392; Cock M. J. W., 2000, Proceedings of the X International Symposium on Biological Control of Weeds, Bozeman, Montana, USA, 4-14 July, 1999, P155; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Egan SP, 2008, EVOLUTION, V62, P1162, DOI 10.1111/j.1558-5646.2008.00352.x; Ellison CA, 2008, BIOL CONTROL, V45, P133, DOI 10.1016/j.biocontrol.2007.12.001; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Fjellheim S, 2005, THEOR APPL GENET, V111, P640, DOI 10.1007/s00122-005-2006-8; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gagnaire PA, 2009, MOL ECOL, V18, P1678, DOI 10.1111/j.1365-294X.2009.04142.x; Galindo J, 2009, MOL ECOL, V18, P919, DOI 10.1111/j.1365-294X.2008.04076.x; Geleta M, 2007, HEREDITAS, V144, P53, DOI 10.1111/j.2007.0018-0661.01983.x; Godwin ID, 1997, ELECTROPHORESIS, V18, P1524, DOI 10.1002/elps.1150180906; Haldimann P, 2003, MOL ECOL, V12, P2541, DOI 10.1046/j.1365-294X.2003.01915.x; Hassel K, 2005, AM J BOT, V92, P1684, DOI 10.3732/ajb.92.10.1684; Haubold B, 1998, GENETICS, V150, P1341; Hedrick P.W., 2000, GENETICS POPULATIONS; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Herrera CM, 2009, MOL ECOL, V18, P2602, DOI 10.1111/j.1365-294X.2009.04229.x; Herrera CM, 2008, MOL ECOL, V17, P5378, DOI 10.1111/j.1365-294X.2008.04004.x; Holm L. G., 1977, WORLDS WORST WEEDS D; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Holt RD, 2009, MOL ECOL, V18, P4347, DOI 10.1111/j.1365-294X.2009.04358.x; Hong L, 2007, WEED RES, V47, P280, DOI 10.1111/j.1365-3180.2007.00575.x; Houliston GJ, 2004, AM J BOT, V91, P37, DOI 10.3732/ajb.91.1.37; Huang Zhong-liang, 2000, Journal of Tropical and Subtropical Botany, V8, P131; HUSBAND BC, 1991, HEREDITY, V66, P287, DOI 10.1038/hdy.1991.36; Ismail B. S., 2002, Weed Biology and Management, V2, P31, DOI 10.1046/j.1445-6664.2002.00045.x; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Jorgensen S, 2004, MOL ECOL, V13, P3403, DOI 10.1111/j.1365-294X.2004.02329.x; Kanarek AR, 2010, EVOL APPL, V3, P122, DOI 10.1111/j.1752-4571.2009.00112.x; Kaufman SR, 2001, OECOLOGIA, V127, P487, DOI 10.1007/s004420000621; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kim Y, 2008, GENET EPIDEMIOL, V32, P301, DOI 10.1002/gepi.20305; Klekowski EJ, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P227; Kong GH, 2000, J TROPICAL SUBTROPIC, V8, P27; Kuchma O, 2011, ENVIRON POLLUT, V159, P1606, DOI 10.1016/j.envpol.2011.02.049; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leroux Sophie, 2010, BMC Res Notes, V3, P214, DOI 10.1186/1756-0500-3-214; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 1999, BOTTLENECK PROGRAM D; Manel S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-288; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; Mealor BA, 2006, MOL ECOL, V15, P2291, DOI 10.1111/j.1365-294X.2006.02931.x; Menchari Y, 2007, MOL ECOL, V16, P3161, DOI 10.1111/j.1365-294X.2007.03390.x; Mes THM, 1998, MOL ECOL, V7, P1719, DOI 10.1046/j.1365-294x.1998.00508.x; Meyer CL, 2009, MOL ECOL, V18, P2050, DOI 10.1111/j.1365-294X.2009.04159.x; Michalski SG, 2010, THEOR APPL GENET, V120, P1151, DOI 10.1007/s00122-009-1242-8; Miller NJ, 2007, J APPL ENTOMOL, V131, P378, DOI 10.1111/j.1439-0418.2007.01190.x; Milne RI, 2000, MOL ECOL, V9, P541, DOI 10.1046/j.1365-294x.2000.00906.x; Murray MC, 2006, MOL ECOL, V15, P4229, DOI 10.1111/j.1365-294X.2006.03060.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Ni GY, 2006, ALLELOPATHY J, V17, P247; Nielsen LR, 2004, HEREDITY, V93, P434, DOI 10.1038/sj.hdy.6800520; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Nunes VL, 2011, MOL ECOL, V20, P193, DOI 10.1111/j.1365-294X.2010.04936.x; Paris M, 2010, MOL ECOL, V19, P325, DOI 10.1111/j.1365-294X.2009.04437.x; Parisod C, 2010, ANN BOT-LONDON, V105, P655, DOI 10.1093/aob/mcq014; Paun O, 2006, MOL ECOL, V15, P897, DOI 10.1111/j.1365-294X.2006.02800.x; Pellegrin D, 1999, AQUAT BOT, V63, P241, DOI 10.1016/S0304-3770(98)00120-X; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Prentis PJ, 2010, ANN BOT-LONDON, V106, P1009, DOI 10.1093/aob/mcq201; PRICE SC, 1981, OECOLOGIA, V49, P283, DOI 10.1007/BF00349202; Pritchard JK, 2000, GENETICS, V155, P945; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; Rannala B, 1996, GENET RES, V67, P147, DOI 10.1017/S0016672300033607; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rottenberg A, 2004, P ROY SOC B-BIOL SCI, V271, pS206, DOI 10.1098/rsbl.2003.0135; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Schonswetter P, 2003, MOL ECOL, V12, P3373, DOI 10.1046/j.1365-294X.2003.01984.x; Shimada Y, 2011, MOL BIOL EVOL, V28, P181, DOI 10.1093/molbev/msq181; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Smith TB, 2008, MOL ECOL, V17, P58, DOI 10.1111/j.1365-294X.2007.03478.x; Su YJ, 2005, MOL PHYLOGENET EVOL, V34, P323, DOI 10.1016/j.ympev.2004.10.016; SWAMY PS, 1987, AGR ECOSYST ENVIRON, V18, P195, DOI 10.1016/0167-8809(87)90083-1; Tice KA, 2011, J EVOLUTION BIOL, V24, P1814, DOI 10.1111/j.1420-9101.2011.02314.x; Tollenaere C, 2011, MOL ECOL, V20, P1026, DOI 10.1111/j.1365-294X.2010.04633.x; Van Buskirk J, 2006, EVOLUTION, V60, P2428, DOI 10.1111/j.0014-3820.2006.tb01879.x; van der Hulst RGM, 2000, MOL ECOL, V9, P1, DOI 10.1046/j.1365-294x.2000.00704.x; Van Treuren R, 2005, MOL ECOL, V14, P39, DOI 10.1111/j.1365-294X.2004.02391.x; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walker NF, 2003, MOL ECOL, V12, P1747, DOI 10.1046/j.1365-294X.2003.01866.x; [王伯荪 Wang Bosun], 2003, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V42, P47; Wang JY, 2007, PLANT MOL BIOL REP, V25, P37, DOI 10.1007/s11105-007-0005-4; Wen D, 2000, J TROP SUB BOT, V8, P139; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wilkinson M., 2001, PICA 4 0 SOFTWARE DO; Williams LM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-282; Wirjahardja S., 1976, Proceedings of 5th Asian-Pacific Weed Science Society Conference, Tokyo, Japan, 1975., P70; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114; Xu CY, 2010, ECOL LETT, V13, P32, DOI 10.1111/j.1461-0248.2009.01395.x; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zan Q.J., 2000, CHINESE J ECOL, V19, P58, DOI DOI 10.13292/J.1000; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x; Zhou XM, 2001, WORLD AGR, V10, P42; [No title captured]	139	39	40	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41310	10.1371/journal.pone.0041310	http://dx.doi.org/10.1371/journal.pone.0041310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829939	gold, Green Submitted, Green Published			2022-12-25	WOS:000306956300078
J	Strom, MA; Zebrowitz, LA; Zhang, SN; Bronstad, PM; Lee, HK				Strom, Michael A.; Zebrowitz, Leslie A.; Zhang, Shunan; Bronstad, P. Matthew; Lee, Hoon Koo			Skin and Bones: The Contribution of Skin Tone and Facial Structure to Racial Prototypicality Ratings	PLOS ONE			English	Article							TRAIT IMPRESSIONS; AFRICAN-AMERICAN; ASIAN-AMERICANS; RACE; PERCEPTION; RECOGNITION; APPEARANCE; FEATURES; ATTRACTIVENESS; STEREOTYPES	Previous research reveals that a more 'African' appearance has significant social consequences, yielding more negative first impressions and harsher criminal sentencing of Black or White individuals. This study is the first to systematically assess the relative contribution of skin tone and facial metrics to White, Black, and Korean perceivers' ratings of the racial prototypicality of faces from the same three groups. Our results revealed that the relative contribution of metrics and skin tone depended on both perceiver race and face race. White perceivers' racial prototypicality ratings were less responsive to variations in skin tone than were Black or Korean perceivers' ratings. White perceivers ratings' also were more responsive to facial metrics than to skin tone, while the reverse was true for Black perceivers. Additionally, across all perceiver groups, skin tone had a more consistent impact than metrics on racial prototypicality ratings of White faces, with the reverse for Korean faces. For Black faces, the relative impact varied with perceiver race: skin tone had a more consistent impact than metrics for Black and Korean perceivers, with the reverse for White perceivers. These results have significant implications for predicting who will experience racial prototypicality biases and from whom.	[Strom, Michael A.; Zebrowitz, Leslie A.; Zhang, Shunan; Bronstad, P. Matthew] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Lee, Hoon Koo] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea	Brandeis University; Yonsei University	Strom, MA (corresponding author), Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA.	zebrowitz@brandeis.edu			NIH [MH066836, K02MH72603]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH072603, R01MH066836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH Grants MH066836 and K02MH72603 to the first author (http://www.nimh.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BP, 1996, J APPL SOC PSYCHOL, V26, P884, DOI 10.1111/j.1559-1816.1996.tb01116.x; Averhart CJ, 1997, J EXP CHILD PSYCHOL, V67, P363, DOI 10.1006/jecp.1997.2413; Balas B, 2010, NEUROPSYCHOLOGIA, V48, P498, DOI 10.1016/j.neuropsychologia.2009.10.007; Bar-Haim Y, 2009, PERCEPTION, V38, P145, DOI 10.1068/p6307; Blair IV, 2004, J PERS SOC PSYCHOL, V87, P763, DOI 10.1037/0022-3514.87.6.763; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Brooks KR, 2010, PERCEPTION, V39, P1142, DOI 10.1068/p6703; Brown TD, 1998, J SOC BEHAV PERS, V13, P295; Dixon TL, 2005, J APPL SOC PSYCHOL, V35, P1555, DOI 10.1111/j.1559-1816.2005.tb02184.x; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Hancock KJ, 2008, BRIT J PSYCHOL, V99, P45, DOI 10.1348/000712607X199981; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Ho C, 2001, J APPL SOC PSYCHOL, V31, P1553, DOI 10.1111/j.1559-1816.2001.tb02742.x; Hugenberg K, 2003, PSYCHOL SCI, V14, P640, DOI 10.1046/j.0956-7976.2003.psci_1478.x; Jarvis B. G., 2004, MEDIALAB VERSION 200; JUDD CM, 1995, J PERS SOC PSYCHOL, V69, P460, DOI 10.1037/0022-3514.69.3.460; Kawai Y, 2005, HOWARD J COMMUN, V16, P109, DOI 10.1080/10646170590948974; Komori M, 2011, J EXP PSYCHOL HUMAN, V37, P626, DOI 10.1037/a0020369; Livingston RW, 2002, J PERS SOC PSYCHOL, V82, P5, DOI 10.1037//0022-3514.82.1.5; Maddox KB, 2004, PERS SOC PSYCHOL REV, V8, P383, DOI 10.1207/s15327957pspr0804_4; Maddox KB, 2002, PERS SOC PSYCHOL B, V28, P250, DOI 10.1177/0146167202282010; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Martinez A., 1998, 24 CVC; Ronquillo J, 2007, SOC COGN AFFECT NEUR, V2, P39, DOI 10.1093/scan/nsl043; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Russell R, 2007, VISION RES, V47, P157, DOI 10.1016/j.visres.2006.11.002; Russell R, 2006, PERCEPTION, V35, P749, DOI 10.1068/p5490; Santos IM, 2008, PERCEPTION, V37, P1061, DOI 10.1068/p5278; Sparko AL, 2011, J NONVERBAL BEHAV, V35, P243, DOI 10.1007/s10919-011-0111-8; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Young SG, 2012, SOC PSYCHOL PERS SCI, V3, P80, DOI 10.1177/1948550611409759; Zebrowitz L, 1999, PERS SOC PSYCHOL B, V25, P569; Zebrowitz L. A., 1997, READING FACES WINDOW; Zebrowitz LA, 2003, PERS SOC PSYCHOL REV, V7, P194, DOI 10.1207/S15327957PSPR0703_01; Zebrowitz LA, 1998, J PERS SOC PSYCHOL, V75, P1300, DOI 10.1037/0022-3514.75.5.1300; Zebrowitz LA, 2007, PERS SOC PSYCHOL B, V33, P648, DOI 10.1177/0146167206297399; Zebrowitz LA, 2007, SOC COGNITION, V25, P306, DOI 10.1521/soco.2007.25.2.306; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990; ZEBROWITZMCARTHUR L, 1989, J NONVERBAL BEHAV, V13, P189, DOI 10.1007/BF00987049	42	28	28	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41193	10.1371/journal.pone.0041193	http://dx.doi.org/10.1371/journal.pone.0041193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815966	Green Published, gold			2022-12-25	WOS:000306548900094
J	Korzyukov, O; Sattler, L; Behroozmand, R; Larson, CR				Korzyukov, Oleg; Sattler, Lindsey; Behroozmand, Roozbeh; Larson, Charles R.			Neuronal Mechanisms of Voice Control Are Affected by Implicit Expectancy of Externally Triggered Perturbations in Auditory Feedback	PLOS ONE			English	Article							PITCH FEEDBACK; CORTEX; RESPONSES; BRAIN; ERP; PERCEPTION; PREDICTION; COMPONENTS; SPEECH; SOUNDS	Accurate vocal production relies on several factors including sensory feedback and the ability to predict future challenges to the control processes. Repetitive patterns of perturbations in sensory feedback by themselves elicit implicit expectations in the vocal control system regarding the timing, quality and direction of perturbations. In the present study, the predictability of voice pitch-shifted auditory feedback was experimentally manipulated. A block of trials where all pitch-shift stimuli were upward, and therefore predictable was contrasted against an unpredictable block of trials in which the stimulus direction was randomized between upward and downward pitch-shifts. It was found that predictable perturbations in voice auditory feedback led to a reduction in the proportion of compensatory vocal responses, which might be indicative of a reduction in vocal control. The predictable perturbations also led to a reduction in the magnitude of the N1 component of cortical Event Related Potentials (ERP) that was associated with the reflexive compensations to the perturbations. We hypothesize that formation of expectancy in our study is accompanied by involuntary allocation of attentional resources occurring as a result of habituation or learning, that in turn trigger limited and controlled exploration-related motor variability in the vocal control system.	[Korzyukov, Oleg; Sattler, Lindsey; Behroozmand, Roozbeh; Larson, Charles R.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA	Northwestern University	Korzyukov, O (corresponding author), Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA.	o-korzyukov@northwestern.edu			National Institutes of Health [1R01DC006243]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by a grant from National Institutes of Health, Grant No. 1R01DC006243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIPOURHAGHIGHI F, 1991, ANN OTO RHINOL LARYN, V100, P626, DOI 10.1177/000348949110000805; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; Baess P, 2011, PSYCHOPHYSIOLOGY, V48, P1276, DOI 10.1111/j.1469-8986.2011.01196.x; Behroozmand R, 2011, CLIN NEUROPHYSIOL, V122, P2408, DOI 10.1016/j.clinph.2011.04.019; Behroozmand R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-54; Behroozmand R, 2009, CLIN NEUROPHYSIOL, V120, P1303, DOI 10.1016/j.clinph.2009.04.022; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; Boersma P, 2001, GLOT INT, V5, P341; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Burkard RF., 2007, AUDITORY EVOKED POTE; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Chait M, 2004, NEUROREPORT, V15, P2455, DOI 10.1097/00001756-200411150-00004; Conley EM, 1999, CLIN NEUROPHYSIOL, V110, P2086, DOI 10.1016/S1388-2457(99)00183-2; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Deroost N, 2006, PSYCHOL RES-PSYCH FO, V70, P88, DOI 10.1007/s00426-004-0196-3; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Ford JM, 2001, BIOL PSYCHIAT, V50, P540, DOI 10.1016/S0006-3223(01)01166-0; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Ghajar J, 2009, NEUROSCIENTIST, V15, P232, DOI 10.1177/1073858408326429; GIARD MH, 1994, ELECTROEN CLIN NEURO, V92, P238, DOI 10.1016/0168-5597(94)90067-1; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Hain TC, 2000, EXP BRAIN RES, V130, P133, DOI 10.1007/s002219900237; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Kawahara H., 1994, Journal of the Acoustical Society of Japan (E), V15, P201, DOI 10.1250/ast.15.201; Korzyukov O, 2012, INT J PSYCHOPHYSIOL, V83, P71, DOI 10.1016/j.ijpsycho.2011.10.006; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Larson CR, 2007, J ACOUST SOC AM, V121, P2862, DOI 10.1121/1.2715657; LARSON CR, 1987, J SPEECH HEAR RES, V30, P552, DOI 10.1044/jshr.3004.552; Liu HJ, 2011, CLIN NEUROPHYSIOL, V122, P951, DOI 10.1016/j.clinph.2010.08.010; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Ludlow CL, 1996, VOCAL FOLD, P201; Mandelblat-Cerf Y, 2009, J NEUROSCI, V29, P15053, DOI 10.1523/JNEUROSCI.3011-09.2009; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pavlov I.P., 1955, SELECTED WORKS; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Roberts TPL, 2000, J CLIN NEUROPHYSIOL, V17, P114, DOI 10.1097/00004691-200003000-00002; Rodel RMW, 2004, LARYNGOSCOPE, V114, P918; SIDDLE DAT, 1991, PSYCHOPHYSIOLOGY, V28, P245, DOI 10.1111/j.1469-8986.1991.tb02190.x; Sokolov EN, 1963, PERCEPTION CONDITION, Vx; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wright BA, 2004, PERCEPT PSYCHOPHYS, V66, P508, DOI 10.3758/BF03194897	55	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41216	10.1371/journal.pone.0041216	http://dx.doi.org/10.1371/journal.pone.0041216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JG	22815974	Green Submitted, gold, Green Published			2022-12-25	WOS:000306507000080
J	Sorokin, AV; Chen, J				Sorokin, A. V.; Chen, J.			MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells	ONCOGENE			English	Article						MEMO1; IRS1; EMT; Snail1; breast cancer	INSULIN-RECEPTOR SUBSTRATE-1; NF-KAPPA-B; PLECKSTRIN-HOMOLOGY DOMAIN; GLYCOGEN-SYNTHASE KINASE-3; HUMAN PANCREATIC-CANCER; GROWTH-FACTOR RECEPTOR; E-CADHERIN; BREAST-CANCER; IRS PROTEINS; SIGNAL-TRANSDUCTION	MEMO1 (mediator of ErbB2-driven cell motility 1) regulates HER2-dependent cell migration. Increased MEMO1 expression is associated with cancer aggressiveness. Here, we found that MEMO1 is also involved in breast carcinogenesis via regulating insulin-like growth factor-I receptor-dependent signaling events. We showed that MEMO1 binds to insulin receptor substrate 1, activates the downstream PI3K/Akt signaling pathway, leads to upregulation of Snail1 and thereby triggers the epithelial-mesenchymal transition (EMT) program. In addition, MEMO1 overexpression is accompanied by growth factor-independent proliferation, anchorage-independent growth in soft agar, and enhanced metastatic potential. Together, these findings suggest that MEMO1 acts as an oncogene and is a potential therapeutic target for cancer treatment.	[Sorokin, A. V.; Chen, J.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org			Era of Hope Research award [W81XWH-09-1-0409]; Department of Defense [W81XWH-05-1-0470]; MD Anderson's Cancer Center Support Grant [CA016672]	Era of Hope Research award; Department of Defense(United States Department of Defense); MD Anderson's Cancer Center Support Grant	We thank all our colleagues in the Chen laboratory for insightful discussions and technical assistance. We thank Dr Douglas Yee at the University of Minnesota for sharing hIRS2 cDNA and Dr Cosima Baldari at the University of Siena (Italy) for sharing ShcA(p66) cDNA. This work was supported in part by an Era of Hope Research award to JC (W81XWH-09-1-0409). JC is also a recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470). This work was supported by MD Anderson's Cancer Center Support Grant (CA016672).	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Backer JM, 1997, EUR J BIOCHEM, V245, P91, DOI 10.1111/j.1432-1033.1997.t01-1-00091.x; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bergmann U, 1996, BIOCHEM BIOPH RES CO, V220, P886, DOI 10.1006/bbrc.1996.0500; Boissan M, 2005, AM J PATHOL, V167, P869, DOI 10.1016/S0002-9440(10)62058-5; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Cantarini MC, 2006, HEPATOLOGY, V44, P446, DOI 10.1002/hep.21272; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Del Valle L, 2002, CLIN CANCER RES, V8, P1822; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Hellawell GO, 2002, CANCER RES, V62, P2942; Hemi R, 2002, J BIOL CHEM, V277, P8961, DOI 10.1074/jbc.M109391200; Hoang CD, 2004, CANCER RES, V64, P7479, DOI 10.1158/0008-5472.CAN-04-1898; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kornmann M, 1998, CANCER RES, V58, P4250; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pelicci G, 1996, ONCOGENE, V13, P633; Qiu C, 2008, J BIOL CHEM, V283, P2734, DOI 10.1074/jbc.M703523200; Ravikumar S, 2007, CANCER RES, V67, P9266, DOI 10.1158/0008-5472.CAN-07-2088; Rocha RL, 1997, CLIN CANCER RES, V3, P103; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Sakai R, 2000, NEURON, V28, P819, DOI 10.1016/S0896-6273(00)00156-2; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Szabolcs M, 2009, AM J PATHOL, V174, P276, DOI 10.2353/ajpath.2009.080086; Werner H, 2000, CELL MOL LIFE SCI, V57, P932, DOI 10.1007/PL00000735; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	57	47	47	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 27	2013	32	26					3130	3138		10.1038/onc.2012.327	http://dx.doi.org/10.1038/onc.2012.327			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22824790				2022-12-25	WOS:000321004600003
J	Bourguignon, LYW; Wong, G; Earle, C; Chen, LQ				Bourguignon, Lilly Y. W.; Wong, Gabriel; Earle, Christine; Chen, Liqun			Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MARKER NANOG; IN-VITRO; CD44; MICRORNA; ISOFORMS; BREAST; SOX2	Human head and neck squamous cell carcinoma (HNSCC) is a highly malignant cancer associated with major morbidity and mortality. In this study, we determined that human HNSCC-derived HSC-3 cells contain a subpopulation of cancer stem cells (CSCs) characterized by high levels of CD44v3 and aldehyde dehydrogenase-1 (ALDH1) expression. These tumor cells also express several stem cell markers (the transcription factors Oct4, Sox2, and Nanog) and display the hallmark CSC properties of self-renewal/clonal formation and the ability to generate heterogeneous cell populations. Importantly, hyaluronan (HA) stimulates the CD44v3 (an HA receptor) interaction with Oct4-Sox2-Nanog leading to both a complex formation and the nuclear translocation of three CSC transcription factors. Further analysis reveals that microRNA-302 (miR-302) is controlled by an upstream promoter containing Oct4-Sox2-Nanog-binding sites, whereas chromatin immunoprecipitation (ChIP) assays demonstrate that stimulation of miR-302 expression by HA-CD44 is Oct4-Sox2-Nanog-dependent in HNSCC-specific CSCs. This process results in suppression of several epigenetic regulators (AOF1/AOF2 and DNMT1) and the up-regulation of several survival proteins (cIAP-1, cIAP-2, and XIAP) leading to self-renewal, clonal formation, and cisplatin resistance. These CSCs were transfected with a specific anti-miR-302 inhibitor to silence miR-302 expression and block its target functions. Our results demonstrate that the anti-miR-302 inhibitor not only enhances the expression of AOF1/AOF2 and DNMT1 but also abrogates the production of cIAP-1, cIAP-2, and XIAP and HA-CD44v3-mediated cancer stem cell functions. Taken together, these findings strongly support the contention that the HA-induced CD44v3 interaction with Oct4-Sox2-Nanog signaling plays a pivotal role in miR-302 production leading to AOF1/AOF2/DNMT1 down-regulation and survival of protein activation. All of these events are critically important for the acquisition of cancer stem cell properties, including self-renewal, clonal formation, and chemotherapy resistance in HA-CD44v3-activated head and neck cancer.	Univ Calif San Francisco, Dept Med, Endocrine Unit 111N2, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu			National Institutes of Health from USPHS [R01 CA66163]; Veterans Affairs Merit Review grants; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA066163] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Veterans Affairs Merit Review grants(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA66163 from USPHS. This work was also supported by Veterans Affairs Merit Review grants and a Department of Defense grant.	Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Astachov L, 2011, FRONT BIOSCI-LANDMRK, V16, P261, DOI 10.2741/3687; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Do JT, 2006, E SCHERING RES FDN W, V60, P35; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Franzmann EJ, 2001, OTOLARYNG HEAD NECK, V124, P426, DOI 10.1067/mhn.2001.114674; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Liu HY, 2011, MOL BIOL REP, V38, P2155, DOI 10.1007/s11033-010-0343-4; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakamura M, 2005, ONCOL REP, V14, P1281; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schulenburg A, 2006, CANCER-AM CANCER SOC, V107, P2512, DOI 10.1002/cncr.22277; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Torre C, 2010, ARCH OTOLARYNGOL, V136, P493, DOI 10.1001/archoto.2010.25; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; UNDERHILL C, 1992, J CELL SCI, V103, P293; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Q, 2009, ANTICANCER RES, V29, P1233; Wang SJ, 2007, HEAD NECK-J SCI SPEC, V29, P550, DOI 10.1002/hed.20544; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Wang SJ, 2009, LARYNGOSCOPE, V119, P1518, DOI 10.1002/lary.20506; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; WHEATLEY SC, 1995, CELL ADHES COMMUN, V3, P217, DOI 10.3109/15419069509081288; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x	70	204	217	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32800	32824		10.1074/jbc.M111.308528	http://dx.doi.org/10.1074/jbc.M111.308528			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22847005	Green Published, hybrid			2022-12-25	WOS:000309168300047
J	Palakodeti, A; Sandstrom, A; Sundaresan, L; Harly, C; Nedellec, S; Olive, D; Scotet, E; Bonneville, M; Adams, EJ				Palakodeti, Aparna; Sandstrom, Andrew; Sundaresan, Lakshmi; Harly, Christelle; Nedellec, Steven; Olive, Daniel; Scotet, Emmanuel; Bonneville, Marc; Adams, Erin J.			The Molecular Basis for Modulation of Human V gamma 9V delta 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPEPTIDE ANTIGENS; CRYSTAL-STRUCTURE; BUTYROPHILIN; RECOGNITION; FAMILY; PYROPHOSPHATE; DOMAIN	Human V gamma 9V delta 2 T cells are well known for their rapid and potent response to infection and tumorigenesis when in the presence of endogenous or exogenous phosphoisoprenoids. However, the molecular mechanisms behind the activation of this gamma delta T cell population remains unclear. Evidence pointing to a role for the CD277/butyrophilin-3 (BTN3A) molecules in this response led us to investigate the structures of these molecules and their modifications upon binding to an agonist antibody (20.1) that mimics phosphoisoprenoid-mediated V gamma 9V delta 2 activation and an antagonist antibody (103.2) that inhibits this reactivity. We find that the three BTN3A isoforms: BTN3A1, BTN3A2, and BTN3A3, have high structural homology to the B7 superfamily of proteins and exist as V-shaped homodimers in solution, associating through the membrane proximal C-type Ig domain. The 20.1 and 103.2 antibodies bind to separate epitopes on the BTN3A Ig-V domain with high affinity but likely with different valencies based on their binding orientation. These structures directly complement functional studies of this system that demonstrate that BTN3A1 is necessary for V gamma 9V delta 2 activation and begin to unravel the extracellular events that occur during stimulation through the V gamma 9V delta 2 T cell receptor.	[Palakodeti, Aparna; Sandstrom, Andrew; Sundaresan, Lakshmi; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Palakodeti, Aparna; Adams, Erin J.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Harly, Christelle; Nedellec, Steven; Scotet, Emmanuel; Bonneville, Marc] Univ Nantes, INSERM, Inst Rech Therapeut, Ctr Rech Cancerol Nantes Angers,UMR892, F-44007 Nantes, France; [Olive, Daniel] Inst J Paoli I Calmettes, INSERM, Ctr Rech Cancerol Marseille, UMR891, F-13009 Marseille, France	University of Chicago; University of Chicago; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St,GCIS W236, Chicago, IL 60637 USA.	ejadams@uchicago.edu	SCOTET, Emmanuel/AAC-9971-2019; SCOTET, Emmanuel/L-2576-2015	SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET, Emmanuel/0000-0001-8010-9556; Sandstrom, Andrew/0000-0002-8629-9087; Harly, Christelle/0000-0002-8045-9166	National Institutes of Health [R01AI073922]; Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI073922. This work was also supported by and the Kinship Foundation Searle Scholars Award (to E. J. A.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Arnett HA, 2009, CYTOKINE, V46, P370, DOI 10.1016/j.cyto.2009.03.009; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Compte E, 2004, EUR J IMMUNOL, V34, P2089, DOI 10.1002/eji.200425227; DeBartolo J, 2009, P NATL ACAD SCI USA, V106, P3734, DOI 10.1073/pnas.0811363106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; Harly C., 2012, BLOOD IN PRESS; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Kabelitz D., 2010, F1000 MED REP, V2, P45; LANG F, 1995, J IMMUNOL, V154, P5986; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Ruddy DA, 1997, GENOME RES, V7, P441, DOI 10.1101/gr.7.5.441; Smith IA, 2010, J IMMUNOL, V184, P3514, DOI 10.4049/jimmunol.0900416; Sugita M, 1998, CLIN IMMUNOL IMMUNOP, V87, P8, DOI 10.1006/clin.1997.4500; TaziAhnini R, 1997, IMMUNOGENETICS, V47, P55, DOI 10.1007/s002510050326; Wang H, 2003, J IMMUNOL, V170, P3696, DOI 10.4049/jimmunol.170.7.3696; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Yamashiro H, 2010, J LEUKOCYTE BIOL, V88, P757, DOI 10.1189/jlb.0309156; Yamazaki T, 2010, J IMMUNOL, V185, P5907, DOI 10.4049/jimmunol.1000835; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499	39	115	124	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32780	32790		10.1074/jbc.M112.384354	http://dx.doi.org/10.1074/jbc.M112.384354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846996	Green Published, hybrid			2022-12-25	WOS:000309168300045
J	Soares, DC; Bradshaw, NJ; Zou, J; Kennaway, CK; Hamilton, RS; Chen, ZA; Wear, MA; Blackburn, EA; Bramham, J; Bottcher, B; Millar, JK; Barlow, PN; Walkinshaw, MD; Rappsilber, J; Porteous, DJ				Soares, Dinesh C.; Bradshaw, Nicholas J.; Zou, Juan; Kennaway, Christopher K.; Hamilton, Russell S.; Chen, Zhuo A.; Wear, Martin A.; Blackburn, Elizabeth A.; Bramham, Janice; Boettcher, Bettina; Millar, J. Kirsty; Barlow, Paul N.; Walkinshaw, Malcolm D.; Rappsilber, Juri; Porteous, David J.			The Mitosis and Neurodevelopment Proteins NDE1 and NDEL1 Form Dimers, Tetramers, and Polymers with a Folded Back Structure in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; CROSS-LINKING; MASS-SPECTROMETRY; NUDEL; LIS1; SCHIZOPHRENIA; COMPLEX; PROTEOMICS; BINDING	Paralogs NDE1 (nuclear distribution element 1) and NDEL1 (NDE-like 1) are essential for mitosis and neurodevelopment. Both proteins are predicted to have similar structures, based upon high sequence similarity, and they co-complex inmammalian cells. X-ray diffraction studies and homology modeling suggest that their N-terminal regions (residues 8-167) adopt continuous, extended alpha-helical coiled-coil structures, but no experimentally derived information on the structure of their C-terminal regions or the architecture of the full-length proteins is available. In the case of NDE1, no biophysical data exists. Here we characterize the structural architecture of both full-length proteins utilizing negative stain electron microscopy along with our established paradigm of chemical cross-linking followed by tryptic digestion, mass spectrometry, and database searching, which we enhance using isotope labeling for mixed NDE1-NDEL1. We determined that full-length NDE1 forms needle-like dimers and tetramers in solution, similar to crystal structures of NDEL1, as well as chain-like end-to-end polymers. The C-terminal domain of each protein, required for interaction with key protein partners dynein and DISC1 (disrupted-inschizophrenia 1), includes a predicted disordered region that allows a bent back structure. This facilitates interaction of the C-terminal region with the N-terminal coiled-coil domain and is in agreement with previous results showing N- and C-terminal regions of NDEL1 and NDE1 cooperating in dynein interaction. It sheds light on recently identified mutations in the NDE1 gene that cause truncation of the encoded protein. Additionally, analysis of mixed NDE1-NDEL1 complexes demonstrates that NDE1 and NDEL1 can interact directly.	[Soares, Dinesh C.; Bradshaw, Nicholas J.; Millar, J. Kirsty; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Bradshaw, Nicholas J.] Univ Dusseldorf, Inst Neuropathol, D-40225 Dusseldorf, Germany; [Zou, Juan; Chen, Zhuo A.; Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Kennaway, Christopher K.; Boettcher, Bettina] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Hamilton, Russell S.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Wear, Martin A.; Blackburn, Elizabeth A.; Bramham, Janice; Barlow, Paul N.; Walkinshaw, Malcolm D.] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Rappsilber, Juri] Tech Univ Berlin, Dept Biotechnol, D-13353 Berlin, Germany	University of Edinburgh; Heinrich Heine University Dusseldorf; University of Edinburgh; University of Edinburgh; University of Oxford; University of Edinburgh; Technical University of Berlin	Soares, DC (corresponding author), Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Inst Genet & Mol Med, Crewe Rd S, Edinburgh EH4 2XU, Midlothian, Scotland.	Dinesh.Soares@ed.ac.uk; Nicholas.Bradshaw@uni-duesseldorf.de	Rappsilber, Juri/B-7265-2015; walkinshaw, malcolm/AAB-7497-2019; Bottcher, Bettina/E-9397-2010; Soares, Dinesh C/A-4425-2012; Rappsilber, Juri/ABF-3328-2020; Hamilton, Russell/T-7240-2019; Porteous, David J/C-7289-2013; Bradshaw, Nicholas J./A-5625-2009; Porteous, David/AAA-3446-2021	Rappsilber, Juri/0000-0001-5999-1310; Bottcher, Bettina/0000-0002-7962-4849; Soares, Dinesh C/0000-0001-7557-0495; Hamilton, Russell/0000-0002-0598-3793; Porteous, David J/0000-0003-1249-6106; Bradshaw, Nicholas J./0000-0001-5581-8828; Porteous, David/0000-0003-1249-6106; walkinshaw, malcolm/0000-0001-5955-9325; Blackburn, Elizabeth A/0000-0003-1325-9575; CHEN, ZHUO/0000-0003-0811-8348; Zou, Juan/0000-0003-2594-6217	Wellcome Trust [088179/A/09/Z, 084229, 091020]; Wellcome Trust; Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council; Alexander von Humboldt Foundation; Darwin-Trust of Edinburgh; Wellcome Trust Centre [077707, 092076]; Medical Research Council [G0902166, G0100266, G0600014] Funding Source: researchfish; MRC [G0600014, G0100266, G0902166] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Darwin-Trust of Edinburgh; Wellcome Trust Centre(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 088179/A/09/Z (to D. C. S., N. J. B., J. K. M., P. N. B., M. D. W., J. R., and D. J. P.) and funds from the Wellcome Trust (to M. A. W., E. A. B., and J. B.), the Scottish University Life Sciences Alliance, and the Biotechnology and Biological Sciences Research Council.; Now supported by a fellowship from the Alexander von Humboldt Foundation. To whom correspondence may be addressed: Inst. fur Neuropathologie, Geb. 14.79, Universitatsklinikum Dusseldorf, Moorenstr. 5, 40225 Dusseldorf, Germany. Tel.: 49-211-811-8652; Fax: 49-211-811-7804; E-mail: Nicholas.Bradshaw@uni-duesseldorf.de.; Supported by the Darwin-Trust of Edinburgh.; Supported by the Wellcome Trust through Senior Research Fellowship 084229, Wellcome Trust Centre Core Grants 077707 and 092076, and a Wellcome Trust Instrument Grant 091020.	Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Bakircioglu M, 2011, AM J HUM GENET, V88, P523, DOI 10.1016/j.ajhg.2011.03.019; Bariola PA, 2004, PLANT MOL BIOL, V55, P579, DOI 10.1007/s11103-004-1520-4; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Bradshaw NJ, 2011, J NEUROSCI, V31, P9043, DOI 10.1523/JNEUROSCI.5410-10.2011; Bradshaw NJ, 2009, NEUROSCI LETT, V449, P228, DOI 10.1016/j.neulet.2008.10.095; Bradshaw NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1091, DOI 10.1016/j.bbrc.2008.10.120; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Chansard M, 2011, CYTOSKELETON, V68, P540, DOI 10.1002/cm.20532; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Collins DM, 2008, CELL SIGNAL, V20, P2356, DOI 10.1016/j.cellsig.2008.09.017; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Hayashi MAF, 2005, P NATL ACAD SCI USA, V102, P3828, DOI 10.1073/pnas.0500330102; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Matic I, 2011, J PROTEOME RES, V10, P4869, DOI 10.1021/pr2004715; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Narayanan S, 2011, J BIOL CHEM, V286, P44266, DOI 10.1074/jbc.M111.271593; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Segal M, 2012, BIOL OPEN, V1, P220, DOI 10.1242/bio.2012307; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	54	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32381	32393		10.1074/jbc.M112.393439	http://dx.doi.org/10.1074/jbc.M112.393439			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843697	Green Published, hybrid			2022-12-25	WOS:000309168300009
J	Richter, K; Burch, L; Chao, F; Henke, D; Jiang, CC; Daly, J; Zhao, ML; Kissling, G; Diaz, M				Richter, Kathleen; Burch, Lauranell; Chao, Frank; Henke, David; Jiang, Chuancang; Daly, Janssen; Zhao, Ming-Lang; Kissling, Grace; Diaz, Marilyn			Altered Pattern of Immunoglobulin Hypermutation in Mice Deficient in Slip-GC Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; ACTIVATION-INDUCED DEAMINASE; SWITCH DNA RECOMBINATION; SOMATIC HYPERMUTATION; B-CELLS; IG HYPERMUTATION; LUPUS NEPHRITIS; MRL/LPR MICE; AID; ANTIBODY	We recently identified a novel germinal center GTPase, SLIP-GC, that localizes to replication factories in B cells and that, when reduced, induces DNA breaks in lymphoma B cell lines in an activation-induced deaminase (AID)-dependent manner. Herein, we generated mice deficient in SLIP-GC and examined the impact of SLIP-GC deficiency in immunoglobulin hypermutation and class switch recombination, both AID-dependent mechanisms. SLIP-GC-deficient mice experienced a substantial increase in mutations at G:C base pairs at the region down-stream of JH4 in the immunoglobulin heavy chain locus. This change was reflected in the overall mutation frequency, and it was associated with an increase in transitions from G:C base pairs, a hallmark of AID-mediated deamination during replication. In addition, G:C transitions at non-immunoglobulin loci also increased in these mice. Given the intracellular localization of SLIP-GC to sites of replicating DNA, these results suggest that SLIP-GC protects replicating DNA from AID-mediated deamination of cytosines in both strands.	[Richter, Kathleen; Jiang, Chuancang; Daly, Janssen; Zhao, Ming-Lang; Diaz, Marilyn] NIEHS, Somat Hypermutat Grp, NIH, Res Triangle Pk, NC 27709 USA; [Burch, Lauranell; Chao, Frank; Henke, David] NIEHS, Mol Genet Core, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kissling, Grace] NIEHS, Biostat Branch, Environm Dis & Med Program, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Diaz, M (corresponding author), NIEHS, Somat Hypermutat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	diaz@niehs.nih.gov		Diaz, Marilyn/0000-0002-3046-2746	Division of Intramural Research of the National Institutes of Health through the NIEHS [Z01 ES101603]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425, ZIAES101603, ZICES102546, ZIAES103106] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institutes of Health through the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Project Z01 ES101603 from the Division of Intramural Research of the National Institutes of Health through the NIEHS (to M. D.).	Borchert GM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-347; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; Diaz M, 2005, TRENDS IMMUNOL, V26, P215, DOI 10.1016/j.it.2005.02.008; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hsu HC, 2007, J IMMUNOL, V178, P5357, DOI 10.4049/jimmunol.178.8.5357; Hsu HC, 2011, ARTHRITIS RHEUM-US, V63, P2038, DOI 10.1002/art.30257; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Jiang CC, 2011, ARTHRITIS RHEUM-US, V63, P1086, DOI 10.1002/art.30230; Jiang CC, 2009, IMMUNOLOGY, V126, P102, DOI 10.1111/j.1365-2567.2008.02882.x; KLINMAN NR, 1972, J EXP MED, V136, P241, DOI 10.1084/jem.136.2.241; Krijger PHL, 2009, J EXP MED, V206, P2603, DOI 10.1084/jem.20091707; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; McCall MN, 1999, BBA-GENE STRUCT EXPR, V1447, P43, DOI 10.1016/S0167-4781(99)00131-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Richter K, 2009, J BIOL CHEM, V284, P30652, DOI 10.1074/jbc.M109.014506; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Sabouri Z, 2009, INT IMMUNOL, V21, P947, DOI 10.1093/intimm/dxp061; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; White CA, 2011, AUTOIMMUNITY, V44, P585, DOI 10.3109/08916934.2011.577128; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zan H, 2008, MOL IMMUNOL, V46, P45, DOI 10.1016/j.molimm.2008.07.003; Zan H, 2009, AUTOIMMUNITY, V42, P89, DOI 10.1080/08916930802629554; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; ZIEGNER M, 1994, EUR J IMMUNOL, V24, P2393, DOI 10.1002/eji.1830241020	39	6	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31856	31865		10.1074/jbc.M112.340661	http://dx.doi.org/10.1074/jbc.M112.340661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833677	Green Published, hybrid			2022-12-25	WOS:000309059400026
J	Wennman, A; Jerneren, F; Hamberg, M; Oliw, EH				Wennman, Anneli; Jerneren, Fredrik; Hamberg, Mats; Oliw, Ernst H.			Catalytic Convergence of Manganese and Iron Lipoxygenases by Replacement of a Single Amino Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CHIRAL COLUMN CHROMATOGRAPHY; POSITIONAL SPECIFICITY; HUMAN 5-LIPOXYGENASE; ENANTIOMERIC SEPARATION; MASS-SPECTROMETRY; PROTEIN-STRUCTURE; PICHIA-PASTORIS; LINOLEIC-ACID; OXYGENATION	Lipoxygenases (LOXs) contain a hydrophobic substrate channel with the conserved Gly/Ala determinant of regio- and stereospecificity and a conserved Leu residue near the catalytic non-heme iron. Our goal was to study the importance of this region (Gly(332), Leu(336), and Phe(337)) of a lipoxygenase with catalytic manganese (13R-MnLOX). Recombinant 13R-MnLOX oxidizes 18:2n-6 and 18:3n-3 to 13R-, 11(S or R)-, and 9S-hydroperoxy metabolites (similar to 80-85, 15-20, and 2-3%, respectively) by suprafacial hydrogen abstraction and oxygenation. Replacement of Phe(337) with Ile changed the stereochemistry of the 13-hydroperoxy metabolites of 18:2n-6 and 18:3n-3 (from similar to 100% R to 69-74% S) with little effect on regiospecificity. The abstraction of the pro-S hydrogen of 18:2n-6 was retained, suggesting antarafacial hydrogen abstraction and oxygenation. Replacement of Leu(336) with smaller hydrophobic residues (Val, Ala, and Gly) shifted the oxygenation from C-13 toward C-9 with formation of 9S- and 9R-hydroperoxy metabolites of 18:2n-6 and 18:3n-3. Replacement of Gly(332) and Leu(336) with larger hydrophobic residues (G332A and L336F) selectively augmented dehydration of 13R-hydroperoxyoctadeca-9Z,11E,15Z-trienoic acid and increased the oxidation at C-13 of 18:1n-6. We conclude that hydrophobic replacements of Leu(336) can modify the hydroperoxide configurations at C-9 with little effect on the R configuration at C-13 of the 18:2n-6 and 18:3n-3 metabolites. Replacement of Phe(337) with Ile changed the stereospecific oxidation of 18:2n-6 and 18:3n-3 with formation of 13S-hydroperoxides by hydrogen abstraction and oxygenation in analogy with soybean LOX-1.	[Oliw, Ernst H.] Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Solna, Sweden	Uppsala University; Karolinska Institutet	Oliw, EH (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, Biomed Ctr, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se		Jerneren, Fredrik/0000-0003-0897-7177; Hamberg, Mats/0000-0002-8910-7810; Oliw, Ernst/0000-0002-7986-8130	Vetenskapsradet Grant [03X-06523]; SciLifeLab; Knut and Alice Wallenberg Foundation [KAW 2004.0123]	Vetenskapsradet Grant; SciLifeLab; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by Vetenskapsradet Grant 03X-06523, SciLifeLab, and Knut and Alice Wallenberg Foundation Grant KAW 2004.0123.	Andreou A, 2010, J BIOL CHEM, V285, P14178, DOI 10.1074/jbc.M109.094771; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Cheng HR, 2006, BIOTECHNOL LETT, V28, P55, DOI 10.1007/s10529-005-4688-z; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; GARDNER HW, 1989, BIOCHIM BIOPHYS ACTA, V1001, P274, DOI 10.1016/0005-2760(89)90111-2; Garreta A., 2011, RECENT ADV PHARM SCI, P247; Garscha U, 2008, J CHROMATOGR B, V872, P90, DOI 10.1016/j.jchromb.2008.07.013; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Goldsmith CR, 2006, INORG CHEM, V45, P6048, DOI 10.1021/ic060621e; Haas U, 2011, P NATL ACAD SCI USA, V108, P20479, DOI 10.1073/pnas.1117094108; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; HAMBERG M, 1971, ANAL BIOCHEM, V43, P515, DOI 10.1016/0003-2697(71)90282-X; Hamberg M, 2011, LIPIDS, V46, P201, DOI 10.1007/s11745-010-3510-4; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hornsten L, 2002, EUR J BIOCHEM, V269, P2690, DOI 10.1046/j.1432-1033.2002.02936.x; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; Hughes RK, 2001, EUR J BIOCHEM, V268, P1030, DOI 10.1046/j.1432-1327.2001.01964.x; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jansen C, 2011, J BIOL CHEM, V286, P37804, DOI 10.1074/jbc.M111.259242; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Leber A, 1999, J BIOL CHEM, V274, P37658, DOI 10.1074/jbc.274.53.37658; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; McClellan JE, 2002, ANAL CHEM, V74, P402, DOI 10.1021/ac015610b; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oliw EH, 2008, J LIPID RES, V49, P420, DOI 10.1194/jlr.M700514-JLR200; Oliw EH, 2011, BBA-MOL CELL BIOL L, V1811, P138, DOI 10.1016/j.bbalip.2010.12.002; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Rickert KW, 1999, BIOCHEMISTRY-US, V38, P12218, DOI 10.1021/bi990834y; Schneider C, 2007, METHOD ENZYMOL, V433, P145, DOI 10.1016/S0076-6879(07)33008-5; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwarz K, 2000, BIOCHEMISTRY-US, V39, P14515, DOI 10.1021/bi001447n; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Vicente J, 2012, MOL PLANT, V5, P914, DOI 10.1093/mp/ssr105; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182; Zheng YX, 2010, J BIOL CHEM, V285, P39876, DOI 10.1074/jbc.M110.180794; Zheng YX, 2010, J BIOL CHEM, V285, P39866, DOI 10.1074/jbc.M110.155374	52	18	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31757	31765		10.1074/jbc.M112.364331	http://dx.doi.org/10.1074/jbc.M112.364331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822060	hybrid, Green Published			2022-12-25	WOS:000309059400017
J	Apte-Deshpande, A; Paingankar, M; Gokhale, MD; Deobagkar, DN				Apte-Deshpande, Anjali; Paingankar, Mandar; Gokhale, Mangesh D.; Deobagkar, Dileep N.			Serratia odorifera a Midgut Inhabitant of Aedes aegypti Mosquito Enhances Its Susceptibility to Dengue-2 Virus	PLOS ONE			English	Article							ANOPHELES-STEPHENSI; SPOROGONIC DEVELOPMENT; PROTEOMICS ANALYSIS; BRUGIA-MALAYI; PROHIBITIN; BACTERIA; INFECTION; CELLS; CULICIDAE; PROTEINS	Mosquito midgut plays a crucial role in its vector susceptibility and pathogen interaction. Identification of the sustainable microflora of the midgut environment can therefore help in evaluating its contribution in mosquito-pathogen interaction and in turn vector competence. To understand the bacterial diversity in the midgut of Aedes aegypti mosquitoes, we conducted a screening study of the gut microbes of these mosquitoes which were either collected from fields or reared in the laboratory "culture-dependent'' approach. This work demonstrated that the microbial flora of larvae and adult Ae. aegypti midgut is complex and is dominated by Gram negative proteobacteria. Serratia odorifera was found to be stably associated in the midguts of field collected and laboratory reared larvae and adult females. The potential influence of this sustainable gut microbe on DENV-2 susceptibility of this vector was evaluated by co-feeding S. odorifera with DENV-2 to adult Ae. aegypti females (free of gut flora). The observations revealed that the viral susceptibility of these Aedes females enhanced significantly as compared to solely dengue-2 fed and another gut inhabitant, Microbacterium oxydans co-fed females. Based on the results of this study we proposed that the enhancement in the DENV-2 susceptibility of Ae. aegypti females was due to blocking of prohibitin molecule present on the midgut surface of these females by the polypeptide of gut inhabitant S. odorifera.	[Apte-Deshpande, Anjali; Paingankar, Mandar; Deobagkar, Dileep N.] Univ Pune, Ctr Adv Studies, Dept Zool, Mol Biol Res Lab, Pune, Maharashtra, India; [Gokhale, Mangesh D.] Natl Inst Virol, Dept Med Entomol & Zool, Pune, Maharashtra, India; [Deobagkar, Dileep N.] Goa Univ, Taleigaon Plateau, Goa, India	Savitribai Phule Pune University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Goa University	Apte-Deshpande, A (corresponding author), Univ Pune, Ctr Adv Studies, Dept Zool, Mol Biol Res Lab, Pune, Maharashtra, India.	dileep_deobagkar@hotmail.com	Paingankar, Mandar/H-9254-2019	Paingankar, Mandar/0000-0002-9359-1879	UGC-CAS; ICMR	UGC-CAS(University Grants Commission, IndiaChinese Academy of Sciences); ICMR(Indian Council of Medical Research (ICMR))	This research was supported by UGC-CAS and ICMR grants to Dileep Deobagkar. Mandar Paingankar is a CSIR Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnoult D, 2009, SEMIN IMMUNOL, V21, P223, DOI 10.1016/j.smim.2009.05.009; Artal-Sanz M, 2010, AGING-US, V2, P1004, DOI 10.18632/aging.100246; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Degallier N, 2010, CLIMATIC CHANGE, V98, P581, DOI 10.1007/s10584-009-9747-3; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gusamo DS, 2007, MEM I O CRUZ, V102, P919; ILKAL MA, 1984, INDIAN J MED RES, V79, P587; JADIN J, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P514; Joyce JD, 2011, J MED ENTOMOL, V48, P389, DOI 10.1603/ME09268; KAY BH, 1989, MED VET ENTOMOL, V3, P415, DOI 10.1111/j.1365-2915.1989.tb00249.x; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; MACDONALD WW, 1965, ANN TROP MED PARASIT, V59, P64, DOI 10.1080/00034983.1965.11686284; MACDONALD WW, 1962, ANN TROP MED PARASIT, V56, P368, DOI 10.1080/00034983.1962.11686134; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; MCGREEVY PB, 1974, ANN TROP MED PARASIT, V68, P97, DOI 10.1080/00034983.1974.11686929; Mishra S, 2007, MOL IMMUNOL, V44, P1897, DOI 10.1016/j.molimm.2006.09.025; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Mourya D. T., 2002, Dengue Bulletin, V26, P190; Mourya DT, 1998, INDIAN J MED RES, V107, P10; Mourya DT, 2000, INDIAN J MED RES, V111, P157; Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859; Paingankar MS, 2010, ARCH VIROL, V155, P1453, DOI 10.1007/s00705-010-0728-7; Patil NS, 1996, MED VET ENTOMOL, V10, P277, DOI 10.1111/j.1365-2915.1996.tb00743.x; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; SEITZ HM, 1987, ZBL BAKT-INT J MED M, V266, P155; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Toure AM, 2000, J MED ENTOMOL, V37, P246, DOI 10.1603/0022-2585-37.2.246; Tsutsumi T, 2009, HEPATOLOGY, V50, P378, DOI 10.1002/hep.22998; Wang JH, 2009, PROTEOMICS, V9, P1672, DOI 10.1002/pmic.200800621; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098	48	122	126	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40401	10.1371/journal.pone.0040401	http://dx.doi.org/10.1371/journal.pone.0040401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848375	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200017
J	Xiao, L; Li, ZY; Xu, PJ; Li, ZG; Xu, J; Yang, Z				Xiao, Lu; Li, Zhanyong; Xu, Pengjuan; Li, Zhigui; Xu, Jing; Yang, Zhuo			The Expression of EPOR in Renal Cortex during Postnatal Development	PLOS ONE			English	Article							ERYTHROPOIETIN ENHANCES RECOVERY; RECEPTOR; CELLS; PROTECTS; MOUSE; RAT; FAILURE; KIDNEY; INJURY; BRAIN	Erythropoietin (EPO), known for its role in erythroid differentiation, has been shown to be an important growth factor for brain and heart. EPO is synthesized by fibroblast-like cells in the renal cortex. Prompted by this anatomical relationship and its significant impact on the maturation process of brain and heart, we asked whether EPO could play a role during the development of renal cortex. The relationship between the development of renal cortex and the change of EPO receptor (EPOR), through which EPO could act as a renotropic cytokine, became interesting to us. In this study, the day of birth was recorded as postnatal day 0(P0). P7, P14, P21, P28, P35, P42 and mature mice (postnatal days. 56) were used as the animal model of different developmental stages. Immunohistochemistry and Western blotting were used to detect the expression of EPOR in mouse renal cortex. Results showed that expression of EPOR decreased with the development of renal cortex and became stable when kidney became mature. The expression of EPOR was detected at the renal tubule of all developmental stages and a relatively higher expression was observed at P14. However, at the renal corpuscle the expression was only observed at P7 and quickly became undetectable after that. All these suggested that a translocation of EPOR from renal corpuscle to renal tubule may take place during the developmental process of renal cortex. Also, EPO may be an essential element for the maturation of renal cortex, and the requirement for EPO was changed during postnatal development process.	[Xiao, Lu; Xu, Pengjuan; Li, Zhigui; Xu, Jing; Yang, Zhuo] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Li, Zhanyong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Yang, Z (corresponding author), Nankai Univ, Coll Med, Tianjin 300071, Peoples R China.	zhuoyang@nankai.edu.cn	Li, Zhigui/I-9108-2019; xu, jing/GRR-8698-2022; Jingjun, Xu/A-1282-2010	Li, Zhigui/0000-0003-1317-8679; 	National Basic Research Program of China [2011CB944003]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by a grant from the National Basic Research Program of China (2011CB944003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammarguellat F, 1996, NEPHROL DIAL TRANSPL, V11, P687, DOI 10.1093/oxfordjournals.ndt.a027361; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; BACALLAO R, 1989, AM J PHYSIOL, V257, pF913, DOI 10.1152/ajprenal.1989.257.6.F913; Bagnis C, 2001, NEPHROL DIAL TRANSPL, V16, P932, DOI 10.1093/ndt/16.5.932; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; EKBLOM P, 1981, J CELL BIOL, V91, P1, DOI 10.1083/jcb.91.1.1; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Juul SE, 1999, PEDIATR DEVEL PATHOL, V2, P148, DOI 10.1007/s100249900103; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; KOURY ST, 1991, BLOOD, V77, P2497; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Liu C, 1997, J BIOL CHEM, V272, P32395, DOI 10.1074/jbc.272.51.32395; MASUDA S, 1994, J BIOL CHEM, V269, P19488; NARBAITZ R, 1991, ANAT EMBRYOL, V183, P353; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Sasaki R, 2001, NEWS PHYSIOL SCI, V16, P110; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; Starck J, 1999, EXP HEMATOL, V27, P630, DOI 10.1016/S0301-472X(99)00006-5; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; VAZIRI ND, 1994, AM J PHYSIOL, V266, pF360, DOI 10.1152/ajprenal.1994.266.3.F360; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Westenfelder C, 1999, KIDNEY INT, V55, P808, DOI 10.1046/j.1523-1755.1999.055003808.x; Westenfelder C, 2002, EXP NEPHROL, V10, P294, DOI 10.1159/000065304; Wu H, 1999, DEVELOPMENT, V126, P3597; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223; Yu XB, 2002, DEVELOPMENT, V129, P505; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41993	10.1371/journal.pone.0041993	http://dx.doi.org/10.1371/journal.pone.0041993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844537	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600060
J	Chang, MY; Huang, DY; Ho, FM; Huang, KC; Lin, WW				Chang, Mei-Ying; Huang, Duen-Yi; Ho, Feng-Ming; Huang, Kuo-Chin; Lin, Wan-Wan			PKC-Dependent Human Monocyte Adhesion Requires AMPK and Syk Activation	PLOS ONE			English	Article							PROTEIN-KINASE-C; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; TYROSINE KINASES; PHOSPHORYLATION; EXPRESSION; PATHWAY; INHIBITION	PKC plays a pivotal role in mediating monocyte adhesion; however, the underlying mechanisms of PKC-mediated cell adhesion are still unclear. In this study, we elucidated the signaling network of phorbol ester PMA-stimulated human monocyte adhesion. Our results with pharmacological inhibitors suggested the involvement of AMPK, Syk, Src and ERK in PKC-dependent adhesion of THP-1 monocytes to culture plates. Biochemical analysis further confirmed the ability of PMA to activate these kinases, as well as the involvement of AMPK-Syk-Src signaling in this event. Direct protein interaction between AMPK and Syk, which requires the kinase domain of AMPK and linker region of Syk, was observed following PMA stimulation. Notably, we identified Syk as a novel downstream target of AMPK; AICAR can induce Syk phosphorylation at Ser178 and activation of this kinase. However, activation of AMPK alone, either by stimulation with AICAR or by overexpression, is not sufficient to induce monocyte adhesion. Studies further demonstrated that PKC-mediated ERK signaling independent of AMPK activation is also involved in cell adhesion. Moreover, AMPK, Syk, Src and ERK signaling were also required for PMA to induce THP-1 cell adhesion to endothelial cells as well as to induce adhesion response of human primary monocytes. Taken together, we propose a bifurcated kinase signaling pathway involved in PMA-mediated adhesion of monocytes. PKC can activate LKB1/AMPK, leading to phosphorylation and activation of Syk, and subsequent activation of Src and FAK. In addition, PKC-dependent ERK activation induces a coordinated signal for cytoskeleton rearrangement and cell adhesion. For the first time we demonstrate Syk as a novel substrate target of AMPK, and shed new light on the role of AMPK in monocyte adhesion, in addition to its well identified functions in energy homeostasis.	[Chang, Mei-Ying; Huang, Duen-Yi; Lin, Wan-Wan] Natl Taiwan Univ, Dept Pharmacol, Coll Med, Taipei 10764, Taiwan; [Ho, Feng-Ming] Tao Yuan Gen Hosp, Dept Internal Med, Dept Hlth Execut Yuan, Tao Yuan, Taiwan; [Ho, Feng-Ming] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Huang, Kuo-Chin] Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Wan-Wan] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	National Taiwan University; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Chang, MY (corresponding author), Natl Taiwan Univ, Dept Pharmacol, Coll Med, Taipei 10764, Taiwan.	wwllaura1119@ntu.edu.tw		Lin, Wan Wan/0000-0002-3207-734X; HUANG, KUO-CHIN/0000-0002-6029-5520	National Science Council [NSC 100-2314-B-002-075]; National Health Research Institute, Taiwan [NHRI-EX100-10052SI];  [PTH9801]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); 	This work was supported by the National Science Council (NSC 100-2314-B-002-075), the National Health Research Institute, Taiwan (NHRI-EX100-10052SI) and PTH9801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2007, IMMUNOL REV, V218, P29, DOI 10.1111/j.1600-065X.2007.00531.x; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Borowski P, 1998, BIOCHEM J, V331, P649, DOI 10.1042/bj3310649; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chang MY, 2010, BIOCHEM PHARMACOL, V80, P1210, DOI 10.1016/j.bcp.2010.06.049; Ewart MA, 2008, ARTERIOSCL THROM VAS, V28, P2255, DOI 10.1161/ATVBAHA.108.175919; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Hai CM, 2006, EUR J CELL BIOL, V85, P305, DOI 10.1016/j.ejcb.2005.08.008; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Kurihara Y, 2011, CELL IMMUNOL, V270, P25, DOI 10.1016/j.cellimm.2011.03.017; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Pullikuth AK, 2010, MOL CELL BIOL, V30, P3233, DOI 10.1128/MCB.01178-09; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsai JS, 2010, J CELL BIOCHEM, V110, P1410, DOI 10.1002/jcb.22657; Wang YH, 2009, EUR J CELL BIOL, V88, P701, DOI 10.1016/j.ejcb.2009.06.001; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yang RS, 2005, TOXICON, V46, P387, DOI 10.1016/j.toxicon.2005.05.002; Zarbock A, 2011, ARCH BIOCHEM BIOPHYS, V510, P112, DOI 10.1016/j.abb.2011.02.009; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	45	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40999	10.1371/journal.pone.0040999	http://dx.doi.org/10.1371/journal.pone.0040999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848421	gold, Green Submitted, Green Published			2022-12-25	WOS:000306806600033
J	Blanc, P; Coste, K; Pouchin, P; Azais, JM; Blanchon, L; Gallot, D; Sapin, V				Blanc, Pierre; Coste, Karen; Pouchin, Pierre; Azais, Jean-Marc; Blanchon, Loic; Gallot, Denis; Sapin, Vincent			A Role for Mesenchyme Dynamics in Mouse Lung Branching Morphogenesis	PLOS ONE			English	Article							FGF10 EXPRESSION; ARCHITECTURE; MECHANISMS; FORCE; MODEL; GROWTH	Mammalian airways are highly ramified tree-like structures that develop by the repetitive branching of the lung epithelium into the surrounding mesenchyme through reciprocal interactions. Based on a morphometric analysis of the epithelial tree, it has been recently proposed that the complete branching scheme is specified early in each lineage by a programme using elementary patterning routines at specific sites and times in the developing lung. However, the coupled dynamics of both the epithelium and mesenchyme have been overlooked in this process. Using a qualitative and quantitative in vivo morphometric analysis of the E11.25 to E13.5 mouse whole right cranial lobe structure, we show that beyond the first generations, the branching stereotypy relaxes and both spatial and temporal variations are common. The branching pattern and branching rate are sensitive to the dynamic changes of the mesoderm shape that is in turn mainly dependent upon the volume and shape of the surrounding intrathoracic organs. Spatial and temporal variations of the tree architecture are related to local and subtle modifications of the mesoderm growth. Remarkably, buds never meet after suffering branching variations and continue to homogenously fill the opening spaces in the mesenchyme. Moreover despite inter-specimen variations, the growth of the epithelial tree and the mesenchyme remains highly correlated over time at the whole lobe level, implying a long-range regulation of the lung lobe morphogenesis. Together, these findings indicate that the lung epithelial tree is likely to adapt in real time to fill the available space in the mesenchyme, rather than being rigidly specified and predefined by a global programme. Our results strongly support the idea that a comprehensive understanding of lung branching mechanisms cannot be inferred from the branching pattern or behavior alone. Rather it needs to be elaborated upon with the reconsideration of mesenchyme-epithelium coupled growth and lung tissues mechanics.	[Blanc, Pierre; Coste, Karen; Blanchon, Loic; Gallot, Denis; Sapin, Vincent] Auvergne Univ, Sch Med, Retinoids Dev & Dev Dis EA 7281, Clermont Ferrand, France; [Blanc, Pierre; Sapin, Vincent] Univ Hosp, Dept Biochem & Mol Biol, Clermont Ferrand, France; [Pouchin, Pierre] Clermont Univ, UMR, INSERM 1103, CNRS 6247,GReD, Clermont Ferrand, France; [Azais, Jean-Marc] Univ Toulouse 3, Math Inst, F-31062 Toulouse, France; [Coste, Karen] Univ Hosp, Dept Pediat, Clermont Ferrand, France; [Gallot, Denis] Univ Hosp, Dept Obstet, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); Universite de Franche-Comte; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Clermont Ferrand; CHU Clermont Ferrand	Blanc, P (corresponding author), Auvergne Univ, Sch Med, Retinoids Dev & Dev Dis EA 7281, Clermont Ferrand, France.	pblanc@chu-clermontferrand.fr	Pouchin, Pierre/P-5954-2016	Pouchin, Pierre/0000-0003-3858-3152; Coste, Karen/0000-0003-0429-6964; BLANC, Pierre/0000-0003-3802-0923; BLANCHON, LOIC/0000-0001-8842-0162	Auvergne University; Medecine School of Clermont-Ferrand; University Hospital of Clermont-ferrand	Auvergne University; Medecine School of Clermont-Ferrand; University Hospital of Clermont-ferrand	This research was supported by the Auvergne University, the Medecine School of Clermont-Ferrand and the University Hospital of Clermont-ferrand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bejan A., 2000, SHAPE STRUCTURE ENG; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Florens M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178104; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j; Hirashima T, 2009, DEV DYNAM, V238, P2813, DOI 10.1002/dvdy.22108; Kojic N, 2010, BIOPHYS J, V99, P3517, DOI 10.1016/j.bpj.2010.09.044; Lai-Fook SJ, 2004, PHYSIOL REV, V84, P385, DOI 10.1152/physrev.00026.2003; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Lozoya OA, 2012, J BIOMECH, V45, P319, DOI 10.1016/j.jbiomech.2011.10.013; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lubkin SR, 2002, BIOMECH MODEL MECHAN, V1, P5, DOI 10.1007/s10237-002-0001-4; Lubkin SR, 2008, CURR TOP DEV BIOL, V81, P249, DOI 10.1016/S0070-2153(07)81008-8; LUBKIN SR, 1995, J MATH BIOL, V34, P77, DOI 10.1007/BF00180137; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Menshykau D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002377; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Miura T, 2002, MECH DEVELOP, V116, P29, DOI 10.1016/S0925-4773(02)00132-6; Miura T, 2009, MECH DEVELOP, V126, P160, DOI 10.1016/j.mod.2008.11.006; Miura T, 2008, CURR TOP DEV BIOL, V81, P291, DOI 10.1016/S0070-2153(07)81010-6; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelson CM, 2009, BBA-MOL CELL RES, V1793, P903, DOI 10.1016/j.bbamcr.2008.12.014; Peralta CFA, 2006, ULTRASOUND OBST GYN, V27, P551, DOI 10.1002/uog.2752; Reis AH, 2004, MED PHYS, V31, P1135, DOI 10.1118/1.1705443; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Tebockhorst S, 2007, J APPL PHYSIOL, V102, P294, DOI 10.1152/japplphysiol.00665.2006; Tschumperlin DJ, 2010, J BIOMECH, V43, P99, DOI 10.1016/j.jbiomech.2009.09.015; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Tuysuz B, 2009, AM J MED GENET A, V149A, P1727, DOI 10.1002/ajmg.a.32962; Unbekandt M, 2008, MECH DEVELOP, V125, P314, DOI 10.1016/j.mod.2007.10.013; VILOS G A, 1982, Journal of Developmental Physiology (Eynsham), V4, P247; Wan XH, 2008, BIOMECH MODEL MECHAN, V7, P417, DOI 10.1007/s10237-007-0105-y; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Warburton D, 2008, NATURE, V453, P733, DOI 10.1038/453733a; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009; Yinon Y, 2008, BEST PRACT RES CL OB, V22, P77, DOI 10.1016/j.bpobgyn.2007.09.004; Zhao XY, 2009, SURG RADIOL ANAT, V31, P85, DOI 10.1007/s00276-008-0404-8	45	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41643	10.1371/journal.pone.0041643	http://dx.doi.org/10.1371/journal.pone.0041643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844507	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700132
J	Chen, F; Feng, YM; Zheng, KE; De Keyzer, F; Li, JJ; Feng, YB; Cona, MM; Wang, HJ; Jiang, YS; Yu, J; Marchal, G; Verfaillie, C; De Geest, B; Oyen, R; Ni, YC				Chen, Feng; Feng, Yingmei; Zheng, Kaier; De Keyzer, Frederik; Li, Junjie; Feng, Yuanbo; Cona, Marlein Miranda; Wang, Huaijun; Jiang, Yansheng; Yu, Jie; Marchal, Guy; Verfaillie, Catherine; De Geest, Bart; Oyen, Raymond; Ni, Yicheng			Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; COMBRETASTATIN A-4; CLINICAL MRI; SOLID TUMORS; THALIDOMIDE; THERAPY; CANCER; ANGIOGENESIS; MICROANGIOGRAPHY; NORMALIZATION	A key problem in solid tumor therapy is tumor regrowth from a residual viable rim after treatment with a vascular disrupting agent (VDA). As a potential solution, we studied a combined treatment of a VDA and antiangiogenic. This study was approved by the institutional ethical committee for the use and care of laboratory animals. Rats with implanted liver tumors were randomized into four treatment groups: 1) Zd6126 (Zd); 2) Thalidomide (Tha); 3) Zd in combination with Tha (ZdTha); and 4) controls. Multiparametric MRIs were performed and quantified before and after treatment. Circulating endothelial progenitor cells (EPCs) and plasma stromal cell-derived factor-1 alpha (SDF-1 alpha) were monitored. Tumor apoptosis, necrosis, and microvessels were verified by histopathology. A single use of Zd or Tha did not significantly delay tumor growth. The combined ZdTha showed enhanced antitumor efficacy due to synergistic effects; it induced a cumulative tumor apoptosis or necrosis, which resulted in significant delay in tumor growth and reduction in the viable tumor rim; it also reduced tumor vessel permeability; and it improved tumor hemodynamic indexes, most likely via a transient normalization of tumor vasculature induced by Tha. A stepwise linear regression analysis showed that the apparent diffusion coefficient was an independent predictor of tumor growth. We found no significant increases in Zd-induced circulating EPCs or plasma SDF-1 alpha. ZdTha showed improved therapeutic efficacy in solid tumors compared to either agent alone. The therapeutic effects were successfully tracked in vivo with multiparametric MRI.	[Chen, Feng; De Keyzer, Frederik; Li, Junjie; Feng, Yuanbo; Cona, Marlein Miranda; Wang, Huaijun; Jiang, Yansheng; Yu, Jie; Marchal, Guy; Oyen, Raymond; Ni, Yicheng] Katholieke Univ Leuven, Univ Hosp, Theragnost Lab, Dept Imaging & Pathol, Louvain, Belgium; [Chen, Feng] Southeast Univ, Zhong Da Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Feng, Yingmei; Verfaillie, Catherine] Katholieke Univ Leuven, Interdept Stem Cell Inst, Louvain, Belgium; [Zheng, Kaier] Nanjing Med Univ, Dept Radiol, BenQ Med Ctr, Nanjing, Jiangsu, Peoples R China; [De Geest, Bart] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium	KU Leuven; Southeast University - China; KU Leuven; Nanjing Medical University; KU Leuven	Chen, F (corresponding author), Katholieke Univ Leuven, Univ Hosp, Theragnost Lab, Dept Imaging & Pathol, Louvain, Belgium.	feng.chen@med.kuleuven.be	Wang, Huaijun/F-3219-2015; De Keyzer, Frederik/U-7175-2019; De Geest, Bart/AHB-0394-2022; Ni, Yicheng/O-5887-2017; Verfaillie, Catherine/H-5148-2013	Wang, Huaijun/0000-0003-0078-5592; Ni, Yicheng/0000-0002-8553-7565; De Geest, Bart/0000-0001-5580-686X; Verfaillie, Catherine/0000-0001-7564-4079	National Natural Science Foundation of China (NSFC) [30670603]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Natural Science Foundation of China (NSFC) project 30670603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansiaux R, 2005, CLIN CANCER RES, V11, P743; Blakey DC, 2002, INT J RADIAT ONCOL, V54, P1497, DOI 10.1016/S0360-3016(02)03922-6; Chen F, 2006, RADIOLOGY, V239, P554, DOI 10.1148/radiol.2392050277; Chen F, 2007, METHODS, V43, P12, DOI 10.1016/j.ymeth.2007.03.007; Chen F, 2011, METHODS MOL BIOL, V771, P489, DOI 10.1007/978-1-61779-219-9_26; Dachs GU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-280; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Dark GG, 1997, CANCER RES, V57, P1829; DENEKAMP J, 1982, BRIT J CANCER, V46, P711, DOI 10.1038/bjc.1982.263; Feng Y, 2008, ARTERIOSCL THROM VAS, V28, P278, DOI 10.1161/ATVBAHA.107.158741; Figg WD, 2007, BJU INT, V99, P1047, DOI 10.1111/j.1464-410X.2007.06763.x; Freter CE, 2008, ABELOFFS CLIN ONCOLO, P449; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kanthou C, 2009, INT J EXP PATHOL, V90, P284, DOI 10.1111/j.1365-2613.2009.00651.x; Kiessling F, 2007, EUR RADIOL, V17, P2136, DOI 10.1007/s00330-006-0566-x; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kivivuori SM, 2011, ACTA PAEDIATR, V100, P134, DOI 10.1111/j.1651-2227.2010.01961.x; Kobayashi H, 2010, LANCET ONCOL, V11, P589, DOI 10.1016/S1470-2045(10)70009-7; Lang P, 1998, RADIOLOGY, V206, P227, DOI 10.1148/radiology.206.1.9423677; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Rajkumar SV, 2000, CANCER TREAT REV, V26, P351, DOI 10.1053/ctrv.2000.0188; Reck M, 2010, NAT REV CLIN ONCOL, V7, P134, DOI 10.1038/nrclinonc.2010.11; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shaked Y, 2009, CANCER RES, V69, P7524, DOI 10.1158/0008-5472.CAN-09-0381; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Siemann DW, 2004, INT J RADIAT ONCOL, V60, P1233, DOI 10.1016/j.ijrobp.2004.08.002; Sleijfer S, 2004, EUR J CANCER, V40, P2377, DOI 10.1016/j.ejca.2004.07.023; Thoeny HC, 2005, NEOPLASIA, V7, P779, DOI 10.1593/neo.04748; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; van Heeckeren WJ, 2007, CURR OPIN HEMATOL, V14, P468, DOI 10.1097/MOH.0b013e3282a6457f; Wang HJ, 2009, INVEST RADIOL, V44, P44, DOI 10.1097/RLI.0b013e31818e5ace; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8	37	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41140	10.1371/journal.pone.0041140	http://dx.doi.org/10.1371/journal.pone.0041140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815943	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900079
J	Hogel, M; Laprairie, RB; Denovan-Wright, EM				Hogel, Matthew; Laprairie, Robert B.; Denovan-Wright, Eileen M.			Promoters Are Differentially Sensitive to N-Terminal Mutant Huntingtin-Mediated Transcriptional Repression	PLOS ONE			English	Article							MOUSE MODEL; DISEASE PROTEIN; BINDING PROTEIN; EXPRESSION; CLEAVAGE; NUCLEAR; AGE; LOCALIZATION; DYSFUNCTION; INTERACTS	Huntington's disease (HD) is a neurodegenerative disorder caused by the inheritance of one mutant copy of the huntingtin gene. Mutant huntingtin protein (mHtt) contains an expanded polyglutamine repeat region near the N-terminus. Cleavage of mHtt releases an N-terminal fragment (N-mHtt) which accumulates in the nucleus. Nuclear accumulation of N-mHtt has been directly associated with cellular toxicity. Decreased transcription is among the earliest detected changes that occur in the brains of HD patients, animal and cellular models of HD. Transcriptional dysregulation may trigger many of the perturbations that occur later in disease progression. An understanding of the effects of mHtt may lead to strategies to slow the progression of HD. Current models of N-mHtt-mediated transcriptional dysregulation suggest that abnormal interactions between N-mHtt and transcription factors impair the ability of these transcription factors to associate at N-mHtt-affected promoters and properly regulate gene expression. We tested various aspects of the current models using two N-mHtt-affected promoters in two cell models of HD using overexpression of known N-mHtt-interacting transcription factors, promoter deletion and mutation analyses and in vitro promoter binding assays. Consequently, we proposed a new model of N-mHtt-mediated transcriptional dysregulation centered on the presence of N-mHtt at promoters. In this model, N-mHtt interacts with multiple partners whose presence and affinity for N-mHtt influence the severity of gene dysregulation. We concluded that simultaneous interaction of N-mHtt with multiple binding partners within the transcriptional machinery would explain the gene-specificity of N-mHtt-mediated transcriptional dysregulation, as well as why some genes are affected early in disease progression while others are affected later. Our model explains why alleviating N-mHtt-mediated transcriptional dysregulation through overexpression of N-mHtt-interacting proteins has proven to be difficult and suggests that the most realistic strategy for restoring gene expression across the spectrum of N-mHtt affected genes is by reducing the amount of soluble nuclear N-mHtt.	[Hogel, Matthew; Laprairie, Robert B.; Denovan-Wright, Eileen M.] Dalhousie Univ, Dept Pharmacol, Mol Neurobiol Lab, Halifax, NS B3H 4H7, Canada	Dalhousie University	Hogel, M (corresponding author), Dalhousie Univ, Dept Pharmacol, Mol Neurobiol Lab, Halifax, NS B3H 4H7, Canada.	emdenova@dal.ca		Hogel, Matthew/0000-0002-1193-1746	Nova Scotia Health Research Foundation [42673]; Canadian Institutes of Health Research [42337]; Huntington Society of Canada [42721]	Nova Scotia Health Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Huntington Society of Canada	Funding was provided by the Nova Scotia Health Research Foundation (Grant No. 42673), http://www.nshrf.ca/; the Canadian Institutes of Health Research (Grant No. 42337), http://www.cihr-irsc.gc.ca/e/193.html; and the Huntington Society of Canada (Grant No. 42721), http://www.huntingtonsociety.ca/english/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS P, 1988, AM J HUM GENET, V43, P695; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Chiang MC, 2005, J BIOL CHEM, V280, P14331, DOI 10.1074/jbc.M413279200; Chiang MC, 2007, HUM MOL GENET, V16, P483, DOI 10.1093/hmg/ddl481; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Foroud T, 1999, J NEUROL NEUROSUR PS, V66, P52, DOI 10.1136/jnnp.66.1.52; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gomez GT, 2006, MOL CELL NEUROSCI, V31, P661, DOI 10.1016/j.mcn.2005.12.004; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hodges A, 2008, GENES BRAIN BEHAV, V7, P288, DOI 10.1111/j.1601-183X.2007.00350.x; Hu H, 2007, THESIS HALIFAX; Lebedeva LA, 2005, P NATL ACAD SCI USA, V102, P18087, DOI 10.1073/pnas.0509063102; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Li SH, 2000, HUM MOL GENET, V9, P2859, DOI 10.1093/hmg/9.19.2859; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P375, DOI 10.1111/j.1469-1809.1981.tb00351.x; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x	41	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41152	10.1371/journal.pone.0041152	http://dx.doi.org/10.1371/journal.pone.0041152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815947	Green Published, gold, Green Submitted			2022-12-25	WOS:000306548900082
J	Jean, K; Anglaret, X; Moh, R; Lert, F; Dray-Spira, R				Jean, Kevin; Anglaret, Xavier; Moh, Raoul; Lert, France; Dray-Spira, Rosemary			Barriers to HIV Testing in Cote d'Ivoire: The Role of Individual Characteristics and Testing Modalities	PLOS ONE			English	Article							OPT-OUT; PREVENTION; TRANSMISSION; SEROSTATUS; COUNTRIES; SERVICES; CARE	Background: Expanding HIV testing requires a better understanding of barriers to its uptake. We investigated barriers to HIV testing in Cote d'Ivoire, taking into account test circumstances (client vs. provider-initiated). Methods: We used data from the 2005 nationally representative Demographic and Health Survey conducted in Cote d'Ivoire. Socio-demographic characteristics, sexual behaviour and knowledge and attitudes toward HIV/AIDS associated with recent (<2 years) HIV testing were identified using gender-specific univariate and multivariate logistic regressions. Among women, differential effects of barriers to testing according to test circumstance (whether they have been offered for a prenatal test or not) were assessed through interaction tests. Results: Recent HIV testing was reported by 6.1% of men and 9.5% of women (including 4.6% as part of antenatal care). Among men, having a low socioeconomic status, having a low HIV-related knowledge level and being employed [ compared to those inactive: adjusted Odds Ratio (aOR) 0.46; 95% confidence interval (CI) 0.25-0.87] were associated with lower proportions of recent HIV testing. Among women without a prenatal HIV testing offer, living outside the capital (aOR 0.38; CI 0.19-0.77) and reporting a unique lifetime sexual partner constituted additional barriers to HIV testing. By contrast, among women recently offered to be tested in prenatal care, none of these variables was found to be associated with recent HIV testing. Conclusions: Various dimensions of individuals' characteristics constituted significant barriers to HIV testing in Cote d'Ivoire in 2005, with gender specificities. Such barriers are substantially reduced when testing was proposed in the framework of antenatal care. This suggests that provider-initiated testing strategies may help overcome individual barriers to HIV testing.	[Jean, Kevin; Lert, France; Dray-Spira, Rosemary] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Jean, Kevin; Lert, France; Dray-Spira, Rosemary] Univ Versailles St Quentin, UMRS 1018, Villejuif, France; [Anglaret, Xavier] Univ Bordeaux Segalen, INSERM, U897, Bordeaux, France; [Anglaret, Xavier; Moh, Raoul] CHU Treichville, PAC CI Program, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Jean, K (corresponding author), INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France.	kevin.jean@inserm.fr	Anglaret, Xavier/F-7333-2013; Anglaret, Xavier/T-2757-2019; Jean, Kevin/ABA-6355-2020	Jean, Kevin/0000-0001-6462-7185; Anglaret, Xavier/0000-0003-3319-8423; Moh, Desmorys Raoul/0000-0002-1678-3340; Dray-Spira, Rosemary/0000-0001-7646-3667	EHESP (Ecole des Hautes Etudes en Sante Publique)-School of Public Heath, Rennes, France	EHESP (Ecole des Hautes Etudes en Sante Publique)-School of Public Heath, Rennes, France	Kevin Jean is the recipient of a PhD grant from the EHESP (Ecole des Hautes Etudes en Sante Publique)-School of Public Heath, Rennes, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], SAMPL MAN; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Coffie PA, 2011, JAIDS-J ACQ IMM DEF, V57, pS3, DOI 10.1097/QAI.0b013e31821ea539; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Conseil National de Lutte contre le SIDA Republique de Cote d'Ivoire, 2011, PLAN STRAT NAT LUTT; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Cremin I, 2009, PATTERNS UPTAKE HIV; Cremin I, 2010, AIDS BEHAV, V14, P708, DOI 10.1007/s10461-009-9592-4; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; De Cock KM, 2003, LANCET, V362, P1847, DOI 10.1016/S0140-6736(03)14906-9; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinstead OA, 2001, AIDS, V15, P1045, DOI 10.1097/00002030-200105250-00013; Hendriksen ES, 2009, AIDS BEHAV, V13, P1213, DOI 10.1007/s10461-009-9608-0; Institut National de la Statistique (INS) & Ministere de la Lutte contre le Sida [Cote d'Ivoire] & ORC Macro, 2006, AIDS IND SURV COT IV; Koku EF, 2011, J COMMUN HEALTH, V36, P289, DOI 10.1007/s10900-010-9310-1; Mitchell S, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-23; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Mutale W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-347; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Peltzer K, 2010, AIDS BEHAV, V14, P1115, DOI 10.1007/s10461-009-9662-7; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Perez F, 2006, JAIDS-J ACQ IMM DEF, V41, P514, DOI 10.1097/01.qai.0000191285.70331.a0; Rutstein SO., 2004, DHS COMP REPORTS DHS; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2000, NATL AIDS PROGRAMMES; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Wringe A, 2008, TROP MED INT HEALTH, V13, P319, DOI 10.1111/j.1365-3156.2008.02005.x; Young SD, 2010, J ACQUIR IMMUNE DEFI	39	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41353	10.1371/journal.pone.0041353	http://dx.doi.org/10.1371/journal.pone.0041353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815995	Green Published, gold, Green Submitted			2022-12-25	WOS:000306548900113
J	Ni, KF; Zhou, X; Zhao, L; Wang, HL; Ren, YH; Wei, DZ				Ni, Kefeng; Zhou, Xu; Zhao, Li; Wang, Hualei; Ren, Yuhong; Wei, Dongzhi			Magnetic Catechol-Chitosan with Bioinspired Adhesive Surface: Preparation and Immobilization of omega-Transaminase	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; FE3O4-CHITOSAN NANOPARTICLES; CROSS-LINKING; MEMBRANES	The magnetic chitosan nanocomposites have been studied intensively and been used practically in various biomedical and biological applications including enzyme immobilization. However, the loading capacity and the remained activity of immobilized enzyme based on existing approaches are not satisfied. Simpler and more effective immobilization strategies are needed. Here we report a simple catechol modified protocol for preparing a novel catechol-chitosan (CCS) - iron oxide nanoparticles (IONPs) composites carrying adhesive moieties with strong surface affinity. The omega-transaminase (omega-TA) was immobilized onto this magnetic composite via nucleophilic reactions between catechol and omega-TA. Under optimal conditions, 87.5% of the available omega-TA was immobilized on the composite, yielding an enzyme loading capacity as high as 681.7 mg/g. Furthermore, the valuation of enzyme activity showed that omega-TA immobilized on CCS-IONPs displayed enhanced pH and thermal stability compared to free enzyme. Importantly, the immobilized omega-TA retained more than 50% of its initial activity after 15 repeated reaction cycles using magnetic separation and 61.5% of its initial activity after storage at 4 degrees C in phosphate buffered saline (PBS) for 15 days. The results suggested that such adhesive magnetic composites may provide an improved platform technology for bio-macromolecules immobilized.	[Ni, Kefeng; Zhou, Xu; Zhao, Li; Wang, Hualei; Ren, Yuhong; Wei, Dongzhi] E China Univ Sci & Technol, New World Inst Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ni, KF (corresponding author), E China Univ Sci & Technol, New World Inst Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	yhren@ecust.edu.cn; dzhwei@ecust.edu.cn	Wei, Dongzhi/AAJ-3404-2021		National Natural Foundation of China [21076079]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funding Project of the State Key Laboratory of Bioreactor Engineering	This work was supported by The National Natural Foundation of China (NO.21076079), and Open Funding Project of the State Key Laboratory of Bioreactor Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Desbrieres J, 1996, INT J BIOL MACROMOL, V19, P21, DOI 10.1016/0141-8130(96)01095-1; Orrego CE, 2009, CATAL LETT, V129, P312, DOI 10.1007/s10562-009-9857-6; Ge YQ, 2009, NANOSCALE RES LETT, V4, P287, DOI 10.1007/s11671-008-9239-9; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Jiang YY, 2009, J MOL CATAL B-ENZYM, V58, P103, DOI 10.1016/j.molcatb.2008.12.001; Kaushika A, 2008, BIOSENS BIOELECTRON, V24, P676, DOI 10.1016/j.bios.2008.06.032; Kim JY, 2003, INT J BIOL MACROMOL, V32, P23, DOI 10.1016/S0141-8130(03)00021-7; Koszelewski D, 2010, TRENDS BIOTECHNOL, V28, P324, DOI 10.1016/j.tibtech.2010.03.003; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222; Orrego CE, 2010, CARBOHYD POLYM, V79, P9, DOI 10.1016/j.carbpol.2009.06.015; Orrego CE, 2009, BIOPROC BIOSYST ENG, V32, P197, DOI 10.1007/s00449-008-0237-1; Stepanow S, 2004, J PHYS CHEM B, V108, P19392, DOI 10.1021/jp046766t; Tran HV, 2010, MAT SCI ENG C-MATER, V30, P304, DOI 10.1016/j.msec.2009.11.008; Truppo MD, 2010, ORG PROCESS RES DEV, V14, P234, DOI 10.1021/op900303q; Wu Y, 2009, BIORESOURCE TECHNOL, V100, P3459, DOI 10.1016/j.biortech.2009.02.018; Yi SS, 2007, PROCESS BIOCHEM, V42, P895, DOI 10.1016/j.procbio.2007.01.008; Yuan Q, 2008, ACTA BIOMATER, V4, P1024, DOI 10.1016/j.actbio.2008.02.002; Zhang LY, 2010, CURR APPL PHYS, V10, P828, DOI 10.1016/j.cap.2009.10.002; Zhao DL, 2009, J ALLOY COMPD, V477, P739, DOI 10.1016/j.jallcom.2008.10.104; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zhu LZ, 2009, COLLOID SURFACE B, V68, P1, DOI 10.1016/j.colsurfb.2008.07.020	24	27	29	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41101	10.1371/journal.pone.0041101	http://dx.doi.org/10.1371/journal.pone.0041101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815930	Green Published, Green Submitted, gold			2022-12-25	WOS:000306507000066
J	Benktander, J; Angstrom, J; Breimer, ME; Teneberg, S				Benktander, John; Angstrom, Jonas; Breimer, Michael E.; Teneberg, Susann			Redefinition of the Carbohydrate Binding Specificity of Helicobacter pylori BabA Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP-A; HUMAN SMALL-INTESTINE; MASS-SPECTROMETRY; GROUP ANTIGENS; GLYCOSPHINGOLIPIDS; EXPRESSION; DETERMINANTS; GLYCOLIPIDS; ABH; OLIGOSACCHARIDES	Certain Helicobacter pylori strains adhere to the human gastric epithelium using the blood group antigen-binding adhesin (BabA). All BabA-expressing H. pylori strains bind to the blood group O determinants on type 1 core chains, i.e. to the Lewis b antigen (Fuc alpha 2Gal beta 3(Fuc alpha 4) GlcNAc; Le(b)) and the H type 1 determinant (Fuc alpha 2Gal beta 3GlcNAc). Recently, BabA strains have been categorized into those recognizing only Le(b) and H type 1 determinants (designated specialist strains) and those that also bind to A and B type 1 determinants (designated generalist strains). Here, the structural requirements for carbohydrate recognition by generalist and specialist BabA were further explored by binding of these types of strains to a panel of different glycosphingolipids. Three glycosphingolipids recognized by both specialist and generalist BabA were isolated from the small intestine of a blood group O pig and characterized by mass spectrometry and proton NMR as H type 1 pentaglycosylceramide (Fuc alpha 2Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer), Globo H hexaglycosylceramide (Fuc alpha 2Gal beta 3GalNAc beta 3Gal alpha 4Gal beta 4Glc beta 1Cer), and a mixture of three complex glycosphingolipids (Fuc alpha 2Gal beta 4GlcNAc beta 6(Fuc alpha 2Gal beta 3GlcNAc beta 3)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer, Fuc alpha 2Gal beta 3GlcNAc beta 6(Fuc alpha 2Gal beta 3GlcNAc beta 3)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer, and Fuc alpha 2Gal beta 4(Fuc alpha 3)GlcNAc beta 6(Fuc alpha 2Gal beta 3GlcNAc beta 3)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer). In addition to the binding of both strains to the Globo H hexaglycosylceramide, i.e. a blood group O determinant on a type 4 core chain, the generalist strain bound to the Globo A heptaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GalNAc beta 3Gal alpha 4Gal beta 4Glc beta 1Cer), i.e. a blood groupAdeterminant on a type 4 core chain. The binding of BabA to the two sets of isoreceptors is due to conformational similarities of the terminal disaccharides of H type 1 and Globo H and of the terminal trisaccharides of A type 1 and Globo A.	[Benktander, John; Angstrom, Jonas; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, S-40530 Gothenburg, Sweden; [Breimer, Michael E.] Sahlgrens Univ Hosp, Dept Surg, S-41345 Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Teneberg, S (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, POB 440, S-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se			Swedish Research Council [342-2004-4434, 12628]; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	The use of the LTQ linear quadrupole ion trap mass spectrometer (obtained by Swedish Research Council Grant 342-2004-4434 to Gunnar Hansson) and the Varian 600-MHz machine at the Swedish NMR Centre, Hasselblad Laboratory, University of Gothenburg, is gratefully acknowledged.; This study was supported by Swedish Research Council Grant 12628, the Swedish Cancer Foundation, and governmental grants (to the Sahlgrenska University Hospital).	Angstrom J, 2004, GLYCOBIOLOGY, V14, P1, DOI 10.1093/glycob/cwh003; Angstrom J, 2000, J BIOL CHEM, V275, P3231, DOI 10.1074/jbc.275.5.3231; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; BJORK S, 1987, J BIOL CHEM, V262, P6758; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BREIMER ME, 1982, J BIOL CHEM, V257, P906; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; CEDERBERG A, 1991, SCAND J GASTROENTERO, V26, P33, DOI 10.3109/00365529109103985; Chai WG, 2002, J AM SOC MASS SPECTR, V13, P670, DOI 10.1016/S1044-0305(02)00363-X; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; Chang WW, 2008, P NATL ACAD SCI USA, V105, P11667, DOI 10.1073/pnas.0804979105; CLAUSEN H, 1985, P NATL ACAD SCI USA, V82, P1199, DOI 10.1073/pnas.82.4.1199; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P3578, DOI 10.1021/bi00335a028; Coddens A, 2009, J BIOL CHEM, V284, P9713, DOI 10.1074/jbc.M807866200; Diswall M, 2008, TRANSPL P, V40, P543, DOI 10.1016/j.transproceed.2008.01.032; ESKO JD, 1999, ESSENTIALS GLYCOBIOL, P429; Fagerberg D, 2009, GLYCOBIOLOGY, V19, P182, DOI 10.1093/glycob/cwn125; Fujimoto S, 2007, CLIN GASTROENTEROL H, V5, P49, DOI 10.1016/j.cgh.2006.09.015; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; HOLGERSSON J, 1990, J BIOCHEM-TOKYO, V108, P766, DOI 10.1093/oxfordjournals.jbchem.a123279; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; IMBERTY A, 1995, GLYCOCONJUGATE J, V12, P331, DOI 10.1007/BF00731336; Ishijima N, 2011, J BIOL CHEM, V286, P25256, DOI 10.1074/jbc.M111.233601; ITO M, 1989, J BIOL CHEM, V264, P9510; IWAMORI M, 1981, BIOCHIM BIOPHYS ACTA, V665, P205, DOI 10.1016/0005-2760(81)90004-7; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KOSCIELAK J, 1973, EUR J BIOCHEM, V37, P214, DOI 10.1111/j.1432-1033.1973.tb02978.x; Koscielak J., 1970, BLOOD TISSUE ANTIGEN, P163; Kundu S. K., 1993, GLYCOCONJUGATES COMP, P203; Li YT, 2009, GLYCOCONJUGATE J, V26, P929, DOI 10.1007/s10719-008-9125-9; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; MCKIBBIN JM, 1982, J BIOL CHEM, V257, P755; Nyholm P G, 1989, J Mol Recognit, V2, P103, DOI 10.1002/jmr.300020302; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Rad R, 2002, J IMMUNOL, V168, P3033, DOI 10.4049/jimmunol.168.6.3033; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; STELLNER K, 1973, BIOCHEMISTRY-US, V12, P656, DOI 10.1021/bi00728a014; STULTS CLM, 1989, METHOD ENZYMOL, V179, P167; Teneberg S, 2002, J BIOL CHEM, V277, P19709, DOI 10.1074/jbc.M201113200; Waldi D., 1962, THIN LAYER CHROMATOG, P496; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; ZHOU B, 1989, J BIOL CHEM, V264, P12272	47	23	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31712	31724		10.1074/jbc.M112.387654	http://dx.doi.org/10.1074/jbc.M112.387654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822069	Green Published, hybrid			2022-12-25	WOS:000309059400013
J	Vanaman, T; Carafoli, E				Vanaman, Thomas; Carafoli, Ernesto			Introduction to Thematic Minireview Series on Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RAT KIDNEY MITOCHONDRIA		[Vanaman, Thomas] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Carafoli, Ernesto] Univ Padua, Venetian Inst Mol Med, I-35129 Padua, Italy	University of Kentucky; University of Padua; Veneto Institute Molecular Medicine	Vanaman, T (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tvanaman@asbmb.org	Carafoli, Ernesto/K-5192-2016	Carafoli, Ernesto/0000-0002-7826-0094				Bailey K, 1942, BIOCHEM J, V36, P121, DOI 10.1042/bj0360121; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; EBASHI S, 1965, J BIOCHEM-TOKYO, V58, P107, DOI 10.1093/oxfordjournals.jbchem.a128157; EBASHI S, 1968, J BIOCHEM-TOKYO, V64, P465, DOI 10.1093/oxfordjournals.jbchem.a128918; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HEILBRUNN L. V., 1940, PHYSIOL ZOOL, V13, P88; Ringer S, 1883, J Physiol, V4, P29; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670	9	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31623	31623		10.1074/jbc.R112.402354	http://dx.doi.org/10.1074/jbc.R112.402354			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822054	Green Published, hybrid			2022-12-25	WOS:000309059400002
J	Dreesen, L; Rinaldi, M; Chiers, K; Li, R; Geurden, T; Van den Broeck, W; Goddeeris, B; Vercruysse, J; Claerebout, E; Geldhof, P				Dreesen, Leentje; Rinaldi, Manuela; Chiers, Koen; Li, Robert; Geurden, Thomas; Van den Broeck, Wim; Goddeeris, Bruno; Vercruysse, Jozef; Claerebout, Edwin; Geldhof, Peter			Microarray Analysis of the Intestinal Host Response in Giardia duodenalis Assemblage E Infected Calves	PLOS ONE			English	Article							GENE-EXPRESSION; LAMBLIA; NORMALIZATION; INFLAMMATION; VARIANCE; GENOTYPE; ROLES	Despite Giardia duodenalis being one of the most commonly found intestinal pathogens in humans and animals, little is known about the host-parasite interactions in its natural hosts. Therefore, the objective of this study was to investigate the intestinal response in calves following a G. duodenalis infection, using a bovine high-density oligo microarray to analyze global gene expression in the small intestine. The resulting microarray data suggested a decrease in inflammation, immune response, and immune cell migration in infected animals. These findings were examined in more detail by histological analyses combined with quantitative real-time PCR on a panel of cytokines. The transcription levels of IL-6, IL-8, IL-13, IL-17, and IFN-gamma showed a trend of being downregulated in the jejunum of infected animals compared to the negative controls,. No immune cell recruitment could be seen after infection, and no intestinal pathologies, such as villus shortening or increased levels of apoptosis. Possible regulators of this intestinal response are the nuclear peroxisome proliferator-activated receptors alpha (PPAR alpha), and gamma (PPAR gamma) and the enzyme adenosine deaminase (ADA), all for which an upregulated expression was found in the microarray and qRT-PCR analyses.	[Dreesen, Leentje; Rinaldi, Manuela; Geurden, Thomas; Goddeeris, Bruno; Vercruysse, Jozef; Claerebout, Edwin; Geldhof, Peter] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Chiers, Koen] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Li, Robert] USDA ARS, Bovine Funct Genom Lab, Anim & Nat Resources Inst, Beltsville, MD USA; [Van den Broeck, Wim] Univ Ghent, Fac Vet Med, Dept Morphol, Merelbeke, Belgium	Ghent University; Ghent University; United States Department of Agriculture (USDA); Ghent University	Dreesen, L (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	peter.geldhof@UGent.be	Goddeeris, Bruno Maria/L-2440-2015	Goddeeris, Bruno Maria/0000-0003-3729-7592; Claerebout, Edwin/0000-0002-8292-2791	Ghent University [BOF09/GOA/002]	Ghent University(Ghent University)	The project was funded by the Concerted Research Actions of Ghent University (grant number BOF09/GOA/002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bansal D, 2005, BRIT J BIOMED SCI, V62, P63, DOI 10.1080/09674845.2005.11732686; Barigye R, 2008, VET PARASITOL, V157, P196, DOI 10.1016/j.vetpar.2008.07.033; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chan MM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/828951; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Das S, 2002, INT J PARASITOL, V32, P655, DOI 10.1016/S0020-7519(02)00006-1; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Eckmann L, 2003, PARASITE IMMUNOL, V25, P259, DOI 10.1046/j.1365-3024.2003.00634.x; Farthing MJG, 1996, GASTROENTEROL CLIN N, V25, P493, DOI 10.1016/S0889-8553(05)70260-0; Fraser D, 2000, CLIN INFECT DIS, V30, P419, DOI 10.1086/313722; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Geurden T, 2004, INT J PARASITOL, V34, P1121, DOI 10.1016/j.ijpara.2004.05.007; Geurden T, 2010, EXP PARASITOL, V124, P98, DOI 10.1016/j.exppara.2009.03.001; GILMAN RH, 1988, LANCET, V1, P343, DOI 10.1016/S0140-6736(88)91131-2; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hanevik K, 2011, J INFECT DIS, V204, P1779, DOI 10.1093/infdis/jir639; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Homan WL, 2001, INT J PARASITOL, V31, P822, DOI 10.1016/S0020-7519(01)00183-7; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; ISHHOROWICZ M, 1989, PEDIATR INFECT DIS J, V8, P773, DOI 10.1097/00006454-198911000-00009; Kamda JD, 2009, INFECT IMMUN, V77, P685, DOI 10.1128/IAI.00718-08; KATELARIS P, 1991, PARASITOLOGY, V103, P35, DOI 10.1017/S0031182000059266; Koudela B, 1998, VET PARASITOL, V74, P9, DOI 10.1016/S0304-4017(97)00146-5; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Newman RD, 2001, TROP MED INT HEALTH, V6, P624, DOI 10.1046/j.1365-3156.2001.00757.x; O'Handley RM, 2006, VET CLIN N AM-FOOD A, V22, P623, DOI 10.1016/j.cvfa.2006.07.002; Oberhuber G, 1997, SCAND J GASTROENTERO, V32, P48, DOI 10.3109/00365529709025062; Read C, 2002, INT J PARASITOL, V32, P229, DOI 10.1016/S0020-7519(01)00340-X; RENDTORFF ROBERT C., 1954, AMER JOUR HYG, V59, P209; Rishniw M, 2010, J VET INTERN MED, V24, P293, DOI 10.1111/j.1939-1676.2010.0475.x; Roxstrom-Lindquist K, 2005, INFECT IMMUN, V73, P8204, DOI 10.1128/IAI.73.12.8204-8208.2005; Ruest N, 1997, VET PARASITOL, V69, P177, DOI 10.1016/S0304-4017(96)01121-1; Singer SM, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P451, DOI 10.1079/9781845933913.0451; Singer SM, 2000, INFECT IMMUN, V68, P170, DOI 10.1128/IAI.68.1.170-175.2000; Solaymani-Mohammadi S, 2011, J IMMUNOL, V187, P3769, DOI 10.4049/jimmunol.1100606; Solaymani-Mohammadi S, 2010, EXP PARASITOL, V126, P292, DOI 10.1016/j.exppara.2010.06.014; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Sweeny JPA, 2011, MOL BIOCHEM PARASIT, V180, P62, DOI 10.1016/j.molbiopara.2011.07.007; Tsuji K, 2009, BIOORG MED CHEM LETT, V19, P1643, DOI 10.1016/j.bmcl.2009.02.004; Vangeel L, 2012, VET PARASITOL, V183, P224, DOI 10.1016/j.vetpar.2011.07.048; Xiao LH, 1996, VET PARASITOL, V61, P165, DOI 10.1016/0304-4017(95)00802-0; Zhang K, 2010, ADV EXP MED BIOL, V688, P238	46	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40985	10.1371/journal.pone.0040985	http://dx.doi.org/10.1371/journal.pone.0040985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848418	Green Published, gold			2022-12-25	WOS:000306950200036
J	Jawhara, S; Habib, K; Maggiotto, F; Pignede, G; Vandekerckove, P; Maes, E; Dubuquoy, L; Fontaine, T; Guerardel, Y; Poulain, D				Jawhara, Samir; Habib, Khalid; Maggiotto, Francois; Pignede, Georges; Vandekerckove, Pascal; Maes, Emmanuel; Dubuquoy, Laurent; Fontaine, Thierry; Guerardel, Yann; Poulain, Daniel			Modulation of Intestinal Inflammation by Yeasts and Cell Wall Extracts: Strain Dependence and Unexpected Anti-Inflammatory Role of Glucan Fractions	PLOS ONE			English	Article							CHEMICALLY-INDUCED COLITIS; CANDIDA-ALBICANS; SACCHAROMYCES-BOULARDII; BETA-GLUCAN; ESCHERICHIA-COLI; DENDRITIC CELLS; BOWEL-DISEASE; MOUSE MODEL; MICE; INFECTION	Yeasts and their glycan components can have a beneficial or adverse effect on intestinal inflammation. Previous research has shown that the presence of Saccharomyces cerevisiae var. boulardii (Sb) reduces intestinal inflammation and colonization by Candida albicans. The aim of this study was to identify dietary yeasts, which have comparable effects to the anti-C. albicans and anti-inflammatory properties of Sb and to assess the capabilities of yeast cell wall components to modulate intestinal inflammation. Mice received a single oral challenge of C. albicans and were then given 1.5% dextran-sulphatesodium (DSS) for 2 weeks followed by a 3-day restitution period. S. cerevisiae strains (Sb, Sc1 to Sc4), as well as mannoprotein (MP) and beta-glucan crude fractions prepared from Sc2 and highly purified beta-glucans prepared from C. albicans were used in this curative model, starting 3 days after C. albicans challenge. Mice were assessed for the clinical, histological and inflammatory responses related to DSS administration. Strain Sc1-1 gave the same level of protection against C. albicans as Sb when assessed by mortality, clinical scores, colonization levels, reduction of TNF alpha and increase in IL-10 transcription. When Sc1-1 was compared with the other S. cerevisiae strains, the preparation process had a strong influence on biological activity. Interestingly, some S. cerevisiae strains dramatically increased mortality and clinical scores. Strain Sc4 and MP fraction favoured C. albicans colonization and inflammation, whereas beta-glucan fraction was protective against both. Surprisingly, purified beta-glucans from C. albicans had the same protective effect. Thus, some yeasts appear to be strong modulators of intestinal inflammation. These effects are dependent on the strain, species, preparation process and cell wall fraction. It was striking that beta-glucan fractions or pure beta-glucans from C. albicans displayed the most potent anti-inflammatory effect in the DSS model.	[Jawhara, Samir; Habib, Khalid; Maggiotto, Francois; Dubuquoy, Laurent; Poulain, Daniel] Univ Lille Nord France, Lille, France; [Jawhara, Samir; Habib, Khalid; Maggiotto, Francois; Dubuquoy, Laurent; Poulain, Daniel] UDSL, Lille, France; [Jawhara, Samir; Habib, Khalid; Maggiotto, Francois; Dubuquoy, Laurent; Poulain, Daniel] INSERM, U995, F-59045 Lille, France; [Poulain, Daniel] Serv Parasitol Mycol, Lille, France; [Poulain, Daniel] CHRU Lille, Lille, France; [Maes, Emmanuel; Guerardel, Yann] Univ Lille 1, UGSF, F-59655 Villeneuve Dascq, France; [Maes, Emmanuel; Guerardel, Yann] Univ Lille 1, Ctr Hyperfrequences & Semicond, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France; [Pignede, Georges; Vandekerckove, Pascal] Lesaffre Int, Div R&D, Marcq En Baroeul, France; [Fontaine, Thierry] Inst Pasteur, Unite Aspergillus, Paris, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jawhara, S (corresponding author), Univ Lille Nord France, Lille, France.	dpoulain@univ-lille2.fr	Dubuquoy, laurent/J-4978-2015; Fontaine, Thierry/F-8227-2011; Jawhara, Samir/A-9310-2019; Fontaine, thierry/Q-2201-2018; Poulain, Daniel/C-8683-2014; Dubuquoy, Laurent/N-1623-2019; Jawhara, Samir/AAC-5789-2019; Poulain, Daniel/I-6095-2018	Dubuquoy, laurent/0000-0003-3596-5497; Jawhara, Samir/0000-0002-2759-975X; Fontaine, thierry/0000-0002-8184-789X; Jawhara, Samir/0000-0002-2759-975X; Guerardel, Yann/0000-0003-4967-9512; Poulain, Daniel/0000-0002-0729-5468	French Government [082906131]; European funds FEDER; Region Nord-Pas de Calais, Lille Me tropole Communaute Urbaine; FP7 Health "ALLFUN'' project [260338]	French Government; European funds FEDER(European Commission); Region Nord-Pas de Calais, Lille Me tropole Communaute Urbaine(Region Hauts-de-France); FP7 Health "ALLFUN'' project	This work was funded by the program LEVACI issued from the French Government research plan FUI 5th AAP (DGE- Lille University contract number 082906131, European funds FEDER and local funds from the Region Nord-Pas de Calais, Lille Me tropole Communaute Urbaine). LEVACI partners belong to research clusters Nutrition-Sante-Longe vite and Vegepolys. This work was also funded by the FP7 Health 260338 "ALLFUN'' project "Fungi in the setting of inflammation, allergy and auto-immune diseases: translating basic science into clinical practices.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HM, 2010, PHARMACOTHERAPY, V30, P361, DOI 10.1592/phco.30.4.361; Avalueva E B, 2010, Eksp Klin Gastroenterol, P103; Bonifazi P, 2009, MUCOSAL IMMUNOL, V2, P362, DOI 10.1038/mi.2009.17; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Buddington KK, 2002, J NUTR, V132, P472, DOI 10.1093/jn/132.3.472; Buts JP, 2006, DIGEST DIS SCI, V51, P1485, DOI 10.1007/s10620-005-9016-x; Buts JP, 2010, SCAND J GASTROENTERO, V45, P175, DOI 10.3109/00365520903453141; Canonici A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018427; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Chung YH, 2011, J DAIRY SCI, V94, P2431, DOI 10.3168/jds.2010-3277; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Driscoll M, 2009, CANCER BIOL THER, V8, P214; Edwards-Ingram L, 2007, APPL ENVIRON MICROB, V73, P2458, DOI 10.1128/AEM.02201-06; Fidan I, 2009, MYCOSES, V52, P29, DOI 10.1111/j.1439-0507.2008.01545.x; Forsyth CB, 2002, INFECT IMMUN, V70, P517, DOI 10.1128/IAI.70.2.517-527.2002; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; Garner RE, 1996, INFECT IMMUN, V64, P4561, DOI 10.1128/IAI.64.11.4561-4566.1996; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Guslandi M, 2000, DIGEST DIS SCI, V45, P1462, DOI 10.1023/A:1005588911207; Guslandi M, 2003, EUR J GASTROEN HEPAT, V15, P697, DOI 10.1097/00042737-200306000-00017; HASHIMOTO K, 1983, J PHARMACOBIO-DYNAM, V6, P668; Hetland G, 2000, FEMS IMMUNOL MED MIC, V27, P111, DOI 10.1111/j.1574-695X.2000.tb01420.x; Hida S, 2007, BIOL PHARM BULL, V30, P1589, DOI 10.1248/bpb.30.1589; HILENSKI LL, 1986, J GEN MICROBIOL, V132, P1441; Ishibashia K, 2002, INT IMMUNOPHARMACOL, V2, P1109, DOI 10.1016/S1567-5769(02)00062-0; Jawhara S, 2012, J BIOL CHEM IN PRESS; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Jawhara S, 2007, MED MYCOL, V45, P691, DOI 10.1080/13693780701523013; Kuhle AVA, 2003, SYST APPL MICROBIOL, V26, P564, DOI 10.1078/072320203770865873; Lee JN, 2001, BIOSCI BIOTECH BIOCH, V65, P837, DOI 10.1271/bbb.65.837; Li J, 2006, J ANIM SCI, V84, P2374, DOI 10.2527/jas.2004-541; Liang JS, 1998, INT J IMMUNOPHARMACO, V20, P595, DOI 10.1016/S0192-0561(98)00007-1; Lourens-Hattingh A, 2001, FOOD RES INT, V34, P791, DOI 10.1016/S0963-9969(01)00085-0; Martins FS, 2009, LETT APPL MICROBIOL, V49, P738, DOI 10.1111/j.1472-765X.2009.02732.x; Martins FS, 2005, J GEN APPL MICROBIOL, V51, P83, DOI 10.2323/jgam.51.83; Mitterdorfer G, 2002, PROTEOMICS, V2, P1532, DOI 10.1002/1615-9861(200211)2:11<1532::AID-PROT1532>3.0.CO;2-H; Murzyn A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012050; Murzyn A, 2010, FEMS MICROBIOL LETT, V310, P17, DOI 10.1111/j.1574-6968.2010.02037.x; Pannerden CMFVT, 2011, DRUGS, V71, P853, DOI 10.2165/11591230-000000000-00000; Periti P, 2001, J CHEMOTHERAPY, V13, P473, DOI 10.1179/joc.2001.13.5.473; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; Reed KL, 2005, DIGEST DIS SCI, V50, P2366, DOI 10.1007/s10620-005-3066-y; Rousseau V, 2005, ANAEROBE, V11, P145, DOI 10.1016/j.anaerobe.2004.12.002; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Samonis G, 2011, MED MYCOL, V49, P395, DOI 10.3109/13693786.2010.533203; Sendid B, 2008, CLIN VACCINE IMMUNOL, V15, P1868, DOI 10.1128/CVI.00200-08; Sendid B, 2007, J MED MICROBIOL, V56, P495, DOI 10.1099/jmm.0.46715-0; Sener G, 2006, INT IMMUNOPHARMACOL, V6, P724, DOI 10.1016/j.intimp.2005.10.010; Shanahan F, 2000, INFLAMM BOWEL DIS, V6, P107, DOI 10.1097/00054725-200005000-00007; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Sindhu Sangeeta C., 2002, Nutrition and Health (Bicester), V16, P173; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thomas S, 2011, AM J PHYSL GASTROINT; Thornton BP, 1996, J IMMUNOL, V156, P1235; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Yanaba K, 2011, AM J PATHOL, V178, P735, DOI 10.1016/j.ajpath.2010.10.022; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	64	75	78	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40648	10.1371/journal.pone.0040648	http://dx.doi.org/10.1371/journal.pone.0040648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848391	Green Published, gold			2022-12-25	WOS:000306950200025
J	Ni, K; Li, SM; Xia, QL; Zang, N; Deng, Y; Xie, XH; Luo, ZX; Luo, Y; Wang, LJ; Fu, Z; Liu, EM				Ni, Ke; Li, Simin; Xia, Qiuling; Zang, Na; Deng, Yu; Xie, Xiaohong; Luo, Zhengxiu; Luo, Yan; Wang, Lijia; Fu, Zhou; Liu, Enmei			Pharyngeal Microflora Disruption by Antibiotics Promotes Airway Hyperresponsiveness after Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; BACTERIAL-COLONIZATION; MICE; BRONCHIOLITIS; DISEASE; HYPERREACTIVITY; SENSITIZATION; PERSPECTIVE; PERSISTENCE; ALLERGEN	Background: Regulatory T cells (Treg cells), which are essential for regulation of immune response to respiratory syncytial virus (RSV) infection, are promoted by pharyngeal commensal pneumococcus. The effects of pharyngeal microflora disruption by antibiotics on airway responsiveness and relative immune responses after RSV infection have not been clarified. Methods: Female BALB/c mice (aged 3 weeks) were infected with RSV and then treated with either oral antibiotics or oral double distilled water (ddH(2)O) from 1 d post infection (pi). Changes in pharyngeal microflora were analyzed after antibiotic treatment for 7 d and 14 d. At 8 d pi and 15 d pi, the inflammatory cells in bronchoalveolar lavage fluid (BALF) were investigated in combination with tests of pulmonary histopathology, airway hyperresponsiveness (AHR), pulmonary and splenic Treg cells responses. Pulmonary Foxp3 mRNA expression, IL-10 and TGF-beta 1 in BALF and lung homogenate were investigated at 15 d pi. Ovalbumin (OVA) challenge was used to induce AHR after RSV infection. Results: The predominant pharyngeal commensal, Streptococcus, was cleared by antibiotic treatment for 7 d. Same change also existed after antibiotic treatment for 14 d. After RSV infection, AHR was promoted by antibiotic treatment at 15 d pi. Synchronous decreases of pulmonary Treg cells, Foxp3 mRNA and TGF-beta 1 were detected. Similar results were observed under OVA challenge. Conclusions: After RSV infection, antibiotic treatment cleared pharyngeal commensal bacteria such as Streptococcus, which consequently, might induce AHR and decrease pulmonary Treg cells.	[Deng, Yu; Xie, Xiaohong; Luo, Zhengxiu; Fu, Zhou; Liu, Enmei] Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China; [Ni, Ke; Li, Simin; Xia, Qiuling; Zang, Na; Luo, Yan; Wang, Lijia] Chongqing Med Univ, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing, Minist Educ,Key Lab Child Dev & Disorders, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Liu, EM (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China.	emliu186@hotmail.com			National Natural Science Foundation of China [NSFC 30972698, NSFC 81170010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant numbers: NSFC 30972698, NSFC 81170010)(http://isis.nsfc.gov.cn/portal/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2007, AM J RESP CRIT CARE, V176, P974, DOI 10.1164/rccm.200702-334OC; Antonow JA, 1998, PEDIATR INFECT DIS J, V17, P231, DOI 10.1097/00006454-199803000-00011; Basset C, 2010, TOXINS, V2, P1774, DOI 10.3390/toxins2071774; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Burchell JT, 2009, AM J PHYSIOL-LUNG C, V296, pL307, DOI 10.1152/ajplung.00521.2007; Chavez-Bueno S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-46; Cusi Maria Grazia, 2010, Immun Ageing, V7, P14, DOI 10.1186/1742-4933-7-14; de Gutierrez RC, 1999, MEM I OSWALDO CRUZ, V94, P701, DOI 10.1590/S0074-02761999000500027; DELPRETE G, 1993, J IMMUNOL, V150, P353; Estripeaut D, 2008, J INFECT DIS, V198, P1435, DOI 10.1086/592714; Fjaerli Hans-Olav, 2005, BMC Pediatr, V5, P31, DOI 10.1186/1471-2431-5-31; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Gordon ED, 2012, CLIN EXP ALLERGY, V42, P144, DOI 10.1111/j.1365-2222.2011.03840.x; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Lee DCP, 2010, J VIROL, V84, P8790, DOI 10.1128/JVI.00796-10; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Nagayama Y, 2007, PEDIAT ALLERG IMM-UK, V18, P110, DOI 10.1111/j.1399-3038.2006.00492.x; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; O'Flaherty S, 2010, GUT MICROBES, V1, P293, DOI 10.4161/gmic.1.5.12924; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Penders J, 2011, EUR RESP J; Presser K, 2008, J IMMUNOL, V181, P7751, DOI 10.4049/jimmunol.181.11.7751; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Samson L, 1999, Paediatr Child Health, V4, P195; Scerbo MJ, 2012, J NEUROIMMUNOL, V242, P16, DOI 10.1016/j.jneuroim.2011.11.006; Schwarze J, 1999, J IMMUNOL, V163, P5729; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub2; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Steiner RWP, 2004, AM FAM PHYSICIAN, V69, P325; Sun Da-qing, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P473; Uhl EW, 1996, AM J RESP CRIT CARE, V154, P1834, DOI 10.1164/ajrccm.154.6.8970378; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zhang QB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002175	40	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41104	10.1371/journal.pone.0041104	http://dx.doi.org/10.1371/journal.pone.0041104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844430	gold, Green Published, Green Submitted			2022-12-25	WOS:000309240600015
J	Kolodecik, TR; Shugrue, CA; Thrower, EC; Levin, LR; Buck, J; Gorelick, FS				Kolodecik, Thomas R.; Shugrue, Christine A.; Thrower, Edwin C.; Levin, Lonny R.; Buck, Jochen; Gorelick, Fred S.			Activation of Soluble Adenylyl Cyclase Protects against Secretagogue Stimulated Zymogen Activation in Rat Pancreaic Acinar Cells	PLOS ONE			English	Article							PH-REGULATORY MECHANISMS; ENZYME ACTIVATION; CAMP; CALCIUM; IDENTIFICATION; SECRETION; MICRODOMAINS; EXPRESSION; AUTOPHAGY; RESPONSES	An early feature of acute pancreatitis is activation of zymogens, such as trypsinogen, within the pancreatic acinar cell. Supraphysiologic concentrations of the hormone cholecystokinin (CCK; 100 nM), or its orthologue cerulein (CER), induce zymogen activation and elevate levels of cAMP in pancreatic acinar cells. The two classes of adenylyl cyclase, transmembrane (tmAC) and soluble (sAC), are activated by distinct mechanisms, localize to specific subcellular domains, and can produce locally high concentrations of cAMP. We hypothesized that sAC activity might selectively modulate acinar cell zymogen activation. sAC was identified in acinar cells by PCR and immunoblot. It localized to the apical region of the cell under resting conditions and redistributed intracellularly after treatment with supraphysiologic concentrations of cerulein. In cerulein-treated cells, pre-incubation with a trans-membrane adenylyl cyclase inhibitor did not affect zymogen activation or amylase secretion. However, treatment with a sAC inhibitor (KH7), or inhibition of a downstream target of cAMP, protein kinase A (PKA), significantly enhanced secretagogue-stimulated zymogen activation and amylase secretion. Activation of sAC with bicarbonate significantly inhibited secretagogue-stimulated zymogen activation; this response was decreased by inhibition of sAC or PKA. Bicarbonate also enhanced secretagogue-stimulated cAMP accumulation; this effect was inhibited by KH7. Bicarbonate treatment reduced secretagogue-stimulated acinar cell vacuolization, an early marker of pancreatitis. These data suggest that activation of sAC in the pancreatic acinar cell has a protective effect and reduces the pathologic activation of proteases during pancreatitis.	[Kolodecik, Thomas R.; Shugrue, Christine A.; Thrower, Edwin C.; Gorelick, Fred S.] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA; [Gorelick, Fred S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Kolodecik, Thomas R.; Shugrue, Christine A.; Thrower, Edwin C.; Gorelick, Fred S.] Vet Adm Connecticut Healthcare, West Haven, CT USA; [Levin, Lonny R.; Buck, Jochen] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Yale University; Yale University; Cornell University	Kolodecik, TR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA.	fred.gorelick@yale.edu		Gorelick, Fred/0000-0001-8293-6803; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [DK-54021]; Veterans Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health R01 Grant DK-54021 and a Veterans Administration Merit Award to Fred S. Gorelick. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Akiyama T, 1998, AM J PHYSIOL-GASTR L, V275, pG1202, DOI 10.1152/ajpgi.1998.275.5.G1202; BAHNSON TD, 1993, J BIOL CHEM, V268, P10808; Bhoomagoud M, 2009, GASTROENTEROLOGY, V137, P1083, DOI 10.1053/j.gastro.2009.05.041; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; BRAUN T, 1977, BIOCHIM BIOPHYS ACTA, V481, P227, DOI 10.1016/0005-2744(77)90155-3; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chaloupka JA, 2006, MOL REPROD DEV, V73, P361, DOI 10.1002/mrd.20409; Chaudhuri A, 2005, AM J PHYSIOL-GASTR L, V288, pG235, DOI 10.1152/ajpgi.00334.2004; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Halm ST, 2010, AM J PHYSIOL-GASTR L, V299, pG81, DOI 10.1152/ajpgi.00035.2010; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; HAYMOVITS A, 1976, P NATL ACAD SCI USA, V73, P156, DOI 10.1073/pnas.73.1.156; Hilvo M, 2004, J HISTOCHEM CYTOCHEM, V52, P1313, DOI 10.1369/jhc.3A6225.2004; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; KOPELMAN H, 1995, AM J PHYSIOL-CELL PH, V269, pC626, DOI 10.1152/ajpcell.1995.269.3.C626; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Lu Z, 2003, AM J PHYSIOL-GASTR L, V285, pG822, DOI 10.1152/ajpgi.00213.2003; Lu Z, 2002, AM J PHYSIOL-GASTR L, V282, pG501, DOI 10.1152/ajpgi.00388.2001; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; MARINO CR, 1993, FEBS LETT, V316, P48, DOI 10.1016/0014-5793(93)81734-H; MUALLEM S, 1990, J BIOL CHEM, V265, P12813; MUALLEM S, 1990, J BIOL CHEM, V265, P12806; Nomura M, 2005, GENE, V353, P231, DOI 10.1016/j.gene.2005.04.034; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Salonikidis PS, 2008, BIOPHYS J, V95, P5412, DOI 10.1529/biophysj.107.125666; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Strazzabosco M, 2009, HEPATOLOGY, V50, P244, DOI 10.1002/hep.22926; Thrower EC, 2006, AM J PHYSIOL-GASTR L, V290, pG894, DOI 10.1152/ajpgi.00373.2005; Warrier S, 2007, J PHYSIOL-LONDON, V580, P765, DOI 10.1113/jphysiol.2006.124891; Whisnant RE, 1996, P NATL ACAD SCI USA, V93, P6621, DOI 10.1073/pnas.93.13.6621; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Wuttke M S, 2001, JOP, V2, P154; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	51	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41320	10.1371/journal.pone.0041320	http://dx.doi.org/10.1371/journal.pone.0041320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844459	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700071
J	Petkeviciene, J; Smalinskiene, A; Luksiene, DI; Jureniene, K; Ramazauskiene, V; Klumbiene, J; Lesauskaite, V				Petkeviciene, Janina; Smalinskiene, Alina; Luksiene, Dalia Ieva; Jureniene, Kristina; Ramazauskiene, Vitalija; Klumbiene, Jurate; Lesauskaite, Vaiva			Associations between Apolipoprotein E Genotype, Diet, Body Mass Index, and Serum Lipids in Lithuanian Adult Population	PLOS ONE			English	Article							CORONARY HEART-DISEASE; E POLYMORPHISM; CARDIOVASCULAR-DISEASE; PLASMA-LIPOPROTEINS; RURAL-POPULATION; FATTY-ACIDS; CHOLESTEROL; RISK; OBESITY; HABITS	Background: Apolipoprotein E (APOE) polymorphism is associated with lipid levels. Some studies have reported that blood lipid response to diet or obesity varies depending on APOE genotypes. The aim of this study was to assess the effect of APOE genotypes, the intake of saturated fatty acids (SFA), and obesity on serum lipid levels in Lithuanian adult population. Methodology/Principal Findings: A cross-sectional health survey was carried out in five municipalities of Lithuania. The random sample was obtained from lists of 25-64 year-old inhabitants registered at primary health care centres. The data from 996 subjects (416 men and 580 women) were analysed in this study. Two single-nucleotide polymorphisms (rs429358 and rs7412) were assessed using a real-time polymerase chain reaction. 24-hour recall and food frequency questionnaire were used for evaluation of dietary habits. Serum lipids were determined using enzymatic methods. Men and women with the APOE2 genotype had the lowest level of total cholesterol (TC) (p = 0.002 for men, and p = 0.02 for women) and low-density lipoprotein cholesterol (LDL-C) (p<0.001). Multivariate linear regression analysis showed that age, genotype APOE2, SFA intake, and body mass index (BMI) were significant determinants of TC and LDL-C level (with p values ranging from 0.043 to 0.001). Our data did not reveal any statistically significant interactions between APOE genotype and SFA intake or between APOE genotype and BMI regarding TC and LDL-C level (all p>0.05). However, the predictive power of the regression model for LDL-C improved when gene-BMI interaction and gene-BMI interaction plus gene-nutrient interaction were added (p = 0.04 and p = 0.032 for R-2 change, respectively). Conclusions/Significance: APOE genotypes, SFA intake, and obesity were found to be associated with blood lipid levels in Lithuanian adult population. Analysis of gene-diet and gene-obesity interactions did not confirm that the effects of diet and obesity on TC and LDL-C level significantly depended on APOE genotype.	[Petkeviciene, Janina; Ramazauskiene, Vitalija; Klumbiene, Jurate] Lithuanian Univ Hlth Sci, Med Acad, Fac Publ Hlth, Kaunas, Lithuania; [Smalinskiene, Alina; Luksiene, Dalia Ieva; Jureniene, Kristina; Lesauskaite, Vaiva] Lithuanian Univ Hlth Sci, Med Acad, Inst Cardiol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Petkeviciene, J (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Fac Publ Hlth, Kaunas, Lithuania.	janpet@vector.kmu.lt		Lesauskaite, Vaiva/0000-0003-2736-3111	Research Council of Lithuania [LIG-02/2010]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	The study was supported by research grant from the Research Council of Lithuania for National Research Programme 'Chronic Noncommunicable Diseases' (Agreement No LIG-02/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzda A, 2005, PATIEKALU SUDETIS MA; Bednarska-Makaruk M, 2001, EUR J EPIDEMIOL, V17, P789, DOI 10.1023/A:1015657709060; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Campos H, 2001, GENET EPIDEMIOL, V20, P117, DOI 10.1002/1098-2272(200101)20:1<117::AID-GEPI10>3.0.CO;2-C; Corella D, 2009, CIRC-CARDIOVASC GENE, V2, P637, DOI 10.1161/CIRCGENETICS.109.891366; de Andrade FM, 2010, BIOCHEM GENET, V48, P342, DOI 10.1007/s10528-010-9331-6; Emerging Risk Factors Collaboration, 2009, JAMA-J AM MED ASSOC, V302, P1999; Franssen R, 2008, ENDOCRIN METAB CLIN, V37, P623, DOI 10.1016/j.ecl.2008.06.003; Frikke-Schmidt R, 2000, J LIPID RES, V41, P1812; Frikke-Schmidt R, 2000, J AM COLL CARDIOL, V35, P1192, DOI 10.1016/S0735-1097(00)00520-9; Grabauskas V, 2011, HLTH BEHAV LITHUANIA; Grabauskas V, 2008, MEDICINA-LITHUANIA, V44, P633, DOI 10.3390/medicina44080082; Health Statistics of Lithuania, 2009, HLTH STAT LITHUANIA; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hubacek JA, 2003, PHYSIOL RES, V52, P195; Kofler BM, 2012, ATHEROSCLEROSIS, V221, P467, DOI 10.1016/j.atherosclerosis.2012.01.042; Kriaucioniene V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-218; Lefevre M, 1997, ARTERIOSCL THROM VAS, V17, P2914, DOI 10.1161/01.ATV.17.11.2914; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marques-Vidal P, 2003, OBES RES, V11, P1200, DOI 10.1038/oby.2003.165; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Ordovas JM, 2006, AM J CLIN NUTR, V83, p443S; Prattalla R., 2011, SOCIAL DETERMINANTS; Ramazauskiene V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-447; REILLY SL, 1994, AM J HUM GENET, V55, P1001; Reklaitiene R, 2001, MEDICINA, V37, P1544; Salminen M, 2006, PUBLIC HEALTH NUTR, V9, P859, DOI 10.1017/PHN2006972; Sarkkinen E, 1998, AM J CLIN NUTR, V68, P1215, DOI 10.1093/ajcn/68.6.1215; Schiele F, 2000, ATHEROSCLEROSIS, V152, P475, DOI 10.1016/S0021-9150(99)00501-8; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513; Suciliene S, 2002, MAISTO PRODUKTU SUDE; Tikkanen MJ, 1997, WORLD REV NUTR DIET, V80, P15; UTERMANN G, 1980, AM J HUM GENET, V32, P339; Ward H, 2009, ARCH INTERN MED, V169, P1424, DOI 10.1001/archinternmed.2009.234; Weggemans RM, 2001, ATHEROSCLEROSIS, V154, P547, DOI 10.1016/S0021-9150(00)00720-6; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WHO, 2003, WHO TECHN REP SER; Wu K, 2007, EUR HEART J, V28, P2930, DOI 10.1093/eurheartj/ehm482	40	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41525	10.1371/journal.pone.0041525	http://dx.doi.org/10.1371/journal.pone.0041525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844488	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700099
J	Jiang, TY; Ci, YP; Chou, WI; Lee, YC; Sun, YJ; Chou, WY; Li, KM; Chang, MDT				Jiang, Ting-Ying; Ci, Yuan-Pei; Chou, Wei-I; Lee, Yuan-Chuan; Sun, Yuh-Ju; Chou, Wei-Yao; Li, Kun-Mou; Chang, Margaret Dah-Tsyr			Two Unique Ligand-Binding Clamps of Rhizopus oryzae Starch Binding Domain for Helical Structure Disruption of Amylose	PLOS ONE			English	Article							ASPERGILLUS-NIGER GLUCOAMYLASE; ATOMIC-FORCE MICROSCOPY; STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURES; BIOLOGICAL ROLES; ALPHA-GLUCAN; CARBOHYDRATE; MODULE; RECOGNITION; PROTEIN	The N-terminal starch binding domain of Rhizopus oryzae glucoamylase (RoSBD) has a high binding affinity for raw starch. RoSBD has two ligand-binding sites, each containing a ligand-binding clamp: a polyN clamp residing near binding site I is unique in that it is expressed in only three members of carbohydrate binding module family 21 (CBM21) members, and a Y32/F58 clamp located at binding site II is conserved in several CBMs. Here we characterized different roles of these sites in the binding of insoluble and soluble starches using an amylose-iodine complex assay, atomic force microscopy, isothermal titration calorimetry, site-directed mutagenesis, and structural bioinformatics. RoSBD induced the release of iodine from the amylose helical cavity and disrupted the helical structure of amylose type III, thereby significantly diminishing the thickness and length of the amylose type III fibrils. A point mutation in the critical ligand-binding residues of sites I and II, however, reduced both the binding affinity and amylose helix disruption. This is the first molecular model for structure disruption of the amylose helix by a non-hydrolytic CBM21 member. RoSBD apparently twists the helical amylose strands apart to expose more ligand surface for further SBD binding. Repeating the process triggers the relaxation and unwinding of amylose helices to generate thinner and shorter amylose fibrils, which are more susceptible to hydrolysis by glucoamylase. This model aids in understanding the natural roles of CBMs in protein-glycan interactions and contributes to potential molecular engineering of CBMs.	[Jiang, Ting-Ying; Ci, Yuan-Pei; Chou, Wei-I; Lee, Yuan-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Jiang, Ting-Ying; Ci, Yuan-Pei; Chou, Wei-I; Lee, Yuan-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Chou, Wei-I] Simpson Biotech Co Ltd, Tao Yuan, Taiwan; [Lee, Yuan-Chuan] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Sun, Yuh-Ju; Li, Kun-Mou] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Sun, Yuh-Ju; Li, Kun-Mou] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chou, Wei-I] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan	National Tsing Hua University; National Tsing Hua University; Johns Hopkins University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Jiang, TY (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	dtchang@life.nthu.edu.tw			National Tsing Hua University, Taiwan [98N2903E1, 101N2060E1]; National Science Council, Taiwan [100-2628-B-007-003-MY3, 99-2311-B-007-007-MY3, 98-2917-I-007-105]; J.-C. Shen Tsing Hua Fellowship; Simpson Biotech Company, Ltd.	National Tsing Hua University, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); J.-C. Shen Tsing Hua Fellowship; Simpson Biotech Company, Ltd.	This work was funded by National Tsing Hua University, Taiwan (grants 98N2903E1 to M.D.-T.C., and 101N2060E1 to T.-Y.J.), National Science Council, Taiwan (grants 100-2628-B-007-003-MY3 to M.D.-T.C., 99-2311-B-007-007-MY3 to Y.-J.S., and 98-2917-I-007-105 to W.-Y.C.), J.-C. Shen Tsing Hua Fellowship to T.-Y.J., and Simpson Biotech Company, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; BAILEY JM, 1961, J BIOL CHEM, V236, P969; Baker AA, 2001, CARBOHYD RES, V330, P249, DOI 10.1016/S0008-6215(00)00275-5; BHIDE SV, 1976, BIOCHIM BIOPHYS ACTA, V444, P719, DOI 10.1016/0304-4165(76)90319-6; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chou WI, 2006, BIOCHEM J, V396, P469, DOI 10.1042/BJ20051982; Chou WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024814; Chou WY, 2010, BIOINFORMATICS, V26, P1022, DOI 10.1093/bioinformatics/btq084; Cohen R, 2011, J AGR FOOD CHEM, V59, P7932, DOI 10.1021/jf2013277; Coutinho PM, 1997, PROTEINS, V29, P334, DOI [10.1002/(SICI)1097-0134(199711)29:3<334::AID-PROT7>3.0.CO;2-A, 10.1002/(SICI)1097-0134(199711)29:3&lt;334::AID-PROT7&gt;3.0.CO;2-A]; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Frandsen TP, 1999, ENG SPECIFICITY STAB, P189; Giardina T, 2001, J MOL BIOL, V313, P1149, DOI 10.1006/jmbi.2001.5097; Glaring MA, 2011, FEBS J, V278, P1175, DOI 10.1111/j.1742-4658.2011.08043.x; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Heuer WB, 1999, MACROMOL SYMP, V138, P79, DOI 10.1002/masy.19991380109; IMBERTY A, 1988, J MOL BIOL, V201, P365, DOI 10.1016/0022-2836(88)90144-1; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirby AR, 1996, BIOPOLYMERS, V38, P355, DOI 10.1002/(SICI)1097-0282(199603)38:3<355::AID-BIP8>3.0.CO;2-T; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; Lin SC, 2009, PROTEIN EXPRES PURIF, V65, P261, DOI 10.1016/j.pep.2009.01.008; Liu YF, 2012, J AGR FOOD CHEM, V60, P4914, DOI 10.1021/jf300957k; Liu YN, 2007, BIOCHEM J, V403, P21, DOI 10.1042/BJ20061312; Machovic M, 2005, FEBS J, V272, P5497, DOI 10.1111/j.1742-4658.2005.04942.x; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; McIntire TM, 1999, INT J BIOL MACROMOL, V26, P303, DOI 10.1016/S0141-8130(99)00097-5; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; Mikkelsen R, 2006, BIOCHEMISTRY-US, V45, P4674, DOI 10.1021/bi051712a; Morris VJ, 2005, STARCH-STARKE, V57, P1, DOI 10.1002/star.200400333; Paldi T, 2003, BIOCHEM J, V372, P905, DOI 10.1042/BJ20021527; Parker R, 2001, J CEREAL SCI, V34, P1, DOI 10.1006/jcrs.2000.0402; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Redel E, 2009, CHEM COMMUN, P2103, DOI 10.1039/b820151j; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Stanley D, 2011, PLANT PHYSIOL, V155, P932, DOI 10.1104/pp.110.168328; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Tung JY, 2008, BIOCHEM J, V416, P27, DOI 10.1042/BJ20080580; Valdez HA, 2008, BIOCHEMISTRY-US, V47, P3026, DOI 10.1021/bi702418h; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Vincent TC, 1999, J POLYM SCI A, V37, P2711; Williamson MP, 1997, BIOCHEMISTRY-US, V36, P7535, DOI 10.1021/bi9702896; Xie HF, 2001, BIOCHEMISTRY-US, V40, P5700, DOI 10.1021/bi010034z; Xu GG, 2008, J MOL BIOL, V384, P436, DOI 10.1016/j.jmb.2008.09.032; Zabar S, 2009, FOOD HYDROCOLLOID, V23, P1918, DOI 10.1016/j.foodhyd.2009.02.004	58	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41131	10.1371/journal.pone.0041131	http://dx.doi.org/10.1371/journal.pone.0041131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815939	gold, Green Published, Green Submitted			2022-12-25	WOS:000306507000070
J	Shrivastava, N; Nag, JK; Misra-Bhattacharya, S				Shrivastava, Nidhi; Nag, Jeetendra Kumar; Misra-Bhattacharya, Shailja			Molecular Characterization of NAD(+)-Dependent DNA Ligase from Wolbachia Endosymbiont of Lymphatic Filarial Parasite Brugia malayi	PLOS ONE			English	Article							ALPHA-PROTEOBACTERIA; MUTATIONAL ANALYSES; ESCHERICHIA-COLI; INHIBITION; CLONING; EVOLUTION; LIGATION; PROTEINS; DOMAINS; BINDING	The lymphatic filarial parasite, Brugia malayi contains Wolbachia endobacteria that are essential for development, viability and fertility of the parasite. Therefore, wolbachial proteins have been currently seen as the potential antifilarial drug targets. NAD(+)-dependent DNA ligase is characterized as a promising drug target in several organisms due to its crucial, indispensable role in DNA replication, recombination and DNA repair. We report here the cloning, expression and purification of NAD(+)-dependent DNA ligase of Wolbachia endosymbiont of B. malayi (wBm-LigA) for its molecular characterization. wBm-LigA has all the domains that are present in nearly all the eubacterial NAD(+)-dependent DNA ligases such as N-terminal adenylation domain, OB fold, helix-hairpin-helix (HhH) and BRCT domain except zinc-binding tetracysteine domain. The purified recombinant protein (683-amino acid) was found to be biochemically active and was present in its native form as revealed by the circular dichroism and fluorescence spectra. The purified recombinant enzyme was able to catalyze intramolecular strand joining on a nicked DNA as well as intermolecular joining of the cohesive ends of BstEII restricted lamda DNA in an in vitro assay. The enzyme was localized in the various life-stages of B. malayi parasites by immunoblotting and high enzyme expression was observed in Wolbachia within B. malayi microfilariae and female adult parasites along the hypodermal chords and in the gravid portion as evident by the confocal microscopy. Ours is the first report on this enzyme of Wolbachia and these findings would assist in validating the antifilarial drug target potential of wBm-LigA in future studies.	[Shrivastava, Nidhi; Nag, Jeetendra Kumar; Misra-Bhattacharya, Shailja] Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Shrivastava, N (corresponding author), Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India.	shailja_cdri@rediffmail.com			Council for Scientific and Industrial Research Institute, New Delhi, India	Council for Scientific and Industrial Research Institute, New Delhi, India	supported by Council for Scientific and Industrial Research Institute, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PA, 2001, PROTEINS, P39; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brotz-Oesterhelt H, 2003, J BIOL CHEM, V278, P39435, DOI 10.1074/jbc.M306479200; Ciarrocchi G, 1999, ANTIMICROB AGENTS CH, V43, P2766, DOI 10.1128/AAC.43.11.2766; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Ettema TJG, 2009, BIOL LETTERS, V5, P429, DOI 10.1098/rsbl.2008.0793; Ferrer M, 2008, P NATL ACAD SCI USA, V105, P8878, DOI 10.1073/pnas.0800071105; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Georlette D, 2000, EUR J BIOCHEM, V267, P3502, DOI 10.1046/j.1432-1327.2000.01377.x; GOTTESMAN MM, 1973, J MOL BIOL, V77, P531, DOI 10.1016/0022-2836(73)90221-0; Grothe HL, 2009, MOL VIS, V15, P2617; Gupta RS, 2005, CRIT REV MICROBIOL, V31, P101, DOI 10.1080/10408410590922393; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Hoerauf A, 2003, MICROBES INFECT, V5, P261, DOI 10.1016/S1286-4579(03)00026-1; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; Kaczmarek FS, 2001, J BACTERIOL, V183, P3016, DOI 10.1128/JB.183.10.3016-3024.2001; Keppetipola N, 2005, J BACTERIOL, V187, P6902, DOI 10.1128/JB.187.20.6902-6908.2005; LEHMAN IR, 1974, SCIENCE, V186, P790; Lim JH, 2001, ARCH BIOCHEM BIOPHYS, V388, P253, DOI 10.1006/abbi.2001.2291; LINDAHL T, 1992, ANNU REV BIOCHEM, V61, P251, DOI 10.1146/annurev.bi.61.070192.001343; Lu J, 2004, BBA-PROTEINS PROTEOM, V1701, P37, DOI 10.1016/j.bbapap.2004.06.008; Machala M. K., 2007, ANTIMICROB AGENTS CH, V51, P2888; Muerhoff AS, 2004, J VIROL METHODS, V119, P171, DOI 10.1016/j.jviromet.2004.04.003; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Petit MA, 2000, NUCLEIC ACIDS RES, V28, P4642, DOI 10.1093/nar/28.23.4642; Sambrook J, 2000, MOL CLONING LAB MANU, V2, P916; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Seo MS, 2007, J BIOTECHNOL, V128, P519, DOI 10.1016/j.jbiotec.2006.09.024; Singh M, 2009, PARASITOL RES, V104, P753, DOI 10.1007/s00436-008-1251-6; Sriskanda V, 2001, J BIOL CHEM, V276, P36100, DOI 10.1074/jbc.M105643200; Srivastava SK, 2005, J BIOL CHEM, V280, P30273, DOI 10.1074/jbc.M503780200; Taylor MJ, 2001, CURR OPIN INFECT DIS, V14, P727, DOI 10.1097/00001432-200112000-00011; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; Wilkinson A, 2005, BBA-PROTEINS PROTEOM, V1749, P113, DOI 10.1016/j.bbapap.2005.03.003	35	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41113	10.1371/journal.pone.0041113	http://dx.doi.org/10.1371/journal.pone.0041113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815933	Green Published, gold, Green Submitted			2022-12-25	WOS:000306466100120
J	Bidinosti, M; Shimshek, DR; Mollenhauer, B; Marcellin, D; Schweizer, T; Lotz, GP; Schlossmacher, MG; Weiss, A				Bidinosti, Michael; Shimshek, Derya R.; Mollenhauer, Brit; Marcellin, David; Schweizer, Tatjana; Lotz, Gregor P.; Schlossmacher, Michael G.; Weiss, Andreas			Novel One-step Immunoassays to Quantify alpha-Synuclein APPLICATIONS FOR BIOMARKER DEVELOPMENT AND HIGH-THROUGHPUT SCREENING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; ELEVATED LEVELS; LEWY BODIES; DEMENTIA; OLIGOMERS; MUTATION; PROTEIN; LOCUS; CSF	Familial Parkinson disease (PD) can result from alpha-synuclein gene multiplication, implicating the reduction of neuronal alpha-synuclein as a therapeutic target. Moreover, alpha-synuclein content in human cerebrospinal fluid (CSF) represents a PD biomarker candidate. However, capture-based assays for alpha-synuclein quantification in CSF (such as by ELISA) have shown discrepancies and have limited suitability for high-throughput screening. Here, we describe two sensitive, in-solution, time-resolved Forster's resonance energy transfer (TR-FRET)-based immuno-assays for total and oligomeric alpha-synuclein quantification. CSF analysis showed strong concordance for total alpha-synuclein content between two TR-FRET assays and, in agreement with a previously characterized 36 h protocol-based ELISA, demonstrated lower alpha-synuclein levels in PD donors. Critically, the assay suitability for high-throughput screening of siRNA constructs and small molecules aimed at reducing endogenous alpha-synuclein levels was established and validated. In a small-scale proof of concept compound screen using 384 well plates, signals ranged from < 30 to > 120% of the mean of vehicle-treated cells for molecules known to lower and increase cellular alpha-synuclein, respectively. Furthermore, a reverse genetic screen of a kinase-directed siRNA library identified seven genes that modulated alpha-synuclein protein levels (five whose knockdown increased and two that decreased cellular alpha-synuclein protein). This provides critical new biological insight into cellular pathways regulating alpha-synuclein steady-state expression that may help guide further drug discovery efforts. Moreover, we describe an inherent limitation in current alpha-synuclein oligomer detection methodology, a finding that will direct improvement of future assay design. Our one-step TR-FRET-based platform for alpha-synuclein quantification provides a novel platform with superior performance parameters for the rapid screening of large biomarker cohorts and of compound and genetic libraries, both of which are essential to the development of PD therapies.	[Bidinosti, Michael; Shimshek, Derya R.; Marcellin, David; Schweizer, Tatjana; Lotz, Gregor P.; Weiss, Andreas] Novartis Pharma AG, Novartis Inst Biomed Res, Neurosci Discovery Grp, CH-4002 Basel, Switzerland; [Mollenhauer, Brit] Paracelsus Elena Klin, D-34128 Kassel, Germany; [Mollenhauer, Brit] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Mollenhauer, Brit] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany; [Schlossmacher, Michael G.] Univ Ottawa, Div Neurosci, Ottawa Hosp Res Inst, Ottawa, ON, Canada	Novartis; University of Gottingen; University of Gottingen; University of Ottawa; Ottawa Hospital Research Institute	Weiss, A (corresponding author), Novartis Pharma AG, Novartis Inst Biomed Res, Neurosci Discovery Grp, WSJ 355-2-051-11, CH-4002 Basel, Switzerland.	andreas-1.weiss@novartis.com	Mollenhauer, Brit/F-8863-2010	Shimshek, Derya/0000-0001-8602-7850; Schlossmacher, Michael/0000-0002-0394-0300; Lotz, Gregor/0000-0002-0231-5503	Michael J. Fox Foundation; Parkinson Research Consortium of Ottawa; Government of Canada	Michael J. Fox Foundation; Parkinson Research Consortium of Ottawa; Government of Canada(CGIAR)	This work was supported by funds from the Michael J. Fox Foundation (to B. M. and M. G. S.), the Parkinson Research Consortium of Ottawa, and the Government of Canada (to M. G. S.).	Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cronin KD, 2009, HUM MOL GENET, V18, P3274, DOI 10.1093/hmg/ddp265; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Kasuga K, 2010, J NEUROL NEUROSUR PS, V81, P608, DOI 10.1136/jnnp.2009.197483; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Montine TJ, 2011, NAT REV NEUROL, V7, P308, DOI 10.1038/nrneurol.2011.66; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Noguchi-Shinohara M, 2009, BRAIN RES, V1251, P1, DOI 10.1016/j.brainres.2008.11.055; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rieker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024834; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spies PE, 2009, J ALZHEIMERS DIS, V16, P363, DOI 10.3233/JAD-2009-0955; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tomlinson J. J., 2010, PROTEIN MISFOLDING D, P817; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou ZG, 2011, MOL CELL NEUROSCI, V48, P29, DOI 10.1016/j.mcn.2011.06.002	48	38	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33691	33705		10.1074/jbc.M112.379792	http://dx.doi.org/10.1074/jbc.M112.379792			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22843695	Green Published, hybrid			2022-12-25	WOS:000309602100052
J	Begum, NA; Stanlie, A; Nakata, M; Akiyama, H; Honjo, T				Begum, Nasim A.; Stanlie, Andre; Nakata, Mikiyo; Akiyama, Hideo; Honjo, Tasuku			The Histone Chaperone Spt6 Is Required for Activation-induced Cytidine Deaminase Target Determination through H3K4me3 Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CLASS-SWITCH RECOMBINATION; URACIL DNA GLYCOSYLASE; HEAVY-CHAIN GENES; TRANSCRIPTION ELONGATION; SOMATIC HYPERMUTATION; REPETITIVE SEQUENCES; H3K36 METHYLATION; QUALITY-CONTROL; NONCODING RNAS	H3K4me3 plays a critical role in the activation-induced cytidine deaminase (AID)-induced DNA cleavage of switch (S) regions in the immunoglobulin heavy chain (IgH) locus during class-switch recombination (CSR). The histone chaperone complex facilitates chromatin transcription (FACT) is responsible for forming H3K4me3 at AID target loci. Here we show that the histone chaperone suppressor of Ty6 (Spt6) also participates in regulating H3K4me3 for CSR and for somatic hypermutation in AID target loci. We found that H3K4me3 loss was correlated with defects in AID-induced DNA breakage and reduced mutation frequencies in IgH loci in both S and variable regions and in non-IgH loci such as metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and small nucleolar RNA host gene 3 (SNHG3). Global gene expression analysis revealed that Spt6 can act as both a positive and negative transcriptional regulator in B cells, affecting similar to 5% of the genes that includes suppressor of Ty4 (Spt4) and AID. Interestingly, Spt6 regulates CSR and AID expression through two distinct histone modification pathways, H3K4me3 and H3K36me3, respectively. Tandem SH2 domain of Spt6 plays a critical role in CSR and H3K4me3 regulation involving Set1 histone methyltransferase. We conclude that Spt6 is a unique histone chaperone capable of regulating the histone epigenetic state of both AID targets and the AID locus.	[Begum, Nasim A.; Stanlie, Andre; Nakata, Mikiyo; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan; [Akiyama, Hideo] Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa 2488555, Japan	Kyoto University; Toray Industries, Inc.	Begum, NA (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.	nasim@mfour.med.kyoto-u.ac.jp; honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016	Begum, Nasim/0000-0001-7177-188X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17002015, 24590352]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grant-in-aid for Specially Promoted Research 17002015 and Grant-in-Aid for Scientific Research 24590352 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Close D, 2011, J MOL BIOL, V408, P697, DOI 10.1016/j.jmb.2011.03.002; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; Doi T, 2009, P NATL ACAD SCI USA, V106, P2758, DOI 10.1073/pnas.0813253106; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Endoh M, 2004, MOL CELL BIOL, V24, P3324, DOI 10.1128/MCB.24.8.3324-3336.2004; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Hubert L, 2011, MOL CELL BIOL, V31, P3105, DOI 10.1128/MCB.05158-11; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8; Kato L, 2012, P NATL ACAD SCI USA, V109, P2479, DOI 10.1073/pnas.1120791109; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Liu JP, 2011, J BIOL CHEM, V286, P29218, DOI 10.1074/jbc.M111.252130; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Okazaki I, 2011, P NATL ACAD SCI USA, V108, P7920, DOI 10.1073/pnas.1104423108; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peckl-Schmid D, 2010, EUR J IMMUNOL, V40, P3161, DOI 10.1002/eji.200940221; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Stanlie A, 2010, P NATL ACAD SCI USA, V107, P22190, DOI 10.1073/pnas.1016923108; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Yu KF, 2005, MOL CELL BIOL, V25, P1730, DOI 10.1128/MCB.25.5.1730-1736.2005; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	57	48	50	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32415	32429		10.1074/jbc.M112.351569	http://dx.doi.org/10.1074/jbc.M112.351569			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843687	Green Published, hybrid			2022-12-25	WOS:000309168300012
J	Boscher, C; Zheng, YZ; Lakshminarayan, R; Johannes, L; Dennis, JW; Foster, LJ; Nabi, IR				Boscher, Cecile; Zheng, Yu Zi; Lakshminarayan, Ramya; Johannes, Ludger; Dennis, James W.; Foster, Leonard J.; Nabi, Ivan R.			Galectin-3 Protein Regulates Mobility of N-cadherin and GM1 Ganglioside at Cell-Cell Junctions of Mammary Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; GLYCOSYLATION AFFECTS; ADHERENS JUNCTIONS; PLASMA-MEMBRANE; P120 CATENIN; ASSOCIATION; BINDING; ORGANIZATION; ACTIVATION; RECEPTOR	Galectin-3 binding to cell surface glycoproteins, including branched N-glycans generated by N-acetylglucosaminyltransferase V (Mgat5) activity, forms a multivalent, heterogeneous, and dynamic lattice. This lattice has been shown to regulate integrin and receptor tyrosine kinase signaling promoting tumor cell migration. N-cadherin is a homotypic cell-cell adhesion receptor commonly overexpressed in tumor cells that contributes to cell motility. Here we show that galectin-3 and N-cadherin interact and colocalize with the lipid raft marker GM1 ganglioside in cell-cell junctions of mammary epithelial cancer cells. Disruption of the lattice by deletion of Mgat5, siRNA depletion of galectin-3, or competitive inhibition with lactose stabilizes cell-cell junctions. It also reduces, in a p120-catenin-dependent manner, the dynamic pool of junctional N-cadherin. Proteomic analysis of detergent-resistant membranes (DRMs) revealed that the galectin lattice opposes entry of many proteins into DRM rafts. N-cadherin and catenins are present in DRMs; however, their DRM distribution is not significantly affected by lattice disruption. Galectin lattice integrity increases the mobile fraction of the raft marker, GM1 ganglioside binding cholera toxin B subunit Ctb, at cell-cell contacts in a p120-catenin-independent manner, but does not affect the mobility of either Ctb-labeled GM1 or GFP-coupled N-cadherin in nonjunctional regions. Our results suggest that the galectin lattice independently enhances lateral molecular diffusion by direct interaction with specific glycoconjugates within the adherens junction. By promoting exchange between raft and non-raft microdomains as well as molecular dynamics within junction-specific raft microdomains, the lattice may enhance turnover of N-cadherin and other glycoconjugates that determine junctional stability and rates of cell migration.	[Boscher, Cecile; Nabi, Ivan R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Zheng, Yu Zi; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z, Canada; [Zheng, Yu Zi; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z, Canada; [Lakshminarayan, Ramya; Johannes, Ludger] Inst Curie, Traff Signaling & Delivery Lab, Ctr Rech, CNRS,UMR144, F-75248 Paris 05, France; [Dennis, James W.] Univ Toronto, Dept Med Genet & Lab Med & Pathol, Toronto, ON M5G 1L5, Canada	University of British Columbia; University of British Columbia; University of British Columbia; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of Toronto	Nabi, IR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	irnabi@mail.ubc.ca	Dennis, James/E-7268-2013; Lakshminarayan, Ramya/AAT-9527-2021; Johannes, Ludger/M-9778-2017; Nabi, Ivan/GWZ-5144-2022; Johannes, Ludger/W-8593-2019	Johannes, Ludger/0000-0002-2168-0004; Nabi, Ivan/0000-0002-0670-0513; Johannes, Ludger/0000-0002-2168-0004	Canadian Institutes of Health Research (CIHR) [MOP-43938, MOP-77688]; University of British Columbia Four-year Fellowship; Agence Nationale de la Recherche (ProLipCys); Human Science Frontier Program [RGP26/2007]; Canada Foundation for Innovation; British Columbia (BC) Knowledge Development Fund; BC Proteomics Network	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of British Columbia Four-year Fellowship; Agence Nationale de la Recherche (ProLipCys)(French National Research Agency (ANR)); Human Science Frontier Program(Human Frontier Science Program); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia (BC) Knowledge Development Fund; BC Proteomics Network	This work was supported by Canadian Institutes of Health Research (CIHR) operating Grants MOP-43938 (to I. R. N. and J. W. D.) and MOP-77688 (to L. J. F.).; Supported by a University of British Columbia Four-year Fellowship.; Supported by the Agence Nationale de la Recherche (ProLipCys) and Human Science Frontier Program (Grant RGP26/2007).; The mass spectrometry infrastructure used in this study was supported, in part, by the Canada Foundation for Innovation, the British Columbia (BC) Knowledge Development Fund, and the BC Proteomics Network. These studies were enabled by the imaging platform of LSI Imaging.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Chiu CG, 2010, AM J PATHOL, V176, P2067, DOI 10.2353/ajpath.2010.090353; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Lu SY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000127; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; MEHUL B, 1995, FEBS LETT, V360, P160, DOI 10.1016/0014-5793(95)00100-N; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; RAZ A, 1981, CANCER RES, V41, P3642; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Taulet N, 2009, J BIOL CHEM, V284, P23137, DOI 10.1074/jbc.M109.017665; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thoumine O, 2006, MOL BIOL CELL, V17, P862, DOI 10.1091/mbc.E05-04-0335; Troyanovsky RB, 2007, MOL BIOL CELL, V18, P4343, DOI 10.1091/mbc.E07-01-0084; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; VOLBERG T, 1986, J CELL BIOL, V102, P1832, DOI 10.1083/jcb.102.5.1832; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608; Zheng YZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007146; Zheng YZ, 2009, J PROTEOMICS, V72, P12, DOI 10.1016/j.jprot.2008.09.003	55	72	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32940	32952		10.1074/jbc.M112.353334	http://dx.doi.org/10.1074/jbc.M112.353334			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846995	Green Published, hybrid			2022-12-25	WOS:000309168300058
J	Sakurai, A; Matsuda, M; Kiyokawa, E				Sakurai, Atsuro; Matsuda, Michiyuki; Kiyokawa, Etsuko			Activated Ras Protein Accelerates Cell Cycle Progression to Perturb Madin-Darby Canine Kidney Cystogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL ACINI; LUMEN FORMATION; CANCER; MORPHOGENESIS; MEMBRANE; KINASES; TRANSFORMATION; PROLIFERATION; ARCHITECTURE; MECHANISMS	In a number of human cancer cells, K-RAS is frequently mutated and activated constitutively, culminating in the induction of continuous cell growth, a hallmark of cancer cells. It is still unclear, however, how the mutated K-RAS induces morphological abnormalities in cancerous tissues. To investigate the mechanism underlying the K-RAS-induced morphological changes, we utilized an auxin-dependent protein expression system, which enabled us to rapidly induce and evaluate constitutively active K-Ras in MDCK (Madin-Darby canine kidney) cysts, a model for polarized epithelial structure. Cells carrying the constitutively active KRasV12 gene were morphologically indistinguishable from normal cells in two-dimensional culture. However, in a gel of extracellular matrix, KRasV12-expressing cells failed to form a spherical cyst. When KRasV12 induction was delayed until after cyst formation, some cells in the cyst wall lost polarity and were extruded into and accumulated in the luminal space. With effector-specific mutants of KRasV12 and inhibitors for MEK and PI3-kinase, we found that both the Raf-MEK-ERK and PI3-kinase axes are necessary and sufficient for this phenotype. Live cell imaging with cell cycle indicators showed that KRasV12 expression promoted cell cycle progression, which was prevented by either MEK or PI3-kinase inhibitors. From these results, we provide a model wherein active-Ras induces cell cycle progression leading to apical cell extrusion through Raf and PI3-kinase in a cooperative manner. The system developed here can be applied to drug screening for various cancers originating from epithelial cells.	[Sakurai, Atsuro; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Matsuda, Michiyuki; Kiyokawa, Etsuko] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; [Kiyokawa, Etsuko] Kanazawa Med Univ, Dept Oncol Pathol, Uchinada, Ishikawa 9200293, Japan	Kyoto University; Kyoto University; Kanazawa Medical University	Kiyokawa, E (corresponding author), 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	kiyokawa@kanazawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [22113001, 22590358] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.; Supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.	Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Blum R, 2005, DRUG RESIST UPDATE, V8, P369, DOI 10.1016/j.drup.2005.11.002; BOS JL, 1989, CANCER RES, V49, P4682; BRINKMANN V, 1995, J CELL BIOL, V131, P1573, DOI 10.1083/jcb.131.6.1573; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gutierrez-Barrera AM, 2007, BIOCHEM BIOPH RES CO, V358, P698, DOI 10.1016/j.bbrc.2007.04.166; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Lehnert L, 2001, J CELL BIOL, V152, P911, DOI 10.1083/jcb.152.5.911; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pearson GW, 2007, J CELL BIOL, V179, P1555, DOI 10.1083/jcb.200706099; Pearson GW, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2259; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tarutani M, 2003, CANCER RES, V63, P319; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yagi S, 2012, EMBO REP, V13, P237, DOI 10.1038/embor.2011.249; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	43	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31703	31711		10.1074/jbc.M112.377804	http://dx.doi.org/10.1074/jbc.M112.377804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829590	hybrid, Green Published			2022-12-25	WOS:000309059400012
J	Vogelauer, M; Krall, AS; Mcbrian, MA; Li, JY; Kurdistani, SK				Vogelauer, Maria; Krall, Abigail S.; Mcbrian, Matthew A.; Li, Jing-Yu; Kurdistani, Siavash K.			Stimulation of Histone Deacetylase Activity by Metabolites of Intermediary Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DEACETYLASES; COMPLEX; FAMILY; SIR2; HDAC1; ACETYLATION; INHIBITION; EVOLUTION; SIRTUINS; BINDING	Histone deacetylases (HDACs) function in a wide range of molecular processes, including gene expression, and are of significant interest as therapeutic targets. Although their native complexes, subcellular localization, and recruitment mechanisms to chromatin have been extensively studied, much less is known about whether the enzymatic activity of non-sirtuin HDACs can be regulated by natural metabolites. Here, we show that several coenzyme A (CoA) derivatives, such as acetyl-CoA, butyryl-CoA, HMG-CoA, and malonyl-CoA, as well as NADPH but not NADP(+), NADH, or NAD(+), act as allosteric activators of recombinant HDAC1 and HDAC2 in vitro following a mixed activation kinetic. In contrast, free CoA, like unconjugated butyrate, inhibits HDAC activity in vitro. Analysis of a large number of engineered HDAC1 mutants suggests that the HDAC activity can potentially be decoupled from "activatability" by the CoA derivatives. In vivo, pharmacological inhibition of glucose-6-phosphate dehydrogenase (G6PD) to decrease NADPH levels led to significant increases in global levels of histone H3 and H4 acetylation. The similarity in structures of the identified metabolites and the exquisite selectivity of NADPH over NADP(+), NADH, and NAD(+) as an HDAC activator reveal a previously unrecognized biochemical feature of the HDAC proteins with important consequences for regulation of histone acetylation as well as the development of more specific and potent HDAC inhibitors.	[Vogelauer, Maria; Krall, Abigail S.; Mcbrian, Matthew A.; Li, Jing-Yu; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Vogelauer, Maria; Krall, Abigail S.; Mcbrian, Matthew A.; Li, Jing-Yu; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Li, Jing-Yu; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Mcbrian, Matthew A.; Kurdistani, Siavash K.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	skurdistani@mednet.ucla.edu	Li, Jingyu/GSD-1924-2022	Kurdistani, Siavash/0000-0003-3295-3511	California Institute for Regenerative Medicine award; Beckman Young Investigator award; Howard Hughes Medical Institute Early Career award; UCLA Genetics Training Grant fellowship	California Institute for Regenerative Medicine award; Beckman Young Investigator award; Howard Hughes Medical Institute Early Career award(Howard Hughes Medical Institute); UCLA Genetics Training Grant fellowship	This work was supported in part by a California Institute for Regenerative Medicine award and Beckman Young Investigator and Howard Hughes Medical Institute Early Career awards (to S. K. K.).; Supported in part by a UCLA Genetics Training Grant fellowship.	Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Cairns SP, 2008, EXP PHYSIOL, V93, P851, DOI 10.1113/expphysiol.2007.041285; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; CORNISHBOWDEN A, 1986, FEBS LETT, V203, P3, DOI 10.1016/0014-5793(86)81424-7; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dowling DP, 2008, CELL MOL LIFE SCI, V65, P2039, DOI 10.1007/s00018-008-7554-z; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hagelkruys Astrid, 2011, Handb Exp Pharmacol, V206, P13, DOI 10.1007/978-3-642-21631-2_2; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hill AV, 1909, J PHYSIOL-LONDON, V39, P361; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Johnson CA, 2002, J BIOL CHEM, V277, P9590, DOI 10.1074/jbc.M107942200; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Leunissen CLF, 2011, RES DEV DISABIL, V32, P2660, DOI 10.1016/j.ridd.2011.06.007; Levy H R, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P97; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Reinhart GD, 2004, METHOD ENZYMOL, V380, P187; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; ZIBOH VA, 1970, J LIPID RES, V11, P346	37	58	59	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32006	32016		10.1074/jbc.M112.362467	http://dx.doi.org/10.1074/jbc.M112.362467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822071	Green Published, hybrid			2022-12-25	WOS:000309059400039
J	Zhou, XB; Wulfsen, I; Korth, M; McClafferty, H; Lukowski, R; Shipston, MJ; Ruth, P; Dobrev, D; Wieland, T				Zhou, Xiaobo; Wulfsen, Iris; Korth, Michael; McClafferty, Heather; Lukowski, Robert; Shipston, Michael J.; Ruth, Peter; Dobrev, Dobromir; Wieland, Thomas			Palmitoylation and Membrane Association of the Stress Axis Regulated Insert (STREX) Controls BK Channel Regulation by Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; SMOOTH-MUSCLE; NEURONAL DEVELOPMENT; ADRENAL CHROMAFFIN; CELLS; PHOSPHORYLATION; PITUITARY; EXPRESSION; CGMP	Large-conductance, calcium- and voltage-gated potassium (BK) channels play an important role in cellular excitability by controlling membrane potential and calcium influx. The stress axis regulated exon (STREX) at splice site 2 inverts BK channel regulation by protein kinase A(PKA) from stimulatory to inhibitory. Here we show that palmitoylation of STREX controls BK channel regulation also by protein kinase C(PKC). In contrast to the 50% decrease of maximal channel activity by PKC in the insertless (ZERO) splice variant, STREX channels were completely resistant to PKC. STREX channel mutants in which Ser(700), located between the two regulatory domains of K+ conductance (RCK) immediately downstream of the STREX insert, was replaced by the phosphomimetic amino acid glutamate (S700E) showed a similar to 50% decrease in maximal channel activity, whereas the S700A mutant retained its normal activity. BK channel inhibition by PKC, however, was effectively established when the palmitoylation-mediated membrane-anchor of the STREX insert was removed by either pharmacological inhibition of palmitoyl transferases or site-directed mutagenesis. These findings suggest that STREX confers a conformation on BK channels where PKC fails to phosphorylate and to inhibit channel activity. Importantly, PKA which inhibits channel activity by disassembling the STREX insert from the plasma membrane, allows PKC to further suppress the channel gating independent from voltage and calcium. Our results present an important example for the cross-talk between ion channel palmitoylation and phosphorylation in regulation of cellular excitability.	[Zhou, Xiaobo; Dobrev, Dobromir] Univ Heidelberg, Mannheim Med Fac, Div Expt Cardiol, D-68167 Mannheim, Germany; [Wulfsen, Iris] Univ Med Ctr Hamburg Eppendorf, Sch Life Sci Hamburg gGmbH, D-20246 Hamburg, Germany; [Korth, Michael] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, D-20246 Hamburg, Germany; [McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Lukowski, Robert; Ruth, Peter] Univ Tubingen, Inst Pharm, Div Pharmacol Toxicol & Clin Pharm, D-72076 Tubingen, Germany; [Wieland, Thomas] Univ Heidelberg, Mannheim Med Fac, Inst Expt & Clin Pharmacol & Toxicol, D-68169 Mannheim, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Edinburgh; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Zhou, XB (corresponding author), Univ Heidelberg, Mannheim Med Fac, Div Expt Cardiol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	xiaobo.zhou@medma.uni-heidelberg.de; thomas.wieland@medma.uni-heidelberg.de	Dobrev, Dobromir/C-7388-2014; Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/AAS-1666-2020; Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012; Shipston, Mike/C-7309-2013; Zhou, Xiaobo/AAH-4320-2019	Dobrev, Dobromir/0000-0002-4612-117X; Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/0000-0002-4612-117X; Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Shipston, Mike/0000-0001-7544-582X; 	German Center for Cardiovascular Research; Deutsche Forschungsgemeinschaft [SFB 773]	German Center for Cardiovascular Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported the German Center for Cardiovascular Research (grants to D. D. and T. W.) and the Deutsche Forschungsgemeinschaft (SFB 773, Project A2 to P. R.)	Barman SA, 2004, AM J PHYSIOL-LUNG C, V286, pL1275, DOI 10.1152/ajplung.00259.2003; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Ferrer J, 1996, DIABETOLOGIA, V39, P891, DOI 10.1007/BF00403907; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Hall SK, 2000, J BIOL CHEM, V275, P3749, DOI 10.1074/jbc.275.6.3749; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holdiman AJ, 2002, MOL CELL ENDOCRINOL, V192, P1, DOI 10.1016/S0303-7207(02)00136-3; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Kundu P, 2007, J BIOL CHEM, V282, P27478, DOI 10.1074/jbc.M704777200; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; Lai GJ, 2006, ENDOCRINOLOGY, V147, P3961, DOI 10.1210/en.2005-1551; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lovell PV, 2001, J NEUROSCI, V21, P3429, DOI 10.1523/JNEUROSCI.21-10-03429.2001; Mahmoud SF, 2004, J NEUROENDOCRINOL, V16, P237, DOI 10.1111/j.0953-8194.2004.01154.x; Mahmoud SF, 2002, J NEUROSCI METH, V115, P189, DOI 10.1016/S0165-0270(02)00015-8; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; Ruth P, 1997, J BIOL CHEM, V272, P10522; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Schubert R, 1999, AM J PHYSIOL-CELL PH, V276, pC648, DOI 10.1152/ajpcell.1999.276.3.C648; Shipston MJ, 1996, J PHYSIOL-LONDON, V493, P665, DOI 10.1113/jphysiol.1996.sp021413; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2003, J BIOL CHEM, V278, P8669, DOI 10.1074/jbc.M211661200; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107; Zhu N, 2005, FEBS LETT, V579, P4856, DOI 10.1016/j.febslet.2005.07.069	45	42	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32161	32171		10.1074/jbc.M112.386359	http://dx.doi.org/10.1074/jbc.M112.386359			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843729	hybrid, Green Published			2022-12-25	WOS:000309059400053
J	Buggele, WA; Johnson, KE; Horvath, CM				Buggele, William A.; Johnson, Karen E.; Horvath, Curt M.			Influenza A Virus Infection of Human Respiratory Cells Induces Primary MicroRNA Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; POSTTRANSCRIPTIONAL REGULATION; CELLULAR MICRORNAS; MESSENGER-RNAS; ANTIVIRAL IMMUNITY; SIGNALING PROTEINS; INNATE IMMUNITY; DEADENYLATION; REPLICATION; RECOGNITION	The cellular response to virus infection is initiated by recognition of the invading pathogen and subsequent changes in gene expression mediated by both transcriptional and translational mechanisms. In addition to well established means of regulating antiviral gene expression, it has been demonstrated that RNA interference (RNAi) can play an important role in antiviral responses. Virus-derived small interfering RNA (siRNA) is a primary antiviral response exploited by plants and invertebrate animals, and host-encoded microRNA (miRNA) species have been clearly implicated in the regulation of innate and adaptive immune responses in mammals and other vertebrates. Examination of miRNA abundance in human lung cell lines revealed endogenous miRNAs, including miR-7, miR-132, miR-146a, miR-187, miR-200c, and miR-1275, to specifically accumulate in response to infection with two influenza A virus strains, A/Udorn/72 and A/WSN/33. Known antiviral response pathways, including Toll-like receptor, RIG-I-like receptor, and direct interferon or cytokine stimulation did not alter the abundance of the tested miRNAs to the extent of influenza A virus infection, which initiates primary miRNA transcription via a secondary response pathway. Gene expression profiling identified 26 cellular mRNAs targeted by these miRNAs, including IRAK1, MAPK3, and other components of innate immune signaling systems.	[Buggele, William A.; Johnson, Karen E.; Horvath, Curt M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Horvath, CM (corresponding author), Northwestern Univ, Dept Mol Biosci, Pancoe Pavil,Rm 4401,2200 Campus Dr, Evanston, IL 60208 USA.	horvath@northwestern.edu		Horvath, Curt/0000-0003-2449-225X	National Institutes of Health from the NIAID IMVC program [U01AI082984]; National Institutes of Health Cellular and Molecular Basis of Disease Training Grant [T32 GM008061]; Robert H. Lurie Comprehensive Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID IMVC program; National Institutes of Health Cellular and Molecular Basis of Disease Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert H. Lurie Comprehensive Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01AI082984 from the NIAID IMVC program.; Supported by a predoctoral fellowship from the National Institutes of Health Cellular and Molecular Basis of Disease Training Grant T32 GM008061 and a Malkin Scholar award from the Robert H. Lurie Comprehensive Cancer Center.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; KRUG RM, 1979, CELL, V18, P329, DOI 10.1016/0092-8674(79)90052-7; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Perry MM, 2009, FEBS LETT, V583, P3349, DOI 10.1016/j.febslet.2009.09.038; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-512; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com	52	90	95	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31027	31040		10.1074/jbc.M112.387670	http://dx.doi.org/10.1074/jbc.M112.387670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822053	Green Published, hybrid			2022-12-25	WOS:000308791300016
J	Janzer, A; Stamm, K; Becker, A; Zimmer, A; Buettner, R; Kirfel, J				Janzer, Andreas; Stamm, Katrin; Becker, Astrid; Zimmer, Andreas; Buettner, Reinhard; Kirfel, Jutta			The H3K4me3 Histone Demethylase Fbxl10 Is a Regulator of Chemokine Expression, Cellular Morphology, and the Metabolome of Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASES; DEPENDENT MANNER; BINDING PROTEIN; 1 LSD1; CELLS; PHD; TRANSCRIPTION; APOPTOSIS; DOMAIN; PROLIFERATION	Fbxl10 (Jhdm1b/Kdm2b) is a conserved and ubiquitously expressed member of the JHDM (JmjC domain-containing histone demethylase) family. Fbxl10 was implicated in the demethylation of H3K4me3 or H3K36me2 thereby removing active chromatin marks and inhibiting gene transcription. Apart from the JmjC domain, Fbxl10 consists of a CxxC domain, a PHD domain, and an Fbox domain. By purifying the JmjC and the PHD domain of Fbxl10 and using different approaches we were able to characterize the properties of these domains in vitro. Our results suggest that Fbxl10 is rather a H3K4me3 than a H3K36me2 histone demethylase. The PHD domain exerts a dual function in binding H3K4me3 and H3K36me2 and exhibiting E3 ubiquitin ligase activity. We generated mouse embryonic fibroblasts stably overexpressing Fbxl10. These cells reveal an increase in cell size but no changes in proliferation, mitosis, or apoptosis. Using a microarray approach we were able to identify potentially new target genes for Fbxl10 including chemokines, the noncoding RNA Xist, and proteins involved in metabolic processes. Additionally, we found that Fbxl10 is recruited to the promoters of Ccl7, Xist, Crabp2, and RipK3. Promoter occupancy by Fbxl10 was accompanied by reduced levels of H3K4me3 but unchanged levels of H3K36me2. Furthermore, knockdown of Fbxl10 using small interfering RNA approaches showed inverse regulation of Fbxl10 target genes. In summary, our data reveal a regulatory role of Fbxl10 in cell morphology, chemokine expression, and the metabolic control of fibroblasts.	[Janzer, Andreas; Kirfel, Jutta] Univ Bonn, Inst Pathol, D-53127 Bonn, Germany; [Stamm, Katrin; Buettner, Reinhard] Univ Cologne, Inst Pathol, D-50924 Cologne, Germany; [Becker, Astrid; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, D-53127 Bonn, Germany	University of Bonn; University of Cologne; University of Bonn	Kirfel, J (corresponding author), Univ Bonn, Inst Pathol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	jutta.kirfel@ukb.uni-bonn.de	Zimmer, Andreas/B-8357-2009		Deutsche Forschungsgemeinschaft Grants [GRK 804, FOR 926]	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grants GRK 804 and FOR 926.	Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chasapis CT, 2009, CURR PHARM DESIGN, V15, P3716, DOI 10.2174/138161209789271825; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Eyman D, 2009, J CELL PHYSIOL, V220, P376, DOI 10.1002/jcp.21776; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Ge R, 2011, CELL DEATH DIFFER, V18, P1184, DOI 10.1038/cdd.2010.185; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Hembruff SL, 2010, NEOPLASIA, V12, P425, DOI 10.1593/neo.10200; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Janzer A, 2012, BIOCHEM BIOPH RES CO, V421, P665, DOI 10.1016/j.bbrc.2012.04.057; Kavi Harsh H, 2009, BMC Res Notes, V2, P217, DOI 10.1186/1756-0500-2-217; Konuma T, 2011, EXP HEMATOL, V39, P697, DOI 10.1016/j.exphem.2011.03.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; McWhinnie R, 2007, AM J PHYSIOL-LUNG C, V292, pL278, DOI 10.1152/ajplung.00111.2006; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Upadhyay AK, 2011, PROG DRUG RES, V67, P107, DOI 10.1007/978-3-7643-8989-5_6; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	38	53	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30984	30992		10.1074/jbc.M112.341040	http://dx.doi.org/10.1074/jbc.M112.341040			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22825849	Green Published, hybrid			2022-12-25	WOS:000308791300012
J	Pednekar, MS; Hakama, M; Gupta, PC				Pednekar, Mangesh S.; Hakama, Matti; Gupta, Prakash C.			Tobacco Use or Body Mass - Do They Predict Tuberculosis Mortality in Mumbai, India? Results from a Population-Based Cohort Study	PLOS ONE			English	Article							EXCLUDING EARLY DEATHS; ALL-CAUSE; SMOKING; INDEX; ASSOCIATION; BOMBAY; RISK; HEALTH	Tobacco use and under-nutrition are major public health concerns and tuberculosis is a major cause of morbidity and mortality in India. Using a cohort of 148,173 persons (recruited 1991-1997 and followed-up 1997-2003) the joint effects of tobacco use and BMI on tuberculosis mortality was studied. Tobacco use in any form and low-BMI had joint effect on tuberculosis mortality and the interaction effect was synergistic in men and antagonistic in women. Self-reported tuberculosis was associated with increased risk of tuberculosis mortality. In contrast, no such association was observed for self-reported diabetes persons. The risk pattern remained unchanged even after excluding tuberculosis deaths occurred within 1 st two years of follow-up. This study highlights importance of age consideration of individual while excluding early deaths. Around 27% male tuberculosis deaths were attributable to their being underweight and smoker, while 22% male and 37% female deaths were attributable to their being underweight and smokeless tobacco user.	[Pednekar, Mangesh S.; Gupta, Prakash C.] Sekhsaria Inst Publ Hlth, Cbd Belapur, India; [Hakama, Matti] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland	Tampere University	Pednekar, MS (corresponding author), Sekhsaria Inst Publ Hlth, Cbd Belapur, India.	pednekarmangesh@rediffmail.com		Pednekar, Mangesh/0000-0001-6266-5356	International Agency for Research on Cancer, Lyon, France; Clinical Trial Service Unit of the University of Oxford, Oxford, United Kingdom; World Health Organization Geneva, Switzerland; Centre for Global Health Research, University of Toronto, Toronto, Canada	International Agency for Research on Cancer, Lyon, France; Clinical Trial Service Unit of the University of Oxford, Oxford, United Kingdom; World Health Organization Geneva, Switzerland(World Health Organization); Centre for Global Health Research, University of Toronto, Toronto, Canada	The authors appreciate the collaborative efforts of the International Agency for Research on Cancer, Lyon, France; the Clinical Trial Service Unit of the University of Oxford, Oxford, United Kingdom; the World Health Organization Geneva, Switzerland; and Centre for Global Health Research, University of Toronto, Toronto, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Allison DB, 1999, ANN EPIDEMIOL, V9, P132, DOI 10.1016/S1047-2797(98)00039-8; Allison DB, 1999, OBES RES, V7, P342, DOI 10.1002/j.1550-8528.1999.tb00417.x; [Anonymous], 2011, GLOB TUB CONTR; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Corwin Elizabeth J, 2002, Biol Res Nurs, V3, P222, DOI 10.1177/109980040200300407; COX DR, 1972, J R STAT SOC B, V34, P187; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Ezzati M, 2004, COMP QUANTIFICATION, V2; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Keusch GT, 2003, J NUTR, V133, p336S, DOI 10.1093/jn/133.1.336S; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; MARTI B, 1989, BRIT MED J, V298, P1287, DOI 10.1136/bmj.298.6683.1287; Maurya V, 2002, INT J TUBERC LUNG D, V6, P942; Moszczynski P, 2001, TOXICOL LETT, V118, P121, DOI 10.1016/S0378-4274(00)00270-8; Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Pednekar MS, 2008, AM J EPIDEMIOL, V167, P330, DOI 10.1093/aje/kwm293; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Pednekar MS, 2012, ALCOHOL, V46, P139, DOI 10.1016/j.alcohol.2011.08.006; Pednekar MS, 2009, CANCER EPIDEMIOL, V33, P424, DOI 10.1016/j.canep.2009.09.007; Pednekar MS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-70; Pednekar MS, 2008, ACTA U TAMPERENSIS, V1340; Reddy KS, 2004, REPORT TOBACCO CONTR; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Shukla HC, 2002, J EPIDEMIOL COMMUN H, V56, P876, DOI 10.1136/jech.56.11.876; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Sorensen G, 2005, AM J PUBLIC HEALTH, V95, P1003, DOI 10.2105/AJPH.2004.045039; Stevens J, 2001, AM J EPIDEMIOL, V153, P946, DOI 10.1093/aje/153.10.946; Yew WW, 2006, AM J RESP CRIT CARE, V174, P236, DOI 10.1164/rccm.200605-669ED	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39443	10.1371/journal.pone.0039443	http://dx.doi.org/10.1371/journal.pone.0039443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848354	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950200010
J	Gismondi, E; Rigaud, T; Beisel, JN; Cossu-Leguille, C				Gismondi, Eric; Rigaud, Thierry; Beisel, Jean-Nicolas; Cossu-Leguille, Carole			Effect of Multiple Parasitic Infections on the Tolerance to Pollutant Contamination	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; POMPHORHYNCHUS-LAEVIS ACANTHOCEPHALA; AMPHIPOD GAMMARUS-ROESELI; INTERMEDIATE HOST; MICROSPORIDIA PARASITES; TRANSMISSION STRATEGIES; POLYMORPHUS-MINUTUS; NONHOST PREDATOR; CADMIUM EXPOSURE; FIELD EVIDENCE	The horizontally-transmitted acanthocephalan parasite Polymorphus minutus and the vertically-transmitted microsporidian parasite Dictyocoela roeselum have both been shown to influence on the antitoxic responses of mono-infected Gammarus roeseli exposed to cadmium. The present study investigates the effect of this co-infection on the antitoxic defence responses of naturally infected females exposed to cadmium stress. Our results revealed that, depending on the cadmium dose, bi-infection induced only slight, significant increased cell damage in G. roeseli as compared to non-infection. In addition, the antitoxic defence pattern of cadmium-exposed bi-infected hosts was similar to the pattern of cadmium-exposed D. roeselum-infected hosts. Reduced glutathione concentrations, carotenoid levels and c-glutamylcystein ligase activity decreased, while metallothionein concentrations increased. This similar pattern indicates that host physiology can be controlled to some extent by microsporidia under stress conditions. It supports the hypothesis of a disruption of acanthocephalan effects in the presence of microsporidia. However, the global negative effects of bi-infection on host condition should be tested on more biological models, since competition between parasites depends on life history trade-off.	[Gismondi, Eric; Beisel, Jean-Nicolas; Cossu-Leguille, Carole] UdL, LIEBE, Metz, France; [Rigaud, Thierry] Univ Bourgogne, Equipe Ecol Evolut, Dijon, France	Universite de Lorraine; Universite de Bourgogne	Gismondi, E (corresponding author), UdL, LIEBE, Campus Bridoux,Bat IBiSE, Metz, France.	eric.gismondi@hotmail.fr	Gismondi, Eric/ABC-4356-2020; Rigaud, Thierry/ABE-2552-2020; Rigaud, Thierry/T-4053-2017; Beisel, Jean-Nicolas/H-4392-2011	Rigaud, Thierry/0000-0002-0163-6639; Rigaud, Thierry/0000-0002-0163-6639; Beisel, Jean-Nicolas/0000-0002-1935-7689; Cossu-Leguille, Carole/0000-0002-6284-4415; Gismondi, Eric/0000-0003-3102-3443	French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche); research program EC2CO (Ecosphere Continentale et Cotiere)	French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche); research program EC2CO (Ecosphere Continentale et Cotiere)	This study was supported by the French Ministry of Education and Research (Ministere de l'Enseignement Superieur et de la Recherche). The present work was funded by the research program EC2CO (Ecosphere Continentale et Cotiere). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhama J, 2006, J CHROMATOGR A, V1107, P52, DOI 10.1016/j.chroma.2005.11.057; Allan IJ, 2006, TALANTA, V69, P302, DOI 10.1016/j.talanta.2005.09.043; Baudrimont M, 2007, PARASITOLOGY, V134, P237, DOI 10.1017/S0031182006001375; Bauer A, 2000, INT J PARASITOL, V30, P1453, DOI 10.1016/S0020-7519(00)00138-7; BEHRENS WA, 1991, LIPIDS, V26, P232, DOI 10.1007/BF02543977; Beisel JN, 2010, ETHOL ECOL EVOL, V22, P265, DOI 10.1080/03949370.2010.502321; Beliaeff B, 2002, ENVIRON TOXICOL CHEM, V21, P1316, DOI 10.1002/etc.5620210629; Ben-Ami F, 2011, J EVOLUTION BIOL, V24, P1307, DOI 10.1111/j.1420-9101.2011.02264.x; Bigot A, 2011, ENVIRON TOXICOL, V26, P623, DOI 10.1002/tox.20599; Bollache L, 2002, J INVERTEBR PATHOL, V79, P102, DOI 10.1016/S0022-2011(02)00027-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; CARGILL AS, 1985, FRESHWATER BIOL, V15, P455, DOI 10.1111/j.1365-2427.1985.tb00215.x; Cezilly F, 2000, PARASITOLOGY, V120, P625, DOI 10.1017/S0031182099005910; Dezfuli BS, 2003, J FISH DIS, V26, P155, DOI 10.1046/j.1365-2761.2003.00446.x; Dianne L, 2011, EVOLUTION, V65, P2692, DOI 10.1111/j.1558-5646.2011.01330.x; GILCHRIST BM, 1972, COMP BIOCHEM PHYSIOL, V42, P263, DOI 10.1016/0305-0491(72)90273-8; Gismondi E, 2012, PARASITOLOGY, V139, P1054, DOI 10.1017/S0031182012000315; Gismondi E, ECOTOXICOLO IN PRESS; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Haine ER, 2004, INT J PARASITOL, V34, P1137, DOI 10.1016/j.ijpara.2004.06.006; Haine ER, 2005, P ROY SOC B-BIOL SCI, V272, P2505, DOI 10.1098/rspb.2005.3244; Hughes WOH, 2004, P ROY SOC B-BIOL SCI, V271, pS104, DOI 10.1098/rsbl.2003.0115; Hynes H. B. N., 1963, Journal of Helminthology, V37, P185, DOI 10.1017/S0022149X00003771; Jones EO, 2007, J THEOR BIOL, V246, P10, DOI 10.1016/j.jtbi.2006.12.007; Jones EO, 2010, EVOLUTION, V64, P2408, DOI 10.1111/j.1558-5646.2010.00992.x; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1, DOI 10.2277/ 0521850088; Kunz PY, 2010, REV ENVIRON CONTAM T, V205, P1, DOI 10.1007/978-1-4419-5623-1_1; Lagrue C, 2007, ECOLOGY, V88, P2839, DOI 10.1890/06-2105.1; LEROY P, 1993, CHROMATOGRAPHIA, V36, P130, DOI 10.1007/BF02263849; Lohr JN, 2010, PARASITOLOGY, V137, P1493, DOI 10.1017/S0031182010000296; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marcogliese DJ, 2005, DIS AQUAT ORGAN, V63, P77, DOI 10.3354/dao063077; Maynard BJ, 1998, J PARASITOL, V84, P1102, DOI 10.2307/3284656; MCCAHON CP, 1991, FRESHWATER BIOL, V25, P507, DOI 10.1111/j.1365-2427.1991.tb01393.x; Medoc V, 2006, INT J PARASITOL, V36, P1351, DOI 10.1016/j.ijpara.2006.07.001; Medoc V, 2009, NATURWISSENSCHAFTEN, V96, P513, DOI 10.1007/s00114-008-0503-8; Medoc V, 2009, ANIM BEHAV, V77, P1235, DOI 10.1016/j.anbehav.2009.01.029; Minguez L, 2009, ENVIRON RES, V109, P843, DOI 10.1016/j.envres.2009.07.012; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; PALOZZA P, 1992, METHOD ENZYMOL, V213, P403; Parmentier C, 1998, J CHROMATOGR B, V719, P37, DOI 10.1016/S0378-4347(98)00414-9; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Perrot-Minnot MJ, 2004, INT J PARASITOL, V34, P45, DOI 10.1016/j.ijpara.2003.10.005; Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1; Rauque CA, 2009, J INVERTEBR PATHOL, V100, P35, DOI 10.1016/j.jip.2008.10.001; Rigaud T, 2005, BEHAV PROCESS, V68, P259, DOI 10.1016/j.beproc.2004.09.005; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; ROESIJADI G, 1992, AQUAT TOXICOL, V22, P81, DOI 10.1016/0166-445X(92)90026-J; Sparkes TC, 1996, OECOLOGIA, V106, P166, DOI 10.1007/BF00328595; Sures B, 2007, J HELMINTHOL, V81, P191, DOI 10.1017/S0022149X07751465; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Thomas MB, 2003, ECOL LETT, V6, P183, DOI 10.1046/j.1461-0248.2003.00414.x; Vasseur P, 2004, ENVIRON TOXICOL, V19, P433, DOI 10.1002/tox.20024	56	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41950	10.1371/journal.pone.0041950	http://dx.doi.org/10.1371/journal.pone.0041950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844535	Green Published, gold			2022-12-25	WOS:000309240600058
J	Li, SW; He, J; Li, S; Cao, GQ; Tang, ST; Tong, QS; Joshi, HC				Li, Shiwang; He, Jing; Li, Shuai; Cao, Guoqing; Tang, Shaotao; Tong, Qiangsong; Joshi, Harish C.			Noscapine Induced Apoptosis via Downregulation of Survivin in Human Neuroblastoma Cells Having Wild Type or Null p53	PLOS ONE			English	Article							CANCER CELLS; AGENTS; EXPRESSION; PROTEIN; GROWTH; GENE; INHIBITOR; PATHWAY; ASSAY; IAPS	Neuroblastoma is the most common extracranial solid tumor of childhood. It accounts for 15% of pediatric cancer deaths. Chemotherapy is the mainstay of treatment in children with advanced neuroblastoma. Noscapine, a nontoxic natural compound, can trigger apoptosis in many cancer types. We now show that p53 is dispensable for Noscapine-induced cell death in neuroblastoma cell lines, proapoptotic response to this promising chemopreventive agent is mediated by suppression of survivin protein expression. The Noscapine treatment increased levels of total and Ser(15)-phosphorylated p53 protein in SK-SY5Y cells, but the proapoptotic response to this agent was maintained even after knockdown of the p53 protein level. Exposure of SK-SY5Y and LA1-5S cells to Noscapine resulted in a marked decrease in protein and mRNA level of survivin as early as 12 hours after treatment. Ectopic expression of survivin conferred statistically significant protection against Noscapine-mediated cytoplasmic histone-associated apoptotic DNA fragmentation. Also, the Noscapine-induced apoptosis was modestly but statistically significantly augmented by RNA interference of survivin in both cell lines. Furthermore, Noscapine-induced apoptotic cell death was associated with activation of caspase-3 and cleavage of PARP. In conclusion, the present study provides novel insight into the molecular circuitry of Noscapine-induced apoptosis to indicate suppression of survivin expression as a critical mediator of this process.	[He, Jing] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430074, Peoples R China; [Li, Shiwang; Li, Shuai; Cao, Guoqing; Tang, Shaotao; Tong, Qiangsong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat Surg, Wuhan 430074, Peoples R China; [Joshi, Harish C.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Emory University	He, J (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430074, Peoples R China.	jing937@hotmail.com	Tong, Qiangsong/B-4500-2014	Tong, Qiangsong/0000-0002-2615-6404	National Natural Science Foundation of China (NSFC) [81070429, 30600278, 30772359]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Grant support: the National Natural Science Foundation of China (NSFC) grants 81070429 (Jing He), 30600278 and 30772359 (Qiangsong Tong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Anderson JT, 2005, J MED CHEM, V48, P7096, DOI 10.1021/jm050674q; Anderson JT, 2005, J MED CHEM, V48, P2756, DOI 10.1021/jm0494220; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2007, CANCER RES, V67, P3862, DOI 10.1158/0008-5472.CAN-06-4282; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Arkin M, 2005, CURR OPIN CHEM BIOL, V9, P317, DOI 10.1016/j.cbpa.2005.03.001; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Duflos Alain, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P55, DOI 10.2174/1568011023354452; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gu L, 2011, ONCOGENE; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; He J, 2011, CELL CYCLE, V10, P2994, DOI 10.4161/cc.10.17.17118; Heidari N, 2007, ANTI-CANCER DRUG, V18, P1139, DOI 10.1097/CAD.0b013e3282eea257; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Ke Y, 2000, CANCER IMMUNOL IMMUN, V49, P217, DOI 10.1007/s002620000109; Landen JW, 2004, CLIN CANCER RES, V10, P5187, DOI 10.1158/1078-0432.CCR-04-0360; Landen JW, 2002, CANCER RES, V62, P4109; Lens SMA, 2003, CELL CYCLE, V2, P507, DOI 10.4161/cc.2.6.559; Li FZ, 1999, CANCER RES, V59, P3143; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Reed JC, 2000, CELL, V102, P545, DOI 10.1016/S0092-8674(00)00076-3; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Rowinsky EK, 1997, ANNU REV MED, V48, P353; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Tamm I, 2004, CLIN CANCER RES, V10, P3737, DOI 10.1158/1078-0432.CCR-03-0642; Tamm I, 1998, CANCER RES, V58, P5315; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tanaka N, 2008, INT J ONCOL, V33, P815, DOI 10.3892/ijo_00000069; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; von Reitzenstein C, 2001, EUR J BIOCHEM, V268, P326, DOI 10.1046/j.1432-1327.2001.01883.x; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	40	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40076	10.1371/journal.pone.0040076	http://dx.doi.org/10.1371/journal.pone.0040076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848370	gold, Green Published, Green Submitted			2022-12-25	WOS:000309240600006
J	Bomtorin, AD; Barchuk, AR; Moda, LM; Simoes, ZLP				Bomtorin, Ana Durvalina; Barchuk, Angel Roberto; Moda, Livia Maria; Paulino Simoes, Zila Luz			Hox Gene Expression Leads to Differential Hind Leg Development between Honeybee Castes	PLOS ONE			English	Article							BEE APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; CUTICLE GENE; CUTICULAR PROTEINS; JUVENILE-HORMONE; ULTRABITHORAX; EVOLUTION; TOOL; MECHANORECEPTORS; CYTOCHROME-P450	Beyond the physiological and behavioural, differences in appendage morphology between the workers and queens of Apis mellifera are pre-eminent. The hind legs of workers, which are highly specialized pollinators, deserve special attention. The hind tibia of worker has an expanded bristle-free region used for carrying pollen and propolis, the corbicula. In queens this structure is absent. Although the morphological differences are well characterized, the genetic inputs driving the development of this alternative morphology remain unknown. Leg phenotype determination takes place between the fourth and fifth larval instar and herein we show that the morphogenesis is completed at brown-eyed pupa. Using results from the hybridization of whole genome-based oligonucleotide arrays with RNA samples from hind leg imaginal discs of pre-pupal honeybees of both castes we present a list of 200 differentially expressed genes. Notably, there are castes preferentially expressed cuticular protein genes and members of the P450 family. We also provide results of qPCR analyses determining the developmental transcription profiles of eight selected genes, including abdominal-A, distal-less and ultrabithorax (Ubx), whose roles in leg development have been previously demonstrated in other insect models. Ubx expression in workers hind leg is approximately 25 times higher than in queens. Finally, immunohistochemistry assays show that Ubx localization during hind leg development resembles the bristles localization in the tibia/basitarsus of the adult legs in both castes. Our data strongly indicate that the development of the hind legs diphenism characteristic of this corbiculate species is driven by a set of caste-preferentially expressed genes, such as those encoding cuticular protein genes, P450 and Hox proteins, in response to the naturally different diets offered to honeybees during the larval period.	[Bomtorin, Ana Durvalina; Moda, Livia Maria] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil; [Barchuk, Angel Roberto] Univ Fed Alfenas, Inst Ciencias Biomed, Dept Biol Celular Tecidual & Desenvolvimento, Alfenas, MG, Brazil; [Paulino Simoes, Zila Luz] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Alfenas; Universidade de Sao Paulo	Bomtorin, AD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil.	zlpsimoe@usp.br	Simoes, Zila Luz Paulino/H-7314-2014; Bomtorin, Ana/I-8817-2012; Moda, Livia M/I-6451-2012	Bomtorin, Ana/0000-0002-3331-7843; Moda, Livia M/0000-0001-6381-7788; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) [2005/03926-5, 2011/03171-5, 2009/05675-0, 2004/08868-0]	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by the Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP grants 2005/03926-5 and 2011/03171-5), which also provided a fellowship to ADB (2009/05675-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Luiz Roberto Aguiar for technical assistance in the apiary of Ribeira ~ o Preto; Marcela A. F. B. Laure for technical assistance during dissections; Jose ' Augusto Maulin and Maria Dolores Seabra Ferreira for help with the scanning electron microscope; Dr. Rodrigo Panepucci for the Axon Genepix 4000B scanner; Lenaldo Branco Rocha for help with Laser Confocal Microscopy [ facility at FMRP- USP ( FAPESP grant number 2004/08868-0)]; Robert White for the FP6.87 antibody and Ricardo G. P. Ramos for secondary antibodies. We also thank Dr. Alexandre S. Cristino for his help with the Limma package for microarray analyses, and Dr. Klaus Hartfelder and anonymous reviewers for critical comments on an earlier version of this manuscript.	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alonso CR, 2002, CURR BIOL, V12, pR776, DOI 10.1016/S0960-9822(02)01291-5; Andersen SO, 2011, INSECT BIOCHEM MOLEC, V41, P620, DOI 10.1016/j.ibmb.2011.03.015; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Charroux B, 2006, DEV BIOL, V291, P278, DOI 10.1016/j.ydbio.2005.12.012; COHEN SM, 1989, EMBO J, V8, P2045, DOI 10.1002/j.1460-2075.1989.tb03613.x; Crickmore MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000633; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; FORD DM, 1981, J INSECT PHYSIOL, V27, P339, DOI 10.1016/0022-1910(81)90080-9; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809; Hartfelder K, 2012, 11 ENDOCRINE CONTROL, P464; Haydak MH, 1943, J ECON ENTOMOL, V36, P778, DOI 10.1093/jee/36.5.778; Hewes RS, 2000, GENETICS, V155, P1711; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Kawasaki H, 2002, DEV GROWTH DIFFER, V44, P419, DOI 10.1046/j.1440-169X.2002.00655.x; Kayashima Y, 2005, DEV GENES EVOL, V215, P545, DOI 10.1007/s00427-005-0013-z; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; Kojima T, 2004, DEV GROWTH DIFFER, V46, P115; Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Mahfooz NS, 2004, P NATL ACAD SCI USA, V101, P4877, DOI 10.1073/pnas.0401216101; Maibeche-Coisne M, 2000, BIOCHEM BIOPH RES CO, V273, P1132, DOI 10.1006/bbrc.2000.3058; MARDON G, 1994, DEVELOPMENT, V120, P3473; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MCIVER SB, 1975, ANNU REV ENTOMOL, V20, P381, DOI 10.1146/annurev.en.20.010175.002121; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Michener C.D., 1990, University of Kansas Science Bulletin, V54, P75; Michener Charles D., 2000, pi; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pepple KL, 2008, DEVELOPMENT, V135, P4071, DOI 10.1242/dev.028951; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Rozowski M, 2002, GENE DEV, V16, P1150, DOI 10.1101/gad.219302; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Satterfield TF, 2002, GENETICS, V162, P1687; Snodgrass R.E., 1956, ANATOMY HONEY BEE, P334; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; THURM U, 1964, SCIENCE, V145, P1063, DOI 10.1126/science.145.3636.1063; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Walldorf U, 2000, DEV GENES EVOL, V210, P483, DOI 10.1007/s004270000091; Willingham AT, 2004, MECH DEVELOP, V121, P1289, DOI 10.1016/j.mod.2004.04.017; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001	60	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40111	10.1371/journal.pone.0040111	http://dx.doi.org/10.1371/journal.pone.0040111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848371	gold, Green Submitted, Green Published			2022-12-25	WOS:000306806600013
J	Greenberg, R; Cadena, V; Danner, RM; Tattersall, G				Greenberg, Russell; Cadena, Viviana; Danner, Raymond M.; Tattersall, Glenn			Heat Loss May Explain Bill Size Differences between Birds Occupying Different Habitats	PLOS ONE			English	Article							EVOLUTION; TEMPERATURE; ADAPTATION; MORPHOLOGY; ECOLOGY; POPULATION; RESPONSES; SPARROW; FINCHES; WATER	Background: Research on variation in bill morphology has focused on the role of diet. Bills have other functions, however, including a role in heat and water balance. The role of the bill in heat loss may be particularly important in birds where water is limiting. Song sparrows localized in coastal dunes and salt marsh edge (Melospiza melodia atlantica) are similar in size to, but have bills with a 17% greater surface area than, those that live in mesic habitats (M. m. melodia), a pattern shared with other coastal sparrows. We tested the hypotheses that sparrows can use their bills to dissipate "dry" heat, and that heat loss from the bill is higher in M. m. atlantica than M. m. melodia, which would indicate a role of heat loss and water conservation in selection for bill size. Methodology/Principal Findings: Bill, tarsus, and body surface temperatures were measured using thermal imaging of sparrows exposed to temperatures from 15-37 degrees C and combined with surface area and physical modeling to estimate the contribution of each body part to total heat loss. Song sparrow bills averaged 5-10 degrees C hotter than ambient. The bill of M. m atlantica dissipated up to 33% more heat and 38% greater proportion of total heat than that of M. m. melodia. This could potentially reduce water loss requirements by approximately 7.7%. Conclusions/Significance: This >30% higher heat loss in the bill of M. m. atlantica is independent of evaporative water loss and thus could play an important role in the water balance of sparrows occupying the hot and exposed dune/salt marsh environments during the summer. Heat loss capacity and water conservation could play an important role in the selection for bill size differences between bird populations and should be considered along with trophic adaptations when studying variation in bill size.	[Greenberg, Russell; Danner, Raymond M.] Smithsonian Conservat Biol Inst, Smithsonian Migratory Bird Ctr, Washington, DC USA; [Cadena, Viviana; Tattersall, Glenn] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Danner, Raymond M.] Virginia Polytech Inst & State Univ, Avian Ecol Grp, Dept Biol Sci, Blacksburg, VA 24061 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Brock University; Virginia Polytechnic Institute & State University	Greenberg, R (corresponding author), Smithsonian Conservat Biol Inst, Smithsonian Migratory Bird Ctr, Natl Zool Pk, Washington, DC USA.	greenbergr@si.edu	Tattersall, Glenn J/D-3469-2009; Danner, Raymond/J-8350-2013	Tattersall, Glenn J/0000-0002-6591-6760; Danner, Raymond/0000-0002-3999-8141	Abbott Endowment; Smithsonian Institution	Abbott Endowment; Smithsonian Institution(Smithsonian Institution)	Research was supported by the Abbott Endowment, short-term visitor award, and Research Equipment Pool Grants of the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1877, RADICAL REV, V1, P108, DOI DOI 10.1038/SCIENTIFICAMERICAN05251907-26247SUPP; Badyaev AV, 2008, EVOLUTION, V62, P1951, DOI 10.1111/j.1558-5646.2008.00428.x; BARTHOLOMEW GEORGE A., 1963, AUK, V80, P504; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BAUDINETTE RV, 1976, AM J PHYSIOL, V230, P920, DOI 10.1152/ajplegacy.1976.230.4.920; BENKMAN CW, 1993, ECOL MONOGR, V63, P305, DOI 10.2307/2937103; Blaxter K, 1986, ENERGY METABOLISM AN; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Bowman R.I., 1961, MORPHOLOGICAL DIFFER; Buchholz R, 1996, AUK, V113, P310, DOI 10.2307/4088897; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; DAWSON WR, 1982, COMP BIOCHEM PHYS A, V71, P495, DOI 10.1016/0300-9629(82)90198-0; EHRENFELD JG, 1990, REV AQUAT SCI, V2, P437; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GRANT PR, 1965, EVOLUTION, V19, P355, DOI 10.1111/j.1558-5646.1965.tb01727.x; Greenberg R, 2012, ECOGRAPHY, V35, P146, DOI 10.1111/j.1600-0587.2011.07002.x; Greenberg R, 2010, ECOLOGY, V91, P2428, DOI 10.1890/09-1136.1; Grenier JL, 2005, EVOLUTION, V59, P1588; HAGAN AA, 1980, J THERM BIOL, V5, P95, DOI 10.1016/0306-4565(80)90006-6; Haynie D. T, 2001, BIOL THERMODYNAMICS; Herrel A, 2005, FUNCT ECOL, V19, P43, DOI 10.1111/j.0269-8463.2005.00923.x; HESP PA, 1991, J ARID ENVIRON, V21, P165, DOI 10.1016/S0140-1963(18)30681-5; JOHANSEN K, 1973, J COMP PHYSIOL, V85, P47, DOI 10.1007/BF00694140; Lucas A., 1972, AVIAN ANATOMY INTEGU; Matessi G, 2002, BIOL J LINN SOC, V75, P21, DOI 10.1046/j.1095-8312.2002.00003.x; MATTHYSEN E, 1989, ARDEA, V77, P117; Mazerolle MJ, 2011, AICCMODAVG MODEL SEL; Millard R.W., 1970, J APPL PHYSIOL, V38, P26; MITCHELL JW, 1976, BIOPHYS J, V16, P561, DOI 10.1016/S0006-3495(76)85711-6; Nudds RL, 2007, EVOLUTION, V61, P2839, DOI 10.1111/j.1558-5646.2007.00242.x; Patten MA, 2009, SYST BIODIVERS, V7, P33, DOI 10.1017/S1477200008002867; PHILLIPS PK, 1994, J THERM BIOL, V19, P423, DOI 10.1016/0306-4565(94)90042-6; PULLIAM HR, 1971, ECOLOGY, V52, P557, DOI 10.2307/1934143; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Remsen J. V. J., 1991, COMMUNITY ECOLOGY NE; Rensch B., 1938, Proceedings of the Linnean Society of London, V150, P275; SCHOLANDER PF, 1955, EVOLUTION, V9, P15, DOI 10.1111/j.1558-5646.1955.tb01510.x; Scott GR, 2008, J EXP BIOL, V211, P1326, DOI 10.1242/jeb.015958; SEAMANS TW, 1995, IBIS, V137, P424; SMITH TB, 1990, ECOLOGY, V71, P1246, DOI 10.2307/1938261; SNOW DW, 1954, EVOLUTION, V8, P19, DOI 10.1111/j.1558-5646.1954.tb00105.x; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Symonds MRE, 2010, AM NAT, V176, P188, DOI 10.1086/653666; Tattersall GJ, 2009, SCIENCE, V325, P468, DOI 10.1126/science.1175553; Van Hemert C, 2012, J MORPHOL, V273, P226, DOI 10.1002/jmor.11023; VanderWerf E.A., 2012, ORNITHOLOGICAL MONOG, V73, P1, DOI DOI 10.1525/OM.2011.73.1.1; WALSBERG GE, 1978, J EXP BIOL, V76, P185; Ward S, 2005, J AVIAN BIOL, V36, P280, DOI 10.1111/j.0908-8857.2005.03379.x; Williams JB, 2005, BIOSCIENCE, V55, P416, DOI 10.1641/0006-3568(2005)055[0416:PAIDB]2.0.CO;2; Wolf BO, 1996, J EXP BIOL, V199, P451; YARBROUGH CG, 1971, COMP BIOCHEM PHYSIOL, V39, P235, DOI 10.1016/0300-9629(71)90082-X; Zuur Alain F., 2009, P1	52	86	87	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40933	10.1371/journal.pone.0040933	http://dx.doi.org/10.1371/journal.pone.0040933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848413	Green Published, Green Submitted, gold			2022-12-25	WOS:000306806600030
J	Galle, M; Jin, SG; Bogaert, P; Haegman, M; Vandenabeele, P; Beyaert, R				Galle, Marlies; Jin, Shouguang; Bogaert, Pieter; Haegman, Mira; Vandenabeele, Peter; Beyaert, Rudi			The Pseudomonas aeruginosa Type III Secretion System Has an Exotoxin S/T/Y Independent Pathogenic Role during Acute Lung Infection	PLOS ONE			English	Article							PROTEIN SECRETION; IN-VITRO; NEUTROPHIL APOPTOSIS; MACROPHAGE APOPTOSIS; TRANSLOCATION; EFFECTORS; CELLS; PORE; INDUCTION; PYOCYANIN	The type III secretion system (T3SS) is a complex nanomachine of many pathogenic Gram-negative bacteria. It forms a proteinaceous channel that is inserted into the host eukaryotic cell membrane for injection of bacterial proteins that manipulate host cell signaling. However, few studies have focused on the effector-independent functions of the T3SS. Using a murine model of acute lung infection with Pseudomonas aeruginosa, an important human opportunistic pathogen, we compared the pathogenicity of mutant bacteria that lack all of the known effector toxins (Delta STY), with mutant bacteria that also lack the major translocator protein PopB (Delta STY/Delta PopB) and so cannot form a functional T3SS channel in the host cell membrane. Mortality was higher among mice challenged with Delta STY compared to mice challenged with Delta STY/Delta PopB mutant bacteria. In addition, mice infected with Delta STY showed decreased bacterial clearance from the lungs compared to those infected with Delta STY/Delta PopB. Infection was in both cases associated with substantial killing of lung infiltrating macrophages. However, macrophages from Delta STY-infected mice died by pro-inflammatory necrosis characterized by membrane permeabilization and caspase-1 mediated IL-1 beta production, whereas macrophages from Delta STY/Delta PopB infected mice died by apoptosis, which is characterized by annexin V positive staining of the cell membrane and caspase-3 activation. This was confirmed in macrophages infected in vitro. These results demonstrate a T3SS effector toxin independent role for the T3SS, in particular the T3SS translocator protein PopB, in the pathogenicity of P. aeruginosa during acute lung infection.	[Galle, Marlies; Bogaert, Pieter; Haegman, Mira; Vandenabeele, Peter; Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Galle, Marlies; Haegman, Mira; Beyaert, Rudi] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Ghent, Belgium; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Bogaert, Pieter; Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signaling & Cell Death, Ghent, Belgium; [Bogaert, Pieter] Univ Ghent VIB, Cell Culture & Sorting Core Facil, Dept Mol Biomed Res, Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; State University System of Florida; University of Florida; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Galle, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.	rudi.beyaert@dmbr.vib-UGent.be	Jin, Shouguang/N-5548-2016; Beyaert, Rudi/B-2589-2009; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Vandenabeele, Peter/0000-0002-6669-8822; Haegman, Mira/0000-0002-4883-312X; Beyaert, Rudi/0000-0002-5704-582X	Special Research Fund (BOF) of Ghent University; "Interuniversity Attraction Poles Program" (IAP-VII); "Fonds voor Wetenschappelijk Onderzoek-Vlaanderen" (FWO) [G.0089.10, G.0619.10]; Belgian Foundation against Cancer; "Strategic Basic Research program" of the IWT; Centrum voor Gezwelziekten; "Concerted Research Actions" (GOA) [01G06B6]; Methusalem [BOF09/01M00709]; 'Group-ID MRP' grants from Ghent University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Special Research Fund (BOF) of Ghent University(Ghent University); "Interuniversity Attraction Poles Program" (IAP-VII); "Fonds voor Wetenschappelijk Onderzoek-Vlaanderen" (FWO)(FWO); Belgian Foundation against Cancer; "Strategic Basic Research program" of the IWT; Centrum voor Gezwelziekten; "Concerted Research Actions" (GOA); Methusalem; 'Group-ID MRP' grants from Ghent University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	M. Galle was supported by a predoctoral fellowship from the Special Research Fund (BOF) of Ghent University. Work in the authors' lab is supported by research grants from the "Interuniversity Attraction Poles Program" (IAP-VII), the "Fonds voor Wetenschappelijk Onderzoek-Vlaanderen" (FWO; G.0089.10 and G.0619.10), the "Belgian Foundation against Cancer", the "Strategic Basic Research program" of the IWT, the "Centrum voor Gezwelziekten" and the "Concerted Research Actions" (GOA; 01G06B6), 'Methusalem' (BOF09/01M00709) and 'Group-ID MRP' grants from Ghent University. R. Beyaert is member of the EU COST Action BM1003 (Microbial cell surface determinants of virulence as targets for new therapeutics in CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader F, 2005, INFECT IMMUN, V73, P4263, DOI 10.1128/IAI.73.7.4263-4271.2005; Aiello D, 2010, ANTIMICROB AGENTS CH, V54, P1988, DOI 10.1128/AAC.01598-09; Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Broms JE, 2003, J INFECT DIS, V188, P1909; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Cowell BA, 2005, FEMS MICROBIOL LETT, V250, P71, DOI 10.1016/j.femsle.2005.06.044; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Desmedt M, 1998, J IMMUNOL, V160, P5300; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Faure K, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-1; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Francois B, 2012, CRIT CARE MED, V40, P2320, DOI 10.1097/CCM.0b013e31825334f6; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galle M, 2008, J CELL MOL MED, V12, P1767, DOI 10.1111/j.1582-4934.2007.00190.x; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Imamura Y, 2007, EUR RESPIR J, V29, P965, DOI 10.1183/09031936.00147406; Kaufman MR, 2000, MICROBIOL-UK, V146, P2531, DOI 10.1099/00221287-146-10-2531; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kooguchi K, 1998, INFECT IMMUN, V66, P3164, DOI 10.1128/IAI.66.7.3164-3169.1998; Lee VT, 2007, INFECT IMMUN, V75, P1089, DOI 10.1128/IAI.01184-06; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Ojielo CI, 2003, J IMMUNOL, V171, P4416, DOI 10.4049/jimmunol.171.8.4416; Poot M, 1997, CYTOMETRY, V27, P358, DOI 10.1002/(SICI)1097-0320(19970401)27:4<358::AID-CYTO7>3.0.CO;2-8; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sawa T, 1998, INFECT IMMUN, V66, P3242, DOI 10.1128/IAI.66.7.3242-3249.1998; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Shafikhani SH, 2008, CELL MICROBIOL, V10, P994, DOI 10.1111/j.1462-5822.2007.01102.x; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Urbanowski ML, 2007, INFECT IMMUN, V75, P4432, DOI 10.1128/IAI.00664-07; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Valencia M, 2009, CURR OPIN CRIT CARE, V15, P30, DOI 10.1097/MCC.0b013e3283220e78; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Viboud GI, 2003, MOL MICROBIOL, V47, P1305, DOI 10.1046/j.1365-2958.2003.03350.x; Wangdi T, 2010, INFECT IMMUN, V78, P4744, DOI 10.1128/IAI.00744-10; Wullaert A, 2005, HEPATOLOGY, V42, P381, DOI 10.1002/hep.20785; Yang HJ, 2007, J BACTERIOL, V189, P2599, DOI 10.1128/JB.01680-06; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	55	31	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41547	10.1371/journal.pone.0041547	http://dx.doi.org/10.1371/journal.pone.0041547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844497	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700109
J	Kuntner, M; Gregoric, M; Zhang, SC; Kralj-Fiser, S; Li, DQ				Kuntner, Matjaz; Gregoric, Matjaz; Zhang, Shichang; Kralj-Fiser, Simona; Li, Daiqin			Mating Plugs in Polyandrous Giants: Which Sex Produces Them, When, How and Why?	PLOS ONE			English	Article							ORB-WEB SPIDER; SEXUALLY CANNIBALISTIC SPIDER; SPERM COMPETITION; COPULATORY PLUGS; ARGIOPE-BRUENNICHI; GENITAL MUTILATION; ARANEAE ARANEIDAE; NEPHILID SPIDERS; SPECIES ARANEAE; MALE ADAPTATION	Background: Males usually produce mating plugs to reduce sperm competition. However, females can conceivably also produce mating plugs in order to prevent unwanted, superfluous and energetically costly matings. In spiders-appropriate models for testing plugging biology hypotheses-mating plugs may consist of male genital parts and/or of amorphous covers consisting of glandular or sperm secretions. In the giant wood spider Nephila pilipes, a highly sexually dimorphic and polygamous species, males are known to produce ineffective embolic plugs through genital damage, but nothing is known about the origin and function of additional conspicuous amorphous plugs (AP) covering female genitals. Methodology: We tested alternative hypotheses of the nature and function of AP in N. pilipes by staging mating trials with varying degrees of polyandry. No APs were ever formed during mating trials, which rules out the possibility of male AP formation. Instead, those females that oviposited produced the AP from a liquid secreted during egg sac formation. Polyandrous females were more likely to lay eggs and to produce the AP, as were those that mated longer and with more total insertions. Our further tests revealed that, in spite of being a side product of egg sac production, AP, when hardened, prevented any subsequent copulation. Conclusions: We conclude that in the giant wood spider (Nephila pilipes), the amorphous mating plugs are not produced by the males, that repeated copulations (most likely polyandrous) are necessary for egg fertilization and AP formation, and that the AP represents a female adaptation to sexual conflict through prevention of unwanted, excessive copulations. Considering the largely unknown origin of amorphous plugs in spiders, we predict that a similar pattern might be detected in other clades, which would help elucidate the evolutionary interplay of various selection pressures responsible for the origin and maintenance of mating plugs.	[Kuntner, Matjaz; Gregoric, Matjaz; Kralj-Fiser, Simona] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia; [Kuntner, Matjaz] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kuntner, Matjaz; Li, Daiqin] Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China; [Zhang, Shichang; Li, Daiqin] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Smithsonian Institution; Smithsonian National Museum of Natural History; Hubei University; National University of Singapore	Kuntner, M (corresponding author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.	kuntner@gmail.com	Kuntner, Matjaz/AAE-2195-2020; Gregorič, Matjaž/AAG-5913-2021; Li, Daiqin/CAH-3746-2022; Li, Daiqin/D-6922-2013	Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734; Gregoric, Matjaz/0000-0002-4882-4282; Kralj-Fiser, Simona/0000-0001-6604-2332	Slovenian Research Agency [J1-2063]; Raffles Museum of Biodiversity Research Fellowship; Ministry of Education Academic Research Fund [AcRF: R-154-000-435-112]; Humboldt Postdoctoral Fellowship; ARRS Postdoctoral Fellowship [Z1-4194]; Humboldt Return Fellowship	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Raffles Museum of Biodiversity Research Fellowship; Ministry of Education Academic Research Fund; Humboldt Postdoctoral Fellowship; ARRS Postdoctoral Fellowship; Humboldt Return Fellowship	This research was supported by the Slovenian Research Agency (grant J1-2063) and a Raffles Museum of Biodiversity Research Fellowship to M. Kuntner, by the Ministry of Education Academic Research Fund (AcRF: R-154-000-435-112) to D. Li, and by Humboldt Postdoctoral and Return Fellowships, and an ARRS Postdoctoral Fellowship Z1-4194 to S. Kralj-Fiser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN RB, 1992, ETHOL ECOL EVOL, V4, P245, DOI 10.1080/08927014.1992.9523136; Aisenberg A, 2011, NATURWISSENSCHAFTEN, V98, P605, DOI 10.1007/s00114-011-0807-y; Aisenberg A, 2009, BEHAV ECOL, V20, P1236, DOI 10.1093/beheco/arp117; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Baer B, 2000, J CHEM ECOL, V26, P1869, DOI 10.1023/A:1005596707591; Baer B, 2001, P NATL ACAD SCI USA, V98, P3926, DOI 10.1073/pnas.061027998; Baer B, 2011, MYRMECOL NEWS, V14, P55; BARKER DM, 1994, ANIM BEHAV, V48, P147, DOI 10.1006/anbe.1994.1221; BAUER RT, 1994, J EXP MAR BIOL ECOL, V182, P205, DOI 10.1016/0022-0981(94)90052-3; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Bretman A, 2010, J INSECT PHYSIOL, V56, P107, DOI 10.1016/j.jinsphys.2009.09.010; Burger M, 2010, ZOOLOGY, V113, P19, DOI 10.1016/j.zool.2009.04.002; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Colonello NA, 2005, APIDOLOGIE, V36, P231, DOI 10.1051/apido:2005012; Contreras-Garduno J, 2006, ETHOLOGY, V112, P152, DOI 10.1111/j.1439-0310.2006.01149.x; DICKINSON JL, 1989, ANIM BEHAV, V38, P154, DOI 10.1016/S0003-3472(89)80074-0; Dixson AF, 2002, FOLIA PRIMATOL, V73, P63, DOI 10.1159/000064784; Eberhard WG, 1998, J ARACHNOL, V26, P342; Eberhard WG, 2004, J ARACHNOL, V32, P545, DOI 10.1636/0161-8202(2004)032[0545:WSSSST]2.0.CO;2; Eberhard WG, 1996, TECHNICAL BOOKS; Engelhardt Victor v., 1910, Zeitschrift fuer Wissenschaftliche Zoologie Leipzig, V96; Foellmer MW, 2008, EVOL ECOL RES, V10, P449; Fromhage L, 2006, BEHAV ECOL, V17, P353, DOI 10.1093/beheco/arj037; Fromhage L, 2012, EVOLUTION, V66, P31, DOI 10.1111/j.1558-5646.2011.01406.x; Ghione S, 2011, J ARACHNOL, V39, P197, DOI 10.1636/Hi10-92.1; Gillott C, 1996, INVERTEBR REPROD DEV, V30, P199, DOI 10.1080/07924259.1996.9672546; Groot AT, 2000, INVERTEBR REPROD DEV, V38, P143, DOI 10.1080/07924259.2000.9652449; Jia ZY, 2002, J MAMMAL, V83, P1035, DOI 10.1644/1545-1542(2002)083<1035:CPIMPC>2.0.CO;2; Jivoff P, 1997, BEHAV ECOL SOCIOBIOL, V40, P175, DOI 10.1007/s002650050331; Johnston SD, 1997, J REPROD FERTIL, V109, P319, DOI 10.1530/jrf.0.1090319; Knoflach B, 1998, J NAT HIST, V32, P545, DOI 10.1080/00222939800770301; KOPROWSKI JL, 1992, J MAMMAL, V73, P572, DOI 10.2307/1382026; Kralj-Fiser S, 2011, ANIM BEHAV, V81, P933, DOI 10.1016/j.anbehav.2011.02.010; Kuntner M, 2005, INVERTEBR SYST, V19, P391, DOI 10.1071/IS05024; Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x; Kuntner M, J ARACHNOLO IN PRESS; Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x; Kuntner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007516; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Lemaitre JF, 2011, P ROY SOC B-BIOL SCI, V278, P1171, DOI 10.1098/rspb.2010.1828; Lung O, 2001, INSECT BIOCHEM MOLEC, V31, P543, DOI 10.1016/S0965-1748(00)00154-5; MASUMOTO T, 1993, J ARACHNOL, V21, P55; Moreira PL, 2007, BEHAV ECOL SOCIOBIOL, V62, P281, DOI 10.1007/s00265-007-0463-6; Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074; Nessler S, 2009, BEHAV ECOL SOCIOBIOL, V63, P355, DOI 10.1007/s00265-008-0669-2; O'Donnell RP, 2004, ANIM BEHAV, V68, P677, DOI 10.1016/j.anbehav.2003.09.020; ORR AG, 1991, J NAT HIST, V25, P703, DOI 10.1080/00222939100770461; Parga JA, 2003, INT J PRIMATOL, V24, P889, DOI 10.1023/A:1024637024088; Polak M, 2001, BEHAV ECOL SOCIOBIOL, V49, P196, DOI 10.1007/s002650000281; Poulin R, 2000, J ZOOL, V250, P551, DOI 10.1017/S0952836900004118; Robinson M.H., 1973, Smithsonian Contributions to Zoology, VNo. 149, P1; Robinson M. H., 1976, SMITHSON CONTRIB ZOO, V218, P1; Sauter A, 2001, P ROY SOC B-BIOL SCI, V268, P1449, DOI 10.1098/rspb.2001.1680; Schneider JM, 2001, BEHAV ECOL SOCIOBIOL, V49, P410, DOI 10.1007/s002650000307; Schneider Jutta, 2011, P215; Snow LSE, 2006, ETHOLOGY, V112, P379, DOI 10.1111/j.1439-0310.2006.01163.x; Strand E, 1906, Z WISS ZOOL ABT A, V80, P515; Suhm M, 1996, ZOOL ANZ, V234, P191; Timmermeyer N, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-28; Uhl G, 2007, ZOOLOGY, V110, P398, DOI 10.1016/j.zool.2007.07.003; Uhl G, 2010, GENETICA, V138, P75, DOI 10.1007/s10709-009-9388-5; WING S, 1983, FLA ENTOMOL, V66, P86, DOI 10.2307/3494553; Yasui Y, 1997, EXP APPL ACAROL, V21, P651, DOI 10.1023/A:1018456618435; Zhang SC, 2011, ANIM BEHAV, V82, P1299, DOI 10.1016/j.anbehav.2011.09.010	64	19	19	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40939	10.1371/journal.pone.0040939	http://dx.doi.org/10.1371/journal.pone.0040939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829900	Green Submitted, gold, Green Published			2022-12-25	WOS:000306956300038
J	Fort, J; Beaugrand, G; Gremillet, D; Phillips, RA				Fort, Jerome; Beaugrand, Gregory; Gremillet, David; Phillips, Richard A.			Biologging, Remotely-Sensed Oceanography and the Continuous Plankton Recorder Reveal the Environmental Determinants of a Seabird Wintering Hotspot	PLOS ONE			English	Article							NORTH-ATLANTIC; CLIMATE; TRACKING; ECOLOGY; BIODIVERSITY; METABOLISM; MOVEMENTS; SHIFTS	Marine environments are greatly affected by climate change, and understanding how this perturbation affects marine vertebrates is a major issue. In this context, it is essential to identify the environmental drivers of animal distribution. Here, we focused on the little auk (Alle alle), one of the world's most numerous seabirds and a major component in Arctic food webs. Using a multidisciplinary approach, we show how little auks adopt specific migratory strategies and balance environmental constraints to optimize their energy budgets. Miniature electronic loggers indicate that after breeding, birds from East Greenland migrate >2000 km to overwinter in a restricted area off Newfoundland. Synoptic data available from the Continuous Plankton Recorder (CPR) indicate that this region harbours some of the highest densities of the copepod Calanus finmarchicus found in the North Atlantic during winter. Examination of large-scale climatic and oceanographic data suggests that little auks favour patches of high copepod abundance in areas where air temperature ranges from 0 degrees C to 5 degrees C. These results greatly advance our understanding of animal responses to extreme environmental constraints, and highlight that information on habitat preference is key to identifying critical areas for marine conservation.	[Fort, Jerome] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Beaugrand, Gregory] Univ Sci & Technol Lille 1, CNRS, UMR 8087, Lab Oceanol & Geosci,Stn Marine, Wimereux, France; [Beaugrand, Gregory] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Gremillet, David] CNRS, UMR 5175, Ctr Ecol Fonct & Evolut, Montpellier, France; [Gremillet, David] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Aarhus University; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Fort, J (corresponding author), Aarhus Univ, Dept Biosci, Roskilde, Denmark.	fort.jerome@gmail.com	Gremillet, David/W-1946-2018; Fort, Jerome/F-1157-2016	Gremillet, David/0000-0002-7711-9398; Fort, Jerome/0000-0002-0860-6707; BEAUGRAND, GREGORY/0000-0002-0712-5223	French Polar Institute [388]; Fyssen Foundation; European Commission [273061]; NERC [bas0100025, SAH01001] Funding Source: UKRI; Natural Environment Research Council [SAH01001, bas0100025] Funding Source: researchfish	French Polar Institute; Fyssen Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the French Polar Institute Paul Emile Victor (Grant 388 to D. G. and J.F.) and grants from the Fyssen Foundation (to J.F.) and the European Commission (Marie Curie Intra European Fellowship to J.F.; Project 273061), and also represents a contribution to the British Antarctic Survey Ecosystems programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugrand G, 2000, MAR ECOL PROG SER, V204, P299, DOI 10.3354/meps204299; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2010, P NATL ACAD SCI USA, V107, P10120, DOI 10.1073/pnas.0913855107; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boertmann D, 2004, BIRD CONSERV INT, V14, P87, DOI 10.1017/S0959270904000127; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Falk-Petersen S, 2009, MAR BIOL RES, V5, P18, DOI 10.1080/17451000802512267; Fort J, 2010, MAR ECOL PROG SER, V414, P293, DOI 10.3354/meps08721; Fort J, 2010, BIOL LETTERS, V6, P682, DOI 10.1098/rsbl.2010.0082; Fort J, 2009, J EXP BIOL, V212, P2483, DOI 10.1242/jeb.032300; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; GABRIELSEN GW, 1991, AUK, V108, P71; Gaston A.J., 1998, THE AUKS ALCIDAE; Gaston AJ, 2011, MAR BIOL, V158, P1929, DOI 10.1007/s00227-011-1704-9; Harding AMA, 2008, POLAR BIOL, V31, P725, DOI 10.1007/s00300-008-0413-4; Harding AMA, 2011, OECOLOGIA, V167, P49, DOI 10.1007/s00442-011-1971-7; Helaouet P, 2011, PROG OCEANOGR, V91, P217, DOI 10.1016/j.pocean.2010.11.003; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; KAMPP K, 1987, Dansk Ornitologisk Forenings Tidsskrift, V81, P129; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Lake S, 2006, POLAR BIOL, V29, P270, DOI 10.1007/s00300-005-0050-0; Montevecchi W, 2012, BIOL LETTERS, V8, P218, DOI 10.1098/rsbl.2011.0880; Mosbech A, 2012, POLAR BIOL, V35, P305, DOI 10.1007/s00300-011-1064-4; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Oro D, 2002, ECOLOGY, V83, P2516; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Planque B, 1997, DEEP-SEA RES PT I, V44, P315, DOI 10.1016/S0967-0637(96)00100-8; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Reygondeau G, 2011, GLOBAL CHANGE BIOL, V17, P756, DOI 10.1111/j.1365-2486.2010.02310.x; Richman SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P316, DOI 10.1086/660008; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Shaffer SA, 2011, COMP BIOCHEM PHYS A, V158, P315, DOI 10.1016/j.cbpa.2010.07.012; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Stempniewicz L, 2001, J BIRDS W PALEARCTIC, V3, P175; Wilson RP, 1992, WILDLIFE TELEMETRY R	37	29	31	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41194	10.1371/journal.pone.0041194	http://dx.doi.org/10.1371/journal.pone.0041194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815967	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000306548900095
J	Liu, YC; Han, YH; Huang, WR; Duan, YG; Mou, LS; Jiang, ZM; Fa, PP; Xie, J; Diao, RY; Chen, YB; Ye, YW; Yang, RL; Chen, J; Sun, XJ; Li, ZS; Tang, AF; Gui, YT; Cai, ZM				Liu, Yuchen; Han, Yonghua; Huang, Weiren; Duan, Yonggang; Mou, Lisha; Jiang, Zhimao; Fa, Pingping; Xie, Jun; Diao, Ruiying; Chen, Yuanbin; Ye, Yiwang; Yang, Ruilin; Chen, Jing; Sun, Xiaojuan; Li, Zesong; Tang, Aifa; Gui, Yaoting; Cai, Zhiming			Whole-Genome Synthesis and Characterization of Viable S13-Like Bacteriophages	PLOS ONE			English	Article							FUNCTIONAL-RELATIONSHIP; NUCLEOTIDE-SEQUENCE; EVOLUTION; PHI-X174; PHIX174; BIOLOGY; PHAGES; G4; GENERATION; ADAPTATION	Background: Unprecedented progresses in high-throughput DNA sequencing and de novo gene synthesis technologies have allowed us to create living organisms in the absence of natural template. Methodology/Principal Findings: The sequence of wild-type S13 phage genome was downloaded from GenBank. Two synonymous mutations were introduced into wt-S13 genome to generate m1-S13 genome. Another mutant, m2-S13 genome, was obtained by engineering two nonsynonymous mutations in the capsid protein coding region of wt-S13 genome. A chimeric phage genome was designed by replacing the F capsid protein open reading frame (ORF) from phage S13 with the F capsid protein ORF from phage G4. The whole genomes of all four phages were assembled from a series of chemically synthesized short overlapping oligonucleotides. The linear synthesized genomes were circularized and electroporated into E. coli C, the standard laboratory host of S13 phage. All four phages were recovered and plaques were visualized. The results of sequencing showed the accuracy of these synthetic genomes. The synthetic phages were capable of lysing their bacterial host and tolerating general environmental conditions. While no phenotypic differences among the variant strains were observed when grown in LB medium with CaCl2, the S13/G4 chimera was found to be much more sensitive to the absence of calcium and to have a lower adsorption rate under calcium free condition. Conclusions/Significance: The bacteriophage S13 and its variants can be chemically synthesized. The major capsid gene of phage G4 is functional in the phage S13 life cycle. These results support an evolutional hypothesis which has been proposed that a homologous recombination event involving gene F of quite divergent ancestral lineages should be included in the history of the microvirid family.	[Liu, Yuchen; Han, Yonghua; Huang, Weiren; Duan, Yonggang; Mou, Lisha; Jiang, Zhimao; Fa, Pingping; Xie, Jun; Diao, Ruiying; Chen, Yuanbin; Ye, Yiwang; Yang, Ruilin; Chen, Jing; Sun, Xiaojuan; Li, Zesong; Tang, Aifa; Gui, Yaoting; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Shenzhen PKUHKUST Med Ctr,Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China; [Liu, Yuchen] Shantou Univ, Coll Med, Shantou, Peoples R China; [Cai, Zhiming] Shenzhen Univ, Inst Urogenital Dis, Shenzhen, Peoples R China; [Huang, Weiren; Cai, Zhiming] Shenzhen Second Peoples Hosp, Shenzhen, Peoples R China	Peking University; Shantou University; Shenzhen University; Second People's Hospital of Shenzhen	Liu, YC (corresponding author), Peking Univ, Shenzhen Hosp, Shenzhen PKUHKUST Med Ctr,Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China.	guiyaoting2007@yahoo.com.cn; caizhiming2000@yahoo.com.cn	gui, yaoting/GLT-3684-2022; Mou, Lisha/I-4739-2012; Duan, Yong-Gang/AAH-1061-2019; liu, yuchen/GYQ-6286-2022	Mou, Lisha/0000-0001-6232-8341; Duan, Yong-Gang/0000-0002-5350-892X; 	National Natural Science Foundation of China [81100460]; Postdoctoral Science Foundation of China [20100480776]; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A]; Ph.D. Programs Foundation of Ministry of Education of China [200800010106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Promotion Program for Shenzhen Key Laboratory, Shenzhen, China; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was funded by the National Natural Science Foundation of China [81100460]; the Postdoctoral Science Foundation of China [20100480776]; the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A to ZC); and the Ph.D. Programs Foundation of Ministry of Education of China (200800010106 to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Bernal RA, 2003, J MOL BIOL, V325, P11, DOI 10.1016/S0022-2836(02)01201-9; BORRIAS WE, 1979, J VIROL, V31, P288, DOI 10.1128/JVI.31.2.288-298.1979; Bull JJ, 2004, EVOLUTION, V58, P692; Burnet FM, 1927, BRIT J EXP PATHOL, V8, P121; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Crill WD, 2000, GENETICS, V154, P27; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; FANE BA, 1992, J BACTERIOL, V174, P2717, DOI 10.1128/jb.174.8.2717-2719.1992; FUJIMURA R, 1962, BIOPHYS J, V2, P433, DOI 10.1016/S0006-3495(62)86866-0; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GODSON GN, 1974, VIROLOGY, V58, P272, DOI 10.1016/0042-6822(74)90161-5; GODSON GN, 1978, NATURE, V276, P236, DOI 10.1038/276236a0; Hayashi M., 1988, BACTERIOPHAGES, V2, P1; JENG Y, 1970, J MOL BIOL, V49, P521, DOI 10.1016/0022-2836(70)90262-7; KAPTEIN JS, 1978, BIOCHEMISTRY-US, V17, P841, DOI 10.1021/bi00598a015; LAU PCK, 1985, GENE, V40, P273, DOI 10.1016/0378-1119(85)90050-2; McKenna R, 1996, J MOL BIOL, V256, P736, DOI 10.1006/jmbi.1996.0121; Mueller S, 2009, CHEM BIOL, V16, P337, DOI 10.1016/j.chembiol.2009.03.002; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rokyta DR, 2009, MOL BIOL EVOL, V26, P2831, DOI 10.1093/molbev/msp199; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; STOREY CC, 1989, J GEN VIROL, V70, P1321, DOI 10.1099/0022-1317-70-6-1321; TESSMAN ES, 1963, VIROLOGY, V19, P239, DOI 10.1016/0042-6822(63)90015-1; THOMPSON BJ, 1978, VIROLOGY, V87, P212, DOI 10.1016/0042-6822(78)90175-7; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731; Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593	30	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41124	10.1371/journal.pone.0041124	http://dx.doi.org/10.1371/journal.pone.0041124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815936	Green Submitted, gold, Green Published			2022-12-25	WOS:000306548900076
J	Kim, SW; Zhang, HZ; Guo, L; Kim, JM; Kim, MH				Kim, Sung-Whan; Zhang, Hong-Zhe; Guo, Longzhe; Kim, Jong-Min; Kim, Moo Hyun			Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities	PLOS ONE			English	Article							CARDIAC-FUNCTION; SKIN; DIFFERENTIATION; FIBROBLASTS; MYOCARDIUM; APOPTOSIS; DISEASE; FOOT; CARDIOMYOCYTES; PROLIFERATION	Although human amniotic mesenchymal stem cells (AMMs) have been recognised as a promising stem cell resource, their therapeutic potential for wound healing has not been widely investigated. In this study, we evaluated the therapeutic potential of AMMs using a diabetic mouse wound model. Quantitative real-time PCR and ELISA results revealed that the angiogenic factors, IGF-1, EGF and IL-8 were markedly upregulated in AMMs when compared with adipose-derived mesenchymal stem cells (ADMs) and dermal fibroblasts. In vitro scratch wound assays also showed that AMM-derived conditioned media (CM) significantly accelerated wound closure. Diabetic mice were generated using streptozotocin and wounds were created by skin excision, followed by AMM transplantation. AMM transplantation significantly promoted wound healing and increased re-epithelialization and cellularity. Notably, transplanted AMMs exhibited high engraftment rates and expressed keratinocyte-specific proteins and cytokeratin in the wound area, indicating a direct contribution to cutaneous closure. Taken together, these data suggest that AMMs possess considerable therapeutic potential for chronic wounds through the secretion of angiogenic factors and enhanced engraftment/differentiation capabilities.	[Kim, Sung-Whan; Zhang, Hong-Zhe; Guo, Longzhe; Kim, Moo Hyun] Dong A Univ Hosp, Reg Clin Ctr, Pusan, South Korea; [Kim, Sung-Whan; Zhang, Hong-Zhe; Guo, Longzhe; Kim, Moo Hyun] Dong A Univ, Coll Med, Dept Cardiol, Pusan, South Korea; [Kim, Jong-Min] Dong A Univ, Coll Med, Dept Anat & Cell Biol, Pusan, South Korea	Dong A University; Dong A University; Dong A University	Kim, SW (corresponding author), Dong A Univ Hosp, Reg Clin Ctr, Pusan, South Korea.	sungwhk@yahoo.co.kr; kimmh@dau.ac.kr			Ministry of Health & Welfare, Republic of Korea [A070001]; National Research Foundation of Korea (NRF); Korean government (MEST) [2009 0093191]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A070001) and the National Research Foundation of Korea (NRF) Grant funded by the Korean government (MEST) (2009 0093191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Campbell WB, 2000, EUR J VASC ENDOVASC, V19, P174, DOI 10.1053/ejvs.1999.1006; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Desbois-Mouthon C, 2006, FASEB J, V20, P773, DOI 10.1096/fj.05-4704fje; Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509; Gao Feng, 2007, Zhongguo Zhen Jiu, V27, P645; Kim MH, 2011, INT J CARDIOL; Kim SW, 2006, STEM CELLS, V24, P1620, DOI 10.1634/stemcells.2005-0365; Kim SW, 2012, CARDIOVASC RES, V93, P525, DOI 10.1093/cvr/cvr328; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lamme EN, 2002, WOUND REPAIR REGEN, V10, P152, DOI 10.1046/j.1524-475X.2002.10901.x; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Loomans CJM, 2005, ANTIOXID REDOX SIGN, V7, P1468, DOI 10.1089/ars.2005.7.1468; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Medina RJ, 2006, INT J MOL MED, V17, P721; MICHEL G, 1992, FEBS LETT, V305, P241, DOI 10.1016/0014-5793(92)80677-9; Moulik PK, 2003, DIABETES CARE, V26, P491, DOI 10.2337/diacare.26.2.491; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Perks CM, 2000, J CELL BIOCHEM, V80, P248; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Stepanovic V, 2003, CIRC RES, V92, P1247, DOI 10.1161/01.RES.0000074906.98021.55; Sumpio Bauer E, 2003, Clin Podiatr Med Surg, V20, P689, DOI 10.1016/S0891-8422(03)00088-0; Tsuji H, 2010, CIRC RES, V106, P1613, DOI 10.1161/CIRCRESAHA.109.205260; TUSCHIL A, 1992, J INVEST DERMATOL, V99, P294, DOI 10.1111/1523-1747.ep12616634; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; Wu JI, 2007, INT J OBSTET ANESTH, V16, P122, DOI 10.1016/j.ijoa.2006.11.004; Wu SC, 2007, VASC HEALTH RISK MAN, V3, P65; Wu Y, STEM CELLS, V905-915; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Zhao P, 2005, TRANSPLANTATION, V79, P528, DOI 10.1097/01.TP.0000149503.92433.39; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	45	100	113	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41105	10.1371/journal.pone.0041105	http://dx.doi.org/10.1371/journal.pone.0041105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815931	Green Published, gold			2022-12-25	WOS:000306507000067
J	Caleo, M; Restani, L; Vannini, E; Siskova, Z; Al-Malki, H; Morgan, R; O'Connor, V; Perry, VH				Caleo, Matteo; Restani, Laura; Vannini, Eleonora; Siskova, Zuzana; Al-Malki, Hussain; Morgan, Ruth; O'Connor, Vincent; Perry, V. Hugh			The Role of Activity in Synaptic Degeneration in a Protein Misfolding Disease, Prion Disease	PLOS ONE			English	Article							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; BOTULINUM-TOXIN-A; AMYLOID-BETA; IN-VIVO; CHRONIC NEURODEGENERATION; PRESYNAPTIC DEGENERATION; INFLAMMATORY RESPONSE; ALZHEIMERS-DISEASE; TRANSGENIC MICE	In chronic neurodegenerative diseases associated with aggregates of misfolded proteins (such as Alzheimer's, Parkinson's and prion disease), there is an early degeneration of presynaptic terminals prior to the loss of the neuronal somata. Identifying the mechanisms that govern synapse degeneration is of paramount importance, as cognitive decline is strongly correlated with loss of presynaptic terminals in these disorders. However, very little is known about the processes that link the presence of a misfolded protein to the degeneration of synapses. It has been suggested that the process follows a simple linear sequence in which terminals that become dysfunctional are targeted for death, but there is also evidence that high levels of activity can speed up degeneration. To dissect the role of activity in synapse degeneration, we infused the synaptic blocker botulinum neurotoxin A (BoNT/A) into the hippocampus of mice with prion disease and assessed synapse loss at the electron microscopy level. We found that injection of BoNT/A in naive mice caused a significant enlargement of excitatory presynaptic terminals in the hippocampus, indicating transmission impairment. Long-lasting blockade of activity by BoNT/A caused only minimal synaptic pathology and no significant activation of microglia. In mice with prion disease infused with BoNT/A, rates of synaptic degeneration were indistinguishable from those observed in control diseased mice. We conclude that silencing synaptic activity neither prevents nor enhances the degree of synapse degeneration in prion disease. These results challenge the idea that dysfunction of synaptic terminals dictates their elimination during prion-induced neurodegeneration.	[Caleo, Matteo; Restani, Laura] CNR, Neurosci Inst, Pisa, Italy; [Vannini, Eleonora] Scuola Normale Super Pisa, Pisa, Italy; [Siskova, Zuzana; Al-Malki, Hussain; Morgan, Ruth; O'Connor, Vincent; Perry, V. Hugh] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England	Consiglio Nazionale delle Ricerche (CNR); Scuola Normale Superiore di Pisa; University of Southampton	Caleo, M (corresponding author), CNR, Neurosci Inst, Pisa, Italy.	caleo@in.cnr.it	Perry, V. Hugh/Y-2935-2019; Vannini, Eleonora/P-2303-2018; Restani, Laura/ABH-1733-2020; Restani, Laura/AAY-5659-2020	Vannini, Eleonora/0000-0002-1337-3901; RESTANI, LAURA/0000-0002-8295-8452; O'Connor, Vincent/0000-0003-3185-5709; CALEO, MATTEO/0000-0002-4333-6378	Italian Ministry of Health (Progetti di Rilevante Interesse Nazionale); Tuscany region (Health Research Program); Medical Research Council, United Kingdom [G0501636]; Ministry of Education, Kingdom of Saudi Arabia; MRC [G0501636] Funding Source: UKRI; Medical Research Council [G0501636] Funding Source: researchfish	Italian Ministry of Health (Progetti di Rilevante Interesse Nazionale); Tuscany region (Health Research Program); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Kingdom of Saudi Arabia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Italian Ministry of Health (Progetti di Rilevante Interesse Nazionale - 2008; MC) the Tuscany region (Health Research Program 2009; MC) and the Medical Research Council, United Kingdom (G0501636). HAM was supported by the Ministry of Education, Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Betmouni S, 1999, NEUROPATH APPL NEURO, V25, P20, DOI 10.1046/j.1365-2990.1999.00153.x; Bozzi Y, 2006, NEUROTOX RES, V9, P197, DOI 10.1007/BF03033939; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Caleo M, 2007, J NEUROSCI, V27, P4530, DOI 10.1523/JNEUROSCI.0772-07.2007; Capogna M, 1997, J NEUROSCI, V17, P7190; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dickey CA, 2003, J NEUROSCI, V23, P5219; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; KAO I, 1976, SCIENCE, V193, P1256, DOI 10.1126/science.785600; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Matak I, 2011, NEUROSCIENCE, V186, P201, DOI 10.1016/j.neuroscience.2011.04.026; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Restani L, 2011, J NEUROSCI, V31, P15650, DOI 10.1523/JNEUROSCI.2618-11.2011; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; Siskova Z, 2010, BIOCHEM SOC T, V38, P471, DOI 10.1042/BST0380471; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; SUMNER BEH, 1977, EXP BRAIN RES, V30, P313; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Wree A, 2011, NEUROBIOL DIS, V41, P291, DOI 10.1016/j.nbd.2010.09.017	52	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41182	10.1371/journal.pone.0041182	http://dx.doi.org/10.1371/journal.pone.0041182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815961	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000306466100125
J	Loffler, H; Fechter, A; Liu, FY; Poppelreuther, S; Kramer, A				Loeffler, H.; Fechter, A.; Liu, F. Y.; Poppelreuther, S.; Kraemer, A.			DNA damage-induced centrosome amplification occurs via excessive formation of centriolar satellites	ONCOGENE			English	Article						DNA damage; centrosome amplification; centriolar satellites; Chk1	CHROMOSOMAL INSTABILITY; GENOME MAINTENANCE; MAMMALIAN-CELLS; DUPLICATION; CHECKPOINT; INVOLVEMENT; INDUCTION; RADIATION; INTEGRITY; PATHWAY	Centrosome amplification is a frequent phenomenon in malignancies and may facilitate tumorigenesis by promoting chromosomal instability. On the other hand, a centrosome inactivation checkpoint comprising centrosome amplification leading to elimination of cells by mitotic catastrophe has been described in response to DNA damage by ionizing radiation or cytostatic drugs. So far, the exact nature of DNA damage-induced centrosome amplification, which might be overduplication or fragmentation of existing centrosomes, has been controversial. To solve this controversy, we have established a method to distinguish between these two possibilities using A549 cells expressing photoconvertible CETN2-Dendra2. In response to various DNA-damaging treatments, centrosome amplification but not fragmentation was observed. Moreover, centrosome amplification was preceded by excessive formation of centrin-containing centriolar satellites, which were identified as de novo-generated atypical centrin dots staining positive for centriolar satellite markers but negative or only weakly positive for other established centrosomal markers, and which could be verified as centriolar satellites using immunogold electron microscopy. In line with this notion, disruption of dynein-mediated recruitment of centrosomal proteins via centriolar satellites suppressed centrosome amplification after DNA damage, and excessive formation of centriolar satellites could be inhibited by interference with Chk1, a known mediator of centrosome amplification in response to DNA damage. In conclusion, we provide a model in which a Chk1-mediated DNA damage checkpoint induces excessive formation of centriolar satellites constituting assembly platforms for centrosomal proteins, which subsequently leads to centrosome amplification.	[Loeffler, H.; Fechter, A.; Liu, F. Y.; Kraemer, A.] German Canc Res Ctr, Clin Cooperat Unit Mol Hematol Oncol, D-69120 Heidelberg, Germany; [Loeffler, H.; Fechter, A.; Liu, F. Y.; Kraemer, A.] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Poppelreuther, S.] Carl Zeiss Applicat Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Carl Zeiss AG	Kramer, A (corresponding author), German Canc Res Ctr, Clin Cooperat Unit Mol Hematol Oncol, D-69120 Heidelberg, Germany.	a.kraemer@dkfz.de			Deutsche Krebshilfe [108560]	Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank Birgit Hub and Sigrid Heil for excellent technical assistance, and Andrew M Fry, Andreas Merdes, Jeffrey L Salisbury and Richard B Vallee for important reagents. This work was supported by the Deutsche Krebshilfe (grant 108560).	Barenz F, 2011, EUR J CELL BIOL, V90, P983, DOI 10.1016/j.ejcb.2011.07.007; Bourke E, 2010, ONCOGENE, V29, P616, DOI 10.1038/onc.2009.340; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; FETNER RH, 1965, EXP CELL RES, V37, P429, DOI 10.1016/0014-4827(65)90190-4; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Heilig CE, 2010, J CELL MOL MED, V14, P895, DOI 10.1111/j.1582-4934.2009.00905.x; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; KOBAYASHI T, 1978, BIOCHEM BIOPH RES CO, V81, P1313, DOI 10.1016/0006-291X(78)91279-2; Kodani A, 2010, MOL BIOL CELL, V21, P3376, DOI 10.1091/mbc.E10-05-0430; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kramer A, 2005, LEUKEMIA, V19, P1142, DOI 10.1038/sj.leu.2403780; Kramer A, 2004, CELL CYCLE, V3, P1390, DOI 10.4161/cc.3.11.1252; Kubo A, 2003, J CELL SCI, V116, P919, DOI 10.1242/jcs.00282; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; LEVIS AG, 1963, EXP CELL RES, V31, P448, DOI 10.1016/0014-4827(63)90026-0; Loffler H, 2007, CELL CYCLE, V6, P2541; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Loffler H, 2011, CANCER RES, V71, P2129, DOI 10.1158/0008-5472.CAN-10-2684; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Robinson HMR, 2007, CELL CYCLE, V6, P982, DOI 10.4161/cc.6.8.4111; SATO C, 1983, J CELL BIOL, V96, P776, DOI 10.1083/jcb.96.3.776; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Yih LH, 2006, CANCER RES, V66, P2098, DOI 10.1158/0008-5472.CAN-05-2308; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	36	43	44	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 13	2013	32	24					2963	2972		10.1038/onc.2012.310	http://dx.doi.org/10.1038/onc.2012.310			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22824794				2022-12-25	WOS:000320369700006
J	Bouayad, D; Pederzoli-Ribeil, M; Mocek, J; Candalh, C; Arlet, JB; Hermine, O; Reuter, N; Davezac, N; Witko-Sarsat, V				Bouayad, Dikra; Pederzoli-Ribeil, Magali; Mocek, Julie; Candalh, Celine; Arlet, Jean-Benoit; Hermine, Olivier; Reuter, Nathalie; Davezac, Noelie; Witko-Sarsat, Veronique			Nuclear-to-cytoplasmic Relocalization of the Proliferating Cell Nuclear Antigen (PCNA) during Differentiation Involves a Chromosome Region Maintenance 1 (CRM1)-dependent Export and Is a Prerequisite for PCNA Antiapoptotic Activity in Mature Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; SIGNAL; APOPTOSIS; PROTEIN; DNA; TRANSLOCATION; INFLAMMATION; REPLICATION; ACTIVATION; INHIBITORS	Neutrophils are deprived of proliferative capacity and have a tightly controlled lifespan to avoid their persistence at the site of injury. We have recently described that the proliferating cell nuclear antigen (PCNA), a nuclear factor involved in DNA replication and repair of proliferating cells, is a key regulator of neutrophil survival. In neutrophils, PCNA was localized exclusively in the cytoplasm due to its nuclear-to-cytoplasmic relocalization during granulocytic differentiation. We showed here that leptomycin B, an inhibitor of the chromosome region maintenance 1 (CRM1) exportin, inhibited PCNA relocalization during granulocytic differentiation of HL-60 and NB4 promyelocytic cell lines and of human CD34(+) primary cells. Using enhanced green fluorescent protein fusion constructs, we have demonstrated that PCNA relocalization involved a nuclear export signal (NES) located from Ile-11 to Ile-23 in the PCNA sequence. However, this NES, located at the inner face of the PCNA trimer, was not functional in wild-type PCNA, but instead, was fully active and leptomycin B-sensitive in the monomeric PCNAY114A mutant. To test whether a defect in PCNA cytoplasmic relocalization would affect its antiapoptotic activity in mature neutrophils, a chimeric PCNA fused with the SV40 nuclear localization sequence (NLS) was generated to preclude its cytoplasmic localization. As expected, neutrophil-differentiated PLB985 cells expressing ectopic SV40NLS-PCNA had an increased nuclear PCNA as compared with cells expressing wild-type PCNA. Accordingly, the nuclear PCNA mutant did not show any antiapoptotic activity as compared with wild-type PCNA. Nuclear-to-cytoplasmic relocalization that occurred during myeloid differentiation is essential for PCNA antiapoptotic activity in mature neutrophils and is dependent on the newly identified monomerization-dependent PCNA NES.	[Witko-Sarsat, Veronique] INSERM, U1016, Cochin Inst, F-75014 Paris, France; [Bouayad, Dikra; Pederzoli-Ribeil, Magali; Mocek, Julie; Candalh, Celine; Witko-Sarsat, Veronique] Univ Paris 05, Cochin Hosp, Inst Cochin, F-75015 Paris, France; [Bouayad, Dikra; Pederzoli-Ribeil, Magali; Mocek, Julie; Candalh, Celine; Witko-Sarsat, Veronique] CNRS, UMR8104, F-75014 Paris, France; [Hermine, Olivier] Univ Paris 05, Dept Hematol, Necker Hosp, F-75015 Paris, France; [Arlet, Jean-Benoit; Hermine, Olivier] Univ Paris 05, CNRS, Necker Hosp, UMR8147, F-75015 Paris, France; [Reuter, Nathalie] Univ Bergen, Computat Biol Unit, N-5008 Bergen, Norway; [Davezac, Noelie] Univ Toulouse 3, CNRS, UMR5547, F-31400 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Witko-Sarsat, V (corresponding author), INSERM, U1016, Cochin Inst, 27Bis Rue Faubourg St Jacques, F-75014 Paris, France.	veronique.witko@inserm.fr	Hermine, Olivier/Q-7072-2018; Witko-Sarsat, Veronique/L-9714-2017; Arlet, Jean Benoit/D-3124-2016; Reuter, Nathalie/G-2037-2012	Witko-Sarsat, Veronique/0000-0002-5296-9601; Reuter, Nathalie/0000-0002-3649-7675; Hermine, Olivier/0000-0003-2574-3874	Institut National de la Sante et de la Recherche Medicale (Inserm); association ABCF Mucoviscidose, Societe Francaise d'Hematologie (SFH, fellowship); National Program for Research in Functional Genomics (FUGE) in Norway	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); association ABCF Mucoviscidose, Societe Francaise d'Hematologie (SFH, fellowship); National Program for Research in Functional Genomics (FUGE) in Norway	This work was supported by Institut National de la Sante et de la Recherche Medicale (Inserm), the association ABCF Mucoviscidose, Societe Francaise d'Hematologie (SFH, fellowship to D.B.), and National Program for Research in Functional Genomics (FUGE) in Norway (to N. R.).	Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Fridell RA, 1996, P NATL ACAD SCI USA, V93, P4421, DOI 10.1073/pnas.93.9.4421; Hino M, 2000, BRIT J HAEMATOL, V109, P314, DOI 10.1046/j.1365-2141.2000.02054.x; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; JONSSON ZO, 1995, EMBO J, V14, P5745, DOI 10.1002/j.1460-2075.1995.tb00261.x; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kim BJ, 2008, BIOL CELL, V100, P675, DOI 10.1042/BC20070158; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LANOTTE M, 1991, BLOOD, V77, P1080; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312; NISHI K, 1994, J BIOL CHEM, V269, P6320; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Piard K, 1998, NUCLEIC ACIDS RES, V26, P2598, DOI 10.1093/nar/26.11.2598; Prosperi E, 2006, FASEB J, V20, P833, DOI 10.1096/fj.05-5469hyp; Rodriguez JA, 2004, ONCOGENE, V23, P1809, DOI 10.1038/sj.onc.1207302; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Scovassi A Ivana, 2006, Methods Mol Biol, V314, P457; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Theilgaard-Monch K, 2006, CURR OPIN IMMUNOL, V18, P54, DOI 10.1016/j.coi.2005.11.010; Uchida S, 2004, BIOCHEM BIOPH RES CO, V316, P226, DOI 10.1016/j.bbrc.2004.02.039; Vischioni B, 2004, EXP CELL RES, V298, P535, DOI 10.1016/j.yexcr.2004.04.040; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yaroslavskiy B, 1999, BLOOD, V93, P2907; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	42	28	29	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33812	33825		10.1074/jbc.M112.367839	http://dx.doi.org/10.1074/jbc.M112.367839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22846997	hybrid, Green Published			2022-12-25	WOS:000309602100062
J	Lee, MB; Kooistra, M; Zhang, BH; Slow, S; Fortier, AL; Garrow, TA; Lever, M; Trasler, JM; Baltz, JM				Lee, Martin B.; Kooistra, Megan; Zhang, Baohua; Slow, Sandy; Fortier, Amanda L.; Garrow, Timothy A.; Lever, Michael; Trasler, Jacquetta M.; Baltz, Jay M.			Betaine Homocysteine Methyltransferase Is Active in the Mouse Blastocyst and Promotes Inner Cell Mass Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREIMPLANTATION EMBRYOS; S-METHYLTRANSFERASE; MAMMALIAN DEVELOPMENT; DNA METHYLATION; METABOLISM; EXPRESSION; MICE; REPRODUCTION; TRANSPORT; LINEAGES	Methyltransferases are an important group of enzymes with diverse roles that include epigenetic gene regulation. The universal donor of methyl groups for methyltransferases is S-adenosylmethionine (AdoMet), which in most cells is synthesized using methyl groups carried by a derivative of folic acid. Another mechanism for AdoMet synthesis uses betaine as the methyl donor via the enzyme betaine-homocysteine methyltransferase (BHMT, EC 2.1.1.5), but it has been considered to be significant only in liver. Here, we show that mouse preimplantation embryos contain endogenous betaine; Bhmt mRNA is first expressed at the morula stage; BHMT is abundant at the blastocyst stage but not other preimplantation stages, and BHMT activity is similarly detectable in blastocyst homogenates but not those of two-cell or morula stage embryos. Knockdown of BHMT protein levels and reduction of enzyme activity using Bhmt-specific antisense morpholinos or a selective BHMT inhibitor resulted in decreased development of embryos to the blastocyst stage in vitro and a reduction in inner cell mass cell number in blastocysts. The detrimental effects of BHMT knockdown were fully rescued by the immediate methyl-carrying product of BHMT, methionine. A physiological role for betaine and BHMT in blastocyst viability was further indicated by increased fetal resorption following embryo transfer of BHMT knockdown blastocysts versus control. Thus, mouse blastocysts are unusual in being able to generate AdoMet not only by the ubiquitous folate-dependent mechanism but also from betaine metabolized by BHMT, likely a significant pool of methyl groups in blastocysts.	[Lee, Martin B.; Kooistra, Megan; Zhang, Baohua; Baltz, Jay M.] Ottawa Hosp Res Inst, Ottawa, ON K1Y 4E9, Canada; [Baltz, Jay M.] Univ Ottawa, Fac Med, Dept Obstet & Gynecol, Div Reprod Med, Ottawa, ON K1H 8L6, Canada; [Lee, Martin B.; Baltz, Jay M.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Slow, Sandy; Lever, Michael] Canterbury Hlth Labs, Biochem Unit, Christchurch 8140, New Zealand; [Garrow, Timothy A.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Fortier, Amanda L.; Trasler, Jacquetta M.] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3H 1P3, Canada; [Fortier, Amanda L.; Trasler, Jacquetta M.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Canterbury Health Laboratories; University of Illinois System; University of Illinois Urbana-Champaign; McGill University; McGill University; McGill University; McGill University	Baltz, JM (corresponding author), Ottawa Hosp Res Inst, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	jmbaltz@ohri.ca		Baltz, Jay/0000-0002-9749-2480	Canadian Institutes of Health Research [MOP97972]; Program on Oocyte Health; Canadian Institutes of Health Research Institute of Human Development Child and Youth Health Strategic Initiative Grant [HGG62293]; Lalor Foundation; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Program on Oocyte Health; Canadian Institutes of Health Research Institute of Human Development Child and Youth Health Strategic Initiative Grant(Canadian Institutes of Health Research (CIHR)); Lalor Foundation; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Operating Grant MOP97972 (to J. M. B. and J. T.).; Supported in part by the Program on Oocyte Health funded by Canadian Institutes of Health Research Institute of Human Development Child and Youth Health Strategic Initiative Grant HGG62293.; Supported by a Lalor Foundation postdoctoral fellowship.; Member of the Research Institute of the McGill University Health Centre, which is supported in part by the Fonds de la Recherche en Sante du Quebec.	Anas MKI, 2007, J CELL PHYSIOL, V210, P266, DOI 10.1002/jcp.20872; Anas MKI, 2008, DEVELOPMENT, V135, P4123, DOI 10.1242/dev.026575; ANBARI K, 1993, MOL REPROD DEV, V35, P24, DOI 10.1002/mrd.1080350105; BIGGERS JD, 1993, MOL REPROD DEV, V34, P380, DOI 10.1002/mrd.1080340406; BIGGERS JD, 1988, AM J PHYSIOL, V255, pC419, DOI 10.1152/ajpcell.1988.255.4.C419; Clark DA, 2008, AM J REPROD IMMUNOL, V60, P192, DOI 10.1111/j.1600-0897.2008.00612.x; Collinsova M, 2006, J NUTR, V136, P1493, DOI 10.1093/jn/136.6.1493; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; FitzHarris G, 2006, DEVELOPMENT, V133, P591, DOI 10.1242/dev.02246; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Fowler B, 2001, KIDNEY INT, V59, pS221, DOI 10.1046/j.1523-1755.2001.07851.x; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Gasperowicz M, 2011, BIOL REPROD, V84, P621, DOI 10.1095/biolreprod.110.085209; Hammer MA, 2002, MOL REPROD DEV, V62, P195, DOI 10.1002/mrd.10088; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Hogan B., 1994, MANIPULATING MOUSE E, P178; Ikeda S, 2010, J EXP ZOOL PART A, V313A, P129, DOI 10.1002/jez.581; Jiracek J, 2006, J MED CHEM, V49, P3982, DOI 10.1021/jm050885v; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kwong WY, 2010, REPRODUCTION, V139, P705, DOI 10.1530/REP-09-0517; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lucifero D, 2004, HUM REPROD UPDATE, V10, P3, DOI 10.1093/humupd/dmh002; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; MENEZO Y, 1989, LIFE SCI, V44, P1601, DOI 10.1016/0024-3205(89)90455-4; MILLER JGO, 1985, J EMBRYOL EXP MORPH, V89, P149; MONK M, 1987, DEVELOPMENT, V99, P371; O'Neill C, 1998, HUM REPROD, V13, P1312, DOI 10.1093/humrep/13.5.1312; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Siddall LS, 2002, MOL REPROD DEV, V63, P413, DOI 10.1002/mrd.10202; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Steele W, 2005, REPROD BIOMED ONLINE, V10, P755, DOI 10.1016/S1472-6483(10)61120-0; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Tgarashi H, 2007, DEV BIOL, V312, P321, DOI 10.1016/j.ydbio.2007.09.028; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	45	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33094	33103		10.1074/jbc.M112.365478	http://dx.doi.org/10.1074/jbc.M112.365478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22847001	hybrid, Green Published			2022-12-25	WOS:000309168300071
J	van Oosterwijk, N; Knol, J; Dijkhuizen, L; van der Geize, R; Dijkstra, BW				van Oosterwijk, Niels; Knol, Jan; Dijkhuizen, Lubbert; van der Geize, Robert; Dijkstra, Bauke W.			Structure and Catalytic Mechanism of 3-Ketosteroid-Delta 4-(5 alpha)-dehydrogenase from Rhodococcus jostii RHA1 Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FUMARATE REDUCTASE; GENE-CLUSTER; PROTEIN; BINDING; DEHYDROGENASE; CRYSTALLOGRAPHY; SUBSTRATE; SURVIVAL; STEROIDS	3-Ketosteroid Delta 4-(5 alpha)-dehydrogenases ( Delta 4-(5 alpha)-KSTDs) are enzymes that introduce a double bond between the C4 and C5 atoms of 3-keto-(5 alpha)-steroids. Here we show that the ro05698 gene from Rhodococcus jostii RHA1 codes for a flavoprotein with Delta 4-(5 alpha)-KSTD activity. The 1.6 angstrom resolution crystal structure of the enzyme revealed three conserved residues ( Tyr-319, Tyr-466, and Ser-468) in a pocket near the isoalloxazine ring system of the FAD co-factor. Site-directed mutagenesis of these residues confirmed that they are absolutely essential for catalytic activity. A crystal structure with bound product 4-androstene-3,17-dione showed that Ser-468 is in a position in which it can serve as the base abstracting the 4 beta-proton from the C4 atom of the substrate. Ser-468 is assisted by Tyr-319, which possibly is involved in shuttling the proton to the solvent. Tyr-466 is at hydrogen bonding distance to the C3 oxygen atom of the substrate and can stabilize the keto-enol intermediate occurring during the reaction. Finally, the FAD N5 atom is in a position to be able to abstract the 5 alpha-hydrogen of the substrate as a hydride ion. These features fully explain the reaction catalyzed by Delta 4-(5 alpha)-KSTDs.	[van Oosterwijk, Niels; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Knol, Jan; Dijkhuizen, Lubbert; van der Geize, Robert] Univ Groningen, Biophys Chem Lab, Dept Microbiol, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Dijkstra, BW (corresponding author), Univ Groningen, Biophys Chem Lab, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	b.w.dijkstra@rug.nl	Dijkstra, Bauke W./H-4308-2019; Dijkhuizen, Lubbert/K-3539-2019; Dijkhuizen, Lubbert/E-9454-2014	Dijkstra, Bauke W./0000-0001-9731-6586; Dijkhuizen, Lubbert/0000-0003-2312-7162; 	Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic, a public-private Advanced Chemical Technologies for Sustainability program; Schering-Plough	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic, a public-private Advanced Chemical Technologies for Sustainability program; Schering-Plough(Merck & CompanySchering Plough Corporation)	This was project was supported in part by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations through B-Basic, a public-private Advanced Chemical Technologies for Sustainability program. This work was also supported by Schering-Plough.	ABULHAJJ YJ, 1978, J BIOL CHEM, V253, P2356; Bamford V, 1999, NAT STRUCT BIOL, V6, P1104; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fagan RL, 2006, BIOCHEMISTRY-US, V45, P14926, DOI 10.1021/bi060919g; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Fujii C, 1999, J BIOCHEM-TOKYO, V126, P662, DOI 10.1093/oxfordjournals.jbchem.a022500; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P4421, DOI 10.1128/AEM.69.8.4421-4430.2003; ITAGAKI E, 1990, J BIOCHEM-TOKYO, V108, P122, DOI 10.1093/oxfordjournals.jbchem.a123150; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LEVY HR, 1959, J BIOL CHEM, V234, P2014; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Lyubimov AY, 2007, PROTEIN SCI, V16, P2647, DOI 10.1110/ps.073168207; MASSEY V, 1974, ANN NY ACAD SCI, V227, P446, DOI 10.1111/j.1749-6632.1974.tb14407.x; MATSUSHITA H, 1992, J BIOCHEM-TOKYO, V111, P594, DOI 10.1093/oxfordjournals.jbchem.a123803; Mattevi A, 1998, BIOPHYS CHEM, V70, P217, DOI 10.1016/S0301-4622(97)00126-9; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; MEDENTSEV AG, 1985, J STEROID BIOCHEM, V23, P365, DOI 10.1016/0022-4731(85)90418-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; RINGOLD HJ, 1963, J BIOL CHEM, V238, P1960; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vallon O, 2000, PROTEINS, V38, P95, DOI 10.1002/(SICI)1097-0134(20000101)38:1<95::AID-PROT10>3.0.CO;2-A; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; van Oosterwijk N, 2011, ACTA CRYSTALLOGR F, V67, P1269, DOI 10.1107/S1744309111028727; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WIERENGA RK, 1979, J MOL BIOL, V131, P55, DOI 10.1016/0022-2836(79)90301-2; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	52	19	19	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30975	30983		10.1074/jbc.M112.374306	http://dx.doi.org/10.1074/jbc.M112.374306			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22833669	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000308791300011
J	Torbensen, R; Moller, HD; Gresham, D; Alizadeh, S; Ochmann, D; Boles, E; Regenberg, B				Torbensen, Rasmus; Moller, Henrik Devitt; Gresham, David; Alizadeh, Sefa; Ochmann, Doreen; Boles, Eckhard; Regenberg, Birgitte			Amino Acid Transporter Genes Are Essential for FLO11-Dependent and FLO11-Independent Biofilm Formation and Invasive Growth in Saccharomyces cerevisiae	PLOS ONE			English	Article							PROTEIN-KINASE; PSEUDOHYPHAL DIFFERENTIATION; HIGH-AFFINITY; MAP KINASE; CELL-CELL; YEAST; EXPRESSION; PERMEASE; SPECIFICITY; AMMONIUM	Amino acids can induce yeast cell adhesion but how amino acids are sensed and signal the modulation of the FLO adhesion genes is not clear. We discovered that the budding yeast Saccharomyces cerevisiae CEN.PK evolved invasive growth ability under prolonged nitrogen limitation. Such invasive mutants were used to identify amino acid transporters as regulators of FLO11 and invasive growth. One invasive mutant had elevated levels of FLO11 mRNA and a Q320STOP mutation in the SFL1 gene that encodes a protein kinase A pathway regulated repressor of FLO11. Glutamine-transporter genes DIP5 and GNP1 were essential for FLO11 expression, invasive growth and biofilm formation in this mutant. Invasive growth relied on known regulators of FLO11 and the Ssy1-Ptr3-Ssy5 complex that controls DIP5 and GNP1, suggesting that Dip5 and Gnp1 operates downstream of the Ssy1-Ptr3-Ssy5 complex for regulation of FLO11 expression in a protein kinase A dependent manner. The role of Dip5 and Gnp1 appears to be conserved in the S. cerevisiae strain Sigma 1278b since the dip5 gnp1 Sigma 1278b mutant showed no invasive phenotype. Secondly, the amino acid transporter gene GAP1 was found to influence invasive growth through FLO11 as well as other FLO genes. Cells carrying a dominant loss-of-function PTR3(647::CWNKNPLSSIN) allele had increased transcription of the adhesion genes FLO1, 5, 9, 10, 11 and the amino acid transporter gene GAP1. Deletion of GAP1 caused loss of FLO11 expression and invasive growth. However, deletions of FLO11 and genes encoding components of the mitogen-activated protein kinase pathway or the protein kinase A pathway were not sufficient to abolish invasive growth, suggesting involvement of other FLO genes and alternative pathways. Increased intracellular amino acid pools in the PTR3(647::CWNKNPLSSIN)-containing strain opens the possibility that Gap1 regulates the FLO genes through alteration of the amino acid pool sizes.	[Torbensen, Rasmus; Moller, Henrik Devitt; Alizadeh, Sefa; Regenberg, Birgitte] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Gresham, David] NYU, Ctr Genom & Syst Biol, New York, NY USA; [Gresham, David] NYU, Dept Biol, New York, NY 10003 USA; [Ochmann, Doreen; Boles, Eckhard] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany	University of Copenhagen; New York University; New York University; Goethe University Frankfurt	Regenberg, B (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	BRegenberg@bio.ku.dk	Møller, Henrik/K-5415-2014; Regenberg, Brigit/C-2699-2009	Møller, Henrik/0000-0002-1886-3053; Regenberg, Brigit/0000-0003-4996-7012; Boles, Eckhard/0000-0002-5713-1883	Danish Agency for Science Technology and Innovation [FNU 09-062220, 272-06-0287]; National Institutes of Health Research Grant [GM046406]; National Institute of General Medical Sciences Center for Quantitative Biology [GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046406, R37GM046406, P50GM071508] Funding Source: NIH RePORTER	Danish Agency for Science Technology and Innovation; National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Center for Quantitative Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this work was received from the Danish Agency for Science Technology and Innovation FNU 09-062220 and 272-06-0287, http://en.fi.dk/; a National Institutes of Health Research Grant GM046406, http://www.nihr.ac.uk/Pages/default.aspx; the National Institute of General Medical Sciences Center for Quantitative Biology (GM071508), http://www.nigms.nih.gov/News/Results/quantitative_bio_center.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braus GH, 2003, MOL BIOL CELL, V14, P4272, DOI 10.1091/mbc.e03-01-0042; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; COFFMAN JA, 1995, J BACTERIOL, V177, P6910, DOI 10.1128/jb.177.23.6910-6918.1995; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; DELFORGE J, 1975, EUR J BIOCHEM, V57, P231, DOI 10.1111/j.1432-1033.1975.tb02295.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Douglas LM, 2007, EUKARYOT CELL, V6, P2214, DOI 10.1128/EC.00284-06; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Fichtner L, 2007, MOL MICROBIOL, V66, P1276, DOI 10.1111/j.1365-2958.2007.06014.x; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Gresham D, 2010, P NATL ACAD SCI USA, V107, P18551, DOI 10.1073/pnas.1014023107; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Lambrechts MG, 1996, P NATL ACAD SCI USA, V93, P8419, DOI 10.1073/pnas.93.16.8419; LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Mosch HU, 1999, MOL BIOL CELL, V10, P1325, DOI 10.1091/mbc.10.5.1325; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Regenberg B, 1998, CURR GENET, V33, P171, DOI 10.1007/s002940050324; Regenberg B, 2000, YEAST, V16, P1111, DOI 10.1002/1097-0061(20000915)16:12<1111::AID-YEA611>3.0.CO;2-3; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Rupp S, 2007, FUTURE MICROBIOL, V2, P141, DOI 10.2217/17460913.2.2.141; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TEUNISSEN AWRH, 1995, YEAST, V11, P435, DOI 10.1002/yea.320110506; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Usaite R, 2006, APPL ENVIRON MICROB, V72, P6194, DOI 10.1128/AEM.00548-06; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Vanhalewyn M, 1999, MOL MICROBIOL, V33, P363, DOI 10.1046/j.1365-2958.1999.01479.x; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Zhu X, 1996, CURR GENET, V30, P107, DOI 10.1007/s002940050108	49	18	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41272	10.1371/journal.pone.0041272	http://dx.doi.org/10.1371/journal.pone.0041272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844449	Green Published, Green Submitted, gold			2022-12-25	WOS:000309240600019
J	Kreuzer, HW; Quaroni, L; Podlesak, DW; Zlateva, T; Bollinger, N; McAllister, A; Lott, MJ; Hegg, EL				Kreuzer, Helen W.; Quaroni, Luca; Podlesak, David W.; Zlateva, Theodora; Bollinger, Nikki; McAllister, Aaron; Lott, Michael J.; Hegg, Eric L.			Detection of Metabolic Fluxes of O and H Atoms into Intracellular Water in Mammalian Cells	PLOS ONE			English	Article							PHASE ESCHERICHIA-COLI; HYDROGEN; OXYGEN; TRANSFORMATION; FRACTIONATION; ISOTOPES; HAIR	Metabolic processes result in the release and exchange of H and O atoms from organic material as well as some inorganic salts and gases. These fluxes of H and O atoms into intracellular water result in an isotopic gradient that can be measured experimentally. Using isotope ratio mass spectroscopy, we revealed that slightly over 50% of the H and O atoms in the intracellular water of exponentially-growing cultured Rat-1 fibroblasts were isotopically distinct from growth medium water. We then employed infrared spectromicroscopy to detect in real time the flux of H atoms in these same cells. Importantly, both of these techniques indicate that the H and O fluxes are dependent on metabolic processes; cells that are in lag phase or are quiescent exhibit a much smaller flux. In addition, water extracted from the muscle tissue of rats contained a population of H and O atoms that were isotopically distinct from body water, consistent with the results obtained using the cultured Rat-1 fibroblasts. Together these data demonstrate that metabolic processes produce fluxes of H and O atoms into intracellular water, and that these fluxes can be detected and measured in both cultured mammalian cells and in mammalian tissue.	[Kreuzer, Helen W.; Bollinger, Nikki] Pacific NW Natl Lab, Richland, WA 99352 USA; [Quaroni, Luca] Paul Scherrer Inst, Villigen, Switzerland; [Podlesak, David W.; Lott, Michael J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Zlateva, Theodora] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada; [Zlateva, Theodora] Univ Saskatchewan, Saskatchewan Canc Res Unit, Saskatoon, SK, Canada; [McAllister, Aaron; Hegg, Eric L.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Utah System of Higher Education; University of Utah; University of Saskatchewan; University of Saskatchewan; Utah System of Higher Education; University of Utah; Michigan State University	Kreuzer, HW (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	helen.kreuzer@pnnl.gov; Luca.Quaroni@psi.ch; erichegg@msu.edu	Quaroni, Luca/O-4629-2019; Quaroni, Luca/I-3027-2014; Quaroni, Luca/G-3604-2013; Source, Mid IR Beamline Canadian Light/I-2869-2014	Quaroni, Luca/0000-0002-0225-9775; 	National Institutes of Health [GM 66236]; University of Utah Research Foundation; Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory, a multiprogram laboratory operated by Battelle for the United States Department of Energy [DE-AC05-76RL01830]; United States Department of Energy, Office of Biological and Environmental Research (BER) as part of BER's Genomic Science Program; Canadian Light Source and the Paul Scherrer Institut; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Utah Research Foundation; Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory, a multiprogram laboratory operated by Battelle for the United States Department of Energy; United States Department of Energy, Office of Biological and Environmental Research (BER) as part of BER's Genomic Science Program(United States Department of Energy (DOE)); Canadian Light Source and the Paul Scherrer Institut; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research funding was provided by National Institutes of Health (GM 66236) (ELH), the University of Utah Research Foundation (ELH), the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory, a multiprogram laboratory operated by Battelle for the United States Department of Energy under Contract DE-AC05-76RL01830 (HK), by the United States Department of Energy, Office of Biological and Environmental Research (BER) as part of BER's Genomic Science Program (HK), and the Canadian Light Source and the Paul Scherrer Institut (LQ). The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coplen T.B., 1996, GEOCHIM COSMOCHIM AC, V60, P3359, DOI [10.1016/0016-7037(96)00263-3, DOI 10.1016/0016-7037(96)00263-3]; FREEMAN AE, 1970, J NATL CANCER I, V44, P65; FREEMAN AE, 1973, P NATL ACAD SCI USA, V70, P2415, DOI 10.1073/pnas.70.8.2415; Garcia-Martin ML, 2001, PROG NUCL MAG RES SP, V39, P41, DOI 10.1016/S0079-6565(01)00031-0; Gehre M, 2004, RAPID COMMUN MASS SP, V18, P2650, DOI 10.1002/rcm.1672; Goff KL, 2009, ANALYST, V134, P2216, DOI 10.1039/b915810c; Gretebeck RJ, 1997, J APPL PHYSIOL, V82, P563, DOI 10.1152/jappl.1997.82.2.563; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kreuzer H, 2010, ELEMENTAL ISOTOPE RA, P968; Kreuzer-Martin HW, 2006, BIOCHEMISTRY-US, V45, P13622, DOI 10.1021/bi0609164; Kreuzer-Martin HW, 2005, P NATL ACAD SCI USA, V102, P17337, DOI 10.1073/pnas.0506531102; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Nagy K.A., 1989, Ecological Studies, V68, P270; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Quaroni L, 2011, ANALYST, V136, P3219, DOI 10.1039/c1an15060j; Robins Richard J., 2003, Phytochemistry Reviews, V2, P87, DOI 10.1023/B:PHYT.0000004301.52646.a8; Sachs JP, 2011, GEOCHIM COSMOCHIM AC, V75, P444, DOI 10.1016/j.gca.2010.10.013; Sachse D, 2008, GEOCHIM COSMOCHIM AC, V72, P793, DOI 10.1016/j.gca.2007.11.022; SCHIMMELMANN A, 1991, ANAL CHEM, V63, P2456, DOI 10.1021/ac00021a013; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; STERNBERG LDL, 1986, PLANT PHYSIOL, V82, P423, DOI 10.1104/pp.82.2.423; STERNBERG LDLO, 1983, GEOCHIM COSMOCHIM AC, V47, P2271	24	21	21	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39685	10.1371/journal.pone.0039685	http://dx.doi.org/10.1371/journal.pone.0039685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848359	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000306806600009
J	Ochoa-Alvarez, JA; Krishnan, H; Shen, YQ; Acharya, NK; Han, M; McNulty, DE; Hasegawa, H; Hyodo, T; Senga, T; Geng, JG; Kosciuk, M; Shin, SS; Goydos, JS; Temiakov, D; Nagele, RG; Goldberg, GS				Ochoa-Alvarez, Jhon Alberto; Krishnan, Harini; Shen, Yongquan; Acharya, Nimish K.; Han, Min; McNulty, Dean E.; Hasegawa, Hitoki; Hyodo, Toshinori; Senga, Takeshi; Geng, Jian-Guo; Kosciuk, Mary; Shin, Seung S.; Goydos, James S.; Temiakov, Dmitry; Nagele, Robert G.; Goldberg, Gary S.			Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and Migration	PLOS ONE			English	Article							LYMPHATIC MARKER PODOPLANIN; MAACKIA-AMURENSIS HEMAGGLUTININ; PLATELET-AGGREGATION; BREAST-CANCER; MALIGNANT-MELANOMA; PA2.26 ANTIGEN; ORAL-CANCER; IN-VITRO; EXPRESSION; TUMOR	Cancer is a leading cause of death of men and women worldwide. Tumor cell motility contributes to metastatic invasion that causes the vast majority of cancer deaths. Extracellular receptors modified by alpha 2,3-sialic acids that promote this motility can serve as ideal chemotherapeutic targets. For example, the extracellular domain of the mucin receptor podoplanin (PDPN) is highly O-glycosylated with alpha 2,3-sialic acid linked to galactose. PDPN is activated by endogenous ligands to induce tumor cell motility and metastasis. Dietary lectins that target proteins containing alpha 2,3-sialic acid inhibit tumor cell growth. However, anti-cancer lectins that have been examined thus far target receptors that have not been identified. We report here that a lectin from the seeds of Maackia amurensis (MASL) with affinity for O-linked carbohydrate chains containing sialic acid targets PDPN to inhibit transformed cell growth and motility at nanomolar concentrations. Interestingly, the biological activity of this lectin survives gastrointestinal proteolysis and enters the cardiovascular system to inhibit melanoma cell growth, migration, and tumorigenesis. These studies demonstrate how lectins may be used to help develop dietary agents that target specific receptors to combat malignant cell growth.	[Ochoa-Alvarez, Jhon Alberto; Krishnan, Harini; Acharya, Nimish K.; Han, Min; Temiakov, Dmitry; Nagele, Robert G.; Goldberg, Gary S.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ USA; [Ochoa-Alvarez, Jhon Alberto; Krishnan, Harini; Shen, Yongquan; Goldberg, Gary S.] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA; [McNulty, Dean E.] GlaxoSmithKline, Mol Discovery Res, Prote & Biol Mass Spectrometry, Collegeville, PA USA; [Hasegawa, Hitoki; Hyodo, Toshinori; Senga, Takeshi] Nagoya Univ, Sch Med, Div Canc Biol, Nagoya, Aichi 466, Japan; [Geng, Jian-Guo] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Acharya, Nimish K.; Han, Min; Kosciuk, Mary; Nagele, Robert G.] Univ Med & Dent New Jersey, New Jersey Inst Successful Aging, Stratford, NJ USA; [Shin, Seung S.; Goydos, James S.] Canc Inst New Jersey, Dept Surg, New Brunswick, NJ USA; [Temiakov, Dmitry] Univ Med & Dent New Jersey, Dept Cell Biol, Stratford, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; GlaxoSmithKline; Nagoya University; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ochoa-Alvarez, JA (corresponding author), Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ USA.	gary.goldberg@umdnj.edu	Goydos, James/AAR-8990-2020; Krishnan, Harini/J-5632-2019	Goydos, James/0000-0001-9811-939X; Krishnan, Harini/0000-0003-0286-0322; Shin, Seung-Shick/0000-0002-8536-2056; Han, Min/0000-0002-8350-687X; Hyodo, Toshinori/0000-0003-3046-5338; Han, Min/0000-0002-7348-9121	NIH [R01CA126897]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Research Foundation of UMDNJ; Northarvest Bean Growers Association; Sentrimed; NATIONAL CANCER INSTITUTE [R01CA126897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation of UMDNJ; Northarvest Bean Growers Association; Sentrimed; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the NIH (R01CA126897) to J-GG, the Ministry of Education, Culture, Sports, Science and Technology of Japan to TS, and the Research Foundation of UMDNJ, the Northarvest Bean Growers Association, and Sentrimed to GSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DB, 2004, CANCER RES, V64, P1347, DOI 10.1158/0008-5472.CAN-03-2558; [Anonymous], 1955, ILUSTRATED MANUAL CH; Augustin M, 2005, ARZNEIMITTELFORSCH, V55, P38; Bange J, 2001, NAT MED, V7, P548, DOI 10.1038/87872; Beuth J, 2008, ANTICANCER RES, V28, P523; Buonaccorsi JN, 2012, AM J DERMATOPATH; Cerna A, 2002, ACTA HISTOCHEM, V104, P339, DOI 10.1078/0065-1281-00669; Chovanec M, 2004, ONCOL REP, V12, P297; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; CROW DS, 1992, ONCOGENE, V7, P999; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; Cui HX, 2011, ONCOL REP, V25, P1365, DOI 10.3892/or.2011.1192; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Estler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-478; Fedoreev SA, 2010, PHARM CHEM J, V38, P605, DOI DOI 10.1007/s11094-005-0039-6; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gandarillas A, 1997, MOL CARCINOGEN, V20, P10, DOI 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M; Grimaldo S, 2010, LYMPHOLOGY, V43, P128; Hasan SS, 2007, CANCER LETT, V253, P25, DOI 10.1016/j.canlet.2006.11.030; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Icirsch A, 2007, J ALTERN COMPLEM MED, V13, P443, DOI 10.1089/acm.2007.6175; Imberty A, 2000, J BIOL CHEM, V275, P17541, DOI 10.1074/jbc.M000560200; Inagaki Y, 2007, HEPATO-GASTROENTEROL, V54, P53; Ingrassia L, 2006, CURR MED CHEM, V13, P3513, DOI 10.2174/092986706779026219; Ito M, 2012, CHEST; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson KA, 2010, SEMIN ONCOL, V37, P345, DOI 10.1053/j.seminoncol.2010.05.012; Kapoor S, 2008, LEUKEMIA RES, V32, P559, DOI 10.1016/j.leukres.2007.08.007; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kato Y, 2010, NUCL MED BIOL, V37, P785, DOI 10.1016/j.nucmedbio.2010.03.010; Kawaguchi H, 2008, J CLIN ONCOL, V26, P354, DOI 10.1200/JCO.2007.13.4072; KAWAGUCHI T, 1974, J BIOL CHEM, V249, P2786; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kono T, 2007, INT J ONCOL, V31, P501; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Li X, 2009, CHEM PHARM BULL, V57, P302, DOI 10.1248/cpb.57.302; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Liang HH, 2007, AM J SURG PATHOL, V31, P304, DOI 10.1097/01.pas.0000213388.47913.f1; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Loos B, 2009, AUTOPHAGY, V5, P590, DOI 10.4161/auto.5.5.8479; Los M, 2007, ONCOLOGIST, V12, P443, DOI 10.1634/theoncologist.12-4-443; Maenuma K, 2008, PROTEOMICS, V8, P3274, DOI 10.1002/pmic.200800037; Maenuma K, 2009, J PROTEOME RES, V8, P3617, DOI 10.1021/pr800816w; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Martin-Villar E, 2009, INT J BIOCHEM CELL B, V41, P1421, DOI 10.1016/j.biocel.2008.12.010; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; Navarro A, 2010, ATLAS LIBRO ROJO FLO; Nelson MH, 2006, ANN PHARMACOTHER, V40, P261, DOI 10.1345/aph.1G387; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; NOSE K, 1990, CELL GROWTH DIFFER, V1, P511; Ogasawara S, 2008, HYBRIDOMA, V27, P259, DOI 10.1089/hyb.2008.0017; Pryme IF, 2006, HISTOL HISTOPATHOL, V21, P285, DOI 10.14670/HH-21.285; Pryme IF, 2002, HISTOL HISTOPATHOL, V17, P261, DOI 10.14670/HH-17.261; Pryme IF, 1999, CANCER LETT, V146, P87, DOI 10.1016/S0304-3835(99)00242-6; Pryme IF, 2007, CANC THERAPY, V5, P287; Pula B, 2011, HISTOPATHOLOGY, V59, P1249, DOI 10.1111/j.1365-2559.2011.04060.x; Pusztai A, 2008, FRONT BIOSCI-LANDMRK, V13, P1130, DOI 10.2741/2750; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Scholl FG, 1999, J CELL SCI, V112, P4601; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shen YQ, 2010, J BIOL CHEM, V285, P9649, DOI 10.1074/jbc.M109.047696; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Theiss C, 2007, EXP CELL RES, V313, P38, DOI 10.1016/j.yexcr.2006.09.029; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; VanDamme EJM, 1997, GLYCOCONJUGATE J, V14, P449, DOI 10.1023/A:1018595300863; Wang FL, 2009, CANCER DETECT PREV, V32, P437, DOI 10.1016/j.cdp.2009.01.001; Wang HX, 2000, INT J BIOCHEM CELL B, V32, P365, DOI 10.1016/S1357-2725(99)00130-2; Wang Q, 1998, LANCET, V352, P1831, DOI 10.1016/S0140-6736(05)79894-9; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Witz IP, 2006, IMMUNOL LETT, V104, P89, DOI 10.1016/j.imlet.2005.11.008; Witz IP, 2006, CANC TREAT, V130, P125; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yamamoto K, 1997, J BIOCHEM-TOKYO, V121, P756; Yu HB, 2007, AM J CLIN PATHOL, V128, P767, DOI 10.1309/4GMREAULY257R3AY; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061	87	47	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41845	10.1371/journal.pone.0041845	http://dx.doi.org/10.1371/journal.pone.0041845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844530	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700158
J	Dasgupta, N; Davis, J; Funk, MJ; Dart, R				Dasgupta, Nabarun; Davis, Jonathan; Funk, Michele Jonsson; Dart, Richard			Using Poison Center Exposure Calls to Predict Methadone Poisoning Deaths	PLOS ONE			English	Article							PRESCRIPTION OPIOID ANALGESICS; UNITED-STATES; CANCER PAIN; ABUSE; SURVEILLANCE; MORTALITY; ASSOCIATION; MANAGEMENT; TEXAS	Purpose: There are more drug overdose deaths in the Untied States than motor vehicle fatalities. Yet the US vital statistics reporting system is of limited value because the data are delayed by four years. Poison centers report data within an hour of the event, but previous studies suggested a small proportion of poisoning deaths are reported to poison centers (PC). In an era of improved electronic surveillance capabilities, exposure calls to PCs may be an alternate indicator of trends in overdose mortality. Methods: We used PC call counts for methadone that were reported to the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS (R)) System in 2006 and 2007. US death certificate data were used to identify deaths due to methadone. Linear regression was used to quantify the relationship of deaths and poison center calls. Results: Compared to decedents, poison center callers tended to be younger, more often female, at home and less likely to require medical attention. A strong association was found with PC calls and methadone mortality (b = 0.88, se = 0.42, t = 9.5, df = 1, p<0.0001, R-2 = 0.77). These findings were robust to large changes in a sensitivity analysis assessing the impact of underreporting of methadone overdose deaths. Conclusions: Our results suggest that calls to poison centers for methadone are correlated with poisoning mortality as identified on death certificates. Calls received by poison centers may be used for timely surveillance of mortality due to methadone. In the midst of the prescription opioid overdose epidemic, electronic surveillance tools that report in real-time are powerful public health tools.	[Dasgupta, Nabarun; Funk, Michele Jonsson] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Davis, Jonathan; Dart, Richard] Denver Hlth, Rocky Mt Poison & Drug Ctr, Denver, CO USA; [Dart, Richard] Univ Colorado, Sch Med, Denver, CO USA	University of North Carolina; University of North Carolina Chapel Hill; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Dasgupta, N (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	nabarund@unc.edu	Funk, Michele Jonsson/F-6885-2011	Funk, Michele Jonsson/0000-0002-3756-7540; Dasgupta, Nabarun/0000-0002-4098-605X; Dart, Richard/0000-0001-5989-9354	UNC/GSK Center for Excellence in Pharmacoepidemiology and Public Health through the University of North Carolina at Chapel Hill	UNC/GSK Center for Excellence in Pharmacoepidemiology and Public Health through the University of North Carolina at Chapel Hill	Dr. Dasgupta received a graduate student fellowship from the UNC/GSK Center for Excellence in Pharmacoepidemiology and Public Health through the University of North Carolina at Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angalakuditi MV, 2006, AM J HEALTH-SYST PH, V63, P323, DOI 10.2146/ajhp050227; Ayonrinde OT, 2000, MED J AUSTRALIA, V173, P536, DOI 10.5694/j.1326-5377.2000.tb139323.x; Banerji S, 2001, AM J HEALTH-SYST PH, V58, P1811, DOI 10.1093/ajhp/58.19.1811; BLANC PD, 1995, WESTERN J MED, V162, P505; Brands B, 2002, DRUG ALCOHOL DEPEN, V66, P11, DOI 10.1016/S0376-8716(01)00176-4; Breiding MJ, 2006, INJURY PREV, V12, P49, DOI 10.1136/ip.2006.012591; Bryner JK, 2006, ARCH PEDIAT ADOL MED, V160, P1217, DOI 10.1001/archpedi.160.12.1217; Bunn TL, 2010, PHARMACOEPIDEM DR S, V19, P124, DOI 10.1002/pds.1901; Cicero TJ, 2007, PAIN MED, V8, P157, DOI 10.1111/j.1526-4637.2006.00259.x; Cicero TJ, 2005, J PAIN, V6, P662, DOI 10.1016/j.jpain.2005.05.004; Dart RC, 2011, ANN PHARMACOTHER, V45, P424, DOI 10.1345/aph.1P064b; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Dasgupta N, 2008, GEOGRAPHY DRUG ADDIC; Dasgupta N, 2010, PAIN MED, V11, P1078, DOI 10.1111/j.1526-4637.2010.00877.x; Dasgupta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007758; Donaldson AE, 2006, INJURY PREV, V12, P338, DOI 10.1136/ip.2005.011171; Forrester MB, 2007, J TOXICOL ENV HEAL A, V70, P534, DOI 10.1080/15287390600870924; Forrester MB, 2006, J TOXICOL ENV HEAL A, V69, P1145, DOI 10.1080/15287390500360273; Hayes BD, 2009, CLIN TOXICOL, V47, P905, DOI 10.3109/15563650903301702; Hoppe-Roberts JM, 2000, ANN EMERG MED, V35, P440, DOI 10.1067/mem.2000.105932; Hughes AA, 2007, CLIN TOXICOL, V45, P144, DOI 10.1080/15563650600981137; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; KleinSchwartz W, 1997, ANN EMERG MED, V29, P232, DOI 10.1016/S0196-0644(97)70274-9; Kreshak AA, 2009, ANN PHARMACOTHER, V43, P1986, DOI 10.1345/aph.1M454; LINAKIS JG, 1993, ANN EMERG MED, V22, P1822, DOI 10.1016/S0196-0644(05)80408-1; Marquardt KA, 2005, ANN PHARMACOTHER, V39, P1039, DOI 10.1345/aph.1E577; Matlock A, 2011, CLIN TOXICOL, V49, P443, DOI 10.3109/15563650.2011.564585; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Reifler LM, 2012, PAIN MED; Ripamonti C, 2001, DRUGS, V61, P955, DOI 10.2165/00003495-200161070-00005; Rosenblum A, 2007, DRUG ALCOHOL DEPEN, V90, P64, DOI 10.1016/j.drugalcdep.2007.02.012; Schneider MF, 2009, PHARMACOEPIDEM DR S, V18, P778, DOI 10.1002/pds.1780; Sims SA, 2007, J BIOMED INFORM, V40, P382, DOI 10.1016/j.jbi.2006.10.004; Smith MY, 2008, PHARMACOEPIDEM DR S, V17, P1050, DOI 10.1002/pds.1658; Smith MY, 2006, AM J DRUG ALCOHOL AB, V32, P465, DOI 10.1080/00952990600753982; SOSLOW AR, 1992, AM J EMERG MED, V10, P124, DOI 10.1016/0735-6757(92)90043-W; Spiller HA, 1997, J TOXICOL-CLIN TOXIC, V35, P167, DOI 10.3109/15563659709001188; Spiller HA, 2010, ANN PHARMACOTHER, V44, P1016, DOI 10.1345/aph.1P064; Stephens BG, 2004, AM J FOREN MED PATH, V25, P11, DOI 10.1097/01.paf.0000114041.70865.24; Tormoehlen LM, 2011, CLIN TOXICOL, V49, P492, DOI 10.3109/15563650.2011.587819; Toxic Exposure Surveillance System (TESS), 2002, INSTR AM ASS POIS CO; Vassilev ZP, 2003, J TOXICOL ENV HEAL A, V66, P1905, DOI 10.1080/713853953; Webster LR, 2011, PAIN MED, V12, pS86, DOI 10.1111/j.1526-4637.2011.01132.x; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	46	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41181	10.1371/journal.pone.0041181	http://dx.doi.org/10.1371/journal.pone.0041181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829925	gold, Green Published			2022-12-25	WOS:000306956300064
J	Vitoriano-Souza, J; Moreira, ND; Teixeira-Carvalho, A; Carneiro, CM; Siqueira, FAM; Vieira, PMD; Giunchetti, RC; Moura, SAD; Fujiwara, RT; Melo, MN; Reis, AB				Vitoriano-Souza, Juliana; Moreira, Nadia das Dores; Teixeira-Carvalho, Andrea; Carneiro, Claudia Martins; Mathias Siqueira, Fernando Augusto; de Abreu Vieira, Paula Melo; Giunchetti, Rodolfo Cordeiro; de Lima Moura, Sandra Aparecida; Fujiwara, Ricardo Toshio; Melo, Maria Norma; Reis, Alexandre Barbosa			Cell Recruitment and Cytokines in Skin Mice Sensitized with the Vaccine Adjuvants: Saponin, Incomplete Freund's Adjuvant, and Monophosphoryl Lipid A	PLOS ONE			English	Article							ANTIGEN DELIVERY; NEUTROPHILS; INNATE; EXPRESSION; IMMUNIZATION; ACTIVATION; INCREASES; RESPONSES; EFFECTOR; IMMUNITY	Vaccine adjuvants are substances associated with antigens that are fundamental to the formation of an intense, durable, and fast immune response. In this context, the use of vaccine adjuvants to generate an effective cellular immune response is crucial for the design and development of vaccines against visceral leishmaniasis. The objective of this study was to evaluate innate inflammatory response induced by the vaccine adjuvants saponin (SAP), incomplete Freund's adjuvant (IFA), and monophosphoryl lipid A (MPL). After a single dose of adjuvant was injected into the skin of mice, we analyzed inflammatory reaction, selective cell migration, and cytokine production at the injection site, and inflammatory cell influx in the peripheral blood. We found that all vaccine adjuvants were able to promote cell recruitment to the site without tissue damage. In addition, they induced selective migration of neutrophils, macrophages, and lymphocytes. The influx of neutrophils was notable at 12 h in all groups, but at other time points it was most evident after inoculation with SAP. With regard to cytokines, the SAP led to production of interleukin (IL)-2, IL-6, and IL-4. IFA promoted production of tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, IL-6, IL-17, IL-4, and IL-10. We also observed that MPL induced high production of IL-2, TNF-alpha, and IFN-gamma, in addition to IL-6, IL-17, and IL-10. In peripheral blood, values of certain cell populations in the local response changed after stimulation. Our data demonstrate that the three vaccine adjuvants stimulate the early events of innate immune response at the injection site, suggesting their ability to increase the immunogenicity of co-administered antigens. Moreover, this work provides relevant information about elements of innate and acquired immune response induced by vaccine adjuvants administered alone.	[Vitoriano-Souza, Juliana; Fujiwara, Ricardo Toshio; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Vitoriano-Souza, Juliana; Moreira, Nadia das Dores; Carneiro, Claudia Martins; Mathias Siqueira, Fernando Augusto; de Abreu Vieira, Paula Melo; Giunchetti, Rodolfo Cordeiro; de Lima Moura, Sandra Aparecida; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz, Lab Biomarcadores Diagnost & Monitoracao, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Carneiro, Claudia Martins; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Dept Anal Clin, Escola Farm, Ouro Preto, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto	Vitoriano-Souza, J (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	alexreis@nupeb.ufop.br	Reis, Alexandre Barbosa/I-9945-2014; Giunchetti, Rodolfo/O-9878-2014; de Moura, Sandra Aparecida Lima/AAW-3214-2021; carneiro, Claudia Martins/AAP-4455-2020; carneiro, claudia m/B-6205-2013; Fujiwara, Ricardo Toshio/J-7579-2012	Reis, Alexandre Barbosa/0000-0001-8123-4164; carneiro, Claudia Martins/0000-0002-6002-857X; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Vieira, Paula/0000-0001-7033-7686; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546; Siqueira Mathias, Fernando Augusto/0000-0003-2071-0344	FAPEMIG; CNPq; CAPES	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPEMIG, CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLGOWER M, 1995, BURNS, V21, pS7, DOI 10.1016/0305-4179(95)90028-4; Aucouturier J, 2006, VACCINE, V24, pS44, DOI 10.1016/j.vaccine.2005.01.116; Becker PFL, 1997, PATOLOGIA GERAL, P140; Behboudi S, 1999, SCAND J IMMUNOL, V50, P371, DOI 10.1046/j.1365-3083.1999.00603.x; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; CASTRO AP, 1993, CLIN EXP IMMUNOL, V92, P466; CHAMPION RH, 1998, TXB DERMATOLOGY; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Dahl MV, 1996, CLIN IMMUNODERMATOLO; Debenedictis C, 2001, CLIN DERMATOL, V19, P573, DOI 10.1016/S0738-081X(00)00173-5; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Firestein GS, 2004, CECIL TXB MED; Fogg CN, 2007, VACCINE, V25, P2787, DOI 10.1016/j.vaccine.2006.12.037; FREUND J, 1947, ANNU REV MICROBIOL, V1, P291, DOI 10.1146/annurev.mi.01.100147.001451; Gerdts V, 2011, EXPERT REV VACCINES, V10, P433, DOI [10.1586/erv.11.31, 10.1586/ERV.11.31]; Giunchetti RC, 2007, VACCINE, V25, P7674, DOI 10.1016/j.vaccine.2007.08.009; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; HAY JB, 1974, CELL IMMUNOL, V10, P145, DOI 10.1016/0008-8749(74)90158-0; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kensil CR, 2004, FRONT BIOSCI-LANDMRK, V9, P2972, DOI 10.2741/1452; Kensil CR, 1998, DEV BIOL STAND, V92, P41; Korsholm KS, 2010, IMMUNOLOGY, V129, P75, DOI 10.1111/j.1365-2567.2009.03164.x; Liu G, 2002, VACCINE, V20, P2808, DOI 10.1016/S0264-410X(02)00209-8; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Moreira ND, 2009, VET IMMUNOL IMMUNOP, V128, P418, DOI 10.1016/j.vetimm.2008.11.030; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; MUSSENER A, 1995, SCAND J IMMUNOL, V42, P128, DOI 10.1111/j.1365-3083.1995.tb03635.x; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; O'Hagan DT, 2000, VACCINES ADJUVANTS P; Ravindran R, 2004, CURR MOL MED, V4, P697, DOI 10.2174/1566524043360212; Schijns VEJC, 2002, VET IMMUNOL IMMUNOP, V87, P195, DOI 10.1016/S0165-2427(02)00072-7; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; Shen SS, 2012, VACCINE, V30, P1560, DOI 10.1016/j.vaccine.2011.12.120; Singh M, 2002, PHARM RES-DORDR, V19, P715, DOI 10.1023/A:1016104910582; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Singh M., 2007, VACCINE ADJUVANTS DE; Smith RE, 1999, J IMMUNOL, V162, P5536; STEWART RJ, 1984, AUST NZ J SURG, V54, P565, DOI 10.1111/j.1445-2197.1984.tb05447.x; TAYLOR CE, 1995, INFECT IMMUN, V63, P3241, DOI 10.1128/IAI.63.9.3241-3244.1995; Wang W., 2011, WORLD J VACCINE, V01, P33, DOI DOI 10.4236/WJV.2011.12007; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Zhang WW, 2008, INFECT IMMUN, V76, P3777, DOI 10.1128/IAI.01527-07	50	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40745	10.1371/journal.pone.0040745	http://dx.doi.org/10.1371/journal.pone.0040745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829882	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300020
J	Xiao, Y; Karnati, S; Qian, GF; Nenicu, A; Fan, W; Tchatalbachev, S; Holand, A; Hossain, H; Guillou, F; Luers, GH; Baumgart-Vogt, E				Xiao, Yu; Karnati, Srikanth; Qian, Guofeng; Nenicu, Anca; Fan, Wei; Tchatalbachev, Svetlin; Hoeland, Anita; Hossain, Hamid; Guillou, Florian; Lueers, Georg H.; Baumgart-Vogt, Eveline			Cre-Mediated Stress Affects Sirtuin Expression Levels, Peroxisome Biogenesis and Metabolism, Antioxidant and Proinflammatory Signaling Pathways	PLOS ONE			English	Article							HORMONE RECEPTOR SUPERFAMILY; STRAND BREAK REPAIR; ZELLWEGER-SYNDROME; OXIDATIVE STRESS; GERM-CELLS; CONDITIONAL CONTROL; GENE-EXPRESSION; BETA-OXIDATION; MICE; MOUSE	Cre-mediated excision of loxP sites is widely used in mice to manipulate gene function in a tissue-specific manner. To analyze phenotypic alterations related to Cre-expression, we have used AMH-Cre-transgenic mice as a model system. Different Cre expression levels were obtained by investigation of C57BL/6J wild type as well as heterozygous and homozygous AMH-Cre-mice. Our results indicate that Cre-expression itself in Sertoli cells already has led to oxidative stress and lipid peroxidation (4-HNE lysine adducts), inducing PPAR alpha/gamma, peroxisome proliferation and alterations of peroxisome biogenesis (PEX5, PEX13 and PEX14) as well as metabolic proteins (ABCD1, ABCD3, MFP1, thiolase B, catalase). In addition to the strong catalase increase, a NRF2- and FOXO3-mediated antioxidative response (HMOX1 of the endoplasmic reticulum and mitochondrial SOD2) and a NF-kappa B activation were noted. TGF beta 1 and proinflammatory cytokines like IL1, IL6 and TNF alpha were upregulated and stress-related signaling pathways were induced. Sertoli cell mRNA-microarray analysis revealed an increase of TNFR2-signaling components. 53BP1 recruitment and expression levels for DNA repair genes as well as for p53 were elevated and the ones for related sirtuin deacetylases affected (SIRT 1, 3-7) in Sertoli cells. Under chronic Cre-mediated DNA damage conditions a strong downregulation of Sirt1 was observed, suggesting that the decrease of this important coordinator between DNA repair and metabolic signaling might induce the repression release of major transcription factors regulating metabolic and cytokine-mediated stress pathways. Indeed, caspase-3 was activated and increased germ cell apoptosis was observed, suggesting paracrine effects. In conclusion, the observed wide stress-induced effects and metabolic alterations suggest that it is essential to use the correct control animals (Cre/Wt) with matched Cre expression levels to differentiate between Cre-mediated and specific gene-knock out-mediated effects.	[Xiao, Yu; Karnati, Srikanth; Qian, Guofeng; Nenicu, Anca; Fan, Wei; Lueers, Georg H.; Baumgart-Vogt, Eveline] Univ Giessen, Inst Anat & Cell Biol 2, Giessen, Germany; [Tchatalbachev, Svetlin; Hoeland, Anita; Hossain, Hamid] Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Guillou, Florian] Univ Francois Rabelais Tours, INRA UMR 85, CNRS UMR 6175, IFCE Physiologie Reprod & Comportements, Nouzilly, France	Justus Liebig University Giessen; Justus Liebig University Giessen; INRAE	Xiao, Y (corresponding author), Univ Giessen, Inst Anat & Cell Biol 2, Giessen, Germany.	Eveline.Baumgart-Vogt@anatomie.med.uni-giessen.de	Karnati, Srikanth/AAP-9038-2021; Baumgart-Vogt, Eveline/I-5945-2013	Karnati, Srikanth/0000-0001-9083-2916; Baumgart-Vogt, Eveline/0000-0002-8265-3763; Windhorst, Anita C/0000-0002-7357-2080	German Research Foundation (Deutsche Forschungsgemeinschaft - DFG); Clinical Research Unit [KFO 181, Ba 2465, Lu 978]; State of Hesse (Germany) LOEWE-focus group "Male Infertility during Infection and Inflammation" (MIBIE) [A4]	German Research Foundation (Deutsche Forschungsgemeinschaft - DFG)(German Research Foundation (DFG)); Clinical Research Unit; State of Hesse (Germany) LOEWE-focus group "Male Infertility during Infection and Inflammation" (MIBIE)	This study was funded by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft - DFG) Clinical Research Unit (KFO 181, project 3, Ba 2465 and Lu 978; http://www.uni-giessen.de/cms/fbz/fb11/forschung/forschergruppen/kfo_181/home, and State of Hesse (Germany) LOEWE-focus group "Male Infertility during Infection and Inflammation" (MIBIE, project A4; http://www.uni-giessen.de/cms/fbz/fb11/forschung/schwerpunkte/loewe/male_infertility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Allan CM, 2009, AM J PHYSIOL-ENDOC M, V296, pE1022, DOI 10.1152/ajpendo.90941.2008; Allan CM, 2004, ENDOCRINOLOGY, V145, P1587, DOI 10.1210/en.2003-1164; Awasthi Yogesh C., 2003, Molecular Aspects of Medicine, V24, P219; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Baes M, 2006, BBA-MOL CELL RES, V1763, P1785, DOI 10.1016/j.bbamcr.2006.08.018; Barrera G, 2008, PPAR RES, V2008, DOI 10.1155/2008/524671; Baumgart E, 2003, MICROSC RES TECHNIQ, V61, P121, DOI 10.1002/jemt.10322; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; Baumgart E, 1997, HISTOCHEM CELL BIOL, V108, P185, DOI 10.1007/s004180050160; Baur J, 2010, PATHWAYS SABIOSCIENC, V12, P12; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chaudhary P, 2010, BIOCHEMISTRY-US, V49, P6263, DOI 10.1021/bi100517x; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dastig S, 2011, HISTOCHEM CELL BIOL, V136, P413, DOI 10.1007/s00418-011-0832-0; del Rio LA, 2003, IUBMB LIFE, V55, P71, DOI 10.1080/1521654031000094694; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fahimi HD, 1996, ANN NY ACAD SCI, V804, P341, DOI 10.1111/j.1749-6632.1996.tb18627.x; Furuta Yasuhide, 2005, Birth Defects Res C Embryo Today, V75, P43, DOI 10.1002/bdrc.20036; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GOLDFISCHER S, 1973, J HISTOCHEM CYTOCHEM, V21, P972, DOI 10.1177/21.11.972; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228; Ishikawa T, 2006, ENDOCRINOLOGY, V147, P1706, DOI 10.1210/en.2005-1576; ISSEMANN I, 1991, J STEROID BIOCHEM, V40, P263, DOI 10.1016/0960-0760(91)90191-7; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JANNINI EA, 1994, BIOL REPROD, V51, P140, DOI 10.1095/biolreprod51.1.140; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Karnati S, 2008, HISTOCHEM CELL BIOL, V130, P719, DOI 10.1007/s00418-008-0462-3; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kinoshita T, 2011, BIOCHEM BIOPH RES CO, V407, P321, DOI 10.1016/j.bbrc.2011.03.013; Konrad L, 2006, APOPTOSIS, V11, P739, DOI 10.1007/s10495-006-5542-z; Konrad L, 2006, MOL REPROD DEV, V73, P1211, DOI 10.1002/mrd.20399; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Latruffe N, 2000, BIOCHEM PHARMACOL, V60, P1027, DOI 10.1016/S0006-2952(00)00416-0; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Lobe CG, 1998, BIOESSAYS, V20, P200, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;200::AID-BIES3&gt;3.0.CO;2-V; Lombard DB, 2009, AGING-US, V1, P12, DOI 10.18632/aging.100014; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luers GH, 2006, HISTOCHEM CELL BIOL, V125, P693, DOI 10.1007/s00418-005-0114-9; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MASTERS CJ, 1995, MECH AGEING DEV, V80, P69, DOI 10.1016/0047-6374(94)01563-2; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nenicu A, 2009, BIOL REPROD, V81; Nenicu A, 2007, BIOL REPROD, V77, P1060, DOI 10.1095/biolreprod.107.061242; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Ozawa Y, 2010, OPHTHALMIC RES, V44, P199, DOI 10.1159/000316484; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Purushotham A, 2009, AGING-US, V1, P669, DOI 10.18632/aging.100076; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; SAUER B, 1992, J MOL BIOL, V223, P911, DOI 10.1016/0022-2836(92)90252-F; Schlatt S, 1997, EUR J ENDOCRINOL, V137, P107, DOI 10.1530/eje.0.1370107; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Whitsett JA, 2006, AM J RESP CELL MOL, V34, P519, DOI 10.1165/rcmb.F310; Winnall WR, 2007, BIOL REPROD, V76, P759, DOI 10.1095/biolreprod.106.053124; Xavier F, 2003, MOL CELL ENDOCRINOL, V211, P115, DOI 10.1016/j.mce.2003.09.022; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zarkovic N, 1999, LIFE SCI, V65, P1901, DOI 10.1016/S0024-3205(99)00444-0; Zarkovic Neven, 2003, Molecular Aspects of Medicine, V24, P281, DOI 10.1016/S0098-2997(03)00023-2; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	91	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41097	10.1371/journal.pone.0041097	http://dx.doi.org/10.1371/journal.pone.0041097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829911	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300050
J	Nicholson, E; Collen, B; Barausse, A; Blanchard, JL; Costelloe, BT; Sullivan, KME; Underwood, FM; Burn, RW; Fritz, S; Jones, JPG; McRae, L; Possingham, HP; Milner-Gulland, EJ				Nicholson, Emily; Collen, Ben; Barausse, Alberto; Blanchard, Julia L.; Costelloe, Brendan T.; Sullivan, Kathryn M. E.; Underwood, Fiona M.; Burn, Robert W.; Fritz, Steffen; Jones, Julia P. G.; McRae, Louise; Possingham, Hugh P.; Milner-Gulland, E. J.			Making Robust Policy Decisions Using Global Biodiversity Indicators	PLOS ONE			English	Article							PARTIALLY PROTECTED AREAS; ECOSYSTEM SERVICES; REFERENCE POINTS; MANAGEMENT; CONSERVATION; POPULATIONS; FRAMEWORK; TRACKING; COLLAPSE; BENGUELA	In order to influence global policy effectively, conservation scientists need to be able to provide robust predictions of the impact of alternative policies on biodiversity and measure progress towards goals using reliable indicators. We present a framework for using biodiversity indicators predictively to inform policy choices at a global level. The approach is illustrated with two case studies in which we project forwards the impacts of feasible policies on trends in biodiversity and in relevant indicators. The policies are based on targets agreed at the Convention on Biological Diversity (CBD) meeting in Nagoya in October 2010. The first case study compares protected area policies for African mammals, assessed using the Red List Index; the second example uses the Living Planet Index to assess the impact of a complete halt, versus a reduction, in bottom trawling. In the protected areas example, we find that the indicator can aid in decision-making because it is able to differentiate between the impacts of the different policies. In the bottom trawling example, the indicator exhibits some counter-intuitive behaviour, due to over-representation of some taxonomic and functional groups in the indicator, and contrasting impacts of the policies on different groups caused by trophic interactions. Our results support the need for further research on how to use predictive models and indicators to credibly track trends and inform policy. To be useful and relevant, scientists must make testable predictions about the impact of global policy on biodiversity to ensure that targets such as those set at Nagoya catalyse effective and measurable change.	[Nicholson, Emily; Blanchard, Julia L.; Costelloe, Brendan T.; Sullivan, Kathryn M. E.; Milner-Gulland, E. J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, Berks, England; [Nicholson, Emily] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Collen, Ben; Costelloe, Brendan T.; Sullivan, Kathryn M. E.; McRae, Louise] Zool Soc London, Inst Zool, London NW1 4RY, England; [Barausse, Alberto] Univ Padua, Environm Syst Anal Lab, Padua, Italy; [Blanchard, Julia L.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Underwood, Fiona M.; Burn, Robert W.] Univ Reading, Dept Math & Stat, Reading RG6 2AH, Berks, England; [Fritz, Steffen] IIASA, Laxenburg, Austria; [Jones, Julia P. G.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Possingham, Hugh P.] Univ Queensland, Australian Res Council Ctr Excellence Environm De, St Lucia, Qld, Australia	Imperial College London; University of Melbourne; Zoological Society of London; University of Padua; University of Sheffield; University of Reading; International Institute for Applied Systems Analysis (IIASA); Bangor University; University of Queensland	Nicholson, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, Berks, England.	emily.nicholson@unimelb.edu.au	POSSINGHAM, HUGH/R-8310-2019; Collen, Ben/D-5055-2011; Blanchard, Julia L/E-4919-2010; Jones, Julia P G/ABD-5629-2021; Jones, Julia P G/A-3031-2011; Possingham, Hugh/B-1337-2008; Nicholson, Emily/H-9001-2013; Gatali, Callixte/S-2549-2018; Collen, Ben/F-2543-2016; Underwood, Fiona/O-6072-2016	POSSINGHAM, HUGH/0000-0001-7755-996X; Blanchard, Julia L/0000-0003-0532-4824; Jones, Julia P G/0000-0002-5199-3335; Jones, Julia P G/0000-0002-5199-3335; Possingham, Hugh/0000-0001-7755-996X; Nicholson, Emily/0000-0003-2199-3446; Collen, Ben/0000-0003-2564-4243; Barausse, Alberto/0000-0002-2849-7624; Underwood, Fiona/0000-0001-8701-7136; , Steffen/0000-0003-0420-8549; Milner-Gulland, E.J./0000-0003-0324-2710	NERC Centre for Population Biology; Marie Curie Fellowship; Centenary Fellowship, Faculty of Science, The University of Melbourne; Rufford Foundation; EC; WWF International; Australian Research Council; ARC Centre of Excellence for Environmental Decisions; AEDA; Commonwealth Environmental Research Facility; Royal Society Wolfson Research Merit award	NERC Centre for Population Biology(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Marie Curie Fellowship(European Commission); Centenary Fellowship, Faculty of Science, The University of Melbourne; Rufford Foundation; EC(European CommissionEuropean Commission Joint Research Centre); WWF International; Australian Research Council(Australian Research Council); ARC Centre of Excellence for Environmental Decisions(Australian Research Council); AEDA; Commonwealth Environmental Research Facility; Royal Society Wolfson Research Merit award(Royal Society of London)	This paper was a product of a workshop funded by the NERC Centre for Population Biology. EN was funded by a Marie Curie Fellowship, and thanks the Grantham Institute for Climate Change at Imperial College for institutional support. EN is supported by a Centenary Fellowship, Faculty of Science, The University of Melbourne. BC was supported by the Rufford Foundation; AB by the EC FP7 KnowSeas project; JLB by the EU F7 project DEEPFISHMAN; LM by WWF International; HPP by the Australian Research Council, The ARC Centre of Excellence for Environmental Decisions, and AEDA, a Commonwealth Environmental Research Facility; and EJMG by a Royal Society Wolfson Research Merit award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER J, 2007, ECOSYSTEM BASED GLOB, DOI DOI 10.1016/J.ECOLMODEL.2003.09.003; Alder J, 2007, GLOBAL BIODIVERSITY; Arreguin-Sanchez F, 2002, ECOL MODEL, V156, P167, DOI 10.1016/S0304-3800(02)00159-X; BALL IR, 2000, MARXAN VERSION 1 8 3, DOI DOI 10.1016/J.BIOCON.2007.01.001; Barausse A, 2009, ESTUAR COAST SHELF S, V83, P577, DOI 10.1016/j.ecss.2009.05.003; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caro TM, 1999, J APPL ECOL, V36, P205, DOI 10.1046/j.1365-2664.1999.00392.x; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chee YE, 2010, J APPL ECOL, V47, P1169, DOI 10.1111/j.1365-2664.2010.01877.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; CoP10, 2010, AD HOC TECHN EXP GRO; COSTELLOE BT, 2010, POWER GLOBAL BIODIVE, DOI DOI 10.1073/PNAS.0703015105; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Failing L, 2003, J ENVIRON MANAGE, V68, P121, DOI 10.1016/S0301-4797(03)00014-8; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; GIANNI M, 2004, HIGH SEAS BOTTOM TRA, DOI DOI 10.1146/ANNUREV.ECOLYSIS.33.010802.150515; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Green RE, 2005, CONSERV BIOL, V19, P56, DOI 10.1111/j.1523-1739.2005.00289.x; Heymans S.J.J., 2005, FOODWEB MODELS DATA, V13, P8, DOI DOI 10.1016/J.ECOLMODEL.2003.09.015; Hong J, 2008, ECOL MODEL, V212, P492, DOI 10.1016/j.ecolmodel.2007.10.048; *IUCN, 2008, GUID US IUCN RED LIS, DOI DOI 10.1111/J.1523-1739.2008.01044.X; *IUCN, 2001, IUCN RED LIST CAT CR, DOI DOI 10.1111/J.1523-1739.2005.00204.X; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Jennings S, 2005, ICES J MAR SCI, V62, P397, DOI 10.1016/j.icesjms.2004.07.030; Jiang H, 2008, ECOSYSTEM MODELLING, V212, P492; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Keith DA, 2011, BIOL CONSERV, V144, P1175, DOI 10.1016/j.biocon.2010.11.022; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; Leadley P, 2010, CONSERVATIO IN PRESS; Leadley P., 2010, BIODIVERSITY SCENARI; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Lindegren M, 2009, P NATL ACAD SCI USA, V106, P14722, DOI 10.1073/pnas.0906620106; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mackinson S, 2007, ECOSYSTEM MODEL N SE; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Margoluis R, 2009, EVAL PROGRAM PLANN, V32, P138, DOI 10.1016/j.evalprogplan.2008.09.007; Milner-Gulland EJ, 2011, P NATL ACAD SCI USA, V108, P1741, DOI 10.1073/pnas.1010533108; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Okey T., 2002, ECOSYSTEM MODEL W FL, VII; Okey TA, 2004, ECOL MODEL, V172, P339, DOI 10.1016/j.ecolmodel.2003.09.015; Okey TA, 2002, THESIS CENTRO INTERD; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pereira HM, 2010, FRONT ECOL ENVIRON, V8, P458, DOI 10.1890/10.WB.23; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Piet GJ, 2004, ICES J MAR SCI, V61, P1305, DOI 10.1016/j.icesjms.2004.08.009; POSSINGHAM HP, 2002, SETTING BIODIVERSITY, DOI DOI 10.1111/J.1523-1739.2008.01124.X; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rochet MJ, 2010, J APPL ECOL, V47, P741, DOI 10.1111/j.1365-2664.2010.01841.x; Rondinini C, 2005, CONSERV BIOL, V19, P1488, DOI 10.1111/j.1523-1739.2005.00204.x; Roux JP, 2004, AFR J MAR SCI, V26, P79, DOI 10.2989/18142320409504051; Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737; *SECR CBD, 2010, GLOB BIOD OUTL, V3, DOI DOI 10.1126/SCIENCE.1196624; Secretariat of the CBD, 2010, BIOD IND 2010 TARG E; Setsaas TH, 2007, BIOL CONSERV, V136, P563, DOI 10.1016/j.biocon.2007.01.001; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Shea K, 1998, TRENDS ECOL EVOL, V13, P371, DOI 10.1016/S0169-5347(98)01381-0; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; SINCLAIR ARE, 1995, SERENGETI, V2, DOI DOI 10.1016/J.BIOCON.2004.10.007; Sparks TH, 2011, ORYX, V45, P411, DOI 10.1017/S003060531100024X; Struhsaker TT, 2005, BIOL CONSERV, V123, P45, DOI 10.1016/j.biocon.2004.10.007; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; WALTERS CJ, 1986, ADAPTIVE MANAGEMENT, DOI DOI 10.1016/S0301-4797(03)00014-8; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; 2010, C PART CONV BIOL DIV, DOI DOI 10.1126/SCIENCE.1175466	74	63	65	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41128	10.1371/journal.pone.0041128	http://dx.doi.org/10.1371/journal.pone.0041128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815938	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000306548900078
J	Gelling, M; Johnson, PJ; Moorhouse, TP; Macdonald, DW				Gelling, Merryl; Johnson, Paul J.; Moorhouse, Tom P.; Macdonald, David W.			Measuring Animal Welfare within a Reintroduction: An Assessment of Different Indices of Stress in Water Voles Arvicola amphibius	PLOS ONE			English	Article							SEASONAL-CHANGES; BODY-WEIGHT; TRANSLOCATION; CONSERVATION; MAMMALS; MELES; REPRODUCTION; METABOLITES; TRANSPORT; HYDRATION	Reintroductions are an increasingly common conservation restoration tool; however, little attention has hitherto been given to different methods for monitoring the stress encountered by reintroduced individuals. We compared ten potential measures of stress within four different categories (neuroendocrine, cell function, body condition and immune system function) as proxies for animal welfare in water voles being reintroduced to the Upper Thames region, Oxfordshire, UK. Captive-bred voles were assessed pre-release, and each month post-release for up to five months. Wild-born voles were captured in the field and assessed from two months post-release. Plasma corticosteroid, hydration and body condition of captive-bred voles differed between their pre-release measures and both their first ("short-term") recapture, and their final recapture ("long-term" release), however only body condition and immunocompetence measured using the Nitroblue Tetrazolium (NBT) test were significantly different post-release between the first and last recaptures. Captive-bred animals had lower fat reserves, higher weight/length ratios and better immunocompetence (NBT) than did wild-born voles. Captive-bred males had higher ectoparasite burdens compared to wild-born males and, as reintroduction site quality decreased, became less hydrated. These observations indicate that some methods can identify changes in the stress response in individuals, highlighting areas of risk in a reintroduction programme. In addition, a single measure may not provide a full picture of the stress experienced; instead, a combination of measures of different physiological systems may give a more complete indication of stress during the reintroduction process. We highlight the need to monitor stress in reintroductions using measures from different physiological systems to inform on possible animal welfare improvements and thus the overall success rate of reintroductions.	[Gelling, Merryl; Johnson, Paul J.; Moorhouse, Tom P.; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney, England	University of Oxford	Gelling, M (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney, England.	merryl.gelling@zoo.ox.ac.uk	Gelling, Merryl/I-8448-2012		Environment Agency; Peoples Trust for Endangered Species (PTES); Holly Hill Trust	Environment Agency; Peoples Trust for Endangered Species (PTES); Holly Hill Trust	M. Gelling was funded by the Environment Agency and Peoples Trust for Endangered Species (PTES) with contributions from D. Gow Consultancies. T. Moorhouse was funded by the Holly Hill Trust and PTES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Bonacic C, 2006, BIOL CONSERV, V129, P543, DOI 10.1016/j.biocon.2005.11.021; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Charbonnel N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P63, DOI 10.1086/523306; Clauss M, 2007, J ANIM PHYSIOL AN N, V91, P187, DOI 10.1111/j.1439-0396.2007.00691.x; DeVries AC, 2002, PSYCHONEUROENDOCRINO, V27, P705, DOI 10.1016/S0306-4530(01)00073-7; Dhabhar FS, 1998, ANN NY ACAD SCI, V840, P359, DOI 10.1111/j.1749-6632.1998.tb09575.x; Disalvo EA, 2008, BBA-BIOMEMBRANES, V1778, P2655, DOI 10.1016/j.bbamem.2008.08.025; Dugdale HL, 2003, ECOLOGY, V84, P40, DOI 10.1890/0012-9658(2003)084[0040:OSRVIT]2.0.CO;2; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fletcher QE, 2006, J ZOOL, V270, P473, DOI 10.1111/j.1469-7998.2006.00153.x; Franceschini MD, 2008, ANIM CONSERV, V11, P263, DOI 10.1111/j.1469-1795.2008.00175.x; Gelling M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009791; Gentle LK, 2001, P ROY SOC B-BIOL SCI, V268, P487, DOI 10.1098/rspb.2000.1405; Hartup BK, 2005, ZOO BIOL, V24, P15, DOI 10.1002/zoo.20033; IUCN, 1998, IUCN GUID REINTR; IUCN, 2012, GUID REINTR OT UNPUB; Kenagy GJ, 2000, GEN COMP ENDOCR, V117, P189, DOI 10.1006/gcen.1999.7397; Lerner IM, 1954, GENETIC HOMEOSTASIS; Macdonald DW, 2002, ECOLOGY, V83, P2056, DOI 10.2307/3071787; Macdonald DW, 2009, REINTRODUCTION TOP O; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; Mathews F, 2002, VET REC, V150, P785, DOI 10.1136/vr.150.25.785; Mathews F, 2006, BIOL CONSERV, V131, P338, DOI 10.1016/j.biocon.2006.04.011; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; McLaren Graeme, 2006, P120; McLaren GW, 2004, ANIM WELFARE, V13, P337; McLaren GW, 2003, EXP PHYSIOL, V88, P541, DOI 10.1113/eph8802571; Mendoza SP, 2000, BIOL ANIMAL STRESS; Mian R, 2003, STRESS, V6, P41, DOI 10.1080/1025389031000101349; Mian Rubina, 2005, P61; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Moberg GP, 1999, LAB ANIMAL, V28, P22; MOBERG GP, 1987, J AM VET MED ASSOC, V191, P1207; Montes I, 2004, ANIM WELFARE, V13, P355; Moorhouse TP, 2007, J ZOOL, V271, P19, DOI 10.1111/j.1469-7998.2006.00175.x; Moorhouse TP, 2009, BIOL CONSERV, V142, P53, DOI 10.1016/j.biocon.2008.09.023; Moorhouse TP, 2008, J ANIM ECOL, V77, P1288, DOI 10.1111/j.1365-2656.2008.01431.x; Morand S, 2004, PARASITOLOGY, V129, P505, DOI 10.1017/S0031182004005840; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 1997, Z SAUGETIERKD, V62, P192; REDEI E, 1994, NEUROENDOCRINOLOGY, V60, P113, DOI 10.1159/000126741; Ritz P, 2005, NUTR REV, V63, pS6, DOI [10.1301/nr.2005.jun.S6-S13, 10.1111/j.1753-4887.2005.tb00155.x]; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Rothschild DM, 2008, J WILDLIFE MANAGE, V72, P138, DOI 10.2193/2005-700; Shutler D, 2004, CAN J ZOOL, V82, P442, DOI [10.1139/z04-016, 10.1139/Z04-016]; Soorae PS, 2011, GLOBAL REINTRODUCTIO; Stevenson RD, 2005, INTEGR COMP BIOL, V45, P1, DOI 10.1093/icb/45.1.1; Stirling I, 2008, J WILDLIFE MANAGE, V72, P568, DOI 10.2193/2007-123; Strachan R, 1993, WATER VOLE ARVICOLA; Strachan R., 2011, WATER VOLE CONSERVAT; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Viswanathan K, 2005, INT IMMUNOL, V17, P1059, DOI 10.1093/intimm/dxh286; Zapata B, 2004, ANIM WELFARE, V13, P439	58	9	10	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41081	10.1371/journal.pone.0041081	http://dx.doi.org/10.1371/journal.pone.0041081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815923	Green Published, gold, Green Submitted			2022-12-25	WOS:000306507000062
J	Violato, M; Gray, A; Papanicolas, I; Ouellet, M				Violato, Mara; Gray, Alastair; Papanicolas, Irini; Ouellet, Melissa			Resource Use and Costs Associated with Coeliac Disease before and after Diagnosis in 3,646 Cases: Results of a UK Primary Care Database Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; IRRITABLE-BOWEL-SYNDROME; CO-MORBIDITY; MORTALITY; BURDEN; SPRUE; PREVALENCE; SYMPTOMS; PATIENT; PEOPLE	Background: Despite the considerable health impact of coeliac disease (CD), reliable estimates of the impact of diagnosis on health care use and costs are lacking. Aims: To quantify the volume, type and costs, in a United Kingdom primary care setting, of healthcare resources used by individuals diagnosed with CD up to ten years before and after diagnosis, and to estimate medical costs associated with CD. Methods: A cohort of 3,646 CD cases and a parallel cohort of 32,973 matched controls, extracted from the General Practice Research Database (GPRD) over the period 1987-2005 were used i) to evaluate the impact of diagnosis on the average resource use and costs of cases; ii) to assess direct healthcare costs due to CD by comparing average resource use and costs incurred by cases vs. controls. Results: Average annual healthcare costs per patient increased by 310 pound (95% CI 299 pound, 320) pound after diagnosis. CD cases experienced higher healthcare costs than controls both before diagnosis (mean difference 91; pound 95% CI: 86 pound, 97) pound and after diagnosis (mean difference 354; pound 95% CI: 347 pound, 361) pound. These differences were driven mainly by higher test and referral costs before diagnosis, and by increased prescription costs after diagnosis. Conclusions: This study shows significant additional primary care costs associated with coeliac disease. It provides novel evidence that will assist researchers evaluating interventions in this area, and will challenge policymakers, clinicians, researchers and the public to develop strategies that maximise the health benefits of the resources associated with this disease.	[Violato, Mara; Gray, Alastair; Ouellet, Melissa] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England; [Papanicolas, Irini] London Sch Econ, LSE Hlth, Dept Social Policy, London WC2A 2AE, England	University of Oxford; University of London; London School Economics & Political Science	Violato, M (corresponding author), Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England.	mara.violato@dph.ox.ac.uk		Violato, Mara/0000-0002-0484-7706	Coeliac UK [BXGCXLT1]; National Institute for Health Research [NF-SI-0509-10206] Funding Source: researchfish	Coeliac UK; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by Coeliac UK (http://www.coeliac.org.uk/), grant number BXGCXLT1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They, however, provided valuable comments, support and encouragement throughout the duration of the study.	Armitage P., 2002, STAT METHODS MED RES; Bingley PJ, 2004, BRIT MED J, V328, P322, DOI 10.1136/bmj.328.7435.322; Byass P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022774; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ciacci C, 2003, DIGEST DIS SCI, V48, P2216, DOI 10.1023/B:DDAS.0000004530.11738.a2; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Department of Health, 2010, NAT SCHED REF COSTS; Department of Health, 2010, HOSP COMM HLTH SERV; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dorn SD, 2008, DIGEST DIS SCI, V53, P680, DOI 10.1007/s10620-007-9939-5; Fernandez A, 2010, REV ESP ENFERM DIG, V102, P466, DOI 10.4321/s1130-01082010000800002; Gray AM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-105; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green Peter H R, 2008, J Insur Med, V40, P218; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hallert C, 2002, SCAND J GASTROENTERO, V37, P39, DOI 10.1080/003655202753387338; Hallert C, 1998, SCAND J GASTROENTERO, V33, P933, DOI 10.1080/003655298750026949; Harewood GC, 2004, DIGEST DIS SCI, V49, P1808, DOI 10.1007/s10620-004-9575-2; Harewood GC, 2001, DIGEST DIS SCI, V46, P2510, DOI 10.1023/A:1012396408370; Hauser W, 2007, ALIMENT PHARM THER, V25, P569, DOI 10.1111/j.1365-2036.2006.03227.x; Hershcovici T, 2010, ALIMENT PHARM THER, V31, P901, DOI 10.1111/j.1365-2036.2010.04242.x; Hodgson C, 2001, HLTH STAT Q, P14; Hollowell J, 1997, Popul Trends, P36; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Long KH, 2010, ALIMENT PHARM THER, V32, P261, DOI 10.1111/j.1365-2036.2010.04327.x; Mearin ML, 2005, BEST PRACT RES CL GA, V19, P441, DOI 10.1016/j.bpg.2005.02.004; Mein SM, 2004, ALIMENT PHARM THER, V19, P1199, DOI 10.1111/j.1365-2036.2004.01958.x; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; National Institute for Health and Care Excellence (NICE), 2009, ET INFL AD TREATM PS; National Institute for Health and Clinical Excellence (NICE), 2009, COEL DIS REC ASS COE; NHS, 2008, NO IR PRESCR; NHS England, 2011, PRESCR COSTS; NIELSEN OH, 1985, SCAND J GASTROENTERO, V20, P13, DOI 10.3109/00365528509089626; Personal Social Services Research Unit, 2010, UN COSTS HLTH SOC CA; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Rowlands S, 2002, BRIT J GEN PRACT, V52, P658; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Scottish Government, 2011, NHS PRESCR; Spiegel BMR, 2004, GASTROENTEROLOGY, V126, P1721, DOI 10.1053/j.gastro.2004.03.012; STEVENS L, 2008, REV CANADIENNE PRATI, V69, P147; Usai P, 2007, DIGEST LIVER DIS, V39, P824, DOI 10.1016/j.dld.2007.05.017; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; Viljamaa M, 2005, ALIMENT PHARM THER, V22, P317, DOI 10.1111/j.1365-2036.2005.02574.x; Welsh Government, 2006, FREE PRESCR WAL; West J, 2003, GASTROENTEROLOGY, V125, P429, DOI 10.1016/S0016-5085(03)00891-6; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Whitaker JKH, 2009, ALIMENT PHARM THER, V29, P1131, DOI 10.1111/j.1365-2036.2009.03983.x; Yagil Y, 2005, DIGEST DIS SCI, V50, P796, DOI 10.1007/s10620-005-2576-y	51	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41308	10.1371/journal.pone.0041308	http://dx.doi.org/10.1371/journal.pone.0041308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815991	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000306507000086
J	Gaucher, JF; Mauge, C; Didry, D; Guichard, B; Renault, L; Carlier, MF				Gaucher, Jean-Francois; Mauge, Chloe; Didry, Dominique; Guichard, Berengere; Renault, Louis; Carlier, Marie-France			Interactions of Isolated C-terminal Fragments of Neural Wiskott-Aldrich Syndrome Protein (N-WASP) with Actin and Arp2/3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; FILAMENT NUCLEATION; STRUCTURAL BASIS; FAMILY PROTEINS; MONOMERIC ACTIN; WH2 DOMAINS; ACTIVATION; MECHANISM; NETWORK; SPIRE	Wiskott-Aldrich syndrome proteins (WASP) are a family of proteins that all catalyze actin filament branching with the Arp2/3 complex in a variety of actin-based motile processes. The constitutively active C-terminal domain, called VCA, harbors one or more WASP homology 2 (WH2) domains that bind G-actin, whereas the CA extension binds the Arp2/3 complex. The VCA.actin.Arp2/3 entity associates with a mother filament to form a branched junction from which a daughter filament is initiated. The number and function of WH2-bound actin(s) in the branching process are not known, and the stoichiometry of the VCA.actin.Arp2/3 complex is debated. We have expressed the tandem WH2 repeats of N-WASP, either alone (V) or associated with the C (VC) and CA (VCA) extensions. We analyzed the structure of actin in complex with V, VC, and VCA using protein crystallography and hydrodynamic and spectrofluorimetric methods. The partial crystal structure of the VC.actin 1:1 complex shows two actins in the asymmetric unit with extensive actin-actin contacts. In solution, each of the two WH2 domains in V, VC, and VCA binds G-actin in 1: 2 complexes that participate in barbed end assembly. V, VC, and VCA enhance barbed end depolymerization like profilin but neither nucleate nor sever filaments, in contrast with other WH2 repeats. VCA binds the Arp2/3 complex in a 1: 1 complex even in the presence of a large excess of VCA. VCA.Arp2/3binds one actin in a latrunculin A-sensitive fashion, in a 1: 1: 1 complex, indicating that binding of the second actin to VCA is weakened in the ternary complex.	[Mauge, Chloe; Didry, Dominique; Guichard, Berengere; Renault, Louis; Carlier, Marie-France] CNRS, Cytoskeleton Dynam & Motil Grp, Lab Enzymol & Biochim Struct, UPR 3082, F-91198 Gif Sur Yvette, France; [Gaucher, Jean-Francois] Univ Paris 05, Fac Pharm, CNRS, Lab Cristallog & RMN Biol,UMR 801, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Carlier, MF (corresponding author), CNRS, Cytoskeleton Dynam & Motil Grp, Lab Enzymol & Biochim Struct, UPR 3082, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	carlier@lebs.cnrs-gif.fr		RENAULT, Louis/0000-0003-1722-074X	European Research Council ["Forcefulactin" 249982]; European Community [241548]; Agence Nationale pour la Recherche	European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR))	Recipient of Ligue Nationale Contre le Cancer Equipe Labellisee 2010-2013, European Research Council Advanced Grant "Forcefulactin" 249982, funding from the European Community Seventh Framework Programme FP7/2007-2013 under Grant Agreement 241548, and an Agence Nationale pour la Recherche, Programme Physique et Chimie du Vivant 2006-2009 "Motilactin." To whom correspondence should be addressed. Tel.: 33-01-69-82-34-65; E-mail: carlier@lebs.cnrs-gif.fr.	Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Carlier MF, 2011, NAT STRUCT MOL BIOL, V18, P967, DOI 10.1038/nsmb.2130; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; CASELLA JF, 1995, CELL MOTIL CYTOSKEL, V30, P164, DOI 10.1002/cm.970300208; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Husson C, 2011, MOL CELL, V43, P464, DOI 10.1016/j.molcel.2011.07.010; Ito T, 2011, J MOL BIOL, V408, P18, DOI 10.1016/j.jmb.2010.12.045; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kinosian HJ, 2002, BIOCHEMISTRY-US, V41, P6734, DOI 10.1021/bi016083t; Kollmar Martin, 2012, BMC Res Notes, V5, P88, DOI 10.1186/1756-0500-5-88; Kreishman-Deitrick M, 2005, BIOCHEMISTRY-US, V44, P15247, DOI 10.1021/bi051065n; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Rebowski G, 2008, P NATL ACAD SCI USA, V105, P10785, DOI 10.1073/pnas.0801650105; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	71	30	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34646	34659		10.1074/jbc.M112.394361	http://dx.doi.org/10.1074/jbc.M112.394361			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22847007	Green Published, hybrid			2022-12-25	WOS:000309654200067
J	Kruger, V; Deckers, M; Hildenbeutel, M; van der Laan, M; Hellmers, M; Dreker, C; Preuss, M; Herrmann, JM; Rehling, P; Wagner, R; Meinecke, M				Krueger, Vivien; Deckers, Markus; Hildenbeutel, Markus; van der Laan, Martin; Hellmers, Maike; Dreker, Christina; Preuss, Marc; Herrmann, Johannes M.; Rehling, Peter; Wagner, Richard; Meinecke, Michael			The Mitochondrial Oxidase Assembly Protein1 (Oxa1) Insertase Forms a Membrane Pore in Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; INNER MEMBRANE; YIDC; EXPORT; TRANSLOCATION; COMPONENT; CHANNEL; COMPLEX; IMPORT; MACHINERY	The inner membrane of mitochondria is especially protein-rich. To direct proteins into the inner membrane, translocases mediate transport and membrane insertion of precursor proteins. Although the majority of mitochondrial proteins are imported from the cytoplasm, core subunits of respiratory chain complexes are inserted into the inner membrane from the matrix. Oxa1, a conserved membrane protein, mediates the insertion of mitochondrion-encoded precursors into the inner mitochondrial membrane. The molecular mechanism by which Oxa1 mediates insertion of membrane spans, entailing the translocation of hydrophilic domains across the inner membrane, is still unknown. We investigated if Oxa1 could act as a protein-conducting channel for precursor transport. Using a biophysical approach, we show that Oxa1 can form a pore capable of accommodating a translocating protein segment. After purification and reconstitution, Oxa1 acts as a cation-selective channel that specifically responds to mitochondrial export signals. The aqueous pore formed by Oxa1 displays highly dynamic characteristics with a restriction zone diameter between 0.6 and 2 nm, which would suffice for polypeptide translocation across the membrane. Single channel analyses revealed four discrete channels per active unit, suggesting that the Oxa1 complex forms several cooperative hydrophilic pores in the inner membrane. Hence, Oxa1 behaves as a pore-forming translocase that is regulated in a membrane potential and substrate-dependent manner.	[Deckers, Markus; Rehling, Peter; Meinecke, Michael] Univ Gottingen, Abt Biochem 2, D-37073 Gottingen, Germany; [Krueger, Vivien; Hellmers, Maike; Dreker, Christina; Wagner, Richard; Meinecke, Michael] Univ Osnabruck, FB Biol Chem, D-49034 Osnabruck, Germany; [Hildenbeutel, Markus; Preuss, Marc; Herrmann, Johannes M.] Tech Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [van der Laan, Martin] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Meinecke, Michael] European Neurosci Inst Gottingen, D-37077 Gottingen, Germany	University of Gottingen; University Osnabruck; University of Kaiserslautern; University of Freiburg; Max Planck Society	Rehling, P (corresponding author), Univ Gottingen, Abt Biochem 2, Humboldtallee 23, D-37073 Gottingen, Germany.	peter.rehling@medizin.uni-goettingen.de; wagner@uos.de	Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; van der Laan, Martin/0000-0003-0789-9912	Human Frontiers in Science Program; Deutsche Forschungsgemeinschaft Grant [FOR967]; Max Planck Society	Human Frontiers in Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by Human Frontiers in Science Program (to M. M.), Deutsche Forschungsgemeinschaft Grant FOR967 (to P. R. and R. W.), the Max Planck Society (to P. R.).	BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; COHEN FS, 1980, J GEN PHYSIOL, V75, P251, DOI 10.1085/jgp.75.3.251; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; Harsman A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454102; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; HERRMANN JM, 1995, J BIOL CHEM, V270, P27079, DOI 10.1074/jbc.270.45.27079; HILLE B, 2001, ION CHANNELS EXCITAB, P347; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Reif S, 2005, J MOL BIOL, V354, P520, DOI 10.1016/j.jmb.2005.09.054; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schwartz MP, 1999, P NATL ACAD SCI USA, V96, P13086, DOI 10.1073/pnas.96.23.13086; Schwartz MP, 1999, J BIOL CHEM, V274, P12759, DOI 10.1074/jbc.274.18.12759; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Smallridge R, 2003, NAT REV MOL CELL BIO, V4, P343, DOI 10.1038/nrm1107; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200	41	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33314	33326		10.1074/jbc.M112.387563	http://dx.doi.org/10.1074/jbc.M112.387563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22829595	Green Published, hybrid			2022-12-25	WOS:000309602100020
J	Wang, P; Zhu, F; Konstantopoulos, K				Wang, Pu; Zhu, Fei; Konstantopoulos, Konstantinos			The Antagonistic Actions of Endogenous Interleukin-1 beta and 15-Deoxy-Delta(12,14)-prostaglandin J(2) Regulate the Temporal Synthesis of Matrix Metalloproteinase-9 in Sheared Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MATRIX METALLOPROTEINASES 1; GENE-EXPRESSION; ARTICULAR-CARTILAGE; MMP-9 EXPRESSION; P38 MAPK; INHIBITION; OSTEOARTHRITIS; ACTIVATION; CELLS	Mechanical overloading of articular cartilage producing hydrostatic stress, tensile strain, and fluid flow results in irreversible cartilage erosion and osteoarthritis (OA). Application of high fluid shear to chondrocytes recapitulates the earmarks of OA as evidenced by the induction of proinflammatory cytokines and prostaglandins, which are capable of inducing the expression of matrix-degrading enzymes. Matrix metalloproteinase-9 (MMP-9) synthesis is detected at early but not late stages of OA. However, the underlying mechanism(s) of the MMP-9 temporal regulation remains unknown. Using the T/C-28a2 chondrocyte cell line as a model system, we demonstrated that high fluid shear induces a marked increase in MMP-9 expression at short shear exposure times (3-6 h), which falls below basal levels after prolonged shear exposure (12-48 h). High fluid shear stress induced the rapid and sustained synthesis of IL-1 beta, activating PI3K, ERK1/2, and JNK, which are in turn responsible for MMP-9 expression. Prolonged shear exposure (> 12 h) induced 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) synthesis, which exerted an antagonistic effect on IL-1 beta-mediated PI3K-, ERK1/2-, and JNK-dependent NF-kappa B activation, thereby suppressing MMP-9 expression in human chondrocytes. Reconstructing the signaling network that regulates shear-mediated MMP-9 expression in human chondrocytes may provide insights for developing strategies to treat arthritic disorders.	[Wang, Pu; Zhu, Fei; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Wang, Pu] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110004, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Northeastern University - China	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kkonsta1@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		National Institutes of Health from NIAMS [RO1 AR053358]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053358] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AR053358 from NIAMS.	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Ahmed S, 2005, J NUTR, V135, P2096, DOI 10.1093/jn/135.9.2096; Akhtar N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-66; Boyault S, 2004, FEBS LETT, V572, P33, DOI 10.1016/j.febslet.2004.06.090; Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Freemont AJ, 1997, ANN RHEUM DIS, V56, P542, DOI 10.1136/ard.56.9.542; Funovics P, 2006, PROSTAG OTH LIPID M, V79, P230, DOI 10.1016/j.prostaglandins.2006.02.002; Goldring M B, 2000, Curr Rheumatol Rep, V2, P459, DOI 10.1007/s11926-000-0021-y; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Grau R, 2004, CANCER RES, V64, P5162, DOI 10.1158/0008-5472.CAN-04-0849; Hashimoto K, 2002, J GASTROINTEST CANC, V32, P7, DOI 10.1385/IJGC:32:1:7; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; Hu D, 2007, CONNECT TISSUE RES, V48, P198, DOI 10.1080/03008200701458731; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lianxu C, 2006, OSTEOARTHR CARTILAGE, V14, P367, DOI 10.1016/j.joca.2005.10.009; Lin YC, 2008, RHEUMATOL INT, V28, P1009, DOI 10.1007/s00296-008-0561-4; Lu YC, 2011, J AGR FOOD CHEM, V59, P4969, DOI 10.1021/jf1046738; Martel-Pelletier Johanne, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS31; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Naito K, 1999, RHEUMATOLOGY, V38, P510, DOI 10.1093/rheumatology/38.6.510; Papageorgiou E, 2007, EXPERT OPIN THER TAR, V11, P1071, DOI 10.1517/14728222.11.8.1071; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Pustovrh MC, 2009, EUR J CLIN INVEST, V39, P1082, DOI 10.1111/j.1365-2362.2009.02200.x; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Soeder S, 2006, CLIN EXP RHEUMATOL, V24, P302; Tacon CE, 2010, AM J RESP CELL MOL, V43, P201, DOI 10.1165/rcmb.2009-0216OC; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Tsuchiya K, 1997, J ORTHOP RES, V15, P94, DOI 10.1002/jor.1100150114; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027630; Wang P, 2011, FASEB J, V25, P3401, DOI 10.1096/fj.11-184861; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Wu CY, 2008, J NEUROCHEM, V105, P1499, DOI 10.1111/j.1471-4159.2008.05318.x; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Xie ZL, 2004, J BIOL CHEM, V279, P39513, DOI 10.1074/jbc.M405844200; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958; Zhu F, 2010, CELL DEATH DIFFER, V17, P1325, DOI 10.1038/cdd.2010.13; Zhu F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015174	46	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31877	31893		10.1074/jbc.M112.362731	http://dx.doi.org/10.1074/jbc.M112.362731			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829602	Green Published, hybrid			2022-12-25	WOS:000309059400028
J	Xie, HR; Sun, XF; Piao, YL; Jegga, AG; Handwerger, S; Ko, MSH; Dey, SK				Xie, Huirong; Sun, Xiaofei; Piao, Yulan; Jegga, Anil G.; Handwerger, Stuart; Ko, Minoru S. H.; Dey, Sudhansu K.			Silencing or Amplification of Endocannabinoid Signaling in Blastocysts via CB1 Compromises Trophoblast Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREIMPLANTATION MOUSE EMBRYO; HYDROLYZING ACID AMIDASE; CANNABINOID RECEPTOR; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; ANANDAMIDE; BRAIN; PALMITOYLETHANOLAMIDE; ACTIVATION; MOTILITY	Endocannabinoid signaling plays key roles in multiple female reproductive events. Previous studies have shown an interesting phenomenon, that mice with either silenced or elevated endocannabinoid signaling via Cnr1 encoding CB1 show similar defects in several pregnancy events, including preimplantation embryo development. To unravel the downstream signaling of this phenomenon, microarray studies were performed using RNAs collected from WT, Cnr1(-/-), and Faah(-/-) mouse blastocysts on day 4 of pregnancy. The results indicate that about 100 genes show unidirectional changes under either silenced or elevated anandamide signaling via CB1. Functional enrichment analysis of the microarray data predicted that multiple biological functions and pathways are affected under aberrant endocannabinoid signaling. Among them, genes enriched in cell migration are suppressed in Cnr1(-/-) or Faah(-/-) blastocysts. Cell migration assays validated the prediction of functional enrichment analysis that cell mobility and spreading of either Cnr1(-/-) or Faah(-/-) trophoblast stem cells are compromised. Either silenced or elevated endocannabinoid signaling via CB1 causes similar changes in downstream targets in preimplantation embryos and trophoblast stem cells. This study provides evidence that a tightly regulated endocannabinoid signaling is critical to normal preimplantation embryo development and migration of trophoblast stem cells.	[Xie, Huirong; Sun, Xiaofei; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, Cincinnati, OH 45229 USA; [Jegga, Anil G.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Handwerger, Stuart] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA; [Piao, Yulan; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA; [Ko, Minoru S. H.] Keio Univ, Sch Med, Dept Syst Med, Sakaguchi Lab, Tokyo 160, Japan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Keio University	Dey, SK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	sk.dey@cchmc.org	Ko, Minoru S. H./B-7969-2009; Jegga, Anil/H-6140-2011	Ko, Minoru S. H./0000-0002-3530-3015; Jegga, Anil/0000-0002-4881-7752	National Institutes of Health [DA006668]; National Institutes of Health, NIA; March of Dimes; Lalor Foundation; NATIONAL INSTITUTE ON AGING [ZIAAG000655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); March of Dimes(March of Dimes); Lalor Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant DA006668 and the Intramural Research Program of the National Institutes of Health, NIA. This work was also supported by the March of Dimes.; Supported by a Lalor Foundation postdoctoral fellowship.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Alvarez-Jaimes LJ, 2011, CURR PHARM BIOTECHNO, V12, P1644; Ambrosini A, 2006, BIOL REPROD, V74, P659, DOI 10.1095/biolreprod.105.046060; Ambrosini A, 2005, J ANDROL, V26, P429, DOI 10.2164/jandrol.04141; ANDREWS GK, 1991, DEV BIOL, V145, P13, DOI 10.1016/0012-1606(91)90209-L; Bari M, 2011, FRONT BIOSCI-LANDMRK, V16, P498, DOI 10.2741/3701; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2002, CHEM PHYS LIPIDS, V121, P135, DOI 10.1016/S0009-3084(02)00147-0; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Felder CC, 1996, FEBS LETT, V393, P231, DOI 10.1016/0014-5793(96)00891-5; Franklin A, 2003, J NEUROSCI, V23, P7767; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Ito A, 2004, CARCINOGENESIS, V25, P2015, DOI 10.1093/carcin/bgh208; Lee KF, 2006, ENDOCRINOLOGY, V147, P79, DOI 10.1210/en.2005-0596; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McAllister SD, 2002, PROSTAG LEUKOTR ESS, V66, P161, DOI 10.1054/plef.2001.0344; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NATARAJAN V, 1984, J NEUROCHEM, V42, P1613, DOI 10.1111/j.1471-4159.1984.tb12750.x; NATARAJAN V, 1982, BIOCHIM BIOPHYS ACTA, V712, P342, DOI 10.1016/0005-2760(82)90352-6; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Owen JD, 1999, MOL CELL BIOL, V19, P4806; PARIA BC, 1995, P NATL ACAD SCI USA, V92, P9460, DOI 10.1073/pnas.92.21.9460; Paria BC, 1998, BIOL REPROD, V58, P1490, DOI 10.1095/biolreprod58.6.1490; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Robins JC, 2007, PLACENTA, V28, P1141, DOI 10.1016/j.placenta.2007.05.006; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Schmid PC, 1997, P NATL ACAD SCI USA, V94, P4188, DOI 10.1073/pnas.94.8.4188; Sharov AA, 2010, METHOD ENZYMOL, V477, P511, DOI 10.1016/S0076-6879(10)77025-7; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Sidhpura N, 2011, NEUROPHARMACOLOGY, V61, P1070, DOI 10.1016/j.neuropharm.2011.05.034; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Song ZH, 2000, J PHARMACOL EXP THER, V294, P204; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Sun XF, 2010, P NATL ACAD SCI USA, V107, P16887, DOI 10.1073/pnas.1010892107; Sun YX, 2005, BBA-MOL CELL BIOL L, V1736, P211, DOI 10.1016/j.bbalip.2005.08.010; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REP 2010; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang H, 2006, J CLIN INVEST, V116, P2122, DOI 10.1172/JCI28621; Wang HB, 2007, J BIOL CHEM, V282, P37770, DOI 10.1074/jbc.M706577200; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Wang J, 1999, BIOL REPROD, V60, P839, DOI 10.1095/biolreprod60.4.839; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Zhong P, 2011, J PHYSIOL-LONDON, V589, P4847, DOI 10.1113/jphysiol.2011.215509; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	69	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32288	32297		10.1074/jbc.M112.381145	http://dx.doi.org/10.1074/jbc.M112.381145			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833670	Green Published, hybrid			2022-12-25	WOS:000309059400065
J	Wheeler, LJ; Mathews, CK				Wheeler, Linda J.; Mathews, Christopher K.			Effects of a Mitochondrial Mutator Mutation in Yeast POS5 NADH Kinase on Mitochondrial Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR POOLS; DNA; MUTAGENESIS; IDENTIFICATION; EXTENSION; FIDELITY	Saccharomyces cerevisiae contains three NADH/NAD(+) kinases, one of which is localized in mitochondria and phosphorylates NADH in preference to NAD(+). Strand et al. reported that a yeast mutation in POS5, which encodes the mitochondrial NADH kinase, is a mutator, specific for mitochondrial genes (Strand, M. K., Stuart, G. R., Longley, M. J., Graziewicz, M. A., Dominick, O. C., and Copeland, W. C. (2003) Eukaryot. Cell 2, 809-820). Because of the involvement of NADPH in deoxyribonucleotide biosynthesis, we asked whether mitochondria in a pos5 deletion mutant contain abnormal deoxyribonucleoside triphosphate (dNTP) pools. We found the pools of the four dNTPs to be more than doubled in mutant mitochondrial extracts relative to wild-type mitochondrial extracts. This might partly explain the mitochondrial mutator phenotype. However, the loss of antioxidant protection is also likely to be significant. To this end, we measured pyridine nucleotide pools in mutant and wild-type mitochondrial extracts and found NADPH levels to be diminished by similar to 4-fold in Delta pos5 mitochondrial extracts, with NADP(+) diminished to a lesser degree. Our data suggest that both dNTP abnormalities and lack of antioxidant protection contribute to elevated mitochondrial gene mutagenesis in cells lacking the mitochondrial NADH kinase. The data also confirm previous reports of the specific function of Pos5p in mitochondrial NADP(+) and NADPH biosynthesis.	[Wheeler, Linda J.; Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.	mathewsc@onid.orst.edu			National Institutes of Health [R01 GM073744]; Army Research Office [55953-LS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073744. This work was also supported by Army Research Office Grant 55953-LS.	Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2; Mathews CK, 2007, FASEB J, V21, P2294, DOI 10.1096/fj.06-7977rev; Mathews CK, 2009, METHODS MOL BIOL, V554, P371, DOI 10.1007/978-1-59745-521-3_22; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Minard KI, 2005, J BIOL CHEM, V280, P39890, DOI 10.1074/jbc.M509461200; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; PASSONEAU JV, 1993, ENZYMATIC ANAL PRACT; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; Wheeler LJ, 2005, DNA REPAIR, V4, P1450, DOI 10.1016/j.dnarep.2005.09.003	21	3	3	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31218	31222		10.1074/jbc.M112.394031	http://dx.doi.org/10.1074/jbc.M112.394031			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22843688	Green Published, hybrid			2022-12-25	WOS:000308791300034
J	Ge, GH; Wang, SX; Han, YP; Zhang, CH; Lu, S; Huang, ZH				Ge, Guohong; Wang, Shixia; Han, Yaping; Zhang, Chunhua; Lu, Shan; Huang, Zuhu			Removing N-Terminal Sequences in Pre-S1 Domain Enhanced Antibody and B-Cell Responses by an HBV Large Surface Antigen DNA Vaccine	PLOS ONE			English	Article							LARGE ENVELOPE PROTEIN; HEPATITIS-B; T-CELL; RECOMBINANT YEAST; IMMUNE-RESPONSES; PRES1 REGION; VIRUS; IMMUNOGENICITY; RECOGNITION; PREVENTION	Although the use of recombinant B virus surface (HBsAg) protein vaccine has successfully reduced global hepatitis B infection, there are still a number of vaccine recipients who do not develop detectable antibody responses. Various novel vaccination approaches, including DNA vaccines, have been used to futrher improve the coverage of vaccine protection. Our previous studies demonstrated that HBsAg-based DNA vaccines could induce both humoral and CMI responses in experimental animal models. However, one form of the HBsAg antigen, the large S antigen (HBs-L), expressed by DNA vaccine, was not sufficiently immunogenic in eliciting antibody responses. In the current study, we produced a modified large S antigen DNA vaccine, HBs-L(T), which has a truncated N-terminal sequence in the pre-S1 region. Compared to the original HBs-L DNA vacciene, the HBs-L(T) DNA vaccine improved secretion in cultured mammalian cells and generated significantly enhanced HBsAg-specific antibody and B cell responses. Futhermore, this improved HBsL DNA vaccine, along with other HBsAg-expressing DNA vaccines, was able to maintain predominantly Th1 type antibody responses while recombinant HBsAg protein vaccines produced in either yeast or CHO cells elicited mostly Th2 type antibody response. Our data indicate that HBsAg DNA vaccines with improved immunogenicity offer a useful alternative choice to recombinant protein-based HBV vaccines, particularly for therapeutic purposes against chronic hepatitis infection where immune tolerance led to poor antibody responses to S antigens.	[Wang, Shixia; Han, Yaping; Zhang, Chunhua; Lu, Shan; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Ge, Guohong; Han, Yaping; Zhang, Chunhua; Lu, Shan; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester; Nanjing Medical University	Ge, GH (corresponding author), Third Hosp Zhenjiang City, Zhenjiang, Jiangsu, Peoples R China.	shan.lu@umassmed.edu		Lu, Shan/0000-0002-8417-7588	Jiangsu Province Key Laboratory in Infectious Diseases, China	Jiangsu Province Key Laboratory in Infectious Diseases, China	This study was supported by Jiangsu Province Key Laboratory in Infectious Diseases, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI A, 1988, LANCET, V1, P1421; ALTER HJ, 1966, BLOOD-J HEMATOL, V27, P297, DOI 10.1182/blood.V27.3.297.297; [Anonymous], 2011, JAKARTA POST; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; BRUSS V, 1991, J VIROL, V65, P3813, DOI 10.1128/JVI.65.7.3813-3820.1991; CHENG KC, 1986, J VIROL, V60, P337, DOI 10.1128/JVI.60.2.337-344.1986; CRAVEN DE, 1986, ANN INTERN MED, V105, P356, DOI 10.7326/0003-4819-105-3-356; DAVIDSON M, 1986, J INFECTION, V13, P31, DOI 10.1016/S0163-4453(86)92653-8; FERRARI C, 1989, J CLIN INVEST, V84, P1314, DOI 10.1172/JCI114299; FORTUIN M, 1994, J INFECT DIS, V169, P1374, DOI 10.1093/infdis/169.6.1374; GALLINA A, 1995, VIROLOGY, V213, P57, DOI 10.1006/viro.1995.1546; ITOH Y, 1986, P NATL ACAD SCI USA, V83, P9174, DOI 10.1073/pnas.83.23.9174; JIN Y, 1988, J EXP MED, V168, P293, DOI 10.1084/jem.168.1.293; Kim SB, 2009, EXP MOL MED, V41, P812, DOI 10.3858/emm.2009.41.11.087; KUROKI K, 1989, MOL CELL BIOL, V9, P4459, DOI 10.1128/MCB.9.10.4459; Le Duff Y, 2009, J VIROL, V83, P12443, DOI 10.1128/JVI.01594-09; Lepere-Douard C, 2009, J VIROL, V83, P11819, DOI 10.1128/JVI.01026-09; Madalinski K, 2004, MED SCI MONITOR, V10, pPI10; MAUPAS P, 1976, LANCET, V1, P1367; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; MILICH DR, 1988, IMMUNOL TODAY, V9, P380, DOI 10.1016/0167-5699(88)91239-X; NEURATH AR, 1989, VACCINE, V7, P234; OKAMOTO H, 1992, PEDIATR RES, V32, P264, DOI 10.1203/00006450-199209000-00002; Papatheodoridis GV, 2009, J HEPATOL, V51, P226, DOI 10.1016/j.jhep.2009.02.017; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Raz R, 1996, VACCINE, V14, P207, DOI 10.1016/0264-410X(95)00185-4; Rendi-Wagner P, 2006, VACCINE, V24, P2781, DOI 10.1016/j.vaccine.2006.01.007; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shen ML, 2010, VACCINE, V28, P7288, DOI 10.1016/j.vaccine.2010.08.081; Thomas HC, 1998, J VIRAL HEPATITIS, V5, P31, DOI 10.1046/j.1365-2893.1998.0050s2031.x; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Wang SX, 2008, VACCINE, V26, P2100, DOI 10.1016/j.vaccine.2008.02.033; Wang SX, 2006, J VIROL, V80, P11628, DOI 10.1128/JVI.01065-06; Wiegand J, 2010, J VIRAL HEPATITIS, V17, P631, DOI 10.1111/j.1365-2893.2009.01220.x; Wilson JN, 2000, EPIDEMIOL INFECT, V124, P295, DOI 10.1017/S0950268800003605; Xing YP, 2008, VACCINE, V26, P5145, DOI 10.1016/j.vaccine.2008.03.072; Yu X, 1991, CHINA SCI B, VB, P633; YU XM, 1991, VIROLOGY, V181, P386, DOI 10.1016/0042-6822(91)90510-I; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018	43	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41573	10.1371/journal.pone.0041573	http://dx.doi.org/10.1371/journal.pone.0041573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844502	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700115
J	Ouyang, NT; Zhu, CH; Zhou, DY; Nie, T; Go, MF; Richards, RJ; Rigas, B				Ouyang, Nengtai; Zhu, Caihua; Zhou, Dingying; Nie, Ting; Go, Mae F.; Richards, Robert J.; Rigas, Basil			MC-12, an Annexin A1-Based Peptide, Is Effective in the Treatment of Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; SODIUM-INDUCED COLITIS; PHOSPHOLIPASE A(2); COLORECTAL-CANCER; EPITHELIAL-CELLS; ACTIVATION; INHIBITION; EXPRESSION; CYTOKINES	Annexin A1 (ANXA1) inhibits NF-kappa B, a key regulator of inflammation, the common pathophysiological mechanism of inflammatory bowel diseases (IBD). MC-12, an ANXA1-based tripeptide, suppresses NF-kappa B activation. Here, we determined the efficacy of MC-12 in the control of IBD. Mice with colitis induced by dextran sodium sulfate (DSS) or 2,4,6-trinitro benzene sulfonic acid (TNBS) were treated with various doses of MC-12 administered intraperitoneally, orally or intrarectally. We determined colon length and the histological score of colitis, and assayed: in colon tissue the levels of TNF-alpha, IFN-gamma, IL-1 beta, IL-6 and IL-10 by RT-PCR; prostaglandin E-2 (PGE(2)), cytoplasmic phospholipase A(2) (cPLA(2)) and myeloperoxidase by immunoassay; and COX-2 and NF-kappa B by immunohistochemistry; and in serum the levels of various cytokines by immunoassay. In both models MC-12: reversed dose-dependently colonic inflammation; inhibited by up to 47% myeloperoxidase activity; had a minimal effect on cytoplasmic phospholipase A(2); reduced significantly the induced levels of TNF-alpha, IFN-gamma, IL-1 beta, IL-6 and IL-10, returning them to baseline. DSS and TNBS markedly activated NF-kappa B in colonic epithelial cells and MC-12 decreased this effect by 85.8% and 72.5%, respectively. MC-12 had a similar effect in cultured NCM460 normal colon epithelial cells. Finally, MC-12 suppressed the induction of COX-2 expression, the level of PGE(2) in the colon and PGE(2) metabolite in serum. In conclusion, MC-12, representing a novel class of short peptide inhibitors of NF-kappa B, has a strong effect against colitis in two preclinical models recapitulating features of human IBD. Its mechanism of action is complex and includes pronounced inhibition of NF-kappa B. MC-12 merits further development as an agent for the control of IBD.	[Ouyang, Nengtai; Zhu, Caihua; Zhou, Dingying; Nie, Ting; Richards, Robert J.; Rigas, Basil] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Go, Mae F.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs	Ouyang, NT (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	basil.rigas@stonybrookmedicine.edu			National Institutes of Health [R01CA139454, R01CA09242308]; NATIONAL CANCER INSTITUTE [R01CA139454, R01CA092423, R03CA158669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants: R01CA139454 and R01CA09242308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen L, 2005, GUT, V54, P503, DOI 10.1136/gut.2003.034165; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Barros KV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-68; Benchimol EI, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006792.pub2; Bhattacharyya S, 2009, INFLAMM BOWEL DIS, V15, P673, DOI 10.1002/ibd.20821; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; de Silva S, 2010, NAT REV GASTRO HEPAT, V7, P93, DOI 10.1038/nrgastro.2009.221; Devlin SM, 2009, GASTROENTEROL CLIN N, V38, P577, DOI 10.1016/j.gtc.2009.07.007; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fantini MC, 2008, CURR DRUG TARGETS, V9, P375, DOI 10.2174/138945008784221206; GUSTAFSONSVARD C, 1995, SCAND J GASTROENTERO, V30, P1000, DOI 10.3109/00365529509096345; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Hendel J, 1997, AM J GASTROENTEROL, V92, P1170; Herfarth H, 2000, CLIN EXP IMMUNOL, V120, P59, DOI 10.1046/j.1365-2249.2000.01184.x; Hori Y, 2007, J PATHOL, V212, P218, DOI 10.1002/path.2176; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karrasch T, 2008, INFLAMM BOWEL DIS, V14, P114, DOI 10.1002/ibd.20243; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Kim SW, 2001, J BIOL CHEM, V276, P15712, DOI 10.1074/jbc.M009905200; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Marrero JA, 2000, AM J PHYSIOL-GASTR L, V278, pG797, DOI 10.1152/ajpgi.2000.278.5.G797; Mayer L, 2010, J GASTROENTEROL, V45, P9, DOI 10.1007/s00535-009-0138-3; Moreels TG, 2004, GUT, V53, P99, DOI 10.1136/gut.53.1.99; Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Perretti M, 2003, NEWS PHYSIOL SCI, V18, P60, DOI 10.1152/nips.01424.2002; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Petersen JW, 1996, GUT, V39, P698, DOI 10.1136/gut.39.5.698; Paiotti APR, 2009, J MOL HISTOL, V40, P317, DOI 10.1007/s10735-009-9243-0; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Roncucci L, 2008, CANCER EPIDEM BIOMAR, V17, P2291, DOI 10.1158/1055-9965.EPI-08-0224; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Szigethy E, 2010, CHILD ADOL PSYCH CL, V19, P301, DOI 10.1016/j.chc.2010.01.007; Takada Y, 2010, J IMMUNOL, V184, P1014, DOI 10.4049/jimmunol.0901196; Tanaka K, 2009, EUR J PHARMACOL, V603, P120, DOI 10.1016/j.ejphar.2008.11.058; Vatn Morten H, 2009, Curr Gastroenterol Rep, V11, P481; Williams JL, 2008, CARCINOGENESIS, V29, P390, DOI 10.1093/carcin/bgm275; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204	44	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41585	10.1371/journal.pone.0041585	http://dx.doi.org/10.1371/journal.pone.0041585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844504	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700119
J	Weiner, J; Parida, SK; Maertzdorf, J; Black, GF; Repsilber, D; Telaar, A; Mohney, RP; Arndt-Sullivan, C; Ganoza, CA; Fae, KC; Walzl, G; Kaufmann, SHE				Weiner, January, III; Parida, Shreemanta K.; Maertzdorf, Jeroen; Black, Gillian F.; Repsilber, Dirk; Telaar, Anna; Mohney, Robert P.; Arndt-Sullivan, Cordelia; Ganoza, Christian A.; Fae, Kellen C.; Walzl, Gerhard; Kaufmann, Stefan H. E.			Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; ADENOSINE RECEPTORS; MASS-SPECTROMETRY; GENE-EXPRESSION; TNF-ALPHA; R-PACKAGE; BLOOD	Although tuberculosis (TB) causes more deaths than any other pathogen, most infected individuals harbor the pathogen without signs of disease. We explored the metabolome of >400 small molecules in serum of uninfected individuals, latently infected healthy individuals and patients with active TB. We identified changes in amino acid, lipid and nucleotide metabolism pathways, providing evidence for anti-inflammatory metabolomic changes in TB. Metabolic profiles indicate increased activity of indoleamine 2,3 dioxygenase 1 (IDO1), decreased phospholipase activity, increased abundance of adenosine metabolism products, as well as indicators of fibrotic lesions in active disease as compared to latent infection. Consistent with our predictions, we experimentally demonstrate TB-induced IDO1 activity. Furthermore, we demonstrate a link between metabolic profiles and cytokine signaling. Finally, we show that 20 metabolites are sufficient for robust discrimination of TB patients from healthy individuals. Our results provide specific insights into the biology of TB and pave the way for the rational development of metabolic biomarkers for TB.	[Weiner, January, III; Parida, Shreemanta K.; Maertzdorf, Jeroen; Arndt-Sullivan, Cordelia; Ganoza, Christian A.; Fae, Kellen C.; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Black, Gillian F.; Walzl, Gerhard] Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa; [Repsilber, Dirk; Telaar, Anna] Leibniz Inst Farm Anim Biol, FBN, Biomath Bioinformat Grp, Dummerstorf, Germany; [Mohney, Robert P.] Metabolon Inc, Durham, NC USA	Max Planck Society; Stellenbosch University; Forschungsinstitut fur Nutztierbiologie (FBN); Metabolon	Weiner, J (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	january.weiner@mpiib-berlin.mpg.de; Kaufmann@mpiib-berlin.mpg.de	Ganoza, Christian A/A-8875-2014; Walzl, Gerhard/N-6371-2016; Kaufmann, Stefan HE/I-5454-2014	Ganoza, Christian A/0000-0002-5891-5372; Walzl, Gerhard/0000-0003-2487-125X; Parida, Shreemanta K/0000-0003-2129-6691; Kaufmann, Stefan HE/0000-0001-9866-8268	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by a floating grant from the Max Planck Society to SHEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila MA, 1998, GASTROENTEROLOGY, V114, P364, DOI 10.1016/S0016-5085(98)70489-5; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; Chan TYK, 2000, CALCIFIED TISSUE INT, V66, P476, DOI 10.1007/s002230010095; Chang WK, 1999, CLIN EXP IMMUNOL, V117, P482, DOI 10.1046/j.1365-2249.1999.01009.x; Cohen G, 2001, KIDNEY INT, V59, pS48, DOI 10.1046/j.1523-1755.2001.59780048.x; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Dever JT, 2006, DRUG METAB DISPOS, V34, P2036, DOI 10.1124/dmd.106.012104; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Gomez G, 2003, BLOOD, V102, P4472, DOI 10.1182/blood-2002-11-3624; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HARRISON RA, 1988, COMPLEMENT INFLAMMAT, V5, P27, DOI 10.1159/000463028; HUTCHINGS A, 1994, J ETHNOPHARMACOL, V43, P89, DOI 10.1016/0378-8741(94)90008-6; Huttmann A, 2006, BASIC RES CARDIOL, V101, P78, DOI 10.1007/s00395-005-0556-1; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jin XW, 1997, J CLIN INVEST, V100, P2849, DOI 10.1172/JCI119833; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Kinscherf R, 1996, J MOL MED-JMM, V74, P393, DOI 10.1007/s001090050040; Kono H, 2000, AM J PHYSIOL-GASTR L, V278, pG467, DOI 10.1152/ajpgi.2000.278.3.G467; Laiakis EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012655; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; MEHTA D, 1990, AM REV RESPIR DIS, V142, P157, DOI 10.1164/ajrccm/142.1.157; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller A, 2009, J CELL MOL MED, V13, P1125, DOI 10.1111/j.1582-4934.2008.00542.x; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sakamoto M, 1998, NUTRITION, V14, P391, DOI 10.1016/S0899-9007(97)00473-5; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Schwenk A, 2000, Curr Opin Clin Nutr Metab Care, V3, P285, DOI 10.1097/00075197-200007000-00008; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Slupsky CM, 2009, J PROTEOME RES, V8, P5550, DOI 10.1021/pr9006427; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Suhre K, 2011, NAT GENET, V43, P565, DOI 10.1038/ng.837; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Suzuki Y, 2012, CLIN VACCINE IMMUNOL; Szeplaki G, 2004, ATHEROSCLEROSIS, V177, P383, DOI 10.1016/j.atherosclerosis.2004.07.022; Taylor LA, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-17; To LB, 1997, BLOOD, V89, P2233, DOI 10.1182/blood.V89.7.2233; Ustianowski A, 2005, J INFECTION, V50, P432, DOI 10.1016/j.jinf.2004.07.006; Wang C, 2005, ANAL CHEM, V77, P4108, DOI 10.1021/ac0481001; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Yang J, 2004, J CHROMATOGR B, V813, P59, DOI 10.1016/j.jchromb.2004.09.032; Yuan KL, 2007, J CHROMATOGR B, V850, P236, DOI 10.1016/j.jchromb.2006.11.035	74	172	179	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40221	10.1371/journal.pone.0040221	http://dx.doi.org/10.1371/journal.pone.0040221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844400	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700009
J	Wilson, DM; Boughter, JD; Lemon, CH				Wilson, David M.; Boughter, John D., Jr.; Lemon, Christian H.			Bitter Taste Stimuli Induce Differential Neural Codes in Mouse Brain	PLOS ONE			English	Article							RECEPTOR; SUCROSE; RESPONSES; DISCRIMINATION; NEURONS; SENSITIVITIES; FAMILY; CELLS; NERVE; MICE	A growing literature suggests taste stimuli commonly classified as "bitter" induce heterogeneous neural and perceptual responses. Here, the central processing of bitter stimuli was studied in mice with genetically controlled bitter taste profiles. Using these mice removed genetic heterogeneity as a factor influencing gustatory neural codes for bitter stimuli. Electrophysiological activity (spikes) was recorded from single neurons in the nucleus tractus solitarius during oral delivery of taste solutions (26 total), including concentration series of the bitter tastants quinine, denatonium benzoate, cycloheximide, and sucrose octaacetate (SOA), presented to the whole mouth for 5 s. Seventy-nine neurons were sampled; in many cases multiple cells (2 to 5) were recorded from a mouse. Results showed bitter stimuli induced variable gustatory activity. For example, although some neurons responded robustly to quinine and cycloheximide, others displayed concentration-dependent activity (p<0.05) to quinine but not cycloheximide. Differential activity to bitter stimuli was observed across multiple neurons recorded from one animal in several mice. Across all cells, quinine and denatonium induced correlated spatial responses that differed (p<0.05) from those to cycloheximide and SOA. Modeling spatiotemporal neural ensemble activity revealed responses to quinine/denatonium and cycloheximide/SOA diverged during only an early, at least 1 s wide period of the taste response. Our findings highlight how temporal features of sensory processing contribute differences among bitter taste codes and build on data suggesting heterogeneity among "bitter" stimuli, data that challenge a strict monoguesia model for the bitter quality.	[Wilson, David M.; Lemon, Christian H.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Boughter, John D., Jr.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA	Saint Louis University; University of Tennessee System; University of Tennessee Health Science Center	Wilson, DM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	clemon@slu.edu		Lemon, Christian/0000-0003-1710-508X	St. Louis University; National Institutes of Health (NIH) [DC-011579, GM-008306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011579] Funding Source: NIH RePORTER	St. Louis University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by St. Louis University seed funds and National Institutes of Health (NIH) grant DC-011579 (CHL). DMW is supported by NIH training grant GM-008306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 2001, MAMM GENOME, V12, P695, DOI 10.1007/s00335-001-2061-7; BARTOSHUK LM, 1979, SCIENCE, V205, P934, DOI 10.1126/science.472717; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; BOUGHTER JD, 1995, BEHAV GENET, V25, P233, DOI 10.1007/BF02197181; Boughter JD, 1997, PHYSIOL BEHAV, V63, P101, DOI 10.1016/S0031-9384(97)00398-3; Brasser SM, 2005, CHEM SENSES, V30, P793, DOI 10.1093/chemse/bji071; Breslin PAS, 1996, PERCEPT PSYCHOPHYS, V58, P327, DOI 10.3758/BF03206809; Brightsmith DJ, 2008, BIOTROPICA, V40, P766, DOI 10.1111/j.1744-7429.2008.00429.x; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Carstens E, 1998, J NEUROPHYSIOL, V80, P465, DOI 10.1152/jn.1998.80.2.465; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Delwiche JF, 2001, PERCEPT PSYCHOPHYS, V63, P761, DOI 10.3758/BF03194436; Di Lorenzo PM, 2009, J NEUROSCI, V29, P9227, DOI 10.1523/JNEUROSCI.5995-08.2009; Erickson RP, 2008, BEHAV BRAIN SCI, V31, P59, DOI 10.1017/S0140525X08003348; FALCO EA, 1951, BRIT J PHARM CHEMOTH, V6, P185, DOI 10.1111/j.1476-5381.1951.tb00634.x; Felizardo R, 2009, BRAIN RES, V1288, P60, DOI 10.1016/j.brainres.2009.07.002; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Frank ME, 2004, PHYSIOL BEHAV, V80, P421, DOI 10.1016/j.physbeh.2003.09.009; Geran LC, 2006, J NEUROPHYSIOL, V96, P2513, DOI 10.1152/jn.00607.2006; Geran LC, 2011, BEHAV NEUROSCI, V125, P519, DOI 10.1037/a0023934; Geran LC, 2009, J NEUROPHYSIOL, V101, P1598, DOI 10.1152/jn.91168.2008; GILL JM, 1985, CHEM SENSES, V10, P531, DOI 10.1093/chemse/10.4.531; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 2002, J NEUROSCI, V22, P7281; Glendinning JI, 2001, J EXP BIOL, V204, P3355; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hettinger TP, 2007, BEHAV BRAIN RES, V180, P4, DOI 10.1016/j.bbr.2007.02.027; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Inoue M, 2001, PHYSIOL GENOMICS, V5, P181, DOI 10.1152/physiolgenomics.2001.5.4.181; JOHNS T, 1991, AM J CLIN NUTR, V53, P448, DOI 10.1093/ajcn/53.2.448; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; KREULEN DA, 1985, MAMMAL REV, V15, P107, DOI 10.1111/j.1365-2907.1985.tb00391.x; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; LAWLESS H, 1979, CHEM SENS FLAV, V4, P249, DOI 10.1093/chemse/4.3.249; Lemon CH, 2005, J NEUROPHYSIOL, V94, P3719, DOI 10.1152/jn.00700.2005; Lemon CH, 2004, J NEUROPHYSIOL, V92, P536, DOI 10.1152/jn.00097.2004; Lemon CH, 2009, J NEUROPHYSIOL, V101, P2459, DOI 10.1152/jn.90892.2008; Lewis RJ, 1996, SAXS DANGEROUS PROPE; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Scott TR, 1999, J NEUROPHYSIOL, V81, P60, DOI 10.1152/jn.1999.81.1.60; SHINGAI T, 1985, CHEM SENSES, V10, P51, DOI 10.1093/chemse/10.1.51; Sollars SI, 1998, BEHAV NEUROSCI, V112, P991, DOI 10.1037/0735-7044.112.4.991; Spector AC, 2002, J NEUROSCI, V22, P1937, DOI 10.1523/JNEUROSCI.22-05-01937.2002; Spector AC, 1997, AM J PHYSIOL-REG I, V272, pR1210, DOI 10.1152/ajpregu.1997.272.4.R1210; St John SJ, 1998, J NEUROSCI, V18, P4353; St John SJ, 2004, CHEM SENSES, V29, P775, DOI 10.1093/chemse/bjh082; Stapleton JR, 2002, CHEM SENSES, V27, P375, DOI 10.1093/chemse/27.4.375; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Vitazkova SK, 2001, ANIM BEHAV, V61, P887, DOI 10.1006/anbe.2000.1677; WHITNEY G, 1994, PHYSIOL BEHAV, V56, P1141, DOI 10.1016/0031-9384(94)90358-1; YOKOMUKAI Y, 1993, CHEM SENSES, V18, P669, DOI 10.1093/chemse/18.6.669	72	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41597	10.1371/journal.pone.0041597	http://dx.doi.org/10.1371/journal.pone.0041597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844505	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700121
J	Han, L; Zhang, YJ; Song, JN; Liu, MS; Zhang, ZD				Han, Lei; Zhang, Yong-Jun; Song, Jiangning; Liu, Ming S.; Zhang, Ziding			Identification of Catalytic Residues Using a Novel Feature that Integrates the Microenvironment and Geometrical Location Properties of Residues	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; ACTIVE-SITES; ANTHRANILATE SYNTHASE; AMINO-ACID; PREDICTION; ENZYME; SEQUENCE; ACCURATE; NETWORK; EVOLUTIONARY	Enzymes play a fundamental role in almost all biological processes and identification of catalytic residues is a crucial step for deciphering the biological functions and understanding the underlying catalytic mechanisms. In this work, we developed a novel structural feature called MEDscore to identify catalytic residues, which integrated the microenvironment (ME) and geometrical properties of amino acid residues. Firstly, we converted a residue's ME into a series of spatially neighboring residue pairs, whose likelihood of being located in a catalytic ME was deduced from a benchmark enzyme dataset. We then calculated an ME-based score, termed as MEscore, by summing up the likelihood of all residue pairs. Secondly, we defined a parameter called Dscore to measure the relative distance of a residue to the center of the protein, provided that catalytic residues are typically located in the center of the protein structure. Finally, we defined the MEDscore feature based on an effective nonlinear integration of MEscore and Dscore. When evaluated on a well-prepared benchmark dataset using fivefold cross-validation tests, MEDscore achieved a robust performance in identifying catalytic residues with an AUC1.0 of 0.889. At a <= 10% false positive rate control, MEDscore correctly identified approximately 70% of the catalytic residues. Remarkably, MEDscore achieved a competitive performance compared with the residue conservation score (e.g. CONscore), the most informative singular feature predominantly employed to identify catalytic residues. To the best of our knowledge, MEDscore is the first singular structural feature exhibiting such an advantage. More importantly, we found that MEDscore is complementary with CONscore and a significantly improved performance can be achieved by combining CONscore with MEDscore in a linear manner. As an implementation of this work, MEDscore has been made freely accessible at http://protein.cau. edu.cn/mepi/.	[Han, Lei; Zhang, Ziding] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhang, Yong-Jun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Liu, Ming S.] CSIRO Math Informat & Stat, Clayton, Vic, Australia	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Han, L (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ming.liu@csiro.au; zidingzhang@cau.edu.cn	, zidingzhang/E-9320-2011; Liu, Ming S./A-4886-2008; Song, Jiangning/F-9787-2010	, zidingzhang/0000-0002-9296-571X; Song, Jiangning/0000-0001-8031-9086	National Key Basic Research Program of China [2009CB918802, 2012CB1141004]; National Natural Science Foundation of China [30700137]; National Health and Medical Research Council of Australia (NHMRC); Hundred Talents Program of the Chinese Academy of Sciences (CAS); Knowledge Innovative Program of CAS [KSCX2-EW-G-8]; Tianjin Municipal Science and Technology Commission [10ZCKFSY05600]; Hundred Talents Program of CAS; CSIRO-Advanced Materials TCP and Computational and Simulation Sciences-TCP	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hundred Talents Program of the Chinese Academy of Sciences (CAS); Knowledge Innovative Program of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences); Tianjin Municipal Science and Technology Commission; Hundred Talents Program of CAS(Chinese Academy of Sciences); CSIRO-Advanced Materials TCP and Computational and Simulation Sciences-TCP	This work was supported by grants from the National Key Basic Research Program of China (2009CB918802 and 2012CB1141004), the National Natural Science Foundation of China (30700137), the National Health and Medical Research Council of Australia (NHMRC), the Hundred Talents Program of the Chinese Academy of Sciences (CAS), the Knowledge Innovative Program of CAS (KSCX2-EW-G-8) and Tianjin Municipal Science and Technology Commission (10ZCKFSY05600). JS is an NHMRC Peter Doherty Fellow and the Recipient of the Hundred Talents Program of CAS. MSL thanks China Agricultural University for hosting his visits and acknowledges the support from CSIRO-Advanced Materials TCP and Computational and Simulation Sciences-TCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; BAGLEY SC, 1995, PROTEIN SCI, V4, P622; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Ben-Shimon A, 2005, J MOL BIOL, V351, P309, DOI 10.1016/j.jmb.2005.06.047; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Brylinski M, 2007, PLOS COMPUT BIOL, V3, P909, DOI 10.1371/journal.pcbi.0030094; Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Chien TY, 2008, NUCLEIC ACIDS RES, V36, pW291, DOI 10.1093/nar/gkn324; Cilia E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-115; Cirilli M, 1998, BIOCHEMISTRY-US, V37, P16452, DOI 10.1021/bi982138o; Csardi N., 2006, INT J COMP SYST, V1695, P1; David-Eden H, 2008, NUCLEIC ACIDS RES, V36, P4641, DOI 10.1093/nar/gkn433; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dou YC, 2010, AMINO ACIDS, V39, P1353, DOI 10.1007/s00726-010-0587-2; Dukka BKC, 2008, BIOINFORMATICS, V24, P2308, DOI 10.1093/bioinformatics/btn454; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Gutteridge A, 2003, J MOL BIOL, V330, P719, DOI 10.1016/S0022-2836(03)00515-1; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; Hubbard SJ., 1993, COMPUTER PROGRAM; Knochel T, 1999, P NATL ACAD SCI USA, V96, P9479, DOI 10.1073/pnas.96.17.9479; Ko JJ, 2005, PROTEINS, V59, P183, DOI 10.1002/prot.20418; Koo CW, 2000, J AM CHEM SOC, V122, P6122, DOI 10.1021/ja001193t; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Laskowski Roman A., 2003, Journal of Structural and Functional Genomics, V4, P167, DOI 10.1023/A:1026127927612; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Lengauer T, 2010, PLOS COMPUT BIOL, V6; Li GH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-439; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016932; Li YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-14; Liang MP, 2003, NUCLEIC ACIDS RES, V31, P3324, DOI 10.1093/nar/gkg553; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Morollo AA, 2001, NAT STRUCT BIOL, V8, P243, DOI 10.1038/84988; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Ota M, 2003, J MOL BIOL, V327, P1053, DOI 10.1016/S0022-2836(03)00207-9; Pande S, 2007, 2007 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P247; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; ROMERO RM, 1995, PHYTOCHEMISTRY, V39, P263, DOI 10.1016/0031-9422(95)00010-5; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sonavane S, 2010, J CHEM INF MODEL, V50, P2266, DOI 10.1021/ci1002922; Tang YR, 2008, PROTEIN ENG DES SEL, V21, P295, DOI 10.1093/protein/gzn003; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Wang K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000181; Wu S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r8; Xin FX, 2011, CURR PROTEIN PEPT SC, V12, P456, DOI 10.2174/138920311796957685; Xin FX, 2010, BIOINFORMATICS, V26, P1975, DOI 10.1093/bioinformatics/btq319; Yahalom R, 2011, PROTEINS, V79, P1952, DOI 10.1002/prot.23020; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Yao H, 2003, J MOL BIOL, V326, P255, DOI 10.1016/S0022-2836(02)01336-0; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang ZD, 2009, CURR BIOINFORM, V4, P197, DOI 10.2174/157489309789071110; ZVELEBIL MJJM, 1988, PROTEIN ENG, V2, P127, DOI 10.1093/protein/2.2.127	75	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41370	10.1371/journal.pone.0041370	http://dx.doi.org/10.1371/journal.pone.0041370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829945	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300084
J	Kotarsky, H; Keller, M; Davoudi, M; Leveen, P; Karikoski, R; Enot, DP; Fellman, V				Kotarsky, Heike; Keller, Matthias; Davoudi, Mina; Leveen, Per; Karikoski, Riitta; Enot, David P.; Fellman, Vineta			Metabolite Profiles Reveal Energy Failure and Impaired Beta-Oxidation in Liver of Mice with Complex III Deficiency Due to a BCS1L Mutation	PLOS ONE			English	Article							CYTOCHROME BC(1) COMPLEX; FATTY-ACID OXIDATION; IRON-SULFUR PROTEIN; RESPIRATORY-CHAIN; MITOCHONDRIAL DYSFUNCTION; HEPATIC STEATOSIS; MOUSE MODEL; GENE; DISEASE; CELLS	Background & Aims: Liver is a target organ in many mitochondrial disorders, especially if the complex III assembly factor BCS1L is mutated. To reveal disease mechanism due to such mutations, we have produced a transgenic mouse model with c.232A>G mutation in Bcs1l, the causative mutation for GRACILE syndrome. The homozygous mice develop mitochondrial hepatopathy with steatosis and fibrosis after weaning. Our aim was to assess cellular mechanisms for disease onset and progression using metabolomics. Methods: With mass spectrometry we analyzed metabolite patterns in liver samples obtained from homozygotes and littermate controls of three ages. As oxidative stress might be a mechanism for mitochondrial hepatopathy, we also assessed H2O2 production and expression of antioxidants. Results: Homozygotes had a similar metabolic profile at 14 days of age as controls, with the exception of slightly decreased AMP. At 24 days, when hepatocytes display first histopathological signs, increases in succinate, fumarate and AMP were found associated with impaired glucose turnover and beta-oxidation. At end stage disease after 30 days, these changes were pronounced with decreased carbohydrates, high levels of acylcarnitines and amino acids, and elevated biogenic amines, especially putrescine. Signs of oxidative stress were present in end-stage disease. Conclusions: The findings suggest an early Krebs cycle defect with increases of its intermediates, which might play a role in disease onset. During disease progression, carbohydrate and fatty acid metabolism deteriorate leading to a starvation-like condition. The mouse model is valuable for further investigations on mechanisms in mitochondrial hepatopathy and for interventions.	[Kotarsky, Heike; Davoudi, Mina; Leveen, Per; Fellman, Vineta] Lund Univ, Dept Pediat, Lund, Sweden; [Karikoski, Riitta] Helsinki Univ Hosp Lab Diagnost, Cent Pathol Lab, Helsinki, Finland; [Keller, Matthias; Enot, David P.] Univ Hosp, Dept Pediat, Essen, Germany; [Fellman, Vineta] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Fellman, Vineta] Univ Helsinki, Helsinki, Finland; [Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland	Lund University; University of Duisburg Essen; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center	Kotarsky, H (corresponding author), Lund Univ, Dept Pediat, Lund, Sweden.	Vineta.Fellman@med.lu.se		Davoudi, Mina/0000-0002-4952-1099	Swedish Research Council [2005-6599, 2008-2898]; Lund University; A Tielman; Kock; Segerfalk; H and G Dunkers; Royal Physiographic Society in Lund, Sweden; Finnish Physicians' Society; Foundation for Pediatric Research, Finland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University; A Tielman; Kock; Segerfalk; H and G Dunkers; Royal Physiographic Society in Lund, Sweden; Finnish Physicians' Society; Foundation for Pediatric Research, Finland	The project was funded by grants to V.F. from the Swedish Research Council (2005-6599, 2008-2898), Lund University funding, and several foundations (A Tielman, Kock, Segerfalk, H and G Dunkers, Royal Physiographic Society in Lund, Sweden, and Finnish Physicians' Society and the Foundation for Pediatric Research, Finland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Benit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Diaz F, 2011, SEMIN FETAL NEONAT M, V16, P197, DOI 10.1016/j.siny.2011.05.004; Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6; Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Holm S, 1979, SCAND J STAT, V6; Jung YS, 2011, AMINO ACIDS; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Leveen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031; Moran M, 2010, HUM MUTAT, V31, P930, DOI 10.1002/humu.21294; MORRIS AAM, 1995, PEDIATR NEPHROL, V9, P407, DOI 10.1007/BF00866711; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Urban M, 2010, ANAL BIOCHEM, V406, P124, DOI 10.1016/j.ab.2010.07.002; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; Vankoningsloo S, 2005, J LIPID RES, V46, P1133, DOI 10.1194/jlr.M400464-JLR200; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Zara V, 2004, EUR J BIOCHEM, V271, P1209, DOI 10.1111/j.1432-1033.2004.04024.x	48	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41156	10.1371/journal.pone.0041156	http://dx.doi.org/10.1371/journal.pone.0041156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829922	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300061
J	Mamaghani, S; Simpson, CD; Cao, PJM; Cheung, M; Chow, S; Bandarchi, B; Schimmer, AD; Hedley, DW				Mamaghani, Shadi; Simpson, Craig D.; Cao, Pinjiang M.; Cheung, May; Chow, Sue; Bandarchi, Bizhan; Schimmer, Aaron D.; Hedley, David W.			Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis	PLOS ONE			English	Article							FACTOR-KAPPA-B; UP-REGULATION; HYDROGEN-PEROXIDE; RECEPTOR AGONISTS; WNT/BETA-CATENIN; REACTIVE OXYGEN; COLON-CANCER; TUMOR-CELL; IN-VIVO; K-RAS	Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) induces apoptosis in a variety of cancer cell lines with little or no effect on normal cells. However, its effect is limited as some cancers including pancreatic cancer show de novo resistance to TRAIL induced apoptosis. In this study we report that GSK-3 inhibition using the pharmacologic agent AR-18, enhanced TRAIL sensitivity in a range of pancreatic and prostate cancer cell lines. This sensitization was found to be caspase-dependent, and both pharmacological and genetic knock-down of GSK-3 isoforms resulted in apoptotic features as shown by cleavage of PARP and caspase-3. Elevated levels of reactive oxygen intermediates and disturbance of mitochondrial membrane potential point to a mitochondrial amplification loop for TRAIL-induced apoptosis after GSK-3 inhibition. Consistent with this, overexpression of anti-apoptotic mitochondrial targets such as Bcl-XL, Mcl-1, and Bcl-2 rescued PANC-1 and PPC-1 cells from TRAIL sensitization. However, overexpression of the caspase-8 inhibitor CrmA also inhibited the sensitizing effects of GSK-3 inhibitor, suggesting an additional role for GSK-3 that inhibits death receptor signaling. Acute treatment of mice bearing PANC-1 xenografts with a combination of AR-18 and TRAIL also resulted in a significant increase in apoptosis, as measured by caspase-3 cleavage. Sensitization to TRAIL occurred despite an increase in beta-catenin due to GSK-3 inhibition, suggesting that the approach might be effective even in cancers with dysregulated beta-catenin. These results suggest that GSK-3 inhibitors might be effectively combined with TRAIL for the treatment of pancreatic cancer.	[Mamaghani, Shadi; Cao, Pinjiang M.; Cheung, May; Chow, Sue; Hedley, David W.] Univ Hlth Network, Div Appl Mol Oncol, Toronto, ON, Canada; [Mamaghani, Shadi; Hedley, David W.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mamaghani, Shadi; Simpson, Craig D.; Cao, Pinjiang M.; Cheung, May; Chow, Sue; Bandarchi, Bizhan; Schimmer, Aaron D.; Hedley, David W.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Schimmer, Aaron D.; Hedley, David W.] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Mamaghani, S (corresponding author), Univ Hlth Network, Div Appl Mol Oncol, Toronto, ON, Canada.	david.hedley@uhn.on.ca		Schimmer, Aaron/0000-0003-4023-3899; Hedley, David/0000-0003-1323-2655	Campbell Family Institute for Cancer Research	Campbell Family Institute for Cancer Research	Funding was provided by the Campbell Family Institute for Cancer Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Beurel E, 2009, BIOCHEM PHARMACOL, V77, P54, DOI 10.1016/j.bcp.2008.09.026; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Dessimoz J, 2006, CELL CYCLE, V5, P7, DOI 10.4161/cc.5.1.2293; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hirpara JL, 2001, J BIOL CHEM, V276, P514, DOI 10.1074/jbc.M004687200; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holcom B, 2008, PANCREAS, V36, P225, DOI 10.1097/MPA.0b013e31815b3207; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Kerfoot C, 2004, J HISTOCHEM CYTOCHEM, V52, P419, DOI 10.1177/002215540405200314; Khanbolooki S, 2006, MOL CANCER THER, V5, P2251, DOI 10.1158/1535-7163.MCT-06-0075; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kwon D, 2006, YONSEI MED J, V47, P551, DOI 10.3349/ymj.2006.47.4.551; Liao XB, 2003, MOL CANCER THER, V2, P1215; Mamaghani S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-132; Masood Ashiq, 2011, Cancers (Basel), V3, P1527, DOI 10.3390/cancers3021527; Oikonomou E, 2009, INT J CANCER, V125, P2127, DOI 10.1002/ijc.24613; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Ozawa F, 2001, CANCER LETT, V163, P71, DOI 10.1016/S0304-3835(00)00660-1; Papenfuss K, 2008, J CELL MOL MED, V12, P2566, DOI 10.1111/j.1582-4934.2008.00514.x; PELLEGATA NS, 1994, CANCER RES, V54, P1556; Pham NA, 2000, CYTOMETRY, V41, P245, DOI 10.1002/1097-0320(20001201)41:4<245::AID-CYTO2>3.0.CO;2-#; Pham NA, 2004, MOL CANCER THER, V3, P1239; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Slebos RJC, 2000, CANCER EPIDEM BIOMAR, V9, P1223; Song L, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-20; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Xia T, 2002, CHINESE SCI BULL, V47, P480, DOI 10.1360/02tb9111; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	50	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41102	10.1371/journal.pone.0041102	http://dx.doi.org/10.1371/journal.pone.0041102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829912	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300051
J	Schultz, B; Otto, C; Schultz, A; Osthaus, WA; Krauss, T; Dieck, T; Sander, B; Rahe-Meyer, N; Raymondos, K				Schultz, Barbara; Otto, Christian; Schultz, Arthur; Osthaus, Wilhelm Alexander; Krauss, Terence; Dieck, Thorben; Sander, Bjoern; Rahe-Meyer, Niels; Raymondos, Konstantinos			Incidence of Epileptiform EEG Activity in Children during Mask Induction of Anaesthesia with Brief Administration of 8% Sevoflurane	PLOS ONE			English	Article							ELECTROENCEPHALOGRAM	Background: A high incidence of epileptiform activity in the electroencephalogram (EEG) was reported in children undergoing mask induction of anaesthesia with administration of high doses of sevoflurane for 5 minutes and longer. This study was performed to investigate whether reducing the time of exposure to a high inhaled sevoflurane concentration would affect the incidence of epileptiform EEG activity. It was hypothesized that no epileptiform activity would occur, when the inhaled sevoflurane concentration would be reduced from 8% to 4% immediately after the loss of consciousness. Methodology/Principal Findings: 70 children (age 7-96 months, ASA I-II, premedication with midazolam) were anaesthetized with 8% sevoflurane in 100% oxygen via face mask. Immediately after loss of consciousness, the sevoflurane concentration was reduced to 4%. EEGs were recorded continuously and were later analyzed visually with regard to epileptiform EEG patterns. Sevoflurane at a concentration of 8% was given for 1.2 +/- 0.4 min (mean +/- SD). In 14 children (20%) epileptiform EEG patterns without motor manifestations were observed (delta with spikes (DSP), rhythmic polyspikes (PSR), epileptiform discharges (PED) in 10, 10, 4 children (14%, 14%, 6%)). 38 children (54%) had slow, rhythmic delta waves with high amplitudes (DS) appearing on average before DSP. Conclusions/Significance: The hypothesis that no epileptiform potentials would occur during induction of anaesthesia with a reduction of the inspired sevoflurane concentration from 8% to 4% directly after LOC was not proved. Even if 8% sevoflurane is administered only briefly for induction of anaesthesia, epileptiform EEG activity may be observed in children despite premedication with midazolam.	[Schultz, Barbara; Otto, Christian; Schultz, Arthur; Osthaus, Wilhelm Alexander; Krauss, Terence; Dieck, Thorben; Sander, Bjoern; Rahe-Meyer, Niels; Raymondos, Konstantinos] Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, D-3000 Hannover, Germany	Hannover Medical School	Schultz, B (corresponding author), Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, D-3000 Hannover, Germany.	ab.schultz@t-online.de			German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Publication costs were covered by the Open Access Publication Program of the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1992, BRIT J ANAESTH, V68, P214, DOI 10.1093/bja/68.2.214; Akeson J, 2004, ACTA ANAESTH SCAND, V48, P405, DOI 10.1111/j.1399-6576.2004.00365.x; Baum Victor C., 1997, Anesthesia and Analgesia, V85, P313, DOI 10.1097/00000539-199708000-00013; Constant I, 2005, PEDIATR ANESTH, V15, P266, DOI 10.1111/j.1460-9592.2004.01538.x; Dubois MC, 1999, PAEDIATR ANAESTH, V9, P19, DOI 10.1046/j.1460-9592.1999.9120327.x; Haga S, 1992, Masui, V41, P1951; Holzki J, 1999, PAEDIATR ANAESTH, V9, P283, DOI 10.1046/j.1460-9592.1999.00415.x; Jaaskelainen SK, 2003, NEUROLOGY, V61, P1073, DOI 10.1212/01.WNL.0000090565.15739.8D; Johr M, 2005, BEST PRACT RES-CLIN, V19, P501, DOI 10.1016/j.bpa.2005.01.001; Julliac B, 2007, ANESTHESIOLOGY, V106, P243, DOI 10.1097/00000542-200702000-00011; Kreuer S, 2003, ANESTHESIOLOGY, V99, P34, DOI 10.1097/00000542-200307000-00009; Kurita N, 2005, J NEUROSURG ANESTH, V17, P199, DOI 10.1097/01.ana.0000178914.36157.c8; Nieminen K, 2002, BRIT J ANAESTH, V89, P853, DOI 10.1093/bja/aef290; Schultz A, 2001, PHARM WORLD SCI, V23, P82, DOI 10.1023/A:1011276016529; Sonkajarvi E, 2009, ACTA ANAESTH SCAND, V53, P77, DOI 10.1111/j.1399-6576.2008.01725.x; Vakkuri A, 2001, ACTA ANAESTH SCAND, V45, P805, DOI 10.1034/j.1399-6576.2001.045007805.x; Vakkuri A, 2000, ACTA ANAESTH SCAND, V44, P713, DOI 10.1034/j.1399-6576.2000.440609.x; Voss LJ, 2008, ANESTH ANALG, V107, P1689, DOI 10.1213/ane.0b013e3181852595; Woodforth IJ, 1997, ANESTHESIOLOGY, V87, P1579, DOI 10.1097/00000542-199712000-00041; Yli-Hankala A, 1999, ANESTHESIOLOGY, V91, P1596, DOI 10.1097/00000542-199912000-00009	20	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40903	10.1371/journal.pone.0040903	http://dx.doi.org/10.1371/journal.pone.0040903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829896	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300034
J	Yoon, KD; Yamamoto, K; Ueda, K; Zhou, JL; Sparrow, JR				Yoon, Kee Dong; Yamamoto, Kazunori; Ueda, Keiko; Zhou, Jilin; Sparrow, Janet R.			A Novel Source of Methylglyoxal and Glyoxal in Retina: Implications for Age-Related Macular Degeneration	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; GLYCATION END-PRODUCTS; FACTOR-H POLYMORPHISM; BRUCHS MEMBRANE; LIPOFUSCIN FLUOROPHORE; ALPHA-OXOALDEHYDES; OXIDATIVE STRESS; A2E; RPE; PROTEINS	Aging of retinal pigment epithelial (RPE) cells of the eye is marked by accumulations of bisretinoid fluorophores; two of the compounds within this lipofuscin mixture are A2E and all-trans-retinal dimer. These pigments are implicated in pathological mechanisms involved in some vision-threatening disorders including age-related macular degeneration (AMD). Studies have shown that bisretinoids are photosensitive compounds that undergo photooxidation and photodegradation when irradiated with short wavelength visible light. Utilizing ultra performance liquid chromatography (UPLC) with electrospray ionization mass spectrometry (ESI-MS) we demonstrate that photodegradation of A2E and all-trans-retinal dimer generates the dicarbonyls glyoxal (GO) and methylglyoxal (MG), that are known to modify proteins by advanced glycation endproduct (AGE) formation. By extracellular trapping with aminoguanidine, we established that these oxo-aldehydes are released from irradiated A2E-containing RPE cells. Enzyme-linked immunosorbant assays (ELISA) revealed that the substrate underlying A2E-containing RPE was AGE-modified after irradiation. This AGE deposition was suppressed by prior treatment of the cells with aminoguanidine. AGE-modification causes structural and functional impairment of proteins. In chronic diseases such as diabetes and atherosclerosis, MG and GO modify proteins by non-enzymatic glycation and oxidation reactions. AGE-modified proteins are also components of drusen, the sub-RPE deposits that confer increased risk of AMD onset. These results indicate that photodegraded RPE bisretinoid is likely to be a previously unknown source of MG and GO in the eye.	[Yoon, Kee Dong; Yamamoto, Kazunori; Ueda, Keiko; Zhou, Jilin; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Sparrow, Janet R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University	Yoon, KD (corresponding author), Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA.	jrs88@columbia.edu			National Institutes of Health [EY12951, P30EY019007]; Research to Prevent Blindness to the Department of Ophthalmology; National Research Foundation of Korea [NRF-2009-352-E00060]; NATIONAL EYE INSTITUTE [R01EY012951, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness to the Department of Ophthalmology(Research to Prevent Blindness (RPB)); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health grants EY12951 (JRS) and P30EY019007; and a grant from Research to Prevent Blindness to the Department of Ophthalmology. KDY was supported in part by National Research Foundation of Korea (NRF-2009-352-E00060). KDY is currently at the Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Alderson NL, 2004, DIABETOLOGIA, V47, P1385, DOI 10.1007/s00125-004-1474-8; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Farboud B, 1999, MOL VIS, V5, pU1; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Glenn JV, 2007, FASEB J, V21, P3542, DOI 10.1096/fj.06-7896com; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grey AC, 2011, INVEST OPHTH VIS SCI, V52, P3926, DOI 10.1167/iovs.10-7020; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Handa JT, 1999, INVEST OPHTH VIS SCI, V40, P775; Howes KA, 2004, INVEST OPHTH VIS SCI, V45, P3713, DOI 10.1167/iovs.04-0404; Hussain AA, 2010, EXP EYE RES, V90, P703, DOI 10.1016/j.exer.2010.02.013; Ishibashi T, 1998, ARCH OPHTHALMOL-CHIC, V116, P1629, DOI 10.1001/archopht.116.12.1629; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; MOORE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1290; Nawa A, 2010, LIFE SCI, V86, P402, DOI 10.1016/j.lfs.2010.01.009; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Price CL, 2009, TRENDS ENDOCRIN MET, V20, P312, DOI 10.1016/j.tem.2009.03.010; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Rabbani N, 2008, ANN NY ACAD SCI, V1126, P124, DOI 10.1196/annals.1433.043; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Roy S, 2011, MOL VIS, V17, P3166; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Thornalley PJ, 2000, BIOCHEM PHARMACOL, V60, P55, DOI 10.1016/S0006-2952(00)00287-2; Wang W, 1998, PHARMACOL REV, V50, P335; Wolff DJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P73, DOI 10.1006/abbi.1996.9811; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Yamamoto K, 2011, INVEST OPHTH VIS SCI, V52, P9084, DOI 10.1167/iovs.11-8632; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	47	60	63	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41309	10.1371/journal.pone.0041309	http://dx.doi.org/10.1371/journal.pone.0041309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829938	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300077
J	Rajshankar, D; Downey, GP; McCulloch, CA				Rajshankar, Dhaarmini; Downey, Gregory P.; McCulloch, Christopher A.			IL-1 beta enhances cell adhesion to degraded fibronectin	FASEB JOURNAL			English	Article						integrins; talins; kindlins; MMP	TYROSINE PHOSPHATASE-ALPHA; HUMAN PERIODONTAL-LIGAMENT; LINK FOCAL ADHESIONS; MATRIX METALLOPROTEINASES; ENDOPLASMIC-RETICULUM; GINGIVAL FIBROBLASTS; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; INTERLEUKIN-1	IL-1 beta is a prominent proinflammatory cytokine that mediates degradation of extracellular matrix proteins through increased expression of matrix metalloproteinases, which involves a signaling pathway in adherent cells that is restricted by focal adhesions. Currently, the mechanism by which IL-1 beta affects cell adhesion to matrix proteins is not defined, and it is not known whether degraded matrix proteins affect IL-1 beta signaling. We examined adhesion-related IL-1 beta signaling in fibroblasts attaching to native or MMP3-degraded fibronectin. IL-1 beta increased cell attachment, resistance to shear force and the numbers of focal adhesions containing activated beta(1) integrins. IL-1 beta-enhanced attachment required FAK, kindlins 1/2, and talin. MMP3-degraded fibronectin-inhibited IL-1 beta-enhanced cell adhesion and promoted spontaneous ERK activation that was independent of IL-1 beta treatment. We conclude that IL-1 beta enhances the adhesion of anchorage-dependent cells to MMP3-degraded fibronectin, which, in turn, is associated with deregulated cellular responses to IL-1 beta. These data point to a novel role of IL-1 beta as a proadhesive signaling molecule in inflammation that employs kindlins and talin to regulate adhesion.-Rajshankar, D., Downey, G. P., McCulloch, C. A. IL-1 beta enhances cell adhesion to degraded fibronectin. FASEB J. 26, 4429-4444 (2012). www.fasebj.org	[Rajshankar, Dhaarmini; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Downey, Gregory P.] Natl Jewish Hlth, Dept Med, Div Pulm & Crit Care Med, Denver, CO USA; [Downey, Gregory P.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Downey, Gregory P.] Univ Colorado, Integrated Dept Immunol, Aurora, CO USA	University of Toronto; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McCulloch, CA (corresponding author), Univ Toronto, Matrix Dynam Grp, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca		Downey, Gregory P/0000-0003-3253-5862	Canadian Institutes of Health Research [MOP 84254]; Canada Research Chair (Tier 1); U.S. National Institutes of Health [HL090669]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090669] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier 1)(Canada Research Chairs); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by Canadian Institutes of Health Research operating grant MOP 84254 to C. A. M., who is also supported by a Canada Research Chair (Tier 1). This work was also supported, in part, by U.S. National Institutes of Health grant HL090669 (to G. P. D.).	Abreu MTH, 2006, J CELL PHYSIOL, V207, P132, DOI 10.1002/jcp.20544; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Auron PE, 1998, CYTOKINE GROWTH F R, V9, P221, DOI 10.1016/S1359-6101(98)00018-5; Bhide VM, 2005, J BIOL CHEM, V280, P23103, DOI 10.1074/jbc.M410060200; Boch JA, 2001, J DENT RES, V80, P400, DOI 10.1177/00220345010800020101; Bolcato-Bellemin AL, 2000, J DENT RES, V79, P1712, DOI 10.1177/00220345000790091201; Boyle DL, 1997, ARTHRITIS RHEUM, V40, P1772, DOI 10.1002/art.1780401008; Brauchle M, 2000, EXP CELL RES, V258, P135, DOI 10.1006/excr.2000.4913; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Chong SAC, 2007, J BIOL CHEM, V282, P8510, DOI 10.1074/jbc.M609859200; Chung Kian F., 2005, Current Drug Targets - Inflammation and Allergy, V4, P619, DOI 10.2174/156801005774912806; DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; FORSYTH KD, 1990, J PATHOL, V161, P313, DOI 10.1002/path.1711610407; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Glogauer M, 1998, PFLUG ARCH EUR J PHY, V435, P320; HAKKINEN L, 1994, BBA-MOL CELL RES, V1224, P33, DOI 10.1016/0167-4889(94)90110-4; Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kim C., 2012, ANNU REV CELL DEV BI, V3, P67; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Lallier TE, 2005, J PERIODONTOL, V76, P1044, DOI 10.1902/jop.2005.76.7.1044; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Phares DJ, 2000, J FLUID MECH, V418, P351, DOI 10.1017/S002211200000121X; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; QWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232, DOI 10.1073/pnas.88.4.1232; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rescorla F. J., CELL SIGNAL, V24, P393; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Szabo K.A., 2004, CLIN APPL IMMUNOL RE, V4, P295, DOI DOI 10.1016/J.CAIR.2004.02.001; Szabo K. A., 2004, CLIN APPL IMMUNOL RE, V4, P319; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Thomas P., CLIN EXP METASTASIS, V28, P923; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; van den Berg WB, 1999, Z RHEUMATOL, V58, P136, DOI 10.1007/s003930050163; van der Pauw MTM, 2002, J PERIODONTAL RES, V37, P317, DOI 10.1034/j.1600-0765.2002.00349.x; Wang Q, 2005, J BIOL CHEM, V280, P8397, DOI 10.1074/jbc.M410462200; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Qin, 2003, FASEB Journal, V17, P1898; Wang Q, 2011, FASEB J, V25, P3448, DOI 10.1096/fj.11-183459; Wang Q, 2010, J BIOL CHEM, V285, P22308, DOI 10.1074/jbc.M110.102426; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zhang H., NEUROTHERAPEUTICS, V8, P206; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	63	20	20	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4429	4444		10.1096/fj.12-207381	http://dx.doi.org/10.1096/fj.12-207381			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22829527	Green Published			2022-12-25	WOS:000310574200007
J	Roudier, E; Forn, P; Perry, ME; Birot, O				Roudier, Emilie; Forn, Paul; Perry, Mary Ellen; Birot, Olivier			Murine double minute-2 expression is required for capillary maintenance and exercise-induced angiogenesis in skeletal muscle	FASEB JOURNAL			English	Article						VEGF-A; endothelial cell; p53; physiology	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FACTOR MESSENGER-RNA; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS; MDM2; P53; HDM2; UBIQUITINATION; STABILIZATION; INHIBITION	Exercise-induced angiogenesis is a key determinant of skeletal muscle function. Here, we investigated whether the E3 ubiquitin ligase murine double minute-2 (Mdm2) exerts a proangiogenic function in exercised skeletal muscle. Mdm2 hypomorphic (Mdm2(Puro/Delta 7-9)) mice have a 60% reduction in Mdm2 expression compared with that in wild-type animals. Capillary staining on muscle sections from Mdm2(Puro/Delta 7-9) sedentary mice with a wild-type or knockout background for p53 revealed that deficiency in Mdm2 resulted in 20% capillary regression independently of p53 status. In response to one bout of exercise, protein expression of the proangiogenic vascular endothelial growth factor-A (VEGF-A) was increased by 64% in muscle from wild-type animals, and endothelial cell outgrowth from exercised muscle biopsy samples cultured in a 3-dimensional collagen gel was enhanced by 37%. These proangiogenic responses to exercise were impaired in exercised Mdm2(Puro/Delta 7-9) mice. Prolonged exercise training resulted in increased Mdm2 protein expression (+49%) and capillarization (+24%) in wildtype muscles. However, exercise training-induced angiogenesis was abolished in Mdm2(Puro/Delta 7-9) mice. Finally, exercise training restored Mdm2, VEGF-A, and capillarization levels in skeletal muscles from obese Zucker diabetic fatty rats compared with those in healthy animals. Our results define Mdm2 as a crucial regulator of capillary maintenance and exercise-induced angiogenesis in skeletal muscle.-Roudier, E., Forn, P., Perry, M. E., Birot, O. Murine double minute-2 expression is required for capillary maintenance and exercise-induced angiogenesis in skeletal muscle. FASEB J. 26, 4530-4539 (2012). www.fasebj.org	[Birot, Olivier] York Univ, Fac Hlth, Norman Bethune Coll, Angiogenesis Res Grp, Toronto, ON M3J 1P3, Canada; [Roudier, Emilie; Birot, Olivier] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Perry, Mary Ellen] NCI, Lab Prot Dynam & Signaling, US Natl Inst Hlth, Frederick, MD 21701 USA	York University - Canada; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Birot, O (corresponding author), York Univ, Fac Hlth, Norman Bethune Coll, Angiogenesis Res Grp, Room 353,4700 Keele St, Toronto, ON M3J 1P3, Canada.	birot@yorku.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [341258]; NIH, National Cancer Institute, Center for Cancer Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Nicole Morris [National Cancer Institute, U.S. National Institutes of Health (NIH)] for maintaining the Mdm2<SUP>puro/Delta 7-9</SUP> mice, and Dr. Raynald Bergeron (University of Montreal) for his help in the ZDF mouse conditioning. This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC discovery grant 341258 to O.B.) and by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (M. E. P.). E. R. and O.B. conceived the study; E. R., M. E. P., and O.B. designed experiments; E. R., P. F., and O.B. performed experiments and analyzed data; M. E. P. supplied Mdm2<SUP>puro/Delta 7-9</SUP> mice; E. R., M. E. P., and O.B. participated in the redaction of the manuscript.	Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Assadin S, 2008, EXPERT OPIN BIOL TH, V8, P941, DOI [10.1517/14712590802184482, 10.1517/14712598.8.7.941 ]; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Birot OJG, 2003, J PHYSIOL-LONDON, V552, P213, DOI 10.1113/jphysiol.2003.043026; Bloor Colin M., 2005, Angiogenesis, V8, P263, DOI 10.1007/s10456-005-9013-x; Bouvet M, 1998, CANCER RES, V58, P2288; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carroll VA, 2008, CANCER RES, V68, P545, DOI 10.1158/0008-5472.CAN-06-4738; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Gustafsson T, 2001, FRONT BIOSCI-LANDMRK, V6, pD75, DOI 10.2741/gustafss; HIATT WR, 1990, CIRCULATION, V81, P602, DOI 10.1161/01.CIR.81.2.602; Hohberg M, 2011, J CELL PHYSIOL, V226, P350, DOI 10.1002/jcp.22340; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; LaRusch GA, 2007, CANCER RES, V67, P450, DOI 10.1158/0008-5472.CAN-06-2710; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lee YM, 2009, CARCINOGENESIS, V30, P1768, DOI 10.1093/carcin/bgp196; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Milkiewicz M, 2011, AM J PATHOL, V178, P935, DOI 10.1016/j.ajpath.2010.10.042; Millard M, 2011, CURR PHARM DESIGN, V17, P536, DOI 10.2174/138161211795222649; Nieminen AL, 2005, J CELL PHYSIOL, V204, P364, DOI 10.1002/jcp.20406; Olfert IM, 2010, AM J PHYSIOL-REG I, V299, pR1059, DOI 10.1152/ajpregu.00347.2010; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Qin G., 2006, P NATL ACAD SCI USA, V103, P11015; Ravi R, 2000, GENE DEV, V14, P34; Roudier E, 2010, J PHYSIOL-LONDON, V588, P4579, DOI 10.1113/jphysiol.2010.193243; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Secchiero P, 2007, CIRC RES, V100, P61, DOI 10.1161/01.RES.0000253975.76198.ff; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Su F, 2010, ONCOGENE, V29, P421, DOI 10.1038/onc.2009.326; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Uguccioni G, 2011, AM J PHYSIOL-ENDOC M, V300, pE361, DOI 10.1152/ajpendo.00292.2010; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wang ZF, 2010, PROTEIN CELL, V1, P1063, DOI 10.1007/s13238-010-0140-9; Yang HT, 2008, J PHYSIOL PHARMACOL, V59, P57; Yoshioka Y, 2012, J SURG RES, V174, P291, DOI 10.1016/j.jss.2010.12.028; Zhang LL, 2000, CANCER RES, V60, P3655; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	54	28	28	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4530	4539		10.1096/fj.12-212720	http://dx.doi.org/10.1096/fj.12-212720			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22835827	Green Published			2022-12-25	WOS:000310574200015
J	Uyama, T; Ikematsu, N; Inoue, M; Shinohara, N; Jin, XH; Tsuboi, K; Tonai, T; Tokumura, A; Ueda, N				Uyama, Toru; Ikematsu, Natsuki; Inoue, Manami; Shinohara, Naoki; Jin, Xing-Hua; Tsuboi, Kazuhito; Tonai, Takeharu; Tokumura, Akira; Ueda, Natsuo			Generation of N-Acylphosphatidylethanolamine by Members of the Phospholipase A/Acyltransferase (PLA/AT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS CANNABINOID PRECURSOR; HYDROLYZING ACID AMIDASE; MOLECULAR CHARACTERIZATION; ACYL ETHANOLAMINE; BIOSYNTHESIS; ACYLETHANOLAMINE; ANANDAMIDE; RECEPTOR; CLONING; BRAIN	Bioactive N-acylethanolamines (NAEs), including N-palmitoylethanolamine, N-oleoylethanolamine, and N-arachidonoylethanolamine (anandamide), are formed from membrane glycerophospholipids in animal tissues. The pathway is initiated by N-acylation of phosphatidylethanolamine to form N-acylphosphatidylethanolamine (NAPE). Despite the physiological importance of this reaction, the enzyme responsible, N-acyltransferase, remains molecularly uncharacterized. We recently demonstrated that all five members of the HRAS-like suppressor tumor family are phospholipid-metabolizing enzymes with N-acyltransferase activity and are renamed HRASLS1-5 as phospholipase A/acyltransferase (PLA/AT)-1-5. However, it was poorly understood whether these proteins were involved in the formation of NAPE in living cells. In the present studies, we first show that COS-7 cells transiently expressing recombinant PLA/AT-1, -2, -4, or -5, and HEK293 cells stably expressing PLA/AT-2 generated significant amounts of [C-14]NAPE and [C-14]NAE when cells were metabolically labeled with [C-14]ethanolamine. Second, as analyzed by liquid chromatography-tandem mass spectrometry, the stable expression of PLA/AT-2 in cells remarkably increased endogenous levels of NAPEs and NAEs with various N-acyl species. Third, when NAPE-hydrolyzing phospholipase D was additionally expressed in PLA/AT-2-expressing cells, accumulating NAPE was efficiently converted to NAE. We also found that PLA/AT-2 was partly responsible for NAPE formation in HeLa cells that endogenously express PLA/AT-2. These results suggest that PLA/AT family proteins may produce NAPEs serving as precursors of bioactive NAEs in vivo.	[Uyama, Toru; Shinohara, Naoki; Jin, Xing-Hua; Tsuboi, Kazuhito; Ueda, Natsuo] Kagawa Univ, Sch Med, Dept Biochem, Miki, Kagawa 7610793, Japan; [Ikematsu, Natsuki; Inoue, Manami; Tokumura, Akira] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708505, Japan; [Jin, Xing-Hua] Qiqihar Med Univ, Dept Chem, Qiqihar 161006, Peoples R China; [Tonai, Takeharu] Natl Zentsuji Hosp, Clin Res Inst, Zentsuji, Kagawa 7650001, Japan; [Tonai, Takeharu] Natl Zentsuji Hosp, Dept Orthoped Surg, Zentsuji, Kagawa 7650001, Japan	Kagawa University; Tokushima University; Qiqihar Medical University	Ueda, N (corresponding author), Kagawa Univ, Sch Med, Dept Biochem, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	nueda@med.kagawa-u.ac.jp	Jin, Xinghua/K-1142-2015	Jin, Xinghua/0000-0002-8883-5234	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Kagawa University Faculty of Medicine Specially Promoted Research Fund; Fund for Kagawa University Young Scientists; Ichiro Kanehara Foundation; Sumitomo Foundation; Uehara Memorial Foundation; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kagawa University Faculty of Medicine Specially Promoted Research Fund; Fund for Kagawa University Young Scientists; Ichiro Kanehara Foundation; Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Suzuken Memorial Foundation	This study was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. U. and K. T.), the Japan Society for the Promotion of Science (to N. U.), Kagawa University Faculty of Medicine Specially Promoted Research Fund 2010 (to T. U.), Fund for Kagawa University Young Scientists 2011 (to T. U. and K. T.), grants from the Ichiro Kanehara Foundation (to T. U.), the Sumitomo Foundation (to T. U.), the Uehara Memorial Foundation (to T. U.), and the Suzuken Memorial Foundation (to K. T.).	Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; Akiyama H, 1999, J BIOL CHEM, V274, P32192, DOI 10.1074/jbc.274.45.32192; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cadas H, 1996, J NEUROSCI, V16, P3934; Cadas H, 1997, J NEUROSCI, V17, P1226; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; HAJNAL A, 1994, ONCOGENE, V9, P479; HANSEN HS, 1995, BBA-LIPID LIPID MET, V1258, P303, DOI 10.1016/0005-2760(95)00134-X; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Okamoto Y, 2005, BIOCHEM J, V389, P241, DOI 10.1042/BJ20041790; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; SCHMID HHO, 1990, PROG LIPID RES, V29, P1, DOI 10.1016/0163-7827(90)90004-5; SCHMID PC, 1983, J BIOL CHEM, V258, P9302; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Shyu RY, 2008, AMINO ACIDS, V35, P129, DOI 10.1007/s00726-007-0612-2; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Sun YX, 2004, BIOCHEM J, V380, P749, DOI 10.1042/BJ20040031; Tokumura A, 2009, INT J MED SCI, V6, P168; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2011, BBA-MOL CELL BIOL L, V1811, P565, DOI 10.1016/j.bbalip.2011.07.009; UEDA N, 1995, BBA-LIPID LIPID MET, V1254, P127, DOI 10.1016/0005-2760(94)00170-4; Ueda N, 2010, BBA-MOL CELL BIOL L, V1801, P1274, DOI 10.1016/j.bbalip.2010.08.010; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	43	43	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31905	31919		10.1074/jbc.M112.368712	http://dx.doi.org/10.1074/jbc.M112.368712			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22825852	Green Published, hybrid			2022-12-25	WOS:000309059400030
J	Ohnishi, T; Godza, B; Watanabe, B; Fujioka, S; Hategan, L; Ide, K; Shibata, K; Yokota, T; Szekeres, M; Mizutani, M				Ohnishi, Toshiyuki; Godza, Blanka; Watanabe, Bunta; Fujioka, Shozo; Hategan, Lidia; Ide, Kouhei; Shibata, Kiyomi; Yokota, Takao; Szekeres, Miklos; Mizutani, Masaharu			CYP90A1/CPD, a Brassinosteroid Biosynthetic Cytochrome P450 of Arabidopsis, Catalyzes C-3 Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; STEPS; DEHYDROGENASE; HYDROXYLATION; BRASSINOLIDE; ELONGATION; METABOLISM; THALIANA; CYP90C1; ENCODES	Brassinosteroids (BRs) are steroidal phytohormones that regulate plant growth and development. Whereas in Arabidopsis the network-like routes of BR biosynthesis have been elucidated in considerable detail, the roles of some of the biosynthetic enzymes and their participation in the different subpathways remained to be clarified. We investigated the function of the cytochrome P450 monooxygenase CYP90A1/CPD, which earlier had been proposed to act as a BR C-23 hydroxylase. Our GC-MS and genetic analyses demonstrated that the cpd mutation arrests BR synthesis upstream of the DET2-mediated 5 alpha reduction step and that overexpression of the C-23 hydroxylase CYP90C1 does not alleviate BR deficiency in the cpd mutant. In line with these results, we found that CYP90A1/CPD heterologously expressed in a baculovirus-insect cell system catalyzes C-3 oxidation of the early BR intermediates (22S)-22-hydroxycampesterol and (22R, 23R)-22,23-dihydroxycampesterol, as well as of 6-deoxocathasterone and 6-deoxoteasterone. Enzyme kinetic data of CYP90A1/CPD and DET2, together with those of the earlier studied CYP90B1, CYP90C1, and CYP90D1, suggest that BR biosynthesis proceeds mainly via the campestanol-independent pathway.	[Ohnishi, Toshiyuki] Shizuoka Univ, Div Global Res Leaders, Suruga Ku, Shizuoka 4228529, Japan; [Godza, Blanka; Hategan, Lidia; Szekeres, Miklos] Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [Watanabe, Bunta; Ide, Kouhei] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Fujioka, Shozo] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Shibata, Kiyomi; Yokota, Takao] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Mizutani, Masaharu] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Shizuoka University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Kyoto University; RIKEN; Teikyo University; Kobe University	Ohnishi, T (corresponding author), Shizuoka Univ, Div Global Res Leaders, Suruga Ku, Shizuoka 4228529, Japan.	dtonish@ipc.shizuoka.ac.jp; szekeres@brc.hu		Szekeres, Miklos/0000-0002-6354-1790; Mizutani, Masaharu/0000-0002-4321-0644; Watanabe, Bunta/0000-0003-3645-5712	Hungarian Scientific Research Fund [T68201]; "BRAVISSIMO" Marie Curie Initial Training Grant of the European Union; Ministry of Education, Culture, Sports, Science, and Technology of Japan [19380069, 23380066, 18580091]; Collaborative Research Program of the Institute for Chemical Research, Kyoto University [2010-16, 2011-17]; MEXT-supported Program for the Strategic Research Foundation at Private Universities [2008-2012]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "BRAVISSIMO" Marie Curie Initial Training Grant of the European Union; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Collaborative Research Program of the Institute for Chemical Research, Kyoto University; MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Hungarian Scientific Research Fund Grant T68201 (to M. S.), "BRAVISSIMO" Marie Curie Initial Training Grant of the European Union (to B. G.), Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants 19380069 and 23380066 (to S. F.) and Grant 18580091 (to M. M.), Collaborative Research Program of the Institute for Chemical Research, Kyoto University, Grants 2010-16 and 2011-17 (to T. O.), and MEXT-supported Program for the Strategic Research Foundation at Private Universities Grant 2008-2012 (to T. Y.).	Bajguz A, 2003, PHYTOCHEMISTRY, V62, P1027, DOI 10.1016/S0031-9422(02)00656-8; Bajguz A, 2007, PLANT PHYSIOL BIOCH, V45, P95, DOI 10.1016/j.plaphy.2007.01.002; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Bishop GJ, 2001, PLANT CELL PHYSIOL, V42, P114, DOI 10.1093/pcp/pce018; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Finsterbusch A, 1999, PLANTA, V209, P478, DOI 10.1007/s004250050751; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Fujioka S, 2000, PHYTOCHEMISTRY, V53, P549, DOI 10.1016/S0031-9422(99)00582-8; Fujita S, 2006, PLANT J, V45, P765, DOI 10.1111/j.1365-313X.2005.02639.x; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Kim GT, 2005, PLANT J, V41, P710, DOI 10.1111/j.1365-313X.2004.02330.x; Kim GT, 1998, GENE DEV, V12, P2381, DOI 10.1101/gad.12.15.2381; KONCZ C, 1994, PLANT MOL BIOL MAN B, V2, P1; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; Mizutani M, 1998, PLANT PHYSIOL, V116, P357, DOI 10.1104/pp.116.1.357; Noguchi T, 2000, PLANT PHYSIOL, V124, P201, DOI 10.1104/pp.124.1.201; Nomura T, 2001, PHYTOCHEMISTRY, V57, P171, DOI 10.1016/S0031-9422(00)00440-4; Nomura T, 2007, PLANT PHYSIOL, V143, P1680, DOI 10.1104/pp.106.093096; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Ohnishi T, 2009, PHYTOCHEMISTRY, V70, P1918, DOI 10.1016/j.phytochem.2009.09.015; Shimada Y, 2001, PLANT PHYSIOL, V126, P770, DOI 10.1104/pp.126.2.770; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Stundl U, 2001, PHYTOCHEMISTRY, V58, P989, DOI 10.1016/S0031-9422(01)00387-9; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; YOKOTA T, 1990, AGR BIOL CHEM TOKYO, V54, P1107, DOI 10.1080/00021369.1990.10870046	31	93	109	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31551	31560		10.1074/jbc.M112.392720	http://dx.doi.org/10.1074/jbc.M112.392720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822057	hybrid, Green Published			2022-12-25	WOS:000308791300067
J	Yang, ZL; Martens, CA; Bruno, DP; Porcella, SF; Moss, B				Yang, Zhilong; Martens, Craig A.; Bruno, Daniel P.; Porcella, Stephen F.; Moss, Bernard			Pervasive Initiation and 3 '-End Formation of Poxvirus Postreplicative RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA VIRUS INTERMEDIATE; NUCLEOSIDE TRIPHOSPHATE PHOSPHOHYDROLASES; EARLY MESSENGER-RNAS; TRANSCRIPTION TERMINATION; POLY(A) POLYMERASE; DNA-REPLICATION; NONCODING RNAS; LATE GENES; NPH-II; GENOME	Poxviruses are large DNA viruses that replicate within the cytoplasm and encode a complete transcription system, including a multisubunit RNA polymerase, stage-specific transcription factors, capping and methylating enzymes, and a poly(A) polymerase. Expression of the more than 200 open reading frames by vaccinia virus, the prototype poxvirus, is temporally regulated: early mRNAs are synthesized immediately after infection, whereas intermediate and late mRNAs are synthesized following genome replication. The postreplicative transcripts are heterogeneous in length and overlap the entire genome, which pose obstacles for high resolution mapping. We used tag-based methods in conjunction with high throughput cDNA sequencing to determine the precise 5'-capped and 3'-polyadenylated ends of postreplicative RNAs. Polymerase slippage during initiation of intermediate and late RNA synthesis results in a 5'-poly(A) leader that allowed the unambiguous identification of true transcription start sites. Ninety RNA start sites were located just upstream of intermediate and late open reading frames, but many more appeared anomalous, occurring within coding and non-coding regions, indicating pervasive transcription initiation. We confirmed the presence of functional promoter sequences upstream of representative anomalous start sites and demonstrated that alternative start sites within open reading frames could generate truncated isoforms of proteins. In an analogous manner, poly(A) sequences allowed accurate mapping of the numerous 3'-ends of postreplicative RNAs, which were preceded by a pyrimidine-rich sequence in the DNA coding strand. The distribution of postreplicative promoter sequences throughout the genome provides enormous transcriptional complexity, and the large number of previously unmapped RNAs may have novel functions.	[Yang, Zhilong; Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Martens, Craig A.; Bruno, Daniel P.; Porcella, Stephen F.] NIAID, Res Technol Sect, Genom Unit, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Moss, B (corresponding author), NIAID, Viral Dis Lab, NIH, 33 North Dr,MSC 3210, Bethesda, MD 20892 USA.	bmoss@nih.gov		Moss, Bernard/0000-0002-2154-8564; Yang, Zhilong/0000-0001-8995-2654	National Institutes of Health Grant from the Division of Intramural Research, NIAID [A1000307-31]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000307] Funding Source: NIH RePORTER	National Institutes of Health Grant from the Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant ZIA A1000307-31 from the Division of Intramural Research, NIAID.	AHN BY, 1989, J VIROL, V63, P226, DOI 10.1128/JVI.63.1.226-232.1989; AHN BY, 1992, J VIROL, V66, P971, DOI 10.1128/JVI.66.2.971-982.1992; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ANTCZAK JB, 1992, P NATL ACAD SCI USA, V89, P12033, DOI 10.1073/pnas.89.24.12033; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BALDICK CJ, 1993, J VIROL, V67, P3515, DOI 10.1128/JVI.67.6.3515-3527.1993; BALDICK CJ, 1992, J VIROL, V66, P4710, DOI 10.1128/JVI.66.8.4710-4719.1992; BERTHOLET C, 1987, CELL, V50, P153, DOI 10.1016/0092-8674(87)90211-X; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOONE RF, 1979, J VIROL, V30, P365, DOI 10.1128/JVI.30.1.365-374.1979; Carninci P, 2008, CURR OPIN CELL BIOL, V20, P274, DOI 10.1016/j.ceb.2008.03.008; COLBY C, 1971, J VIROL, V7, P71, DOI 10.1128/JVI.7.1.71-76.1971; COOPER JA, 1981, J VIROL, V39, P733, DOI 10.1128/JVI.39.3.733-745.1981; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; D'Costa SM, 2004, VIROLOGY, V319, P1, DOI 10.1016/j.virol.2003.09.041; D'Costa SM, 2008, J BIOL CHEM, V283, P5267, DOI 10.1074/jbc.M709258200; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; Earl P L, 2001, Curr Protoc Mol Biol, VChapter 16, DOI 10.1002/0471142727.mb1617s43; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; GERSHON PD, 1993, EMBO J, V12, P4705, DOI 10.1002/j.1460-2075.1993.tb06159.x; GERSHON PD, 1991, CELL, V66, P1269, DOI 10.1016/0092-8674(91)90048-4; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Gross CH, 1996, J VIROL, V70, P8549, DOI 10.1128/JVI.70.12.8549-8557.1996; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Howard ST, 1999, VIROLOGY, V255, P190, DOI 10.1006/viro.1998.9547; INK BS, 1990, P NATL ACAD SCI USA, V87, P1536, DOI 10.1073/pnas.87.4.1536; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P; Knutson BA, 2006, J VIROL, V80, P6784, DOI 10.1128/JVI.02705-05; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Larsen B, 2000, P NATL ACAD SCI USA, V97, P1683, DOI 10.1073/pnas.97.4.1683; LEECHEN GJ, 1988, VIROLOGY, V163, P80, DOI 10.1016/0042-6822(88)90235-8; Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109; MAHR A, 1984, J VIROL, V49, P510, DOI 10.1128/JVI.49.2.510-520.1984; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; MOSS B, 1973, NATURE-NEW BIOL, V245, P59, DOI 10.1038/newbio245059a0; Moss B, 2007, FIELDS VIROLOGY; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; ODA KI, 1967, J MOL BIOL, V27, P395, DOI 10.1016/0022-2836(67)90047-2; PAOLETTI E, 1974, J BIOL CHEM, V249, P3273; PAOLETTI E, 1974, J BIOL CHEM, V249, P3281; PARSONS BL, 1990, VIROLOGY, V175, P69, DOI 10.1016/0042-6822(90)90187-V; PATEL DD, 1987, EMBO J, V6, P3787, DOI 10.1002/j.1460-2075.1987.tb02714.x; PATEL DD, 1988, P NATL ACAD SCI USA, V85, P9431, DOI 10.1073/pnas.85.24.9431; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; SCHWER B, 1987, CELL, V50, P163, DOI 10.1016/0092-8674(87)90212-1; SEBRING E. D., 1967, J VIROL, V1, P550; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Shirokikh NE, 2008, P NATL ACAD SCI USA, V105, P10738, DOI 10.1073/pnas.0804940105; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Taylor SD, 2010, J BIOL CHEM, V285, P11692, DOI 10.1074/jbc.M109.088559; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; VOS JC, 1988, EMBO J, V7, P3487, DOI 10.1002/j.1460-2075.1988.tb03224.x; Xia XH, 2011, GENETICS, V189, P469, DOI 10.1534/genetics.111.132068; Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11; Yang Z, 2011, J VIROL, V85, P5897, DOI 10.1128/JVI.00428-11; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; Zhao HX, 2012, VIROLOGY, V424, P115, DOI 10.1016/j.virol.2011.12.006	65	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31050	31060		10.1074/jbc.M112.390054	http://dx.doi.org/10.1074/jbc.M112.390054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829601	Green Published, hybrid			2022-12-25	WOS:000308791300018
J	Cao, DC; Li, JW; Huang, ZY; Baskin, CC; Baskin, JM; Hao, P; Zhou, WL; Li, JQ				Cao, Dechang; Li, Jingwen; Huang, Zhenying; Baskin, Carol C.; Baskin, Jerry M.; Hao, Peng; Zhou, Weilei; Li, Junqing			Reproductive Characteristics of a Populus euphratica Population and Prospects for Its Restoration in China	PLOS ONE			English	Article							RIPARIAN COTTONWOODS; TAKLAMAKAN DESERT; INNER-MONGOLIA; HEIHE RIVER; NW CHINA; VEGETATION; GROWTH; VULNERABILITY; CAVITATION; MANAGEMENT	Populus euphratica is a dominant tree in riparian ecosystems in arid areas of northwest China, but it fails to regenerate in these systems. This study evaluates causes for the failure of sexual and asexual regeneration of this species in the wild. P. euphratica disperses as many as 85743 seeds/m(2) during summer, and the seeds germinate to 92.0% in distilled water and to 60.8% on silt. However, very few seeds (3.6%) can germinate on unflooded soil. The seed-rain season is prolonged by temporal variability in seed dispersal among individuals, which ensures that seedling emergence can occur during favorable conditions (i.e., floods and rainfall). As a result of water shortage and river channeling due to water usage and altered river flows, there are no safe sites on river banks for seed germination, which has led to the failure of P. euphratica to regenerate from seed. Root suckers of P. euphratica were present in 86% of the forest gaps investigated. However, extensive grazing has destroyed many of them and thus has reduced this form of regeneration. This research suggests that human activities are resulting in the failure of P. euphratica to regenerate. Changes in land management such as reduced use of concrete canals in Populus forests and/or reduced sheep grazing in these areas may promote their regeneration.	[Cao, Dechang; Li, Jingwen; Hao, Peng; Zhou, Weilei; Li, Junqing] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Cao, Dechang; Huang, Zhenying] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Cao, Dechang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Baskin, Carol C.; Baskin, Jerry M.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Kentucky; University of Kentucky	Li, JW (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	lijingwen@bjfu.edu.cn; zhenying@ibcas.ac.cn	Cao, Dechang/X-3232-2019	Cao, Dechang/0000-0002-0397-4316	National Natural Science Foundation of China [31070553, 30570332]; 11th Five-Year Plan of the National Scientific and Technological Support Projects [2008BADB0B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 11th Five-Year Plan of the National Scientific and Technological Support Projects	This work was financially supported by National Natural Science Foundation of China (No. 31070553, 30570332) and the 11th Five-Year Plan of the National Scientific and Technological Support Projects (2008BADB0B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T., 2009, ICCS J MODERN CHINES, V1, P35; Akiyama T, 2007, B GLACIOLOGICAL RES, V24, P87; Beschta RL, 2005, ECOLOGY, V86, P391, DOI 10.1890/04-0964; Bruelheide H, 2003, PHYTOCOENOLOGIA, V33, P801, DOI 10.1127/0340-269X/2003/0033-0801; Chen Y, 2005, PHYS CHEM EARTH, V30, P408, DOI 10.1016/j.pce.2005.06.019; Chen YP, 2006, PHOTOSYNTHETICA, V44, P622, DOI 10.1007/s11099-006-0081-y; [高润宏 Gao Runhong], 2005, [生态学报, Acta Ecologica Sinica], V25, P1019; Gries D, 2003, PLANT CELL ENVIRON, V26, P725, DOI 10.1046/j.1365-3040.2003.01009.x; Guilloy-Froget H, 2002, WETLANDS, V22, P478, DOI 10.1672/0277-5212(2002)022[0478:DGASOP]2.0.CO;2; Hukin D, 2005, J EXP BOT, V56, P2003, DOI 10.1093/jxb/eri198; Ji F., 2001, ACTA PHYTOECOLOGICA, V25, P17; Kurschner H, 2004, PHYTOCOENOLOGIA, V34, P169, DOI 10.1127/0340-269X/2004/0034-0169; Liu PX, 2007, J INTEGR PLANT BIOL, V49, P150, DOI 10.1111/j.1744-7909.2007.00425.x; Lytle DA, 2004, ECOLOGY, V85, P2493, DOI 10.1890/04-0282; Ma HC, 1997, FOREST ECOL MANAG, V93, P55, DOI 10.1016/S0378-1127(96)03943-6; Merritt DM, 2000, REGUL RIVER, V16, P543, DOI 10.1002/1099-1646(200011/12)16:6&lt;543::AID-RRR590&gt;3.0.CO;2-N; Monda Y, 2008, LANDSC ECOL ENG, V4, P115, DOI 10.1007/s11355-008-0050-7; Ruger N, 2005, ECOL MODEL, V184, P313, DOI 10.1016/j.ecolmodel.2004.10.010; Samuelson GM, 2004, J BIOGEOGR, V31, P435, DOI 10.1111/j.0305-0270.2003.01052.x; Scott ML, 1997, ECOL APPL, V7, P677, DOI 10.1890/1051-0761(1997)007[0677:FDOCEA]2.0.CO;2; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; TYREE MT, 1994, TREE PHYSIOL, V14, P455, DOI 10.1093/treephys/14.5.455; Wang Genxu, 2005, Journal of Geographical Sciences, V15, P405, DOI 10.1360/gs050403; Westermann J, 2008, J INTEGR PLANT BIOL, V50, P536, DOI 10.1111/j.1744-7909.2007.00626.x; Xu W., 1988, POPLARS; Xu ZM, 2003, ECOL ECON, V44, P345, DOI 10.1016/S0921-8009(02)00280-X; Yang XP, 2006, GEOGR RES-AUST, V44, P146, DOI 10.1111/j.1745-5871.2006.00378.x; Zhang YB, 2005, SCI TECHNOLOGY ENG, V5, P467; Zhao WZ, 2007, SCI CHINA SER D, V50, P121, DOI 10.1007/s11430-007-2035-z; [赵文智 Zhao Wenzhi], 2005, [生态学报, Acta Ecologica Sinica], V25, P1987	30	23	35	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e39121	10.1371/journal.pone.0039121	http://dx.doi.org/10.1371/journal.pone.0039121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848351	Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600001
J	Chen, HJ; Palmer, JS; Thiagarajan, RD; Dinger, ME; Lesieur, E; Chiu, HS; Schulz, A; Spiller, C; Grimmond, SM; Little, MH; Koopman, P; Wilhelm, D				Chen, Huijun; Palmer, James S.; Thiagarajan, Rathi D.; Dinger, Marcel E.; Lesieur, Emmanuelle; Chiu, Hansheng; Schulz, Alexandra; Spiller, Cassy; Grimmond, Sean M.; Little, Melissa H.; Koopman, Peter; Wilhelm, Dagmar			Identification of Novel Markers of Mouse Fetal Ovary Development	PLOS ONE			English	Article							LONG NONCODING RNAS; MAMMALIAN SEX DETERMINATION; TRANSCRIPTION FACTOR FOXL2; X-CHROMOSOME INACTIVATION; DOUBLESEX-RELATED GENES; GERM-CELLS; TESTIS DEVELOPMENT; BETA-CATENIN; DETERMINATION REVEALS; EMBRYONIC GONAD	In contrast to the developing testis, molecular pathways driving fetal ovarian development have been difficult to characterise. To date no single master regulator of ovarian development has been identified that would be considered the female equivalent of Sry. Using a genomic approach we identified a number of novel protein-coding as well as non-coding genes that were detectable at higher levels in the ovary compared to testis during early mouse gonad development. We were able to cluster these ovarian genes into different temporal expression categories. Of note, Lrrc34 and AK015184 were detected in XX but not XY germ cells before the onset of sex-specific germ cell differentiation marked by entry into meiosis in an ovary and mitotic arrest in a testis. We also defined distinct spatial expression domains of somatic cell genes in the developing ovary. Our data expands the set of markers of early mouse ovary differentiation and identifies a classification of early ovarian genes, thus providing additional avenues with which to dissect this process.	[Chen, Huijun; Palmer, James S.; Thiagarajan, Rathi D.; Dinger, Marcel E.; Lesieur, Emmanuelle; Chiu, Hansheng; Schulz, Alexandra; Spiller, Cassy; Grimmond, Sean M.; Little, Melissa H.; Koopman, Peter; Wilhelm, Dagmar] Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia	University of Queensland	Wilhelm, D (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia.	d.wilhelm@imb.uq.edu.au	Koopman, Peter A/C-9416-2009; Grimmond, Sean M/J-5304-2016; Dinger, Marcel/N-1398-2019; Grimmond, Sean/K-3246-2019; Spiller, Cassy/C-2779-2013; Wilhelm, Dagmar/B-6915-2009; Little, Melissa H/A-6170-2010	Koopman, Peter A/0000-0001-6939-0914; Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Spiller, Cassy/0000-0002-1343-8269; Wilhelm, Dagmar/0000-0002-7757-4075; Little, Melissa H/0000-0003-0380-2263; Dinger, Marcel/0000-0003-4423-934X	NIDDK, National Institute of Health, United States of America [DK070136]; Australian Research Council (ARC) [DP0879913]; National Health and Medical Research Council of Australia (NHMRC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070136] Funding Source: NIH RePORTER	NIDDK, National Institute of Health, United States of America; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the NIDDK, National Institute of Health, United States of America, (http://www2.niddk.nih.gov/, DK070136), Australian Research Council (ARC, http://www.arc.gov.au/) (DP0879913) and National Health and Medical Research Council of Australia (NHMRC; http://www.nhmrc.gov.au/455902). DW and MED are CDA Fellows of the NHMRC (519737). ML is a Principal Research Fellow of the NHMRC. PK is an ARC Federation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Arango NA, 2006, DEV DYNAM, V235, P2613, DOI 10.1002/dvdy.20907; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bono H, 2003, GENOME RES, V13, P1318, DOI 10.1101/gr.1075103; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Bowles J, 2000, AUSTR BIOCH, V31, P4; Bowles J, 2010, REPRODUCTION, V139, P943, DOI 10.1530/REP-10-0075; Bradford ST, 2007, SEX DEV, V1, P305, DOI 10.1159/000108933; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Cheng A, 2005, CELL CYCLE, V4, P155, DOI 10.4161/cc.4.1.1347; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Combes AN, 2009, DEV DYNAM, V238, P1033, DOI 10.1002/dvdy.21925; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; Coveney D, 2008, GENE EXPR PATTERNS, V8, P529, DOI 10.1016/j.gep.2008.05.006; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Di Carlo A, 2000, DEV BIOL, V226, P209, DOI 10.1006/dbio.2000.9861; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hu J, 1999, ENDOCRINOLOGY, V140, P3416, DOI 10.1210/en.140.8.3416; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jimenez R, 2010, SEX DEV, V3, P291, DOI 10.1159/000280584; Jorgensen JS, 2005, GENE EXPR PATTERNS, V5, P756, DOI 10.1016/j.modgep.2005.04.011; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Kim SS, 2003, GENE EXPR PATTERNS, V3, P77, DOI 10.1016/S1567-133X(02)00071-6; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Liu CF, 2010, CURR TOP DEV BIOL, V90, P263, DOI 10.1016/S0070-2153(10)90007-0; Luense LJ, 2009, TRENDS ENDOCRIN MET, V20, P265, DOI 10.1016/j.tem.2009.05.001; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Magoffin DA, 2005, INT J BIOCHEM CELL B, V37, P1344, DOI 10.1016/j.biocel.2005.01.016; MAGOFFIN DA, 1994, BIOL REPROD, V51, P766, DOI 10.1095/biolreprod51.4.766; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Orisaka M, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-9; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Ottolenghi C, 2002, GENOMICS, V79, P333, DOI 10.1006/geno.2002.6711; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Polanco JC, 2010, HUM MOL GENET, V19, P506, DOI 10.1093/hmg/ddp520; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Rolland AD, 2011, BIOL REPROD, V84, P790, DOI 10.1095/biolreprod.110.088443; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Takabayashi S, 2009, EXP BIOL MED, V234, P994, DOI 10.3181/0808-RM-244; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Veith AM, 2006, GENOMICS, V88, P185, DOI 10.1016/j.ygeno.2006.01.003; Wainwright EN, 2010, CURR TOP DEV BIOL, V90, P231, DOI 10.1016/S0070-2153(10)90006-9; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7	84	36	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41683	10.1371/journal.pone.0041683	http://dx.doi.org/10.1371/journal.pone.0041683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844512	Green Published, gold			2022-12-25	WOS:000309240600039
J	Tiira, K; Hakosalo, O; Kareinen, L; Thomas, A; Hielm-Bjorkman, A; Escriou, C; Arnold, P; Lohi, H				Tiira, Katriina; Hakosalo, Osmo; Kareinen, Lauri; Thomas, Anne; Hielm-Bjorkman, Anna; Escriou, Catherine; Arnold, Paul; Lohi, Hannes			Environmental Effects on Compulsive Tail Chasing in Dogs	PLOS ONE			English	Article							PERSONALITY-TRAITS; SLEEP DISORDER; ANIMAL-MODELS; BEHAVIOR; TEMPERAMENT; VALIDATION; RECEPTOR; QUESTIONNAIRE; CLOMIPRAMINE; AGGRESSION	Obsessive Compulsive Disorder (OCD) is a neuropsychiatric disorder observed both in humans and animals. Examples of Canine Compulsive Disorder (CD) include excessive tail chasing (TC), light/shadow chasing and flank sucking. We performed a questionnaire survey to investigate the characteristics of compulsive (TC) and its possible associations with environmental correlates and personality in a pet population of 368 dogs from four dog breeds. We observed an early onset of TC at 36 months of age and a large variation in TC frequency in all breeds, with an overrepresentation of milder cases. Almost half of the TC dogs showed lowered responsiveness during bouts and displayed also other types of compulsions more often than the controls. Interestingly, dogs that received dietary supplements, especially vitamins and minerals, expressed less TC compared to dogs that did not receive any supplements. Neutered females had less TC, suggesting an influence of ovarian hormones on TC. Tail chasers were shyer and had separated earlier from their mothers than the controls. Finally, our genetic study did not find an association between TC and CDH2, a locus previously associated with the canine flank sucking compulsion. In conclusion, the early- onset and the variable nature of the repetitive behaviour, which is affected by environmental factors such as micronutrients, neutering and maternal care, share several similar components between canine and human compulsions and supports canine TC as a model for human OCD.	[Tiira, Katriina; Hakosalo, Osmo; Kareinen, Lauri; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland; [Tiira, Katriina; Hakosalo, Osmo; Kareinen, Lauri; Lohi, Hannes] Folkhalsan Res Ctr, Helsinki, Finland; [Thomas, Anne] Anim Genet Lab, Lyon, France; [Hielm-Bjorkman, Anna] Univ Helsinki, Dept Equine & Small Anim Med, Helsinki, Finland; [Escriou, Catherine] Natl Vet Sch Lyon, Lyon, France; [Arnold, Paul] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada	University of Helsinki; Folkhalsan Research Center; University of Helsinki; VetAgro Sup; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011; Tiira, Katriina/U-4035-2018	Lohi, Hannes/0000-0003-1087-5532; Hielm-Bjorkman, Anna/0000-0003-1343-3473; Kareinen, Lauri/0000-0003-2525-7817; Tiira, Katriina/0000-0002-2253-8755	ERCStG [HL 260997]; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; University of Helsinki Research Funds, Folkhalsan Research Center; Finnish Cultural Foundation	ERCStG; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Funds, Folkhalsan Research Center; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the ERCStG (HL 260997; http://erc.europa.eu/starting-grants), the Jane and Aatos Erkko Foundation (http://www.jaes.fi/en/), the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), the University of Helsinki Research Funds, Folkhalsan Research Center (http://www.folkhalsan.fi/en/startsida/About-Folkhalsan/), and the Finnish Cultural Foundation (KT) (http://www.skr.fi/default.asp?docId = 12256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuso-Mateos JL., 2006, GLOBAL BURDEN OBSESS; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P377; Burn CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026553; Bush WW, 2004, J AM ANIM HOSP ASSOC, V40, P495, DOI 10.5326/0400495; CARNEY MWP, 1995, CNS DRUGS, V3, P279, DOI 10.2165/00023210-199503040-00005; Cheyne SM, 2006, PRIMATES, V47, P322, DOI 10.1007/s10329-006-0190-z; Coles ME, 2006, J ANXIETY DISORD, V20, P1118, DOI 10.1016/j.janxdis.2006.03.003; Dakshinamurti K, 1995, VITAMIN B6 ITS ROLE, P99; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Dodman NH, 1996, J AM VET MED ASSOC, V208, P688; Fernandez-Guasti A, 2006, PSYCHONEUROENDOCRINO, V31, P924, DOI 10.1016/j.psyneuen.2006.05.003; Fernando ABP, 2011, ANNU REV CLIN PSYCHO, V7, P39, DOI 10.1146/annurev-clinpsy-032210-104454; Flaisher-Grinberg S, 2009, HORM BEHAV, V55, P356, DOI 10.1016/j.yhbeh.2008.10.002; Franklin ME, 2011, ANNU REV CLIN PSYCHO, V7, P229, DOI 10.1146/annurev-clinpsy-032210-104533; Friedlander L, 2006, CLIN PSYCHOL REV, V26, P32, DOI 10.1016/j.cpr.2005.06.010; Fuchs T, 2005, APPL ANIM BEHAV SCI, V94, P287, DOI 10.1016/j.applanim.2005.02.016; Gagnon DR, 2008, J TRAUMA STRESS, V21, P448, DOI 10.1002/jts.20359; Gargaro BA, 2011, NEUROSCI BIOBEHAV R, V35, P1081, DOI 10.1016/j.neubiorev.2010.11.002; George D, 2003, SPSS WINDOWS STEP ST; Grisham JR, 2008, EUR ARCH PSY CLIN N, V258, P107, DOI 10.1007/s00406-007-0789-0; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Jones MA, 2010, APPL ANIM BEHAV SCI, V123, P63, DOI 10.1016/j.applanim.2009.12.013; Kaplan BJ, 2002, J CHILD ADOL PSYCHOP, V12, P205, DOI 10.1089/104454602760386897; Kaplan PW, 2011, EPILEPSY BEHAV, V22, P428, DOI 10.1016/j.yebeh.2011.07.029; Katerberg H, 2010, BEHAV GENET, V40, P505, DOI 10.1007/s10519-010-9339-z; Konno A, 2011, BIOL LETTERS, V7, P658, DOI 10.1098/rsbl.2011.0087; Kurup RK, 2002, INT J NEUROSCI, V112, P797, DOI 10.1080/00207450290025824; Latham NR, 2008, APPL ANIM BEHAV SCI, V110, P84, DOI 10.1016/j.applanim.2007.03.026; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Liinamo AE, 2007, APPL ANIM BEHAV SCI, V104, P95, DOI 10.1016/j.applanim.2006.04.025; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Luescher AU, 2003, VET CLIN N AM-SMALL, V33, P253, DOI 10.1016/S0195-5616(02)00100-6; Man J., 2004, Current Neuropharmacology, V2, P169, DOI 10.2174/1570159043476792; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Moon-Fanelli AA, 1998, J AM VET MED ASSOC, V212, P1252; Moon-Fanelli AA, 2007, JAVMA-J AM VET MED A, V231, P907, DOI 10.2460/javma.231.6.907; Moon-Fanelli AA, 2011, JAVMA-J AM VET MED A, V238, P883, DOI 10.2460/javma.238.7.883; National Research Council (U.S.). Ad Hoc Committee on Dog and Cat Nutrition, 2006, NUTR REQ DOGS CATS, P398; Nicolini H, 2009, PSYCHIAT RES, V170, P7, DOI 10.1016/j.psychres.2008.10.011; Overall KL, 2006, J VET BEHAV, V1, P1, DOI 10.1016/j.jveb.2006.04.008; Overall KL, 2002, J AM VET MED ASSOC, V221, P1445, DOI 10.2460/javma.2002.221.1445; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; RAPOPORT JL, 1992, ARCH GEN PSYCHIAT, V49, P517; Richter MA, 2003, DEPRESS ANXIETY, V18, P118, DOI 10.1002/da.10126; Rucklidge JJ, 2009, J ANXIETY DISORD, V23, P836, DOI 10.1016/j.janxdis.2009.02.012; Sallander MH, 2001, PREV VET MED, V50, P35, DOI 10.1016/S0167-5877(01)00217-3; Schneider BM, 2009, J VET BEHAV, V4, P118, DOI 10.1016/j.jveb.2008.10.008; Schonecker B, 2009, APPL ANIM BEHAV SCI, V121, P55, DOI 10.1016/j.applanim.2009.08.003; Seksel K, 2001, AUST VET J, V79, P252, DOI 10.1111/j.1751-0813.2001.tb11976.x; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Skarupski KA, 2010, AM J CLIN NUTR, V92, P330, DOI 10.3945/ajcn.2010.29413; Spady TC, 2008, AM J HUM GENET, V82, P10, DOI 10.1016/j.ajhg.2007.12.001; Stein DJ, 2002, LANCET, V360, P397, DOI 10.1016/S0140-6736(02)09620-4; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Takeuchi T, 1997, BEHAV RES THER, V35, P445, DOI 10.1016/S0005-7967(96)00123-4; Uchida Y, 1997, AM J VET RES, V58, P808; Uguz F, 2007, COMPR PSYCHIAT, V48, P558, DOI 10.1016/j.comppsych.2007.05.010; van Grootheest DS, 2005, TWIN RES HUM GENET, V8, P450, DOI 10.1375/183242705774310060; Vas J, 2007, APPL ANIM BEHAV SCI, V103, P105, DOI 10.1016/j.applanim.2006.03.017; Vermeire S, 2012, PSYCHIAT RES-NEUROIM, V201, P78, DOI 10.1016/j.pscychresns.2011.06.006; Vermeire S, 2009, BRAIN IMAGING BEHAV, V3, P342, DOI 10.1007/s11682-009-9076-1; Vulink NCC, 2006, INT CLIN PSYCHOPHARM, V21, P171, DOI 10.1097/01.yic.0000199454.62423.99; Walitza S, 2010, EUR CHILD ADOLES PSY, V19, P227, DOI 10.1007/s00787-010-0087-7; Wang Huei-Shyong, 2007, Chang Gung Med J, V30, P396; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wu K, 2011, PHARM BIOCH BEHAV, V100, P726	69	40	40	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41684	10.1371/journal.pone.0041684	http://dx.doi.org/10.1371/journal.pone.0041684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844513	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600040
J	Qi, XL; Constantinidis, C				Qi, Xue-Lian; Constantinidis, Christos			Variability of Prefrontal Neuronal Discharges before and after Training in a Working Memory Task	PLOS ONE			English	Article							CORTICAL-NEURONS; SINGLE NEURONS; ATTENTION; NOISE; CELLS; RELIABILITY; PERFORM; CORTEX; MOTOR; CAT	Variability of neural discharges can be revealing about the computations and network properties of neuronal populations during the performance of cognitive tasks. We sought to quantify neuronal variability in the prefrontal cortex of naive monkeys that were only required to fixate, and to examine how this measure was altered by learning and execution of a working memory task. We therefore performed analysis of a large database of recordings in the same animals, using the same stimuli, before and after training. Our results indicate that the Fano Factor, a measure of variability, differs across neurons depending on their functional properties both before and after learning. Fano Factor generally decreased after learning the task. Variability was modulated by task events and displayed lowest values during the stimulus presentation. Nonetheless, the decrease in variability after training was present even prior to the presentation of any stimuli, in the fixation period. The greatest decreases were observed comparing populations of neurons that exhibited elevated firing rate during the trial events. Our results offer insights on how properties of the prefrontal network are affected by performance of a cognitive task.	[Qi, Xue-Lian; Constantinidis, Christos] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center	Qi, XL (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27109 USA.	cconstan@wfubmc.edu	Constantinidis, Christos/ABB-5760-2021	Constantinidis, Christos/0000-0001-7441-022X	National Eye Institute of the National Institutes of Health [R01 EY017077]; NATIONAL EYE INSTITUTE [R01EY017077] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported in this paper was supported by the National Eye Institute of the National Institutes of Health under award number R01 EY017077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hussar C, 2010, P NATL ACAD SCI USA, V107, P21842, DOI 10.1073/pnas.1009956107; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Lee D, 1998, J NEUROSCI, V18, P1161; Maynard EM, 1999, J NEUROSCI, V19, P8083; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Meyer T, 2005, J NEUROSCI METH, V142, P27, DOI 10.1016/j.jneumeth.2004.07.009; Meyer T, 2011, J NEUROSCI, V31, P6266, DOI 10.1523/JNEUROSCI.6798-10.2011; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Oram MW, 2011, J NEUROPHYSIOL, V105, P942, DOI 10.1152/jn.00711.2009; Qi XL, 2012, J NEUROSCI, V32, P6161, DOI 10.1523/JNEUROSCI.6365-11.2012; Qi XL, 2011, CEREB CORTEX, V21, P2722, DOI 10.1093/cercor/bhr058; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SOFTKY WR, 1993, J NEUROSCI, V13, P334; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Vigneswaran G, 2011, J NEUROSCI, V31, P14235, DOI 10.1523/JNEUROSCI.3142-11.2011; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002	30	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41053	10.1371/journal.pone.0041053	http://dx.doi.org/10.1371/journal.pone.0041053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848426	gold, Green Submitted, Green Published			2022-12-25	WOS:000306806600035
J	Byrne, RD; Applebee, C; Poccia, DL; Larijani, B				Byrne, Richard D.; Applebee, Christopher; Poccia, Dominic L.; Larijani, Banafshe			Dynamics of PLC gamma and Src Family Kinase 1 Interactions during Nuclear Envelope Formation Revealed by FRET-FLIM	PLOS ONE			English	Article							PHOSPHOLIPASE C-GAMMA; CA2+ RELEASE; IN-VITRO; TYROSINE KINASE; SPERM CHROMATIN; EGG; ACTIVATION; BINDING; FUSION; PHOSPHORYLATION	The nuclear envelope (NE) breaks down and reforms during each mitotic cycle. A similar process happens to the sperm NE following fertilisation. The formation of the NE in both these circumstances involves endoplasmic reticulum membranes enveloping the chromatin, but PLC gamma-dependent membrane fusion events are also essential. Here we demonstrate the activation of PLC gamma by a Src family kinase (SFK1) during NE assembly. We show by time-resolved FRET for the first time the direct in vivo interaction and temporal regulation of PLC gamma and SFK1 in sea urchins. As a prerequisite for protein activation, there is a rapid phosphorylation of PLC gamma on its Y783 residue in response to GTP in vitro. This phosphorylation is dependent upon SFK activity; thus Y783 phosphorylation and NE assembly are susceptible to SFK inhibition. Y783 phosphorylation is also observed on the surface of the male pronucleus (MPN) in vivo during NE formation. Together the corroborative in vivo and in vitro data demonstrate the phosphorylation and activation of PLC gamma by SFK1 during NE assembly. We discuss the potential generality of such a mechanism.	[Byrne, Richard D.; Applebee, Christopher; Larijani, Banafshe] London Res Inst, Canc Res UK, Cell Biophys Lab, London, England; [Poccia, Dominic L.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Cancer Research UK; Amherst College	Byrne, RD (corresponding author), London Res Inst, Canc Res UK, Cell Biophys Lab, London, England.	richard.byrne@cancer.org.uk; banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015	Larijani, Banafshe/0000-0003-4735-1169	Cancer Research UK; Amherst College Faculty Research Award of the H. Axel Schupf '57 Fund for Intellectual Life; Royal Society [GA3335]	Cancer Research UK(Cancer Research UK); Amherst College Faculty Research Award of the H. Axel Schupf '57 Fund for Intellectual Life; Royal Society(Royal Society of London)	The project was funded by Cancer Research UK core funding to London Research Institute (RDB, CA & BL), an Amherst College Faculty Research Award of the H. Axel Schupf '57 Fund for Intellectual Life (DLP), and Royal Society travel grant no. GA3335 (BL & DLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcor Damien, 2009, V462, P307, DOI 10.1007/978-1-60327-115-8_21; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; ARKINSTALL S, 1995, MOL CELL BIOL, V15, P1431; Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; Byrne RD, 2005, BIOCHEM J, V387, P393, DOI 10.1042/BJ20040947; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; Byrne RD, 2009, CLIN LIPIDOL, V4, P103, DOI 10.2217/17584299.4.1.103; Byrne RD, 2009, ADV ENZYME REGUL, V49, P148, DOI 10.1016/j.advenzreg.2008.12.010; Byrne Richard D., 2008, V464, P207; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; CAMERON LA, 1994, DEV BIOL, V162, P568, DOI 10.1006/dbio.1994.1110; COLLAS P, 1995, DEV BIOL, V169, P123, DOI 10.1006/dbio.1995.1132; Collas P, 1996, J CELL SCI, V109, P1275; COLLAS P, 1995, MOL REPROD DEV, V42, P106, DOI 10.1002/mrd.1080420114; Collas P, 1996, J CELL BIOL, V135, P1715, DOI 10.1083/jcb.135.6.1715; Collas P, 1996, EUR J CELL BIOL, V71, P22; Conner S, 1998, DEV BIOL, V203, P334, DOI 10.1006/dbio.1998.9057; Conner SD, 2000, FASEB J, V14, P1559, DOI 10.1096/fj.14.11.1559; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; Dumas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012208; Foltz KR, 2004, METHOD CELL BIOL, V74, P39; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Giusti AF, 2003, DEV BIOL, V256, P367, DOI 10.1016/S0012-1606(03)00043-5; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Imschenetzky M, 2003, GENE, V322, P33, DOI 10.1016/j.gene.2003.08.024; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Khare S, 1997, J CLIN INVEST, V99, P1831, DOI 10.1172/JCI119350; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Larijani B, 2001, BIOCHEM J, V356, P495, DOI 10.1042/0264-6021:3560495; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; LIAO F, 1993, BIOCHEM BIOPH RES CO, V191, P1028, DOI 10.1006/bbrc.1993.1320; LONGO FJ, 1968, J CELL BIOL, V39, P339, DOI 10.1083/jcb.39.2.339; LONGO FJ, 1976, DEV BIOL, V49, P347, DOI 10.1016/0012-1606(76)90180-9; LONGO FJ, 1973, BIOL REPROD, V9, P149, DOI 10.1093/biolreprod/9.2.149; LONGO FJ, 1981, DEV BIOL, V84, P173, DOI 10.1016/0012-1606(81)90381-X; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; O'Neill FJ, 2004, J CELL SCI, V117, P6227, DOI 10.1242/jcs.01547; OKADA M, 1991, J BIOL CHEM, V266, P24249; Poccia D, 1997, DEV GROWTH DIFFER, V39, P541; Poccia D, 1996, CURR TOP DEV BIOL, V34, P25, DOI 10.1016/S0070-2153(08)60708-5; POCCIA DL, 1992, TRENDS BIOCHEM SCI, V17, P223, DOI 10.1016/0968-0004(92)90382-J; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Runft LL, 2004, DEV BIOL, V269, P220, DOI 10.1016/j.ydbio.2004.01.031; Sharma D, 2006, DEV BIOL, V295, P604, DOI 10.1016/j.ydbio.2006.03.041; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stricker SA, 2010, INT J DEV BIOL, V54, P787, DOI 10.1387/ijdb.092918ss; Townley IK, 2006, SEMIN CELL DEV BIOL, V17, P293, DOI 10.1016/j.semcdb.2006.02.006; Townley IK, 2009, DEV BIOL, V327, P465, DOI 10.1016/j.ydbio.2008.12.032; Voronina E, 2004, J CELL SCI, V117, P5995, DOI 10.1242/jcs.01518; Wilson EB, 1925, SCIENCE, V61, P184, DOI 10.1126/science.61.1572.184	57	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40669	10.1371/journal.pone.0040669	http://dx.doi.org/10.1371/journal.pone.0040669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848394	Green Submitted, gold, Green Published			2022-12-25	WOS:000306751300008
J	Chen, H; Untiveros, GM; McKee, LAK; Perez, J; Li, J; Antin, PB; Konhilas, JP				Chen, Hao; Untiveros, Gustavo M.; McKee, Laurel A. K.; Perez, Jessica; Li, Jing; Antin, Parker B.; Konhilas, John P.			Micro-RNA-195 and-451 Regulate the LKB1/AMPK Signaling Axis by Targeting MO25	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIAC-HYPERTROPHY; MOUSE MODEL; GENE-EXPRESSION; HEART-DISEASE; MICRORNAS; LKB1; METABOLISM; ENERGETICS; SIGNATURE	Background: Recently, MicroRNAs (miR) and AMP-kinase (AMPK) have emerged as prominent players in the development of cardiac hypertrophy and heart failure. We hypothesized that components of the adenosine monophosphate-activated kinase (AMPK) pathway are targeted by miRs and alter AMPK signaling during pathological cardiac stress. Methodology/Principal Findings: Using a mouse model of hypertrophic cardiomyopathy (HCM), we demonstrated early elevation of miR-195 and miR-451 in HCM hearts, which targets MO25, a central component of the MO25/STRAD/LKB1 complex that acts as an upstream kinase for AMPK. We show functional targeting of MO25 by miR-195 and -451. Further in vitro interrogation of MO25 as a functional target validated this hypothesis where over-expression of miR-195 in C2C12 cells knocked down MO25 expression levels and downstream AMPK signaling (phosphorylation of Acetyl CoA carboxylase [ACC] and AMPK activity assay), similar to MO25 knockdown in C2C12 cells by siRNA. Parallel changes were measured in 60 day R403Q HCM male hearts that were rescued by short-term administration of AICAR, an AMPK agonist. Conclusions/Significance: Elevated miR-195 targets the LKB1/AMPK signaling axis in HCM progression and implicates a functional role in HCM disease progression. MiR-195 may serve as potential therapeutics or therapeutic targets for heart disease.	[Chen, Hao; McKee, Laurel A. K.; Perez, Jessica; Konhilas, John P.] Univ Arizona, Dept Physiol, Tucson, AZ 85719 USA; [Untiveros, Gustavo M.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Antin, Parker B.] Univ Arizona, Dept Cellular & Mol Med, Mol Cardiovasc Res Program, Tucson, AZ USA; [Antin, Parker B.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA; [Li, Jing] Steele Childrens Res Ctr, Dept Pediat, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Chen, H (corresponding author), Univ Arizona, Dept Physiol, Tucson, AZ 85719 USA.	konhilas@arizona.edu		Antin, Parker/0000-0001-9066-7412; Konhilas, John/0000-0002-3579-087X	NIH [HL 098256, K01 AR052840, K02 HL105799, HD064559]; Interdisciplinary Training Grant in Cardiovascular Sciences [HL007249]; AHA WSA Postdoctoral Fellowship [11POST7900010]; Sarver Heart Center at the University of Arizona; Steven M. Gootter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064559] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098256, T32HL007249, K02HL105799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Training Grant in Cardiovascular Sciences; AHA WSA Postdoctoral Fellowship; Sarver Heart Center at the University of Arizona; Steven M. Gootter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant (HL 098256), by a National and Mentored Research Science Development Award (K01 AR052840) and Independent Scientist Award (K02 HL105799) from the NIH awarded to JPK and the Interdisciplinary Training Grant in Cardiovascular Sciences (HL007249), and by AHA WSA Postdoctoral Fellowship (11POST7900010) awarded to CH. Also, support was provided by NIH grant (HD064559) awarded to PBA. Support was received from the Sarver Heart Center at the University of Arizona and from the Steven M. Gootter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 1998, J AM COLL NUTR, V17, P548, DOI 10.1080/07315724.1998.10718802; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Bell GW, 2004, DEV DYNAM, V229, P677, DOI 10.1002/dvdy.10503; Bostjancic E, 2009, DIS MARKERS, V27, P255, DOI 10.3233/DMA-2009-0671; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Degens H, 2006, BASIC RES CARDIOL, V101, P17, DOI 10.1007/s00395-005-0549-0; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dyck JRB, 2006, CIRCULATION, V114, P1721, DOI 10.1161/CIRCULATIONAHA.106.642009; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Glazov Evgeny A, 2006, RNA Biol, V3, P36; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; Hammond SM, 2006, CANCER CHEMOTH PHARM, V58, pS63, DOI 10.1007/s00280-006-0318-2; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Kalsi KK, 1999, EUR J CLIN INVEST, V29, P469, DOI 10.1046/j.1365-2362.1999.00468.x; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lucas DT, 2003, AM J PHYSIOL-HEART C, V284, pH575, DOI 10.1152/ajpheart.00619.2002; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; Olsson MC, 2004, CIRC RES, V94, P201, DOI 10.1161/01.RES.0000111521.40760.18; Olsson MC, 2001, AM J PHYSIOL-HEART C, V280, pH1136, DOI 10.1152/ajpheart.2001.280.3.H1136; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940; Stauffer BL, 2006, J CLIN INVEST, V116, P209, DOI 10.1172/JCI24676; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vikstrom KL, 1996, MOL MED, V2, P556, DOI 10.1007/BF03401640; Vikstrom KL, 1998, CIRC RES, V82, P773, DOI 10.1161/01.RES.82.7.773; Watson PA, 2007, AM J PHYSIOL-HEART C, V293, pH246, DOI 10.1152/ajpheart.00734.2006; Williamson DL, 2006, AM J PHYSIOL-ENDOC M, V291, pE80, DOI 10.1152/ajpendo.00566.2005; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066; Woods SC, 2003, EXP BIOL MED, V228, P1175; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang CX, 2011, CLIN EXP PHARMACOL P, V38, P55, DOI 10.1111/j.1440-1681.2010.05461.x; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	52	43	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41574	10.1371/journal.pone.0041574	http://dx.doi.org/10.1371/journal.pone.0041574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844503	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700116
J	Goncalves, L; Subtil, A; de Oliveira, MR; do Rosario, V; Lee, PW; Shaio, MF				Goncalves, Luzia; Subtil, Ana; Rosario de Oliveira, M.; do Rosario, Virgilio; Lee, Pei-Wen; Shaio, Men-Fang			Bayesian Latent Class Models in Malaria Diagnosis	PLOS ONE			English	Article							LABORATORY COMPARATIVE-EVALUATION; PLASMODIUM-FALCIPARUM MALARIA; MONTE-CARLO METHODS; TOME-AND-PRINCIPE; CONDITIONAL DEPENDENCE; CONFIDENCE-INTERVALS; BINOMIAL PROPORTION; FIELD-EVALUATION; TESTS; ACCURACY	Aims: The main focus of this study is to illustrate the importance of the statistical analysis in the evaluation of the accuracy of malaria diagnostic tests, without admitting a reference test, exploring a dataset (n = 3317) collected in Sao Tome and Principe. Methods: Bayesian Latent Class Models (without and with constraints) are used to estimate the malaria infection prevalence, together with sensitivities, specificities, and predictive values of three diagnostic tests (RDT, Microscopy and PCR), in four subpopulations simultaneously based on a stratified analysis by age groups (<5, >= 5 years old) and fever status (febrile, afebrile). Results: In the afebrile individuals with at least five years old, the posterior mean of the malaria infection prevalence is 3.2% with a highest posterior density interval of [2.3-4.1]. The other three subpopulations (febrile >= 5 years, afebrile or febrile children less than 5 years) present a higher prevalence around 10.3% [8.8-11.7]. In afebrile children under-five years old, the sensitivity of microscopy is 50.5% [37.7-63.2]. In children under-five, the estimated sensitivities/specificities of RDT are 95.4% [90.3-99.5]/93.8% [91.6-96.0] - afebrile - and 94.1% [87.5-99.4]/97.5% [95.5-99.3] - febrile. In individuals with at least five years old are 96.0% [91.5-99.7]/98.7% [98.1-99.2] - afebrile - and 97.9% [95.3-99.8]/97.7% [96.6-98.6] - febrile. The PCR yields the most reliable results in four subpopulations. Conclusions: The utility of this RDT in the field seems to be relevant. However, in all subpopulations, data provide enough evidence to suggest caution with the positive predictive values of the RDT. Microscopy has poor sensitivity compared to the other tests, particularly, in the afebrile children less than 5 years. This type of findings reveals the danger of statistical analysis based on microscopy as a reference test. Bayesian Latent Class Models provide a powerful tool to evaluate malaria diagnostic tests, taking into account different groups of interest.	[Goncalves, Luzia] Univ Nova Lisboa, Inst Higiene & Med Trop, CEAUL, P-1200 Lisbon, Portugal; [Goncalves, Luzia] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Saude Publ Int & Bioestat, P-1200 Lisbon, Portugal; [Subtil, Ana; Rosario de Oliveira, M.] Univ Tecn Lisboa, Inst Super Tecn, CEMAT, P-1096 Lisbon, Portugal; [Subtil, Ana; Rosario de Oliveira, M.] Univ Tecn Lisboa, Inst Super Tecn, Dept Matemat, P-1096 Lisbon, Portugal; [do Rosario, Virgilio] Univ Nova Lisboa, Inst Higiene & Med Trop, CMDT LA, P-1200 Lisbon, Portugal; [do Rosario, Virgilio] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol Med, P-1200 Lisbon, Portugal; [Lee, Pei-Wen] HungKuang Univ, Inst Biomed Nutr, Taichung, Taiwan; [Shaio, Men-Fang] Natl Yang Ming Univ, Dept Trop Med, Taipei 112, Taiwan	Universidade de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Hungkuang University; National Yang Ming Chiao Tung University	Goncalves, L (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, CEAUL, P-1200 Lisbon, Portugal.	luziag@ihmt.unl.pt	Oliveira, M. Rosário/G-9130-2014; Gonçalves, Luzia/J-6649-2012; Subtil, Ana/G-7470-2019	Oliveira, M. Rosário/0000-0002-5234-3713; Gonçalves, Luzia/0000-0002-9710-1945; Oliveira Martins, Maria do Rosario/0000-0002-7941-0285; Subtil, Ana/0000-0002-1079-9624	STP malaria control programme; International Cooperation and Development Fund of Taiwan; RIDES/Malaria CPLP; Fundacao Nacional para a Ciencia e Tecnologia (FCT), Portugal [PTDC/SAU-ESA/81240/2006, PEst-OE/MAT/UI0006/2011]; FCT [SFRH/BD/69793/2010]	STP malaria control programme; International Cooperation and Development Fund of Taiwan; RIDES/Malaria CPLP; Fundacao Nacional para a Ciencia e Tecnologia (FCT), Portugal; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by STP malaria control programme financed by the International Cooperation and Development Fund of Taiwan and RIDES/Malaria CPLP. Statistical research was partially sponsored by national funds through the Fundacao Nacional para a Ciencia e Tecnologia (FCT), Portugal, under the projects PTDC/SAU-ESA/81240/2006 and PEst-OE/MAT/UI0006/2011. A. Subtil has an FCT PhD grant SFRH/BD/69793/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2004, BIOMETRICS, V60, P427, DOI 10.1111/j.0006-341X.2004.00187.x; Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Altman DG., 2000, STAT CONFIDENCE CONF; Batwala V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-349; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Bendezu J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-154; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Bernatsky S, 2005, STAT MED, V24, P2365, DOI 10.1002/sim.2116; Bronsvoort B, 2006, BMC VET RES, P2; Brown LD, 2002, ANN STAT, V30, P160; Canavate C, 2011, AM J TROP MED HYG, V84, P102, DOI 10.4269/ajtmh.2011.10-0229; Celeux G, 2000, J AM STAT ASSOC, V95, P957, DOI 10.2307/2669477; Chinkhumba J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-209; Cho SJ, 2010, J EDUC BEHAV STAT, V35, P336, DOI 10.3102/1076998609353111; Christensen R, 1997, LOG LINEAR MODELS LO; Coleman RE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-121; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; Dayton C.Mitchell., 2002, APPL LATENT CLASS AN, P213, DOI DOI 10.1017/CBO9780511499531.009; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Dendukuri N, 2009, STAT MED, V28, P441, DOI 10.1002/sim.3470; Dias JG, 2006, STUD CLASS DATA ANAL, P91, DOI 10.1007/3-540-34416-0_11; Dohoo IR, 2008, PREV VET MED, V86, P260, DOI 10.1016/j.prevetmed.2008.02.012; Drewe JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011196; ESPELAND MA, 1989, BIOMETRICS, V45, P587, DOI 10.2307/2531499; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Formann AK, 2003, BIOMETRICS, V59, P189, DOI 10.1111/1541-0420.00023; Gardner IA, 2010, ZOONOSES PUBLIC HLTH, V57, P82, DOI 10.1111/j.1863-2378.2009.01281.x; Garrett ES, 2000, BIOMETRICS, V56, P1055, DOI 10.1111/j.0006-341X.2000.01055.x; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Ghosh J, 2011, BIOMETRICS, V67, P917, DOI 10.1111/j.1541-0420.2010.01502.x; Gustafson P, 2005, STAT SCI, V20, P111, DOI 10.1214/088342305000000098; Gustafson P, 2009, J AM STAT ASSOC, V104, P1682, DOI 10.1198/jasa.2009.tm08603; Hadgu A, 1998, J R STAT SOC C-APPL, V47, P603, DOI 10.1111/1467-9876.00131; HAGENAARS JA, 1988, SOCIOL METHOD RES, V16, P379, DOI 10.1177/0049124188016003002; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; Jones G, 2010, BIOMETRICS, V66, P855, DOI 10.1111/j.1541-0420.2009.01330.x; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-264; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Machado C, 2009, J APPL STAT, V36, P871, DOI 10.1080/02664760802520769; Martinez EZ, 2008, CANCER INFORM, V6, P33; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Mendes JM, 2007, ENVIRONMETRICS, V18, P27, DOI 10.1002/env.800; Mens P, 2007, TROP MED INT HEALTH, V12, P238, DOI 10.1111/j.1365-3165.2006.01779.x; Menten J, 2008, STAT MED, V27, P4469, DOI 10.1002/sim.3317; Moonasar D, 2009, SAMJ S AFR MED J, V99, P810; Neelon B, 2011, BIOMETRICS, V67, P280, DOI 10.1111/j.1541-0420.2010.01439.x; Nerette P, 2008, PREV VET MED, V85, P207, DOI 10.1016/j.prevetmed.2008.01.011; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ngasala B, 2010, THESIS KAROLINSKA I; Nielsen LR, 2004, J VET DIAGN INVEST, V16, P212, DOI 10.1177/104063870401600306; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Pinto J, 2000, ACTA TROP, V76, P185, DOI 10.1016/S0001-706X(00)00100-5; Pires AM, 2008, REVSTAT-STAT J, V6, P165; Portero JL, 2010, MALARIA RES TREATMEN; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Sepulveda R, 2008, STAT MED, V27, P1855, DOI 10.1002/sim.3194; Sergeant E.S.G., 2018, EPITOOLS EPIDEMIOLOG; Singh N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-191; Smith BJ, 2007, J STAT SOFTW, V21, P1; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Sperrin M, 2010, STAT COMPUT, V20, P357, DOI 10.1007/s11222-009-9129-8; Speybroeck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016705; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stauffer WM, 2009, CLIN INFECT DIS, V49, P908, DOI 10.1086/605436; Stephens M, 2000, ANN STAT, V28, P40, DOI 10.1214/aos/1016120364; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; Subtil A, 2012, STAT PROBABIL LETT, V82, P1407, DOI 10.1016/j.spl.2012.03.030; Team. RDC, 2007, R LANG ENV STAT COMP; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Toft N, 2007, PREV VET MED, V79, P244, DOI 10.1016/j.prevetmed.2007.01.003; UNICEF, 2007, INERT1989 ROC; Weber MF, 2009, PREV VET MED, V92, P256, DOI 10.1016/j.prevetmed.2009.08.017; WHO, 2010, INERT1989 ROC; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	79	30	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40633	10.1371/journal.pone.0040633	http://dx.doi.org/10.1371/journal.pone.0040633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844405	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700014
J	Mattiazzi, M; Sun, YD; Wolinski, H; Bavdek, A; Petan, T; Anderluh, G; Kohlwein, SD; Drubin, DG; Krizaj, I; Petrovic, U				Mattiazzi, Mojca; Sun, Yidi; Wolinski, Heimo; Bavdek, Andrej; Petan, Toni; Anderluh, Gregor; Kohlwein, Sepp D.; Drubin, David G.; Krizaj, Igor; Petrovic, Uros			A Neurotoxic Phospholipase A(2) Impairs Yeast Amphiphysin Activity and Reduces Endocytosis	PLOS ONE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; BAR DOMAIN PROTEINS; SACCHAROMYCES-CEREVISIAE; BETA-BUNGAROTOXIN; CLATHRIN; ACTIN; DYNAMIN; AMMODYTOXIN; 14-3-3-PROTEINS; BINDING	Background: Presynaptically neurotoxic phospholipases A(2) inhibit synaptic vesicle recycling through endocytosis. Principal Findings: Here we provide insight into the action of a presynaptically neurotoxic phospholipase A(2) ammodytoxin A (AtxA) on clathrin-dependent endocytosis in budding yeast. AtxA caused changes in the dynamics of vesicle formation and scission from the plasma membrane in a phospholipase activity dependent manner. Our data, based on synthetic dosage lethality screen and the analysis of the dynamics of sites of endocytosis, indicate that AtxA impairs the activity of amphiphysin. Conclusions: We identified amphiphysin and endocytosis as the target of AtxA intracellular activity. We propose that AtxA reduces endocytosis following a mechanism of action which includes both a specific protein-protein interaction and enzymatic activity, and which is applicable to yeast and mammalian cells. Knowing how neurotoxic phospholipases A(2) work can open new ways to regulate endocytosis.	[Mattiazzi, Mojca; Petan, Toni; Krizaj, Igor; Petrovic, Uros] Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia; [Sun, Yidi; Drubin, David G.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wolinski, Heimo; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, Graz, Austria; [Bavdek, Andrej; Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of California System; University of California Berkeley; University of Graz; University of Ljubljana	Mattiazzi, M (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.	uros.petrovic@ijs.si	Anderluh, Gregor/C-6905-2014; Petan, Toni/AAN-4453-2020; Petan, Toni/ABA-2506-2021	Anderluh, Gregor/0000-0002-9916-8465; Petan, Toni/0000-0003-1223-2397; Mattiazzi Usaj, Mojca/0000-0002-7389-8478; Wolinski, Heimo/0000-0002-1583-6092; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Sun, Yidi/0000-0002-2157-1983; Petrovic, Uros/0000-0002-9743-9145	Slovenian Research Agency [P1-0207, Z1-4468, J1-6507]; Osterreichische Akademische Austauschdienst OAW [Sl13/2009]; Austrian Science Funds, FWF (Project LIPOTOX); Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Osterreichische Akademische Austauschdienst OAW; Austrian Science Funds, FWF (Project LIPOTOX); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been funded by grants P1-0207, Z1-4468, and J1-6507 from the Slovenian Research Agency to UP, IK, GA, and MM, the Osterreichische Akademische Austauschdienst OAW (project WTZ Slovenia Sl13/2009) to UP and SDK, and the Austrian Science Funds, FWF (Project LIPOTOX) to SDK and HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2004, ANAL BIOCHEM, V328, P233, DOI 10.1016/j.ab.2004.01.018; ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; Anderluh G, 2005, ANAL BIOCHEM, V344, P43, DOI 10.1016/j.ab.2005.06.013; Augustine GJ, 2006, BIOCHEM SOC T, V34, P68, DOI 10.1042/BST0340068; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bayburt T, 1997, BIOCHEMISTRY-US, V36, P3216, DOI 10.1021/bi961659d; Bazaa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010124; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Conibear E, 2010, CURR OPIN CELL BIOL, V22, P513, DOI 10.1016/j.ceb.2010.05.009; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DAVID C, 1994, FEBS LETT, V351, P73, DOI 10.1016/0014-5793(94)00826-4; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Delom F, 2006, PROTEOMICS, V6, P3029, DOI 10.1002/pmic.200500762; Dixon RW, 1999, AM J PATHOL, V154, P447, DOI 10.1016/S0002-9440(10)65291-1; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grandbois M, 1998, BIOPHYS J, V74, P2398, DOI 10.1016/S0006-3495(98)77948-2; Harris JB, 2000, EXP NEUROL, V161, P517, DOI 10.1006/exnr.1999.7275; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kini RM, 1997, VENOM PHOSPHOLIPASE, pxii; KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; LEE CY, 1984, ARCH INT PHARMACOD T, V268, P313; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Logonder U, 2009, EXP NEUROL, V219, P591, DOI 10.1016/j.expneurol.2009.07.017; Logonder U, 2008, J NEUROPATH EXP NEUR, V67, P1011, DOI 10.1097/NEN.0b013e318188c2d7; Lombardi R, 2001, J BIOL CHEM, V276, P6016, DOI 10.1074/jbc.M008735200; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Mattiazzi M, 2010, MOL GENET GENOMICS, V283, P519, DOI 10.1007/s00438-010-0533-8; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Montecucco C, 2000, TRENDS BIOCHEM SCI, V25, P266, DOI 10.1016/S0968-0004(00)01556-5; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; Neco P, 2003, J NEUROCHEM, V85, P329, DOI 10.1046/j.1471-4159.2003.01682.x; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Petan T, 2005, BIOCHEMISTRY-US, V44, P12535, DOI 10.1021/bi051024r; Petan T, 2007, BIOCHEMISTRY-US, V46, P12795, DOI 10.1021/bi701304e; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Petrovic U, 2005, BIOCHEM J, V391, P383, DOI 10.1042/BJ20050417; Petrovic U, 2004, BIOCHEM BIOPH RES CO, V324, P981, DOI 10.1016/j.bbrc.2004.09.144; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Prasarnpun S, 2004, NEUROPHARMACOLOGY, V47, P304, DOI 10.1016/j.neuropharm.2004.04.012; Praznikar ZJ, 2008, BBA-MOL CELL RES, V1783, P1129, DOI 10.1016/j.bbamcr.2008.01.011; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Pungercar J, 2011, ACTA CHIM SLOV, V58, P660; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Sribar J, 2005, BIOCHEM BIOPH RES CO, V329, P733, DOI 10.1016/j.bbrc.2005.02.036; Sribar J, 2003, FEBS LETT, V553, P309, DOI 10.1016/S0014-5793(03)01035-4; Sribar J, 2003, BIOCHEM BIOPH RES CO, V302, P691, DOI 10.1016/S0006-291X(03)00228-6; Sribar J, 2001, J BIOL CHEM, V276, P12493, DOI 10.1074/jbc.C100048200; Tabor S., 2001, CURR PROTOC MOL BIOL; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; VANHEUSDEN GPH, 1992, FEBS LETT, V302, P145, DOI 10.1016/0014-5793(92)80426-H; WALTSCHEWA L, 1991, YEAST, V7, P211, DOI 10.1002/yea.320070303; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; WILSCHUT JC, 1978, BIOCHIM BIOPHYS ACTA, V508, P185, DOI 10.1016/0005-2736(78)90324-3; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	85	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40931	10.1371/journal.pone.0040931	http://dx.doi.org/10.1371/journal.pone.0040931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844417	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700024
J	Reifenberg, K; Cheng, F; Orning, C; Crain, J; Kupper, I; Wiese, E; Protschka, M; Blessing, M; Lackner, KJ; Torzewski, M				Reifenberg, Kurt; Cheng, Fei; Orning, Carolin; Crain, Jeanine; Kuepper, Ines; Wiese, Elena; Protschka, Martina; Blessing, Manfred; Lackner, Karl J.; Torzewski, Michael			Overexpression of TGF-beta 1 in Macrophages Reduces and Stabilizes Atherosclerotic Plaques in ApoE-Deficient Mice	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; LATENT TGF-BETA; E KNOCKOUT MICE; T-CELLS; ACCELERATES ATHEROSCLEROSIS; RECEPTOR EXPRESSION; LESION DEVELOPMENT; GENE-EXPRESSION; IMAGE-ANALYSIS	Although macrophages represent the hallmark of both human and murine atherosclerotic lesions and have been shown to express TGF-beta 1 (transforming growth factor beta 1) and its receptors, it has so far not been experimentally addressed whether the pleiotropic cytokine TGF-beta 1 may influence atherogenesis by a macrophage specific mechanism. We developed transgenic mice with macrophage specific TGF-beta 1 overexpression, crossed the transgenics to the atherosclerotic ApoE (apolipoprotein E) knock-out strain and quantitatively analyzed both atherosclerotic lesion development and composition of the resulting double mutants. Compared with control ApoE(-/-) mice, animals with macrophage specific TGF-beta 1 overexpression developed significantly less atherosclerosis after 24 weeks on the WTD (Western type diet) as indicated by aortic plaque area en face (p<0.05). Reduced atherosclerotic lesion development was associated with significantly less macrophages (p<0.05 after both 8 and 24 weeks on the WTD), significantly more smooth muscle cells (SMCs; p<0.01 after 24 weeks on the WTD), significantly more collagen (p<0.01 and p<0.05 after 16 and 24 weeks on the WTD, respectively) without significant differences of inner aortic arch intima thickness or the number of total macrophages in the mice pointing to a plaque stabilizing effect of macrophage-specific TGF-beta 1 overexpression. Our data shows that macrophage specific TGF-beta 1 overexpression reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice.	[Reifenberg, Kurt; Crain, Jeanine; Kuepper, Ines; Wiese, Elena] Johannes Gutenberg Univ Mainz, Cent Lab Anim Facil, Univ Med Ctr, Mainz, Germany; [Cheng, Fei; Orning, Carolin; Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Inst Clin Chem & Lab Med, Univ Med Ctr, Mainz, Germany; [Protschka, Martina; Blessing, Manfred] Univ Leipzig, Ctr Biotechnol & Biomed, Fac Vet, Leipzig, Germany; [Torzewski, Michael] Robert Bosch Krankenhaus, Dept Lab Med, Stuttgart, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Leipzig University; Bosch; Robert Bosch Krankenhaus	Reifenberg, K (corresponding author), Johannes Gutenberg Univ Mainz, Cent Lab Anim Facil, Univ Med Ctr, Mainz, Germany.	michael.torzewski@rbk.de			Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine	Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine	The project was supported by the Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bobik A, 1999, CIRCULATION, V99, P2883, DOI 10.1161/01.CIR.99.22.2883; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Bot PT, 2011, ATHEROSCLEROSIS, V218, P33, DOI 10.1016/j.atherosclerosis.2011.05.017; BRAND T, 1993, J BIOL CHEM, V268, P11500; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; Frutkin AD, 2009, ARTERIOSCL THROM VAS, V29, P1251, DOI 10.1161/ATVBAHA.109.186593; FYFE AI, 1994, J CLIN INVEST, V94, P2516, DOI 10.1172/JCI117622; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Gojova A, 2003, BLOOD, V102, P4052, DOI 10.1182/blood-2003-05-1729; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; Gratchev A, 2008, J IMMUNOL, V180, P6553, DOI 10.4049/jimmunol.180.10.6553; HANSSON J, 1989, J BIOL CHEM, V264, P21788; HORVAI A, 1995, P NATL ACAD SCI USA, V92, P5391, DOI 10.1073/pnas.92.12.5391; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Lehr HA, 2001, CIRCULATION, V104, P914, DOI 10.1161/hc3401.093153; Li DY, 2006, BIOCHEM BIOPH RES CO, V344, P701, DOI 10.1016/j.bbrc.2006.04.010; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Maeda N, 2011, ARTERIOSCL THROM VAS, V31, P1957, DOI 10.1161/ATVBAHA.110.220574; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McCaffrey TA, 2000, CYTOKINE GROWTH F R, V11, P103, DOI 10.1016/S1359-6101(99)00034-9; MCCARTNEYFRANCIS NL, 1994, J LEUKOCYTE BIOL, V55, P401, DOI 10.1002/jlb.55.3.401; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; NUNES I, 1995, J IMMUNOL, V155, P1450; OWENS GK, 1988, J CELL BIOL, V107, P771, DOI 10.1083/jcb.107.2.771; Petkov PM, 2004, GENOMICS, V83, P902, DOI 10.1016/j.ygeno.2003.11.007; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84; SHARPLES K, 1987, DNA-J MOLEC CELL BIO, V6, P239, DOI 10.1089/dna.1987.6.239; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Song L, 2001, J CLIN INVEST, V108, P251, DOI 10.1172/JCI11380; Tashiro H, 2002, CORONARY ARTERY DIS, V13, P139, DOI 10.1097/00019501-200205000-00001; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Wilson K, 2001, ARTERIOSCL THROM VAS, V21, P1809, DOI 10.1161/hq1101.097805; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2005, CIRC RES, V96, P427, DOI 10.1161/01.RES.0000156889.22364.f1	48	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40990	10.1371/journal.pone.0040990	http://dx.doi.org/10.1371/journal.pone.0040990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829904	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300042
J	Flynn, R; Labrie-Dion, E; Bernier, N; Colicos, MA; De Koninck, P; Zamponi, GW				Flynn, Robyn; Labrie-Dion, Etienne; Bernier, Nikolas; Colicos, Michael A.; De Koninck, Paul; Zamponi, Gerald W.			Activity-Dependent Subcellular Cotrafficking of the Small GTPase Rem2 and Ca2+/CaM-Dependent Protein Kinase II alpha	PLOS ONE			English	Article							CALCIUM-CHANNEL ACTIVITY; SYNAPTIC STRENGTH; BINDING PROTEINS; CAMKII; GEM; RAD; CALMODULIN; CYTOSKELETON; FAMILY; BRAIN	Background: Rem2 is a small monomeric GTP-binding protein of the RGK family, whose known functions are modulation of calcium channel currents and alterations of cytoskeletal architecture. Rem2 is the only RGK protein found predominantly in the brain, where it has been linked to synaptic development. We wished to determine the effect of neuronal activity on the subcellular distribution of Rem2 and its interacting partners. Results: We show that Rem2 undergoes activity-and N-Methyl-D-Aspartate Receptor (NMDAR)-dependent translocation in rat hippocampal neurons. This redistribution of Rem2, from a diffuse pattern to one that is highly punctate, is dependent on Ca2+ influx, on binding to calmodulin (CaM), and also involves an auto-inhibitory domain within the Rem2 distal C-terminus region. We found that Rem2 can bind to Ca2+/CaM-dependent protein kinase II alpha (CaMKII) a in Ca2+/CaM-dependent manner. Furthermore, our data reveal a spatial and temporal correlation between NMDAR-dependent clustering of Rem2 and CaMKII in neurons, indicating co-assembly and co-trafficking in neurons. Finally, we show that inhibiting CaMKII aggregation in neurons and HEK cells reduces Rem2 clustering, and that Rem2 affects the baseline distribution of CaMKII in HEK cells. Conclusions: Our data suggest a novel function for Rem2 in co-trafficking with CaMKII, and thus potentially expose a role in neuronal plasticity.	[Flynn, Robyn; Colicos, Michael A.; Zamponi, Gerald W.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Labrie-Dion, Etienne; Bernier, Nikolas; De Koninck, Paul] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [De Koninck, Paul] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	University of Calgary; Laval University; Laval University	Flynn, R (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	zamponi@ucalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported by operating grants to GWZ, MAC, and PDK from the Canadian Institutes of Health Research (CIHR), and funding from the Heart and Stroke Foundation of Alberta, the Northwest Territories and Nunavut. RF held a studentship award from the Alberta Heritage Foundation for Medical Research (AHFMR). MAC is an AHFMR Scholar, GWZ is and AHFMR Scientist and a Canada Research Chair, and PDK was a CIHR career awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresta S, 2002, BIOCHEM J, V367, P57, DOI 10.1042/BJ20020829; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Bilan PJ, 1998, EXP CELL RES, V242, P391, DOI 10.1006/excr.1998.4092; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Crump SM, 2006, AM J PHYSIOL-HEART C, V291, pH1959, DOI 10.1152/ajpheart.00956.2005; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fan M, 2010, P NATL ACAD SCI US; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; Goda Y, 2006, NAT PROTOC, V1, P461, DOI 10.1038/nprot.2006.67; Gutierrez RC, 2009, EUR J NEUROSCI, V30, P2042, DOI 10.1111/j.1460-9568.2009.07007.x; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Jourdain P, 2003, J NEUROSCI, V23, P10645; Leone A, 2001, ONCOGENE, V20, P3217, DOI 10.1038/sj.onc.1204420; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Moyers JS, 1997, J BIOL CHEM, V272, P11832, DOI 10.1074/jbc.272.18.11832; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Pan JY, 2000, J CELL BIOL, V149, P1107, DOI 10.1083/jcb.149.5.1107; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Piddini E, 2001, EMBO J, V20, P4076, DOI 10.1093/emboj/20.15.4076; Sanabria H, 2009, J BIOL CHEM, V284, P9770, DOI 10.1074/jbc.M809518200; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41185	10.1371/journal.pone.0041185	http://dx.doi.org/10.1371/journal.pone.0041185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815963	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900092
J	Goncalves, RLS; Oliveira, JHM; Oliveira, GA; Andersen, JF; Oliveira, MF; Oliveira, PL; Barillas-Mury, C				Goncalves, Renata L. S.; Oliveira, Jose Henrique M.; Oliveira, Giselle A.; Andersen, John F.; Oliveira, Marcus F.; Oliveira, Pedro L.; Barillas-Mury, Carolina			Mitochondrial Reactive Oxygen Species Modulate Mosquito Susceptibility to Plasmodium Infection	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; ANOPHELES-GAMBIAE; UNCOUPLING PROTEIN-2; HYDROGEN-PEROXIDE; IMMUNE-RESPONSES; MIDGUT CELLS; KAPPA-B; OXIDASE; CARRIER; BERGHEI	Background: Mitochondria perform multiple roles in cell biology, acting as the site of aerobic energy-transducing pathways and as an important source of reactive oxygen species (ROS) that modulate redox metabolism. Methodology/Principal Findings: We demonstrate that a novel member of the mitochondrial transporter protein family, Anopheles gambiae mitochondrial carrier 1 (AgMC1), is required to maintain mitochondrial membrane potential in mosquito midgut cells and modulates epithelial responses to Plasmodium infection. AgMC1 silencing reduces mitochondrial membrane potential, resulting in increased proton-leak and uncoupling of oxidative phosphorylation. These metabolic changes reduce midgut ROS generation and increase A. gambiae susceptibility to Plasmodium infection. Conclusion: We provide direct experimental evidence indicating that ROS derived from mitochondria can modulate mosquito epithelial responses to Plasmodium infection.	[Goncalves, Renata L. S.; Oliveira, Jose Henrique M.; Oliveira, Giselle A.; Andersen, John F.; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Goncalves, Renata L. S.; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Resposta Estresse, Rio De Janeiro, Brazil; [Oliveira, Jose Henrique M.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Artropodes Hematofagos, Rio De Janeiro, Brazil; [Goncalves, Renata L. S.; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Inflamacao & Metab, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Goncalves, RLS (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	cbarillas@niaid.nih.gov	Oliveira, Marcus/G-3158-2011; L. Oliveira, Pedro/A-9438-2010	Oliveira, Marcus/0000-0002-9890-8425; L. Oliveira, Pedro/0000-0003-0307-354X; Oliveira, Giselle/0000-0002-5898-7843; Oliveira, Jose Henrique M./0000-0003-3814-5312	National Institutes of Health, United States of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000947] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the intramural program of the National Institutes of Health, United States of America, there are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2011, FREE RADICAL BIO MED, V50, P609, DOI 10.1016/j.freeradbiomed.2010.12.020; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; CHANCE B, 1955, J BIOL CHEM, V217, P409; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Ishida I, 2002, J IMMUNOL, V169, P2069, DOI 10.4049/jimmunol.169.4.2069; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Jaramillo-Gutierrez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011168; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Oliveira JHM, 2011, INSECT BIOCHEM MOLEC, V41, P349, DOI 10.1016/j.ibmb.2011.02.001; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yu XX, 2001, BIOCHEM J, V353, P369, DOI 10.1042/bj3530369; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	47	24	26	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41083	10.1371/journal.pone.0041083	http://dx.doi.org/10.1371/journal.pone.0041083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815925	Green Submitted, gold, Green Published			2022-12-25	WOS:000306548900074
J	Bagci-Onder, T; Agarwal, A; Flusberg, D; Wanningen, S; Sorger, P; Shah, K				Bagci-Onder, T.; Agarwal, A.; Flusberg, D.; Wanningen, S.; Sorger, P.; Shah, K.			Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors	ONCOGENE			English	Article						live-cell imaging; DR4/5; TRAIL; GBM; neural stem cell; dual luciferase imaging	PHASE-II TRIAL; CANCER-CELLS; INDUCED APOPTOSIS; UP-REGULATION; DOWN-REGULATION; STEM-CELLS; DR5; EXPRESSION; GLIOMA; INHIBITION	Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induces apoptosis specifically in tumor cells and its efficacy has been tested in pre-clinical models by delivering it systemically as a purified ligand or via engineered stem cells (SC). However, about 50% of tumor lines are resistant to TRAIL and overcoming TRAIL resistance in aggressive tumors, such as glioblastoma-multiforme (GBM), and understanding the molecular dynamics of TRAIL-based combination therapies are critical to broadly use TRAIL as a therapeutic agent. In this study, we developed death receptor (DR)4/5-reporters that offer an imaging-based platform to identify agents that act in concert with a potent, secretable variant of TRAIL (S-TRAIL) by monitoring changes in DR4/5 expression. Utilizing these reporters, we show a differential regulation of DR4/5 when exposed to a panel of clinically relevant agents. A histone deacetylase inhibitor, MS-275, resulted in upregulation of DR4/5 in all GBM cell lines, and these changes could be followed in real time both in vitro and in vivo in mice bearing tumors and they correlated with increased TRAIL sensitivity. To further assess the dynamics of combinatorial strategies that overcome resistance of tumors to SC released S-TRAIL, we also engineered tumor cells to express live-cell caspase-reporters and SCs to express S-TRAIL. Utilizing DR4/5 and caspase reporters in parallel, we show that MS-275 sensitizes TRAIL-resistant GBM cells to stem cell (SC) delivered S-TRAIL by changing the time-to-death in vitro and in vivo. This study demonstrates the effectiveness of a combination of real-time reporters of TRAIL-induced apoptosis pathway in evaluating the efficacy of SC-TRAIL-based therapeutics and may have implications in targeting a broad range of cancers.	[Bagci-Onder, T.; Agarwal, A.; Wanningen, S.; Shah, K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA; [Bagci-Onder, T.; Agarwal, A.; Wanningen, S.; Shah, K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA 02114 USA; [Flusberg, D.; Sorger, P.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02114 USA; [Shah, K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA; [Shah, K.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Shah, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA.	kshah@mgh.harvard.edu	Onder, Tugba Bagci/AAN-1392-2021	Bagci Onder, Tugba/0000-0003-3646-2613; Sorger, Peter/0000-0002-3364-1838; Flusberg, Deborah/0000-0001-9506-6990	American Cancer Society; NIH [CA138922, NS071197, CA139980]; James McDonnell Foundation; NATIONAL CANCER INSTITUTE [P01CA139980, R01CA138922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071197] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James McDonnell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Shi-Yon Sun for providing pDR4 and pDR5 basic constructs; real-time PCR core facility of Neuroscience Department, Massachusetts General Hospital; flow cytometry core facility of Ragon Institute, Massachusetts General Hospital; and Nikon Imaging Center, Harvard Medical School for technical help and equipments. This work was supported by American Cancer Society (KS), NIH grants CA138922, NS071197 (KS), CA139980 (PKS) and the James McDonnell Foundation (KS). There are no competing financial interests to disclose.	Aguilera DG, 2009, J NEURO-ONCOL, V93, P303, DOI 10.1007/s11060-008-9788-x; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Baritaki S, 2007, MOL CANCER THER, V6, P1387, DOI 10.1158/1535-7163.MCT-06-0521; Booth NL, 2009, CANCER IMMUNOL IMMUN, V58, P1229, DOI 10.1007/s00262-008-0637-8; Crosswell HE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-411; Dhandapani L, 2011, CANCER RES, V71, P5245, DOI 10.1158/0008-5472.CAN-10-4180; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Finlay D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013375; Hingtgen S, 2008, MOL CANCER THER, V7, P3575, DOI 10.1158/1535-7163.MCT-08-0640; Hingtgen SD, 2010, STEM CELLS, V28, P832, DOI 10.1002/stem.313; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Kim MO, 2010, MOL CANCER THER, V9, P833, DOI 10.1158/1535-7163.MCT-09-0610; Kock N, 2007, NEOPLASIA, V9, P435, DOI 10.1593/neo.07223; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Nagane M, 2010, NEURO-ONCOLOGY, V12, P687, DOI 10.1093/neuonc/nop069; Nagar S, 2010, ADV EXP MED BIOL, V678, P124; Nakata S, 2004, ONCOGENE, V23, P6261, DOI 10.1038/sj.onc.1207830; Neyns B, 2009, ANN ONCOL, V20, P1596, DOI 10.1093/annonc/mdp032; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Prasad S, 2010, MOL CANCER THER, V9, P856, DOI 10.1158/1535-7163.MCT-09-1113; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Raizer JJ, 2010, NEURO-ONCOLOGY, V12, P95, DOI 10.1093/neuonc/nop015; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Song JH, 2008, J BIOL CHEM, V283, P25003, DOI 10.1074/jbc.M802511200; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693	39	34	35	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2013	32	23					2818	2827		10.1038/onc.2012.304	http://dx.doi.org/10.1038/onc.2012.304			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	22824792	Green Accepted			2022-12-25	WOS:000320369100002
J	Rubio, SE; Vega-Flores, G; Martinez, A; Bosch, C; Perez-Mediavilla, A; del Rio, J; Gruart, A; Delgado-Garcia, JM; Soriano, E; Pascual, M				Rubio, Sara E.; Vega-Flores, German; Martinez, Albert; Bosch, Carles; Perez-Mediavilla, Alberto; del Rio, Joaquin; Gruart, Agnes; Maria Delgado-Garcia, Jose; Soriano, Eduardo; Pascual, Marta			Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						&theta rhythm; J20 mice; medial septum	AMYLOID-BETA PATHOLOGY; THETA OSCILLATIONS; CONTAINING NEURONS; GABA(A) RECEPTORS; BASAL FOREBRAIN; DENTATE GYRUS; INTERNEURONS; CALRETININ; MICE; PERFORMANCE	Patients with Alzheimer's disease (AD) display altered functioning of cortical networks, including altered patterns of synchronous activity and a serious deficit in cholinergic septohippocampal (SH) innervation. However, the mechanisms underlying these alterations and the implication of the GABAergic SH component in AD are largely unknown. In addition, the GABAergic septohippocampal pathway (SHP) is believed to regulate synchronous hippocampal activity by controlling the activity of interneurons. Here we show, using well-characterized pathway tracing experiments, that innervation of the GABAergic SHP decreases during normal aging. Furthermore, in an AD mouse model (hAPP(Sw,Ind); J20 mice), the GABAergic SHP shows a dramatic and early onset of this decrease in 8-mo-old mice. This decline is not caused by neuronal loss, but by the reduced number and complexity of GABAergic SH axon terminals. Finally, we demonstrate that hippocampal theta and gamma rhythm power spectra are markedly diminished in 8-mo-old behaving mice expressing mutated hAPP. In addition to the well-known loss of cholinergic input to the hippocampus in AD, these data suggest that the altered patterns of synchronous activity seen in patients with AD could be caused by the loss of GABAergic SH axons, which modulate hippocampal network activities.-Rubio, S. E., Vega-Flores, G., Martinez, A., Bosch, C., Perez-Mediavilla, A., del Rio, J., Gruart, A., Delgado-Garcia, J. M., Soriano, E., Pascual, M. Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer's disease. FASEB J. 26, 4458-4467 (2012). www.fasebj.org	[Rubio, Sara E.; Martinez, Albert; Bosch, Carles; Soriano, Eduardo; Pascual, Marta] Inst Res Biomed, Dev Neurobiol & Regenerat Lab, E-08028 Barcelona, Spain; [Rubio, Sara E.; Martinez, Albert; Bosch, Carles; Soriano, Eduardo; Pascual, Marta] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Rubio, Sara E.; Martinez, Albert; Bosch, Carles; Perez-Mediavilla, Alberto; del Rio, Joaquin; Soriano, Eduardo; Pascual, Marta] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Vega-Flores, German; Gruart, Agnes; Maria Delgado-Garcia, Jose] Pablo Olavide Univ, Div Neurosci, Seville, Spain; [Perez-Mediavilla, Alberto; del Rio, Joaquin] Univ Navarra, Ctr Invest Med Aplicada, Div Neurosci, E-31080 Pamplona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBERNED; Universidad Pablo de Olavide; University of Navarra	Pascual, M (corresponding author), Inst Res Biomed, Dev Neurobiol & Regenerat Lab, Baldiri & Reixac 10, E-08028 Barcelona, Spain.	marta.pascual@irbbarcelona.org	Delgado-Garcia, Jose M./V-1567-2019; Vega-Flores, German/AAD-2013-2022; Pascual, Marta/Q-8103-2018; Perez-Mediavilla, Alberto/A-5246-2011; Soriano, Eduardo/AAB-3216-2019; Bosch, Carles/D-7899-2016; Pascual Sánchez, Marta/V-3144-2017	Vega-Flores, German/0000-0001-5605-4567; Pascual, Marta/0000-0002-2621-650X; Perez-Mediavilla, Alberto/0000-0003-1926-0972; Soriano, Eduardo/0000-0002-3204-9285; Bosch, Carles/0000-0003-4179-0451; Pascual Sánchez, Marta/0000-0002-2621-650X; Vega Flores, German/0000-0002-1279-1925; Martinez, Albert/0000-0003-0831-9916; Rubio, Sara E./0000-0002-9719-9719	Ministry of Science and Innovation of Spain [SAF2008-02342, BFU2008-03390, BFU2008-00899]; Union Temporal de Empresas (UTE) project Foundation for Applied Medical Research (FIMA), Spain; Caixa Catalunya-Obra Social Foundation; Ministry of Science and Innovation [BFU2008-3980]; Fondo de Investigaciones Sanitarias, Ministry of Science and Innovation [PI08/1891, PI11/00704]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Union Temporal de Empresas (UTE) project Foundation for Applied Medical Research (FIMA), Spain; Caixa Catalunya-Obra Social Foundation; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias, Ministry of Science and Innovation	The authors thank Natalia Ruiz and Dr. Raudel Sanchez-Campusano for excellent technical support, Tanya Yates for editorial assistance, and the personnel of Advanced Digital Microscopy and Biostatistics and Bioinformatics Facilities at the Institute for Research in Biomedicine for support. This work was supported by the Ministry of Science and Innovation of Spain (SAF2008-02342 to A. P. M., BFU2008-03390 to A. G., and BFU2008-00899 to J. M. D.-G); the Union Temporal de Empresas (UTE) project Foundation for Applied Medical Research (FIMA), Spain (to A. P. M.); the Caixa Catalunya-Obra Social Foundation and the Ministry of Science and Innovation (BFU2008-3980 to E. S.); and Fondo de Investigaciones Sanitarias, Ministry of Science and Innovation (PI08/1891 and PI11/00704 to M. P.).	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Hangya B, 2009, J NEUROSCI, V29, P8094, DOI 10.1523/JNEUROSCI.5665-08.2009; Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; Bayer T. A., 2010, INT J ALZHEIMERS DIS, V2010; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; FISCHER W, 1989, EUR J NEUROSCI, V1, P34, DOI 10.1111/j.1460-9568.1989.tb00772.x; Freund TF, 1997, CAN J PHYSIOL PHARM, V75, P479, DOI 10.1139/y97-033; FREUND TF, 1989, BRAIN RES, V478, P375, DOI 10.1016/0006-8993(89)91520-5; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; GAGE FH, 1984, NEUROBIOL AGING, V5, P43, DOI 10.1016/0197-4580(84)90084-8; GALLAGHER M, 1995, CURR OPIN NEUROBIOL, V5, P161, DOI 10.1016/0959-4388(95)80022-0; GAZTELU JM, 1982, ELECTROEN CLIN NEURO, V54, P375, DOI 10.1016/0013-4694(82)90201-2; Geula C, 2008, J NEUROPATH EXP NEUR, V67, P309, DOI 10.1097/NEN.0b013e31816a1df3; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gulyas AI, 1996, J NEUROSCI, V16, P3397; GULYAS AI, 1990, NEUROSCIENCE, V37, P31, DOI 10.1016/0306-4522(90)90189-B; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Iachini Ina, 2009, Curr Aging Sci, V2, P43; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Lecourtier L, 2011, HIPPOCAMPUS, V21, P1277, DOI 10.1002/hipo.20837; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Matyas F, 2004, HIPPOCAMPUS, V14, P460, DOI 10.1002/hipo.10191; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mufson EJ, 2003, J CHEM NEUROANAT, V26, P233, DOI 10.1016/S0891-0618(03)00068-1; Muir JL, 1997, PHARMACOL BIOCHEM BE, V56, P687, DOI 10.1016/S0091-3057(96)00431-5; Munera A, 2000, NEUROSCI LETT, V292, P33, DOI 10.1016/S0304-3940(00)01430-0; Newman MC, 2000, AGING NEUROPSYCHOL C, V7, P86, DOI 10.1076/1382-5585(200006)7:2;1-U;FT086; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pascual M, 2005, HIPPOCAMPUS, V15, P184, DOI 10.1002/hipo.20040; Pascual M, 2004, MOL CELL NEUROSCI, V25, P679, DOI 10.1016/j.mcn.2003.12.009; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Popovic M, 2008, NEUROSCIENCE, V155, P182, DOI 10.1016/j.neuroscience.2008.05.023; Rabinowicz AL, 2000, ALZ DIS ASSOC DIS, V14, P231, DOI 10.1097/00002093-200010000-00008; Ribe EM, 2005, NEUROBIOL DIS, V20, P814, DOI 10.1016/j.nbd.2005.05.027; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Rissman RA, 2011, J NEUROCHEM, V117, P613, DOI 10.1111/j.1471-4159.2011.07237.x; Rocamora N, 1996, J NEUROSCI, V16, P3991; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Shetty AK, 1998, J COMP NEUROL, V394, P252; STROESSNERJOHNSON HM, 1992, J NEUROSCI, V12, P1936; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Toth K, 1997, J PHYSIOL-LONDON, V500, P463, DOI 10.1113/jphysiol.1997.sp022033; Vela J, 2003, J NEUROCHEM, V85, P368, DOI 10.1046/j.1471-4159.2003.01681.x; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Villette V, 2010, J NEUROSCI, V30, P10991, DOI 10.1523/JNEUROSCI.6284-09.2010; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wilkniss SM, 1997, PSYCHOL AGING, V12, P372, DOI 10.1037/0882-7974.12.2.372; Winkler J, 1998, J MOL MED-JMM, V76, P555, DOI 10.1007/s001090050250; Ypsilanti AR, 2008, NEUROBIOL AGING, V29, P1666, DOI 10.1016/j.neurobiolaging.2007.04.001	58	67	68	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4458	4467		10.1096/fj.12-208413	http://dx.doi.org/10.1096/fj.12-208413			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22835830				2022-12-25	WOS:000310574200009
J	Mathes, T; van Stokkum, IHM; Stierl, M; Kennis, JTM				Mathes, Tilo; van Stokkum, Ivo H. M.; Stierl, Manuela; Kennis, John T. M.			Redox Modulation of Flavin and Tyrosine Determines Photoinduced Proton-coupled Electron Transfer and Photoactivation of BLUF Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED STRUCTURAL-CHANGES; MARCUS INVERTED REGION; HYDROGEN-BOND; ADENYLYL-CYCLASE; LIGHT RECEPTOR; RHODOBACTER-SPHAEROIDES; CRYSTAL-STRUCTURES; CELLULAR CAMP; SIDE-CHAINS; APPA	Photoinduced electron transfer in biological systems, especially in proteins, is a highly intriguing matter. Its mechanistic details cannot be addressed by structural data obtained by crystallography alone because this provides only static information on a given redox system. In combination with transient spectroscopy and site-directed manipulation of the protein, however, a dynamic molecular picture of the ET process may be obtained. In BLUF (blue light sensors using FAD) photoreceptors, proton-coupled electron transfer between a tyrosine and the flavin cofactor is the key reaction to switch from a dark-adapted to a light-adapted state, which corresponds to the biological signaling state. Particularly puzzling is the fact that, although the various naturally occurring BLUF domains show little difference in the amino acid composition of the flavin binding pocket, the reaction rates of the forward reaction differ quite largely from a few ps up to several hundred ps. In this study, we modified the redox potential of the flavin/tyrosine redox pair by site-directed mutagenesis close to the flavin C2 carbonyl and fluorination of the tyrosine, respectively. We provide information on how changes in the redox potential of either reaction partner significantly influence photoinduced proton-coupled electron transfer. The altered redox potentials allowed us furthermore to experimentally describe an excited state charge transfer intermediately prior to electron transfer in the BLUF photocycle. Additionally, we show that the electron transfer rate directly correlates with the quantum yield of signaling state formation.	[Mathes, Tilo; van Stokkum, Ivo H. M.; Kennis, John T. M.] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Grp, NL-1081 HV Amsterdam, Netherlands; [Stierl, Manuela] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Vrije Universiteit Amsterdam; Humboldt University of Berlin	Mathes, T (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Grp, Boelelaan 1081A, NL-1081 HV Amsterdam, Netherlands.	t.mathes@vu.nl	van Stokkum, Ivo HM/E-7175-2015; Mathes, Tilo/C-5715-2011	van Stokkum, Ivo HM/0000-0002-6143-2021; Mathes, Tilo/0000-0002-9694-748X	Chemical Sciences Council of the Netherlands Organization for Scientific Research through an ECHO grant; LaserLab Europe access program [LCVU-1618]; Deutsche Forschungsgemeinschaft; Chemical Sciences Council of the Netherlands Foundation for Scientific Research through a Vici grant	Chemical Sciences Council of the Netherlands Organization for Scientific Research through an ECHO grant; LaserLab Europe access program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chemical Sciences Council of the Netherlands Foundation for Scientific Research through a Vici grant	Supported by the Chemical Sciences Council of the Netherlands Organization for Scientific Research through an ECHO grant to (J. T. M. K.), the LaserLab Europe access program (LCVU-1618), and the Deutsche Forschungsgemeinschaft.; Supported by the Chemical Sciences Council of the Netherlands Foundation for Scientific Research through a Vici grant.	Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; Arents JC, 2011, FEBS LETT, V585, P167, DOI 10.1016/j.febslet.2010.11.035; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Barry BA, 2011, J PHOTOCH PHOTOBIO B, V104, P60, DOI 10.1016/j.jphotobiol.2011.01.026; Berera R, 2009, PHOTOSYNTH RES, V101, P105, DOI 10.1007/s11120-009-9454-y; Bonetti C, 2008, BIOPHYS J, V95, P4790, DOI 10.1529/biophysj.108.139246; Bonetti C, 2009, BIOCHEMISTRY-US, V48, P11458, DOI 10.1021/bi901196x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Braatsch S, 2004, J BACTERIOL, V186, P7726, DOI 10.1128/JB.186.22.7726-7735.2004; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; Bucher D, 2009, J NEUROGENET, V23, P220, DOI 10.1080/01677060802441356; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Domratcheva T, 2008, BIOPHYS J, V94, P3872, DOI 10.1529/biophysj.107.124172; Dragnea V, 2005, BIOCHEMISTRY-US, V44, P15978, DOI 10.1021/bi050839x; Dunitz JD, 2004, CHEMBIOCHEM, V5, P614, DOI 10.1002/cbic.200300801; Fiedler B, 2005, PHOTOCHEM PHOTOBIOL, V81, P1481, DOI 10.1562/2005-06-28-RA-592; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gauden M, 2005, BIOCHEMISTRY-US, V44, P3653, DOI 10.1021/bi047359a; Gauden M, 2007, BIOCHEMISTRY-US, V46, P7405, DOI 10.1021/bi7006433; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; GRAMPP G, 1993, ANGEW CHEM INT EDIT, V32, P691, DOI 10.1002/anie.199306911; Grinstead JS, 2006, J AM CHEM SOC, V128, P15066, DOI 10.1021/ja0660103; Grinstead JS, 2006, CHEMBIOCHEM, V7, P187, DOI 10.1002/cbic.200500270; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; Hasegawa K, 2004, BIOCHEMISTRY-US, V43, P14979, DOI 10.1021/bi048671n; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Ishikita H, 2007, J BIOL CHEM, V282, P25240, DOI 10.1074/jbc.M702788200; Ishikita H, 2008, J BIOL CHEM, V283, P30618, DOI 10.1074/jbc.M803864200; Iwata T, 2011, J PHYS CHEM LETT, V2, P1015, DOI 10.1021/jz2003974; Jager A, 2007, J BACTERIOL, V189, P2274, DOI 10.1128/JB.01699-06; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; Kennis JTM, 2007, CURR OPIN STRUC BIOL, V17, P623, DOI 10.1016/j.sbi.2007.09.006; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Laan W, 2004, PHOTOCH PHOTOBIO SCI, V3, P1011, DOI 10.1039/b410923f; Larsen DS, 2004, BIOPHYS J, V87, P1858, DOI 10.1529/biophysj.104.043794; Liu ZY, 2012, J AM CHEM SOC, V134, P8104, DOI 10.1021/ja2105009; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Masuda S, 2004, BIOCHEMISTRY-US, V43, P5304, DOI 10.1021/bi049836v; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2007, J MOL BIOL, V368, P1223, DOI 10.1016/j.jmb.2007.02.087; Mathes T., 2007, PHOTOCHEMIE SIGNALTR, P62; Mathes T, 2012, J PHYS CHEM LETT, V3, P203, DOI 10.1021/jz201579y; Mathes T, 2011, J PHYS CHEM B, V115, P7963, DOI 10.1021/jp201296m; Mathes T, 2009, J MOL BIOL, V385, P1511, DOI 10.1016/j.jmb.2008.11.001; Metz S, 2009, J BACTERIOL, V191, P4473, DOI 10.1128/JB.00262-09; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Miura R, 2001, CHEM REC, V1, P183, DOI 10.1002/tcr.1007; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moore GF, 2010, J PHYS CHEM B, V114, P14450, DOI 10.1021/jp101592m; MOSER CC, 1995, J BIOENERG BIOMEMBR, V27, P263, DOI 10.1007/BF02110096; Mullen K.M., 2007, J STAT SOFTW, V18, P1, DOI DOI 10.18637/JSS.V018.I03; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Nagahama T, 2007, NEUROSCI RES, V59, P81, DOI 10.1016/j.neures.2007.05.015; Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223; Nunthaboot N, 2009, J PHOTOCH PHOTOBIO A, V207, P274, DOI 10.1016/j.jphotochem.2009.07.020; Pal PP, 2005, BIOCHEMISTRY-US, V44, P3663, DOI 10.1021/bi0484825; Pandey R, 2011, BIOPHYS J, V100, P2347, DOI 10.1016/j.bpj.2011.04.017; Porcal G, 2003, PHYS CHEM CHEM PHYS, V5, P4123, DOI 10.1039/b306945a; Sadeghian K, 2008, J AM CHEM SOC, V130, P12501, DOI 10.1021/ja803726a; Seyedsayamdost MR, 2006, J AM CHEM SOC, V128, P1569, DOI 10.1021/ja055926r; Shibata Y, 2009, J PHYS CHEM B, V113, P8192, DOI 10.1021/jp901631b; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Stelling AL, 2007, J AM CHEM SOC, V129, P15556, DOI 10.1021/ja074074n; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Thanasekaran P, 1997, J PHYS CHEM A, V101, P8195, DOI 10.1021/jp971746v; Toh KC, 2008, BIOPHYS J, V95, P312, DOI 10.1529/biophysj.107.117788; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Udvarhelyi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P554, DOI 10.1111/j.1751-1097.2010.00884.x; Unno M, 2005, J PHYS CHEM B, V109, P12620, DOI 10.1021/jp0522664; van den Berg PAW, 2004, BIOPHYS J, V87, P2577, DOI 10.1529/biophysj.104.040030; van der Horst MA, 2005, PHOTOCH PHOTOBIO SCI, V4, P688, DOI 10.1039/b418442b; Weber S, 2011, PHOTOCHEM PHOTOBIOL, V87, P574, DOI 10.1111/j.1751-1097.2010.00885.x; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n; Zirak P, 2007, CHEM PHYS, V335, P15, DOI 10.1016/j.chemphys.2007.03.013; Zirak P, 2006, J PHOTOCH PHOTOBIO B, V83, P180, DOI 10.1016/j.jphotobiol.2005.12.015; Zirak P, 2005, CHEM PHYS, V315, P142, DOI 10.1016/j.chemphys.2005.04.008	82	50	50	1	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31725	31738		10.1074/jbc.M112.391896	http://dx.doi.org/10.1074/jbc.M112.391896			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833672	Green Published, hybrid			2022-12-25	WOS:000309059400014
J	Zakikhany, K; Allen, DJ; Brown, D; Iturriza-Gomara, M				Zakikhany, Katherina; Allen, David J.; Brown, David; Iturriza-Gomara, Miren			Molecular Evolution of GII-4 Norovirus Strains	PLOS ONE			English	Article							GASTROENTERITIS OUTBREAKS; HOST SUSCEPTIBILITY; NORWALK VIRUS; VARIANT; INFECTION; DISEASE	Background: Human Noroviruses (NoV) are the major cause of acute nonbacterial gastroenteritis and the leading cause of outbreaks of gastroenteritis worldwide. Genotype II-4 (GII-4) NoV has been shown to spread rapidly and is the most commonly detected strain worldwide, particularly in association with outbreaks. Previously, we have shown that circulating GII-4 NoV strains exist as populations of selectively neutral variants, and that the emergence of epidemic GII-4 NoV strains correlated with mutations in at least two key sites (Sites A and B) within the P2 domain of the surface exposed major capsid protein (VP1). Methodology: We developed a rapid pyrosequencing method for screening of the two Sites A and B and a homology based modelling system was used to predict the effects of amino acid substitutions at these sites on the antigenic properties of the virus (defined as surface motif types). Principle Finding/Conclusion: Here, we describe the characterisation of amino acid diversity at Sites A and B for 1062 GII-4 NoV strains from clinical specimen associated with outbreak of gastroenteritis (2000-2011) and 250 GII-4 NoV sequences from Genbank. Our data identified a high diversity of different Site A and B site combinations at amino acid level and amino acid diversity was higher at Site B than Site A. Site A motifs could be grouped into 3 clusters based on similar surface motif types. We predict that Site A is a major epitope on the virus surface, responsible for defining the antigenic profile, and a more subtle role for Site B, maintaining minor antigenic variation within the virus population.	[Zakikhany, Katherina; Allen, David J.; Brown, David; Iturriza-Gomara, Miren] Hlth Protect Agcy Microbiol Serv, Virus Reference Dept, London, England; [Zakikhany, Katherina] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden	European Centre for Disease Prevention & Control	Allen, DJ (corresponding author), Hlth Protect Agcy Microbiol Serv, Virus Reference Dept, London, England.	david.james.allen@hpa.org.uk	Gomara, Miren Iturriza/B-4351-2013	Gomara, Miren Iturriza/0000-0001-5816-6423; Allen, David/0000-0002-1194-0415				Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Allen DJ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-150; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; JOHNSON PC, 1990, J INFECT DIS, V161, P18, DOI 10.1093/infdis/161.1.18; KOOPMAN JS, 1982, AM J EPIDEMIOL, V115, P173, DOI 10.1093/oxfordjournals.aje.a113288; Kroneman A, 2004, EUROSURVEILLANCE, V8; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Matsui SM, 2000, J INFECT DIS, V181, pS331, DOI 10.1086/315587; Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2008, J INFECT DIS, V198, P940, DOI 10.1086/589810; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Wingfield T, 2010, J CLIN VIROL, V49, P219, DOI 10.1016/j.jcv.2010.07.025; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	31	40	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41625	10.1371/journal.pone.0041625	http://dx.doi.org/10.1371/journal.pone.0041625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844506	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600035
J	Wang, YY; Sacchetti, A; van Dijk, MR; van der Zee, M; van der Horst, PH; Joosten, R; Burger, CW; Grootegoed, JA; Blok, LJ; Fodde, R				Wang, Yongyi; Sacchetti, Andrea; van Dijk, Matthijs R.; van der Zee, Marten; van der Horst, Paul H.; Joosten, Rosalie; Burger, Curt W.; Grootegoed, J. Anton; Blok, Leen J.; Fodde, Riccardo			Identification of Quiescent, Stem-Like Cells in the Distal Female Reproductive Tract	PLOS ONE			English	Article							FALLOPIAN-TUBE; EXPRESSION; ORIGIN; POPULATIONS; CARCINOMA; REVEALS; MARKER; SYSTEM	In fertile women, the endometrium undergoes regular cycles of tissue build-up and regression. It is likely that uterine stem cells are involved in this remarkable turn over. The main goal of our current investigations was to identify slow-cycling (quiescent) endometrial stem cells by means of a pulse-chase approach to selectively earmark, prospectively isolate, and characterize label-retaining cells (LRCs). To this aim, transgenic mice expressing histone2B-GFP (H2B-GFP) in a Tet-inducible fashion were administered doxycycline (pulse) which was thereafter withdrawn from the drinking water (chase). Over time, dividing cells progressively loose GFP signal whereas infrequently dividing cells retain H2B-GFP expression. We evaluated H2B-GFP retaining cells at different chase time points and identified long-term (LT; >12weeks) LRCs. The LT-LRCs are negative for estrogen receptor-alpha and express low levels of progesterone receptors. LRCs sorted by FACS are able to form spheroids capable of self-renewal and differentiation. Upon serum stimulation spheroid cells are induced to differentiate and form glandular structures which express markers of mature Mullerian epithelial cells. Overall, the results indicate that quiescent cells located in the distal oviduct have stem-like properties and can differentiate into distinct cell lineages specific of endometrium, proximal and distal oviduct. Future lineage-tracing studies will elucidate the role played by these cells in homeostasis, tissue injury and cancer of the female reproductive tract in the mouse and eventually in man.	[Wang, Yongyi; van Dijk, Matthijs R.; van der Zee, Marten; van der Horst, Paul H.; Burger, Curt W.; Blok, Leen J.] Erasmus MC, Josephine Nefkens Inst, Dept Obstet & Gynecol, Rotterdam, Netherlands; [Wang, Yongyi; Sacchetti, Andrea; Joosten, Rosalie; Fodde, Riccardo] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [Grootegoed, J. Anton] Erasmus MC, Dept Reprod & Dev, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wang, YY (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Obstet & Gynecol, Rotterdam, Netherlands.	l.blok@erasmusmc.nl; r.fodde@erasmusmc.nl	Sacchetti, Andrea/H-8763-2019; Fodde, Riccardo/AAW-9394-2021	Fodde, Riccardo/0000-0001-9839-4324				Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Halttunen M, 2000, BBA-PROTEIN STRUCT M, V1482, P149, DOI 10.1016/S0167-4838(00)00158-8; Hirst JE, 2009, INT J GYNECOL CANCER, V19, P826, DOI 10.1111/IGC.0b013e3181a1b5dc; JACOBS I, 1989, HUM REPROD, V4, P1; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Katsantoni EZ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-108; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Okada Akinobu, 2005, Journal of Toxicological Sciences, V30, P75, DOI 10.2131/jts.30.75; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; Rabban JT, 2009, AM J SURG PATHOL, V33, P111, DOI 10.1097/PAS.0b013e31817d74a7; Schulz MM, 2010, J FORENSIC SCI, V55, P492, DOI 10.1111/j.1556-4029.2009.01071.x; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Tong GX, 2007, MODERN PATHOL, V20, P856, DOI 10.1038/modpathol.3800827; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	39	49	51	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40691	10.1371/journal.pone.0040691	http://dx.doi.org/10.1371/journal.pone.0040691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848396	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300010
J	Bender, S; Rellum, T; Freitag, C; Resch, F; Rietschel, M; Treutlein, J; Jennen-Steinmetz, C; Brandeis, D; Banaschewski, T; Laucht, M				Bender, Stephan; Rellum, Thomas; Freitag, Christine; Resch, Franz; Rietschel, Marcella; Treutlein, Jens; Jennen-Steinmetz, Christine; Brandeis, Daniel; Banaschewski, Tobias; Laucht, Manfred			Time-Resolved Influences of Functional DAT1 and COMT Variants on Visual Perception and Post-Processing	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; DOPAMINE TRANSPORTER GENE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CATECHOL-O-METHYLTRANSFERASE; NUCLEUS RETICULARIS THALAMI; SLOW CORTICAL POTENTIALS; WORKING-MEMORY; PREFRONTAL CORTEX; MOTOR PREPARATION; TERM-MEMORY	Background: Dopamine plays an important role in orienting and the regulation of selective attention to relevant stimulus characteristics. Thus, we examined the influences of functional variants related to dopamine inactivation in the dopamine transporter (DAT1) and catechol-O-methyltransferase genes (COMT) on the time-course of visual processing in a contingent negative variation (CNV) task. Methods: 64-channel EEG recordings were obtained from 195 healthy adolescents of a community-based sample during a continuous performance task (A-X version). Early and late CNV as well as preceding visual evoked potential components were assessed. Results: Significant additive main effects of DAT1 and COMT on the occipito-temporal early CNV were observed. In addition, there was a trend towards an interaction between the two polymorphisms. Source analysis showed early CNV generators in the ventral visual stream and in frontal regions. There was a strong negative correlation between occipito-temporal visual post-processing and the frontal early CNV component. The early CNV time interval 500-1000 ms after the visual cue was specifically affected while the preceding visual perception stages were not influenced. Conclusions: Late visual potentials allow the genomic imaging of dopamine inactivation effects on visual post-processing. The same specific time-interval has been found to be affected by DAT1 and COMT during motor post-processing but not motor preparation. We propose the hypothesis that similar dopaminergic mechanisms modulate working memory encoding in both the visual and motor and perhaps other systems.	[Bender, Stephan] Tech Univ Dresden, Child & Adolescent Psychiat Dept, Sect Clin Neurophysiol & Multimodal Neuroimaging, D-01062 Dresden, Germany; [Bender, Stephan; Freitag, Christine] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Bender, Stephan; Resch, Franz] Univ Heidelberg Hosp, Dept Child & Adolescent Psychiat & Psychotherapy, Heidelberg, Germany; [Rellum, Thomas; Brandeis, Daniel; Banaschewski, Tobias; Laucht, Manfred] Univ Heidelberg, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Heidelbert, Germany; [Rietschel, Marcella; Treutlein, Jens] Univ Heidelberg, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Heidelberg, Germany; [Jennen-Steinmetz, Christine] Univ Heidelberg, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Biostat, Heidelberg, Germany; [Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Laucht, Manfred] Univ Potsdam, Div Clin Psychol, Dept Psychol, Potsdam, Germany	Technische Universitat Dresden; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Potsdam	Bender, S (corresponding author), Tech Univ Dresden, Child & Adolescent Psychiat Dept, Sect Clin Neurophysiol & Multimodal Neuroimaging, D-01062 Dresden, Germany.	Stephan.Bender@uniklinik-dresden.de	Bender, Stephan/AAT-1266-2021; Banaschewski, Tobias/ABE-5985-2020	Banaschewski, Tobias/0000-0003-4595-1144; Freitag, Christine Margarete/0000-0001-9676-4782	Deutsche Forschungsgemeinschaft (DFG); Ministry of Science and Investigation, Baden-Wurttemberg, Germany; Medical Faculty of the Goethe University, Frankfurt, Germany [7601002]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Science and Investigation, Baden-Wurttemberg, Germany; Medical Faculty of the Goethe University, Frankfurt, Germany	This study was supported by multiple grants from the Deutsche Forschungsgemeinschaft (DFG), the Ministry of Science and Investigation, Baden-Wurttemberg, Germany, and a grant by the Medical Faculty of the Goethe University, Frankfurt, Germany (7601002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; Bender S, 2008, CLIN NEUROPHYSIOL, V119, P587, DOI 10.1016/j.clinph.2007.11.008; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; Bender S, 2004, COGNITIVE BRAIN RES, V21, P49, DOI 10.1016/j.cogbrainres.2004.05.004; Bender S, 2004, CLIN NEUROPHYSIOL, V115, P1836, DOI 10.1016/j.clinph.2004.03.023; Bender S, PLOS ONE IN PRESS; Bender S, 2007, NEUROIMAGE, V38, P367, DOI 10.1016/j.neuroimage.2007.07.044; Bender S, 2007, PAIN, V127, P221, DOI 10.1016/j.pain.2006.08.017; Bender S, 2006, NEUROIMAGE, V32, P333, DOI 10.1016/j.neuroimage.2006.03.009; Bender S, 2010, CLIN NEUROPHYSIOL, V121, P2044, DOI 10.1016/j.clinph.2010.05.008; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Brandeis D, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00018; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; BRUNIA CHM, 1993, PSYCHOPHYSIOLOGY, V30, P327, DOI 10.1111/j.1469-8986.1993.tb02054.x; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Durston S, 2008, J AM ACAD CHILD PSY, V47, P61, DOI 10.1097/chi.0b013e31815a5f17; Franke B, 2008, AM J MED GENET B, V147B, P1576, DOI 10.1002/ajmg.b.30861; Franke B, 2010, NEUROPSYCHOPHARMACOL, V35, P656, DOI 10.1038/npp.2009.170; GAILLARD AWK, 1976, BIOL PSYCHOL, V4, P139, DOI 10.1016/0301-0511(76)90013-2; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; Hahn T, 2011, HUM BRAIN MAPP, V32, P1557, DOI 10.1002/hbm.21127; Hellwig S, 2008, INT J PSYCHOPHYSIOL, V69, P41, DOI 10.1016/j.ijpsycho.2008.02.011; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Koychev I, 2010, NEUROPSYCHOLOGIA, V48, P2205, DOI 10.1016/j.neuropsychologia.2010.04.014; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Laucht M, 1997, J CHILD PSYCHOL PSYC, V38, P843, DOI 10.1111/j.1469-7610.1997.tb01602.x; Laucht M, 2007, ARCH GEN PSYCHIAT, V64, P585, DOI 10.1001/archpsyc.64.5.585; Linssen AMW, 2011, PSYCHOPHARMACOLOGY, V218, P533, DOI 10.1007/s00213-011-2345-x; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Luthringer R, 1999, NEUROPSYCHOBIOLOGY, V39, P49, DOI 10.1159/000026560; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Mishra J, 2012, NEUROIMAGE, V59, P1968, DOI 10.1016/j.neuroimage.2011.09.028; NIGHTINGALE S, 1986, J NEUROL NEUROSUR PS, V49, P1280, DOI 10.1136/jnnp.49.11.1280; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owesson-White CA, 2012, J NEUROCHEM, V121, P252, DOI 10.1111/j.1471-4159.2012.07677.x; Rockstroh B., 1989, SLOW CORTICAL POTENT; ROHRBAUGH JW, 1980, SCIENCE, V208, P1165, DOI 10.1126/science.7375925; Ruchkin DS, 1997, COGNITIVE BRAIN RES, V6, P95, DOI 10.1016/S0926-6410(97)00021-9; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; SANO A, 1993, HUM GENET, V91, P405; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack S R, 1998, Adv Pharmacol, V42, P171; Shumay E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022754; Singhal A, 2006, INT J NEUROSCI, V116, P1457, DOI 10.1080/00207450500514342; Siniatchkin M, 2000, CEPHALALGIA, V20, P881, DOI 10.1046/j.1468-2982.2000.00132.x; SKINNER JE, 1976, ELECTROEN CLIN NEURO, V40, P288, DOI 10.1016/0013-4694(76)90152-8; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; SQUIRES K C, 1977, Electroencephalography and Clinical Neurophysiology, V42, P1, DOI 10.1016/0013-4694(77)90146-8; van Leeuwen TH, 1998, BEHAV BRAIN RES, V94, P97, DOI 10.1016/S0166-4328(97)00173-3; Vandenbergh DJ, 2000, MOL PSYCHIATR, V5, P283, DOI 10.1038/sj.mp.4000701; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; YINGLING CD, 1976, ELECTROEN CLIN NEURO, V41, P476, DOI 10.1016/0013-4694(76)90059-6	55	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41552	10.1371/journal.pone.0041552	http://dx.doi.org/10.1371/journal.pone.0041552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844499	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000306687700110
J	Chu, CL; Yu, YL; Kung, YC; Liao, PY; Liu, KJ; Tseng, YT; Lin, YC; Hsieh, SSY; Chong, PCS; Yang, CY				Chu, Ching-Liang; Yu, Yen-Ling; Kung, Yueh-Chen; Liao, Pei-Yu; Liu, Ko-Jiunn; Tseng, Yen-Tzu; Lin, Yuan-Chuen; Hsieh, Steve Shih-Yang; Chong, Pele Choi-Sing; Yang, Chiou-Ying			The Immunomodulatory Activity of Meningococcal Lipoprotein Ag473 Depends on the Conformation Made up of the Lipid and Protein Moieties	PLOS ONE			English	Article							DENDRITIC CELL ACTIVATION; TOLL-LIKE RECEPTORS; NEISSERIA-MENINGITIDIS; IMMUNE-RESPONSE; PATTERN-RECOGNITION; IN-VIVO; VACCINE; IDENTIFICATION; LIPOPEPTIDES; INDUCTION	We have previously demonstrated that the meningococcal antigen Ag473 in the presence of Freund's adjuvant can elicit protective immune responses in mouse challenge model. In this study, we evaluated the structural requirement for the immunological activity and the possible signaling pathway of recombinant Ag473 antigen produced in E. coli. We found that lipidated Ag473 (L-Ag473) possesses an intrinsic adjuvant activity that could be attributed to its ability to activate dendritic cells and promote their maturation. In addition, we found that L-Ag473 can activate human monocytes and promote maturation of human monocyte-derived dendritic cells. These results provide an indirect support that L-Ag473 may also be immunogenic in human. Interestingly, the observed activity is dependent on the overall conformation of L-Ag473 because heating and proteinase K treatment can diminish and abolish the activity. Furthermore, our data suggest a species-differential TLR recognition of L-Ag473. Overall, these data suggest a new paradigm for the ligand-TLR interaction in addition to demonstrating the self-adjuvanting activity of the vaccine candidate L-Ag473.	[Chu, Ching-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Yu, Yen-Ling; Kung, Yueh-Chen; Hsieh, Steve Shih-Yang; Chong, Pele Choi-Sing; Yang, Chiou-Ying] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Miaoli, Taiwan; [Liao, Pei-Yu; Tseng, Yen-Tzu; Lin, Yuan-Chuen; Yang, Chiou-Ying] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Liu, Ko-Jiunn] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Liu, Ko-Jiunn] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; National Chung Hsing University; National Health Research Institutes - Taiwan; Taipei Medical University	Chu, CL (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	cyyang@dragon.nchu.edu.tw	Chong, Pele/E-3855-2010; Liu, Ko-Jiunn/D-2098-2010	Chu, Ching-Liang/0000-0002-8463-526X; Yang, Chiou-Ying/0000-0001-7130-1781	National Health Research Institutes, Taiwan [NHRI-EX96-9613BI]; NTUCM [100R311001]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); NTUCM	This research was supported by grant NHRI-EX96-9613BI from National Health Research Institutes, Taiwan, to CYY, and grant 100R311001 of NTUCM to CLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Bobie J, 2003, VACCINE, V21, P605, DOI 10.1016/S0264-410X(02)00566-2; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Buckwalter MR, 2009, CURR BIOL, V19, pR355, DOI 10.1016/j.cub.2009.03.012; Cavaillon JM, 2011, LANCET INFECT DIS, V11, P426, DOI 10.1016/S1473-3099(11)70131-1; Chang GC, 2005, CANCER-AM CANCER SOC, V103, P763, DOI 10.1002/cncr.20843; Chen HW, 2009, VACCINE, V27, P1400, DOI 10.1016/j.vaccine.2008.12.043; Dietrich G, 2003, J BACTERIOL, V185, P155, DOI 10.1128/JB.185.1.155-164.2003; Duesberg U, 2002, IMMUNOL LETT, V84, P89, DOI 10.1016/S0165-2478(02)00178-5; Ganapamo F, 2003, EUR J IMMUNOL, V33, P1934, DOI 10.1002/eji.200323655; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hsu CA, 2008, PROTEOMICS, V8, P2115, DOI 10.1002/pmic.200700574; Huang RY, 2010, J IMMUNOL, V184, P6815, DOI 10.4049/jimmunol.0903991; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kimmel SR, 2005, AM FAM PHYSICIAN, V72, P2049; Kurz S, 2003, VACCINE, V21, P768, DOI 10.1016/S0264-410X(02)00596-0; Leng CH, 2010, MOL IMMUNOL, V47, P2015, DOI 10.1016/j.molimm.2010.04.012; Lin CC, 2011, CANCER IMMUNOL IMMUN, V60, P1019, DOI 10.1007/s00262-011-1016-4; Lin MK, 2011, IMMUNOBIOLOGY, V216, P1103, DOI 10.1016/j.imbio.2011.05.002; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Revets H, 2005, J IMMUNOL, V174, P1097, DOI 10.4049/jimmunol.174.2.1097; Schromm AB, 2007, J BIOL CHEM, V282, P11030, DOI 10.1074/jbc.M700287200; Sung JWC, 2010, VACCINE, V28, P8175, DOI 10.1016/j.vaccine.2010.09.091; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yang XL, 2008, MICROBES INFECT, V10, P1300, DOI 10.1016/j.micinf.2008.07.029; Yu YL, 2009, EUR J IMMUNOL, V39, P2482, DOI 10.1002/eji.200839039; Zhang HW, 1998, INFECT IMMUN, V66, P5196, DOI 10.1128/IAI.66.11.5196-5201.1998	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40873	10.1371/journal.pone.0040873	http://dx.doi.org/10.1371/journal.pone.0040873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844415	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700021
J	Gonzalez-Castro, A; Yang, S; Nogales, M; Carlo, TA				Gonzalez-Castro, Aaron; Yang, Suann; Nogales, Manuel; Carlo, Tomas A.			What Determines the Temporal Changes of Species Degree and Strength in an Oceanic Island Plant-Disperser Network?	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; COEVOLUTIONARY NETWORKS; POLLINATION NETWORKS; FRUGIVOROUS BIRDS; DIGESTIVE-SYSTEM; ABUNDANCE; SPECIALIZATION; DYNAMICS; BIODIVERSITY; PREFERENCES	Network models of frugivory and seed dispersal are usually static. To date, most studies on mutualistic networks assert that interaction properties such as species' degree (k) and strength (s) are strongly influenced by species abundances. We evaluated how species' degree and strength change as a function of temporal variation not only in species abundance, but also in species persistence (i.e., phenology length). In a two-year study, we collected community-wide data on seed dispersal by birds and examined the seasonal dynamics of the above-mentioned interaction properties. Our analyses revealed that species abundance is an important predictor for plant strength within a given sub-network. However, our analyses also reveal that species' degree can often be best explained by the length of fruiting phenology (for plants degree) or by the number of fruiting species (for dispersers degree), which are factors that can be decoupled from the relative abundance of the species participating in the network. Moreover, our results suggest that generalist dispersers (when total study period is considered) act as temporal generalists, with degree constrained by the number of plant species displaying fruits in each span. Along with species identity, our findings underscore the need for a temporal perspective, given that seasonality is an inherent property of many mutualistic networks.	[Gonzalez-Castro, Aaron; Nogales, Manuel] CSIC, Inst Prod Nat & Agrobiol, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Canary Islands, Spain; [Yang, Suann; Carlo, Tomas A.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gonzalez-Castro, A (corresponding author), CSIC, Inst Prod Nat & Agrobiol, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Canary Islands, Spain.	aarongonzalezcastro@gmail.com	González-Castro, Aarón/K-3290-2016; Nogales, Manuel/I-9831-2014	González-Castro, Aarón/0000-0002-5311-1017; Nogales, Manuel/0000-0002-5327-3104; Yang, Suann/0000-0001-7985-3011; Carlo, Tomas/0000-0002-2092-0053	Spanish National Research Council; National Science Foundation; Spanish Ministry of Science and Education [CGL2007-61165/BOS, GGL2010-18759/BOS]; European Union; Biology Department; Eberly College of Science at Penn State University	Spanish National Research Council; National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Science and Education(Spanish Government); European Union(European Commission); Biology Department; Eberly College of Science at Penn State University	A. Gonzalez-Castro benefited from a JAE-PRE fellowship from the Spanish National Research Council (http://www.csic.es). S. Yang was funded by the National Science Foundation under a grant awarded in 2008 (http://www.nsf.gov). This work was financed by the Spanish Ministry of Science and Education project (CGL2007-61165/BOS) and is also framed within project GGL2010-18759/BOS, supported by Fondo Europeo de Desarrollo Regional funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are especially grateful to Benito Perez, Daniel Gonzalez, Yurena Gavilan, Leandro de Leon, Beatriz Rumeu, David Padilla and Juan Carlos Illera for their help during fieldwork. Jofre Carnicer, Ruben Heleno and two anonymous referees read an early draft of this manuscript, making useful comments and suggestions. The Biology Department and the Eberly College of Science at Penn State University provided support to T. A. Carlo, S. Yang, and A. Gonzalez-Castro during the Spring and Summer of 2011.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Bates D., 2011, IME4 LINEAR MIXED EF; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Carlo TA, 2003, OECOLOGIA, V134, P119, DOI 10.1007/s00442-002-1087-1; Carlo TA, 2011, ACTA OECOL, V37, P619, DOI 10.1016/j.actao.2011.08.001; Carnicer J, 2009, ECOLOGY, V90, P1958, DOI 10.1890/07-1939.1; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Gonzalez-Castro A, 2012, J BIOGEOGR, V39, P1938, DOI 10.1111/j.1365-2699.2012.02693.x; HERRERA CM, 1995, ANNU REV ECOL SYST, V26, P705, DOI 10.1146/annurev.es.26.110195.003421; HOWE HF, 1977, AM NAT, V111, P817, DOI 10.1086/283216; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano P., 1985, Ardeola, V32, P69; JORDANO P, 1987, IBIS, V129, P175, DOI 10.1111/j.1474-919X.1987.tb03199.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; KARASOV WH, 1990, PHYSIOL ZOOL, V63, P1248, DOI 10.1086/physzool.63.6.30152643; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; Martin A., 2001, AVES ARCHIPIELAGO CA; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; PINHEIRO J, 2009, R PACKAGE VERSION 3, P1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rezende EL, 2007, OIKOS, V116, P1919, DOI 10.1111/j.2007.0030-1299.16029.x; Mello MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017395; Schleuning M, 2011, ECOLOGY, V92, P26, DOI 10.1890/09-1842.1; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; TYRVAINEN H, 1975, Ornis Fennica, V52, P23; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; WILLSON MF, 1990, CONDOR, V92, P545, DOI 10.2307/1368671	41	26	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41385	10.1371/journal.pone.0041385	http://dx.doi.org/10.1371/journal.pone.0041385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844470	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700081
J	Volkmann, K; Pfander, C; Burstroem, C; Ahras, M; Goulding, D; Rayner, JC; Frischknecht, F; Billker, O; Brochet, M				Volkmann, Katrin; Pfander, Claudia; Burstroem, Charlotte; Ahras, Malika; Goulding, David; Rayner, Julian C.; Frischknecht, Friedrich; Billker, Oliver; Brochet, Mathieu			The Alveolin IMC1h Is Required for Normal Ookinete and Sporozoite Motility Behaviour and Host Colonisation in Plasmodium berghei	PLOS ONE			English	Article							MALARIA PARASITE; PROTEINS; FAMILY; TRANSMISSION; INFECTIVITY; MOSQUITO; LIVER; CYCLE	Alveolins, or inner membrane complex (IMC) proteins, are components of the subpellicular network that forms a structural part of the pellicle of malaria parasites. In Plasmodium berghei, deletions of three alveolins, IMC1a, b, and h, each resulted in reduced mechanical strength and gliding velocity of ookinetes or sporozoites. Using time lapse imaging, we show here that deletion of IMC1h (PBANKA_143660) also has an impact on the directionality and motility behaviour of both ookinetes and sporozoites. Despite their marked motility defects, sporozoites lacking IMC1h were able to invade mosquito salivary glands, allowing us to investigate the role of IMC1h in colonisation of the mammalian host. We show that IMC1h is essential for sporozoites to progress through the dermis in vivo but does not play a significant role in hepatoma cell transmigration and invasion in vitro. Colocalisation of IMC1h with the residual IMC in liver stages was detected up to 30 hours after infection and parasites lacking IMC1h showed developmental defects in vitro and a delayed onset of blood stage infection in vivo. Together, these results suggest that IMC1h is involved in maintaining the cellular architecture which supports normal motility behaviour, access of the sporozoites to the blood stream, and further colonisation of the mammalian host.	[Volkmann, Katrin; Pfander, Claudia; Burstroem, Charlotte; Ahras, Malika; Goulding, David; Rayner, Julian C.; Billker, Oliver; Brochet, Mathieu] Wellcome Trust Sanger Inst, Hinxton, England; [Frischknecht, Friedrich] Heidelberg Univ, Sch Med, Inst Hyg, Dept Parasitol, Heidelberg, Germany	Wellcome Trust Sanger Institute; Ruprecht Karls University Heidelberg	Volkmann, K (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	ob4@sanger.ac.uk; mb13@sanger.ac.uk	Brochet, Mathieu/B-3413-2018	Brochet, Mathieu/0000-0003-3911-5537; Pfander, Claudia/0000-0002-9574-9553; Frischknecht, Friedrich/0000-0002-8332-6668; Rayner, Julian/0000-0002-9835-1014; Billker, Oliver/0000-0003-1716-168X	Wellcome Trust [WT089085/Z/09/Z]; Medical Research Council [G0501670]; EVIMalaR European Networks of Excellence [242095]; EMBO long term fellowship [ALTF 45-2009]; Marie Curie Grant [PIEF-GA-2009-253899]; MRC [G0501670] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EVIMalaR European Networks of Excellence; EMBO long term fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Grant(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work received support from the Wellcome Trust (WT089085/Z/09/Z), the Medical Research Council (grant number G0501670) and the EVIMalaR European Networks of Excellence (No. 242095). MB is supported by an EMBO long term fellowship (ALTF 45-2009) and a Marie Curie Grant (PIEF-GA-2009-253899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Bano N, 2007, INT J PARASITOL, V37, P1329, DOI 10.1016/j.ijpara.2007.04.005; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gomes-Santos CSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029408; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hegge Stephan, 2009, Biotechnology Journal, V4, P903, DOI 10.1002/biot.200900007; Hellmann JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002080; Janse CJ, 2006, NAT PROTOC, V1, P614, DOI 10.1038/nprot.2006.88; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Montagna G, 2011, J BIOL CHEM, V2, DOI [10.1074/jbc.M1111.302109, DOI 10.1074/JBC.M1111.302109]; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Rayavara K, 2009, MOL BIOCHEM PARASIT, V167, P135, DOI 10.1016/j.molbiopara.2009.05.006; Tewari R, 2005, MOL MICROBIOL, V58, P1253, DOI 10.1111/j.1365-2958.2005.04793.x; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; Tremp AZ, 2011, J BIOL CHEM, V286, P5383, DOI 10.1074/jbc.M110.187195; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x	33	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41409	10.1371/journal.pone.0041409	http://dx.doi.org/10.1371/journal.pone.0041409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844474	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700086
J	Kadarusman; Hubert, N; Hadiaty, RK; Sudaro; Paradis, E; Pouyaud, L				Kadarusman; Hubert, Nicolas; Hadiaty, Renny Kurnia; Sudaro; Paradis, Emmanuel; Pouyaud, Laurent			Cryptic Diversity in Indo-Australian Rainbowfishes Revealed by DNA Barcoding: Implications for Conservation in a Biodiversity Hotspot Candidate	PLOS ONE			English	Article							FISHES; IDENTIFICATIONS; COMMUNITIES; PATTERNS	The rainbowfishes of the family Melanotaeniidae represent one of the largest radiations of freshwater fishes from the Indo-Australian archipelago. A total of 75 nominal species have been described, among which several have become very popular among tropical fish hobbyists because of their tendency to form large schools of colourful individuals. Facing habitat loss and competition or predation by introduced species, this group has become a priority in the conservation of ornamental fishes in Indonesia. In this context, several expeditions have been conducted between 2007 and 2010 in Indonesian Papua with the aim to initiate a large-scale survey of the genetic resources in this group. We assessed the diversity of the Papua rainbowfishes with DNA barcoding. We sequenced the mitochondrial COI gene for 350 specimens belonging to 53 nominal species throughout the Indo-Australian archipelago. Unexpected levels of cryptic diversity and endemism were detected since additional cryptic lineages were detected in several watersheds from the Vogelkop and the Lengguru massif. DNA barcoding supports the presence of nearly 30 evolutionary lineages among the 15 nominal species sampled in the Vogelkop and all these lineages are endemic to a single lake or watershed. This result highlights that the diversity of the family has been largely underestimated and urges for the identification of conservation priorities in Papua.	[Kadarusman] Minist Marine Affairs & Fisheries, Akad Perikanan Sorong, Sorong, West Papua, Indonesia; [Kadarusman; Hubert, Nicolas; Paradis, Emmanuel; Pouyaud, Laurent] Inst Rech Dev, ISE M UR226, Montpellier, France; [Hadiaty, Renny Kurnia] Indonesian Inst Sci, Museum Zoologicum Bogoriense, Cibinong, West Java, Indonesia; [Sudaro] Minist Marine Affairs & Fisheries, Inst Res & Dev Ornamental Fish Culture, Depok, West Java, Indonesia	Ministry of Marine Affairs and Fisheries; Institut de Recherche pour le Developpement (IRD); Bogor Zoology Museum; Indonesian Institute of Sciences; Ministry of Marine Affairs and Fisheries	Kadarusman (corresponding author), Minist Marine Affairs & Fisheries, Akad Perikanan Sorong, Sorong, West Papua, Indonesia.	nicolas.hubert@ird.fr		Laurent, Pouyaud/0000-0003-4415-9198; Hubert, Nicolas/0000-0001-9248-3377	french Fondation de la Recherche pour la Biodiversite; COLAS Company in Indonesia; Veolia Environment Foundation	french Fondation de la Recherche pour la Biodiversite; COLAS Company in Indonesia; Veolia Environment Foundation	Funding was provided by the french Fondation de la Recherche pour la Biodiversite, the COLAS Company in Indonesia, and the Veolia Environment Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Allen GR, 1982, RAINBOWFISHES AUSTR; Allen GR, 1995, RAINBOWFISHES NATURE; Allen GR, 2006, ECOLOGY PAPUA, P637; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Bailly V, 2009, LITHOS, V113, P306, DOI 10.1016/j.lithos.2009.08.013; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Burnett JB, 2006, ECOLOGY PAPUA, P1230; Clements R, 2008, BIOL CONSERV, V141, P2751, DOI 10.1016/j.biocon.2008.08.011; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Dennis C, 2004, NATURE, V430, P396, DOI 10.1038/430396a; Eastman JM, 2011, BIOINFORMATICS, V27, P2437, DOI 10.1093/bioinformatics/btr403; Fraser S, 2006, ECOLOGY INDONESIA, P1199; Frodin DG, 2006, ECOLOGY INDONESIA, P14; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Hardman M, 2006, MOL PHYLOGENET EVOL, V40, P410, DOI 10.1016/j.ympev.2006.03.011; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Kiew R, 1991, STATE NATURE CONSERV, P42; Marshall AJ, 2006, ECOLOGY PAPUA; McAlpine J R, 2001, Asia Pac Viewp, V42, P209, DOI 10.1111/1467-8373.00145; McGuigan K, 2000, MAR FRESHWATER RES, V51, P713, DOI 10.1071/MF99159; Mertens B, 2002, SPATIAL ANAL RAPID A; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Polhemus DA, 2006, ECOLOGY PAPUA; Polhemus DA, 2004, FRESHWATER BIOTAS NE; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Read CI, 2006, MOL PHYLOGENET EVOL, V38, P808, DOI 10.1016/j.ympev.2005.08.001; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Schilthuizen M, 2005, CONSERV BIOL, V19, P949; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Sriwattanarothai N, 2010, J FISH BIOL, V77, P414, DOI 10.1111/j.1095-8649.2010.02715.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tappin AR, 2011, RAINBOWFISHES THEIR; Villeneuve M, 2010, GONDWANA RES, V18, P420, DOI 10.1016/j.gr.2009.12.011; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; ZHU DQ, 1994, MOL BIOL EVOL, V11, P672	45	28	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40627	10.1371/journal.pone.0040627	http://dx.doi.org/10.1371/journal.pone.0040627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829879	gold, Green Submitted, Green Published			2022-12-25	WOS:000306956300017
J	Ritz, N; Strach, M; Yau, C; Dutta, B; Tebruegge, M; Connell, TG; Hanekom, WA; Britton, WJ; Robins-Browne, R; Curtis, N				Ritz, Nicole; Strach, Madeleine; Yau, Carmen; Dutta, Binita; Tebruegge, Marc; Connell, Tom G.; Hanekom, Willem A.; Britton, Warwick J.; Robins-Browne, Roy; Curtis, Nigel			A Comparative Analysis of Polyfunctional T Cells and Secreted Cytokines Induced by Bacille Calmette-Guerin Immunisation in Children and Adults	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; IMMUNE-RESPONSES; BCG VACCINATION; IFN-GAMMA; PUBLISHED LITERATURE; DENDRITIC CELLS; PROTECTION; CORRELATE; NEWBORNS; INFANTS	BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protective efficacy of BCG against TB is better for children than for adults. One potential explanation is that BCG induces a better protective immune response in children. Twenty six children and adults were immunised with BCG. The proportion of Th1-cytokine-producing mycobacterial-specific T cells, and the concentrations of secreted cytokines, were measured before and 10 weeks after BCG immunisation. A significant increase in the proportion of mycobacterial-specific cytokine-producing T cells was observed in both age groups. After BCG immunisation, children and adults had comparable proportions of mycobacterial-specific polyfunctional CD4 T cells when measured relative to the total number of CD4 T cells. However, relative to the subset of Th1-cytokine-producing CD4 T cells, the proportion of polyfunctional cells was greater in children. Concentrations of secreted cytokines were comparable in children and adults. These findings suggest that the mycobacterial-specific cell-mediated immune response induced by BCG immunisation in children and adults is similar. The implication of a shift to a more polyfunctional immune response within the Th1-cytokine-producing CD4 T cells in children is uncertain as this aspect of the immune response has not been assessed as a potential correlate of protection against TB.	[Ritz, Nicole; Strach, Madeleine; Yau, Carmen; Tebruegge, Marc; Connell, Tom G.; Robins-Browne, Roy; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Ritz, Nicole; Strach, Madeleine; Yau, Carmen; Dutta, Binita; Tebruegge, Marc; Connell, Tom G.; Robins-Browne, Roy; Curtis, Nigel] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Ritz, Nicole; Tebruegge, Marc; Connell, Tom G.; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Dept Gen Med, Parkville, Vic, Australia; [Hanekom, Willem A.] Univ Cape Town, S African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Hanekom, Willem A.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Britton, Warwick J.] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Camperdown, NSW, Australia; [Robins-Browne, Roy] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Britton, Warwick J.] Univ Sydney, Dept Med, Camperdown, NSW, Australia	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Cape Town; University of Cape Town; University of Sydney; Centenary Institute; University of Melbourne; University of Sydney	Ritz, N (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	nicole.ritz@rch.org.au	Ritz, Nicole/G-2924-2015; Ritz, Nicole/L-1452-2019; Curtis, Nigel/B-3491-2012; Robinsbrowne, Roy/ABF-8434-2020; Strach, Madeleine/AAP-1125-2021	Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Curtis, Nigel/0000-0003-3446-4594; Robinsbrowne, Roy/0000-0001-9179-7884; Strach, Madeleine/0000-0002-5516-2619; Britton, Warwick/0000-0001-6721-9646; Hanekom, Willem/0000-0003-3070-6154	European Society for Paediatric Infectious Diseases; University of Melbourne; Murdoch Children's Research Institute, Parkville, Australia; Royal Children's Hospital Melbourne, Parkville, Australia; National Institute for Health Research [CL-2011-26-004] Funding Source: researchfish	European Society for Paediatric Infectious Diseases; University of Melbourne(University of Melbourne); Murdoch Children's Research Institute, Parkville, Australia; Royal Children's Hospital Melbourne, Parkville, Australia; National Institute for Health Research(National Institute for Health Research (NIHR))	NR and MT were supported by Fellowship awards from the European Society for Paediatric Infectious Diseases and scholarships from The University of Melbourne. This work was supported by a grant from the Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Britton WJ, 1998, INFECT IMMUN, V66, P2122, DOI 10.1128/IAI.66.5.2122-2127.1998; Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Demangel C, 2000, IMMUNOL CELL BIOL, V78, P318, DOI 10.1046/j.1440-1711.2000.00935.x; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Finan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003485; Fjallbrant H, 2007, SCAND J INFECT DIS, V39, P792, DOI 10.1080/00365540701367777; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hartel C, 2005, CLIN EXP IMMUNOL, V142, P446, DOI 10.1111/j.1365-2249.2005.02928.x; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Hoft DF, 1999, J LAB CLIN MED, V134, P244, DOI 10.1016/S0022-2143(99)90204-4; Hussey GD, 2002, IMMUNOLOGY, V105, P314, DOI 10.1046/j.1365-2567.2002.01366.x; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Marchant A, 1999, J IMMUNOL, V163, P2249; Mazzola TN, 2007, VACCINE, V25, P6313, DOI 10.1016/j.vaccine.2007.06.039; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; O'Garra AB, 2008, CELL BIOL, V2, P185; Ota MOC, 2006, J TROP PEDIATRICS, V52, P136, DOI 10.1093/tropej/fmi087; Ravn P, 1997, J IMMUNOL, V158, P1949; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Smith SM, 1999, INFECT IMMUN, V67, P5223, DOI 10.1128/IAI.67.10.5223-5230.1999; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tchilian EZ, 2009, INFECT IMMUN, V77, P622, DOI 10.1128/IAI.00685-08; Thurnher M, 1997, INT J CANCER, V70, P128; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Vekemans J, 2004, INFECT IMMUN, V72, P381, DOI 10.1128/IAI.72.1.381-388.2004; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731	44	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e37535	10.1371/journal.pone.0037535	http://dx.doi.org/10.1371/journal.pone.0037535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829867	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000306956300005
J	Torikoshi, K; Abe, H; Matsubara, T; Hirano, T; Ohshima, T; Murakami, T; Araki, M; Mima, A; Iehara, N; Fukatsu, A; Kita, T; Arai, H; Doi, T				Torikoshi, Kazuo; Abe, Hideharu; Matsubara, Takeshi; Hirano, Takahiro; Ohshima, Takayuki; Murakami, Taichi; Araki, Makoto; Mima, Akira; Iehara, Noriyuki; Fukatsu, Atsushi; Kita, Toru; Arai, Hidenori; Doi, Toshio			Protein Inhibitor of Activated STAT, PIASy Regulates alpha-Smooth Muscle Actin Expression by Interacting with E12 in Mesangial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LOOP-HELIX PROTEINS; TRANSCRIPTIONAL ACTIVITY; IN-VIVO; PROLIFERATIVE GLOMERULONEPHRITIS; DEPENDENT TRANSCRIPTION; DIABETIC-NEPHROPATHY; SUMO-1 MODIFICATION; FACTOR ANTAGONIZES; NUCLEAR-BODIES	Phenotypic transformation of mesangial cells (MCs) is implicated in the development of glomerular disease; however, the mechanisms underlying their altered genetic program is still unclear. alpha-smooth muscle actin (alpha-SMA) is known to be a crucial marker for phenotypic transformation of MCs. Recently, E-boxes and the class I basic helix-loop-helix proteins, such as E12 have been shown to regulate alpha-SMA expression. Therefore, we tried to identify a novel E12 binding protein in MCs and to examine its role in glomerulonephritis. We found that PIASy, one of the protein inhibitors of activated STAT family protein, interacted with E12 by yeast two-hybrid screens and coimmunopreciptation assays. Overexpression of E12 significantly enhanced the alpha-SMA promoter activity, and the increase was blocked by co-transfection of PIASy, but not by a PIASy RING mutant. In vivo sumoylation assays revealed that PIASy was a SUMO E3 ligase for E12. Furthermore, transforming growth factor-beta (TGF-beta) treatment induced expression of both PIASy and E12, consistent with alpha-SMA expression. Moreover, reduced expression of PIASy protein by siRNA specific for PIASy resulted in increased TGF-beta-mediated alpha-SMA expression. In vivo, PIASy and E12 were dramatically upregulated along with alpha-SMA and TGF-beta in the proliferative phase of Thy1 glomerulonephritis. Furthermore, an association between PIASy and E12 proteins was observed at day 6 by IP-western blotting, but not at day 0. These results suggest that TGF-beta up-regulates PIASy expression in MCs to down-regulate alpha-SMA gene transcription by the interaction with E12.	[Torikoshi, Kazuo; Matsubara, Takeshi; Araki, Makoto; Mima, Akira; Iehara, Noriyuki; Fukatsu, Atsushi] Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan; [Abe, Hideharu; Hirano, Takahiro; Murakami, Taichi; Doi, Toshio] Univ Tokushima, Dept Nephrol, Hlth Biosci Inst, Grad Sch Med, Tokushima 770, Japan; [Ohshima, Takayuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa, Japan; [Kita, Toru] Gen Hosp, Kobe City Med Ctr, Kobe, Hyogo, Japan; [Arai, Hidenori] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan	Kyoto University; Tokushima University; Tokushima Bunri University; Kobe City Medical Center General Hospital; Kyoto University	Torikoshi, K (corresponding author), Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan.	mtake@kuhp.kyoto-u.ac.jp	FUKATSU, ATSUSHI/R-7941-2019; Arai, Hidenori/P-9816-2017	Arai, Hidenori/0000-0002-9000-6849; Araki, Makoto/0000-0003-0854-4064; OHSHIMA, Takayuki/0000-0002-1501-6430	Takeda Science Foundation;  [21790808];  [21591033]; Grants-in-Aid for Scientific Research [22390169] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Young Scientists (B) (21790808), Grants-in-Aid for Scientific Research (21591033), and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; ALPERS CE, 1992, KIDNEY INT, V41, P1134, DOI 10.1038/ki.1992.173; Conlon Thomas M., 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-11; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; Gerhardinger C, 2009, DIABETES, V58, P1659, DOI 10.2337/db08-1008; Huggins GS, 1999, J BIOL CHEM, V274, P28690, DOI 10.1074/jbc.274.40.28690; Imoto S, 2003, J BIOL CHEM, V278, P34253, DOI 10.1074/jbc.M304961200; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kawai-Kowase K, 2004, ARTERIOSCL THROM VAS, V24, P1384, DOI 10.1161/01.ATV.0000136548.17816.07; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; LEDENT V, 2002, GENOME BIOL, V3; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nelson V, 2001, APOPTOSIS, V6, P221, DOI 10.1023/A:1011392811628; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Nishida T, 2007, BIOCHEM J, V405, P481, DOI 10.1042/BJ20070026; Nishida T, 2007, BIOCHEM BIOPH RES CO, V360, P226, DOI 10.1016/j.bbrc.2007.06.037; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Pippin JW, 1997, J CLIN INVEST, V100, P2512, DOI 10.1172/JCI119793; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Slattery C, 2006, FEBS LETT, V580, P4021, DOI 10.1016/j.febslet.2006.06.039; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; STRIKER LJ, 1989, SEMIN NEPHROL, V9, P318; Sumi E, 2007, AM J PATHOL, V170, P1854, DOI 10.2353/ajpath.2007.060899; Watanabe M, 2011, BBA-PROTEINS PROTEOM, V1814, P900, DOI 10.1016/j.bbapap.2011.04.006; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200; Ziswiler R, 1998, J AM SOC NEPHROL, V9, P2055	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41186	10.1371/journal.pone.0041186	http://dx.doi.org/10.1371/journal.pone.0041186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829926	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300065
J	Zhang, W; O'Brien, N; Forrest, JI; Salters, KA; Patterson, TL; Montaner, JSG; Hogg, RS; Lima, VD				Zhang, Wendy; O'Brien, Nadia; Forrest, Jamie I.; Salters, Kate A.; Patterson, Thomas L.; Montaner, Julio S. G.; Hogg, Robert S.; Lima, Viviane D.			Validating a Shortened Depression Scale (10 Item CES-D) among HIV-Positive People in British Columbia, Canada	PLOS ONE			English	Article							CD4 CELL COUNT; VIRAL LOAD; SHORT-FORM; SYMPTOMS; ASSOCIATION; INFECTION; MORTALITY; DECLINE; ADULT; WOMEN	Objective: To establish the reliability and validity of a shortened (10-item) depression scale used among HIV-positive patients enrolled in the Drug Treatment Program in British Columbia, Canada. Methods: The 10-item CES-D (Center for Epidemiologic Studies Depression Scale) was examined among 563 participants who initiated antiretroviral therapy (ART) between August 1, 1996 and June 30, 2002. Internal consistency of the scale was measured by Cronbach's alpha. Using the original CES-D 20 as primary criteria, comparisons were made using the Kappa statistic. Predictive accuracy of CES-D 10 was assessed by calculating sensitivity, specificity, positive predictive values and negative predictive values. Factor analysis was also performed to determine if the CES-D 10 contained the same factors of positive and negative affect found in the original development of the CES-D. Results: The correlation between the original and the shortened scale is very high (Spearman correlation coefficient = 0.97 (P < 0.001). Internal consistency reliability coefficients of the CES-D 10 were satisfactory (Cronbach alpha = 0.88). The CES-D 10 showed comparable accuracy to the original CES-D 20 in classifying participants with depressive symptoms (Kappa = 0.82, P < 0.001). Sensitivity of CES-D 10 was 91%; specificity was 92%; and positive predictive value was 92%. Factor analysis demonstrates that CES-D 10 contains the same underlying factors of positive and negative affect found in the original development of the CES-D 20. Conclusion: The 10-item CES-D is a comparable tool to measure depressive symptoms among HIV-positive research participants.	[Zhang, Wendy; O'Brien, Nadia; Forrest, Jamie I.; Salters, Kate A.; Montaner, Julio S. G.; Hogg, Robert S.; Lima, Viviane D.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Patterson, Thomas L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Montaner, Julio S. G.; Lima, Viviane D.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of California System; University of California San Diego; University of British Columbia; Simon Fraser University	Zhang, W (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	vlima@cfenet.ubc.ca	Montaner, Julio/K-7621-2012	Hogg, Robert/0000-0003-3463-5488	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; National Institutes of Health; Canadian Institutes of Health Research National Health Research Development Program; Health Canada; GlaxoSmithKline; Merck Laboratory; Frosst Laboratory; Abbott; Biolytical; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck; ViiV Healthcare; Ministry of Health Services; Ministry of Healthy Living and Sport; Province of British Columbia; Canadian Institutes of Health Research (CIHR); National Institute of Drug Abuse, at the U.S. National Institutes of Health [1DP1DA026182-01]; International AIDS Society; United Nations AIDS Program; World Health Organization; National Institute on Drug Abuse; National Institutes of Health Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); Bill & Melinda Gates Foundation; French National Agency for Research on AIDS & Viral Hepatitis (ANRS); Public Health Agency of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research National Health Research Development Program(Canadian Institutes of Health Research (CIHR)); Health Canada; GlaxoSmithKline(GlaxoSmithKline); Merck Laboratory(Merck & Company); Frosst Laboratory; Abbott(Abbott Laboratories); Biolytical; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); ViiV Healthcare; Ministry of Health Services; Ministry of Healthy Living and Sport; Province of British Columbia; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Drug Abuse, at the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health Research-Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); French National Agency for Research on AIDS & Viral Hepatitis (ANRS); Public Health Agency of Canada	This work was supported by the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research through Fellowship Awards to Dr. Lima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts to report: Dr. Robert Hogg has held grant funding from the National Institutes of Health, Canadian Institutes of Health Research National Health Research Development Program, Health Canada, GlaxoSmithKline and Merck Frosst Laboratories. Dr. Julio S.G. Montaner has received grants from Abbott, Biolytical, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. He is also supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); and through an Avant-Garde Award (No. 1DP1DA026182-01) from the National Institute of Drug Abuse, at the U.S. National Institutes of Health. He has also received support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institute on Drug Abuse, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), Bill & Melinda Gates Foundation, French National Agency for Research on AIDS & Viral Hepatitis (ANRS), Public Health Agency of Canada. He has academic partnerships with the University of British Columbia, Simon Fraser University, Providence Health Care and Vancouver Coastal Health. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boey KW, 1999, INT J GERIATR PSYCH, V14, P608, DOI 10.1002/(SICI)1099-1166(199908)14:8<608::AID-GPS991>3.0.CO;2-Z; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Evans DL, 2002, AM J PSYCHIAT, V159, P1752, DOI 10.1176/appi.ajp.159.10.1752; Golub ET, 2004, J URBAN HEALTH, V81, P278, DOI 10.1093/jurban/jth114; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hartzell JD, 2007, JAIDS-J ACQ IMM DEF, V44, P411, DOI 10.1097/QAI.0b013e31802f83a6; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Mayne TJ, 1996, ARCH INTERN MED, V156, P2233, DOI 10.1001/archinte.156.19.2233; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; Penzak SR, 2000, AM J HEALTH-SYST PH, V57, P376, DOI 10.1093/ajhp/57.4.376; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Wilcox H, 1998, ADOLESCENCE, V33, P565	21	262	262	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40793	10.1371/journal.pone.0040793	http://dx.doi.org/10.1371/journal.pone.0040793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981GZ	22829885	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300023
J	Rogers, TE; Ataide, SF; Dare, K; Katz, A; Seveau, S; Roy, H; Ibba, M				Rogers, Theresa E.; Ataide, Sandro F.; Dare, Kiley; Katz, Assaf; Seveau, Stephanie; Roy, Herve; Ibba, Michael			A Pseudo-tRNA Modulates Antibiotic Resistance in Bacillus cereus	PLOS ONE			English	Article							REGULATED SMALL RNA; NITRIC-OXIDE; FUNCTIONAL IMPLICATIONS; ESCHERICHIA-COLI; IRON-METABOLISM; BACTERIA; SUBTILIS; GENES; MECHANISM; PROTEINS	Bacterial genomic islands are often flanked by tRNA genes, which act as sites for the integration of foreign DNA into the host chromosome. For example, Bacillus cereus ATCC14579 contains a pathogenicity island flanked by a predicted pseudo-tRNA, tRNA(Other), which does not function in translation. Deletion of tRNA(Other) led to significant changes in cell wall morphology and antibiotic resistance and was accompanied by changes in the expression of numerous genes involved in oxidative stress responses, several of which contain significant complementarities to sequences surrounding tRNA(Other). This suggested that tRNA(Other) might be expressed as part of a larger RNA, and RACE analysis subsequently confirmed the existence of several RNA species that significantly extend both the 39 and 5'-ends of tRNA(Other). tRNA(Other) expression levels were found to be responsive to changes in extracellular iron concentration, consistent with the presence of three putative ferric uptake regulator (Fur) binding sites in the 59 leader region of one of these larger RNAs. Taken together with previous data, this study now suggests that tRNA(Other) may function by providing a tRNA-like structural element within a larger regulatory RNA. These findings illustrate that while integration of genomic islands often leaves tRNA genes intact and functional, in other instances inactivation may generate tRNA-like elements that are then recruited to other functions in the cell.	[Rogers, Theresa E.; Ataide, Sandro F.; Dare, Kiley; Katz, Assaf; Seveau, Stephanie; Roy, Herve; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Roy, Herve] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Ibba, Michael] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; State University System of Florida; University of Central Florida; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Rogers, TE (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu	Katz, Assaf/R-7504-2019; Katz, Assaf/K-7130-2018; Seveau, Stephanie/E-4060-2011	Katz, Assaf/0000-0001-5481-7399; Rogers, Theresa/0000-0002-9741-5768; F Ataide, Sandro/0000-0003-1807-5708	National Institutes of Health [GM 65183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM 65183 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataide SF, 2009, RNA BIOL, V6, P479, DOI 10.4161/rna.6.4.9332; Ataide SF, 2005, EMBO REP, V6, P742, DOI 10.1038/sj.embor.7400474; Banerjee R, 2010, FEBS LETT, V584, P387, DOI 10.1016/j.febslet.2009.11.013; Baron Christian, 1995, P529; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buddha MR, 2004, P NATL ACAD SCI USA, V101, P15881, DOI 10.1073/pnas.0405483101; Cao Y, 2009, BIOINFORMATION, V3, P364, DOI 10.6026/97320630003364; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Dorazi R, 2003, J THEOR BIOL, V225, P383, DOI 10.1016/S0022-5193(03)00268-6; Dreher TW, 2009, VIRUS RES, V139, P217, DOI 10.1016/j.virusres.2008.06.010; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Fechter P, 2001, CELL MOL LIFE SCI, V58, P1547, DOI 10.1007/PL00000795; Francklyn CS, 2010, FEBS LETT, V584, P366, DOI 10.1016/j.febslet.2009.11.045; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Giannouli S, 2009, BIOCHIMIE, V91, P344, DOI 10.1016/j.biochi.2008.10.009; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Haghighat AC, 2010, J IMMUNOL METHODS, V352, P186, DOI 10.1016/j.jim.2009.11.013; Haiser HJ, 2008, NUCLEIC ACIDS RES, V36, P732, DOI 10.1093/nar/gkm1096; Hammond JA, 2009, RNA, V15, P294, DOI 10.1261/rna.1360709; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Hou YM, 1999, TRENDS BIOCHEM SCI, V24, P295, DOI 10.1016/S0968-0004(99)01428-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; LANGENBERGER D, PAC S BIOCOMPUT, P80; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li Y, 2008, NUCLEIC ACIDS RES, V36, P6048, DOI 10.1093/nar/gkn596; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POPHAM DL, 1995, J BACTERIOL, V177, P326, DOI 10.1128/jb.177.2.326-335.1995; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Ryckelynck M, 2005, BIOCHIMIE, V87, P835, DOI 10.1016/j.biochi.2005.02.014; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Steinberg S, 1997, J MOL BIOL, V266, P269, DOI 10.1006/jmbi.1996.0803; STEWART TS, 1971, NATURE, V230, P36, DOI 10.1038/230036a0; Strube K, 2007, J BIOL CHEM, V282, P20292, DOI 10.1074/jbc.M702003200; Taquist H, 2007, NUCLEIC ACIDS RES, V35, pW350, DOI 10.1093/nar/gkm393; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yan L, 2009, SCI CHINA SER C, V52, P245, DOI 10.1007/s11427-009-0039-y	61	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41248	10.1371/journal.pone.0041248	http://dx.doi.org/10.1371/journal.pone.0041248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815980	gold, Green Published			2022-12-25	WOS:000306548900100
J	Wu, J; Mukherjee, A; Lebman, DA; Fang, X				Wu, J.; Mukherjee, A.; Lebman, D. A.; Fang, X.			Gene expression of the lysophosphatidic acid receptor 1 is a target of transforming growth factor beta	ONCOGENE			English	Article						cancer; LPA; TGF beta; LPA1; migration; invasion	BREAST-CANCER CELLS; PROTEIN-COUPLED RECEPTOR; SMAD-BINDING-ELEMENT; TGF-BETA; OVARIAN-CANCER; EPITHELIAL-CELLS; LPA RECEPTORS; C-MYC; MOTILITY; METASTASIS	The lysophosphatidic acid (LPA) receptor LPA(1)/Edg2 is the first identified LPA receptor. Although its wide tissue distribution and biological functions have been well studied, little is known about how LPA(1) is transcriptionally regulated. In the current study, we showed that LPA(1) is a physiological target of transforming growth factor beta (TGF beta)-mediated repression. In both normal and neoplastic cells, TGF beta inhibits LPA(1) promoter activity, LPA(1) mRNA expression and LPA(1)-dependent chemotaxis and tumor cell invasion. Knockdown of the TGF beta intracellular effector Smad3 or Smad4 with lentivirally transduced short hairpin RNA relieved these inhibitory effects of TGF beta. Interestingly, the LPA(1) promoter contains two potential TGF beta inhibitory elements (TIEs), each consisting of a Smad-binding site and an adjacent E2F4/5 element, structurally similar to the TIE found on the promoter of the well-defined TGF beta target gene c-myc. Deletion and point mutation analyses indicate that the distal TIE located at 401 bp from the transcription initiation site, is required for TGF beta repression of the LPA(1) promoter. A DNA pull-down assay showed that the -401 TIE was capable of binding Samd3 and E2F4 in TGF beta-treated cells. TGF beta-induced binding of the Smad complex to the native -401 TIE sequence of the LPA(1) gene promoter was further verified by chromatin immunoprecipitation assays. We therefore identified a novel role of TGF beta in the control of LPA(1) expression and LPA(1)-coupled biological functions, adding LPA(1) to the list of TGF beta-repressed target genes.	[Wu, J.; Mukherjee, A.; Fang, X.] Virginia Commonwealth Univ, Dept Biochem, Sch Med, Richmond, VA 23298 USA; [Wu, J.; Mukherjee, A.; Fang, X.] Virginia Commonwealth Univ, Dept Mol Biol, Sch Med, Richmond, VA 23298 USA; [Lebman, D. A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Fang, X (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, POB 980614,Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA.	xfang@vcu.edu			NIH/NCI [2R01CA102196]; Department of Defense [W81XWH-11-1-0541]; Jeffress Memorial Fund award; NIH [P30 CA16059]; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA102196] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Jeffress Memorial Fund award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported in part by the NIH/NCI grant 2R01CA102196 (XF), the Department of Defense ovarian cancer research program grant W81XWH-11-1-0541 (XF), the Jeffress Memorial Fund award (XF), and the NIH grant P30 CA16059 to Massey Cancer Center of Virginia Commonwealth University School of Medicine.	AUERSPERG N, 1994, LAB INVEST, V71, P510; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blount AL, 2008, J BIOL CHEM, V283, P7016, DOI 10.1074/jbc.M709502200; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Horak CE, 2007, CANCER RES, V67, P11751, DOI 10.1158/0008-5472.CAN-07-3175; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jazag A, 2005, ONCOGENE, V24, P662, DOI 10.1038/sj.onc.1208102; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Li JM, 1997, P NATL ACAD SCI USA, V94, P4948, DOI 10.1073/pnas.94.10.4948; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Marshall JC, 2010, EUR J CANCER, V46, P1278, DOI 10.1016/j.ejca.2010.02.042; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pradere JP, 2007, J AM SOC NEPHROL, V18, P3110, DOI 10.1681/ASN.2007020196; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Sauer B, 2004, J INVEST DERMATOL, V123, P840, DOI 10.1111/j.0022-202X.2004.23458.x; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Shida D, 2004, LAB INVEST, V84, P1352, DOI 10.1038/labinvest.3700146; Shida D, 2003, CANCER RES, V63, P1706; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Stadler CR, 2006, CELL SIGNAL, V18, P783, DOI 10.1016/j.cellsig.2005.07.002; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sugiyama N, 2010, P NATL ACAD SCI USA, V107, P15786, DOI 10.1073/pnas.0914459107; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; Wu JH, 2011, MOL CANCER RES, V9, P1562, DOI 10.1158/1541-7786.MCR-11-0340; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378	51	8	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 27	2013	32	26					3198	3206		10.1038/onc.2012.325	http://dx.doi.org/10.1038/onc.2012.325			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22824789	Green Accepted			2022-12-25	WOS:000321004600010
J	Su, PC; Berger, BW				Su, Pin-Chuan; Berger, Bryan W.			Identifying Key Juxtamembrane Interactions in Cell Membranes Using AraC-based Transcriptional Reporter Assay (AraTM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN INTERACTIONS; PROTEIN-PROTEIN INTERACTIONS; SIGNAL-TRANSDUCTION; RECEPTOR; RAGE; DIMERIZATION; ASSOCIATION; EXPRESSION; BINDING; OLIGOMERIZATION	Dimerization is a key regulatory mechanism in activation of transmembrane (TM) receptors during signal transduction. This process involves a coordinated interplay between extracellular (EX), TM, and cytoplasmic (CYTO) regions to form a specific interface required for both ligand binding and intracellular signaling to occur. While several transcriptional activator-based methods exist for investigating TM interactions in bacterial membranes, expression of TM chimera in these methods occurs in a reverse orientation, and are limited to only TM domains for proper membrane trafficking and integration. We therefore developed a new, AraC-based transcriptional reporter assay (AraTM) that expresses EX-TM-CYTO chimera in their native orientation, thereby enabling membrane trafficking to occur independent of the TM chimera used as well as permitting analysis of EX-TM-CYTO interactions in biological membranes. Using integrin alpha(IIb) TM-CYTO as a model, we observe a large increase in homodimerization for the constitutively active TM mutant L980A relative to wild-type in the TM-CYTO construct (A963-E1008). We also characterized the receptor for advanced glycation endproducts (RAGE), whose homooligomeric state is critical in ligand recognition, and find the specific juxtamembrane region within the CYTO (A375-P394) mediates homodimerization, and is dominant over effects observed when the extracellular C2 domain is included. Furthermore, we find good agreement between our AraTM measurements in bacterial membranes and BRET measurements made on corresponding RAGE constructs expressed in transfected HEK293 cells. Overall, the AraTM assay provides a new approach to identify specific interactions between receptor EX-TM-CYTO domains in biological membranes that are important in regulation of signal transduction.	[Su, Pin-Chuan; Berger, Bryan W.] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA; [Berger, Bryan W.] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University	Berger, BW (corresponding author), Lehigh Univ, Dept Chem Engn, B320 Iacocca Hall,111 Res Dr, Bethlehem, PA 18015 USA.	bwb209@lehigh.edu	Berger, Bryan/D-7985-2014	Berger, Bryan/0000-0002-6135-8677	Lehigh University	Lehigh University	This work was supported by Lehigh University, including funds provided through a Faculty Research Grant (FRG).	Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; Buensuceso C, 2003, J BIOL CHEM, V278, P15217, DOI 10.1074/jbc.M213234200; BUSTOS SA, 1993, P NATL ACAD SCI USA, V90, P5638, DOI 10.1073/pnas.90.12.5638; DIRITA VJ, 1992, MOL MICROBIOL, V6, P451, DOI 10.1111/j.1365-2958.1992.tb01489.x; Duong MT, 2007, J MOL BIOL, V371, P422, DOI 10.1016/j.jmb.2007.05.026; Eustance RJ, 1996, PROTEINS, V25, P501, DOI 10.1002/(SICI)1097-0134(199608)25:4<501::AID-PROT9>3.3.CO;2-1; Gurezka R, 2001, J BIOL CHEM, V276, P45580, DOI 10.1074/jbc.M105362200; Haber-Pohlmeier S, 2007, BIOPHYS J, V92, P3207, DOI 10.1529/biophysj.106.094847; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; KOLMAR H, 1995, EMBO J, V14, P3895, DOI 10.1002/j.1460-2075.1995.tb00061.x; Ladant D, 2000, RES MICROBIOL, V151, P711, DOI 10.1016/S0923-2508(00)01136-0; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Metcalf DG, 2009, J MOL BIOL, V392, P1087, DOI 10.1016/j.jmb.2009.06.032; Mo X, 2008, J THROMB HAEMOST, V6, P1789, DOI 10.1111/j.1538-7836.2008.03088.x; Mo X, 2008, FEBS LETT, V582, P3270, DOI 10.1016/j.febslet.2008.08.036; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; NIKAIDO H, 1994, FEBS LETT, V346, P55, DOI 10.1016/0014-5793(94)00315-7; Oates J, 2010, BBA-BIOMEMBRANES, V1798, P605, DOI 10.1016/j.bbamem.2009.12.016; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ott CM, 2002, J CELL SCI, V115, P2003; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Scartezzini P, 1997, HUM GENET, V99, P387, DOI 10.1007/s004390050377; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Weldon JE, 2006, PROTEIN SCI, V15, P2828, DOI 10.1110/ps.062327506; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	40	19	19	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31515	31526		10.1074/jbc.M112.396895	http://dx.doi.org/10.1074/jbc.M112.396895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822084	Green Published, hybrid			2022-12-25	WOS:000308791300064
J	Shingate, P; Sowdhamini, R				Shingate, Prashant; Sowdhamini, R.			Analysis of Domain-Swapped Oligomers Reveals Local Sequence Preferences and Structural Imprints at the Linker Regions and Swapped Interfaces	PLOS ONE			English	Article							HIV-INACTIVATING PROTEIN; CRYSTAL-STRUCTURE; CYANOVIRIN-N; 3D; EVOLUTION; SERVER; BETA-B2-CRYSTALLIN; CONSERVATION; DIMERIZATION; PREDICTION	Background: 3D domain swapping is an oligomerization process in which structural elements get exchanged between subunits. This mechanism grasped interest of many researchers due to its association with neurodegenerative diseases like Alzheimer's disease, spongiform encephalopathy etc. Despite the biomedical relevance, very little is known about understanding this mechanism. The quest for ruling principles behind this curious phenomenon that could enable early prediction provided an impetus for our bioinformatics studies. Methodology: A novel method, HIDE, has been developed to find non-domain-swapped homologues and to identify hinge from domain-swapped oligomers. Non-domain-swapped homologues were identified from the protein structural databank for majority of the domain-swapped entries and hinge boundaries could be recognised automatically by means of successive superposition techniques. Different sequence and structural features in domain-swapped proteins and related proteins have also been analysed. Conclusions: The HIDE algorithm was able to identify hinge region in 83% cases. Sequence and structural analyses of hinge and interfaces reveal amino acid preferences and specific conformations of residues at hinge regions, while comparing the domain-swapped and non-domain-swapped states. Interactions differ significantly between regular dimeric interfaces and interface formed at the site of domain-swapped examples. Such preferences of residues, conformations and interactions could be of predictive value.	[Shingate, Prashant; Sowdhamini, R.] Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Shingate, P (corresponding author), Natl Ctr Biol Sci, UAS GKVK Campus, Bangalore, Karnataka, India.	mini@ncbs.res.in	Shingate, Prashant/ABC-1411-2020					Alva V, 2008, PROTEIN PEPTIDE LETT, V15, P33; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chirgadze DY, 2004, STRUCTURE, V12, P1489, DOI 10.1016/j.str.2004.06.011; Chu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013361; Hadjithomas M, 2011, P NATL ACAD SCI USA, V108, P13462, DOI 10.1073/pnas.1108649108; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang K, 1999, STRUCT FOLD DES, V7, P539, DOI 10.1016/S0969-2126(99)80070-7; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Nagradova NK, 2002, BIOCHEMISTRY-MOSCOW+, V67, P839, DOI 10.1023/A:1019958402194; O'Neill JW, 2001, STRUCTURE, V9, P1017, DOI 10.1016/S0969-2126(01)00667-0; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Pintar A, 2002, BIOINFORMATICS, V18, P980, DOI 10.1093/bioinformatics/18.7.980; RAMAKRISHNAN C, 1988, COLLECT CZECH CHEM C, V53, P2801, DOI 10.1135/cccc19882801; Ramoni R, 2002, BIOCHEM J, V365, P739, DOI 10.1042/BJ20011631; Shameer K, 2011, DATABASE         APR, V2011, P1; Shameer K, 2011, PROTEIN PEPTIDE LETT, V18, P1010, DOI 10.2174/092986611796378729; Smith MA, 2007, PROTEIN SCI, V16, P615, DOI 10.1110/ps.062659107; SRINIVASAN N, 1991, MOL CONFORMATION BIO, P59; TRINKL S, 1994, PROTEIN SCI, V3, P1392, DOI 10.1002/pro.5560030905; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	35	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39305	10.1371/journal.pone.0039305	http://dx.doi.org/10.1371/journal.pone.0039305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848353	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950200009
J	Sharron, M; Hoptay, CE; Wiles, AA; Garvin, LM; Geha, M; Benton, AS; Nagaraju, K; Freishtat, RJ				Sharron, Matthew; Hoptay, Claire E.; Wiles, Andrew A.; Garvin, Lindsay M.; Geha, Mayya; Benton, Angela S.; Nagaraju, Kanneboyina; Freishtat, Robert J.			Platelets Induce Apoptosis during Sepsis in a Contact-Dependent Manner That Is Inhibited by GPIIb/IIIa Blockade	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; GRANZYME-B; SEPTIC SHOCK; ESCHERICHIA-COLI; ANTIPLATELET DRUGS; MURINE MODEL; FAILURE; SURVIVAL; EPIDEMIOLOGY; INVOLVEMENT	Purpose: End-organ apoptosis is well-described in progressive sepsis and Multiple Organ Dysfunction Syndrome (MODS), especially where platelets accumulate (e.g. spleen and lung). We previously reported an acute sepsis-induced cytotoxic platelet phenotype expressing serine protease granzyme B. We now aim to define the site(s) of and mechanism(s) by which platelet granzyme B induces end-organ apoptosis in sepsis. Methods: End-organ apoptosis in murine sepsis (i.e. polymicrobial peritonitis) was analyzed by immunohistochemistry. Platelet cytotoxicity was measured by flow cytometry following 90 minute ex vivo co-incubation with healthy murine splenocytes. Sepsis progression was measured via validated preclinical murine sepsis score. Measurements and Main Results: There was evident apoptosis in spleen, lung, and kidney sections from septic wild type mice. In contrast, there was a lack of TUNEL staining in spleens and lungs from septic granzyme B null mice and these mice survived longer following induction of sepsis than wild type mice. In co-incubation experiments, physical separation of septic platelets from splenocytes by a semi-permeable membrane reduced splenocyte apoptosis to a rate indistinguishable from negative controls. Chemical separation by the platelet GPIIb/IIIa receptor inhibitor eptifibatide decreased apoptosis by 66.6 +/- 10.6% (p = 0.008). Mice treated with eptifibatide in vivo survived longer following induction of sepsis than vehicle control mice. Conclusions: In sepsis, platelet granzyme B-mediated apoptosis occurs in spleen and lung, and absence of granzyme B slows sepsis progression. This process proceeds in a contact-dependent manner that is inhibited ex vivo and in vivo by the platelet GPIIb/ IIIa receptor inhibitor eptifibatide. The GPIIb/ IIIa inhibitors and other classes of anti-platelet drugs may be protective in sepsis.	[Sharron, Matthew; Geha, Mayya; Nagaraju, Kanneboyina; Freishtat, Robert J.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Sharron, Matthew] Childrens Natl Med Ctr, Div Crit Care Med, Washington, DC 20010 USA; [Sharron, Matthew; Nagaraju, Kanneboyina; Freishtat, Robert J.] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA; [Hoptay, Claire E.; Wiles, Andrew A.; Garvin, Lindsay M.; Benton, Angela S.; Nagaraju, Kanneboyina; Freishtat, Robert J.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Hoptay, Claire E.; Garvin, Lindsay M.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Freishtat, Robert J.] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA	George Washington University; Children's National Health System; George Washington University; Children's National Health System; George Washington University; Children's National Health System	Freishtat, RJ (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.	rfreishtat@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021	Freishtat, Robert/0000-0002-7411-2342	NIH National Center for Advancing Translational Sciences [UL1RR031988 /UL1TR000075]; National Institutes of Health, Bethesda, Maryland, USA [K23RR020069]; George Washington University School of Medicine and Health Sciences; Children's National Medical Center, Washington, DC, USA; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR020069, UL1RR031988] Funding Source: NIH RePORTER	NIH National Center for Advancing Translational Sciences; National Institutes of Health, Bethesda, Maryland, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); George Washington University School of Medicine and Health Sciences; Children's National Medical Center, Washington, DC, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by Award Number UL1RR031988 /UL1TR000075 from the NIH National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. Additional funding support was provided by grants K23RR020069 (RJF) from the National Institutes of Health, Bethesda, Maryland, USA and institutional grants from George Washington University School of Medicine and Health Sciences (MS) and Children's National Medical Center (MS, RJF), Washington, DC, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Azevedo L. C. P., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P159; Bougaki M, 2010, SHOCK, V34, P281, DOI 10.1097/SHK.0b013e3181cdc327; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Chung CS, 2010, SHOCK, V34, P150, DOI 10.1097/SHK.0b013e3181cf70fb; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Dmowski WP, 2001, HUM REPROD, V16, P1802, DOI 10.1093/humrep/16.9.1802; DRAKE TA, 1993, AM J PATHOL, V142, P1458; Erlich JM, 2011, CHEST, V139, P289, DOI 10.1378/chest.10-0891; Freishtat RJ, 2009, AM J RESP CRIT CARE, V179, P467, DOI 10.1164/rccm.200807-1085OC; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hamiovigtz-Friedman A, 1997, J EXP MED, V186, P1831; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inoue S, 2010, J IMMUNOL, V184, P1401, DOI 10.4049/jimmunol.0902307; Janiszewski M, 2004, CRIT CARE MED, V32, P818, DOI 10.1097/01.CCM.0000114829.17746.19; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; KNAUS WA, 1989, CRIT CARE CLIN, V5, P221; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lipcsey M, 2005, PLATELETS, V16, P408, DOI 10.1080/09537100500163168; Mutunga M, 2001, AM J RESP CRIT CARE, V163, P195, DOI 10.1164/ajrccm.163.1.9912036; Phillips DR, 1997, AM J CARDIOL, V80, pB11, DOI 10.1016/S0002-9149(97)00572-9; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; PHILLIPS DR, 1988, BLOOD, V71, P831; Pu Q, 2001, CRIT CARE MED, V29, P1181, DOI 10.1097/00003246-200106000-00019; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; SCHNEIDER RC, 1980, AM REV RESPIR DIS, V122, P445; Seidel M, 2009, J THROMB HAEMOST, V7, P1030, DOI 10.1111/j.1538-7836.2009.03352.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shibazaki M, 1999, INFECT IMMUN, V67, P5186, DOI 10.1128/IAI.67.10.5186-5191.1999; Shibazaki M, 1996, INFECT IMMUN, V64, P5290, DOI 10.1128/IAI.64.12.5290-5294.1996; SIGURDSSON GH, 1992, CRIT CARE MED, V20, P458, DOI 10.1097/00003246-199204000-00005; Taylor FB, 1997, BLOOD, V89, P4078, DOI 10.1182/blood.V89.11.4078; Trapani JA, 1998, J BIOL CHEM, V273, P27934, DOI 10.1074/jbc.273.43.27934; Vollmar B, 2003, MICROCIRCULATION, V10, P143, DOI 10.1038/sj.mn.7800179; Waterhouse NJ, 2006, IMMUNOL CELL BIOL, V84, P72, DOI 10.1111/j.1440-1711.2005.01416.x; Waterhouse NJ, 2006, CELL DEATH DIFFER, V13, P607, DOI 10.1038/sj.cdd.4401772; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; WILKINSON JD, 1986, CRIT CARE MED, V14, P271, DOI 10.1097/00003246-198604000-00002; WILKINSON JD, 1987, J PEDIATR-US, V111, P324, DOI 10.1016/S0022-3476(87)80448-1; Winning J, 2010, CRIT CARE MED, V38, P32, DOI 10.1097/CCM.0b013e3181b4275c; Winning J, 2009, PLATELETS, V20, P50, DOI 10.1080/09537100802503368; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998; Zhou M, 2004, ANN SURG, V240, P321, DOI 10.1097/01.sla.0000133253.45591.5b	51	47	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41549	10.1371/journal.pone.0041549	http://dx.doi.org/10.1371/journal.pone.0041549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844498	Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600034
J	Carranza, F; Falcon, CR; Nunez, N; Knubel, C; Correa, SG; Bianco, I; Maccioni, M; Fretes, R; Triquell, MF; Motran, CC; Cervi, L				Carranza, Franco; Roberto Falcon, Cristian; Nunez, Nicolas; Knubel, Carolina; Graciela Correa, Silvia; Bianco, Ismael; Maccioni, Mariana; Fretes, Ricardo; Fernanda Triquell, Maria; Cristina Motran, Claudia; Cervi, Laura			Helminth Antigens Enable CpG-Activated Dendritic Cells to Inhibit the Symptoms of Collagen-induced Arthritis through Foxp3+Regulatory T Cells	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE TOLERANCE; TH1 RESPONSES; MOUSE MODEL; SUPPRESSION; MECHANISMS; INDUCTION; IMMUNOMODULATION; GENERATION	Dendritic cells (DC) have the potential to control the outcome of autoimmunity by modulating the immune response. In this study, we tested the ability of Fasciola hepatica total extract (TE) to induce tolerogenic properties in CpG-ODN (CpG) maturated DC, to then evaluate the therapeutic potential of these cells to diminish the inflammatory response in collagen induced arthritis (CIA). DBA/1J mice were injected with TE plus CpG treated DC (T/C-DC) pulsed with bovine collagen II (CII) between two immunizations with CII and clinical scores CIA were determined. The levels of CII-specific IgG2 and IgG1 in sera, the histological analyses in the joints, the cytokine profile in the draining lymph node (DLN) cells and in the joints, and the number, and functionality of CD4+CD25+Foxp3+ T cells (Treg) were evaluated. Vaccination of mice with CII pulsed T/C-DC diminished the severity and incidence of CIA symptoms and the production of the inflammatory cytokine, while induced the production of anti-inflammatory cytokines. The therapeutic effect was mediated by Treg cells, since the adoptive transfer of CD4+CD25+ T cells, inhibited the inflammatory symptoms in CIA. The in vitro blockage of TGF-beta in cultures of DLN cells plus CII pulsed T/C-DC inhibited the expansion of Treg cells. Vaccination with CII pulsed T/C-DC seems to be a very efficient approach to diminish exacerbated immune response in CIA, by inducing the development of Treg cells, and it is therefore an interesting candidate for a cell-based therapy for rheumatoid arthritis (RA).	[Carranza, Franco; Roberto Falcon, Cristian; Nunez, Nicolas; Knubel, Carolina; Graciela Correa, Silvia; Maccioni, Mariana; Cristina Motran, Claudia; Cervi, Laura] Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, RA-5000 Cordoba, Argentina; [Bianco, Ismael] Consejo Nacl Invest Cient & Tecn, Agencia Cordoba Ciencia, Ctr Excelencia Prod & Proc Prov Cordoba CEPROCOR, Cordoba, Argentina; [Fretes, Ricardo; Fernanda Triquell, Maria] Univ Nacl Cordoba, Fac Ciencias Med, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Carranza, F (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, RA-5000 Cordoba, Argentina.	lcervi@fcq.unc.edu.ar	Motran, Claudia/U-9106-2019	Motran, Claudia/0000-0002-8088-3901	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET); Agencia de Promocion Cientifica y Tecnologica [PICT 2005-32027]	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) and Agencia de Promocion Cientifica y Tecnologica (PICT 2005-32027). FC, CRF, NN, CK and MFT are PhD fellows of CONICET, LC, SGC, IB, MM and CCM are members of the Scientific Career of Consejo Nacional de Investigaciones Cientificas de Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2004, SEMIN IMMUNOL, V16, P127, DOI 10.1016/j.smim.2003.12.008; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Bianco ID, 2000, FEBS LETT, V466, P292, DOI 10.1016/S0014-5793(00)01089-9; Brady MT, 1999, INFECT IMMUN, V67, P5372, DOI 10.1128/IAI.67.10.5372-5378.1999; Breedveld FC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3093; Campbell IK, 2009, ARTHRITIS RHEUM-US, V60, P1683, DOI 10.1002/art.24501; Cervi L, 1996, VET PARASITOL, V61, P97, DOI 10.1016/0304-4017(95)00816-0; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Falcon C, 2010, VET IMMUNOL IMMUNOP, V137, P36, DOI 10.1016/j.vetimm.2010.04.007; Falcon CR, 2012, J INFECT DIS, V205, P506, DOI 10.1093/infdis/jir606; Fallarino F, 2011, CURR MED CHEM, V18, P2215, DOI 0929-8673/11 $58.00+.00; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Gonzalez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007009; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; Harry RA, 2010, ANN RHEUM DIS, V69, P2042, DOI 10.1136/ard.2009.126383; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Khan S, 2009, NAT REV RHEUMATOL, V5, P566, DOI 10.1038/nrrheum.2009.185; Kudo Y, 2000, BBA-MOL BASIS DIS, V1500, P119, DOI 10.1016/S0925-4439(99)00096-4; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; MAIZELS R, 2007, NOVART FDN SYMP, V281, P204; Maizels Rick, 2007, Novartis Found Symp, V281, P192; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2361; Popov I, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2031; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; SEKI N, 1988, J IMMUNOL, V140, P1477; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Sidhu M, 2009, CLIN EXP IMMUNOL, V157, P350, DOI 10.1111/j.1365-2249.2009.03968.x; Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x; Stoop JN, 2011, ANN RHEUM DIS, V70, P1526, DOI 10.1136/ard.2011.151654; Thomson AW, 2008, ANN RHEUM DIS, V67, P90, DOI 10.1136/ard.2008.099176; van Duivenvoorde LM, 2007, J IMMUNOL, V179, P1506, DOI 10.4049/jimmunol.179.3.1506; van Duivenvoorde LM, 2004, ARTHRITIS RHEUM-US, V50, P3354, DOI 10.1002/art.20513; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803	44	46	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40356	10.1371/journal.pone.0040356	http://dx.doi.org/10.1371/journal.pone.0040356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848374	Green Published, gold, Green Submitted			2022-12-25	WOS:000306806600015
J	Ohana, O; Portner, H; Martin, KAC				Ohana, Ora; Portner, Hanspeter; Martin, Kevan A. C.			Fast Recruitment of Recurrent Inhibition in the Cat Visual Cortex	PLOS ONE			English	Article							THALAMOCORTICAL FEEDFORWARD INHIBITION; FAST-SPIKING INTERNEURONS; RECEPTIVE-FIELD STRUCTURE; SPINY STELLATE NEURONS; LAYER 4 NEURONS; STRIATE CORTEX; SYNAPTIC CONNECTIONS; GABA(A) RECEPTORS; IN-VITRO; ORIENTATION SELECTIVITY	Neurons of the same column in L4 of the cat visual cortex are likely to share the same sensory input from the same region of the visual field. Using visually-guided patch clamp recordings we investigated the biophysical properties of the synapses of neighboring layer 4 neurons. We recorded synaptic connections between all types of excitatory and inhibitory neurons in L4. The E-E, E-I, and I-E connections had moderate CVs and failure rates. However, E-I connections had larger amplitudes, faster rise-times, and shorter latencies. Identification of the sites of putative synaptic contacts together with compartmental simulations on 3D reconstructed cells, suggested that E-I synapses tended to be located on proximal dendritic branches, which would explain their larger EPSP amplitudes and faster kinetics. Excitatory and inhibitory synapses were located at the same distance on distal dendrites of excitatory neurons. We hypothesize that this co-localization and the fast recruitment of local inhibition provides an efficient means of modulating excitation in a precisely timed way.	[Ohana, Ora] Univ Med Ctr Hamburg Eppendorf, ZMNH, Ctr Mol Neurobiol, Inst Mol & Cellular Cognit, Hamburg, Germany; [Portner, Hanspeter] Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland; [Martin, Kevan A. C.] Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; ETH Zurich; ETH Zurich; University of Zurich	Ohana, O (corresponding author), Univ Med Ctr Hamburg Eppendorf, ZMNH, Ctr Mol Neurobiol, Inst Mol & Cellular Cognit, Hamburg, Germany.	ora.ohana@zmnh.uni-hamburg.de			EU research grant ['SECO' FP7-216593]; ETH grant [2-73246-08]; DFG [SFB 936]	EU research grant; ETH grant; DFG(German Research Foundation (DFG))	This work was supported by a EU research grant ('SECO' FP7-216593) and by a ETH grant (2-73246-08) to KACM. OO was supported by a DFG, SFB 936 Multi-Site Communication in the Brain, project B4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 1997, J COMP NEUROL, V380, P230; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Ali AB, 2007, J PHYSIOL-LONDON, V580, P149, DOI 10.1113/jphysiol.2006.124214; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; Angulo MC, 1997, J NEUROSCI, V17, P6685; Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Ayaz A, 2009, J NEUROPHYSIOL, V101, P958, DOI 10.1152/jn.90547.2008; Banitt Y, 2007, J NEUROSCI, V27, P10230, DOI 10.1523/JNEUROSCI.1640-07.2007; Bannister NJ, 2002, PHILOS T R SOC B, V357, P1793, DOI 10.1098/rstb.2002.1160; BAUMFALK U, 1988, BRAIN RES, V463, P398, DOI 10.1016/0006-8993(88)90418-0; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Carnevale NT, 2006, NEURON BOOK; Chitwood RA, 1999, J PHYSIOL-LONDON, V515, P743, DOI 10.1111/j.1469-7793.1999.743ab.x; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; da Costa NM, 2009, J NEUROSCI, V29, P13919, DOI 10.1523/JNEUROSCI.2785-09.2009; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Douglas RJ, 1989, NEURAL COMPUT, V1, P480, DOI 10.1162/neco.1989.1.4.480; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1997, J NEUROSCI, V17, P7220; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GU Q, 1993, J COMP NEUROL, V333, P94, DOI 10.1002/cne.903330108; GutierrezIgarza K, 1996, VISUAL NEUROSCI, V13, P61, DOI 10.1017/S0952523800007136; Hines ML, 2004, NEUROCOMPUTING, V58, P1117, DOI 10.1016/j.neucom.2004.01.175; IWAKIRI M, 1993, DEV BRAIN RES, V74, P89, DOI 10.1016/0165-3806(93)90087-Q; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; KISVARDAY ZF, 1985, J COMP NEUROL, V241, P111, DOI 10.1002/cne.902410202; KISVARDAY ZF, 1986, EXP BRAIN RES, V62, P89; Li G, 2008, NEUROSCIENCE, V155, P914, DOI 10.1016/j.neuroscience.2008.06.032; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; Mainen ZF, 1996, J NEUROPHYSIOL, V76, P1904, DOI 10.1152/jn.1996.76.3.1904; MARTIN KAC, 1983, EXP BRAIN RES, V50, P193; MARTIN KAC, 1988, Q J EXP PHYSIOL CMS, V73, P637, DOI 10.1113/expphysiol.1988.sp003190; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Murthy A, 1999, J NEUROPHYSIOL, V81, P1212, DOI 10.1152/jn.1999.81.3.1212; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Petersen CCH, 2000, J NEUROSCI, V20, P7579; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rall W, 1998, METHODS NEURONAL MOD, P27; Saez I, 2009, J NEUROSCI, V29, P4930, DOI 10.1523/JNEUROSCI.0046-09.2009; SEGEV I, 1995, J COMPUT NEUROSCI, V2, P117, DOI 10.1007/BF00961883; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SUAREZ H, 1995, J NEUROSCI, V15, P6700; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Szentagothai J, 1973, HDB SENSORY PHYSL, P269; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Troyer TW, 1998, J NEUROSCI, V18, P5908; van Elburg RAJ, 2009, NEURAL COMPUT, V21, P1913, DOI 10.1162/neco.2009.07-08-815; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; VIDYASAGAR TR, 1994, EXP BRAIN RES, V98, P31; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	75	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40601	10.1371/journal.pone.0040601	http://dx.doi.org/10.1371/journal.pone.0040601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848386	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000306806600022
J	Harren, K; Schumacher, J; Tudzynski, B				Harren, Karin; Schumacher, Julia; Tudzynski, Bettina			The Ca2+/Calcineurin-Dependent Signaling Pathway in the Gray Mold Botrytis cinerea: The Role of Calcipressin in Modulating Calcineurin Activity	PLOS ONE			English	Article							REGULATE GENE-EXPRESSION; ALPHA SUBUNIT BCG1; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-FUMIGATUS; HYPHAL ELONGATION; BINDING-PROTEIN; VIRULENCE; GROWTH	In the gray mold fungus Botrytis cinerea the G alpha subunit Bcg1 of a heterotrimeric G protein is an upstream activator of the Ca2+/calmodulin-dependent phosphatase calcineurin. In this study we focused on the functional characterization of the catalytic subunit of calcineurin (BcCnA) and its putative regulator calcipressin (BcRcn1). We deleted the genes encoding both proteins to examine their role concerning growth, differentiation and virulence. The Delta bccnA mutant shows a severe growth defect, does not produce conidia and is avirulent, while the loss of BcRcn1 caused retardation of hyphal growth and delayed infection of host plants, but had no impact on conidiation and sclerotia formation. Expression of several calcineurin-dependent genes and bccnA itself is positively affected by BcRcn1. Complementation of the Delta bcrcn1 mutant with a GFP-BcRcn1 fusion construct revealed that BcRcn1 is localized in the cytoplasm and accumulates around the nuclei. Furthermore, we showed that BcCnA physically interacts with BcRcn1 and the regulatory subunit of calcineurin, BcCnB. We investigated the impact of several protein domains characteristic for modulation and activation of BcCnA via BcRcn1, such as the phosphorylation sites and the calcineurin-docking site, by physical interaction studies between BcCnA and wild-type and mutated copies of BcRcn1. Based on the observed phenotypes we conclude that BcRcn1 acts as a positive modulator of BcCnA and the Ca2+/calcineurin-mediated signal transduction in B. cinerea, and that both proteins regulate fungal development and virulence.	[Harren, Karin; Schumacher, Julia; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Plants, Munster, Germany	University of Munster	Harren, K (corresponding author), Univ Munster, Inst Biol & Biotechnol Plants, Munster, Germany.	tudzynsb@uni-muenster.de	Schumacher, Julia/B-9142-2019	Schumacher, Julia/0000-0001-9120-9675	Deutsche Forschungsgemeinschaft (DFG) [TU101/10-6]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding was provided by Deutsche Forschungsgemeinschaft (DFG) grant TU101/10-6. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; Bader T, 2006, INFECT IMMUN, V74, P4366, DOI 10.1128/IAI.00142-06; Bastidas RJ, 2008, CURR OPIN INVEST DR, V9, P856; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Egan JD, 2009, MOL PLANT MICROBE IN, V22, P1293, DOI 10.1094/MPMI-22-10-1293; Fox DS, 2005, EUKARYOT CELL, V4, P1526, DOI 10.1128/EC.4.9.1526-1538.2005; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gioti A, 2006, J MOL BIOL, V358, P372, DOI 10.1016/j.jmb.2006.01.076; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Gronover CS, 2004, MOL PLANT MICROBE IN, V17, P537, DOI 10.1094/MPMI.2004.17.5.537; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hilioti Z, 2003, BIOCHEM BIOPH RES CO, V311, P1089, DOI 10.1016/S0006-291X(03)01515-8; Juvvadi PR, 2003, ARCH MICROBIOL, V179, P416, DOI 10.1007/s00203-003-0546-3; Juvvadi PR, 2008, EUKARYOT CELL, V7, P1606, DOI 10.1128/EC.00200-08; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; KANGATHARALINGAM N, 1984, CURR MICROBIOL, V10, P99, DOI 10.1007/BF01575767; Kawai M, 2001, CURR GENET, V39, P166; KAWAMURA A, 1995, J BIOL CHEM, V270, P15463, DOI 10.1074/jbc.270.26.15463; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Leroch M, 2011, APPL ENVIRON MICROB, V77, P2887, DOI 10.1128/AEM.02644-10; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Pinchai N, 2009, EUKARYOT CELL, V8, P511, DOI 10.1128/EC.00336-08; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Reedy J. L., 2010, Fungal Genetics and Biology, V47, P107, DOI 10.1016/j.fgb.2009.09.002; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Rolke Y, 2004, MOL PLANT PATHOL, V5, P17, DOI 10.1111/j.1364-3703.2004.00201.x; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schumacher J, 2008, MOL PLANT MICROBE IN, V21, P1443, DOI 10.1094/MPMI-21-11-1443; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Schumacher J, 2008, MOL MICROBIOL, V67, P1027, DOI 10.1111/j.1365-2958.2008.06105.x; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Soriani FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-12; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Viaud M, 2003, MOL MICROBIOL, V50, P1451, DOI 10.1046/j.1365-2958.2003.03798.x; Wang HL, 2007, IUBMB LIFE, V59, P388, DOI 10.1080/15216540701370721; Wang HL, 2008, BIOCHEMISTRY-US, V47, P4461, DOI 10.1021/bi702539e; Wiesenberger G, 2007, EUKARYOT CELL, V6, P592, DOI 10.1128/EC.00382-06; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI 10.1111/J.1364-3703.2007.00417.X; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	71	31	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41761	10.1371/journal.pone.0041761	http://dx.doi.org/10.1371/journal.pone.0041761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844520	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700147
J	Lee, AWS; Hengstler, H; Schwald, K; Berriel-Diaz, M; Loreth, D; Kirsch, M; Kretz, O; Haas, CA; de Angelis, MH; Herzig, S; Brummendorf, T; Klingenspor, M; Rathjen, FG; Rozman, J; Nicholson, G; Cox, RD; Schafer, MKE				Lee, Angela W. S.; Hengstler, Heidi; Schwald, Kathrin; Berriel-Diaz, Mauricio; Loreth, Desiree; Kirsch, Matthias; Kretz, Oliver; Haas, Carola A.; de Angelis, Martin Hrabe; Herzig, Stephan; Bruemmendorf, Thomas; Klingenspor, Martin; Rathjen, Fritz G.; Rozman, Jan; Nicholson, George; Cox, Roger D.; Schaefer, Michael K. E.			Functional Inactivation of the Genome-Wide Association Study Obesity Gene Neuronal Growth Regulator 1 in Mice Causes a Body Mass Phenotype	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; INCREASED ENERGY-EXPENDITURE; EPITHELIAL OVARIAN-CANCER; NEURITE OUTGROWTH; IGLON FAMILY; HETEROPHILIC INTERACTIONS; TUMOR-SUPPRESSOR; NERVOUS-SYSTEM; DEFICIENT MICE; RAT-BRAIN	To date, genome-wide association studies (GWAS) have identified at least 32 novel loci for obesity and body mass-related traits. However, the causal genetic variant and molecular mechanisms of specific susceptibility genes in relation to obesity are yet to be fully confirmed and characterised. Here, we examined whether the candidate gene NEGR1 encoding the neuronal growth regulator 1, also termed neurotractin or Kilon, accounts for the obesity association. To characterise the function of NEGR1 for body weight control in vivo, we generated two novel mutant mouse lines, including a constitutive NEGR1-deficient mouse line as well as an ENU-mutagenised line carrying a loss-of-function mutation (Negr1-I87N) and performed metabolic phenotypic analyses. Ablation of NEGR1 results in a small but steady reduction of body mass in both mutant lines, accompanied with a small reduction in body length in the Negr1-I87N mutants. Magnetic resonance scanning reveals that the reduction of body mass in Negr1-I87N mice is due to a reduced proportion of lean mass. Negr1-I87N mutants display reduced food intake and physical activity while normalised energy expenditure remains unchanged. Expression analyses confirmed the brain-specific distribution of NEGR1 including strong expression in the hypothalamus. In vitro assays show that NEGR1 promotes cell-cell adhesion and neurite growth of hypothalamic neurons. Our results indicate a role of NEGR1 in the control of body weight and food intake. This study provides evidence that supports the link of the GWAS candidate gene NEGR1 with body weight control.	[Lee, Angela W. S.; Nicholson, George; Cox, Roger D.] MRC Mammalian Genet Unit, Harwell, Oxon, England; [Hengstler, Heidi; Schwald, Kathrin; Loreth, Desiree; Kirsch, Matthias; Kretz, Oliver; Schaefer, Michael K. E.] Univ Freiburg, Ctr Neurosci, Inst Anat & Cell Biol, D-79106 Freiburg, Germany; [Loreth, Desiree] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Berriel-Diaz, Mauricio; Herzig, Stephan] Ctr Mol Biol ZMBH, German Canc Res Ctr DKFZ, Joint Div Mol Metab Control, Heidelberg, Germany; [Berriel-Diaz, Mauricio; Herzig, Stephan] Univ Heidelberg Hosp, Heidelberg, Germany; [Haas, Carola A.] Univ Clin Freiburg, Neuroctr, Expt Epilepsy Grp, Freiburg, Germany; [de Angelis, Martin Hrabe; Rozman, Jan] Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Bruemmendorf, Thomas; Rathjen, Fritz G.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Klingenspor, Martin; Rozman, Jan] Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Klingenspor, Martin; Rozman, Jan] Tech Univ Munich, Res Ctr Nutr & Food Sci, ZIEL, Freising Weihenstephan, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany; [Nicholson, George] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	MRC Harwell; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Technical University of Munich; Technical University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Oxford	Lee, AWS (corresponding author), MRC Mammalian Genet Unit, Harwell, Oxon, England.	angela.lee@well.ox.ac.uk; r.cox@har.mrc.ac.uk; michael.schaefer@unimedizin-mainz.de	de Angelis, Martin Hrabe/F-5531-2012; Diaz, Mauricio Berriel/AAF-8285-2021; Rozman, Jan/A-2540-2010; Klingenspor, Martin/D-6930-2011; Kirsch, Matthias/G-7227-2015; Klingenspor, Martin/K-5033-2019	de Angelis, Martin Hrabe/0000-0002-7898-2353; Rozman, Jan/0000-0002-8035-8904; Klingenspor, Martin/0000-0002-4502-6664; Kirsch, Matthias/0000-0002-2090-8556; Kretz, Oliver/0000-0003-1152-5956; Herzig, Stephan/0000-0003-3950-3652; Nicholson, George/0000-0001-9588-6075; Cox, Roger/0000-0001-7170-5014; Berriel Diaz, Mauricio/0000-0003-4670-919X; Lee, Angela/0000-0002-7591-825X	UK Medical Research Council (MRC Mammalian Genetics Unit); Wellcome Trust [081219]; Bundesministerium fur Bildung und Forschung [01GS0869, 01GS0850]; Muller-Fahnenberg-Stiftung (Medizinische Fakultat Freiburg); Deutsche Forschungsgemeinschaft [BR1217/3-1]; UK Medical Research Council; Medical Research Council [MC_U142661184] Funding Source: researchfish; MRC [MC_U142661184] Funding Source: UKRI	UK Medical Research Council (MRC Mammalian Genetics Unit)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Muller-Fahnenberg-Stiftung (Medizinische Fakultat Freiburg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by UK Medical Research Council (MRC Mammalian Genetics Unit) and the Wellcome Trust (081219). Grants from the Bundesministerium fur Bildung und Forschung to M Klingenspor (01GS0869), to MHA (01GS0850) and to the German Center for Diabetes Research (DZD e.V.), from the Muller-Fahnenberg-Stiftung (Medizinische Fakultat Freiburg) to MS and from the Deutsche Forschungsgemeinschaft to TB (BR1217/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the UK Medical Research Council and the Wellcome Trust for funding. We thank the staff of the Mary Lyon Centre, MRC Harwell, FESA, GEMS cores and the Center for Neurosciences (University of Freiburg) as well as Ann-Elisabeth Schwarz and Brigitte Herrmann from the German Mouse Clinic for excellent technical support. We are grateful to Carmen Birchmeier, Max-Delbruck-Center for Molecular Medicine, Berlin, Germany, for providing the pTV0 vector and to Daniela-Nebenius Oosthuizen (Biocenter Basel) for blastocyst injection and chimera generation, and Susanne Huber for help with in situ hybridisation. Part of this research is in partial fulfilment of the requirements for the degree of Dr. med. (HH; KS) and Dr. rer. nat. (DL) at the University of Freiburg.	Akeel M, 2011, BRAIN RES, V1374, P27, DOI 10.1016/j.brainres.2010.12.028; Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Catania EH, 2008, BEHAV BRAIN RES, V188, P380, DOI 10.1016/j.bbr.2007.11.022; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Edwards D, 1995, INTRO GRAPHICAL MODE; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Gil OD, 1998, J NEUROSCI, V18, P9312; Gil OD, 2002, J NEUROBIOL, V51, P190, DOI 10.1002/neu.10050; Guijarro C, 2006, J NEUROCHEM, V97, P747, DOI 10.1111/j.1471-4159.2006.03728.x; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hashimoto T, 2008, BRAIN RES, V1224, P1, DOI 10.1016/j.brainres.2008.05.069; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Hester JM, 2011, INT J OBES LOND; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Hough TA, 2002, MAMM GENOME, V13, P595, DOI 10.1007/s00335-002-2188-1; Innos J, 2011, BEHAV BRAIN RES, V217, P21, DOI 10.1016/j.bbr.2010.09.019; Kilpelaeinen TO, 2011, AM J CLIN NUTR, V93, P851, DOI 10.3945/ajcn.110.000828; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lauritzen SL, 2004, GRAPHICAL MODELS; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; Lodge AP, 2000, MOL BRAIN RES, V82, P84, DOI 10.1016/S0169-328X(00)00184-4; Lodge AP, 2001, MOL CELL NEUROSCI, V17, P746, DOI 10.1006/mcne.2001.0964; Marg A, 1999, J CELL BIOL, V145, P865, DOI 10.1083/jcb.145.4.865; Marx M, 2012, NEUROGENETICS, V13, P49, DOI 10.1007/s10048-011-0307-4; Miyata S, 2003, NEUROSCIENCE, V117, P645, DOI 10.1016/S0306-4522(02)00873-4; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Ntougkos E, 2005, CLIN CANCER RES, V11, P5764, DOI 10.1158/1078-0432.CCR-04-2388; Pimenta AF, 2004, GENOMICS, V83, P790, DOI 10.1016/j.ygeno.2003.11.013; Pinheiro J, 2001, MIXED EFFECTS MODELS; Qiu SF, 2010, BIOL PSYCHIAT, V68, P197, DOI 10.1016/j.biopsych.2010.02.013; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed JE, 2007, NEUROPATH APPL NEURO, V33, P77, DOI 10.1111/j.1365-2990.2006.00786.x; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Schaefer MKE, 2007, J NEUROSCI, V27, P8779, DOI 10.1523/JNEUROSCI.1599-07.2007; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Schafer M, 2005, MOL CELL NEUROSCI, V29, P580, DOI 10.1016/j.mcn.2005.04.010; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sellar GC, 2003, NAT GENET, V34, P337, DOI 10.1038/ng1183; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sugimoto C, 2010, J NEUROCHEM, V112, P818, DOI 10.1111/j.1471-4159.2009.06513.x; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Walley AJ, 2011, INT J OBES LOND; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	56	45	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41537	10.1371/journal.pone.0041537	http://dx.doi.org/10.1371/journal.pone.0041537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844493	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000306687700105
J	Wang, B; Lindley, LE; Fernandez-Vega, V; Rieger, ME; Sims, AH; Briegel, KJ				Wang, Bin; Lindley, Linsey E.; Fernandez-Vega, Virneliz; Rieger, Megan E.; Sims, Andrew H.; Briegel, Karoline J.			The T Box Transcription Factor TBX2 Promotes Epithelial-Mesenchymal Transition and Invasion of Normal and Malignant Breast Epithelial Cells	PLOS ONE			English	Article							ULNAR-MAMMARY SYNDROME; E-CADHERIN EXPRESSION; GENE-EXPRESSION; TUMOR-METASTASIS; CANCER SUBTYPES; FACTOR SNAIL; CLAUDIN-LOW; STEM-CELLS; SENESCENCE; REPRESSES	The T box transcription factor TBX2, a master regulator of organogenesis, is aberrantly amplified in aggressive human epithelial cancers. While it has been shown that overexpression of TBX2 can bypass senescence, a failsafe mechanism against cancer, its potential role in tumor invasion has remained obscure. Here we demonstrate that TBX2 is a strong cell-autonomous inducer of the epithelial-mesenchymal transition (EMT), a latent morphogenetic program that is key to tumor progression from noninvasive to invasive malignant states. Ectopic expression of TBX2 in normal HC11 and MCF10A mammary epithelial cells was sufficient to induce morphological, molecular, and behavioral changes characteristic of EMT. These changes included loss of epithelial adhesion and polarity gene (E-cadherin, beta-catenin, ZO1) expression, and abnormal gain of mesenchymal markers (N-cadherin, Vimentin), as well as increased cell motility and invasion. Conversely, abrogation of endogenous TBX2 overexpression in the malignant human breast carcinoma cell lines MDA-MB-435 and MDA-MB-157 led to a restitution of epithelial characteristics with reciprocal loss of mesenchymal markers. Importantly, TBX2 inhibition abolished tumor cell invasion and the capacity to form lung metastases in a Xenograft mouse model. Meta-analysis of gene expression in over one thousand primary human breast tumors further showed that high TBX2 expression was significantly associated with reduced metastasis-free survival in patients, and with tumor subtypes enriched in EMT gene signatures, consistent with a role of TBX2 in oncogenic EMT. ChIP analysis and cell-based reporter assays further revealed that TBX2 directly represses transcription of E-cadherin, a tumor suppressor gene, whose loss is crucial for malignant tumor progression. Collectively, our results uncover an unanticipated link between TBX2 deregulation in cancer and the acquisition of EMT and invasive features of epithelial tumor cells.	[Wang, Bin; Lindley, Linsey E.; Fernandez-Vega, Virneliz; Rieger, Megan E.; Briegel, Karoline J.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Biochem & Mol Biol,Braman Family Breast Canc, Miami, FL 33136 USA; [Sims, Andrew H.] Edinburgh Canc Res Ctr, Breakthrough Res Unit, Appl Bioinformat Canc Res Grp, Edinburgh, Midlothian, Scotland	University of Miami; University of Edinburgh	Wang, B (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Biochem & Mol Biol,Braman Family Breast Canc, Miami, FL 33136 USA.	kbriegel@med.miami.edu	wang, bin/C-3163-2013; Sims, Andrew/E-4819-2012	Sims, Andrew/0000-0001-9082-3665	Flight Attendant Medical Research Institute/FAMRI [CIA_072080]; Bankhead Coley Cancer Research Program - Florida State Department of Health [08-BB-03]; Braman Family Breast Cancer Institute, UM Sylvester Cancer Center; DOD [W81XWH-08-1-0253]; Breakthrough Breast Cancer	Flight Attendant Medical Research Institute/FAMRI; Bankhead Coley Cancer Research Program - Florida State Department of Health; Braman Family Breast Cancer Institute, UM Sylvester Cancer Center; DOD(United States Department of Defense); Breakthrough Breast Cancer	This work was supported by grants from the Flight Attendant Medical Research Institute/FAMRI (CIA_072080), the Bankhead Coley Cancer Research Program - Florida State Department of Health (08-BB-03), and the Braman Family Breast Cancer Institute, UM Sylvester Cancer Center to KJB; a DOD predoctoral fellowship (W81XWH-08-1-0253) to MER; and from Breakthrough Breast Cancer to AHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Andersen CL, 2002, AM J PATHOL, V161, P73, DOI 10.1016/S0002-9440(10)64158-2; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Barlund M, 2000, CANCER RES, V60, P5340; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Briegel KJ, 2006, IUBMB LIFE, V58, P123, DOI 10.1080/15216540600686870; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen JR, 2001, MOL CELL ENDOCRINOL, V177, P43, DOI 10.1016/S0303-7207(01)00456-7; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Cho GS, 2011, DEVELOPMENT, V138, P465, DOI 10.1242/dev.061234; Christoffels VM, 2004, DEV DYNAM, V229, P763, DOI 10.1002/dvdy.10487; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Davis E, 2008, ONCOGENE, V27, P976, DOI 10.1038/sj.onc.1210701; Dimova I, 2009, TUMORI, V95, P357; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Fisher B, 2004, LANCET, V364, P858, DOI 10.1016/S0140-6736(04)16981-X; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Ismail A, 2009, CANCER LETT, V278, P230, DOI 10.1016/j.canlet.2009.01.006; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; Kelemen LE, 2009, CANCER EPIDEM BIOMAR, V18, P1864, DOI 10.1158/1055-9965.EPI-08-0486; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lindley LE, 2010, BIOCHEM BIOPH RES CO, V399, P659, DOI 10.1016/j.bbrc.2010.07.138; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Liu WK, 2010, ONKOLOGIE, V33, P241, DOI 10.1159/000305098; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Mani SA, 2007, P NATL ACAD SCI US; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manning L, 2006, DEV CELL, V11, P873, DOI 10.1016/j.devcel.2006.09.021; Martin N, 2012, EMBO J, V31, P95, DOI 10.1038/emboj.2011.370; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Paxton C, 2002, GENE, V283, P117, DOI 10.1016/S0378-1119(01)00878-2; Peres J, 2011, GENES CANC, V1, P272; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Redmond KL, 2010, ONCOGENE, V29, P3252, DOI 10.1038/onc.2010.84; Ribeiro I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000398; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Sinclair CS, 2002, CANCER RES, V62, P3587; Song D, 2009, ASIAN PAC J CANCER P, V10, P119; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Taneja P, 2010, CLIN MED INSIGHTS-ON, V4, P15; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trujillo KA, 2011, INT J CANCER, V129, P1310, DOI 10.1002/ijc.25788; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vance KW, 2010, MOL BIOL CELL, V21, P2770, DOI 10.1091/mbc.E09-12-1029; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vormer TL, 2008, MOL CELL BIOL, V28, P7263, DOI 10.1128/MCB.00313-08; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu M, 2009, GENE DEV, V23, P1737, DOI 10.1101/gad.1809309	92	46	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41355	10.1371/journal.pone.0041355	http://dx.doi.org/10.1371/journal.pone.0041355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844464	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700076
J	Gehrmann, M; Stangl, S; Kirschner, A; Foulds, GA; Sievert, W; Doss, BT; Walch, A; Pockley, AG; Multhoff, G				Gehrmann, Mathias; Stangl, Stefan; Kirschner, Andreas; Foulds, Gemma A.; Sievert, Wolfgang; Doss, Brigitte T.; Walch, Axel; Pockley, Alan G.; Multhoff, Gabriele			Immunotherapeutic Targeting of Membrane Hsp70-Expressing Tumors Using Recombinant Human Granzyme B	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BOUND HEAT-SHOCK-PROTEIN-70 HSP70; HEAT-SHOCK PROTEINS; CYTOTOXIC LYMPHOCYTES; CANCER; APOPTOSIS; EXPRESSION; BINDING; SURFACE; LOCALIZATION	Background: We have previously reported that human recombinant granzyme B (grB) mediates apoptosis in membrane heat shock protein 70 (Hsp70)-positive tumor cells in a perforin-independent manner. Methodology/Principal Findings: Optical imaging of uptake kinetics revealed co-localization of grB with recycling endosomes (Rab9/11) as early as 5 min after internalization, with late endosomes (Rab7) after 30 min, and the lysosomal compartment (LAMP1/2) after 60 to 120 min. Active caspase-3-mediated apoptosis was induced in mouse CT26 monolayer cells and 3D tumor spheroids, but not in normal mouse endothelial cells. Granzyme B selectively reduced the proportion of membrane Hsp70-positive cells in CT26 tumor spheroids. Consecutive i.v. injections of recombinant human grB into mice bearing membrane Hsp70-positive CT26 tumors resulted in significant tumor suppression, and a detailed inspection of normal mouse organs revealed that the administration of anti-tumoral concentrations of grB elicited no clinicopathological changes. Conclusions/Significance: These findings support the future clinical evaluation of human grB as a potential adjuvant therapeutic agent, especially for treating immunosuppressed patients that bear membrane Hsp70-positive tumors.	[Gehrmann, Mathias; Stangl, Stefan; Kirschner, Andreas; Foulds, Gemma A.; Sievert, Wolfgang; Doss, Brigitte T.; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany; [Gehrmann, Mathias; Stangl, Stefan; Kirschner, Andreas; Foulds, Gemma A.; Sievert, Wolfgang; Doss, Brigitte T.; Multhoff, Gabriele] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Clin Cooperat Grp CCG Innate Immun Tumor Biol, Munich, Germany; [Foulds, Gemma A.; Pockley, Alan G.] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Walch, Axel] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Inst Pathol, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Sheffield; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gehrmann, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Walch, Axel/B-4554-2012; Multhoff, Gabriele/AAW-9796-2021; Pockley, Alan G/I-4704-2015; Doß, Brigitte Tina Maria/AAF-1448-2021	Walch, Axel/0000-0001-5578-4023; Multhoff, Gabriele/0000-0002-2616-3137; Pockley, Alan G/0000-0001-9593-6431; Foulds, Gemma/0000-0002-2053-7580	Deutsche Forschungsgemeinschaft (DFG) [SFB824]; DFG [INST95/980-1 FUGG]; DFG-Cluster of Excellence: Munich Advanced Photonics (MAP); Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM [01EZ0826]; m4 Cluster of Excellence [01EX1021C]; Kompetenzverbund Strahlenforschung [03NUK007E]; European Union (EU CARDIORISK, FP7) [211403]; multimmune GmbH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DFG-Cluster of Excellence: Munich Advanced Photonics (MAP)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM(Federal Ministry of Education & Research (BMBF)); m4 Cluster of Excellence; Kompetenzverbund Strahlenforschung; European Union (EU CARDIORISK, FP7); multimmune GmbH	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB824, (DFG) INST95/980-1 FUGG, DFG-Cluster of Excellence: Munich Advanced Photonics (MAP), Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM (01EZ0826), m4 Cluster of Excellence (01EX1021C), Kompetenzverbund Strahlenforschung (03NUK007E), the European Union (EU CARDIORISK, FP7-211403) and multimmune GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Gabriele Multhoff and Alan Graham Pockley serve as Academic Editors of PLoS ONE. This study was partly funded by multimmune GmbH. The membrane Hsp70 phenotype on viable tumor and metastatic cells of patients was determined by flow cytometry using FITC-conjugated cmHsp70.1 mAb (multimmune GmbH, Germany). There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Balkow S, 2001, J VIROL, V75, P8781, DOI 10.1128/JVI.75.18.8781-8791.2001; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Botzler C, 1996, CANCER IMMUNOL IMMUN, V43, P226, DOI 10.1007/s002620050326; Botzler C, 1998, CELL STRESS CHAPERON, V3, P6, DOI 10.1379/1466-1268(1998)003<0006:DOELEO>2.3.CO;2; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Chavez-Galan L, 2009, CELL MOL IMMUNOL, V6, P15, DOI 10.1038/cmi.2009.3; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cullen SP, 2010, CELL DEATH DIFFER, V17, P616, DOI 10.1038/cdd.2009.206; DERTINGER H, 1984, RECENT RESULTS CANC, V95, P67; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gehrmann M, 2004, CLIN CANCER RES, V10, P3354, DOI 10.1158/1078-0432.CCR-03-0382; Gehrmann M, 2005, CELL DEATH DIFFER, V12, P38, DOI 10.1038/sj.cdd.4401510; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Gehrmann M, 2011, J IMMUNOL METHODS, V371, P8, DOI 10.1016/j.jim.2011.06.007; Gehrmann M, 2002, BIOL CHEM, V383, P1715, DOI 10.1515/BC.2002.192; Giesubel U, 2006, BIOCHEM J, V394, P563, DOI 10.1042/BJ20050687; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Krause SW, 2004, CLIN CANCER RES, V10, P3699, DOI 10.1158/1078-0432.CCR-03-0683; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liu YY, 2006, NEOPLASIA, V8, P125, DOI 10.1593/neo.05556; Liu YY, 2003, MOL CANCER THER, V2, P1341; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; Milani V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-50; Multhoff G, 1997, J IMMUNOL, V158, P4341; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Pfister K, 2007, CANCER-AM CANCER SOC, V110, P926, DOI 10.1002/cncr.22864; Rerole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16; Schilling D, 2009, FASEB J, V23, P2467, DOI 10.1096/fj.08-125229; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Stangl S, 2011, J CELL MOL MED, V15, P874, DOI 10.1111/j.1582-4934.2010.01067.x; Stangl S, 2011, P NATL ACAD SCI USA, V108, P733, DOI 10.1073/pnas.1016065108; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Trapani JA, 1996, J BIOL CHEM, V271, P4127; WANG M, 1995, J IMMUNOL, V154, P4685; Xia ZN, 1998, BIOCHEM BIOPH RES CO, V243, P384, DOI 10.1006/bbrc.1998.8102	41	24	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41341	10.1371/journal.pone.0041341	http://dx.doi.org/10.1371/journal.pone.0041341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829941	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300080
J	Yvert, T; He, ZH; Santiago, C; Hu, Y; Li, YC; Gomez-Gallego, F; Fiuza-Luces, C; Verde, Z; Muniesa, CA; Olivan, J; Santalla, A; Ruiz, JR; Lucia, A				Yvert, Thomas; He, Zi-Hong; Santiago, Catalina; Hu, Yang; Li, Yan-Chun; Gomez-Gallego, Felix; Fiuza-Luces, Carmen; Verde, Zoraida; Muniesa, Carlos A.; Olivan, Jesus; Santalla, Alfredo; Ruiz, Jonatan R.; Lucia, Alejandro			Acyl Coenzyme A Synthetase Long-Chain 1 (ACSL1) Gene Polymorphism (rs6552828) and Elite Endurance Athletic Status: A Replication Study	PLOS ONE			English	Article							FATTY-ACIDS; ASSOCIATION ANALYSIS; EXPRESSION; ENZYMES; PROTEIN; PPAR	The aim of this study was to determine the association between the rs6552828 polymorphism in acyl coenzyme A synthetase (ACSL1) and elite endurance athletic status. We studied 82 Caucasian (Spanish) World/Olympic-class endurance male athletes, and a group of sex and ethnically matched healthy young adults (controls, n = 197). The analyses were replicated in a cohort of a different ethnic origin (Chinese of the Han ethnic group), composed of elite endurance athletes (runners) [cases, n = 241 (128 male)] and healthy sedentary adults [controls, n = 504 (267 male)]. In the Spanish cohort, genotype (P = 0.591) and minor allele (A) frequencies were similar in cases and controls (P = 0.978). In the Chinese cohort, genotype (P = 0.973) and minor allele (G) frequencies were comparable in female endurance athletes and sedentary controls (P = 0.881), whereas in males the frequency of the G allele was higher in endurance athletes (0.40) compared with their controls (0.32, P = 0.040). The odds ratio (95% CI) for an elite endurance Chinese athlete to carry the G allele compared with ethnically matched controls was 1.381 (1.015-1.880) (P-value = 0.04). Our findings suggest that the ACSL1 gene polymorphism rs6552828 is not associated with elite endurance athletic status in Caucasians, yet a marginal association seems to exist for the Chinese (Han) male population.	[Yvert, Thomas; Santiago, Catalina; Gomez-Gallego, Felix; Fiuza-Luces, Carmen; Verde, Zoraida; Lucia, Alejandro] European Univ Madrid, Dept Biomed, Madrid, Spain; [He, Zi-Hong] China Inst Sport Sci, Ctr Biol, Beijing, Peoples R China; [Hu, Yang; Li, Yan-Chun] Beijing Sports Univ, Sci & Res Ctr, Beijing, Peoples R China; [Muniesa, Carlos A.; Olivan, Jesus] European Univ Madrid, Fac Sports Sci, Madrid, Spain; [Santalla, Alfredo] Pabo de Olavide Univ, Fac Sports Sci, Seville, Spain; [Ruiz, Jonatan R.] Univ Granada, Dept Phys Educ & Sport, Sch Sport Sci, Granada, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Dept Biosci & Nutr, Novum, Unit Prevent Nutr, Stockholm, Sweden	European University of Madrid; China Institute of Sport Science; Beijing Sport University; European University of Madrid; Universidad Pablo de Olavide; University of Granada; Karolinska Institutet	Yvert, T (corresponding author), European Univ Madrid, Dept Biomed, Madrid, Spain.	alejandro.lucia@uem.es	Gomez-Gallego, Felix/H-6925-2013; li, yan/GTI-4638-2022; Lucia, Alejandro/M-2759-2014; Santiago, Catalina/K-6803-2014; Santiago, Catalina/P-8177-2019; VERDE, ZORAIDA/A-9914-2012; RUIZ, JONATAN R/M-1338-2015; Gomez-Gallego, Felix/AAD-9617-2020	Gomez-Gallego, Felix/0000-0002-1968-1761; Lucia, Alejandro/0000-0002-3025-2060; Santiago, Catalina/0000-0003-3852-8217; Santiago, Catalina/0000-0003-3852-8217; VERDE, ZORAIDA/0000-0002-9260-7672; RUIZ, JONATAN R/0000-0002-7548-7138; Yvert, Thomas/0000-0002-9451-9799; Lucia, Alejandro/0000-0002-5565-0997; Santalla Hernandez, Alfredo/0000-0001-9418-0564; Fiuza-Luces, Carmen/0000-0001-8131-7007	Consejo Superior de Deportes [UPR12]; Spanish Ministry of Science and Innovation [RYC-2010-05957]; Fondo de Investigaciones Sanitarias [PS09/00194]; China Institute of Sport Science [2011-03]; Ministry of Science and Technology of the People's Republic of China [2003BA904B04]	Consejo Superior de Deportes; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); China Institute of Sport Science; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The present study was funded by the Consejo Superior de Deportes (grant #UPR12) Spanish Ministry of Science and Innovation (RYC-2010-05957) and Fondo de Investigaciones Sanitarias (ref. # PS09/00194), and grants from China Institute of Sport Science (Grant code: 2011-03) and grants from Ministry of Science and Technology of the People's Republic of China (Grant code: 2003BA904B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Daniels J, 1979, OXYGEN POWER, P5; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; He ZH, 2011, MED SCI SPORT EXER, V43, P1433, DOI 10.1249/MSS.0b013e31820e7f38; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Phillips CM, 2010, J LIPID RES, V51, P1793, DOI 10.1194/jlr.M003046; Sasabe T, 2007, NEUROSCI LETT, V412, P139, DOI 10.1016/j.neulet.2006.10.064; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schoonjans K, 1996, J LIPID RES, V37, P907	21	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41268	10.1371/journal.pone.0041268	http://dx.doi.org/10.1371/journal.pone.0041268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829935	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300074
J	Szentirmai, E				Szentirmai, Eva			Central but Not Systemic Administration of Ghrelin Induces Wakefulness in Mice	PLOS ONE			English	Article							GROWTH-HORMONE SECRETAGOGUE; SLOW-WAVE SLEEP; STIMULATES LOCOMOTOR-ACTIVITY; MESSENGER-RNA; DEFICIENT MICE; RATS; SECRETION; RECEPTOR; PEPTIDE; APPETITE	Ghrelin is a brain-gut peptide hormone widely known for its orexigenic and growth hormone-releasing activities. Findings from our and other laboratories indicate a role of ghrelin in sleep regulation. The effects of exogenous ghrelin on sleep-wake activity in mice are, however, unknown. The aim of the present study was to determine the sleep-modulating effects of ghrelin after central and systemic administrations in mice. Sleep-wake activity after intracerebroventricular (icv) administration of 0.2, 1 and 5 mu g ghrelin and intraperitoneal injections of 40, 100, and 400 mu g/kg ghrelin prior to light onset were determined in C57BL/6 mice. In addition, body temperature, motor activity and 1-hour food intake was measured after the systemic injections. Sleep effects of systemic ghrelin (40 and 400 mu g/kg) injected before dark onset were also determined. Icv injection of ghrelin increased wakefulness and suppressed non-rapid-eye-movement sleep and electroencephalographic slow-wave activity in the first hour after injections. Rapid-eye-movement sleep was decreased for 2-4 hours after each dose of ghrelin. Sytemic administration of ghrelin did not induce changes in sleep-wake activity in mice at dark or light onset. Motor activity and body temperature remained unaltered and food intake was significantly increased after systemic injections of ghrelin given prior the light period. These findings indicate that the activation of central, but not peripheral, ghrelin-sensitive mechanisms elicits arousal in mice. The results are consistent with the hypothesis that the activation of the hypothalamic neuronal circuit formed by ghrelin, orexin, and neuropeptide Y neurons triggers behavioral sequence characterized by increased wakefulness, motor activity and feeding in nocturnal rodents.	[Szentirmai, Eva] Washington State Univ, Washington Wyoming Alaska Montana & Idaho WWAMI M, Spokane, WA USA; [Szentirmai, Eva] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Spokane, WA USA; [Szentirmai, Eva] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA	Washington State University; Washington State University; Washington State University	Szentirmai, E (corresponding author), Washington State Univ, Washington Wyoming Alaska Montana & Idaho WWAMI M, Spokane, WA USA.	eszentirmai@wsu.edu			Washington State University	Washington State University	This work was supported by a Faculty Seed Grant to Dr. Szentirmai by the Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2006, J NEUROSCI, V26, P11052, DOI 10.1523/JNEUROSCI.2606-06.2006; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Baragli A, 2011, PEPTIDES, V32, P2323, DOI 10.1016/j.peptides.2011.10.024; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Borbely AA, 2001, ARCH ITAL BIOL, V139, P53; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Copinschi G, 1997, NEUROENDOCRINOLOGY, V66, P278, DOI 10.1159/000127249; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; Date Y, 2006, CELL METAB, V4, P323, DOI 10.1016/j.cmet.2006.09.004; Dieguez C, 2010, FRONT HORM RES, V38, P196, DOI 10.1159/000318511; Esposito M, 2012, EUR J NEUROSCI, V35, P233, DOI 10.1111/j.1460-9568.2011.07946.x; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Frieboes RM, 2004, PSYCHONEUROENDOCRINO, V29, P851, DOI 10.1016/S0306-4530(03)00152-5; FRIEBOES RM, 1995, NEUROENDOCRINOLOGY, V61, P584, DOI 10.1159/000126883; Granata R, 2011, EXP BIOL MED, V236, P505, DOI 10.1258/ebm.2011.010365; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Harrold JA, 2008, BRAIN RES, V1196, P59, DOI 10.1016/j.brainres.2007.12.055; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Jaszberenyi M, 2006, HORM BEHAV, V50, P266, DOI 10.1016/j.yhbeh.2006.03.010; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Kluge M, 2007, PSYCHONEUROENDOCRINO, V32, P1079, DOI 10.1016/j.psyneuen.2007.09.001; Kluge M, 2007, PSYCHONEUROENDOCRINO, V32, P287, DOI 10.1016/j.psyneuen.2006.12.015; Kluge M, 2010, PSYCHONEUROENDOCRINO, V35, P297, DOI 10.1016/j.psyneuen.2009.07.007; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2010, ANN NY ACAD SCI, V1200, P140, DOI 10.1111/j.1749-6632.2010.05516.x; Leite-Moreira AF, 2007, DRUG DISCOV TODAY, V12, P276, DOI 10.1016/j.drudis.2007.02.009; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Moreno-Reyes R, 1998, AM J PHYSIOL-ENDOC M, V274, pE779, DOI 10.1152/ajpendo.1998.274.5.E779; Obal F, 2003, AM J PHYSIOL-REG I, V284, pR131, DOI 10.1152/ajpregu.00361.2002; Sakurai T, 2010, ANN NY ACAD SCI, V1200, P149, DOI 10.1111/j.1749-6632.2010.05513.x; Steiger A, 2011, MOL CELL ENDOCRINOL, V340, P88, DOI 10.1016/j.mce.2011.02.013; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Szentirmai E, 2006, AM J PHYSIOL-REG I, V291, pR473, DOI 10.1152/ajpregu.00919.2005; Szentirmai E, 2006, BRAIN RES, V1088, P131, DOI 10.1016/j.brainres.2006.02.072; Szentirmai E, 2007, AM J PHYSIOL-REG I, V293, pR510, DOI 10.1152/ajpregu.00155.2007; Szentirmai E, 2007, AM J PHYSIOL-REG I, V292, pR575, DOI 10.1152/ajpregu.00448.2006; Szentirmai E, 2010, AM J PHYSIOL-REG I, V298, pR467, DOI 10.1152/ajpregu.00557.2009; Szentirmai E, 2009, P NATL ACAD SCI USA, V106, P14069, DOI 10.1073/pnas.0903090106; Tolle V, 2002, ENDOCRINOLOGY, V143, P1353, DOI 10.1210/en.143.4.1353; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Weikel JC, 2003, AM J PHYSIOL-ENDOC M, V284, pE407, DOI 10.1152/ajpendo.00184.2002; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	54	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41172	10.1371/journal.pone.0041172	http://dx.doi.org/10.1371/journal.pone.0041172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815958	gold, Green Published, Green Submitted			2022-12-25	WOS:000306507000076
J	Bianchi-Smiraglia, A; Paesante, S; Bakin, AV				Bianchi-Smiraglia, A.; Paesante, S.; Bakin, A. V.			Integrin beta 5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways	ONCOGENE			English	Article						integrin; focal adhesion kinase (FAK); extracellular signal-regulated kinase (ERK); anchorage-independent growth; transforming growth factor beta (TGF-beta)	FOCAL-ADHESION KINASE; GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; REGULATED KINASE; PHOSPHORYLATION; ALPHA-V-BETA-5; EXPRESSION; MATRIX-METALLOPROTEINASE-9; TYROSINE-861; MIGRATION	Cancer progression, response to therapy and metastasis depend on tumor microenvironment. Integrins are cell-adhesion receptors that mediate interactions of cells with extracellular matrix. The alpha v-beta-family of integrins contributes to tumorigenesis, response to therapy and cancer stem cell biology. Thus, understanding the function of specific integrins in cancer is critical for the development of therapeutic approaches targeting integrins. The study investigated the role of integrin beta 5 in breast carcinomas by depleting integrin b5 using RNA interference and reexpression of integrin beta 5. Depletion of integrin b5 in triple-negative breast carcinoma cells markedly reduced tumor take, growth and tumor angiogenesis, whereas reexpression of integrin b5 rescued this phenotype. Reduction in tumor angiogenesis is associated with lower expression of vascular endothelial growth factor-A in integrin beta 5-depleted tumors. Tumor cells deficient in integrin beta 5 have lower migration and proliferative capacities. Biochemical assays revealed that integrin beta 5 mediates the Src-focal adhesion kinase and MEK-extracellular signal-regulated kinase signaling events that operate independently, and inhibition of these pathways phenocopies integrin beta 5 deficiency. Breast carcinoma cells express high levels of integrin beta 5, whereas expression of integrin beta 3 is limited to stromal compartments and integrin beta 6 is lost in metastatic cells. Together, these findings show a critical role for integrin beta 5 in the tumorigenic potential of breast carcinoma cells and therapeutic targeting of integrin beta 5 is especially attractive for triple-negative breast carcinomas, which are refractory to most of the current therapies.	[Bianchi-Smiraglia, A.; Paesante, S.; Bakin, A. V.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Bakin, AV (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Elm Carlton St, Buffalo, NY 14263 USA.	Andrei.Bakin@RoswellPark.org		Bakin, Andrei/0000-0002-7728-1969; Bianchi-Smiraglia, Anna/0000-0002-5963-103X	NYSDOH-HSRB Peter T Rowley Breast Cancer Project; RPCI Cancer Center Support Grant [CA 16056]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA095263] Funding Source: NIH RePORTER	NYSDOH-HSRB Peter T Rowley Breast Cancer Project; RPCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NYSDOH-HSRB Peter T Rowley Breast Cancer Project and in part by RPCI Cancer Center Support Grant CA 16056. We thank Dr Irwin Gelman for his helpful discussion of the manuscript, Drs Raymond Birge, Jianmin Zhang and Yahao Bu for providing reagents and Drs Kitty De Jong and Janice Hoffmann (RPCI flow cytometry facility) for their technical help.	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Alvarez RH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2572; Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Berditchevski F, 2001, J CELL SCI, V114, P4143; Bianchi A, 2010, CELL CYCLE, V9, P1647, DOI 10.4161/cc.9.8.11517; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Frey RS, 1997, CANCER RES, V57, P628; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Lim YM, 2004, J BIOL CHEM, V279, P29060, DOI 10.1074/jbc.M401183200; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Maubant S, 2002, INT J CANCER, V97, P186, DOI 10.1002/ijc.1600; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Mitra SK, 2006, ONCOGENE, V25, P5969, DOI 10.1038/sj.onc.1209588; Monferran S, 2008, INT J CANCER, V123, P357, DOI 10.1002/ijc.23498; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; Ogata H, 2001, CANCER LETT, V172, P159, DOI 10.1016/S0304-3835(01)00648-6; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Safina A, 2008, ONCOGENE, V27, P1198, DOI 10.1038/sj.onc.1210768; Safina A, 2007, ONCOGENE, V26, P2407, DOI 10.1038/sj.onc.1210046; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schneider BP, 2007, NAT CLIN PRACT ONCOL, V4, P181, DOI 10.1038/ncponc0740; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Yom CK, 2011, BREAST CANCER RES TR, V128, P647, DOI 10.1007/s10549-010-1150-2; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008	47	90	96	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2013	32	25					3049	3058		10.1038/onc.2012.320	http://dx.doi.org/10.1038/onc.2012.320			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22824793	Green Accepted, Green Submitted			2022-12-25	WOS:000320705700005
J	Fay, JF; Farrens, DL				Fay, Jonathan F.; Farrens, David L.			A Key Agonist-induced Conformational Change in the Cannabinoid Receptor CB1 Is Blocked by the Allosteric Ligand Org 27569	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; ADENOSINE A(2A) RECEPTOR; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BINDING-SITE; ACTIVATION; RHODOPSIN; EXPRESSION; COMPLEX	Allosteric ligands that modulate how G protein-coupled receptors respond to traditional orthosteric drugs are an exciting and rapidly expanding field of pharmacology. An allosteric ligand for the cannabinoid receptor CB1, Org 27569, exhibits an intriguing effect; it increases agonist binding, yet blocks agonist-induced CB1 signaling. Here we explored the mechanism behind this behavior, using a site-directed fluorescence labeling approach. Our results show that Org 27569 blocks conformational changes in CB1 that accompany G protein binding and/or activation, and thus inhibit formation of a fully active CB1 structure. The underlying mechanism behind this behavior is that simultaneous binding of Org 27569 produces a unique agonist-bound conformation, one that may resemble an intermediate structure formed on the pathway to full receptor activation.	[Fay, Jonathan F.; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Farrens, DL (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Mail Code L224,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	farrensd@ohsu.edu			National Institutes of Health from the National Institute on Drug Abuse (NIDA), NIDA [5R01DA018169, T32 DA007262]; NEI Grant [2R01EY015436-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025684] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262, R01DA018169] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Drug Abuse (NIDA), NIDA; NEI Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01DA018169 (to D. L. F.) from the National Institute on Drug Abuse (NIDA), NIDA Training Grant T32 DA007262 (to J. F. F.), and NEI Grant 2R01EY015436-05 (to D. L. F.).	Calandra B, 1997, BIOTECHNOL LETT, V19, P425, DOI 10.1023/A:1018383808401; Chillakuri CR, 2007, FEBS J, V274, P6106, DOI 10.1111/j.1742-4658.2007.06132.x; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Farrens DL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1466, DOI 10.1039/c0pp00283f; Farrens DL, 2002, J PEPT RES, V60, P336, DOI 10.1034/j.1399-3011.2002.21066.x; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fay JF, 2005, BIOCHEMISTRY-US, V44, P8757, DOI 10.1021/bi0472651; GETHER U, 1995, J BIOL CHEM, V270, P28268; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Hall DA, 2000, MOL PHARMACOL, V58, P1412, DOI 10.1124/mol.58.6.1412; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Katoch-Rouse R, 2003, J MED CHEM, V46, P642, DOI 10.1021/jm020157x; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kim TK, 2005, PROTEIN EXPRES PURIF, V40, P60, DOI 10.1016/j.pep.2004.10.026; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lakowicz J. R, 2006, PRINCIPLES FLUORESCE, V3rd; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Link AJ, 2008, PROTEIN SCI, V17, P1857, DOI 10.1110/ps.035980.108; Makriyannis A., 1995, CANNABINOID RECEPTOR, P105; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; Matsuda T, 2000, METHOD ENZYMOL, V316, P465; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Michalke K, 2010, ANAL BIOCHEM, V401, P74, DOI 10.1016/j.ab.2010.02.017; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shire D, 1996, J BIOL CHEM, V271, P6941, DOI 10.1074/jbc.271.12.6941; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Tsukamoto H, 2010, J BIOL CHEM, V285, P7351, DOI 10.1074/jbc.M109.078709; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Xu W, 2005, J PEPT RES, V66, P138, DOI 10.1111/j.1399-3011.2005.00283.x; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948	61	35	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33873	33882		10.1074/jbc.M112.352328	http://dx.doi.org/10.1074/jbc.M112.352328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22846992	hybrid, Green Published			2022-12-25	WOS:000309602100068
J	Mokrosinski, J; Frimurer, TM; Sivertsen, B; Schwartz, TW; Holst, B				Mokrosinski, Jacek; Frimurer, Thomas M.; Sivertsen, Bjorn; Schwartz, Thue W.; Holst, Birgitte			Modulation of Constitutive Activity and Signaling Bias of the Ghrelin Receptor by Conformational Constraint in the Second Extracellular Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; 7-TRANSMEMBRANE RECEPTOR; STRUCTURAL BASIS; OPIOID RECEPTOR; LIGAND-BINDING; HELIX MOVEMENT; AGONIST; IDENTIFICATION; RHODOPSIN	Based on a rare, natural Glu for Ala-204(C+6) variant located six residues after the conserved Cys residue in extracellular loop 2b (ECL2b) associated with selective elimination of the high constitutive signaling of the ghrelin receptor, this loop was subjected to a detailed structure functional analysis. Introduction of Glu in different positions demonstrated that although the constitutive signaling was partly reduced when introduced in position 205(C+7) it was only totally eliminated in position 204(C+6). No charge-charge interaction partner could be identified for the Glu(C+6) variant despite mutational analysis of a number of potential partners in the extracellular loops and outer parts of the transmembrane segments. Systematic probing of position 204(C+6) with amino acid residues of different physicochemical properties indicated that a positively charged Lys surprisingly provided phenotypes similar to those of the negatively charged Glu residue. Computational chemistry analysis indicated that the propensity for the C-terminal segment of extracellular loop 2b to form an extended alpha-helix was increased from 15% in the wild type to 89 and 82% by introduction in position 204(C+6) of a Glu or a Lys residue, respectively. Moreover, the constitutive activity of the receptor was inhibited by Zn2+ binding in an engineered metal ion site, stabilizing an alpha-helical conformation of this loop segment. It is concluded that the high constitutive activity of the ghrelin receptor is dependent upon flexibility in the C-terminal segment of extracellular loop 2 and that mutations or ligand binding that constrains this segment and therebyc onceivably the movements of transmembrane domain V relative to transmembrane domain III inhibits the high constitutive signaling.	[Mokrosinski, Jacek; Sivertsen, Bjorn; Schwartz, Thue W.; Holst, Birgitte] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Mokrosinski, Jacek; Sivertsen, Bjorn; Schwartz, Thue W.; Holst, Birgitte] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen N, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Holst, B (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	holst@sund.ku.dk	Mokrosinski, Jacek/M-1963-2019; Mokrosinski, Jacek/J-9506-2012	Mokrosinski, Jacek/0000-0001-5008-0457; Mokrosinski, Jacek/0000-0003-1710-1679; Holst, Birgitte/0000-0001-7432-097X; Frimruer, Thomas/0000-0002-9682-8245; Schwartz, Thue W./0000-0002-0261-6904	Danish Medical Research Council; The NovoNordisk Foundation; Lundbeck Foundation; Alfred Benzon Foundation; German Science Foundation [KFO 152]; Danish Ministry of Science, Technology, and Innovation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The NovoNordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Alfred Benzon Foundation; German Science Foundation(German Research Foundation (DFG)); Danish Ministry of Science, Technology, and Innovation	This work was supported by grants from the Danish Medical Research Council, The NovoNordisk Foundation, the Lundbeck Foundation, the Alfred Benzon Foundation, and the German Science Foundation for Financial Support (Grant KFO 152). This work was carried out as part of the "Food, Fitness and Pharma for Health and Disease" research program of the UNIK project, supported by the Danish Ministry of Science, Technology, and Innovation.	Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Bockenhauer S, 2011, J PHYS CHEM B, V115, P13328, DOI 10.1021/jp204843r; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Couture L, 1996, EUR J BIOCHEM, V241, P627, DOI 10.1111/j.1432-1033.1996.00627.x; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; Elling CE, 2000, BIOCHEMISTRY-US, V39, P667, DOI 10.1021/bi991777b; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Han SJ, 2005, J BIOL CHEM, V280, P34849, DOI 10.1074/jbc.M506711200; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Hornak V, 2010, J MOL BIOL, V396, P510, DOI 10.1016/j.jmb.2009.12.003; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lu ZL, 2000, J BIOL CHEM, V275, P5682, DOI 10.1074/jbc.275.8.5682; Macdonald D, 2001, BIOCHEMISTRY-US, V40, P2530, DOI 10.1021/bi001880x; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Portier M, 1999, J PHARMACOL EXP THER, V288, P582; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rosenkilde MM, 2006, MOL PHARMACOL, V70, P1892, DOI 10.1124/mol.106.027425; Ryu KS, 1998, J BIOL CHEM, V273, P6285, DOI 10.1074/jbc.273.11.6285; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sanchez-Mas J, 2004, PIGM CELL RES, V17, P386, DOI 10.1111/j.1600-0749.2004.00160.x; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; SCHWARTZ TW, 2003, TXB RECEPTOR PHARM, P81; Sivertsen B, 2011, J BIOL CHEM, V286, P20845, DOI 10.1074/jbc.M110.173237; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wheatley M, 1999, HUM REPROD UPDATE, V5, P356, DOI 10.1093/humupd/5.4.356; Wheatley M, 2007, BIOCHEM SOC T, V35, P717, DOI 10.1042/BST0350717; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zoffmann S, 2002, MOL PHARMACOL, V62, P729, DOI 10.1124/mol.62.3.729	72	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33488	33502		10.1074/jbc.M112.383240	http://dx.doi.org/10.1074/jbc.M112.383240			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22846991	Green Published, hybrid			2022-12-25	WOS:000309602100035
J	Wang, WY; Linsdell, P				Wang, Wuyang; Linsdell, Paul			Relative Movements of Transmembrane Regions at the Outer Mouth of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Pore during Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNEL; POSITIVE CHARGES; CONFORMATIONAL-CHANGES; ANION CONDUCTION; SEGMENT; DOMAIN; STATE; IDENTIFICATION; TRANSPORTERS; PERMEATION	Multiple transmembrane (TM) segments line the pore of the cystic fibrosis transmembrane conductance regulator Cl- channel; however, the relative alignment of these TMs and their relative movements during channel gating are unknown. To gain three-dimensional structural information on the outer pore, we have used patch clamp recording to study the proximity of pairs of cysteine side chains introduced into TMs 6 and 11, using both disulfide cross-linking and Cd2+ coordination. Following channel activation, disulfide bonds could apparently be formed between three cysteine pairs (of 15 studied): R334C/T1122C, R334C/G1127C, and T338C/S1118C. To examine the state dependence of cross-linking, we combined these cysteine mutations with a nucleotide-binding domain mutation (E1371Q) that stabilizes the channel open state. Investigation of the effects of the E1371Q mutation on disulfide bond formation and Cd2+ coordination suggests that although R334C/T1122C and T338C/S1118C are closer together in the channel open state, R334C/G1127C are close together and can form disulfide bonds only when the channel is closed. These results provide important new information on the three-dimensional structure of the outer mouth of the cystic fibrosis transmembrane conductance regulator channel pore: TMs 6 and 11 are close enough together to form disulfide bonds in both open and closed channels. Moreover, the altered relative locations of residues in open and in closed channels that we infer allow us to propose that channel opening and closing may be associated with a relative translational movement of TMs 6 and 11, with TM6 moving "down" (toward the cytoplasm) during channel opening.	[Wang, Wuyang; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		Linsdell, Paul/0000-0001-6257-6273; Wang, Wuyang/0000-0003-1875-5463	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Bell DC, 2009, PFLUG ARCH EUR J PHY, V458, P259, DOI 10.1007/s00424-008-0613-3; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Fatehi M, 2008, J BIOL CHEM, V283, P6102, DOI 10.1074/jbc.M707736200; Fatehi M, 2007, BIOPHYS J, V92, P1241, DOI 10.1529/biophysj.106.095349; Fatehi M, 2009, J MEMBRANE BIOL, V228, P151, DOI 10.1007/s00232-009-9167-3; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Gupta J, 2001, BIOCHEMISTRY-US, V40, P6620, DOI 10.1021/bi002819v; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Li MS, 2011, AM J PHYSIOL-CELL PH, V300, pC65, DOI 10.1152/ajpcell.00290.2010; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6	40	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32136	32146		10.1074/jbc.M112.385096	http://dx.doi.org/10.1074/jbc.M112.385096			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843683	Green Published, hybrid			2022-12-25	WOS:000309059400051
J	Panter, MS; Jain, A; Leonhardt, RM; Ha, T; Cresswell, P				Panter, Michaela S.; Jain, Ankur; Leonhardt, Ralf M.; Ha, Taekjip; Cresswell, Peter			Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; HLA CLASS-I; CYTOMEGALOVIRUS US6 GLYCOPROTEIN; CELL-SURFACE EXPRESSION; ANTIGEN PRESENTATION; REDOX REGULATION; TRANSPORTER TAP; HEAVY-CHAINS; TAPASIN; MOLECULES	Although the human peptide-loading complex (PLC) is required for optimal major histocompatibility complex class I (MHC I) antigen presentation, its composition is still incompletely understood. The ratio of the transporter associated with antigen processing (TAP) and MHC I to tapasin, which is responsible for MHCI recruitment and peptide binding optimization, is particularly critical for modeling of the PLC. Here, we characterized the stoichiometry of the human PLC using both biophysical and biochemical approaches. By means of single-molecule pulldown (SiMPull), we determined a TAP/tapasin ratio of 1: 2, consistent with previous studies of insect-cell microsomes, rat-human chimeric cells, and HeLa cells expressing truncated TAP subunits. We also report that the tapasin/MHC I ratio varies, with the PLC population comprising both 2: 1 and 2: 2 complexes, based on mutational and co-precipitation studies. The MHC I-saturated PLC may be particularly prevalent among peptide-selective alleles, such as HLA-C4. Additionally, MHC I association with the PLC increases when its peptide supply is reduced by inhibiting the proteasome or by blocking TAP-mediated peptide transport using viral inhibitors. Taken together, our results indicate that the composition of the human PLC varies under normal conditions and dynamically adapts to alterations in peptide supply that may arise during viral infection. These findings improve our understanding of the quality control of MHC I peptide loading and may aid the structural and functional modeling of the human PLC.	[Panter, Michaela S.; Leonhardt, Ralf M.; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Panter, Michaela S.; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Jain, Ankur; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Jain, Ankur; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	Yale University; Howard Hughes Medical Institute; Yale University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,TAC S670, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Leonhardt, Ralf Max/0000-0001-6673-8217	National Institutes of Health [AI083025, GM065367, T32AI07019]; Howard Hughes Medical Institute; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025, R01AI097206, T32AI007019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI083025 and GM065367 (to T. H.) and Training Grant T32AI07019 (to the Yale Department of Immunobiology). This work was also supported by the Howard Hughes Medical Institute and a Cancer Research Institute Fellowship (to R. M. L.).	Alberts P, 2001, CURR BIOL, V11, P242, DOI 10.1016/S0960-9822(01)00073-2; Antoniou AN, 2002, IMMUNOLOGY, V106, P182, DOI 10.1046/j.1365-2567.2002.01415.x; Arunachalam B, 1998, J IMMUNOL, V160, P5797; Bangia N, 2005, IMMUNOLOGY, V114, P346, DOI 10.1111/j.1365-2567.2005.02103.x; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; Barnden MJ, 2000, J IMMUNOL, V165, P322, DOI 10.4049/jimmunol.165.1.322; BARNSTABLE CJ, 1978, BRIT MED BULL, V34, P241, DOI 10.1093/oxfordjournals.bmb.a071504; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; EDWARDS PAW, 1982, EUR J IMMUNOL, V12, P641, DOI 10.1002/eji.1830120804; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Halenius A, 2006, J BIOL CHEM, V281, P5383, DOI 10.1074/jbc.M510223200; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Hughes EA, 1996, J EXP MED, V183, P1569, DOI 10.1084/jem.183.4.1569; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Hulpke S., 2012, CELL MOL LI IN PRESS; Jain A, 2012, NAT PROTOC, V7, P445, DOI 10.1038/nprot.2011.452; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Karttunen JT, 2001, P NATL ACAD SCI USA, V98, P7431, DOI 10.1073/pnas.121180198; Keusekotten K, 2006, J BIOL CHEM, V281, P17545, DOI 10.1074/jbc.M602360200; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; KLEIN E, 1968, CANCER RES, V28, P1300; Knittler MR, 1999, CURR BIOL, V9, P999, DOI 10.1016/S0960-9822(99)80448-5; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; KUSARI J, 1986, MOL CELL BIOL, V6, P2062, DOI 10.1128/MCB.6.6.2062; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; Neisig A, 1998, J IMMUNOL, V160, P171; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Plewnia G, 2007, J MOL BIOL, V369, P95, DOI 10.1016/j.jmb.2007.02.102; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Praveen PVK, 2010, EUR J IMMUNOL, V40, P214, DOI 10.1002/eji.200939342; Rufer E, 2007, J IMMUNOL, V179, P5717, DOI 10.4049/jimmunol.179.9.5717; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; SEONG RH, 1988, J EXP MED, V167, P288, DOI 10.1084/jem.167.2.288; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stepensky D, 2007, TRAFFIC, V8, P1530, DOI 10.1111/j.1600-0854.2007.00639.x; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; TRAPANI JA, 1989, IMMUNOGENETICS, V29, P25, DOI 10.1007/BF02341610; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	66	42	44	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31172	31184		10.1074/jbc.M112.387704	http://dx.doi.org/10.1074/jbc.M112.387704			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829594	Green Published, hybrid			2022-12-25	WOS:000308791300030
J	Yahiro, K; Satoh, M; Nakano, M; Hisatsune, J; Isomoto, H; Sap, J; Suzuki, H; Nomura, F; Noda, M; Moss, J; Hirayama, T				Yahiro, Kinnosuke; Satoh, Mamoru; Nakano, Masayuki; Hisatsune, Junzo; Isomoto, Hajime; Sap, Jan; Suzuki, Hidekazu; Nomura, Fumio; Noda, Masatoshi; Moss, Joel; Hirayama, Toshiya			Low-density Lipoprotein Receptor-related Protein-1 (LRP1) Mediates Autophagy and Apoptosis Caused by Helicobacter pylori VacA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE-BETA; GASTRIC EPITHELIAL-CELLS; ANION-SELECTIVE CHANNELS; VACUOLATING-CYTOTOXIN; MITOCHONDRIAL APOPTOSIS; TUMOR-GROWTH; LIPID RAFTS; T-CELL; TOXIN; DEATH	In Helicobacter pylori infection, vacuolating cytotoxin (VacA)-induced mitochondrial damage leading to apoptosis is believed to be a major cause of cell death. It has also been proposed that VacA-induced autophagy serves as a host mechanism to limit toxin-induced cellular damage. Apoptosis and autophagy are two dynamic and opposing processes that must be balanced to regulate cell death and survival. Here we identify the low-density lipoprotein receptor-related protein-1 (LRP1) as the VacA receptor for toxin-induced autophagy in the gastric epithelial cell line AZ-521, and show that VacA internalization through binding to LRP1 regulates the autophagic process including generation of LC3-II from LC3-I, which is involved in formation of autophagosomes and autolysosomes. Knockdown of LRP1 and Atg5 inhibited generation of LC3-II as well as cleavage of PARP, a marker of apoptosis, in response to VacA, whereas caspase inhibitor, benzyloxycarbonyl-VAD-fluoromethylketone (Z-VAD-fmk), and necroptosis inhibitor, Necrostatin-1, did not inhibit VacA-induced autophagy, suggesting that VacA-induced autophagy via LRP1 binding precedes apoptosis. Other VacA receptors such as RPTP alpha, RPTP beta, and fibronectin did not affect VacA-induced autophagy or apoptosis. Therefore, we propose that the cell surface receptor, LRP1, mediates VacA-induced autophagy and apoptosis.	[Nakano, Masayuki; Hisatsune, Junzo; Hirayama, Toshiya] Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan; [Yahiro, Kinnosuke; Noda, Masatoshi] Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chiba 2608670, Japan; [Satoh, Mamoru; Nomura, Fumio] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba 2608670, Japan; [Hisatsune, Junzo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Bacteriol, Hiroshima 7348551, Japan; [Isomoto, Hajime] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki 8528523, Japan; [Sap, Jan] Univ Paris Diderot, CNRS, UMR 7216, Sorbonne Paris Cite, Paris, France; [Suzuki, Hidekazu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan; [Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	Nagasaki University; Chiba University; Chiba University; Hiroshima University; Nagasaki University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Keio University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hirayama, T (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan.	hirayama@net.nagasaki-u.ac.jp	SUZUKI, HIDEKAZU/S-9376-2019; Suzuki, Hidekazu/J-4396-2013	Yahiro, Kinnosuke/0000-0002-9813-0780	Ministry of Education, Culture, Sports, Science and Technology of Japan; Improvement of Research Environment for Young Researchers from the Japan Science and Technology Agency; National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Improvement of Research Environment for Young Researchers from the Japan Science and Technology Agency; National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Improvement of Research Environment for Young Researchers from the Japan Science and Technology Agency.; Supported by the Intramural Research Program, National Institutes of Health, NHLBI.	Akada JK, 2010, DIS MODEL MECH, V3, P605, DOI 10.1242/dmm.004879; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Boquet P, 2012, TRENDS MICROBIOL, V20, P165, DOI 10.1016/j.tim.2012.01.008; Calore F, 2010, CELL DEATH DIFFER, V17, P1707, DOI 10.1038/cdd.2010.42; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Cover TL, 2003, CANCER RES, V63, P951; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Foo JH, 2010, J MOL BIOL, V401, P792, DOI 10.1016/j.jmb.2010.06.065; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Genisset C, 2007, CELL MICROBIOL, V9, P1481, DOI 10.1111/j.1462-5822.2006.00886.x; GHIRA P, 1995, INFECT IMMUN, V63, P4154, DOI 10.1128/IAI.63.10.4154-4160.1995; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Hennig EE, 2005, FEMS IMMUNOL MED MIC, V44, P143, DOI 10.1016/j.femsim.2004.10.020; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Isomoto H, 2010, TOHOKU J EXP MED, V220, P3, DOI 10.1620/tjem.220.3; Jain P, 2011, P NATL ACAD SCI USA, V108, P16032, DOI 10.1073/pnas.1105175108; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kuck D, 2001, INFECT IMMUN, V69, P5080, DOI 10.1128/IAI.69.8.5080-5087.2001; Kuo CH, 2003, BIOCHEM BIOPH RES CO, V303, P640, DOI 10.1016/S0006-291X(03)00380-2; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; MARCHETTI M, 1995, SCIENCE, V267, P1655, DOI 10.1126/science.7886456; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Nakayama M, 2006, INFECT IMMUN, V74, P6571, DOI 10.1128/IAI.00356-06; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; PAPINI E, 1994, P NATL ACAD SCI USA, V91, P9720, DOI 10.1073/pnas.91.21.9720; Radin JN, 2011, INFECT IMMUN, V79, P2535, DOI 10.1128/IAI.01370-10; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Sewald X, 2008, CELL HOST MICROBE, V3, P20, DOI 10.1016/j.chom.2007.11.003; Sewald X, 2011, CELL MICROBIOL, V13, P482, DOI 10.1111/j.1462-5822.2010.01551.x; Singh M, 2006, CURR MICROBIOL, V52, P254, DOI 10.1007/s00284-005-0103-1; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; Terebiznik MR, 2009, AUTOPHAGY, V5, P370, DOI 10.4161/auto.5.3.7663; Tombola F, 1999, BIOPHYS J, V76, P1401, DOI 10.1016/S0006-3495(99)77301-7; Torres VJ, 2005, J BIOL CHEM, V280, P21107, DOI 10.1074/jbc.M501042200; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yahiro K, 1999, J BIOL CHEM, V274, P36693, DOI 10.1074/jbc.274.51.36693; Yahiro K, 2003, J BIOL CHEM, V278, P19183, DOI 10.1074/jbc.M300117200; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yoshimori T, 2007, CELL, V128, P833, DOI 10.1016/j.cell.2007.02.023; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; ZHU HJ, 1995, FEBS LETT, V374, P303, DOI 10.1016/0014-5793(95)01116-V	54	91	97	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31104	31115		10.1074/jbc.M112.387498	http://dx.doi.org/10.1074/jbc.M112.387498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822085	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000308791300023
J	Li, XQ; Zhu, YH; Zhang, HF; Yue, Y; Cai, ZX; Lu, QP; Zhang, L; Weng, XG; Zhang, FJ; Zhou, D; Yang, JC; Wang, JF				Li, Xiao-Qiong; Zhu, Yao-Hong; Zhang, Hong-Fu; Yue, Yuan; Cai, Zheng-Xing; Lu, Qing-Ping; Zhang, Lu; Weng, Xiao-Gang; Zhang, Fan-Jian; Zhou, Dong; Yang, Jin-Cai; Wang, Jiu-Feng			Risks Associated with High-Dose Lactobacillus rhamnosus in an Escherichia coli Model of Piglet Diarrhoea: Intestinal Microbiota and Immune Imbalances	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-2; EPITHELIAL-CELLS; FUNCTIONAL-CHARACTERIZATION; ANTIMICROBIAL ACTIVITY; POSTWEANING DIARRHEA; DIAMINOPIMELIC ACID; MOLECULAR-CLONING; EXPRESSION; GG	Probiotic could be a promising alternative to antibiotics for the prevention of enteric infections; however, further information on the dose effects is required. In this study, weanling piglets were orally administered low-or high-dose Lactobacillus rhamnosus ACTT 7469 (10(10) CFU/d or 10(12) CFU/d) for 1 week before F4 (K88)-positive Escherichia coli challenge. The compositions of faecal and gastrointestinal microbiota were recorded; gene expression in the intestines was assessed by real-time PCR; serum tumour necrosis factor-alpha (TNF-alpha) concentrations and intestinal Toll-like receptor 4 (TLR4) were detected by ELISA and immunohistochemistry, respectively. Unexpectedly, high-dose administration increased the incidence of diarrhoea before F4(+)ETEC challenge, despite the fact that both doses ameliorated F4(+)ETEC-induced diarrhoea with increased Lactobacillus and Bifidobacterium counts accompanied by reduced coliform shedding in faeces. Interestingly, L. rhamnosus administration reduced Lactobacillus and Bifidobacterium counts in the colonic contents, and the high-dose piglets also had lower Lactobacillius and Bacteroides counts in the ileal contents. An increase in the concentration of serum TNF-alpha induced by F4(+)ETEC was observed, but the increase was delayed by L. rhamnosus. In piglets exposed to F4(+)ETEC, jejunal TLR4 expression increased at the mRNA and protein levels, while jejunal interleukin (IL)-8 and ileal porcine beta-defensins 2 (pBD2) mRNA expression increased; however, these increases were attenuated by administration of L. rhamnosus. Notably, expression of jejunal TLR2, ileal TLR9, Nod-like receptor NOD1 and TNF-alpha mRNA was upregulated in the low-dose piglets after F4(+)ETEC challenge, but not in the high-dose piglets. These findings indicate that pretreatment with a low dose of L. rhamnosus might be more effective than a high dose at ameliorating diarrhoea. There is a risk that high-dose L. rhamnosus pretreatment may negate the preventative effects, thus decreasing the prophylactic benefits against potential enteric pathogens. Our data suggest a safe threshold for preventative use of probiotics in clinical practice.	[Li, Xiao-Qiong; Zhu, Yao-Hong; Yue, Yuan; Cai, Zheng-Xing; Weng, Xiao-Gang; Zhang, Fan-Jian; Zhou, Dong; Yang, Jin-Cai; Wang, Jiu-Feng] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Zhang, Hong-Fu; Lu, Qing-Ping] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Zhang, Lu] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Aarhus University	Li, XQ (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	Jiufeng_wang@hotmail.com			Program for New Century Excellent Talents in University (China) [NCET-10-0791]; Special Fund for Agro-Scientific Research in the Public Interest (China) [201003060-07]; State Key Laboratory of Animal Nutrition (China) [2004DA125184F1017]	Program for New Century Excellent Talents in University (China)(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-Scientific Research in the Public Interest (China); State Key Laboratory of Animal Nutrition (China)	This project was supported by grants from the Program for New Century Excellent Talents in University (China) (Project No. NCET-10-0791) and the Special Fund for Agro-Scientific Research in the Public Interest (China) (Project No. 201003060-07), and the State Key Laboratory of Animal Nutrition (China) (Project No. 2004DA125184F1017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2009, J CLIN GASTROENTEROL, V43, P208, DOI 10.1097/MCG.0b013e31815a5780; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; Casini L, 2007, LIVEST SCI, V108, P226, DOI 10.1016/j.livsci.2007.01.072; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; COCONNIER MH, 1993, J DIARRHOEAL DIS RES, V11, P235; Collado MC, 2007, CURR MICROBIOL, V55, P260, DOI 10.1007/s00284-007-0144-8; Collado-Romero M, 2010, VET RES, V41, DOI 10.1051/vetres/2009072; Cutler SA, 2007, ANTIMICROB AGENTS CH, V51, P3830, DOI 10.1128/AAC.00360-07; Daudelin JF, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-69; Devriendt B, 2010, DEV COMP IMMUNOL, V34, P1175, DOI 10.1016/j.dci.2010.06.009; Duvigneau JC, 2005, J IMMUNOL METHODS, V306, P16, DOI 10.1016/j.jim.2005.06.021; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Franklin MA, 2002, J ANIM SCI, V80, P2904; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghadimi D, 2010, INFLAMM BOWEL DIS, V16, P410, DOI 10.1002/ibd.21057; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Hermes RG, 2011, COMP IMMUNOL MICROB, V34, P479, DOI 10.1016/j.cimid.2011.08.006; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Llopis M, 2009, INFLAMM BOWEL DIS, V15, P275, DOI 10.1002/ibd.20736; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Meurens F, 2009, MOL IMMUNOL, V46, P927, DOI 10.1016/j.molimm.2008.09.036; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salazar-Lindo Eduardo, 2004, BMC Pediatr, V4, P18, DOI 10.1186/1471-2431-4-18; Saleh M, 2011, IMMUNOL REV, V243, P235, DOI 10.1111/j.1600-065X.2011.01045.x; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Shu Q, 2001, J PEDIATR GASTR NUTR, V33, P171, DOI 10.1097/00005176-200108000-00014; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tohno M, 2008, MOL IMMUNOL, V45, P1807, DOI 10.1016/j.molimm.2007.09.029; Tohno M, 2008, MOL IMMUNOL, V45, P194, DOI 10.1016/j.molimm.2007.04.019; Tohno M, 2006, VET RES, V37, P791, DOI 10.1051/vetres:2006036; Toki S, 2009, INT ARCH ALLERGY IMM, V148, P45, DOI 10.1159/000151505; Trevisi P, 2011, ANIMAL, V5, P1354, DOI 10.1017/S1751731111000462; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Veldhuizen EJA, 2007, MOL IMMUNOL, V44, P276, DOI 10.1016/j.molimm.2006.03.005; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wolvers D, 2010, J NUTR, V140, p698S, DOI 10.3945/jn.109.113753; Zhang L, 2010, VET MICROBIOL, V141, P142, DOI 10.1016/j.vetmic.2009.09.003; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752; Zhu YH, 2007, VET RES, V38, P871, DOI 10.1051/vetres:2007035	64	83	99	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40666	10.1371/journal.pone.0040666	http://dx.doi.org/10.1371/journal.pone.0040666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848393	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950200027
J	Latinus, M; Belin, P				Latinus, Marianne; Belin, Pascal			Perceptual Auditory Aftereffects on Voice Identity Using Brief Vowel Stimuli	PLOS ONE			English	Article							ADAPTATION	Humans can identify individuals from their voice, suggesting the existence of a perceptual representation of voice identity. We used perceptual aftereffects - shifts in perceived stimulus quality after brief exposure to a repeated adaptor stimulus to - further investigate the representation of voice identity in two experiments. Healthy adult listeners were familiarized with several voices until they reached a recognition criterion. They were then tested on identification tasks that used vowel stimuli generated by morphing between the different identities, presented either in isolation (baseline) or following short exposure to different types of voice adaptors (adaptation). Experiment 1 showed that adaptation to a given voice induced categorization shifts away from that adaptor's identity even when the adaptors consisted of vowels different from the probe stimuli. Moreover, original voices and caricatures resulted in comparable aftereffects, ruling out an explanation of identity aftereffects in terms of adaptation to low-level features. In Experiment 2, we show that adaptors with a disrupted configuration, i.e., altered fundamental frequency or formant frequencies, failed to produce perceptual aftereffects showing the importance of the preserved configuration of these acoustical cues in the representation of voices. These two experiments indicate a high-level, dynamic representation of voice identity based on the combination of several lower-level acoustical features into a specific voice configuration.	[Latinus, Marianne; Belin, Pascal] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Belin, Pascal] Univ Montreal, Int Labs Brain Mus & Sound BRAMS, Quebec City, PQ, Canada; [Belin, Pascal] McGill Univ, Quebec City, PQ, Canada; [Latinus, Marianne] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Glasgow; Universite de Montreal; McGill University; Indiana University System; Indiana University Bloomington	Latinus, M (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	mlatinus@gmail.com	Latinus, Marianne/A-8173-2011; Belin, Pascal/C-6247-2009	Latinus, Marianne/0000-0002-4406-2962; Belin, Pascal/0000-0002-7578-6365	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBE0039581]; Economic and Social Research Council/Medical Research Council [RES-060-25-0010]	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council/Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC))	This work was supported by UK Biotechnology and Biological Sciences Research Council grant (BBSRC, BBE0039581, http://www.bbsrc.ac.uk/) and a Economic and Social Research Council (http://www.esrc.ac.uk/)/Medical Research Council grant (http://www.mrc.ac.uk/index.htm) (RES-060-25-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 1976, ADAPTING PROPERTY DE, P55; Baumann O, 2010, PSYCHOL RES-PSYCH FO, V74, P110, DOI 10.1007/s00426-008-0185-z; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2006, PHILOS T R SOC B, V361, P2091, DOI 10.1098/rstb.2006.1933; BENSON PJ, 1994, PERCEPTION, V23, P75, DOI 10.1068/p230075; Blanz V, 2000, PERCEPTION, V29, P885, DOI 10.1068/p2851; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Charest I, 2012, CEREB CORTEX; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Ghazanfar AA, 2008, CURR BIOL, V18, pR457, DOI 10.1016/j.cub.2008.03.030; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Holt LL, 2006, J ACOUST SOC AM, V120, P2801, DOI 10.1121/1.2354071; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; Kawahara H, 1999, SPEECH COMMUN, V27, P187, DOI 10.1016/S0167-6393(98)00085-5; Kreiman J., 1997, TALKER VARIABILITY S, P85; Latinus M, 2011, CEREB CORTEX, V21, P2820, DOI 10.1093/cercor/bhr077; Latinus M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00175; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Mullennix JW, 1995, J ACOUST SOC AM, V98, P3080, DOI 10.1121/1.413832; PAPCUN G, 1989, J ACOUST SOC AM, V85, P913, DOI 10.1121/1.397564; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; SAMUEL AG, 1986, COGNITIVE PSYCHOL, V18, P452, DOI 10.1016/0010-0285(86)90007-1; Schweinberger SR, 2008, CURR BIOL, V18, P684, DOI 10.1016/j.cub.2008.04.015; Schweinberger SR, 2011, BRIT J PSYCHOL, V102, P748, DOI 10.1111/j.2044-8295.2011.02048.x; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Yamashita JA, 2005, J EXP PSYCHOL HUMAN, V31, P420, DOI 10.1037/0096-1523.31.3.420; Zaske R, 2010, HEARING RES, V268, P38, DOI 10.1016/j.heares.2010.04.011; Zaske R, 2011, HEAR RES	34	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41384	10.1371/journal.pone.0041384	http://dx.doi.org/10.1371/journal.pone.0041384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844469	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000306687700080
J	Smith, DW; Gardiner, BS; Dunstan, C				Smith, David W.; Gardiner, Bruce S.; Dunstan, Colin			Bone Balance within a Cortical BMU: Local Controls of Bone Resorption and Formation	PLOS ONE			English	Article							MULTICELLULAR UNIT; METABOLIC-CONTROL; HOMEOSTASIS; OSTEOPOROSIS; OSTEOBLAST; SYSTEMS; CELLS; INSIGHTS; BEHAVIOR	Maintaining bone volume during bone turnover by a BMU is known as bone balance. Balance is required to maintain structural integrity of the bone and is often dysregulated in disease. Consequently, understanding how a BMU controls bone balance is of considerable interest. This paper develops a methodology for identifying potential balance controls within a single cortical BMU. The theoretical framework developed offers the possibility of a directed search for biological processes compatible with the constraints of balance control. We first derive general control constraint equations and then introduce constitutive equations to identify potential control processes that link key variables that describe the state of the BMU. The paper describes specific local bone volume balance controls that may be associated with bone resorption and bone formation. Because bone resorption and formation both involve averaging over time, short-term fluctuations in the environment are removed, leaving the control systems to manage deviations in longer-term trends back towards their desired values. The length of time for averaging is much greater for bone formation than for bone resorption, which enables more filtering of variability in the bone formation environment. Remarkably, the duration for averaging of bone formation may also grow to control deviations in long-term trends of bone formation. Providing there is sufficient bone formation capacity by osteoblasts, this leads to an extraordinarily robust control mechanism that is independent of either osteoblast number or the cellular osteoid formation rate. A complex picture begins to emerge for the control of bone volume. Different control relationships may achieve the same objective, and the 'integration of information' occurring within a BMU may be interpreted as different sets of BMU control systems coming to the fore as different information is supplied to the BMU, which in turn leads to different observable BMU behaviors.	[Smith, David W.; Gardiner, Bruce S.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia; [Dunstan, Colin] Univ Sydney, Sch Aeronaut Mech & Mechatron Engn, Sydney, NSW 2006, Australia	University of Western Australia; University of Sydney	Smith, DW (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	david.smith@uwa.edu.au	Dunstan, Colin/G-6214-2013; Smith, David W/H-5856-2014; Gardiner, Bruce/C-8593-2012	Dunstan, Colin/0000-0001-7586-4071; Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908				BARON R, 2003, ANATOMY BIOL BONE MA; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brogan WL., 1990, MODERN CONTROL THEOR; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; CARTER DR, 1981, ACTA ORTHOP SCAND, V52, P481, DOI 10.3109/17453678108992136; Cooper DML, 2006, ANAT REC PART A, V288A, P806, DOI 10.1002/ar.a.20344; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Doyle J., 1990, FEEDBACK CONTROL THE; Edwards Claire M, 2008, Int J Med Sci, V5, P263; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Engin F, 2010, BONE, V46, P274, DOI 10.1016/j.bone.2009.05.027; ERIKSEN EF, 1986, BONE, V7, P213, DOI 10.1016/8756-3282(86)90020-7; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664; Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heinrich R, 1986, REGULATION CELL SYST; Helfrich MH, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P385, DOI 10.1016/B978-0-12-373884-4.00039-2; Heuett WJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-44; JAWORSKI ZFG, 1980, J ANAT, V131, P91; Karsdal MA, 2005, AM J PATHOL, V166, P467, DOI 10.1016/S0002-9440(10)62269-9; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Khalil H., 2003, NONLINEAR SYSTEMS; Komarova S V, 2003, J THEOR BIOL, V229, P293; Lanyon L.E., 2009, IBMS BONEKEY, V6, P218, DOI [10.1138/20090382, DOI 10.1138/20090382]; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Lerner UH, 2006, J DENT RES, V85, P584, DOI 10.1177/154405910608500703; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANSON JD, 1965, J ANAT, V99, P539; Martin RB, 2007, BONE, V40, P1574, DOI 10.1016/j.bone.2007.02.023; Martin RB, 2000, BONE, V26, P1, DOI 10.1016/S8756-3282(99)00241-0; Martin RB, 1998, SKELETAL TISSUE MECH; Metz LN, 2003, BONE, V33, P753, DOI 10.1016/S8756-3282(03)00245-X; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; PARFITT AM, 1976, METABOLISM, V25, P909, DOI 10.1016/0026-0495(76)90124-4; Parfitt M, 1987, J BONE MINER RES, V2, P595; Parfitt MA, 1983, PHYSL CLIN SIGNIFICA; Parfitt MA, 1994, J CELL BIOCHEM, V55, P273; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Pivonka P, 2010, J THEOR BIOL, V262, P306, DOI 10.1016/j.jtbi.2009.09.021; Reeve J, 1987, J BONE MINERAL RES, V2; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Ryser MD, 2009, J BONE MINER RES, V24, P860, DOI 10.1359/JBMR.081229; SAURO HM, 1987, EUR J BIOCHEM, V165, P215, DOI 10.1111/j.1432-1033.1987.tb11214.x; SAVAGEAU MA, 1987, MATH BIOSCI, V86, P147, DOI 10.1016/0025-5564(87)90008-3; St-Arnaud R, 2008, ARCH BIOCHEM BIOPHYS, V473, P225, DOI 10.1016/j.abb.2008.03.038; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yue H, 2006, MOL BIOSYST, V2, P640, DOI 10.1039/b609442b; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	55	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40268	10.1371/journal.pone.0040268	http://dx.doi.org/10.1371/journal.pone.0040268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844401	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700010
J	Jiang, LL; Lin, JJ; Han, HY; Dong, H; Zhao, QP; Zhu, SH; Huang, B				Jiang, Lianlian; Lin, Jiaojiao; Han, Hongyu; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Huang, Bing			Identification and Characterization of Eimeria tenella Apical Membrane Antigen-1 (AMA1)	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; TOXOPLASMA-GONDII; HOST-CELL; INVASION; COCCIDIOSIS; INFECTION; PARASITES; PURIFICATION; MEROZOITES; EXPRESSION	Apical membrane antigen-1 (AMA1) is a micronemal protein of apicomplexan parasites that appears to be essential during the invasion of host cells. In this study, a full-length cDNA of AMA1 was identified from Eimeria tenella (Et) using expressed sequence tag and the rapid amplification of cDNA ends technique. EtAMA1 had an open reading frame of 1608 bp encoding a protein of 535 amino acids. Quantitative real-time PCR analysis revealed that EtAMA1 was expressed at higher levels in sporozoites than in the other developmental stages (unsporulated oocysts, sporulated oocysts and second-generation merozoites). The ectodomain sequence was expressed as recombinant EtAMA1 (rEtAMA1) and rabbit polyclonal antibodies raised against the rEtAMA1 recognized a 58-kDa native parasite protein by Western Blotting and had a potent inhibitory effect on parasite invasion, decreasing it by approximately 70%. Immunofluorescence analysis and immunohistochemistry analysis showed EtAMA1 might play an important role in sporozoite invasion and development.	[Jiang, Lianlian; Lin, Jiaojiao; Han, Hongyu; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Huang, Bing] Chinese Acad Agr Sci, Key Lab Anim Parasitol, Minist Agr, Shanghai Vet Res Inst, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Jiang, LL (corresponding author), Chinese Acad Agr Sci, Key Lab Anim Parasitol, Minist Agr, Shanghai Vet Res Inst, Shanghai, Peoples R China.	hb@shvri.ac.cn			Shanghai Science Foundation of China [09ZR1438700]; National Nonprofit Institute Research Grant of CATAS-ITBB [2010JB02]	Shanghai Science Foundation of China; National Nonprofit Institute Research Grant of CATAS-ITBB	This work was supported by the Shanghai Science Foundation of China (Grant No. 09ZR1438700) and by the National Nonprofit Institute Research Grant of CATAS-ITBB (Grant No. 2010JB02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Allen PC, 2002, CLIN MICROBIOL REV, V15, P58, DOI 10.1128/CMR.15.1.58-65.2002; Belli SL, 2005, PROTEOMICS, V5, P918, DOI 10.1002/pmic.200401161; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Blake DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001279; Curtidor H, 2011, GENE, V474, P22, DOI 10.1016/j.gene.2010.12.005; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; Daszak P, 1999, PARASITOL TODAY, V15, P67, DOI 10.1016/S0169-4758(98)01379-9; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Han HY, 2010, J PARASITOL, V96, P95, DOI 10.1645/GE-2221.1; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Innes EA, 2006, PARASITOLOGY, V133, pS145, DOI 10.1017/S0031182006001855; Jahn D, 2009, PARASITOL RES, V105, P655, DOI 10.1007/s00436-009-1437-6; Jiang Lian-lian, 2011, Zhongguo Shouyi Kexue, V41, P551; Jiang LL, 2012, PARASITOL RES, V110, P865, DOI 10.1007/s00436-011-2568-0; Kimbita EN, 2001, VET PARASITOL, V102, P35, DOI 10.1016/S0304-4017(01)00522-2; Klotz C, 2005, EXP PARASITOL, V111, P14, DOI 10.1016/j.exppara.2005.04.005; Lal K, 2009, PROTEOMICS, V9, P4566, DOI 10.1002/pmic.200900305; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; Morris GM, 2007, PARASITOL RES, V101, P583, DOI 10.1007/s00436-007-0516-9; Ng ST, 2002, EXP PARASITOL, V101, P168, DOI 10.1016/S0014-4894(02)00109-1; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Sasai K, 2008, J PARASITOL, V94, P1432, DOI 10.1645/GE-1558.1; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Shirley MW, 2004, TRENDS PARASITOL, V20, P199, DOI 10.1016/j.pt.2004.02.005; Tabares E, 2004, MOL BIOCHEM PARASIT, V135, P123, DOI 10.1016/j.molbiopara.2004.01.013; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Tomley F, 1997, METHODS, V13, P171, DOI 10.1006/meth.1997.0509; Tonukari NJ, 2010, INT J BIOTECH MOL BI, V1, P36; Tyler JS, 2011, TRENDS PARASITOL, V27, P410, DOI 10.1016/j.pt.2011.04.002; Vermeulen A, 2001, VET PARASITOL, V100, P13, DOI 10.1016/S0304-4017(01)00479-4; Williams RB, 2006, VET PARASITOL, V135, P1, DOI 10.1016/j.vetpar.2005.10.012; Williams RB, 1998, INT J PARASITOL, V28, P1089, DOI 10.1016/S0020-7519(98)00066-6; WILSON PA, 1961, J PROTOZOOL, V8, P410, DOI 10.1111/j.1550-7408.1961.tb01236.x; XIE MQ, 1990, PARASITOL RES, V76, P566, DOI 10.1007/BF00932562; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005	43	55	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41115	10.1371/journal.pone.0041115	http://dx.doi.org/10.1371/journal.pone.0041115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829917	gold, Green Submitted, Green Published			2022-12-25	WOS:000306956300056
J	Xu, X; Xi, L; Zeng, J; Yao, QH				Xu, Xin; Xi, Lei; Zeng, Jie; Yao, Qinhong			A Functional+61G/A Polymorphism in Epidermal Growth Factor Is Associated with Glioma Risk among Asians	PLOS ONE			English	Article							EGF GENE; +61 G/A; CANCER; METAANALYSIS; LOCI	Background: Epidermal growth factor (EGF), a potent mitogenic protein, plays an important role in the development of cancers, including glioma. Previous studies showed that the EGF +61G/A polymorphism (rs4444903) may lead to an alteration in EGF production and/or activity, which can result in individual susceptibility to glioma. However, published data regarding the association between the +61G/A polymorphism and glioma risk was contradictory. Objective: The aim of this study was to perform a meta-analysis of eligible studies to derive precise estimation of the association of EGF +61G/A with glioma risk. Methods: We performed a pooled analysis of seven published studies that included 1,613 glioma cases and 2,267 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association. The pooled ORs were performed for codominant model, dominant model, and recessive model, respectively. Results: Overall, no significant associations between the EGF +61G/A polymorphism and glioma cancer risk were found for AA versus GG (OR = 0.95, 95% CI = 0.62-1.45), GA versus GG (OR = 0.94, 95% CI = 0.72-1.22), AA/GA versus GG (OR = 0.93, 95% CI = 0.70-1.23), and AA versus GA/GG (OR = 1.04, 95% CI = 0.77-1.39). However, in the stratified analysis by ethnicity, the EGF +61G/A polymorphism had a higher risk of glioma development among Asians, but a lower risk among Caucasians. Conclusions: Taken together, the results suggest that the EGF +61G/A polymorphism may contribute to the susceptibility of glioma in different ethnic groups.	[Xu, Xin; Xi, Lei; Zeng, Jie; Yao, Qinhong] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Wuxi, Peoples R China	Southeast University - China	Xu, X (corresponding author), Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Wuxi, Peoples R China.	drqhyao@163.com						Bao G, 2010, J INT MED RES, V38, P1645, DOI 10.1177/147323001003800509; Bhowmick DA, 2004, CANCER RES, V64, P1220, DOI 10.1158/0008-5472.CAN-03-3137; Bondy ML, 2001, J NATL CANCER I, V93, P1553, DOI 10.1093/jnci/93.20.1553; Costa BM, 2007, CLIN CANCER RES, V13, P2621, DOI 10.1158/1078-0432.CCR-06-2606; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fenstermaker RA, 2000, ONCOGENE, V19, P4542, DOI 10.1038/sj.onc.1203802; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; LAURENCE DJR, 1990, TUMOR BIOL, V11, P229, DOI 10.1159/000217659; Liu XQ, 2009, INT J BIOL MARKER, V24, P77, DOI 10.1177/172460080902400203; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mullhaupt B, 2000, GENE, V250, P191, DOI 10.1016/S0378-1119(00)00178-5; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Normanno N, 2001, FRONT BIOSCI-LANDMRK, V6, pD685, DOI 10.2741/Normano; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Pinto GR, 2009, INT J BIOL MARKER, V24, P277, DOI 10.1177/172460080902400410; Ramos-Corpas D, 2006, PRENATAL DIAG, V26, P1124, DOI 10.1002/pd.1568; Sauter G, 1996, AM J PATHOL, V148, P1047; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Vauleon E, 2007, CANCER GENET CYTOGEN, V172, P33, DOI 10.1016/j.cancergencyto.2006.07.013; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-221; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Xu W, 2010, MED ONCOL, V27, P1389, DOI 10.1007/s12032-009-9392-8; Zhang YM, 2010, CANCER EPIDEMIOL, V34, P150, DOI 10.1016/j.canep.2010.02.004	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41470	10.1371/journal.pone.0041470	http://dx.doi.org/10.1371/journal.pone.0041470			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829952	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300092
J	Wolf, S; Rudolph, C; Morgan, M; Busche, G; Salguero, G; Stripecke, R; Schlegelberger, B; Baum, C; Modlich, U				Wolf, S.; Rudolph, C.; Morgan, M.; Buesche, G.; Salguero, G.; Stripecke, R.; Schlegelberger, B.; Baum, C.; Modlich, U.			Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas	ONCOGENE			English	Article						NRas; myelomonocytic leukemia; malignant histiocytosis; murine BMT model; retroviral vector; Evi1	ACUTE MYELOID-LEUKEMIA; N-RAS PROTOONCOGENE; HEMATOPOIETIC-CELLS; DENDRITIC CELLS; RETROVIRAL VECTORS; TRANSGENIC MICE; DOWN-REGULATION; TARGETING RAS; MOUSE MODEL; MUTATIONS	Activation of NRas signaling is frequently found in human myeloid leukemia and can be induced by activating mutations as well as by mutations in receptors or signaling molecules upstream of NRas. To study NRas-induced leukemogenesis, we retrovirally overexpressed wild-type NRas in a murine bone marrow transplantation (BMT) model in C57BL/6J mice. Overexpression of wild-type NRas caused myelomonocytic leukemias similar to 3 months after BMT in the majority of mice. A subset of mice (30%) developed malignant histiocytosis similar to mice that received mutationally activated NRas(G12D)-expressing bone marrow. Aberrant Ras signaling was demonstrated in cells expressing mutationally active or wild-type NRas, as increased activation of Erk and Akt was observed in both models. However, more NRas(G12D) were found to be in the activated, GTP-bound state in comparison with wild-type NRas. Consistent with observations reported for primary human myelomonocytic leukemia cells, Stat5 activation was also detected in murine leukemic cells. Furthermore, clonal evolution was detected in NRas wild-type-induced leukemias, including expansion of clones containing activating vector insertions in known oncogenes, such as Evi1 and Prdm16. In vitro cooperation of NRas and Evi1 improved long-term expansion of primary murine bone marrow cells. Evi1-positive cells upregulated Bcl-2 and may, therefore, provide anti-apoptotic signals that collaborate with the NRas-induced proliferative effects. As activation of Evi1 has been shown to coincide with NRAS mutations in human acute myeloid leukemia, our murine model recapitulates crucial events in human leukemogenesis.	[Wolf, S.; Baum, C.; Modlich, U.] Hannover Med Sch, Inst Expt Hematol, D-30625 Hannover, Germany; [Rudolph, C.; Schlegelberger, B.] Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany; [Morgan, M.; Salguero, G.; Stripecke, R.] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-30625 Hannover, Germany; [Buesche, G.] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Modlich, U (corresponding author), Hannover Med Sch, Inst Expt Hematol, OE6960,Carl Neuberg Str 1, D-30625 Hannover, Germany.	modlich.ute@mh-hannover.de	Stripecke, Renata/G-3252-2013	Modlich, Ute/0000-0001-8018-4118; Wolf, Susanne/0000-0003-0922-8418; Salguero, Gustavo/0000-0002-5018-9927	Deutsche Forschungsgemeinschaft [DFG RU- 1476]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Hans Grundtke, Jorg Fruhauf and Martin Werner (Radiotherapy) for irradiation of the mice, Sabine Knoss, Johanna Krause (Institute of Experimental Hematology) and Andrea Schienke (Institute of Cell and Molecular Pathology) for their excellent technical help, Axel Schambach (Institute of Experimental Hematology) for providing the vector backbone and Sandra Liessem (Institute of Pathology) for help with the immunohistochemistry (all Hannover Medical School). This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG RU- 1476 and Excellence Cluster REBIRTH).	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Arico M, 1997, BLOOD, V90, P479, DOI 10.1182/blood.V90.2.479.479_479_488; Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; BAUM C, 1995, J VIROL, V69, P7541, DOI 10.1128/JVI.69.12.7541-7547.1995; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braun BS, 2008, CLIN CANCER RES, V14, P2249, DOI 10.1158/1078-0432.CCR-07-1005; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; CLINE MJ, 1994, BLOOD, V84, P2840; Cuenco GM, 2004, ONCOGENE, V23, P569, DOI 10.1038/sj.onc.1207143; De Weer A, 2011, BRIT J HAEMATOL, V154, P337, DOI 10.1111/j.1365-2141.2011.08737.x; Diaz R, 2004, CARCINOGENESIS, V25, P535, DOI 10.1093/carcin/bgh026; Diaz R, 2002, CANCER RES, V62, P4514; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gomez-Benito M, 2002, BRIT J CANCER, V103, P1292; Haferlach C, 2011, LEUKEMIA, V25, P874, DOI 10.1038/leu.2011.5; Hao X, 2010, VET PATHOL, V47, P434, DOI 10.1177/0300985810363705; HAUPT Y, 1992, ONCOGENE, V7, P981; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Koike K, 2008, BRIT J HAEMATOL, V141, P567, DOI 10.1111/j.1365-2141.2008.07104.x; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova Olga S., 2009, V506, P373, DOI 10.1007/978-1-59745-409-4_25; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Leenen PJM, 2010, J LEUKOCYTE BIOL, V87, P949, DOI 10.1189/jlb.0609432; LEENEN PJM, 1990, EUR J IMMUNOL, V20, P27, DOI 10.1002/eji.1830200105; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; LOHLER J, 1987, LEUKEMIA, V1, P58; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Lugthart S, 2010, J CLIN ONCOL, V28, P3890, DOI 10.1200/JCO.2010.29.2771; MacKenzie KL, 1999, BLOOD, V93, P2043, DOI 10.1182/blood.V93.6.2043.406k17_2043_2056; MANGUES R, 1994, CANCER RES, V54, P6395; Mangues R, 1996, ONCOGENE, V13, P1053; MANGUES R, 1992, ONCOGENE, V7, P2073; Meyer J, 1998, BLOOD, V91, P1901, DOI 10.1182/blood.V91.6.1901.1901_1901_1908; Modlich U, 2008, LEUKEMIA, V22, P1519, DOI 10.1038/leu.2008.118; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Morgan MA, 2003, LEUKEMIA, V17, P1482, DOI 10.1038/sj.leu.2403024; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Omidvar N, 2007, CANCER RES, V67, P11657, DOI 10.1158/0008-5472.CAN-07-0196; Parikh C, 2006, BLOOD, V108, P2349, DOI 10.1182/blood-2004-08-009498; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Pradhan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025370; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Steinemann D, 2010, HAEMATOL-HEMATOL J, V95, P320, DOI 10.3324/haematol.2009.010355; Takaoka M, 2004, ONCOGENE, V23, P6760, DOI 10.1038/sj.onc.1207923; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; Wahlers A, 2002, MOL THER, V6, P313, DOI 10.1006/mthe.2002.0671; Wahlers A, 2002, J VIROL, V76, P303, DOI 10.1128/JVI.76.1.303-312.2002; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Wiesner SM, 2005, BLOOD, V106, P1054, DOI 10.1182/blood-2004-08-3306	66	6	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 20	2013	32	25					3028	3038		10.1038/onc.2012.329	http://dx.doi.org/10.1038/onc.2012.329			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22847614				2022-12-25	WOS:000320705700003
J	Filippova, N; Yang, XH; King, P; Nabors, LBZ				Filippova, Natalia; Yang, Xiuhua; King, Peter; Nabors, L. Burt			Phosphoregulation of the RNA-binding Protein Hu Antigen R (HuR) by Cdk5 Affects Centrosome Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; MESSENGER-RNA; CELL-CYCLE; BETA-CATENIN; STABILITY; NUCLEAR; PHOSPHORYLATION; PROLIFERATION; LOCALIZATION; NEUROGENESIS	Hu antigen R(HuR) is an mRNA-binding protein belonging to the ELAV family. It is highly expressed in cancer and involved in cell survival and proliferation. The impact of post-translational regulation of HuR and resulting cellular effects are poorly understood. In the current report, we describe a direct interaction between HuR and Cdk5 in glioma. We determined that Cdk5 specifically phosphorylates HuR at the serine 202 residue in the unique hinge region. The molecular consequences of this interaction are an altered HuR ability to bind, stabilize, and promote translation of mRNAs. At the cellular level, the anomalous HuR phosphorylation at this site evokes robust defects in centrosome duplication and cohesion as well as arrest of cell cycle progression. Subcellular fractionation and immunofluorescence technique confirm a direct integration of HuR and Cdk5 with centrosomes. We propose that HuR stores mRNA in the centrosome and that HuR phosphorylation by Cdk5 controls de novo protein synthesis in near proximity to centrosomes and, thus, impacts centrosome function.	[Filippova, Natalia; Yang, Xiuhua; King, Peter; Nabors, L. Burt] Univ Alabama Birmingham, Dept Neurol, Sch Med, Birmingham, AL 35294 USA; [King, Peter] Vet Affairs Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nabors, LBZ (corresponding author), Univ Alabama Birmingham, Dept Neurol, Sch Med, 510 20th St S,FOT 1020, Birmingham, AL 35294 USA.	bnabors@uab.edu	Nabors, Louis/ABB-8223-2021	Nabors, Louis/0000-0001-5926-2230; King, Peter/0000-0001-9391-7464; Filippova, Natalia/0000-0003-2128-5511	National Institutes of Health [R01 CA112397]; Southern Research Institute; NATIONAL CANCER INSTITUTE [R01CA112397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA112397 (to L. B. N.).; We greatly appreciate the space and support provided by the Southern Research Institute. We thank Dr. Lynn Rasmussen for great advice and Robert E McHugh for technical assistance.	Ale-Agha N, 2009, HEPATOLOGY, V50, P1567, DOI 10.1002/hep.23146; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bahmanyar S, 2010, J CELL SCI, V123, P3125, DOI 10.1242/jcs.064782; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Chi MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004900; Courapied S, 2010, J BIOL CHEM, V285, P26765, DOI 10.1074/jbc.M109.092304; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Duensing S, 2001, BBA-REV CANCER, V1471, pM81, DOI 10.1016/S0304-419X(00)00025-1; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Goodyear S, 2007, EXP MOL PATHOL, V82, P25, DOI 10.1016/j.yexmp.2006.09.002; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hirasawa M, 2004, P NATL ACAD SCI USA, V101, P6249, DOI 10.1073/pnas.0307322101; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; John PCL, 2001, PROTOPLASMA, V216, P119, DOI 10.1007/BF02673865; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lagace DC, 2008, P NATL ACAD SCI USA, V105, P18567, DOI 10.1073/pnas.0810137105; Lai PY, 2011, CELL DEATH DIFFER, V18, P1836, DOI 10.1038/cdd.2011.54; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Meigs T. E., 2008, CSH PROTOC, V2008; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nabors LB, 2001, CANCER RES, V61, P2154; Nabors LLB, 2003, CANCER RES, V63, P4181; Nebreda AR, 2006, CURR OPIN CELL BIOL, V18, P192, DOI 10.1016/j.ceb.2006.01.001; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Qina L, 2009, CANCER LETT, V275, P77, DOI 10.1016/j.canlet.2008.10.011; Rosales JL, 2010, CELL CYCLE, V9, P618, DOI 10.4161/cc.9.3.10597; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vijayakumar S., 2011, LOW DOS RAD RES INV; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010	58	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32277	32287		10.1074/jbc.M112.353912	http://dx.doi.org/10.1074/jbc.M112.353912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829587	Green Published, hybrid			2022-12-25	WOS:000309059400064
J	Lima, BP; Huyen, TTT; Basell, K; Becher, D; Antelmann, H; Wolfe, AJ				Lima, Bruno P.; Huyen, Tran Thi Thanh; Baesell, Katrin; Becher, Doerte; Antelmann, Haike; Wolfe, Alan J.			Inhibition of Acetyl Phosphate-dependent Transcription by an Acetylatable Lysine on RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR CPXR; ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; ENVELOPE STRESS; ALPHA-SUBUNIT; GLOBAL SIGNAL; COENZYME-A; PROTEIN; PHOSPHORYLATION; TRANSDUCTION	The ability of bacteria to adapt to environmental changes has allowed these organisms to thrive in all parts of the globe. By monitoring their extracellular and intracellular environments, bacteria assure their most appropriate response for each environment. Post-translational modification of proteins is one mechanism by which cells respond to their changing environments. Here, we report that two post-translational modifications regulate transcription of the extracytoplasmic stress-responsive promoter cpxP: (i) acetyl phosphate-dependent phosphorylation of the response regulator CpxR and (ii) acetyl coenzyme A-dependent acetylation of the alpha subunit of RNA polymerase. Together, these two post-translational modifications fine-tune cpxP transcription in response to changes in the intracellular environment.	[Lima, Bruno P.; Wolfe, Alan J.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Huyen, Tran Thi Thanh; Baesell, Katrin; Becher, Doerte; Antelmann, Haike] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany	Loyola University Chicago; Ernst Moritz Arndt Universitat Greifswald	Wolfe, AJ (corresponding author), 2160 S 1st Ave,Bldg 105, Maywood, IL 60153 USA.	awolfe@lumc.edu	Lima, Bruno/K-3228-2019; Becher, Doerte/B-4454-2015; Antelmann, Haike/I-3129-2019	Lima, Bruno/0000-0003-4619-4712; Becher, Doerte/0000-0002-9630-5735; Antelmann, Haike/0000-0002-1766-4386	National Institutes of Health [GM066130]; Loyola University Chicago Potts Foundation [LU11200]; Deutsche Forschungsgemeinschaft [AN746/2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loyola University Chicago Potts Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066130 and Loyola University Chicago Potts Foundation Award LU11200 (to A. J. W.) and Deutsche Forschungsgemeinschaft Project AN746/2-1 (to H. A.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Beatty CM, 2003, J BACTERIOL, V185, P5148, DOI 10.1128/JB.185.17.5148-5157.2003; Boll JM, 2011, P NATL ACAD SCI USA, V108, P20160, DOI 10.1073/pnas.1113013108; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chang DE, 1999, J BACTERIOL, V181, P6656, DOI 10.1128/JB.181.21.6656-6663.1999; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Chi BK, 2010, PROTEOMICS, V10, P3155, DOI 10.1002/pmic.201000230; Chohnan S, 1998, BIOSCI BIOTECH BIOCH, V62, P1122, DOI 10.1271/bbb.62.1122; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Fleischer R, 2007, J BIOL CHEM, V282, P8583, DOI 10.1074/jbc.M605785200; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; JACKOWSKI S, 1986, J BACTERIOL, V166, P866, DOI 10.1128/jb.166.3.866-871.1986; Keating DH, 2008, BIOL PROCED ONLINE, V10, P36, DOI 10.1251/bpo141; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; Liu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023314; MCCLEARY WR, 1993, J BACTERIOL, V175, P2793, DOI 10.1128/JB.175.10.2793-2798.1993; Miot M, 2011, NEW BIOTECHNOL, V28, P277, DOI 10.1016/j.nbt.2010.06.012; Park D, 2009, MOL MICROBIOL, V73, P938, DOI 10.1111/j.1365-2958.2009.06817.x; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; POWELL BS, 1994, NUCLEIC ACIDS RES, V22, P5765, DOI 10.1093/nar/22.25.5765; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Raivio TL, 1997, J BACTERIOL, V179, P7724, DOI 10.1128/jb.179.24.7724-7733.1997; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Schweimer K, 2011, STRUCTURE, V19, P945, DOI 10.1016/j.str.2011.03.024; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Silhavy T.J., 1984, EXPT GENE FUSIONS; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Spinola SM, 2010, INFECT IMMUN, V78, P3898, DOI 10.1128/IAI.00432-10; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Vogt SL, 2012, FEMS MICROBIOL LETT, V326, P2, DOI 10.1111/j.1574-6968.2011.02406.x; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2003, MOL MICROBIOL, V48, P977, DOI 10.1046/j.1365-2958.2003.03457.x; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	53	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32147	32160		10.1074/jbc.M112.365502	http://dx.doi.org/10.1074/jbc.M112.365502			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829598	hybrid, Green Published			2022-12-25	WOS:000309059400052
J	Prigge, M; Schneider, F; Tsunoda, SP; Shilyansky, C; Wietek, J; Deisseroth, K; Hegemann, P				Prigge, Matthias; Schneider, Franziska; Tsunoda, Satoshi P.; Shilyansky, Carrie; Wietek, Jonas; Deisseroth, Karl; Hegemann, Peter			Color-tuned Channelrhodopsins for Multiwavelength Optogenetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPTICAL CONTROL; VOLVOX-CARTERI; IN-VIVO; LIGHT; ACTIVATION; CHANNEL; CELLS; PHOTOCYCLE; CIRCUITRY	Channelrhodopsin-2 is a light-gated ion channel and a major tool of optogenetics. It is used to control neuronal activity via blue light. Here we describe the construction of color-tuned high efficiency channelrhodopsins (ChRs), based on chimeras of Chlamydomonas channelrhodopsin-1 and Volvox channelrhodopsin-1. These variants show superb expression and plasma membrane integration, resulting in 3-fold larger photocurrents in HEK cells compared with channelrhodopsin-2. Further molecular engineering gave rise to chimeric variants with absorption maxima ranging from 526 to 545 nm, dovetailing well with maxima of channelrhodopsin-2 derivatives ranging from 461 to 492 nm. Additional kinetic fine-tuning led to derivatives in which the lifetimes of the open state range from 19 ms to 5 s. Finally, combining green-with blue-absorbing variants allowed independent activation of two distinct neural cell populations at 560 and 405 nm. This novel panel of channelrhodopsin variants may serve as an important toolkit element for dual-color cell stimulation in neural circuits.	[Prigge, Matthias; Schneider, Franziska; Tsunoda, Satoshi P.; Wietek, Jonas; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Shilyansky, Carrie; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Comp Numer Control Program, Dept Bioengn, Stanford, CA 94305 USA; [Shilyansky, Carrie; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Comp Numer Control Program, Dept Psychiat, Stanford, CA 94305 USA	Humboldt University of Berlin; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Hegemann, P (corresponding author), Humboldt Univ, Inst Biol, D-10115 Berlin, Germany.	hegemape@rz.hu-berlin.de	Wietek, Jonas/AFQ-6404-2022; Tsunoda, Satoshi/AAN-7023-2021; Wietek, Jonas/I-5911-2015	Wietek, Jonas/0000-0002-8079-7042; Wietek, Jonas/0000-0002-8079-7042; Tsunoda, Satoshi/0000-0003-3636-1521	National Institutes of Health; Howard Hughes Medical Institute; Gatsby Foundation; DARPA REPAIR program (reorganization and plasticity to accelerate injury recovery); German Research Foundation; Deutsche Forschungsgemeinschaft [HE3824/9-3, HE3824/9-4]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gatsby Foundation; DARPA REPAIR program (reorganization and plasticity to accelerate injury recovery); German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported, in whole or in part, by the National Institutes of Health. Also supported by the Howard Hughes Medical Institute, the Gatsby Foundation, and the DARPA REPAIR program (reorganization and plasticity to accelerate injury recovery).; Supported by the German Research Foundation and Deutsche Forschungsgemeinschaft Grants HE3824/9-3 and 9-4. To whom correspondence should be addressed. Tel.: 0049-30-2093-8681; E-mail: hegemape@rz.huberlin.de.	Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kianianmomeni A, 2009, PLANT PHYSIOL, V151, P347, DOI 10.1104/pp.109.143297; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Prigge M, 2010, CHANNELS, V4, P241, DOI 10.4161/chan.4.3.11888; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	25	114	137	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31804	31812		10.1074/jbc.M112.391185	http://dx.doi.org/10.1074/jbc.M112.391185			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843694	Green Published, hybrid			2022-12-25	WOS:000309059400021
J	Beck, R; Dejeans, N; Glorieux, C; Creton, M; Delaive, E; Dieu, M; Raes, M; Leveque, P; Gallez, B; Depuydt, M; Collet, JF; Calderon, PB; Verrax, J				Beck, Raphael; Dejeans, Nicolas; Glorieux, Christophe; Creton, Melanie; Delaive, Edouard; Dieu, Marc; Raes, Martine; Leveque, Philippe; Gallez, Bernard; Depuydt, Matthieu; Collet, Jean-Francois; Calderon, Pedro Buc; Verrax, Julien			Hsp90 Is Cleaved by Reactive Oxygen Species at a Highly Conserved N-Terminal Amino Acid Motif	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; ATP-BINDING; LEADS; DEGRADATION; INHIBITION; MECHANISMS; CHAPERONE; COMPLEX; CELLS	Hsp90 is an essential chaperone that is necessary for the folding, stability and activity of numerous proteins. In this study, we demonstrate that free radicals formed during oxidative stress conditions can cleave Hsp90. This cleavage occurs through a Fenton reaction which requires the presence of redox-active iron. As a result of the cleavage, we observed a disruption of the chaperoning function of Hsp90 and the degradation of its client proteins, for example, Bcr-Abl, RIP, c-Raf, NEMO and hTert. Formation of Hsp90 protein radicals on exposure to oxidative stress was confirmed by immuno-spin trapping. Using a proteomic analysis, we determined that the cleavage occurs in a conserved motif of the N-terminal nucleotide binding site, between Ile-126 and Gly-127 in Hsp90 beta, and between Ile-131 and Gly-132 in Hsp90 alpha. Given the importance of Hsp90 in diverse biological functions, these findings shed new light on how oxidative stress can affect cellular homeostasis.	[Beck, Raphael; Dejeans, Nicolas; Glorieux, Christophe; Creton, Melanie; Leveque, Philippe; Gallez, Bernard; Calderon, Pedro Buc; Verrax, Julien] UCL, Louvain Drug Res Inst, Brussels, Belgium; [Delaive, Edouard; Dieu, Marc; Raes, Martine] FUNDP Univ Namur, URBC NARILIS, Namur, Belgium; [Depuydt, Matthieu; Collet, Jean-Francois] UCL, de Duve Inst, Brussels, Belgium; [Calderon, Pedro Buc] Arturo Prat Univ, Dept Ciencias Quim & Farmaceut, Iquique, Chile	Universite Catholique Louvain; University of Namur; Universite Catholique Louvain; Universidad Arturo Prat	Beck, R (corresponding author), UCL, Louvain Drug Res Inst, Brussels, Belgium.	julien.verrax@uclouvain.be		Collet, Jean-Francois/0000-0001-8069-7036; Beck, Raphael/0000-0002-5368-3808; Depuydt, Matthieu/0000-0002-4069-3521; Dieu, Marc/0000-0002-3902-542X	Belgian Fonds National de la Recherche Scientifique (FNRS) [3.4594.04]; Fonds Speciaux de Recherche (FSR) of the University of Louvain; FNRS; FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture); FNRS-Televie	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherche (FSR) of the University of Louvain; FNRS(Fonds de la Recherche Scientifique - FNRS); FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS); FNRS-Televie(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Belgian Fonds National de la Recherche Scientifique (FNRS) (3.4594.04) and by the Fonds Speciaux de Recherche (FSR) of the University of Louvain. The mass spectrometry facility of the Unite de Recherche en Biologie Cellulaire (URBC, University of Namur) is supported by the FNRS. R. Beck is an FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) recipient. N. Dejeans is an FNRS-Televie Postdoctoral Researcher. C. Glorieux is an FNRS-Televie recipient. J. Verrax is a Scientific Research Worker of the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck R, 2011, INVEST NEW DRUG, V29, P891, DOI 10.1007/s10637-010-9441-3; Beck R, 2009, BIOCHEM PHARMACOL, V77, P375, DOI 10.1016/j.bcp.2008.10.019; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BURTON K, 1959, BIOCHEM J, V71, P388, DOI 10.1042/bj0710388; Clark CB, 2009, FREE RADICAL BIO MED, V47, P1440, DOI 10.1016/j.freeradbiomed.2009.08.012; Dikalov S, 2002, J BIOL CHEM, V277, P25480, DOI 10.1074/jbc.M203271200; ESTERBAUER H, 1982, BIOCHEM J, V208, P129, DOI 10.1042/bj2080129; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Gomez-Mejiba SE, 2009, FREE RADICAL BIO MED, V46, P853, DOI 10.1016/j.freeradbiomed.2008.12.020; GOUCHER CR, 1964, J BIOL CHEM, V239, P2251; GUTTERIDGE JMC, 1987, BIOCHEM J, V243, P709, DOI 10.1042/bj2430709; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; OHKUMA S, 1986, J CELL BIOL, V102, P959, DOI 10.1083/jcb.102.3.959; Panopoulos A, 2005, J BIOL CHEM, V280, P2912, DOI 10.1074/jbc.M409524200; Pantano C, 2003, J BIOL CHEM, V278, P44091, DOI 10.1074/jbc.M308487200; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; SAMUNI A, 1983, EUR J BIOCHEM, V137, P119, DOI 10.1111/j.1432-1033.1983.tb07804.x; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Shen SC, 2008, TOXICOL APPL PHARM, V229, P239, DOI 10.1016/j.taap.2008.01.018; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Verrax F, 2005, FREE RADICAL RES, V39, P649, DOI 10.1080/10715760500097906; Verrax J, 2009, CURR MED CHEM, V16, P1821, DOI 10.2174/092986709788186057; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Ye XD, 2011, FREE RADICAL RES, V45, P1289, DOI 10.3109/10715762.2011.616199	36	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40795	10.1371/journal.pone.0040795	http://dx.doi.org/10.1371/journal.pone.0040795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848402	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950200032
J	Lin, IF; Kashino, M				Lin, I-Fan; Kashino, Makio			Perceptual Grouping over Time within and across Auditory and Tactile Modalities	PLOS ONE			English	Article							RHYTHMIC MASKING RELEASE; STREAM SEGREGATION; ORGANIZATION; REPRESENTATION; SEPARATION; CORTEX; STIMULATION; INTEGRATION; NEURONS; VISION	In auditory scene analysis, population separation and temporal coherence have been proposed to explain how auditory features are grouped together and streamed over time. The present study investigated whether these two theories can be applied to tactile streaming and whether temporal coherence theory can be applied to crossmodal streaming. The results show that synchrony detection between two tones/taps at different frequencies/locations became difficult when one of the tones/taps was embedded in a perceptual stream. While the taps applied to the same location were streamed over time, the taps applied to different locations were not. This observation suggests that tactile stream formation can be explained by population-separation theory. On the other hand, temporally coherent auditory stimuli at different frequencies were streamed over time, but temporally coherent tactile stimuli applied to different locations were not. When there was withinmodality streaming, temporally coherent auditory stimuli and tactile stimuli were not streamed over time, either. This observation suggests the limitation of temporal coherence theory when it is applied to perceptual grouping over time.	[Lin, I-Fan; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Morinosato, Wakamiya, Japan	Nippon Telegraph & Telephone Corporation	Lin, IF (corresponding author), NTT Corp, NTT Commun Sci Labs, Morinosato, Wakamiya, Japan.	lin.ifan@lab.ntt.co.jp	Lin, Ifan/HHM-7112-2022		Nippon Telegraph and Telephone Corporation	Nippon Telegraph and Telephone Corporation	This work was supported by Nippon Telegraph and Telephone Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast TL, 2002, J ACOUST SOC AM, V112, P2086, DOI 10.1121/1.1510141; BERNSTEIN LE, 1991, J ACOUST SOC AM, V90, P2971, DOI 10.1121/1.401771; Best V, 2005, J ACOUST SOC AM, V118, P3766, DOI 10.1121/1.2130949; Bregman A.S., 1990, AUDITORY SCENE ANAL; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; DYKES RW, 1981, NEUROSCIENCE, V6, P1687, DOI 10.1016/0306-4522(81)90235-9; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Friedman RM, 2008, J NEUROPHYSIOL, V100, P3185, DOI 10.1152/jn.90278.2008; GARDNER EP, 1972, J NEUROPHYSIOL, V35, P954, DOI 10.1152/jn.1972.35.6.954; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Gutschalk A, 2007, J NEUROSCI, V27, P13074, DOI 10.1523/JNEUROSCI.2299-07.2007; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P539, DOI 10.1113/jphysiol.1978.sp012518; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; Kanold PO, 2001, J NEUROSCI, V21, P7848, DOI 10.1523/JNEUROSCI.21-19-07848.2001; Keetels M, 2007, EXP BRAIN RES, V180, P449, DOI 10.1007/s00221-007-0881-8; Kitagawa N, 2009, J EXP PSYCHOL HUMAN, V35, P1784, DOI 10.1037/a0016891; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LASKIN SE, 1979, J NEUROPHYSIOL, V42, P1048, DOI 10.1152/jn.1979.42.4.1048; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Micheyl C, 2010, J EXP PSYCHOL HUMAN, V36, P1029, DOI 10.1037/a0017601; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; Roseboom W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018309; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; SHERRICK CE, 1964, AM J PSYCHOL, V77, P42, DOI 10.2307/1419270; Shore SE, 2000, J COMP NEUROL, V419, P271, DOI 10.1002/(SICI)1096-9861(20000410)419:3<271::AID-CNE1>3.0.CO;2-M; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; SPARKS DW, 1978, J ACOUST SOC AM, V63, P246, DOI 10.1121/1.381720; Turgeon M, 2005, J EXP PSYCHOL HUMAN, V31, P939, DOI 10.1037/0096-1523.31.5.939; Turgeon M, 2002, J ACOUST SOC AM, V111, P1819, DOI 10.1121/1.1453450; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vliegen J, 1999, J ACOUST SOC AM, V105, P339, DOI 10.1121/1.424503; VONBEKESY G, 1958, J ACOUST SOC AM, V30, P399; WARREN RM, 1984, PSYCHOL BULL, V96, P371, DOI 10.1037/0033-2909.96.2.371; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; Yau JM, 2009, CURR BIOL, V19, P561, DOI 10.1016/j.cub.2009.02.013; YOUNG ED, 1995, J NEUROPHYSIOL, V73, P743, DOI 10.1152/jn.1995.73.2.743	43	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41661	10.1371/journal.pone.0041661	http://dx.doi.org/10.1371/journal.pone.0041661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	012MO	22844509	Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600038
J	Xu, QP; van Wezel, GP; Chiu, HJ; Jaroszewski, L; Klock, HE; Knuth, MW; Miller, MD; Lesley, SA; Godzik, A; Elsliger, MA; Deacon, AM; Wilson, IA				Xu, Qingping; van Wezel, Gilles P.; Chiu, Hsiu-Ju; Jaroszewski, Lukasz; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Lesley, Scott A.; Godzik, Adam; Elsliger, Marc-Andre; Deacon, Ashley M.; Wilson, Ian A.			Structure of an MmyB-Like Regulator from C-aurantiacus, Member of a New Transcription Factor Family Linked to Antibiotic Metabolism in Actinomycetes	PLOS ONE			English	Article							REPRESSOR-OPERATOR COMPLEX; CRYSTAL-STRUCTURE; STREPTOMYCES-COELICOLOR; SECONDARY METABOLISM; GENE-CLUSTER; A-FACTOR; PROTEIN; DNA; MECHANISM; BIOSYNTHESIS	Actinomycetes are important bacterial sources of antibiotics and other secondary metabolites. Many antibiotic gene clusters are controlled by pathway-specific activators that act in response to growth conditions. Here we present the crystal structure of an MmyB-like transcription regulator MltR (PDB code 3pxp) (Caur_2278) from Chloroflexus aurantiacus, in complex with a fatty acid (myristic acid). MltR is a distant homolog of the methylenomycin activator MmyB and consists of an Xre-type N-terminal DNA-binding domain and a C-terminal ligand-binding module that is related to the Per-Arnt-Sim (PAS) domain. This structure has enabled identification of a new family of bacterial transcription factors that are distributed predominantly in actinomycetes. Bioinformatics analysis of MltR and other characterized family members suggest that they are likely associated with antibiotic and fatty acid metabolism in actinomycetes. Streptomyces coelicolor SCO4944 is a candidate as an ancestral member of the family. Its ortholog in S. griseus, SGR_6891, is induced by A-factor, a gamma-butyrolactone that controls antibiotic production and development, and is adjacent to the A-factor synthase gen, afsA. The location of mltR/mmyB homologs, in particular those adjacent to less well-studied antibiotic-related genes, makes them interesting genetic markers for identifying new antibiotic genes. A model for signal-triggered DNA-binding by MltR is proposed.	[Xu, Qingping; Chiu, Hsiu-Ju; Jaroszewski, Lukasz; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Lesley, Scott A.; Godzik, Adam; Elsliger, Marc-Andre; Deacon, Ashley M.; Wilson, Ian A.] Joint Ctr Struct Genom, La Jolla, CA USA; [Xu, Qingping; Chiu, Hsiu-Ju; Miller, Mitchell D.; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [van Wezel, Gilles P.] Leiden Univ, Gorlaeus Labs, Dept Biol, NL-2300 RA Leiden, Netherlands; [Jaroszewski, Lukasz; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Jaroszewski, Lukasz; Godzik, Adam] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, La Jolla, CA USA; [Klock, Heath E.; Knuth, Mark W.; Lesley, Scott A.] Novartis Res Fdn, Prot Sci Dept, Genom Inst, San Diego, CA USA; [Lesley, Scott A.; Elsliger, Marc-Andre; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Leiden University; Leiden University - Excl LUMC; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Novartis; Scripps Research Institute	Wilson, IA (corresponding author), Joint Ctr Struct Genom, La Jolla, CA USA.	wilson@scripps.edu	van Wezel, Gilles/ABC-7854-2021; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	van Wezel, Gilles/0000-0003-0341-1561; Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Miller, Mitchell/0000-0003-1626-4943; Elsliger, Marc Andre/0000-0002-1989-7626	DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; Netherlands Applied Research Council (STW); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, U54GM074898, P41GM103393] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Netherlands Applied Research Council (STW); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209). GPvW was supported by a VICI grant from the Netherlands Applied Research Council (STW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2009, BUSTER; Chater KF, 2008, J MICROBIOL, V46, P1, DOI 10.1007/s12275-007-0233-1; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Corre C, 2008, P NATL ACAD SCI USA, V105, P17510, DOI 10.1073/pnas.0805530105; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cundliffe E, 2006, J IND MICROBIOL BIOT, V33, P500, DOI 10.1007/s10295-006-0083-6; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Genick UK, 1998, NATURE, V392, P206, DOI 10.1038/32462; Hara H, 2009, MICROBIOL-SGM, V155, P2197, DOI 10.1099/mic.0.027862-0; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horinouchi S, 2002, FRONT BIOSCI-LANDMRK, V7, pD2045, DOI 10.2741/horinouc; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Lopez P, 2010, GENE, V461, P5, DOI 10.1016/j.gene.2010.03.016; MCDONNELL GE, 1994, J BACTERIOL, V176, P5831, DOI 10.1128/JB.176.18.5831-5834.1994; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; McLuskey K, 2005, P NATL ACAD SCI USA, V102, P14221, DOI 10.1073/pnas.0504314102; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Notredame C., 2010, CURR PROTOC BIOINFOR; O'Rourke S, 2004, MICROBIOL AUST, V25, P2; O'Rourke S, 2009, MOL MICROBIOL, V71, P763, DOI 10.1111/j.1365-2958.2008.06560.x; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x; Russo S, 2009, J BIOL CHEM, V284, P5208, DOI 10.1074/jbc.M806591200; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833	52	11	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41359	10.1371/journal.pone.0041359	http://dx.doi.org/10.1371/journal.pone.0041359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844465	Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600023
J	MacKenzie, BR; Mariani, P				MacKenzie, Brian R.; Mariani, Patrizio			Spawning of Bluefin Tuna in the Black Sea: Historical Evidence, Environmental Constraints and Population Plasticity	PLOS ONE			English	Article							COD GADUS-MORHUA; SPRAT SPRATTUS-SPRATTUS; THUNNUS-THYNNUS L.; VERTICAL-DISTRIBUTION; ATLANTIC COD; EGG BUOYANCY; PLEURONECTES-PLATESSA; STOCK FLUCTUATIONS; FERTILIZED-EGGS; FISH EGGS	The lucrative and highly migratory Atlantic bluefin tuna, Thunnus thynnus (Linnaeus 1758; Scombridae), used to be distributed widely throughout the north Atlantic Ocean, Mediterranean Sea and Black Sea. Its migrations have supported sustainable fisheries and impacted local cultures since antiquity, but its biogeographic range has contracted since the 1950s. Most recently, the species disappeared from the Black Sea in the late 1980s and has not yet recovered. Reasons for the Black Sea disappearance, and the species-wide range contraction, are unclear. However bluefin tuna formerly foraged and possibly spawned in the Black Sea. Loss of a locally-reproducing population would represent a decline in population richness, and an increase in species vulnerability to perturbations such as exploitation and environmental change. Here we identify the main genetic and phenotypic adaptations that the population must have (had) in order to reproduce successfully in the specific hydrographic (estuarine) conditions of the Black Sea. By comparing hydrographic conditions in spawning areas of the three species of bluefin tunas, and applying a mechanistic model of egg buoyancy and sinking rate, we show that reproduction in the Black Sea must have required specific adaptations of egg buoyancy, fertilisation and development for reproductive success. Such adaptations by local populations of marine fish species spawning in estuarine areas are common as is evident from a meta-analysis of egg buoyancy data from 16 species of fish. We conclude that these adaptations would have been necessary for successful local reproduction by bluefin tuna in the Black Sea, and that a locally-adapted reproducing population may have disappeared. Recovery of bluefin tuna in the Black Sea, either for spawning or foraging, will occur fastest if any remaining locally adapted individuals are allowed to survive, and by conservation and recovery of depleted Mediterranean populations which could through time re-establish local Black Sea spawning and foraging.	[MacKenzie, Brian R.] Tech Univ Denmark, Natl Inst Aquat Resources DTU Aqua, Ctr Macroecol Evolut & Climate, Charlottenlund, Denmark; [Mariani, Patrizio] Tech Univ Denmark, Natl Inst Aquat Resources DTU Aqua, Ctr Ocean Life, Charlottenlund, Denmark	Technical University of Denmark; Technical University of Denmark	MacKenzie, BR (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources DTU Aqua, Ctr Macroecol Evolut & Climate, Charlottenlund, Denmark.	brm@aqua.dtu.dk	Mariani, Patrizio/AAP-2007-2021; MacKenzie, Brian R./T-9379-2019	Mariani, Patrizio/0000-0002-8015-1583; MacKenzie, Brian R./0000-0002-4798-0363	Census of Marine Life-History of Marine Animal Populations (CoML-HMAP); Danish National Research Foundation (Dansk Grundforskningsfond); EU [287844]; Census of Marine Life-History of Marine Animal Populations (Sloan Foundation); Villum Fonden [00007178] Funding Source: researchfish	Census of Marine Life-History of Marine Animal Populations (CoML-HMAP); Danish National Research Foundation (Dansk Grundforskningsfond)(Danmarks Grundforskningsfond); EU(European Commission); Census of Marine Life-History of Marine Animal Populations (Sloan Foundation); Villum Fonden(Villum Fonden)	The authors thank the Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation), the Danish National Research Foundation (Dansk Grundforskningsfond), and the EU project "Towards COast to COast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential" (COCONET, EU FP7 No. 287844) for support including publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlandsvik B, 2001, FISH RES, V50, P59, DOI 10.1016/S0165-7836(00)00242-3; Akyuz EF, 1957, GEN FISH COUN MEDIT, V4, P93; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; ANDERSON JT, 1994, ICES MAR SC, V198, P654; Aristotle, 1910, WORKS ARISTOTLE, VIV; Arkhipov A., 2009, J ICHTHYOL, V49, P228; Arkhipov A.G., 2011, J ICHTHYOL, V51, P98, DOI [10.1134/S0032945211010024, DOI 10.1134/S0032945211010024]; Bakun A, 2003, FISH OCEANOGR, V12, P458, DOI 10.1046/j.1365-2419.2003.00258.x; Bakun A., 1996, OCEAN PROCESSES MARI; Begg GA, 2002, MAR ECOL PROG SER, V229, P245, DOI 10.3354/meps229245; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bradbury IR, 2000, CAN J FISH AQUAT SCI, V57, P1761, DOI 10.1139/cjfas-57-9-1761; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Burchard H, 2001, J PHYS OCEANOGR, V31, P1943, DOI 10.1175/1520-0485(2001)031<1943:CAOFSM>2.0.CO;2; Burchard H, 2006, J MARINE SYST, V61, P180, DOI 10.1016/j.jmarsys.2005.04.011; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Cavallaro G., 1991, COL VOL SCI PAP ICCA, V35, P502; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Coombs SH, 2004, MAR BIOL, V145, P959, DOI 10.1007/s00227-004-1389-4; COOMBS SH, 1985, J MAR BIOL ASSOC UK, V65, P461, DOI 10.1017/S0025315400050542; COOMBS SH, 1990, J CONSEIL, V47, P133; Coombs SH, 1981, 1981G84 ICES CM; Coombs Stephen, 1997, Acta Adriatica, V38, P33; Corten A, 2002, REV FISH BIOL FISHER, V11, P339; CRAIK JCA, 1987, J MAR BIOL ASSOC UK, V67, P169, DOI 10.1017/S0025315400026436; Cury Phillipe, 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V50, P239; De Metrio G, 2010, J APPL ICHTHYOL, V26, P596, DOI 10.1111/j.1439-0426.2010.01475.x; Dekhnik TV, 1950, AZCHERNIRO T, V14, P151; Drinkwater KF, 2010, ICES COOP RES REP, P1; Farley JH, 1998, FISH B-NOAA, V96, P223; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Goarant A, 2007, MAR BIOL, V151, P1907, DOI 10.1007/s00227-007-0624-1; Gordina AD, 1996, MAR FRESHWATER RES, V47, P315, DOI 10.1071/MF9960315; Gordina AD, 2001, ESTUAR COAST SHELF S, V52, P1, DOI 10.1006/ecss.2000.0662; Gordina AD, 1993, J ICHTHYOL, P33; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; HAIDER A, 1989, POWDER TECHNOL, V58, P63, DOI 10.1016/0032-5910(89)80008-7; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; ICCAT, 2010, REP 2010 ATL BLUEF T, P1; IOC SCOR and IAPSO, 2010, INTERGOVERNMENTAL OC, V56, DOI DOI 10.0RG/TE0S-10_MANUAL.PDF; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Isari S, 2011, J MAR BIOL ASSOC UK, V91, P51, DOI 10.1017/S0025315410000123; Johannesson K, 2011, AMBIO, V40, P179, DOI 10.1007/s13280-010-0129-x; JOHNSTON CE, 1988, CAN J ZOOL, V66, P737, DOI 10.1139/z88-109; Kandler R, 1965, INT COUNC EXPLOR SEA, P1; Kara AB, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004569; Karakulak F.S., 2009, COLLECTIVE VOLUME SC, V63, P153; Karakulak FS, 2004, FISH RES, V68, P361, DOI 10.1016/j.fishres.2004.02.007; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Kimura S, 2010, PROG OCEANOGR, V86, P39, DOI 10.1016/j.pocean.2010.04.018; Kitagawa T, 2010, J EXP MAR BIOL ECOL, V393, P23, DOI 10.1016/j.jembe.2010.06.016; KJESBU OS, 1992, J FISH BIOL, V41, P581, DOI 10.1111/j.1095-8649.1992.tb02685.x; Kucera CJ, 2002, J EXP MAR BIOL ECOL, V272, P147, DOI 10.1016/S0022-0981(02)00081-3; LAPRISE R, 1995, MAR ECOL PROG SER, V122, P73, DOI 10.3354/meps122073; Limborg MT, 2009, MAR ECOL PROG SER, V379, P213, DOI 10.3354/meps07889; Loaning S., 1972, Fiskeridirektoratets Skr (Havundersok), V16, P77; Locarnini RA, 2009, WORLD OCEAN ATLAS DA; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Makarchouk A., 1998, CMR11 ICES, V11, P1; Mantzouni I, 2010, ICES J MAR SCI, V67, P833, DOI 10.1093/icesjms/fsp291; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Masuma S, 2008, 034 WORLD S STUD STO, P1; Masuma Shukei, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V63, P207; Mather F.J., 1995, NMFSSEFSC370 NOAA; McDougall T.J., 2011, GETTING STARTED TEOS, V127, P1; Muhling BA, 2011, B MAR SCI, V87, P687, DOI 10.5343/bms.2010.1101; Muhling BA, 2011, ICES J MAR SCI, V68, P1051, DOI 10.1093/icesjms/fsr008; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; NIERMANN U, 1994, ICES J MAR SCI, V51, P395, DOI 10.1006/jmsc.1994.1041; NISSLING A, 1991, MAR BIOL, V111, P33, DOI 10.1007/BF01986342; Nissling A, 1996, J FISH BIOL, V48, P217; Nissling A, 1997, MAR ECOL PROG SER, V152, P261, DOI 10.3354/meps152261; Nissling A, 2003, J FISH BIOL, V63, P280, DOI 10.1046/j.1095-8649.2003.00139.x; NISSLING A, 1994, MAR ECOL PROG SER, V110, P67, DOI 10.3354/meps110067; Nissling A, 2002, ICES J MAR SCI, V59, P93, DOI 10.1006/jmsc.2001.1134; NISSLING A, 1991, MAR BIOL, V111, P29, DOI 10.1007/BF01986341; NISSLING A, 1994, J FISH BIOL, V45, P435, DOI 10.1111/j.1095-8649.1994.tb01326.x; Ogata A., 1961, US GEOLOGICAL SURVEY, P1; Ospina-Alvarez A, 2012, FISH RES, V117, P86, DOI 10.1016/j.fishres.2011.01.030; Ouellet P, 1997, CAN J FISH AQUAT SCI, V54, P211, DOI 10.1139/cjfas-54-1-211; Oven L. S, 1959, P KARADAG BIOLOGICAL, P13; PAGE FH, 1989, CAN J FISH AQUAT SCI, V46, P55; Pepin P, 2007, ICES J MAR SCI, V64, P18, DOI 10.1093/icesjms/fsl016; Petereit C, 2009, SCI MAR, V73, P59, DOI 10.3989/scimar.2009.73s1059; Petitgas P, 2010, ICES J MAR SCI, V67, P1841, DOI 10.1093/icesjms/fsq082; Philippart CJM, 2011, J EXP MAR BIOL ECOL, V400, P52, DOI 10.1016/j.jembe.2011.02.023; Piccinetti C, 1993, ICCAT COLL VOL SCI P, V40, P186; Piccinetti C, 1996, SCRS9657 ICCAT, P207; Piccinetti-Manfrin G, 1994, SCRS9496 ICCAT, P316; Potoschi A., 1994, BIOL MARINA MEDITERR, V1, P119; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; RICKER WE, 1958, J FISH RES BOARD CAN, V15, P991, DOI 10.1139/f58-054; RODI W, 1987, J GEOPHYS RES-OCEANS, V92, P5305, DOI 10.1029/JC092iC05p05305; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Ruzzante DE, 1998, MOL ECOL, V7, P1663, DOI 10.1046/j.1365-294x.1998.00497.x; Sakamoto W, 2005, NIPPON SUISAN GAKK, V71, P80, DOI 10.2331/suisan.71.80; Satilmis HH, 2003, ACTA OECOL, V24, pS275, DOI 10.1016/S1146-609X(03)00022-5; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SELFDOTT, 2009, 2 SELFDOTT PROJ, P1; Sinclair M, 1988, MARINE POPULATIONS E; Snelgrove PVR, 2008, CAN J FISH AQUAT SCI, V65, P159, DOI 10.1139/F07-148; SOLEMDAL P, 1973, OIKOS, P268; Solemdal P., 1967, Sarsia, VNo. 29, P431; Solemdal P., 1971, VIE MILIEU SUPPL, V22, P409; Stenevik EK, 2008, ICES J MAR SCI, V65, P1198, DOI 10.1093/icesjms/fsn101; SUNDBY S, 1983, DEEP-SEA RES, V30, P645, DOI 10.1016/0198-0149(83)90042-0; Tanaka Y, 2006, MAR ECOL PROG SER, V319, P225, DOI 10.3354/meps319225; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Thorsen A, 1996, J FISH BIOL, V48, P457, DOI 10.1111/j.1095-8649.1996.tb01440.x; Tibshirani R., 1995, GEN ADDITIVE MODELS; Vassilopoulou V, 2008, MEDITERR MAR SCI, V9, P21, DOI 10.12681/mms.141; Vinohradov KO, 1948, DOIPOVIDI AKAD NAUK, V1, P18; VODIANITSKII V. A., 1954, TRUDY VSESOIUSNOVO N I INST [MORSKOVO] RYBNOVO KHOZIAISTVA I OKEANOGRAFII, V28, P240; Vodyanitsky V., 1936, T SEVASTOPOL BIOI ST, V5, P3; WARE DM, 1985, CAN J FISH AQUAT SCI, V42, P577, DOI 10.1139/f85-075; WESTIN L, 1991, MAR BIOL, V108, P5, DOI 10.1007/BF01313465; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108; Zaitsev Y., 2003, WORKSH FARM MAN CONS, V13, P118; Zaitsev Y., 2008, INTRO BLACK SEA ECOL; Zaitsev Y. P., 1971, MARINE NEUSTONOLOGY; Zaitsev Y.P., 1997, MARINE BIOL DIVERSIT; ZAITSEV Yu. P., 1959, NAUK ZAP ODES K BIOL ST AKAD NAUK UKRAIN R, V1, P77	127	24	24	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e39998	10.1371/journal.pone.0039998	http://dx.doi.org/10.1371/journal.pone.0039998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848367	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300006
J	Burmolle, M; Norman, A; Sorensen, SJ; Hansen, LH				Burmolle, Mette; Norman, Anders; Sorensen, Soren J.; Hansen, Lars Hestbjerg			Sequencing of IncX-Plasmids Suggests Ubiquity of Mobile Forms of a Biofilm-Promoting Gene Cassette Recruited from Klebsiella pneumoniae	PLOS ONE			English	Article							RESISTANT HEMAGGLUTINATING FIMBRIAE; ESCHERICHIA-COLI; BACTERIAL PLASMIDS; TYPE-3 FIMBRIAE; CONFERRING RESISTANCE; MULTIDRUG EFFLUX; IDENTIFICATION; REPLICATION; PROTEIN; EXPRESSION	Plasmids are a highly effective means with which genetic traits that influence human health, such as virulence and antibiotic resistance, are disseminated through bacterial populations. The IncX-family is a hitherto sparsely populated group of plasmids that are able to thrive within Enterobacteriaceae. In this study, a replicon-centric screening method was used to locate strains from wastewater sludge containing plasmids belonging to the IncX-family. A transposon aided plasmid capture method was then employed to transport IncX-plasmids from their original hosts (and co-hosted plasmids) into a laboratory strain (Escherichia coli Genehogs (R)) for further study. The nucleotide sequences of the three newly isolated IncX-plasmids (pLN126_33, pMO17_54, pMO440_54) and the hitherto un-sequenced type-plasmid R485 revealed a remarkable occurrence of whole or partial gene cassettes that promote biofilm-formation in Klebsiella pneumonia or E. coli, in all four instances. Two of the plasmids (R485 and pLN126_33) were shown to directly induce biofilm formation in a crystal violet retention assay in E. coli. Sequence comparison revealed that all plasmid-borne forms of the type 3 fimbriae encoding gene cassette mrkABCDF were variations of a composite transposon Tn6011 first described in the E. coli IncX plasmid pOLA52. In conclusion, IncX-plasmids isolated from Enterobacteriaceae over almost 40 years and on three different continents have all been shown to carry a type 3 fimbriae gene cassette mrkABCDF stemming from pathogenic K. pneumoniae. Apart from contributing general knowledge about IncX-plasmids, this study also suggests an apparent ubiquity of a mobile form of an important virulence factor and is an illuminating example of the recruitment, evolution and dissemination of genetic traits through plasmid-mediated horizontal gene transfer.	[Burmolle, Mette; Norman, Anders; Sorensen, Soren J.; Hansen, Lars Hestbjerg] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Burmolle, M (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	burmolle@bio.ku.dk	Sørensen, Søren J/J-5015-2014; Norman, Anders/E-2515-2011; Burmølle, Mette/L-8002-2014; Sørensen, Søren Johannes/N-2120-2019	Sørensen, Søren J/0000-0001-6227-9906; Norman, Anders/0000-0002-1282-394X; Burmølle, Mette/0000-0003-1870-632X; Sørensen, Søren Johannes/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524	Faculty of Science - University of Copenhagen; Lundbeck Foundation [R44-2009-4384] Funding Source: researchfish	Faculty of Science - University of Copenhagen; Lundbeck Foundation(Lundbeckfonden)	This work was funded by a Ph.D. fellowship grant awarded to AN by the Faculty of Science - University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahl MI, 2007, APPL ENVIRON MICROB, V73, P341, DOI 10.1128/AEM.01971-06; Bergstrom CT, 2000, GENETICS, V155, P1505; BRADLEY DE, 1978, PLASMID, V1, P376, DOI 10.1016/0147-619X(78)90053-7; BRADLEY DE, 1982, PLASMID, V7, P95, DOI 10.1016/0147-619X(82)90031-2; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; Burmolle M, 2007, MICROB ECOL, V54, P352, DOI 10.1007/s00248-007-9222-5; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALES BA, 1986, J MED MICROBIOL, V22, P297, DOI 10.1099/00222615-22-4-297; HALES BA, 1986, J GEN MICROBIOL, V132, P2243; Hansen LH, 2007, J ANTIMICROB CHEMOTH, V60, P145, DOI 10.1093/jac/dkm167; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; Hayes F, 1998, J BACTERIOL, V180, P6415; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; HEDGES RW, 1973, J GEN MICROBIOL, V77, P249, DOI 10.1099/00221287-77-2-249; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HOCHMANNOVA J, 1982, J GEN MICROBIOL, V128, P529; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Johnson JG, 2011, J BACTERIOL, V193, P3453, DOI 10.1128/JB.00286-11; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; JONES C, 1992, J GEN MICROBIOL, V138, P189, DOI 10.1099/00221287-138-1-189; JONES CS, 1993, J GEN MICROBIOL, V139, P735, DOI 10.1099/00221287-139-4-735; KAUR P, 1992, PLASMID, V27, P29, DOI 10.1016/0147-619X(92)90004-T; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lili LN, 2007, GENETICS, V177, P399, DOI 10.1534/genetics.107.077420; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Madsen JS, 2012, FEMS IMMUNOL MED MIC; MUKHOPADHYAY P, 1986, J BIOL CHEM, V261, P9534; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ong CLY, 2008, J BACTERIOL, V190, P1054, DOI 10.1128/JB.01523-07; Ong CLY, 2009, APPL ENVIRON MICROB, V75, P6783, DOI 10.1128/AEM.00974-09; Singh Pushpendra, 2006, J Commun Dis, V38, P288; Smajs D, 2008, PLASMID, V59, P1, DOI 10.1016/j.plasmid.2007.08.002; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	46	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41259	10.1371/journal.pone.0041259	http://dx.doi.org/10.1371/journal.pone.0041259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844447	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700060
J	Inukai, S; de Lencastre, A; Turner, M; Slack, F				Inukai, Sachi; de Lencastre, Alexandre; Turner, Michael; Slack, Frank			Novel MicroRNAs Differentially Expressed during Aging in the Mouse Brain	PLOS ONE			English	Article							GENE-EXPRESSION; LIFE-SPAN; RNA; NEURODEGENERATION; OVEREXPRESSION; MECHANISMS; DISEASE; TARGETS; BIOMART; TOOLS	MicroRNAs (miRNAs) are endogenous small RNA molecules that regulate gene expression post-transcriptionally. Work in Caenorhabditis elegans has shown that specific miRNAs function in lifespan regulation and in a variety of age-associated pathways, but the roles of miRNAs in the aging of vertebrates are not well understood. We examined the expression of small RNAs in whole brains of young and old mice by deep sequencing and report here on the expression of 558 known miRNAs and identification of 41 novel miRNAs. Of these miRNAs, 75 known and 18 novel miRNAs exhibit greater than 2.0-fold expression changes. The majority of expressed miRNAs in our study decline in relative abundance in the aged brain, in agreement with trends observed in other miRNA studies in aging tissues and organisms. Target prediction analysis suggests that many of our novel aging-associated miRNAs target genes in the insulin signaling pathway, a central node of aging-associated genetic networks. These novel miRNAs may thereby regulate aging-related functions in the brain. Since many mouse miRNAs are conserved in humans, the aging-affected brain miRNAs we report here may represent novel regulatory genes that also function during aging in the human brain.	[Inukai, Sachi; de Lencastre, Alexandre; Turner, Michael; Slack, Frank] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Inukai, S (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	frank.slack@yale.edu		Slack, Frank/0000-0001-8263-0409; de Lencastre, Alexandre/0000-0002-3951-8515; Inukai, Sachi/0000-0002-6404-1384	National Research Service Award Postdoctoral Fellowship from the National Institutes of Health (NIH) [1F32AG030851]; Ellison Medical Foundation; NIH [AG033921]; NATIONAL INSTITUTE ON AGING [F32AG030851, R01AG033921] Funding Source: NIH RePORTER	National Research Service Award Postdoctoral Fellowship from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A.d.L. was supported by a National Research Service Award Postdoctoral Fellowship from the National Institutes of Health (NIH; 1F32AG030851). This work was also supported by grants from the Ellison Medical Foundation and the NIH (AG033921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefian E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr214; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blalock EM, 2003, J NEUROSCI, V23, P3807; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kato M, 2011, RNA, V17, P1804, DOI 10.1261/rna.2714411; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee ST, 2006, MECH AGEING DEV, V127, P432, DOI 10.1016/j.mad.2006.01.022; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Ling KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-176; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	57	100	107	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40028	10.1371/journal.pone.0040028	http://dx.doi.org/10.1371/journal.pone.0040028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844398	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700007
J	Niu, Q; Wang, W; Li, Y; Ruden, DM; Wang, FH; Li, Y; Wang, FY; Song, JY; Zheng, K				Niu, Qi; Wang, Wei; Li, Yong; Ruden, Douglas M.; Wang, Fenghua; Li, Yue; Wang, Fangying; Song, Jingying; Zheng, Kun			Low Molecular Weight Heparin Ablates Lung Cancer Cisplatin-Resistance by Inducing Proteasome-Mediated ABCG2 Protein Degradation	PLOS ONE			English	Article							STEM-CELLS; SURVIVAL; IDENTIFICATION; CHEMOTHERAPY; COMBINATION; TRIAL	Cancer side population (SP) cells, which are often referred to as cancer stem cells, are thought to be responsible for lung cancer chemotherapy resistance, and currently no drug can specifically target these cells. We hypothesize low-molecular-weight heparin (LMWH) may affect the biological properties of SP cells and could be used to clinically target these cells. To test this, SP cells were isolated from cisplatin (DDP)-resistant lung adenocarcinoma A549/DDP cells by flow cytometric sorting. Compared to non-SP cells, SP cells formed increased numbers of colonies in vitro, and had a 1000-fold increase in tumorigenicity in vivo. Proliferation and apoptosis assays demonstrated LMWH had no significant effect on lung SP cell proliferation or apoptosis. However, LMWH reduced lung SP cell colony formation ability and protein expression of the multidrug transporter, ABCG2, by FACS and western blot analyses without affecting its mRNA levels by RT-PCR. Consistently, immunohistochemistry stainings of ABCG2 in LMWH-treated tumor tissues were significantly reduced compared with those in controls. Further, we found proteasomal inhibitor MG132, but not lysosomal inhibitors leupeptin and pepstatin A, could restore ABCG2 protein levels in LMWH-treated SP cells. These suggest LMWH ablates lung SP cell chemoresistance by proteasome-mediated reduction of ABCG2 protein levels without affecting its mRNA levels. We also determined LMWH combined with cisplatin could overcome cisplatin-resistance and induced lung SP cells apoptosis both in vitro and in vivo. This study provides an experimental basis for using a combination of LMWH, which targets lung SP cells, with chemotherapy to improve lung cancer survival.	[Niu, Qi; Wang, Wei; Li, Yong; Wang, Fangying; Zheng, Kun] 309 PLA Hosp, Dept Med Oncol, Beijing, Peoples R China; [Ruden, Douglas M.] CS Mott Ctr Human Hlth & Dev, Dept Obstet & Gynecol, Inst Environm Hlth Sci, Detroit, MI USA; [Wang, Fenghua; Song, Jingying] 309 PLA Hosp, Dept Pathol, Beijing, Peoples R China; [Li, Yue] Beijing Ctr Phys & Chem Anal, Beijing, Peoples R China		Niu, Q (corresponding author), 309 PLA Hosp, Dept Med Oncol, Beijing, Peoples R China.	qi_niu@hotmail.com	Ruden, Douglas/A-5008-2016; Ruden, Douglas/ABE-1418-2021	Ruden, Douglas/0000-0002-0070-437X; Li, Yong/0000-0002-8910-9787	Scientific Research Foundation for the Returned Overseas Chinese Scholars, China State Education Ministry [2007-1108]; National Institutes of Health [ES012933]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021983, R01ES012933] Funding Source: NIH RePORTER	Scientific Research Foundation for the Returned Overseas Chinese Scholars, China State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, China State Education Ministry (No. 2007-1108) to QN and National Institutes of Health grant ES012933 to DMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-4; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Altinbas M, 2004, J THROMB HAEMOST, V2, P1266, DOI 10.1111/j.1538-7836.2004.00871.x; Angelini A, 2007, ANTICANCER RES, V27, P351; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chatzinikolaou G, 2010, CELL PROLIFERAT, V43, P9, DOI 10.1111/j.1365-2184.2009.00649.x; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hettiarachchi RJK, 1999, THROMB HAEMOSTASIS, V82, P947, DOI 10.1055/s-0037-1615937; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Icli F, 2007, J SURG ONCOL, V95, P507, DOI 10.1002/jso.20728; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Klerk CPW, 2005, J CLIN ONCOL, V23, P2130, DOI 10.1200/JCO.2005.03.134; Lazo-Langner A, 2007, J THROMB HAEMOST, V5, P729, DOI 10.1111/j.1538-7836.2007.02427.x; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Maia RC, 1996, CANCER LETT, V106, P101, DOI 10.1016/0304-3835(96)04309-1; Mitrovska S, 2009, BRATISL MED J, V110, P45; Niers TMH, 2007, CRIT REV ONCOL HEMAT, V61, P195, DOI 10.1016/j.critrevonc.2006.07.007; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Phillips PG, 2011, ANTICANCER RES, V31, P411; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Thodiyil P, 2002, CANCER TREAT REV, V28, P151, DOI 10.1016/S0305-7372(02)00040-3; van Doormaal FF, 2011, J CLIN ONCOL, V29, P2071, DOI 10.1200/JCO.2010.31.9293; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3	35	30	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41035	10.1371/journal.pone.0041035	http://dx.doi.org/10.1371/journal.pone.0041035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844424	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700035
J	Qi, Y; Noble, DWA; Fu, JZ; Whiting, MJ				Qi, Yin; Noble, Daniel W. A.; Fu, Jinzhong; Whiting, Martin J.			Spatial and Social Organization in a Burrow-Dwelling Lizard (Phrynocephalus vlangalii) from China	PLOS ONE			English	Article							EGERNIA-SAXATILIS SCINCIDAE; HOME-RANGE SIZE; PARENTAL CARE; FEMALE AGGRESSION; GENETIC-MARKERS; MATING SYSTEMS; MATERNAL-CARE; EVOLUTION; PRZEWALSKII; PATERNITY	Shared ecological resources such as burrow complexes can set the stage for social groupings and the evolution of more complex social behavior such as parental care. Paternity testing is increasingly revealing cases of kin-based groupings, and lizards may be a good system to inform on the early evolution of sociality. We examined spatial and social organization in the lizard Phrynocephalus vlangalii from China and tested genetic relatedness (based on eight microsatellite DNA loci) between offspring and parents that shared burrow complexes. Adult males and females had similar spatial patterns: they overlapped most with members of the opposite sex and least with their own sex. Males in better body condition overlapped with more females, and both sexes showed high site fidelity. Most lizards used a single burrow, but some individuals used two or three burrows. While high site fidelity is consistent with sociality in lizards, juveniles did not preferentially share burrows with parents, and we documented only a few cases of parent-offspring associations through burrow sharing. We suggest that P. vlangalii conforms to a classical polygynous mating system in which the burrow forms the core of the male's territory and may be offered as an important resource for females, but this remains to be determined.	[Qi, Yin; Fu, Jinzhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Noble, Daniel W. A.; Whiting, Martin J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Noble, Daniel W. A.; Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Macquarie University; University of Guelph	Qi, Y (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	qiyin@cib.ac.cn	Noble, Daniel/H-6214-2013; Whiting, Martin J./E-2999-2010	Noble, Daniel/0000-0001-9460-8743; Whiting, Martin J./0000-0002-4662-0227	Chinese Academy of Sciences [Y1C2021]; West Light Foundation of The Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences); West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Knowledge Innovation Program of The Chinese Academy of Sciences to JF (Y1C2021) and the West Light Foundation of The Chinese Academy of Sciences to YQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Aragon P, 2001, CAN J ZOOL, V79, P1965, DOI 10.1139/cjz-79-11-1965; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; Chapple DG, 2006, ETHOLOGY, V112, P247, DOI 10.1111/j.1439-0310.2006.01153.x; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Davis AR, 2011, P ROY SOC B-BIOL SCI, V278, P1507, DOI 10.1098/rspb.2010.1703; Earley Ryan L., 2010, P285; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Hibbitts TJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P1169, DOI 10.1007/s00265-006-0330-x; Huang WS, 2006, ANIM BEHAV, V72, P791, DOI 10.1016/j.anbehav.2005.12.011; Huang WS, 2011, FUNCT ECOL, V25, P1125, DOI 10.1111/j.1365-2435.2011.01855.x; Lourdais O, 2007, J COMP PHYSIOL B, V177, P569, DOI 10.1007/s00360-007-0155-6; Masters C., 2003, Australian Zoologist, V32, P377; McAlpin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019041; McCoy JK, 2003, LIZARD SOCIAL BEHAV; Morrison SF, 2002, MOL ECOL, V11, P535, DOI 10.1046/j.0962-1083.2002.01450.x; O'Connor D, 2003, MOL ECOL, V12, P743, DOI 10.1046/j.1365-294X.2003.01777.x; O'Connor DE, 2004, ANIM BEHAV, V68, P1361, DOI 10.1016/j.anbehav.2004.02.014; Qi Y, 2011, ASIAN HERPETOL RES, V2, P110, DOI 10.3724/SP.J.1245.2011.00110; Qi Y, 2011, J ETHOL, V29, P381, DOI 10.1007/s10164-010-0252-y; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Reaney LT, 2003, ETHOL ECOL EVOL, V15, P205; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; Shine R., 1988, BIOL REPTILIA, P275; Sinn DL, 2008, ANIM BEHAV, V76, P1249, DOI 10.1016/j.anbehav.2008.06.009; Smith GR, 1995, ACTA OECOL, V16, P413; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Stamps J. A., 1983, LIZARD ECOLOGY STUDI; Stamps J. A., 1977, BIOL REPTILIA ECOL A, V7, P149; Stapley J, 2005, BEHAV ECOL, V16, P514, DOI 10.1093/beheco/ari019; Urquhart J, 2005, MOL ECOL NOTES, V5, P928, DOI 10.1111/j.1471-8286.2005.01119.x; VITT LJ, 1989, J HERPETOL, V23, P29, DOI 10.2307/1564312; While GM, 2009, P ROY SOC B-BIOL SCI, V276, P2021, DOI 10.1098/rspb.2008.1926; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Wu Pengfei, 2005, Shengtaixue Zazhi, V24, P1241; Zhan AB, 2009, MOL ECOL RESOUR, V9, P535, DOI 10.1111/j.1755-0998.2008.02248.x; ZHAO KT, 1999, FAUNA SINICA REPTILI, P153	41	22	22	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41130	10.1371/journal.pone.0041130	http://dx.doi.org/10.1371/journal.pone.0041130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844434	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700047
J	van Lutterveld, R; Hillebrand, A; Diederen, KMJ; Daalman, K; Kahn, RS; Stam, CJ; Sommer, IEC				van Lutterveld, Remko; Hillebrand, Arjan; Diederen, Kelly M. J.; Daalman, Kirstin; Kahn, Rene S.; Stam, Cornelis J.; Sommer, Iris E. C.			Oscillatory Cortical Network Involved in Auditory Verbal Hallucinations in Schizophrenia	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; TASK-RELATED CHANGES; TIME-COURSE; ACTIVATION; CORTEX; BRAIN; SYNCHRONIZATION; INHIBITION; MEMORY; GAMMA	Background: Auditory verbal hallucinations (AVH), a prominent symptom of schizophrenia, are often highly distressing for patients. Better understanding of the pathogenesis of hallucinations could increase therapeutic options. Magnetoencephalography (MEG) provides direct measures of neuronal activity and has an excellent temporal resolution, offering a unique opportunity to study AVH pathophysiology. Methods: Twelve patients (10 paranoid schizophrenia, 2 psychosis not otherwise specified) indicated the presence of AVH by button-press while lying in a MEG scanner. As a control condition, patients performed a self-paced button-press task. AVH-state and non-AVH state were contrasted in a region-of-interest (ROI) approach. In addition, the two seconds before AVH onset were contrasted with the two seconds after AVH onset to elucidate a possible triggering mechanism. Results: AVH correlated with a decrease in beta-band power in the left temporal cortex. A decrease in alpha-band power was observed in the right inferior frontal gyrus. AVH onset was related to a decrease in theta-band power in the right hippocampus. Conclusions: These results suggest that AVH are triggered by a short aberration in the theta band in a memory-related structure, followed by activity in language areas accompanying the experience of AVH itself.	[van Lutterveld, Remko; Diederen, Kelly M. J.; Daalman, Kirstin; Kahn, Rene S.; Sommer, Iris E. C.] Univ Med Ctr, Dept Psychiat, Utrecht, Netherlands; [van Lutterveld, Remko; Diederen, Kelly M. J.; Daalman, Kirstin; Kahn, Rene S.; Sommer, Iris E. C.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [Hillebrand, Arjan; Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Lutterveld, R (corresponding author), Univ Med Ctr, Dept Psychiat, Utrecht, Netherlands.	R.vanlutterveld@umcutrecht.nl	sommer, iris E/D-1190-2014	sommer, iris E/0000-0002-2682-5313; Sommer, Iris/0000-0001-5597-3262; Diederen, Kelly/0000-0002-9619-6583; Hillebrand, Arjan/0000-0002-8508-3532; Stam, Cornelis/0000-0001-9163-7274	Dutch Science Organization (Nederlandse Wetenschappelijke Organisatie NWO) [916.56.172]	Dutch Science Organization (Nederlandse Wetenschappelijke Organisatie NWO)	This work was supported by the Dutch Science Organization (Nederlandse Wetenschappelijke Organisatie NWO), Operating Grant: 916.56.172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Badcock Johanna C, 2005, Cogn Neuropsychiatry, V10, P125, DOI 10.1080/13546800344000363; Badcock JC, 2010, SCHIZOPHRENIA BULL, V36, P576, DOI 10.1093/schbul/sbn128; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Behrendt RP, 2010, NEUROSCI BIOBEHAV R, V34, P1121, DOI 10.1016/j.neubiorev.2009.12.009; Binder M, 2006, RADIOLOGY, V238, P256, DOI 10.1148/radiol.2381041622; Centorrino F, 2002, AM J PSYCHIAT, V159, P109, DOI 10.1176/appi.ajp.159.1.109; Cheung P, 1997, SCHIZOPHR RES, V26, P181, DOI 10.1016/S0920-9964(97)00049-2; Copolov DL, 2003, PSYCHIAT RES-NEUROIM, V122, P139, DOI 10.1016/S0925-4927(02)00121-X; Cornwell BR, 2010, AM J PSYCHIAT, V167, P836, DOI 10.1176/appi.ajp.2009.09050614; Daalman K, 2011, J CLIN PSYCHIAT, V72, P320, DOI 10.4088/JCP.09m05797yel; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hanlon FM, 2011, NEUROIMAGE; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hoffman RE, 2008, BRIT J PSYCHIAT, V193, P424, DOI 10.1192/bjp.bp.107.040501; Hoffman RE, 2011, BRIT J PSYCHIAT, V198, P277, DOI 10.1192/bjp.bp.110.086835; Hoffman RE, 2003, ARCH GEN PSYCHIAT, V60, P49, DOI 10.1001/archpsyc.60.1.49; Ishii R, 2000, NEUROREPORT, V11, P3283, DOI 10.1097/00001756-200009280-00047; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kisley MA, 2006, CLIN NEUROPHYSIOL, V117, P2549, DOI 10.1016/j.clinph.2006.08.003; Lenartowicz A, 2011, J COGNITIVE NEUROSCI, V23, P3388, DOI 10.1162/jocn_a_00031; Lennox BR, 1999, LANCET, V353, P644, DOI 10.1016/S0140-6736(98)05923-6; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; MCGUIRE PK, 1993, LANCET, V342, P703, DOI 10.1016/0140-6736(93)91707-S; Nayani TH, 1996, PSYCHOL MED, V26, P177, DOI 10.1017/S003329170003381X; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Quraan MA, 2011, HUM BRAIN MAPP, V32, P812, DOI 10.1002/hbm.21068; Reulbach U, 2007, NEUROPSYCHOBIOLOGY, V55, P89, DOI 10.1159/000103907; Riggs L, 2009, NEUROIMAGE, V45, P627, DOI 10.1016/j.neuroimage.2008.11.018; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Ropohl A, 2004, NEUROREPORT, V15, P523, DOI 10.1097/00001756-200403010-00028; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Schipul SE, 2012, CEREB CORTEX, V22, P937, DOI 10.1093/cercor/bhr162; Shergill SS, 2004, BRIT J PSYCHIAT, V185, P516, DOI 10.1192/bjp.185.6.516; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Slade P, 2002, SENSORY DECEPTION SC; Sommer IEC, 2008, BRAIN, V131, P3169, DOI 10.1093/brain/awn251; Sritharan A, 2005, PSYCHIAT RES, V136, P189, DOI 10.1016/j.psychres.2005.05.010; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; van de Ven VG, 2005, NEUROIMAGE, V27, P644, DOI 10.1016/j.neuroimage.2005.04.041; van Lutterveld R., 2011, FRONT PSYCHIATRY, V2, P1; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Vrba J, 1999, RECENT ADV BIOMAGN, P93; Waters Flavie A V, 2006, Cogn Neuropsychiatry, V11, P65, DOI 10.1080/13546800444000191; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027	56	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41149	10.1371/journal.pone.0041149	http://dx.doi.org/10.1371/journal.pone.0041149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844436	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700049
J	Winhofer, Y; Kiefer, FW; Handisurya, A; Klein, K; Schneider, B; Marculescu, R; Wagner, OF; Pacini, G; Luger, A; Stulnig, TM; Kautzky-Willer, A; Tura, A				Winhofer, Yvonne; Kiefer, Florian W.; Handisurya, Ammon; Klein, Katharina; Schneider, Barbara; Marculescu, Rodrig; Wagner, Oswald F.; Pacini, Giovanni; Luger, Anton; Stulnig, Thomas M.; Kautzky-Willer, Alexandra; Tura, Andrea			CTX (Crosslaps) Rather than Osteopontin Is Associated with Disturbed Glucose Metabolism in Gestational Diabetes	PLOS ONE			English	Article							ENERGY-METABOLISM; POSTMENOPAUSAL WOMEN; BONE TURNOVER; INSULIN; MODEL; MICE; EXPRESSION; STEATOSIS; PREGNANCY; ESTROGEN	Objective: Reciprocal interaction between bone and glucose metabolism might play a pivotal role in the development of type 2 diabetes. We recently demonstrated that osteocalcin is increased in women with gestational diabetes (GDM) compared to healthy pregnant women and related to enhanced insulin secretion. Here, we aimed to investigate the role of the bone resorption marker CTX and osteopontin (OPN), a key molecule in subclinical inflammation underlying insulin resistance, in gestational diabetes. Methods: Insulin sensitivity and secretion (derived from OGTT) as well as CTX and osteopontin were investigated in 26 GDM and 52 women with normal glucose tolerance during pregnancy [CON] between 24th and 28th gestational weeks; 24 women also underwent postpartum examination. Results: CTX was significantly higher in GDM compared to CON (0.44 +/- 0.20 vs. 0.28 +/- 0.12 ng/ml, p<.0001) and positively correlated with osteocalcin (R = 0.64, p<.0001) and parameters of insulin secretion. Osteopontin plasma concentrations were decreased in GDM compared to CON (28.81 +/- 22.12 vs. 37.68 +/- 19.63 ng/ml, p = 0.04), and did not show any relation to insulin secretion or sensitivity, but were significantly correlated with CRP (R = 0.3, p<0.007) and liver enzymes. Twelve weeks after delivery CTX and OPN were increased compared to pregnancy (both p,. 0001) and did not differ between GDM and CON. Conclusion: Our findings support the idea of a tight regulation between bone and glucose metabolism, and suggest, that less curbed CTX during pregnancy might be involved in osteocalcin-mediated amelioration of insulin secretion in GDM. On the other hand, osteopontin was unrelated to insulin resistance in GDM, but associated with inflammatory markers and liver enzymes in all women.	[Winhofer, Yvonne; Kiefer, Florian W.; Luger, Anton; Stulnig, Thomas M.; Kautzky-Willer, Alexandra] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria; [Handisurya, Ammon] Med Univ Vienna, Div Nephrol, Dept Internal Med 3, Vienna, Austria; [Pacini, Giovanni; Tura, Andrea] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy; [Klein, Katharina] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Schneider, Barbara] Med Univ Vienna, Sect Med Stat, CeMSIIS, Vienna, Austria; [Marculescu, Rodrig] Gen Hosp Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; [Stulnig, Thomas M.] Med Univ Vienna, Christian Doppler Lab Cardio Metab Immunotherapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Winhofer, Y (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria.	alexandra.kautzky-willer@meduniwien.ac.at	Marculescu, Rodrig/B-6474-2016	Marculescu, Rodrig/0000-0003-1772-6695; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Kiefer, Florian/0000-0003-2191-025X; Stulnig, Thomas/0000-0003-3300-6161; Winhofer, Yvonne/0000-0002-0555-9044	Austrian National Bank [13244, 12735]; "Fond des Burgermeisters der Stadt Wien" [09063]; Austrian Science Fund as part of the PhD program Cell Communication in Health and Disease [W1205-B09]; European Community [201608]	Austrian National Bank; "Fond des Burgermeisters der Stadt Wien"; Austrian Science Fund as part of the PhD program Cell Communication in Health and Disease; European Community(European Commission)	This work was supported by The Austrian National Bank, grant-no: 13244, and the "Fond des Burgermeisters der Stadt Wien", no: 09063 (all to AK); and the Austrian Science Fund as part of the PhD program Cell Communication in Health and Disease (W1205-B09), by the Austrian National Bank (project no. 12735), as well as the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant no. 201608 (all to TMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2004, ACTA OBSTET GYN SCAN, V83, P1049, DOI 10.1111/j.0001-6349.2004.00428.x; Banerjee A, 2009, TOXICOL PATHOL, V37, P492, DOI 10.1177/0192623309335633; Bautista DS, 1996, CLIN BIOCHEM, V29, P231, DOI 10.1016/0009-9120(96)84728-A; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Carpenter MW, 2007, DIABETES CARE, V30, pS246, DOI 10.2337/dc07-s224; Christgau S, 1998, CLIN CHEM, V44, P2290; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; Ferron M, 2012, BONE, V50, P568, DOI 10.1016/j.bone.2011.04.017; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; GOLDSTEIN DE, 1986, CLIN CHEM, V32, pB64; Hwang YC, 2012, OSTEOPOROSIS INT, V23, P1337, DOI 10.1007/s00198-011-1679-x; Isoda K, 2003, CIRCULATION, V107, P679, DOI 10.1161/01.CIR.0000055739.13639.D7; Kanazawa I, 2011, BONE, V48, P720, DOI 10.1016/j.bone.2010.12.020; KATTERMANN R, 1984, J CLIN CHEM CLIN BIO, V22, P245; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Lee N. K., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P351; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leen LLS, 2008, ARTERIOSCL THROM VAS, V28, P2131, DOI 10.1161/ATVBAHA.108.167965; Majima T, 2008, ENDOCR J, V55, P143, DOI 10.1507/endocrj.K07E-004; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; Seibel M J, 1998, Ther Umsch, V55, P676; Stenczer B, 2010, CLIN CHEM LAB MED, V48, P181, DOI 10.1515/CCLM.2010.042; Tanko LB, 2003, BONE, V32, P8, DOI 10.1016/S8756-3282(02)00918-3; Tura A, 2001, AM J PHYSIOL-ENDOC M, V281, pE966, DOI 10.1152/ajpendo.2001.281.5.E966; Viccica G, 2007, J Endocrinol Invest, V30, P8; Winhofer Y, 2010, DIABETES CARE, V33, P139, DOI 10.2337/dc09-1237; Xu GW, 2005, J RHEUMATOL, V32, P410	29	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40947	10.1371/journal.pone.0040947	http://dx.doi.org/10.1371/journal.pone.0040947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844418	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700026
J	Eickhoff, R; Lorbeer, RA; Scheiblich, H; Heisterkamp, A; Meyer, H; Stern, M; Bicker, G				Eickhoff, Rene; Lorbeer, Raoul-Amadeus; Scheiblich, Hannah; Heisterkamp, Alexander; Meyer, Heiko; Stern, Michael; Bicker, Gerd			Scanning Laser Optical Tomography Resolves Structural Plasticity during Regeneration in an Insect Brain	PLOS ONE			English	Article							PROJECTION TOMOGRAPHY; AXONAL REGENERATION; GENE-EXPRESSION; MUSHROOM BODIES; TYMPANAL NERVE; DESERT LOCUST; ANTENNAL LOBE; MICROSCOPY; NEURONS; ZEBRAFISH	Background: Optical Projection Tomography (OPT) is a microscopic technique that generates three dimensional images from whole mount samples the size of which exceeds the maximum focal depth of confocal laser scanning microscopes. As an advancement of conventional emission-OPT, Scanning Laser Optical Tomography (SLOTy) allows simultaneous detection of fluorescence and absorbance with high sensitivity. In the present study, we employ SLOTy in a paradigm of brain plasticity in an insect model system. Methodology: We visualize and quantify volumetric changes in sensory information procession centers in the adult locust, Locusta migratoria. Olfactory receptor neurons, which project from the antenna into the brain, are axotomized by crushing the antennal nerve or ablating the entire antenna. We follow the resulting degeneration and regeneration in the olfactory centers (antennal lobes and mushroom bodies) by measuring their size in reconstructed SLOTy images with respect to the untreated control side. Within three weeks post treatment antennal lobes with ablated antennae lose as much as 60% of their initial volume. In contrast, antennal lobes with crushed antennal nerves initially shrink as well, but regain size back to normal within three weeks. The combined application of transmission-and fluorescence projections of Neurobiotin labeled axotomized fibers confirms that recovery of normal size is restored by regenerated afferents. Remarkably, SLOTy images reveal that degeneration of olfactory receptor axons has a trans-synaptic effect on second order brain centers and leads to size reduction of the mushroom body calyx. Conclusions: This study demonstrates that SLOTy is a suitable method for rapid screening of volumetric plasticity in insect brains and suggests its application also to vertebrate preparations.	[Eickhoff, Rene; Scheiblich, Hannah; Stern, Michael; Bicker, Gerd] Univ Vet Med Hannover, Div Cell Biol, Hannover, Germany; [Lorbeer, Raoul-Amadeus; Heisterkamp, Alexander; Meyer, Heiko] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Heisterkamp, Alexander] Univ Jena, Inst Appl Opt, Jena, Germany; [Meyer, Heiko] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Friedrich Schiller University of Jena; Leibniz University Hannover	Eickhoff, R (corresponding author), Univ Vet Med Hannover, Div Cell Biol, Hannover, Germany.	gerd.bicker@tiho-hannover.de	Heisterkamp, Alexander/V-5376-2017; Stern, Michael/E-7980-2011; Scheiblich, Hannah/ABC-3883-2021	Heisterkamp, Alexander/0000-0001-8770-0859; Stern, Michael/0000-0002-5088-5439	Deutsche Forschungsgemeinschaft (DFG); excellence cluster REBIRTH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); excellence cluster REBIRTH	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG) and the excellence cluster REBIRTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton S, 1996, J COMP NEUROL, V370, P85; Ayaz D, 2008, J NEUROSCI, V28, P6010, DOI 10.1523/JNEUROSCI.0101-08.2008; DeMicco A, 2010, TOXICOL SCI, V113, P177, DOI 10.1093/toxsci/kfp258; Eickhoff R, 2012, J COMP NEUROL, V520, P2021, DOI 10.1002/cne.23026; El Jundi B, 2009, J COMP NEUROL, V517, P210, DOI 10.1002/cne.22150; ERNST KD, 1977, CELL TISSUE RES, V176, P285, DOI 10.1007/BF00221789; Groh Claudia, 2010, Front Biosci (Schol Ed), V2, P268; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jacobs K, 1999, CELL TISSUE RES, V298, P167, DOI 10.1007/s004419900056; Kerwin J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-27; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Kruger S, 2011, J COMP PHYSIOL A, V197, P181, DOI 10.1007/s00359-010-0598-1; Kurylas AE, 2008, CELL TISSUE RES, V333, P125, DOI 10.1007/s00441-008-0620-x; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LAKESHARLAN R, 1995, J COMP PHYSIOL A, V176, P797, DOI 10.1007/BF00192627; LAURENT G, 1994, J NEUROSCI, V14, P2993; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Lorbeer RA, 2011, OPT EXPRESS, V19, P5419, DOI 10.1364/OE.19.005419; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Ott SR, 2008, J NEUROSCI METH, V172, P220, DOI 10.1016/j.jneumeth.2008.04.031; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; Patschke A, 2004, DEV BRAIN RES, V150, P73, DOI 10.1016/j.devbrainres.2004.02.006; Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007; Sharpe J, 2004, ANNU REV BIOMED ENG, V6, P209, DOI 10.1146/annurev.bioeng.6.040803.140210; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SPIRA ME, 1987, J EXP BIOL, V132, P111; Sprecher SG, 2007, GENE EXPR PATTERNS, V7, P584, DOI 10.1016/j.modgep.2007.01.004; Stern M, 1997, J NEUROBIOL, V33, P439; Stern M, 2008, DEV NEUROBIOL, V68, P295, DOI 10.1002/dneu.20585; Stern M, 2012, J COMP NEUROL, V520, P679, DOI 10.1002/cne.22770; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7; Trowe T, 1996, DEVELOPMENT, V123, P439; Vinegoni C, 2009, OPT EXPRESS, V17, P22320, DOI 10.1364/OE.17.022320; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0	41	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41236	10.1371/journal.pone.0041236	http://dx.doi.org/10.1371/journal.pone.0041236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829931	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300070
J	Greene, CM; Soto, D				Greene, Ciara M.; Soto, David			Neural Repetition Effects in the Medial Temporal Lobe Complex are Modulated by Previous Encoding Experience	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; HIGH-RESOLUTION FMRI; EVENT-RELATED FMRI; RECOGNITION MEMORY; PREFRONTAL CORTEX; EPISODIC MEMORY; BRAIN IMAGES; SUPPRESSION; RETRIEVAL; FAMILIARITY	It remains an intriguing question why the medial temporal lobe (MTL) can display either attenuation or enhancement of neural activity following repetition of previously studied items. To isolate the role of encoding experience itself, we assessed neural repetition effects in the absence of any ongoing task demand or intentional orientation to retrieve. Experiment 1 showed that the hippocampus and surrounding MTL regions displayed neural repetition suppression (RS) upon repetition of past items that were merely attended during an earlier study phase but this was not the case following re-occurrence of items that had been encoded into working memory (WM). In this latter case a trend toward neural repetition enhancement (RE) was observed, though this was highly variable across individuals. Interestingly, participants with a higher degree of neural RE in the MTL complex displayed higher memory sensitivity in a later, surprise recognition test. Experiment 2 showed that massive exposure at encoding effected a change in the neural architecture supporting incidental repetition effects, with regions of the posterior parietal and ventral-frontal cortex in addition to the hippocampus displaying neural RE, while no neural RS was observed. The nature of encoding experience therefore modulates the expression of neural repetition effects in the MTL and the neocortex in the absence of memory goals.	[Greene, Ciara M.; Soto, David] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Fac Med, London, England	Imperial College London	Greene, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Fac Med, London, England.	c.greene@imperial.ac.uk; d.soto@imperial.ac.uk	Soto, David/R-3711-2019	Soto, David/0000-0003-0205-7513; Greene, Ciara/0000-0002-8833-9046	Medical Research Council (UK) [89631]; MRC [G0802212] Funding Source: UKRI; Medical Research Council [G0802212] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK, 89631, www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Brozinsky CJ, 2005, HIPPOCAMPUS, V15, P557, DOI 10.1002/hipo.20087; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Ciaramelli E, 2010, J NEUROSCI, V30, P4943, DOI 10.1523/JNEUROSCI.1209-09.2010; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Dorfel D, 2009, EUR J NEUROSCI, V30, P1947, DOI 10.1111/j.1460-9568.2009.06973.x; Dudukovic NM, 2011, J COGNITIVE NEUROSCI, V23, P670, DOI 10.1162/jocn.2010.21509; Elman JA, 2011, NEUROIMAGE, V56, P345, DOI 10.1016/j.neuroimage.2011.02.017; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gonsalves BD, 2005, NEURON, V47, P751, DOI 10.1016/j.neuron.2005.07.013; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Guerin SA, 2011, NEUROIMAGE, V55, P801, DOI 10.1016/j.neuroimage.2010.11.066; Harris A, 2007, CEREB CORTEX, V17, P63, DOI 10.1093/cercor/bhj124; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson JD, 2008, HIPPOCAMPUS, V18, P975, DOI 10.1002/hipo.20456; Kirwan CB, 2009, P NATL ACAD SCI USA, V106, P14617, DOI 10.1073/pnas.0907624106; Korsnes MS, 2008, NEUROPSYCHOLOGIA, V46, P1454, DOI 10.1016/j.neuropsychologia.2007.12.028; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Lacy JW, 2011, LEARN MEMORY, V18, P15, DOI [10.1101/lm.1971110, 10.1101/lm.1971111]; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Mandzia JL, 2004, HUM BRAIN MAPP, V21, P1, DOI 10.1002/hbm.10140; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Montaldi D, 2006, HIPPOCAMPUS, V16, P504, DOI 10.1002/hipo.20178; Nolde SF, 1998, TRENDS COGN SCI, V2, P399, DOI 10.1016/S1364-6613(98)01233-9; Norman KA, 2010, HIPPOCAMPUS, V20, P1217, DOI 10.1002/hipo.20855; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Raposo A, 2006, NEUROPSYCHOLOGIA, V44, P2284, DOI 10.1016/j.neuropsychologia.2006.05.017; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Soto D, 2007, P NATL ACAD SCI USA, V104, P17186, DOI 10.1073/pnas.0703706104; Stark CEL, 2003, J NEUROSCI, V23, P6748; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Suzuki M, 2011, J COGNITIVE NEUROSCI, V23, P1522, DOI 10.1162/jocn.2010.21535; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Trenner MU, 2004, COGNITIVE BRAIN RES, V21, P388, DOI 10.1016/j.cogbrainres.2004.06.017; Trepel C, 1998, CEREB CORTEX, V8, P719, DOI 10.1093/cercor/8.8.719; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vilberg KL, 2007, NEUROPSYCHOLOGIA, V45, P2216, DOI 10.1016/j.neuropsychologia.2007.02.027; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wais PE, 2010, J COGNITIVE NEUROSCI, V22, P109, DOI 10.1162/jocn.2009.21190; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wixted JT, 2011, TRENDS COGN SCI, V15, P210, DOI 10.1016/j.tics.2011.03.005; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	66	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40870	10.1371/journal.pone.0040870	http://dx.doi.org/10.1371/journal.pone.0040870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829892	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300030
J	Luhtala, N; Parker, R				Luhtala, Natalie; Parker, Roy			Structure-Function Analysis of Rny1 in tRNA Cleavage and Growth Inhibition	PLOS ONE			English	Article							GLYCOPROTEIN E-RNS; SWINE-FEVER VIRUS; RIBOSOMAL-RNA; SELF-INCOMPATIBILITY; CYSTIC LEUKOENCEPHALOPATHY; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; NICOTIANA-ALATA; T2 RIBONUCLEASE; S-RNASE	T2 ribonucleases are conserved nucleases that affect a variety of processes in eukaryotic cells including the regulation of self-incompatibility by S-RNases in plants, modulation of host immune cell responses by viral and schistosome T2 enzymes, and neurological development and tumor progression in humans. These roles for RNaseT2's can be due to catalytic or catalytic-independent functions of the molecule. Despite this broad importance, the features of RNaseT2 proteins that modulate catalytic and catalytic-independent functions are poorly understood. Herein, we analyze the features of Rny1 in Saccharomyces cerevisiae to determine the requirements for cleaving tRNA in vivo and for inhibiting cellular growth in a catalytic-independent manner. We demonstrate that catalytic-independent inhibition of growth is a combinatorial property of the protein and is affected by a fungal-specific C-terminal extension, the conserved catalytic core, and the presence of a signal peptide. Catalytic functions of Rny1 are independent of the C-terminal extension, are affected by many mutations in the catalytic core, and also require a signal peptide. Biochemical flotation assays reveal that in rny1 Delta cells, some tRNA molecules associate with membranes suggesting that cleavage of tRNAs by Rny1 can involve either tRNA association with, or uptake into, membrane compartments.	[Luhtala, Natalie] Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA; [Parker, Roy] Univ Arizona, Howard Hughes Med Inst, Tucson, AZ USA; [Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona; University of Arizona	Luhtala, N (corresponding author), Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu			National Institutes of Health [R37 GM45443, T32 CA09213]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA009213, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided as follows: National Institutes of Health [R37 GM45443 to R. P.], http://www.nih.gov/; National Institutes of Health [T32 CA09213 to N.L.], http://www.nih.gov/ and the Howard Hughes Medical Institute to R. P., http://www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquati F, 2005, INT J ONCOL, V26, P1159; Acquati F, P NATL ACAD SCI US, V108, P1104; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; Bruschke CJM, 1997, J VIROL, V71, P6692, DOI 10.1128/JVI.71.9.6692-6696.1997; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Cabrera M, 2008, METHOD ENZYMOL, V451, P177, DOI 10.1016/S0076-6879(08)03213-8; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; de Leeuw M, 2007, ACTA CRYSTALLOGR F, V63, P716, DOI 10.1107/S1744309107034483; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; GRAY JE, 1991, PLANT CELL, V3, P271, DOI 10.1105/tpc.3.3.271; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398; Hillwig MS, 2011, P NATL ACAD SCI USA, V108, P1093, DOI 10.1073/pnas.1009809108; Hulst MM, 1998, J VIROL, V72, P151, DOI 10.1128/JVI.72.1.151-157.1998; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kobayashi H, 2003, BIOSCI BIOTECH BIOCH, V67, P2307, DOI 10.1271/bbb.67.2307; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kurihara H, 1996, J MOL BIOL, V255, P310, DOI 10.1006/jmbi.1996.0025; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; McCubbin AG, 1997, PLANT CELL, V9, P85, DOI 10.2307/3870373; Meyers G, 1999, J VIROL, V73, P10224, DOI 10.1128/JVI.73.12.10224-10235.1999; Murfett J, 1996, PLANT CELL, V8, P943, DOI 10.1105/tpc.8.6.943; Rodriguez SM, 2008, PROTEIN SCI, V17, P681, DOI 10.1110/ps.073420708; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Vidalino L, 2012, BIOL CELL, V104, P13, DOI 10.1111/boc.201100092; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767	37	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41111	10.1371/journal.pone.0041111	http://dx.doi.org/10.1371/journal.pone.0041111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829915	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300054
J	Carnevali, L; Mastorci, F; Audero, E; Graiani, G; Rossi, S; Macchi, E; Callegari, S; Bartolomucci, A; Nalivaiko, E; Quaini, F; Gross, C; Sgoifo, A				Carnevali, Luca; Mastorci, Francesca; Audero, Enrica; Graiani, Gallia; Rossi, Stefano; Macchi, Emilio; Callegari, Sergio; Bartolomucci, Alessandro; Nalivaiko, Eugene; Quaini, Federico; Gross, Cornelius; Sgoifo, Andrea			Stress-Induced Susceptibility to Sudden Cardiac Death in Mice with Altered Serotonin Homeostasis	PLOS ONE			English	Article							CENTRAL 5-HT RECEPTORS; HEART-RATE-VARIABILITY; KNOCKOUT MICE; CARDIOVASCULAR-RESPONSES; VENTROLATERAL MEDULLA; PSYCHOLOGICAL STRESS; MYOCARDIAL-ISCHEMIA; PSYCHOSOCIAL STRESS; BODY-TEMPERATURE; SOCIAL STRESS	In humans, chronic stressors have long been linked to cardiac morbidity. Altered serotonergic neurotransmission may represent a crucial pathophysiological mechanism mediating stress-induced cardiac disturbances. Here, we evaluated the physiological role of serotonin (5-HT) 1A receptors in the autonomic regulation of cardiac function under acute and chronic stress conditions, using 5-HT1A receptor knockout mice (KOs). When exposed to acute stressors, KO mice displayed a higher tachycardic stress response and a larger reduction of vagal modulation of heart rate than wild type counterparts (WTs). During a protocol of chronic psychosocial stress, 6 out of 22 (27%) KOs died from cardiac arrest. Close to death, they displayed a severe bradycardia, a lengthening of cardiac interval (P wave, PQ and QRS) duration, a notched QRS complex and a profound hypothermia. In the same period, the remaining knockouts exhibited higher values of heart rate than WTs during both light and dark phases of the diurnal rhythm. At sacrifice, KO mice showed a larger expression of cardiac muscarinic receptors (M2), whereas they did not differ for gross cardiac anatomy and the amount of myocardial fibrosis compared to WTs. This study demonstrates that chronic genetic loss of 5-HT1A receptors is detrimental for cardiovascular health, by intensifying acute, stress-induced heart rate rises and increasing the susceptibility to sudden cardiac death in mice undergoing chronic stress.	[Carnevali, Luca; Mastorci, Francesca; Rossi, Stefano; Macchi, Emilio; Sgoifo, Andrea] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Audero, Enrica; Gross, Cornelius] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Graiani, Gallia; Quaini, Federico] Univ Parma, Dept Internal Med, I-43100 Parma, Italy; [Callegari, Sergio] Vaio Hosp, Div Cardiol, Parma, Italy; [Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Nalivaiko, Eugene] Univ Newcastle, Sch Pharm & Biomed Sci, Newcastle, NSW 2300, Australia	University of Parma; European Molecular Biology Laboratory (EMBL); University of Parma; University of Minnesota System; University of Minnesota Twin Cities; University of Newcastle	Carnevali, L (corresponding author), Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy.	andrea.sgoifo@unipr.it	Rossi, Stefano/L-2556-2016; Carnevali, Luca/P-9508-2019; Carnevali, Luca/E-5322-2017; Sgoifo, Andrea/AAC-6278-2022	Rossi, Stefano/0000-0003-0346-8410; Carnevali, Luca/0000-0001-9053-7976; Carnevali, Luca/0000-0001-9053-7976; Sgoifo, Andrea/0000-0002-9428-6198; Quaini, Federico/0000-0003-2377-4810; Audero, Enrica/0000-0002-6138-244X; Nalivaiko, Eugene/0000-0002-6449-8181; Graiani, Gallia/0000-0003-1926-7568	Italian Ministry for Education, University and Research [2007WB35CW_004]; 'Fondi Regionali Ministero della Sanita' - Medicina Rigenerativa - THEAPPL'; EUROPEAN GRANT FP7-NMP [214539-BIOSCENT]	Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); 'Fondi Regionali Ministero della Sanita' - Medicina Rigenerativa - THEAPPL'; EUROPEAN GRANT FP7-NMP	This study was supported by a grant from the Italian Ministry for Education, University and Research (PRIN2007, 2007WB35CW_004), 'Fondi Regionali Ministero della Sanita' - Medicina Rigenerativa 2007- THEAPPL' and 'EUROPEAN GRANT FP7-NMP-2007: No 214539-BIOSCENT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameova A, 2009, CAN J PHYSIOL PHARM, V87, P493, DOI [10.1139/Y09-042, 10.1139/y09-042]; Bago M, 1999, J AUTONOM NERV SYST, V76, P127, DOI 10.1016/S0165-1838(99)00021-1; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; BERNE RM, 1954, CIRC RES, V2, P236, DOI 10.1161/01.RES.2.3.236; BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Bouwknecht JA, 2000, EUR J PHARMACOL, V400, P59, DOI 10.1016/S0014-2999(00)00387-3; Costoli T, 2004, AM J PHYSIOL-HEART C, V286, pH2133, DOI 10.1152/ajpheart.00869.2003; DAUCHOT P, 1976, ANESTHESIOLOGY, V44, P501, DOI 10.1097/00000542-197606000-00008; DEANFIELD JE, 1984, AM J CARDIOL, V54, P1195, DOI 10.1016/S0002-9149(84)80066-1; Dhalla NS, 2008, FUTUR CARDIOL, V4, P339, DOI 10.2217/14796678.4.4.339; DODGE HT, 1969, AM J CARDIOL, V23, P528, DOI 10.1016/0002-9149(69)90006-X; FELDMAN T, 1986, AM J CARDIOL, V58, P885, DOI 10.1016/S0002-9149(86)80004-2; Friedman BH, 1998, BIOL PSYCHOL, V49, P303; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gross C, 2000, BIOL PSYCHIAT, V48, P1157, DOI 10.1016/S0006-3223(00)01041-6; GUDELSKY GA, 1986, NEUROPHARMACOLOGY, V25, P1307, DOI 10.1016/0028-3908(86)90101-2; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Helke CJ, 1997, J COMP NEUROL, V379, P261; Holmes DR, 1999, CIRCULATION, V100, P2067, DOI 10.1161/01.CIR.100.20.2067; Jordan D, 2005, EXP PHYSIOL, V90, P175, DOI 10.1113/expphysiol.2004.029058; LOVICK TA, 1989, J AUTONOM NERV SYST, V28, P35, DOI 10.1016/0165-1838(89)90005-2; MARAZZITI D, 1992, PHYSIOL BEHAV, V52, P393, DOI 10.1016/0031-9384(92)90290-I; MCCALL RB, 1994, PHARMACOL REV, V46, P231; Meerlo P, 1999, BEHAV NEUROSCI, V113, P1283, DOI 10.1037/0735-7044.113.6.1283; MICZEK KA, 1979, PSYCHOPHARMACOLOGY, V60, P253, DOI 10.1007/BF00426664; Morrison SF, 2001, ANN NY ACAD SCI, V940, P286; Nalivaiko E, 2005, AM J PHYSIOL-REG I, V289, pR596, DOI 10.1152/ajpregu.00845.2004; Nalivaiko E, 2009, PHYSIOL BEHAV, V96, P320, DOI 10.1016/j.physbeh.2008.10.017; Nalivaiko E, 2009, NEUROSCI BIOBEHAV R, V33, P95, DOI 10.1016/j.neubiorev.2008.05.026; Ngampramuan S, 2008, AM J PHYSIOL-REG I, V294, pR132, DOI 10.1152/ajpregu.00464.2007; NOSJEAN A, 1991, AM J PHYSIOL, V260, pR600, DOI 10.1152/ajpregu.1991.260.3.R600; Olivier B, 1999, Prog Drug Res, V52, P103; Ootsuka Y, 2007, NEUROSCIENCE, V147, P127, DOI 10.1016/j.neuroscience.2007.04.015; Pattij T, 2002, NEUROPSYCHOPHARMACOL, V27, P380, DOI 10.1016/S0893-133X(02)00317-2; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Ramachandruni S, 2004, CURR OPIN CARDIOL, V19, P494, DOI 10.1097/01.hco.0000132321.24004.25; Ramage AG, 2001, BRAIN RES BULL, V56, P425, DOI 10.1016/S0361-9230(01)00612-8; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Samuels BC, 2002, J PHYSIOL-LONDON, V538, P941, DOI 10.1113/jphysiol.2001.013302; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; STEIN PK, 1994, AM HEART J, V127, P1376, DOI 10.1016/0002-8703(94)90059-0; Tiainen M, 2009, CRIT CARE MED, V37, P403, DOI 10.1097/CCM.0b013e31819572c4; van den Buuse M, 2005, EUR J PHARMACOL, V507, P187, DOI 10.1016/j.ejphar.2004.11.048; Zhuang XX, 1999, NEUROPSYCHOPHARMACOL, V21, pS52, DOI 10.1016/S0893-133X(99)00047-0	46	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41184	10.1371/journal.pone.0041184	http://dx.doi.org/10.1371/journal.pone.0041184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815962	gold, Green Published			2022-12-25	WOS:000306548900091
J	Kimbler, DE; Shields, J; Yanasak, N; Vender, JR; Dhandapani, KM				Kimbler, Donald E.; Shields, Jessica; Yanasak, Nathan; Vender, John R.; Dhandapani, Krishnan M.			Activation of P2X7 Promotes Cerebral Edema and Neurological Injury after Traumatic Brain Injury in Mice	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; SEVERE HEAD-INJURY; CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; ATP-INDUCED RELEASE; SPINAL-CORD-INJURY; CEREBROSPINAL-FLUID; INTRACRANIAL HYPERTENSION; COGNITIVE DYSFUNCTION; AQUAPORIN-4	Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Cerebral edema, the abnormal accumulation of fluid within the brain parenchyma, contributes to elevated intracranial pressure (ICP) and is a common life-threatening neurological complication following TBI. Unfortunately, neurosurgical approaches to alleviate increased ICP remain controversial and medical therapies are lacking due in part to the absence of viable drug targets. In the present study, genetic inhibition (P2X7-/- mice) of the purinergic P2x7 receptor attenuated the expression of the pro-inflammatory cytokine, interleukin-1 beta (IL-1 beta) and reduced cerebral edema following controlled cortical impact, as compared to wild-type mice. Similarly, brilliant blue G (BBG), a clinically non-toxic P2X7 inhibitor, inhibited IL-1 beta expression, limited edemic development, and improved neurobehavioral outcomes after TBI. The beneficial effects of BBG followed either prophylactic administration via the drinking water for one week prior to injury or via an intravenous bolus administration up to four hours after TBI, suggesting a clinically-implementable therapeutic window. Notably, P2X7 localized within astrocytic end feet and administration of BBG decreased the expression of glial fibrillary acidic protein (GFAP), a reactive astrocyte marker, and attenuated the expression of aquaporin-4 (AQP4), an astrocytic water channel that promotes cellular edema. Together, these data implicate P2X7 as a novel therapeutic target to prevent secondary neurological injury after TBI, a finding that warrants further investigation.	[Kimbler, Donald E.; Shields, Jessica; Vender, John R.; Dhandapani, Krishnan M.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA; [Yanasak, Nathan] Georgia Hlth Sci Univ, Dept Radiol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kimbler, DE (corresponding author), Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA.	kdhandapani@georgiahealth.edu	Yanasak, Nathan/CAG-5116-2022	Dhandapani, Krishnan/0000-0001-7044-1117	National Institutes of Health [NS065172]; TriServices Nursing Research Program [HU0001-10-1-TS11]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TriServices Nursing Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was provided by grants from the National Institutes of Health (NS065172) and from the TriServices Nursing Research Program (HU0001-10-1-TS11). The content and views expressed herein do not necessarily represent the views of the Department of Defense, the TriServices Nursing Research Program, Uniformed Services University of the Health Sciences, or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], FED REG; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cristofori L, 2005, CLIN BIOCHEM, V38, P97, DOI 10.1016/j.clinbiochem.2004.09.013; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Dhandapani KM, 2003, ENDOCRINE, V21, P59, DOI 10.1385/ENDO:21:1:59; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kawamata T, 2006, ACTA NEUROCHIR SUPPL, V96, P3; Kawamata T, 2007, PROG BRAIN RES, V161, P235, DOI 10.1016/S0079-6123(06)61016-9; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kleinschmidt JJ, 2000, NEUROLOGY, V54, P319, DOI 10.1212/WNL.54.2.319; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2009, CURR OPIN INVEST DR, V10, P664; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Latini S, 1996, NEUROCHEM INT, V28, P113, DOI 10.1016/0197-0186(95)00062-D; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; Lin HW, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-15; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; NEARY JT, 1994, ACTA NEUROPATHOL, V87, P8; Norman GJ, 2010, MOL PSYCHIATR, V15, P404, DOI 10.1038/mp.2009.91; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oprica M, 2005, BRAIN BEHAV IMMUN, V19, P223, DOI 10.1016/j.bbi.2004.07.006; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/neu.2004.21.1553; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Pillai A, 2007, NEUROPSYCHOPHARMACOL; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Wakade C, 2009, ANTIOXID REDOX SIGN, V11, P35, DOI 10.1089/ars.2008.2056; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wheaton P., 2011, J PSYCHOPHARMACOL; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	76	112	118	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41229	10.1371/journal.pone.0041229	http://dx.doi.org/10.1371/journal.pone.0041229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815977	gold, Green Published, Green Submitted			2022-12-25	WOS:000306507000083
J	Skalka, N; Caspi, M; Caspi, E; Loh, YP; Rosin-Arbesfeld, R				Skalka, N.; Caspi, M.; Caspi, E.; Loh, Y. P.; Rosin-Arbesfeld, R.			Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathway	ONCOGENE			English	Article						Wnt signaling; carboxypeptidase E (CPE); beta-catenin; functional screen	NEUROPEPTIDE-PROCESSING ENZYME; BETA-CATENIN; SECRETORY GRANULES; CANCER CELLS; AXIN; POLYMERIZATION; TRANSDUCTION; ENDOCRINE; MUTATIONS; PROTEINS	Aberrant activation of the canonical Wnt signal transduction pathway is involved in many diseases including cancer and is especially implicated in the development and progression of colorectal cancer. The key effector protein of the canonical Wnt pathway is beta-catenin, which functions with T-cell factor/lymphoid enhancer factor to activate expression of Wnt target genes. In this study, we used a new functional screen based on cell survival in the presence of cDNAs encoding proteins that activate the Wnt pathway thus identifying novel Wnt signaling components. Here we identify carboxypeptidase E (vertical bar CPE) and its splice variant, Delta N-CPE, as novel regulators of the Wnt pathway. We show that whereas Delta N-CPE activates the Wnt signal, the full-length CPE (F-CPE) protein is an inhibitor of Wnt/beta-catenin signaling. F-CPE forms a complex with the Wnt3a ligand and the Frizzled receptor. Moreover, F-CPE disrupts disheveled-induced signalosomes that are important for transducing the Wnt signal and reduces beta-catenin protein levels and activity. Taken together, our data indicate that F-CPE and Delta N-CPE regulate the canonical Wnt signaling pathway negatively and positively, respectively, and demonstrate that this screening approach can be a rapid means for isolation of novel Wnt signaling components.	[Skalka, N.; Caspi, M.; Caspi, E.; Rosin-Arbesfeld, R.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Loh, Y. P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Neurobiol, Program Dev Neurosci, NIH, Bethesda, MD USA	Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rosin-Arbesfeld, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	arina@post.tau.ac.il			Israel Science Foundation; Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel [20120016]; Recanati Foundation; Israel Cancer Association through the Estate of the late Alexander Smidoda; US-Israel Binational Science Foundation; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008804, ZIAHD000056] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel; Recanati Foundation; Israel Cancer Association through the Estate of the late Alexander Smidoda; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Israel Science Foundation, by grant no. 20120016 from the Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel, the Recanati Foundation, Israel Cancer Association through the Estate of the late Alexander Smidoda, US-Israel Binational Science Foundation and in part by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development to YPL.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Du JL, 2001, CANCER LETT, V165, P211, DOI 10.1016/S0304-3835(01)00409-8; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FRICKER LD, 1983, J BIOL CHEM, V258, P950; FRICKER LD, 1993, J NEUROCHEM, V61, P1404, DOI 10.1111/j.1471-4159.1993.tb13634.x; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; He P, 2004, HUM PATHOL, V35, P1196, DOI 10.1016/j.humpath.2004.06.014; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Lee TK, 2011, J CLIN INVEST, V121, P880, DOI 10.1172/JCI40433; Liu YT, 2011, J BIOL CHEM, V286, P8597, DOI 10.1074/jbc.M110.186742; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Metcalfe C, 2010, J CELL SCI, V123, P1588, DOI 10.1242/jcs.067546; Moeller C, 2003, DEVELOPMENT, V130, P5103, DOI 10.1242/dev.00686; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Murthy SRK, 2010, CELL MOL NEUROBIOL, V30, P1377, DOI 10.1007/s10571-010-9592-y; Murthy SR, 2012, AACR ANN M 2012 CHIC; Park J, 2009, J MOL NEUROSCI, V37, P151, DOI 10.1007/s12031-008-9098-y; Polakis P, 2000, GENE DEV, V14, P1837; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; STROUS GJAM, 1983, J CELL BIOL, V97, P1815, DOI 10.1083/jcb.97.6.1815; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tang SS, 2009, MOL CELL ENDOCRINOL, V303, P43, DOI 10.1016/j.mce.2009.01.020; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wang L, 2009, J BONE MINER RES, V24, P265, DOI [10.1359/jbmr.081014, 10.1359/JBMR.081014]; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	39	33	35	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 6	2013	32	23					2836	2847		10.1038/onc.2012.308	http://dx.doi.org/10.1038/onc.2012.308			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	22824791	Green Accepted			2022-12-25	WOS:000320369100004
J	Yang, CZ; Matro, JC; Huntoon, KM; Ye, DY; Huynh, TT; Fliedner, SMJ; Breza, J; Zhuang, ZP; Pacak, K				Yang, Chunzhang; Matro, Joey C.; Huntoon, Kristin M.; Ye, Donald Y.; Huynh, Thanh T.; Fliedner, Stephanie M. J.; Breza, Jan; Zhuang, Zhengping; Pacak, Karel			Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function	FASEB JOURNAL			English	Article						pheochromocytoma; paraganglioma; succinate dehydrogenase subunit B; histone deacetylase inhibitor	SUCCINATE-DEHYDROGENASE; QUALITY-CONTROL; GERMLINE SDHB; IN-VIVO; PHEOCHROMOCYTOMA; PARAGANGLIOMA; SUBUNIT; HYPOXIA; CHAPERONES; INSERTION	Mutations of succinate dehydrogenase subunit B (SDHB) play a crucial role in the pathogenesis of the most aggressive and metastatic pheochromocytomas (PHEOs) and paragangliomas (PGLs). Although a variety of missense mutations in the coding sequence of the SDHB gene have been found in PHEOs and PGLs, it has been unclear whether these mutations impair mRNA expression, protein stability, subcellular localization, or intrinsic protein function. RT-PCR and Western blot analysis of SDHB mRNA and protein expression from SDHB-related PHEOs and PGLs demonstrated intact mRNA expression but significantly reduced protein expression compared to non-SDHB PHEOs and PGLs. A pulse-chase assay of common SDHB missense mutations in transfected HeLa cell lines demonstrated that the loss of SDHB function was due to a reduction in mutant protein half-life, whereas colocalization of SDHB with mitochondria and immunoprecipitation with SDHA demonstrated intact subcellular localization and complex formation. The half-life of the SDHB protein increased after treatment with histone deacetylase inhibitors (HDACis), implicating the protein quality control machinery in the degradation of mutant SDHB protein. These findings provide the first direct mechanism of functional loss resulting from SDHBmutations and suggest that reducing protein degradation with HDACis may serve as a novel therapeutic paradigm for preventing the development of SDHB-related tumors.-Yang, C., Matro, J. C., Huntoon, K. M., Ye, D. Y., Huynh, T. T., Fliedner, S. M. J., Breza, J., Zhuang, Z., Pacak, K. Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function. FASEB J. 26, 4506-4516 (2012). www.fasebj.org	[Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, CRC, Bethesda, MD 20892 USA; [Zhuang, Zhengping] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Breza, Jan] Comenius Univ, Sch Med, Dept Urol, Bratislava, Slovakia	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Comenius University Bratislava	Pacak, K (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, CRC, Bldg 10,Rm 1E-3140,10 Ctr Dr,MSC 1109, Bethesda, MD 20892 USA.	zhuangp@ninds.nih.gov; karel@mail.nih.gov	Fliedner, Stephanie MJ/D-3406-2012	Yang, Chunzhang/0000-0001-6433-0867; Fliedner, Stephanie/0000-0001-5515-8196; Huntoon, Kristin/0000-0002-7211-8986	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke at the U. S. National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003053, ZIANS003052] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke at the U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke at the U. S. National Institutes of Health.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6; Astuti D, 2011, ENDOCR-RELAT CANCER, V18, P73, DOI 10.1677/ERC-10-0113; Baysal BE, 2003, TRENDS ENDOCRIN MET, V14, P453, DOI 10.1016/j.tem.2003.08.004; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benn DE, 2003, ONCOGENE, V22, P1358, DOI 10.1038/sj.onc.1206300; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CHEN F, 1995, CANCER RES, V55, P4804; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Delellis RA, 2004, TUMORS ENDOCRINE ORG; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Eisenhofer G, 2004, ENDOCR-RELAT CANCER, V11, P423, DOI 10.1677/erc.1.00829; Eng C, 1999, J CLIN ONCOL, V17, P380, DOI 10.1200/JCO.1999.17.1.380; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Favier J, 2010, BEST PRACT RES CL EN, V24, P957, DOI 10.1016/j.beem.2010.10.004; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Fliedner SMJ, 2010, CELL TISSUE RES, V340, P607, DOI 10.1007/s00441-010-0965-9; Furuta M, 2004, ONCOGENE, V23, P6806, DOI 10.1038/sj.onc.1207770; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gill AJ, 2011, NEW ENGL J MED, V364, P885, DOI 10.1056/NEJMc1012357; Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Henderson A, 2009, FAM CANCER, V8, P257, DOI 10.1007/s10689-009-9234-z; Hensen EF, 2011, FAM CANCER, V10, P355, DOI 10.1007/s10689-010-9402-1; Huang H, 2008, CANCER-AM CANCER SOC, V113, P2020, DOI 10.1002/cncr.23812; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lu J, 2010, P NATL ACAD SCI USA, V107, P21665, DOI 10.1073/pnas.1014376107; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943; Pawlu C, 2005, FAM CANCER, V4, P49, DOI 10.1007/s10689-004-4227-4; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; Ricketts CJ, 2010, HUM MUTAT, V31, P41, DOI 10.1002/humu.21136; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Van Nederveen FH, 2006, ANN NY ACAD SCI, V1073, P177, DOI 10.1196/annals.1353.018; van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0; Yang CZ, 2011, P NATL ACAD SCI USA, V108, P4980, DOI 10.1073/pnas.1102198108; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; ZHUANG Z, 1988, FEBS LETT, V238, P185, DOI 10.1016/0014-5793(88)80253-9; Zhuang Z., 2001, J NEUROSURG, V115, P789; ZHUANG ZP, 1992, J BIOL CHEM, V267, P591; ZHUANG ZP, 1995, AM J PATHOL, V146, P620	58	39	40	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4506	4516		10.1096/fj.12-210146	http://dx.doi.org/10.1096/fj.12-210146			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22835832	Green Published			2022-12-25	WOS:000310574200013
J	Garner, K; Hunt, AN; Koster, G; Somerharju, P; Groves, E; Li, M; Raghu, P; Holic, R; Cockcroft, S				Garner, Kathryn; Hunt, Alan N.; Koster, Grielof; Somerharju, Pentti; Groves, Emily; Li, Michelle; Raghu, Padinjat; Holic, Roman; Cockcroft, Shamshad			Phosphatidylinositol Transfer Protein, Cytoplasmic 1 (PITPNC1) Binds and Transfers Phosphatidic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; PHOSPHOLIPASE-D ACTIVATION; RETINAL-DEGENERATION-B; II TYPE-1 RECEPTOR; DROSOPHILA PHOTORECEPTORS; DIACYLGLYCEROL KINASE; ENDOPLASMIC-RETICULUM; STREPTOLYSIN-O; LIPID TRANSFER; HL-60 CELLS	Phosphatidylinositol transfer proteins (PITPs) are versatile proteins required for signal transduction and membrane traffic. The best characterized mammalian PITPs are the Class I PITPs, PITP alpha (PITPNA) and PITP beta (PITPNB), which are single domain proteins with a hydrophobic cavity that binds a phosphatidylinositol (PI) or phosphatidylcholine molecule. In this study, we report the lipid binding properties of an uncharacterized soluble PITP, phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1) (alternative name, RdgB beta), of the Class II family. We show that the lipid binding properties of this protein are distinct to Class I PITPs because, besides PI, RdgB beta binds and transfers phosphatidic acid (PA) but hardly binds phosphatidylcholine. RdgB beta when purified from Escherichia coli is preloaded with PA and phosphatidylglycerol. When RdgB beta was incubated with permeabilized HL60 cells, phosphatidylglycerol was released, and PA and PI were now incorporated into RdgB beta. After an increase in PA levels following activation of endogenous phospholipase D or after addition of bacterial phospholipase D, binding of PA to RdgB beta was greater at the expense of PI binding. We propose that RdgB beta, when containing PA, regulates an effector protein or can facilitate lipid transfer between membrane compartments.	[Garner, Kathryn; Groves, Emily; Li, Michelle; Holic, Roman; Cockcroft, Shamshad] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6JJ, England; [Hunt, Alan N.; Koster, Grielof] Univ Southampton, Fac Med, Southampton SO16 6YD, Hants, England; [Somerharju, Pentti] Univ Helsinki, Dept Biochem & Dev Biol, Inst Biomed, FIN-00014 Helsinki, Finland; [Raghu, Padinjat] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	University of London; University College London; University of Southampton; University of Helsinki; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Cockcroft, S (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6JJ, England.	s.cockcroft@ucl.ac.uk	Holic, Roman/AAC-8402-2019; Padinjat, Raghu/Z-5578-2019; Hunt, Alan N/A-7432-2008; Cockcroft, Shamshad/F-9480-2011; Garner, Kathryn/AAQ-2052-2020; Roman, Holic/X-7500-2018	Holic, Roman/0000-0003-1347-4785; Hunt, Alan N/0000-0001-5938-2152; Garner, Kathryn/0000-0001-8539-8959; Roman, Holic/0000-0003-1347-4785; Cockcroft, Shamshad/0000-0002-5731-476X	British Heart Foundation [FS/08/044/25498]; Lister Institute	British Heart Foundation(British Heart Foundation); Lister Institute	This work was supported in part by British Heart Foundation Grant FS/08/044/25498.; Supported by a studentship from the Lister Institute.	Alb JG, 2007, J LIPID RES, V48, P1857, DOI 10.1194/jlr.M700145-JLR200; Alb JG, 2002, MOL BIOL CELL, V13, P739, DOI 10.1091/mbc.01-09-0457; Allen-Baume V, 2002, FEBS LETT, V531, P74, DOI 10.1016/S0014-5793(02)03412-9; Carvou N, 2010, J CELL SCI, V123, P1262, DOI 10.1242/jcs.061986; Cockcroft S, 2011, CRIT REV BIOCHEM MOL, V46, P89, DOI 10.3109/10409238.2010.538664; Cockcroft Shamshad, 2009, V462, P363, DOI 10.1007/978-1-60327-115-8_23; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Garner K, 2011, BIOCHEM J, V439, P97, DOI 10.1042/BJ20110649; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HOLBROOK PG, 1992, J BIOL CHEM, V267, P16834; Hong KW, 2010, J HUM HYPERTENS, V24, P763, DOI 10.1038/jhh.2010.9; Hunt AN, 2004, BBA-MOL CELL BIOL L, V1686, P50, DOI 10.1016/j.bbalip.2004.08.003; Iwata R, 2011, P NATL ACAD SCI USA, V108, P7589, DOI 10.1073/pnas.1016232108; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Lopez-Ilasaca M, 2003, MOL BIOL CELL, V14, P5038, DOI 10.1091/mbc.E03-06-0383; Lu C, 2001, NEUROSCIENCE, V107, P35, DOI 10.1016/S0306-4522(01)00337-2; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; Milligan SC, 1997, J CELL BIOL, V139, P351, DOI 10.1083/jcb.139.2.351; Nakada T, 2011, CRIT CARE MED, V39, P1641, DOI 10.1097/CCM.0b013e318218665a; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Raghu P, 2009, J CELL BIOL, V185, P129, DOI 10.1083/jcb.200807027; Segui B, 2002, BIOCHEM J, V366, P23, DOI 10.1042/BJ20020317; Shadan S, 2008, TRAFFIC, V9, P1743, DOI 10.1111/j.1600-0854.2008.00794.x; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; STUTCHFIELD J, 1993, BIOCHEM J, V293, P649, DOI 10.1042/bj2930649; STUTCHFIELD J, 1988, BIOCHEM J, V250, P375, DOI 10.1042/bj2500375; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; VANPARIDON PA, 1988, BIOCHEMISTRY-US, V27, P6208, DOI 10.1021/bi00417a003; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; Vordtriede PB, 2005, BIOCHEMISTRY-US, V44, P14760, DOI 10.1021/bi051191r; Whatmore J, 1999, BIOCHEM J, V341, P435, DOI 10.1042/0264-6021:3410435; Xie Y, 2005, NAT CELL BIOL, V7, P1124, DOI 10.1038/ncb1321; Yanase Y, 2010, BIOCHEM J, V425, P179, DOI 10.1042/BJ20091122; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	44	54	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32263	32276		10.1074/jbc.M112.375840	http://dx.doi.org/10.1074/jbc.M112.375840			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822086	hybrid, Green Published			2022-12-25	WOS:000309059400063
J	Valentin-Hansen, L; Groenen, M; Nygaard, R; Frimurer, TM; Holliday, ND; Schwartz, TW				Valentin-Hansen, Louise; Groenen, Marleen; Nygaard, Rie; Frimurer, Thomas M.; Holliday, Nicholas D.; Schwartz, Thue W.			The Arginine of the DRY Motif in Transmembrane Segment III Functions as a Balancing Micro-switch in the Activation of the beta 2-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2) ADRENERGIC-RECEPTOR; PROTEIN-COUPLED RECEPTORS; HYDROGEN-BOND NETWORK; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; IONIC LOCK; CONSTITUTIVE ACTIVITY; SCREENING ASSAY; ACTIVE STATE; RHODOPSIN	Recent high resolution x-ray structures of the beta 2-adrenergic receptor confirmed a close salt-bridge interaction between the suspected micro-switch residue ArgIII:26 (Arg3.50) and the neighboring AspIII:25 (Asp3.49). However, neither the expected "ionic lock" interactions between ArgIII:26 and GluVI:-06 (Glu6.30) in the inactive conformation nor the interaction with TyrV:24 (Tyr5.58) in the active conformation were observed in the x-ray structures. Here we find through molecular dynamics simulations, after removal of the stabilizing T4 lysozyme, that the expected salt bridge between ArgIII:26 and GluVI:-06 does form relatively easily in the inactive receptor conformation. Moreover, mutational analysis of GluVI:-06 in TM-VI and the neighboring AspIII:25 in TM-III demonstrated that these two residues do function as locks for the inactive receptor conformation as we observed increased G(s) signaling, arrestin mobilization, and internalization upon alanine substitutions. Conversely, TyrV:24 appears to play a role in stabilizing the active receptor conformation as loss of function of G(s) signaling, arrestin mobilization, and receptor internalization was observed upon alanine substitution of TyrV:24. The loss of function of the TyrV:24 mutant could partly be rescued by alanine substitution of either AspIII:25 or GluVI:-06 in the double mutants. Surprisingly, removal of the side chain of the ArgIII:26 micro-switch itself had no effect on G(s) signaling and internalization and only reduced arrestin mobilization slightly. It is suggested that ArgIII:26 is equally important for stabilizing the inactive and the active conformation through interaction with key residues in TM-III, -V, and -VI, but that the ArgIII:26 micro-switch residue itself apparently is not essential for the actual G protein activation.	[Valentin-Hansen, Louise; Nygaard, Rie; Schwartz, Thue W.] Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Valentin-Hansen, Louise; Schwartz, Thue W.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Ctr Prot Res, Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Groenen, Marleen; Holliday, Nicholas D.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Cell Signalling Res Grp, Nottingham NG7 2UH, England	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Nottingham	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	tws@sund.ku.dk	Nygaard, Rie/B-7351-2013	Holliday, Nicholas/0000-0002-2900-828X; Schwartz, Thue W./0000-0002-0261-6904; Frimruer, Thomas/0000-0002-9682-8245	Novo Nordisk Foundation; Health and Medical Sciences faculty at University of Copenhagen	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Health and Medical Sciences faculty at University of Copenhagen	The recipient of a Ph.D. stipend from the Health and Medical Sciences faculty at University of Copenhagen.; We thank a persistent referee for forcing us to make the crucial double mutants. The Novo Nordisk Foundation Center for Basic Metabolic Research is based on an unconditional grant from the Novo Nordisk Foundation.	Arora KK, 1997, MOL ENDOCRINOL, V11, P1203, DOI 10.1210/me.11.9.1203; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elster L, 2007, J BIOMOL SCREEN, V12, P41, DOI 10.1177/1087057106295895; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Huang RRC, 1995, BIOCHEMISTRY-US, V34, P16467, DOI 10.1021/bi00050a030; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenkilde MM, 2005, MOL PHARMACOL, V68, P11, DOI 10.1124/mol.105.011239; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seibold A, 1998, RECEPTOR CHANNEL, V5, P375; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vrecl M, 2004, J BIOMOL SCREEN, V9, P322, DOI 10.1177/1087057104263212; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	36	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31973	31982		10.1074/jbc.M112.348565	http://dx.doi.org/10.1074/jbc.M112.348565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843684	Green Published, hybrid			2022-12-25	WOS:000309059400036
J	Yu, JH; Oh, MH; Park, JU; Myers, AC; Dong, C; Zhu, Z; Zheng, T				Yu, Jinho; Oh, Min Hee; Park, Ju-Un; Myers, Allen C.; Dong, Chen; Zhu, Zhou; Zheng, Tao			Epicutaneous Exposure to Staphylococcal Superantigen Enterotoxin B Enhances Allergic Lung Inflammation via an IL-17A Dependent Mechanism	PLOS ONE			English	Article							HOUSE-DUST MITE; ATOPIC-DERMATITIS; T-CELLS; NEUTROPHIL RECRUITMENT; AIRWAY INFLAMMATION; FILAGGRIN MUTATIONS; MURINE MODEL; TH17 CELLS; FOLLOW-UP; IN-VIVO	Atopic dermatitis (AD) is the initial step of the atopic march: the progression from AD to allergic rhinitis and asthma. There is a close association between skin barrier abnormalities and the development of AD and the atopic march. One of cardinal features of AD is that the lesional skin of the majority of AD patients is chronically colonized with Staphylococcus aureus with half isolates producing superantigen enterotoxin B (SEB). Although diverse roles of SEB in the pathogenesis and severity of AD have been recognized, whether SEB contributes to the dermal inflammation that drives lung inflammation and airway hyperresponsiveness (AHR) has not been examined. Here we show a novel role of S. aureus superantigen SEB in augmenting allergen ovalbumin (Ova) induced atopic march through an IL-17A dependent mechanism. When mice epicutaneously (EC) sensitized with allergen Ova, addition of topical SEB led to not only augmented systemic Th2 responses but also a markedly exaggerated systemic Th17/IL-17 immune environment. The ability of SEB in enhancing Th17/IL-17 was mediated through stimulating lymphocytes in spleen and draining lymph nodes to promote IL-6 production. Epicutaneous sensitization of mice with a combination of Ova and SEB significantly enhanced Ova-induced AHR and granulocytic lung inflammation than Ova allergen alone. When IL-17A was deleted genetically, the effects of SEB on augmenting lung inflammation and AHR were markedly diminished. These findings suggest that chronic heavy colonization of enterotoxin producing S. aureus in the skin of patients with atopic dermatitis may have an important role in the development of atopic march via an IL-17A dependent mechanism.	[Yu, Jinho; Oh, Min Hee; Park, Ju-Un; Myers, Allen C.; Zhu, Zhou; Zheng, Tao] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Dong, Chen] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Dept Immunol, Houston, TX 77030 USA	Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center	Yu, JH (corresponding author), Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	tzheng@jhmi.edu	Yu, Jinho/P-4293-2014; dong, chen/B-3181-2009	Yu, Jinho/0000-0002-1226-8077; dong, chen/0000-0002-0084-9130; Oh, Min-Hee/0000-0003-1581-4288	NIH [R01AI075025, P01HL107151, R01HL079349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079349, P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01AI075025 to TZ; P01HL107151 and R01HL079349 to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Breuer K, 2001, ALLERGY, V56, P1034, DOI 10.1034/j.1398-9995.2001.00146.x; Bright JJ, 1999, J LEUKOCYTE BIOL, V65, P665, DOI 10.1002/jlb.65.5.665; Brown SJ, 2008, J ALLERGY CLIN IMMUN, V121, P940, DOI 10.1016/j.jaci.2008.01.013; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Bunikowski R, 2000, J ALLERGY CLIN IMMUN, V105, P814, DOI 10.1067/mai.2000.105528; Burgess JA, 2008, J ALLERGY CLIN IMMUN, V122, P280, DOI 10.1016/j.jaci.2008.05.018; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Eyerich K, 2009, J ALLERGY CLIN IMMUN, V123, P59, DOI 10.1016/j.jaci.2008.10.031; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Fujiwara M, 2007, J ALLERGY CLIN IMMUN, V119, P662, DOI 10.1016/j.jaci.2006.12.643; Gould Hannah J, 2007, Chem Immunol Allergy, V93, P106, DOI 10.1159/000100861; Gustafsson PM, 2000, RESP MED, V94, P466, DOI 10.1053/rmed.1999.0763; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; He R, 2009, J ALLERGY CLIN IMMUN, V124, P761, DOI 10.1016/j.jaci.2009.07.040; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Ivanov S, 2007, AM J RESP CELL MOL, V36, P442, DOI 10.1165/rcmb.2006-0020OC; Kawaguchi Mio, 2009, Inflammation & Allergy Drug Targets, V8, P383; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Laan M, 2008, RECENT PATENTS INFLA, V2, P82, DOI 10.2174/187221308784543683; Langer K, 2007, EXP DERMATOL, V16, P124, DOI 10.1111/j.1600-0625.2006.00523.x; LEUNG DYM, 1995, J INVEST DERMATOL, V105, pS37, DOI 10.1111/1523-1747.ep12315250; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mandron M, 2006, J ALLERGY CLIN IMMUN, V117, P1141, DOI 10.1016/j.jaci.2005.12.1360; Nomura I, 1999, J ALLERGY CLIN IMMUN, V104, P441, DOI 10.1016/S0091-6749(99)70390-8; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Ohshima Y, 2002, ANN ALLERG ASTHMA IM, V89, P265, DOI 10.1016/S1081-1206(10)61953-9; Ou LS, 2004, J ALLERGY CLIN IMMUN, V113, P756, DOI 10.1016/j.jaci.2004.01.772; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Ricci G, 2006, J AM ACAD DERMATOL, V55, P765, DOI 10.1016/j.jaad.2006.04.064; Savinko T, 2005, J IMMUNOL, V175, P8320, DOI 10.4049/jimmunol.175.12.8320; Schlievert PM, 2008, CLIN INFECT DIS, V46, P1562, DOI 10.1086/586746; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Simpson EL, 2006, MED CLIN N AM, V90, P149, DOI 10.1016/j.mcna.2005.09.002; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Spergel JM, 2005, CURR OPIN ALLERGY CL, V5, P17, DOI 10.1097/00130832-200502000-00005; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Spergel JM, 2010, IMMUNOL ALLERGY CLIN, V30, P269, DOI 10.1016/j.iac.2010.06.003; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Toda M, 2003, J ALLERGY CLIN IMMUN, V111, P875, DOI 10.1067/mai.2003.1414; Tomi NS, 2005, J AM ACAD DERMATOL, V53, P67, DOI 10.1016/j.jaad.2005.02.034; Travers JB, 2009, J ALLERGY CLIN IMMUN, V125, p[146, e141]; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; WILLIAMS REA, 1990, BRIT J DERMATOL, V123, P493; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu Z, 2011, SCI REP-UK, V1, DOI 10.1038/srep00023; Zollner TM, 2000, CLIN EXP ALLERGY, V30, P994	59	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39032	10.1371/journal.pone.0039032	http://dx.doi.org/10.1371/journal.pone.0039032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848348	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950200008
J	Achanta, S; Kumar, AMV; Nagaraja, SB; Jaju, J; Shamrao, SRM; Uppaluri, R; Tekumalla, RR; Gupta, D; Kumar, A; Satyanarayana, S; Dewan, PK				Achanta, Shanta; Kumar, Ajay M. V.; Nagaraja, Sharath Burugina; Jaju, Jyoti; Shamrao, Srinivas Rao Motta; Uppaluri, Ramakrishna; Tekumalla, Rama Rao; Gupta, Devesh; Kumar, Ashok; Satyanarayana, Srinath; Dewan, Puneet K.			Feasibility and Effectiveness of Provider Initiated HIV Testing and Counseling of TB Suspects in Vizianagaram District, South India	PLOS ONE			English	Article								Background: Though internationally recommended, provider initiated HIV testing and counseling (PITC) of persons suspected of tuberculosis (TB) is not a policy in India; HIV seroprevalence among TB suspects has never been reported. The current policy of PITC for diagnosed TB cases may limit opportunities of early HIV diagnosis and treatment. We determined HIV seroprevalence among persons suspected of TB and assessed feasibility and effectiveness of PITC implementation at this earlier stage in the TB diagnostic pathway. Methods: All adults examined for diagnostic sputum microscopy (TB suspects) in Vizianagaram district (population 2.5 million), in November-December 2010, were offered voluntary HIV counseling and testing (VCT) and assessed for TB diagnosis. Results: Of 2918 eligible TB suspects, 2465(85%) consented to VCT. Among these, 246(10%) were HIV-positive. Of the 246, 84(34%) were newly diagnosed as HIV (HIV status not known previously). To detect a new case of HIV infection, the number needed to screen (NNS) was 26 among 'TB suspects', comparable to that among 'TB patients'. Among suspects aged 25-54 years, not diagnosed as TB, the NNS was 17. Conclusion: The seroprevalence of HIV among 'TB suspects' was as high as that among 'TB patients'. Implementation of PITC among TB suspects was feasible and effective, detecting a large number of new HIV cases with minimal additional workload on staff of HIV testing centre. HIV testing of TB suspects aged 25-54 years demonstrated higher yield for a given effort, and should be considered by policy makers at least in settings with high HIV prevalence.	[Achanta, Shanta; Kumar, Ajay M. V.; Nagaraja, Sharath Burugina; Jaju, Jyoti; Dewan, Puneet K.] Off World Hlth Org WHO Representat India, New Delhi, India; [Kumar, Ajay M. V.; Nagaraja, Sharath Burugina; Gupta, Devesh; Kumar, Ashok] Govt India, Cent TB Div, Directorate Gen Hlth Serv, Minist Hlth & Family Welf, New Delhi, India; [Shamrao, Srinivas Rao Motta] Directorate Hlth Serv, State TB Cell, Hyderabad, Andhra Pradesh, India; [Uppaluri, Ramakrishna] Andhra Pradesh State AIDS Prevent & Control Soc, Directorate Hlth Serv, Hyderabad, Andhra Pradesh, India; [Tekumalla, Rama Rao] Dist TB Ctr, Directorate Hlth Serv, Vizianagaram, Andhra Pradesh, India; [Satyanarayana, Srinath] SE Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India	World Health Organization	Achanta, S (corresponding author), Off World Hlth Org WHO Representat India, New Delhi, India.	AchantaS@rntcp.org	Nagaraja, Sharath Burugina/ABD-7238-2021; Nagaraja, Sharath Burugina/ABD-7748-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Satyanarayana, Srinath/0000-0002-5420-2551; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Union from Global Fund Round 9 India TB Project funds; WHO-India from USAID funds	Union from Global Fund Round 9 India TB Project funds; WHO-India from USAID funds(United States Agency for International Development (USAID)World Health Organization)	Funding support was provided in part by the Union from Global Fund Round 9 India TB Project funds and the rest by WHO-India from USAID funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei A A, 2006, West Afr J Med, V25, P38; Bishnu B, 2011, INT J TUBERC LUNG D, V15, pS214; Central TB Division, 2005, TEHCHN OP GUID TUB C; Central TB Division, 2011, TB IND 2011 REV NAT; Deribew A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018614; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; EpiData Association, EPIDATA ASS EPIDATA; Munthali L, 2006, INT J TUBERC LUNG D, V10, P199; Naik B, 2011, J ACQUIRED IMMUNE DE; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization, 2010, HIV EST IND 2009; National AIDS Control Organization and Central TB Division, 2009, MIN NAT TECHN WORK G; National AIDS Control Organization and Central TB Division, 2009, NAT FRAM JOINT HIV T; National AIDS Control Organization ICMR-National Institute of Medical Statistics, 2018, HIV EST 2017 TECHN R; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; WHO, 2004, INT POL COLL TB HIV; WHO, 2010, GLOB TUB CONTR 2010	19	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41378	10.1371/journal.pone.0041378	http://dx.doi.org/10.1371/journal.pone.0041378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844467	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700078
J	Ferro, F; Spelat, R; D'Aurizio, F; Puppato, E; Pandolfi, M; Beltrami, AP; Cesselli, D; Falini, G; Beltrami, CA; Curcio, F				Ferro, Federico; Spelat, Renza; D'Aurizio, Federica; Puppato, Elisa; Pandolfi, Maura; Beltrami, Antonio Paolo; Cesselli, Daniela; Falini, Giuseppe; Beltrami, Carlo Alberto; Curcio, Francesco			Dental Pulp Stem Cells Differentiation Reveals New Insights in Oct4A Dynamics	PLOS ONE			English	Article							PROTEIN-KINASE CK2; IN-VITRO; ADIPOSE-TISSUE; DNA-BINDING; NUCLEAR EXPORT; SELF-RENEWAL; EXPRESSION; PLURIPOTENCY; MOUSE; POPULATION	Although the role played by the core transcription factor network, which includes c-Myc, Klf4, Nanog, and Oct4, in the maintenance of embryonic stem cell (ES) pluripotency and in the reprogramming of adult cells is well established, its persistence and function in adult stem cells are still debated. To verify its persistence and clarify the role played by these molecules in adult stem cell function, we investigated the expression pattern of embryonic and adult stem cell markers in undifferentiated and fully differentiated dental pulp stem cells (DPSC). A particular attention was devoted to the expression pattern and intracellular localization of the stemness-associated isoform A of Oct4 (Oct4A). Our data demonstrate that: Oct4, Nanog, Klf4 and c-Myc are expressed in adult stem cells and, with the exception of c-Myc, they are significantly down-regulated following differentiation. Cell differentiation was also associated with a significant reduction in the fraction of DPSC expressing the stem cell markers CD10, CD29 and CD117. Moreover, a nuclear to cytoplasm shuttling of Oct4A was identified in differentiated cells, which was associated with Oct4A phosphorylation. The present study would highlight the importance of the post-translational modifications in DPSC stemness maintenance, by which stem cells balance self-renewal versus differentiation. Understanding and controlling these mechanisms may be of great importance for stemness maintenance and stem cells clinical use, as well as for cancer research.	[Ferro, Federico; Spelat, Renza; Pandolfi, Maura; Beltrami, Antonio Paolo; Cesselli, Daniela; Beltrami, Carlo Alberto; Curcio, Francesco] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [D'Aurizio, Federica; Curcio, Francesco] Univ Udine, Teaching Hosp, Dept Lab Med, I-33100 Udine, Italy; [Puppato, Elisa; Pandolfi, Maura; Beltrami, Antonio Paolo; Cesselli, Daniela; Beltrami, Carlo Alberto] Regenerat Med Ctr CIME, Udine, Italy; [Falini, Giuseppe] Univ Bologna, Dept Chem G Ciamican, Bologna, Italy	University of Udine; University of Udine; University of Bologna	Ferro, F (corresponding author), Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.	ferro.federico@libero.it	Pandolfi, Margareth/H-7616-2016; Ferro, Federico/GPK-8383-2022; Curcio, Francesco/K-4669-2014; Spelat, Renza/AAZ-2980-2021; Beltrami, Antonio/C-5291-2008; d'aurizio, federica/AAC-7832-2022; CESSELLI, DANIELA/C-7052-2008	Spelat, Renza/0000-0001-5794-8976; Beltrami, Antonio/0000-0002-0679-2710; d'aurizio, federica/0000-0003-2311-859X; Ferro, Federico/0000-0002-6023-8227; CURCIO, Francesco/0000-0002-9070-4807; Cesselli, Daniela/0000-0002-0562-7852	A.S.I. Italian Space Agency	A.S.I. Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This work was supported by A.S.I. Italian Space Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Beltrami AP, 2009, PHARMACOL THERAPEUT, V124, P23, DOI 10.1016/j.pharmthera.2009.06.003; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cohen SL, 1997, ANAL BIOCHEM, V247, P257, DOI 10.1006/abio.1997.2072; CURCIO F, 1994, P NATL ACAD SCI USA, V91, P9004, DOI 10.1073/pnas.91.19.9004; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2000.1391; Ferro F, 2010, TISSUE ENG PT A, V16, P3657, DOI 10.1089/ten.TEA.2009.0750; Ferro F, 2011, AM J PATHOL, V178, P2299, DOI 10.1016/j.ajpath.2011.01.055; Gallagher MF, 2009, J OVARIAN RES, V16, P2; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gonzalez R, 2007, BIOCHEM BIOPH RES CO, V362, P491, DOI 10.1016/j.bbrc.2007.08.033; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hu B, 2005, ARCH ORAL BIOL, V50, P131, DOI 10.1016/j.archoralbio.2004.09.007; Huang AHC, 2008, J ORAL PATHOL MED, V37, P571, DOI 10.1111/j.1600-0714.2008.00654.x; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Leor J, 1996, CIRCULATION, V94, P332; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Matoba R, 2006, PLOS ONE, V20, P1; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400; Panasyuk G, 2006, J BIOL CHEM, V281, P31188, DOI 10.1074/jbc.M602618200; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; PRUITT SC, 1994, DEVELOPMENT, V120, P37; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Scaggiante B, 1998, EUR J BIOCHEM, V252, P207, DOI 10.1046/j.1432-1327.1998.2520207.x; Sengupta R, 2009, FEBS LETT, V583, P3525, DOI 10.1016/j.febslet.2009.10.016; Seybold J, 2005, BLOOD, V105, P3569, DOI 10.1182/blood-2004-07-2729; Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3; Soen Y, 2005, MOL SYST BIOL, V2, P1; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Tweddle DA, 2001, CANCER RES, V61, P8; von Knethen A, 2010, J CELL SCI, V123, P192, DOI 10.1242/jcs.055475; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wernig M, 2007, CELL STEM CELL, V2, P2; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young HE, 2004, CELL BIOCHEM BIOPHYS, V40, P1, DOI 10.1385/CBB:40:1:1; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	67	38	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41774	10.1371/journal.pone.0041774	http://dx.doi.org/10.1371/journal.pone.0041774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844522	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700149
J	Gueroult, M; Boittin, O; Mauffret, O; Etchebest, C; Hartmann, B				Gueroult, Marc; Boittin, Olivier; Mauffret, Oliver; Etchebest, Catherine; Hartmann, Brigitte			Mg2+ in the Major Groove Modulates B-DNA Structure and Dynamics	PLOS ONE			English	Article							T-C-G; METAL-ION BINDING; MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; CRYSTAL-STRUCTURES; ATOMIC-RESOLUTION; CATION INTERACTIONS; NUCLEOSOME CORE; MINOR GROOVES; FORCE-FIELD	This study investigates the effect of Mg2+ bound to the DNA major groove on DNA structure and dynamics. The analysis of a comprehensive dataset of B-DNA crystallographic structures shows that divalent cations are preferentially located in the DNA major groove where they interact with successive bases of (A/G)pG and the phosphate group of 5'-CpA or TpG. Based on this knowledge, molecular dynamics simulations were carried out on a DNA oligomer without or with Mg2+ close to an ApG step. These simulations showed that the hydrated Mg2+ forms a stable intra-strand cross-link between the two purines in solution. ApG generates an electrostatic potential in the major groove that is particularly attractive for cations; its intrinsic conformation is well-adapted to the formation of water-mediated hydrogen bonds with Mg2+. The binding of Mg2+ modulates the behavior of the 5'-neighboring step by increasing the BII (epsilon-zeta > 0 degrees) population of its phosphate group. Additional electrostatic interactions between the 5'-phosphate group and Mg2+ strengthen both the DNA-cation binding and the BII character of the 5'-step. Cation binding in the major groove may therefore locally influence the DNA conformational landscape, suggesting a possible avenue for better understanding how strong DNA distortions can be stabilized in protein-DNA complexes.	[Gueroult, Marc; Boittin, Olivier; Etchebest, Catherine; Hartmann, Brigitte] Univ Paris Diderot, INSERM, Inst Natl Transfus Sanguine, UMR 665, Paris, France; [Gueroult, Marc] CNRS, Inst Biol Phys Chim, Lab Biochim Theor, UPR 9080, Paris, France; [Mauffret, Oliver; Hartmann, Brigitte] CNRS ENS Cachan, Lab Biol & Pharmacol Appl, UMR 8113, Cachan, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Gueroult, M (corresponding author), Univ Paris Diderot, INSERM, Inst Natl Transfus Sanguine, UMR 665, Paris, France.	bhartman@ens-cachan.fr	etchebest, catherine/O-2485-2019	etchebest, catherine/0000-0002-5871-2372; Gueroult, Marc/0000-0003-1036-7490	Institut National de la Transfusion Sanguine, 6 rue Alexandre Cabanel, Paris, France	Institut National de la Transfusion Sanguine, 6 rue Alexandre Cabanel, Paris, France	Funding was provided by the Institut National de la Transfusion Sanguine, 6 rue Alexandre Cabanel, 75015 Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Ghanem J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1061; Abrescia NGA, 1999, NUCLEIC ACIDS RES, V27, P1593, DOI 10.1093/nar/27.7.1593; Ahmad R, 2003, BIOPHYS J, V84, P2460, DOI 10.1016/S0006-3495(03)75050-4; Auffinger P, 2000, J MOL BIOL, V300, P1113, DOI 10.1006/jmbi.2000.3894; Auffinger P, 2011, METAL IONS LIFE SCI, V9, P1, DOI 10.1039/978184973251200001; Bai Y, 2007, J AM CHEM SOC, V129, P14981, DOI 10.1021/ja075020g; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRUKNER I, 1994, J MOL BIOL, V236, P26, DOI 10.1006/jmbi.1994.1115; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chiu TK, 2000, J MOL BIOL, V301, P915, DOI 10.1006/jmbi.2000.4012; Chiu TK, 1999, J MOL BIOL, V292, P589, DOI 10.1006/jmbi.1999.3075; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; Djuranovic D, 2004, BIOPOLYMERS, V73, P356, DOI 10.1002/bip.10528; Djuranovic D, 2003, J BIOMOL STRUCT DYN, V20, P771, DOI 10.1080/07391102.2003.10506894; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Egli M, 2002, CHEM BIOL, V9, P277, DOI 10.1016/S1074-5521(02)00116-3; Froystein N, 1993, ACTA CHEM SCAND, V47, P49; FROYSTEIN NA, 1991, ACTA CHEM SCAND, V45, P219, DOI 10.3891/acta.chem.scand.45-0219; GRZESKOWIAK K, 1991, J BIOL CHEM, V266, P8861; GRZESKOWIAK K, 1993, BIOCHEMISTRY-US, V32, P8923, DOI 10.1021/bi00085a025; Han WH, 1997, P NATL ACAD SCI USA, V94, P10565, DOI 10.1073/pnas.94.20.10565; HARTMANN B, 1993, NUCLEIC ACIDS RES, V21, P561, DOI 10.1093/nar/21.3.561; Heddi B, 2008, J MOL BIOL, V382, P956, DOI 10.1016/j.jmb.2008.07.047; Heddi B, 2007, J MOL BIOL, V368, P1403, DOI 10.1016/j.jmb.2007.03.010; Heddi B, 2006, J AM CHEM SOC, V128, P9170, DOI 10.1021/ja061686j; Heddi B, 2010, NUCLEIC ACIDS RES, V38, P1034, DOI 10.1093/nar/gkp962; Hud NV, 1999, J MOL BIOL, V285, P233, DOI 10.1006/jmbi.1998.2327; Hud NV, 1999, J MOL BIOL, V286, P651, DOI 10.1006/jmbi.1998.2513; Hud NV, 2001, CURR OPIN STRUC BIOL, V11, P293, DOI 10.1016/S0959-440X(00)00205-0; Jerkovic B, 2001, BIOCHEMISTRY-US, V40, P9406, DOI 10.1021/bi010853j; Joli F, 2006, NUCLEIC ACIDS RES, V34, P5740, DOI 10.1093/nar/gkl617; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kielkopf CL, 2000, J MOL BIOL, V296, P787, DOI 10.1006/jmbi.1999.3478; Lankas F, 2010, NUCLEIC ACIDS RES, V38, P3414, DOI 10.1093/nar/gkq001; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Liu J, 1999, J BIOL CHEM, V274, P24749, DOI 10.1074/jbc.274.35.24749; Mack DR, 2001, J MOL BIOL, V312, P1037, DOI 10.1006/jmbi.2001.4994; Millonig H, 2009, J INORG BIOCHEM, V103, P876, DOI 10.1016/j.jinorgbio.2009.03.004; Minasov G, 1999, J MOL BIOL, V291, P83, DOI 10.1006/jmbi.1999.2934; Moldrheim E, 1998, INORG CHIM ACTA, V273, P41, DOI 10.1016/S0020-1693(97)06010-6; Oguey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015931; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Ponomarev SY, 2004, P NATL ACAD SCI USA, V101, P14771, DOI 10.1073/pnas.0406435101; PULLMAN A, 1981, Q REV BIOPHYS, V14, P289, DOI 10.1017/S0033583500002341; QUINTANA JR, 1992, J MOL BIOL, V225, P379, DOI 10.1016/0022-2836(92)90928-D; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Soler-Lopez M, 2000, J BIOL CHEM, V275, P23034, DOI 10.1074/jbc.M002119200; Srinivasan A R, 2009, Biophys Rev, V1, P13, DOI 10.1007/s12551-008-0003-2; STEINKOPF S, 1994, ACTA CHEM SCAND, V48, P388, DOI 10.3891/acta.chem.scand.48-0388; Subirana JA, 2003, ANNU REV BIOPH BIOM, V32, P27, DOI 10.1146/annurev.biophys.32.110601.141726; Tereshko V, 1999, J AM CHEM SOC, V121, P470, DOI 10.1021/ja9832919; van Dam L, 2000, J MOL BIOL, V304, P541, DOI 10.1006/jmbi.2000.4194; Varnai P, 2004, NUCLEIC ACIDS RES, V32, P4269, DOI 10.1093/nar/gkh765; Varnai P, 2010, NUCLEIC ACIDS RES, V38, P4163, DOI 10.1093/nar/gkq150; Winger RH, 1999, J BIOMOL STRUCT DYN, V17, P223, DOI 10.1080/07391102.1999.10508355; Wu B, 2010, J MOL BIOL, V398, P633, DOI 10.1016/j.jmb.2010.03.038; Young MA, 1998, J MOL BIOL, V281, P675, DOI 10.1006/jmbi.1998.1962	62	30	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41704	10.1371/journal.pone.0041704	http://dx.doi.org/10.1371/journal.pone.0041704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844516	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700142
J	Shimizu, K; Kawakami, S; Hayashi, K; Kinoshita, H; Kuwahara, K; Nakao, K; Hashida, M; Konishi, S				Shimizu, Kazunori; Kawakami, Shigeru; Hayashi, Kouji; Kinoshita, Hideyuki; Kuwahara, Koichiro; Nakao, Kazuwa; Hashida, Mitsuru; Konishi, Satoshi			In vivo Site-Specific Transfection of Naked Plasmid DNA and siRNAs in Mice by Using a Tissue Suction Device	PLOS ONE			English	Article							PRESSURE-MEDIATED TRANSFECTION; GENE DELIVERY; LIVER; INJECTION; EXPRESSION; THERAPY; PIG	We have developed an in vivo transfection method for naked plasmid DNA (pDNA) and siRNA in mice by using a tissue suction device. The target tissue was suctioned by a device made of polydimethylsiloxane (PDMS) following the intravenous injection of naked pDNA or siRNA. Transfection of pDNA encoding luciferase was achieved by the suction of the kidney, liver, spleen, and heart, but not the duodenum, skeletal muscle, or stomach. Luciferase expression was specifically observed at the suctioned region of the tissue, and the highest luciferase expression was detected at the surface of the tissue (0.12 +/- 0.03 ng/mg protein in mice liver). Luciferase expression levels in the whole liver increased linearly with an increase in the number of times the liver was suctioned. Transfection of siRNA targeting glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene significantly suppressed the expression of GAPDH mRNA in the liver. Histological analysis shows that severe damage was not observed in the suctioned livers. Since the suction device can be mounted onto the head of the endoscope, this method is a minimally invasive. These results indicate that the in vivo transfection method developed in this study will be a viable approach for biological research and therapies using nucleic acids.	[Shimizu, Kazunori; Hashida, Mitsuru; Konishi, Satoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Inst Innovat NanoBio Drug Discovery & Dev, Kyoto, Japan; [Shimizu, Kazunori; Konishi, Satoshi] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Kusatsu, Shiga, Japan; [Kawakami, Shigeru; Hayashi, Kouji; Hashida, Mitsuru] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Kyoto, Japan; [Kinoshita, Hideyuki; Kuwahara, Koichiro; Nakao, Kazuwa] Kyoto Univ Grad, Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Hashida, Mitsuru] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Konishi, Satoshi] Ritsumeikan Univ, Dept Micro Syst Technol, Kusatsu, Shiga, Japan	Kyoto University; Ritsumeikan University; Kyoto University; Kyoto University; Kyoto University; Ritsumeikan University	Shimizu, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Inst Innovat NanoBio Drug Discovery & Dev, Kyoto, Japan.	kshimizu@pharm.kyoto-u.ac.jp; konishi@se.ritsumei.ac.jp	Kuwahara, Koichiro/AFK-1723-2022; Shimizu, Kazunori/B-7553-2008; Kawakami, Shigeru/R-1460-2019	Kuwahara, Koichiro/0000-0003-2670-7170; Shimizu, Kazunori/0000-0002-9713-7016; hashida, mitsuru/0000-0001-7383-8080	Japan Science and Technology Agency [AS221Z01400F]; Showa Hokokai Foundation; Ritsumeikan University; Grants-in-Aid for Scientific Research [24591095, 21229013] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Showa Hokokai Foundation; Ritsumeikan University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (AS221Z01400F), Ritsumeikan Global Innovation Research Organisation project in Ritsumeikan University, and Showa Hokokai Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alino SF, 2010, J GENE MED, V12, P920, DOI 10.1002/jgm.1510; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ayuni EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014467; Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Kawakami S, 2000, PHARMACEUT RES, V17, P306, DOI 10.1023/A:1007501122611; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim A, 2004, BIOMATERIALS, V25, P305, DOI 10.1016/S0142-9612(03)00534-9; Kwon SM, 2008, J CONTROL RELEASE, V128, P89, DOI 10.1016/j.jconrel.2008.02.004; Lin CM, 2012, ARCH DERMATOL RES, V304, P139, DOI 10.1007/s00403-011-1181-5; Liu F, 2004, MOL THER, V9, P452, DOI 10.1016/j.ymthe.2003.12.003; Liu F, 2002, HEPATOLOGY, V35, P1314, DOI 10.1053/jhep.2002.33467; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Marshall WG, 2010, GENE THER, V17, P419, DOI 10.1038/gt.2009.153; Miao CH, 2001, MOL THER, V3, P947, DOI 10.1006/mthe.2001.0333; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; Mukai H, 2008, BIOCHEM BIOPH RES CO, V372, P383, DOI 10.1016/j.bbrc.2008.04.097; Mukai H, 2010, BIOL PHARM BULL, V33, P1627, DOI 10.1248/bpb.33.1627; Mukai H, 2009, HUM GENE THER, V20, P1157, DOI 10.1089/hum.2008.213; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Rastogi S, 2011, AM J PHYSIOL-HEART C, V300, pH1501, DOI 10.1152/ajpheart.00636.2010; Shimizu K, 2012, J CONTROL RELEASE, V159, P85, DOI 10.1016/j.jconrel.2011.12.033; Shimizu K, 2011, J BIOSCI BIOENG, V112, P508, DOI 10.1016/j.jbiosc.2011.07.015; Takemoto H, 2010, BIOMATERIALS, V31, P8097, DOI 10.1016/j.biomaterials.2010.07.015; Tani, 2009, J JAPAN SOC COMPUTER, V11, P59, DOI DOI 10.5759/JSCAS.11.59; Un K, 2010, HUM GENE THER, V21, P65, DOI 10.1089/hum.2009.106	27	20	20	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41319	10.1371/journal.pone.0041319	http://dx.doi.org/10.1371/journal.pone.0041319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844458	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700070
J	Wu, XY; Ellmann, S; Rubin, E; Gil, M; Jin, K; Han, LF; Chen, HX; Kwon, EM; Guo, JH; Ha, HC; Sukumar, S				Wu, Xinyan; Ellmann, Stephan; Rubin, Ethel; Gil, Minchan; Jin, Kideok; Han, Liangfeng; Chen, Hexin; Kwon, Erika M.; Guo, Jianhui; Ha, Hyo Chol; Sukumar, Saraswati			ADP Ribosylation by PARP-1 Suppresses HOXB7 Transcriptional Activity	PLOS ONE			English	Article							HOMEODOMAIN-CONTAINING PROTEIN; COOPERATIVE DNA-BINDING; POLY(ADP-RIBOSE) POLYMERASE; GENE-EXPRESSION; BREAST-CANCER; B-MYB; IDENTIFICATION; CELLS; COACTIVATOR; ACTIVATION	Interactions with cofactors regulate transcriptional activity and also help HOX proteins to achieve the specificity required for transcriptional regulation of target genes. In this study, we describe a novel protein/protein interaction of HOXB7 with poly (ADP-ribose) polymerase-1 (PARP-1) that involves the homeodomain of HOXB7 and the first zinc finger domain of PARP-1. Upon binding to PARP-1, HOXB7 undergoes poly(ADP-ribosyl)altion resulting in a reduction of its transcriptional activity. Since aspartic acid and glutamic acid residues are acceptors of the ADP ribose moiety transferred by PARP-1, deletion of the evolutionarily conserved C-terminal Glu-rich tail of HOXB7 dramatically attenuates ADP-ribosylation of HOXB7 by PARP-1. Further, a mutant of HOXB7 without the Glu-rich tail loses the ability to be negatively regulated by PARP-1 and becomes transcriptionally more active in luciferase reporter assays. Since the homeodomain is highly conserved among HOX proteins, five other HOX proteins were tested. All six showed interaction with, and were poly(ADP-ribosyl)ated by PARP-1. However, among them, this modification altered the DNA binding activity of only HOXA7 and HOXB7. In summary, this study identifies a new interacting partner of HOX proteins. More importantly, this study reveals a novel mechanism whereby polyADP-ribosylation regulates transcriptional activities of HOX proteins such as HOXB7 and HOXA7.	[Wu, Xinyan; Ellmann, Stephan; Rubin, Ethel; Jin, Kideok; Han, Liangfeng; Chen, Hexin; Kwon, Erika M.; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Gil, Minchan; Guo, Jianhui; Ha, Hyo Chol] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA	Johns Hopkins University; Georgetown University	Wu, XY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	xinyan@jhmi.edu; saras@jhmi.edu	Gil, Minchan/R-1280-2019; chen, hexin/F-1714-2011; Guo, Jianhui/AAJ-6220-2020; Ellmann, Stephan/P-3824-2016	Ellmann, Stephan/0000-0003-2737-5526	Breast Cancer SPORE: NIH [P50CA88843, DOD-COE W81XWH-04-1-0595]; NIH [AI64706, ES015210];  [DOD-DAMD-17-02-1-0429]; NATIONAL CANCER INSTITUTE [P50CA088843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015210] Funding Source: NIH RePORTER	Breast Cancer SPORE: NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for this work was provided by DOD-DAMD-17-02-1-0429 postdoctoral fellowship (X.W.), the Breast Cancer SPORE: NIH P50CA88843 and DOD-COE W81XWH-04-1-0595 (S.S.), NIH AI64706 and ES015210 (H.C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chariot A, 1999, ONCOGENE, V18, P4007, DOI 10.1038/sj.onc.1202776; Chariot A, 1999, J BIOL CHEM, V274, P5318, DOI 10.1074/jbc.274.9.5318; Chen HX, 2005, J BIOL CHEM, V280, P19373, DOI 10.1074/jbc.M413528200; Chen HX, 2003, CANCER BIOL THER, V2, P524, DOI 10.4161/cbt.2.5.525; Chen HX, 2004, MOL CELL BIOL, V24, P924, DOI 10.1128/MCB.24.2.924-935.2004; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Elser M, 2008, MOL CANCER RES, V6, P282, DOI 10.1158/1541-7786.MCR-07-0377; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Iwasaki M, 2005, BLOOD, V105, P784, DOI 10.1182/blood-2004-04-1508; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; Li XL, 2006, EXP CELL RES, V312, P854, DOI 10.1016/j.yexcr.2005.12.002; Li YM, 2006, MOL CELL ENDOCRINOL, V257-8, P35, DOI 10.1016/j.mce.2006.06.008; Lu QA, 1997, ONCOGENE, V14, P75, DOI 10.1038/sj.onc.1200799; LU QA, 1995, MOL CELL BIOL, V15, P3786; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Santilli G, 2001, ONCOGENE, V20, P8167, DOI 10.1038/sj.onc.1204943; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yaron Y, 2001, J IMMUNOL, V166, P5058, DOI 10.4049/jimmunol.166.8.5058; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200	45	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40644	10.1371/journal.pone.0040644	http://dx.doi.org/10.1371/journal.pone.0040644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844406	Green Published, gold			2022-12-25	WOS:000306687700015
J	Clawson, GA; Kimchi, E; Patrick, SD; Xin, P; Harouaka, R; Zheng, SY; Berg, A; Schell, T; Staveley-O'Carroll, KF; Neves, RI; Mosca, PJ; Thiboutot, D				Clawson, Gary A.; Kimchi, Eric; Patrick, Susan D.; Xin, Ping; Harouaka, Ramdane; Zheng, Siyang; Berg, Arthur; Schell, Todd; Staveley-O'Carroll, Kevin F.; Neves, Rogerio I.; Mosca, Paul J.; Thiboutot, Diane			Circulating Tumor Cells in Melanoma Patients	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; POLYMERASE CHAIN-REACTION; MESSENGER-RNA; MOLECULAR-DETECTION; MALIGNANT-MELANOMA; PROGNOSTIC VALUE; FUSION HYBRIDS; BREAST; EXPRESSION; MARKER	Circulating tumor cells (CTCs) are of recognized importance for diagnosis and prognosis of cancer patients. With melanoma, most studies do not show any clear relationship between CTC levels and stage of disease. Here, CTCs were enriched (similar to 400X) from blood of melanoma patients using a simple centrifugation device (OncoQuick), and 4 melanocyte target RNAs (TYR, MLANA, MITF, and MIF) were quantified using QPCR. Approximately one-third of melanoma patients had elevated MIF and MLANA transcripts (p<0.0001 and p<0.001, respectively) compared with healthy controls. In contrast, healthy controls had uniformly higher levels of TYR and MITF than melanoma patients (p<0.0001). There was a marked shift of leukocytes into the CTC-enriched fractions (a 430% increase in RNA recovery, p<0.001), and no relationship between CTC levels and stage of disease was found. CTCs were captured on microfabricated filters and cultured. Captured melanoma CTCs were large cells, and consisted of 2 subpopulations, based on immunoreactivity. One subpopulation (similar to 50%) stained for both pan-cytokeratin (KRT) markers and the common leukocyte marker CD-45, whereas the second subpopulation stained for only KRT. Since similar cells are described in many cancers, we also examined blood from colorectal and pancreatic cancer patients. We observed analogous results, with most captured CTCs staining for both CD-45/KRT markers (and for the monocyte differentiation marker CD-14). Our results suggest that immature melanocyte-related cells (expressing TYR and MITF RNA) may circulate in healthy controls, although they are not readily detectable without considerable enrichment. Further, as early-stage melanomas develop, immature melanocyte migration into the blood is somehow curtailed, whereas a significant proportion of patients develop elevated CTC levels (based on MIF and MLANA RNAs). The nature of the captured CTCs is consistent with literature describing leukocyte/macrophage-tumor cell fusion hybrids, and their role in metastatic progression.	[Clawson, Gary A.; Patrick, Susan D.; Xin, Ping] Penn State Univ, Gittlen Canc Res Fdn, Hershey, PA USA; [Clawson, Gary A.; Patrick, Susan D.; Xin, Ping] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA; [Clawson, Gary A.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Kimchi, Eric; Staveley-O'Carroll, Kevin F.] Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Hershey, PA 17033 USA; [Harouaka, Ramdane; Zheng, Siyang] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA; [Berg, Arthur] Penn State Univ, Milton S Hershey Med Ctr, Div Biostat, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Schell, Todd] Penn State Univ, Milton S Hershey Med Ctr, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Neves, Rogerio I.] Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Div Plast Surg, Hershey, PA 17033 USA; [Mosca, Paul J.] Duke Univ, Dept Surg, Durham, NC USA; [Thiboutot, Diane] Penn State Univ, Milton S Hershey Med Ctr, Dept Dermatol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Clawson, GA (corresponding author), Penn State Univ, Gittlen Canc Res Fdn, Hershey, PA USA.	Gac4@psu.edu	Zheng, Si-Yang/N-5826-2016; Zheng, sy/GRS-3136-2022; Neves, Rogerio Izar/AAV-5842-2020; Schell, Todd/AAC-7261-2021	Zheng, Si-Yang/0000-0002-0616-030X; Neves, Rogerio Izar/0000-0003-4866-5215; Berg, Arthur/0000-0002-4097-7348; Schell, Todd/0000-0002-6788-6518; Harouaka, Ramdane/0000-0002-1425-3960	National Institutes of Health/National Cancer Institute [CA137595]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R21CA137595] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded in part by National Institutes of Health/National Cancer Institute (www.nih.gov) grant CA137595 and with funds from the Pennsylvania Department of Health (www.health.state.pa.us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chakraborty AK, 2000, CANCER RES, V60, P2512; Chen N, 2009, MELANOMA RES, V19, P87, DOI 10.1097/CMR.0b013e3283252feb; Curry BJ, 1999, J CLIN ONCOL, V17, P2562, DOI 10.1200/JCO.1999.17.8.2562; Danila DC, 2011, CLIN CANCER RES, V17, P3903, DOI 10.1158/1078-0432.CCR-10-2650; De Giorgi V, 2010, J INVEST DERMATOL, V130, P2440, DOI 10.1038/jid.2010.141; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Erin N, 2009, INT J CANCER, V124, P1503, DOI 10.1002/ijc.24131; Fusi A, 2010, BR J DERMATOL; Garbe C, 2003, CANCER-AM CANCER SOC, V97, P1737, DOI 10.1002/cncr.11250; GATTER KC, 1985, J CLIN PATHOL, V38, P1353, DOI 10.1136/jcp.38.12.1353; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Ireland A, 2011, CLIN EXP METASTAS, V28, P327, DOI 10.1007/s10585-010-9368-2; Itakura E, 2011, AM J SURG PATHOL, V35, P1657, DOI 10.1097/PAS.0b013e3182322cf7; Kitago M, 2009, CLIN CHEM, V55, P757, DOI 10.1373/clinchem.2008.116467; Klingenstein A, 2011, MELANOMA RES, V21, P352, DOI 10.1097/CMR.0b013e328347105e; Kluk MJ, 2004, AM J DERMATOPATH, V26, P504, DOI 10.1097/00000372-200412000-00011; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Koyanagi K, 2005, J CLIN ONCOL, V23, P8057, DOI 10.1200/JCO.2005.02.0958; Lagoudianakis EE, 2009, J SURG RES, V155, P183, DOI 10.1016/j.jss.2007.10.013; Lee H, 2008, AM J CLIN PATHOL, V129, P772, DOI 10.1309/GFCLLRH8A68XKMJN; Lee J, 2010, AFR J BIOTECHNOL, V9, P5975; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Lu B, 2009, P 13 INT C MIN SYST, V13, P588; Lugini L, 2003, LAB INVEST, V83, P1555, DOI 10.1097/01.LAB.0000098425.03006.42; Mocellin S, 2004, INT J CANCER, V111, P741, DOI 10.1002/ijc.20347; Mocellin S, 2006, CLIN CANCER RES, V12, P4605, DOI 10.1158/1078-0432.CCR-06-0823; Obermayr E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-666; Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182; Pan WH, 2004, MOL THER, V9, P596, DOI 10.1016/j.ymthe.2003.12.013; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Pawelek JM, 2000, MELANOMA RES, V10, P507, DOI 10.1097/00008390-200012000-00001; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Pinzani P, 2011, CLIN CHIM ACTA, V412, P2141, DOI 10.1016/j.cca.2011.07.027; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rupani R, 2004, PIGM CELL RES, V17, P281, DOI 10.1111/j.1600-0749.2004.00148.x; Sable MS, 2011, INT J PROTEOMICS, V2011; Samija I, 2010, MELANOMA RES, V20, P293, DOI 10.1097/CMR.0b013e32833906b6; Sing T, 2009, ROCR VISUALIZING PER; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025224; Sioss JA, 2012, NANOMED-NANOTECHNOL, V8, P1017, DOI 10.1016/j.nano.2011.11.009; Sodi SA, 1998, PIGM CELL RES, V11, P299, DOI 10.1111/j.1600-0749.1998.tb00739.x; Steen S, 2008, P BAYL U MED CENT, V21, P127; Team R. D. C, 2011, R LANG ENV STAT COMP; Tsao H, 2001, ARCH DERMATOL, V137, P325; Xi L, 2007, CLIN CHEM, V53, P1206, DOI 10.1373/clinchem.2006.081828; Yang LY, 2009, BIOTECHNOL BIOENG, V102, P521, DOI 10.1002/bit.22066; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135; Yasasever V, 2007, CANCER INVEST, V25, P715, DOI 10.1080/07357900701560695	53	60	61	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41052	10.1371/journal.pone.0041052	http://dx.doi.org/10.1371/journal.pone.0041052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829910	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300048
J	Guo, LJ; Fu, YJ; Wang, YP; Lu, YH; Wei, YW; Tang, QH; Fan, PH; Liu, JB; Zhang, L; Zhang, FY; Huang, LP; Liu, D; Li, SB; Wu, HL; Liu, CM				Guo, Longjun; Fu, Yujie; Wang, Yiping; Lu, Yuehua; Wei, Yanwu; Tang, Qinghai; Fan, Peihu; Liu, Jianbo; Zhang, Long; Zhang, Feiyan; Huang, Liping; Liu, Dan; Li, Shengbin; Wu, Hongli; Liu, Changming			A Porcine Circovirus Type 2 (PCV2) Mutant with 234 Amino Acids in Capsid Protein Showed More Virulence In Vivo, Compared with Classical PCV2a/b Strain	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; WASTING SYNDROME PMWS; GENETIC-CHARACTERIZATION; LEUKOCYTE SUBPOPULATIONS; PERIPHERAL-BLOOD; INFECTION; GENOTYPES; PIGS; CONSTRUCTION; REPLICATION	Background: Porcine circovirus type 2 (PCV2) is considered to be the primary causative agent of postweaning multisystemic wasting syndrome (PMWS), which has become a serious economic problem for the swine industry worldwide. The major genotypes, PCV2a and PCV2b, are highly prevalent in the pig population and are present worldwide. However, another newly emerging PCV2b genotype mutant, which has a mutation in its ORF2-encoded capsid protein, has been sporadically present in China, as well as in other countries. It is therefore important to determine the relative virulence of the newly emerging PCV2b genotype mutant, compared with the existing PCV2a and PCV2b genotypes, and to investigate whether the newly emerging mutant virus induces more severe illness. Methodology/Principal Findings: Twenty healthy, 30-day-old, commercial piglets served as controls or were challenged with PCV2a, PCV2b and the newly emerging mutant virus. A series of indexes representing different parameters were adopted to evaluate virulence, including clinical signs, serological detection, viral load and distribution, changes in immune cell subsets in the peripheral blood, and evaluation of pathological lesions. The newly emerging PCV2 mutant demonstrated more severe signs compatible with PMWS, characterized by wasting, coughing, dyspnea, diarrhea, rough hair-coat and depression. Moreover, the pathological lesions and viremia, as well as the viral loads in lymph nodes, tonsils and spleen, were significantly more severe (P<0.05) for piglets challenged with the newly emerging mutant compared with those in the groups challenged with PCV2a and PCV2b. In addition, a significantly lower average daily weight gain (P<0.05) was recorded in the group challenged with the newly emerging PCV2 mutant than in the groups challenged with the prevailing PCV2a and PCV2b. Conclusions: This is believed to be the first report to confirm the enhanced virulence of the newly emerging PCV2 mutant in vivo.	[Guo, Longjun; Fu, Yujie; Wang, Yiping; Lu, Yuehua; Wei, Yanwu; Tang, Qinghai; Fan, Peihu; Liu, Jianbo; Zhang, Long; Zhang, Feiyan; Huang, Liping; Liu, Dan; Li, Shengbin; Wu, Hongli; Liu, Changming] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Swine Infect Dis, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Guo, LJ (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Swine Infect Dis, Harbin, Peoples R China.	lcm@hvri.ac.cn	Wang, Yiping/AAN-8548-2021	Wang, Yiping/0000-0002-3178-3752	National Science Foundation (China) [30871859]; State Key Laboratory of Veterinary Biotechnology (China) [NKLVBP200807]; Transformation Foundation Project of the Agricultural Scientific and Technological Achievements of China [2010GB23260563]	National Science Foundation (China)(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Biotechnology (China); Transformation Foundation Project of the Agricultural Scientific and Technological Achievements of China	This work was supported by grants from the National Science Foundation (China; 30871859) and the State Key Laboratory of Veterinary Biotechnology (China; NKLVBP200807), and the Transformation Foundation Project of the Agricultural Scientific and Technological Achievements of China (2010GB23260563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN GM, 1994, VET IMMUNOL IMMUNOP, V43, P357, DOI 10.1016/0165-2427(94)90157-0; Cheung AK, 2007, ARCH VIROL, V152, P1035, DOI 10.1007/s00705-006-0909-6; Choi KS, 2008, RES VET SCI, V84, P497, DOI 10.1016/j.rvsc.2007.05.017; Dupont K, 2008, VET MICROBIOL, V128, P56, DOI 10.1016/j.vetmic.2007.09.016; Fenaux M, 2004, J VIROL, V78, P13440, DOI 10.1128/JVI.78.24.13440-13446.2004; Fenaux M, 2003, J VIROL, V77, P11232, DOI 10.1128/JVI.77.20.11232-11243.2003; Finsterbusch T, 2009, VIRUS RES, V143, P177, DOI 10.1016/j.virusres.2009.02.009; Grau-Roma L, 2008, VET MICROBIOL, V128, P23, DOI 10.1016/j.vetmic.2007.09.007; Guo LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-291; Guo LJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-273; Harding JCS, 2010, VET MICROBIOL, V145, P209, DOI 10.1016/j.vetmic.2010.03.026; Harding JCS, 1997, SWINE HEALTH PROD, V5, P201; Huang LP, 2011, VIRUS RES, V161, P115, DOI 10.1016/j.virusres.2011.05.015; Jantafong T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-88; Knell S, 2005, VET MICROBIOL, V109, P169, DOI 10.1016/j.vetmic.2005.06.004; Kyriakis SC, 2002, J VET MED B, V49, P317, DOI 10.1046/j.1439-0450.2002.00574.x; Lager KM, 2007, VET REC, V161, P428, DOI 10.1136/vr.161.12.428; Li WL, 2010, VIRUS GENES, V40, P244, DOI 10.1007/s11262-009-0438-y; Liu CM, 2004, J VET MED SCI, V66, P237, DOI 10.1292/jvms.66.237; Lohse L, 2004, VIRAL IMMUNOL, V17, P594, DOI 10.1089/vim.2004.17.594; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Nielsen J, 2003, VET IMMUNOL IMMUNOP, V93, P135, DOI 10.1016/S0165-2427(03)00068-0; Nielsen J, 2003, VET IMMUNOL IMMUNOP, V92, P97, DOI 10.1016/S0165-2427(03)00031-X; Olvera A, 2007, VIROLOGY, V357, P175, DOI 10.1016/j.virol.2006.07.047; Opriessnig T, 2008, J GEN VIROL, V89, P2482, DOI 10.1099/vir.0.2008/001081-0; Opriessnig T, 2006, J GEN VIROL, V87, P2923, DOI 10.1099/vir.0.82099-0; Rosell C, 1999, J COMP PATHOL, V120, P59, DOI 10.1053/jcpa.1998.0258; Segales J, 2008, VET REC, V162, P867, DOI 10.1136/vr.162.26.867; Segales J, 2002, VET QUART, V24, P109, DOI 10.1080/01652176.2002.9695132; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; Shi KC, 2008, VET MICROBIOL, V129, P367, DOI 10.1016/j.vetmic.2007.11.020; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Todd D., 2005, VIRUS TAXONOMY, P327; Trible BR, 2012, VIRUS RES, V164, P68, DOI 10.1016/j.virusres.2011.11.018; Wang F, 2009, VIRUS RES, V145, P151, DOI 10.1016/j.virusres.2009.05.015; Wen LB, 2005, VET MICROBIOL, V110, P141, DOI 10.1016/j.vetmic.2005.07.003	38	86	96	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41463	10.1371/journal.pone.0041463	http://dx.doi.org/10.1371/journal.pone.0041463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829951	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300091
J	Lindhoud, S; van den Berg, WAM; van den Heuvel, RHH; Heck, AJR; van Mierlo, CPM; van Berkel, WJH				Lindhoud, Simon; van den Berg, Willy A. M.; van den Heuvel, Robert H. H.; Heck, Albert J. R.; van Mierlo, Carlo P. M.; van Berkel, Willem J. H.			Cofactor Binding Protects Flavodoxin against Oxidative Stress	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; PARA-HYDROXYBENZOATE HYDROXYLASE; CYSTEINE SULFINIC ACID; BETA PARALLEL PROTEIN; AZOTOBACTER-VINELANDII; SULFENIC ACID; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; ENZYME CATALYSIS; SULFONIC-ACID	In organisms, various protective mechanisms against oxidative damaging of proteins exist. Here, we show that cofactor binding is among these mechanisms, because flavin mononucleotide (FMN) protects Azotobacter vinelandii flavodoxin against hydrogen peroxide-induced oxidation. We identify an oxidation sensitive cysteine residue in a functionally important loop close to the cofactor, i.e., Cys69. Oxidative stress causes dimerization of apoflavodoxin (i.e., flavodoxin without cofactor), and leads to consecutive formation of sulfinate and sulfonate states of Cys69. Use of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-CI) reveals that Cys69 modification to a sulfenic acid is a transient intermediate during oxidation. Dithiothreitol converts sulfenic acid and disulfide into thiols, whereas the sulfinate and sulfonate forms of Cys69 are irreversible with respect to this reagent. A variable fraction of Cys69 in freshly isolated flavodoxin is in the sulfenic acid state, but neither oxidation to sulfinic and sulfonic acid nor formation of intermolecular disulfides is observed under oxidising conditions. Furthermore, flavodoxin does not react appreciably with NBD-Cl. Besides its primary role as redoxactive moiety, binding of flavin leads to considerably improved stability against protein unfolding and to strong protection against irreversible oxidation and other covalent thiol modifications. Thus, cofactors can protect proteins against oxidation and modification.	[Lindhoud, Simon; van den Berg, Willy A. M.; van Mierlo, Carlo P. M.; van Berkel, Willem J. H.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands; [van den Heuvel, Robert H. H.; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [van den Heuvel, Robert H. H.; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University	Lindhoud, S (corresponding author), Wageningen Univ, Biochem Lab, Wageningen, Netherlands.	willem.vanberkel@wur.nl	vanMierlo, Carlo p/B-4491-2016; van Berkel, Willem J.H./O-2431-2014; Heck, Albert/D-7098-2011	vanMierlo, Carlo p/0000-0002-5358-8392; van Berkel, Willem J.H./0000-0002-6551-2782; Heck, Albert/0000-0002-2405-4404	Netherlands Organisation for Scientific Research [700.56.002]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organisation for Scientific Research (http://www.nwo.nl), grant number: 700.56.002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; ALLISON WS, 1976, ACCOUNTS CHEM RES, V9, P293, DOI 10.1021/ar50104a003; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BANERJEE SK, 1992, ARCH BIOCHEM BIOPHYS, V295, P84, DOI 10.1016/0003-9861(92)90491-E; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENEMANN JR, 1969, P NATL ACAD SCI USA, V64, P1079, DOI 10.1073/pnas.64.3.1079; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200; Chang YC, 2010, PROTEOMICS, V10, P2961, DOI 10.1002/pmic.200900850; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Chiappetta G, 2010, METHOD ENZYMOL, V473, P199, DOI 10.1016/S0076-6879(10)73010-X; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Creighton TE, 1993, PROTEINS STUCTURES M; Davis DA, 2002, METHOD ENZYMOL, V348, P249, DOI 10.1016/S0076-6879(02)48643-0; De Luca A, 2010, P NATL ACAD SCI USA, V107, P18628, DOI 10.1073/pnas.1010171107; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; ESCHRICH K, 1990, FEBS LETT, V277, P197, DOI 10.1016/0014-5793(90)80843-8; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Hamann M, 2002, METHOD ENZYMOL, V348, P146, DOI 10.1016/S0076-6879(02)48634-X; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Hochgrafe F, 2005, MOL MICROBIOL, V58, P409, DOI 10.1111/j.1365-2958.2005.04845.x; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Leferink NGH, 2009, PLANT PHYSIOL, V150, P596, DOI 10.1104/pp.109.136929; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; LITTLE C, 1969, EUR J BIOCHEM, V10, P533, DOI 10.1111/j.1432-1033.1969.tb00721.x; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Nabuurs SM, 2009, J AM CHEM SOC, V131, P2739, DOI 10.1021/ja8089476; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Peelen S, 1996, J BIOMOL NMR, V7, P315; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Poole LB, 2002, METHOD ENZYMOL, V348, P122, DOI 10.1016/S0076-6879(02)48632-6; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Slavica A, 2005, APPL ENVIRON MICROB, V71, P8061, DOI 10.1128/AEM.71.12.8061-8068.2005; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Steensma E, 1998, PROTEIN SCI, V7, P306; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; TANAKA M, 1977, BIOCHEMISTRY-US, V16, P3525, DOI 10.1021/bi00635a005; van Mierlo CPM, 2000, J BIOTECHNOL, V79, P281, DOI 10.1016/S0168-1656(00)00244-3; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; VANBERKEL WJH, 1987, EUR J BIOCHEM, V167, P35; Wang Y, 2012, ANTIOXID REDOX SIGN, V16, P649, DOI 10.1089/ars.2011.4313; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wolfova J, 2009, BBA-PROTEINS PROTEOM, V1794, P1288, DOI 10.1016/j.bbapap.2009.08.001; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; YOCH DC, 1975, ARCH BIOCHEM BIOPHYS, V170, P326, DOI 10.1016/0003-9861(75)90124-1	56	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41363	10.1371/journal.pone.0041363	http://dx.doi.org/10.1371/journal.pone.0041363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829943	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300082
J	Grant, CL; Caromile, LA; Durrani, K; Rahman, MM; Claffey, KP; Fong, GH; Shapiro, LH				Grant, Christina L.; Caromile, Leslie A.; Durrani, Khayyam; Rahman, M. Mamunur; Claffey, Kevin P.; Fong, Guo-Hua; Shapiro, Linda H.			Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization	PLOS ONE			English	Article							GLUTAMATE-CARBOXYPEPTIDASE-II; FOCAL ADHESION KINASE; ENDOTHELIAL GROWTH-FACTOR; PATHOLOGICAL ANGIOGENESIS; INTRAVITREAL BEVACIZUMAB; MACULAR DEGENERATION; FOLATE HYDROLASE; CELL-ADHESION; RETINOPATHY; PREMATURITY	Background: Aberrant growth of blood vessels in the eye forms the basis of many incapacitating diseases and currently the majority of patients respond to anti-angiogenic therapies based on blocking the principal angiogenic growth factor, vascular endothelial growth factor (VEGF). While highly successful, new therapeutic targets are critical for the increasing number of individuals susceptible to retina-related pathologies in our increasingly aging population. Prostate specific membrane antigen (PSMA) is a cell surface peptidase that is absent on normal tissue vasculature but is highly expressed on the neovasculature of most solid tumors, where we have previously shown to regulate angiogenic endothelial cell invasion. Because pathologic angiogenic responses are often triggered by distinct signals, we sought to determine if PSMA also contributes to the pathologic angiogenesis provoked by hypoxia of the retina, which underlies many debilitating retinopathies. Methodology/Principal Findings: Using a mouse model of oxygen-induced retinopathy, we found that while developmental angiogenesis is normal in PSMA null mice, hypoxic challenge resulted in decreased retinal vascular pathology when compared to wild type mice as assessed by avascular area and numbers of vascular tufts/glomeruli. The vessels formed in the PSMA null mice were more organized and highly perfused, suggesting a more 'normal' phenotype. Importantly, the decrease in angiogenesis was not due to an impaired hypoxic response as levels of pro-angiogenic factors are comparable; indicating that PSMA regulation of angiogenesis is independent of VEGF. Furthermore, both systemic and intravitreal administration of a PSMA inhibitor in wild type mice undergoing OIR mimicked the PSMA null phenotype resulting in improved retinal vasculature. Conclusions/Significance: Our data indicate that PSMA plays a VEGF-independent role in retinal angiogenesis and that the lack of or inhibition of PSMA may represent a novel therapeutic strategy for treatment of angiogenesis-based ocular diseases.	[Grant, Christina L.; Caromile, Leslie A.; Durrani, Khayyam; Rahman, M. Mamunur; Claffey, Kevin P.; Fong, Guo-Hua; Shapiro, Linda H.] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT USA	University of Connecticut	Grant, CL (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT USA.	lshapiro@neuron.uchc.edu	Caromile, Leslie A/Q-2980-2016	Caromile, Leslie A/0000-0003-2193-5190	Prostate Cancer Foundation; Department of Defense Prostate Cancer Program [PC073976]	Prostate Cancer Foundation; Department of Defense Prostate Cancer Program(United States Department of Defense)	This work was supported by the Prostate Cancer Foundation and the Department of Defense Prostate Cancer Program #PC073976 to LHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2008, METHOD ENZYMOL, V444, P115, DOI 10.1016/S0076-6879(08)02806-1; Arsham Sheybani M, 2010, REV OPHTHAMOLOGY, V17, P52; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carter RE, 1996, P NATL ACAD SCI USA, V93, P749, DOI 10.1073/pnas.93.2.749; Chang SS, 1999, CANCER RES, V59, P3192; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; da Silva RG, 2010, AM J PATHOL, V177, P1534, DOI 10.2353/ajpath.2010.100043; David E, 2009, OCULAR DIS MECH MANA, P536; Dhoot DS, 2012, EXPERT OPIN BIOL TH, V12, P371, DOI 10.1517/14712598.2012.660523; Duncan GS, 1999, J IMMUNOL, V162, P3022; Ellsbury DL, 2010, CLIN PERINATOL, V37, P203, DOI 10.1016/j.clp.2010.01.012; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Fuxe J, 2011, AM J PATHOL, V178, P2897, DOI 10.1016/j.ajpath.2011.02.008; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heston WDW, 1997, UROLOGY, V49, P104, DOI 10.1016/S0090-4295(97)00177-5; Hussain N, 2008, EXPERT REV OPHTHALMO, V3, P43, DOI 10.1586/17469899.3.1.43; Hynes RO, 1999, TRENDS BIOCHEM SCI, V24, pM33, DOI 10.1016/S0968-0004(99)01479-6; ISRAELI RS, 1993, CANCER RES, V53, P227; Jefferies AL, 2010, PAED CHILD HEALT-CAN, V15, P667, DOI 10.1093/pch/15.10.667; Kahook MY, 2009, OPHTHAL SURG LAS IM, V40, P293, DOI 10.3928/15428877-20090430-12; Kamisasanuki T, 2011, BIOCHEM BIOPH RES CO, V413, P128, DOI 10.1016/j.bbrc.2011.08.068; Kornberg LJ, 2004, INVEST OPHTH VIS SCI, V45, P4463, DOI 10.1167/iovs.03-1201; Lapidus RG, 2000, PROSTATE, V45, P350, DOI 10.1002/1097-0045(20001201)45:4<350::AID-PROS10>3.0.CO;2-U; Liu H, 1997, CANCER RES, V57, P3629; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Murphy GP, 1998, CANCER-AM CANCER SOC, V83, P2259, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2259::AID-CNCR5>3.0.CO;2-T; Nguyen QD, OPHTHALMOLOGY; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rizzo MT, 2004, CARDIOVASC RES, V64, P377, DOI 10.1016/j.cardiores.2004.09.011; Rojas C, 2002, ANAL BIOCHEM, V310, P50, DOI 10.1016/S0003-2697(02)00286-5; Rojas C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-27; Sabet-Peyman EJ, 2009, OPHTHAL SURG LAS IM, V40, P316, DOI 10.3928/15428877-20090430-17; SAHAGUN G, 1989, AM J PATHOL, V134, P1227; Sivakumar B, 2004, JAMA-J AM MED ASSOC, V292, P972, DOI 10.1001/jama.292.8.972; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stupack DG, 2003, ONCOGENE, V22, P9022, DOI 10.1038/sj.onc.1207110; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; van der Post JP, 2005, BRIT J CLIN PHARMACO, V60, P128, DOI 10.1111/j.1365-2125.2005.02396.x; Wilkinson-Berka JL, 2006, INVEST OPHTH VIS SCI, V47, P1600, DOI 10.1167/iovs.05-1314; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903	51	25	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41285	10.1371/journal.pone.0041285	http://dx.doi.org/10.1371/journal.pone.0041285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815987	gold, Green Submitted, Green Published			2022-12-25	WOS:000306548900106
J	Hu, ZQ; Wang, ZQ; Xu, SZ				Hu, Zhiqiu; Wang, Zhiquan; Xu, Shizhong			An Infinitesimal Model for Quantitative Trait Genomic Value Prediction	PLOS ONE			English	Article							FEED-EFFICIENCY; SELECTION; LOCI; GROWTH; POLYMORPHISM; ASSOCIATION; SHRINKAGE; FRAMEWORK; BEHAVIOR; GENE	We developed a marker based infinitesimal model for quantitative trait analysis. In contrast to the classical infinitesimal model, we now have new information about the segregation of every individual locus of the entire genome. Under this new model, we propose that the genetic effect of an individual locus is a function of the genome location (a continuous quantity). The overall genetic value of an individual is the weighted integral of the genetic effect function along the genome. Numerical integration is performed to find the integral, which requires partitioning the entire genome into a finite number of bins. Each bin may contain many markers. The integral is approximated by the weighted sum of all the bin effects. We now turn the problem of marker analysis into bin analysis so that the model dimension has decreased from a virtual infinity to a finite number of bins. This new approach can efficiently handle virtually unlimited number of markers without marker selection. The marker based infinitesimal model requires high linkage disequilibrium of all markers within a bin. For populations with low or no linkage disequilibrium, we develop an adaptive infinitesimal model. Both the original and the adaptive models are tested using simulated data as well as beef cattle data. The simulated data analysis shows that there is always an optimal number of bins at which the predictability of the bin model is much greater than the original marker analysis. Result of the beef cattle data analysis indicates that the bin model can increase the predictability from 10% (multiple marker analysis) to 33% (multiple bin analysis). The marker based infinitesimal model paves a way towards the solution of genetic mapping and genomic selection using the whole genome sequence data.	[Hu, Zhiqiu; Xu, Shizhong] Univ Calif Reverside, Dept Bot & Plant Sci, Reverside, CA USA; [Wang, Zhiquan] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta	Hu, ZQ (corresponding author), Univ Calif Reverside, Dept Bot & Plant Sci, Reverside, CA USA.	Shizhong.Xu@ucr.edu		Hu, Zhiqiu/0000-0001-5600-4236	United States Department of Agriculture National Institute of Food and Agriculture Grant [2007-02784]; Alberta Ingenuity Bio Solution Grant [RES0008133]; Alberta Livestock and Meat Agency/Alberta Agricultural Research Institute Grant [G550000127]	United States Department of Agriculture National Institute of Food and Agriculture Grant; Alberta Ingenuity Bio Solution Grant; Alberta Livestock and Meat Agency/Alberta Agricultural Research Institute Grant	The project was supported by the United States Department of Agriculture National Institute of Food and Agriculture Grant 2007-02784 to Dr. Xu, The Alberta Ingenuity Bio Solution Grant RES0008133 to Dr. Wang and The Alberta Livestock and Meat Agency/Alberta Agricultural Research Institute Grant G550000127 to Dr. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DM, 1971, TECHNOMETRICS, V13, P469, DOI 10.2307/1267161; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Axenovich TI, 1996, GENET EPIDEMIOL, V13, P271; Bayes M, 2012, MOLECULAR ANALYSIS AND GENOME DISCOVERY, 2ND EDITION, P1; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Che Xiaohong, 2010, Int J Plant Genomics, V2010, P893206, DOI 10.1155/2010/893206; Falconer D. S, 1996, INTRO QUANTITATIVE G; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; Jiang X, 2010, GENET EPIDEMIOL, V34, P575, DOI 10.1002/gepi.20514; Kao CH, 1999, GENETICS, V152, P1203; LANDER ES, 1989, GENETICS, V121, P185; Mather K, 1941, J GENET, V41, P159, DOI 10.1007/BF02983019; Meuwissen THE, 2001, GENETICS, V157, P1819; MORTON NE, 1974, AM J HUM GENET, V26, P489; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Nkrumah JD, 2007, J ANIM SCI, V85, P2382, DOI 10.2527/jas.2006-657; Nkrumah JD, 2004, CAN J ANIM SCI, V84, P211, DOI 10.4141/A03-033; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Satagopan JM, 1996, GENETICS, V144, P805; Sen S, 2001, GENETICS, V159, P371; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Sillanpaa MJ, 1998, GENETICS, V148, P1373; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wang H, 2005, GENETICS, V170, P465, DOI 10.1534/genetics.104.039354; Whittaker J, 2000, ANN HUM GENET, V63, P366; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Xu SZ, 2010, GENET RES, V92, P423, DOI 10.1017/S0016672310000583; Xu SZ, 2003, GENETICS, V163, P789; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yi NJ, 2004, GENETICS, V167, P967, DOI 10.1534/genetics.104.026286; ZENG ZB, 1994, GENETICS, V136, P1457	44	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41336	10.1371/journal.pone.0041336	http://dx.doi.org/10.1371/journal.pone.0041336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815992	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900110
J	Inacio, A; Pinho, J; Pereira, PM; Comai, L; Coelho, MM				Inacio, Angela; Pinho, Joana; Pereira, Patricia Matos; Comai, Luca; Coelho, Maria Manuela			Global Analysis of the Small RNA Transcriptome in Different Ploidies and Genomic Combinations of a Vertebrate Complex - The Squalius alburnoides	PLOS ONE			English	Article							GENE-EXPRESSION; DOSAGE COMPENSATION; HYBRIDIZATION; MICRORNAS; EVOLUTION; BIOGENESIS; SENECIO; MODES; SHOCK; FISH	The Squalius alburnoides complex (Steindachner) is one of the most intricate hybrid polyploid systems known in vertebrates. In this complex, the constant switch of the genome composition in consecutive generations, very frequently involving a change on the ploidy level, promotes repetitive situations of potential genomic shock. Previously in this complex, it was showed that in response to the increase in genome dosage, triploids hybrids could regulate gene expression to a diploid state. In this work we compared the small RNA profiles in the different genomic compositions interacting in the complex in order to explore the miRNA involvement in gene expression regulation of triploids. Using high-throughput arrays and sequencing technologies we were able to verify that diploid and triploid hybrids shared most of their sequences and their miRNA expression profiles were high correlated. However, an overall view indicates an up-regulation of several miRNAs in triploids and a global miRNA expression in triploids higher than the predicted from an additive model. Those results point to a participation of miRNAs in the cellular functional stability needed when the ploidy change.	[Inacio, Angela; Pinho, Joana; Coelho, Maria Manuela] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal; [Pereira, Patricia Matos] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Pereira, Patricia Matos] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Comai, Luca] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Comai, Luca] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Universidade de Lisboa; Universidade de Aveiro; Universidade de Aveiro; University of California System; University of California Davis; University of California System; University of California Davis	Inacio, A (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal.	mainacio@fc.ul.pt	Coelho, Maria M/B-8672-2009; Comai, Luca/F-4279-2010	Coelho, Maria M/0000-0003-3288-1693; Pereira, Patricia/0000-0002-4828-7632; Comai, Luca/0000-0003-2642-6619; Inacio, Angela/0000-0003-0396-6743	Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-BIC/110277/2009]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BIC/110277/2009] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by project PTDC/BIA-BIC/110277/2009 from Fundacao para a Ciencia e a Tecnologia-http://www.fct.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Crespo-Lopez ME, 2006, ZOOLOGY, V109, P277, DOI 10.1016/j.zool.2006.03.008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Guo M, 1996, GENETICS, V142, P1349; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; Ha M, 2008, BBA-GENE REGUL MECH, V1779, P735, DOI 10.1016/j.bbagrm.2008.03.004; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Hegarty MJ, 2005, MOL ECOL, V14, P2493, DOI 10.1111/j.1365-294X.2005.02608.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Inacio A, 2010, J FISH BIOL, V76, P1995, DOI 10.1111/j.1095-8649.2010.02637.x; Kenan-Eichler M, 2011, GENETICS, V188, P263, DOI 10.1534/genetics.111.128348; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Lu YL, 2010, BMB REP, V43, P635, DOI 10.3858/BMBRep.2010.43.9.635; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matos I, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-101; Pala I, 2008, CURR BIOL, V18, P1344, DOI 10.1016/j.cub.2008.07.096; Pala I, 2010, P ROY SOC B-BIOL SCI, V277, P3519, DOI 10.1098/rspb.2010.1071; Pala I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006401; Ribeiro F, 2003, ARCH HYDROBIOL, V156, P471, DOI 10.1127/0003-9136/2003/0156-0471; Ruber L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-38; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; Soares AR, 2012, TOXICOL SCI, V127, P18, DOI 10.1093/toxsci/kfs068; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711	34	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41158	10.1371/journal.pone.0041158	http://dx.doi.org/10.1371/journal.pone.0041158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815952	Green Published, gold, Green Submitted			2022-12-25	WOS:000306548900085
J	Lau, KS; Zhang, TH; Kendall, KR; Lauffenburger, D; Gray, NS; Haigis, KM				Lau, Ken S.; Zhang, Tinghu; Kendall, Krystle R.; Lauffenburger, Douglas; Gray, Nathanael S.; Haigis, Kevin M.			BAY61-3606 Affects the Viability of Colon Cancer Cells in a Genotype-Directed Manner	PLOS ONE			English	Article							SYNTHETIC LETHAL INTERACTION; GERMINAL CENTER KINASE; COLORECTAL-CANCER; K-RAS; MEDIATES RESISTANCE; AZD6244 ARRY-142886; PATHWAY ACTIVATION; RNA INTERFERENCE; IN-VIVO; INHIBITOR	Background: K-RAS mutation poses a particularly difficult problem for cancer therapy. Activating mutations in K-RAS are common in cancers of the lung, pancreas, and colon and are associated with poor response to therapy. As such, targeted therapies that abrogate K-RAS-induced oncogenicity would be of tremendous value. Methods: We searched for small molecule kinase inhibitors that preferentially affect the growth of colorectal cancer cells expressing mutant K-RAS. The mechanism of action of one inhibitor was explored using chemical and genetic approaches. Results: We identified BAY61-3606 as an inhibitor of proliferation in colorectal cancer cells expressing mutant forms of K-RAS, but not in isogenic cells expressing wild-type K-RAS. In addition to its anti-proliferative effects in mutant cells, BAY61-3606 exhibited a distinct biological property in wild-type cells in that it conferred sensitivity to inhibition of RAF. In this context, BAY61-3606 acted by inhibiting MAP4K2 (GCK), which normally activates NFkb signaling in wild-type cells in response to inhibition of RAF. As a result of MAP4K2 inhibition, wild-type cells became sensitive to AZ-628, a RAF inhibitor, when also treated with BAY61-3606. Conclusions: These studies indicate that BAY61-3606 exerts distinct biological activities in different genetic contexts.	[Lau, Ken S.; Kendall, Krystle R.; Haigis, Kevin M.] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA USA; [Lau, Ken S.; Kendall, Krystle R.; Haigis, Kevin M.] Massachusetts Gen Hosp, Ctr Syst Biol, Charlestown, MA USA; [Lau, Ken S.; Lauffenburger, Douglas] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lau, Ken S.; Lauffenburger, Douglas] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Zhang, Tinghu; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Lau, KS (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA USA.	khaigis@partners.org	Lau, Ken/I-7958-2019	Lau, Ken/0000-0001-8438-0319	National Cancer Institute [K01-CA118425, P30-CA006516]; American Cancer Society [MGO-114877]; Merlino Family Endowment Fund; NATIONAL CANCER INSTITUTE [P30CA006516, K01CA118425] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Merlino Family Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (K01-CA118425 and P30-CA006516) and the American Cancer Society (MGO-114877) and a donation from the Merlino Family Endowment Fund. KSL is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmanno K, 2009, INT J CANCER, V125, P2332, DOI 10.1002/ijc.24604; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Ivanov VN, 2000, ONCOGENE, V19, P933, DOI 10.1038/sj.onc.1203415; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lau KS, 2009, MOL CELLS; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Lyne PD, 2009, BIOORG MED CHEM LETT, V19, P1026, DOI 10.1016/j.bmcl.2008.10.053; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang YL, 2005, NEOPLASIA, V7, P336, DOI 10.1593/neo.04532; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zhao YC, 2010, J BIOL CHEM, V285, P25213, DOI 10.1074/jbc.M110.123067; Zhong J, 2009, P NATL ACAD SCI USA, V106, P4372, DOI 10.1073/pnas.0812642106	39	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41343	10.1371/journal.pone.0041343	http://dx.doi.org/10.1371/journal.pone.0041343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815993	Green Published, gold, Green Submitted			2022-12-25	WOS:000306548900111
J	Sleimen-Malkoun, R; Temprado, JJ; Huys, R; Jirsa, V; Berton, E				Sleimen-Malkoun, Rita; Temprado, Jean-Jacques; Huys, Raoul; Jirsa, Viktor; Berton, Eric			Is Fitts' Law Continuous in Discrete Aiming?	PLOS ONE			English	Article							INFORMATION CAPACITY; TARGET WIDTH; MOVEMENT; DYNAMICS; COORDINATION; TASK; PERFORMANCE; MODEL	The lawful continuous linear relation between movement time and task difficulty (i.e., index of difficulty; ID) in a goal-directed rapid aiming task (Fitts' law) has been recently challenged in reciprocal performance. Specifically, a discontinuity was observed at critical ID and was attributed to a transition between two distinct dynamic regimes that occurs with increasing difficulty. In the present paper, we show that such a discontinuity is also present in discrete aiming when ID is manipulated via target width (experiment 1) but not via target distance (experiment 2). Fitts' law's discontinuity appears, therefore, to be a suitable indicator of the underlying functional adaptations of the neuro-muscular-skeletal system to task properties/requirements, independently of reciprocal or discrete nature of the task. These findings open new perspectives to the study of dynamic regimes involved in discrete aiming and sensori-motor mechanisms underlying the speed-accuracy trade-off.	[Sleimen-Malkoun, Rita; Temprado, Jean-Jacques; Berton, Eric] CNRS, UMR 7287, Inst Sci Mouvement EJ Marey, Marseille, France; [Sleimen-Malkoun, Rita; Temprado, Jean-Jacques; Berton, Eric] Aix Marseille Univ, Marseille, France; [Huys, Raoul; Jirsa, Viktor] Fac Med La Timone, INSERM, UMR 1106, Inst Neurosci Syst, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Sleimen-Malkoun, R (corresponding author), CNRS, UMR 7287, Inst Sci Mouvement EJ Marey, Marseille, France.	rita.sleimen-malkoun@univ-amu.fr	Jirsa, Viktor/M-4630-2016	Jirsa, Viktor/0000-0002-8251-8860; Sleimen-Malkoun, Rita/0000-0002-3508-3403	Aix-Marseille Universite	Aix-Marseille Universite	Support for this study was provided through a funded Ph.D. fellowship from Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIZZI E, 1992, BEHAV BRAIN SCI, V15, P808; Bootsma RJ, 2004, INT J HUM-COMPUT ST, V61, P811, DOI 10.1016/j.ijhcs.2004.09.004; Buchanan JJ, 2004, NEUROSCI LETT, V367, P317, DOI 10.1016/j.neulet.2004.06.028; Buchanan JJ, 2006, EXP BRAIN RES, V175, P710, DOI 10.1007/s00221-006-0589-1; CROSSMAN ERFW, 1983, Q J EXP PSYCHOL-A, V35, P251, DOI 10.1080/14640748308402133; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Davis NJ, 2008, EXP BRAIN RES, V188, P141, DOI 10.1007/s00221-008-1379-8; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; Fernandez L, 2008, ACTA PSYCHOL, V129, P217, DOI 10.1016/j.actpsy.2008.06.001; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Friedrich R, 1997, PHYS REV LETT, V78, P863, DOI 10.1103/PhysRevLett.78.863; Friedrich R, 1997, PHYSICA D, V102, P147, DOI 10.1016/S0167-2789(96)00235-7; GUIARD Y, 1993, ACTA PSYCHOL, V82, P139, DOI 10.1016/0001-6918(93)90009-G; Guiard Y, 1997, HUM MOVEMENT SCI, V16, P97, DOI 10.1016/S0167-9457(96)00045-0; Hoffmann E, 1981, P 9 NAT C I IND ENG, P34; Huys R, 2010, P ROY SOC B-BIOL SCI, V277, P1179, DOI 10.1098/rspb.2009.1954; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Kistemaker DA, 2006, J NEUROPHYSIOL, V95, P2898, DOI 10.1152/jn.00983.2005; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; LANGOLF GD, 1976, J MOTOR BEHAV, V8, P113, DOI 10.1080/00222895.1976.10735061; MacKenzie I. S., 1992, Human-Computer Interaction, V7, P91, DOI 10.1207/s15327051hci0701_3; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Mottet D, 1999, BIOL CYBERN, V80, P235, DOI 10.1007/s004220050521; Mottet D, 2001, J EXP PSYCHOL HUMAN, V27, P1275, DOI 10.1037//0096-1523.27.6.1275; Perdikis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016589; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; SALTZMAN E, 1987, PSYCHOL REV, V94, P84, DOI 10.1037/0033-295X.94.1.84; SCHONER G, 1990, BIOL CYBERN, V63, P257, DOI 10.1007/BF00203449; Shannon C., 1964, MATH THEORY COMMUNIC; TEASDALE N, 1993, J MOTOR BEHAV, V25, P97, DOI 10.1080/00222895.1993.9941644; van Mourik AM, 2006, BIOL CYBERN, V94, P233, DOI 10.1007/s00422-005-0041-9; Welford A.T., 1968, FUNDAMENTALS SKILL; Woodworth RS, 1988, PSYCHOL REV, V3, P1; Zaal FTJM, 2005, J EXP PSYCHOL HUMAN, V31, P1266, DOI 10.1037/0096-1523.31.6.1266; Zaal FTJM, 1999, J EXP PSYCHOL HUMAN, V25, P149, DOI 10.1037/0096-1523.25.1.149; Zaal FTJM, 1998, EXP BRAIN RES, V119, P427, DOI 10.1007/s002210050358	41	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41190	10.1371/journal.pone.0041190	http://dx.doi.org/10.1371/journal.pone.0041190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815965	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900093
J	Yamaguchi, K; Shiozaki, K; Moriya, S; Koseki, K; Wada, T; Tateno, H; Sato, I; Asano, M; Iwakura, Y; Miyagi, T				Yamaguchi, Kazunori; Shiozaki, Kazuhiro; Moriya, Setsuko; Koseki, Koichi; Wada, Tadashi; Tateno, Hiroo; Sato, Ikuro; Asano, Masahide; Iwakura, Yoichiro; Miyagi, Taeko			Reduced Susceptibility to Colitis-Associated Colon Carcinogenesis in Mice Lacking Plasma Membrane-Associated Sialidase	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; NF-KAPPA-B; GANGLIOSIDE SIALIDASE; MOLECULAR-CLONING; CRUCIAL ROLE; EXPRESSION; CANCER; NEU3; CELLS; INFLAMMATION	Sialic acids are acidic monosaccharides that bind to the sugar chains of glycoconjugates and change their conformation, intermolecular interactions, and/or half-life. Thus, sialidases are believed to modulate the function of sialoglycoconjugates by desialylation. We previously reported that the membrane-associated mammalian sialidase NEU3, which preferentially acts on gangliosides, is involved in cell differentiation, motility, and tumorigenesis. The NEU3 gene expression is aberrantly elevated in several human cancers, including colon, renal, prostate, and ovarian cancers. The small interfering RNA-mediated knock-down of NEU3 in cancer cell lines, but not in normal cell-derived primary cultures, downregulates EGFR signaling and induces apoptosis. Here, to investigate the physiological role of NEU3 in tumorigenesis, we established Neu3-deficient mice and then subjected them to carcinogen-induced tumorigenesis, using a sporadic and a colitis-associated colon cancer models. The Neu3-deficient mice showed no conspicuous accumulation of gangliosides in the brain or colon mucosa, or overt abnormalities in their growth, development, behavior, or fertility. In dimethylhydrazine-induced colon carcinogenesis, there were no differences in the incidence or growth of tumors between the Neu3-deficient and wild-type mice. On the other hand, the Neu3-deficient mice were less susceptible than wild-type mice to the colitis-associated colon carcinogenesis induced by azoxymethane and dextran sodium sulfate. These results suggest that NEU3 plays an important role in inflammation-dependent tumor development.	[Yamaguchi, Kazunori; Koseki, Koichi] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi 9811293, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Marine Biochem Lab, Kagoshima 890, Japan; [Moriya, Setsuko; Miyagi, Taeko] Tohoku Pharmaceut Univ, Div Canc Glycosylat Res, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan; [Wada, Tadashi; Sato, Ikuro] Miyagi Canc Ctr, Res Inst, Div Pathol, Natori, Miyagi 9811293, Japan; [Tateno, Hiroo] Surg Pathol Japan Inc, Sendai, Miyagi, Japan; [Asano, Masahide] Kanazawa Univ, Div Transgen Anim Sci, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan	Miyagi Cancer Center; Kagoshima University; Tohoku Medical & Pharmaceutical University; Miyagi Cancer Center; Kanazawa University; University of Tokyo	Yamaguchi, K (corresponding author), Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, 47-1 Aza Nodayama, Natori, Miyagi 9811293, Japan.	kyamaguchi@med.tohoku.ac.jp	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Shiozaki, Kazuhiro/0000-0002-0523-838X	Ministry of Education, Culture, Sports, Science and Technology in Japan [21570122]	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp) #21570122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1962, CANCER RES, V22, P525; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Auger KR, 2000, BIOCHEM BIOPH RES CO, V272, P822, DOI 10.1006/bbrc.2000.2806; Aureli M, 2011, J NEUROCHEM, V116, P891, DOI 10.1111/j.1471-4159.2010.07019.x; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bird RP, 2000, TOXICOL LETT, V112, P395, DOI 10.1016/S0378-4274(99)00261-1; BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Finlay TM, 2010, GLYCOCONJUGATE J, V27, P583, DOI 10.1007/s10719-010-9302-5; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020859; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Hata K, 1998, J BIOCHEM-TOKYO, V123, P899; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Katoh S, 1999, J IMMUNOL, V162, P5058; Katoh S, 2010, CLIN EXP IMMUNOL, V161, P233, DOI 10.1111/j.1365-2249.2010.04165.x; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Matkowskyj KA, 1999, AM J PHYSIOL-GASTR L, V277, pG455, DOI 10.1152/ajpgi.1999.277.2.G455; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2007, COMPREHENSIVE GLYCOS, P297; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Nomura H, 2006, ONCOL RES, V16, P289, DOI 10.3727/000000006783981035; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Proshin S, 2002, NEUROCHEM RES, V27, P841, DOI 10.1023/A:1020269326825; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Schauer R, 1995, BIOL SIALIC ACIDS, DOI [10.1007/978-1-4757-9504-2, DOI 10.1007/978-1-4757-9504-2]; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; STEINMANN KE, 1991, P NATL ACAD SCI USA, V88, P6843, DOI 10.1073/pnas.88.15.6843; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; TUDEK B, 1989, CANCER RES, V49, P1236; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang P, 2004, BIOCHEM J, V380, P425, DOI 10.1042/BJ20031896; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Witz IP, 2008, ADV CANCER RES, V100, P203, DOI 10.1016/S0065-230X(08)00007-9; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531	61	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41132	10.1371/journal.pone.0041132	http://dx.doi.org/10.1371/journal.pone.0041132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815940	Green Submitted, gold, Green Published			2022-12-25	WOS:000306507000071
J	Yang, NW; Ji, LL; Lovei, GL; Wan, FH				Yang, Nian-Wan; Ji, Lu-Lu; Lovei, Gabor L.; Wan, Fang-Hao			Shifting Preference between Oviposition vs. Host-Feeding under Changing Host Densities in Two Aphelinid Parasitoids	PLOS ONE			English	Article							TABACI BIOTYPE-B; BEMISIA-TABACI; DIFFERENT INSTARS; HYMENOPTERA; BEHAVIOR; STRATEGIES; HOMOPTERA; SUITABILITY; EVOLUTION	Destructive host-feeding is common in hymenopteran parasitoids. Such feeding may be restricted to host stages not preferred for oviposition. However, whether this is a fixed strategy or can vary according to resource levels or parasitoid needs is less clear. We tested the trade-off between host feeding and oviposition on two whitefly parasitoids under varying host densities. Females of two aphelinid parasitoids, Eretmocerus hayati and Encarsia sophia were exposed to nine different densities of their whitefly host, Bemisia tabaci, in single-instar tests to identify their functional response. Mixed-instar host choice tests were also conducted by exposing whiteflies at four densities to the parasitoids. We hypothesized that the parasitoid females can detect different host densities, and decide on oviposition vs. host-feeding accordingly. The results showed that both Er. hayati and En. sophia females tended to increase both oviposition and host-feeding with increased host density within a certain range. Oviposition reached a plateau at lower host density than host-feeding in Er. hayati, while En. sophia reached its oviposition plateau at higher densities. At low densities, Er. hayati parasitized most on first and second (the optimal ones), and fed most on third nymphal instars (the suboptimal one) of the whitefly host as theory predicts, while at high densities, both parasitism and host-feeding occurred on first and second instars which are preferred for oviposition. En. sophia parasitized most on third and fourth (the optimal ones), while fed on first instars (the suboptimal one) at low densities, and utilized third and fourth instars for both at high densities. In conclusion, oviposition vs. host-feeding strategy of parasitoid females was found to vary at different host densities. The balance between reserving optimal hosts for oviposition or using them for host-feeding depended on parasitoid life history and the availability of host resources.	[Yang, Nian-Wan; Ji, Lu-Lu; Lovei, Gabor L.; Wan, Fang-Hao] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Lovei, Gabor L.] Aarhus Univ, Dept Agroecol, Flakkebjerg, Denmark	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Aarhus University	Yang, NW (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	wanfh@caas.net.cn	Yang, Nianwan/AAH-7371-2019; Lövei, Gabor L./B-7763-2008	Yang, Nianwan/0000-0002-6014-3383; Lövei, Gabor L./0000-0002-6467-9812	National Natural Science Foundation of China [30930062]; National Basic Research and Development Program of China [2009CB119200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China)	The research was financially supported by the National Natural Science Foundation of China (30930062) and the National Basic Research and Development Program of China (2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI B, 1990, ECOL ENTOMOL, V15, P9, DOI 10.1111/j.1365-2311.1990.tb00778.x; Burger JMS, 2004, OIKOS, V106, P117, DOI 10.1111/j.0030-1299.2004.12908.x; CHAN MS, 1993, EVOL ECOL, V7, P593, DOI 10.1007/BF01237823; COLLIER TR, 1995, ANN ENTOMOL SOC AM, V88, P206, DOI 10.1093/aesa/88.2.206; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Gerling D, 2004, ENTOMOL EXP APPL, V110, P87, DOI 10.1111/j.0013-8703.2004.00125.x; Gerling D, 2001, CROP PROT, V20, P779, DOI 10.1016/S0261-2194(01)00111-9; Giorgini M, 2004, BIOL CONTROL, V30, P25, DOI 10.1016/j.biocontrol.2003.09.013; Giron D, 2004, PHYSIOL ENTOMOL, V29, P436, DOI 10.1111/j.0307-6962.2004.00414.x; Heimpel GE, 1996, BIOL REV, V71, P373, DOI 10.1111/j.1469-185X.1996.tb01279.x; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; KIDD NAC, 1991, RES POPUL ECOL, V33, P87, DOI 10.1007/BF02514576; Lauziere I, 1999, ENTOMOL EXP APPL, V92, P21, DOI 10.1023/A:1003745606862; Le Lann C, 2011, FUNCT ECOL, V25, P641, DOI 10.1111/j.1365-2435.2010.01813.x; McAuslane HJ, 1996, ANN ENTOMOL SOC AM, V89, P686, DOI 10.1093/aesa/89.5.686; ROSENHEIM JA, 1992, ECOL ENTOMOL, V17, P263, DOI 10.1111/j.1365-2311.1992.tb01057.x; Tran TV, 2000, APPL ENTOMOL ZOOL, V35, P549, DOI 10.1303/aez.2000.549; Urbaneja A, 2004, BIOCONTROL, V49, P153, DOI 10.1023/B:BICO.0000017365.37010.e0; van Alphen JJM, 1976, B OILB SROP, V4, P165; Videllet P., 1997, IOBC-WPRS Bulletin, V20, P147; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Yang NW, 2011, BIOL CONTROL, V59, P313, DOI 10.1016/j.biocontrol.2011.07.019; Zang LS, 2008, ENTOMOL EXP APPL, V127, P55, DOI 10.1111/j.1570-7458.2008.00667.x; Zang LS, 2007, BIOL CONTROL, V41, P142, DOI 10.1016/j.biocontrol.2007.01.009; Zang LS, 2011, INSECT SCI, V18, P78, DOI 10.1111/j.1744-7917.2010.01382.x; Zang LS, 2009, BIOCONTROL SCI TECHN, V19, P573, DOI 10.1080/09583150902912673; Zolnerowich G, 1998, P ENTOMOL SOC WASH, V100, P310	28	24	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41189	10.1371/journal.pone.0041189	http://dx.doi.org/10.1371/journal.pone.0041189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815964	gold, Green Published			2022-12-25	WOS:000306507000077
J	Stampar, SN; Maronna, MM; Vermeij, MJA; Silveira, FLD; Morandini, AC				Stampar, Sergio N.; Maronna, Maximiliano M.; Vermeij, Mark J. A.; Silveira, Fabio L. D.; Morandini, Andre C.			Evolutionary Diversification of Banded Tube-Dwelling Anemones (Cnidaria; Ceriantharia; Isarachnanthus) in the Atlantic Ocean	PLOS ONE			English	Article							MOLECULAR EVIDENCE; SEQUENCE EVOLUTION; PHYLUM CNIDARIA; MITOCHONDRIAL; DISPERSAL; ANTHOZOA; MIOCENE; SPECIATION; PRIMERS; ISTHMUS	The use of molecular data for species delimitation in Anthozoa is still a very delicate issue. This is probably due to the low genetic variation found among the molecular markers (primarily mitochondrial) commonly used for Anthozoa. Ceriantharia is an anthozoan group that has not been tested for genetic divergence at the species level. Recently, all three Atlantic species described for the genus Isarachnanthus of Atlantic Ocean, were deemed synonyms based on morphological simmilarities of only one species: Isarachnanthus maderensis. Here, we aimed to verify whether genetic relationships (using COI, 16S, ITS1 and ITS2 molecular markers) confirmed morphological affinities among members of Isarachnanthus from different regions across the Atlantic Ocean. Results from four DNA markers were completely congruent and revealed that two different species exist in the Atlantic Ocean. The low identification success and substantial overlap between intra and interspecific COI distances render the Anthozoa unsuitable for DNA barcoding, which is not true for Ceriantharia. In addition, genetic divergence within and between Ceriantharia species is more similar to that found in Medusozoa (Hydrozoa and Scyphozoa) than Anthozoa and Porifera that have divergence rates similar to typical metazoans. The two genetic species could also be separated based on micromorphological characteristics of their cnidomes. Using a specimen of Isarachnanthus bandanensis from Pacific Ocean as an outgroup, it was possible to estimate the minimum date of divergence between the clades. The cladogenesis event that formed the species of the Atlantic Ocean is estimated to have occured around 8.5 million years ago (Miocene) and several possible speciation scenarios are discussed.	[Stampar, Sergio N.; Silveira, Fabio L. D.; Morandini, Andre C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Maronna, Maximiliano M.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Vermeij, Mark J. A.] Carmabi Fdn, Willemstad, Curacao, Netherlands; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Amsterdam	Stampar, SN (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	sergiostampar@gmail.com	Maronna, Maximiliano/AAY-6734-2020; Fapesp, Biota/F-8655-2017; Maronna, Maximiliano M/G-9432-2016; Stampar, Sergio N/K-2334-2012; Morandini, André Carrara/A-9892-2012; Stampar, Sergio N/AAC-2019-2020; Morandini, Andre Carrara/AAC-2320-2020; Vermeij, Mark/AAR-6757-2020; Stampar, Sergio N/C-3193-2014; Vermeij, Mark/B-2752-2013	Maronna, Maximiliano/0000-0002-2590-639X; Fapesp, Biota/0000-0002-9887-8449; Maronna, Maximiliano M/0000-0002-2590-639X; Stampar, Sergio N/0000-0002-9782-1619; Morandini, André Carrara/0000-0003-3747-8748; Stampar, Sergio N/0000-0002-9782-1619; Morandini, Andre Carrara/0000-0003-3747-8748; Vermeij, Mark/0000-0001-9612-9527; Stampar, Sergio N/0000-0002-9782-1619; Vermeij, Mark/0000-0001-9612-9527	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia (Instituto de Biociencias Universidade de Sao Paulo (IBUSP); FAPESP [2012/01771-8, 2006/56211-6]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50174-7]; CAPES PROEX	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia (Instituto de Biociencias Universidade de Sao Paulo (IBUSP); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES PROEX(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SNS was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia (Instituto de Biociencias Universidade de Sao Paulo (IBUSP) and FAPESP 2012/01771-8. Part of this work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2010/50174-7 and CAPES PROEX to ACM, and FAPESP 2006/56211-6 to MMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna FH, 2003, ZOOL ANZ, V242, P75, DOI 10.1078/0044-5231-00088; ARNAULT S, 1987, J GEOPHYS RES-OCEANS, V92, P5076, DOI 10.1029/JC092iC05p05076; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; Bird CE, 2012, EVOL BIOL, V39, P158, DOI 10.1007/s11692-012-9183-6; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Bruun P, 2005, PORT COASTAL ENG DEV; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Carlgren O., 1924, Videnskabelige Meddelelser Nat For Kjobenhavn, V75, P169; Carlgren O, 1912, DANISH INGOLF EXPEDI, V5, P1; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Claremont M, 2011, J BIOGEOGR, V38, P1016, DOI 10.1111/j.1365-2699.2011.02482.x; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins Allen G., 2011, Zootaxa, V2753, P53; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Coyne JA, 2004, SPECIATION, V37; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Daly M, 2010, INTEGR COMP BIOL, V50, P371, DOI 10.1093/icb/icq081; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; de Paula TS, 2012, MOL PHYLOGENET EVOL, V62, P529, DOI 10.1016/j.ympev.2011.11.001; den Hartog J.C., 1977, ZOOLOGISCHE MEDEDELI, V51, P211, DOI DOI 10.1016/B978-0-12-345320-4.50030-4; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dominguez J.M.L., 1983, REV BRASILEIRA GEOCI, V13, P98, DOI DOI 10.25249/0375-7536.198313298105; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2002, GENETICS, V161, P1307; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forster A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001349; Frey MA, 2010, J BIOGEOGR, V37, P1515, DOI 10.1111/j.1365-2699.2010.02283.x; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; GORDON ARNOLD L., 1966, DEEP SEA RES OCEANOGR ABSTR, V13, P1125, DOI 10.1016/0011-7471(66)90704-2; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; HEDGECOCK D, 1986, B MAR SCI, V39, P550; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; HODELL DA, 1986, NATURE, V320, P411, DOI 10.1038/320411a0; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lee KM, 2012, MARINE BIOL IN PRESS; Lunt DJ, 2008, CLIM DYNAM, V30, P1, DOI 10.1007/s00382-007-0265-6; Marshall LG, 1996, SCIENCE, V273, P123; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Molnar P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001574; Molodtsova T.N., 2003, Zoologische Verhandelingen (Leiden), V345, P249; Molodtsova TN, 2011, AFR NAT HIST, V7, P1; Nei M., 2000, MOL EVOLUTION PHYLOG; Nisancioglu KH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000767; Norris RD, 2011, EVOLUTIONAR IN PRESS; Perez LM, 2010, MALACOLOGIA, V53, P61, DOI 10.4002/040.053.0104; Reimer JD, 2010, CAH BIOL MAR, V51, P451; Reimer JD, 2004, ZOOL SCI, V21, P517, DOI 10.2108/zsj.21.517; RKP KIKUCHI, 2002, SITIOS GEOLOGICOS PA, V1, P379; Rodriguez CS, 2011, ZOOTAXA, P49, DOI 10.11646/zootaxa.2971.1.5; Shanks AL, 2009, BIOL BULL-US, V216, P373; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Soares MO, 2011, GEST COSTEIRA INTEG, V11, P149; Song JI, 1997, KOREAN J BIOL SCI, P43; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Beneden E, 1897, ERGEBNISSE PLANKTON, V2, P1; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wesselingh FP, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P421; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x	70	31	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41091	10.1371/journal.pone.0041091	http://dx.doi.org/10.1371/journal.pone.0041091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815928	Green Published, gold			2022-12-25	WOS:000306466100119
J	Li, Q; Yang, XH; Xu, F; Sharma, C; Wang, HX; Knoblich, K; Rabinovitz, I; Granter, SR; Hemler, ME				Li, Q.; Yang, X. H.; Xu, F.; Sharma, C.; Wang, H-X; Knoblich, K.; Rabinovitz, I.; Granter, S. R.; Hemler, M. E.			Tetraspanin CD151 plays a key role in skin squamous cell carcinoma	ONCOGENE			English	Article						tetraspanin CD151; skin squamous cell carcinoma; chemical carcinogenesis; integrin alpha 6 beta 4; STAT3; PKC alpha	TRANSMEMBRANE 4 SUPERFAMILY; KERATINOCYTE STEM-CELLS; ALPHA-6-BETA-4 INTEGRIN; BETA-4 INTEGRIN; MICE LACKING; MALIGNANT PROGRESSION; PROSTATE-CANCER; IN-VIVO; KINASE; STAT3	Here we provide the first evidence that tetraspanin CD151 can support de novo carcinogenesis. During two-stage mouse skin chemical carcinogenesis, CD151 reduces tumor lag time and increases incidence, multiplicity, size and progression to malignant squamous cell carcinoma (SCC), while supporting both cell survival during tumor initiation and cell proliferation during the promotion phase. In human skin SCC, CD151 expression is selectively elevated compared with other skin cancer types. CD151 support of keratinocyte survival and proliferation may depend on activation of transcription factor STAT3 (signal transducers and activators of transcription), a regulator of cell proliferation and apoptosis. CD151 also supports protein kinase C (PKC)alpha-alpha 6 beta 4 integrin association and PKC-dependent beta 4 S1424 phosphorylation, while regulating alpha 6 beta 4 distribution. CD151-PKC alpha effects on integrin beta 4 phosphorylation and subcellular localization are consistent with epithelial disruption to a less polarized, more invasive state. CD151 ablation, while minimally affecting normal cell and normal mouse functions, markedly sensitized mouse skin and epidermoid cells to chemicals/drugs including 7,12-dimethylbenz[alpha]anthracene (mutagen) and camptothecin (topoisomerase inhibitor), as well as to agents targeting epidermal growth factor receptor, PKC, Jak2/Tyk2 and STAT3. Hence, CD151 'co-targeting' may be therapeutically beneficial. These findings not only support CD151 as a potential tumor target, but also should apply to other cancers utilizing CD151/laminin-binding integrin complexes. Oncogene (2013) 32, 1772-1783; doi: 10.1038/onc.2012.205; published online 23 July 2012	[Li, Q.; Xu, F.; Sharma, C.; Wang, H-X; Knoblich, K.; Hemler, M. E.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Li, Q.; Xu, F.; Sharma, C.; Wang, H-X; Knoblich, K.; Rabinovitz, I.; Hemler, M. E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Yang, X. H.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA; [Rabinovitz, I.] Beth Israel Deaconess Med Ctr, Div Canc Biol & Angiogenesis, Dept Pathol, Boston, MA 02215 USA; [Granter, S. R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Kentucky; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hemler, ME (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Room D1430,44 Binney St, Boston, MA 02115 USA.	martin_hemler@dfci.harvard.edu	Knoblich, Konstantin/B-5980-2009; Li, Qinglin/K-2570-2015	Knoblich, Konstantin/0000-0002-5646-837X; Li, Qinglin/0000-0002-4125-1944	NIH [CA42368]; SG Komen Career Catalyst Award; NATIONAL CANCER INSTITUTE [R01CA042368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SG Komen Career Catalyst Award(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr R Bronson for assistance with mouse histopathology, Dr Julie Aldridge for assistance with statistical analyses, and Drs David Frank, Sarah Walker and coworkers for nifuroxazide, ST3-01, assistance with STAT3 functional assay and helpful discussions. This work was supported by NIH grant CA42368 (to MEH), and a SG Komen Career Catalyst Award (to XHY).	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Baldwin G, 2008, J BIOL CHEM, V283, P35445, DOI 10.1074/jbc.M806394200; Baleato RM, 2008, AM J PATHOL, V173, P927, DOI 10.2353/ajpath.2008.071149; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; Cowin AJ, 2006, J INVEST DERMATOL, V126, P680, DOI 10.1038/sj.jid.5700142; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; de Wit J, 2011, BLOOD, V118, P6107, DOI 10.1182/blood-2011-05-352682; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Dudley Andrew C, 2004, Cell Commun Signal, V2, P8, DOI 10.1186/1478-811X-2-8; Fitter S, 1999, BIOCHEM J, V338, P61, DOI 10.1042/0264-6021:3380061; Franco M, 2010, J BIOL CHEM, V285, P38756, DOI 10.1074/jbc.M110.145417; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hara T, 2005, CANCER RES, V65, P7356, DOI 10.1158/0008-5472.CAN-04-4241; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HENNINGS H, 1993, CARCINOGENESIS, V14, P2353, DOI 10.1093/carcin/14.11.2353; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Kangsamaksin T, 2007, MOL CARCINOGEN, V46, P579, DOI 10.1002/mc.20355; Kashyap T, 2011, LAB INVEST, V91, P1414, DOI 10.1038/labinvest.2011.104; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Madoux F., 2010, MODULATORS STAT TRAN; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Owens DM, 2001, CANCER RES, V61, P5248; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Romanska HM, 2011, J PATHOL, V223, P4, DOI 10.1002/path.2779; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Sattler M, 2003, CANCER RES, V63, P5462; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Sheng KC, 2009, EUR J IMMUNOL, V39, P50, DOI 10.1002/eji.200838798; Sincock PM, 1999, J CELL SCI, V112, P833; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Sterk LMT, 2002, J CELL SCI, V115, P1161; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Syed ZA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-180; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Takeda Y, 2011, BLOOD, V118, P464, DOI 10.1182/blood-2010-08-302240; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; TENNENBAUM T, 1993, CANCER RES, V53, P4803; Tokura Yoshiki, 2010, Journal of UOEH, V32, P317; Torrero MN, 2006, CLIN CANCER RES, V12, P257, DOI 10.1158/1078-0432.CCR-05-1514; Tran M, 2008, CANCER RES, V68, P2885, DOI 10.1158/0008-5472.CAN-07-6160; Voss MA, 2011, BRIT J CANCER, V104, P1611, DOI 10.1038/bjc.2011.80; Weinberg AS, 2007, DERMATOL SURG, V33, P885, DOI 10.1111/j.1524-4725.2007.33190.x; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XWH, 2012, J CELL SCI, V125, P1478, DOI 10.1242/jcs.093963; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	77	58	62	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2013	32	14					1772	1783		10.1038/onc.2012.205	http://dx.doi.org/10.1038/onc.2012.205			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22824799	Green Accepted, Green Submitted			2022-12-25	WOS:000317043900004
J	Waltereit, R; Leimer, U; Halbach, OVU; Panke, J; Holter, SM; Garrett, L; Wittig, K; Schneider, M; Schmitt, C; Calzada-Wack, J; Neff, F; Becker, L; Prehn, C; Kutscherjawy, S; Endris, V; Bacon, C; Fuchs, H; Gailus-Durner, V; Berger, S; Schonig, K; Adamski, J; Klopstock, T; Esposito, I; Wurst, W; de Angelis, MH; Rappold, G; Wieland, T; Bartsch, D				Waltereit, Robert; Leimer, Uwe; Halbach, Oliver von Bohlen Und; Panke, Jutta; Hoelter, Sabine M.; Garrett, Lillian; Wittig, Karola; Schneider, Miriam; Schmitt, Camie; Calzada-Wack, Julia; Neff, Frauke; Becker, Lore; Prehn, Cornelia; Kutscherjawy, Sergej; Endris, Volker; Bacon, Claire; Fuchs, Helmut; Gailus-Durner, Valerie; Berger, Stefan; Schoenig, Kai; Adamski, Jerzy; Klopstock, Thomas; Esposito, Irene; Wurst, Wolfgang; de Angelis, Martin Hrabe; Rappold, Gudrun; Wieland, Thomas; Bartsch, Dusan			Srgap3(-/-) mice present a neurodevelopmental disorder with schizophrenia-related intermediate phenotypes	FASEB JOURNAL			English	Article						intellectual disability; hydrocephalus; knockout mouse; RHO proteins; polygenetic disease	NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; MEMORY; RAC; EXPRESSION; PATHOLOGY; SPINES; GENE; METAANALYSIS; MAINTENANCE	Mutations in the SRGAP3 gene residing on chromosome 3p25 have previously been associated with intellectual disability. Genome-wide association studies have also revealed SRGAP3, together with genes from the same cellular network, as risk genes for schizophrenia. SRGAP3 regulates cytoskeletal dynamics through the RHO protein RAC1. RHO proteins are known to be involved in cytoskeletal reorganization during brain development to control processes such as synaptic plasticity. To elucidate the importance of SRGAP3 in brain development, we generated Srgap3-knockout mice. Ten percent of these mice developed a hydrocephalus and died before adulthood. Surviving mice showed various neuroanatomical changes, including enlarged lateral ventricles, white matter tracts, and dendritic spines together with molecular changes, including an increased basal activity of RAC1. Srgap3(-/-) mice additionally exhibited a complex behavioral phenotype. Behavioral studies revealed an impaired spontaneous alternation and social behavior, while long-term memory was unchanged. The animals also had tics. Lower locomotor activity was observed in male Srgap3(-/-) only. Srgap3(-/-) mice showed increased methylphenidate stimulation in males and an impaired prepulse inhibition in females. Together, the results show neurodevelopmental aberration in Srgap3(-/-) mice, with many of the observed phenotypes matching several schizophrenia-related intermediate phenotypes. Mutations of SRGAP3 may thus contribute to various neurodevelopmental disorders.-Waltereit, R., Leimer, U., von Bohlen und Halbach, O., Panke, J., Holter, S. M., Garrett, L., Wittig, K., Schneider, M., Schmitt, C., Calzada-Wack, J., Neff, F., Becker, L., Prehn, C., Kutscherjawy, S., Endris, V., Bacon, C., Fuchs, H., Gailus-Durner, V., Berger, S., Schonig, K., Adamski, J., Klopstock, T., Esposito, I., Wurst, W., Hrabe. de Angelis, M., Rappold, G., Wieland, T., Bartsch, D. Srgap3(-/-) mice present a neurodevelopmental disorder with schizophrenia-related intermediate phenotypes. FASEB J. 26, 4418-4428 (2012). www.fasebj.org	[Waltereit, Robert] Heidelberg Univ, Cent Inst Mental Hlth, Dept Mol Biol, D-68159 Mannheim, Germany; [Waltereit, Robert] Cent Inst Mental Hlth, Dept Psychiat, D-6800 Mannheim, Germany; [Schneider, Miriam] Cent Inst Mental Hlth, Inst Psychopharmacol, D-6800 Mannheim, Germany; [Wittig, Karola; Wieland, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Expt & Clin Pharmacol & Toxicol, D-68159 Mannheim, Germany; [Halbach, Oliver von Bohlen Und] Ernst Moritz Arndt Univ Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Hoelter, Sabine M.; Garrett, Lillian] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Calzada-Wack, Julia; Neff, Frauke] Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Becker, Lore; Prehn, Cornelia; Fuchs, Helmut; Gailus-Durner, Valerie; Adamski, Jerzy; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; [Endris, Volker; Bacon, Claire; Rappold, Gudrun] Heidelberg Univ, Dept Human Mol Genet, Heidelberg, Germany; [Esposito, Irene] Tech Univ Munich, Inst Allgemeine Pathol & Pathol Anat, Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-8000 Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich, Lehrstuhl Entwicklungsgenet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Technical University of Munich	Bartsch, D (corresponding author), Heidelberg Univ, Cent Inst Mental Hlth, Dept Mol Biol, J 5, D-68159 Mannheim, Germany.	dusan.bartsch@zi-mannheim.de	Wieland, Thomas/G-1772-2012; Wieland, Thomas/Q-1506-2019; Becker, Lore/AAJ-1203-2020; Becker, Lore/E-3717-2010; Fuchs, Helmut/M-7347-2014; von Bohlen und Halbach, Oliver/A-1060-2008; Hölter, Sabine M./N-5868-2014; de Angelis, Martin Hrabe/F-5531-2012; Cabrera, Mariel/GMX-2706-2022; von Bohlen und Halbach, Oliver/R-3464-2019; Gailus-Durner, Valerie/M-7337-2014	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Becker, Lore/0000-0002-6890-4984; Fuchs, Helmut/0000-0002-5143-2677; Hölter, Sabine M./0000-0003-4878-5241; de Angelis, Martin Hrabe/0000-0002-7898-2353; von Bohlen und Halbach, Oliver/0000-0002-6265-9156; Garrett, Lillian/0000-0003-4880-7076; Adamski, Jerzy/0000-0001-9259-0199; Wurst, Wolfgang/0000-0003-4422-7410; Prehn, Cornelia/0000-0002-1274-4715; Calzada, Julia/0000-0003-0816-9305; von Bohlen und Halbach, Oliver/0000-0002-2613-2517	EU [HEALTH-F2-2007-201714 DEVANX, LSHG-2006-037188]; Bundesministerium fur Bildung und Forschung (BMBF) Bernstein Center for Computational Neuroscience Heidelberg/Mannheim grant [01GQ1003A]; BMBF NGFN-Plus grant [01GS0851]; Deutsche Forshungsgemeinschaft [BO 1971/5-1]; BMBF NGFN-Plus [01GS0851, 01GS0850]	EU(European Commission); Bundesministerium fur Bildung und Forschung (BMBF) Bernstein Center for Computational Neuroscience Heidelberg/Mannheim grant(Federal Ministry of Education & Research (BMBF)); BMBF NGFN-Plus grant(Federal Ministry of Education & Research (BMBF)); Deutsche Forshungsgemeinschaft(German Research Foundation (DFG)); BMBF NGFN-Plus(Federal Ministry of Education & Research (BMBF))	The authors thank Drs. Birgit Rathkolb and Eckhard Wolf for the clinical chemistry screening and Drs. Jan Rozman and Martin Klingenspor for the energy metabolism screening; Dr. Vera Baier and Stefano Clementi for help with initial experiments; Lena Wendler, Ariana Frommig, Elke Hermann, Waltraut Stettinger, Albert Langer, Maria Kugler, Tamara Halex, Sabine Holthaus, Katrin Laube, Jacqueline Muller, Elenore Samson, Waldemar Schneider, and Lucie Thurmann for excellent technical support; and finally the Central Institute of Mental Health and German Mouse Clinic animal caretaker teams. The authors thank Dr. Beatrix Naton for excellent administrative support. The authors also thank the members of the German Mouse Clinic for comprehensive phenotyping of the Srgap3<SUP>-/-</SUP> mice and fruitful discussions. The work was supported by EU HEALTH-F2-2007-201714 DEVANX, Bundesministerium fur Bildung und Forschung (BMBF) Bernstein Center for Computational Neuroscience Heidelberg/Mannheim grant 01GQ1003A and BMBF NGFN-Plus grant 01GS0851 to D.B.; Deutsche Forshungsgemeinschaft grant BO 1971/5-1 to O.V.B.U.H; BMBF NGFN-Plus grants 01GS0850 to S.M.H, L.G., J.C.-W., F.N., C.P., J.A., I.E., H.F., V.G.-D., W.W. and M.H.D.A. and 01GS0851 to L.B. and T.K.; and EU grant LSHG-2006-037188 to the German Mouse Clinic.	Addington AM, 2009, CURR PSYCHIAT REP, V11, P156, DOI 10.1007/s11920-009-0024-y; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Arguello PA, 2010, SCHIZOPHRENIA BULL, V36, P289, DOI 10.1093/schbul/sbp153; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Benard V, 2002, METHOD ENZYMOL, V345, P349; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chen L, 2007, J NEUROSCI, V27, P3884, DOI 10.1523/JNEUROSCI.3509-06.2007; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Deussing JM, 2010, J NEUROSCI, V30, P9103, DOI 10.1523/JNEUROSCI.1049-10.2010; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Hamdan FF, 2009, ARCH NEUROL-CHICAGO, V66, P675, DOI 10.1001/archneurol.2009.65; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Joyner AL, 2000, GENE TARGETING PRACT; Kassai H, 2008, EUR J NEUROSCI, V28, P257, DOI 10.1111/j.1460-9568.2008.06343.x; Ko YH, 2007, PSYCHONEUROENDOCRINO, V32, P385, DOI 10.1016/j.psyneuen.2007.02.002; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mata I, 2009, BIOL PSYCHIAT, V65, P535, DOI 10.1016/j.biopsych.2008.10.020; Mitchell KJ, 2010, CURR OPIN NEUROBIOL, V21, P1; Mohl M, 2006, N-S ARCH PHARMACOL, V373, P333, DOI 10.1007/s00210-006-0083-0; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; MOWREY PN, 1993, AM J MED GENET, V46, P623, DOI 10.1002/ajmg.1320460604; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; O'Tuathaigh CMP, 2010, SCHIZOPHRENIA BULL, V36, P271, DOI 10.1093/schbul/sbp125; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Ramakers GJA, 2000, AM J MED GENET, V94, P367, DOI 10.1002/1096-8628(20001023)94:5<367::AID-AJMG4>3.0.CO;2-I; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Ramon-Moliner E, 1970, GOLGI COX TECHNIQUE; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Schneider I, 2006, J NEUROSCI METH, V157, P82, DOI 10.1016/j.jneumeth.2006.04.002; Schneider M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-105; SCHURR PH, 1953, J NEUROSURG, V10, P515, DOI 10.3171/jns.1953.10.5.0515; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shprecher D, 2009, MOVEMENT DISORD, V24, P15, DOI 10.1002/mds.22378; Shuib S, 2009, AM J MED GENET A, V149A, P2099, DOI 10.1002/ajmg.a.32824; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sweatt JD, 2003, MECH MEMORY; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; von Bohlen und Halbach O, 2008, NEUROBIOL AGING, V29, P1247, DOI 10.1016/j.neurobiolaging.2007.02.028; von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759; Waltereit R, 2006, J NEUROCHEM, V96, P407, DOI 10.1111/j.1471-4159.2005.03538.x; Waltereit R, 2008, GENE EXPR PATTERNS, V8, P307, DOI 10.1016/j.gep.2008.01.006; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5	68	35	35	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4418	4428		10.1096/fj.11-202317	http://dx.doi.org/10.1096/fj.11-202317			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22820399				2022-12-25	WOS:000310574200006
J	Burns, V; Kerppola, TK				Burns, Veronica; Kerppola, Tom Klaus			Opposite Orientations of a Transcription Factor Heterodimer Bind DNA Cooperatively with Interaction Partners but Have Different Effects on Interferon-beta Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOS-JUN; FOS-JUN-NFAT1 COMPLEXES; CRYSTAL-STRUCTURE; IN-VITRO; ENHANCEOSOME; RECRUITMENT; PROMOTERS; DOMAINS; SITES	ATF2-Jun, IRF3, and HMGI recognize a composite regulatory element within the interferon-beta enhancer (IFNb). Cooperative ATF2-Jun-IRF3 complex formation at IFNb has been proposed to require a fixed orientation of ATF2-Jun binding. Our results show that ATF2-Jun heterodimers bound IFNb in both orientations alone and in association with IRF3 and HMGI. Two sets of symmetrically located amino acid residues in ATF2 and Jun facilitated the interactions between heterodimers bound in opposite orientations and IRF3 at IFNb. IRF3 and HMGI bound IFNb in association with both orientations of ATF2-Jun heterodimers with the same cooperativity. ATF2-Jun heterodimers that bound IFNb in opposite orientations in vitro had different effects on interferon-beta gene transcription when they were co-expressed with IRF3 in cultured cells. These heterodimers had different transcriptional activities at different endogenous genes. Different regions of ATF2 and Jun mediated their orientation-dependent transcriptional activities at different genes. These studies revealed that cooperative DNA binding does not require a unique nucleoprotein complex configuration, and that transcription factor complexes that bind the same enhancer in different configurations can have different transcriptional activities.	[Burns, Veronica; Kerppola, Tom Klaus] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kerppola, TK (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	kerppola@umich.edu	Kerppola, Tom/AFK-6155-2022; Kerppola, Tom/AAG-4457-2022	Kerppola, Tom/0000-0002-0611-9446; Kerppola, Tom/0000-0002-0611-9446; Burns, Veronica/0000-0002-7491-8338	National Institutes of Health [R01-DA030339]; University of Michigan Molecular Biophysics Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Molecular Biophysics Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DA030339 (to T. K. K.) and by the University of Michigan Molecular Biophysics Training Grant (to V. E. B.).	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; CHEN L, 1995, CURR BIOL, V5, P882, DOI 10.1016/S0960-9822(95)00178-3; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cox JM, 1997, P NATL ACAD SCI USA, V94, P13475, DOI 10.1073/pnas.94.25.13475; Diebold RJ, 1998, P NATL ACAD SCI USA, V95, P7915, DOI 10.1073/pnas.95.14.7915; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Leonard DA, 1998, NAT STRUCT BIOL, V5, P877, DOI 10.1038/2316; Leonard DA, 1997, P NATL ACAD SCI USA, V94, P4913, DOI 10.1073/pnas.94.10.4913; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Ramirez-Carrozzi V, 2003, MOL CELL BIOL, V23, P1737, DOI 10.1128/MCB.23.5.1737-1749.2003; Ramirez-Carrozzi V, 2001, METHODS, V25, P31, DOI 10.1006/meth.2001.1213; Ramirez-Carrozzi VR, 2001, P NATL ACAD SCI USA, V98, P4893, DOI 10.1073/pnas.091095998; Ramirez-Carrozzi VR, 2001, J BIOL CHEM, V276, P21797, DOI 10.1074/jbc.M101494200; SCHRADER M, 1994, NATURE, V370, P382, DOI 10.1038/370382a0; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6	24	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31833	31844		10.1074/jbc.M112.374462	http://dx.doi.org/10.1074/jbc.M112.374462			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843696	Green Published, hybrid			2022-12-25	WOS:000309059400024
J	Zhong, SP; Xu, J; Li, P; Tsukamoto, H				Zhong, Shuping; Xu, Jun; Li, Peggy; Tsukamoto, Hidekazu			Caveosomal Oxidative Stress Causes Src-p21(ras) Activation and Lysine 63 TRAF6 Protein Polyubiquitination in Iron-induced M1 Hepatic Macrophage Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTRACELLULAR IRON; KINASE; INTERLEUKIN-1; INDUCTION; FERRITIN; PATHWAY; P21RAS; CELLS; LIVER	Proinflammatory M1 activation of hepatic macrophages (HM) is critical in pathogenesis of hepatitis, but its mechanisms are still elusive. Our earlier work demonstrates the role of ferrous iron (Fe2+) as a pathogen-associated molecular pattern-independent agonist for activation of I kappa B kinase (IKK) and NF-kappa B in HM via activation and interaction of p21(ras), transforming growth factor beta-activated kinase-1 (TAK1), and phosphatidylinositol 3-kinase (PI3K) in caveosomes. However, iron-induced signaling upstream of these kinases is not known. Here we show that Fe2+ induces generation of superoxide anion (O-2(radical anion)) in endosomes, reduces protein-tyrosine phosphatase (PTP) activity, and activates Src at 2 similar to 10 min of Fe2+ addition to rat primary HM culture. Superoxide dismutase (SOD) blocks O-2(radical anion) generation, PTP inhibition, and Src activation. Fe2+-induced p21(ras) activity is abrogated with the Src inhibitor PP2 and SOD. Fe2+ stimulates Lys(63)-linked polyubiquitination (polyUb) of TRAF6 in caveosomes, and a dominant negative K63R mutant of ubiquitin or SOD prevents iron-induced TRAF6 polyUb and TAK1 activation. These results demonstrate that Fe2+-generated O-2(radical anion) mediates p21(ras) and TAK1 activation via PTP inhibition and Lys(63)-polyUb of TRAF6 in caveosomes for proinflammatory M1 activation in HM.	[Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Zhong, Shuping; Xu, Jun; Li, Peggy; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, So Calif Res Ctr Alcohol Liver & Pancreat Dis & C, Los Angeles, CA 90033 USA; [Zhong, Shuping; Xu, Jun; Li, Peggy; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Tsukamoto, Hidekazu] Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA 90073 USA	University of Southern California; University of Southern California; University of Southern California	Tsukamoto, H (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, 1333 San Pablo St,MMR 402, Los Angeles, CA 90033 USA.	htsukamo@usc.edu			National Institutes of Health [P50AA011999, R24AA012885, RC2AA019392, R21AA017288, K01AA020524]; Medical Research Service of the Department of Veterans Affairs; Suntory Business Expert Ltd.; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885, RC2AA019392, P50AA011999, R21AA017288, K01AA020524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); Suntory Business Expert Ltd.; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P50AA011999 (to H. T.), R24AA012885 (to H. T.), RC2AA019392 (to H. T.), R21AA017288 (to S. Z.), and K01AA020524 (to J. X.), and by the Medical Research Service of the Department of Veterans Affairs (to H. T.) and Suntory Business Expert Ltd.	Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; David MD, 2005, J IMMUNOL, V175, P8236, DOI 10.4049/jimmunol.175.12.8236; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; KENNEDY JI, 1986, CHEST, V89, pS123, DOI 10.1378/chest.89.3_Supplement.123S; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Satchell L, 2012, BIOCHEMISTRY-US, V51, P3767, DOI 10.1021/bi2017975; She HY, 2002, AM J PHYSIOL-GASTR L, V283, pG719, DOI 10.1152/ajpgi.00108.2002; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tacchini L, 1997, GASTROENTEROLOGY, V113, P946, DOI 10.1016/S0016-5085(97)70191-4; Tsukamoto H, 1999, AM J PHYSIOL-GASTR L, V277, pG1240, DOI 10.1152/ajpgi.1999.277.6.G1240; Williams R, 2012, J NEUROCHEM, V120, P7, DOI 10.1111/j.1471-4159.2011.07536.x; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Xiong S, 2008, AM J PHYSIOL-GASTR L, V295, pG512, DOI 10.1152/ajpgi.90327.2008; Yuan XM, 1999, FREE RADICAL RES, V30, P221, DOI 10.1080/10715769900300241; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	22	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32078	32084		10.1074/jbc.M112.377358	http://dx.doi.org/10.1074/jbc.M112.377358			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829592	Green Published, hybrid			2022-12-25	WOS:000309059400045
J	Hey, F; Czyzewicz, N; Jones, P; Sablitzky, F				Hey, Fiona; Czyzewicz, Nathan; Jones, Peter; Sablitzky, Fred			DEF6, a Novel Substrate for the Tec Kinase ITK, Contains a Glutamine-rich Aggregation-prone Region and Forms Cytoplasmic Granules that Co-localize with P-bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN STRESS GRANULES; GUANINE-NUCLEOTIDE EXCHANGE; T-CELL-ACTIVATION; IMMUNOLOGICAL SYNAPSE; TRANSCRIPTION FACTOR; PROCESSING BODIES; FAMILY KINASES; MESSENGER-RNA; COILED COILS; PROTEIN	Localization of DEF6 (SLAT/IBP), a Rho-family guanine nucleotide exchange factor, to the center of the immune synapse is dependent upon ITK, a Tec-family kinase that regulates the spatiotemporal organization of components of T cell signaling pathways and Cdc42-dependent actin polymerization. Here we demonstrate that ITK both interacts with DEF6 and phosphorylates DEF6 at tyrosine residues Tyr(210) and Tyr(222). Expression of a GFP-tagged Y210E-Y222E phosphomimic resulted in the formation of DEF6 cytoplasmic granules that co-localized with decapping enzyme 1 (DCP1), a marker of P-bodies; sites of mRNA degradation. Similarly treatment of cells with puromycin or sodium arsenite, reagents that arrest translation, also resulted in the accumulation of DEF6 in cytoplasmic granules. Bioinformatics analysis identified a glutamine-rich, heptad-repeat region; a feature of aggregating proteins, within the C-terminal region of DEF6 with the potential to promote granule formation through a phosphorylation-dependent unmasking of this region. These data suggest that in addition to its role as a GEF, DEF6 may also function in regulating mRNA translation.	[Sablitzky, Fred] Univ Nottingham, Queens Med Ctr, Sch Biol Mol Cell & Dev Biol, Nottingham NG7 2UH, England; [Jones, Peter] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Sablitzky, F (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Biol Mol Cell & Dev Biol, Nottingham NG7 2UH, England.	fred.sablitzky@nottingham.ac.uk	Sablitzky, Fred/A-2276-2011	Sablitzky, Fred/0000-0001-9718-1546	University of Nottingham; MRC studentship	University of Nottingham; MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported through the University of Nottingham and a MRC studentship (to F. H.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Altman A, 2009, IMMUNITY, V31, P1, DOI 10.1016/j.immuni.2009.06.013; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Blomberg KEM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-233; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Canonigo-Balancio AJ, 2009, J IMMUNOL, V183, P7259, DOI 10.4049/jimmunol.0902573; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; COLLOCH N, 1991, J MOL BIOL, V221, P603, DOI 10.1016/0022-2836(91)80075-6; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Finkelstein LD, 2005, J IMMUNOL, V175, P5923, DOI 10.4049/jimmunol.175.9.5923; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gomez-Rodriguez J, 2007, IMMUNOL REV, V218, P45, DOI 10.1111/j.1600-065X.2007.00534.x; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5595, DOI 10.1021/bi700127c; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5455, DOI 10.1021/bi602512e; Joseph RE, 2009, J MOL BIOL, V391, P164, DOI 10.1016/j.jmb.2009.06.023; Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Mavrakis KJ, 2004, EXP CELL RES, V294, P335, DOI 10.1016/j.yexcr.2003.12.004; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Min L, 2009, P NATL ACAD SCI USA, V106, P21143, DOI 10.1073/pnas.0911309106; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	53	20	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31073	31084		10.1074/jbc.M112.346767	http://dx.doi.org/10.1074/jbc.M112.346767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829599	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000308791300020
J	Feuerstein, P; Puard, V; Chevalier, C; Teusan, R; Cadoret, V; Guerif, F; Houlgatte, R; Royere, D				Feuerstein, Prisca; Puard, Vincent; Chevalier, Catherine; Teusan, Raluca; Cadoret, Veronique; Guerif, Fabrice; Houlgatte, Remi; Royere, Dominique			Genomic Assessment of Human Cumulus Cell Marker Genes as Predictors of Oocyte Developmental Competence: Impact of Various Experimental Factors	PLOS ONE			English	Article							PREGNANCY PREDICTORS; EXPRESSION PROFILES; HUMAN IVF; EMBRYO; IDENTIFICATION; FERTILIZATION; TRANSCRIPTOME; METABOLOMICS; BIOMARKERS; MORPHOLOGY	Background: Single embryo transfer (SET) is the most successful way to reduce the frequency of multiple pregnancies following in vitro fertilisation. However, selecting the embryo for SET with the highest chances of pregnancy remains a difficult challenge since morphological and kinetics criteria provide poor prediction of both developmental and implantation ability. Partly through the expression of specific genes, the oocyte-cumulus interaction helps the oocyte to acquire its developmental competence. Our aim was therefore to identify at the level of cumulus cells (CCs) genes related to oocyte developmental competence. Methodology/Principal Findings: 197 individual CCs were collected from 106 patients undergoing an intra-cytoplasmic sperm injection procedure. Gene expression of CCs was studied using microarray according to the nuclear maturity of the oocyte (immature vs. mature oocyte) and to the developmental competence of the oocyte (ability to reach the blastocyst stage after fertilisation). Microarray study was followed by a meta-analysis of the behaviour of these genes in other datasets available in Gene Expression Omnibus which showed the consistency of this list of genes. Finally, 8 genes were selected according to oocyte developmental competence from the 308 differentially expressed genes (p, 0.0001) for further validation by quantitative PCR (qPCR). Three of these 8 selected genes were validated as potential biomarkers (PLIN2, RGS2 and ANG). Experimental factors such as inter-patient and qPCR series variability were then assessed using the Generalised Linear Mixed Model procedure, and only the expression level of RGS2 was confirmed to be related to oocyte developmental competence. The link between biomarkers and pregnancy was finally evaluated and level of RGS2 expression was also correlated with clinical pregnancy. Conclusion/Significance: RGS2, known as a regulator of G protein signalling, was the only gene among our 8 selected candidates biomarkers of oocyte competence to cover many factors of variability, including inter-patient factors and experimental conditions.	[Feuerstein, Prisca; Puard, Vincent; Cadoret, Veronique; Guerif, Fabrice; Royere, Dominique] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Feuerstein, Prisca; Puard, Vincent; Cadoret, Veronique; Guerif, Fabrice; Royere, Dominique] CNRS, UMR6175, Nouzilly, France; [Feuerstein, Prisca; Puard, Vincent; Guerif, Fabrice; Royere, Dominique] Univ Tours, Tours, France; [Cadoret, Veronique; Guerif, Fabrice; Royere, Dominique] CHRU Tours, Reprod Biol Lab, Tours, France; [Chevalier, Catherine; Teusan, Raluca; Houlgatte, Remi] Univ Nantes, Plateforme Puces ADN Nantes, Inst Rech Therapeut, Nantes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours; CHU Tours; Nantes Universite	Feuerstein, P (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	royere@med.univ-tours.fr	Houlgatte, Remi/P-3020-2017; chevalier, catherine/L-4803-2015; TEUSAN, Raluca/D-4069-2015	TEUSAN, Raluca/0000-0002-1428-5719; Puard, Vincent/0000-0003-4634-7627; cadoret, veronique/0000-0002-5260-0812	Institut National de la Sante et de la Recherche Medicale (Reseau de Recherche Reproduction Humaine-AMP [4REO3H]; Institut National de la Recherche Agronomique (INRA); INRA/Ferring SA fellowship; INRA/Merck Serono fellowship	Institut National de la Sante et de la Recherche Medicale (Reseau de Recherche Reproduction Humaine-AMP; Institut National de la Recherche Agronomique (INRA); INRA/Ferring SA fellowship; INRA/Merck Serono fellowship	This study was supported by a grant from the Institut National de la Sante et de la Recherche Medicale (Reseau de Recherche Reproduction Humaine-AMP', contrat No. 4REO3H) and the Institut National de la Recherche Agronomique (INRA). P.F. is supported by an INRA/Ferring SA fellowship. V.P. is supported by an INRA/Merck Serono fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens T, 2010, HUM REPROD; Anderson RA, 2009, REPRODUCTION, V138, P629, DOI 10.1530/REP-09-0144; Assidi M, 2011, J ASSIST REPROD GEN, V28, P173, DOI 10.1007/s10815-010-9491-7; Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Bergh C, 2005, HUM REPROD, V20, P323, DOI 10.1093/humrep/deh744; Botros L, 2008, MOL HUM REPROD, V14, P679, DOI 10.1093/molehr/gan066; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Canipari R, 2000, HUM REPROD UPDATE, V6, P279, DOI 10.1093/humupd/6.3.279; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fauser BC, 2010, HUM REPROD UPDATE, V17, P829; Ferrari S, 2010, J ASSIST REPROD GEN, V27, P429, DOI 10.1007/s10815-010-9428-1; Feuerstein P, 2007, HUM REPROD, V22, P3069, DOI 10.1093/humrep/dem336; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gebhardt KM, 2011, FERTIL STERIL, V96, P47, DOI 10.1016/j.fertnstert.2011.04.033; Gilbert I, 2010, MOL HUM REPROD, V16, P601, DOI 10.1093/molehr/gaq038; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Guerif F, 2007, HUM REPROD, V22, P1973, DOI 10.1093/humrep/dem100; Guerif F, 2003, THERIOGENOLOGY, V60, P1457, DOI 10.1016/S0093-691X(03)00130-4; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Hamel M, 2010, MOL HUM REPROD, V16, P548, DOI 10.1093/molehr/gaq051; Hamel M, 2010, MOL HUM REPROD, V16, P87, DOI 10.1093/molehr/gap079; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Huang ZW, 2010, MOL HUM REPROD, V16, P715, DOI 10.1093/molehr/gaq031; Jones GM, 2008, HUM REPROD, V23, P1748, DOI 10.1093/humrep/den123; Katz-Jaffe MG, 2009, MOL HUM REPROD, V15, P271, DOI 10.1093/molehr/gap012; Katz-Jaffe MG, 2006, FERTIL STERIL, V85, P101, DOI 10.1016/j.fertnstert.2005.09.011; Koks S, 2010, MOL HUM REPROD, V16, P229, DOI 10.1093/molehr/gap103; Land J. A., 2003, Human Reproduction (Oxford), V18, P455, DOI 10.1093/humrep/deg081; Li Q, 2008, MOL HUM REPROD; Milki AA, 2002, FERTIL STERIL, V78, P1244, DOI 10.1016/S0015-0282(02)04273-5; O'Shea LC, 2012, SYST BIOL REPROD MED, V0, P1; Ouandaogo ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027179; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Rijnders PM, 1998, HUM REPROD, V13, P2869, DOI 10.1093/humrep/13.10.2869; Royere D, 2009, GYNECOL OBSTET FERTI, V37, P917, DOI 10.1016/j.gyobfe.2009.09.016; Scott L, 2008, REPROD BIOMED ONLINE, V17, P461, DOI 10.1016/S1472-6483(10)60232-5; Singh R, 2007, THERIOGENOLOGY, V68, pS56, DOI 10.1016/j.theriogenology.2007.04.007; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Ujioka T, 2000, BIOL REPROD, V63, P1513, DOI 10.1095/biolreprod63.5.1513; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wang X, 2007, EMBO J, V26, P2768, DOI 10.1038/sj.emboj.7601701; Wu YL, 2008, CHINESE J PHYSIOL, V51, P282; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	52	62	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40449	10.1371/journal.pone.0040449	http://dx.doi.org/10.1371/journal.pone.0040449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848380	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950200021
J	Wibrand, K; Pai, B; Siripornmongcolchai, T; Bittins, M; Berentsen, B; Ofte, ML; Weigel, A; Skaftnesmo, KO; Bramham, CR				Wibrand, Karin; Pai, Balagopal; Siripornmongcolchai, Taweeporn; Bittins, Margarethe; Berentsen, Birgitte; Ofte, May Lillian; Weigel, Arwed; Skaftnesmo, Kai Ove; Bramham, Clive R.			MicroRNA Regulation of the Synaptic Plasticity-Related Gene Arc	PLOS ONE			English	Article							CYTOSKELETON-ASSOCIATED PROTEIN; MESSENGER-RNA TRANSLATION; GYRUS IN-VIVO; NEUROTROPHIC FACTOR; RECEPTOR ACTIVATION; AMPA RECEPTORS; FEEDBACK LOOP; ARC/ARG3.1; EXPRESSION; BRAIN	Expression of activity-regulated cytoskeleton associated protein (Arc) is crucial for diverse types of experience-dependent synaptic plasticity and long-term memory in mammals. However, the mechanisms governing Arc-specific translation are little understood. Here, we asked whether Arc translation is regulated by microRNAs. Bioinformatic analysis predicted numerous candidate miRNA binding sites within the Arc 3'-untranslated region (UTR). Transfection of the corresponding microRNAs in human embryonic kidney cells inhibited expression of an Arc 3'UTR luciferase reporter from between 10 to 70% across 16 microRNAs tested. Point mutation and deletion of the microRNA-binding seed-region for miR-34a, miR-326, and miR-19a partially or fully rescued reporter expression. In addition, expression of specific microRNA pairs synergistically modulated Arc reporter expression. In primary rat hippocampal neuronal cultures, ectopic expression of miR-34a, miR-193a, or miR-326, downregulated endogenous Arc protein expression in response to BDNF treatment. Conversely, treatment of neurons with cell-penetrating, peptide nucleic acid (PNA) inhibitors of miR-326 enhanced Arc mRNA expression. BDNF dramatically upregulated neuronal expression of Arc mRNA and miR-132, a known BDNF-induced miRNA, without affecting expression of Arc-targeting miRNAs. Developmentally, miR-132 was upregulated at day 10 in vitro whereas Arc-targeting miRNAs were downregulated. In the adult brain, LTP induction in the dentate gyrus triggered massive upregulation of Arc and upregulation of miR-132 without affecting levels of mature Arc-targeting miRNAs. Turning to examine miRNA localization, qPCR analysis of dentate gyrus synaptoneurosome and total lysates fractions demonstrated synaptic enrichment relative to small nucleolar RNA. In conclusion, we find that Arc is regulated by multiple miRNAs and modulated by specific miRNA pairs in vitro. Furthermore, we show that, in contrast to miR-132, steady state levels of Arc-targeting miRNAs do not change in response to activity-dependent expression of Arc in hippocampal neurons in vitro or during LTP in vivo.	[Wibrand, Karin; Pai, Balagopal; Siripornmongcolchai, Taweeporn; Bittins, Margarethe; Berentsen, Birgitte; Ofte, May Lillian; Weigel, Arwed; Skaftnesmo, Kai Ove; Bramham, Clive R.] Univ Bergen, Dept Biomed, Bergen, Norway; [Wibrand, Karin; Pai, Balagopal; Siripornmongcolchai, Taweeporn; Bittins, Margarethe; Berentsen, Birgitte; Ofte, May Lillian; Weigel, Arwed; Skaftnesmo, Kai Ove; Bramham, Clive R.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway	University of Bergen; University of Bergen	Bramham, CR (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	clive.bramham@biomed.uib.no	Skaftnesmo, kai ove/AAF-6071-2021; Pai, Balagopal/AAY-8292-2020; Berentsen, Birgitte/AAK-9028-2021; Berentsen, Birgitte/AAG-9398-2020; Bramham, Clive/Q-1854-2018	Pai, Balagopal/0000-0003-3196-055X; Berentsen, Birgitte/0000-0003-3574-7078; Berentsen, Birgitte/0000-0003-3574-7078; Bramham, Clive/0000-0001-5958-7115	Research Council of Norway [186115, 204861, 199355]; Poland-Norway Financial Mechanism, ERASysBio+ Project [122]; University of Bergen	Research Council of Norway(Research Council of Norway); Poland-Norway Financial Mechanism, ERASysBio+ Project; University of Bergen	Supported by The Research Council of Norway (Grants 186115, 204861, and 199355), the Poland-Norway Financial Mechanism, ERASysBio+ Project 122, and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2011, P NATL ACAD SCI USA, V108, P21093, DOI 10.1073/pnas.1112061109; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Alder J, 2003, J NEUROSCI, V23, P10800; ALME MN, 2007, NEURAL PLAST, P26496; Ashraf SI, 2006, CURR OPIN NEUROBIOL, V16, P535, DOI 10.1016/j.conb.2006.08.007; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Czerniawski J, 2011, J NEUROSCI, V31, P11200, DOI 10.1523/JNEUROSCI.2211-11.2011; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiore R, 2009, EMBO J; Fiore R, 2011, EMBO J, V30, P4116, DOI 10.1038/emboj.2011.356; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Haramati S, 2011, J NEUROSCI, V31, P14191, DOI 10.1523/JNEUROSCI.1673-11.2011; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Junker A, 2011, FEBS LETT, V585, P3738, DOI 10.1016/j.febslet.2011.03.052; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Kosik KS, 2009, NAT REV NEUROSCI, V10, P754, DOI 10.1038/nrn2713; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lugli G, 2008, NEUROCHEMISTRY; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Moonat S, 2011, ADDICT BIOL, V16, P238, DOI 10.1111/j.1369-1600.2010.00275.x; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Oh SY, 2010, OLIGONUCLEOTIDES, V20, P225, DOI 10.1089/oli.2010.0238; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Raju CS, 2011, MOL BIOL CELL, V22, P1864, DOI 10.1091/mbc.E10-11-0904; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Shin CY, 2004, J NEUROSCI, V24, P9425, DOI 10.1523/JNEUROSCI.2457-04.2004; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Smalheiser NR, 2008, NEUROSCI RES, V62, P236, DOI 10.1016/j.neures.2008.08.010; Soule J, 2012, J BIOL CHEM, V287, P22354, DOI 10.1074/jbc.M112.376491; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Tognini P, 2011, NAT NEUROSCI, V14, P1237, DOI 10.1038/nn.2920; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vo NK, 2010, CURR OPIN NEUROBIOL, V20, P457, DOI 10.1016/j.conb.2010.04.002; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	75	68	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41688	10.1371/journal.pone.0041688	http://dx.doi.org/10.1371/journal.pone.0041688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844515	Green Published, Green Submitted, gold			2022-12-25	WOS:000309240600042
J	Hamanaka, Y; Kinoshita, M; Homberg, U; Arikawa, K				Hamanaka, Yoshitaka; Kinoshita, Michiyo; Homberg, Uwe; Arikawa, Kentaro			Immunocytochemical Localization of Amines and GABA in the Optic Lobe of the Butterfly, Papilio xuthus	PLOS ONE			English	Article							SEROTONIN-IMMUNOREACTIVE NEURONS; OCTOPAMINE-LIKE IMMUNOREACTIVITY; VISUAL-SYSTEM; DROSOPHILA-MELANOGASTER; NERVOUS-SYSTEM; SUBESOPHAGEAL GANGLION; SYNAPTIC ORGANIZATION; DETECTION PATHWAY; TANGENTIAL CELLS; MOTION DETECTION	Butterflies have sophisticated color vision. While the spectral organization of the compound eye has been well characterized in the Japanese yellow swallowtail butterfly, Papilio xuthus, neural mechanisms underlying its color vision are largely unexplored. Towards a better understanding of signal processing in the visual system of P. xuthus, we used immunocytochemical techniques to analyze the distribution of transmitter candidates, namely, histamine, serotonin, tyramine and gamma-aminobutyric acid (GABA). Photoreceptor terminals in the lamina and medulla exhibited histamine immunoreactivity as demonstrated in other insects. The anti-histamine antiserum also labeled a few large medulla neurons. Medulla intrinsic neurons and centrifugal neurons projecting to the lamina showed serotonin immunoreactivity. Tyramine immunostaining was detected in a subset of large monopolar cells (LMCs) in the lamina, transmedullary neurons projecting to the lobula plate, and cell bodies surrounding the first optic chiasma. An anti-GABA antiserum labeled a subset of LMCs and populations of columnar and tangential neurons surrounding the medulla. Each of the four antisera also labeled a few centrifugal neurons that innervate the lobula complex from the central brain, suggesting that they have neuromodulatory roles. A distinctive feature we found in this study is the possibility that tyramine and GABA act as transmitters in LMCs of P. xuthus, which has not been reported in any other insects so far.	[Hamanaka, Yoshitaka; Kinoshita, Michiyo; Arikawa, Kentaro] Grad Univ Adv Studies, Lab Neuroethol, Hayama, Kanagawa, Japan; [Homberg, Uwe] Univ Marburg, Dept Biol, Marburg, Germany	Graduate University for Advanced Studies - Japan; Philipps University Marburg	Hamanaka, Y (corresponding author), Grad Univ Adv Studies, Lab Neuroethol, Hayama, Kanagawa, Japan.	arikawa@soken.ac.jp	Homberg, Uwe/AFH-8214-2022	Homberg, Uwe/0000-0002-8229-7236; Kinoshita, Michiyo/0000-0002-5818-9622; Arikawa, Kentaro/0000-0002-4365-0762	Japanese Society for Promotion of Science (JSPS) [21247009]; Kazato research foundation; Canon Foundation in Europe	Japanese Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kazato research foundation(Kazato Research Foundation); Canon Foundation in Europe(Canon Foundation)	Japanese Society for Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (A) No. 21247009 to Kentaro Arikawa/Kazato research foundation grant to Yoshitaka Hamanaka Canon Foundation in Europe grant to Michiyo Kinoshita. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BICKER G, 1988, J NEUROSCI, V8, P2108; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brotz TM, 1996, J NEUROPHYSIOL, V76, P1786, DOI 10.1152/jn.1996.76.3.1786; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; CAMPOSOR.JA, 1973, BRAIN RES, V59, P119, DOI 10.1016/0006-8993(73)90255-2; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V338, P1189, DOI 10.1016/j.bbrc.2005.10.058; Chen B, 1999, J COMP PHYSIOL A, V185, P393, DOI 10.1007/s003590050400; Dahdal D, 2010, NEURON, V68, P964, DOI 10.1016/j.neuron.2010.11.017; DATUM KH, 1986, J COMP PHYSIOL A, V159, P241, DOI 10.1007/BF00612306; Elphick MR, 1996, J EXP BIOL, V199, P2395; Fabian-Fine R, 1999, J NEUROSCI, V19, P298, DOI 10.1523/JNEUROSCI.19-01-00298.1999; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FULLER H, 1989, CELL TISSUE RES, V255, P225; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Hamanaka Y, 2007, CELL TISSUE RES, V329, P581, DOI 10.1007/s00441-007-0433-3; HARDIE RC, 1987, J COMP PHYSIOL A, V161, P201, DOI 10.1007/BF00615241; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Harzsch S, 1999, J NEUROSCI, V19, P3472; Heinze S, 2012, J COMP NEUROL, V520, P1599, DOI 10.1002/cne.23054; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; HEVERS W, 1995, NEURON, V14, P845, DOI 10.1016/0896-6273(95)90228-7; Homberg U, 2004, CELL TISSUE RES, V318, P439, DOI 10.1007/s00441-004-0913-7; Homberg U, 2003, CHRONOBIOL INT, V20, P577, DOI 10.1081/CBI-120022412; Homberg U, 2002, MICROSC RES TECHNIQ, V56, P189, DOI 10.1002/jemt.10024; HOMBERG U, 1989, J COMP NEUROL, V288, P243, DOI 10.1002/cne.902880204; HOMBERG U, 1987, CELL TISSUE RES, V248, P1, DOI 10.1007/BF01239957; Homberg U., 1994, PROG ZOOL, V40, P1; ICHIKAWA T, 1994, NEUROSCI LETT, V172, P115, DOI 10.1016/0304-3940(94)90675-0; ICHIKAWA T, 1994, J EXP BIOL, V195, P361; ICHIKAWA T, 1994, J COMP NEUROL, V340, P185, DOI 10.1002/cne.903400205; Kinoshita M, 1999, J EXP BIOL, V202, P95; Kinoshita M, 2000, J EXP BIOL, V203, P3521; Kinoshita M, 2008, J EXP BIOL, V211, P3504, DOI 10.1242/jeb.017848; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Kononenko NL, 2009, J COMP NEUROL, V512, P433, DOI 10.1002/cne.21911; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; Lange AB, 2009, GEN COMP ENDOCR, V162, P18, DOI 10.1016/j.ygcen.2008.05.021; Leitinger G, 1999, BRAIN RES, V823, P11, DOI 10.1016/S0006-8993(98)01339-0; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MEYER EP, 1986, HISTOCHEMISTRY, V84, P207, DOI 10.1007/BF00495784; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; NASSEL DR, 1991, PROG NEUROBIOL, V37, P179, DOI 10.1016/0301-0082(91)90027-X; Nassel DR, 1999, MICROSC RES TECHNIQ, V44, P121, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<121::AID-JEMT6>3.0.CO;2-F; NASSEL DR, 1988, PROG NEUROBIOL, V30, P1, DOI 10.1016/0301-0082(88)90002-0; NASSEL DR, 1985, J COMP NEUROL, V232, P190, DOI 10.1002/cne.902320205; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Pyza E, 1996, J COMP PHYSIOL A, V178, P33, DOI 10.1007/BF00189588; Raghu SV, 2007, J COMP NEUROL, V502, P598, DOI 10.1002/cne.21319; Raghu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019472; Raghu SV, 2011, J COMP NEUROL, V519, P162, DOI 10.1002/cne.22512; RIBI WA, 1987, CELL TISSUE RES, V247, P393; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; Sattelle D.B., 1990, Advances in Insect Physiology, V22, P1, DOI 10.1016/S0065-2806(08)60005-3; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Sdhof TC, 1989, SCIENCE, V245, P1474; Seidel C, 1997, BRAIN RES, V769, P273, DOI 10.1016/S0006-8993(97)00716-6; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; STERN M, 1995, J COMP PHYSIOL A, V177, P611, DOI 10.1007/BF00207190; Stern M, 1999, MICROSC RES TECHNIQ, V45, P135, DOI 10.1002/(SICI)1097-0029(19990501)45:3<135::AID-JEMT1>3.0.CO;2-G; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; STRAUSFELD NJ, 1970, PHILOS T R SOC B, V258, P135, DOI 10.1098/rstb.1970.0033; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; STRAUSFELD NJ, 1970, PHILOS T R SOC B, V258, P81, DOI 10.1098/rstb.1970.0032; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Takemura SY, 2006, J COMP NEUROL, V494, P663, DOI 10.1002/cne.20830; Takemura SY, 2005, J COMP NEUROL, V483, P341, DOI 10.1002/cne.20446; Takeuchi Y, 2006, J EXP BIOL, V209, P2873, DOI 10.1242/jeb.02311; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0	84	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41109	10.1371/journal.pone.0041109	http://dx.doi.org/10.1371/journal.pone.0041109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844431	Green Published, gold			2022-12-25	WOS:000306687700044
J	Hooton, H; Angquist, L; Holst, C; Hager, J; Rousseau, F; Hansen, RD; Tjonneland, A; Roswall, N; van der A, DL; Overvad, K; Jakobsen, MU; Boeing, H; Meidtner, K; Palli, D; Masala, G; Bouatia-Naji, N; Saris, WHM; Feskens, EJM; Wareham, NJ; Vimaleswaran, KS; Langin, D; Loos, RJF; Sorensen, TIA; Clement, K				Hooton, Henri; Aengquist, Lars; Holst, Claus; Hager, Jorg; Rousseau, Francis; Hansen, Rikke D.; Tjonneland, Anne; Roswall, Nina; van der A, Daphne L.; Overvad, Kim; Jakobsen, Marianne Uhre; Boeing, Heiner; Meidtner, Karina; Palli, Domenico; Masala, Giovanna; Bouatia-Naji, Nabila; Saris, Wim H. M.; Feskens, Edith J. M.; Wareham, Nicolas J.; Vimaleswaran, Karani S.; Langin, Dominique; Loos, Ruth J. F.; Sorensen, Thorkild I. A.; Clement, Karine			Dietary Factors Impact on the Association between CTSS Variants and Obesity Related Traits	PLOS ONE			English	Article							CATHEPSIN-S; WEIGHT-LOSS; FAT INTAKE; ADIPOSE-TISSUE; GLYCEMIC INDEX; FLIP-FLOP; WOMEN; PROTEIN; CANCER; GENE	Background/Aims: Cathepsin S, a protein coded by the CTSS gene, is implicated in adipose tissue biology-this protein enhances adipose tissue development. Our hypothesis is that common variants in CTSS play a role in body weight regulation and in the development of obesity and that these effects are influenced by dietary factors-increased by high protein, glycemic index and energy diets. Methods: Four tag SNPs (rs7511673, rs11576175, rs10888390 and rs1136774) were selected to capture all common variation in the CTSS region. Association between these four SNPs and several adiposity measurements (BMI, waist circumference, waist for given BMI and being a weight gainer-experiencing the greatest degree of unexplained annual weight gain during follow-up or not) given, where applicable, both as baseline values and gain during the study period (6-8 years) were tested in 11,091 European individuals (linear or logistic regression models). We also examined the interaction between the CTSS variants and dietary factors-energy density, protein content (in grams or in % of total energy intake) and glycemic index-on these four adiposity phenotypes. Results: We found several associations between CTSS polymorphisms and anthropometric traits including baseline BMI (rs11576175 (SNP N degrees 2), p = 0.02, beta = -0.2446), and waist change over time (rs7511673 (SNP N degrees 1), p = 0.01, beta = -0.0433 and rs10888390 (SNP N degrees 3), p = 0.04, beta = -0.0342). In interaction with the percentage of proteins contained in the diet, rs11576175 (SNP N degrees 2) was also associated with the risk of being a weight gainer (p(interaction) = 0.01, OR = 1.0526)-the risk of being a weight gainer increased with the percentage of proteins contained in the diet. Conclusion: CTSS variants seem to be nominally associated to obesity related traits and this association may be modified by dietary protein intake.	[Hooton, Henri; Clement, Karine] INSERM, U872, Paris, France; [Hooton, Henri; Clement, Karine] Univ Paris 06, Ctr Rech Cordeliers, U872, Paris, France; [Hooton, Henri; Bouatia-Naji, Nabila; Clement, Karine] Univ Paris 05, Paris, France; [Aengquist, Lars; Holst, Claus; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Hager, Jorg] CNG, Paris, France; [Rousseau, Francis] INTEGRAGEN, Paris, France; [Hansen, Rikke D.; Tjonneland, Anne; Roswall, Nina] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [van der A, Daphne L.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Overvad, Kim; Jakobsen, Marianne Uhre] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Boeing, Heiner; Meidtner, Karina] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Palli, Domenico; Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Bouatia-Naji, Nabila; Wareham, Nicolas J.; Vimaleswaran, Karani S.; Loos, Ruth J. F.] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Bouatia-Naji, Nabila] INSERM, U970, Paris Cardiovasc Res Ctr, Paris, France; [Saris, Wim H. M.] Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Human Biol, Maastricht, Netherlands; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Vimaleswaran, Karani S.] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Vimaleswaran, Karani S.] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Langin, Dominique] Inst Metab & Cardiovasc Dis, INSERM, U1048, Obes Res Lab,Team 4, Toulouse, France; [Langin, Dominique] Univ Toulouse 3, U1048, Univ Toulouse, F-31062 Toulouse, France; [Langin, Dominique] Toulouse Univ Hosp, Dept Clin Biochem, Toulouse, France; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Clement, Karine] Hop La Pitie Salpetriere, AP HP, Dept Nutr, Paris, France; [Clement, Karine] Ctr Rech Nutr Humaine Ile France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Danish Cancer Society; Netherlands National Institute for Public Health & the Environment; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Maastricht University; Wageningen University & Research; University of London; University College London; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Novo Nordisk Foundation; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hooton, H (corresponding author), INSERM, U872, Paris, France.	henri.hooton@upmc.fr	Clément, karine/R-1120-2017; Loos, Ruth J F/Q-2862-2016; Feskens, Edith/ABI-1446-2020; Roswall, Nina/AAJ-6700-2020; Bouatia-Naji, Nabila/AGF-1400-2022; Masala, Giovanna/AAC-5474-2022; BOUATIA-NAJI, NABILA/D-5863-2013; Jakobsen, Marianne Uhre/I-8550-2018; Loos, Ruth/GON-5877-2022	Loos, Ruth J F/0000-0002-8532-5087; Feskens, Edith/0000-0001-5819-2488; Roswall, Nina/0000-0003-3071-1658; Bouatia-Naji, Nabila/0000-0001-5424-2134; Masala, Giovanna/0000-0002-5758-9069; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Meidtner, Karina/0000-0001-5810-4062; Karani, Vimal/0000-0002-8485-8930; Angquist, Lars/0000-0002-9516-4424; Tjonneland, Anne/0000-0003-4385-2097; tumino, rosario/0000-0003-2666-414X; PALLI, Domenico/0000-0002-5558-2437; Langin, Dominique/0000-0002-2669-7825; Overvad, Kim/0000-0001-6429-7921	European grant DIOGENES; European grant GENDINOB; Region Ile de France (CODDIM); Fondation pour la recherche medicale/Danone; l'Agence Nationale de la Recherche (Programme OBCAT); Medical Research Council [MC_U106179471] Funding Source: researchfish	European grant DIOGENES; European grant GENDINOB; Region Ile de France (CODDIM)(Region Ile-de-France); Fondation pour la recherche medicale/Danone(Danone Nutricia); l'Agence Nationale de la Recherche (Programme OBCAT)(French National Research Agency (ANR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by two European grants: the DIOGENES grant and the GENDINOB grant. Work on Cathepsins in Nutriomique laboratory is supported by Region Ile de France (CODDIM), Fondation pour la recherche medicale/Danone and l'Agence Nationale de la Recherche (Programme OBCAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders simply provided the funds for the study.	Astrup A, 2000, INT J OBESITY, V24, P1545, DOI 10.1038/sj.ijo.0801453; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Brehm BJ, 2005, J CLIN ENDOCR METAB, V90, P1475, DOI 10.1210/jc.2004-1540; Carmichael HE, 1998, J AM DIET ASSOC, V98, P35, DOI 10.1016/S0002-8223(98)00011-X; Clarke GM, 2010, GENET EPIDEMIOL, V34, P266, DOI 10.1002/gepi.20458; Dolley G, 2008, INT J OBESITY, V32, P669, DOI 10.1038/sj.ijo.0803773; Du H, 2009, INT J OBESITY, V33, P1280, DOI 10.1038/ijo.2009.163; Du HD, 2006, ACTA CARDIOL, V61, P383, DOI 10.2143/AC.61.4.2017298; Du HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017436; Fontanesi L, 2010, MEAT SCI, V85, P331, DOI 10.1016/j.meatsci.2010.01.023; Forouhi NG, 2009, AM J CLIN NUTR, V90, P1632, DOI 10.3945/ajcn.2009.27828; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gelb BD, 1997, GENOMICS, V41, P258, DOI 10.1006/geno.1997.4631; Halkjaer J, 2010, INT J OBES LOND; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hasselbalch AL, 2008, OBESITY, V16, P2723, DOI 10.1038/oby.2008.440; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hooton H, 2011, OBESITY FACTS, V4, P131, DOI 10.1159/000327797; Jeor STS, 2001, CIRCULATION, V104, P1869, DOI 10.1161/hc4001.096152; Katunuma N, 2000, BIOCHEM BIOPH RES CO, V272, P151, DOI 10.1006/bbrc.2000.2738; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Lafarge JC, 2010, BIOCHIMIE, V92, P1580, DOI 10.1016/j.biochi.2010.04.011; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu Y-J, 2010, OBESITY SILVER SPRIN; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moonesinghe R, 2010, EUR J HUM GENET, V18, P485, DOI 10.1038/ejhg.2009.209; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Naukkarinen J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000976; Oarada M, 2010, BIOSCI BIOTECH BIOCH, V74, P620, DOI 10.1271/bbb.90829; Pirozzo S, 2003, Obes Rev, V4, P83, DOI 10.1046/j.1467-789X.2003.00099.x; Pirozzo S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003640; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2006, INT J CANCER, V118, P2832, DOI 10.1002/ijc.21730; Rock CL, 2001, CANCER-AM CANCER SOC, V91, P25, DOI 10.1002/1097-0142(20010101)91:1&lt;25::AID-CNCR4&gt;3.0.CO;2-G; Rood JA, 1997, GENOMICS, V41, P169, DOI 10.1006/geno.1997.4614; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Saris WHM, 2005, OBES REV, V6, P175, DOI 10.1111/j.1467-789x.2005.00200.x; SHEPPARD L, 1991, AM J CLIN NUTR, V54, P821, DOI 10.1093/ajcn/54.5.821; Sherwood NE, 2000, INT J OBESITY, V24, P395, DOI 10.1038/sj.ijo.0801169; SHI GP, 1994, J BIOL CHEM, V269, P11530; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spielmann N, 2008, CLIN GENET, V74, P155, DOI 10.1111/j.1399-0004.2008.01043.x; Taleb S, 2006, J CLIN ENDOCR METAB, V91, P1042, DOI 10.1210/jc.2005-1601; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vimaleswaran KS, 2012, OBESITY, V20, P1669, DOI 10.1038/oby.2012.49; Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P14, DOI 10.1038/sj.ijo.0800538; Westerterp-Plantenga MS, 2003, CURR OPIN CLIN NUTR, V6, P635, DOI 10.1097/00075197-200311000-00005; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x; Willett WC, 2002, AM J MED, V113, P47, DOI 10.1016/S0002-9343(01)00992-5; Yang M, 2008, ARTERIOSCL THROM VAS, V28, P2202, DOI 10.1161/ATVBAHA.108.172320; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001	61	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40394	10.1371/journal.pone.0040394	http://dx.doi.org/10.1371/journal.pone.0040394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844403	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000306687700012
J	Steinmann, C; Fedorov, DG; Jensen, JH				Steinmann, Casper; Fedorov, Dmitri G.; Jensen, Jan H.			The Effective Fragment Molecular Orbital Method for Fragments Connected by Covalent Bonds	PLOS ONE			English	Article							POTENTIAL METHOD; QUANTUM-CHEMISTRY; LARGE SYSTEMS; FORCE-FIELD; ACCURATE; CAPS; FRACTIONATION; FORMULATION; PRINCIPLES; PREDICTION	We extend the effective fragment molecular orbital method (EFMO) into treating fragments connected by covalent bonds. The accuracy of EFMO is compared to FMO and conventional ab initio electronic structure methods for polypeptides including proteins. Errors in energy for RHF and MP2 are within 2 kcal/mol for neutral polypeptides and 6 kcal/mol for charged polypeptides similar to FMO but obtained two to five times faster. For proteins, the errors are also within a few kcal/mol of the FMO results. We developed both the RHF and MP2 gradient for EFMO. Compared to ab initio, the EFMO optimized structures had an RMSD of 0.40 and 0.44 A for RHF and MP2, respectively.	[Steinmann, Casper; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Fedorov, Dmitri G.] Natl Inst Adv Ind Sci & Technol, NRI, Tsukuba, Ibaraki, Japan	University of Copenhagen; National Institute of Advanced Industrial Science & Technology (AIST)	Steinmann, C (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	steinmann@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; Svendsen, Casper/T-6775-2018	Jensen, Jan Halborg/0000-0002-1465-1010; Svendsen, Casper/0000-0002-5638-1346	Danish research Council; insilico rational engineering of novel enzymes (IRENE) [10502564]; Next Generation Super Computing Project Nanoscience Program (MEXT, Japan); Computational Materials Science Initiative	Danish research Council(Det Frie Forskningsrad (DFF)); insilico rational engineering of novel enzymes (IRENE); Next Generation Super Computing Project Nanoscience Program (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Computational Materials Science Initiative	This work was funded by a Schou Fellowship to JHJ from the Danish research Council. CS was sponsored by the insilico rational engineering of novel enzymes (IRENE). URL: http://cordis.europa.eu/search/index.cfm?fuseaction = proj.document&PJ_RCN = 10502564. DF is sponsored by Next Generation Super Computing Project Nanoscience Program (MEXT, Japan) and the Computational Materials Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovic I, 2005, MOL PHYS, V103, P379, DOI 10.1080/00268970512331317246; [Anonymous], 2011, OPEN BABEL PACKAGE V; Beran GJO, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3121323; Dahlke EE, 2007, J CHEM THEORY COMPUT, V3, P46, DOI 10.1021/ct600253j; Day PN, 1996, J CHEM PHYS, V105, P1968, DOI 10.1063/1.472045; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; EDMISTON C, 1963, REV MOD PHYS, V35, P457, DOI 10.1103/RevModPhys.35.457; Fedorov DG, 2004, J CHEM PHYS, V121, P2483, DOI 10.1063/1.1769362; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; Fedorov DG, 2004, J COMPUT CHEM, V25, P872, DOI 10.1002/jcc.20018; Fedorov DG, 2005, J PHYS CHEM A, V109, P2638, DOI 10.1021/jp047186z; Fedorov DG, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2007588; Fedorov DG, 2008, J PHYS CHEM A, V112, P11808, DOI 10.1021/jp805435n; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Fedorov DG, 2007, J PHYS CHEM A, V111, P2722, DOI 10.1021/jp0671042; Fedorov DG, 2007, J COMPUT CHEM, V28, P1476, DOI 10.1002/jcc.20645; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Fedorov DG, 2011, J PHYS CHEM LETT, V2, P282, DOI 10.1021/jz1016894; Fedorov DG, 2009, CHEM PHYS LETT, V477, P169, DOI 10.1016/j.cplett.2009.06.072; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Ghosh D, 2010, J PHYS CHEM A, V114, P12739, DOI 10.1021/jp107557p; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Gordon MS, 2009, J PHYS CHEM B, V113, P9646, DOI 10.1021/jp811519x; GORDON MS, 1982, J AM CHEM SOC, V104, P2797, DOI 10.1021/ja00374a017; Gordon MS, 2001, J PHYS CHEM A, V105, P293, DOI 10.1021/jp002747h; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Ishimura K, 2006, J COMPUT CHEM, V27, P407, DOI 10.1002/jcc.20348; Jacobson LD, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3560026; James J. P, 2008, MOPAC2009 STEWART CO; Jensen JH, 2005, J PHYS CHEM A, V109, P6634, DOI 10.1021/jp051922x; Jiang N, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2178796; Kairys V, 2000, J PHYS CHEM A, V104, P6656, DOI 10.1021/jp000887l; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Mazanetz MP, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-2; Minikis RM, 2001, J PHYS CHEM A, V105, P3829, DOI 10.1021/jp0032659; Molina PA, 2003, J COMPUT CHEM, V24, P1971, DOI 10.1002/jcc.10333; Nagata T, 2011, CHALL ADV COMPUT CHE, V13, P17, DOI 10.1007/978-90-481-2853-2_2; Nagata T, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3611020; Nagata T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3568010; Nagata T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3517110; Nagata T, 2010, CHEM PHYS LETT, V492, P302, DOI 10.1016/j.cplett.2010.04.043; Nagata T, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3156313; Nakano T, 2000, CHEM PHYS LETT, V318, P614, DOI 10.1016/S0009-2614(00)00070-1; Nakano T, 2002, CHEM PHYS LETT, V351, P475, DOI 10.1016/S0009-2614(01)01416-6; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohno K, 2011, CURR MED CHEM, V18, P220, DOI 10.2174/092986711794088335; Sawada T, 2010, J AM CHEM SOC, V132, P16862, DOI 10.1021/ja105051e; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sebetci A, 2010, J CHEM THEORY COMPUT, V6, P155, DOI 10.1021/ct900545v; Soderhjelm P, 2009, J PHYS CHEM B, V113, P11085, DOI 10.1021/jp810551h; Soderhjelm P, 2009, J PHYS CHEM A, V113, P617, DOI 10.1021/jp8073514; Steinmann C, 2010, J PHYS CHEM A, V114, P8705, DOI 10.1021/jp101498m; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; STONE AJ, 1981, CHEM PHYS LETT, V83, P233, DOI 10.1016/0009-2614(81)85452-8; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Xie WS, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2936122; Xie WS, 2007, J CHEM THEORY COMPUT, V3, P1890, DOI 10.1021/ct700167b; Zhang DW, 2003, J COMPUT CHEM, V24, P1846, DOI 10.1002/jcc.10346; Zhang DW, 2003, J CHEM PHYS, V119, P3599, DOI 10.1063/1.1591727	60	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41117	10.1371/journal.pone.0041117	http://dx.doi.org/10.1371/journal.pone.0041117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844433	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700046
J	Zhang, YB; Li, X; Zhang, F; Wang, DM; Yu, J				Zhang, Yong-Biao; Li, Xin; Zhang, Feng; Wang, Duen-Mei; Yu, Jun			A Preliminary Study of Copy Number Variation in Tibetans	PLOS ONE			English	Article							HUMAN GENOME; NATURAL-SELECTION; MALE-INFERTILITY; HUMAN-DISEASE; Y-CHROMOSOME; GENE; POPULATION; VARIANTS; DIFFERENTIATION; EXPRESSION	Genetic features of Tibetans have been broadly investigated, but the properties of copy number variation (CNV) have not been well examined. To get a preliminary view of CNV in Tibetans, we scanned 29 Tibetan genomes with the Illumina Human-1 M high-resolution genotyping microarray and identified 139 putative copy number variable regions (CNVRs), consisting of 70 deletions, 61 duplications, and 8 multi-allelic loci. Thirty-four of the 139 CNVRs showed differential allele frequencies versus other East-Asian populations, with P values < 0.0001. These results indicated a distinct pattern of CNVR allele frequency distribution in Tibetans. The Tibetan CNVRs are enriched for genes in the disease class of human reproduction (such as genes from the DAZ, BPY2, CDY, and HLA-DQ and -DR gene clusters) and biological process categories of "response to DNA damage stimulus" and "DNA repair" (such as RAD51, RAD52, and MRE11A). These genes are related to the adaptive traits of high infant birth weight and darker skin tone of Tibetans, and may be attributed to recent local adaptation. Our results provide a different view of genetic diversity in Tibetans and new insights into their high-altitude adaptation.	[Zhang, Yong-Biao; Li, Xin; Zhang, Feng; Wang, Duen-Mei; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhang, YB (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	zhangf@big.ac.cn			Knowledge Innovation Program of the Chinese Academy of Sciences	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroviita P, 2004, EUR J IMMUNOGENET, V31, P21, DOI 10.1111/j.1365-2370.2004.00434.x; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Beall CA, 2007, RESP PHYSIOL NEUROBI, V158, P161, DOI 10.1016/j.resp.2007.05.013; Buroker NE, 2010, CLIN CHIM ACTA, V411, P1466, DOI 10.1016/j.cca.2010.05.043; Chen W, 2011, NEPHROL DIAL TRANSPL, V26, P1592, DOI 10.1093/ndt/gfq608; Chen XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012185; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gayden T, 2009, J HUM GENET, V54, P216, DOI 10.1038/jhg.2009.14; Halper-Stromberg E, 2011, BIOINFORMATICS, V27, P1052, DOI 10.1093/bioinformatics/btr106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kang LL, 2010, J HUM GENET, V55, P270, DOI 10.1038/jhg.2010.21; Kruse C, 2004, HUM REPROD, V19, P1215, DOI 10.1093/humrep/deh200; Li J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007958; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Lin CH, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-92; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Ouzhu B, 1998, J TIBET U, V24, P5; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Roll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013750; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thompson PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023543; Tse JYM, 2003, BIOL REPROD, V69, P746, DOI 10.1095/biolreprod.103.015792; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564; Zasloff M, 2005, J INVEST DERMATOL, V125, pXVI, DOI 10.1111/j.0022-202X.2005.23924.x; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang Y, 2010, J HUM GENET; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	46	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41768	10.1371/journal.pone.0041768	http://dx.doi.org/10.1371/journal.pone.0041768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844521	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700148
J	Fu, SJ; Peng, ZG; Cao, ZD; Peng, JL; He, XK; Xu, DD; Zhang, AJ				Fu, Shi-Jian; Peng, Zuogang; Cao, Zhen-Dong; Peng, Jiang-Lan; He, Xiao-Ke; Xu, Dandan; Zhang, An-Jie			Habitat-Specific Locomotor Variation among Chinese Hook Snout Carp (Opsariichthys bidens) along a River	PLOS ONE			English	Article							SWIMMING PERFORMANCE; GENETIC-DIVERGENCE; CYPRINUS-CARPIO; FISH; MORPHOLOGY; LAKE; TEMPERATURE; EXERCISE	The Wujiang River is a tributary of the upper Yangtze River that shows great variations in its flow regime and habitat condition. Dams have been built along the Wujiang River and have altered the habitats profoundly enough that they may give rise to reproductive isolation. To test whether the swimming performance and morphology of the Chinese hook snout carp (Opsariichthys bidens), varied among habitats and whether the possible differences had a genetic basis, we measured the steady and unsteady swimming performance, external body shape and genetic distance among fish collected from both the main and tributary streams of the upper, middle and lower reaches along the river. We also measured the routine energy expenditure (RMR), maximum metabolic rate (MMR), cost of transport (COT) and calculated the optimal swimming speed. The steady swimming capacity, RMR, MMR and optimal swimming speed were all higher and the COT was lower in the upper reach or tributary streams compared with the lower reach or main stream. However, unsteady swimming performance showed no variation among collecting sites. Flow regimes as suggested by river slope and water velocity were positively correlated with steady swimming performance but not with unsteady swimming performance. Predation stress were significantly related with body morphology and hence energy cost during swimming but not U-crit value. The fish from only one population (Hao-Kou) showed relatively high genetic differentiation compared with the other populations. Fish from the upper reach or tributary streams exhibited improved steady swimming performance through improved respiratory capacity and lower energy expenditure during swimming at the cost of higher maintenance metabolism. There was no correlation between the steady and unsteady swimming performance at either the population or the individual levels. These results suggest that a trade-off between steady and unsteady swimming does not occur in O. bidens.	[Fu, Shi-Jian; Cao, Zhen-Dong; Peng, Jiang-Lan; He, Xiao-Ke; Zhang, An-Jie] Chongqing Normal Univ, Chongqing Key Lab Anim Biol, Lab Evolutionary Physiol & Behav, Chongqing, Peoples R China; [Peng, Zuogang; Xu, Dandan] Southwest Univ, Sch Life Sci, Key Lab Freshwater Fish Reprod & Dev MOE, Chongqing, Peoples R China	Chongqing Normal University; Southwest University - China	Fu, SJ (corresponding author), Chongqing Normal Univ, Chongqing Key Lab Anim Biol, Lab Evolutionary Physiol & Behav, Chongqing, Peoples R China.	shijianfu9@126.com	Fu, Shi-Jian/R-8084-2019; Peng, Zuogang/D-4448-2011	Fu, Shi-Jian/0000-0001-7665-9037; Peng, Zuogang/0000-0001-8810-2025	National Science Foundation of China [NSFC 31172096]; Natural Science Foundation Project of Chongqing [CSTC2010BB1089]; Project of Chongqing Science & Technology Commission [2010CA1010]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing); Project of Chongqing Science & Technology Commission	This study was funded by grants from the National Science Foundation of China (NSFC 31172096), the Natural Science Foundation Project of Chongqing (CSTC2010BB1089) and the Project of Chongqing Science & Technology Commission (No. CSTC, 2010CA1010) granted to SJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake R.W., 1983, FISH LOCOMOTION; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Fu SJ, 2011, J EXP BIOL, V214, P2080, DOI 10.1242/jeb.053132; Fu SJ, 2009, J EXP BIOL, V212, P2296, DOI 10.1242/jeb.027102; He Xiao-ke, 2011, Shengtaixue Zazhi, V30, P2523; Hendry AP, 2011, J EVOLUTION BIOL, V24, P23, DOI 10.1111/j.1420-9101.2010.02155.x; Kieffer JD, 2010, COMP BIOCHEM PHYS A, V156, P163, DOI 10.1016/j.cbpa.2010.02.009; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; Langerhans RB, 2006, PREDATION ORGANISMS, P177; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law TC, 1996, J EXP BIOL, V199, P2595; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; McGuigan K, 2003, EVOLUTION, V57, P104; Nelson JA, 2003, CAN J FISH AQUAT SCI, V60, P301, DOI 10.1139/F03-023; Oufiero CE, 2011, ECOLOGY, V92, P170, DOI 10.1890/09-1912.1; Pang X, 2011, COMP BIOCHEM PHYS A, V159, P253, DOI 10.1016/j.cbpa.2011.03.013; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Reidy SP, 2000, J EXP BIOL, V203, P347; Rouleau S, 2010, FUNCT ECOL, V24, P310, DOI 10.1111/j.1365-2435.2009.01636.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Varian A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012950; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Webb P.W., 1985, P110; Webster MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021060; Xiao WH, 2001, MOL PHYLOGENET EVOL, V18, P163, DOI 10.1006/mpev.2000.0879; Yan GJ, 2012, J THERM BIOL, V37, P424, DOI 10.1016/j.jtherbio.2012.04.006	34	19	27	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40791	10.1371/journal.pone.0040791	http://dx.doi.org/10.1371/journal.pone.0040791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829884	Green Submitted, gold, Green Published			2022-12-25	WOS:000306956300022
J	Guo, HJ; Sun, YC; Ren, Q; Zhu-Salzman, K; Kang, L; Wang, CZ; Li, CY; Ge, F				Guo, Huijuan; Sun, Yucheng; Ren, Qin; Zhu-Salzman, Keyan; Kang, Le; Wang, Chenzhu; Li, Chuanyou; Ge, Feng			Elevated CO2 Reduces the Resistance and Tolerance of Tomato Plants to Helicoverpa armigera by Suppressing the JA Signaling Pathway	PLOS ONE			English	Article							SEASON SQUARE ABSCISSION; TRANSGENIC BT COTTON; JASMONIC ACID; ARABIDOPSIS-THALIANA; POLYPHENOL OXIDASE; HERBIVORE DAMAGE; CARBON TRANSPORT; RAPID CHANGES; AVAILABILITY; IMPACTS	Both resistance and tolerance, which are two strategies that plants use to limit biotic stress, are affected by the abiotic environment including atmospheric CO2 levels. We tested the hypothesis that elevated CO2 would reduce resistance (i.e., the ability to prevent damage) but enhance tolerance (i.e., the ability to regrow and compensate for damage after the damage has occurred) of tomato plants to the cotton bollworm, Helicoverpa armigera. The results showed that elevated CO2 reduced resistance by decreasing the jasmonic acid (JA) level and activities of lipoxygenase, proteinase inhibitors, and polyphenol oxidase in wild-type (WT) plants infested with H. armigera. Consequently, the activities of total protease, trypsin-like enzymes, and weak and active alkaline trypsin-like enzymes increased in the midgut of H. armigera when fed on WT plants grown under elevated CO2. Unexpectedly, the tolerance of the WT to H. armigera (in terms of photosynthetic rate, activity of sucrose phosphate synthases, flower number, and plant biomass and height) was also reduced by elevated CO2. Under ambient CO2, the expression of resistance and tolerance to H. armigera was much greater in wild type than in spr2 (a JA-deficient genotype) plants, but elevated CO2 reduced these differences of the resistance and tolerance between WT and spr2 plants. The results suggest that the JA signaling pathway contributes to both plant resistance and tolerance to herbivorous insects and that by suppressing the JA signaling pathway, elevated CO2 will simultaneously reduce the resistance and tolerance of tomato plants.	[Guo, Huijuan; Sun, Yucheng; Kang, Le; Wang, Chenzhu; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China; [Guo, Huijuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Ren, Qin] Jining Normal Coll, Jining, Inner Mongolia, Peoples R China; [Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Li, Chuanyou] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Guo, HJ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China.	gef@ioz.ac.cn	Li, Chuanyou/ABF-4143-2020; Kang, Le/ABD-1116-2022	Kang, Le/0000-0003-4262-2329; Sun, Yucheng/0000-0003-2353-0218	National Nature Science Fund of China [30921063, 31030012]; Innovation Program of Beijing Institutes of Life Science, CAS [2010-Biols-CAS-0102]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Beijing Institutes of Life Science, CAS	This project was supported by the National Nature Science Fund of China (No. 30921063; No. 31030012) and the Innovation Program of Beijing Institutes of Life Science, CAS (2010-Biols-CAS-0102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2004, AGR FOREST METEOROL, V122, P85, DOI 10.1016/j.agrformet.2003.09.002; Babst BA, 2005, NEW PHYTOL, V167, P63, DOI 10.1111/j.1469-8137.2005.01388.x; Babst BA, 2008, ENTOMOL EXP APPL, V128, P117, DOI 10.1111/j.1570-7458.2008.00698.x; Bailey JK, 2010, BIOL INVASIONS, V12, P337, DOI 10.1007/s10530-009-9630-1; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Bezemer TM, 2000, BIOCHEM SYST ECOL, V28, P839, DOI 10.1016/S0305-1978(99)00130-1; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Bidart-Bouzat MG, 2004, ECOL LETT, V7, P837, DOI 10.1111/j.1461-0248.2004.00648.x; Bidart-Bouzat MG, 2004, ECOLOGY, V85, P297, DOI 10.1890/03-3062; BLACKWOOD CE, 1965, ANAL BIOCHEM, V12, P128, DOI 10.1016/0003-2697(65)90150-8; Chen F. J, 2004, ENTOMOL KNOWLEDGE, V41, P279; Chen FJ, 2007, ENTOMOL EXP APPL, V124, P27, DOI 10.1111/j.1570-7458.2007.00563.x; Chen FJ, 2004, J APPL ENTOMOL, V128, P723, DOI 10.1111/j.1439-0418.2004.00921.x; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Couture JJ, 2010, CHEMOECOLOGY, V20, P277, DOI 10.1007/s00049-010-0058-y; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; Fornoni J, 2003, EVOL ECOL RES, V5, P1049; Ge Feng, 2003, Yingyong Shengtai Xuebao, V14, P241; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Halitschke R, 2004, J PLANT GROWTH REGUL, V23, P238, DOI 10.1007/s00344-004-0037-z; Hartley SE, 2000, GLOBAL CHANGE BIOL, V6, P497, DOI 10.1046/j.1365-2486.2000.00333.x; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Karowe DN, 2011, J CHEM ECOL, V37, P1332, DOI 10.1007/s10886-011-0044-z; Katjiua MLJ, 2006, J CHEM ECOL, V32, P1431, DOI 10.1007/s10886-006-9060-9; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; Li CR, 2002, PLANT CELL ENVIRON, V25, P369, DOI 10.1046/j.0016-8025.2001.00818.x; Li CY, 2003, PLANT CELL, V15, P1646, DOI 10.1105/tpc.012237; MAHANTA PK, 1993, J AGR FOOD CHEM, V41, P272, DOI 10.1021/jf00026a026; Marshall CB, 2008, PLANT ECOL, V196, P1, DOI 10.1007/s11258-007-9331-8; Matros A, 2006, PLANT CELL ENVIRON, V29, P126, DOI 10.1111/j.1365-3040.2005.01406.x; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Ren Q, 2010, WEED SCI, V58, P252, DOI 10.1614/WS-D-09-00002.1; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; STOUT MJ, 1994, J CHEM ECOL, V20, P2575, DOI 10.1007/BF02036193; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Sun YC, 2010, PLANT CELL ENVIRON, V33, P729, DOI 10.1111/j.1365-3040.2009.02098.x; Tegelberg R, 2008, ENVIRON EXP BOT, V62, P308, DOI 10.1016/j.envexpbot.2007.10.003; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Vigue LM, 2010, AGR FOREST ENTOMOL, V12, P267, DOI 10.1111/j.1461-9563.2010.00475.x; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wu G, 2007, FIELD CROP RES, V102, P239, DOI 10.1016/j.fcr.2007.03.007; Wu G, 2007, AGRON J, V99, P791, DOI 10.2134/agronj2006.0138; Yin J, 2010, ENTOMOL EXP APPL, V136, P12, DOI 10.1111/j.1570-7458.2010.00998.x; Yin J, 2009, AGR ECOSYST ENVIRON, V132, P267, DOI 10.1016/j.agee.2009.04.010; Zavala JA, 2008, P NATL ACAD SCI USA, V105, P10631, DOI 10.1073/pnas.0805247105; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x; Zavala JA, 2009, OECOLOGIA, V161, P35, DOI 10.1007/s00442-009-1360-7	52	39	41	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41426	10.1371/journal.pone.0041426	http://dx.doi.org/10.1371/journal.pone.0041426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829948	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300088
J	Ho-Pun-Cheung, A; Bazin, H; Gaborit, N; Larbouret, C; Garnero, P; Assenat, E; Castan, F; Bascoul-Mollevi, C; Ramos, J; Ychou, M; Pelegrin, A; Mathis, G; Lopez-Crapez, E				Ho-Pun-Cheung, Alexandre; Bazin, Herve; Gaborit, Nadege; Larbouret, Christel; Garnero, Patrick; Assenat, Eric; Castan, Florence; Bascoul-Mollevi, Caroline; Ramos, Jeanne; Ychou, Marc; Pelegrin, Andre; Mathis, Gerard; Lopez-Crapez, Evelyne			Quantification of HER Expression and Dimerization in Patients' Tumor Samples Using Time-Resolved Forster Resonance Energy Transfer	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; PHASE-II; ADJUVANT CHEMOTHERAPY; 1ST-LINE TREATMENT; TRASTUZUMAB; RECEPTOR; HER2; EFFICACY; SAFETY	Following the development of targeted therapies against EGFR and HER2, two members of the human epidermal receptor (HER) family of receptor tyrosine kinases, much interest has been focused on their expression in tumors. However, knowing the expression levels of individual receptors may not be sufficient to predict drug response. Here, we describe the development of antibody-based time-resolved Forster resonance energy transfer (TR-FRET) assays for the comprehensive analysis not only of EGFR and HER2 expression in tumor cryosections, but also of their activation through quantification of HER homo-or heterodimers. First, EGFR and HER2 expression levels were quantified in 18 breast tumors and the results were compared with those obtained by using reference methods. The EGFR number per cell determined by TR-FRET was significantly correlated with EGFR mRNA copy number (P < 0.0001). Moreover, our method detected HER2 overexpression with 100% specificity and sensibility, as confirmed by the standard IHC, FISH and qPCR analyses. EGFR and HER2 dimerization was then assessed, using as controls xenograft tumors from cell lines with known dimer expression profiles. Our results show that quantification of HER dimerization provides information about receptor activation that cannot be obtained by quantification of single receptors. Quantifying HER expression and dimerization by TR-FRET assays might help identifying novel clinical markers for optimizing patients' treatment in oncology.	[Ho-Pun-Cheung, Alexandre; Lopez-Crapez, Evelyne] CRLC Val dAurelle Paul Lamarque, Translat Res Unit, Montpellier, France; [Bazin, Herve; Garnero, Patrick; Mathis, Gerard] Cisbio Bioassays, Res Dept, Codolet, France; [Gaborit, Nadege; Larbouret, Christel; Ychou, Marc; Pelegrin, Andre] Univ Montpellier I, CRLC Val dAurelle Paul Lamarque, IRCM, INSERM,U896, Montpellier, France; [Assenat, Eric; Ychou, Marc] CRLC Val dAurelle Paul Lamarque, Dept Med & Digest Oncol, Montpellier, France; [Castan, Florence; Bascoul-Mollevi, Caroline] CRLC Val dAurelle Paul Lamarque, Dept Biostat, Montpellier, France; [Ramos, Jeanne] CHU Montpellier, Dept Pathol, Montpellier, France	UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; CHU de Montpellier	Ho-Pun-Cheung, A (corresponding author), CRLC Val dAurelle Paul Lamarque, Translat Res Unit, Montpellier, France.	evelyne.crapez@montpellier.unicancer.fr	Mollevi, Caroline/AAA-6839-2019; Pèlegrin, André/J-3167-2016; Gaborit, Nadège A/O-7825-2017	Mollevi, Caroline/0000-0003-4827-3684; Ychou, Marc/0000-0001-7378-9469; Crapez, evelyne/0000-0002-8261-3470; Pelegrin, Andre/0000-0001-9254-2648	Agence Nationale de la Recherche (ANR) [ANR-07-RIB]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This study was supported by a grant from the Agence Nationale de la Recherche (ANR), program "Recherche & Innovation en Biotechnologie" ANR-07-RIB (http://www.agence-nationale-recherche.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Andresen BT, 2010, METHOD ENZYMOL, V484, P631, DOI [10.1016/S0076-6879(10)84031-5, 10.1016/B978-0-12-381298-8.00031-9]; Baselga J, 1999, SEMIN ONCOL, V26, P78; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; CHAZIN VR, 1992, ONCOGENE, V7, P1859; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Desmedt C, 2009, DIAGN MOL PATHOL, V18, P22, DOI 10.1097/PDM.0b013e31818ebc69; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Gaborit N, 2011, J BIOL CHEM, V286, P11337, DOI 10.1074/jbc.M111.223503; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; Ho-Pun-Cheung A, 2011, INT J CANCER, V128, P2938, DOI 10.1002/ijc.25639; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Jensen KHR, 2010, J BIOMOL SCREEN, V15, P1071, DOI 10.1177/1087057110376834; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Johannessen LE, 2001, BIOCHEM J, V356, P87, DOI 10.1042/0264-6021:3560087; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Perez EA, 2006, J CLIN ONCOL, V24, P3032, DOI 10.1200/JCO.2005.03.4744; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spears M, 2011, BREAST CANC IN PRESS; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	30	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e37065	10.1371/journal.pone.0037065	http://dx.doi.org/10.1371/journal.pone.0037065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829865	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300003
J	Morales-Botello, ML; Aguilar, J; Foffani, G				Morales-Botello, M. L.; Aguilar, J.; Foffani, G.			Imaging the Spatio-Temporal Dynamics of Supragranular Activity in the Rat Somatosensory Cortex in Response to Stimulation of the Paws	PLOS ONE			English	Article							SPINAL-CORD-INJURY; SENSORY-MOTOR CORTEX; BARREL CORTEX; RECEPTIVE-FIELDS; FUNCTIONAL-ORGANIZATION; IN-VIVO; CORTICAL REPRESENTATION; ADULT-RATS; LAYER 2/3; VOLTAGE	We employed voltage-sensitive dye (VSD) imaging to investigate the spatio-temporal dynamics of the responses of the supragranular somatosensory cortex to stimulation of the four paws in urethane-anesthetized rats. We obtained the following main results. (1) Stimulation of the contralateral forepaw evoked VSD responses with greater amplitude and smaller latency than stimulation of the contralateral hindpaw, and ipsilateral VSD responses had a lower amplitude and greater latency than contralateral responses. (2) While the contralateral stimulation initially activated only one focus, the ipsilateral stimulation initially activated two foci: one focus was typically medial to the focus activated by contralateral stimulation and was stereotaxically localized in the motor cortex; the other focus was typically posterior to the focus activated by contralateral stimulation and was stereotaxically localized in the somatosensory cortex. (3) Forepaw and hindpaw somatosensory stimuli activated large areas of the sensorimotor cortex, well beyond the forepaw and hindpaw somatosensory areas of classical somatotopic maps, and forepaw stimuli activated larger cortical areas with greater activation velocity than hindpaw stimuli. (4) Stimulation of the forepaw and hindpaw evoked different cortical activation dynamics: forepaw responses displayed a clear medial directionality, whereas hindpaw responses were much more uniform in all directions. In conclusion, this work offers a complete spatio-temporal map of the supragranular VSD cortical activation in response to stimulation of the paws, showing important somatotopic differences between contralateral and ipsilateral maps as well as differences in the spatio-temporal activation dynamics in response to forepaw and hindpaw stimuli.	[Morales-Botello, M. L.; Aguilar, J.; Foffani, G.] Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Spain; [Foffani, G.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Hospital Nacional de Paraplejicos; Drexel University	Morales-Botello, ML (corresponding author), Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Spain.	guglielmo.foffani@drexel.edu	Aguilar, Juan/Q-2206-2015; Morales Botello, Maria de la Luz/O-8755-2015; Foffani, Guglielmo/ABD-5897-2020; Aguilar, Juan/N-3850-2019	Aguilar, Juan/0000-0002-8070-3923; Morales Botello, Maria de la Luz/0000-0002-5347-8388; Aguilar, Juan/0000-0002-8070-3923; Foffani, Guglielmo/0000-0001-7289-6668	FISCAM (Gobierno de Castilla-La Mancha) [MOV-2008_JI/9]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (Spain) [PI08/1852 PI11/02451]; FEDER (Fondo Europeo de Desarrollo Regional)	FISCAM (Gobierno de Castilla-La Mancha); Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This work was supported by FISCAM (Gobierno de Castilla-La Mancha) MOV-2008_JI/9 and Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III PI08/1852 PI11/02451 (Spain), co-funded by FEDER (Fondo Europeo de Desarrollo Regional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2008, EUR J NEUROSCI, V27, P378, DOI 10.1111/j.1460-9568.2008.06025.x; Aguilar JR, 2005, J NEUROSCI, V25, P10990, DOI 10.1523/JNEUROSCI.3229-05.2005; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1988, EXP BRAIN RES, V70, P155; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Bermejo PE, 2003, J COMP NEUROL, V463, P419, DOI 10.1002/cne.10747; BERNARDO KL, 1990, J COMP NEUROL, V291, P231, DOI 10.1002/cne.902910207; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; BURSTEIN R, 1990, BRAIN RES, V511, P329, DOI 10.1016/0006-8993(90)90179-F; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Chakraibarti S, 2006, J COMP NEUROL, V498, P624, DOI 10.1002/cne.21052; CHAPIN JK, 1987, J COMP NEUROL, V263, P326, DOI 10.1002/cne.902630303; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Chemla S, 2010, NEUROIMAGE, V53, P420, DOI 10.1016/j.neuroimage.2010.06.026; Civillico EF, 2006, J NEUROPHYSIOL, V96, P336, DOI 10.1152/jn.00128.2006; CLARKE KA, 1995, PHYSIOL BEHAV, V58, P415, DOI 10.1016/0031-9384(95)00072-Q; Cliffer KD, 1998, MUSCLE NERVE, V21, P1405, DOI 10.1002/(SICI)1097-4598(199811)21:11<1405::AID-MUS7>3.3.CO;2-D; COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968; Colechio EM, 2009, BRAIN STRUCT FUNCT, V213, P423, DOI 10.1007/s00429-009-0215-7; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; DAWSON DR, 1987, J COMP NEUROL, V256, P246, DOI 10.1002/cne.902560205; Derdikman D, 2003, J NEUROSCI, V23, P3100; Devonshire IM, 2010, EUR J NEUROSCI, V32, P786, DOI 10.1111/j.1460-9568.2010.07322.x; DONOGHUE JP, 1979, J COMP NEUROL, V183, P647, DOI 10.1002/cne.901830312; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; ERZURUMLU RS, 1980, NEUROSCIENCE, V5, P1891, DOI 10.1016/0306-4522(80)90037-8; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Foffani G, 2009, J NEUROSCI, V29, P5964, DOI 10.1523/JNEUROSCI.4416-08.2009; Foffani G, 2008, J NEUROPHYSIOL, V100, P268, DOI 10.1152/jn.01015.2007; Francis JT, 2008, J NEUROPHYSIOL, V99, P2291, DOI 10.1152/jn.01206.2007; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; GOCHIN PM, 1992, P NATL ACAD SCI USA, V89, P8381, DOI 10.1073/pnas.89.17.8381; Goloshevsky AG, 2011, NEUROIMAGE, V57, P526, DOI 10.1016/j.neuroimage.2011.04.002; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Higley MJ, 2007, J NEUROPHYSIOL, V97, P647, DOI 10.1152/jn.00777.2006; JAIN N, 1995, J NEUROPHYSIOL, V73, P1537, DOI 10.1152/jn.1995.73.4.1537; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Laaris N, 2000, J NEUROSCI, V20, P1529; Lam YW, 2010, CEREB CORTEX, V20, P13, DOI 10.1093/cercor/bhp077; Lee KH, 2011, J NEUROTRAUM, V28, P797, DOI 10.1089/neu.2010.1492; Lilja J, 2006, J NEUROSCI, V26, P6330, DOI 10.1523/JNEUROSCI.0626-06.2006; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MANZONI T, 1980, EXP BRAIN RES, V39, P1; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Rocco-Donovan M, 2011, SOMATOSENS MOT RES, V28, P63, DOI 10.3109/08990220.2011.606660; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Sigler A, 2009, P NATL ACAD SCI USA, V106, P11759, DOI 10.1073/pnas.0812695106; Tsytsarev V, 2010, NEUROIMAGE, V53, P233, DOI 10.1016/j.neuroimage.2010.06.022; Tutunculer B, 2006, CEREB CORTEX, V16, P791, DOI 10.1093/cercor/bhj023; Urban J, 2002, EUR J NEUROSCI, V16, P1772, DOI 10.1046/j.1460-9568.2002.02225.x; Usunoff KG, 1999, ANAT EMBRYOL, V200, P265, DOI 10.1007/s004290050278; Weng JC, 2011, NEUROIMAGE, V54, P1122, DOI 10.1016/j.neuroimage.2010.08.046; Whishaw IQ, 2010, BEHAV BRAIN RES, V206, P21, DOI 10.1016/j.bbr.2009.08.030; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; WOOLF CJ, 1982, BRAIN RES, V242, P77, DOI 10.1016/0006-8993(82)90497-8; Wree A, 2005, ANAT EMBRYOL, V210, P155, DOI 10.1007/s00429-005-0012-x; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011; Yu X, 2010, NEUROIMAGE, V49, P1667, DOI 10.1016/j.neuroimage.2009.09.021	83	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40174	10.1371/journal.pone.0040174	http://dx.doi.org/10.1371/journal.pone.0040174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829873	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300011
J	Zurek, B; Schoultz, I; Neerincx, A; Napolitano, LM; Birkner, K; Bennek, E; Sellge, G; Lerm, M; Meroni, G; Soderholm, JD; Kufer, TA				Zurek, Birte; Schoultz, Ida; Neerincx, Andreas; Napolitano, Luisa M.; Birkner, Katharina; Bennek, Eveline; Sellge, Gernot; Lerm, Maria; Meroni, Germana; Soderholm, Johan D.; Kufer, Thomas A.			TRIM27 Negatively Regulates NOD2 by Ubiquitination and Proteasomal Degradation	PLOS ONE			English	Article							RET FINGER PROTEIN; INTESTINAL EPITHELIAL-CELLS; CLASS-II TRANSACTIVATOR; KAPPA-B ACTIVATION; TRIPARTITE-MOTIF; GENE-EXPRESSION; FAMILY-MEMBER; INNATE; MHC; INTERACTS	NOD2, the nucleotide-binding domain and leucine-rich repeat containing gene family (NLR) member 2 is involved in mediating antimicrobial responses. Dysfunctional NOD2 activity can lead to severe inflammatory disorders, but the regulation of NOD2 is still poorly understood. Recently, proteins of the tripartite motif (TRIM) protein family have emerged as regulators of innate immune responses by acting as E3 ubiquitin ligases. We identified TRIM27 as a new specific binding partner for NOD2. We show that NOD2 physically interacts with TRIM27 via the nucleotide-binding domain, and that NOD2 activation enhances this interaction. Dependent on functional TRIM27, ectopically expressed NOD2 is ubiquitinated with K48-linked ubiquitin chains followed by proteasomal degradation. Accordingly, TRIM27 affects NOD2-mediated pro-inflammatory responses. NOD2 mutations are linked to susceptibility to Crohn's disease. We found that TRIM27 expression is increased in Crohn's disease patients, underscoring a physiological role of TRIM27 in regulating NOD2 signaling. In HeLa cells, TRIM27 is partially localized in the nucleus. We revealed that ectopically expressed NOD2 can shuttle to the nucleus in a Walker A dependent manner, suggesting that NOD2 and TRIM27 might functionally cooperate in the nucleus. We conclude that TRIM27 negatively regulates NOD2-mediated signaling by degradation of NOD2 and suggest that TRIM27 could be a new target for therapeutic intervention in NOD2-associated diseases.	[Zurek, Birte; Neerincx, Andreas; Birkner, Katharina; Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Schoultz, Ida; Lerm, Maria; Soderholm, Johan D.] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Schoultz, Ida; Lerm, Maria; Soderholm, Johan D.] Linkoping Univ Hosp, Dept Surg, S-58185 Linkoping, Sweden; [Napolitano, Luisa M.] Telethon Inst Genet & Med, Naples, Italy; [Bennek, Eveline; Sellge, Gernot] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Napolitano, Luisa M.; Meroni, Germana] Cluster Biomed CBM, Trieste, Italy	University of Cologne; Linkoping University; Linkoping University; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); RWTH Aachen University; RWTH Aachen University Hospital	Zurek, B (corresponding author), Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany.	thomas.kufer@uk-koeln.de	Napolitano, Luisa Maria Rosaria/S-4088-2016; Kufer, Thomas A/I-5146-2015; Lerm, Maria/AAM-8705-2020; Lerm, Maria/AAA-1780-2020	Napolitano, Luisa Maria Rosaria/0000-0001-9214-7269; Kufer, Thomas A/0000-0003-4563-0412; Lerm, Maria/0000-0002-5092-9892; Zurek, PhD, Birte/0000-0002-8200-7542; Schoultz, Ida/0000-0002-8391-1576	German Research Foundation (DFG) [SFB670-NG01]; Swedish Society of Medicine; Regional Research Council of South-East Sweden (FORSS); Swedish Research Council division of Medicine; Gustav V 90th anniversary foundation; Italian Telethon Foundation; DFG [SE 1122/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); Swedish Society of Medicine; Regional Research Council of South-East Sweden (FORSS); Swedish Research Council division of Medicine; Gustav V 90th anniversary foundation; Italian Telethon Foundation(Fondazione Telethon); DFG(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG), grant SFB670-NG01 to TAK and grants from the Swedish Society of Medicine, the Regional Research Council of South-East Sweden (FORSS) and the Swedish Research Council division of Medicine and Gustav V 90th anniversary foundation to ML and JDS. GM is partly funded by the Italian Telethon Foundation. EB and GS acknowledge funding from the DFG, grant SE 1122/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 1997, CELL, V90, P797; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Bernot A, 1997, NAT GENET, V17, P25; Bielig H, 2009, MOL IMMUNOL, V46, P2647, DOI 10.1016/j.molimm.2009.04.022; Bloor AJC, 2005, ONCOGENE, V24, P6729, DOI 10.1038/sj.onc.1208828; Borzutzky A, 2009, CLIN IMMUNOL; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Cao TY, 1998, J CELL SCI, V111, P1319; Cao TY, 1997, J CELL SCI, V110, P1563; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dho SH, 2003, J BIOL CHEM, V278, P31902, DOI 10.1074/jbc.M304062200; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Hasegawa N, 1996, BIOCHEM BIOPH RES CO, V225, P627, DOI 10.1006/bbrc.1996.1221; Henry J, 1997, IMMUNOGENETICS, V46, P383, DOI 10.1007/s002510050292; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Ishii T, 2003, J IMMUNOL, V170, P3653, DOI 10.4049/jimmunol.170.7.3653; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Lecat A, 2010, BIOCHEM PHARMACOL, V80, P2021, DOI 10.1016/j.bcp.2010.07.016; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu J, 2008, MOL PLANT, V1, P411, DOI 10.1093/mp/ssn010; Liu YD, 2003, PLANT J, V34, P149, DOI 10.1046/j.1365-313X.2003.01709.x; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Magalhaes JG, 2011, CURR OPIN IMMUNOL, V23, P29, DOI 10.1016/j.coi.2010.12.003; Matsuura T, 2005, EXP CELL RES, V308, P65, DOI 10.1016/j.yexcr.2005.04.022; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Nakayama EE, 2010, REV MED VIROL, V20, P77, DOI 10.1002/rmv.637; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Neerincx A, 2012, J IMMUNOL, V188, P4940, DOI 10.4049/jimmunol.1103136; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh HM, 2005, CELL IMMUNOL, V237, P37, DOI 10.1016/j.cellimm.2005.09.006; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Patel CA, 2005, BIOCHEM BIOPH RES CO, V330, P333, DOI 10.1016/j.bbrc.2005.02.162; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; RASBAND W, 2007, IMAGEJ; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Shimono Y, 2000, J BIOL CHEM, V275, P39411, DOI 10.1074/jbc.M006585200; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Tameling WIL, 2007, PLANT CELL, V19, P1682, DOI 10.1105/tpc.107.050880; Tezel G, 1999, PATHOL INT, V49, P881, DOI 10.1046/j.1440-1827.1999.00957.x; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Toniato E, 2002, J BIOL CHEM, V277, P37315, DOI 10.1074/jbc.M205900200; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Yamamoto-Furusho JK, 2006, J BIOL CHEM, V281, P36060, DOI 10.1074/jbc.M602383200; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zika E, 2005, CURR OPIN IMMUNOL, V17, P58, DOI 10.1016/j.coi.2004.11.008; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	88	79	83	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41255	10.1371/journal.pone.0041255	http://dx.doi.org/10.1371/journal.pone.0041255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829933	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300072
J	Eskine, KJ; Kacinik, NA; Webster, GD				Eskine, Kendall J.; Kacinik, Natalie A.; Webster, Gregory D.			The Bitter Truth about Morality: Virtue, Not Vice, Makes a Bland Beverage Taste Nice	PLOS ONE			English	Article							BAD TASTE; DISGUST	To demonstrate that sensory and emotional states play an important role in moral processing, previous research has induced physical disgust in various sensory modalities (visual, tactile, gustatory, and olfactory modalities, among others) and measured its effects on moral judgment. To further assess the strength of the connection between embodied states and morality, we investigated whether the directionality of the effect could be reversed by exposing participants to different types of moral events prior to rating the same neutral tasting beverage. As expected, reading about moral transgressions, moral virtues, or control events resulted in inducing gustatory disgust, delight, or neutral taste experiences, respectively. Results are discussed in terms of the relation between embodied cognition and processing abstract conceptual representations.	[Eskine, Kendall J.] Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA; [Kacinik, Natalie A.] CUNY, Grad Ctr, Dept Psychol, New York, NY USA; [Kacinik, Natalie A.] CUNY Brooklyn Coll, New York, NY USA; [Webster, Gregory D.] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; State University System of Florida; University of Florida	Eskine, KJ (corresponding author), Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA.	kjeskine@loyno.edu						Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Damasio A.R., 1994, DESCARTES ERROR EMOT; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Eskine KJ, EMOT IN PRESS; Gray K, 2011, EMOT REV, V3, P258, DOI 10.1177/1754073911402388; Greene JD, 2011, EMOT REV, V3, P227, DOI 10.1177/1754073911409629; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Hume D, 2004, ENQUIRY HUMAN UNDERS; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; Lakoff G., 2003, METAPHORS WE LIVE; Lakoff George., 1999, PHILOS FLESH EMBODIE; Lee SWS, 2010, PSYCHOL SCI, V21, P1423, DOI 10.1177/0956797610382788; Lee SWS, 2012, EMB PREC SOC PERS SO; Liljenquist K, 2010, PSYCHOL SCI, V21, P381, DOI 10.1177/0956797610361426; Moretti L, 2010, EMOTION, V10, P169, DOI 10.1037/a0017826; Pizarro D, 2011, EMOT REV, V3, P267, DOI 10.1177/1754073911402394; Ritter RS, 2011, J EXP SOC PSYCHOL, V47, P1225, DOI 10.1016/j.jesp.2011.05.006; Royzman E, 2011, EMOT REV, V3, P274, DOI 10.1177/1754073911402402; Rozin P., 2009, DISGUST ITS DISORDER, P9, DOI DOI 10.1037/11856-001; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schnall S, 2008, PSYCHOL SCI, V19, P1219, DOI 10.1111/j.1467-9280.2008.02227.x; Schwarz N, 1998, AFFECT COGNITION SOC, P44; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	30	25	29	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41159	10.1371/journal.pone.0041159	http://dx.doi.org/10.1371/journal.pone.0041159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815953	gold, Green Published			2022-12-25	WOS:000306548900086
J	Kinde, I; Papadopoulos, N; Kinzler, KW; Vogelstein, B				Kinde, Isaac; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert			FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; GENOME BROWSER DATABASE; MATERNAL PLASMA; FETAL DNA; ALIGNMENT; IMPACT; BLOOD; AGE	Massively parallel sequencing of cell-free, maternal plasma DNA was recently demonstrated to be a safe and effective screening method for fetal chromosomal aneuploidies. Here, we report an improved sequencing method achieving significantly increased throughput and decreased cost by replacing laborious sequencing library preparation steps with PCR employing a single primer pair designed to amplify a discrete subset of repeated regions. Using this approach, samples containing as little as 4% trisomy 21 DNA could be readily distinguished from euploid samples.	[Kinde, Isaac] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Kinde, I (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA.	ik@jhmi.edu; kinzlke@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012		Virginia; D.K. Ludwig Fund for Cancer Research; National Institutes of Health [CA62924, CA43460, CA57345]; UNCF-Merck Graduate Fellowship; NATIONAL CANCER INSTITUTE [R37CA043460, P50CA062924, R01CA043460, R37CA057345, R01CA057345] Funding Source: NIH RePORTER	Virginia; D.K. Ludwig Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF-Merck Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Virginia and D.K. Ludwig Fund for Cancer Research, the National Institutes of Health (CA62924, CA43460, and CA57345), and by a UNCF-Merck Graduate Fellowship to I. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Bianchi DW, 2012, OBSTET GYNECOL; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hsu LYF, 1998, GENETIC DISORDERS FE, V4th, P179; Jones KL., 2006, SMITHS RECOGNIZABLE, V6th ed., P268; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; Resta RG, 2005, AM J MED GENET A, V133A, P31, DOI 10.1002/ajmg.a.30553; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Sparks AB, 2012, PRENAT DIAGN; Staebler M, 2005, PRENATAL DIAG, V25, P567, DOI 10.1002/pd.1187; Tukey JW, 1977, EXPLORATORY DATA ANA; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	30	46	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41162	10.1371/journal.pone.0041162	http://dx.doi.org/10.1371/journal.pone.0041162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815955	Green Published, gold, Green Submitted			2022-12-25	WOS:000306548900087
J	Wei, CJ; Bhattaram, VK; Igwe, JC; Fleming, E; Tirnauer, JS				Wei, Chongjuan; Bhattaram, Varun Kumar; Igwe, John C.; Fleming, Elizabeth; Tirnauer, Jennifer S.			The LKB1 Tumor Suppressor Controls Spindle Orientation and Localization of Activated AMPK in Mitotic Epithelial Cells	PLOS ONE			English	Article							PEUTZ-JEGHERS-SYNDROME; PROTEIN-KINASE; DROSOPHILA LKB1; CANCER; POLARITY; GENE; DIVISION; LKB1/STK11; MUTATIONS; TIGHT	Orientation of mitotic spindles plays an integral role in determining the relative positions of daughter cells in a tissue. LKB1 is a tumor suppressor that controls cell polarity, metabolism, and microtubule stability. Here, we show that germline LKB1 mutation in mice impairs spindle orientation in cells of the upper gastrointestinal tract and causes dramatic mislocalization of the LKB1 substrate AMPK in mitotic cells. RNAi of LKB1 causes spindle misorientation in three-dimensional MDCK cell cysts. Maintaining proper spindle orientation, possibly mediated by effects on the downstream kinase AMPK, could be an important tumor suppressor function of LKB1.	[Wei, Chongjuan] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Bhattaram, Varun Kumar; Igwe, John C.; Fleming, Elizabeth; Tirnauer, Jennifer S.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT USA; [Tirnauer, Jennifer S.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT USA	University of Texas System; UTMD Anderson Cancer Center; University of Connecticut; University of Connecticut	Wei, CJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	tirnauer@uchc.edu			Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center	Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center	Funded by the Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bonaccorsi S, 2007, DEVELOPMENT, V134, P2183, DOI 10.1242/dev.02848; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Chen XY, 2006, METHOD ENZYMOL, V406, P362, DOI 10.1016/S0076-6879(06)06026-5; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V48, P592; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Launonen V, 2005, HUM MUTAT, V26, P291, DOI 10.1002/humu.20222; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; McCarthy A, 2009, J PATHOLOGY; Mehenni H, 1998, AM J HUM GENET, V63, P1641, DOI 10.1086/302159; Mian I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031583; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Miyoshi H, 2002, CANCER RES, V62, P2261; MORTON DG, 1992, GENETICS, V130, P771; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Nakau M, 2002, CANCER RES, V62, P4549; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Sebbagh M, 2011, FAMILAIL CANC; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shelly M, 2011, DEV NEUROBIOLOGY; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Spicer J, 2003, ONCOGENE, V22, P4752, DOI 10.1038/sj.onc.1206669; Su GH, 1999, AM J PATHOL, V154, P1835, DOI 10.1016/S0002-9440(10)65440-5; Thoma CR, 2009, NATURE CELL BIOL; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Vazquez-Martin A, 2009, CELL CYCLE, V8, P2385, DOI 10.4161/cc.8.15.9082; Vazquez-Martin A, 2009, CELL CYCLE, V8, P788, DOI 10.4161/cc.8.5.7787; Wang ZJ, 1999, J PATHOL, V188, P9, DOI 10.1002/(SICI)1096-9896(199905)188:1<9::AID-PATH326>3.0.CO;2-E; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wei CJ, 2005, CANCER RES, V65, P11297, DOI 10.1158/0008-5472.CAN-05-0716; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Xu XJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-77; Ylikorkala A, 1999, HUM MOL GENET, V8, P45, DOI 10.1093/hmg/8.1.45; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	72	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41118	10.1371/journal.pone.0041118	http://dx.doi.org/10.1371/journal.pone.0041118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815934	Green Submitted, Green Published, gold			2022-12-25	WOS:000306548900075
J	Liu, SS; Kelvin, DJ; Leon, AJ; Jin, LQ; Farooqui, A				Liu, Shanshan; Kelvin, David J.; Leon, Alberto J.; Jin, Liqun; Farooqui, Amber			Induction of Fas Mediated Caspase-8 Independent Apoptosis in Immune Cells by Armigeres subalbatus Saliva	PLOS ONE			English	Article							AEDES-AEGYPTI; PATHOGEN TRANSMISSION; JAPANESE ENCEPHALITIS; VIRUS-INFECTION; GLAND EXTRACTS; MOSQUITO; CHINA; MODULATION; RESPONSES; DISEASE	Background: It is widely recognized that the introduction of saliva of bloodsucking arthropods at the site of pathogen transmission might play a central role in vector-borne infections. However, how the interaction between salivary components and the host immune system takes place and which physiological processes this leads to has yet to be investigated. Armigeres subalbatus is one of the prominent types of mosquitoes involved in the transmission of parasitic and viral diseases in humans and animals. Methodology/Principal Findings: Using murine peritoneal macrophages and lymphocytes, and human peripheral mononuclear cells (PBMCs), this study shows that saliva of the female Ar. subalbatus induces apoptosis via interaction with the Fas receptor within a few hours but without activating caspase-8. The process further activates downstream p38 MAPK signaling, a cascade that leads to the induction of apoptosis in capase-3 dependent manner. We further illustrate that Ar. subalbatus saliva suppresses proinflammatory cytokines without changing IL-10 levels, which might happen as a result of apoptosis. Conclusions: Our study shows for the first time that saliva-induced apoptosis is the leading phenomenon exerted by Ar. subalbatus that impede immune cells leading to the suppression of their effecter mechanism.	[Liu, Shanshan; Kelvin, David J.; Leon, Alberto J.; Farooqui, Amber] Shantou Univ, Coll Med, Div Immunol, Int Inst Infect & Immun, Shantou, Peoples R China; [Liu, Shanshan; Jin, Liqun] Shantou Univ, Coll Med, Dept Pathogen Biol, Shantou, Peoples R China; [Kelvin, David J.; Leon, Alberto J.; Farooqui, Amber] Univ Hlth Network, Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada; [Kelvin, David J.] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy	Shantou University; Shantou University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Sassari	Liu, SS (corresponding author), Shantou Univ, Coll Med, Div Immunol, Int Inst Infect & Immun, Shantou, Peoples R China.	lqjin@stu.edu.cn; amberfarooqui@hotmail.com	Farooqui, Amber/D-1402-2009	Farooqui, Amber/0000-0002-6031-9561	Li Ka-Shing Foundation of Canada; Shantou University Medical College, China	Li Ka-Shing Foundation of Canada; Shantou University Medical College, China	The study is supported by the grants from the Li Ka-Shing Foundation of Canada and Shantou University Medical College, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliota MT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000666; Andersen JF, 2010, TOXICON, V56, P1120, DOI 10.1016/j.toxicon.2009.11.002; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arjona A, 2011, CELLULAR MICROBIOLOG; Belkin J. N., 1962, MOSQUITOES S PACIFIC, V1 and 2; Boppana VD, 2009, PARASITE IMMUNOL, V31, P287, DOI 10.1111/j.1365-3024.2009.01096.x; Cao MQ, 2010, TROP MED INT HEALTH, V15, P918, DOI 10.1111/j.1365-3156.2010.02563.x; Chu BK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000708; Conceicao TM, 2010, J INFECTION, V60, P65, DOI 10.1016/j.jinf.2009.10.003; Daehnel K, 2007, PARASITE IMMUNOL, V29, P455, DOI 10.1111/j.1365-3024.2007.00962.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Espada-Murao LA, 2011, TROPICAL MED HLTH; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Gubler DJ, 2010, VECTOR BIOLOGY, ECOLOGY AND CONTROL, P39, DOI 10.1007/978-90-481-2458-9_4; Jin LQ, 2008, MED VET ENTOMOL, V22, P359, DOI 10.1111/j.1365-2915.2008.00758.x; Lee ACY, 2010, TRENDS PARASITOL, V26, P168, DOI 10.1016/j.pt.2010.01.003; Lee SE, 2007, VET PARASITOL, V148, P149, DOI 10.1016/j.vetpar.2007.04.015; Leitner WW, 2011, EUR J IMMUNOL, V41, P3396, DOI 10.1002/eji.201190075; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Lin W, 2005, J TROPICAL MED, V4; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Pan XL, 2011, J VIROL, V85, P9847, DOI 10.1128/JVI.00825-11; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Tsujimoto H, 2010, PARASITE IMMUNOL, V32, P275, DOI 10.1111/j.1365-3024.2009.01186.x; Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; Zeidner N, 2009, COINOCULATION BORREL; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zieler H, 2000, J EXP BIOL, V203, P1599	35	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41145	10.1371/journal.pone.0041145	http://dx.doi.org/10.1371/journal.pone.0041145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815944	gold, Green Submitted, Green Published			2022-12-25	WOS:000306507000074
J	Zhang, LJ; Xue, YQ; Yang, C; Yang, WH; Chen, L; Zhang, QJ; Qu, TY; Huang, SL; Zhao, LR; Wang, XM; Duan, WM				Zhang, Li-Juan; Xue, Yue-Qiang; Yang, Chun; Yang, Wei-Hua; Chen, Long; Zhang, Qian-Jin; Qu, Ting-Yu; Huang, Shile; Zhao, Li-Ru; Wang, Xiao-Min; Duan, Wei-Ming			Human Albumin Prevents 6-Hydroxydopamine-Induced Loss of Tyrosine Hydroxylase in In Vitro and In Vivo	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEURONAL CELL-DEATH; PROTECTS DOPAMINERGIC-NEURONS; SIGNAL-REGULATED KINASE; CYTOCHROME-C RELEASE; HUMAN SERUM-ALBUMIN; PARKINSONS-DISEASE; OXIDATIVE STRESS; INDUCED APOPTOSIS; MOLECULAR-MECHANISMS	Human albumin has recently been demonstrated to protect brain neurons from injury in rat ischemic brain. However, there is no information available about whether human albumin can prevent loss of tyrosine hydroxylase (TH) expression of dopaminergic (DA) neurons induced by 6-hydroxydopamine (6-OHDA) toxicity that is most commonly used to create a rat model of Parkinson's disease (PD). In the present study, two microliters of 1.25% human albumin were stereotaxically injected into the right striatum of rats one day before or 7 days after the 6-OHDA lesion in the same side. D-Amphetamine-induced rotational asymmetry was measured 7 days, 3 and 10 weeks after 6-OHDA lesion. We observed that intrastriatal administration of human albumin significantly reduced the degree of rotational asymmetry. The number of TH-immunoreactive neurons present in the substantia nigra was greater in 6-OHDA lesioned rats following human albumin-treatment than non-human albumin treatment. TH-immunoreactivity in the 6-OHDA-lesioned striatum was also significantly increased in the human albumin-treated rats. To examine the mechanisms underlying the effects of human albumin, we challenged PC12 cells with 6-OHDA as an in vitro model of PD. Incubation with human albumin prevented 6-OHDA-induced reduction of cell viability in PC12 cell cultures, as measured by MTT assay. Furthermore, human albumin reduced 6-OHDA-induced formation of reactive oxygen species (ROS) and apoptosis in cultured PC12 cells, as assessed by flow cytometry. Western blot analysis showed that human albumin inhibited 6-OHDA-induced activation of JNK, c-Jun, ERK, and p38 mitogen-activated protein kinases (MAPK) signaling in PC12 cultures challenged with 6-OHDA. Human albumin may protect against 6-OHDA toxicity by influencing MAPK pathway followed by anti-ROS formation and anti-apoptosis.	[Zhang, Li-Juan; Yang, Chun; Yang, Wei-Hua; Duan, Wei-Ming] Capital Med Univ, Dept Anat, Beijing, Peoples R China; [Zhang, Li-Juan; Wang, Xiao-Min] Capital Med Univ, Dept Physiol, Beijing, Peoples R China; [Xue, Yue-Qiang] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Chen, Long; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Zhang, Qian-Jin] Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA; [Qu, Ting-Yu] Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA; [Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA	Capital Medical University; Capital Medical University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Xavier University of Louisiana; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Zhang, LJ (corresponding author), Capital Med Univ, Dept Anat, Beijing, Peoples R China.	xmwang@ccmu.edu.cn; duanwm08@yahoo.com	Zhang, Li/GWM-7501-2022; qu, tingyu/AGX-7752-2022; qu, tingyu/AHA-0840-2022; Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072	Chinese Ministry of Science and Technology [2011CB504100]; Beijing Natural Science Foundation [11120087, 7112011]; Louisiana Board of Regents; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Louisiana Board of Regents; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB504100, WMD), Beijing Natural Science Foundation (11120087, WMD; 7112011, WMD), and the Louisiana Board of Regents (WMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bolitho C, 2007, J VASC RES, V44, P313, DOI 10.1159/000101777; Bowenkamp KE, 1996, EXP BRAIN RES, V111, P1; Bozyczko-Coyne D, 2002, CNS NEUROL DISORD-DR, V1, P31, DOI 10.2174/1568007023339472; Canals S, 2003, MOL CELL NEUROSCI, V24, P1012, DOI 10.1016/j.mcn.2003.08.004; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; de Bernardo S, 2004, J NEUROCHEM, V91, P667, DOI 10.1111/j.1471-4159.2004.02744.x; DUAN WM, 1995, EXP BRAIN RES, V104, P227; Duan WM, 1998, EUR J NEUROSCI, V10, P2595, DOI 10.1046/j.1460-9568.1998.t01-1-00279.x; EMERSON TE, 1989, CRIT CARE MED, V17, P690, DOI 10.1097/00003246-198907000-00020; Eminel S, 2004, J BIOL CHEM, V279, P55385, DOI 10.1074/jbc.M405858200; Gallego-Sandin S, 2005, EUR J PHARMACOL, V520, P1, DOI 10.1016/j.ejphar.2005.06.044; Ganguly A, 2004, J NEUROCHEM, V88, P469, DOI 10.1046/j.1471-4159.2003.02176.x; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Gum ET, 2004, STROKE, V35, P590, DOI 10.1161/01.STR.0000110790.05859.DA; Han BS, 2003, J NEUROSCI, V23, P5069; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; HANSON RW, 1968, J LIPID RES, V9, P667; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Jeohn GH, 2002, ANN NY ACAD SCI, V962, P332, DOI 10.1111/j.1749-6632.2002.tb04078.x; Jones RGA, 2011, J PHARMACEUT BIOMED, V54, P74, DOI 10.1016/j.jpba.2010.08.013; JUURLINK BHJ, 1990, BRAIN RES, V533, P73, DOI 10.1016/0006-8993(90)91797-K; Klintworth H, 2007, TOXICOL SCI, V97, P149, DOI 10.1093/toxsci/kfm029; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu YT, 2001, EUR J PHARMACOL, V428, P193, DOI 10.1016/S0014-2999(01)01255-9; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Moran EC, 2002, BRIT J HAEMATOL, V116, P316, DOI 10.1046/j.1365-2141.2002.03280.x; Newhouse K, 2004, TOXICOL SCI, V79, P137, DOI 10.1093/toxsci/kfh089; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Pan J, 2007, NEUROSCI LETT, V428, P82, DOI 10.1016/j.neulet.2007.09.032; Remmers M, 1999, BRAIN RES, V827, P237, DOI 10.1016/S0006-8993(99)01304-9; Rodriguez-Blanco J, 2008, J NEUROCHEM, V107, P127, DOI 10.1111/j.1471-4159.2008.05588.x; Rodriguez-Pallares J, 2007, J NEUROCHEM, V103, P145, DOI 10.1111/j.1471-4159.2007.04699.x; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SCHNITZER JE, 1992, J BIOL CHEM, V267, P24544; Soto-Otero R, 2000, J NEUROCHEM, V74, P1605, DOI 10.1046/j.1471-4159.2000.0741605.x; Tabernero A, 2002, J NEUROCHEM, V81, P881, DOI 10.1046/j.1471-4159.2002.00843.x; Tabernero A, 1999, GLIA, V25, P1; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wu SS, 2005, CNS DRUGS, V19, P723, DOI 10.2165/00023210-200519090-00001; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xue YQ, 2007, NEUROSCIENCE, V146, P1245, DOI 10.1016/j.neuroscience.2007.02.004; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; Zoellner H, 1996, J CELL SCI, V109, P2571	66	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41226	10.1371/journal.pone.0041226	http://dx.doi.org/10.1371/journal.pone.0041226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815976	Green Published, gold			2022-12-25	WOS:000306507000082
J	Bernal-Bayard, P; Hervas, M; Cejudo, FJ; Navarro, JA				Bernal-Bayard, Pilar; Hervas, Manuel; Cejudo, Francisco J.; Navarro, Jose A.			Electron Transfer Pathways and Dynamics of Chloroplast NADPH-dependent Thioredoxin Reductase C (NTRC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; PLANT PEROXIREDOXINS; 2-CYS PEROXIREDOXINS; HALF-REACTION; MECHANISM; ENZYME; GLUTAREDOXINS; PROTECTION; KINETICS	NADPH-dependent thioredoxin reductases (NTRs) contain a flavin cofactor and a disulfide as redox-active groups. The catalytic mechanism of standard NTR involves a large conformational change between two configurations. Oxygenic photosynthetic organisms possess a plastid-localized NTR, called NTRC, with a thioredoxin module fused at the C terminus. NTRC is an efficient reductant of 2-Cys peroxiredoxins (2-Cys Prxs) and thus is involved in the protection against oxidative stress, among other functions. Although the mechanism of electron transfer of canonical NTRs is well established, it is not yet known in NTRC. By employing stopped-flow spectroscopy, we have carried out a comparative kinetic study of the electron transfer reactions involving NTRC, the truncated NTR module of NTRC, and NTRB, a canonical plant NTR. Whereas the three NTRs maintain the conformational change associated with the reductive cycle of catalysis, NTRC intramolecular electron transfer to the thioredoxin module presents two kinetic components (k(ET) of similar to 2 and 0.1 s(-1)), indicating the occurrence of additional dynamic motions. Moreover, the dynamic features associated with the electron transfer to the thioredoxin module are altered in the presence of 2-Cys Prx. NTRC shows structural constraints that may locate the thioredoxin module in positions with different efficiencies for electron transfer, the presence of 2-Cys Prx shifting the conformational equilibrium of the thioredoxin module to a specific position, which is not the most efficient.	[Navarro, Jose A.] CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; Univ Seville, CicCartuja, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla	Navarro, JA (corresponding author), CSIC, Inst Bioquim Vegetal & Fotosintesis, Avda Americo Vespucio 49, Seville 41092, Spain.	jnavarro@ibvf.csic.es	navarro, jose a/B-6354-2015; Cejudo, Francisco Javier/M-2749-2014; Hervas, Manuel/K-9279-2014	navarro, jose a/0000-0002-0536-6074; Cejudo, Francisco Javier/0000-0002-3936-5491; Hervas, Manuel/0000-0003-4523-8891; BERNAL-BAYARD, PILAR/0000-0003-0243-1827	Andalusian Government European Regional Development Fund from Ministry of Science and Innovation [BIO-022, CVI-4528]; European Regional Development Fund from Ministry of Science and Innovation [BIO2010-15430]; Andalusian Government Grant [BIO-182, CVI-5919]	Andalusian Government European Regional Development Fund from Ministry of Science and Innovation; European Regional Development Fund from Ministry of Science and Innovation; Andalusian Government Grant	This work was supported by Andalusian Government European Regional Development Fund-cofinanced Grants BIO-022 and CVI-4528 (to J.A.N.) and European Regional Development Fund-cofinanced Grant BIO2010-15430 from Ministry of Science and Innovation and Andalusian Government Grant BIO-182 and CVI-5919 (to F.J.C.).	Alkhalfioui F, 2007, J EXP BOT, V58, P969, DOI 10.1093/jxb/erl248; Bhatt I, 2011, BIOTECHNOL ADV, V29, P850, DOI 10.1016/j.biotechadv.2011.07.002; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Hervas M, 2012, BIOCHEMISTRY-US, V51, P1178, DOI 10.1021/bi201904p; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Kirchsteiger K, 2012, PLANT CELL, V24, P1534, DOI 10.1105/tpc.111.092304; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; LENNON BW, 1995, BIOCHEMISTRY-US, V34, P3670, DOI 10.1021/bi00011a023; Lennon BW, 1997, BIOCHEMISTRY-US, V36, P9464, DOI 10.1021/bi970307j; Lepisto A, 2009, PLANT PHYSIOL, V149, P1261, DOI 10.1104/pp.108.133777; Perez-Ruiz JM, 2009, MOL PLANT, V2, P457, DOI 10.1093/mp/ssp011; Perez-Ruiz JM, 2009, FEBS LETT, V583, P1399, DOI 10.1016/j.febslet.2009.03.067; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Massey V., 1970, PYRIDINE NUCLEOTIDE, P393; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; MEYER TE, 1993, BIOCHEMISTRY-US, V32, P4552, DOI 10.1021/bi00068a010; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Moon JC, 2006, BIOCHEM BIOPH RES CO, V348, P478, DOI 10.1016/j.bbrc.2006.07.088; NAVARRO JA, 1991, BIOCHEMISTRY-US, V30, P2192, DOI 10.1021/bi00222a024; Negri A, 2010, PROTEINS, V78, P36, DOI 10.1002/prot.22490; Pascual MB, 2010, J BIOL CHEM, V285, P34485, DOI 10.1074/jbc.M110.160465; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Poole LB, 2000, EUR J BIOCHEM, V267, P6126, DOI 10.1046/j.1432-1327.2000.01704.x; Reichheld JP, 2005, FEBS LETT, V579, P337, DOI 10.1016/j.febslet.2004.11.094; Reynolds CM, 2001, BIOCHEMISTRY-US, V40, P3912, DOI 10.1021/bi002766h; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Stenbaek A, 2008, FEBS LETT, V582, P2773, DOI 10.1016/j.febslet.2008.07.006; TOLLIN G, 1995, J BIOENERG BIOMEMBR, V27, P303, DOI 10.1007/BF02110100; van Berkel W. J. H., 2008, WILEY ENCY CHEM BIOL, P1; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Veine DM, 1998, PROTEIN SCI, V7, P369; Wang PF, 1998, BIOCHEMISTRY-US, V37, P16378, DOI 10.1021/bi980754e; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wulff RP, 2011, BIOCHEMISTRY-US, V50, P3713, DOI 10.1021/bi200058a	42	28	29	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33865	33872		10.1074/jbc.M112.388991	http://dx.doi.org/10.1074/jbc.M112.388991			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22833674	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000309602100067
J	Vakili, H; Jin, Y; Cattini, PA				Vakili, Hana; Jin, Yan; Cattini, Peter A.			Negative Regulation of Human Growth Hormone Gene Expression by Insulin Is Dependent on Hypoxia-inducible Factor Binding in Primary Non-tumor Pituitary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; GH-RELEASING HORMONE; FACTOR 1-ALPHA; FACTOR-I; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; TARGET GENES; CANCER CELLS; OBESITY; MICE	Insulin controls growth hormone (GH) production at multiple levels, including via a direct effect on pituitary somatotrophs. There are no data, however, on the regulation of the intact human (h) GHgene (hGH1) by insulin in non-tumor pituitary cells, but the proximal promoter region (nucleotides -496/+1) responds negatively to insulin in transfected pituitary tumor cells. A DNA-protein interaction was also induced by insulin at nucleotides -308/-235. Here, we confirmed the presence of a hypoxia-inducible factor 1 (HIF-1) binding site within these sequences (-264/-259) and investigated whether HIF-1 is associated with insulin regulation of "endogenous" hGH1. In the absence of primary human pituitary cells, transgenic mice expressing the intact hGH locus in a somatotroph-specific manner were generated. A significant and dose-dependent decrease in hGH and mouse GH RNA levels was detected in primary pituitary cell cultures from these mice with insulin treatment. Increasing HIF-1 alpha availability with a hypoxia mimetic significantly decreased hGH RNA levels and was accompanied by recruitment of HIF-1 alpha to the hGH1 promoter in situ as seen with insulin. Both inhibition of HIF-1 DNA binding by echinomycin and RNA interference of HIF-1 alpha synthesis blunted the negative effect of insulin on hGH1 but not mGH. The insulin response is also sensitive to histone deacetylase inhibition/trichostatin A and associated with a decrease in H3/H4 hyperacetylation in the proximal hGH1 promoter region. These data are consistent with HIF-1-dependent down-regulation of hGH1 by insulin via chromatin remodeling specifically in the proximal promoter region.	[Vakili, Hana; Jin, Yan; Cattini, Peter A.] Univ Manitoba, Dept Physiol, Div Endocrine & Metab Dis, Winnipeg, MB R3E 3J9, Canada	University of Manitoba	Cattini, PA (corresponding author), Univ Manitoba, Dept Physiol, Div Endocrine & Metab Dis, 745 Bannatyne Ave, Winnipeg, MB R3E 3J9, Canada.	peter_cattini@umanitoba.ca			Canadian Institutes of Health Research Grant [MT-10853]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MT-10853.	Adams JM, 2009, ACTA PHYSIOL HUNG, V96, P19, DOI 10.1556/APhysiol.96.2009.1.2; Aza-Carmona M, 2011, HUM MOL GENET, V20, P1547, DOI 10.1093/hmg/ddr032; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Buettner R, 2000, AM J PHYSIOL-ENDOC M, V278, pE563, DOI 10.1152/ajpendo.2000.278.3.E563; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Christoforidis Athanasios, 2005, Pediatr Endocrinol Rev, V3, P5; Cornford AS, 2011, J CLIN ENDOCR METAB, V96, P824, DOI 10.1210/jc.2010-1895; De Marinis L, 2004, J CLIN ENDOCR METAB, V89, P174, DOI 10.1210/jc.2002-021308; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Erman A, 2011, INT J OBESITY, V35, P1520, DOI 10.1038/ijo.2011.10; FORMICA JV, 1983, ANTIMICROB AGENTS CH, V24, P735, DOI 10.1128/AAC.24.5.735; Fukuda R, 2003, CANCER RES, V63, P2330; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Ho YG, 2002, MOL CELL, V9, P291, DOI 10.1016/S1097-2765(02)00447-1; Ho YG, 2008, EMBO REP, V9, P891, DOI 10.1038/embor.2008.126; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jin Y, 2009, PLACENTA, V30, P226, DOI 10.1016/j.placenta.2008.12.011; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kietzmann T, 2003, BLOOD, V101, P907, DOI 10.1182/blood-2002-06-1693; Krawczak M, 1999, GENE, V237, P143, DOI 10.1016/S0378-1119(99)00313-3; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Lanzi R, 1999, METABOLISM, V48, P1152, DOI 10.1016/S0026-0495(99)90130-0; Lanzi R, 1997, J CLIN ENDOCR METAB, V82, P2239, DOI 10.1210/jc.82.7.2239; Lee KJ, 2010, BBA-MOL CELL RES, V1803, P608, DOI 10.1016/j.bbamcr.2010.01.004; Lee YS, 2007, MOL CELL BIOL, V27, P438, DOI 10.1128/MCB.00490-06; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; LIRA SA, 1993, MOL ENDOCRINOL, V7, P694, DOI 10.1210/me.7.5.694; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Lombardero Matilde, 2006, Pituitary, V9, P137, DOI 10.1007/s11102-006-9989-2; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Luque RM, 2006, J MOL ENDOCRINOL, V37, P25, DOI 10.1677/jme.1.02042; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; LYTRAS A, 1994, MOL ENDOCRINOL, V8, P478, DOI 10.1210/me.8.4.478; MACCARIO M, 1995, J CLIN ENDOCR METAB, V80, P3774, DOI 10.1210/jc.80.12.3774; Moller N, 2003, GROWTH HORM IGF RES, V13, pS18, DOI 10.1016/S1096-6374(03)00048-0; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; NICKEL BE, 1990, ENDOCRINOLOGY, V126, P971, DOI 10.1210/endo-126-2-971; Norquay LD, 2006, MOL ENDOCRINOL, V20, P598, DOI 10.1210/me.2005-0221; Pataky Z, 2010, EXP CLIN ENDOCR DIAB, V118, P427, DOI 10.1055/s-0029-1233448; PERITZ LN, 1988, J BIOL CHEM, V263, P5005; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509; PRAGER D, 1988, J BIOL CHEM, V263, P16580; PRAGER D, 1990, J CLIN INVEST, V85, P1680, DOI 10.1172/JCI114620; Procopio M, 1995, CLIN ENDOCRINOL, V43, P665, DOI 10.1111/j.1365-2265.1995.tb00532.x; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Ratan RR, 2004, STROKE, V35, P2687, DOI 10.1161/01.STR.0000143216.85349.9e; Ronsch K, 2011, EPIGENETICS-US, V6, P610, DOI 10.4161/epi.6.5.15300; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Scacchi M, 2010, EUR J ENDOCRINOL, V163, P201, DOI 10.1530/EJE-10-0160; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; STRASBURGER CJ, 1990, ACTA PAEDIATR SCAND, P82; Takahashi S, 2002, HORM RES, V58, P157, DOI 10.1159/000065488; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Vakili N, 2011, MOL CELL ENDOCRINOL, V345, P48, DOI 10.1016/j.mce.2011.07.010; VANDYKE MM, 1984, SCIENCE, V225, P1122, DOI 10.1126/science.6089341; Vidal S, 2002, J HISTOCHEM CYTOCHEM, V50, P533, DOI 10.1177/002215540205000410; Wang L, 2010, J HUAZHONG U SCI-MED, V30, P349, DOI 10.1007/s11596-010-0355-2; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553; Weng Q., 2010, INVESTIG NEW DRUGS, V9, P1177; Xi L, 2004, AM J PHYSIOL-HEART C, V287, pH2369, DOI 10.1152/ajpheart.00422.2004; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yang SM, 2004, OBES RES, V12, P330, DOI 10.1038/oby.2004.41; Yang XY, 2010, J MOL ENDOCRINOL, V45, P19, DOI 10.1677/JME-10-0017; Yi SJ, 2002, MOL BIOL EVOL, V19, P1083, DOI 10.1093/oxfordjournals.molbev.a004166; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yoshida D, 2006, J NEURO-ONCOL, V78, P217, DOI 10.1007/s11060-005-9017-9; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509	76	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33282	33292		10.1074/jbc.M112.380949	http://dx.doi.org/10.1074/jbc.M112.380949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22833680	Green Published, hybrid			2022-12-25	WOS:000309602100017
J	Curtis, JM; Hahn, WS; Stone, MD; Inda, JJ; Droullard, DJ; Kuzmicic, JP; Donoghue, MA; Long, EK; Armien, AG; Lavandero, S; Arriaga, E; Griffin, TJ; Bernlohr, DA				Curtis, Jessica M.; Hahn, Wendy S.; Stone, Matthew D.; Inda, Jacob J.; Droullard, David J.; Kuzmicic, Jovan P.; Donoghue, Margaret A.; Long, Eric K.; Armien, Anibal G.; Lavandero, Sergio; Arriaga, Edgar; Griffin, Timothy J.; Bernlohr, David A.			Protein Carbonylation and Adipocyte Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; BEEF-HEART MITOCHONDRIA; CYTOCHROME-C RELEASE; COMPLEX-I; OXIDATIVE STRESS; PHOSPHATE CARRIER; PERMEABILITY TRANSITION; SUPEROXIDE-PRODUCTION; LIPID-PEROXIDATION; ATP SYNTHASOME	Carbonylation is the covalent, non-reversible modification of the side chains of cysteine, histidine, and lysine residues by lipid peroxidation end products such as 4-hydroxy- and 4-oxononenal. In adipose tissue the effects of such modifications are associated with increased oxidative stress and metabolic dysregulation centered on mitochondrial energy metabolism. To address the role of protein carbonylation in the pathogenesis of mitochondrial dysfunction, quantitative proteomics was employed to identify specific targets of carbonylation in GSTA4-silenced or overexpressing 3T3-L1 adipocytes. GSTA4-silenced adipocytes displayed elevated carbonylation of several key mitochondrial proteins including the phosphate carrier protein, NADH dehydrogenase 1 alpha subcomplexes 2 and 3, translocase of inner mitochondrial membrane 50, and valyl-tRNA synthetase. Elevated protein carbonylation is accompanied by diminished complex I activity, impaired respiration, increased superoxide production, and a reduction in membrane potential without changes in mitochondrial number, area, or density. Silencing of the phosphate carrier or NADH dehydrogenase 1 alpha subcomplexes 2 or 3 in 3T3-L1 cells results in decreased basal and maximal respiration. These results suggest that protein carbonylation plays a major instigating role in cytokine-dependent mitochondrial dysfunction and may be linked to the development of insulin resistance in the adipocyte.	[Curtis, Jessica M.; Hahn, Wendy S.; Stone, Matthew D.; Inda, Jacob J.; Droullard, David J.; Long, Eric K.; Griffin, Timothy J.; Bernlohr, David A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Donoghue, Margaret A.; Arriaga, Edgar] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Armien, Anibal G.] Univ Minnesota, Coll Vet Med, Minneapolis, MN 55455 USA; [Kuzmicic, Jovan P.; Lavandero, Sergio] Univ Chile, Ctr Estudios Mol Celula, Santiago 8380492, Chile; [Lavandero, Sergio] UT SW Med Ctr, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universidad de Chile; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bernlohr, DA (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	bernl001@umn.edu	Lavandero, Sergio/B-6001-2013	Lavandero, Sergio/0000-0003-4258-1483; Griffin, Timothy/0000-0001-6801-2559; Hahn, Wendy/0000-0002-4374-5876	National Institutes of Health [DE017734, 5T32DK007203, NIH DK084669, MN-70-043, DK050456]; Comision Nacional de Investigacion Cientifica y Tecnologia (Chile); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084669, R56DK084669, P30DK050456, T32DK007203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comision Nacional de Investigacion Cientifica y Tecnologia (Chile); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DE017734 (to T.J.G.), 5T32DK007203 (to M. A. D.), NIH DK084669 and MN-70-043 (to D. A. B.), and DK050456 (to The Minnesota Obesity Center).; Holds a Ph.D. scholarship from Comision Nacional de Investigacion Cientifica y Tecnologia (Chile).	Alcala S, 2008, ONCOGENE, V27, P44, DOI 10.1038/sj.onc.1210600; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; BONADONNA RC, 1990, METABOLISM, V39, P452, DOI 10.1016/0026-0495(90)90002-T; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Cheng JZ, 2001, ARCH BIOCHEM BIOPHYS, V392, P197, DOI 10.1006/abbi.2001.2452; Curtis JM, 2012, TRENDS ENDOCRIN MET, V23, P399, DOI 10.1016/j.tem.2012.05.008; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Griffin TJ, 2007, J PROTEOME RES, V6, P4200, DOI 10.1021/pr070291b; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Haber CA, 2003, AM J PHYSIOL-ENDOC M, V285, pE744, DOI 10.1152/ajpendo.00355.2002; Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; KOLBE HVJ, 1985, J BIOL CHEM, V260, P5899; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kramer R, 1998, EXP PHYSIOL, V83, P259, DOI 10.1113/expphysiol.1998.sp004111; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lautt WW, 2010, CAN J PHYSIOL PHARM, V88, P313, DOI 10.1139/Y09-130; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Long EK, 2010, FREE RADICAL BIO MED, V48, P384, DOI 10.1016/j.freeradbiomed.2009.10.048; Mark RJ, 1997, J NEUROSCI, V17, P1046; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nagai K, 2008, FREE RADICAL RES, V42, P921, DOI 10.1080/10715760802555585; Nishi Y, 2011, BIOCHEM J, V435, P421, DOI 10.1042/BJ20101708; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Onsongo G, 2010, PROTEOMICS, V10, P3533, DOI 10.1002/pmic.201000189; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Picklo MJ, 1999, J NEUROCHEM, V72, P1617, DOI 10.1046/j.1471-4159.1999.721617.x; Raza H, 2002, BIOCHEM J, V366, P45, DOI 10.1042/BJ20020533; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Sharma R, 2008, BIOCHEMISTRY-US, V47, P143, DOI 10.1021/bi701559f; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; STAPPEN R, 1994, J BIOL CHEM, V269, P11240; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; TYLER DD, 1969, BIOCHEM J, V111, P665, DOI 10.1042/bj1110665; Xu X, 2010, ANAL CHEM, V82, P4570, DOI 10.1021/ac100577q; Xu X, 2009, FREE RADICAL BIO MED, V46, P905, DOI 10.1016/j.freeradbiomed.2008.12.019; Yang YZ, 2008, TOXICOL APPL PHARM, V230, P187, DOI 10.1016/j.taap.2008.03.018; Yuan Q, 2007, CHEM RES TOXICOL, V20, P129, DOI 10.1021/tx600270f	65	47	47	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32967	32980		10.1074/jbc.M112.400663	http://dx.doi.org/10.1074/jbc.M112.400663			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22822087	hybrid, Green Published			2022-12-25	WOS:000309168300060
J	Winiarska, M; Nowis, D; Bil, J; Glodkowska-Mrowka, E; Muchowicz, A; Wanczyk, M; Bojarczuk, K; Dwojak, M; Firczuk, M; Wilczek, E; Wachowska, M; Roszczenko, K; Miaczynska, M; Chlebowska, J; Basak, GW; Golab, J				Winiarska, Magdalena; Nowis, Dominika; Bil, Jacek; Glodkowska-Mrowka, Eliza; Muchowicz, Angelika; Wanczyk, Malgorzata; Bojarczuk, Kamil; Dwojak, Michal; Firczuk, Malgorzata; Wilczek, Ewa; Wachowska, Malgorzata; Roszczenko, Katarzyna; Miaczynska, Marta; Chlebowska, Justyna; Basak, Grzegorz Wladyslaw; Golab, Jakub			Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; FARNESYLTRANSFERASE INHIBITOR TIPIFARNIB; ANTIGEN-EXPRESSION; DOWN-REGULATION; IMMUNOPHENOTYPIC CHANGES; RITUXIMAB THERAPY; PHASE-II; IN-VITRO	Anti-CD20 monoclonal antibodies (mAbs) are successfully used in the management of non-Hodgkin lymphomas and chronic lymphocytic leukemia. We have reported previously that statins induce conformational changes in CD20 molecules and impair rituximab-mediated complement-dependent cytotoxicity. Here we investigated in more detail the influence of farnesyltransferase inhibitors (FTIs) on CD20 expression and antitumor activity of anti-CD20 mAbs. Among all FTIs studied, L-744,832 had the most significant influence on CD20 levels. It significantly increased rituximab-mediated complement-dependent cytotoxicity against primary tumor cells isolated from patients with non-Hodgkin lymphomas or chronic lymphocytic leukemia and increased CD20 expression in the majority of primary lymphoma/leukemia cells. Incubation of Raji cells with L-744,832 led to up-regulation of CD20 at mRNA and protein levels. Chromatin immunoprecipitation assay revealed that inhibition of farnesyltransferase activity was associated with increased binding of PU.1 and Oct-2 to the CD20 promoter sequences. These studies indicate that CD20 expression can be modulated by FTIs. The combination of FTIs with anti-CD20 mAbs is a promising therapeutic approach, and its efficacy should be examined in patients with B-cell tumors.	[Winiarska, Magdalena; Nowis, Dominika; Bil, Jacek; Glodkowska-Mrowka, Eliza; Muchowicz, Angelika; Wanczyk, Malgorzata; Bojarczuk, Kamil; Dwojak, Michal; Firczuk, Malgorzata; Wachowska, Malgorzata; Roszczenko, Katarzyna; Chlebowska, Justyna; Golab, Jakub] Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, PL-02097 Warsaw, Poland; [Bil, Jacek] Minist Interior & Adm, Cent Clin Hosp, Dept Invas Cardiol, PL-02507 Warsaw, Poland; [Wilczek, Ewa] Med Univ Warsaw, Dept Pathol, Ctr Biostruct Res, PL-02004 Warsaw, Poland; [Miaczynska, Marta] Int Inst Mol & Cell Biol, Cell Biol Lab, PL-02109 Warsaw, Poland; [Basak, Grzegorz Wladyslaw] Med Univ Warsaw, Dept Hematol Oncol & Internal Dis, PL-02097 Warsaw, Poland; [Golab, Jakub] Polish Acad Sci, Inst Phys Chem, PL-01224 Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Medical University of Warsaw; Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences	Golab, J (corresponding author), Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, 1A Banacha Str,F Bldg, PL-02097 Warsaw, Poland.	jakub.golab@wum.edu.pl	Firczuk, Małgorzata/G-3414-2013; Nowis, Dominika/P-6866-2019; Nowis, Dominika/P-1213-2017; Bojarczuk, Kamil/AAC-4824-2020; Golab, Jakub/K-6974-2013; Bil, Jacek/D-4850-2015; Muchowicz, Angelika/J-7494-2012; Glodkowska-Mrowka, Eliza/AAC-7294-2020; Wolinska, Ewa/AAE-4628-2021; Wachowska, Malgorzata/X-1707-2018; Glodkowska-Mrowka, Eliza/AAR-8503-2021	Firczuk, Małgorzata/0000-0002-1719-5233; Nowis, Dominika/0000-0003-2748-9523; Nowis, Dominika/0000-0003-2748-9523; Bojarczuk, Kamil/0000-0002-6110-4060; Golab, Jakub/0000-0002-2830-5100; Bil, Jacek/0000-0002-8724-5611; Muchowicz, Angelika/0000-0003-4707-1722; Glodkowska-Mrowka, Eliza/0000-0002-5865-8425; Wachowska, Malgorzata/0000-0001-7199-9649; Glodkowska-Mrowka, Eliza/0000-0002-5865-8425; Chlebowska-Tuz, Justyna/0000-0002-3997-3948; Wolinska, Ewa/0000-0001-9592-1301; Bobrowicz, Malgorzata/0000-0002-9078-5168; Basak, Grzegorz/0000-0003-3858-8180; Miaczynska, Marta/0000-0003-0031-5267; Winiarska, Magdalena/0000-0001-5605-3329	Medical University of Warsaw [1M19/NM4/11, 1M19/PM13]; Polish Ministry of Science [3JP3, 3JP4, N N402 352938]; European Union within the European Regional Development Fund through Innovative Economy Grant [POIG.01.01.02-00-008/08]; Genmab A/S; Foundation for Polish Science; European Union European Regional Development Fund	Medical University of Warsaw; Polish Ministry of Science(Ministry of Science and Higher Education, Poland); European Union within the European Regional Development Fund through Innovative Economy Grant; Genmab A/S(Genmab); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union European Regional Development Fund(European Commission)	This work was supported in part by Medical University of Warsaw Grants 1M19/NM4/11 (to M. Wanczyk) and 1M19/PM13 (to M. Winiarska), Grants 3JP3 (to D. N.) and 3JP4 and N N402 352938 (to M. Winiarska) from the Polish Ministry of Science and the European Union within the European Regional Development Fund through Innovative Economy Grant POIG.01.01.02-00-008/08, and by Genmab A/S.; Members of TEAM Programme co-financed by the Foundation for Polish Science and the European Union European Regional Development Fund.	Adjei AA, 2003, J CLIN ONCOL, V21, P1760, DOI 10.1200/JCO.2003.09.075; Alsina M, 2004, BLOOD, V103, P3271, DOI 10.1182/blood-2003-08-2764; Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bellosillo B, 2001, BLOOD, V98, P2771, DOI 10.1182/blood.V98.9.2771; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Bezombes C, 2011, MOL CANCER RES, V9, P1435, DOI 10.1158/1541-7786.MCR-11-0154; Bil J, 2010, BLOOD, V115, P3745, DOI 10.1182/blood-2009-09-244129; Czuczman MS, 2008, CLIN CANCER RES, V14, P1561, DOI 10.1158/1078-0432.CCR-07-1254; Davis TA, 1999, CLIN CANCER RES, V5, P611; Efuet ET, 2006, CANCER RES, V66, P1040, DOI 10.1158/0008-5472.CAN-05-3416; Foran JM, 2001, BRIT J HAEMATOL, V114, P881, DOI 10.1046/j.1365-2141.2001.03019.x; Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383; Haidar JH, 2003, EUR J HAEMATOL, V70, P330, DOI 10.1034/j.1600-0609.2003.00007.x; Hainsworth JD, 2005, J CLIN ONCOL, V23, P1088, DOI 10.1200/JCO.2005.12.191; Henry C, 2010, BLOOD, V115, P2420, DOI 10.1182/blood-2009-06-229112; Hiraga J, 2009, BLOOD, V113, P4885, DOI 10.1182/blood-2008-08-175208; Jilani I, 2003, BLOOD, V102, P3514, DOI 10.1182/blood-2003-01-0055; Kinoshita T, 1998, J CLIN ONCOL, V16, P3916; Lapalombella R, 2008, BLOOD, V112, P5180, DOI 10.1182/blood-2008-01-133108; Maeshima AM, 2009, CANCER SCI, V100, P54, DOI 10.1111/j.1349-7006.2008.01005.x; Mankai A, 2008, CANCER RES, V68, P7512, DOI 10.1158/0008-5472.CAN-07-6446; Mankai A, 2009, ANN NY ACAD SCI, V1173, P721, DOI 10.1111/j.1749-6632.2009.04614.x; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Michel RB, 2002, CLIN CANCER RES, V8, P2632; Michel RB, 2002, CLIN CANCER RES, V8, P2701; Pickartz T, 2001, EXP HEMATOL, V29, P1410, DOI 10.1016/S0301-472X(01)00753-6; Schmitz K, 1999, BRIT J HAEMATOL, V106, P571, DOI 10.1046/j.1365-2141.1999.01608.x; Seliem RM, 2006, APPL IMMUNOHISTO M M, V14, P18, DOI 10.1097/01.pai.0000145130.02931.74; Sivaraman S, 2000, CYTOKINES CELL MOL T, V6, P81, DOI 10.1080/13684730050515804; Tomita A, 2007, INT J HEMATOL, V86, P49, DOI 10.1532/IJH97.07028; Tsai PC, 2012, CLIN CANCER RES, V18, P1039, DOI 10.1158/1078-0432.CCR-11-1429; Turzanski J, 2008, LEUKEMIA LYMPHOMA, V49, P1578, DOI 10.1080/10428190802163313; Ushmorov A, 2006, BLOOD, V107, P2493, DOI 10.1182/blood-2005-09-3765; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; Venugopal P, 2000, LEUKEMIA RES, V24, P411, DOI 10.1016/S0145-2126(99)00206-4; Winiarska M, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050064; Winiarska M, 2011, FRONT BIOSCI-LANDMRK, V16, P277, DOI 10.2741/3688; Witzig TE, 2011, BLOOD, V118, P4882, DOI 10.1182/blood-2011-02-334904; Wojciechowski W, 2005, J IMMUNOL, V174, P7859, DOI 10.4049/jimmunol.174.12.7859	41	15	15	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31983	31993		10.1074/jbc.M112.374751	http://dx.doi.org/10.1074/jbc.M112.374751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843692	Green Published, hybrid			2022-12-25	WOS:000309059400037
J	Joachim, SC; Gramlich, OW; Laspas, P; Schmid, H; Beck, S; von Pein, HD; Dick, HB; Pfeiffer, N; Grus, FH				Joachim, Stephanie C.; Gramlich, Oliver W.; Laspas, Panagiotis; Schmid, Heiko; Beck, Sabine; von Pein, Harald D.; Dick, H. Burkhard; Pfeiffer, Norbert; Grus, Franz H.			Retinal Ganglion Cell Loss Is Accompanied by Antibody Depositions and Increased Levels of Microglia after Immunization with Retinal Antigens	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEAT-SHOCK PROTEINS; OPTIC-NERVE HEAD; ELEVATED INTRAOCULAR-PRESSURE; EXPERIMENTAL RAT MODEL; GLAUCOMA PATIENTS; MULTIPLE-SCLEROSIS; DIFFERENTIAL EXPRESSION; AUTOREACTIVE ANTIBODIES; MACULAR DEGENERATION	Background: Antibodies against retinal and optic nerve antigens are detectable in glaucoma patients. Recent studies using a model of experimental autoimmune glaucoma demonstrated that immunization with certain ocular antigens causes an immun-mediated retinal ganglion cell loss in rats. Methodology/Principal Findings: Rats immunized with a retinal ganglion cell layer homogenate (RGA) had a reduced retinal ganglion cell density on retinal flatmounts (p = 0.007) and a lower number of Brn3(+) retinal ganglion cells (p = 0.0001) after six weeks. The autoreactive antibody development against retina and optic nerve was examined throughout the study. The levels of autoreactive antibodies continuously increased up to 6 weeks (retina: p = 0.004; optic nerve: p = 0.000003). Additionally, antibody deposits were detected in the retina (p = 0.02). After 6 weeks a reactive gliosis (GFAP density: RGA: 174.7 +/- 41.9; CO: 137.6 +/- 36.8, p = 0.0006; %GFAP(+) area: RGA: 8.5 +/- 3.4; CO: 5.9 +/- 3.6, p = 0.006) as well as elevated level of Iba1(+) microglia cells (p = 0.003) was observed in retinas of RGA animals. Conclusions/Significance: Our findings suggest that these antibodies play a substantial role in mechanisms leading to retinal ganglion cell death. This seems to lead to glia cell activation as well as the invasion of microglia, which might be associated with debris clearance.	[Joachim, Stephanie C.; Schmid, Heiko; Dick, H. Burkhard] Ruhr Univ Bochum, Hosp Eye, Expt Eye Res Inst, Bochum, Germany; [Gramlich, Oliver W.; Laspas, Panagiotis; Beck, Sabine; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [von Pein, Harald D.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuropathol, Mainz, Germany	Ruhr University Bochum; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Joachim, SC (corresponding author), Ruhr Univ Bochum, Hosp Eye, Expt Eye Res Inst, Univ Str 150, Bochum, Germany.	stephanie.joachim@rub.de	Pfeiffer, Norbert/AAO-7586-2020; Dick, Burkhard/AAI-7504-2020; Joachim, Stephanie/AAV-5980-2021	Gramlich, Oliver W/0000-0001-6948-0522	German Research Foundation [JO 886/1-1]; Gertrud Kusen Foundation; Herbert Funke Foundation	German Research Foundation(German Research Foundation (DFG)); Gertrud Kusen Foundation; Herbert Funke Foundation	This work was supported by the German Research Foundation (grant JO 886/1-1), the Gertrud Kusen Foundation, and the Herbert Funke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badie B, 2001, J NEUROIMMUNOL, V120, P19, DOI 10.1016/S0165-5728(01)00361-7; Bjorkqvist M, 2009, NEURON, V64, P21, DOI 10.1016/j.neuron.2009.09.034; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boehm N., 2011, INVEST OPHTHALMOL VI; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Gellrich MM, 1996, GRAEF ARCH CLIN EXP, V234, P315, DOI 10.1007/BF00220707; Gramlich OW, 2010, INVEST OPHTH VIS SCI, V51; Gramlich OW, 2011, ARVO M, V52, P2928; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Grus FH, 2006, INVEST OPHTH VIS SCI, V47, P968, DOI 10.1167/iovs.05-0685; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Harrer MD, 2009, EXP NEUROL, V216, P431, DOI 10.1016/j.expneurol.2008.12.027; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Howlett DR, 2011, EXP BRAIN RES, V214, P185, DOI 10.1007/s00221-011-2819-4; Huizinga R, 2008, TRENDS IMMUNOL, V29, P54, DOI 10.1016/j.it.2007.11.002; Husain D, 2005, ARCH OPHTHALMOL-CHIC, V123, P509, DOI 10.1001/archopht.123.4.509; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Joachim SC, 2005, GRAEF ARCH CLIN EXP, V243, P817, DOI 10.1007/s00417-004-1094-5; Joachim SC, 2003, EUR J OPHTHALMOL, V13, P752, DOI 10.1177/1120672103013009-1003; Joachim SC, 2008, GRAEF ARCH CLIN EXP, V246, P573, DOI 10.1007/s00417-007-0737-8; Joachim SC, 2009, INVEST OPHTH VIS SCI, V50, P4734, DOI 10.1167/iovs.08-3144; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Lam TT, 2003, INVEST OPHTH VIS SCI, V44, P638, DOI 10.1167/iovs.02-0255; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Laspas P, 2011, INVEST OPHTH VIS SCI, V52, P8835, DOI 10.1167/iovs.10-6889; Lim MJ, 2006, NEUROPATH APPL NEURO, V32, P469, DOI 10.1111/j.1365-2990.2006.00738.x; Lim MJ, 2007, NEUROBIOL DIS, V25, P239, DOI 10.1016/j.nbd.2006.09.005; Maruyama I, 2002, TOHOKU J EXP MED, V197, P125, DOI 10.1620/tjem.197.125; Moore S, 1996, PROG NEUROBIOL, V48, P441, DOI 10.1016/0301-0082(95)00051-8; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Palagina G, 2009, P NATL ACAD SCI USA, V106, P8743, DOI 10.1073/pnas.0900068106; Park CK, 2009, EXP BRAIN RES, V197, P101, DOI 10.1007/s00221-009-1896-0; Patel N, 2005, IMMUNOLOGY, V115, P422, DOI 10.1111/j.1365-2567.2005.02173.x; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Qu J, 2010, EXP EYE RES; Reichelt J, 2008, CURR EYE RES, V33, P253, DOI 10.1080/02713680701871157; Ross RJ, 2008, EXP EYE RES, V86, P675, DOI 10.1016/j.exer.2008.01.014; Rudehill S, 2006, ACTA NEUROCHIR, V148, P199, DOI 10.1007/s00701-005-0673-5; Sakurai T, 2011, J NEUROIMMUNOL, V233, P175, DOI 10.1016/j.jneuroim.2010.11.003; SHIOSAKA S, 1984, J NEUROSCI METH, V10, P229, DOI 10.1016/0165-0270(84)90059-1; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; Simon P, 1998, J NEUROSCI METH, V83, P113, DOI 10.1016/S0165-0270(98)00060-0; Smith AW, 2011, INVEST OPHTH VIS SCI, V52, P4935, DOI 10.1167/iovs.10-7027; SUTTER A, 1991, PATHOBIOLOGY, V59, P254; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Tezel G, 2003, INVEST OPHTH VIS SCI, V44, P3025, DOI 10.1167/iovs.02-1136; Tezel G, 2000, J NEUROSCI, V20, P3552, DOI 10.1523/JNEUROSCI.20-10-03552.2000; Tezel Gulgun, 2004, Curr Opin Ophthalmol, V15, P80, DOI 10.1097/00055735-200404000-00003; ULVESTAD E, 1994, J NEUROPATH EXP NEUR, V53, P27, DOI 10.1097/00005072-199401000-00004; Vidal L, 2010, BRAIN RES BULL, V82, P18, DOI 10.1016/j.brainresbull.2010.02.011; Vilaplana J, 1999, J NEUROSCI METH, V88, P181, DOI 10.1016/S0165-0270(99)00016-3; Vyshkina T, 2008, LAB INVEST, V88, P796, DOI 10.1038/labinvest.2008.53; Wang L, 2002, INVEST OPHTH VIS SCI, V43, P1088; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wax MB, 2001, OPHTHALMOLOGY, V108, P296, DOI 10.1016/S0161-6420(00)00525-X; Wekerle H, 2008, ANN RHEUM DIS, V67, P56, DOI 10.1136/ard.2008.098020; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Ziehn MO, 2010, LAB INVEST, V90, P774, DOI 10.1038/labinvest.2010.6	63	58	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40616	10.1371/journal.pone.0040616	http://dx.doi.org/10.1371/journal.pone.0040616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848388	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600007
J	Tsai, KC; Jian, JW; Yang, EW; Hsu, PC; Peng, HP; Chen, CT; Chen, JB; Chang, JY; Hsu, WL; Yang, AS				Tsai, Keng-Chang; Jian, Jhih-Wei; Yang, Ei-Wen; Hsu, Po-Chiang; Peng, Hung-Pin; Chen, Ching-Tai; Chen, Jun-Bo; Chang, Jeng-Yih; Hsu, Wen-Lian; Yang, An-Suei			Prediction of Carbohydrate Binding Sites on Protein Surfaces with 3-Dimensional Probability Density Distributions of Interacting Atoms	PLOS ONE			English	Article							FEATURES	Non-covalent protein-carbohydrate interactions mediate molecular targeting in many biological processes. Prediction of non-covalent carbohydrate binding sites on protein surfaces not only provides insights into the functions of the query proteins; information on key carbohydrate-binding residues could suggest site-directed mutagenesis experiments, design therapeutics targeting carbohydrate-binding proteins, and provide guidance in engineering protein-carbohydrate interactions. In this work, we show that non-covalent carbohydrate binding sites on protein surfaces can be predicted with relatively high accuracy when the query protein structures are known. The prediction capabilities were based on a novel encoding scheme of the three-dimensional probability density maps describing the distributions of 36 non-covalent interacting atom types around protein surfaces. One machine learning model was trained for each of the 30 protein atom types. The machine learning algorithms predicted tentative carbohydrate binding sites on query proteins by recognizing the characteristic interacting atom distribution patterns specific for carbohydrate binding sites from known protein structures. The prediction results for all protein atom types were integrated into surface patches as tentative carbohydrate binding sites based on normalized prediction confidence level. The prediction capabilities of the predictors were benchmarked by a 10-fold cross validation on 497 non-redundant proteins with known carbohydrate binding sites. The predictors were further tested on an independent test set with 108 proteins. The residue-based Matthews correlation coefficient (MCC) for the independent test was 0.45, with prediction precision and sensitivity (or recall) of 0.45 and 0.49 respectively. In addition, 111 unbound carbohydrate-binding protein structures for which the structures were determined in the absence of the carbohydrate ligands were predicted with the trained predictors. The overall prediction MCC was 0.49. Independent tests on anti-carbohydrate antibodies showed that the carbohydrate antigen binding sites were predicted with comparable accuracy. These results demonstrate that the predictors are among the best in carbohydrate binding site predictions to date.	[Tsai, Keng-Chang; Jian, Jhih-Wei; Yang, Ei-Wen; Hsu, Po-Chiang; Peng, Hung-Pin; Chen, Ching-Tai; Chen, Jun-Bo; Chang, Jeng-Yih; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Jian, Jhih-Wei; Peng, Hung-Pin; Chen, Ching-Tai] Acad Sinica, Inst Informat Sci, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan; [Jian, Jhih-Wei; Peng, Hung-Pin] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Ching-Tai] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chen, Jun-Bo] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Tsing Hua University	Tsai, KC (corresponding author), Natl Res Inst Chinese Med, Taipei, Taiwan.	yangas@gate.sinica.edu.tw	Hsu, Wen-Lian/ABB-2851-2020	Hsu, Wen-Lian/0000-0001-7061-3513; Yang, An-Suei/0000-0002-4699-873X; Tsai, Keng-Chang/0000-0001-8277-9174	National Health Research Institutes [NHRI-EX98-9802EI]; National Science Council [NSC 99-2311-B-001-014-MY3]; Genomics Research Center at Academia Sinica [AS-100-TP2-B01]; NRPB program, NSC [NSC 100-2325-B-001-009, 100IDP006-3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Genomics Research Center at Academia Sinica(Academia Sinica - Taiwan); NRPB program, NSC	This work was supported by National Health Research Institutes [NHRI-EX98-9802EI to A-S.Y.], National Science Council [NSC 99-2311-B-001-014-MY3 to A-S.Y.], Genomics Research Center at Academia Sinica [AS-100-TP2-B01 to A-S.Y.], and NRPB program, NSC. [NSC 100-2325-B-001-009; 100IDP006-3 to A-S.Y.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen CT, 2008, BIOINFORMATICS, V24, P2691, DOI 10.1093/bioinformatics/btn538; Kulharia M, 2009, J MOL GRAPH MODEL, V28, P297, DOI 10.1016/j.jmgm.2009.08.009; Laskowski RA, 1996, J MOL BIOL, V259, P175, DOI 10.1006/jmbi.1996.0311; Lebrilla CB, 2009, MOL BIOSYST, V5, P17, DOI 10.1039/b811781k; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; Manning CD, 2007, INTRO INFORM RETRIEV; McConkey BJ, 2003, P NATL ACAD SCI USA, V100, P3215, DOI 10.1073/pnas.0535768100; Nassif H, 2009, PROTEINS, V77, P121, DOI 10.1002/prot.22424; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; Riedmiller M., 1994, RPROP DESCRIPTION IM; Rumelhart D.E., 1985, LEARNING INTERNAL RE, DOI 10.1016/b978-1-4832-1446-7.50035-2; Shionyu-Mitsuyama C, 2003, PROTEIN ENG, V16, P467, DOI 10.1093/protein/gzg065; Taroni C, 2000, PROTEIN ENG, V13, P89, DOI 10.1093/protein/13.2.89; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; Varki A, 2009, ESSENTIALS GLYCOBIOL; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Yu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033340	23	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40846	10.1371/journal.pone.0040846	http://dx.doi.org/10.1371/journal.pone.0040846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848404	gold, Green Published, Green Submitted			2022-12-25	WOS:000306806600025
J	Araki, Y; Hamafuji, T; Noguchi, C; Shimizu, N				Araki, Yoshio; Hamafuji, Tetsuro; Noguchi, Chiemi; Shimizu, Noriaki			Efficient Recombinant Production in Mammalian Cells Using a Novel IR/MAR Gene Amplification Method	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; REPLICATION INITIATION REGION; DNA-REPLICATION; EXPRESSION; LINES; HETEROCHROMATIN; TRANSCRIPTION; METHYLATION; MODULATION; PLASMIDS	We previously found that plasmids bearing a mammalian replication initiation region (IR) and a nuclear matrix attachment region (MAR) efficiently initiate gene amplification and spontaneously increase their copy numbers in animal cells. In this study, this novel method was applied to the establishment of cells with high recombinant antibody production. The level of recombinant antibody expression was tightly correlated with the efficiency of plasmid amplification and the cytogenetic appearance of the amplified genes, and was strongly dependent on cell type. By using a widely used cell line for industrial protein production, CHO DG44, clones expressing very high levels of antibody were easily obtained. High-producer clones stably expressed the antibody over several months without eliciting changes in both the protein expression level and the cytogenetic appearance of the amplified genes. The integrity and reactivity of the protein produced by this method was fine. In serum-free suspension culture, the specific protein production rate in high-density cultures was 29.4 pg/cell/day. In conclusion, the IR/MAR gene amplification method is a novel and efficient platform for recombinant antibody production in mammalian cells, which rapidly and easily enables the establishment of stable high-producer cell clone.	[Araki, Yoshio; Noguchi, Chiemi; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan; [Hamafuji, Tetsuro] Transgenic Inc, Chuo Ku, Kobe, Hyogo, Japan	Hiroshima University	Araki, Y (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan.	shimizu@hiroshima-u.ac.jp			Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a "Practical Application Research" from Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Antoniou M, 2003, GENOMICS, V82, P269, DOI 10.1016/S0888-7543(03)00107-1; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Dorai H, 2012, BIOTECHNOL BIOENG, V109, P1016, DOI 10.1002/bit.24367; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Huang YM, 2010, BIOTECHNOL PROGR, V26, P1400, DOI 10.1002/btpr.436; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Jun SC, 2005, APPL MICROBIOL BIOT, V69, P162, DOI 10.1007/s00253-005-1972-8; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; Kim M., 2011, BIOTECHNOL BIOENG; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Okamoto A, 2011, MUTAGENESIS; Ortega JM, 1998, J CELL SCI, V111, P3663; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2004, J CELL SCI, V117, P5303, DOI 10.1242/jcs.01414; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; Wang F, 2012, GENE, V500, P59, DOI 10.1016/j.gene.2012.03.049; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yang YS, 2010, J BIOTECHNOL, V147, P180, DOI 10.1016/j.jbiotec.2010.04.004; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Zahn-Zabal M, 2001, J BIOTECHNOL, V87, P29, DOI 10.1016/S0168-1656(00)00423-5	36	29	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41787	10.1371/journal.pone.0041787	http://dx.doi.org/10.1371/journal.pone.0041787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844523	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700150
J	Kodandaramaiah, U; Weingartner, E; Janz, N; Leski, M; Slove, J; Warren, A; Nylin, S				Kodandaramaiah, Ullasa; Weingartner, Elisabet; Janz, Niklas; Leski, Michael; Slove, Jessica; Warren, Andrew; Nylin, Soren			Investigating Concordance among Genetic Data, Subspecies Circumscriptions and Hostplant Use in the Nymphalid Butterfly Polygonia faunus	PLOS ONE			English	Article							HOST-PLANT SPECIALIZATION; POPULATION-STRUCTURE; ALPINE BUTTERFLIES; MITOCHONDRIAL-DNA; WOLBACHIA; DIVERSITY; DIFFERENTIATION; PHYLOGEOGRAPHY; EVOLUTIONARY; BIOGEOGRAPHY	Subspecies are commonly used taxonomic units to formally describe intraspecific geographic variation in morphological traits. However, the concept of subspecies is not clearly defined, and there is little agreement about what they represent in terms of evolutionary units, and whether they can be used as reliably useful units in conservation, evolutionary theory and taxonomy. We here investigate whether the morphologically well-characterized subspecies in the North American butterfly Polygonia faunus are supported by genetic data from mitochondrial sequences and eight microsatellite loci. We also investigate the phylogeographic structure of P. faunus and test whether similarities in host-plant use among populations are related to genetic similarity. Neither the nuclear nor the mitochondrial data corroborated subspecies groupings. We found three well defined genetic clusters corresponding to California, Arizona and (New Mexico+Colorado). There was little structuring among the remaining populations, probably due to gene flow across populations. We found no support for the hypothesis that similarities in host use are related to genetic proximity. The results indicate that the species underwent a recent rapid expansion, probably from two glacial refugia in western North America. The mitochondrial haplotype network indicates at least two independent expansion phases into eastern North America. Our results clearly demonstrate that subspecies in P. faunus do not conform to the structuring of genetic variation. More studies on insects and other invertebrates are needed to better understand the scope of this phenomenon. The results of this study will be crucial in designing further experiments to understand the evolution of hostplant utilization in this species.	[Kodandaramaiah, Ullasa; Weingartner, Elisabet; Janz, Niklas; Slove, Jessica; Nylin, Soren] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Warren, Andrew] Univ Florida, Florida Museum Nat Hist, McGuire Ctr Lepidoptera & Biodivers, Gainesville, FL 32611 USA	Stockholm University; State University System of Florida; University of Florida	Kodandaramaiah, U (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	uk214@cam.ac.uk	Nylin, Soren/B-7375-2008; Janz, Niklas/B-1756-2010	Nylin, Soren/0000-0003-4195-8920; Janz, Niklas/0000-0002-6379-7905; Kodandaramaiah, Ullasa/0000-0002-1564-1738	Swedish Research Council [621-2011-5636]; Strategic research programme EkoKlim at Stockholm University; Stockholm University Faculty of Science; ERC	Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic research programme EkoKlim at Stockholm University; Stockholm University Faculty of Science; ERC(European Research Council (ERC)European Commission)	This study was funded by a grant to SN from the Swedish Research Council (# 621-2011-5636) and grants to NJ and SN from the Strategic research programme EkoKlim at Stockholm University as well as a grant from the Stockholm University Faculty of Science to NJ. UK was partially funded by the ERC grant EMARES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRITTEN HB, 1992, CAN J ZOOL, V70, P539, DOI 10.1139/z92-081; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DeChaine EG, 2005, J BIOGEOGR, V32, P1943, DOI 10.1111/j.1365-2699.2005.01356.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Frost Darrel R., 1992, Herpetological Review, V23, P46; Goudet J, 1996, GENETICS, V144, P1933; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Janz N, 1998, P ROY SOC B-BIOL SCI, V265, P1675, DOI 10.1098/rspb.1998.0487; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Joyce DA, 2009, BIOL J LINN SOC, V97, P314, DOI 10.1111/j.1095-8312.2009.01213.x; Kodandaramaiah U, 2011, J EVOLUTION BIOL, V24, P2173, DOI 10.1111/j.1420-9101.2011.02352.x; Mayr E., 1991, PRINCIPLES SYSTEMATI; Mayr E., 1942, SYSTEMATICS ORIGIN S; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Nei M., 1987, MOL EVOLUTIONARY GEN; Nice CC, 2001, ANN ENTOMOL SOC AM, V94, P257, DOI 10.1603/0013-8746(2001)094[0257:PGEORG]2.0.CO;2; Noonan GR, 1999, J BIOGEOGR, V26, P1147, DOI 10.1046/j.1365-2699.1999.00362.x; Nygren GH, 2006, J EVOLUTION BIOL, V19, P1882, DOI 10.1111/j.1420-9101.2006.01174.x; Nylin S, 2009, EVOL ECOL, V23, P137, DOI 10.1007/s10682-007-9205-5; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Patten MA, 2002, AUK, V119, P26, DOI 10.1642/0004-8038(2002)119[0026:DVMDOS]2.0.CO;2; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reiss RA, 1999, J BIOGEOGR, V26, P785, DOI 10.1046/j.1365-2699.1999.00321.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SCOTT JA, 1986, BUTTERFLIES N AM; SLATKIN M, 1991, GENETICS, V129, P555; Slove J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016057; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STANCELAND E. M., 2011, INTERACTIVE LISTING; TEMPLETON AR, 1992, GENETICS, V132, P619; Warren AD, LEPIDOPTERA N AM, V6, P408; Weingartner E, 2006, J EVOLUTION BIOL, V19, P483, DOI 10.1111/j.1420-9101.2005.01009.x; Weingartner E, 2006, SYST ENTOMOL, V31, P621, DOI 10.1111/j.1365-3113.2006.00333.x; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; West-Eberhard Mary Jane, 2003, pi; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2010, J AVIAN BIOL, V41, P1, DOI 10.1111/j.1600-048X.2009.04903.x	47	13	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41058	10.1371/journal.pone.0041058	http://dx.doi.org/10.1371/journal.pone.0041058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844425	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700039
J	Zheng, YB; Zhang, XH; Huang, ZL; Lin, CS; Lai, J; Gu, YR; Lin, BL; Xie, DY; Xie, SB; Peng, L; Gao, ZL				Zheng, Yu-Bao; Zhang, Xiao-Hong; Huang, Zhan-Lian; Lin, Chao-Shuang; Lai, Jing; Gu, Yu-Rong; Lin, Bin-Liang; Xie, Dong-Ying; Xie, Shi-Bin; Peng, Liang; Gao, Zhi-Liang			Amniotic-Fluid-Derived Mesenchymal Stem Cells Overexpressing Interleukin-1 Receptor Antagonist Improve Fulminant Hepatic Failure	PLOS ONE			English	Article							GROWTH-FACTOR; UP-REGULATION; BONE-MARROW; DIFFERENTIATION; REGENERATION; INVOLVEMENT; VECTORS; IL-1RA; INJURY; LINES	Uncontrolled hepatic immunoactivation is regarded as the primary pathological mechanism of fulminant hepatic failure (FHF). The major acute-phase mediators associated with FHF, including IL-1 beta, IL-6, and TNF-alpha, impair the regeneration of liver cells and stem cell grafts. Amniotic-fluid-derived mesenchymal stem cells (AF-MSCs) have the capacity, under specific conditions, to differentiate into hepatocytes. Interleukin-1-receptor antagonist (IL-1Ra) plays an anti-inflammatory and antiapoptotic role in acute and chronic inflammation, and has been used in many experimental and clinical applications. In the present study, we implanted IL-1Ra-expressing AF-MSCs into injured liver via the portal vein, using D-galactosamine-induced FHF in a rat model. IL-1Ra expression, hepatic injury, liver regeneration, cytokines (IL-1 beta, IL-6), and animal survival were assessed after cell transplantation. Our results showed that AF-MSCs over-expressing IL-1Ra prevented liver failure and reduced mortality in rats with FHF. These animals also exhibited improved liver function and increased survival rates after injection with these cells. Using green fluorescent protein as a marker, we demonstrated that the engrafted cells and their progeny were incorporated into injured livers and produced albumin. This study suggests that AF-MSCs genetically modified to over-express IL-1Ra can be implanted into the injured liver to provide a novel therapeutic approach to the treatment of FHF.	[Zheng, Yu-Bao; Zhang, Xiao-Hong; Huang, Zhan-Lian; Lin, Chao-Shuang; Lai, Jing; Gu, Yu-Rong; Lin, Bin-Liang; Xie, Dong-Ying; Xie, Shi-Bin; Peng, Liang; Gao, Zhi-Liang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Yu-Bao; Gao, Zhi-Liang] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zheng, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	zhilianggao@21cn.com	gu, yu/GSD-4507-2022		Natural Science Fund of Guangdong province [10451008901004818]; National Natural Science Foundation of China [30971356]; National Grand Program on Key Infectious Disease(AIDS and viral hepatitis), China [2012ZX10002007-002]	Natural Science Fund of Guangdong province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease(AIDS and viral hepatitis), China	This study was financially supported by grants from the Natural Science Fund of Guangdong province (No. 10451008901004818), the National Natural Science Foundation of China (No. 30971356), the National Grand Program on Key Infectious Disease(AIDS and viral hepatitis), China, No. 2012ZX10002007-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge V, 2012, HEPATOLOGY, V56, P1063, DOI 10.1002/hep.25716; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Baranova A, 2011, DIGESTION, V83, P32, DOI 10.1159/000314592; Chen JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019964; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Dinarello Charles A, 2000, NEW ENGL J MED, V343, P732; Farmer DG, 2009, ANN SURG, V250, P484, DOI 10.1097/SLA.0b013e3181b480ad; Grisafi D, 2008, STEM CELLS DEV, V17, P953, DOI 10.1089/scd.2007.0188; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685; Leifeld L, 2003, J PATHOL, V199, P335, DOI 10.1002/path.1298; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Park JK, 2005, J BIOSCI BIOENG, V99, P311, DOI 10.1263/jbb.99.311; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Sgroi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025442; Shito M, 2001, DIGEST DIS SCI, V46, P1700, DOI 10.1023/A:1010653504568; Siegel N, 2007, STEM CELL REV, V3, P256, DOI 10.1007/s12015-007-9003-z; Stuart WD, 2011, HEPATOLOGY, V53, P1618, DOI 10.1002/hep.24239; Sun CC, 2006, STEM CELLS, V24, P2130, DOI 10.1634/stemcells.2005-0590; Tron K, 2005, LAB INVEST, V85, P376, DOI 10.1038/labinvest.3700228; Xi JF, 2007, PROG BIOCHEM BIOPHYS, V34, P207; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Yumoto E, 2002, J GASTROEN HEPATOL, V17, P285, DOI 10.1046/j.1440-1746.2002.02690.x; Zheng YB, 2008, CELL BIOL INT, V32, P1439, DOI 10.1016/j.cellbi.2008.08.015; Zhu RZ, 2010, WORLD J GASTROENTERO, V16, P2771, DOI 10.3748/wjg.v16.i22.2771	26	35	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41392	10.1371/journal.pone.0041392	http://dx.doi.org/10.1371/journal.pone.0041392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844472	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700083
J	Arias, MA; Van Roey, GA; Tregoning, JS; Moutaftsi, M; Coler, RN; Windish, HP; Reed, SG; Carter, D; Shattock, RJ				Arias, Mauricio A.; Van Roey, Griet A.; Tregoning, John S.; Moutaftsi, Magdalini; Coler, Rhea N.; Windish, Hillarie P.; Reed, Steven G.; Carter, Darrick; Shattock, Robin J.			Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140	PLOS ONE			English	Article							ANTIBODY-RESPONSES; HIV-1 INFECTION; VACCINE; IMMUNITY; CHITOSAN; NASAL; TH17; EFFICACY; DELIVERY; MPL	Successful vaccine development against HIV will likely require the induction of strong, long-lasting humoral and cellular immune responses in both the systemic and mucosal compartments. Based on the known immunological linkage between the upper-respiratory and urogenital tracts, we explored the potential of nasal adjuvants to boost immunization for the induction of vaginal and systemic immune responses to gp140. Mice were immunized intranasally with HIV gp140 together with micellar and emulsion formulations of a synthetic TLR4 agonist, Glucopyranosyl Lipid Adjuvant (GLA) and responses were compared to R848, a TLR7/8 agonist, or chitosan, a non TLR adjuvant. GLA and chitosan but not R848 greatly enhanced serum immunoglobulin levels when compared to antigen alone. Both GLA and chitosan induced high IgG and IgA titers in nasal and vaginal lavage and feces. The high IgA and IgG titers in vaginal lavage were associated with high numbers of gp140-specific antibody secreting cells in the genital tract. Whilst both GLA and chitosan induced T cell responses to immunization, GLA induced a stronger Th17 response and chitosan induced a more Th2 skewed response. Our results show that GLA is a highly potent intranasal adjuvant greatly enhancing humoral and cellular immune responses, both systemically and mucosally.	[Arias, Mauricio A.; Van Roey, Griet A.; Tregoning, John S.; Shattock, Robin J.] St Georges Univ London, Ctr Infect & Immun, London, England; [Tregoning, John S.; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, London, England; [Moutaftsi, Magdalini; Coler, Rhea N.; Windish, Hillarie P.; Reed, Steven G.; Carter, Darrick] IDRI, Seattle, WA USA	St Georges University London; Imperial College London	Arias, MA (corresponding author), St Georges Univ London, Ctr Infect & Immun, London, England.	r.shattock@imperial.ac.uk	Carter, Darrick/N-3304-2016	Carter, Darrick/0000-0001-5901-3402; Tregoning, John/0000-0001-8093-8741	Bill and Melinda Gates Foundation; Wellcome Trust through the Grand Challenges in Global Health initiative; EC [LSHP-CT-2006-037611]; Dormeur Investment Service Ltd.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust through the Grand Challenges in Global Health initiative(Wellcome Trust); EC(European CommissionEuropean Commission Joint Research Centre); Dormeur Investment Service Ltd.	This work was funded by a grant to St George's, University of London, from the Bill and Melinda Gates Foundation and the Wellcome Trust, through the Grand Challenges in Global Health initiative. Griet A. Van Roey was funded on a studentship supported by the FP-6-funded EUROPRISE, EC grant LSHP-CT-2006-037611. The authors are indebted to Dormeur Investment Service Ltd., for funding of equipment used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Arias MA, 2011, VACCINE, V29, P1258, DOI 10.1016/j.vaccine.2010.11.084; Baldrick P, 2002, REGUL TOXICOL PHARM, V35, P398, DOI 10.1006/rtph.2002.1541; Baldwin SL, 2012, J IMMUNOL; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Brewer JM, 1998, J IMMUNOL, V161, P4000; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; Cranage MP, 2011, VACCINE, V29, P1421, DOI 10.1016/j.vaccine.2010.12.034; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; DiTommaso A, 1996, INFECT IMMUN, V64, P974, DOI 10.1128/IAI.64.3.974-979.1996; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Guglani L, 2010, CURR OPIN HIV AIDS, V5, P120, DOI 10.1097/COH.0b013e328335c2f6; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Johnson DA, 1999, BIOORG MED CHEM LETT, V9, P2273, DOI 10.1016/S0960-894X(99)00374-1; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kemp TJ, 2008, VACCINE, V26, P3608, DOI 10.1016/j.vaccine.2008.04.074; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Koff WC, 2012, VACCINE, V30, P4310, DOI 10.1016/j.vaccine.2011.11.014; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lin YY, 2010, SEMIN IMMUNOPATHOL, V32, P79, DOI 10.1007/s00281-009-0191-2; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Nabel GJ, 2011, PHILOS T R SOC B, V366, P2759, DOI 10.1098/rstb.2011.0096; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pantel A, 2012, EUR J IMMUNOL, V42, P101, DOI 10.1002/eji.201141855; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rudin A, 1999, INFECT IMMUN, V67, P2884, DOI 10.1128/IAI.67.6.2884-2890.1999; Schneider LP, 2012, VACCINE, V30, P4216, DOI 10.1016/j.vaccine.2012.04.051; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sui ZW, 2010, VACCINE, V28, P7690, DOI 10.1016/j.vaccine.2010.09.019; TAKAYAMA K, 1984, REV INFECT DIS, V6, P439; van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5; Van Roey GA, 2012, EUR J IMMUNOL, V42, P353, DOI 10.1002/eji.201141787; Vila A, 2004, EUR J PHARM BIOPHARM, V57, P123, DOI 10.1016/j.ejpb.2003.09.006; Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008; Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034	50	72	91	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41144	10.1371/journal.pone.0041144	http://dx.doi.org/10.1371/journal.pone.0041144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829921	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300060
J	Jokela, J; Oftedal, L; Herfindal, L; Permi, P; Wahlsten, M; Doskeland, SO; Sivonen, K				Jokela, Jouni; Oftedal, Linn; Herfindal, Lars; Permi, Perttu; Wahlsten, Matti; Doskeland, Stein Ove; Sivonen, Kaarina			Anabaenolysins, Novel Cytolytic Lipopeptides from Benthic Anabaena Cyanobacteria	PLOS ONE			English	Article							BALTIC SEA; SECONDARY METABOLITES; MARINE CYANOBACTERIA; MICROCYSTIN-LR; GENUS ANABAENA; CELL-LINE; APOPTOSIS; STRAINS; PROLIFERATION; INHIBITORS	Two novel cyclic lipopeptides, anabaenolysin A and anabaenolysin B, were isolated from two benthic cyanobacterial strains of the genus Anabaena. This novel class of cyanobacterial lipopeptides has a general structure of a small peptide ring consisting of four amino acids from which two are proteinogenic and two unusual; glycine(1), glycine(2), 2-(3-amino-5-oxytetrahydrofuran-2-yl)-2-hydroxyacetic acid(3) and a long unsaturated C-18 beta-amino acid(4) with a conjugated triene structure. They are distinguished by the presence of a conjugated dienic structure in the C18 beta-amino acid present in anabaenolysin A but not in anabaenolysin B. Conjugated triene structure generates a typical UV spectrum for anabaenolysins for easy recognition. Anabaenolysin A constituted up to 400 ppm of the cyanobacterial dry weight. We found evidence of thirteen variants of anabaenolysins in one cyanobacterial strain. This suggests that the anabaenolysins are an important class of secondary metabolites in benthic Anabaena cyanobacteria. Both anabaenolysin A and B had cytolytic activity on a number of mammalian cell lines.	[Jokela, Jouni; Wahlsten, Matti; Sivonen, Kaarina] Univ Helsinki, Div Microbiol, Dept Food & Environm Sci, Helsinki, Finland; [Oftedal, Linn; Herfindal, Lars; Doskeland, Stein Ove] Univ Bergen, Dept Biomed, Bergen, Norway; [Herfindal, Lars] Haukeland Hosp, Translat Signaling Grp, N-5021 Bergen, Norway; [Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland	University of Helsinki; University of Bergen; University of Bergen; Haukeland University Hospital; University of Helsinki	Jokela, J (corresponding author), Univ Helsinki, Div Microbiol, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi		Wahlsten, Matti/0000-0002-4107-1695; Sivonen, Kaarina/0000-0002-2904-0458; Herfindal, Lars/0000-0003-0353-3614; Oftedal, Linn/0000-0003-1793-4013; Jokela, Jouni/0000-0001-5096-3575; Doskeland, Stein Ove/0000-0002-4009-4756	Academy of Finland [214457, 118637]; Norwegian Research Council [157338, 138694/432]; Western Norway Regional Health Authority	Academy of Finland(Academy of Finland); Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority	This research was supported by the Academy of Finland (grants 214457 and 118637 to KS), the Norwegian Research Council (157338 and 138694/432) and the Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO T, 1993, J CHEM ECOL, V19, P119, DOI 10.1007/BF00987477; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; Degenkolb T, 2008, CHEM BIODIVERS, V5, P693, DOI 10.1002/cbdv.200890066; Dobson G, 1998, J AM OIL CHEM SOC, V75, P137, DOI 10.1007/s11746-998-0024-9; Gademann K, 2008, CURR ORG CHEM, V12, P326, DOI 10.2174/138527208783743750; Golakoti T, 2001, J NAT PROD, V64, P54, DOI 10.1021/np000316k; Halinen K, 2008, FEMS MICROBIOL ECOL, V64, P199, DOI 10.1111/j.1574-6941.2008.00461.x; Herfindal L, 2005, TOXICON, V46, P252, DOI 10.1016/j.toxicon.2005.04.005; ITOH J, 1982, AGR BIOL CHEM TOKYO, V46, P2659, DOI 10.1080/00021369.1982.10865491; Jokela J, 2010, CHEMBIOCHEM, V11, P1594, DOI 10.1002/cbic.201000179; Jourdan E, 2009, MOL PLANT MICROBE IN, V22, P456, DOI 10.1094/MPMI-22-4-0456; Kaya K, 2002, J NAT PROD, V65, P920, DOI 10.1021/np010660x; LACAZE N, 1983, LEUKEMIA RES, V7, P145, DOI 10.1016/0145-2126(83)90005-X; LANOTTE M, 1991, BLOOD, V77, P1080; Leikoski N, 2010, APPL ENVIRON MICROB, V76, P701, DOI 10.1128/AEM.01061-09; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Martin J, 2001, J MASS SPECTROM, V36, P1294; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; McDermott CM, 1998, TOXICON, V36, P1981, DOI 10.1016/S0041-0101(98)00128-7; MELLGREN G, 1995, J CELL PHYSIOL, V163, P232, DOI 10.1002/jcp.1041630203; Mitchell L, 1994, BIOCHEMISTRY-US, V33, P15223; Neuhof T, 2005, J NAT PROD, V68, P695, DOI 10.1021/np049671r; Nunnery JK, 2010, CURR OPIN BIOTECH, V21, P787, DOI 10.1016/j.copbio.2010.09.019; Oftedal L, 2010, MAR DRUGS, V8, P2659, DOI 10.3390/md8102659; Sano T, 2005, PHYTOCHEMISTRY, V66, P543, DOI 10.1016/j.phytochem.2005.01.001; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shiono Y, 2007, J ANTIBIOT, V60, P309, DOI 10.1038/ja.2007.39; Sivonen Kaarina, 2008, P159; Surakka A, 2005, ENVIRON TOXICOL, V20, P285, DOI 10.1002/tox.20119; Taniguchi M, 2010, J NAT PROD, V73, P393, DOI 10.1021/np900428h; Zheng JK, 2010, J NAT PROD, V73, P1133, DOI 10.1021/np100198h	32	24	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41222	10.1371/journal.pone.0041222	http://dx.doi.org/10.1371/journal.pone.0041222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829929	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300068
J	Wu, SQ; Wu, FQ; Hong, RT; He, J				Wu, Shunquan; Wu, Fuquan; Hong, Rongtao; He, Jia			Incidence Analyses and Space-Time Cluster Detection of Hepatitis C in Fujian Province of China from 2006 to 2010	PLOS ONE			English	Article							VIRUS-INFECTION; UNSAFE INJECTIONS; SURVEILLANCE DATA; DEVELOPING-WORLD; UNITED-STATES; RISK-FACTORS; SYSTEM; EPIDEMIOLOGY; TRANSMISSION; PREVALENCE	Background: There is limited epidemiologic information about the incidence of hepatitis C in China, and few studies have applied space-time scan statistic to detect clusters of hepatitis C and made adjustment for temporal trend and relative risk of regions. Methodology and Principal Findings: We analyzed the temporal changes and characteristics of incidence of hepatitis C in Fujian Province from 2006 through 2010. The discrete Poisson model of space-time scan statistic was chosen for cluster detection. Data on new cases of hepatitis C were obtained from the Center for Disease Control and Prevention of Fujian Province. Between 2006 and 2010, there was an annualized increase in the incidence of hepatitis C of 23.0 percent, from 928 cases (2.63 per 100,000 persons) to 2,180 cases (6.01 per 100,000 persons). The incidence among women increased more rapidly. The cumulative incidence showed that people who were over 60 years had the highest risk to suffer hepatitis C (52.51 per 100,000 persons), and women had lower risk compared to men (OR = 0.69). Putian had the highest cumulative incidence among all the regions (86.95 per 100,000 persons). The most likely cluster was identified in Putian during March to August in 2009 without adjustment, but it shifted to three contiguous cities with a two-month duration after adjustment for temporal trend and relative risk of regions. Conclusions/Significance: The incidence of hepatitis C is increasing in Fujian Province, and women are at a more rapid pace. The space-time scan statistic is useful as a screening tool for clusters of hepatitis C, with adjustment for temporal trend and relative risk of regions recommended.	[Wu, Shunquan; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Wu, Fuquan] Second Mil Med Univ, Int Cooperat Lab Signal Transduct, Eastern Hepatobiliary Surg Inst, Shanghai, Peoples R China; [Hong, Rongtao] Fujian Ctr Dis Control & Prevet, Fuzhou, Fujian Province, Peoples R China	Naval Medical University; Naval Medical University	Wu, SQ (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com		He, Jia/0000-0002-2338-9501	National Natural Science Foundation of China [81072388]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [81072388]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2003, INT J EPIDEMIOL, V32, P725, DOI 10.1093/ije/dyg266; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; Dockerty JD, 1999, J EPIDEMIOL COMMUN H, V53, P154, DOI 10.1136/jech.53.3.154; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; Hagan H, 2002, J URBAN HEALTH, V79, P579, DOI 10.1093/jurban/79.4.579; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Jones RC, 2006, PUBLIC HEALTH REP, V121, P133, DOI 10.1177/003335490612100206; Kane A, 1999, B WORLD HEALTH ORGAN, V77, P801; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 1999, J NATL I PUBLIC HLTH, V48, P94; Kulldorff M, 2022, SATSCAN USER GUIDE V; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Liang HG, 2004, INT J MED INFORM, V73, P675, DOI 10.1016/j.ijmedinf.2004.05.010; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; NOBRE FF, 1994, INT J EPIDEMIOL, V23, P408, DOI 10.1093/ije/23.2.408; Orland JR, 2001, HEPATOLOGY, V33, P321, DOI 10.1053/jhep.2001.22112; Perz JF, 2006, J HEPATOL, V44, P441, DOI 10.1016/j.jhep.2005.12.007; Prati D, 1997, HEPATOLOGY, V25, P702, DOI 10.1002/hep.510250335; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; Robotin MC, 2004, J GASTROEN HEPATOL, V19, P283, DOI 10.1111/j.1440-1746.2003.03270.x; Sheehan T Joseph, 2005, Int J Health Geogr, V4, P15, DOI 10.1186/1476-072X-4-15; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Sowmyanarayanan TV, 2008, INDIAN J MED RES, V128, P32; Spada E, 2001, DIGEST LIVER DIS, V33, P778, DOI 10.1016/S1590-8658(01)80695-2; Sy Theodore, 2006, Int J Med Sci, V3, P41; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3	32	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40872	10.1371/journal.pone.0040872	http://dx.doi.org/10.1371/journal.pone.0040872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829893	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300031
J	Reishofer, G; Koschutnig, K; Enzinger, C; Ebner, F; Ahammer, H				Reishofer, Gernot; Koschutnig, Karl; Enzinger, Christian; Ebner, Franz; Ahammer, Helmut			Fractal Dimension and Vessel Complexity in Patients with Cerebral Arteriovenous Malformations	PLOS ONE			English	Article							GENERALIZED DIMENSIONS; MULTIFRACTAL ANALYSIS; CORTICAL SURFACE; SEGMENTATION; IMAGES; GEOMETRY; MATTER	The fractal dimension (FD) can be used as a measure for morphological complexity in biological systems. The aim of this study was to test the usefulness of this quantitative parameter in the context of cerebral vascular complexity. Fractal analysis was applied on ten patients with cerebral arteriovenous malformations (AVM) and ten healthy controls. Maximum intensity projections from Time-of-Flight MRI scans were analyzed using different measurements of FD, the Box-counting dimension, the Minkowski dimension and generalized dimensions evaluated by means of multifractal analysis. The physiological significance of this parameter was investigated by comparing values of FD first, with the maximum slope of contrast media transit obtained from dynamic contrast-enhanced MRI data and second, with the nidus size obtained from X-ray angiography data. We found that for all methods, the Box-counting dimension, the Minkowski dimension and the generalized dimensions FD was significantly higher in the hemisphere with AVM compared to the hemisphere without AVM indicating that FD is a sensitive parameter to capture vascular complexity. Furthermore we found a high correlation between FD and the maximum slope of contrast media transit and between FD and the size of the central nidus pointing out the physiological relevance of FD. The proposed method may therefore serve as an additional objective parameter, which can be assessed automatically and might assist in the complex workup of AVMs.	[Reishofer, Gernot] Med Univ Graz, MR Phys, Dept Radiol, Graz, Austria; [Koschutnig, Karl; Ebner, Franz] Med Univ Graz, Div Neuroradiol, Dept Radiol, Graz, Austria; [Koschutnig, Karl] Graz Univ, Dept Psychol, Graz, Austria; [Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Ahammer, Helmut] Med Univ Graz, Inst Biophys, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Graz; Medical University of Graz; Medical University of Graz	Reishofer, G (corresponding author), Med Univ Graz, MR Phys, Dept Radiol, Graz, Austria.	gernot.reishofer@medunigraz.at	Koschutnig, Karl/W-3106-2019; Reishofer, Gernot/E-9215-2011	Koschutnig, Karl/0000-0001-6234-0498; Reishofer, Gernot/0000-0002-3068-6475; Ahammer, Helmut/0000-0001-5400-294X				Ahammer H, 2004, CHAOS, V14, P183, DOI 10.1063/1.1638947; Ahammer H, 2011, CHAOS SOLITON FRACT, V44, P86, DOI 10.1016/j.chaos.2010.12.004; Ahammer H, 2003, PHYSICA D, V181, P147, DOI 10.1016/S0167-2789(03)00099-X; Azemin MZC, 2011, IEEE T MED IMAGING, V30, P243, DOI 10.1109/TMI.2010.2076322; Baish JW, 2000, CANCER RES, V60, P3683; Blackburn SL, 2011, J NEUROSURG; Bui A, 2009, MED BIOL ENG COMPUT, V47, P763, DOI 10.1007/s11517-009-0492-6; Cavallari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019150; Di Ieva A, 2010, MICROVASC RES, V80, P267, DOI 10.1016/j.mvr.2010.04.003; DUBUC B, 1989, PHYS REV A, V39, P1500, DOI 10.1103/PhysRevA.39.1500; Esteban FJ, 2007, NEUROIMAGE, V36, P543, DOI 10.1016/j.neuroimage.2007.03.057; Esteban FJ, 2009, J NEUROL SCI, V282, P67, DOI 10.1016/j.jns.2008.12.023; Falconer K. J., 2003, FRACTAL GEOMETRY MAT; Fernandez E, 2001, METHODS, V24, P309, DOI 10.1006/meth.2001.1201; Fleetwood IG, 2002, LANCET, V359, P863, DOI 10.1016/S0140-6736(02)07946-1; Gao X, 2011, J DIGIT IMAGING, V24, P609, DOI 10.1007/s10278-010-9326-1; Gould DJ, 2011, MICROCIRCULATION, V18, P136, DOI 10.1111/j.1549-8719.2010.00075.x; Ha TH, 2005, NEUROSCI LETT, V384, P172, DOI 10.1016/j.neulet.2005.04.078; HENTSCHEL HGE, 1983, PHYSICA D, V8, P435, DOI 10.1016/0167-2789(83)90235-X; Herman P, 2001, J CEREBR BLOOD F MET, V21, P741, DOI 10.1097/00004647-200106000-00012; Im K, 2006, HUM BRAIN MAPP, V27, P994, DOI 10.1002/hbm.20238; Jayaraman MV, 2008, AM J NEURORADIOL, V29, P242, DOI 10.3174/ajnr.A0793; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalda J, 1999, DISCRETE DYN NAT SOC, V3, P297, DOI 10.1155/S102602269900031X; KANMANI S, 1993, J MICROSC-OXFORD, V170, P81, DOI 10.1111/j.1365-2818.1993.tb03325.x; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; Kiselev VG, 2003, NEUROIMAGE, V20, P1765, DOI 10.1016/S1053-8119(03)00380-X; Krings T, 2010, EUR RADIOL, V20, P2723, DOI 10.1007/s00330-010-1834-3; Lauwerier H. A., 1991, FRACTALS IMAGES CHAO; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; Liu JZ, 2003, BIOPHYS J, V85, P4041, DOI 10.1016/S0006-3495(03)74817-6; Lopes R, 2011, MED PHYS, V38, P83, DOI 10.1118/1.3521470; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Losa GA, 2009, RIV BIOL-BIOL FORUM, V102, P29; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MEISEL LV, 1992, PHYS REV A, V45, P6989, DOI 10.1103/PhysRevA.45.6989; Miyazaki M, 2008, RADIOLOGY, V248, P20, DOI 10.1148/radiol.2481071497; Ozsarlak O, 2004, NEURORADIOLOGY, V46, P955, DOI 10.1007/s00234-004-1297-9; Passat N, 2005, J MAGN RESON IMAGING, V21, P715, DOI 10.1002/jmri.20307; Peitgen H.O., 1988, SCI FRACTAL IMAGES; Perfect E, 2009, FRACTALS, V17, P351, DOI 10.1142/S0218348X09004302; PIETRONERO L, 1988, PHYSICA A, V151, P207, DOI 10.1016/0378-4371(88)90014-3; Pruess SA., 1995, FRACTALS EARTH SCI, P10; RUSSELL DA, 1980, PHYS REV LETT, V45, P1175, DOI 10.1103/PhysRevLett.45.1175; Soille P, 1996, J VIS COMMUN IMAGE R, V7, P217, DOI 10.1006/jvci.1996.0020; Stojic T, 2006, PHYSICA A, V367, P494, DOI 10.1016/j.physa.2005.11.030; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; VICSEK T, 1990, EUROPHYS LETT, V12, P217, DOI 10.1209/0295-5075/12/3/005; VICSEK T, 1990, PHYSICA A, V168, P490, DOI 10.1016/0378-4371(90)90401-D; Yampolsky M, 2008, PLACENTA, V29, P790, DOI 10.1016/j.placenta.2008.06.005; Zamir M, 2001, J THEOR BIOL, V212, P183, DOI 10.1006/jtbi.2001.2367	52	39	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41148	10.1371/journal.pone.0041148	http://dx.doi.org/10.1371/journal.pone.0041148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815946	gold, Green Published, Green Submitted			2022-12-25	WOS:000306548900081
J	Hong, IK; Jeoung, DI; Ha, KS; Kim, YM; Lee, H				Hong, In-Kee; Jeoung, Doo-Il; Ha, Kwon-Soo; Kim, Young-Myeong; Lee, Hansoo			Tetraspanin CD151 Stimulates Adhesion-dependent Activation of Ras, Rac, and Cdc42 by Facilitating Molecular Association between beta(1) Integrins and Small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RHO; ACTIN STRESS FIBERS; CELL-ADHESION; TRANSMEMBRANE-4 SUPERFAMILY; CLINICAL-SIGNIFICANCE; ALPHA-3-BETA-1; EXPRESSION; KINASE; PKC; ALPHA-6-BETA-4	Tetraspanin CD151 associates with laminin-binding alpha(3)beta(1)/alpha(6)beta(1) integrins in epithelial cells and regulates adhesion-dependent signaling events. We found here that CD151 plays a role in recruiting Ras, Rac1, and Cdc42, but not Rho, to the cell membrane region, leading to the formation of alpha(3)beta(1)/alpha(6)beta(1) integrin-CD151-GTPases complexes. Furthermore, cell adhesion to laminin enhanced CD151 association with beta(1) integrin and, thereby, increased complex formation between the beta(1) family of integrins and small GTPases, Ras, Rac1, and Cdc42. Adhesion receptor complex-associated small GTPases were activated by CD151-beta(1) integrin complex-stimulating adhesion events, such as alpha(3)beta(1)/alpha(6)beta(1) integrin-activating cell-to-laminin adhesion and homophilic CD151 interaction-generating cell-to-cell adhesion. Additionally, FAK and Src appeared to participate in this adhesion-dependent activation of small GTPases. However, engagement of laminin-binding integrins in CD151-deficient cells or CD151-specific siRNA-transfected cells did not activate these GTPases to the level of cells expressing CD151. Small GTPases activated by engagement of CD151-beta(1) integrin complexes contributed to CD151-induced cell motility and MMP-9 expression in human melanoma cells. Importantly, among the four tetraspanin proteins that associate with beta(1) integrin, only CD151 exhibited the ability to facilitate complex formation between the beta(1) family of integrins and small GTPases and stimulate beta(1) integrin-dependent activation of small GTPases. These results suggest that CD151 links alpha(3)beta(1)/alpha(6)beta(1) integrins to Ras, Rac1, and Cdc42 by promoting the formation of multimolecular complexes in the membrane, which leads to the up-regulation of adhesion-dependent small GTPase activation.	[Hong, In-Kee; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Dept Biol Sci, Chunchon 200701, Kangwon Do, South Korea; [Hong, In-Kee; Jeoung, Doo-Il; Ha, Kwon-Soo; Lee, Hansoo] Kangwon Natl Univ, Med & Biomat Res Ctr, Chunchon 200701, Kangwon Do, South Korea; [Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 200701, Kangwon Do, South Korea	Kangwon National University; Kangwon National University; Kangwon National University	Lee, H (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Dept Biol Sci, Chunchon 200701, Kangwon Do, South Korea.	hslee@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2011-0024380, 2009-0054632]; NRF	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (Grant 2011-0024380). This work was also supported by the Mid-career Researcher Program through an NRF grant funded by the MEST (Grant 2009-0054632).	Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berditchevski F, 2001, J CELL SCI, V114, P4143; Berrier AL, 2000, J CELL BIOL, V151, P1549, DOI 10.1083/jcb.151.7.1549; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Carloni V, 2004, ONCOGENE, V23, P1566, DOI 10.1038/sj.onc.1207287; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Chen G., 2008, OPEN BIOTECHNOL J, V2, P133, DOI [10.2174/1874070700802010133, DOI 10.2174/1874070700802010133]; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Choma DP, 2004, J CELL SCI, V117, P3947, DOI 10.1242/jcs.01251; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kohno M, 2002, INT J CANCER, V97, P336, DOI 10.1002/ijc.1605; Lau LM, 2004, BLOOD, V104, P2368, DOI 10.1182/blood-2003-12-4430; LEE HS, 1993, J BIOL CHEM, V268, P5255; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Sawada S, 2003, J BIOL CHEM, V278, P26323, DOI 10.1074/jbc.C300210200; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Shigeta M, 2003, J CELL BIOL, V163, P165, DOI 10.1083/jcb.200301075; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Soldaini E, 2003, EUR J IMMUNOL, V33, P455, DOI 10.1002/immu.200310021; Sterk LMT, 2002, J CELL SCI, V115, P1161; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Testa JE, 1999, CANCER RES, V59, P3812; Tokuhara T, 2001, CLIN CANCER RES, V7, P4109; Vleggeert-Lankamp CLAM, 2004, BIOMATERIALS, V25, P2741, DOI 10.1016/j.biomaterials.2003.09.067; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yanez-Mo M, 2001, MICROCIRCULATION, V8, P153; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yarwood SJ, 2001, P NATL ACAD SCI USA, V98, P4472, DOI 10.1073/pnas.081069098; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhang XA, 2002, MOL BIOL CELL, V13, P1, DOI 10.1091/mbc.01-10-0481; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	65	43	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32027	32039		10.1074/jbc.M111.314443	http://dx.doi.org/10.1074/jbc.M111.314443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843693	Green Published, hybrid			2022-12-25	WOS:000309059400041
J	Pelisch, F; Pozzi, B; Risso, G; Munoz, MJ; Srebrow, A				Pelisch, Federico; Pozzi, Berta; Risso, Guillermo; Javier Munoz, Manuel; Srebrow, Anabella			DNA Damage-induced Heterogeneous Nuclear Ribonucleoprotein K SUMOylation Regulates p53 Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO E3 LIGASE; PROTEIN SUMOYLATION; HNRNP-K; UBIQUITIN LIGASES; IN-VIVO; HIPK2; COMPLEX; GENE; REPRESSION; PC2	Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a nucleocytoplasmic shuttling protein that is a key player in the p53-triggered DNA damage response, acting as a cofactor for p53 in response to DNA damage. hnRNP K is a substrate of the ubiquitin E3 ligase MDM2 and, upon DNA damage, is de-ubiquitylated. In sharp contrast with the role and consequences of the other post-translational modifications, nothing is known about the role of SUMO conjugation to hnRNP K in p53 transcriptional co-activation. In the present work, we show that hnRNP K is modified by SUMO in lysine 422 within its KH3 domain, and sumoylation is regulated by the E3 ligase Pc2/CBX4. Most interestingly, DNA damage stimulates hnRNP K sumoylation through Pc2 E3 activity, and this modification is required for p53 transcriptional activation. Abrogation of hnRNP K sumoylation leads to an aberrant regulation of the p53 target gene p21. Our findings link the DNA damage-induced Pc2 activation to the p53 transcriptional co-activation through hnRNP K sumoylation.	[Pelisch, Federico; Pozzi, Berta; Risso, Guillermo; Javier Munoz, Manuel; Srebrow, Anabella] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, Consejo Nacl Invest Cient & Tecn,Dept Fisiol Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pelisch, F (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, Consejo Nacl Invest Cient & Tecn,Dept Fisiol Biol, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	fpelisch@fbmc.fcen.uba.ar; asrebrow@fbmc.fcen.uba.ar	Pelisch, Federico/C-3815-2011; Pelisch, Federico/H-9219-2013	Munoz, Manuel J./0000-0002-1152-5449; Pozzi, Berta/0000-0002-4744-9337; Pelisch, Federico/0000-0003-4575-1492	EURSNET; ANPCyT; University of Buenos Aires	EURSNET; ANPCyT(ANPCyT); University of Buenos Aires(University of Buenos Aires)	This work was supported by EURSNET (to A. S.) and ANPCyT and University of Buenos Aires (to F. P. and A. S.).	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Cazalla D, 2005, PROTEIN EXPRES PURIF, V42, P54, DOI 10.1016/j.pep.2005.03.035; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Pelisch F, 2010, P NATL ACAD SCI USA, V107, P16119, DOI 10.1073/pnas.1004653107; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Rosonina E, 2010, GENE DEV, V24, P1242, DOI 10.1101/gad.1917910; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Vassileva MT, 2004, MOL CELL BIOL, V24, P3623, DOI 10.1128/MCB.24.9.3623-3632.2004; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2010, MOL CELL BIOL, V30, P2193, DOI 10.1128/MCB.01510-09; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	54	61	66	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30789	30799		10.1074/jbc.M112.390120	http://dx.doi.org/10.1074/jbc.M112.390120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22825850	Green Published, hybrid			2022-12-25	WOS:000308579800067
J	Chiappini, N; Seubert, A; Telford, JL; Grandi, G; Serruto, D; Margarit, I; Janulczyk, R				Chiappini, Nico; Seubert, Anja; Telford, John L.; Grandi, Guido; Serruto, Davide; Margarit, Immaculada; Janulczyk, Robert			Streptococcus pyogenes SpyCEP Influences Host-Pathogen Interactions during Infection in a Murine Air Pouch Model	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; CHEMOKINE DEGRADATION; BACTERIAL CLEARANCE; REGULATORY SYSTEM; INVASIVE DISEASE; PROTEASE SPYCEP; EXPRESSION; SURFACE; SEPSIS; GENE	Streptococcus pyogenes is a major human pathogen worldwide, responsible for both local and systemic infections. These bacteria express the subtilisin-like protease SpyCEP which cleaves human IL-8 and related chemokines. We show that localization of SpyCEP is growth-phase and strain dependent. Significant shedding was observed only in a strain naturally overexpressing SpyCEP, and shedding was not dependent on SpyCEP autoproteolytic activity. Surface-bound SpyCEP in two different strains was capable of cleaving IL-8. To investigate SpyCEP action in vivo, we adapted the mouse air pouch model of infection for parallel quantification of bacterial growth, host immune cell recruitment and chemokine levels in situ. In response to infection, the predominant cells recruited were neutrophils, monocytes and eosinophils. Concomitantly, the chemokines KC, LIX, and MIP-2 in situ were drastically increased in mice infected with the SpyCEP knockout strain, and growth of this mutant strain was reduced compared to the wild type. SpyCEP has been described as a potential vaccine candidate against S. pyogenes, and we showed that surface-associated SpyCEP was recognized by specific antibodies. In vitro, such antibodies also counteracted the inhibitory effects of SpyCEP on chemokine mediated PMN recruitment. Thus, alpha-SpyCEP antibodies may benefit the host both directly by enabling opsonophagocytosis, and indirectly, by neutralizing an important virulence factor. The animal model we employed shows promise for broad application in the study of bacterial pathogenesis.	[Chiappini, Nico; Seubert, Anja; Telford, John L.; Grandi, Guido; Serruto, Davide; Margarit, Immaculada; Janulczyk, Robert] Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy	Novartis	Chiappini, N (corresponding author), Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy.	Robert.Janulczyk@Novartis.com	Telford, John Laird/ABG-8144-2020	Grandi, Guido/0000-0001-9724-2185; Seubert, Anja/0000-0003-3321-9140	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was supported by internal funding from Novartis Vaccines and Diagnostics, whose role, through the employment of Nico Chiappini, Anja Seubert, John L. Telford, Guido Grandi, Davide Serruto, Immaculada Margarit and Robert Janulczyk, involved conceiving, designing and performing the experiments and analyzing the data.	Bensi G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015693; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CHEN CC, 1990, J BIOL CHEM, V265, P3161; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Delano DL, 2005, INFLAMMATION, V29, P1, DOI 10.1007/s10753-006-8962-6; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Fritzer A, 2010, INFECT IMMUN, V78, P4051, DOI 10.1128/IAI.00295-10; Fritzer A, 2009, BIOCHEM J, V422, P533, DOI 10.1042/BJ20090278; Garcia AF, 2010, MICROBIOL-SGM, V156, P3085, DOI 10.1099/mic.0.042614-0; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Kaur SJ, 2010, J BIOL CHEM, V285, P27798, DOI 10.1074/jbc.M109.098053; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; NickersonNutter CL, 1996, ARTHRITIS RHEUM, V39, P515, DOI 10.1002/art.1780390320; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Sjolinder H, 2008, INFECT IMMUN, V76, P3959, DOI 10.1128/IAI.00128-08; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Turner CE, 2009, VACCINE, V27, P4923, DOI 10.1016/j.vaccine.2009.06.042; Turner CE, 2009, J INFECT DIS, V200, P555, DOI 10.1086/603541; Yamamoto Y, 1998, LIFE SCI, V62, P1767, DOI 10.1016/S0024-3205(98)00138-6; Zingaretti C, 2010, FASEB J, V24, P2839, DOI 10.1096/fj.09-145631; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	37	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40411	10.1371/journal.pone.0040411	http://dx.doi.org/10.1371/journal.pone.0040411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848376	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950200018
J	Zuurbier, CJ; Jong, WMC; Eerbeek, O; Koeman, A; Pulskens, WP; Butter, LM; Leemans, JC; Hollmann, MW				Zuurbier, Coert J.; Jong, Willeke M. C.; Eerbeek, Otto; Koeman, Anneke; Pulskens, Wilco P.; Butter, Loes M.; Leemans, Jaklien C.; Hollmann, Markus W.			Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling	PLOS ONE			English	Article							INFLAMMASOME-INDEPENDENT ROLE; MECHANISMS; INJURY; INTERLEUKIN-6; HYPOXIA; DISEASE	Objective: Recent studies indicate that the innate immune system is not only triggered by exogenous pathogens and pollutants, but also by endogenous danger signals released during ischemia and necrosis. As triggers for the innate immune NLRP3 inflammasome protein complex appear to overlap with those for cardiac ischemia-reperfusion (I/R) and ischemic preconditioning (IPC), we explored the possibility that the NLRP3 inflammasome is involved in IPC and acute I/R injury of the heart. Principal Findings: Baseline cardiac performance and acute I/R injury were investigated in isolated, Langendorff-perfused hearts from wild-type (WT), ASC(-/-) and NLRP3(-/-) mice. Deletion of NLRP3 inflammasome components ASC(-/-) or NLRP3(-)/(-) did not affect baseline performance. The deletions exacerbated I/R-induced mechanical dysfunction, but were without effect on I/R-induced cell death. When subjected to IPC, WT and ASC(-/-) hearts were protected against I/R injury (improved function and less cell death). However, IPC did not protect NLRP3(-/-) hearts against I/R injury. NLRP3(-/-) hearts had significantly decreased cardiac IL-6 levels with a trend towards lower IL-1 beta levels at end reperfusion, suggesting abrogation of IPC through diminished IL-6 and/or IL-1 beta signaling. Subsequent experiments showed that neutralising IL-6 using an antibody against IL-6 abrogated IPC in WT hearts. However, inhibition of the IL-1 receptor with the IL-1 receptor inhibitor Anakinra (100 mg/L) did not abrogate IPC in WT hearts. Analysis of survival kinases after IPC demonstrated decreased STAT3 expression in NLRP3(-/-) hearts when compared to WT hearts. Conclusions: The data suggest that the innate immune NLRP3 protein, in an NLRP3-inflammasome-independentfashion, is an integral component of IPC in the isolated heart, possibly through an IL-6/STAT3 dependent mechanism.	[Zuurbier, Coert J.; Jong, Willeke M. C.; Koeman, Anneke; Hollmann, Markus W.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Eerbeek, Otto] Univ Amsterdam, Acad Med Ctr, Dept Physiol, NL-1105 AZ Amsterdam, Netherlands; [Pulskens, Wilco P.; Butter, Loes M.; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Zuurbier, CJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.zuurbier@amc.uva.nl	Pulskens, Wilco/P-6023-2015; Leemans, Jaklien/AAM-4958-2020	Pulskens, Wilco/0000-0001-9697-3189; 	Academic Medical Center, Amsterdam	Academic Medical Center, Amsterdam	The Academic Medical Center, Amsterdam, supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Belosjorow S, 1999, AM J PHYSIOL-HEART C, V277, pH2470, DOI 10.1152/ajpheart.1999.277.6.H2470; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Dawn B, 2004, CARDIOVASC RES, V64, P61, DOI 10.1016/j.cardiores.2004.05.011; Dong JW, 2010, AM J PHYSIOL-HEART C, V298, pH1079, DOI 10.1152/ajpheart.00306.2009; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gurel E, 2009, J APPL PHYSIOL, V106, P1909, DOI 10.1152/japplphysiol.90537.2008; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Kanno S, 2000, CIRCULATION, V101, P2742, DOI 10.1161/01.CIR.101.23.2742; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Netea MG, 2000, EUR J IMMUNOL, V30, P3057, DOI 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P; Oba T, 2010, CIRCULATION, V122; Peart J, 2003, CARDIOVASC RES, V58, P589, DOI 10.1016/S0008-6363(03)00259-1; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Smeele KMA, 2011, CIRC RES, V108, P1165, DOI 10.1161/CIRCRESAHA.111.244962; Smith RM, 2002, CARDIOVASC RES, V55, P553, DOI 10.1016/S0008-6363(02)00283-3; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Teoh N, 2006, J HEPATOL, V45, P20, DOI 10.1016/j.jhep.2006.01.039; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou WW, 2010, PEDIATR CARDIOL, V31, P22, DOI 10.1007/s00246-009-9536-9	41	60	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40643	10.1371/journal.pone.0040643	http://dx.doi.org/10.1371/journal.pone.0040643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848390	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200024
J	Chua, GL; Tang, XY; Patra, AT; Tan, SM; Bhattacharjya, S				Chua, Geok-Lin; Tang, Xiao-Yan; Patra, Alok Tanala; Tan, Suet-Mien; Bhattacharjya, Surajit			Structure and Binding Interface of the Cytosolic Tails of alpha X beta 2 Integrin	PLOS ONE			English	Article							SUBUNIT CYTOPLASMIC DOMAINS; NMR ANALYSIS; ALPHA-IIB-BETA-3; TRANSMEMBRANE; PROTEIN; ACTIVATION; IDENTIFICATION; MECHANISM; MONOCYTES; MIGRATION	Background: Integrins are signal transducer proteins involved in a number of vital physiological processes including cell adhesion, proliferation and migration. Integrin molecules are hetero-dimers composed of two distinct subunits, alpha and beta. In humans, 18 alpha and 8 beta subunits are combined into 24 different integrin molecules. Each of the subunit comprises a large extracellular domain, a single pass transmembrane segment and a cytosolic tail (CT). The CTs of integrins are vital for bidirectional signal transduction and in maintaining the resting state of the receptors. A large number of intracellular proteins have been found to interact with the CTs of integrins linking integrins to the cytoskeleton. Methodology/Principal Findings: In this work, we have investigated structure and interactions of CTs of the leukocyte specific integrin alpha X beta 2. We determined the atomic resolution structure of a myristoylated CT of alpha X in perdeuterated dodecylphosphocholine (DPC) by NMR spectroscopy. Our results reveal that the 35-residue long CT of alpha X adopts an alpha-helical conformation for residues F4-N17 at the N-terminal region. The remaining residues located at the C-terminal segment of alpha X delineate a long loop of irregular conformations. A segment of the loop maintains packing interactions with the helical structure by an extended non-polar surface of the alpha X CT. Interactions between alpha X and beta 2 CTs are demonstrated by N-15-H-1 HSQC NMR experiments. We find that residues constituting the polar face of the helical conformation of alpha X are involved in interactions with the N-terminal residues of beta 2 CT. A docked structure of the CT complex indicates that a network of polar and/or salt-bridge interactions may sustain the heteromeric interactions. Conclusions/Significance: The current study provides important insights into the conservation of interactions and structures among different CTs of integrins.	[Chua, Geok-Lin; Tang, Xiao-Yan; Patra, Alok Tanala; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	smtan@ntu.edu.sg; surajit@ntu.edu.sg	PATRA, ALOK/HCH-9797-2022; Tan, Suet/A-2224-2011	PATRA, ALOK/0000-0001-6983-911X; Tan, Suet-Mien/0000-0003-2371-8739	A*Star Biomedical Research Council, Singapore [08/1/22/19/556]; Singapore Ministry of Education [2010-T2-2-014]	A*Star Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education(Ministry of Education, Singapore)	This work is supported by grants 08/1/22/19/556 from A*Star Biomedical Research Council, Singapore [SB and SM] and Singapore Ministry of Education grant 2010-T2-2-014 [SM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Bernard E, 2009, ACS CHEM BIOL, V4, P457, DOI 10.1021/cb8002623; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; Chua GL, 2011, J BIOL CHEM, V286, P43842, DOI 10.1074/jbc.M111.280164; Geng X, 2005, IMMUNOLOGY, V115, P347, DOI 10.1111/j.1365-2567.2005.02175.x; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goddard TD, GRAPHICAL NMR ASSIGN; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; KEIZER GD, 1987, EUR J IMMUNOL, V17, P1317, DOI 10.1002/eji.1830170915; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Tang RH, 2006, FEBS LETT, V580, P4435, DOI 10.1016/j.febslet.2006.06.099; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41924	10.1371/journal.pone.0041924	http://dx.doi.org/10.1371/journal.pone.0041924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844534	Green Published, gold			2022-12-25	WOS:000309240600057
J	Janardan, N; Harijan, RK; Wierenga, RK; Murthy, MRN				Janardan, Neelanjana; Harijan, Rajesh K.; Wierenga, Rikkert K.; Murthy, Mathur R. N.			Crystal Structure of a Monomeric Thiolase-Like Protein Type 1 (TLP1) from Mycobacterium smegmatis	PLOS ONE			English	Article							X-RAY-DIFFRACTION; BIOSYNTHETIC THIOLASE; STEROL CARRIER; COA; SUPERFAMILY; MITOCHONDRIAL; TUBERCULOSIS; COENZYME; INSIGHTS; ENZYMES	An analysis of the Mycobacterium smegmatis genome suggests that it codes for several thiolases and thiolase-like proteins. Thiolases are an important family of enzymes that are involved in fatty acid metabolism. They occur as either dimers or tetramers. Thiolases catalyze the Claisen condensation of two acetyl-Coenzyme A molecules in the synthetic direction and the thiolytic cleavage of 3-ketoacyl-Coenzyme A molecules in the degradative direction. Some of the M. smegmatis genes have been annotated as thiolases of the poorly characterized SCP2-thiolase subfamily. The mammalian SCP2-thiolase consists of an N-terminal thiolase domain followed by an additional C-terminal domain called sterol carrier protein-2 or SCP2. The M. smegmatis protein selected in the present study, referred to here as the thiolase-like protein type 1 (MsTLP1), has been biochemically and structurally characterized. Unlike classical thiolases, MsTLP1 is a monomer in solution. Its structure has been determined at 2.7 angstrom resolution by the single wavelength anomalous dispersion method. The structure of the protomer confirms that the N-terminal domain has the thiolase fold. An extra C-terminal domain is indeed observed. Interestingly, it consists of six beta-strands forming an anti-parallel beta-barrel which is completely different from the expected SCP2-fold. Detailed sequence and structural comparisons with thiolases show that the residues known to be essential for catalysis are not conserved in MsTLP1. Consistent with this observation, activity measurements show that MsTLP1 does not catalyze the thiolase reaction. This is the first structural report of a monomeric thiolase-like protein from any organism. These studies show that MsTLP1 belongs to a new group of thiolase related proteins of unknown function.	[Harijan, Rajesh K.; Wierenga, Rikkert K.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Janardan, Neelanjana; Murthy, Mathur R. N.] Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland	Indian Institute of Science (IISC) - Bangalore; Finland National Institute for Health & Welfare; University of Oulu	Wierenga, RK (corresponding author), Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland.	rik.wierenga@oulu.fi; mrn@mbu.iisc.ernet.in	Harijan, Rajesh K./AAY-3277-2021	Janardan, Neelanjana/0000-0001-6028-1279; Harijan, Rajesh/0000-0003-1503-5057	Department of Science and Technology (DST); Department of Biotechnology (DBT), Government of India; BM 14 beam line, ESRF, Grenoble, France; Council for Scientific and Industrial Research (CSIR), Government of India; Academy of Finland Indo-Finnish Grant [BT/FINNISH/27/MRNM/2009]	Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); BM 14 beam line, ESRF, Grenoble, France; Council for Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Academy of Finland Indo-Finnish Grant(Academy of Finland)	The intensity data were collected using the X-ray Facility for Structural Biology at the Molecular Biophysics Unit, Indian Institute of Science, supported by the Department of Science and Technology (DST) and the Department of Biotechnology (DBT), Government of India and at the BM 14 beam line, ESRF, Grenoble, France. We acknowledge the award of Shyama Prasad Mukherji Fellowship by the Council for Scientific and Industrial Research (CSIR), Government of India to NJ. We thank Prof. D. Chatterji for the gift of M. smegmatis genomic DNA. We thank Anju Paul for technical assistance and Dr. Piotr Prus for helping with the Biacore measurements.; Department of Biotechnology, Government of India and Academy of Finland Indo-Finnish Grant Grant number: BT/FINNISH/27/MRNM/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Choinowski T, 2000, BIOCHEMISTRY-US, V39, P1897, DOI 10.1021/bi992742e; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cole ST, 2011, CURR OPIN MICROBIOL, V14, P570, DOI 10.1016/j.mib.2011.07.022; Delarbre L, 2001, J MOL BIOL, V308, P1063, DOI 10.1006/jmbi.2001.4636; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Haapalainen AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/bi6026192; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; Janardan N, 2011, ACTA CRYSTALLOGR F, V67, P817, DOI 10.1107/S1744309111019324; Jiang CG, 2008, MOL PHYLOGENET EVOL, V49, P691, DOI 10.1016/j.ympev.2008.09.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kursula P, 2005, J MOL BIOL, V347, P189, DOI 10.1016/j.jmb.2005.01.018; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATHIEU M, 1994, STRUCTURE, V2, P797, DOI 10.1016/S0969-2126(94)00081-6; Mazet M, 2011, INT J PARASITOL, V41, P1273, DOI 10.1016/j.ijpara.2011.07.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merilainen G, 2009, BIOCHEMISTRY-US, V48, P11011, DOI 10.1021/bi901069h; Merilainen G, 2008, FEBS J, V275, P6136, DOI 10.1111/j.1742-4658.2008.06737.x; Modis Y, 1999, STRUCTURE, V7, P1279, DOI 10.1016/S0969-2126(00)80061-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SEEDORF U, 1994, J BIOL CHEM, V269, P21277; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; WILLIAMS SF, 1992, J BIOL CHEM, V267, P16041	37	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41894	10.1371/journal.pone.0041894	http://dx.doi.org/10.1371/journal.pone.0041894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844533	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000309240600055
J	Barbosa-da-Silva, S; Fraulob-Aquino, JC; Lopes, JR; Mandarim-de-Lacerda, CA; Aguila, MB				Barbosa-da-Silva, Sandra; Fraulob-Aquino, Julio C.; Lopes, Jessica R.; Mandarim-de-Lacerda, Carlos A.; Aguila, Marcia B.			Weight Cycling Enhances Adipose Tissue Inflammatory Responses in Male Mice	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; NECROSIS-FACTOR-ALPHA; HIGH-FAT DIETS; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; GENE-EXPRESSION; OBESE MICE; CALORIC RESTRICTION; METABOLIC SYNDROME; ABDOMINAL OBESITY	Background: Obesity is associated with low-grade chronic inflammation attributed to dysregulated production, release of cytokines and adipokines and to dysregulated glucose-insulin homeostasis and dyslipidemia. Nutritional interventions such as dieting are often accompanied by repeated bouts of weight loss and regain, a phenomenon known as weight cycling (WC). Methods: In this work we studied the effects of WC on the feed efficiency, blood lipids, carbohydrate metabolism, adiposity and inflammatory markers in C57BL/6 male mice that WC two or three consecutive times by alternation of a high-fat (HF) diet with standard chow (SC). Results: The body mass (BM) grew up in each cycle of HF feeding, and decreased after each cycle of SC feeding. The alterations observed in the animals feeding HF diet in the oral glucose tolerance test, in blood lipids, and in serum and adipose tissue expression of adipokines were not recuperated after WC. Moreover, the longer the HF feeding was (two, four and six months), more severe the adiposity was. After three consecutive WC, less marked was the BM reduction during SC feeding, while more severe was the BM increase during HF feeding. Conclusion: In conclusion, the results of the present study showed that both the HF diet and WC are relevant to BM evolution and fat pad remodeling in mice, with repercussion in blood lipids, homeostasis of glucose-insulin and adipokine levels. The simple reduction of the BM during a WC is not able to recover the high levels of adipokines in the serum and adipose tissue as well as the pro-inflammatory cytokines enhanced during a cycle of HF diet. These findings are significant because a milieu with altered adipokines in association with WC potentially aggravates the chronic inflammation attributed to dysregulated production and release of adipokines in mice.	[Barbosa-da-Silva, Sandra; Fraulob-Aquino, Julio C.; Lopes, Jessica R.; Mandarim-de-Lacerda, Carlos A.; Aguila, Marcia B.] Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Barbosa-da-Silva, S (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	mbaguila@uerj.br	Mandarim-de-Lacerda, Carlos A/F-7125-2012; Aguila, Marcia/P-2349-2019; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia Barbosa/ABF-6505-2020; AQUINO, JULIO CESAR FRAULOB/ABG-8977-2020	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Aguila, Marcia Barbosa/0000-0003-3994-4589; 	CNPq (National Council for Science and Technology); Faperj (Rio de Janeiro Foundation for Research)	CNPq (National Council for Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj (Rio de Janeiro Foundation for Research)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This research was supported by CNPq (National Council for Science and Technology) and Faperj (Rio de Janeiro Foundation for Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Altintas MM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-198; Astrup A, 1999, AM J CLIN NUTR, V69, P1117; Azuma K, 2003, OBES RES, V11, P997, DOI 10.1038/oby.2003.137; BLACKBURN GL, 1989, AM J CLIN NUTR, V49, P1105, DOI 10.1093/ajcn/49.5.1105; Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x; Catta-Preta M, 2012, NUTRITION, V28, P212, DOI 10.1016/j.nut.2011.05.011; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Delbue S, 2007, J NEUROVIROL, V13, P73, DOI 10.1080/13550280601094563; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Field AE, 2009, ARCH INTERN MED, V169, P881, DOI 10.1001/archinternmed.2009.67; FLATT JP, 1987, AM J CLIN NUTR, V45, P296, DOI 10.1093/ajcn/45.1.296; Flint AJ, 2010, OBESITY, V18, P377, DOI 10.1038/oby.2009.223; Forbes GB, 2000, ANN NY ACAD SCI, V904, P359; Fumeron F, 2004, DIABETES, V53, P1150, DOI 10.2337/diabetes.53.4.1150; Giesen K, 2003, BIOCHEM BIOPH RES CO, V304, P812, DOI 10.1016/S0006-291X(03)00664-8; Gruson E, 2010, HEART, V96, P136, DOI 10.1136/hrt.2009.171447; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Heitmann BL, 2002, AM J CLIN NUTR, V75, P840, DOI 10.1093/ajcn/75.5.840; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; JOLICOEUR P, 1986, BIOMETRICS, V42, P785, DOI 10.2307/2530693; Kochan Z, 2006, J PHYSIOL PHARMACOL, V57, P115; Korkeila M, 1999, AM J CLIN NUTR, V70, P965; Kshatriya S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/270624; Lee IS, 2010, ENDOCR J, V57, P39, DOI 10.1507/endocrj.K09E-046; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Moreno-Navarrete JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-27; Marques CMM, 2010, BRAZ J MED BIOL RES, V43, P467, DOI 10.1590/S0100-879X2010007500030; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Morin CL, 1997, ENDOCRINOLOGY, V138, P4665, DOI 10.1210/en.138.11.4665; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Ohman Miina K, 2009, Recent Pat Cardiovasc Drug Discov, V4, P164; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; OLEFSKY JM, 1974, AM J MED, V57, P551, DOI 10.1016/0002-9343(74)90006-0; Peake PW, 2005, EUR J ENDOCRINOL, V153, P409, DOI 10.1530/eje.1.01978; Qi QB, 2008, EUR J ENDOCRINOL, V159, P585, DOI 10.1530/EJE-08-0427; REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; ROZEN R, 1994, AM J CLIN NUTR, V59, P560, DOI 10.1093/ajcn/59.3.560; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Shi HF, 2007, AM J PHYSIOL-ENDOC M, V293, pE316, DOI 10.1152/ajpendo.00710.2006; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Smith J, 2006, CLIN SCI, V110, P1; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Strohacker K, 2010, Front Biosci (Elite Ed), V2, P98, DOI 10.2741/e70; Strychar I, 2009, J AM DIET ASSOC, V109, P718, DOI 10.1016/j.jada.2008.12.026; Taing KY, 2011, OBESITY SILVER SPRIN; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Tsochatzis E, 2006, AM J GASTROENTEROL, V101, P2629, DOI 10.1111/j.1572-0241.2006.00848.x; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Valsamakis G, 2004, METABOLISM, V53, P430, DOI 10.1016/j.metabol.2003.11.022; Xydakis AM, 2004, J CLIN ENDOCR METAB, V89, P2697, DOI 10.1210/jc.2003-031826; Zhang YY, 2002, AM J PHYSIOL-REG I, V282, pR226, DOI 10.1152/ajpregu.00392.2001; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	63	73	74	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39837	10.1371/journal.pone.0039837	http://dx.doi.org/10.1371/journal.pone.0039837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848362	Green Published, gold, Green Submitted			2022-12-25	WOS:000306806600010
J	Horn, F; Correa, AMR; Barbieri, NL; Glodde, S; Weyrauch, KD; Kaspers, B; Driemeier, D; Ewers, C; Wieler, LH				Horn, Fabiana; Ribeiro Correa, Andre Mendes; Barbieri, Nicolle Lima; Glodde, Susanne; Weyrauch, Karl Dietrich; Kaspers, Bernd; Driemeier, David; Ewers, Christa; Wieler, Lothar H.			Infections with Avian Pathogenic and Fecal Escherichia coli Strains Display Similar Lung Histopathology and Macrophage Apoptosis	PLOS ONE			English	Article							VIRULENCE FACTORS; CHICKEN; IDENTIFICATION; SYSTEM; EXPRESSION; CELLS; MODEL; IBEA	The purpose of this study was to compare histopathological changes in the lungs of chickens infected with avian pathogenic (APEC) and avian fecal (A(fecal)) Escherichia coli strains, and to analyze how the interaction of the bacteria with avian macrophages relates to the outcome of the infection. Chickens were infected intratracheally with three APEC strains, MT78, IMT5155, and UEL17, and one non-pathogenic A(fecal) strain, IMT5104. The pathogenicity of the strains was assessed by isolating bacteria from lungs, kidneys, and spleens at 24 h post-infection (p.i.). Lungs were examined for histopathological changes at 12, 18, and 24 h p.i. Serial lung sections were stained with hematoxylin and eosin (HE), terminal deoxynucleotidyl dUTP nick end labeling (TUNEL) for detection of apoptotic cells, and an anti-O2 antibody for detection of MT78 and IMT5155. UEL17 and IMT5104 did not cause systemic infections and the extents of lung colonization were two orders of magnitude lower than for the septicemic strains MT78 and IMT5155, yet all four strains caused the same extent of inflammation in the lungs. The inflammation was localized; there were some congested areas next to unaffected areas. Only the inflamed regions became labeled with anti-O2 antibody. TUNEL labeling revealed the presence of apoptotic cells at 12 h p.i in the inflamed regions only, and before any necrotic foci could be seen. The TUNEL-positive cells were very likely dying heterophils, as evidenced by the purulent inflammation. Some of the dying cells observed in avian lungs in situ may also be macrophages, since all four avian E. coli induced caspase 3/7 activation in monolayers of HD11 avian macrophages. In summary, both pathogenic and non-pathogenic fecal strains of avian E. coli produce focal infections in the avian lung, and these are accompanied by inflammation and cell death in the infected areas.	[Horn, Fabiana; Barbieri, Nicolle Lima] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil; [Horn, Fabiana; Glodde, Susanne; Ewers, Christa; Wieler, Lothar H.] Free Univ Berlin, Inst Microbiol & Epizoot, Berlin, Germany; [Ribeiro Correa, Andre Mendes; Driemeier, David] Univ Fed Rio Grande do Sul, Setor Patol Vet, Porto Alegre, RS, Brazil; [Weyrauch, Karl Dietrich] Free Univ Berlin, Inst Vet Anat, Berlin, Germany; [Kaspers, Bernd] Univ Munich, Fac Vet Med, Munich, Germany; [Ewers, Christa] Univ Giessen, Inst Hyg & Infect Dis Animals, Giessen, Germany	Universidade Federal do Rio Grande do Sul; Free University of Berlin; Universidade Federal do Rio Grande do Sul; Free University of Berlin; University of Munich; Justus Liebig University Giessen	Horn, F (corresponding author), Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil.	fabiana.horn@ufrgs.br	Horn, Fabiana/K-9637-2013; Barbieri, Nicolle Lima/L-6477-2013; Barbieri, Nicolle/AAB-3223-2020; Ewers, Christa/AAL-9186-2020; Driemeier, David/H-3461-2012; Lima Barbieri, Nicolle/L-6477-2013	Barbieri, Nicolle Lima/0000-0002-8223-6580; Driemeier, David/0000-0003-3766-0654; Ewers, Christa/0000-0001-6167-1340; Lima Barbieri, Nicolle/0000-0001-8641-7592; Wieler, Lothar H./0000-0003-4365-3717	CNPq (Brazil) [MAPA 57864/2008-5]; FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Brazil); Indo-German Research Training Group - Internationales Graduiertenkolleg - Functional Molecular Infection Epidemiology [GRK1673]; National Genome Research Network in the framework of the FUGATO E. coli chick project; Federal Ministry of Education and Research (Germany); CAPES (Ministry of Education, Brazil) [BEX2204/04-5]	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Brazil)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Indo-German Research Training Group - Internationales Graduiertenkolleg - Functional Molecular Infection Epidemiology; National Genome Research Network in the framework of the FUGATO E. coli chick project; Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); CAPES (Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was partially supported by CNPq (MAPA 57864/2008-5, Brazil), FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Brazil), by the Indo-German Research Training Group - Internationales Graduiertenkolleg (GRK1673) - Functional Molecular Infection Epidemiology, and by the National Genome Research Network in the framework of the FUGATO E. coli chick project funded by the Federal Ministry of Education and Research (Germany). FH was the recipient of a CAPES (Ministry of Education, Brazil, grant number BEX2204/04-5) sponsorship during her stay at the Institute of Microbiology and Epizootics, Freie Universitat Berlin, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007796; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Bastiani M, 2005, FEMS MICROBIOL LETT, V253, P133, DOI 10.1016/j.femsle.2005.09.024; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Caza M, 2011, MOL MICROBIOL, V80, P266, DOI 10.1111/j.1365-2958.2011.07570.x; Chouikha I, 2008, MICROBES INFECT, V10, P432, DOI 10.1016/j.micinf.2008.01.002; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Ciraci C, 2011, DEV COMP IMMUNOL, V35, P392, DOI 10.1016/j.dci.2010.11.012; Dai J, 2010, BMC MICROBIOLOGY, P10; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; DHO M, 1982, AVIAN DIS, V26, P787, DOI 10.2307/1589865; Dho-Moulin M, 1999, VET RES, V30, P299; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Dwars RM, 2009, VET IMMUNOL IMMUNOP, V127, P65, DOI 10.1016/j.vetimm.2008.09.019; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; He HQ, 2011, CYTOKINE, V53, P363, DOI 10.1016/j.cyto.2010.12.009; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Li GW, 2011, INFECT IMMUN, V79, P1951, DOI 10.1128/IAI.01230-10; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; Maina JN, 2006, BIOL REV, V81, P545, DOI 10.1017/S1464793106007111; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Matter LB, 2011, VET MICROBIOL, V148, P51, DOI 10.1016/j.vetmic.2010.08.006; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Pourbakhsh SA, 1997, VET MICROBIOL, V58, P195, DOI 10.1016/S0378-1135(97)00163-6; Pourbakhsh SA, 1997, AVIAN DIS, V41, P221, DOI 10.2307/1592463; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Tyler CD, 2008, AVIAN DIS, V52, P23, DOI 10.1637/8026-053107-Reg; VIDOTTO MC, 1990, AVIAN DIS, V34, P531, DOI 10.2307/1591241	31	37	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41031	10.1371/journal.pone.0041031	http://dx.doi.org/10.1371/journal.pone.0041031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848424	Green Published, Green Submitted, gold			2022-12-25	WOS:000306806600034
J	Lahtinen, AM; Noseworthy, PA; Havulinna, AS; Jula, A; Karhunen, PJ; Kettunen, J; Perola, M; Kontula, K; Newton-Cheh, C; Salomaa, V				Lahtinen, Annukka M.; Noseworthy, Peter A.; Havulinna, Aki S.; Jula, Antti; Karhunen, Pekka J.; Kettunen, Johannes; Perola, Markus; Kontula, Kimmo; Newton-Cheh, Christopher; Salomaa, Veikko			Common Genetic Variants Associated with Sudden Cardiac Death: The FinSCDgen Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LONG QT SYNDROME; MIDDLE-AGED MEN; INTERVAL DURATION; RISK-FACTORS; ARTERY-DISEASE; CHANNEL GENE; POPULATION; MUTATIONS; ARRHYTHMIAS	Background: Sudden cardiac death (SCD) accounts for up to half of cardiac mortality. The risk of SCD is heritable but the underlying genetic variants are largely unknown. We investigated whether common genetic variants predisposing to arrhythmia or related electrocardiographic phenotypes, including QT-interval prolongation, are associated with increased risk of SCD. Methodology/Principal Findings: We studied the association between 28 candidate SNPs and SCD in a meta-analysis of four population cohorts (FINRISK 1992, 1997, 2002 and Health 2000, n = 27,629) and two forensic autopsy series (The Helsinki Sudden Death Study and The Tampere Autopsy Study, n = 694). We also studied the association between established cardiovascular risk factors and SCD. Causes of death were reviewed using registry-based health and autopsy data. Cox regression and logistic regression models were adjusted for age, sex, and geographic region. The total number of SCDs was 716. Two novel SNPs were associated with SCD: SCN5A rs41312391 (relative risk [RR] 1.27 per minor T allele, 95% CI 1.11-1.45, P = 3.4x10(-4)) and rs2200733 in 4q25 (RR 1.28 per minor T allele, 95% CI 1.11-1.48, P = 7.9x10(-4)). We also replicated the associations for 9p21 (rs2383207, RR 1.13 per G allele, 95% CI 1.01-1.26, P = 0.036), as well as for male sex, systolic blood pressure, diabetes, cigarette smoking, low physical activity, coronary heart disease, and digoxin use (P < 0.05). Conclusions/Significance: Two novel genetic variants, one in the cardiac sodium channel gene SCN5A and another at 4q25 previously associated with atrial fibrillation, are associated with SCD.	[Lahtinen, Annukka M.; Kontula, Kimmo] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Lahtinen, Annukka M.; Kontula, Kimmo] Univ Helsinki, Dept Med, Helsinki, Finland; [Noseworthy, Peter A.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Noseworthy, Peter A.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Noseworthy, Peter A.; Newton-Cheh, Christopher] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Havulinna, Aki S.; Perola, Markus; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Jula, Antti] Natl Inst Hlth & Welf, Turku, Finland; [Karhunen, Pekka J.] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Karhunen, Pekka J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kettunen, Johannes; Perola, Markus] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland	University of Helsinki; University of Helsinki; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Tampere University; Tampere University Hospital; Tampere University; University of Helsinki	Lahtinen, AM (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki, Finland.	cnewtoncheh@chgr.mgh.harvard.edu; veikko.salomaa@thl.fi	Tuiskula, Annukka/ABF-6377-2020; Havulinna, Aki/AAM-4769-2021	Tuiskula, Annukka/0000-0002-6538-635X; 	Finnish Cultural Foundation; Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology; Burroughs Wellcome Fund travel grant; Finnish Academy SALVE program "Pubgensense" [10404]; Wellcome Trust; Academy of Finland [129494]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; United States National Institutes of Health [HL080025, HL098283]; Doris Duke Charitable Foundation; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098283, K23HL080025] Funding Source: NIH RePORTER	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology; Burroughs Wellcome Fund travel grant(Burroughs Wellcome Fund); Finnish Academy SALVE program "Pubgensense"; Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Finnish Cultural Foundation (to A. M. L.); the Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology (to P.A.N.); a Burroughs Wellcome Fund travel grant (to P.A.N.); Finnish Academy SALVE program "Pubgensense" (#10404 to M.P.); the Wellcome Trust, the Academy of Finland (to K.K. and #129494 to V.S.); the Finnish Foundation for Cardiovascular Research (to K.K. and V.S.); the Sigrid Juselius Foundation (to K.K. and V.S.); the United States National Institutes of Health (HL080025, HL098283 to C.N.-C.); the Doris Duke Charitable Foundation (to C.N.-C.); and the Burroughs Wellcome Fund (to C.N.-C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabag AS, 2010, NAT REV CARDIOL, V7, P216, DOI 10.1038/nrcardio.2010.3; Adams KF, 2005, J AM COLL CARDIOL, V46, P497, DOI 10.1016/j.jacc.2005.02.091; [Anonymous], 2010, R LANG ENV STAT COMP; Antzelevitch C, 2002, CURR OPIN CARDIOL, V17, P43, DOI 10.1097/00001573-200201000-00007; Aydin A, 2005, J MOL MED, V83, P159, DOI 10.1007/s00109-004-0595-3; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Chugh SS, 2009, CIRCULATION, V119, P663, DOI 10.1161/CIRCULATIONAHA.108.797035; CURB JD, 1995, CIRCULATION, V91, P2591, DOI 10.1161/01.CIR.91.10.2591; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Franco D, 2003, TRENDS CARDIOVAS MED, V13, P157, DOI 10.1016/S1050-1738(03)00039-2; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Gouas L, 2007, EUR J HUM GENET, V15, P974, DOI 10.1038/sj.ejhg.5201866; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Heistaro S, 2008, KTL B, P26; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; KANNEL WB, 1988, AM HEART J, V115, P869, DOI 10.1016/0002-8703(88)90891-5; KANNEL WB, 1985, J AM COLL CARDIOL, V5, pB141, DOI 10.1016/S0735-1097(85)80545-3; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Ni H, 2009, AM HEART J, V157, P46, DOI 10.1016/j.ahj.2008.08.016; Noseworthy PA, 2011, CIRC-CARDIOVASC GENE, V4, P305, DOI 10.1161/CIRCGENETICS.110.959049; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Pedersen OD, 2006, EUR HEART J, V27, P290, DOI 10.1093/eurheartj/ehi629; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Tyynela P, 2009, ANN MED, V41, P57, DOI 10.1080/07853890802258753; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WANNAMETHEE G, 1995, CIRCULATION, V91, P1749, DOI 10.1161/01.CIR.91.6.1749	42	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41675	10.1371/journal.pone.0041675	http://dx.doi.org/10.1371/journal.pone.0041675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844511	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700139
J	Lundquist, D; Gemmell, NJ; Wursig, B				Lundquist, David; Gemmell, Neil J.; Wuersig, Bernd			Behavioural Responses of Dusky Dolphin Groups (Lagenorhynchus obscurus) to Tour Vessels off Kaikoura, New Zealand	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; WHALE-WATCHING BOATS; TURSIOPS-TRUNCATUS; STENELLA-LONGIROSTRIS; SARASOTA BAY; ORCINUS-ORCA; PATTERNS; SWIMMERS; NOISE; DISTURBANCE	Background: Commercial viewing and swimming with dusky dolphins (Lagenorhynchus obscurus) near Kaikoura, New Zealand began in the late 1980s and researchers have previously described changes in vocalisation, aerial behaviour, and group spacing in the presence of vessels. This study was conducted to assess the current effects that tourism has on the activity budget of dusky dolphins to provide wildlife managers with information for current decision-making and facilitate development of quantitative criteria for management of this industry in the future. Methodology/Principal Findings: First-order time discrete Markov chain models were used to assess changes in the behavioural state of dusky dolphin pods targeted by tour vessels. Log-linear analysis was conducted on behavioural state transitions to determine whether the likelihood of dolphins moving from one behavioural state to another changed based on natural and anthropogenic factors. The best-fitting model determined by Akaike Information Criteria values included season, time of day, and vessel presence within 300 m. Interactions with vessels reduced the proportion of time dolphins spent resting in spring and summer and increased time spent milling in all seasons except autumn. Dolphins spent more time socialising in spring and summer, when conception occurs and calves are born, and the proportion of time spent resting was highest in summer. Resting decreased and traveling increased in the afternoon. Conclusions/Significance: Responses to tour vessel traffic are similar to those described for dusky dolphins elsewhere. Disturbance linked to vessels may interrupt social interactions, carry energetic costs, or otherwise affect individual fitness. Research is needed to determine if increased milling is a result of acoustic masking of communication due to vessel noise, and to establish levels at which changes to behavioural budgets of dusky dolphins are likely to cause long-term harm. Threshold values from these studies would allow managers to set appropriate operational conditions based on quantifiable criteria.	[Lundquist, David; Gemmell, Neil J.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Wuersig, Bernd] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	University of Otago; Texas A&M University System	Lundquist, D (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	lundquistdave@hotmail.com	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637	New Zealand Department of Conservation; National Geographic Society Committee for Research and Exploration [8341-07]; University of Otago Postgraduate Scholarship; UC-Santa Cruz MHIRT stipend	New Zealand Department of Conservation; National Geographic Society Committee for Research and Exploration(National Geographic Society); University of Otago Postgraduate Scholarship; UC-Santa Cruz MHIRT stipend	Funding for this work was provided by the New Zealand Department of Conservation (http://www.doc.govt.nz) and the National Geographic Society Committee for Research and Exploration (Grant number 8341-07, http://www.nationalgeographic.com/explorers/grants-programs/cre/). DL was supported by a University of Otago Postgraduate Scholarship and UC-Santa Cruz MHIRT stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Gutierrez A, 2000, MAR MAMMAL SCI, V16, P287, DOI 10.1111/j.1748-7692.2000.tb00925.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2003, THESIS TEXAS AM U; Au WWL, 2000, MAR ENVIRON RES, V49, P469, DOI 10.1016/S0141-1136(99)00086-0; Barr K, 1999, DEP CONSERVATION CON, V229; Barr K, 1997, IMPACTS MARINE TOURI; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L., 2005, LINKING SHORT LONG T; Bejder L, 2004, MARINE MAMMALS FISHE, P229; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; BLANE JM, 1994, ENVIRON CONSERV, V21, P267, DOI 10.1017/S0376892900033282; Brown NC, 2000, DUSKY DOLPHIN LAGENO; Buckstaff KC, 2004, MAR MAMMAL SCI, V20, P709, DOI 10.1111/j.1748-7692.2004.tb01189.x; Burgess WC, 1998, DEEP-SEA RES PT II, V45, P1327, DOI 10.1016/S0967-0645(98)00032-0; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Childerhouse S, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P245, DOI 10.1016/B978-0-12-373723-6.00012-6; Cipriano FW, 1992, BEHAV OCCURRENCE PAT; Cisneros-Montemayor AM, 2010, MAR POLICY, V34, P1273, DOI 10.1016/j.marpol.2010.05.005; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Courbis S, 2009, MAR MAMMAL SCI, V25, P430, DOI 10.1111/j.1748-7692.2008.00254.x; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dans SL, 2008, MAR ECOL PROG SER, V369, P287, DOI 10.3354/meps07629; Duprey NMT, 2008, OCEAN COAST MANAGE, V51, P632, DOI 10.1016/j.ocecoaman.2008.06.013; Duprey NM, 2007, DUSKY DOLPHIN LAGENO; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Foster KR, 2000, SCIENCE, V288, P979, DOI 10.1126/science.288.5468.979; Gordon J, 1992, DEP CONSERVATION SCI, V52; Hanson Mark T., 1993, Aquatic Mammals, V19, P127; Higham JES, 2008, ENVIRON CONSERV, V35, P294, DOI 10.1017/S0376892908005249; Hoyt E, 2007, BLUEPR DOLPH WHAL WA; International Whaling Commission (IWC), 1996, REP SCI COMM IWC; Jahoda M, 2003, MAR MAMMAL SCI, V19, P96, DOI 10.1111/j.1748-7692.2003.tb01095.x; Janik VM, 1996, MAR MAMMAL SCI, V12, P597, DOI 10.1111/j.1748-7692.1996.tb00073.x; Kruse S., 1991, P149; Lusseau D., 2006, Tourism in Marine Environments, V3, P173, DOI 10.3727/154427306779435184; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Mann J, 2000, CETACEAN SOCIETIES, P45; Markov AA, 1906, B SOC PHYS MATH KAZA, V2, P155; Markowitz T. M., 2009, TOURISM EFFECTS DUSK; Markowitz TM, 2004, SOCIAL ORG NZ DUSKY; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; O'Connor S., 2009, WHALE WATCHING WORLD; Richardson WJ, 1995, MARINE MAMMALS NOISE, P387; Richter CF, 2003, SCI CONSERVATION, V219; Rolland RM, 2005, GEN COMP ENDOCR, V142, P308, DOI 10.1016/j.ygcen.2005.02.002; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Scarpaci Carol, 2000, Journal of Cetacean Research and Management, V2, P183; Scheidat Meike, 2004, Journal of Cetacean Research and Management, V6, P63; Shane S.H., 1990, P245; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Speakman JR, 1997, DOUBLY LABELLED WATE; Srinivasan M, 2009, PREDATOR INFLUENCES; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Timmel Gregory, 2008, Aquatic Mammals, V34, P402, DOI 10.1578/AM.34.4.2008.402; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Wursig B, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P1; Wursig B., 1997, Report of the International Whaling Commission, V47, P715; Wursig B, 2007, DUSKY DOLPHINS LAGEN; Yin S, 1999, MOVEMENT PATTERNS BE	69	36	38	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41969	10.1371/journal.pone.0041969	http://dx.doi.org/10.1371/journal.pone.0041969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844536	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700163
J	Palmigiano, A; Pastor, J; de Sola, RG; Ortega, GJ				Palmigiano, Agostina; Pastor, Jesus; Garcia de Sola, Rafael; Ortega, Guillermo J.			Stability of Synchronization Clusters and Seizurability in Temporal Lobe Epilepsy	PLOS ONE			English	Article							NEURAL-NETWORKS; COMPLEX NETWORKS; DYNAMICS; HUBS	Purpose: Identification of critical areas in presurgical evaluations of patients with temporal lobe epilepsy is the most important step prior to resection. According to the "epileptic focus model", localization of seizure onset zones is the main task to be accomplished. Nevertheless, a significant minority of epileptic patients continue to experience seizures after surgery (even when the focus is correctly located), an observation that is difficult to explain under this approach. However, if attention is shifted from a specific cortical location toward the network properties themselves, then the epileptic network model does allow us to explain unsuccessful surgical outcomes. Methods: The intraoperative electrocorticography records of 20 patients with temporal lobe epilepsy were analyzed in search of interictal synchronization clusters. Synchronization was analyzed, and the stability of highly synchronized areas was quantified. Surrogate data were constructed and used to statistically validate the results. Our results show the existence of highly localized and stable synchronization areas in both the lateral and the mesial areas of the temporal lobe ipsilateral to the clinical seizures. Synchronization areas seem to play a central role in the capacity of the epileptic network to generate clinical seizures. Resection of stable synchronization areas is associated with elimination of seizures; nonresection of synchronization clusters is associated with the persistence of seizures after surgery. Discussion: We suggest that synchronization clusters and their stability play a central role in the epileptic network, favoring seizure onset and propagation. We further speculate that the stability distribution of these synchronization areas would differentiate normal from pathologic cases.	[Palmigiano, Agostina] Univ Buenos Aires, Dept Phys, Buenos Aires, DF, Argentina; [Pastor, Jesus; Garcia de Sola, Rafael; Ortega, Guillermo J.] Inst Invest Sanitaria Hosp Princesa, Madrid, Spain	University of Buenos Aires	Palmigiano, A (corresponding author), Univ Buenos Aires, Dept Phys, Buenos Aires, DF, Argentina.	gjortega.hlpr@salud.madrid.org	Pastor, Jesus/AAH-9238-2020	Pastor, Jesus/0000-0001-6870-8409; G. Sola, Rafael/0000-0002-0063-9301	Instituto de Salud Carlos III [PS09/02116, PI10/00160]; PIP, CONICET [11420100100261]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); PIP, CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Instituto de Salud Carlos III (projects PS09/02116 and PI10/00160) and PIP 11420100100261 CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Andrzejak RG, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046203; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Bancaud J., 1965, STEREOELECTROENCEPHA; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2001, CLIN NEUROPHYSIOL, V112, P1746, DOI 10.1016/S1388-2457(01)00591-0; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bertram EH, 1998, EPILEPSY RES, V32, P194, DOI 10.1016/S0920-1211(98)00051-5; Binder DK, 2008, TXB EPILEPSY SURG, P1083; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Dauwels J, 2009, IEEE ENG MED BIO, P2180, DOI 10.1109/IEMBS.2009.5332447; de la Prida LM, 2002, NEUROREPORT, V13, P1421, DOI 10.1097/00001756-200208070-00015; Dichter MA, 1997, EPILEPSIA, V38, pS2, DOI 10.1111/j.1528-1157.1997.tb05200.x; EFRON B, 1979, SIAM REV, V21, P460, DOI 10.1137/1021092; Engel J, 1993, SURG TREATMENT EPILE, P609; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Feinstein A, 2002, PRINCIPLES MED STAT; FERRER I, 1994, J NEUROL SCI, V123, P18, DOI 10.1016/0022-510X(94)90198-8; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Milton GJ, 2007, HDB BRAIN CONNECTIVI; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Netoff TI, 2002, J NEUROSCI, V22, P7297; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Ortega GJ, 2011, CLIN NEUROPHYSIOL, V122, P1106, DOI 10.1016/j.clinph.2010.11.001; Ortega GJ, 2008, NEUROSCI LETT, V447, P129, DOI 10.1016/j.neulet.2008.09.080; Palmigiano A, 2012, REV NEUROLO IN PRESS; Pastor J, 2005, REV NEUROLOGIA, V41, P709, DOI 10.33588/rn.4112.2005477; Pastor J, 2012, EPILEPSY HISTOLOGICA; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pereira T, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036201; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Rosow C, 2001, Anesthesiol Clin North Am, V19, P947; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; SPENCER DD, 1984, NEUROSURGERY, V15, P667, DOI 10.1227/00006123-198411000-00005; Spencer DD, 1995, OPERATIVE NEUROSURGI, P1305; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Tang J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055101; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Towle VL, 1999, J CLIN NEUROPHYSIOL, V16, P528, DOI 10.1097/00004691-199911000-00005; van Dellen E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008081; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhou CS, 2006, CHAOS, V16, DOI 10.1063/1.2150381	53	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41799	10.1371/journal.pone.0041799	http://dx.doi.org/10.1371/journal.pone.0041799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844524	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700151
J	Shi, MG; Beauchamp, RD; Zhang, B				Shi, Mingguang; Beauchamp, R. Daniel; Zhang, Bing			A Network-Based Gene Expression Signature Informs Prognosis and Treatment for Colorectal Cancer Patients	PLOS ONE			English	Article							II COLON-CANCER; BREAST-CANCER; RECURRENCE; CHEMOTHERAPY; METASTASIS; PREDICTION; PROFILES; MARKERS; BENEFIT	Background: Several studies have reported gene expression signatures that predict recurrence risk in stage II and III colorectal cancer (CRC) patients with minimal gene membership overlap and undefined biological relevance. The goal of this study was to investigate biological themes underlying these signatures, to infer genes of potential mechanistic importance to the CRC recurrence phenotype and to test whether accurate prognostic models can be developed using mechanistically important genes. Methods and Findings: We investigated eight published CRC gene expression signatures and found no functional convergence in Gene Ontology enrichment analysis. Using a random walk-based approach, we integrated these signatures and publicly available somatic mutation data on a protein-protein interaction network and inferred 487 genes that were plausible candidate molecular underpinnings for the CRC recurrence phenotype. We named the list of 487 genes a NEM signature because it integrated information from Network, Expression, and Mutation. The signature showed significant enrichment in four biological processes closely related to cancer pathophysiology and provided good coverage of known oncogenes, tumor suppressors, and CRC-related signaling pathways. A NEM signature-based Survival Support Vector Machine prognostic model was trained using a microarray gene expression dataset and tested on an independent dataset. The model-based scores showed a 75.7% concordance with the real survival data and separated patients into two groups with significantly different relapse-free survival (p = 0.002). Similar results were obtained with reversed training and testing datasets (p = 0.007). Furthermore, adjuvant chemotherapy was significantly associated with prolonged survival of the high-risk patients (p = 0.006), but not beneficial to the low-risk patients (p = 0.491). Conclusions: The NEM signature not only reflects CRC biology but also informs patient prognosis and treatment response. Thus, the network-based data integration method provides a convergence between biological relevance and clinical usefulness in gene signature development.	[Shi, Mingguang; Zhang, Bing] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Beauchamp, R. Daniel; Zhang, Bing] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Beauchamp, R. Daniel] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA; [Beauchamp, R. Daniel] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Beauchamp, R. Daniel; Zhang, Bing] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Shi, MG (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	bing.zhang@vanderbilt.edu		Beauchamp, Robert Daniel/0000-0002-8446-4114	NIH [GM088822, CA069457, DK052334]; Vanderbilt Ingram Cancer Center [CA068485]; GI Cancer SPORE [CA095103]; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA069457, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center; GI Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (http://www.nih.gov/) grants GM088822, CA069457, DK052334, and support from the Vanderbilt Ingram Cancer Center Support Grant CA068485 and the GI Cancer SPORE Grant CA095103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2007, ONCOL REP, V17, P1089; Barrier A, 2007, ONCOGENE, V26, P2642, DOI 10.1038/sj.onc.1210060; Barrier A, 2006, J CLIN ONCOL, V24, P4685, DOI 10.1200/JCO.2005.05.0229; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Chen JL, 2011, J AM MED INFORM ASSN, V18, P392, DOI 10.1136/amiajnl-2011-000178; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Drier Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017795; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Evers L, 2008, BIOINFORMATICS, V24, P1632, DOI 10.1093/bioinformatics/btn253; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kopetz S, 2009, CLIN CANCER RES, V15, P7451, DOI 10.1158/1078-0432.CCR-09-2523; Li J, 2010, HUM MUTAT, V31, P219, DOI 10.1002/humu.21176; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Oh S. C., 2011, GUT; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Ransohoff DF, 2004, GASTROENTEROLOGY, V127, P1028, DOI 10.1053/j.gastro.2004.08.030; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Shen RL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-28; SHIKE M, 1990, B WORLD HEALTH ORGAN, V68, P377; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Van Belle V, 2011, BIOINFORMATICS, V27, P87, DOI 10.1093/bioinformatics/btq617; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2011, MOL BIOSYST, V7, P2118, DOI 10.1039/c1mb05014a	41	42	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41292	10.1371/journal.pone.0041292	http://dx.doi.org/10.1371/journal.pone.0041292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844451	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700063
J	Rouzaud-Laborde, C; Hanoun, N; Baysal, I; Rech, JS; Mias, C; Calise, D; Sicard, P; Frugier, C; Seguelas, MH; Parini, A; Pizzinat, N				Rouzaud-Laborde, Charlotte; Hanoun, Naima; Baysal, Ipek; Rech, Jean-Simon; Mias, Celine; Calise, Denis; Sicard, Pierre; Frugier, Celine; Seguelas, Marie-Helene; Parini, Angelo; Pizzinat, Nathalie			Role of Endothelial AADC in Cardiac Synthesis of Serotonin and Nitrates Accumulation	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; CARDIOVASCULAR-SYSTEM; CORONARY ARTERIOLES; REPERFUSION INJURY; MEDIATED DILATION; SMOOTH-MUSCLE; CELLS; 5-HYDROXYTRYPTAMINE; HEART; ACTIVATION	Serotonin (5-HT) regulates different cardiac functions by acting directly on cardiomyocytes, fibroblasts and endothelial cells. Today, it is widely accepted that activated platelets represent a major source of 5-HT. In contrast, a supposed production of 5-HT in the heart is still controversial. To address this issue, we investigated the expression and localization of 5-HT synthesizing enzyme tryptophan hydroxylase (TPH) and L-aromatic amino acid decarboxylase (AADC) in the heart. We also evaluated their involvement in cardiac production of 5-HT. TPH1 was weakly expressed in mouse and rat heart and appeared restricted to mast cells. Degranulation of mast cells by compound 48/80 did not modify 5-HT cardiac content in mice. Western blots and immunolabelling experiments showed an abundant expression of AADC in the mouse and rat heart and its co-localization with endothelial cells. Incubation of cardiac homogenate with the AADC substrate (5-hydroxy-L-tryptophan) 5-HTP or intraperitoneal injection of 5-HTP in mice significantly increased cardiac 5-HT. These effects were prevented by the AADC inhibitor benserazide. Finally, 5-HTP administration in mice increased phosphorylation of aortic nitric oxide synthase 3 at Ser (1177) as well as accumulation of nitrates in cardiac tissue. This suggests that the increase in 5-HT production by AADC leads to activation of endothelial and cardiac nitric oxide pathway. These data show that endothelial AADC plays an important role in cardiac synthesis of 5-HT and possibly in 5-HT-dependent regulation of nitric oxide generation.	[Rouzaud-Laborde, Charlotte; Baysal, Ipek; Rech, Jean-Simon; Mias, Celine; Calise, Denis; Sicard, Pierre; Frugier, Celine; Seguelas, Marie-Helene; Parini, Angelo; Pizzinat, Nathalie] Inst Natl Sante & Rech Med, Inst Malad Metab & Cardiovasc Rangueil, Toulouse, France; [Rouzaud-Laborde, Charlotte; Baysal, Ipek; Rech, Jean-Simon; Mias, Celine; Calise, Denis; Sicard, Pierre; Frugier, Celine; Seguelas, Marie-Helene; Parini, Angelo; Pizzinat, Nathalie] Univ Toulouse 3, Inst Med Mol Rangueil, F-31062 Toulouse, France; [Rouzaud-Laborde, Charlotte; Parini, Angelo] Ctr Hosp Univ Toulouse, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Rouzaud-Laborde, C (corresponding author), Inst Natl Sante & Rech Med, Inst Malad Metab & Cardiovasc Rangueil, Toulouse, France.	nathalie.pizzinat@inserm.fr	Sicard, Pierre/N-7310-2018; hanoun, naima NH/M-6408-2014; Baysal, Ipek/I-8429-2013	Sicard, Pierre/0000-0001-5837-3916; Baysal, Ipek/0000-0002-9607-4199; Parini, Angelo/0000-0002-9848-8838; FRUGIER, Celine/0000-0003-2889-9188; Mias, Celine/0000-0001-8055-8255	region Midi Pyrenees	region Midi Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur)	The authors would like to thank region Midi Pyrenees for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 2009, NEOPLASIA, V11, P408, DOI 10.1593/neo.81630; Bouchard JF, 2000, CARDIOVASC RES, V45, P418, DOI 10.1016/S0008-6363(99)00343-0; COCKS TM, 1992, BRIT J PHARMACOL, V107, P591, DOI 10.1111/j.1476-5381.1992.tb12788.x; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; DeFily DV, 1996, AM J PHYSIOL-HEART C, V270, pH2094, DOI 10.1152/ajpheart.1996.270.6.H2094; dePablo ALL, 1996, J NEUROCHEM, V67, P2060; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Ellwood AJ, 1996, BRIT J PHARMACOL, V119, P721, DOI 10.1111/j.1476-5381.1996.tb15732.x; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; HOUSTON DS, 1988, J PHARMACOL EXP THER, V244, P1; Ishida Tatsuro, 1998, Kobe Journal of Medical Sciences, V44, P51; Izikki M, 2007, AM J PHYSIOL-LUNG C, V293, pL1045, DOI 10.1152/ajplung.00082.2007; Kaumann AJ, 2006, PHARMACOL THERAPEUT, V111, P674, DOI 10.1016/j.pharmthera.2005.12.004; Manjarrez-Gutierrez G, 2009, CIR CIR, V77, P395; MARCUS ML, 1990, CIRCULATION, V82, P1, DOI 10.1161/01.CIR.82.1.1; Mekontso-Dessap A, 2006, CIRCULATION, V113, P81, DOI 10.1161/CIRCULATIONAHA.105.554667; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Ni W, 2008, BRIT J PHARMACOL, V154, P663, DOI 10.1038/bjp.2008.111; Nomura T, 1996, BRAIN RES, V735, P314, DOI 10.1016/0006-8993(96)00790-1; Qamirani E, 2005, ARTERIOSCL THROM VAS, V25, P995, DOI 10.1161/01.ATV.0000159890.10526.1e; SOLE MJ, 1979, CIRC RES, V45, P629, DOI 10.1161/01.RES.45.5.629; Takano S, 2004, J CARDIOVASC PHARM T, V9, P43, DOI 10.1177/107424840400900i107; Tiefenbacher CP, 1996, CIRCULATION, V94, P1423, DOI 10.1161/01.CIR.94.6.1423; Villalon CM, 2007, N-S ARCH PHARMACOL, V376, P45, DOI 10.1007/s00210-007-0179-1; Villeneuve C, 2009, AM J PHYSIOL-HEART C, V297, pH821, DOI 10.1152/ajpheart.00345.2009; Wang W, 2011, MICROCIRCULATION, V18, P36, DOI 10.1111/j.1549-8719.2010.00066.x; Watts SW, 2009, AM J PHYSIOL-REG I, V296, pR252, DOI 10.1152/ajpregu.90676.2008; Wei JF, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-21; Yabanoglu S, 2009, J MOL CELL CARDIOL, V46, P518, DOI 10.1016/j.yjmcc.2008.12.019; Zhang CH, 2001, FASEB J, V15, P1264, DOI 10.1096/fj.00-0681fje	31	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e34893	10.1371/journal.pone.0034893	http://dx.doi.org/10.1371/journal.pone.0034893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829864	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300002
J	Zhang, H; Guo, CF; Wu, DJ; Zhang, AA; Gu, T; Wang, LS; Wang, CQ				Zhang, Huili; Guo, Changfa; Wu, Duojiao; Zhang, Alian; Gu, Ting; Wang, Liansheng; Wang, Changqian			Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; LESION FORMATION; CECAL LIGATION; MICE REVEALS; NITRIC-OXIDE; CELL-LINE; KAPPA-B; FRACTALKINE; CHEMOKINES; CCR2	Hydrogen sulfide, as a novel gaseous mediator, has been suggested to play a key role in atherogenesis. However, the precise mechanisms by which H2S affects atherosclerosis remain unclear. Therefore, the present study aimed to investigate the potential role of H2S in atherosclerosis and the underlying mechanism with respect to chemokines (CCL2, CCL5 and CX3CL1) and chemokine receptors (CCR2, CCR5, and CX3CR1) in macrophages. Mouse macrophage cell line RAW 264.7 or mouse peritoneal macrophages were pre-incubated with saline or NaHS (50 mu M, 100 mu M, 200 mu M), an H2S donor, and then stimulated with interferon-gamma (IFN-gamma) or lipopolysaccharide (LPS). It was found that NaHS dose-dependently inhibited IFN-gamma or LPS-induced CX3CR1 and CX3CL1 expression, as well as CX3CR1-mediated chemotaxis in macrophages. Overexpression of cystathionine gamma-lyase (CSE), an enzyme that catalyzes H2S biosynthesis resulted in a significant reduction in CX3CR1 and CX3CL1 expression as well as CX3CR1-mediated chemotaxis in stimulated macrophages. The inhibitory effect of H2S on CX3CR1 and CX3CL1 expression was mediated by modulation of proliferators-activated receptor-gamma (PPAR-gamma) and NF-kappa B pathway. Furthermore, male apoE(-/-) mice were fed a high-fat diet and then randomly given NaHS (1 mg/kg, i.p., daily) or DL-propargylglycine (PAG, 10 mg/kg, i.p., daily). NaHS significantly inhibited aortic CX3CR1 and CX3CL1 expression and impeded aortic plaque development. NaHS had a better anti-atherogenic benefit when it was applied at the early stage of atherosclerosis. However, inhibition of H2S formation by PAG increased aortic CX3CR1 and CX3CL1 expression and exacerbated the extent of atherosclerosis. In addition, H2S had minimal effect on the expression of CCL2, CCL5, CCR2 and CCR5 in vitro and in vivo. In conclusion, these data indicate that H2S hampers the progression of atherosclerosis in fat-fed apoE(-/-) mice and downregulates CX3CR1 and CX3CL1 expression on macrophages and in lesion plaques.	[Zhang, Huili; Zhang, Alian; Wang, Changqian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China; [Guo, Changfa] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200433, Peoples R China; [Wu, Duojiao] Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai 200433, Peoples R China; [Gu, Ting] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Oral & Maxillofacial Pathol, Shanghai 200030, Peoples R China; [Wang, Liansheng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Clin Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China.	changqianw@gmail.com	Gu, Tingyi/M-6505-2019	Gu, Tingyi/0000-0003-0414-6333	National Natural Science Foundation of China [30900522]; Shanghai Pujiang Program [09PJ1407000]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by the National Natural Science Foundation of China grant (Grant No. 30900522) www.nsfc.gov.cn, the Shanghai Pujiang Program (Grant No. 09PJ1407000) www.stcsm.gov.cn, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China www.cscse.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlic J, 2007, TRENDS CARDIOVAS MED, V17, P269, DOI 10.1016/j.tcm.2007.09.004; Barlic J, 2006, CIRCULATION, V114, P807, DOI 10.1161/CIRCULATIONAHA.105.602359; Bhavsar PK, 2008, FASEB J, V22, P1807, DOI 10.1096/fj.07-094235; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Elsey DJ, 2010, CELL BIOCHEM FUNCT, V28, P95, DOI 10.1002/cbf.1618; Gan LM, 2007, ATHEROSCLEROSIS, V190, P313, DOI 10.1016/j.atherosclerosis.2006.03.035; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Johnson J, 2005, CIRCULATION, V111, P1422, DOI 10.1161/01.CIR.0000158435.98035.8D; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Meng QH, 2007, AM J PATHOL, V170, P1406, DOI 10.2353/ajpath.2007.060939; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Renga Barbara, 2011, Inflammation & Allergy Drug Targets, V10, P85; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Shibuya A, 2002, FEBS LETT, V525, P43, DOI 10.1016/S0014-5793(02)03059-4; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Wan YH, 2010, J MOL ENDOCRINOL, V44, P135, DOI 10.1677/JME-09-0090; Wang QA, 2010, BIOCHEM BIOPH RES CO, V396, P182, DOI 10.1016/j.bbrc.2010.04.061; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Whiteman M, 2006, BIOCHEM BIOPH RES CO, V343, P303, DOI 10.1016/j.bbrc.2006.02.154; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; Wu DJ, 2009, ATHEROSCLEROSIS, V207, P68, DOI 10.1016/j.atherosclerosis.2009.04.025; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhang HL, 2007, J LEUKOCYTE BIOL, V82, P894, DOI 10.1189/jlb.0407237; Zhao QH, 2010, J LEUKOCYTE BIOL, V88, P41, DOI 10.1189/jlb.1009671; Zhao ZZ, 2011, EXP BIOL MED, V236, P169, DOI 10.1258/ebm.2010.010308; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599	38	51	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41147	10.1371/journal.pone.0041147	http://dx.doi.org/10.1371/journal.pone.0041147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815945	Green Submitted, Green Published, gold			2022-12-25	WOS:000306548900080
J	Mishellany-Dutour, A; Woda, A; Laboure, H; Bourdiol, P; Lachaze, P; Guichard, E; Feron, G				Mishellany-Dutour, Anne; Woda, Alain; Laboure, Helene; Bourdiol, Pierre; Lachaze, Pauline; Guichard, Elisabeth; Feron, Gilles			Retro-Nasal Aroma Release Is Correlated with Variations in the In-Mouth Air Cavity Volume after Empty Deglutition	PLOS ONE			English	Article							FLAVOR PERCEPTION; ACOUSTIC REFLECTION; SWALLOWING PROCESS; SOFT PALATE; SOLID FOOD; AREA; RESPIRATION; MASTICATION; CONSEQUENCES; CHEESE	We hypothesized that interindividual differences in motor activities during chewing and/or swallowing were determining factors for the transfer of volatile aroma from the in-mouth air cavity (IMAC) toward the olfactory mucosa. In our first experiment, we looked for changes in IMAC volume after saliva deglutition in 12 healthy subjects. The mean IMAC volume was measured after empty deglutition using an acoustic pharyngometer device. Based on the time course of the IMAC volume after swallowing, we discerned two groups of subjects. The first group displayed a small, constant IMAC volume (2.26 mL +/- 0.62) that corresponded to a high tongue position. The second group displayed a progressive increase in IMAC (from 6.82 mL +/- 2.37 to 22.82 mL +/- 3.04) that corresponded to a progressive lowering of the tongue to its resting position. In our second experiment, we investigated the relationship between IMAC volume changes after deglutition and the level of aroma release at the nostril. For this purpose, the release of menthone was measured at the nostril level in 25 subjects who consumed similar amounts of a mint tablet. The subjects were separated into two groups corresponding to two levels of menthone release: high (H) and low (L). The mean volume of IMAC was measured during and after empty deglutition. Group H displayed a small, constant amplitude of IMAC volume change after deglutition, while Group L displayed a progressive increase in IMAC. It is likely that Group H continuously released the aroma through the veloglossal isthmus as the mint was consumed, while Group L trapped the aroma in the oral cavity and then released it into the nasal cavity upon swallowing. These results show that the in vivo aroma release profile in humans depends closely on the different motor patterns at work during empty deglutition.	[Mishellany-Dutour, Anne; Woda, Alain; Bourdiol, Pierre; Lachaze, Pauline] Ctr Rech Odontol Clin, Fac Dent, Equipe Accueil 3847, Clermont Ferrand, France; [Laboure, Helene; Guichard, Elisabeth; Feron, Gilles] Univ Bourgogne, CNRS, UMR 6265, Ctr Sci Gout & Alimentat,UMR 1324,Inst Natl Rech, Dijon, France; [Woda, Alain; Bourdiol, Pierre] Ctr Hosp Univ, Serv Odontol, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Clermont Ferrand	Mishellany-Dutour, A (corresponding author), Ctr Rech Odontol Clin, Fac Dent, Equipe Accueil 3847, Clermont Ferrand, France.	alain.woda@u-clermont1.fr	Laboure, Helene/S-3006-2016; FERON, Gilles/AAW-8714-2020	Laboure, Helene/0000-0002-8173-6145; Feron, Gilles/0000-0002-9522-9654	French National Research Agency [ANR 07-PNRA-014]; Burgundy region	French National Research Agency(French National Research Agency (ANR)); Burgundy region(Region Bourgogne-Franche-Comte)	This work was supported by the French National Research Agency [grant SensInMouth, ANR 07-PNRA-014] and by the Burgundy region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blissett A, 2006, J TEXTURE STUD, V37, P476, DOI 10.1111/j.1745-4603.2006.00064.x; Bourdiol P, 2010, J ORAL REHABIL, V37, P100, DOI 10.1111/j.1365-2842.2009.02024.x; BROOKS LJ, 1989, J APPL PHYSIOL, V66, P2901, DOI 10.1152/jappl.1989.66.6.2901; Buettner A, 2002, FOOD QUAL PREFER, V13, P497, DOI 10.1016/S0950-3293(02)00052-6; Buettner A, 2001, CHEM SENSES, V26, P1211, DOI 10.1093/chemse/26.9.1211; Buettner A, 2000, LEBENSM-WISS TECHNOL, V33, P553, DOI 10.1006/fstl.2000.0708; Buettner A, 2000, FOOD CHEM, V71, P347, DOI 10.1016/S0308-8146(00)00199-0; COLLINS LMC, 1987, J DENT RES, V66, P285; Eckmann DM, 1996, ANESTH ANALG, V83, P1084, DOI 10.1097/00000539-199611000-00033; FREDBERG JJ, 1980, J APPL PHYSIOL, V48, P749, DOI 10.1152/jappl.1980.48.5.749; Gavião Maria Beatriz Duarte, 2004, J. Appl. Oral Sci., V12, P159, DOI 10.1590/S1678-77572004000200015; Gierczynski I, 2008, J AGR FOOD CHEM, V56, P1697, DOI 10.1021/jf0728505; Hiiemae KM, 1999, DYSPHAGIA, V14, P31, DOI 10.1007/PL00009582; Hodgson M, 2003, J AGR FOOD CHEM, V51, P5052, DOI 10.1021/jf030118+; Hodgson MD, 2005, J AGR FOOD CHEM, V53, P1700, DOI 10.1021/jf040316g; INGHAM KE, 1995, FOOD SCI TECHNOL-LEB, V28, P105; Kamal I, 2001, OTOLARYNG HEAD NECK, V124, P323, DOI 10.1067/mhn.2001.113136; Land DG, 1996, ACS SYM SER, V633, P2; Le Quere Jean-Luc, 2006, V43, P589; LOUIS B, 1994, J APPL PHYSIOL, V76, P2234, DOI 10.1152/jappl.1994.76.5.2234; Matsuo K, 2005, J DENT RES, V84, P39, DOI 10.1177/154405910508400106; Matsuo K, 2010, J DENT RES, V89, P1401, DOI 10.1177/0022034510377336; Matsuo K, 2008, J APPL PHYSIOL, V104, P674, DOI 10.1152/japplphysiol.00527.2007; Normand V, 2004, CHEM SENSES, V29, P235, DOI 10.1093/chemse/bjh028; Ovejero-Lopez I, 2004, J AGR FOOD CHEM, V52, P8119, DOI 10.1021/jf048716r; Palmer JB, 2003, DYSPHAGIA, V18, P169, DOI 10.1007/s00455-002-0097-9; Pionnier E, 2005, ROY SOC CH, P13; Pionnier E, 2004, J AGR FOOD CHEM, V52, P557, DOI 10.1021/jf030544v; Repoux M, 2012, FLAVOUR FRAG J, V27, P40, DOI 10.1002/ffj.2077; Ruijschop RMAJ, 2009, CHEM SENSES, V34, P395, DOI 10.1093/chemse/bjp011; Salles C, 2011, CRIT REV FOOD SCI, V51, P67, DOI 10.1080/10408390903044693; Semon E, 2003, ADV MASS SPECTROME S, P324; Singh GD, 2007, SLEEP BREATH, V11, P209, DOI 10.1007/s11325-007-0104-3	33	26	26	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41276	10.1371/journal.pone.0041276	http://dx.doi.org/10.1371/journal.pone.0041276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815986	Green Published, Green Submitted, gold			2022-12-25	WOS:000306507000085
J	Muller, P; Ruckova, E; Halada, P; Coates, PJ; Hrstka, R; Lane, DP; Vojtesek, B				Muller, P.; Ruckova, E.; Halada, P.; Coates, P. J.; Hrstka, R.; Lane, D. P.; Vojtesek, B.			C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances	ONCOGENE			English	Article						Hsp70; Hsp90; CHIP; HOP; chaperone; folding	HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONES; UBIQUITIN LIGASE; DEGRADATION; COMPLEXES; PATHWAYS; RESIDUES; PEPTIDE; DOMAIN; SITES	Heat shock proteins Hsp90 and Hsp70 facilitate protein folding but can also direct proteins for ubiquitin-mediated degradation. The mechanisms regulating these opposite activities involve Hsp binding to co-chaperones including CHIP and HOP at their C-termini. We demonstrated that the extreme C-termini of Hsp70 and Hsp90 contain phosphorylation sites targeted by kinases including CK1, CK2 and GSK3-beta in vitro. The phosphorylation of Hsp90 and Hsp70 prevents binding to CHIP and thus enhances binding to HOP. Highly proliferative cells contain phosphorylated chaperones in complex with HOP and phospho-mimetic and non-phosphorylable Hsp mutant proteins show that phosphorylation is directly associated with increased proliferation rate. We also demonstrate that primary human cancers contain high levels of phosphorylated chaperones and show increased levels of HOP protein and mRNA. These data identify C-terminal phosphorylation of Hsp70 and Hsp90 as a switch for regulating co-chaperone binding and indicate that cancer cells possess an elevated protein folding environment by the concerted action of co-chaperone expression and chaperone modifications. In addition to identifying the pathway responsible for regulating chaperone-mediated protein folding/degradation balances in normal cells, the data provide novel mechanisms to account for the aberrant chaperone activities observed in human cancer cells and have implications for the application of anti-chaperone therapies in cancer treatment.	[Muller, P.; Ruckova, E.; Hrstka, R.; Vojtesek, B.] Masaryk Mem Canc Inst, Brno 65653, Czech Republic; [Halada, P.] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic; [Coates, P. J.] Univ Dundee, Ctr Oncol & Mol Med, Dundee DD1 4HN, Scotland; [Lane, D. P.] p53 Lab A STAR, Immunos, Singapore	Masaryk Memorial Cancer Institute; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Dundee	Vojtesek, B (corresponding author), Masaryk Mem Canc Inst, Zluty Kopec 7, Brno 65653, Czech Republic.	vojtesek@mou.cz	Hrstka, Roman/AAM-4430-2020; Muller, Petr/AAK-5014-2021; Muller, Petr/F-7762-2015; Halada, Petr/H-3330-2014; Coates, Philip J/H-6854-2019	Hrstka, Roman/0000-0002-6139-2664; Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Halada, Petr/0000-0002-7229-3450; Coates, Philip J/0000-0003-1518-6306; Lane, David/0000-0003-0551-3545	European Regional Development Fund [GACR P301/11/1678, GACR P206/12/G151, IGA NT/13794-4/2012]; State Budget of the Czech Republic [RECAMO CZ.1.05/2.1.00/03.0101]; Ministry of Health of the Czech Republic [FUNDIN MZ0MOU2005]	European Regional Development Fund(European Commission); State Budget of the Czech Republic; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by grants from GACR P301/11/1678, GACR P206/12/G151, IGA NT/13794-4/2012, by the European Regional Development Fund and the State Budget of the Czech Republic RECAMO CZ.1.05/2.1.00/03.0101 and research program of the Ministry of Health of the Czech Republic FUNDIN MZ0MOU2005.	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Hutt D, 2010, SCIENCE, V329, P766, DOI 10.1126/science.1194160; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; LEESMILLER SP, 1989, J BIOL CHEM, V264, P17275; Li J, 2011, BIOCHIM BIOPHYS ACTA, V1823, P624; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Peterson LB, 2009, FUTURE MED CHEM, V1, P267, DOI [10.4155/fmc.09.17, 10.4155/FMC.09.17]; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Ramsey AJ, 2000, J BIOL CHEM, V275, P17857, DOI 10.1074/jbc.M001625200; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Workman P, 2004, TRENDS MOL MED, V10, P47, DOI 10.1016/j.molmed.2003.12.005; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang RM, 2004, ANAL BIOCHEM, V331, P138, DOI 10.1016/j.ab.2004.03.009	31	137	139	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 20	2013	32	25					3101	3110		10.1038/onc.2012.314	http://dx.doi.org/10.1038/onc.2012.314			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22824801				2022-12-25	WOS:000320705700010
J	Erion, R; DiAngelo, JR; Crocker, A; Sehgal, A				Erion, Renske; DiAngelo, Justin R.; Crocker, Amanda; Sehgal, Amita			Interaction between Sleep and Metabolism in Drosophila with Altered Octopamine Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-LIKE PEPTIDES; GENETIC-ANALYSIS; LIFE-SPAN; PROTEIN; GROWTH; STARVATION; RECEPTOR; OBESITY; CELLS; FLIES	Sleep length and metabolic dysfunction are correlated, but the causal relationship between these processes is unclear. Octopamine promotes wakefulness in the fly by acting through the insulin-producing cells (IPCs) in the fly brain. To determine if insulin signaling mediates the effects of octopamine on sleep: wake behavior, we assayed flies in which insulin signaling activity was genetically altered. We found that increasing insulin signaling does not promote wake, nor does insulin appear to mediate the wake-promoting effects of octopamine. Octopamine also affects metabolism in invertebrate species, including, as we show here, Drosophila melanogaster. Triglycerides are decreased in mutants with compromised octopamine signaling and elevated in flies with increased activity of octopaminergic neurons. Interestingly, this effect is mediated at least partially by insulin, suggesting that effects of octopamine on metabolism are independent of its effects on sleep. We further investigated the relative contribution of metabolic and sleep phenotypes to the starvation response of flies with altered octopamine signaling. Hyperactivity (indicative of foraging) induced by starvation was elevated in octopamine receptor mutants, despite their high propensity for sleep, indicating that their metabolic state dictates their behavioral response under these conditions. Moreover, flies with increased octopamine signaling do not suppress sleep in response to starvation, even though they are normally hyper-aroused, most likely because of their high triglyceride levels. Together, these data suggest that observed correlations between sleep and metabolic phenotypes can result from shared molecular pathways rather than causality, and environmental conditions can lead to the dominance of one phenotype over the other.	[Sehgal, Amita] Univ Penn, Perelman Sch Med, Dept Neurosci, Translat Res Ctr 10 135, Philadelphia, PA 19104 USA; [Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [DiAngelo, Justin R.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Hofstra University	Sehgal, A (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Translat Res Ctr 10 135, 3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			National Institutes of Health [P01 AG17628]; Predoctoral Training Grant in Genetics [T32 GM008216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Training Grant in Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part by National Institutes of Health Grant P01 AG17628 and a Predoctoral Training Grant in Genetics (T32 GM008216, to R. E.).	Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Goddard AW, 2010, DEPRESS ANXIETY, V27, P339, DOI 10.1002/da.20642; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hildebrandt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023796; Horne J, 2009, NEUROSCI BIOBEHAV R, V33, P466, DOI 10.1016/j.neubiorev.2008.12.002; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004716; MACFADYEN UM, 1973, J APPL PHYSIOL, V35, P391, DOI 10.1152/jappl.1973.35.3.391; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thimgan MS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000466; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	47	47	47	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32406	32414		10.1074/jbc.M112.360875	http://dx.doi.org/10.1074/jbc.M112.360875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22829591	Green Published, hybrid			2022-12-25	WOS:000309168300011
J	Gabriel, L; Lvov, A; Orthodoxou, D; Rittenhouse, AR; Kobertz, WR; Melikian, HE				Gabriel, Luke; Lvov, Anatoli; Orthodoxou, Demetra; Rittenhouse, Ann R.; Kobertz, William R.; Melikian, Haley E.			The Acid-sensitive, Anesthetic-activated Potassium Leak Channel, KCNK3, Is Regulated by 14-3-3 beta-dependent, Protein Kinase C (PKC)-mediated Endocytic Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; DOMAIN K+ CHANNEL; EPITHELIAL NA+ CHANNELS; DOPAMINE TRANSPORTER; TASK-1 KCNK3; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; MECHANISMS; AMPA	The acid-sensitive neuronal potassium leak channel, KCNK3, is vital for setting the resting membrane potential and is the primary target for volatile anesthetics. Recent reports demonstrate that KCNK3 activity is down-regulated by PKC; however, the mechanisms responsible for PKC-induced KCNK3 down-regulation are undefined. Here, we report that endocytic trafficking dynamically regulates KCNK3 activity. Phorbol esters and Group I metabotropic glutamate receptor (mGluR) activation acutely decreased both native and recombinant KCNK3 currents with concomitant KCNK3 surface losses in cerebellar granule neurons and cell lines. PKC-mediated KCNK3 internalization required the presence of both 14-3-3 beta and a novel potassium channel endocytic motif, because depleting either 14-3-3 beta protein levels or ablating the endocytic motif completely abrogated PKC-regulated KCNK3 trafficking. These results demonstrate that neuronal potassium leak channels are not static membrane residents but are subject to 14-3-3 beta-dependent regulated trafficking, providing a straightforward mechanism to modulate neuronal excitability and synaptic plasticity by Group I mGluRs.	[Gabriel, Luke; Orthodoxou, Demetra; Melikian, Haley E.] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA 01604 USA; [Gabriel, Luke; Rittenhouse, Ann R.; Kobertz, William R.; Melikian, Haley E.] Univ Massachusetts, Sch Med, Grad Program Neurosci, Worcester, MA 01604 USA; [Lvov, Anatoli; Kobertz, William R.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01604 USA; [Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Melikian, HE (corresponding author), Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, 303 Belmont St, Worcester, MA 01604 USA.	haley.melikian@umassmed.edu	Lvov, Anatoli/E-6747-2012; Melikian, Haley/S-8301-2016	Orthodoxou, Demetra/0000-0002-9279-5300; Melikian, Haley/0000-0002-9694-5556	National Institutes of Health [DA15169, GM070650]; University of Massachusetts Center for AIDS Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Center for AIDS Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA15169 (to H. E. M.) and GM070650 (to W. R. K.). This work was also supported by the University of Massachusetts Center for AIDS Research (to H. E. M. and W. R. K.).	Ahern CA, 2009, BIOCHEMISTRY-US, V48, P517, DOI 10.1021/bi8018515; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bayliss DA, 2001, RESP PHYSIOL, V129, P159, DOI 10.1016/S0034-5687(01)00288-2; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Besana A, 2004, J BIOL CHEM, V279, P33154, DOI 10.1074/jbc.M403525200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Buckingham SD, 2005, TRENDS PHARMACOL SCI, V26, P361, DOI 10.1016/j.tips.2005.05.003; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correa SAL, 2009, J CELL SCI, V122, P4186, DOI 10.1242/jcs.058420; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Inoue M, 2008, J NEUROCHEM, V106, P1804, DOI 10.1111/j.1471-4159.2008.05521.x; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kim DY, 2011, J BIOL CHEM, V286, P8106, DOI 10.1074/jbc.M110.134692; Kindler CH, 2005, REGION ANESTH PAIN M, V30, P260, DOI 10.1016/j.rapm.2004.12.001; Kittler JT, 2002, MOL NEUROBIOL, V26, P251, DOI 10.1385/MN:26:2-3:251; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee IH, 2008, CLIN EXP PHARMACOL P, V35, P235, DOI 10.1111/j.1440-1681.2007.04844.x; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Meuth SG, 2003, J NEUROSCI, V23, P6460; Meuth SG, 2009, NEUROBIOL DIS, V33, P1, DOI 10.1016/j.nbd.2008.09.006; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Navaroli DM, 2011, J NEUROSCI, V31, P13758, DOI 10.1523/JNEUROSCI.2649-11.2011; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; PREZEAU L, 1994, MOL PHARMACOL, V45, P570; Putzke C, 2007, AM J PHYSIOL-CELL PH, V293, pC1319, DOI 10.1152/ajpcell.00100.2007; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Ritzen A, 2005, BASIC CLIN PHARMACOL, V97, P202, DOI 10.1111/j.1742-7843.2005.pto_156.x; Sekiyama N, 1996, BRIT J PHARMACOL, V117, P1493, DOI 10.1111/j.1476-5381.1996.tb15312.x; Smith J, 2001, MOL ENDOCRINOL, V15, P1539, DOI 10.1210/me.15.9.1539; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Tang B, 2009, AM J RESP CELL MOL, V41, P476, DOI 10.1165/rcmb.2008-0412OC; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; von Zastrow M, 2010, DRUG ALCOHOL DEPEN, V108, P166, DOI 10.1016/j.drugalcdep.2010.02.014; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	80	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32354	32366		10.1074/jbc.M112.391458	http://dx.doi.org/10.1074/jbc.M112.391458			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846993	Green Published, hybrid			2022-12-25	WOS:000309168300007
J	Lee, SY; Yoon, J; Lee, MH; Jung, SK; Kim, DJ; Bode, AM; Kim, J; Dong, ZG				Lee, Sung-Young; Yoon, Jaeho; Lee, Mee-Hyun; Jung, Sung Keun; Kim, Dong Joon; Bode, Ann M.; Kim, Jaebong; Dong, Zigang			The Role of Heterodimeric AP-1 Protein Comprised of JunD and c-Fos Proteins in Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; TRANSCRIPTIONAL REGULATION; MESODERM INDUCTION; CELL-PROLIFERATION; XENOPUS; PHOSPHORYLATION; DIFFERENTIATION; INVOLVEMENT; EMBRYOS; BMP-4	Activator protein-1 (AP-1) regulates a wide range of cellular processes including proliferation, differentiation, and apoptosis. As a transcription factor, AP-1 is commonly found as a heterodimer comprised of c-Jun and c-Fos proteins. However, other heterodimers may also be formed. The function of these dimers, specifically the heterodimeric AP-1 comprised of JunD and c-Fos (AP-1(JunD/c-Fos)), has not been elucidated. Here, we identified a function of AP-1(JunD/c-Fos) in Xenopus hematopoiesis. A gain-of-function study performed by overexpressing junD and c-fos and a loss-of-function study using morpholino junD demonstrate a critical role for AP-1(JunD/c-Fos) in hematopoiesis during Xenopus embryogenesis. Additionally, we confirmed that JunD of AP-1(JunD/c-Fos) is required for BMP-4-induced hematopoiesis. We also demonstrated that BMP-4 regulated JunD activity at the transcriptional regulation and post-translational modification levels. Collectively, our findings identify AP-1(JunD/c-Fos) as a novel hematopoietic transcription factor and the requirement of AP-1(JunD/c-Fos) in BMP-4-induced hematopoiesis during Xenopus hematopoiesis.	[Yoon, Jaeho; Kim, Jaebong] Hallym Univ, Dept Biochem, Coll Med, Chunchon 200702, Kangwon Do, South Korea; [Lee, Sung-Young; Lee, Mee-Hyun; Jung, Sung Keun; Kim, Dong Joon; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Kim, Dong Joon] Korea Res Inst Biosci & Biotechnol, Med Genom Ctr, Taejon 305806, South Korea	Hallym University; University of Minnesota System; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, J (corresponding author), Hallym Univ, Dept Biochem, Coll Med, 1 Okchon Dong, Chunchon 200702, Kangwon Do, South Korea.	jbkim@hallym.ac.kr; zgdong@hi.umn.edu	Kim, Jaebong/AAV-1986-2021; Kim, Dong Joon/AAL-8967-2020	Kim, Jaebong/0000-0003-1609-338X; Yoon, Jaeho/0000-0003-2730-8606	National Institutes of Health [CA077646, CA111536, CA120388, R37 CA081064, ES016548]; Hormel Foundation; National Research Foundation of Korea [2009-0077052]; Ministry of Education, Science, and Technology; Hallym University [2011 (HRF-201109-058)]; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA077646, R01CA120388, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Hallym University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, CA111536, CA120388, R37 CA081064, and ES016548. This work was also supported by The Hormel Foundation, the Basic Science Research Program (2009-0077052) through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology, and Hallym University Research Fund, 2011 (HRF-201109-058).	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Dong ZG, 1996, J BIOL CHEM, V271, P9942, DOI 10.1074/jbc.271.17.9942; Friedle H, 1998, EMBO J, V17, P2298, DOI 10.1093/emboj/17.8.2298; Gallo A, 2002, ONCOGENE, V21, P6434, DOI 10.1038/sj.onc.1205822; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Huang S, 1998, DEV GROWTH DIFFER, V40, P189; Huber TL, 1998, SEMIN IMMUNOL, V10, P103, DOI 10.1006/smim.1998.0111; Itoh K, 1995, DEVELOPMENT, V121, P3979; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; KAU CL, 1983, J IMMUNOL, V131, P2262; Kim J, 1998, J BIOL CHEM, V273, P1542, DOI 10.1074/jbc.273.3.1542; Lee SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021796; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; Maeno M, 2003, ZOOL SCI, V20, P939, DOI 10.2108/zsj.20.939; Mangia F, 1970, Acta Embryol. exp., V1970, P163; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Perry C, 2002, EUR J BIOCHEM, V269, P3607, DOI 10.1046/j.1432-1033.2002.02999.x; Rosenberger SF, 1999, J BIOL CHEM, V274, P1124, DOI 10.1074/jbc.274.2.1124; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Stocco CO, 2002, J BIOL CHEM, V277, P3293, DOI 10.1074/jbc.M110936200; Tulchinsky E, 2000, HISTOL HISTOPATHOL, V15, P921, DOI 10.14670/HH-15.921; Vinciguerra M, 2004, J BIOL CHEM, V279, P9634, DOI 10.1074/jbc.M308721200; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang HL, 1996, ONCOGENE, V13, P2639; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Xu RH, 1996, P NATL ACAD SCI USA, V93, P834, DOI 10.1073/pnas.93.2.834; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200	31	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31342	31348		10.1074/jbc.M112.387266	http://dx.doi.org/10.1074/jbc.M112.387266			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822070	Green Published, hybrid			2022-12-25	WOS:000308791300045
J	Hu, GL; Huang, K; Yu, JH; Gopalakrishna-Pillai, S; Kong, J; Xu, H; Liu, ZS; Zhang, KS; Xu, J; Luo, YP; Li, SG; Sun, YE; Iverson, LE; Xue, ZG; Fan, GP				Hu, Ganlu; Huang, Kevin; Yu, Juehua; Gopalakrishna-Pillai, Sailesh; Kong, Jun; Xu, He; Liu, Zhenshan; Zhang, Kunshan; Xu, Jun; Luo, Yuping; Li, Siguang; Sun, Yi E.; Iverson, Linda E.; Xue, Zhigang; Fan, Guoping			Identification of miRNA Signatures during the Differentiation of hESCs into Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MICRORNA EXPRESSION; MACULAR DEGENERATION; MOLECULAR SIGNATURE; GENE-EXPRESSION; VISUAL FUNCTION; DICER; RPE; IMPACT	Retinal pigment epithelium (RPE) cells can be obtained through in vitro differentiation of both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). We have previously identified 87 signature genes relevant to RPE cell differentiation and function through transcriptome analysis of both human ESC- and iPSC-derived RPE as well as normal fetal RPE. Here, we profile miRNA expression through small RNA-seq in human ESCs and their RPE derivatives. Much like conclusions drawn from our previous transcriptome analysis, we find that the overall miRNA landscape in RPE is distinct from ESCs and other differentiated somatic tissues. We also profile miRNA expression during intermediate stages of RPE differentiation and identified unique subsets of miRNAs that are gradually up- or down-regulated, suggesting that dynamic regulation of these miRNAs is associated with the RPE differentiation process. Indeed, the down-regulation of a subset of miRNAs during RPE differentiation is associated with up- regulation of RPE-specific genes, such as RPE65, which is exclusively expressed in RPE. We conclude that miRNA signatures can be used to classify different degrees of in vitro differentiation of RPE from human pluripotent stem cells. We suggest that RPE-specific miRNAs likely contribute to the functional maturation of RPE in vitro, similar to the regulation of RPE-specific mRNA expression.	[Hu, Ganlu; Sun, Yi E.; Xue, Zhigang] Tongji Univ, Translat Ctr Stem Cell Res, Tongji Hosp, Sch Med, Shanghai 200092, Peoples R China; [Hu, Ganlu; Liu, Zhenshan; Zhang, Kunshan; Xu, Jun; Luo, Yuping; Li, Siguang; Sun, Yi E.; Xue, Zhigang; Fan, Guoping] Tongji Univ, Stem Cell Res Ctr, Dept Regenerat Med, Sch Med, Shanghai 200092, Peoples R China; [Huang, Kevin; Kong, Jun; Xu, He; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Gopalakrishna-Pillai, Sailesh; Iverson, Linda E.] Beckman Res Inst City Hope, Duarte, CA USA	Tongji University; Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; Beckman Research Institute of City of Hope	Hu, GL (corresponding author), Tongji Univ, Translat Ctr Stem Cell Res, Tongji Hosp, Sch Med, Shanghai 200092, Peoples R China.	Xuezhigang75@gmail.com; GFan@mednet.ucla.edu	Yu, Juehua/G-4596-2013	Fan, Guoping/0000-0001-5235-6410	Ministry of Science and Technology in China [2011CB965102, 2011CB966204, 2012CB966300]; International Science & Technology Cooperation Program of China, National Institutes of Health Grants [2011DFB30010]; California Institute for Regenerative Medicine [P01GM081621, R21NS072924, RC1-0111, TR1-272]; California Institute of Regenerative Medicine Training Grant [TG2-01169]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691, R21NS072924] Funding Source: NIH RePORTER	Ministry of Science and Technology in China(Ministry of Science and Technology, China); International Science & Technology Cooperation Program of China, National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); California Institute of Regenerative Medicine Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by 2011CB965102, 2011CB966204 and 2012CB966300 grants from the Ministry of Science and Technology in China, 2011DFB30010 from the International Science & Technology Cooperation Program of China, National Institutes of Health Grants P01GM081621 and R21NS072924, and RC1-0111 and TR1-272 from the California Institute for Regenerative Medicine. Kevin Huang and Juehua Yu are supported by a California Institute of Regenerative Medicine Training Grant (TG2-01169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Chung EJ, 2011, BIOCHEM BIOPH RES CO, V415, P367, DOI 10.1016/j.bbrc.2011.10.074; da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Gopalakrishna-Pillai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020663; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haruta Masathoshi, 2005, Semin Ophthalmol, V20, P17, DOI 10.1080/08820530590921846; Hirasawa M, 2011, MOL VIS, V17, P1222; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kokkinaki M, 2011, STEM CELLS, V29, P825, DOI 10.1002/stem.635; Kuipers H, 2010, J IMMUNOL, V185, P400, DOI 10.4049/jimmunol.0903912; Kutty RK, 2010, MOL VIS, V16, P1475; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856	34	34	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e37224	10.1371/journal.pone.0037224	http://dx.doi.org/10.1371/journal.pone.0037224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848339	gold, Green Submitted, Green Published			2022-12-25	WOS:000306950200001
J	Latif, AA; Putterill, JF; de Klerk, DG; Pienaar, R; Mans, BJ				Latif, Abdalla A.; Putterill, John F.; de Klerk, Daniel G.; Pienaar, Ronel; Mans, Ben J.			Nuttalliella namaqua (Ixodoidea: Nuttalliellidae): First Description of the Male, Immature Stages and Re-Description of the Female	PLOS ONE			English	Article							TICKS; ACARI; MORPHOLOGY; IXODIDAE; REDESCRIPTION; ARGASIDAE	Nuttalliella namaqua is the only species of the enigmatic third tick family. Females possess features of hard and soft ticks and have been designated as the "missing link'' between the main tick families. Its position at the base of the tick tree suggests that some of the features unique to hard and soft ticks were present in the ancestral tick lineage. Larvae, nymphae and males have not been described to date and questions regarding their biological affinities to the main tick families remain unclear. The current study addressed these questions via the description of larvae, nymphae and males and resolved issues pertaining to female morphology. Field collected as well as laboratory-engorged females laid eggs and viable larvae subsequently hatched. The larvae possess morphological structures not present in subsequent stages: namely, a sclerotized scutum, pores on the dorsal surface of legs and a dentate anal plate. The last two characters are not present in ixodids and argasids. N. namaqua larvae and nymphae show a similar morphology to females: a unique hypostomal structure i.e., bluntly rounded apically in nymphae and females and ball-like in the larvae. A re-description of some structures in female N. namaqua has resolved differences in the original descriptions, namely that N. namaqua have 4 palpal segments as found in ixodids and argasids and posthypostomal setae. The male was discovered for the first time and described. Characteristic male features include: a pseudoscutum over most of the dorsum, an outgrowth on the chelicerae forming a unique rod-like structure similar to a spematodactyl in mites and medial extension of palpal segment 2 forming a large ventral crib for segment 4. All life stages possess some features found in hard and soft ticks and its status as the "missing link'' between the tick families remains.	[Latif, Abdalla A.; Putterill, John F.; de Klerk, Daniel G.; Pienaar, Ronel; Mans, Ben J.] Onderstepoort Vet Inst, Agr Res Council, Parasites Vectors & Vector Borne Dis Programme, Onderstepoort, South Africa; [Latif, Abdalla A.; Mans, Ben J.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa	Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria	Latif, AA (corresponding author), Onderstepoort Vet Inst, Agr Res Council, Parasites Vectors & Vector Borne Dis Programme, Onderstepoort, South Africa.	latifa@arc.agric.za	Pienaar, Ronel/T-6705-2018; Mans, Ben J./M-2427-2017	Pienaar, Ronel/0000-0002-9096-0237; Mans, Ben J./0000-0002-0177-0029; Latif, Abdalla/0000-0003-3138-3975	Joy Liebenberg Trust [21/19/JT02]; South African National Research Foundation	Joy Liebenberg Trust; South African National Research Foundation(National Research Foundation - South Africa)	This project was funded by the Joy Liebenberg Trust (21/19/JT02) allocated to BM, a South African National Research Foundation grant allocated to AL (NRF-Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashov YS., 1972, MISCELLANEOUS PUBLIC, V8, P268; BEDFORD G. A. H., 1931, PARASITOLOGY, V23, P230, DOI 10.1017/S0031182000013573; Coons Lewis B., 1999, P267; CORWIN D, 1979, J MED ENTOMOL, V16, P352, DOI 10.1093/jmedent/16.4.352; ELSHOURA SM, 1984, J PARASITOL, V70, P114; ELSHOURA SM, 1990, ACAROLOGIA, V31, P349; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; HOOGSTRAAL H, 1985, ADV PARASIT, V24, P135, DOI 10.1016/S0065-308X(08)60563-1; Horak IG, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i1.405; KEIRANS JE, 1976, ANN ENTOMOL SOC AM, V69, P926, DOI 10.1093/aesa/69.5.926; Klompen JSH, 1997, SYST PARASITOL, V38, P1, DOI 10.1023/A:1005815925466; Mans BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023675; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; OLIVER JH, 1989, ANNU REV ECOL SYST, V20, P397, DOI 10.1146/annurev.es.20.110189.002145; ROSHDY MA, 1983, Z PARASITENKD, V69, P817, DOI 10.1007/BF00927431; Sonenshine DE, 1991, BIOL TICKS, V1; Walter D, 1999, MITES ECOLOGY EVOLUT, P57	17	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41651	10.1371/journal.pone.0041651	http://dx.doi.org/10.1371/journal.pone.0041651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844508	Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600037
J	de Jong, HJI; Saldi, SRF; Klungel, OH; Vandebriel, RJ; Souverein, PC; Meyboom, RHB; Passier, JLM; van Loveren, H; Tervaert, JWC				de Jong, Hilda J. I.; Saldi, Siti R. F.; Klungel, Olaf H.; Vandebriel, Rob J.; Souverein, Patrick C.; Meyboom, Ronald H. B.; Passier, J. L. M. (Anneke); van Loveren, Henk; Tervaert, Jan Willem Cohen			Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach	PLOS ONE			English	Article							VITAMIN-D; MYOPATHY; MYALGIAS	Objective: To assess whether there is an association between statin use and the occurrence of polymyalgia rheumatic (PMR) in the spontaneous reporting database of the World Health Organisation (WHO). Methods: We conducted a case/non-case study based on individual case safety reports (ICSR) in the WHO global ICSR database (VigiBase). Case reports containing the adverse event term polymyalgia rheumatica (WHOART or MedDRA Preferred Term) were defined as cases. Non-cases were all case reports containing other adverse event terms. Each case was matched to five non-cases by age, gender, and time of reporting. Case reports regarding a statin as suspected or concomitant drug were identified using the Anatomical Therapeutic Chemical (ATC) classification. Multivariate logistic regression was used to calculate reporting odds ratios (RORs) with 95% confidence intervals (CI). Results: We identified 327 reports of PMR as cases and 1635 reports of other ADRs as non-cases. Among cases, statins were more frequently reported as suspected agent (29.4%) compared to non-cases (2.9%). After adjustment for several covariates, statins were significantly associated with reports of PMR (ROR 14.21; 95% CI 9.89-20.85). Conclusion: The results of this study lends support to previous anecdotal case reports in the literature suggesting that the use of a statin may be associated with the occurrence of PMR. Further studies are needed to study the strength of the association in more detail and to elucidate the underlying mechanism.	[de Jong, Hilda J. I.; Vandebriel, Rob J.; van Loveren, Henk] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [de Jong, Hilda J. I.; van Loveren, Henk] Maastricht Univ, Med Ctr, Dept Toxicogen, Maastricht, Netherlands; [de Jong, Hilda J. I.; Saldi, Siti R. F.; Klungel, Olaf H.; Souverein, Patrick C.; Meyboom, Ronald H. B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol,Fac Sci, Utrecht, Netherlands; [Meyboom, Ronald H. B.] World Hlth Org Collaborating Ctr Int Drug Monitor, Uppsala Monitoring Ctr, Uppsala, Sweden; [Passier, J. L. M. (Anneke)] Netherlands Pharmacovigilance Ctr Lareb, Shertogenbosch, Netherlands; [Tervaert, Jan Willem Cohen] Maastricht Univ, Med Ctr, Dept Internal Med, Div Clin & Expt Immunol, Maastricht, Netherlands	Netherlands National Institute for Public Health & the Environment; Maastricht University; Utrecht University; World Health Organization; Maastricht University	de Jong, HJI (corresponding author), Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands.	jw.cohentervaert@maastrichtuniversity.nl	tervaert, jan willem cohen/AAB-1111-2019; Vandebriel, Rob/P-6769-2019	Vandebriel, Rob/0000-0001-9140-952X; Passier, Anneke/0000-0001-5594-6360; Souverein, Patrick/0000-0002-7452-0477; Saldi, Siti Rizny Fitriana/0000-0002-5960-5616; de Jong, Hilda/0000-0002-4112-7572	National Institute for Public Health and the Environment [S340040]; GlaxoSmithKline; Novo Nordisk; Dutch Medicines Evaluation Board	National Institute for Public Health and the Environment; GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Dutch Medicines Evaluation Board	Funding for this study was obtained from the National Institute for Public Health and the Environment (project S340040). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, employing authors HJI de Jong, SRF Saldi, OH Klungel, PC Souverein and RHB Meyboom has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, private-public funded Top Institute Pharma (www.tipharma.nl and includes co-funding from universities, government and industry) and the Dutch Medicines Evaluation Board. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahmed W, 2009, TRANSL RES, V153, P11, DOI 10.1016/j.trsl.2008.11.002; Arnaud C, 2005, TRENDS CARDIOVAS MED, V15, P202, DOI 10.1016/j.tcm.2005.07.002; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bell DSH, 2010, SOUTH MED J, V103, P690, DOI 10.1097/SMJ.0b013e3181e21088; Christopher-Stine L, 2010, ARTHRITIS RHEUM-US, V62, P2757, DOI 10.1002/art.27572; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; de Jong HJI, 2012, ANN RHEUM DIS, V71, P648, DOI 10.1136/ard.2011.155622; de Jong HJI, 2011, SEMIN ARTHRITIS RHEU, V41, P373, DOI 10.1016/j.semarthrit.2011.06.002; Dedeoglu F, 2009, CURR OPIN RHEUMATOL, V21, P547, DOI 10.1097/BOR.0b013e32832f13db; Duell PB, 2008, CIRCULATION, V118, pS470; Goeb V, 2004, CLIN RHEUMATOL, V23, P179, DOI 10.1007/s10067-003-0772-8; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Grable-Esposito P, 2010, MUSCLE NERVE, V41, P185, DOI 10.1002/mus.21486; GREENLAND S, 1985, AM J EPIDEMIOL, V122, P495, DOI 10.1093/oxfordjournals.aje.a114131; Gupta A, 2011, ATHEROSCLEROSIS, V215, P23, DOI 10.1016/j.atherosclerosis.2010.11.039; Haroon Muhammad, 2008, Clin Rheumatol, V27 Suppl 2, pS75, DOI 10.1007/s10067-008-1020-z; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Kay Jonathan, 2006, N Engl J Med, V354, P623; Lee P, 2009, CLIN ENDOCRINOL, V71, P154, DOI 10.1111/j.1365-2265.2008.03448.x; Lindquist M, 2008, DRUG INF J, V42, P409, DOI 10.1177/009286150804200501; LUMLEY C E, 1986, Pharmaceutical Medicine (London), V1, P205; Martin RM, 1998, BRIT MED J, V317, P119, DOI 10.1136/bmj.317.7151.119; Noel B, 2007, J EUR ACAD DERMATOL, V21, P17, DOI 10.1111/j.1468-3083.2006.01838.x; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rudski L, 1998, MEDICINE, V77, P378, DOI 10.1097/00005792-199811000-00002; SALVARANI C, 1995, ARTHRITIS RHEUM, V38, P369, DOI 10.1002/art.1780380311; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Samanta A., 2002, Rheumatology (Oxford), V41, P1455, DOI 10.1093/rheumatology/41.12.1455; Sen D, 2010, INT J RHEUM DIS, V13, pe29, DOI 10.1111/j.1756-185X.2010.01481.x; Smeeth L, 2006, ANN RHEUM DIS, V65, P1093, DOI 10.1136/ard.2005.046912; Smolders J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015235; *WHO COLL CTR DRUG, 1999, GUID ATC CLASS DDD A; Wilson AM, 2004, BRIT J CLIN PHARMACO, V57, P127, DOI 10.1046/j.1365-2125.2003.01968.x	36	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41289	10.1371/journal.pone.0041289	http://dx.doi.org/10.1371/journal.pone.0041289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844450	gold, Green Published			2022-12-25	WOS:000306687700062
J	Lerner, I; Bentin, S; Shriki, O				Lerner, Itamar; Bentin, Shlomo; Shriki, Oren			Excessive Attractor Instability Accounts for Semantic Priming in Schizophrenia	PLOS ONE			English	Article							WORKING-MEMORY DYSFUNCTION; WORD PRONUNCIATION; NEURAL-NETWORKS; MODEL; ACTIVATION; DOPAMINE; THOUGHT; NEURONS; TIME; IMPAIRMENT	One of the most pervasive findings in studies of schizophrenics with thought disorders is their peculiar pattern of semantic priming, which presumably reflects abnormal associative processes in the semantic system of these patients. Semantic priming is manifested by faster and more accurate recognition of a word-target when preceded by a semantically related prime, relative to an unrelated prime condition. Compared to control, semantic priming in schizophrenics is characterized by reduced priming effects at long prime-target Stimulus Onset Asynchrony (SOA) and, sometimes, augmented priming at short SOA. In addition, unlike controls, schizophrenics consistently show indirect (mediated) priming (such as from the prime 'wedding' to the target 'finger', mediated by 'ring'). In a previous study, we developed a novel attractor neural network model with synaptic adaptation mechanisms that could account for semantic priming patterns in healthy individuals. Here, we examine the consequences of introducing attractor instability to this network, which is hypothesized to arise from dysfunctional synaptic transmission known to occur in schizophrenia. In two simulated experiments, we demonstrate how such instability speeds up the network's dynamics and, consequently, produces the full spectrum of priming effects previously reported in patients. The model also explains the inconsistency of augmented priming results at short SOAs using directly related pairs relative to the consistency of indirect priming. Further, we discuss how the same mechanism could account for other symptoms of the disease, such as derailment ('loose associations') or the commonly seen difficulty of patients in utilizing context. Finally, we show how the model can statistically implement the overly-broad wave of spreading activation previously presumed to characterize thought-disorders in schizophrenia.	[Lerner, Itamar; Bentin, Shlomo] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91905 Jerusalem, Israel; [Bentin, Shlomo] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Shriki, Oren] NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lerner, I (corresponding author), Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91905 Jerusalem, Israel.	itamar.lerner@gmail.com; oren70@gmail.com	Shriki, Oren/R-8638-2019	Shriki, Oren/0000-0003-1129-4799	Intramural Research Program of the National Institute of Mental Health	Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Oren Shriki was supported in part by the Intramural Research Program of the National Institute of Mental Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Akrami A, 2012, BRAIN RES, V1434, P4, DOI 10.1016/j.brainres.2011.07.030; ANDREASEN NC, 1979, ARCH GEN PSYCHIAT, V36, P1315, DOI 10.1001/archpsyc.1979.01780120045006; Barch DM, 1996, J ABNORM PSYCHOL, V105, P592, DOI 10.1037/0021-843X.105.4.592; Bibitchkov D, 2002, NETWORK-COMP NEURAL, V13, P115, DOI 10.1088/0954-898X/13/1/304; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bogen IL, 2009, NEUROCHEM INT, V55, P13, DOI 10.1016/j.neuint.2009.02.006; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Carter CS, 1998, AM J PSYCHIAT, V155, P1285, DOI 10.1176/ajp.155.9.1285; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Conklin HM, 2000, AM J PSYCHIAT, V157, P275, DOI 10.1176/appi.ajp.157.2.275; Durstewitz D, 2009, NEURAL NETWORKS, V22, P1189, DOI 10.1016/j.neunet.2009.07.016; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; FLEMING K, 1995, PSYCHIAT RES, V56, P155, DOI 10.1016/0165-1781(95)02589-3; Geva AB, 2000, J INT NEUROPSYCH SOC, V6, P608, DOI 10.1017/S1355617700655108; HERRMANN M, 1993, BIOL CYBERN, V68, P455, DOI 10.1007/BF00198778; Hoff AL, 1996, SCHIZOPHR RES, V20, P21, DOI 10.1016/0920-9964(95)00065-8; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kern RS, 1998, BIOL PSYCHIAT, V44, P726, DOI 10.1016/S0006-3223(98)00088-2; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; KWAPIL TR, 1990, J ABNORM PSYCHOL, V99, P215, DOI 10.1037/0021-843X.99.3.215; Lavigne F, 2008, NEUROPSYCHOLOGIA, V46, P3074, DOI 10.1016/j.neuropsychologia.2008.06.019; Lecardeur L, 2008, BRIT J PSYCHIAT, V193, P82, DOI 10.1192/bjp.193.1.82; Lerner I, 2012, COGN SCI IN PRESS; Lerner I, 2010, COGNITION IN FLUX, P1112; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; Minzenberg Michael J, 2003, Cogn Neuropsychiatry, V8, P107, DOI 10.1080/135468000247; Minzenberg MJ, 2002, J INT NEUROPSYCH SOC, V8, P699, DOI 10.1017/S1355617702801357; Moreno-Bote R, 2005, NEUROCOMPUTING, V65, P441, DOI 10.1016/j.neucom.2004.10.016; Moritz S, 2003, SCHIZOPHR RES, V59, P181, DOI 10.1016/S0920-9964(01)00337-1; Moritz S, 2001, SCHIZOPHR RES, V48, P301, DOI 10.1016/S0920-9964(00)00057-8; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; OBER BA, 1995, NEUROPSYCHOLOGY, V9, P220, DOI 10.1037/0894-4105.9.2.220; Pomarol-Clotet E, 2008, BRIT J PSYCHIAT, V192, P92, DOI 10.1192/bjp.bp.106.032102; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Rossell SL, 2007, CURR PSYCHIATRY REV, V3, P137, DOI 10.2174/157340007780599050; Russo E, 2012, ARXIV12031067V1; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Siekmeier PJ, 2002, BRIT J PSYCHIAT, V180, P345, DOI 10.1192/bjp.180.4.345; SPITZER M, 1993, BIOL PSYCHIAT, V34, P864, DOI 10.1016/0006-3223(93)90054-H; Spitzer M, 1997, SCHIZOPHRENIA BULL, V23, P29, DOI 10.1093/schbul/23.1.29; Treves A, 2005, COGN NEUROPSYCHOL, V22, P276, DOI 10.1080/02643290442000329; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P259, DOI 10.1142/S0217984990000325; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; VINOGRADOV S, 1992, SCHIZOPHR RES, V8, P171, DOI 10.1016/0920-9964(92)90033-2; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025435	54	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40663	10.1371/journal.pone.0040663	http://dx.doi.org/10.1371/journal.pone.0040663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844407	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700016
J	Thayil, SM; Ho, YC; Bollinger, RC; Blankson, JN; Siliciano, RF; Karakousis, PC; Page, KR				Thayil, Seema M.; Ho, Ya-Chi; Bollinger, Robert C.; Blankson, Joel N.; Siliciano, Robert F.; Karakousis, Petros C.; Page, Kathleen R.			Mycobacterium tuberculosis Complex Enhances Susceptibility of CD4 T Cells to HIV through a TLR2-Mediated Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE ACTIVATION; DENDRITIC CELLS; INFECTED PATIENTS; HOST FACTORS; DISEASE; EXPRESSION; RESPONSES; TLR2	Among HIV-infected individuals, co-infection with Mycobacterium tuberculosis is associated with faster progression to AIDS. We investigated the hypothesis that M. bovis BCG and M. tuberculosis (Mtb complex) could enhance susceptibility of CD4+ cells to HIV infection. Peripheral blood mononuclear cells (PBMCs) collected from healthy donors were stimulated with M. bovis BCG, M. tuberculosis CDC1551 and M. smegmatis MC(2)155, and stimulated CD4+ cells were infected with R5- and X4-tropic single replication-competent pseudovirus. CD4+ cells stimulated with Mtb complex showed enhanced infection with R5- and X4-tropic HIV, compared to unstimulated cells or cells stimulated with M. smegmatis (p<0.01). Treatment with TLR2 siRNA reversed the increased susceptibility of CD4+ cells with R5- and X4-tropic virus induced by Mtb complex. These findings suggest that TB infection and/or BCG vaccination may be a risk factor for HIV acquisition.	[Thayil, Seema M.; Ho, Ya-Chi; Bollinger, Robert C.; Blankson, Joel N.; Siliciano, Robert F.; Karakousis, Petros C.; Page, Kathleen R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Thayil, SM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	petros@jhmi.edu	Karakousis, Petros Constantine/AAR-7899-2020	Thayil, SEEMA/0000-0002-3111-6861; Bollinger, Robert/0000-0002-6798-6834; Ho, Ya-Chi/0000-0002-7046-0147	National Institutes of Health [K23HD056957, R01AI083125]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD056957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants K23HD056957 to KRP and R01AI083125 to PCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Bafica A, 2004, J IMMUNOL, V172, P7229, DOI 10.4049/jimmunol.172.12.7229; Bafica A, 2003, J IMMUNOL, V171, P1123, DOI 10.4049/jimmunol.171.3.1123; Barnabas RV, 2011, AIDS, V25, P1559, DOI 10.1097/QAD.0b013e3283491e3e; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bosinger SE, 2011, CURR OPIN HIV AIDS, V6, P411, DOI 10.1097/COH.0b013e3283499cf6; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Chang JS, 2006, J IMMUNOL, V176, P3010, DOI 10.4049/jimmunol.176.5.3010; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Croix DA, 2000, AIDS RES HUM RETROV, V16, P1895, DOI 10.1089/08892220050195856; Ding J, 2012, J IMMUNOL, V188, P992, DOI 10.4049/jimmunol.1102098; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; Equils O, 2003, J IMMUNOL, V170, P5159, DOI 10.4049/jimmunol.170.10.5159; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gonzalez OA, 2010, CLIN VACCINE IMMUNOL, V17, P1417, DOI 10.1128/CVI.00009-10; Hanekom WA, 2005, ANN NY ACAD SCI, V1062, P69, DOI 10.1196/annals.1358.010; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hernandez JC, 2011, AIDS RES HUM RETROV, V27, P1099, DOI [10.1089/aid.2010.0302, 10.1089/AID.2010.0302]; Huang D, 2007, J INFECT DIS, V195, P55, DOI 10.1086/509895; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kalinkovich A, 2001, CLIN IMMUNOL, V100, P107, DOI 10.1006/clim.2001.5040; Kaul R, 2011, AM J REPROD IMMUNOL, V65, P317, DOI 10.1111/j.1600-0897.2010.00962.x; Koesters SA, 2004, J CLIN IMMUNOL, V24, P702, DOI 10.1007/s10875-004-6238-1; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Ogawa Y, 2009, BLOOD, V113, P5157, DOI 10.1182/blood-2008-10-185728; Page KR, 2006, CELL MICROBIOL, V8, P185, DOI 10.1111/j.1462-5822.2005.00653.x; Pancino G, 2010, J INFECT DIS, V202, pS345, DOI 10.1086/655973; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Schreiber HA, 2011, J CLIN INVEST, V121, P3902, DOI 10.1172/JCI45113; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sundstrom JB, 2004, J IMMUNOL, V172, P4391, DOI 10.4049/jimmunol.172.7.4391; Tan DBA, 2011, AIDS, V25, P1455, DOI 10.1097/QAD.0b013e328348fb18; Thibault S, 2007, J IMMUNOL, V179, P4357, DOI 10.4049/jimmunol.179.7.4357; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; van den Biggelaar AHJ, 2009, J ALLERGY CLIN IMMUN, V124, P544, DOI 10.1016/j.jaci.2009.03.040; Walson JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub3; WHO, 2011, TB DAT 2011; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	46	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41093	10.1371/journal.pone.0041093	http://dx.doi.org/10.1371/journal.pone.0041093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844428	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700042
J	Liu, LL; Zhang, CZ; Cai, MY; Fu, J; Chen, GG; Yun, JP				Liu, Lili; Zhang, Chris Zhiyi; Cai, Muyan; Fu, Jia; Chen, George Gong; Yun, Jingping			Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis	PLOS ONE			English	Article							EXPRESSION; PLK4; SAK; AREAS; MICE	Polo-like kinase 4 (PLK4), belonging to serine/threonine kinase family, is critical for centriole replication and cell cycle progression. PLK4 has been proposed as a tumor suppressor in hepatocellular carcinoma (HCC). However, its expression and significance in HCC have not been well studied. In the present study, we found that PLK4 was markedly downregulated in both HCC cell lines and fresh cancer tissues, using quantitative real-time-PCR and western blot. Immunohistochemistry data also revealed that decreased expression of PLK4 was present in 72.4% (178/246) of HCC tissues, compared with the corresponding adjacent nontumorous tissues. Furthermore, PLK4 expression significantly correlated with clinicopathological parameters, including clinical stage (P = 0.034), serum alpha-fetoprotein (AFP) (P = 0.019) and tumor size (P = 0.032). Moreover, HCC patients with low PLK4 expression survived shorter than those with high PLK4 expression, as indicated by overall survival (P = 0.002) and disease-free survival (P = 0.012) assessed by the Kaplan-Meier method. In addition, multivariate analysis suggested PLK4 as an independent predictor of overall survival (HR, 0.556; 95%CI, 0.37-20.822; P = 0.003) and disease-free survival (HR, 0.547; 95%CI, 0.382-0.783; P = 0.001). Collectively, our study demonstrated that PLK4 was remarkably downregulated in HCC and could be served as a potential prognostic marker for patients with this deadly disease.	[Liu, Lili; Zhang, Chris Zhiyi; Cai, Muyan; Fu, Jia; Yun, Jingping] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Lili; Zhang, Chris Zhiyi; Cai, Muyan; Fu, Jia; Yun, Jingping] Sun Yat Sen Univ, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, George Gong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital	Liu, LL (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	yunjp@sysucc.org.cn	Liu, Lili/HHC-6357-2022; Chen, George Gong/I-2757-2016; Zhang, Chris Zhiyi/F-9862-2013		National Natural Science Foundation of China [81172345, 30973506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81172345 and No. 30973506). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban KC, 2004, J SURG ONCOL, V86, P157, DOI 10.1002/jso.20051; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Eckerdt F, 2011, CURR BIOL, V21, P428, DOI 10.1016/j.cub.2011.01.072; Feo F, 2006, BBA-REV CANCER, V1765, P126, DOI 10.1016/j.bbcan.2005.08.007; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Fode C, 1996, MOL CELL BIOL, V16, P4665; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kwon Oh Sang, 2010, Korean J Hepatol, V16, P308, DOI 10.3350/kjhep.2010.16.3.308; Liu L, 2010, LEUKEMIA LYMPHOMA, V51, P1079, DOI 10.3109/10428191003706939; Macmillan JC, 2001, ANN SURG ONCOL, V8, P729, DOI 10.1245/aso.2001.8.9.729; Marwoto Wirasmi, 2000, Kobe Journal of Medical Sciences, V46, P217; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Pellegrino R, 2010, HEPATOLOGY, V51, P857, DOI 10.1002/hep.23467; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; SUNKEL CE, 1988, J CELL SCI, V89, P25; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tanenbaum ME, 2007, NAT CELL BIOL, V9, P1127, DOI 10.1038/ncb1007-1127; Ward A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-71; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; YAMADA H, 1985, HISTOCHEMISTRY, V83, P285, DOI 10.1007/BF00684372; Zhou L, 2011, EJSO-EUR J SURG ONC, V37, P521, DOI 10.1016/j.ejso.2011.03.137; Zimling ZG, 2012, J THORAC ONCOL, V7, P249, DOI 10.1097/JTO.0b013e318233d6a9	32	36	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41293	10.1371/journal.pone.0041293	http://dx.doi.org/10.1371/journal.pone.0041293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829937	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300076
J	Maughan-Brown, B; Venkataramani, AS				Maughan-Brown, Brendan; Venkataramani, Atheendar S.			Learning That Circumcision Is Protective against HIV: Risk Compensation among Men and Women in Cape Town, South Africa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PREVENTION; INFECTION; KENYA; BEHAVIOR; KISUMU; UGANDA; RAKAI	Objectives: We examined whether knowledge of the HIV-protective benefits of male circumcision (MC) led to risk compensating behavior in a traditionally circumcising population in South Africa. We extend the current literature by examining risk compensation among women, which has hitherto been unexplored. Methods: We used data on Xhosa men and women from the 2009 Cape Area Panel Study. Respondents were asked if they had heard that MC reduces a man's risk of contracting HIV, about their perceived risk of contracting HIV, and condom use. For each gender group we assessed whether risk perception and condom use differed by knowledge of the protective benefits of MC using bivariate and then multivariate models controlling for demographic characteristics, HIV knowledge/beliefs, and previous sexual behaviors. In a further check for confounding, we used data from the 2005 wave to assess whether individuals who would eventually become informed about the protective benefits of circumcision were already different in terms of HIV risk perception and condom use. Results: 34% of men (n = 453) and 27% of women (n = 690) had heard that circumcision reduces a man's risk of HIV infection. Informed men perceived slightly higher risk of contracting HIV and were more likely to use condoms at last sex (p < 0.10). Informed women perceived lower HIV risk (p < 0.05), were less likely to use condoms both at last sex (p < 0.10) and more generally (p < 0.01), and more likely to forego condoms with partners of positive or unknown serostatus (p < 0.01). The results were robust to covariate adjustment, excluding people living with HIV, and accounting for risk perceptions and condom use in 2005. Conclusions: We find evidence consistent with risk compensation among women but not men. Further attention should be paid to the role of new information regarding MC, and drivers of HIV risk more broadly, in modulating sexual behavior among women.	[Maughan-Brown, Brendan] Univ Cape Town, So Africa Labour & Dev Res Unit, ZA-7925 Cape Town, South Africa; [Venkataramani, Atheendar S.] Massachusetts Gen Hosp, MGH Charlestown HealthCare Ctr, Dept Med, Charlestown, MA USA	University of Cape Town; Harvard University; Massachusetts General Hospital	Maughan-Brown, B (corresponding author), Univ Cape Town, So Africa Labour & Dev Res Unit, ZA-7925 Cape Town, South Africa.	avenkataramani@partners.org	Maughan-Brown, Brendan/AAH-4254-2019		United States National Institute for Child Health and Human Development; Andrew W. Mellon Foundation; National Institute on Aging; Health Economics & HIV/AIDS Research Division (HEARD) at the University of KwaZulu-Natal; European Union; NRF Research Chair in Poverty and Inequality Research; University Research Committee at the University of Cape Town	United States National Institute for Child Health and Human Development; Andrew W. Mellon Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Health Economics & HIV/AIDS Research Division (HEARD) at the University of KwaZulu-Natal; European Union(European Commission); NRF Research Chair in Poverty and Inequality Research; University Research Committee at the University of Cape Town	Funding for the Cape Area Panel Study was provided by the United States National Institute for Child Health and Human Development, the Andrew W. Mellon Foundation, the National Institute on Aging, the Health Economics & HIV/AIDS Research Division (HEARD) at the University of KwaZulu-Natal, and the European Union. Brendan Maughan-Brown is grateful for funding from the NRF Research Chair in Poverty and Inequality Research and the University Research Committee at the University of Cape Town for his Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA 2008 HIV AIDS P; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dupas P, 2011, AM ECON J-APPL ECON, V3, P1, DOI 10.1257/app.3.1.1; Eaton LA, 2011, INT J STD AIDS, V22, P674, DOI 10.1258/ijsa.2011.011006; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Godlonton S, 2011, 313 BUR RES EC AN DE; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grebe E, 2011, AIDS BEHAV, DOI [10.1007/s10461-10011-19958-10462, DOI 10.1007/S10461-10011-19958-10462]; Green LW, 2010, AM J PREV MED, V39, P479, DOI 10.1016/j.amepre.2010.07.010; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Maughan-Brown B, 2011, JAIDS-J ACQ IMM DEF, V58, P499, DOI 10.1097/QAI.0b013e31823584c1; Mishra V., 2009, LEVELS SPREAD HIV SE; Rain-Taljaard RC, 2003, AIDS CARE, V15, P315, DOI 10.1080/0954012031000105379; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Vincent L, 2008, CULT HEALTH SEX, V10, P431, DOI 10.1080/13691050701861447; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; World Health Organization Joint United Nations Programme on HIV/AIDS, 2011, JOINT STRAT ACT FRAM	21	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40753	10.1371/journal.pone.0040753	http://dx.doi.org/10.1371/journal.pone.0040753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981GZ	22829883	Green Published, gold			2022-12-25	WOS:000306956300021
J	Gonzalez-Montalban, N; Baskakov, IV				Gonzalez-Montalban, Nuria; Baskakov, Ilia V.			Assessment of Strain-Specific PrPSc Elongation Rates Revealed a Transformation of PrPSc Properties during Protein Misfolding Cyclic Amplification	PLOS ONE			English	Article							PRION PROTEIN; CONFORMATIONAL STABILITY; MOLECULES	Prion replication is believed to consist of two components, a growth or elongation of infectious isoform of the prion protein (PrPSc) particles and their fragmentation, a process that provides new replication centers. The current study introduced an experimental approach that employs Protein Misfolding Cyclic Amplification with beads (PMCAb) and relies on a series of kinetic experiments for assessing elongation rates of PrPSc particles. Four prion strains including two strains with short incubation times to disease (263K and Hyper) and two strains with very long incubation times (SSLOW and LOTSS) were tested. The elongation rate of brain-derived PrPSc was found to be strain-specific. Strains with short incubation times had higher rates than strains with long incubation times. Surprisingly, the strain-specific elongation rates increased substantially for all four strains after they were subjected to six rounds of serial PMCAb. In parallel to an increase in elongation rates, the percentages of diglycosylated PrP glycoforms increased in PMCAb-derived PrPSc comparing to those of brain-derived PrPSc. These results suggest that PMCAb selects the same molecular features regardless of strain initial characteristics and that convergent evolution of PrPSc properties occurred during in vitro amplification. These results are consistent with the hypothesis that each prion strain is comprised of a variety of conformers or 'quasi-species' and that change in the prion replication environment gives selective advantage to those conformers that replicate most effectively under specific environment.	[Gonzalez-Montalban, Nuria; Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Baskakov, Ilia V.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Gonzalez-Montalban, N (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu			National Institutes of Health [NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (http://www.nih.gov/) grant NS045585 to Ilia V. Baskakov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Gonzalez-Montalban N, 2011, BIOCHEMISTRY-US, V50, P7933, DOI 10.1021/bi200950v; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Klingeborn M, 2011, PROCACADNAT IN PRESS; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2012, NATURE COMM IN PRESS; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mays CE, 2010, FASEB J, V24, P5102, DOI 10.1096/fj.10-163600; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; Prusiner S. B., 1998, LES PRIX NOBEL, P268; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Shikiya RA, 2011, J VIROL, V85, P13439, DOI 10.1128/JVI.06134-11; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Tattum MH, 2010, TRANSFUSION, V50, P2619, DOI 10.1111/j.1537-2995.2010.02731.x; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748	39	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41210	10.1371/journal.pone.0041210	http://dx.doi.org/10.1371/journal.pone.0041210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815972	Green Published, Green Submitted, gold			2022-12-25	WOS:000306507000079
J	Nakanome, A; Brydun, A; Matsumoto, M; Ota, K; Funayama, R; Nakayama, K; Ono, M; Shiga, K; Kobayashi, T; Igarashi, K				Nakanome, A.; Brydun, A.; Matsumoto, M.; Ota, K.; Funayama, R.; Nakayama, K.; Ono, M.; Shiga, K.; Kobayashi, T.; Igarashi, K.			Bach1 is critical for the transformation of mouse embryonic fibroblasts by Ras(V12) and maintains ERK signaling	ONCOGENE			English	Article						Bach1; ROS; cancer; Ras; ERK	CELL-PROLIFERATION; OXIDATIVE STRESS; FEEDBACK PHOSPHORYLATION; GENETIC ABLATION; DNA-DAMAGE; TNF-ALPHA; SMALL MAF; RAS; PATHWAY; PROTEIN	Reactive oxygen species (ROS), by-products of aerobic respiration, promote genetic instability and contribute to the malignant transformation of cells. Among the genes related to ROS metabolism, Bach1 is a repressor of the oxidative stress response, and a negative regulator of ROS-induced cellular senescence directed by p53 in higher eukaryotes. While ROS are intimately involved in carcinogenesis, it is not clear whether Bach1 is involved in this process. We found that senescent Bach1-deficient mouse embryonic fibroblasts (MEFs) underwent spontaneous immortalization the same as did the wild-type cells. When transduced with constitutively active Ras (H-Ras(V12)), the proliferation and colony formation of these cells in vitro were markedly reduced. When transplanted into athymic nude mice, the growth and vascularization of tumors derived from Bach1-deficient cells were also decreased. Gene expression profiling of the MEFs revealed a new H-Ras(V12) signature, which was distinct from the previously reported signatures in epithelial tumors, and was partly dependent on Bach1. The Bach1-deficient cells showed diminished phosphorylation of MEK and ERK1/2 in response to H-Ras(V12), which was consistent with the alterations in the gene expression profile, including phosphatase genes. Finally, Bach1-deficient mice were less susceptible to 4-nitroquinoline-1-oxidide (4-NQO)-induced tongue carcinoma than wild-type mice. Our data provide evidence for a critical role of Bach1 in cell transformation and tumor growth induced by activated H-Ras(V12).	[Nakanome, A.; Brydun, A.; Matsumoto, M.; Ota, K.; Igarashi, K.] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan; [Nakanome, A.; Shiga, K.; Kobayashi, T.] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan; [Brydun, A.; Igarashi, K.] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 980, Japan; [Matsumoto, M.] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Funayama, R.; Nakayama, K.] Tohoku Univ, Grad Sch Med, Div Cell Proliferat, Sendai, Miyagi 980, Japan; [Funayama, R.; Igarashi, K.] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi, Japan; [Ono, M.] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 980, Japan.	igarashi@med.tohoku.ac.jp	Matsumoto, Mitsuyo/AAC-3065-2019	Igarashi, Kazuhiko/0000-0002-2470-2475	Network Medicine Global-COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Network Medicine Global-COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan	We are grateful to Nobuyuki Tanaka from Nippon Medical University and Fuyuki Ishikawa from Kyoto University for kindly providing plasmids. This work was supported by Grants-in-aid and the Network Medicine Global-COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Additional initial support was provided by the Uehara Foundation, the Takeda Foundation and the Astelas Foundation for Research on Metabolic Disorders. Restoration of laboratory damage from the 2011 Tohoku earthquake was provided in part by the Astelas Foundation for Research on Metabolic Disorders, the Banyu Foundation, the Naito Foundation, A Miyazaki and A Iida.	Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Chiarugi P, 2001, IUBMB LIFE, V52, P55, DOI 10.1080/15216540252774775; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Filleur S, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-28; Friedberg I, 2007, FEBS LETT, V581, P2527, DOI 10.1016/j.febslet.2007.04.059; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; GULBINS E, 1994, MOL CELL BIOL, V14, P906, DOI 10.1128/MCB.14.2.906; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim EY, 2010, ONCOGENE, V29, P1167, DOI 10.1038/onc.2009.412; Kuroishi T, 2008, J LEUKOCYTE BIOL, V83, P912, DOI 10.1189/jlb.0607428; Liu CJ, 2005, EXP CELL RES, V309, P410, DOI 10.1016/j.yexcr.2005.06.022; Liu RG, 2001, ONCOGENE, V20, P1486, DOI 10.1038/sj.onc.1204214; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Masuda K, 2010, BIOCHEM BIOPH RES CO, V393, P201, DOI 10.1016/j.bbrc.2010.01.097; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Moore KA, 1997, BIOCHEM J, V326, P17, DOI 10.1042/bj3260017; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; Omura S, 2005, GENES CELLS, V10, P277, DOI 10.1111/j.1365-2443.2005.00832.x; Oshima Y, 2003, INVEST OPHTH VIS SCI, V44, P1814, DOI 10.1167/iovs.02-0664; Ota K, 2011, ANTIOXID REDOX SIGN, V14, P2441, DOI 10.1089/ars.2010.3574; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzui M, 1995, MOL CARCINOGEN, V14, P294, DOI 10.1002/mc.2940140410; Swift S, 2001, CURR PROTOC IMMUNOL; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tumurbaatar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014711; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899	58	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 4	2013	32	27					3231	3245		10.1038/onc.2012.336	http://dx.doi.org/10.1038/onc.2012.336			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	22847612				2022-12-25	WOS:000321301600003
J	Alibhoy, AA; Giardina, BJ; Dunton, DD; Chiang, HL				Alibhoy, Abbas A.; Giardina, Bennett J.; Dunton, Danielle D.; Chiang, Hui-Ling			Vps34p Is Required for the Decline of Extracellular Fructose-1,6-bisphosphatase in the Vacuole Import and Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; VPS15 PROTEIN-KINASE; CATABOLITE INACTIVATION; PLASMA-MEMBRANE; VID VESICLES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PTDINS 3-KINASE; ACTIN PATCHES; LIPID KINASE; AUTOPHAGY	When Saccharomyces cerevisiae are starved of glucose for a prolonged period of time, gluconeogenic enzymes such as fructose-1,6-bisphosphatase (FBPase), malate dehydrogenase, isocitrate lyase, and phosphoenolpyruvate carboxykinase are induced. However, when glucose is added to prolonged-starved cells, these enzymes are degraded in the vacuole via the vacuole import and degradation (Vid) pathway. The Vid pathway merges with the endocytic pathway to remove intracellular and extracellular proteins simultaneously. Ultrastructural and cell extraction studies indicate that substantial amounts of FBPase were in the extracellular fraction (periplasm) during glucose starvation. FBPase levels in the extracellular fraction decreased after glucose re-feeding in wild-type cells. The decline of FBPase in the extracellular fraction was dependent on the SLA1 and ARC18 genes involved in actin polymerization and endocytosis. Moreover, the reduction of extracellular FBPase was also dependent on the VPS34 gene. VPS34 encodes the PI3 kinase and is also required for the Vid pathway. Vps34p co-localized with actin patches in prolonged-starved cells. In the absence of this gene, FBPase and the Vid vesicle protein Vid24p associated with actin patches before and after the addition of glucose. Furthermore, high levels of FBPase remained in the extracellular fraction in the Delta vps34 mutant during glucose re-feeding. When the Asn-736 residue of Vps34p was mutated and when the C-terminal 11 amino acids were deleted, mutant proteins failed to co-localize with actin patches, and FBPase in the extracellular fraction did not decrease as rapidly. We suggest that VPS34 plays a critical role in the decline of extracellular FBPase in response to glucose.	[Alibhoy, Abbas A.; Giardina, Bennett J.; Dunton, Danielle D.; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	hxc32@psu.edu			National Institutes of Health [R01 GM59480]; Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM59480. This work was also supported by a Tobacco Settlement Fund (to H.-L.C.).	Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; APLIN A, 1992, J CELL PHYSIOL, V152, P458, DOI 10.1002/jcp.1041520304; BANTA LM, 1990, MOL CELL BIOL, V10, P4638, DOI 10.1128/MCB.10.9.4638; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2010, J BIOL CHEM, V285, P23357, DOI 10.1074/jbc.M109.075143; Brown C Randell, 2009, Commun Integr Biol, V2, P177; Brown CR, 2010, J BIOL CHEM, V285, P1516, DOI 10.1074/jbc.M109.028241; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2003, J BIOL CHEM, V278, P25688, DOI 10.1074/jbc.M210549200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bryant NJ, 1998, J CELL BIOL, V142, P651, DOI 10.1083/jcb.142.3.651; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Budovskaya YV, 2002, J BIOL CHEM, V277, P287, DOI 10.1074/jbc.M109263200; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Cui DY, 2004, J BIOL CHEM, V279, P9713, DOI 10.1074/jbc.M310793200; Delgado ML, 2001, MICROBIOL-SGM, V147, P411, DOI 10.1099/00221287-147-2-411; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hoffman M, 1996, GENETICS, V143, P1555; Horak J, 2002, J BIOL CHEM, V277, P8248, DOI 10.1074/jbc.M107255200; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; RIBALLO E, 1995, J BACTERIOL, V177, P5622, DOI 10.1128/jb.177.19.5622-5627.1995; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	59	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33080	33093		10.1074/jbc.M112.360412	http://dx.doi.org/10.1074/jbc.M112.360412			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22833678	Green Published, hybrid			2022-12-25	WOS:000309168300070
J	Shakeri, B; Bourdin, B; Demers-Giroux, PO; Sauve, R; Parent, L				Shakeri, Behzad; Bourdin, Benoite; Demers-Giroux, Pierre-Olivier; Sauve, Remy; Parent, Lucie			A Quartet of Leucine Residues in the Guanylate Kinase Domain of Ca-V beta Determines the Plasma Membrane Density of the Ca(V)2.3 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; I-II-LINKER; SUBUNIT INTERACTION; INACTIVATION; MODULATION; TERMINUS; IDENTIFICATION; TRYPTOPHAN; EXPRESSION; CONTAINS	Ca-V beta subunits are formed by a Src homology 3 domain and a guanylate kinase-like (GK) domain connected through a variable HOOK domain. Complete deletion of the Src homology 3 domain (75 residues) as well as deletion of the HOOK domain (47 residues) did not alter plasma membrane density of Ca(V)2.3 nor its typical activation gating. In contrast, six-residue deletions in the GK domain disrupted cell surface trafficking and functional expression of Ca(V)2.3. Mutations of residues known to carry nanomolar affinity binding in the GK domain of Ca-V beta (P175A, P179A, M195A, M196A, K198A, S295A, R302G, R307A, E339G, N340G, and A345G) did not significantly alter cell surface targeting or gating modulation of Ca(V)2.3. Nonetheless, mutations of a quartet of leucine residues (either single or multiple mutants) in the alpha 3, alpha 6, beta 10, and alpha 9 regions of the GK domain were found to significantly impair cell surface density of Ca(V)2.3 channels. Furthermore, the normalized protein density of Ca(V)2.3 was nearly abolished with the quadruple Ca-V beta 3 Leu mutant L200G/L303G/L337G/L342G. Altogether, our observations suggest that the four leucine residues in Ca-V beta 3 form a hydrophobic pocket surrounding key residues in the alpha-interacting domain of Ca(V)2.3. This interaction appears to play an essential role in conferring Ca-V beta-induced modulation of the protein density of Ca-V alpha 1 subunits in Ca(V)2 channels.	[Parent, Lucie] Univ Montreal, Dept Physiol, Downtown Stn, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca			Canadian Institutes of Health Research [MOP13390]; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was completed with Grant MOP13390 from the Canadian Institutes of Health Research and a grant from the Canadian Heart and Stroke Foundation (to L. P.).	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Butcher AJ, 2006, J PHYSIOL-LONDON, V574, P387, DOI 10.1113/jphysiol.2006.109744; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chen YH, 2009, FEBS LETT, V583, P1969, DOI 10.1016/j.febslet.2009.05.001; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Dresviannikov A, 2009, PFLUG ARCH EUR J PHY, V457, P743, DOI 10.1007/s00424-008-0549-7; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gao TY, 1999, J BIOL CHEM, V274, P2137, DOI 10.1074/jbc.274.4.2137; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Kamp MA, 2012, BBA-PROTEINS PROTEOM, V1824, P1045, DOI 10.1016/j.bbapap.2012.05.008; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; Miranda-Laferte E, 2011, J BIOL CHEM, V286, P22203, DOI 10.1074/jbc.M110.201871; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Pereverzev A, 2002, MOL CELL NEUROSCI, V21, P352, DOI 10.1006/mcne.2002.1179; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Restituito S, 2000, J NEUROSCI, V20, P9046; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	57	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32835	32847		10.1074/jbc.M112.387233	http://dx.doi.org/10.1074/jbc.M112.387233			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846999	Green Published, hybrid			2022-12-25	WOS:000309168300049
J	Ha, CM; Park, D; Han, JK; Jang, JI; Park, JY; Hwang, EM; Seok, H; Chang, S				Ha, Chang Man; Park, Daehun; Han, Jeong-Kyu; Jang, June-Ill; Park, Jae-Yong; Hwang, Eun Mi; Seok, Heon; Chang, Sunghoe			Calcyon Forms a Novel Ternary Complex with Dopamine D-1 Receptor through PSD-95 Protein and Plays a Role in Dopamine Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; UP-REGULATION; INTERACTING PROTEIN; D1 RECEPTORS; DOMAIN; INHIBITION; SCHIZOPHRENIA; BINDING	Calcyon, once known for interacting directly with the dopamine D-1 receptor (D1DR), is implicated in various neuropsychiatric disorders including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder. Although its direct interaction with D1DR has been shown to be misinterpreted, it still plays important roles in D1DR signaling. Here, we found that calcyon interacts with the PSD-95 and subsequently forms a ternary complex with D1DR through PSD-95. Calcyon is phosphorylated on Ser-169 by the PKC activator phorbol 12-myristate 13-acetate or by the D1DR agonist SKF-81297, and its phosphorylation increases its association with PSD-95 and recruitment to the cell surface. Interestingly, the internalization of D1DR at the cell surface was enhanced by phorbol 12-myristate 13-acetate and SKF-81297 in the presence of calcyon, but not in the presence of its S169A phospho-deficient mutant, suggesting that the phosphorylation of calcyon and the internalization of the surface D1DR are tightly correlated. Our results suggest that calcyon regulates D1DR trafficking by forming a ternary complex with D1DR through PSD-95 and thus possibly linking glutamatergic and dopamine receptor signalings. This also raises the possibility that a novel ternary complex could represent a potential therapeutic target for the modulation of related neuropsychiatric disorders.	[Ha, Chang Man; Park, Daehun; Han, Jeong-Kyu; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Ha, Chang Man; Park, Daehun; Han, Jeong-Kyu; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea; [Ha, Chang Man; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Med Res Ctr, Neurosci Res Inst, Seoul 110799, South Korea; [Ha, Chang Man; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomembrane Plast Res Ctr, Seoul 110799, South Korea; [Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomax Inst, Seoul 110799, South Korea; [Jang, June-Ill] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Inst Hlth Sci, Dept Physiol, Sch Med,Biomed Ctr BK21, Jinju 660751, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Sch Med, Med Res Ctr Neural Dysfunct, Jinju 660751, South Korea; [Park, Jae-Yong; Hwang, Eun Mi] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul 136791, South Korea; [Seok, Heon] Jungwon Univ, Dept Biomed Engn, Goesan Gun 367805, Chungcheongbuk, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ulsan National Institute of Science & Technology (UNIST); Gyeongsang National University; Gyeongsang National University; Korea Institute of Science & Technology (KIST); Jungwon University	Ha, CM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 314 Biomed Sci Bldg,28 Yeongeon Dong, Seoul 110799, South Korea.	gkckdaks@snu.ac.kr; sunghoe@snu.ac.kr	Chang, Sunghoe/J-2784-2012; Hwang, Eun Mi/HHN-3030-2022	Park, Daehun/0000-0002-2829-1319; chang, sunghoe/0000-0002-3446-7288; Park, Jae-Yong/0000-0001-7698-7890	National Research Foundation (NRF) of Korea [20100022375, SRC 20100029395]; Ministry of Education, Science and Technology (MEST), Republic of Korea	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program Grant 20100022375 from the National Research Foundation (NRF) of Korea (to C. M. H.) funded by the Ministry of Education, Science and Technology (MEST), Republic of Korea. Research was also supported by grants from the NRF of Korea (SRC 20100029395) (to S. C.) funded by the MEST, Republic of Korea.	Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Clinton SM, 2005, AM J PSYCHIAT, V162, P1859, DOI 10.1176/appi.ajp.162.10.1859; Davidson HT, 2009, EUR J NEUROSCI, V29, P42, DOI 10.1111/j.1460-9568.2008.06563.x; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Heijtz RD, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-33; Heijtz RD, 2007, PHYSIOL BEHAV, V92, P155, DOI 10.1016/j.physbeh.2007.05.024; Hu SQ, 2009, J NEUROSCI RES, V87, P3626, DOI 10.1002/jnr.22163; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koh PO, 2003, ARCH GEN PSYCHIAT, V60, P311, DOI 10.1001/archpsyc.60.3.311; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; Lezcano N, 2002, J NEUROPHYSIOL, V87, P2167, DOI 10.1152/jn.00541.2001; Lezcano N, 2006, SCIENCE, V314, P1681; Lidow MS, 2001, EUR J PHARMACOL, V427, P187, DOI 10.1016/S0014-2999(01)01265-1; Luo XG, 2004, AM J MED GENET B, V125B, P25, DOI 10.1002/ajmg.b.20092; Morell M, 2008, NAT PROTOC, V3, P22, DOI 10.1038/nprot.2007.496; Pegan S, 2007, BIOCHEMISTRY-US, V46, P5315, DOI 10.1021/bi062228q; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Sornarajah L, 2008, J NEUROPHYSIOL, V99, P3052, DOI 10.1152/jn.90301.2008; Sun PH, 2009, CELL RES, V19, P612, DOI 10.1038/cr.2009.30; Thompson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011038; Trantham-Davidson H, 2008, BEHAV BRAIN RES, V189, P244, DOI 10.1016/j.bbr.2007.12.031; Vazdarjanova A, 2011, MOL PSYCHIATR, V16, P672, DOI 10.1038/mp.2011.14; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200; Zhang JP, 2009, J NEUROSCI, V29, P2948, DOI 10.1523/JNEUROSCI.4424-08.2009	33	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31813	31822		10.1074/jbc.M112.370601	http://dx.doi.org/10.1074/jbc.M112.370601			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843680	Green Published, hybrid			2022-12-25	WOS:000309059400022
J	Mukherjee, S; Cruz-Rodriguez, O; Bolton, E; Iniguez-Lluhi, JA				Mukherjee, Sarmistha; Cruz-Rodriguez, Osvaldo; Bolton, Eric; Iniguez-Lluhi, Jorge A.			The in Vivo Role of Androgen Receptor SUMOylation as Revealed by Androgen Insensitivity Syndrome and Prostate Cancer Mutations Targeting the Proline/Glycine Residues of Synergy Control Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO E3 LIGASE; GENE-MUTATIONS; PRENATAL TESTOSTERONE; BINDING; IDENTIFICATION; PIASY; DESUMOYLATION; TRANSCRIPTION; MECHANISMS; SENESCENCE	The androgen receptor (AR) mediates the effects of male sexual hormones on development and physiology. Alterations in AR function are central to reproductive disorders, prostate cancer, and Kennedy disease. AR activity is influenced by post-translational modifications, but their role in AR-based diseases is poorly understood. Conjugation by small ubiquitin-like modifier (SUMO) proteins at two synergy control (SC) motifs in AR exerts a promoter context-dependent inhibitory role. SC motifs are composed of a four-amino acid core that is often preceded and/or followed by nearby proline or glycine residues. The function of these flanking residues, however, has not been examined directly. Remarkably, several AR mutations associated with oligospermia and androgen insensitivity syndrome map to Pro-390, the conserved proline downstream of the first SC motif in AR. Similarly, mutations at Gly-524, downstream of the second SC motif, were recovered in recurrent prostate cancer samples. We now provide evidence that these clinically isolated substitutions lead to a partial loss of SC motif function and AR SUMOylation that affects multiple endogenous genes. Consistent with a structural role as terminators of secondary structure elements, substitution of Pro-390 by Gly fully supports both SC motif function and SUMOylation. As predicted from the functional properties of SC motifs, the clinically isolated mutations preferentially enhance transcription driven by genomic regions harboring multiple AR binding sites. The data support the view that alterations in AR SUMOylation play significant roles in AR-based diseases and offer novel SUMO-based therapeutic opportunities.	[Mukherjee, Sarmistha; Cruz-Rodriguez, Osvaldo; Iniguez-Lluhi, Jorge A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Bolton, Eric] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign	Iniguez-Lluhi, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	Sarmistha.Mukherjee@jefferson.edu; iniguez@umich.edu		Iniguez-Lluhi, Jorge/0000-0001-7010-089X	National Institutes of Health from USPHS [DK61656-01, P60 DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061656, R56DK061656, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK61656-01 from USPHS (to J. A. I.) and Grant P60 DK20572.	Audi L, 2010, J CLIN ENDOCR METAB, V95, P1876, DOI 10.1210/jc.2009-2146; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bhangoo A, 2010, ASIAN J ANDROL, V12, P561, DOI 10.1038/aja.2010.6; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Bormann CL, 2011, REPRODUCTION, V142, P167, DOI 10.1530/REP-10-0210; Bouvattier C, 2002, J CLIN ENDOCR METAB, V87, P29, DOI 10.1210/jc.87.1.29; Chen GC, 2005, PROSTATE, V63, P395, DOI 10.1002/pros.20191; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; Drolet B, 2005, J CLIN INVEST, V115, P2209, DOI 10.1172/JCI23741; Ferlin A, 2006, CLIN ENDOCRINOL, V65, P606, DOI 10.1111/j.1365-2265.2006.02635.x; Garolla A, 2005, ENDOCR-RELAT CANCER, V12, P645, DOI 10.1677/erc.1.00954; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Gottlieb B, 1999, HUM MUTAT, V14, P527, DOI 10.1002/(SICI)1098-1004(199912)14:6<527::AID-HUMU12>3.0.CO;2-X; Hiort O, 2000, J CLIN ENDOCR METAB, V85, P2810, DOI 10.1210/jc.85.8.2810; Hiort O, 1996, AM J MED GENET, V63, P218, DOI 10.1002/(SICI)1096-8628(19960503)63:1<218::AID-AJMG38>3.0.CO;2-P; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Hyytinen ER, 2002, LAB INVEST, V82, P1591, DOI 10.1097/01.LAB.0000038924.67707.75; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; MULLER J, 1987, INT J ANDROL, V10, P543, DOI 10.1111/j.1365-2605.1987.tb00354.x; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Pinsky L., 1994, P 76 ANN M END SOC A; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; RAJPERTDEMEYTS E, 1993, EUR UROL, V23, P54; Recabarren SE, 2008, ENDOCRINOLOGY, V149, P6444, DOI 10.1210/en.2008-0785; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; SAVAGE MO, 1990, CLIN ENDOCRINOL, V32, P519, DOI 10.1111/j.1365-2265.1990.tb00893.x; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; Tilley WD, 1996, CLIN CANCER RES, V2, P277; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Yang HJ, 2009, EXPERT OPIN INV DRUG, V18, P957, DOI 10.1517/13543780903002074; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	57	23	23	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31195	31206		10.1074/jbc.M112.395210	http://dx.doi.org/10.1074/jbc.M112.395210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829593	hybrid, Green Published			2022-12-25	WOS:000308791300032
J	Ghosh, A; Chattopadhyay, S; Chawla-Sarkar, M; Nandy, P; Nandy, A				Ghosh, Ambarnil; Chattopadhyay, Shiladitya; Chawla-Sarkar, Mamta; Nandy, Papiya; Nandy, Ashesh			In Silico Study of Rotavirus VP7 Surface Accessible Conserved Regions for Antiviral Drug/Vaccine Design	PLOS ONE			English	Article							T-CELL EPITOPE; GRAPHICAL REPRESENTATION; PROTECTIVE IMMUNITY; PROTEIN SEQUENCES; VIRAL-PROTEINS; QSAR MODEL; PREDICTION; BIOMARKERS; INFLUENZA; PEPTIDE	Background: Rotaviral diarrhoea kills about half a million children annually in developing countries and accounts for one third of diarrhea related hospitalizations. Drugs and vaccines against the rotavirus are handicapped, as in all viral diseases, by the rapid mutational changes that take place in the DNA and protein sequences rendering most of these ineffective. As of now only two vaccines are licensed and approved by the WHO (World Health Organization), but display reduced efficiencies in the underdeveloped countries where the disease is more prevalent. We approached this issue by trying to identify regions of surface exposed conserved segments on the surface glycoproteins of the virion, which may then be targeted by specific peptide vaccines. We had developed a bioinformatics protocol for these kinds of problems with reference to the influenza neuraminidase protein, which we have refined and expanded to analyze the rotavirus issue. Results: Our analysis of 433 VP7 (Viral Protein 7 from rotavirus) surface protein sequences across 17 subtypes encompassing mammalian hosts using a 20D Graphical Representation and Numerical Characterization method, identified four possible highly conserved peptide segments. Solvent accessibility prediction servers were used to identify that these are predominantly surface situated. These regions analyzed through selected epitope prediction servers for their epitopic properties towards possible T-cell and B-cell activation showed good results as epitopic candidates (only dry lab confirmation). Conclusions: The main reasons for the development of alternative vaccine strategies for the rotavirus are the failure of current vaccines and high production costs that inhibit their application in developing countries. We expect that it would be possible to use the protein surface exposed regions identified in our study as targets for peptide vaccines and drug designs for stable immunity against divergent strains of the rotavirus. Though this study is fully dependent on computational prediction algorithms, it provides a platform for wet lab experiments.	[Nandy, Ashesh] Ctr Interdisciplinary Res & Educ, Kolkata, W Bengal, India; [Ghosh, Ambarnil; Nandy, Papiya] Jadavpur Univ, Dept Phys, Kolkata, W Bengal, India; [Chattopadhyay, Shiladitya; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India	Jadavpur University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Nandy, A (corresponding author), Ctr Interdisciplinary Res & Educ, Kolkata, W Bengal, India.	anandy43@yahoo.com		Ghosh, Ambarnil/0000-0002-1400-0963				Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Aguiar-Pulido V, 2012, MOL BIOSYST, V8, P1716, DOI 10.1039/c2mb25039j; Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020; Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P3173, DOI 10.1073/pnas.1113342109; Blutt SE, 2004, J VIROL, V78, P6974, DOI 10.1128/JVI.78.13.6974-6981.2004; Buesa J, 1999, VIROLOGY, V257, P424, DOI 10.1006/viro.1999.9646; Cantor JR, 2011, P NATL ACAD SCI USA, V108, P1272, DOI 10.1073/pnas.1014739108; Chakladar A, 1998, INTERVIROLOGY, V41, P127, DOI 10.1159/000024924; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; Choi AH, 2002, VACCINE, V20, P3310, DOI 10.1016/S0264-410X(02)00315-8; Cruz-Monteagudo M, 2008, BIOORGAN MED CHEM, V16, P9684, DOI 10.1016/j.bmc.2008.10.004; Dea-Ayuela MA, 2008, BIOORGAN MED CHEM, V16, P7770, DOI 10.1016/j.bmc.2008.07.023; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; FDA, 2010, UPD ROT VACC; FRANCO MA, 1993, J GEN VIROL, V74, P2579, DOI 10.1099/0022-1317-74-12-2579; Ghosh A, 2011, 7 AS BIOPH ASS ABA S, P88; Ghosh A, 2011, ADV PROTEIN CHEM STR, V83, P1, DOI 10.1016/B978-0-12-381262-9.00001-X; Ghosh A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-6; Ghosh A, 2009, J CHEM INF MODEL, V49, P2627, DOI 10.1021/ci9001662; Gonzalez-Diaz H, 2005, BIOPOLYMERS, V77, P296, DOI 10.1002/bip.20234; Gonzalez-Diaz H, 2009, J THEOR BIOL, V261, P136, DOI 10.1016/j.jtbi.2009.07.029; Gonzalez-Diaz H, 2011, MOL BIOSYST, V7, P1938, DOI 10.1039/c1mb05069a; Graff JW, 2007, J GEN VIROL, V88, P613, DOI 10.1099/vir.0.82255-0; Gu Y, 2008, EXP PARASITOL, V118, P66, DOI 10.1016/j.exppara.2007.06.014; Gultyaev AP, 2010, INT REV IMMUNOL, V29, P533, DOI 10.3109/08830185.2010.507828; HART CA, 2003, ANTIGENIC VARIATION, P84; JIANG V, 2010, HUM VACCIN, V6; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JUTILA MA, 1992, J EXP MED, V175, P1565, DOI 10.1084/jem.175.6.1565; Li ZL, 2009, J VIROL, V83, P1754, DOI 10.1128/JVI.01855-08; Ludert JE, 2002, J VIROL, V76, P6643, DOI 10.1128/JVI.76.13.6643-6651.2002; Lynch M, 2001, CLIN INFECT DIS, V33, P932, DOI 10.1086/322650; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mukherjee A, 2010, INFECT GENET EVOL, V10, P311, DOI 10.1016/j.meegid.2010.01.002; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Nandy Ashesh, 2009, In Silico Biology, V9, P77, DOI 10.3233/ISB-2009-0389; Novic M, 2008, SAR QSAR ENVIRON RES, V19, P317, DOI 10.1080/10629360802085066; Perez-Bello A, 2009, J THEOR BIOL, V256, P458, DOI 10.1016/j.jtbi.2008.09.035; Rahman M, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-24; Randic M, 2003, J CHEM INF COMP SCI, V43, P532, DOI 10.1021/ci020051a; Randic M, 2009, SAR QSAR ENVIRON RES, V20, P415, DOI 10.1080/10629360903278685; Randic M, 2007, J MOL GRAPH MODEL, V26, P290, DOI 10.1016/j.jmgm.2006.12.006; Randic M, 2011, CHEM REV, V111, P790, DOI 10.1021/cr800198j; RUGGERI FM, 1991, J VIROL, V65, P2211, DOI 10.1128/JVI.65.5.2211-2219.1991; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009432; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Velazquez RF, 1996, NEW ENGL J MED, V335, P1022; Vilar S, 2008, J COMPUT CHEM, V29, P2613, DOI 10.1002/jcc.21016; Vilar S, 2009, J THEOR BIOL, V261, P449, DOI 10.1016/j.jtbi.2009.07.031; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Ward Richard L, 2008, Ther Clin Risk Manag, V4, P49; Widdowson MA, 2005, CURR OPIN GASTROEN, V21, P26; Zupan J, 2005, J CHEM INF MODEL, V45, P309, DOI 10.1021/ci040104j; 2008, MMWR MORB MORTAL WKL, V57, P1255	61	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40749	10.1371/journal.pone.0040749	http://dx.doi.org/10.1371/journal.pone.0040749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844409	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600008
J	Tetard-Jones, C; Kertesz, MA; Preziosi, RF				Tetard-Jones, Catherine; Kertesz, Michael A.; Preziosi, Richard F.			Identification of Plant Quantitative Trait Loci Modulating a Rhizobacteria-Aphid Indirect Effect	PLOS ONE			English	Article							ECO-EVOLUTIONARY DYNAMICS; HOST-PLANT; ECOLOGICAL COMMUNITIES; SYSTEMIC RESISTANCE; EMERGING SYNTHESIS; MYCORRHIZAL FUNGI; BROWN PLANTHOPPER; GENETIC-VARIATION; CEREAL APHIDS; PERFORMANCE	Plants simultaneously interact with a plethora of species both belowground and aboveground, which can result in indirect effects mediated by plants. Studies incorporating plant genetic variation indicate that indirect effects mediated by plants may be a significant factor influencing the ecology and evolution of species within a community. Here, we present findings of a Quantitative Trait Locus (QTL) mapping study, where we mapped a rhizobacteria-aphid indirect effect onto the barley genome. We measured the size of aphid populations on barley when the barley rhizosphere either was or was not supplemented with a rhizobacterial species. Using a QTL mapping subset, we located five regions of the barley genome associated with the rhizobacteria-aphid indirect effect. Rhizobacterial supplementation led to an increase in aphid population size (mapped to three barley QTL), or a decrease in aphid population size (mapped to two barley QTL). One QTL associated with plant resistance to aphids was affected by a significant QTL-by-environment interaction, because it was not expressed when rhizobacteria was supplemented. Our results indicated that rhizobacterial supplementation of barley roots led to either increased or reduced aphid population size depending on plant genotype at five barley QTL. This indicates that the direction of a rhizobacteria-aphid indirect effect could influence the selection pressure on plants, when considering species that affect plant fitness. Further research may build on the findings presented here, to identify genes within QTL regions that are involved in the indirect interaction.	[Tetard-Jones, Catherine; Kertesz, Michael A.; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Tetard-Jones, C (corresponding author), Newcastle Univ, Mol Agr Grp, Nafferton Ecol Farming Grp, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Catherine.tetard-jones@ncl.ac.uk	Tétard-Jones, Catherine/H-5509-2019; KERTESZ, Michael/Q-7642-2019; Preziosi, Richard F/A-8626-2010; Tétard-Jones, Catherine/G-2961-2011; Kertesz, Michael/A-6720-2011	Tétard-Jones, Catherine/0000-0001-7121-2236; KERTESZ, Michael/0000-0003-2112-4451; Preziosi, Richard F/0000-0003-0468-6655; Tétard-Jones, Catherine/0000-0001-7121-2236; Kertesz, Michael/0000-0003-2112-4451	NERC Environmental Genomics grant; NERC doctoral studentship; Natural Environment Research Council [NER/T/S/2002/00188] Funding Source: researchfish	NERC Environmental Genomics grant; NERC doctoral studentship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by a NERC Environmental Genomics grant and a NERC doctoral studentship to CT-J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SN, 1998, THEOR APPL GENET, V97, P1370, DOI 10.1007/s001220051031; Astles PA, 2005, P ROY SOC B-BIOL SCI, V272, P2577, DOI 10.1098/rspb.2005.3174; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bailey JK, 2009, NEW PHYTOL, V184, P746, DOI 10.1111/j.1469-8137.2009.03081.x; BASTEN CJ, 2002, QTL CARTOGRAPHER; Bennett AE, 2006, AM NAT, V167, P141, DOI 10.1086/499379; BONIERBALE MW, 1994, THEOR APPL GENET, V87, P973, DOI 10.1007/BF00225792; Bonkowski M, 2001, OIKOS, V95, P441, DOI 10.1034/j.1600-0706.2001.950309.x; Bonte D, 2010, PLOS ONE, V5, P9; Broadway RM, 1997, J INSECT PHYSIOL, V43, P855, DOI 10.1016/S0022-1910(97)00028-0; Castro AM, 2004, PLANT BREEDING, V123, P361, DOI 10.1111/j.1439-0523.2004.00995.x; Chen L, 2006, GENETICS, V173, P2371, DOI 10.1534/genetics.105.052506; Cronin JT, 2001, OECOLOGIA, V127, P87, DOI 10.1007/s004420000561; Dodd IC, 2010, ANN APPL BIOL, V157, P361, DOI 10.1111/j.1744-7348.2010.00439.x; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Fuentes-Contreras E, 2002, ECOSCIENCE, V9, P37, DOI 10.1080/11956860.2002.11682688; GAGNE S, 1993, SOIL BIOL BIOCHEM, V25, P269, DOI 10.1016/0038-0717(93)90038-D; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Goellner K, 2008, EUR J PLANT PATHOL, V121, P233, DOI 10.1007/s10658-007-9251-4; Hale BK, 2003, ECOL ENTOMOL, V28, P666, DOI 10.1111/j.1365-2311.2003.00563.x; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Jensen CJ, 1976, BARL GEN 3 P 3 INT B, P316; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Lawson HA, 2010, J LIPID RES, V51, P2976, DOI 10.1194/jlr.M006957; Li AiLi, 2006, Agricultural Sciences in China, V5, P241, DOI 10.1016/S1671-2927(06)60045-X; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Miller TE, 1996, ECOLOGY, V77, P1329, DOI 10.2307/2265530; Moharramipour S, 1997, THEOR APPL GENET, V94, P592, DOI 10.1007/s001220050455; Pate J, 1998, OECOLOGIA, V117, P301, DOI 10.1007/s004420050663; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Poveda K, 2005, OIKOS, V108, P503, DOI 10.1111/j.0030-1299.2005.13664.x; Smith KP, 1999, P NATL ACAD SCI USA, V96, P4786, DOI 10.1073/pnas.96.9.4786; Snoeren TAL, 2007, J ECOL, V95, P17, DOI 10.1111/j.1365-2745.2006.01183.x; Soler R, 2007, OIKOS, V116, P367, DOI 10.1111/j.0030-1299.2007.15501.x; Soundararajan RP, 2004, CROP SCI, V44, P2214, DOI 10.2135/cropsci2004.2214; Steffenson BJ, 1996, THEOR APPL GENET, V92, P552, DOI 10.1007/BF00224557; Stout MJ, 2002, ARCH INSECT BIOCHEM, V51, P222, DOI 10.1002/arch.10066; Strauss SY, 2005, NEW PHYTOL, V165, P81, DOI 10.1111/j.1469-8137.2004.01228.x; Tetard-Jones C, 2011, PHILOS T R SOC B, V366, P1368, DOI 10.1098/rstb.2010.0356; Tetard-Jones C, 2007, AM NAT, V170, P492, DOI 10.1086/520115; Underwood N, 2000, ECOLOGY, V81, P1565, DOI 10.1890/0012-9658(2000)081[1565:TEOHPG]2.0.CO;2; Utsumi S, 2011, POPUL ECOL, V53, P23, DOI 10.1007/s10144-010-0253-2; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; van Loon JJA, 2000, ENTOMOL EXP APPL, V97, P219, DOI 10.1046/j.1570-7458.2000.00733.x; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wooley SC, 2007, ECOL ENTOMOL, V32, P428, DOI 10.1111/j.1365-2311.2007.00883.x; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Wurst S, 2004, NEW PHYTOL, V163, P169, DOI 10.1111/j.1469-8137.2004.01106.x; Zhong SB, 2003, PHYTOPATHOLOGY, V93, P604, DOI 10.1094/PHYTO.2003.93.5.604; Zytynska SE, 2010, ECOLOGY, V91, P1563, DOI 10.1890/09-2070.1	59	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41524	10.1371/journal.pone.0041524	http://dx.doi.org/10.1371/journal.pone.0041524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844487	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600033
J	Cobiac, LJ; Magnus, A; Lim, S; Barendregt, JJ; Carter, R; Vos, T				Cobiac, Linda J.; Magnus, Anne; Lim, Stephen; Barendregt, Jan J.; Carter, Rob; Vos, Theo			Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease?	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; MELBOURNE STROKE INCIDENCE; BLOOD-PRESSURE; RISK-FACTORS; HEALTH; AUSTRALIA; METAANALYSIS; STATINS; CHOLESTEROL; REDUCTION	Background: Despite many decades of declining mortality rates in the Western world, cardiovascular disease remains the leading cause of death worldwide. In this research we evaluate the optimal mix of lifestyle, pharmaceutical and population-wide interventions for primary prevention of cardiovascular disease. Methods and Findings: In a discrete time Markov model we simulate the ischaemic heart disease and stroke outcomes and cost impacts of intervention over the lifetime of all Australian men and women, aged 35 to 84 years, who have never experienced a heart disease or stroke event. Best value for money is achieved by mandating moderate limits on salt in the manufacture of bread, margarine and cereal. A combination of diuretic, calcium channel blocker, ACE inhibitor and low-cost statin, for everyone with at least 5% five-year risk of cardiovascular disease, is also cost-effective, but lifestyle interventions aiming to change risky dietary and exercise behaviours are extremely poor value for money and have little population health benefit. Conclusions: There is huge potential for improving efficiency in cardiovascular disease prevention in Australia. A tougher approach from Government to mandating limits on salt in processed foods and reducing excessive statin prices, and a shift away from lifestyle counselling to more efficient absolute risk-based prescription of preventive drugs, could cut health care costs while improving population health.	[Cobiac, Linda J.; Barendregt, Jan J.; Vos, Theo] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Magnus, Anne; Carter, Rob] Deakin Univ, Deakin Hlth Econ Strateg Res Ctr Populat Hlth, Burwood, Vic, Australia; [Lim, Stephen] Inst Hlth Metr & Evaluat, Seattle, WA USA	University of Queensland; Deakin University; Institute for Health Metrics & Evaluation	Cobiac, LJ (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	l.cobiac@uq.edu.au	Barendregt, Jan J/F-6895-2010	Carter, Rob/0000-0002-1586-5619	National Health and Medical Research Council [351558]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a grant from the National Health and Medical Research Council (Project ID no. 351558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2009, CONS PRIC IND AUSTR; ABS, 1995, NAT NUTR SURV FOODS; AIHW, 2006, HLTH EXP AUSTR; AIHW, 2009, HLTH EXP AUSTR 2007; AIHW, AIHW NAT HOSP MORB D; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baltussen RM., 2003, MAKING CHOICES HLTH; Barnett H, 2010, BMJ-BRIT MED J, V340, pc1805; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Begg S, 2008, AUST HEALTH REV, V32, P148, DOI 10.1071/AH080148; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Beilby J, 2005, GEN PRACTICE AUSTR 2, P128; Britt H, 2009, GEN PRACTICE ACTIVIT; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Brunner EJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub3; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Chen JT, 2005, PHARMACOTHERAPY, V25, P171, DOI 10.1592/phco.25.2.171.56942; Clarke PM, 2010, MED J AUSTRALIA, V192, P633, DOI 10.5694/j.1326-5377.2010.tb03661.x; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Caterina R, 2010, J AM COLL CARDIOL, V55, P198, DOI 10.1016/j.jacc.2009.07.062; Department of Health, 2008, EC MOD VASC CHECKS; Department of Health, 2008, PUTT PREV 1 VASC CHE; Department of Health and Ageing, 2005, GEN PRACT AUSTR 2004; Department of Veterens' Affairs, 2008, EX PHYS SCHED FEES; Department of Veterens' Affairs, 2008, DIET SCHED FEES; Dewey HM, 2001, STROKE, V32, P2409, DOI 10.1161/hs1001.097222; Dunstan D, 2001, DIABESITY ASS DISORD; Ebrahim S, 2006, COCHRANE DATABASE SY; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Food Standards Australia New Zealand, 2010, AUSTR NZ FOOD STAND; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Gold MR, 1996, COST EFFECTIVENESS H; Ha DA, 2010, HLTH POLICY PLANNING; Heeley EL, 2010, MED J AUSTRALIA, V192, P254, DOI 10.5694/j.1326-5377.2010.tb03502.x; Kidd J, 2006, NAT REV DRUG DISCOV, V5, P813, DOI 10.1038/nrd2156; KPMG Health Education and Community Services Group, 2002, COST WEIGHT SUTD; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; Lim S, 2005, THESIS MONASH U MELB; MBS, 2008, MED BEN SCHED; McElduff P, 2000, WHO MONICA STUDY AUS; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; Moon JC, 2006, BMJ-BRIT MED J, V332, P1344, DOI 10.1136/bmj.332.7554.1344; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; National Vascular Disease Prevention Alliance, 2009, GUID ASS ABS CARD DI; NHS Prescription Services, 2010, NHS EL DRUG TAR DEC; OECD, 2009, PURCH POW PAR PPPS O; PBS, 2008, PHARM BEN SCHED; Pennant M, 2010, AM J EPIDEMIOL, V172, P501, DOI 10.1093/aje/kwq171; PHARMAC, 2010, PHARM SCHED; Ronckers ET, 2006, BMC PUBLIC HEALTH, V6; Rubinstein A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-627; Senes S, 2007, MED CARDIOVASCULAR H; Simons LA, 2000, BRIT MED J, V321, P1084, DOI 10.1136/bmj.321.7268.1084; Simons LA, 2008, MED J AUSTRALIA, V188, P224, DOI 10.5694/j.1326-5377.2008.tb01589.x; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Thrift AG, 2000, STROKE, V31, P2087, DOI 10.1161/01.STR.31.9.2087; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Veerman L., 2010, ASSESSING COST EFFEC; Wells S, 2008, EUR J CARDIOV PREV R, V15, P173, DOI 10.1097/HJR.0b013e3282f13af4; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; WHO, 2009, TABL COSTS PRIC US W; World Health Organization, 2008, GLOB BURD DIS 2004 U; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	73	59	59	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41842	10.1371/journal.pone.0041842	http://dx.doi.org/10.1371/journal.pone.0041842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844529	Green Published, gold			2022-12-25	WOS:000306687700157
J	Mendes, LF; Pirraco, RP; Szymczyk, W; Frias, AM; Santos, TC; Reis, RL; Marques, AP				Mendes, Luis F.; Pirraco, Rogerio P.; Szymczyk, Wojciech; Frias, Ana M.; Santos, Tircia C.; Reis, Rui L.; Marques, Alexandra P.			Perivascular-Like Cells Contribute to the Stability of the Vascular Network of Osteogenic Tissue Formed from Cell Sheet-Based Constructs	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; MESENCHYMAL STROMAL CELLS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; STEM-CELLS; MATRIX-METALLOPROTEINASE; CULTURE SURFACES; BLOOD-VESSELS; TGF-BETA; IN-VIVO	In recent years several studies have been supporting the existence of a close relationship in terms of function and progeny between Mesenchymal Stem Cells (MSCs) and Pericytes. This concept has opened new perspectives for the application of MSCs in Tissue Engineering (TE), with special interest for the pre-vascularization of cell dense constructs. In this work, cell sheet technology was used to create a scaffold-free construct composed of osteogenic, endothelial and perivascular-like (CD146(+)) cells for improved in vivo vessel formation, maturation and stability. The CD146 pericyte-associated phenotype was induced from human bone marrow mesenchymal stem cells (hBMSCs) by the supplementation of standard culture medium with TGF-beta 1. Co-cultured cell sheets were obtained by culturing perivascular-like (CD146(+)) cells and human umbilical vein endothelial cells (HUVECs) on an hBMSCs monolayer maintained in osteogenic medium for 7 days. The perivascular-like (CD146(+)) cells and the HUVECs migrated and organized over the collagen-rich osteogenic cell sheet, suggesting the existence of cross-talk involving the co-cultured cell types. Furthermore the presence of that particular ECM produced by the osteoblastic cells was shown to be the key regulator for the singular observed organization. The osteogenic and angiogenic character of the proposed constructs was assessed in vivo. Immunohistochemistry analysis of the explants revealed the integration of HUVECs with the host vasculature as well as the osteogenic potential of the created construct, by the expression of osteocalcin. Additionally, the analysis of the diameter of human CD146 positive blood vessels showed a higher mean vessel diameter for the co-cultured cell sheet condition, reinforcing the advantage of the proposed model regarding blood vessels maturation and stability and for the in vitro pre-vascularization of TE constructs.	[Mendes, Luis F.; Pirraco, Rogerio P.; Szymczyk, Wojciech; Frias, Ana M.; Santos, Tircia C.; Reis, Rui L.; Marques, Alexandra P.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal; [Mendes, Luis F.; Pirraco, Rogerio P.; Szymczyk, Wojciech; Frias, Ana M.; Santos, Tircia C.; Reis, Rui L.; Marques, Alexandra P.] Univ Minho, ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal	Universidade do Minho; Universidade do Minho	Mendes, LF (corresponding author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal.	apmarques@dep.uminho.pt	Santos, Tircia/I-5595-2013; Marques, AP/H-7865-2019; Reis, Rui L./A-8938-2008; Marques, Alexandra P/B-1238-2012; Pirraco, Rogerio/O-8122-2015	Santos, Tircia/0000-0002-5365-4863; Marques, AP/0000-0002-3222-0310; Reis, Rui L./0000-0002-4295-6129; Marques, Alexandra P/0000-0002-3222-0310; Pirraco, Rogerio/0000-0001-5521-950X; Freitas Mendes, Luis Filipe/0000-0002-4170-8617	Fundacao para a Ciencia e a Tecnologia project Skingineering [PTDC/SAU-OSM/099422/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-OSM/099422/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia project Skingineering; Fundação para a Ciência e a Tecnologia	Funding provided by Fundacao para a Ciencia e a Tecnologia project Skingineering (PTDC/SAU-OSM/099422/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Amselgruber WM, 1999, ANAT HISTOL EMBRYOL, V28, P157, DOI 10.1046/j.1439-0264.1999.00195.x; Anfosso F, 2001, J BIOL CHEM, V276, P1564, DOI 10.1074/jbc.M007065200; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Bu PC, 2007, BBA-MOL CELL RES, V1773, P513, DOI 10.1016/j.bbamcr.2007.01.009; Caplan AI, 2011, J ORTHOPAEDIC RES; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Dohle E, 2011, EUR CELLS MATER, V21, P144, DOI 10.22203/eCM.v021a12; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; ENGERMAN RL, 1967, LAB INVEST, V17, P738; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018; Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342; Hirschi K K, 1997, EXS, V79, P419; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Kano K, 2008, HEPATOL RES, V38, P1140, DOI 10.1111/j.1872-034X.2008.00371.x; Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193; Kirkpatrick CJ, 2011, ADV DRUG DE IN PRESS; Kobayashi J, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014111; Krizmanich WJ, 1997, EXP MOL PATHOL, V64, P157, DOI 10.1006/exmp.1997.2217; Kushida A, 2005, Eur Cell Mater, V10, P23; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; Lafleur MA, 2001, BIOCHEM BIOPH RES CO, V282, P463, DOI 10.1006/bbrc.2001.4596; Lennon D. P., 2006, MESENCHYMAL STEM CEL, P23; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016767; Li XY, 2008, WOUND REPAIR REGEN, V16, P346, DOI 10.1111/j.1524-475X.2008.00374.x; NEHLS V, 1992, CELL TISSUE RES, V270, P469, DOI 10.1007/BF00645048; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Obokata H, 2011, NAT PROTOC, V6, P1053, DOI 10.1038/nprot.2011.356; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Ouhtit A, 2009, BBA-REV CANCER, V1795, P130, DOI 10.1016/j.bbcan.2009.01.002; Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535; Pirraco RP, 2011, TISSUE ENG PT A, V17, P1507, DOI [10.1089/ten.TEA.2010.0470, 10.1089/ten.tea.2010.0470]; Pirraco RP, 2011, TERMIS EU 2011 TISS; Pries AR, 2005, HYPERTENSION, V46, P725, DOI 10.1161/01.HYP.0000184428.16429.be; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Sekiya S, 2010, MICROVASC RES, V80, P549, DOI 10.1016/j.mvr.2010.08.001; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Shepherd BR, 2009, TISSUE ENG PT A, V15, P165, DOI 10.1089/ten.tea.2008.0010; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Takakura N, 2011, J THROMB HAEMOST, V9, P144, DOI 10.1111/j.1538-7836.2011.04275.x; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107; Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002; Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032; Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001; von Tell D, 2006, EXP CELL RES, V312, P623, DOI 10.1016/j.yexcr.2005.10.019; Williams C, 2011, BIOMATERIALS, V32, P5625, DOI 10.1016/j.biomaterials.2011.04.050; Williams C, 2011, BIOMATERIALS, V32, P410, DOI 10.1016/j.biomaterials.2010.08.105; Wolfe Margaret, 2008, V449, P3, DOI 10.1007/978-1-60327-169-1_1; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Zimmerlin L, 2011, CYTOMETRY A	74	43	46	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41051	10.1371/journal.pone.0041051	http://dx.doi.org/10.1371/journal.pone.0041051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829909	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300047
J	Perrin, S; Cremer, J; Roll, P; Faucher, O; Menard, A; Reynes, J; Dellamonica, P; Naqvi, A; Micallef, J; Jouve, E; Tamalet, C; Solas, C; Pissier, C; Arnoux, I; Nicolino-Brunet, C; Espinosa, L; Levy, N; Kaspi, E; Robaglia-Schlupp, A; Poizot-Martin, I; Cau, P				Perrin, Sophie; Cremer, Jonathan; Roll, Patrice; Faucher, Olivia; Menard, Amelie; Reynes, Jacques; Dellamonica, Pierre; Naqvi, Alissa; Micallef, Joelle; Jouve, Elisabeth; Tamalet, Catherine; Solas, Caroline; Pissier, Christel; Arnoux, Isabelle; Nicolino-Brunet, Corine; Espinosa, Leon; Levy, Nicolas; Kaspi, Elise; Robaglia-Schlupp, Andree; Poizot-Martin, Isabelle; Cau, Pierre			HIV-1 Infection and First Line ART Induced Differential Responses in Mitochondria from Blood Lymphocytes and Monocytes: The ANRS EP45 "Aging" Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; MONONUCLEAR-CELLS; OXIDATIVE STRESS; INDUCED APOPTOSIS; REDOX REGULATION; DENDRITIC CELLS; COMPLEX-I; TOXICITY; MECHANISMS	Background: The ANRS EP45 "Aging" study investigates the cellular mechanisms involved in the accelerated aging of HIV-1 infected and treated patients. The data reported focus on mitochondria, organelles known to be involved in cell senescence. Methods: 49 HIV-1 infected patients untreated with antiretroviral therapy, together with 49 seronegative age-and sex-matched control subjects and 81 HIV-1 infected and treated patients, were recruited by 3 AIDS centres (Marseille, Montpellier, Nice; France; http://clinicaltrials.gov/, NCT01038999). In more than 88% of treated patients, the viral load was <40 copies/ml and the CD4+ cell count was >500/mm(3). ROS (reactive oxygen species) production and Delta Psi m (inner membrane potential) were measured by flow cytometry in blood lymphocytes and monocytes (functional parameters). Three mitochondrial network quantitative morphological parameters were computed using confocal microscopy and image analysis. Three PBMC mitochondrial proteins (porin and subunits 2 and 4 of cytochrome C oxidase encoded by mtDNA or nuclear DNA, respectively) were analysed by western blotting. Results: Quantitative changes in PBMC mitochondrial proteins were not induced by either HIV-1 infection or ART. Discriminant analysis integrating functional (ROS production and Delta Psi m) or morphological (network volume density, fragmentation and branching) parameters revealed HIV-1 infection and ART differential effects according to cell type. First line ART tended to rescue lymphocytemitochondrial parameters altered by viral infection, but induced slight changes in monocytes. No statistical difference was found between the effects of three ART regimens on mitochondrial parameters. Correlations between functional parameters and viral load confirmed the damaging effects of HIV-1 in lymphocyte mitochondria. Conclusions: In patients considered to be clinically stable, mitochondria exhibited functional and morphological modifications in PBMCs resulting from either direct or indirect effects of HIV-1 infection (lymphocytes), or from first line ART (monocytes). Together with other tissue impairments, these changes may contribute to global aging.	[Perrin, Sophie; Cremer, Jonathan; Roll, Patrice; Levy, Nicolas; Kaspi, Elise; Robaglia-Schlupp, Andree; Cau, Pierre] Aix Marseille Univ, INSERM, UMR 910, Marseille, France; [Perrin, Sophie; Cremer, Jonathan; Roll, Patrice; Kaspi, Elise; Robaglia-Schlupp, Andree; Cau, Pierre] CHU Timone, AP HM, Lab Biol Cellulaire, Marseille, France; [Faucher, Olivia; Menard, Amelie; Poizot-Martin, Isabelle] CHU St Marguerite, AP HM, Serv Immunohematol Clin, Marseille, France; [Reynes, Jacques] CHRU Gui de Chauliac, Dept Maladies Infect & Trop, Montpellier, France; [Dellamonica, Pierre; Naqvi, Alissa] CHU Archet 1, Serv Infectiol, Nice, France; [Micallef, Joelle; Jouve, Elisabeth] CHU Timone, AP HM, CIC, UPCET, Marseille, France; [Tamalet, Catherine] CHU Timone, AP HM, Federat Microbiol Clin, Marseille, France; [Tamalet, Catherine] Aix Marseille Univ, CNRS, UMR 6236, URMITE,IRD, Marseille, France; [Solas, Caroline; Pissier, Christel] CHU Timone, AP HM, Lab Pharmacocinet & Toxicol, Marseille, France; [Solas, Caroline; Pissier, Christel] Aix Marseille Univ, InsermUMR, U911, Marseille, France; [Arnoux, Isabelle] CHU Timone, AP HM, Hematol Lab, Marseille, France; [Nicolino-Brunet, Corine] CHU Concept, AP HM, Hematol Lab, Marseille, France; [Levy, Nicolas] CHU Timone, AP HM, Lab Genet Mol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Perrin, S (corresponding author), Aix Marseille Univ, INSERM, UMR 910, Marseille, France.	pierre.cau@univ-amu.fr	ROLL, Patrice/I-4355-2016; Joëlle, Micallef/P-6977-2016; LEVY, Nicolas/J-1632-2014; ROLL, Patrice/GLS-4467-2022; Cau, Pierre/M-3541-2016; Kaspi, Elise/I-4936-2016; Espinosa, Leon/V-8410-2017; Jouve, Elisabeth/GSN-9120-2022	ROLL, Patrice/0000-0002-0045-5641; LEVY, Nicolas/0000-0001-5171-6365; ROLL, Patrice/0000-0002-0045-5641; Kaspi, Elise/0000-0003-0458-5109; Jouve, Elisabeth/0000-0002-4873-6522; Perrin, Sophie/0000-0003-4950-283X	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [ANRS EP45]; ANRS [ANRS EP45]; Sidaction [B/22-2-02032, A/19-3-01487]; ADEREM (Biological and medical research supportive association for Marseille hospital centres); GlaxoSmithKline; Boehringen Mannheim	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; ADEREM (Biological and medical research supportive association for Marseille hospital centres); GlaxoSmithKline(GlaxoSmithKline); Boehringen Mannheim	This work was supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS, http://www.anrs.fr/) [ANRS EP45 "Aging" to PC]. SP was a recipient of a 3-year Ph.D. grant from ANRS [ANRS EP45 "Aging" to PC] and a fourth additional Ph.D. year from Sidaction (http://www.sidaction.org/) grant [B/22-2-02032 to SP]. SP received a 3-month transition grant from ADEREM (Biological and medical research supportive association for Marseille hospital centres, http://aderem.fr/index.htm). JC was a recipient of a grant from Sidaction [A/19-3-01487 to PC]. PC was a recipient of grants from GlaxoSmithKline and from Boehringen Mannheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Alexaki A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000215; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Caron M, 2004, AIDS, V18, P2127, DOI 10.1097/00002030-200411050-00004; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Ciccosanti F, 2010, ANTIVIR THER, V15, P377, DOI 10.3851/IMP1530; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Cossarizza A, 2003, ANTIVIR THER, V8, P315; Cossarizza A, 1998, PURDUE CYTOMETRY, V4; Cote HCF, 2007, CURR OPIN HIV AIDS, V2, P253, DOI 10.1097/COH.0b013e3281df3410; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Curran A, 2011, EXPERT OPIN DRUG SAF, V10, P389, DOI 10.1517/14740338.2011.542145; Danaher RJ, 2010, AIDS, V24, P2578, DOI 10.1097/QAD.0b013e32833f4022; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Einsiedel L, 2010, MITOCHONDRION, V10, P534, DOI 10.1016/j.mito.2010.05.010; Elbim C, 1999, J VIROL, V73, P4561, DOI 10.1128/JVI.73.6.4561-4566.1999; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Garrabou G, 2011, AIDS, V25, P165, DOI 10.1097/QAD.0b013e3283423219; Gavegnano Christina, 2009, Antiviral Chemistry & Chemotherapy, V20, P63, DOI 10.3851/IMP1374; Gerschenson M, 2009, J ANTIMICROB CHEMOTH, V63, P1244, DOI 10.1093/jac/dkp100; Groener JB, 2011, AIDS RES HUM RETROV, V27, P969, DOI 10.1089/aid.2010.0348; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Huberty C., 2006, APPL MANOVA DISCRIMI; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Jolly C, 2007, TRENDS IMMUNOL, V28, P474, DOI 10.1016/j.it.2007.08.008; Jones SP, 2005, JAIDS-J ACQ IMM DEF, V40, P565, DOI 10.1097/01.qai.0000187443.30838.3e; Kadiu I, 2009, CELL IMMUNOL, V258, P44, DOI 10.1016/j.cellimm.2009.03.012; Karamchand L, 2008, JAIDS-J ACQ IMM DEF, V48, P381, DOI 10.1097/QAI.0b013e3181799662; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klatt NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003862; Koczor CA, 2010, EXPERT OPIN DRUG MET, V6, P1493, DOI 10.1517/17425255.2010.526602; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu X, 2010, EXPERT OPIN DRUG SAF, V9, P743, DOI 10.1517/14740331003767395; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Lopez S, 2006, AIDS RES HUM RETROV, V22, P33, DOI 10.1089/aid.2006.22.33; Lugli E, 2005, CYTOM PART A, V68A, P28, DOI 10.1002/cyto.a.20188; Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012; Maagaard A, 2009, J ANTIMICROB CHEMOTH, V64, P901, DOI 10.1093/jac/dkp316; Maggiolo F, 2010, ANTIVIR THER, V15, P51, DOI 10.3851/IMP1483; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; Mandas A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/749575; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Martin AM, 2007, AIDS, V21, P1233, DOI 10.1097/QAD.0b013e3280119579; McComsey GA, 2008, HIV CLIN TRIALS, V9, P126, DOI 10.1310/hct0902-126; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Montaner JSG, 2003, JAIDS-J ACQ IMM DEF, V34, pS85, DOI 10.1097/00126334-200309011-00013; Morse CG, 2012, J INFECT DIS, V205, P1778, DOI 10.1093/infdis/jis101; Mukhopadhyay A, 2002, MITOCHONDRION, V1, P511, DOI 10.1016/S1567-7249(02)00042-9; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nakamura H, 2002, ANTIOXID REDOX SIGN, V4, P455, DOI 10.1089/15230860260196245; Narayanan A, 2011, EXPERT OPIN BIOL TH, V11, P17, DOI 10.1517/14712598.2011.540564; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Onafuwa-Nuga A, 2010, CELL RES, V20, P1185, DOI 10.1038/cr.2010.140; Pajonk F, 2002, CANCER RES, V62, P5230; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Petrovas C, 2007, BLOOD, V109, P2505, DOI 10.1182/blood-2006-05-021626; Piccinini M, 2002, AIDS, V16, P693, DOI 10.1097/00002030-200203290-00004; Pinti M, 2006, BBA-BIOENERGETICS, V1757, P700, DOI 10.1016/j.bbabio.2006.05.001; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stehbens WE, 2004, EXP MOL PATHOL, V77, P121, DOI 10.1016/j.yexmp.2004.04.007; Sternfeld T, 2009, HIV MED, V10, P512, DOI 10.1111/j.1468-1293.2009.00723.x; Sternfeld T, 2007, ANTIVIR THER, V12, P769; Sun GH, 2011, TRENDS PHARMACOL SCI, V32, P675, DOI 10.1016/j.tips.2011.07.003; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vidal F, 2006, ANTIMICROB AGENTS CH, V50, P3824, DOI 10.1128/AAC.00437-06; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; Wei Yau-Huei, 2009, Chang Gung Med J, V32, P113; WHITELAW DM, 1972, CELL TISSUE KINET, V5, P311, DOI 10.1111/j.1365-2184.1972.tb00369.x; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Zhao C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.69; Zhao CQ, 2009, J PROTEOME RES, V8, P4028, DOI 10.1021/pr900364p	97	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41129	10.1371/journal.pone.0041129	http://dx.doi.org/10.1371/journal.pone.0041129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829920	Green Published, gold			2022-12-25	WOS:000306956300059
J	Saw, S; Kale, SL; Arora, N				Saw, Sanjay; Kale, Sagar Laxman; Arora, Naveen			Serine Protease Inhibitor Attenuates Ovalbumin Induced Inflammation in Mouse Model of Allergic Airway Disease	PLOS ONE			English	Article							MAST-CELL TRYPTASE; DUST-MITE ALLERGEN; MAJOR ALLERGEN; EPICOCCUM-PURPURASCENS; PROTEOLYTIC ACTIVITY; NAFAMOSTAT MESILATE; HISTAMINE-RELEASE; CHYMASE INHIBITOR; MURINE MODEL; ACTIVATION	Background: Serine proteases promote inflammation and tissue remodeling by activating proteinase-activated receptors, urokinase, metalloproteinases and angiotensin. In the present study, 4-(2-Aminoethyl) benzenesulfonyl fluoride (AEBSF) a serine protease inhibitor was evaluated for prophylactic and therapeutic treatment in mouse model of airway allergy. Methods: BALB/c mice were sensitized by i.p route and challenged with ovalbumin. They were treated i.n. with 2, 10 and 50 mu g of AEBSF, one hour before or after challenge and euthanized to collect BALF (bronchoalveolar lavage fluid), blood and lungs. Proteolytic activity, total cell/eosinophil/neutrophil count eosinophil peroxidase activity (EPO), IL-4, IL-5, IL-10, IL-13, cysteinyl leukotrienes and 8-isoprostane were determined in BALF and immunoglobulins were measured in serum. H&E and PAS stained lung sections were examined for cellular infiltration and airway inflammation. Results: Mice exposed to ovalbumin and treated with PBS showed increased cellular infiltration in lungs and higher serum IgE, IgG1 and IgG2a levels as compared to sham mice. Treatment with AEBSF reduced total cells/eosinophil/neutrophil infiltration. Both prophylactic and therapeutic AEBSF treatment of 10 or 50 mg reduced serum IgE and IgG1 significantly (p<0.05) than control. AEBSF treatment reduced the proteolytic activity in BALF. IL-4 IL-5 and IL-13 levels decreased significantly (p<0.05) after AEBSF treatment while IL-10 levels increased significantly (p<0.05) in BALF. Airway inflammation and goblet cell hyperplasia reduced as demonstrated by lung histopathology, EPO activity and cysteinyl leukotrienes in BALF after treatment. AEBSF treatment also suppressed oxidative stress in terms of 8-isoprostane in BALF. Among the treatment doses, 10 or 50 mg of AEBSF were most effective in reducing the inflammatory parameters. Conclusions: Prophylactic and therapeutic treatment with serine protease inhibitor attenuates the airway inflammation in mouse model of airway allergy and have potential for adjunct therapy.	[Saw, Sanjay; Kale, Sagar Laxman; Arora, Naveen] Inst Genom & Integrat Biol, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Saw, S (corresponding author), Inst Genom & Integrat Biol, Delhi Univ Campus, Delhi, India.	naveen@igib.res.in	Kale, Sagar/I-7107-2019	Saw, Sanjay/0000-0002-8973-3731	Council for Scientific and Industrial Reasearch (CSIR)	Council for Scientific and Industrial Reasearch (CSIR)	The work covered in this manuscript was funded by the Council for Scientific and Industrial Reasearch (CSIR). The URL for the funder's website is "http://rdpp.csir.res.in/csir_acsir/Home.aspx". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLDIN G, 1979, H-S Z PHYSIOL CHEM, V360, P651, DOI 10.1515/bchm2.1979.360.1.651; Bisht V, 2004, FEMS IMMUNOL MED MIC, V42, P205, DOI 10.1016/j.femsim.2004.05.003; Chen CL, 2006, J ALLERGY CLIN IMMUN, V118, P105, DOI 10.1016/j.jaci.2006.02.047; Conseil V, 1999, ANTIMICROB AGENTS CH, V43, P1358, DOI 10.1128/AAC.43.6.1358; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Goel C, 2012, CLIN EXP ALLERGY, V42, P412, DOI 10.1111/j.1365-2222.2011.03937.x; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Gupta R, 2004, ALLERGY, V59, P421, DOI 10.1046/j.1398-9995.2003.00378.x; He S, 1998, J PHARMACOL EXP THER, V286, P289; He SH, 2001, EUR J PHARMACOL, V412, P223, DOI 10.1016/S0014-2999(01)00734-8; He SH, 1997, EUR J PHARMACOL, V328, P89, DOI 10.1016/S0014-2999(97)83033-6; HERBERT CA, 1995, AM J RESP CELL MOL, V12, P369, DOI 10.1165/ajrcmb.12.4.7695916; Hewitt CRA, 1998, ALLERGY, V53, P60, DOI 10.1111/j.1398-9995.1998.tb05000.x; Holla LI, 2009, INT ARCH ALLERGY IMM, V148, P73, DOI 10.1159/000151508; Imada T, 2002, JPN J PHARMACOL, V90, P214, DOI 10.1254/jjp.90.214; Inoue KI, 2005, CHEST, V128, P1069, DOI 10.1378/chest.128.2.1069; Ishizaki M, 2008, J PHARMACOL SCI, V108, P355, DOI 10.1254/jphs.08162FP; Kauffman HF, 2003, CURR ALLERGY ASTHM R, V3, P101, DOI 10.1007/s11882-003-0021-x; Kawikova I, 1996, AM J RESP CRIT CARE, V153, P590, DOI 10.1164/ajrccm.153.2.8564103; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Krishna MT, 2001, J ALLERGY CLIN IMMUN, V107, P1039, DOI 10.1067/mai.2001.115631; Kukreja N, 2008, CLIN EXP IMMUNOL, V154, P162, DOI 10.1111/j.1365-2249.2008.03762.x; Liu YC, 1998, BRIT J PHARMACOL, V124, P563, DOI 10.1038/sj.bjp.0701886; Megyeri P, 1995, IMMUNOLOGY, V86, P629; Megyeri P, 1999, EUR J PHARMACOL, V374, P207, DOI 10.1016/S0014-2999(99)00224-1; Mehta AK, 2007, EUR RESPIR J, V30, P662, DOI 10.1183/09031936.00019307; Nadeem Ahmed, 2008, Ther Adv Respir Dis, V2, P215, DOI 10.1177/1753465808094971; Nakamura Y, 1998, THORAX, V53, P835, DOI 10.1136/thx.53.10.835; Oh SW, 2002, J IMMUNOL, V168, P1992, DOI 10.4049/jimmunol.168.4.1992; Post S, 2011, THORAX; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Saito K, 2004, ANN ALLERG ASTHMA IM, V93, P594, DOI 10.1016/S1081-1206(10)61269-0; Sano C, 2000, CLIN EXP IMMUNOL, V121, P77, DOI 10.1046/j.1365-2249.2000.01269.x; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Shen HD, 1999, CLIN EXP ALLERGY, V29, P642, DOI 10.1046/j.1365-2222.1999.00509.x; Shen HD, 2007, CURR ALLERGY ASTHM R, V7, P351, DOI 10.1007/s11882-007-0053-8; Simpson JL, 2005, AM J RESP CRIT CARE, V172, P559, DOI 10.1164/rccm.200503-369OC; Sudha VT, 2008, ALLERGY, V63, P768, DOI 10.1111/j.1398-9995.2007.01602.x; Sudha VT, 2009, EUR J CLIN INVEST, V39, P507, DOI 10.1111/j.1365-2362.2009.02112.x; Tomimori Y, 2002, BIOCHEM PHARMACOL, V64, P1187, DOI 10.1016/S0006-2952(02)01265-0; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P775; Tripathi P, 2009, J CLIN IMMUNOL, V29, P292, DOI 10.1007/s10875-008-9261-9; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Watanabe N, 2002, INT ARCH ALLERGY IMM, V128, P229, DOI 10.1159/000064256; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; Wijayanti N, 2005, J BIOL CHEM, V280, P21820, DOI 10.1074/jbc.M502943200; Zarnowski R, 2007, DIAGN MICR INFEC DIS, V59, P39, DOI 10.1016/j.diagmicrobio.2007.03.020	48	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41107	10.1371/journal.pone.0041107	http://dx.doi.org/10.1371/journal.pone.0041107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829914	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300053
J	Carmichael, RH; Graham, WM; Aven, A; Worthy, G; Howden, S				Carmichael, Ruth H.; Graham, William M.; Aven, Allen; Worthy, Graham; Howden, Stephan			Were Multiple Stressors a 'Perfect Storm' for Northern Gulf of Mexico Bottlenose Dolphins (Tursiops truncatus) in 2011?	PLOS ONE			English	Article							HEAT-LOSS; BLUBBER; MECHANISMS; INFECTION	An unusual number of near term and neonatal bottlenose dolphin (Tursiops truncatus) mortalities occurred in the northern Gulf of Mexico (nGOM) in 2011, during the first calving season after two well documented environmental perturbations; sustained cold weather in 2010 and the Deepwater Horizon oil spill (DWHOS). Preceding the stranding event, large volumes of cold freshwater entered the nGOM due to unusually large snowmelt on the adjacent watershed, providing a third potential stressor. We consider the possibility that this extreme cold and freshwater event contributed to the pattern of perinatal dolphin strandings along the nGOM coast. During the 4-month period starting January 2011, 186 bottlenose dolphins, including 46% perinatal calves (nearly double the percentage for the same time period from 2003-2010) washed ashore from Louisiana to western Florida. Comparison of the frequency distribution of strandings to flow rates and water temperature at a monitoring buoy outside Mobile Bay, Alabama (the 4th largest freshwater drainage in the U. S.) and along the nGOM coast showed that dolphin strandings peaked in Julian weeks 5, 8, and 12 (February and March), following water temperature minima by 2-3 weeks. If dolphin condition was already poor due to depleted food resources, bacterial infection, or other factors, it is plausible that the spring freshet contributed to the timing and location of the unique stranding event in early 2011. These data provide strong observational evidence to assess links between the timing of the DWHOS, other local environmental stressors, and mortality of a top local predator. Targeted analyses of tissues from stranded dolphins will be essential to define a cause of death, and our findings highlight the importance of considering environmental data along with biological samples to interpret stranding patterns during and after an unusual mortality event.	[Carmichael, Ruth H.; Graham, William M.; Aven, Allen] Dauphin Isl Sea Lab, Univ Programs, Dauphin Isl, AL USA; [Carmichael, Ruth H.; Graham, William M.; Aven, Allen] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Howden, Stephan] Univ So Mississippi, Dept Marine Sci, Stennis Space Ctr, MS USA; [Worthy, Graham] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	Dauphin Island Sea Lab; University of South Alabama; University of Southern Mississippi; State University System of Florida; University of Central Florida	Carmichael, RH (corresponding author), Dauphin Isl Sea Lab, Univ Programs, Dauphin Isl, AL USA.	rcarmichael@disl.org		Carmichael, Ruth/0000-0002-6033-3777; Howden, Stephan/0000-0002-7690-6365	Dauphin Island Sea Lab; National Fish and Wildlife Foundation [26321]	Dauphin Island Sea Lab; National Fish and Wildlife Foundation	This work was funded by the Dauphin Island Sea Lab and The National Fish and Wildlife Foundation, project #26321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2001, COAST ESTUAR STUD, V57, P119; Barros NB, 2010, MAR MAMMAL SCI, V26, P324, DOI 10.1111/j.1748-7692.2009.00315.x; Carvan MJ, 2003, N P TOX ENV, P429; Clark S, 2008, FOREST WISDOM, V12, P4; Dunkin RC, 2005, J EXP BIOL, V208, P1469, DOI 10.1242/jeb.01559; El-Tras WF, 2010, VET MICROBIOL, V141, P321, DOI 10.1016/j.vetmic.2009.09.017; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Florida Fish and Wildlife Conservation Commission, 2011, COLD REL MORT EV WIN; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Gutman M, 2011, ABC NEWS; Meagher EM, 2008, J COMP PHYSIOL B, V178, P529, DOI 10.1007/s00360-007-0245-5; MILLER WG, 1992, FISH B-NOAA, V90, P791; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; Mitra S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049505; MMC, 1999, P MAR MAMM COMM WORK; Mobile Bay National Estuary Program, 2012, ENV MON DAUPH ISL; Murphy S., 2010, J NORTHWEST ATL FISH, V42, P153, DOI [10.2960/J.v42.m658, DOI 10.2960/J.V42.M658]; NOAA, 2011, NAT MAR MAMM HLTH ST; NOAA Fisheries Office of Protected Resources, 2011, NOAA FINDS BACT INF; NOAA Fisheries Office of Protected Resources, 2012, MAR MAMM UN MORT EV; NOAA Fisheries Office of Protected Resources, 2011, 2010 2011 CET UN MOR; NOAA Fisheries Office of Protected Resources, 2011, BRUC 2010 2011 CET U; Noren SR, 2009, J MAMMAL, V90, P629, DOI 10.1644/08-MAMM-A-138R.1; NRDA, 2012, NAT RES DAM ASS STAT, P53; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Quinlan P, 2010, PALM BEACH POST; SCHROEDER WW, 1990, ESTUARIES, V13, P145, DOI 10.2307/1351583; Scott M.D., 1990, P235; Semansky P, 2011, NATL GEOGRAPHIC; Slater GF, 2006, ORG GEOCHEM, V37, P981, DOI 10.1016/j.orggeochem.2006.06.014; Smultea Mari Ann, 1995, Aquatic Mammals, V21, P171; Struntz DJ, 2004, J MORPHOL, V259, P7, DOI 10.1002/jmor.10154; Tachibana M, 2006, J WILDLIFE DIS, V42, P412, DOI 10.7589/0090-3558-42.2.412; USGS, 2012, NAT WAT INF SYST WEB; Whitehead A, 2011, P NATL ACAD SCI USA, V108, P6193, DOI 10.1073/pnas.1017542108; Wilson B, 1999, P ROY SOC B-BIOL SCI, V266, P1077, DOI 10.1098/rspb.1999.0746; Worthy G, 1998, CHARACTERISTICS CAUS, V143, P47; Worthy G, 2006, HARBOR BRANCH OCEANO, V93, P27; Worthy G, 1992, 40WCNF202988 SE FISH; WORTHY GAJ, 1990, PHYSIOL ZOOL, V63, P432, DOI 10.1086/physzool.63.2.30158506; Yeates LC, 2008, J EXP BIOL, V211, P3249, DOI 10.1242/jeb.020610	41	45	47	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41155	10.1371/journal.pone.0041155	http://dx.doi.org/10.1371/journal.pone.0041155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815950	Green Submitted, Green Published, gold			2022-12-25	WOS:000306548900084
J	Shizu, R; Shindo, S; Yoshida, T; Numazawa, S				Shizu, Ryota; Shindo, Sawako; Yoshida, Takemi; Numazawa, Satoshi			MicroRNA-122 Down-Regulation Is Involved in Phenobarbital-Mediated Activation of the Constitutive Androstane Receptor	PLOS ONE			English	Article							NUCLEAR RECEPTOR; PROTEIN-KINASE; ACTIVE/ANDROSTANE RECEPTOR; TUMOR PROMOTION; RAT HEPATOCYTES; LIVER; EXPRESSION; CAR; INDUCTION; MIR-122	Constitutive androstane receptor (CAR) is a nuclear receptor that regulates the transcription of target genes, including CYP2B and 3A. Phenobarbital activates CAR, at least in part, in an AMP-activated protein kinase (AMPK)-dependent manner. However, the precise mechanisms underlying phenobarbital activation of AMPK are still unclear. In the present study, it was demonstrated that phenobarbital administration to mice decreases hepatic miR-122, a liver-enriched microRNA involved in both hepatic differentiation and function. The time-course change in the phenobarbital-mediated down-regulation of miR-122 was inversely correlated with AMPK activation. Phenobarbital decreased primary miR-122 to approximately 25% of the basal level as early as 1 h and suppressed transactivity of mir-122 promoter in HuH-7 cells, suggesting that the down-regulation occurred at the transcriptional level. AMPK activation by metformin or 5-aminoimidazole-4-carboxamide 1-beta-D-ribonucleoside had no evident effect on miR-122 levels. An inhibitory RNA specific for miR-122 increased activated AMPK and CAR-mediated trancactivation of the phenobarbital-responsive enhancer module in HepG2 cells. Conversely, the reporter activity induced by the ectopic CAR was almost completely suppressed by co-transfection with the miR-122 mimic RNA. GFP-tagged CAR was expressed in the cytoplasm in addition to the nucleus in the majority of HuH-7 cells in which miR-122 was highly expressed. Co-transfection of the mimic or the inhibitor RNA for miR-122 further increased or decreased, respectively, the number of cells that expressed GFP-CAR in the cytoplasm. Taken together, these results suggest that phenobarbital-mediated down-regulation of miR-122 is an early and important event in the AMPK-dependent CAR activation and transactivation of its target genes.	[Shizu, Ryota; Shindo, Sawako; Yoshida, Takemi; Numazawa, Satoshi] Showa Univ, Sch Pharm, Dept Biochem Toxicol, Tokyo, Japan	Showa University	Shizu, R (corresponding author), Showa Univ, Sch Pharm, Dept Biochem Toxicol, Tokyo, Japan.	numazawa@pharm.showa-u.ac.jp	Numazawa, Satoshi/E-4618-2010; Shizu, Ryota/ACP-9957-2022	Numazawa, Satoshi/0000-0002-4818-1061; Shizu, Ryota/0000-0002-0465-5077	Ministry of Education, Culture, Sports, Science, and Technology of Japan [S1001011];  [22590143]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by a Grant-in-Aid for Scientific Research C [22590143 to S.N.] and by Private University High Technology Research Center Project matching fund subsidy [S1001011] from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Bell AW, 2006, HEPATOLOGY, V44, P186, DOI 10.1002/hep.21234; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Halappanavar S, 2011, TOXICOLOGY, V285, P133, DOI 10.1016/j.tox.2011.04.011; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Joannard F, 2006, TOXICOL LETT, V161, P61, DOI 10.1016/j.toxlet.2005.08.006; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Kodama S, 2006, DRUG METAB REV, V38, P75, DOI 10.1080/03602530600569851; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Osabe M, 2011, J BIOL CHEM, V286, P35763, DOI 10.1074/jbc.M111.284596; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238; Tamasi V, 2009, MOL PHARMACEUT, V6, P1573, DOI 10.1021/mp9001552; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Whysner J, 1996, PHARMACOL THERAPEUT, V71, P153, DOI 10.1016/0163-7258(96)00067-8; Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yokoi T, 2011, TOXICOL SCI, V123, P1, DOI 10.1093/toxsci/kfr168; Yoshioka W, 2011, TOXICOL SCI, V122, P457, DOI 10.1093/toxsci/kfr130; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	37	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41291	10.1371/journal.pone.0041291	http://dx.doi.org/10.1371/journal.pone.0041291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815988	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900107
J	Song, YG; Ji, DD; Li, S; Wang, P; Li, Q; Xiang, FN				Song, Yuguang; Ji, Dandan; Li, Shuo; Wang, Peng; Li, Qiang; Xiang, Fengning			The Dynamic Changes of DNA Methylation and Histone Modifications of Salt Responsive Transcription Factor Genes in Soybean	PLOS ONE			English	Article							H3 LYSINE-9; STRESS TOLERANCE; CPG METHYLATION; ARABIDOPSIS; PROTEIN; ACETYLATION; PATTERNS; EXPRESSION; DROUGHT; ABA	Epigenetic modification contributes to the regulation of gene expression and plant development under salinity stress. Here we describe the identification of 49 soybean transcription factors by microarray analysis as being inducible by salinity stress. A semi-quantitative RT-PCR-based expression assay confirmed the salinity stress inducibility of 45 of these 49 transcription factors, and showed that ten of them were up-regulated when seedlings were exposed to the demethylation agent 5-aza-2-deoxycytidine. Salinity stress was shown to affect the methylation status of four of these ten transcription factors (one MYB, one b-ZIP and two AP2/DREB family members) using a combination of bisulfite sequencing and DNA methylation-sensitive DNA gel blot analysis. ChIP analysis indicated that the activation of three of the four DNA methylated transcription factors was correlated with an increased level of histone H3K4 trimethylation and H3K9 acetylation, and/or a reduced level of H3K9 demethylation in various parts of the promoter or coding regions. Our results suggest a critical role for some transcription factors' activation/repression by DNA methylation and/or histone modifications in soybean tolerance to salinity stress.	[Song, Yuguang; Ji, Dandan; Li, Shuo; Wang, Peng; Li, Qiang; Xiang, Fengning] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China	Shandong University	Song, YG (corresponding author), Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China.	xfn0990@sdu.edu.cn	WANG, Peng/GSN-5263-2022		National Special Science Research Program of China [2007CB948203]; National Natural Science Foundation of China [30970243, 30771116]; Excellent Youth Foundation of Shandong Province of China [JQ200810]; Science & Technology Plan of Shandong Province [2009GG10002001]; Chinese Natural Education Ministry Doctor Station Foundation Fellowship [913111006]	National Special Science Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Shandong Province of China; Science & Technology Plan of Shandong Province; Chinese Natural Education Ministry Doctor Station Foundation Fellowship	This work was supported by the National Special Science Research Program of China (grant no. 2007CB948203) http://www.973.gov.cn/AreaMana.aspx; the National Natural Science Foundation of China (grant nos. 30970243 and 30771116) http://www.nsfc.gov.cn; Excellent Youth Foundation of Shandong Province of China (grant no. JQ200810) http://www.sdnsf.gov.cn/portal/; Science & Technology Plan of Shandong Province (grant 2009GG10002001) http://www.sdstc.gov.cn/index.jsp and the Chinese Natural Education Ministry Doctor Station Foundation Fellowship (grant no. 913111006) http://std.nankai.edu.cn/kyjh-bsd/1.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Chen M, 2009, J EXP BOT, V60, P121, DOI 10.1093/jxb/ern269; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Chinnusamy V, 2008, J INTEGR PLANT BIOL, V50, P1187, DOI 10.1111/j.1744-7909.2008.00727.x; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fahrner JA, 2002, CANCER RES, V62, P7213; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Paszkowski J, 2001, CURR OPIN PLANT BIOL, V4, P123, DOI 10.1016/S1369-5266(00)00147-3; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; Phang TH, 2008, J INTEGR PLANT BIOL, V50, P1196, DOI 10.1111/j.1744-7909.2008.00760.x; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Shibukawa T, 2009, GENE, V437, P22, DOI 10.1016/j.gene.2009.02.011; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Xia R, 2006, PLANT CELL, V18, P85, DOI 10.1105/tpc.105.037507; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhu JK, 2008, CELL, V133, P395, DOI 10.1016/j.cell.2008.04.016; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	53	138	161	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41274	10.1371/journal.pone.0041274	http://dx.doi.org/10.1371/journal.pone.0041274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815985	Green Published, gold, Green Submitted			2022-12-25	WOS:000306548900105
J	Yang, X; Wang, F; Su, J; Lu, BR				Yang, Xiao; Wang, Feng; Su, Jun; Lu, Bao-Rong			Limited Fitness Advantages of Crop-Weed Hybrid Progeny Containing Insect-Resistant Transgenes (Bt/CpTI) in Transgenic Rice Field	PLOS ONE			English	Article							GENETICALLY-MODIFIED CROPS; GENE FLOW; WILD RELATIVES; BRASSICA-RAPA; ORYZA-SATIVA; CULTIVATED RICE; RISK-ASSESSMENT; RED RICE; PLANTS; FECUNDITY	Background: The spread of insect-resistance transgenes from genetically engineered (GE) rice to its coexisting weedy rice (O. sativa f. spontanea) populations via gene flow creates a major concern for commercial GE rice cultivation. Transgene flow to weedy rice seems unavoidable. Therefore, characterization of potential fitness effect brought by the transgenes is essential to assess environmental consequences caused by crop-weed transgene flow. Methodology/Principal Findings: Field performance of fitness-related traits was assessed in advanced hybrid progeny of F-4 generation derived from a cross between an insect-resistant transgenic (Bt/CpTI) rice line and a weedy strain. The performance of transgene-positive hybrid progeny was compared with the transgene-negative progeny and weedy parent in pure and mixed planting of transgenic and nontransgenic plants under environmental conditions with natural vs. low insect pressure. Results showed that under natural insect pressure the insect-resistant transgenes could effectively suppress target insects and bring significantly increased fitness to transgenic plants in pure planting, compared with nontransgenic plants (including weedy parent). In contrast, no significant differences in fitness were detected under low insect pressure. However, such increase in fitness was not detected in the mixed planting of transgenic and nontransgenic plants due to significantly reduced insect pressure. Conclusions/Significance: Insect-resistance transgenes may have limited fitness advantages to hybrid progeny resulted from crop-weed transgene flow owning to the significantly reduced ambient target insect pressure when an insect-resistant GE crop is grown. Given that the extensive cultivation of an insect-resistant GE crop will ultimately reduce the target insect pressure, the rapid spread of insect-resistance transgenes in weedy populations in commercial GE crop fields may be not likely to happen.	[Yang, Xiao; Lu, Bao-Rong] Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Dept Ecol & Evolutionary Biol, Shanghai 200433, Peoples R China; [Wang, Feng; Su, Jun] Fujian Acad Agr Sci, Fujian Prov Key Lab Genet Engn Agr, Fuzhou, Peoples R China	Fudan University; Fujian Academy of Agricultural Sciences	Yang, X (corresponding author), Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Dept Ecol & Evolutionary Biol, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	yang, xiao/K-8509-2013; Lu, Bao-Rong/C-3130-2009	Lu, Bao-Rong/0000-0002-0214-2390; Yang, Xiao/0000-0002-2351-4827	Natural Science Foundation of China [30730066, 30871503]; National Program of Development of Transgenic New Species of China [2011ZX08011-006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Development of Transgenic New Species of China	This research was supported by the Natural Science Foundation of China (Grant no. 30730066 and 30871503), and National Program of Development of Transgenic New Species of China 2011ZX08011-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Cao QJ, 2009, J INTEGR PLANT BIOL, V51, P1138, DOI 10.1111/j.1744-7909.2009.00877.x; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Chen LY, 2006, AM J BOT, V93, P94, DOI 10.3732/ajb.93.1.94; Chen YH, 2002, ENVIRON ENTOMOL, V31, P626, DOI 10.1603/0046-225X-31.4.626; Cohen Michael B., 2008, Environmental Biosafety Research, V7, P73, DOI 10.1051/ebr:2008011; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; Delouche JC, 2007, FOOD AGR ORG UN PLAN, P144; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; FAO, 2004, AGR BIOT M NEEDS POO; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Hails RS, 2005, TRENDS ECOL EVOL, V20, P245, DOI 10.1016/j.tree.2005.02.006; Halfhill MD, 2005, MOL ECOL, V14, P3177, DOI 10.1111/j.1365-294X.2005.02649.x; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Haygood R, 2003, P ROY SOC B-BIOL SCI, V270, P1879, DOI 10.1098/rspb.2003.2426; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Jenczewski E, 2002, ENV BIOSAF RESERV, V2, P9; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Mason Peter, 2003, Environmental Biosafety Research, V2, P263, DOI 10.1051/ebr:2003016; MOA (Ministry of Agriculture China), 2009, 2 BATCH GEN MOD ORG; RAYBOULD AF, 1993, J APPL ECOL, V30, P199, DOI 10.2307/2404623; Rong J, 2005, NEW PHYTOL, V168, P559, DOI 10.1111/j.1469-8137.2005.01539.x; Snow AA, 1997, BIOSCIENCE, V47, P86, DOI 10.2307/1313019; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Vacher C, 2004, THEOR APPL GENET, V109, P806, DOI 10.1007/s00122-004-1696-7; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xia H, 2010, FIELD CROP RES, V118, P215, DOI 10.1016/j.fcr.2010.05.008; Yang X, 2011, EVOL APPL, V4, P672, DOI 10.1111/j.1752-4571.2011.00190.x	33	21	28	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41220	10.1371/journal.pone.0041220	http://dx.doi.org/10.1371/journal.pone.0041220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815975	Green Published, gold, Green Submitted			2022-12-25	WOS:000306507000081
J	Xi, CX; Hu, YZ; Buckhaults, P; Moskophidis, D; Mivechi, NF				Xi, Caixia; Hu, Yanzhong; Buckhaults, Phillip; Moskophidis, Demetrius; Mivechi, Nahid F.			Heat Shock Factor Hsf1 Cooperates with ErbB2 (Her2/Neu) Protein to Promote Mammary Tumorigenesis and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR HSF1; BREAST-CANCER; MOLECULAR CHAPERONES; TUMOR PROGRESSION; GROWTH; DISEASE; STRESS; LEADS; BETA	ErbB2/Neu oncogene is overexpressed in 25% of invasive/metastatic breast cancers. We have found that deletion of heat shock factor Hsf1 in mice overexpressing ErbB2/Neu significantly reduces mammary tumorigenesis and metastasis. Hsf1(+/-)ErbB2/Neu(+) tumors exhibit reduced cellular proliferative and invasive properties associated with reduced activated ERK1/2 and reduced epithelial-mesenchymal transition (EMT). Hsf1(+/+)Neu(+) mammary epithelial cells exposed to TGF beta show high levels of ERK1/2 activity and EMT; this is associated with reduced expression of E-cadherin and increased expression of Slug and vimentin, a mesenchymal marker. In contrast, Hsf1(-/-)Neu(+) or Hsf1(+/+)Neu(+) cells do not exhibit activated ERK1/2 and show reduced EMT in the presence of TGF beta. The ineffective activation of the RAS/RAF/MEK/ERK1/2 signaling pathway in cells with reduced levels of HSF1 is due to the low levels of HSP90 in complex with RAF1 that are required for RAF1 stability and maturation. These results indicate a powerful inhibitory effect conferred by HSF1 downstream target genes in the inhibition of ErbB2-induced breast cancers in the absence of the Hsf1 gene.	[Xi, Caixia; Hu, Yanzhong; Moskophidis, Demetrius; Mivechi, Nahid F.] Georgia Hlth Sci Univ, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA 30912 USA; [Buckhaults, Phillip] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Mivechi, NF (corresponding author), 1120 15th St,CN3141, Augusta, GA 30912 USA.	nmivechi@georgiahealth.edu			National Institutes of Health [CA062130, CA132640, CA121951]; NATIONAL CANCER INSTITUTE [R01CA132640, R01CA121951, R01CA062130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA062130 and CA132640 (to N.F.M.) and CA121951 (to D.M.). Georgia Health Sciences University was formerly known as the Medical College of Georgia.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Calderwood SK, 2010, INT J HYPERTHER, V26, P681, DOI 10.3109/02656736.2010.490254; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Ciocca DR, 2006, J STEROID BIOCHEM, V102, P32, DOI 10.1016/j.jsbmb.2006.09.008; Citri A, 2004, CELL CYCLE, V3, P51; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Foley John, 2010, Semin Cell Dev Biol, V21, P951, DOI 10.1016/j.semcdb.2010.08.009; Gabai VL, 2012, MOL CELL BIOL, V32, P929, DOI 10.1128/MCB.05921-11; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Homma S, 2007, J NEUROSCI, V27, P7974, DOI 10.1523/JNEUROSCI.0006-07.2007; Hu YZ, 2006, MOL CELL BIOL, V26, P3282, DOI 10.1128/MCB.26.8.3282-3294.2006; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jego G., 2010, CANC LETT IN PRESS; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Jin XJ, 2009, J CELL BIOCHEM, V107, P504, DOI 10.1002/jcb.22151; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Lee EYHP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003236; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Li YH, 2011, J GENET GENOMICS, V38, P111, DOI 10.1016/j.jgg.2011.02.001; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Meng L, 2011, ONCOGENE, V30, P2836, DOI 10.1038/onc.2011.5; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Pearson GW, 2007, J CELL BIOL, V179, P1555, DOI 10.1083/jcb.200706099; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Salinthone S, 2008, PHARMACOL THERAPEUT, V119, P44, DOI 10.1016/j.pharmthera.2008.04.005; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Yun CH, 2010, ARCH BIOCHEM BIOPHYS, V495, P8, DOI 10.1016/j.abb.2009.12.003; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	50	68	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35646	35657		10.1074/jbc.M112.377481	http://dx.doi.org/10.1074/jbc.M112.377481			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22847003	Green Published, hybrid			2022-12-25	WOS:000309968000076
J	Taxman, DJ; Swanson, KV; Broglie, PM; Wen, HT; Holley-Guthrie, E; Huang, MTH; Callaway, JB; Eitas, TK; Duncan, JA; Ting, JPY				Taxman, Debra J.; Swanson, Karen V.; Broglie, Peter M.; Wen, Haitao; Holley-Guthrie, Elizabeth; Huang, Max Tze-Han; Callaway, Justin B.; Eitas, Tim K.; Duncan, Joseph A.; Ting, Jenny P. Y.			Porphyromonas gingivalis Mediates Inflammasome Repression in Polymicrobial Cultures through a Novel Mechanism Involving Reduced Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; E-SELECTIN EXPRESSION; FUSOBACTERIUM-NUCLEATUM; ENDOTHELIAL-CELLS; HOST RESPONSE; MOUSE MODEL; PROTEIN; ACTIVATION; INHIBITION; LIPOPOLYSACCHARIDE	The interleukin (IL)-1 beta-processing inflammasome has recently been identified as a target for pathogenic evasion of the inflammatory response by a number of bacteria and viruses. We postulated that the periodontal pathogen, Porphyromonas gingivalis may suppress the inflammasome as a mechanism for its low immunogenicity and pathogenic synergy with other, more highly immunogenic periodontal bacteria. Our results show that P. gingivalis lacks signaling capability for the activation of the inflammasome in mouse macrophages. Furthermore, P. gingivalis can suppress inflammasome activation by another periodontal bacterium, Fusobacterium nucleatum. This repression affects IL-1 beta processing, as well as other inflammasome-mediated processes, including IL-18 processing and cell death, in both human and mouse macrophages. F. nucleatum activates IL-1 beta processing through the Nlrp3 inflammasome; however, P. gingivalis repression is not mediated through reduced levels of inflammasome components. P. gingivalis can repress Nlrp3 inflammasome activation by Escherichia coli, and by danger-associated molecular patterns and pattern-associated molecular patterns that mediate activation through endocytosis. However, P. gingivalis does not suppress Nlrp3 inflammasome activation by ATP or nigericin. This suggests that P. gingivalis may preferentially suppress endocytic pathways toward inflammasome activation. To directly test whether P. gingivalis infection affects endocytosis, we assessed the uptake of fluorescent particles in the presence or absence of P. gingivalis. Our results show that P. gingivalis limits both the number of cells taking up beads and the number of beads taken up for bead-positive cells. These results provide a novel mechanism of pathogen-mediated inflammasome inhibition through the suppression of endocytosis.	[Taxman, Debra J.; Swanson, Karen V.; Wen, Haitao; Holley-Guthrie, Elizabeth; Callaway, Justin B.; Eitas, Tim K.; Ting, Jenny P. Y.] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA; [Taxman, Debra J.; Swanson, Karen V.; Wen, Haitao; Holley-Guthrie, Elizabeth; Huang, Max Tze-Han; Callaway, Justin B.; Eitas, Tim K.; Duncan, Joseph A.; Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Broglie, Peter M.; Duncan, Joseph A.] Univ N Carolina, Div Infect Dis, Sch Med, Chapel Hill, NC 27599 USA; [Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Taxman, DJ (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA.	debra_taxman@med.unc.edu	Wen, Haitao/AAJ-7621-2020	Swanson, Karen V/0000-0003-3105-0599	National Institutes of Health [DE016326, AI029564, AI057157, AI088255]; UNC STD; HIV Training Program (National Institutes of Health) [T32AI007001]; Burroughs Wellcome Fund through the Career Award for Medical Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001, R56AI029564, R01AI029564, R01AI088255, U54AI057157, R37AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC STD; HIV Training Program (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund through the Career Award for Medical Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported, in whole or in part, by National Institutes of Health Grants DE016326, AI029564, and AI057157 (to J. T.) and AI088255 (to J. A. D).; Awardee of the UNC STD and HIV Training Program (National Institutes of Health Grant T32AI007001).; Supported by the Burroughs Wellcome Fund through the Career Award for Medical Scientists.	Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05; Belanger M, 2006, AUTOPHAGY, V2, P165, DOI 10.4161/auto.2828; Belibasakis G. N., 2012, INNATE IMMU IN PRESS; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Bostanci N, 2009, CLIN EXP IMMUNOL, V157, P415, DOI 10.1111/j.1365-2249.2009.03972.x; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Cutler Christopher W., 1995, Trends in Microbiology, V3, P45, DOI 10.1016/S0966-842X(00)88874-5; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; DARVEAU RP, 1995, INFECT IMMUN, V63, P1311, DOI 10.1128/IAI.63.4.1311-1317.1995; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Ebersole JL, 1997, MICROB PATHOGENESIS, V23, P23, DOI 10.1006/mpat.1996.0129; Feuille F, 1996, INFECT IMMUN, V64, P2095, DOI 10.1128/IAI.64.6.2094-2100.1996; GENCO CA, 1991, INFECT IMMUN, V59, P1255, DOI 10.1128/IAI.59.4.1255-1263.1991; Gregory SM, 2011, SCIENCE, V331, P330, DOI 10.1126/science.1199478; Hasegawa Y, 2008, INFECT IMMUN, V76, P2420, DOI 10.1128/IAI.00156-08; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Huang MTH, 2009, J IMMUNOL, V182, P2395, DOI 10.4049/jimmunol.0800909; Jin C., 2003, J CLIN IMMUNOL, V30, P628; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Lu Q, 2009, INNATE IMMUN-LONDON, V15, P325, DOI 10.1177/1753425909104899; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Metzger Z, 2009, J ENDODONT, V35, P86, DOI 10.1016/j.joen.2008.10.015; Nakhjiri SF, 2001, FEMS MICROBIOL LETT, V200, P145, DOI 10.1111/j.1574-6968.2001.tb10706.x; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Okugawa T, 2010, J DENT RES, V89, P186, DOI 10.1177/0022034509354843; Petit F, 1996, J VIROL, V70, P5860, DOI 10.1128/JVI.70.9.5860-5866.1996; Polak D, 2009, J CLIN PERIODONTOL, V36, P406, DOI 10.1111/j.1600-051X.2009.01393.x; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Reife RA, 2006, CELL MICROBIOL, V8, P857, DOI 10.1111/j.1462-5822.2005.00672.x; Reig N, 2008, CELL MICROBIOL, V10, P1190, DOI 10.1111/j.1462-5822.2008.01121.x; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yilmaz O, 2004, INFECT IMMUN, V72, P3743, DOI 10.1128/IAI.72.7.3743-3751.2004; Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x	50	61	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32791	32799		10.1074/jbc.M112.401737	http://dx.doi.org/10.1074/jbc.M112.401737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843689	Green Published, hybrid			2022-12-25	WOS:000309168300046
J	Weinreb, PH; Li, S; Gao, SX; Liu, T; Pepinsky, RB; Caravella, JA; Lee, JH; Woods, VL				Weinreb, Paul H.; Li, Sheng; Gao, Sharon X.; Liu, Tong; Pepinsky, R. Blake; Caravella, Justin A.; Lee, Jun H.; Woods, Virgil L., Jr.			Dynamic Structural Changes Are Observed upon Collagen and Metal Ion Binding to the Integrin alpha 1 I Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; LIGAND-MIMETIC ANTIBODY; DEPENDENT ADHESION SITE; PROTEIN-KINASE-A; CATION-BINDING; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODY; PHOSPHOLIPASE A(2); DIVALENT-CATIONS; H/D EXCHANGE	We have applied hydrogen-deuterium exchange mass spectrometry, in conjunction with differential scanning calorimetry and protein stability analysis, to examine solution dynamics of the integrin alpha 1 I domain induced by the binding of divalent cations, full-length type IV collagen, or a function-blocking monoclonal antibody. These studies revealed features of integrin activation and alpha 1I-ligand complexes that were not detected by static crystallographic data. Mg2+ and Mn2+ stabilized alpha 1I but differed in their effects on exchange rates in the alpha C helix. Ca2+ impacted alpha 1I conformational dynamics without altering its gross thermal stability. Interaction with collagen affected the exchange rates in just one of three metal ion-dependent adhesion site (MIDAS) loops, suggesting that MIDAS loop 2 plays a primary role in mediating ligand binding. Collagen also induced changes consistent with increased unfolding in both the alpha C and allosteric C-terminal helices of alpha 1I. The antibody AQC2, which binds to alpha 1I in a ligand-mimetic manner, also reduced exchange in MIDAS loop 2 and increased exchange in alpha C, but it did not impact the C-terminal region. This is the first study to directly demonstrate the conformational changes induced upon binding of an integrin I domain to a full-length collagen ligand, and it demonstrates the utility of the deuterium exchange mass spectrometry method to study the solution dynamics of integrin/ligand and integrin/metal ion interactions. Based on the ligand and metal ion binding data, we propose a model for collagen-binding integrin activation that explains the differing abilities of Mg2+, Mn2+, and Ca2+ to activate I domain-containing integrins.	[Weinreb, Paul H.] Biogen Idec Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA; [Li, Sheng; Liu, Tong; Lee, Jun H.; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA	Biogen; University of California System; University of California San Diego	Weinreb, PH (corresponding author), Biogen Idec Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA.	paul.weinreb@biogenidec.com; vwoods@ucsd.edu		Weinreb, Paul/0000-0002-0802-0052	National Institutes of Health [CA099835, CA118595, AI076961, AI072106, AI068730, AI081982, AI2008031, GM037684, GM020501, GM066170, GM093325, NS070899, RR029388]; University of California IUCRP Program, Biogen Idec [UC10591]; NATIONAL CANCER INSTITUTE [R33CA099835, R21CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, R21AI076961, R01AI081982, P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093325, F32GM020501, R01GM066170, R01GM020501, R01GM037684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California IUCRP Program, Biogen Idec; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA099835, CA118595, AI076961, AI072106, AI068730, AI081982, AI2008031, GM037684, GM020501, GM066170, GM093325, NS070899, and RR029388. This work was also supported by Discovery Grant UC10591 from the University of California IUCRP Program, Biogen Idec corporate sponsor (to V. L. W.).	Abraham WM, 2004, AM J RESP CRIT CARE, V169, P97, DOI 10.1164/rccm.200304-543OC; Ajroud K, 2004, J BIOL CHEM, V279, P25483, DOI 10.1074/jbc.M402901200; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; Bella J, 2000, STRUCTURE, V8, pR121, DOI 10.1016/S0969-2126(00)00153-2; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen L, 2007, ARCH OPHTHALMOL-CHIC, V125, P783, DOI 10.1001/archopht.125.6.783; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Coales SJ, 2009, RAPID COMMUN MASS SP, V23, P639, DOI 10.1002/rcm.3921; Cosgrove D, 2000, AM J PATHOL, V157, P1649, DOI 10.1016/S0002-9440(10)64802-X; de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X; Dickeson SK, 1999, J BIOL CHEM, V274, P32182, DOI 10.1074/jbc.274.45.32182; DUBAND JL, 1992, DEVELOPMENT, V116, P585; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gotwals PJ, 1999, BIOCHEMISTRY-US, V38, P8280, DOI 10.1021/bi982860m; Griggs DW, 1998, J BIOL CHEM, V273, P22113, DOI 10.1074/jbc.273.34.22113; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Hamuro Y., 2008, MASS SPECTROMETRY AN, P123; Hsu S, 2009, BIOCHEMISTRY-US, V48, P9891, DOI 10.1021/bi9008853; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ianaro A, 2000, LAB INVEST, V80, P73, DOI 10.1038/labinvest.3780010; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Karpusas M, 2003, J MOL BIOL, V327, P1031, DOI 10.1016/S0022-2836(03)00203-1; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; Lambert LJ, 2008, J BIOL CHEM, V283, P16665, DOI 10.1074/jbc.M710483200; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Liddington R, 1998, STRUCT FOLD DES, V6, P937, DOI 10.1016/S0969-2126(98)00094-X; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; LUQUE A, 1994, FEBS LETT, V346, P278, DOI 10.1016/0014-5793(94)00490-0; Mahalingam B, 2011, J IMMUNOL, V187, P6393, DOI 10.4049/jimmunol.1102394; Meharra EJ, 2000, CELL IMMUNOL, V201, P1, DOI 10.1006/cimm.2000.1630; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Nolte M, 1999, FEBS LETT, V452, P379, DOI 10.1016/S0014-5793(99)00666-3; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Obsil T, 1999, FEBS LETT, V457, P311, DOI 10.1016/S0014-5793(99)01063-7; Oyeyemi OA, 2010, P NATL ACAD SCI USA, V107, P10074, DOI 10.1073/pnas.1003678107; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Sacca B, 2002, CHEMBIOCHEM, V3, P904, DOI 10.1002/1439-7633(20020902)3:9<904::AID-CBIC904>3.0.CO;2-I; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; San Sebastian E, 2006, J AM CHEM SOC, V128, P3554, DOI 10.1021/ja054142a; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Truhlar SME, 2006, P NATL ACAD SCI USA, V103, P18951, DOI 10.1073/pnas.0605794103; Tu TT, 2010, J AM SOC MASS SPECTR, V21, P1660, DOI 10.1016/j.jasms.2010.03.030; Weinreb PH, 2002, ANAL BIOCHEM, V306, P305, DOI 10.1006/abio.2002.5723; Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022; Zhang HM, 2009, P NATL ACAD SCI USA, V106, P18345, DOI 10.1073/pnas.0909301106; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	77	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32897	32912		10.1074/jbc.M112.354365	http://dx.doi.org/10.1074/jbc.M112.354365			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22847004	Green Published, hybrid			2022-12-25	WOS:000309168300055
J	Heller, NM; Qi, XL; Gesbert, F; Keegan, AD				Heller, Nicola M.; Qi, Xiulan; Gesbert, Franck; Keegan, Achsah D.			The Extracellular and Transmembrane Domains of the gamma C and Interleukin (IL)-13 Receptor alpha 1 Chains, Not Their Cytoplasmic Domains, Dictate the Nature of Signaling Responses to IL-4 and IL-13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; EPITHELIAL-CELLS; SPECIES-SPECIFICITY; ASTHMA PATHOGENESIS; STRUCTURAL BASIS; FACTOR-I; T-CELLS; ACTIVATION; EXPRESSION; JAK3	Previously, we demonstrated that the gamma C subunit of type I IL-4 receptor was required for robust tyrosine phosphorylation of the downstream adapter protein, IRS-2, correlating with the expression of genes (ArgI, Retnla, and Chi3l3) characteristic of alternatively activated macrophages. We located an I4R-like motif (IRS-2 docking sequence) in the gamma C cytoplasmic domain but not in the IL-13R alpha 1. Thus, we predicted that the gamma C tail directed enhanced IRS-2 phosphorylation. To test this, IL-4 signaling responses were examined in a mutant of the key I4R motif tyrosine residue (Y325F) and different gamma C truncation mutants (gamma 285, gamma 308, gamma 318, gamma 323, and gamma FULL LENGTH (FL)) co-expressed in L-cells or CHO cells with wild-type (WT) IL-4R alpha. Surprisingly, IRS-1 phosphorylation was not diminished in Y325F L-cell mutants suggesting Tyr-325 was not required for the robust insulin receptor substrate response. IRS-2, STAT6, and JAK3 phosphorylation was observed in CHO cells expressing gamma 323 and gamma FL but not in gamma 318 and gamma 285 mutants. In addition, when CHO cells expressed gamma 318, gamma 323, or gamma FL with IL-2R beta, IL-2 induced phospho-STAT5 only in the gamma 323 and gamma FL clones. Our data suggest that a smaller (5 amino acid) interval than previously determined is necessary for JAK3 activation/gamma C-mediated signaling in response to IL-4 and IL-2. Chimeric receptor chains of the gamma C tail fused to the IL-13R alpha 1 extracellular and transmembrane domain did not elicit robust IRS-2 phosphorylation in response to IL-13 suggesting that the extracellular/transmembrane domains of the IL-4/IL-13 receptor, not the cytoplasmic domains, control signaling efficiency. Understanding this pathway fully will lead to rational drug design for allergic disease.	[Heller, Nicola M.; Qi, Xiulan; Keegan, Achsah D.] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Gesbert, Franck] Univ Paris 11, INSERM, UMR S1004, F-94807 Villejuif, France	University System of Maryland; University of Maryland Baltimore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Keegan, AD (corresponding author), Univ Maryland, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	akeegan@som.umaryland.edu		Gesbert, Franck/0000-0002-5800-8385	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096897, R00HL096897] Funding Source: NIH RePORTER; NHLBI NIH HHS [R00 HL096897, K99 HL096897] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Andrews RP, 2001, J IMMUNOL, V166, P1716, DOI 10.4049/jimmunol.166.3.1716; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; BONISCHNETZLER M, 1987, J BIOL CHEM, V262, P8395; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Coombs JH, 2010, ANN RHEUM DIS, V69, P413, DOI 10.1136/ard.2009.108159; Corrigall VM, 2001, J IMMUNOL, V166, P4141, DOI 10.4049/jimmunol.166.6.4141; GOLDSMITH MA, 1995, J BIOL CHEM, V270, P21729, DOI 10.1074/jbc.270.37.21729; Heller N., 2012, ALLERGIC DIS HIGHLIG, P43; Heller NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039673; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Kimura S, 2010, CURR OPIN INVEST DR, V11, P1442; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Lai SY, 1997, J CLIN INVEST, V99, P169, DOI 10.1172/JCI119144; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; LEE JS, 1993, J BIOL CHEM, V268, P4092; Lesur O, 1997, AM J PHYSIOL-LUNG C, V273, pL495, DOI 10.1152/ajplung.1997.273.3.L495; Lindemann MJ, 2003, J BIOL CHEM, V278, P10239, DOI 10.1074/jbc.M209471200; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; LOWENTHAL JW, 1988, J IMMUNOL, V140, P456; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; Malarde V, 2009, BIOCHEM BIOPH RES CO, V387, P409, DOI 10.1016/j.bbrc.2009.07.041; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MOSMANN TR, 1987, J IMMUNOL, V138, P1813; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; Muthukumaran G, 1997, J BIOL CHEM, V272, P4993, DOI 10.1074/jbc.272.8.4993; Nelson BH, 1996, MOL CELL BIOL, V16, P309; Ozawa A, 2003, J LEUKOCYTE BIOL, V74, P352, DOI 10.1189/jlb.0103044; PARK LS, 1987, P NATL ACAD SCI USA, V84, P1669, DOI 10.1073/pnas.84.6.1669; PARK LS, 1987, J EXP MED, V166, P476, DOI 10.1084/jem.166.2.476; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Quaedackers ME, 2009, TRANSPLANTATION, V88, P1002, DOI 10.1097/TP.0b013e3181b9ced7; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; REINECKER HC, 1995, P NATL ACAD SCI USA, V92, P8353, DOI 10.1073/pnas.92.18.8353; Rothenberg ME, 2011, J IMMUNOL, V187, P4873, DOI 10.4049/jimmunol.1004159; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; van der Velden VHJ, 1998, CYTOKINE, V10, P803, DOI 10.1006/cyto.1998.0365; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wang HY, 1996, IMMUNITY, V4, P113, DOI 10.1016/S1074-7613(00)80676-7; Wang HY, 1998, J BIOL CHEM, V273, P9898, DOI 10.1074/jbc.273.16.9898; WANG LM, 1995, BLOOD, V86, P4218, DOI 10.1182/blood.V86.11.4218.bloodjournal86114218; Weidemann T, 2007, J MOL BIOL, V366, P1365, DOI 10.1016/j.jmb.2006.11.095; West K, 2009, CURR OPIN INVEST DR, V10, P491; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Witthuhn BA, 1999, LEUKEMIA LYMPHOMA, V32, P289, DOI 10.3109/10428199909167389; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Zhong J, 2010, MOL IMMUNOL, V47, P1207, DOI 10.1016/j.molimm.2009.12.017	53	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31948	31961		10.1074/jbc.M112.348896	http://dx.doi.org/10.1074/jbc.M112.348896			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829596	Green Published, hybrid			2022-12-25	WOS:000309059400034
J	Shteingart, S; Hadar, R; Cohen, I; Ravid, T; Tirosh, B				Shteingart, Shimon; Hadar, Rivka; Cohen, Itamar; Ravid, Tommer; Tirosh, Boaz			Endoplasmic Reticulum Stress Induces a Caspase-dependent N-terminal Cleavage of RBX1 Protein in B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; TRANSCRIPTION FACTOR XBP-1; ER-ASSOCIATED DEGRADATION; CULLIN-RING LIGASES; MYELOMA CELLS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL INSIGHTS; NLRP3 INFLAMMASOME; IFN-GAMMA; DIFFERENTIATION	Endoplasmic reticulum (ER) stress develops when the ER is overloaded with too many proteins to fold. This elicits a signaling pathway called the unfolded protein response. The unfolded protein response is physiologically required for the terminal development of B cells into antibody-secreting plasma cells. Ring Box Protein 1 (RBX1) is a 14-kDa protein necessary for ubiquitin ligation activity of the multimeric cullin ring ubiquitin ligases (CRLs). As RBX1 is shared by a large number of CRLs, alterations in its activity may lead to global changes in protein stability. We discovered that RBX1 is cleaved in the course of LPS-induced plasma cell differentiation and in multiple myeloma cell lines upon induction of pharmacological ER stress. The cleavage is executed by several caspase proteases that cleave RBX1 eight amino acids from the N terminus. To address the possible implication of RBX1 cleavage for CRL activity, we replaced the endogenous RBX1 homolog of the yeast Saccharomyces cerevisiae, Roc1, with the wild type or the N-terminal Delta 8 mutant human RBX1. We show that yeast expressing the cleaved RBX1 are hypersensitive to ER stress and are impaired in CRL-mediated ubiquitination and degradation. We propose a model by which N-terminal cleavage of RBX1 impairs its activity and promotes susceptibility to ER stress induction.	[Cohen, Itamar; Ravid, Tommer] Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Shteingart, Shimon; Hadar, Rivka; Tirosh, Boaz] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ravid, T (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel.	travid@cc.huji.ac.il; boazt@ekmd.huji.ac.il		Shteingart, Shimon/0000-0002-3975-0138	David R. Bloom Center for Pharmacy; Rosetrees Trust; Israel Cancer Association; Israel Science Foundation [78/09, 786/08]	David R. Bloom Center for Pharmacy; Rosetrees Trust(Rosetrees Trust); Israel Cancer Association; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the David R. Bloom Center for Pharmacy, the Rosetrees Trust, Israel Cancer Association, and Israel Science Foundation Grants 78/09 (to B. T.) and Grant 786/08 (to T. R.).	Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; COZZOLINO F, 1989, BLOOD, V74, P380; Duan HJ, 1999, MOL CELL BIOL, V19, P3145; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu HT, 2008, MOL CANCER THER, V7, P2298, DOI 10.1158/1535-7163.MCT-08-0186; Gu QY, 2007, CANCER RES, V67, P3616, DOI 10.1158/0008-5472.CAN-06-4020; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hassan G, 1997, J HEPATOL, V27, P6, DOI 10.1016/S0168-8278(97)80273-5; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KRONHEIM SR, 1992, ARCH BIOCHEM BIOPHYS, V296, P698, DOI 10.1016/0003-9861(92)90629-B; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee CK, 2000, J IMMUNOL, V164, P1286, DOI 10.4049/jimmunol.164.3.1286; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Obermeier F, 1999, J LEUKOCYTE BIOL, V66, P829, DOI 10.1002/jlb.66.5.829; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ohta T, 1999, ONCOGENE, V18, P6758, DOI 10.1038/sj.onc.1203115; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pal B, 2007, MOL BIOL CELL, V18, P426, DOI 10.1091/mbc.E06-04-0304; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Sun Y, 2001, ANTIOXID REDOX SIGN, V3, P635, DOI 10.1089/15230860152542989; Swaroop M, 2000, ONCOGENE, V19, P2855, DOI 10.1038/sj.onc.1203635; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai Yien Che, 2010, Genes Cancer, V1, P764; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Wei Dongping, 2010, Genes Cancer, V1, P700, DOI 10.1177/1947601910382776; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	50	0	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31223	31232		10.1074/jbc.M111.314583	http://dx.doi.org/10.1074/jbc.M111.314583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822056	Green Published, hybrid			2022-12-25	WOS:000308791300035
J	Nagel, S; Ehrentraut, S; Tomasch, J; Lienenklaus, S; Schneider, B; Geffers, R; Meyer, C; Kaufmann, M; Drexler, HG; MacLeod, RAF				Nagel, Stefan; Ehrentraut, Stefan; Tomasch, Juergen; Lienenklaus, Stefan; Schneider, Bjoern; Geffers, Robert; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.			Transcriptional Activation of Prostate Specific Homeobox Gene NKX3-1 in Subsets of T-Cell Lymphoblastic Leukemia (T-ALL)	PLOS ONE			English	Article							EXPRESSION SIGNATURES; MULTIPLE MECHANISMS; PROTEINS; LINES; PROMOTES; TAL1; DIFFERENTIATION; JUXTAPOSITION; PROLIFERATION; REGULATORS	Homeobox genes encode transcription factors impacting key developmental processes including embryogenesis, organogenesis, and cell differentiation. Reflecting their tight transcriptional control, homeobox genes are often embedded in large non-coding, cis-regulatory regions, containing tissue specific elements. In T-cell acute lymphoblastic leukemia (T-ALL) homeobox genes are frequently deregulated by chromosomal aberrations, notably translocations adding T-cell specific activatory elements. NKX3-1 is a prostate specific homeobox gene activated in T-ALL patients expressing oncogenic TAL1 or displaying immature T-cell characteristics. After investigating regulation of NKX3-1 in primary cells and cell lines, we report its ectopic expression in T-ALL cells independent of chromosomal rearrangements. Using siRNAs and expression profiling, we exploited NKX3-1 positive T-ALL cell lines as tools to investigate aberrant activatory mechanisms. Our data confirmed NKX3-1 activation by TAL1/GATA3/LMO and identified LYL1 as an alternative activator in immature T-ALL cells devoid of GATA3. Moreover, we showed that NKX3-1 is directly activated by early T-cell homeodomain factor MSX2. These activators were regulated by MLL and/or by IL7-, BMP4- and IGF2-signalling. Finally, we demonstrated homeobox gene SIX6 as a direct leukemic target of NKX3-1 in T-ALL. In conclusion, we identified three major mechanisms of NKX3-1 regulation in T-ALL cell lines which are represented by activators TAL1, LYL1 and MSX2, corresponding to particular T-ALL subtypes described in patients. These results may contribute to the understanding of leukemic transcriptional networks underlying disturbed T-cell differentiation in T-ALL.	[Nagel, Stefan; Ehrentraut, Stefan; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, Braunschweig, Germany; [Schneider, Bjoern] Univ Rostock, Inst Pathol, Rostock, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Helmholtz Association; Helmholtz-Center for Infection Research; University of Rostock	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de	Lienenklaus, Stefan/HIK-0899-2022	Tomasch, Jurgen/0000-0002-3914-2781; Lienenklaus, Stefan/0000-0003-4790-3445				BEGUEKIRN C, 1994, INT J DEV BIOL, V38, P405; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Casolaro V, 2000, J BIOL CHEM, V275, P36605, DOI 10.1074/jbc.M007086200; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; Chen S, 2011, LEUKEMIA, V25, P1632, DOI 10.1038/leu.2011.119; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Ferrando AA, 2004, BLOOD, V103, P1909, DOI 10.1182/blood-2003-07-2577; Ferrando AA, 2003, BLOOD, V102, P262, DOI 10.1182/blood-2002-10-3221; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Finetti F, 2011, TRENDS IMMUNOL, V32, P139, DOI 10.1016/j.it.2011.02.001; Graux C, 2006, LEUKEMIA, V20, P1496, DOI 10.1038/sj.leu.2404302; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; Homminga I, 2012, LEUKEMIA, V26, P572, DOI 10.1038/leu.2011.330; Kecha O, 2000, ENDOCRINOLOGY, V141, P1209, DOI 10.1210/en.141.3.1209; KEES UR, 1987, LEUKEMIA RES, V11, P489, DOI 10.1016/0145-2126(87)90082-8; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Lee SH, 2009, BIOCHEM BIOPH RES CO, V381, P214, DOI 10.1016/j.bbrc.2009.02.026; Li X, 2002, SCIENCE, V297, P1180; Licona-Limon P, 2007, IMMUNOL LETT, V109, P1, DOI 10.1016/j.imlet.2006.12.010; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; Nagel S, 2003, CANCER RES, V63, P5329; Nagel S, 2011, LEUKEMIA LYMPHOMA, V52, P1348, DOI 10.3109/10428194.2011.566391; Nagel S, 2011, LEUKEMIA LYMPHOMA, V52, P290, DOI 10.3109/10428194.2010.537003; Nagel S, 2010, LEUKEMIA RES, V34, P521, DOI 10.1016/j.leukres.2009.06.020; Nagel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-371; Nakamura TY, 2011, CIRC RES, V109, P512, DOI 10.1161/CIRCRESAHA.111.248864; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Porter BO, 2000, SEMIN IMMUNOL, V12, P465, DOI 10.1006/smim.2000.0264; Prins GS, 2008, DIFFERENTIATION, V76, P641, DOI 10.1111/j.1432-0436.2008.00277.x; Rice KL, 2008, LEUKEMIA RES, V32, P873, DOI 10.1016/j.leukres.2007.11.001; Riz I, 2009, BIOCHEM BIOPH RES CO, V380, P361, DOI 10.1016/j.bbrc.2009.01.099; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Ryan DP, 2008, PROTEINS, V70, P1461, DOI 10.1002/prot.21638; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418	53	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40747	10.1371/journal.pone.0040747	http://dx.doi.org/10.1371/journal.pone.0040747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848398	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200029
J	Wu, Y; Wang, JX; Xu, T; Liu, JR; Yu, WQ; Lou, Q; Zhu, T; He, NA; Ben, HJ; Hu, J; Gotz, F; Qu, D				Wu, Yang; Wang, Jiaxue; Xu, Tao; Liu, Jingran; Yu, Wenqi; Lou, Qiang; Zhu, Tao; He, Nianan; Ben, Haijing; Hu, Jian; Goetz, Friedrich; Qu, Di			The Two-Component Signal Transduction System ArlRS Regulates Staphylococcus epidermidis Biofilm Formation in an ica-Dependent Manner	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI; ESCHERICHIA-COLI BIOFILMS; IN-VIVO; PROTEOLYTIC ACTIVITY; GENE-EXPRESSION; MAJOR ROLE; AUREUS; SARA; VIRULENCE	Due to its ability to form biofilms on medical devices, Staphylococcus epidermidis has emerged as a major pathogen of nosocomial infections. In this study, we investigated the role of the two-component signal transduction system ArlRS in regulating S. epidermidis biofilm formation. An ArlRS-deficient mutant, WW06, was constructed using S. epidermidis strain 1457 as a parental strain. Although the growth curve of WW06 was similar to that of SE1457, the mutant strain was unable to form biofilms in vitro. In a rabbit subcutaneous infection model, sterile disks made of polymeric materials were implanted subcutaneously followed with inoculation of WW06 or SE1457. The viable bacteria cells of WW06 recovered from biofilms on the embedded disks were much lower than that of SE1457. Complementation of arlRS genes expression from plasmid in WW06 restored biofilm-forming phenotype both in vivo and in vitro. WW06 maintained the ability to undergo initial attachment. Transcription levels of several genes involved in biofilm formation, including icaADBC, sigB, and sarA, were decreased in WW06, compared to SE1457; and icaR expression was increased in WW06, detected by real-time reverse-transcription PCR. The biofilm-forming phenotype was restored by overexpressing icaADBC in WW06 but not by overexpressing sigB, indicating that ArlRS regulates biofilm formation through the regulation of icaADBC. Gel shift assay showed that ArlR can bind to the promoter region of the ica operon. In conclusion, ArlRS regulates S. epidermidis biofilm formation in an ica-dependent manner, distinct from its role in S. aureus.	[Wu, Yang; Wang, Jiaxue; Xu, Tao; Liu, Jingran; Lou, Qiang; Zhu, Tao; Ben, Haijing; Hu, Jian; Qu, Di] Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wu, Yang; Wang, Jiaxue; Xu, Tao; Liu, Jingran; Lou, Qiang; Zhu, Tao; Ben, Haijing; Hu, Jian; Qu, Di] Fudan Univ, Inst Med Microbiol, Shanghai Med Coll, Minist Publ Hlth, Shanghai 200433, Peoples R China; [Wu, Yang; Wang, Jiaxue; Xu, Tao; Liu, Jingran; Lou, Qiang; Zhu, Tao; Ben, Haijing; Hu, Jian; Qu, Di] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yu, Wenqi; Goetz, Friedrich] Univ Tubingen, Tubingen, Germany; [He, Nianan] Fudan Univ, Zhongshan Hosp, Dept Ultrasound, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Eberhard Karls University of Tubingen; Fudan University	Wu, Y (corresponding author), Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	dqu@shmu.edu.cn	Qu, Di/AAO-4590-2020		National Science and Technology Major Project of China [2012ZX09301002-005, 2012ZX10003008-010]; National Natural Science Foundation of China [81101214, 30800036, J0730860]; Scientific Technology Development Foundation of Shanghai [10410700600, 09DZ1908602]; Program of Ministry of Science and Technology of China [2010DFA32100]; Specialized Research Fund for the Doctoral Program of Higher Education [20100071120049]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Development Foundation of Shanghai; Program of Ministry of Science and Technology of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Science and Technology Major Project of China [2012ZX09301002-005, 2012ZX10003008-010; http://www. nmp.gov.cn], the National Natural Science Foundation of China [81101214, 30800036, J0730860; http://www. nsfc.gov.cn/Portal0/default106.htm], the Scientific Technology Development Foundation of Shanghai [10410700600, 09DZ1908602;http:// www.stcsm.gov.cn], the Program of Ministry of Science and Technology of China [2010DFA32100;http://www. nmp.gov.cn], and the Specialized Research Fund for the Doctoral Program of Higher Education [20100071120049; http://www.cutech.edu.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Carmen JC, 2004, J BIOMATER APPL, V18, P237, DOI 10.1177/0885328204040540; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176; Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Lou Q, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-146; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rediske AM, 1999, ANTIMICROB AGENTS CH, V43, P1211, DOI 10.1128/AAC.43.5.1211; Rediske AM, 2000, ANTIMICROB AGENTS CH, V44, P771, DOI 10.1128/AAC.44.3.771-772.2000; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun ZP, 2009, J MICROBES INFECT, V4, P92; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005; Trotonda MP, 2005, J BACTERIOL, V187, P5790, DOI 10.1128/JB.187.16.5790-5798.2005; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x; Zhu T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-287; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	50	31	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40041	10.1371/journal.pone.0040041	http://dx.doi.org/10.1371/journal.pone.0040041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848368	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200016
J	Lin, XB; Dieleman, LA; Ketabi, A; Bibova, I; Sawyer, MB; Xue, HY; Field, CJ; Baracos, VE; Ganzle, MG				Lin, Xiaoxi B.; Dieleman, Levinus A.; Ketabi, Ali; Bibova, Ilona; Sawyer, Michael B.; Xue, Hongyu; Field, Catherine J.; Baracos, Vickie E.; Gaenzle, Michael G.			Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats	PLOS ONE			English	Article							BETA-GLUCURONIDASE; PARENTERAL GLUTAMINE; HYDROCHLORIDE CPT-11; ANTITUMOR EFFICACY; COLORECTAL-CANCER; FECAL MICROFLORA; DIARRHEA; TOXICITY; INHIBITION; MODULATION	Intestinal microbiota mediate toxicity of irinotecan (CPT-11) cancer therapies and cause systemic infection after CPT-11-induced loss of barrier function. The intestinal microbiota and their functions are thus potential targets for treatment to mitigate CPT-11 toxicity. However, microbiota changes during CPT-11 therapy remain poorly described. This study analysed changes in intestinal microbiota induced by CPT-11 chemotherapy. Qualitative and quantitative taxonomic analyses, and functional analyses were combined to characterize intestinal microbiota during CPT-11-based chemotherapy, and in presence or absence of oral glutamine, a treatment known to reduce CPT-11 toxicity. In the first set of experiments tumour-bearing rats received a dose-intensive CPT-11 regimen (125 mg kg(-1)x3 days), with or without oral glutamine bolus (0.75 g kg(-1)). In a subsequent more clinically-oriented chemotherapy regimen, rats received two cycles of CPT-11 (50 mg kg(-1)) followed by 5-flurouracil (50 mg kg(-1)). The analysis of fecal samples over time demonstrated that tumours changed the composition of intestinal microbiota, increasing the abundance of clostrridial clusters I, XI, and Enterobacteriaceae. CPT-11 chemotherapy increased cecal Clostridium cluster XI and Enterobacteriaceae, particularly after the dose-intensive therapy. Glutamine treatment prevented the reduced abundance of major bacterial groups after CPT-11 administration; i.e. total bacteria, Clostridium cluster VI, and the Bacteroides-group. Virulence factor/toxin genes of pathogenic Escherichia coli and Clostridium difficile were not detected in the cecal microbiota. In conclusion, both colon cancer implantation and CPT-11-based chemotherapies disrupted the intestinal microbiota. Oral glutamine partially mitigated CPT-11 toxicity and induced temporary changes of the intestinal microbiota.	[Lin, Xiaoxi B.; Ketabi, Ali; Bibova, Ilona; Field, Catherine J.; Gaenzle, Michael G.] Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada; [Dieleman, Levinus A.] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Sawyer, Michael B.; Xue, Hongyu; Baracos, Vickie E.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Ganzle, MG (corresponding author), Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada.	mgaenzle@ualberta.ca	Xue, Hongyu/E-4201-2013; Bibova, Ilona/J-8051-2014; Gänzle, Michael/F-1432-2017; Dieleman, Levinus/AAT-8198-2021	Gänzle, Michael/0000-0003-0972-928X; Bibova, Ilona/0000-0002-0839-8434; Dieleman, Levinus/0000-0001-7852-2122; Baracos, Vickie/0000-0002-9609-1001; Field, Catherine/0000-0001-7285-4767	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; AFNS PhD Entrance Scholarship; Canada Research Chairs Program; Crohn's and Colitis Foundation of Canada (CCFC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); AFNS PhD Entrance Scholarship; Canada Research Chairs Program(Canada Research Chairs); Crohn's and Colitis Foundation of Canada (CCFC)	The Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council are acknowledged for funding. X.X.B. Lin acknowledges support by the AFNS PhD Entrance Scholarship; M.G. Ganzle acknowledges the Canada Research Chairs Program for funding. L.A. Dieleman was supported by the Crohn's and Colitis Foundation of Canada (CCFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold Renee J Goldberg, 2005, J Support Oncol, V3, P227; Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Dawson LF, 2009, INFECT GENET EVOL, V9, P1410, DOI 10.1016/j.meegid.2009.06.005; Decker-Baumann C, 1999, EUR J CANCER, V35, P202, DOI 10.1016/S0959-8049(98)00389-X; Dorofeyev AE, 2009, DIGEST DIS, V27, P502, DOI 10.1159/000233289; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Faber J, 2009, ONCOL REP, V22, P1403, DOI 10.3892/or_00000581; Franks AH, 2008, APPL ENVIRON MICROB, V64, P3336; Goodhand JR, 2011, ALIMENT PHARM THER, V33, P428, DOI 10.1111/j.1365-2036.2010.04548.x; GUPTA E, 1994, CANCER RES, V54, P3723; Hautmann MG, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-89; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; IKUNO N, 1995, J NATL CANCER I, V87, P1876, DOI 10.1093/jnci/87.24.1876; Janda JM, 2008, PRACTICAL HDB MICROB, P217; Jermy A, 2010, NAT REV MICROBIOL, V8, P838, DOI 10.1038/nrmicro2479; Koleva PT, 2012, BRIT J NUTR, V108, P1633, DOI 10.1017/S0007114511007203; Kurita A, 2011, CANCER CHEMOTH PHARM, V67, P201, DOI 10.1007/s00280-010-1310-4; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Lv ML, 2011, FRONT BIOSCI-LANDMRK, V16, P2515, DOI 10.2741/3869; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Manhart N, 2001, ANN SURG, V234, P92, DOI 10.1097/00000658-200107000-00014; Marteau P, 2011, DIGEST DIS, V29, P166, DOI 10.1159/000323879; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Picazo JJ, 2005, INT J ANTIMICROB AG, V26, pS120, DOI 10.1016/j.ijantimicag.2005.07.010; Reeds PJ, 2001, J NUTR, V131, p2505S, DOI 10.1093/jn/131.9.2505S; Rothenberg ML, 2001, ONCOLOGIST, V6, P66, DOI 10.1634/theoncologist.6-1-66; Schloerb PR, 1999, JPEN-PARENTER ENTER, V23, P117, DOI 10.1177/0148607199023003117; Sinh P, 2011, GASTROENTER IN PRESS; Sparreboom A, 1998, CLIN CANCER RES, V4, P2747; Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940; Stringer AM, 2009, CURR DRUG METAB, V10, P79, DOI 10.2174/138920009787048419; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Takasuna K, 1996, CANCER RES, V56, P3752; Takasuna K, 1998, CANCER CHEMOTH PHARM, V42, P280, DOI 10.1007/s002800050818; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Trifan OC, 2002, CANCER RES, V62, P5778; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wiegand PN, 2012, J HOSP INFECT; Xue HY, 2008, J NUTR, V138, P740, DOI 10.1093/jn/138.4.740; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P74, DOI 10.1177/0148607110377338; Yang XX, 2006, J PHARMACOL EXP THER, V319, P82, DOI 10.1124/jpet.106.103606; Zwielehner JC, 2010, THESIS U WIEN	48	95	107	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e39764	10.1371/journal.pone.0039764	http://dx.doi.org/10.1371/journal.pone.0039764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844397	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600004
J	Huang, SP; Bao, BY; Hour, TC; Huang, CY; Yu, CC; Liu, CC; Lee, YC; Huang, CN; Pao, JB; Huang, CH				Huang, Shu-Pin; Bao, Bo-Ying; Hour, Tzyh-Chyuan; Huang, Chao-Yuan; Yu, Chia-Cheng; Liu, Chia-Chu; Lee, Yung-Chin; Huang, Chun-Nung; Pao, Jiunn-Bey; Huang, Chun-Hsiung			Genetic Variants in CASP3, BMP5, and IRS2 Genes May Influence Survival in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RECEPTOR SUBSTRATE-1; SUSCEPTIBILITY LOCI; INCREASED EXPRESSION; MULTIPLE LOCI; IDENTIFICATION; POLYMORPHISMS; MORTALITY	Several genome-wide association studies (GWAS) have been conducted to identify the common single nucleotide polymorphisms (SNPs) that influence the risk of prostate cancer. It was hypothesized that some prostate cancer-associated SNPs might relate to the clinical outcomes in patients treated for prostate cancer using androgen-deprivation therapy (ADT). A cohort of 601 patients who have received ADT for prostate cancer was genotyped for 29 SNPs that have been associated with prostate cancer in Cancer Genetic Markers of Susceptibility GWAS, and within the genes that have been implicated in cancer. Prognostic significance of these SNPs on the disease progression, prostate cancer-specific mortality (PCSM) and all-cause mortality (ACM) after ADT were assessed by Kaplan-Meier analysis and Cox regression model. Three SNPs, namely CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346, were found to be closely associated with the ACM (P <= 0.042), and BMP5 rs3734444 and IRS2 rs7986346 were also noted to be significantly related to the PCSM (P <= 0.032) after adjusting for the known clinicopathologic predictors. Moreover, patients carrying a greater number of unfavorable genotypes at the loci of interest had a shorter time to ACM and PCSM during ADT (P for trend <0.001). Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	[Huang, Shu-Pin; Liu, Chia-Chu; Lee, Yung-Chin; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin; Liu, Chia-Chu; Lee, Yung-Chin; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Bao, Bo-Ying] China Med Univ, Dept Pharm, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan; [Hour, Tzyh-Chyuan] Kaohsiung Med Univ, Inst Biochem, Kaohsiung, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Yu, Chia-Cheng] Kaohsiung Vet Gen Hosp, Dept Surg, Div Urol, Kaohsiung, Taiwan; [Pao, Jiunn-Bey] Taipei City Hosp, Yangming Branch, Dept Pharm, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Veterans General Hospital; Taipei City Hospital	Huang, SP (corresponding author), Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan.	shpihu@yahoo.com.tw	LIU, CHIA CHU/T-2880-2019; Bao, Bo-Ying/D-1789-2012; Bao, Bo-Ying/H-4589-2019	Bao, Bo-Ying/0000-0001-5510-6513; Bao, Bo-Ying/0000-0001-5510-6513; HUANG, CHAO-YUAN/0000-0002-9322-6062	NSC [NSC-98-2320-B-039-019-MY3, NSC-99-2314-B-037-018-MY3, NSC-100-2314-B-039-009-MY3]; China Medical University [CMU99-COL-13]	NSC(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	This work was supported by the NSC grants NSC-98-2320-B-039-019-MY3, NSC-99-2314-B-037-018-MY3, NSC-100-2314-B-039-009-MY3, and China Medical University grant CMU99-COL-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Bao BY, 2012, INT J CANCER, V130, P876, DOI 10.1002/ijc.26091; Bao BY, 2011, CLIN CANCER RES, V17, P928, DOI 10.1158/1078-0432.CCR-10-2648; BENTLEY H, 1992, BRIT J CANCER, V66, P1159, DOI 10.1038/bjc.1992.427; Bergmann U, 1996, BIOCHEM BIOPH RES CO, V220, P886, DOI 10.1006/bbrc.1996.0500; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Chang Q, 2002, CANCER RES, V62, P6035; Doak SH, 2007, CANCER GENET CYTOGEN, V176, P161, DOI 10.1016/j.cancergencyto.2007.03.011; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; HARRIS SE, 1994, PROSTATE, V24, P204, DOI 10.1002/pros.2990240406; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang CN, 2012, J INTERN MED, V271, P499, DOI 10.1111/j.1365-2796.2011.02449.x; Huang CN, 2012, ANN ONCOL, V23, P707, DOI 10.1093/annonc/mdr264; Huang SP, 2009, CANCER EPIDEM BIOMAR, V18, P3068, DOI 10.1158/1055-9965.EPI-09-0665; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Pao JB, 2013, WORLD J UROL, V31, P281, DOI 10.1007/s00345-011-0813-x; Smith MR, 2006, J CLIN ENDOCR METAB, V91, P1305, DOI 10.1210/jc.2005-2507; Stewart AJ, 2005, J CLIN ONCOL, V23, P6556, DOI 10.1200/JCO.2005.20.966; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Szabolcs M, 2009, AM J PATHOL, V174, P276, DOI 10.2353/ajpath.2009.080086; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Tanaka S, 1996, J CLIN INVEST, V98, P2100, DOI 10.1172/JCI119016; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490	39	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41219	10.1371/journal.pone.0041219	http://dx.doi.org/10.1371/journal.pone.0041219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844442	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700056
J	Mokrousov, I; Vyazovaya, A; Otten, T; Zhuravlev, V; Pavlova, E; Tarashkevich, L; Krishevich, V; Vishnevsky, B; Narvskaya, O				Mokrousov, Igor; Vyazovaya, Anna; Otten, Tatiana; Zhuravlev, Viacheslav; Pavlova, Elena; Tarashkevich, Larisa; Krishevich, Valery; Vishnevsky, Boris; Narvskaya, Olga			Mycobacterium tuberculosis Population in Northwestern Russia: An Update from Russian-EU/Latvian Border Region	PLOS ONE			English	Article							DRUG-RESISTANT; BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; GENETIC DIVERSITY; STRAINS; FAMILY; PREVALENCE; SPREAD; OBLAST	This study aimed to characterize the population structure of Mycobacterium tuberculosis in Pskov oblast in northwestern Russia, to view it in the geographical context, to compare drug resistance properties across major genetic families. Ninety M. tuberculosis strains from tuberculosis (TB) patients, permanent residents in Pskov oblast were subjected to LAM-specific IS6110-PCR and spoligotyping, followed by comparison with SITVITWEB and MIRU-VNTRplus databases. The Beijing genotype (n = 40) was found the most prevalent followed by LAM (n = 18), T (n = 13), Haarlem (n = 10), Ural (n = 5), and Manu2 (n = 1); the family status remained unknown for 3 isolates. The high rate of Beijing genotype and prevalence of LAM family are similar to those in the other Russian settings. A feature specific for M. tuberculosis population in Pskov is a relatively higher rate of Haarlem and T types. Beijing strains were further typed with 12-MIRU (followed by comparison with proprietary global database) and 3 hypervariable loci QUB-3232, VNTR-3820, VNTR-4120. The 12-MIRU typing differentiated 40 Beijing strains into 14 types (HGI = 0.82) while two largest types were M2 (223325153533) prevalent throughout former USSR and M11 (223325173533) prevalent in Russia and East Asia. The use of 3 hypervariable loci increased a discrimination of the Beijing strains (18 profiles, HGI = 0.89). Both major families Beijing and LAM had similar rate of MDR strains (62.5 and 55.6%, respectively) that was significantly higher than in other strains (21.9%; P = 0.001 and 0.03, respectively). The rpoB531 mutations were more frequently found in Beijing strains while LAM drug resistant strains mainly harbored rpoB516 and inhA -15 mutations. Taken together with a high rate of multidrug resistance among Beijing strains from new TB cases (79.3% versus 44.4% in LAM), these findings suggest the critical impact of the Beijing genotype on the current situation with MDR-TB in the Pskov region in northwestern Russia.	[Mokrousov, Igor; Vyazovaya, Anna; Narvskaya, Olga] St Petersburg Pasteur Inst, Mol Microbiol Lab, St Petersburg, Russia; [Otten, Tatiana; Vishnevsky, Boris] Res Inst Phthisiopulmonol, Microbiol Lab, St Petersburg, Russia; [Zhuravlev, Viacheslav] Res Inst Phthisiopulmonol, Lab Mol Genet Methods, St Petersburg, Russia; [Pavlova, Elena; Tarashkevich, Larisa; Krishevich, Valery] Pskov Oblast AntiTB Dispensary, Bacteriol Lab, Pskov, Russia	Saint-Petersburg Pasteur Institute; St. Petersburg State Research Institute of Phthisiopulmonology; St. Petersburg State Research Institute of Phthisiopulmonology	Mokrousov, I (corresponding author), St Petersburg Pasteur Inst, Mol Microbiol Lab, St Petersburg, Russia.	imokrousov@mail.ru	Zhuravlev, Viacheslav Y./H-1223-2017; Narvskaya, Olga/H-1770-2012; Mokrousov, Igor/Q-5941-2019; Mokrousov, Igor/J-3640-2014	Narvskaya, Olga/0000-0002-0830-5808; Mokrousov, Igor/0000-0001-5924-0576; Mokrousov, Igor/0000-0001-5924-0576; Zhuravlev, Viacheslav/0000-0001-6906-6225; Vyazovaya, Anna/0000-0001-9140-8957	Ministry of Health of Russia	Ministry of Health of Russia	This work was done as a regular work in all participating laboratories supported by the regular budget received from the Ministry of Health of Russia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev MV, 2011, EUR J CLIN MICROBIOL, V30, P181, DOI 10.1007/s10096-010-1067-z; Allix-Beguec C, 2011, 32 ESM C LUB GERM 26; [Anonymous], 2010, Tuberk Biolezni Legkih, P54; Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Dymova MA, 2011, J MED MICROBIOL, V60, P1003, DOI 10.1099/jmm.0.027995-0; Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gilman J., 1998, EPICALC 2000 VERSION; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Iwamoto T, 2007, FEMS MICROBIOL LETT, V272, P282, DOI 10.1111/j.1574-6968.2007.00777.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kovalev SY, 2005, INT J TUBERC LUNG D, V9, P746; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Lapina A I, 1970, Bull Int Union Tuberc, V43, P188; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Makinen J, 2011, EUR J CLIN MICROBIOL, V30, P1119, DOI 10.1007/s10096-011-1200-7; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Marttila HJ, 2008, INT J TUBERC LUNG D, V12, P338; Ministry of Health of Russian Federation, 2003, 109 MIN HLTH RUSS FE; Mokrousov I, 2004, EMERG INFECT DIS, V10, P1337; Mokrousov I, 2012, CAUSES CONSEQUENCES, P317; Mokrousov I, 2008, INFECT GENET EVOL, V8, P777, DOI 10.1016/j.meegid.2008.07.003; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Mokrousov I, 2009, FEMS IMMUNOL MED MIC, V55, P13, DOI 10.1111/j.1574-695X.2008.00470.x; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Narvskaia O V, 1999, Probl Tuberk, P39; Narvskaya O, 2005, TRENDS IN DNA FINGERPRINTING RESEARCH, P111; Narvskaya O, 2003, THESIS I EXPT MED ST; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Nikolayevskyy VV, 2007, CLIN MICROBIOL INFEC, V13, P129, DOI 10.1111/j.1469-0691.2006.01583.x; Norkina O. V., 2003, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P9; Ogarkov OB, 2008, MOL MED, V2, P33; Sajduda A, 2004, INT J TUBERC LUNG D, V8, P1448; Shemyakin I. G., 2002, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P30; Sinkov VV, 2010, EPIDEMIOLOGIYA INFEK, V4, P50; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; Tracevska T, 2003, INT J TUBERC LUNG D, V7, P1097; Valcheva V, 2008, INFECT GENET EVOL, V8, P657, DOI 10.1016/j.meegid.2008.06.006; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasilenko N, 2006, IMMUNOPAT ALLERGOL I, V4, P70; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Zhakipbaeva BT, 2009, THESIS ASFENDIYAROV	52	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41318	10.1371/journal.pone.0041318	http://dx.doi.org/10.1371/journal.pone.0041318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844457	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700069
J	Wang, ML; Hada, M; Saha, J; Sridharan, DM; Pluth, JM; Cucinotta, FA				Wang, Minli; Hada, Megumi; Saha, Janapriya; Sridharan, Deepa M.; Pluth, Janice M.; Cucinotta, Francis A.			Protons Sensitize Epithelial Cells to Mesenchymal Transition	PLOS ONE			English	Article							GROWTH; CANCER; EXPOSURE; RECEPTOR; THERAPY; TARGET; EMT	Proton radiotherapy has gained more favor among oncologists as a treatment option for localized and deep-seated tumors. In addition, protons are a major constituent of the space radiation astronauts receive during space flights. The potential for these exposures to lead to, or enhance cancer risk has not been well studied. Our objective is to study the biological effects of low energy protons on epithelial cells and its propensity to enhance transforming growth factor beta 1 (TGF beta 1)-mediated epithelial-mesenchymal transition (EMT), a process occurring during tumor progression and critical for invasion and metastasis. Non-transformed mink lung epithelial cells (Mv1Lu) and hTERT-immortalized human esophageal epithelial cells (EPC) were used in this study. EMT was identified by alterations in cell morphology, EMT-related gene expression changes determined using real-time PCR, and EMT changes in specific cellular markers detected by immunostaining and western blotting. Although TGF beta 1 treatment alone is able to induce EMT in both Mv1Lu and EPC cells, low energy protons (5 MeV) at doses as low as 0.1 Gy can enhance TGF beta 1 induced EMT. Protons alone can also induce a mild induction of EMT. SD208, a potent TGF beta Receptor 1 (TGF beta R1) kinase inhibitor, can efficiently block TGF beta 1/Smad signaling and attenuate EMT induction. We suggest a model for EMT after proton irradiation in normal and cancerous tissue based on our results that showed that low and high doses of protons can sensitize normal human epithelial cells to mesenchymal transition, more prominently in the presence of TGF beta 1, but also in the absence of TGF beta 1.	[Wang, Minli; Hada, Megumi; Saha, Janapriya] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA; [Sridharan, Deepa M.; Pluth, Janice M.] Lawrence Berkeley Natl Lab, Dept Canc & DNA Damage Responses, Berkeley, CA USA; [Cucinotta, Francis A.] NASA, Lyndon B Johnson Space Ctr, Space Radiat Program, Houston, TX 77058 USA	Universities Space Research Association (USRA); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Wang, ML (corresponding author), Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA.	francis.a.cucinotta@nasa.gov	Cucinotta, Francis/AAZ-5941-2020		National Aeronautics and Space Administration; Department of Environment	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Department of Environment	This work supported by National Aeronautics and Space Administration and Department of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andarawewa KL, 2011, INT J RADIAT ONCOL, V79, P1523, DOI 10.1016/j.ijrobp.2010.11.058; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Chen C, 2001, PLOS ONE, V6; CUCINOTTA FA, 1991, RADIAT RES, V127, P130, DOI 10.2307/3577956; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Ehrhart EJ, 1996, RADIAT RES, V145, P157, DOI 10.2307/3579170; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Harada H, 2003, MOL CANCER RES, V1, P729; Isacsson U, 1998, INT J RADIAT ONCOL, V41, P441, DOI 10.1016/S0360-3016(98)00047-9; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Kong Fengming, 1995, International Journal of Radiation Oncology Biology Physics, V32, P239, DOI 10.1016/0360-3016(95)97858-X; Lamouille S, 2011, CELLS TISSUES ORGANS, V193, P8, DOI 10.1159/000320172; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Sigurdsson V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023833; Terasawa T, 2009, ANN INTERN MED, V151, P556, DOI 10.7326/0003-4819-151-8-200910200-00145; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; von Rahden BHA, 2006, MOL CARCINOGEN, V45, P786, DOI 10.1002/mc.20259; Wang ML, 2012, J RADIAT RES, V53, P51, DOI 10.1269/jrr.11121; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Xie YF, 2009, CANCER RES, V69, P7756, DOI 10.1158/0008-5472.CAN-09-0496; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956	31	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41249	10.1371/journal.pone.0041249	http://dx.doi.org/10.1371/journal.pone.0041249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844446	gold, Green Submitted, Green Published			2022-12-25	WOS:000306687700059
J	Lautz, TB; Jie, C; Clark, S; Naiditch, JA; Jafari, N; Qiu, YY; Zheng, X; Chu, F; Madonna, MB				Lautz, Timothy B.; Jie, Chunfa; Clark, Sandra; Naiditch, Jessica A.; Jafari, Nadereh; Qiu, Yi-Yong; Zheng, Xin; Chu, Fei; Madonna, Mary Beth			The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; TUMOR-CELLS; MDR1 GENE; CANCER; APOPTOSIS; ACID; MECHANISMS; PROGRAM	Histone deacetylase (HDAC) inhibitors, especially vorinostat, are currently under investigation as potential adjuncts in the treatment of neuroblastoma. The effect of vorinostat co-treatment on the development of resistance to other chemotherapeutic agents is unknown. In the present study, we treated two human neuroblastoma cell lines [SK-N-SH and SK-N-Be(2)C] with progressively increasing doses of doxorubicin under two conditions: with and without vorinsotat co-therapy. The resultant doxorubicin-resistant (DoxR) and vorinostat-treated doxorubicin resistant (DoxR-v) cells were equally resistant to doxorubicin despite significantly lower P-glycoprotein expression in the DoxR-v cells. Whole genome analysis was performed using the Ilumina Human HT-12 v4 Expression Beadchip to identify genes with differential expression unique to the DoxR-v cells. We uncovered a number of genes whose differential expression in the DoxR-v cells might contribute to their resistant phenotype, including hypoxia inducible factor-2. Finally, we used Gene Ontology to categorize the biological functions of the differentially expressed genes unique to the DoxR-v cells and found that genes involved in cellular metabolism were especially affected.	[Lautz, Timothy B.; Naiditch, Jessica A.; Madonna, Mary Beth] Northwestern Univ, Dept Surg, Lurie Childrens Hosp, Chicago, IL 60611 USA; [Lautz, Timothy B.; Clark, Sandra; Naiditch, Jessica A.; Qiu, Yi-Yong; Zheng, Xin; Chu, Fei; Madonna, Mary Beth] Northwestern Univ, Canc Biol Program, Childrens Mem Res Ctr, Chicago, IL 60611 USA; [Jie, Chunfa; Jafari, Nadereh] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University; Northwestern University	Lautz, TB (corresponding author), Northwestern Univ, Dept Surg, Lurie Childrens Hosp, Chicago, IL 60611 USA.	fchu@childrensmemorial.org; mmadonna@childrensmemorial.org		Naiditch, Jessica/0000-0002-6340-0947; Lautz, Timothy/0000-0002-3323-6509	John W Anderson Foundation, Valparaiso, Indiana [46383-2567]; Children's Research Foundation	John W Anderson Foundation, Valparaiso, Indiana; Children's Research Foundation	Funding provided by John W Anderson Foundation, 402 Wall St # 12, Valparaiso, Indiana 46383-2567 and the Children's Research Foundation, http://www.childrensresearchfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, GENE SET ENRICHMENT; Bhatt RS, 2008, BJU INT, V102, P358, DOI 10.1111/j.1464-410X.2008.07558.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Coffey DC, 2001, CANCER RES, V61, P3591; Comerford KM, 2002, CANCER RES, V62, P3387; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fouladi M, 2010, J CLIN ONCOL, V28, P3623, DOI 10.1200/JCO.2009.25.9119; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Glick RD, 1999, CANCER RES, V59, P4392; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Haber M, 1997, EUR J CANCER, V33, P2031, DOI 10.1016/S0959-8049(97)00229-3; Huang JM, 2010, MOL CANCER THER, V9, P3289, DOI 10.1158/1535-7163.MCT-10-0562; Keenan J, 2009, PROTEOMICS, V9, P1556, DOI 10.1002/pmic.200800633; Keshelava N, 2007, JNCI-J NATL CANCER I, V99, P1107, DOI 10.1093/jnci/djm044; Keshelava N, 2009, PEDIATR BLOOD CANCER, V53, P505, DOI 10.1002/pbc.21988; Kim SH, 2007, ONCOL REP, V17, P647; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Montopoli M, 2011, CURR CANCER DRUG TAR, V11, P226, DOI 10.2174/156800911794328501; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Ozaki K, 2008, CANCER SCI, V99, P376, DOI 10.1111/j.1349-7006.2007.00669.x; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Shankar S, 2009, MOL CANCER THER, V8, P1596, DOI 10.1158/1535-7163.MCT-08-1004; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, LIMMA LINEAR MODELS; Temmink OH, 2010, MOL CANCER THER, V9, P1047, DOI 10.1158/1535-7163.MCT-09-0932; Witt O, 2009, CURR PHARM DESIGN, V15, P436, DOI 10.2174/138161209787315774; Witte I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.91; Zhao LY, 2006, CANCER RES, V66, P9445, DOI 10.1158/0008-5472.CAN-06-1713	32	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40816	10.1371/journal.pone.0040816	http://dx.doi.org/10.1371/journal.pone.0040816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829886	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300024
J	Mamun, AA; O'Callaghan, MJ; Williams, GM; Najman, JM				Mamun, Abdullah A.; O'Callaghan, Michael J.; Williams, Gail M.; Najman, Jake M.			Maternal Smoking During Pregnancy Predicts Adult Offspring Cardiovascular Risk Factors - Evidence from a Community-Based Large Birth Cohort Study	PLOS ONE			English	Article							CHILDHOOD OBESITY; BLOOD-PRESSURE; NICOTINE; WEIGHT; OVERWEIGHT; ADIPOSITY; EXPOSURE; AGE	Background: Maternal smoking during pregnancy is associated with offspring obesity. However, little is known about whether maternal smoking in pregnancy predicts other offspring cardiovascular risk factors including waist circumference (WC), waist-hip-ratio (WHR), pulse rate (PR), systolic (SBP), and diastolic blood pressure (DBP). Methods: We studied a sub-sample of 2038 (50% males) young adults who were born in Brisbane, Australia to investigate the prospective association of maternal smoking during pregnancy with young adult cardiovascular risk factors. We compared offspring mean BMI, WC, WHR, SBP, DBP and PR and the risk of being overweight and obese at 21 years by three mutually exclusive categories of maternal smoking status defined as never smoked, smoked before and/or after pregnancy but not in pregnancy or smoked during pregnancy and other times. Results: Offspring of mothers who smoked during pregnancy had greater mean BMI, WC, WHR and PR and they were at greater risk of being obese at 21 years compared to offspring of those mothers who never smoked. The mean of these risk factors among those adult offspring whose mothers stopped smoking during pregnancy, but who then smoked at other times in the child's life, were similar to those mothers who never smoked. These results were independent of a range of potential confounding factors. Conclusion: The findings of this study suggest a prospective association of maternal smoking during pregnancy and offspring obesity as well as PR in adulthood, and reinforce the need to persuade pregnant women not to smoke.	[Mamun, Abdullah A.; Williams, Gail M.; Najman, Jake M.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [O'Callaghan, Michael J.] Univ Queensland, Mater Childrens Hosp, Child Dev Serv, Brisbane, Qld 4101, Australia; [O'Callaghan, Michael J.] Univ Queensland, Mater Childrens Hosp, Child Rehabil Serv, Brisbane, Qld 4101, Australia; [O'Callaghan, Michael J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Najman, Jake M.] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland	Mamun, AA (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	mamun@sph.uq.edu.au	Williams, Gail/S-8833-2019; Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022; Najman, Jackob M./B-1527-2008	Williams, Gail/0000-0002-4822-5263; Mamun, Abdullah A/0000-0002-1535-8086; Najman, Jackob M./0000-0001-7079-2080	National Health and Medical Research Council (NHMRC) of Australia; NHMRC [519756]; National Heart Foundation of Australia [G07B3135]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	The core study was funded by the National Health and Medical Research Council (NHMRC) of Australia. AAM is supported by a Career Development Awards from the NHMRC (ID 519756). For the work in this paper AAM has a grant from the National Heart Foundation of Australia (ID G07B3135). The views expressed in the paper are those of the authors and not necessarily those of any funding body and no funding body influenced the way in which the data were analysed and presented. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2006, AM J EPIDEMIOL, V164, P317, DOI 10.1093/aje/kwj209; Bergel E, 2000, AM J EPIDEMIOL, V151, P594, DOI 10.1093/oxfordjournals.aje.a010247; Blake KV, 2000, EARLY HUM DEV, V57, P137, DOI 10.1016/S0378-3782(99)00064-X; Chen AM, 2006, INT J EPIDEMIOL, V35, P121, DOI 10.1093/ije/dyi218; Fasting MH, 2009, EARLY HUM DEV, V85, P19, DOI 10.1016/j.earlhumdev.2008.05.009; Gao YJ, 2005, OBES RES, V13, P687, DOI 10.1038/oby.2005.77; Grassi G, 2009, PROG CARDIOVASC DIS, V52, P31, DOI 10.1016/j.pcad.2009.05.007; Ino T, 2010, PEDIATR INT, V52, P94, DOI 10.1111/j.1442-200X.2009.02883.x; Kane JK, 2000, ENDOCRINOLOGY, V141, P3623, DOI 10.1210/en.141.10.3623; KEEPING JD, 1989, BRIT J OBSTET GYNAEC, V96, P289, DOI 10.1111/j.1471-0528.1989.tb02388.x; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Montgomery SM, 2002, BRIT MED J, V324, P26, DOI 10.1136/bmj.324.7328.26; MORLEY R, 1995, ARCH DIS CHILD, V72, P120, DOI 10.1136/adc.72.2.120; Nafstad P, 1997, J EPIDEMIOL COMMUN H, V51, P261, DOI 10.1136/jech.51.3.261; Najman JM, 2005, INT J EPIDEMIOL, V34, P992, DOI 10.1093/ije/dyi119; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Oken E, 2005, OBES RES, V13, P2021, DOI 10.1038/oby.2005.248; Ong KKL, 2000, BRIT MED J, V320, P1244; Power C, 2010, ATHEROSCLEROSIS, V211, P643, DOI 10.1016/j.atherosclerosis.2010.03.015; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Rustemeier K, 2002, FOOD CHEM TOXICOL, V40, P93, DOI 10.1016/S0278-6915(01)00085-0; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Suzuki K, 2009, J EPIDEMIOL, V19, P136, DOI 10.2188/jea.JE20081012; Swauger JE, 2002, REGUL TOXICOL PHARM, V35, P142, DOI 10.1006/rtph.2001.1521; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; Vanhala M, 1999, ANN MED, V31, P236, DOI 10.3109/07853899908995885; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; World Health Organization, 1997, OB PREV MAN GLOB EP	31	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41106	10.1371/journal.pone.0041106	http://dx.doi.org/10.1371/journal.pone.0041106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829913	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300052
J	Pitek, AS; O'Connell, D; Mahon, E; Monopoli, MP; Bombelli, FB; Dawson, KA				Pitek, Andrzej S.; O'Connell, David; Mahon, Eugene; Monopoli, Marco P.; Bombelli, Francesca Baldelli; Dawson, Kenneth A.			Transferrin Coated Nanoparticles: Study of the Bionano Interface in Human Plasma	PLOS ONE			English	Article							PROTEIN CORONA; GOLD NANOPARTICLES; SURFACE-PROPERTIES; CELLULAR UPTAKE; DRUG-DELIVERY; CANCER-CELLS; RECEPTOR; SIZE; NANOMATERIALS; THERAPY	It is now well established that the surface of nanoparticles (NPs) in a biological environment is immediately modified by the adsorption of biomolecules with the formation of a protein corona and it is also accepted that the protein corona, rather than the original nanoparticle surface, defines a new biological identity. Consequently, a methodology to effectively study the interaction between nanomaterials and the biological corona encountered within an organism is a key objective in nanoscience for understanding the impact of the nanoparticle-protein interactions on the biological response in vitro and in vivo. Here, we outline an integrated methodology to address the different aspects governing the formation and the function of the protein corona of polystyrene nanoparticles coated with Transferrin by different strategies. Protein-NP complexes are studied both in situ (in human plasma, full corona FC) and after washing (hard corona, HC) in terms of structural properties, composition and second-order interactions with protein microarrays. Human protein microarrays are used to effectively study NP-corona/proteins interactions addressing the growing demand to advance investigations of the extrinsic function of corona complexes. Our data highlight the importance of this methodology as an analysis to be used in advance of the application of engineered NPs in biological environments.	[Pitek, Andrzej S.; Mahon, Eugene; Monopoli, Marco P.; Bombelli, Francesca Baldelli; Dawson, Kenneth A.] Natl Univ Ireland Univ Coll Dublin, Ctr BioNano Interact, Sch Chem & Chem Biol, Dublin 4, Ireland; [Pitek, Andrzej S.; O'Connell, David; Monopoli, Marco P.; Dawson, Kenneth A.] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Bombelli, Francesca Baldelli] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England	University College Dublin; University College Dublin; University of East Anglia	Pitek, AS (corresponding author), Natl Univ Ireland Univ Coll Dublin, Ctr BioNano Interact, Sch Chem & Chem Biol, Dublin 4, Ireland.	f.baldelli-bombelli@uea.ac.uk	Che Cob, Zaihisma/GLT-0159-2022; Monopoli, Marco P./AAM-6527-2021; Monopoli, Marco P/I-7060-2018; Dawson, Kenneth A. A/L-2540-2016; Bombelli, Francesca Baldelli/M-5368-2015	Che Cob, Zaihisma/0000-0003-0875-9188; Monopoli, Marco P./0000-0002-2035-6894; Monopoli, Marco P/0000-0002-2035-6894; Dawson, Kenneth A. A/0000-0002-0568-6588; Bombelli, Francesca Baldelli/0000-0001-8138-9246; Pitek, Andrzej/0000-0002-4021-835X; Mahon, Eugene/0000-0002-5170-6332; O'Connell, David/0000-0002-6461-7750	EU FP7 Small Collaborative Project NeuroNano [NMP4-SL-2008-214547]; Environmental Protection Agency (EPA) [2008-EH-MS-5]	EU FP7 Small Collaborative Project NeuroNano; Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	Authors would like to acknowledge the INSPIRE programme - an Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013, under which this work was conducted. Additional funding from the EU FP7 Small Collaborative Project NeuroNano (NMP4-SL-2008-214547) and the Environmental Protection Agency (EPA) project (2008-EH-MS-5) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal WT, 2011, ACCOUNTS CHEM RES, V44, P1094, DOI 10.1021/ar200105p; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Barth BM, 2010, ACS NANO, V4, P1279, DOI 10.1021/nn901297q; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Casals E, 2011, SMALL, V7, P3479, DOI 10.1002/smll.201101511; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136; Choi CHJ, 2011, P NATL ACAD SCI USA, V108, P6656, DOI 10.1073/pnas.1103573108; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Dandekar P, 2010, J AEROSOL MED PULM D, V23, P343, DOI 10.1089/jamp.2009.0784; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001; Faneca H, 2004, J GENE MED, V6, P681, DOI 10.1002/jgm.550; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Jung SH, 2010, COLLOID SURFACE B, V76, P434, DOI 10.1016/j.colsurfb.2009.12.002; Kumari A, 2011, EXPERT OPIN DRUG DEL, V8, P141, DOI 10.1517/17425247.2011.547934; Lesniak A, 2010, BIOMATERIALS, V31, P9511, DOI 10.1016/j.biomaterials.2010.09.049; Li JL, 2009, CANCER LETT, V274, P319, DOI 10.1016/j.canlet.2008.09.024; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Marano F, 2011, ARCH TOXICOL, V85, P733, DOI 10.1007/s00204-010-0546-4; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; Monopoli M.P., 2011, J AM CHEM SOC; Monopoli MP, 2011, NAT NANOTECHNOL, V6, P11, DOI 10.1038/nnano.2011.267; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Rosenholm JM, 2009, ACS NANO, V3, P197, DOI 10.1021/nn800781r; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang J, 2010, J AM CHEM SOC, V132, P11306, DOI 10.1021/ja1043177; Wang M, 2010, PHARMACOL RES, V62, P90, DOI 10.1016/j.phrs.2010.03.005; Xia XR, 2011, ACS NANO, V5, P9074, DOI 10.1021/nn203303c; Yang PH, 2005, BIOCONJUGATE CHEM, V16, P494, DOI 10.1021/bc049775d; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; Zheng Y, 2010, INT J PHARMACEUT, V390, P234, DOI 10.1016/j.ijpharm.2010.02.008	40	70	70	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40685	10.1371/journal.pone.0040685	http://dx.doi.org/10.1371/journal.pone.0040685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829881	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300019
J	Vaisman, BL; Andrews, KL; Khong, SML; Wood, KC; Moore, XL; Fu, Y; Kepka-Lenhart, DM; Morris, SM; Remaley, AT; Chin-Dusting, JPF				Vaisman, Boris L.; Andrews, Karen L.; Khong, Sacha M. L.; Wood, Katherine C.; Moore, Xiao L.; Fu, Yi; Kepka-Lenhart, Diane M.; Morris, Sidney M., Jr.; Remaley, Alan T.; Chin-Dusting, Jaye P. F.			Selective Endothelial Overexpression of Arginase II Induces Endothelial Dysfunction and Hypertension and Enhances Atherosclerosis in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LOW-DENSITY-LIPOPROTEIN; VASCULAR ENDOTHELIUM; ARGININE METABOLISM; OXIDATIVE STRESS; TRANSGENIC MICE; CAROTID-ARTERY; CELLS; INHIBITION; EXPRESSION	Background: Cardiovascular disorders associated with endothelial dysfunction, such as atherosclerosis, have decreased nitric oxide (NO) bioavailability. Arginase in the vasculature can compete with eNOS for L-arginine and has been implicated in atherosclerosis. The aim of this study was to evaluate the effect of endothelial-specific elevation of arginase II expression on endothelial function and the development of atherosclerosis. Methodology/Principal Findings: Transgenic mice on a C57BL/6 background with endothelial-specific overexpression of human arginase II (hArgII) gene under the control of the Tie2 promoter were produced. The hArgII mice had elevated tissue arginase activity except in liver and in resident peritoneal macrophages, confirming endothelial specificity of the transgene. Using small-vessel myography, aorta from these mice exhibited endothelial dysfunction when compared to their non-transgenic littermate controls. The blood pressure of the hArgII mice was 17% higher than their littermate controls and, when crossed with apoE -/- mice, hArgII mice had increased aortic atherosclerotic lesions. Conclusion: We conclude that overexpression of arginase II in the endothelium is detrimental to the cardiovascular system.	[Vaisman, Boris L.; Wood, Katherine C.; Remaley, Alan T.] NHLBI, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA; [Andrews, Karen L.; Khong, Sacha M. L.; Moore, Xiao L.; Fu, Yi; Chin-Dusting, Jaye P. F.] Baker IDI Heart & Diabet Inst, Vasc Pharmacol Lab, Melbourne, Vic, Australia; [Kepka-Lenhart, Diane M.; Morris, Sidney M., Jr.] Univ Pittsburgh, Sch Med, Dept Microbiol, Pittsburgh, PA USA; [Kepka-Lenhart, Diane M.; Morris, Sidney M., Jr.] Univ Pittsburgh, Sch Med, Dept Mol Genet, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baker Heart and Diabetes Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vaisman, BL (corresponding author), NHLBI, Cardiovasc Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	karen.andrews@bakeridi.edu.au	Vaisman, Boris L/B-3453-2008; Morris, Sidney M/I-3440-2015		Intramural NHLBI; National Institutes of Health [RO1 GM57384]; National Health and Medical Research Council of Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057384] Funding Source: NIH RePORTER	Intramural NHLBI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by Intramural NHLBI (to ATR), National Institutes of Health funding (RO1 GM57384 to SMM) and a National Health and Medical Research Council of Australia program grant (to JCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anghelina M, 2005, J CELL MOL MED, V9, P113, DOI 10.1111/j.1582-4934.2005.tb00341.x; Basso F, 2006, BIOCHEM BIOPH RES CO, V351, P398, DOI 10.1016/j.bbrc.2006.10.044; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Camilletti A, 2001, AM J HYPERTENS, V14, P382, DOI 10.1016/S0895-7061(00)01297-8; CARVAJAL N, 1986, BIOCHIM BIOPHYS ACTA, V870, P181, DOI 10.1016/0167-4838(86)90219-0; CHEN GF, 1990, J PHYSIOL-LONDON, V421, P521, DOI 10.1113/jphysiol.1990.sp017959; Demougeot C, 2005, J HYPERTENS, V23, P971, DOI 10.1097/01.hjh.0000166837.78559.93; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Erdely A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015253; Gkaliagkousi E, 2009, J HYPERTENS, V27, P2310, DOI 10.1097/HJH.0b013e328330e89a; Topal JLG, 2006, J PHARMACOL EXP THER, V318, P1368, DOI 10.1124/jpet.106.103747; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; Huynh NN, 2009, BRIT J PHARMACOL, V156, P84, DOI 10.1111/j.1476-5381.2008.00036.x; Huynh NN, 2009, HYPERTENSION, V54, P294, DOI 10.1161/HYPERTENSIONAHA.108.121731; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Johnson FK, 2005, AM J PHYSL REGUL INT; Judkins CP, AM J PHYSL HEART CIR, V298, pH24; Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96; Kepka-Lenhart D, 2008, METHOD ENZYMOL, V440, P221, DOI 10.1016/S0076-6879(07)00813-0; Khong SML, 2012, BRIT J PHARMACOL, V166, P2015, DOI 10.1111/j.1476-5381.2012.01876.x; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; Kim NN, 2001, BIOCHEMISTRY-US, V40, P2678, DOI 10.1021/bi002317h; Kim SW, 2003, INT J IMPOT RES, V15, P355, DOI 10.1038/sj.ijir.3901038; Lim HK, 2007, AM J PHYSIOL-HEART C, V293, pH3317, DOI 10.1152/ajpheart.00700.2007; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Matsumoto T, 2003, J PHARMACOL EXP THER, V306, P103, DOI 10.1124/jpet.103.049163; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; Ming XF, 2004, CIRCULATION; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Ryoo S, 2006, CIRC RES, V99, P951, DOI 10.1161/01.RES.0000247034.24662.b4; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Tain YL, 2007, AM J PHYSIOL-RENAL, V292, pF1404, DOI 10.1152/ajprenal.00260.2006; Takaya T, 2007, ARTERIOSCL THROM VAS, V27, P1632, DOI 10.1161/ATVBAHA.107.142182; Tawfik HE, 2008, AM J PHYSIOL-HEART C, V295, pH1736, DOI 10.1152/ajpheart.87.2008; Teng PI, 2002, PHYSIOL GENOMICS, V11, P99, DOI 10.1152/physiolgenomics.00059.2002; Teupser D, 2006, ARTERIOSCL THROM VAS, V26, P365, DOI 10.1161/01.ATV.0000195791.83380.4c; Thuraisingham RC, 2003, KIDNEY INT, V63, pS29, DOI 10.1046/j.1523-1755.63.s84.41.x; VAISMAN BL, 1995, J BIOL CHEM, V270, P12269, DOI 10.1074/jbc.270.20.12269; Vinh A, 2008, CARDIOVASC RES, V77, P178, DOI 10.1093/cvr/cvm021; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang WZ, 2004, ANAL BIOCHEM, V326, P87, DOI 10.1016/j.ab.2003.11.006	48	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e39487	10.1371/journal.pone.0039487	http://dx.doi.org/10.1371/journal.pone.0039487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829869	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000306956300007
J	Gong, J; Zhang, JP; Li, B; Zeng, C; You, K; Chen, MX; Yuan, Y; Zhuang, SM				Gong, J.; Zhang, J-P; Li, B.; Zeng, C.; You, K.; Chen, M-X; Yuan, Y.; Zhuang, S-M			MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R	ONCOGENE			English	Article						miR-125b; apoptosis; Mcl-1; Bcl-w; IL-6R; hepatocellular carcinoma	HEPATOCELLULAR-CARCINOMA; MIR-125B; CANCER; SUPPRESSES; PROLIFERATION; DEREGULATION; TARGET; GROWTH; CELLS; GENE	The microRNA miR-125b is multi-faceted, with the ability to function as a tumor suppressor or an oncogene, depending on the cellular context. To date, the pro-apoptotic role of miR-125b and its underlying mechanisms are unexplored. In this study, both gain-and loss-of-function experiments revealed that miR-125b expression not only induced spontaneous apoptosis in various cell lines derived from the liver, lung and colorectal cancers, but also sensitized cancer cells to diverse apoptotic stimuli, including nutrient starvation and chemotherapeutic treatment. Furthermore, downregulation of miR-125b was a frequent event in hepatocellular carcinoma (HCC) tissues, and the miR-125b level was positively associated with the rate of apoptosis in HCC tissues. Subsequent investigations identified Mcl-1, Bcl-w and interleukin (IL)-6R as direct targets of miR-125b. Restoration of miR-125b expression not only diminished the expression of Mcl-1 and Bcl-w directly but also indirectly reduced the Mcl-1 and Bcl-xL levels by attenuating IL-6/signal transducer and activator of transcription 3 signaling. Consistent with these findings, introduction of miR-125b reduced the mitochondrial membrane potential and promoted the cleavage of pro-caspase-3. These data indicate that miR-125b may promote apoptosis by suppressing the anti-apoptotic molecules of the Bcl-2 family and miR-125b downregulation may facilitate tumor development by conferring upon cells the capability to survive under conditions of nutrient deprivation and chemotherapeutic treatment. Our findings highlight the importance of miR-125b in the regulation of apoptosis and suggest miR-125b as an attractive target for anti-cancer therapy.	[Gong, J.; Zhang, J-P; Zeng, C.; You, K.; Zhuang, S-M] Sch Life Sci, Dept Biochem, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou, Guangdong, Peoples R China; [Li, B.; Chen, M-X; Yuan, Y.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Yuan, Y (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Dongfengdong Rd 651, Guangzhou 510060, Guangdong, Peoples R China.	yuanyf@mail.sysu.edu.cn; zhuangshimei@163.com	ZHANG, JINGPING/AAT-8229-2021; zhang, jingping/AAM-2751-2021	zhang, jingping/0000-0003-0090-6710; , Gong/0000-0003-3767-1636; Yuan, Yunfei/0000-0003-2467-3683; Li, Binkui/0000-0003-3201-2914; Zhuang, Shi-Mei/0000-0002-2512-3942	Ministry of Science and Technology of China [2010CB912803, 2011CB811305]; Ministry of Health of China [2012ZX10002-011]; National Natural Science Foundation of China [30925036]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Health of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Ministry of Science and Technology of China (2010CB912803 and 2011CB811305), the Ministry of Health of China (2012ZX10002-011) and the National Natural Science Foundation of China (30925036).	Alpini G, 2011, J HEPATOL, V55, P1339, DOI 10.1016/j.jhep.2011.04.015; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Glud M, 2011, MELANOMA RES, V21, P253, DOI 10.1097/CMR.0b013e328345333b; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hofmann MH, 2009, MOL CANCER RES, V7, P1635, DOI 10.1158/1541-7786.MCR-09-0043; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee HW, 2003, CANCER RES, V63, P1093; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pogue AI, 2010, NEUROSCI LETT, V476, P18, DOI 10.1016/j.neulet.2010.03.054; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Surdziel E, 2011, BLOOD, V117, P4338, DOI 10.1182/blood-2010-06-289058; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435	35	151	158	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2013	32	25					3071	3079		10.1038/onc.2012.318	http://dx.doi.org/10.1038/onc.2012.318			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22824797				2022-12-25	WOS:000320705700007
J	Fekonja, O; Bencina, M; Jerala, R				Fekonja, Ota; Bencina, Mojca; Jerala, Roman			Toll/Interleukin-1 Receptor Domain Dimers as the Platform for Activation and Enhanced Inhibition of Toll-like Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; TIR-DOMAIN; RHEUMATOID-ARTHRITIS; CELL ACTIVATION; LEUCINE-ZIPPER; COILED-COIL; HUMAN MYD88; FAMILY; RECRUITMENT; COMPLEXES	TIR (Toll/IL-1 receptor) domains mediate interactions between TLR (Toll-like) or IL-1 family receptors and signaling adapters. While homotypic TIR domain interactions mediate receptor activation they are also usurped by microbial TIR domain containing proteins for immunosuppression. Here we show the role of a dimerized TIR domain platform for the suppression as well as for the activation of MyD88 signaling pathway. Coiled-coil dimerization domain, present in many bacterial TCPs, potently augments suppression of TLR/IL-1R signaling. The addition of a strong coiled-coil dimerization domain conferred the superior inhibition against the wide spectrum of TLRs and prevented the constitutive activation by a dimeric TIR platform. We propose a molecular model of MyD88-mediated signaling based on the dimerization of TIR domains as the limiting step.	[Fekonja, Ota; Bencina, Mojca; Jerala, Roman] Natl Inst Chem, Biotechnol Lab, Ljubljana 1000, Slovenia; [Bencina, Mojca; Jerala, Roman] Ctr Excellence EN FIST, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Biotechnol Lab, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si			Slovenian Research Agency; Centre of Excellence EN-FIST, Ljubljana, Slovenia; EU structural funds	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centre of Excellence EN-FIST, Ljubljana, Slovenia; EU structural funds	This work was supported by the Slovenian Research Agency (to R. J. and M. B.) and Centre of Excellence EN-FIST, Ljubljana, Slovenia supported in part by the EU structural funds.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Avbelj M, 2011, J IMMUNOL, V187, P2394, DOI 10.4049/jimmunol.1100515; Bonnert TP, 1997, FEBS LETT, V402, P81, DOI 10.1016/S0014-5793(96)01506-2; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Burch-Smith Tessa M, 2007, Sci STKE, V2007, ppe46; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Dupraz P, 2000, J BIOL CHEM, V275, P37672, DOI 10.1074/jbc.M005150200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hardiman G, 1996, ONCOGENE, V13, P2467; Hua F, 2005, BIOCHEM BIOPH RES CO, V338, P1118, DOI 10.1016/j.bbrc.2005.10.068; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Nagpal K, 2011, J BIOL CHEM, V286, P11875, DOI 10.1074/jbc.M110.199653; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Panter G, 2011, J BIOL CHEM, V286, P23334, DOI 10.1074/jbc.M110.205419; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Roszik J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-346; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Spear AM, 2009, TRENDS MICROBIOL, V17, P393, DOI 10.1016/j.tim.2009.06.005; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	41	23	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30993	31002		10.1074/jbc.M112.376186	http://dx.doi.org/10.1074/jbc.M112.376186			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829600	hybrid, Green Published			2022-12-25	WOS:000308791300013
J	Balasubramanian, P; Lang, JC; Jatana, KR; Miller, B; Ozer, E; Old, M; Schuller, DE; Agrawal, A; Teknos, TN; Summers, TA; Lustberg, MB; Zborowski, M; Chalmers, JJ				Balasubramanian, Priya; Lang, James C.; Jatana, Kris R.; Miller, Brandon; Ozer, Enver; Old, Mathew; Schuller, David E.; Agrawal, Amit; Teknos, Theodoros N.; Summers, Thomas A., Jr.; Lustberg, Maryam B.; Zborowski, Maciej; Chalmers, Jeffrey J.			Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-PATIENTS; DEPLETION	Epithelial to mesenchymal transition (EMT) has been hypothesized as a mechanism by which cells change phenotype during carcinogenesis, as well as tumor metastasis. Whether EMT is involved in cancer metastasis has a specific, practical impact on the field of circulating tumor cells (CTCs). Since the generally accepted definition of a CTC includes the expression of epithelial surface markers, such as EpCAM, if a cancer cell loses its epithelial surface markers (which is suggested in EMT), it will not be separated and/or identified as a CTC. We have developed, and previously reported on the use of, a purely negative enrichment technology enriching for CTCs in the blood of squamous cell carcinoma of the head and neck (SCCHN). This methodology does not depend on the expression of surface epithelial markers. Using this technology, our initial data on SCCHN patient blood indicates that the presence of CTCs correlates with worse disease-free survival. Since our enrichment is not dependent on epithelial markers, we have initiated investigation of the presence of mesenchymal markers in these CTC cells to include analysis of: vimentin, epidermal growth factor receptor, N-cadherin, and CD44. With the aid of confocal microscopy, we have demonstrated not only presumed CTCs that express and/or contain: a nucleus, cytokeratins, vimentin, and either EGFR, CD44, or N-cadherin, but also cells that contain all of the aforementioned proteins except cytokeratins, suggesting that the cells have undergone the EMT process. We suggest that our negative depletion enrichment methodology provides a more objective approach in identifying and evaluating CTCs, as opposed to positive selection approaches, as it is not subjective to a selection bias and can be tailored to accommodate a variety of cytoplasmic and surface markers which can be evaluated to identify a multitude of phenotypic patterns within CTCs from individual patients, including so-called EMT as presented here.	[Balasubramanian, Priya; Miller, Brandon; Chalmers, Jeffrey J.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Lang, James C.; Jatana, Kris R.; Ozer, Enver; Old, Mathew; Schuller, David E.; Agrawal, Amit; Teknos, Theodoros N.] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Jatana, Kris R.] Nationwide Childrens Hosp, Dept Otolaryngol Head & Neck Surg, Columbus, OH USA; [Summers, Thomas A., Jr.] Walter Reed Natl Mil Med Ctr, Dept Pathol & Lab Serv, Bethesda, MD USA; [Lustberg, Maryam B.] James Canc Hosp, Dept Internal Med, Columbus, OH USA; [Lustberg, Maryam B.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Zborowski, Maciej] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Chalmers, Jeffrey J.] OSU Comprehens Canc Ctr, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Walter Reed National Military Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chalmers, JJ (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	chalmers.1@osu.edu	Ozer, Enver/E-3802-2011; Old, Matthew/J-2315-2017; Jatana, Kris/E-3309-2011; Miller, Brandon/B-7645-2013	Old, Matthew/0000-0003-1795-5877; Miller, Brandon/0000-0003-1523-9092	National Science Foundation [BES-0124897, EEC 0425626]; National Cancer Institute [R01 CA97391-01A1]; State of Ohio Third Frontier Program [ODOD 26140000:TECH 07-001]; National Cancer Institute CCC Core Grant [P30 CA16058]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA062349, R01CA097391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); State of Ohio Third Frontier Program; National Cancer Institute CCC Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the following agencies: The National Science Foundation (BES-0124897); the National Cancer Institute (R01 CA97391-01A1); the State of Ohio Third Frontier Program (ODOD 26140000:TECH 07-001); the National Cancer Institute CCC Core Grant (P30 CA16058) and National Science Foundation (EEC 0425626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America Cancer Society, 2011, CANC FACTS FIG; Balasubramanian P, 2009, MOL PHARMACEUT, V6, P1402, DOI 10.1021/mp9000519; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Gath HJ, 1999, CANCER METAST REV, V18, P109, DOI 10.1023/A:1006268621730; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Jatana KR, 2010, ARCH OTOLARYNGOL, V136, P1274, DOI 10.1001/archoto.2010.223; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Lara O, 2004, EXP HEMATOL, V32, P891, DOI 10.1016/j.exphem.2004.07.007; MCGUIRT WF, 1995, ARCH OTOLARYNGOL, V121, P278; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Tkaczuk KHR, 2008, BREAST CANCER RES TR, V111, P355, DOI 10.1007/s10549-007-9771-9; van de Stolpe A, 2011, CANCER RES, V71, P5955, DOI 10.1158/0008-5472.CAN-11-1254; Wang ZP, 2000, CANCER, V88, P2787, DOI 10.1002/1097-0142(20000615)88:12<2787::AID-CNCR18>3.0.CO;2-2; Yang LY, 2009, BIOTECHNOL BIOENG, V102, P521, DOI 10.1002/bit.22066; Yuen APW, 1997, HEAD NECK-J SCI SPEC, V19, P583, DOI 10.1002/(SICI)1097-0347(199710)19:7<583::AID-HED4>3.0.CO;2-3; Zborowski M, 2011, ANAL CHEM, V83, P8050, DOI 10.1021/ac200550d	25	90	92	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42048	10.1371/journal.pone.0042048	http://dx.doi.org/10.1371/journal.pone.0042048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844540	Green Published, Green Submitted, gold			2022-12-25	WOS:000309240600065
J	Tseng, CW; Kyme, PA; Arruda, A; Ramanujan, VK; Tawackoli, W; Liu, GY				Tseng, Ching Wen; Kyme, Pierre A.; Arruda, Andrea; Ramanujan, V. Krishnan; Tawackoli, Wafa; Liu, George Y.			Innate Immune Dysfunctions in Aged Mice Facilitate the Systemic Dissemination of Methicillin-Resistant S.aureus	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; STAPHYLOCOCCUS-AUREUS INFECTIONS; BONE-MARROW; INFLAMMATION; PHAGOCYTOSIS; ACTIVATION; EXPRESSION	Elderly humans show increased susceptibility to invasive staphylococcal disease after skin and soft tissue infection. However, it is not understood how host immunity changes with aging, and how that predisposes to invasive disease. In a model of severe skin infection, we showed that aged mice (16- to 20-month-old) exhibit dramatic bacterial dissemination compared with young adult mice (2-month-old). Bacterial dissemination was associated with significant reductions of CXCL1 (KC), polymorphonuclear cells (PMNs), and extracellular DNA traps (NETs) at the infection site. PMNs and primary skin fibroblasts isolated from aged mice showed decreased secretion of CXCL2 (MIP-2) and KC in response to MRSA, and in vitro analyses of mitochondrial functions revealed that the mitochondrial electron transport chain complex I plays a significant role in induction of chemokines in the cells isolated from young but not old mice. Additionally, PMNs isolated from aged mice have reduced ability to form NETs and to kill MRSA. Expression of nuclease by S. aureus led to increased bacterial systemic dissemination in young but not old mice, suggesting that defective NETs formation in elderly mice permitted nuclease and non-nuclease expressing S. aureus to disseminate equally well. Overall, these findings suggest that gross impairment of both skin barrier function and innate immunity contributes to the propensity for MRSA to disseminate in aged mice. Furthermore, the study indicates that contribution of bacterial factors to pathogenicity may vary with host age.	[Tseng, Ching Wen; Kyme, Pierre A.; Arruda, Andrea; Liu, George Y.] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Tseng, Ching Wen; Kyme, Pierre A.; Arruda, Andrea; Liu, George Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Tseng, Ching Wen; Kyme, Pierre A.; Arruda, Andrea; Liu, George Y.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Ramanujan, V. Krishnan; Tawackoli, Wafa] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Ramanujan, V. Krishnan; Tawackoli, Wafa] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Tseng, CW (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA.	tsengcw@cshs.org; george.liu@cshs.org	Ramanujan, V Krishnan/O-2831-2014		Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) [W81XWH-09-1-0644]	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work is supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) under Award No. W81XWH-09-1-0644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bianchi M, 2011, J ALLERGY CLIN IMMUN; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Demling Robert H, 2007, J Burns Wounds, V7, pe8; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; FU YK, 1994, INFECT IMMUN, V62, P1; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Genova ML, 1997, FEBS LETT, V410, P467; GOLDSTEIN E, 1978, J INFECT DIS, V138, P299, DOI 10.1093/infdis/138.3.299; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Kim SY, 2006, J BIOL CHEM, V281, P28794, DOI 10.1074/jbc.M604964200; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kriete A, 2009, EXP GERONTOL, V44, P250, DOI 10.1016/j.exger.2008.12.005; Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868; Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621; LIPSCHITZ DA, 1986, J GERONTOL, V41, P690, DOI 10.1093/geronj/41.6.690; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; NIWA Y, 1989, LIFE SCI, V44, P1655, DOI 10.1016/0024-3205(89)90482-7; Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Rittie L, 2005, METH MOLEC MED, V117, P83; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011606, 10.1371/journal.pone.0009518]; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Wagner C, 2006, CLIN EXP IMMUNOL, V143, P70, DOI 10.1111/j.1365-2249.2005.02963.x; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wenisch C, 2000, J LEUKOCYTE BIOL, V67, P40, DOI 10.1002/jlb.67.1.40; Young LM, 2008, SURG INFECT, V9, P469, DOI 10.1089/sur.2007.052; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC	38	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41454	10.1371/journal.pone.0041454	http://dx.doi.org/10.1371/journal.pone.0041454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844481	Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600028
J	Storey, AA; Athens, JS; Bryant, D; Carson, M; Emery, K; deFrance, S; Higham, C; Huynen, L; Intoh, M; Jones, S; Kirch, PV; Ladefoged, T; McCoy, P; Morales-Muniz, A; Quiroz, D; Reitz, E; Robins, J; Walter, R; Matisoo-Smith, E				Storey, Alice A.; Athens, J. Stephen; Bryant, David; Carson, Mike; Emery, Kitty; deFrance, Susan; Higham, Charles; Huynen, Leon; Intoh, Michiko; Jones, Sharyn; Kirch, Patrick V.; Ladefoged, Thegn; McCoy, Patrick; Morales-Muniz, Arturo; Quiroz, Daniel; Reitz, Elizabeth; Robins, Judith; Walter, Richard; Matisoo-Smith, Elizabeth			Investigating the Global Dispersal of Chickens in Prehistory Using Ancient Mitochondrial DNA Signatures	PLOS ONE			English	Article							MULTIPLE MATERNAL ORIGINS; GENETIC DIVERSITY; MTDNA SEQUENCES; GALLUS-GALLUS; CHINESE; BREEDS; ISLAND; RADIOCARBON; CALIBRATION; POLYNESIA	Data from morphology, linguistics, history, and archaeology have all been used to trace the dispersal of chickens from Asian domestication centers to their current global distribution. Each provides a unique perspective which can aid in the reconstruction of prehistory. This study expands on previous investigations by adding a temporal component from ancient DNA and, in some cases, direct dating of bones of individual chickens from a variety of sites in Europe, the Pacific, and the Americas. The results from the ancient DNA analyses of forty-eight archaeologically derived chicken bones provide support for archaeological hypotheses about the prehistoric human transport of chickens. Haplogroup E mtDNA signatures have been amplified from directly dated samples originating in Europe at 1000 B.P. and in the Pacific at 3000 B.P. indicating multiple prehistoric dispersals from a single Asian centre. These two dispersal pathways converged in the Americas where chickens were introduced both by Polynesians and later by Europeans. The results of this study also highlight the inappropriate application of the small stretch of D-loop, traditionally amplified for use in phylogenetic studies, to understanding discrete episodes of chicken translocation in the past. The results of this study lead to the proposal of four hypotheses which will require further scrutiny and rigorous future testing.	[Storey, Alice A.] Univ New England, Dept Archaeol & Palaeoanthropol, Armidale, NSW, Australia; [Athens, J. Stephen] Int Archaeol Res Inst Inc, Honolulu, HI USA; [Bryant, David] Univ Otago, Dept Math & Stat, Dunedin, New Zealand; [Carson, Mike] Univ Guam, MARC, Mangilao, GU USA; [Emery, Kitty] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [deFrance, Susan] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Higham, Charles; Walter, Richard] Univ Otago, Dept Anthropol, Dunedin, New Zealand; [Huynen, Leon] Griffith Univ, Sch Environm, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Intoh, Michiko] Natl Museum Ethnol, Osaka, Japan; [Jones, Sharyn] Univ Alabama Birmingham, Dept Anthropol, Birmingham, AL USA; [Kirch, Patrick V.] Univ Calif Berkeley, Dept Anthropol, Berkeley, CA 94720 USA; [Kirch, Patrick V.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ladefoged, Thegn; Robins, Judith] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [McCoy, Patrick] Pacific Consulting Serv Inc, Honolulu, HI USA; [Morales-Muniz, Arturo] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Quiroz, Daniel] Direcc Bibliotecas Archivos & Museos Proyecto Fon, Santiago, Chile; [Reitz, Elizabeth] Univ Georgia, Georgia Museum Nat Hist, Athens, GA 30602 USA; [Robins, Judith] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Matisoo-Smith, Elizabeth] Univ Otago, Otago Sch Med Sci, Dept Anat & Struct Biol, Dunedin, New Zealand; [Matisoo-Smith, Elizabeth] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of New England; University of Otago; University of Guam; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Otago; Griffith University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Auckland; Autonomous University of Madrid; University System of Georgia; University of Georgia; University of Auckland; University of Otago; University of Otago	Storey, AA (corresponding author), Univ New England, Dept Archaeol & Palaeoanthropol, Armidale, NSW, Australia.	astorey2@une.edu.au	Muñiz, Arturo Morales/ABG-7980-2020; Emery, Kitty/B-5850-2011; Quiroz, Daniel/R-8903-2019	Muñiz, Arturo Morales/0000-0002-9933-6836; Emery, Kitty/0000-0002-4031-1968; Quiroz, Daniel/0000-0001-7436-6142; Matisoo-Smith, Elizabeth/0000-0002-3500-8307	Japan Society for the Promotion of Science; Marsden Fund; Allan Wilson Centre for Molecular Ecology and Evolution; University of Auckland	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Allan Wilson Centre for Molecular Ecology and Evolution; University of Auckland	Excavations in Fais by MI were made possible by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. DB gratefully acknowledges support from the Marsden Fund, and the Allan Wilson Centre for Molecular Ecology and Evolution. During the course of this research AS was supported by a Postgraduate Scholarship from the University of Auckland and a Fellowship from the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison DJ, 2010, ARCHAEOL OCEAN, V45, P1; [Anonymous], 2007, PREHISTORY INDO MALA, DOI [DOI 10.26530/OAPEN_459472, 10.22459/PIMA.03.2007, DOI 10.22459/PIMA.03.2007]; Beebe W., 1938, PHEASANTS THEIR LIVE; Berlin S, 2004, P NATL ACAD SCI USA, V101, P15967, DOI 10.1073/pnas.0405126101; Bradley DG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P273; Bradley DG, 2000, ARCHAEOGENETICS DNA, P315; Brisbin IL, 2007, ANIMAL CONSERVATION, V10; Bronk Ramsey C, 2006, OXCAL PROGRAM V4 0; Brown E., 1929, POULTRY BREEDING PRO; Burney J, 1967, CHRONOLOGICAL HIST 1; Burnham GP, 1874, CHINA FOWL; Caudill D., 1975, ARAUCANA POULTERERS; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; Cool HEM, 2006, EATING AND DRINKING IN ROMAN BRITAIN, P1, DOI 10.2277/ 052100327X; Cooper A, 2000, SCIENCE, V289, P1139; Cranstone BAL, 1983, DOMODOMO, V1, P7; Crawford R. D., 1990, POULTRY BREEDING GEN, P1; Crawford R. D., 1984, EVOLUTION DOMESTICAT, P298; Dana N, 2011, ANIM GENET, V42, P125, DOI 10.1111/j.1365-2052.2010.02134.x; Dancause KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016843; Darwin Charles R, 1875, VARIATION ANIMALS PL, Vsecond; Defrance SD, 2010, INT J OSTEOARCHAEOL, V20, P508, DOI 10.1002/oa.1074; Delacour J., 1977, PHEASANTS WORLD; Dixon ES, 1850, ORNAMENTAL DOMESTIC; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Fitzpatrick SM, 2009, J ARCHAEOL SCI, V36, P214, DOI 10.1016/j.jas.2008.09.002; Fu V, 2001, ACTA GENET SINICA, P612; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Glover I., 2004, SE ASIA PREHISTORY H; Gongora J, 2008, P NATL ACAD SCI USA, V105, P10308, DOI 10.1073/pnas.0801991105; Gongora J, 2008, P NATL ACAD SCI USA, V105, pE100, DOI 10.1073/pnas.0809681105; Guan X, 2007, J HERED, DOI 10-1093/jhered/esm094; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Harumi Takashi, 2004, Animal Science Journal, V75, P503, DOI 10.1111/j.1740-0929.2004.00220.x; HATHER J, 1991, ANTIQUITY, V65, P887, DOI 10.1017/S0003598X00080613; Hehn V., 1888, WANDERINGS PLANTS AN, DOI DOI 10.1098/rspb.2010.0708; Hemming John, 1970, CONQUEST INCAS; Hernandez Carrasquilla Francisco, 1992, Archaeofauna, V1, P45; Higham Ch., 1989, ARCHAEOLOGY MAINLAND; Holland B, 2003, LECT N BIOINFORMAT, V2812, P165; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huynen L., 2003, Notornis, V50, P231; Intoh, 2008, ASIAN PERSPECT, V47, P121; Intoh M, 2004, ANTHROPOL SCI, V112, P257, DOI 10.1537/ase.040511; Intoh M, 1999, COLLOQ SEMI, P407; Johnsgard PA, 1999, PHEASANTS WORLD BIOL; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; KELLY L, 2006, LITTLE CHICKEN BOOK; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Komiyama T, 2003, GENE, V317, P195, DOI 10.1016/S0378-1119(03)00703-0; Kovacs-Nolan J, 2005, J AGR FOOD CHEM, V53, P8421, DOI 10.1021/jf050964f; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Lee YJ, 2007, ASIAN AUSTRAL J ANIM, V20, P477, DOI 10.5713/ajas.2007.477; Levesque R, 1992, HIST MICRONESIA, V1; Levesque R, 1992, HIST MICRONESIA, V2; Lind LR, 1963, ALDROVANDI CHICKENS; Liu YP, 2006, BIOCHEM GENET, V44, P18, DOI 10.1007/s10528-006-9012-7; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Liu ZG, 2004, ASIAN AUSTRAL J ANIM, V17, P903, DOI 10.5713/ajas.2004.903; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Markham C, 1967, VOYAGES PF DEQUIROS; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Matisoo-Smith E, 2009, J ISL COAST ARCHAEOL, V4, P151, DOI [DOI 10.1080/15564890903155273, 10.1080/15564890903155273]; MatisooSmith E, 1997, ELECTROPHORESIS, V18, P1534, DOI 10.1002/elps.1150180908; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McCoy P.C., 1988, ARCHAEOL OCEAN, V23, P104, DOI [10.1002/j.1834, DOI 10.1002/J.1834]; Moiseeva IG, 1996, GENETIKA+, V32, P1553; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Mwacharo JM, 2011, MOL PHYLOGENET EVOL, V58, P374, DOI 10.1016/j.ympev.2010.11.027; Newson L.A., 2009, CONQUEST PESTILENCE; Nishibori M, 2005, ANIM GENET, V36, P367, DOI 10.1111/j.1365-2052.2005.01318.x; Niu D, 2002, BIOCHEM GENET, V40, P163, DOI 10.1023/A:1015832108669; Oka T, 2007, ANIM GENET, V38, P287, DOI 10.1111/j.1365-2052.2007.01604.x; OREILLY DJW, 2007, EARLY CIVILIZATIONS; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Peters JP., 1913, J AM ORIENT SOC, V33; Petersen G, 2006, ARCHAEOL OCEAN, V41, P82, DOI 10.1002/j.1834-4453.2006.tb00611.x; Pisenti JM, 2001, AVIAN POULT BIOL REV, V12, P1; Pizzari T, 2002, HEREDITY, V88, P112, DOI 10.1038/sj.hdy.6800014; Pliny, 2009, PLINY YOUNGER COMPLE; Qu LJ, 2009, ASIAN AUSTRAL J ANIM, V22, P1085, DOI 10.5713/ajas.2009.80660; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; REINMAN FRED R, 1977, ARCHAEOLOGICAL SURVE; Reitz E.J., 1995, PUERTO REAL ARCHAEOL, P287; Revay T, 2010, ANIM GENET, V41, P548, DOI 10.1111/j.1365-2052.2010.02041.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schaffer LN, 1996, MARTIME SE ASIA 1500; Serjeantson D, 2009, CAMB MAN ARCHAEOL, P1; Simoons Frederick, 1994, EAT NOT THIS FLESH F; Storey AA, 2008, INT J OSTEOARCHAEOL, V18, P240, DOI 10.1002/oa.947; Storey A.A., 2011, POLYNESIANS AM PRECO, P139; Storey A. A., 2011, RAPA NUI J, V25, P5; Storey AA, 2007, P NATL ACAD SCI USA, V104, P10335, DOI 10.1073/pnas.0703993104; Storey AA, 2010, J ARCHAEOL SCI, V37, P2459, DOI 10.1016/j.jas.2010.05.006; Storey AA, 2008, P NATL ACAD SCI USA, V105, pE99, DOI 10.1073/pnas.0807625105; Swafford DL, 2003, PAUP PHYLOGENETIC AN; Tegetmeier WB, 1867, POULTRY BOOK COMPRIS; Townsend Peterson A., 1998, Bird Conservation International, V8, P387; Underhill AP, 1997, J WORLD PREHIST, V11, P103, DOI 10.1007/BF02221203; Varro MT, 1912, VARRO FARMING; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; WEST B, 1989, WORLD POULTRY SCI J, V45, P205, DOI 10.1079/WPS19890012; Wickler, 2004, COLONISATION MIGRATI, P28; WOODGUSH DGM, 1959, POULTRY SCI, V38, P321, DOI 10.3382/ps.0380321; Yalden D, 2010, HIST BRIT BIRDS; Yen D.E., 1974, SWEET POTATO OCEANIA; Zerega NJC, 2004, AM J BOT, V91, P760, DOI 10.3732/ajb.91.5.760; Zeuner F. E, 1963, HIST DOMESTICATED AN	113	91	92	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e39171	10.1371/journal.pone.0039171	http://dx.doi.org/10.1371/journal.pone.0039171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	979GX	22848352	gold, Green Published, Green Submitted			2022-12-25	WOS:000306806600005
J	Bretana, NA; Lu, CT; Chiang, CY; Su, MG; Huang, KY; Lee, TY; Weng, SL				Bretana, Neil Arvin; Lu, Cheng-Tsung; Chiang, Chiu-Yun; Su, Min-Gang; Huang, Kai-Yao; Lee, Tzong-Yi; Weng, Shun-Long			Identifying Protein Phosphorylation Sites with Kinase Substrate Specificity on Human Viruses	PLOS ONE			English	Article							MAXIMAL DEPENDENCE DECOMPOSITION; WILD-TYPE; PREDICTION; IDENTIFICATION; SEQUENCE; TRANSCRIPTION; REPLICATION; DATABASE; MOTIFS; SERVER	Viruses infect humans and progress inside the body leading to various diseases and complications. The phosphorylation of viral proteins catalyzed by host kinases plays crucial regulatory roles in enhancing replication and inhibition of normal host-cell functions. Due to its biological importance, there is a desire to identify the protein phosphorylation sites on human viruses. However, the use of mass spectrometry-based experiments is proven to be expensive and labor-intensive. Furthermore, previous studies which have identified phosphorylation sites in human viruses do not include the investigation of the responsible kinases. Thus, we are motivated to propose a new method to identify protein phosphorylation sites with its kinase substrate specificity on human viruses. The experimentally verified phosphorylation data were extracted from virPTM - a database containing 301 experimentally verified phosphorylation data on 104 human kinase-phosphorylated virus proteins. In an attempt to investigate kinase substrate specificities in viral protein phosphorylation sites, maximal dependence decomposition (MDD) is employed to cluster a large set of phosphorylation data into subgroups containing significantly conserved motifs. The experimental human phosphorylation sites are collected from Phospho. ELM, grouped according to its kinase annotation, and compared with the virus MDD clusters. This investigation identifies human kinases such as CK2, PKB, CDK, and MAPK as potential kinases for catalyzing virus protein substrates as confirmed by published literature. Profile hidden Markov model is then applied to learn a predictive model for each subgroup. A five-fold cross validation evaluation on the MDD-clustered HMMs yields an average accuracy of 84.93% for Serine, and 78.05% for Threonine. Furthermore, an independent testing data collected from UniProtKB and Phospho. ELM is used to make a comparison of predictive performance on three popular kinase-specific phosphorylation site prediction tools. In the independent testing, the high sensitivity and specificity of the proposed method demonstrate the predictive effectiveness of the identified substrate motifs and the importance of investigating potential kinases for viral protein phosphorylation sites.	[Bretana, Neil Arvin; Lu, Cheng-Tsung; Chiang, Chiu-Yun; Su, Min-Gang; Huang, Kai-Yao; Lee, Tzong-Yi] Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan; [Lee, Tzong-Yi] Yuan Ze Univ, Grad Program Biomed Informat, Chungli, Taiwan; [Weng, Shun-Long] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Weng, Shun-Long] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Weng, Shun-Long] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Weng, Shun-Long] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan	Yuan Ze University; Yuan Ze University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Bretana, NA (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan.	francis@saturn.yzu.edu.tw		Bretana, Neil Arvin/0000-0003-4743-348X	National Science Council of the Republic of China [NSC 100-2221-E-155-079]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors sincerely appreciate the National Science Council of the Republic of China for financially supporting this research under Contract Numbers of NSC 100-2221-E-155-079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1992, J BIOL CHEM, V267, P21977; Agostini I, 2002, AIDS RES HUM RETROV, V18, P283, DOI 10.1089/088922202753472856; Ammosova T, 2005, VIROLOGY, V341, P171, DOI 10.1016/j.virol.2005.06.041; Andrew J, 2009, PLOS COMPUTATIONAL B; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Benetti L, 2006, J VIROL, V80, P3341, DOI 10.1128/JVI.80.7.3341-3348.2006; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang WC, 2009, J COMPUT CHEM; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; COCHRANE AW, 1989, J VIROL, V63, P4438, DOI 10.1128/JVI.63.10.4438-4440.1989; Coito C, 2004, J VIROL, V78, P3502, DOI 10.1128/JVI.78.7.3502-3513.2004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; ECKERT EA, 1967, SCIENCE, V158, P527, DOI 10.1126/science.158.3800.527-b; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Esfandiarei M, 2004, J VIROL, V78, P4289, DOI 10.1128/JVI.78.8.4289-4298.2004; Habran L, 2005, J BIOL CHEM, V280, P29135, DOI 10.1074/jbc.M503312200; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hemonnot B, 2006, VIROLOGY, V349, P430, DOI 10.1016/j.virol.2006.02.043; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Kobe B, 2005, BBA-PROTEINS PROTEOM, V1754, P200, DOI 10.1016/j.bbapap.2005.07.036; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021849; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Lee TY, 2011, BIOINFORMATICS, V27, P1780, DOI 10.1093/bioinformatics/btr291; Lee TY, 2011, NUCLEIC ACIDS RES, V39, pD777, DOI 10.1093/nar/gkq970; LELE S, 1991, AM J PHYS ANTHROPOL, V86, P415, DOI 10.1002/ajpa.1330860307; Lu CT, 2011, J COMPUT AID MOL DES, V25, P987, DOI 10.1007/s10822-011-9477-2; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miller ML, 2009, PROTEOMICS, V9, P116, DOI 10.1002/pmic.200800285; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; NAVARRO J, 1991, J GEN VIROL, V72, P1455, DOI 10.1099/0022-1317-72-6-1455; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ritz A, 2009, BIOINFORMATICS, V25, P14, DOI 10.1093/bioinformatics/btn569; Saunders NFW, 2008, NUCLEIC ACIDS RES, V36, pW286, DOI 10.1093/nar/gkn279; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Schang LM, 2002, J VIROL, V76, P7874, DOI 10.1128/JVI.76.15.7874-7882.2002; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001099; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; St-Denis NA, 2009, MOL CELL BIOL, V29, P2068, DOI 10.1128/MCB.01563-08; STAHL J, 1974, ACTA BIOL MED GER, V33, P667; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Wang L, 2002, MOL CELL BIOCHEM, V237, P137, DOI 10.1023/A:1016555821581; Wang Q, 2009, J VIROL, V83, P3668, DOI 10.1128/JVI.02063-08; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Xue Y, 2010, CURR PROTEIN PEPT SC, V11, P485, DOI 10.2174/138920310791824138; Yang PW, 2008, J GEN VIROL, V89, P884, DOI 10.1099/vir.0.83546-0; Zell R, 2008, CURR OPIN BIOTECH, V19, P652, DOI 10.1016/j.copbio.2008.10.009; Zhou Y, 2000, J VIROL, V74, P6520, DOI 10.1128/JVI.74.14.6520-6527.2000	61	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40694	10.1371/journal.pone.0040694	http://dx.doi.org/10.1371/journal.pone.0040694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844408	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700017
J	Cohen, EB; Moore, FR; Fischer, RA				Cohen, Emily B.; Moore, Frank R.; Fischer, Richard A.			Experimental Evidence for the Interplay of Exogenous and Endogenous Factors on the Movement Ecology of a Migrating Songbird	PLOS ONE			English	Article							PASSERINE MIGRANTS; HABITAT SELECTION; REPRODUCTIVE-PERFORMANCE; FOOD AVAILABILITY; STOPOVER ECOLOGY; SPATIAL-BEHAVIOR; BIRDS; FAT; COMPETITION; POPULATION	Movement patterns during songbird migration remain poorly understood despite their expected fitness consequences in terms of survival, energetic condition and timing of migration that will carry over to subsequent phases of the annual cycle. We took an experimental approach to test hypotheses regarding the influence of habitat, energetic condition, time of season and sex on the hour-by-hour, local movement decisions of a songbird during spring stopover. To simulate arrival of nocturnal migrants at unfamiliar stopover sites, we translocated and continuously tracked migratory red-eyed vireos (Vireo olivaceus) throughout spring stopover with and without energetic reserves that were released in two replicates of three forested habitat types. Migrants moved the most upon release, during which time they selected habitat characterized by greater food abundance and higher foraging attack rates. Presumably under pressure to replenish fuel stores necessary to continue migration in a timely fashion, migrants released in poorer energetic condition moved faster and further than migrants in better condition and the same pattern was true for migrants released late in spring relative to those released earlier. However, a migrant's energetic condition had less influence on their behavior when they were in poor quality habitat. Movement did not differ between sexes. Our study illustrates the importance of quickly finding suitable habitat at each stopover site, especially for energetically constrained migrants later in the season. If an initial period prior to foraging were necessary at each stop along a migrant's journey, non-foraging periods would cumulatively result in a significant energetic and time cost to migration. However, we suggest behavior during stopover is not solely a function of underlying resource distributions but is a complex response to a combination of endogenous and exogenous factors.	[Cohen, Emily B.; Moore, Frank R.] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Fischer, Richard A.] United States Army Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA	University of Southern Mississippi; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Cohen, EB (corresponding author), Smithsonian Conservat Biol Inst, Natl Zool Pk, Migratory Bird Ctr, Washington, DC USA.	cohene@si.edu	Cohen, Emily/AAB-4246-2020	Cohen, Emily/0000-0002-4978-4278	The University of Southern Mississippi; Department of Defense Strategic Environmental Research and Development Program (SERDP) [SI-1469]	The University of Southern Mississippi; Department of Defense Strategic Environmental Research and Development Program (SERDP)	Funding for this project was provided by The University of Southern Mississippi and the Department of Defense Strategic Environmental Research and Development Program (SERDP Project SI-1469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborn DA, 1997, BEHAVIOUR, V134, P1077, DOI 10.1163/156853997X00412; Alerstam T, 2003, AVIAN MIGRATION, P253; Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; [Anonymous], 2010, R LANG ENV STAT COMP; BAIRLEIN F, 1983, ORNIS SCAND, V14, P239, DOI 10.2307/3676157; BLAKE JG, 1986, AUK, V103, P328, DOI 10.1093/auk/103.2.328; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Cerasale DJ, 2010, AUK, V127, P636, DOI 10.1525/auk.2010.09124; Champlin TB, 2009, ECOLOGY, V90, P1586, DOI 10.1890/08-1190.1; Chernetsov N, 2006, J ORNITHOL, V147, P185, DOI 10.1007/s10336-006-0064-6; Chernetsov N, 2005, ANN NY ACAD SCI, V1046, P242, DOI 10.1196/annals.1343.021; Chernetsov N, 2006, WILSON J ORNITHOL, V118, P364, DOI 10.1676/04-134.1; Cimprich DA, 2005, ANIM BEHAV, V69, P1173, DOI 10.1016/j.anbehav.2004.07.021; Cimprich DA, 2000, BIRDS N AM; Cimprich DA, 2006, AUK, V123, P1069, DOI 10.1642/0004-8038(2006)123[1069:FAPBIG]2.0.CO;2; Delingat J, 2006, ARDEA, V94, P593; Fischer RA, 2012, J FIELD ORNITHOL, V83, P61, DOI 10.1111/j.1557-9263.2011.00356.x; FRANCIS CM, 1986, AUK, V103, P548; Hatch MI, 2009, IBIS, V151, P771, DOI 10.1111/j.1474-919X.2009.00964.x; Helms CW, 1960, BIRD BANDING, V31, P1, DOI DOI 10.2307/4510793; HUTTO RL, 1985, AUK, V102, P120, DOI 10.2307/4086827; JAMES F C, 1970, Audubon Field Notes, V24, P727; Jenni L, 2003, AVIAN MIGRATION, P155; Johnson MD, 2000, J FIELD ORNITHOL, V71, P88, DOI 10.1648/0273-8570-71.1.88; Johnson MD, 2001, J ANIM ECOL, V70, P546, DOI 10.1046/j.1365-2656.2001.00522.x; Keddy PA, 2009, SOUTHEAST NAT, V8, P213, DOI 10.1656/058.008.0202; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; LINDSTROM A, 1990, ANIM BEHAV, V40, P453, DOI 10.1016/S0003-3472(05)80525-1; LINDSTROM A, 1991, ORNIS SCAND, V22, P12, DOI 10.2307/3676616; Loria DE, 1990, BEHAV ECOL, V1, P24, DOI 10.1093/beheco/1.1.24; Martin G.R., 1990, P185; Matthews SN, 2010, LANDSCAPE ECOL, V25, P955, DOI 10.1007/s10980-010-9475-0; Moore F, 2003, AVIAN MIGRATION, P281; MOORE FR, 1990, WILSON BULL, V102, P487; MOORE FR, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P345; Moore FR, 2000, STUD AVIAN BIOL-SER, P34; MOORE FR, 1991, BEHAV ECOL SOCIOBIOL, V28, P85; Moore Frank R., 1995, P121; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Mukhin A, 2008, BEHAV ECOL, V19, P716, DOI 10.1093/beheco/arn025; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; Petit DR, 2000, STUD AVIAN BIOL-SER, P15; Pyle P., 1997, IDENTIFICATION GUI 1; Rubolini D, 2004, BEHAV ECOL, V15, P592, DOI 10.1093/beheco/arh048; Schwilch R, 2001, AUK, V118, P698, DOI 10.1642/0004-8038(2001)118[0698:LIRRAS]2.0.CO;2; Seewagen CL, 2010, ACTA OECOL, V36, P484, DOI 10.1016/j.actao.2010.06.005; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Smith RJ, 2003, OECOLOGIA, V134, P325, DOI 10.1007/s00442-002-1152-9; SPINA F, 1990, J ORNITHOL, V131, P429, DOI 10.1007/BF01639819; Tietz JR, 2007, CONDOR, V109, P795, DOI 10.1650/0010-5422(2007)109[795:SEAHSO]2.0.CO;2; Wang Yong, 2005, Acta Zoologica Sinica, V51, P12; Yong W, 1998, AUK, V115, P829, DOI 10.2307/4089502; Zuur Alain F., 2009, P1	58	48	48	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41818	10.1371/journal.pone.0041818	http://dx.doi.org/10.1371/journal.pone.0041818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844528	gold, Green Submitted, Green Published			2022-12-25	WOS:000306687700155
J	Guo, YR; Tukaye, DN; Wu, WJ; Zhu, XP; Book, M; Tan, W; Jones, SP; Rokosh, G; Narumiya, S; Li, QH; Bolli, R				Guo, Yiru; Tukaye, Deepali Nivas; Wu, Wen-Jian; Zhu, Xiaoping; Book, Michael; Tan, Wei; Jones, Steven P.; Rokosh, Gregg; Narumiya, Shuh; Li, Qianhong; Bolli, Roberto			The COX-2/PGI2 Receptor Axis Plays an Obligatory Role in Mediating the Cardioprotection Conferred by the Late Phase of Ischemic Preconditioning	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; HEAT-SHOCK-PROTEIN; JAK-STAT PATHWAY; A(3) ADENOSINE RECEPTOR; CO-RELEASING MOLECULE; CONSCIOUS RABBITS; GENE-THERAPY; PROSTACYCLIN RECEPTOR; 2ND WINDOW	Background: Pharmacologic studies with cyclooxygenase-2 (COX-2) inhibitors suggest that the late phase of ischemic preconditioning (PC) is mediated by COX-2. However, nonspecific effects of COX-2 inhibitors cannot be ruled out, and the selectivity of these inhibitors for COX-2 vs. COX-1 is only relative. Furthermore, the specific prostaglandin (PG) receptors responsible for the salubrious actions of COX-2-derived prostanoids remain unclear. Objective: To determine the role of COX-2 and prostacyclin receptor (IP) in late PC by gene deletion. Methods: COX-2 knockout (KO) mice (COX-2(-/-)), prostacyclin receptor KO (IP-/-) mice, and respective wildtype (WT, COX-2(+/+) and IP+/+) mice underwent sham surgery or PC with six 4-min coronary occlusion (O)/4-min R cycles 24 h before a 30-min O/24 h R. Results: There were no significant differences in infarct size (IS) between non-preconditioned (non-PC) COX-2(+/+), COX-2(-/-), IP+/+, and IP-/- mice, indicating that neither COX-2 nor IP modulates IS in the absence of PC. When COX-2(-/-) or IP-/- mice were preconditioned, IS was not reduced, indicating that the protection of late PC was completely abrogated by deletion of either the COX-2 or the IP gene. Administration of the IP selective antagonist, RO3244794 to C57BL6/J (B6) mice 30 min prior to the 30-min O had no effect on IS. When B6 mice were preconditioned 24 h prior to the 30-min O, IS was markedly reduced; however, the protection of late PC was completely abrogated by pretreatment of RO3244794. Conclusions: This is the first study to demonstrate that targeted disruption of the COX-2 gene completely abrogates the infarct-sparing effect of late PC, and that the IP, downstream of the COX-2/prostanoid pathway, is a key mediator of the late PC. These results provide unequivocal molecular genetic evidence for an essential role of the COX-2/PGI2 receptor axis in the cardioprotection afforded by the late PC.	[Guo, Yiru; Wu, Wen-Jian; Zhu, Xiaoping; Book, Michael; Tan, Wei; Jones, Steven P.; Rokosh, Gregg; Li, Qianhong; Bolli, Roberto] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [Tukaye, Deepali Nivas] Univ Louisville, Dept Internal Med, Louisville, KY 40292 USA; [Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan	University of Louisville; University of Louisville; Kyoto University	Guo, YR (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	rbolli@louisville.edu	Li, Qianhong/AAJ-7643-2020; Guo, Yiru/L-2618-2015; Rokosh, Gregg/J-2730-2013; Jones, Steven P./D-5092-2009; Bolli, Roberto/A-6870-2010	Guo, Yiru/0000-0002-0614-9899; Jones, Steven P./0000-0001-5376-8089; Rokosh, Gregg/0000-0002-9214-2254	NIH [R01HL55757, R01HL060481, R01HL-680888, R01HL-70897, R01HL-76794, R01HL090529, P01HL78825, P20RR024489]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070897, R01HL076794, R01HL055757, P01HL078825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by NIH grants R01HL55757, R01HL060481, R01HL-680888, R01HL-70897, R01HL-76794, R01HL090529, P01HL78825, and P20RR024489. The authors have received no additional external funding for this study.	Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Baxter GF, 1997, ANN MED, V29, P345, DOI 10.3109/07853899708999359; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; Black RG, 2002, CIRC RES, V91, P165, DOI 10.1161/01.RES.0000028007.91385.EE; Bley KR, 2006, BRIT J PHARMACOL, V147, P335, DOI 10.1038/sj.bjp.0706554; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1897, DOI 10.1006/jmcc.2001.1462; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1893, DOI 10.1006/jmcc.2001.1469; Bolli R, 1996, BASIC RES CARDIOL, V91, P57; Bolli R, 1997, CIRC RES, V81, P1094; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; Camitta MGW, 2001, CIRCULATION, V104, P2453, DOI 10.1161/hc4401.098429; Dawn B, 2004, J MOL CELL CARDIOL, V37, P51, DOI 10.1016/j.yjmcc.2004.03.012; Dawn B, 2004, CARDIOVASC RES, V64, P61, DOI 10.1016/j.cardiores.2004.05.011; Emery P, 2005, LANCET, V365, P1538, DOI 10.1016/S0140-6736(05)66447-1; Flaherty MP, 2008, J MOL CELL CARDIOL, V45, P735, DOI 10.1016/j.yjmcc.2008.08.014; Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607; Gres P, 2002, CARDIOVASC RES, V55, P626, DOI 10.1016/S0008-6363(01)00505-3; Guo Y, 2005, AM J PHYSIOL-HEART C, V289, pH2251, DOI 10.1152/ajpheart.00341.2005; Guo Y, 2003, J MOL CELL CARDIOL, V35, pA47; Guo Y, 2001, CIRCULATION, V104, P60; Guo Y, 2001, J MOL CELL CARDIOL, V33, pA41, DOI 10.1016/S0022-2828(01)90163-4; Guo Y, 2001, J MOL CELL CARDIOL, V33, P825, DOI 10.1006/jmcc.2001.1338; Guo Y, 2000, BASIC RES CARDIOL, V95, P479, DOI 10.1007/s003950070024; Guo Y, 1999, P NATL ACAD SCI USA, V96, P11507, DOI 10.1073/pnas.96.20.11507; Guo Y, 2000, ISHR HDB EXPT LAB PR; Guo Y, 2000, J MOL CELL CARDIOL, V32, pA51; Guo Y, 1999, J MOL CELL CARDIOL, V31, pA11; Guo Y, 2008, J MOL CELL CARDIOL, V44, P496, DOI 10.1016/j.yjmcc.2008.01.003; Guo YR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0253-9; Guo YR, 2003, CIRCULATION, V108, P93; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Guo YR, 2002, CIRCULATION, V106, P313; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; Guo YR, 2000, CIRCULATION, V102, P121; Hausenloy DJ, 2010, CARDIOVASC DRUG THER, V24, P235, DOI 10.1007/s10557-010-6237-9; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Hong TT, 2008, AM J PHYSIOL-HEART C, V294, pH145, DOI 10.1152/ajpheart.00646.2007; Hu LF, 2008, PFLUG ARCH EUR J PHY, V455, P971, DOI 10.1007/s00424-007-0346-8; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; JOHNSON G, 1990, CIRC RES, V66, P1362, DOI 10.1161/01.RES.66.5.1362; Jones WK, 1999, J MOL CELL CARDIOL, V31, P1469, DOI 10.1006/jmcc.1999.0983; Jugdutt B I, 1980, Adv Prostaglandin Thromboxane Res, V7, P675; JUGDUTT BI, 1981, CIRC RES, V49, P685, DOI 10.1161/01.RES.49.3.685; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kerr DJ, 2007, NEW ENGL J MED, V357, P360, DOI 10.1056/NEJMoa071841; Kodani E, 2002, AM J PHYSIOL-HEART C, V283, pH1943, DOI 10.1152/ajpheart.00150.2002; Krotz F, 2005, J VASC RES, V42, P312, DOI 10.1159/000086459; LEFER AM, 1978, SCIENCE, V200, P52, DOI 10.1126/science.345441; Li QH, 2006, AM J PHYSIOL-HEART C, V290, pH584, DOI 10.1152/ajpheart.00855.2005; Li QH, 2003, CIRC RES, V92, P741, DOI 10.1161/01.RES.0000065441.72685.29; Li QH, 1998, CIRCULATION, V98, P1438, DOI 10.1161/01.CIR.98.14.1438; Li QH, 2001, CIRCULATION, V103, P1893; Li QH, 2007, CIRCULATION, V116, P1577, DOI 10.1161/CIRCULATIONAHA.107.689810; Li QH, 2011, BASIC RES CARDIOL, V106, P1367, DOI 10.1007/s00395-011-0208-6; Li QH, 2011, BASIC RES CARDIOL, V106, P1355, DOI 10.1007/s00395-011-0207-7; Li QH, 2009, CIRCULATION, V120, P1222, DOI 10.1161/CIRCULATIONAHA.108.778688; Lin H, 2002, CIRCULATION, V105, P1962, DOI 10.1161/01.CIR.0000015365.49180.05; Lo RKH, 2008, CELL SIGNAL, V20, P2095, DOI 10.1016/j.cellsig.2008.08.003; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; OVIZE M, 1992, CIRCULATION, V85, P779, DOI 10.1161/01.CIR.85.2.779; Patel HH, 2004, LIFE SCI, V75, P129, DOI 10.1016/j.lfs.2003.10.036; Przyklenk K, 2003, J AM COLL CARDIOL, V41, P1195, DOI 10.1016/S0735-1097(03)00087-1; Qian YZ, 1999, AM J PHYSIOL-HEART C, V276, pH224, DOI 10.1152/ajpheart.1999.276.1.H224; Qiu YM, 1997, CIRC RES, V80, P730, DOI 10.1161/01.RES.80.5.730; Ruan Cheng-Huai, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-23; Sato H, 2007, AM J PHYSIOL-HEART C, V293, pH2557, DOI 10.1152/ajpheart.00858.2007; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; Shinmura K, 2004, BASIC RES CARDIOL, V99, P46, DOI 10.1007/s00395-003-0436-5; Shinmura K, 2003, J AM COLL CARDIOL, V41, P1183, DOI 10.1016/S0735-1097(03)00086-X; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Shinmura K, 2002, AM J PHYSIOL-HEART C, V283, pH2534, DOI 10.1152/ajpheart.00209.2002; Shinmura K, 2002, CIRC RES, V90, P602, DOI 10.1161/01.RES.0000012202.52809.40; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; Stein AB, 2004, STROKE, V35, P2676, DOI 10.1161/01.STR.0000143220.21382.fd; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Stitham J, 2007, BRIT J PHARMACOL, V152, P513, DOI 10.1038/sj.bjp.0707413; Tanaka K, 2004, ANESTHESIOLOGY, V100, P525, DOI 10.1097/00000542-200403000-00010; Tang XL, 1997, AM J PHYSIOL-HEART C, V273, pH1651, DOI 10.1152/ajpheart.1997.273.4.H1651; Wang GW, 2008, J MOL CELL CARDIOL, V44, P1016, DOI 10.1016/j.yjmcc.2008.03.020; Wang Y, 2004, CIRC RES, V95, P84, DOI 10.1161/01.RES.0000133679.38825.a6; Wang Y, 2002, J MOL CELL CARDIOL, V34, P5, DOI 10.1006/jmcc.2001.1482; West MB, 2008, CIRCULATION, V118, P1970, DOI 10.1161/CIRCULATIONAHA.108.791533; Wilson SJ, 2007, ARTERIOSCL THROM VAS, V27, P290, DOI 10.1161/01.ATV.0000252667.53790.4e; Woodward DF, 2010, PHARMACOL REV, V63, P471; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Xuan YT, 2003, J MOL CELL CARDIOL, V35, P525, DOI 10.1016/S0022-2828(03)00076-2; Xuan YT, 2007, CIRCULATION, V116, P535, DOI 10.1161/CIRCULATIONAHA.107.689471; Yamashita N, 1998, J MOL CELL CARDIOL, V30, P1181, DOI 10.1006/jmcc.1998.0682; Yoshida KI, 1996, MOL CELL BIOCHEM, V156, P1	101	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41178	10.1371/journal.pone.0041178	http://dx.doi.org/10.1371/journal.pone.0041178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844439	Green Published, gold			2022-12-25	WOS:000306687700052
J	Hasdemir, D; Smits, GJ; Westerhuis, JA; Smilde, AK				Hasdemir, Dicle; Smits, Gertien J.; Westerhuis, Johan A.; Smilde, Age K.			Topology of Transcriptional Regulatory Networks: Testing and Improving	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; COMPONENT ANALYSIS; MICROARRAY DATA; BUDDING YEAST; GENE; EXPRESSION; PROTEIN; KINASE; SWI5	With the increasing amount and complexity of data generated in biological experiments it is becoming necessary to enhance the performance and applicability of existing statistical data analysis methods. This enhancement is needed for the hidden biological information to be better resolved and better interpreted. Towards that aim, systematic incorporation of prior information in biological data analysis has been a challenging problem for systems biology. Several methods have been proposed to integrate data from different levels of information most notably from metabolomics, transcriptomics and proteomics and thus enhance biological interpretation. However, in order not to be misled by the dominance of incorrect prior information in the analysis, being able to discriminate between competing prior information is required. In this study, we show that discrimination between topological information in competing transcriptional regulatory network models is possible solely based on experimental data. We use network topology dependent decomposition of synthetic gene expression data to introduce both local and global discriminating measures. The measures indicate how well the gene expression data can be explained under the constraints of the model network topology and how much each regulatory connection in the model refuses to be constrained. Application of the method to the cell cycle regulatory network of Saccharomyces cerevisiae leads to the prediction of novel regulatory interactions, improving the information content of the hypothesized network model.	[Hasdemir, Dicle; Smits, Gertien J.; Westerhuis, Johan A.; Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Hasdemir, Dicle; Westerhuis, Johan A.; Smilde, Age K.] Netherlands Metabol Ctr, Leiden, Netherlands	University of Amsterdam	Hasdemir, D (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	D.Hasdemir@uva.nl	Smits, Gertien J./I-4327-2014	Smits, Gertien J./0000-0002-8439-7791; Smilde, Age/0000-0002-3052-4644	Netherlands Metabolomics Centre (NMC) a part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	Netherlands Metabolomics Centre (NMC) a part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	This project was financed by the Netherlands Metabolomics Centre (NMC) which is a part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis or preparation of the manuscript. They read the manuscript and agreed to publish.	Aerne BL, 1998, MOL BIOL CELL, V9, P945, DOI 10.1091/mbc.9.4.945; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; Bean JM, 2005, GENETICS, V171, P49, DOI 10.1534/genetics.105.044560; Bouquin N, 1999, MOL BIOL CELL, V10, P3389, DOI 10.1091/mbc.10.10.3389; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Chang CQ, 2008, BIOINFORMATICS, V24, P1349, DOI 10.1093/bioinformatics/btn131; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Galbraith SJ, 2006, BIOINFORMATICS, V22, P1886, DOI 10.1093/bioinformatics/btl279; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Kramer W, 1996, MOL GEN GENET, V252, P275; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Sabatti C, 2006, BIOINFORMATICS, V22, P739, DOI 10.1093/bioinformatics/btk017; Schuster T, 1997, Recent Results Cancer Res, V143, P251; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tran LM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511; Tran LM, 2005, METAB ENG, V7, P128, DOI 10.1016/j.ymben.2004.12.001; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Westerhuis JA, 2007, J CHEMOMETR, V21, P474, DOI 10.1002/cem.1072; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yu TW, 2005, BIOINFORMATICS, V21, P4033, DOI 10.1093/bioinformatics/bti656; Zijlstra BJH, 2002, J CHEMOMETR, V16, P596, DOI 10.1002/cem.764	32	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40082	10.1371/journal.pone.0040082	http://dx.doi.org/10.1371/journal.pone.0040082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844399	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700008
J	Power, SD; Kushki, A; Chau, T				Power, Sarah D.; Kushki, Azadeh; Chau, Tom			Intersession Consistency of Single-Trial Classification of the Prefrontal Response to Mental Arithmetic and the No-Control State by NIRS	PLOS ONE			English	Article							COMMUNICATION; CORTEX	Near-infrared spectroscopy (NIRS) has been recently investigated for use in noninvasive brain-computer interface (BCI) technologies. Previous studies have demonstrated the ability to classify patterns of neural activation associated with different mental tasks (e.g., mental arithmetic) using NIRS signals. Though these studies represent an important step towards the realization of an NIRS-BCI, there is a paucity of literature regarding the consistency of these responses, and the ability to classify them on a single-trial basis, over multiple sessions. This is important when moving out of an experimental context toward a practical system, where performance must be maintained over longer periods. When considering response consistency across sessions, two questions arise: 1) can the hemodynamic response to the activation task be distinguished from a baseline (or other task) condition, consistently across sessions, and if so, 2) are the spatiotemporal characteristics of the response which best distinguish it from the baseline (or other task) condition consistent across sessions. The answers will have implications for the viability of an NIRS-BCI system, and the design strategies (especially in terms of classifier training protocols) adopted. In this study, we investigated the consistency of classification of a mental arithmetic task and a no-control condition over five experimental sessions. Mixed model linear regression on intrasession classification accuracies indicate that the task and baseline states remain differentiable across multiple sessions, with no significant decrease in accuracy (p = 0.67). Intersession analysis, however, revealed inconsistencies in spatiotemporal response characteristics. Based on these results, we investigated several different practical classifier training protocols, including scenarios in which the training and test data come from 1) different sessions, 2) the same session, and 3) a combination of both. Results indicate that when selecting optimal classifier training protocols for NIRS-BCI, a compromise between accuracy and convenience (e.g., in terms of duration/frequency of training data collection) must be considered.	[Power, Sarah D.; Chau, Tom] Univ Toronto, Insitute Biomat & Biomed Engn, Toronto, ON, Canada; [Power, Sarah D.; Kushki, Azadeh; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Power, SD (corresponding author), Univ Toronto, Insitute Biomat & Biomed Engn, Toronto, ON, Canada.	tom.chau@utoronto.ca	Chau, Tom TK/C-8426-2009; Power, Sarah/AAU-9422-2020	Chau, Tom TK/0000-0002-7486-0316; Power, Sarah/0000-0001-5132-2753	Natural Sciences and Engineering Research Council [RGPIN 227451]; Canada Research Chairs Program	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	Natural Sciences and Engineering Research Council, Grant number: RGPIN 227451 (http://www.nserc-crsng.gc.ca/Index_eng.asp) and Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind G, 2008, BIOMED TECH, V53, P36, DOI 10.1515/BMT.2008.005; Benaron DA, 2000, J CEREBR BLOOD F MET, V20, P469, DOI 10.1097/00004647-200003000-00005; Buttfield A, 2006, IEEE T NEUR SYS REH, V14, P164, DOI 10.1109/TNSRE.2006.875555; COPE M, 1991, THESIS U LONDON; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Falk TH, 2011, IEEE T NEUR SYS REH, V19, P136, DOI 10.1109/TNSRE.2010.2078516; Franceschini MA, 2000, PROCEEDINGS OF INTER-INSTITUTE WORKSHOP ON IN VIVO OPTICAL IMAGING AT THE NIH, P73; Herrmann MJ, 2003, BIOL PSYCHOL, V64, P255, DOI 10.1016/S0301-0511(03)00095-4; Leeb R., 2007, COMPUTATIONAL INTELL; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mason SG, 2006, INERT1989 ROC; Matthews F, 2008, IEEE SIGNAL PROC MAG, V25, P87, DOI 10.1109/MSP.2008.4408445; Naito M, 2007, IEICE T INF SYST, VE90D, P1028, DOI 10.1093/ietisy/e90-d.7.1028; Ogata H, 2007, P ANN INT IEEE EMBS, P4731, DOI 10.1109/IEMBS.2007.4353396; Pfurtscheller G, 2010, INT J PSYCHOPHYSIOL, V76, P186, DOI 10.1016/j.ijpsycho.2010.03.013; Power SD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066004; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Sitaram R, 2009, NEURAL NETWORKS, V22, P1320, DOI 10.1016/j.neunet.2009.05.009; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Tai K, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-39; Utsugi K, 2007, P ANN INT IEEE EMBS, P5338, DOI 10.1109/IEMBS.2007.4353547; VAUGHN R, 1977, HEADACHE, V16, P313, DOI 10.1111/j.1526-4610.1976.hed1606313.x; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Yamamoto T, 2002, PHYS MED BIOL, V47, P3429, DOI 10.1088/0031-9155/47/18/311	30	64	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e37791	10.1371/journal.pone.0037791	http://dx.doi.org/10.1371/journal.pone.0037791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844390	gold, Green Submitted, Green Published			2022-12-25	WOS:000306687700002
J	Yoshida-Amano, Y; Hachiya, A; Ohuchi, A; Kobinger, GP; Kitahara, T; Takema, Y; Fukuda, M				Yoshida-Amano, Yasuko; Hachiya, Akira; Ohuchi, Atsushi; Kobinger, Gary P.; Kitahara, Takashi; Takema, Yoshinori; Fukuda, Mitsunori			Essential Role of RAB27A in Determining Constitutive Human Skin Color	PLOS ONE			English	Article							KERATINOCYTE-MELANOCYTE INTERACTIONS; BLACK-AND-WHITE; MELANOSOME TRANSPORT; TYROSINASE ACTIVITY; MYOSIN-VA; DISTRIBUTION PATTERNS; GRISCELLI-SYNDROME; SENILE LENTIGO; GENE-TRANSFER; HUMAN HAIR	Human skin color is predominantly determined by melanin produced in melanosomes within melanocytes and subsequently distributed to keratinocytes. There are many studies that have proposed mechanisms underlying ethnic skin color variations, whereas the processes involved from melanin synthesis in melanocytes to the transfer of melanosomes to keratinocytes are common among humans. Apart from the activities in the melanogenic rate-limiting enzyme, tyrosinase, in melanocytes and the amounts and distribution patterns of melanosomes in keratinocytes, the abilities of the actin-associated factors in charge of melanosome transport within melanocytes also regulate pigmentation. Mutations in genes encoding melanosome transport-related molecules, such as MYO5A, RAB27A and SLAC-2A, have been reported to cause a human pigmentary disease known as Griscelli syndrome, which is associated with diluted skin and hair color. Thus we hypothesized that process might play a role in modulating skin color variations. To address that hypothesis, the correlations of expression of RAB27A and its specific effector, SLAC2-A, to melanogenic ability were evaluated in comparison with tyrosinase, using human melanocytes derived from 19 individuals of varying skin types. Following the finding of the highest correlation in RAB27A expression to the melanogenic ability, darkly-pigmented melanocytes with significantly higher RAB27A expression were found to transfer significantly more melanosomes to keratinocytes than lightly-pigmented melanocytes in co-culture and in human skin substitutes (HSSs) in vivo, resulting in darker skin color in concert with the difference observed in African-descent and Caucasian skins. Additionally, RAB27A knockdown by a lentivirus-derived shRNA in melanocytes concomitantly demonstrated a significantly reduced number of transferred melanosomes to keratinocytes in co-culture and a significantly diminished epidermal melanin content skin color intensity (Delta L* = 4.4) in the HSSs. These data reveal the intrinsically essential role of RAB27A in human ethnic skin color determination and provide new insights for the fundamental understanding of regulatory mechanisms underlying skin pigmentation.	[Yoshida-Amano, Yasuko; Hachiya, Akira; Ohuchi, Atsushi; Kitahara, Takashi] Kao Corp, Biol Sci Labs, Haga, Tochigi, Japan; [Kobinger, Gary P.] Univ Manitoba, Special Pathogens Program, Natl Microbiol Lab, Dept Med Microbiol,Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Takema, Yoshinori] Kao Corp, Res & Dev Global, Sumida Ku, Tokyo, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech, Sendai, Miyagi 980, Japan	KAO Corporation; Public Health Agency of Canada; University of Manitoba; KAO Corporation; Tohoku University	Yoshida-Amano, Y (corresponding author), Kao Corp, Biol Sci Labs, Haga, Tochigi, Japan.	hachiya.akira@kao.co.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Kao Corporation; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Kao Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors have read the journal's policy and have the following conflicts: Yasuko Yoshida-Amano, Akira Hachiya, Atsushi Ohuchi, Takashi Kitahara, and Yoshinori Takema are employed by Kao Corporation, who were the funders of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alaluf S, 2003, PIGM CELL RES, V16, P35, DOI 10.1034/j.1600-0749.2003.00005.x; Babiarz-Magee L, 2004, PIGM CELL RES, V17, P241, DOI 10.1111/j.1600-0749.2004.00133.x; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Byers HR, 2003, J INVEST DERMATOL, V121, P813; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Diamond J, 2005, NATURE, V435, P283, DOI 10.1038/435283a; Fitzpatrick T. B., 1975, J MED ESTHETIQUE, V2, P33, DOI DOI 10.1159/000251345; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fuller BB, 2001, EXP CELL RES, V262, P197, DOI 10.1006/excr.2000.5092; Hachiya A, 2007, GENE THER, V14, P648, DOI 10.1038/sj.gt.3302915; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; IWATA M, 1990, J INVEST DERMATOL, V95, P9, DOI 10.1111/1523-1747.ep12872677; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kawasaki A, 2008, PIGM CELL MELANOMA R, V21, P56, DOI 10.1111/j.1755-148X.2007.00420.x; KONRAD K, 1973, ARCH DERMATOL, V107, P853; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; MONTAGNA W, 1991, J AM ACAD DERMATOL, V24, P929, DOI 10.1016/0190-9622(91)70148-U; NAEYAERT JM, 1991, BRIT J DERMATOL, V125, P297, DOI 10.1111/j.1365-2133.1991.tb14161.x; Noblesse E, 2006, SKIN PHARMACOL PHYS, V19, P95, DOI 10.1159/000091976; Paine C, 2001, J INVEST DERMATOL, V116, P587, DOI 10.1046/j.1523-1747.2001.01291.x; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Passeron T, 2004, FASEB J, V18, P989, DOI 10.1096/fj.03-1240fje; POMERANTZ SH, 1975, J CLIN INVEST, V55, P1127, DOI 10.1172/JCI108014; SAEKI H, 1985, J INVEST DERMATOL, V85, P423, DOI 10.1111/1523-1747.ep12277091; Scott MC, 2002, J CELL SCI, V115, P2349; SEARLE AG, 1990, OPHTHALMIC PAED GEN, V11, P159, DOI 10.3109/13816819009020974; Seiberg M, 2000, J INVEST DERMATOL, V115, P162, DOI 10.1046/j.1523-1747.2000.00035.x; Seiberg M, 2000, EXP CELL RES, V254, P25, DOI 10.1006/excr.1999.4692; Seiberg M, 2001, PIGM CELL RES, V14, P236, DOI 10.1034/j.1600-0749.2001.140402.x; Sharlow ER, 2000, J CELL SCI, V113, P3093; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Smith DR, 2004, EXP CELL RES, V298, P521, DOI 10.1016/j.yexcr.2004.04.033; Sriwiriyanont P, 2011, J INVEST DERMATOL, V131, P320, DOI 10.1038/jid.2010.309; Sriwiriyanont P, 2009, J INVEST DERMATOL, V129, P2296, DOI 10.1038/jid.2009.33; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; SZABO G, 1969, NATURE, V222, P1082, DOI 10.1038/2221081a0; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Unver N, 2006, BRIT J DERMATOL, V155, P119, DOI 10.1111/j.1365-2133.2006.07210.x; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yoshida Y, 2007, FASEB J, V21, P2829, DOI 10.1096/fj.06-6845com	53	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41160	10.1371/journal.pone.0041160	http://dx.doi.org/10.1371/journal.pone.0041160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844437	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700050
J	Ritchie, HH; Yee, CT; Tang, XN; Dong, ZH; Fuller, RS				Ritchie, Helena H.; Yee, Colin T.; Tang, Xu-na; Dong, Zhihong; Fuller, Robert S.			DSP-PP Precursor Protein Cleavage by Tolloid-Related-1 Protein and by Bone Morphogenetic Protein-1	PLOS ONE			English	Article							DENTIN SIALOPHOSPHOPROTEIN DSPP; MATRIX PROTEIN-1; C-PROTEINASE; IN-VIVO; PHOSPHOPHORYN; METALLOPROTEINASES; SIALOPROTEIN; MOUSE; EXPRESSION; DENTINOGENESIS	Dentin sialoprotein (DSP) and phosphophoryn (PP), acidic proteins critical to dentin mineralization, are translated from a single transcript as a DSP-PP precursor that undergoes specific proteolytic processing to generate DSP and PP. The cleavage mechanism continues to be controversial, in part because of the difficulty of obtaining DSP-PP from mammalian cells and dentin matrix. We have infected Sf9 cells with a recombinant baculovirus to produce large amounts of secreted DSP-PP240, a variant form of rat DSP-PP. Mass spectrometric analysis shows that DSP-PP240 secreted by Sf9 cells undergoes specific cleavage at the site predicted from the N-terminal sequence of PP extracted from dentin matrix: SMQG(447) down arrow (DDPN)-D-448. DSP-PP240 is cleaved after secretion by a zinc-dependent activity secreted by Sf9 cells, generating DSP430 and PP240 products that are stable in the medium. DSP-PP processing activity is constitutively secreted by Sf9 cells, but secretion is diminished 3 days after infection. Using primers corresponding to the highly conserved catalytic domain of Drosophila melanogaster tolloid (a mammalian BMP1 homolog), we isolated a partial cDNA for a Spodopotera frugiperda tolloid-related-1 protein (TLR1) that is 78% identical to Drosophila TLR1 but only 65% identical to Drosophila tolloid. Tlr1 mRNA decreased rapidly in Sf9 cells after baculovirus infection and was undetectable 4d after infection, paralleling the observed decrease in secretion of the DSP-PP240 processing activity after infection. Human BMP1 is more similar to Sf9 and Drosophila TLR1 than to tolloid, and Sf9 TLR1 is more similar to BMP1 than to other mammalian homologs. Recombinant human BMP1 correctly processed baculovirus-expressed DSP-PP240 in a dose-dependent manner. Together, these data suggest that the physiologically accurate cleavage of mammalian DSP-PP240 in the Sf9 cell system represents the action of a conserved processing enzyme and support the proposed role of BMP1 in processing DSP-PP in dentin matrix.	[Ritchie, Helena H.; Yee, Colin T.; Tang, Xu-na; Dong, Zhihong] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Fuller, Robert S.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Tang, Xu-na] Nanjing Univ, Med Ctr, Sch Stomatol, Dept Endodontol, Nanjing, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Nanjing University	Ritchie, HH (corresponding author), Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.	helenar@umich.edu			National Institutes of Health NIDCR [DE18901]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011442] Funding Source: NIH RePORTER	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health NIDCR DE18901 to HHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; BUTLER WT, 1995, INT J DEV BIOL, V39, P169; FELBER JP, 1962, BIOCHEMISTRY-US, V1, P231, DOI 10.1021/bi00908a006; Godovikova V, 2006, DEV BIOL, V289, P507, DOI 10.1016/j.ydbio.2005.10.002; Godovikova V, 2007, J BIOL CHEM, V282, P31341, DOI 10.1074/jbc.M702605200; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Li JH, 2009, CELLS TISSUES ORGANS, V189, P252, DOI 10.1159/000158571; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Qin CL, 2001, J BIOL CHEM, V276, P904, DOI 10.1074/jbc.M006271200; Salvesen G. S., 2001, PROTEOLYTIC ENZYMES, P105; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Tang XN, 2011, J DERMATOL SCI, V64, P92, DOI 10.1016/j.jdermsci.2011.08.009; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	27	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41110	10.1371/journal.pone.0041110	http://dx.doi.org/10.1371/journal.pone.0041110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815932	Green Submitted, Green Published, gold			2022-12-25	WOS:000306507000068
J	Baba, T; Badr, ME; Tomaru, U; Ishizu, A; Mukaida, N				Baba, Tomohisa; Badr, Mohamed El Sherif; Tomaru, Utano; Ishizu, Akihiro; Mukaida, Naofumi			Novel Process of Intrathymic Tumor-Immune Tolerance through CCR2-Mediated Recruitment of Sirp alpha(+) Dendritic Cells: A Murine Model	PLOS ONE			English	Article							HUMAN THYMIC CORTEX; REGULATORY T-CELLS; NEGATIVE SELECTION; ESCAPE MECHANISM; CLONAL DELETION; THYMOCYTES; RECEPTOR; ANTIGEN; PROTEIN; MICE	Immune surveillance system can detect more efficiently secretory tumor-specific antigens, which are superior as a target for cancer immunotherapy. On the contrary, immune tolerance can be induced in the thymus when a tumor antigen is massively secreted into circulation. Thus, the secretion of tumor-specific antigen may have contradictory roles in tumor immunity in a context-dependent manner. However, it remains elusive on the precise cellular mechanism of intrathymic immune tolerance against tumor antigens. We previously demonstrated that a minor thymic conventional dendritic cell (cDC) subset, CD8 alpha(-)Sirp alpha(+) cDCs, but not the major subset, CD8 alpha(+)Sirp alpha(-) cDCs can selectively capture blood-borne antigens and crucially contribute to the self-tolerance. In the present study, we further demonstrated that Sirp alpha(+) cDCs can capture a blood-borne antigen leaking inside the interlobular vascular-rich regions (IVRs). Blood-borne antigen selectively captured by Sirp alpha(+) cDCs can induce antigen-specific Treg generation or negative selection, depending on the immunogenicity of the presented antigen. Furthermore, CCR2 expression by thymic Sirp alpha(+) cDCs and abundant expression of its ligands, particularly, CCL2 by tumor-bearing mice prompted us to examine the function of thymic Sirp alpha(+) cDCs in tumor-bearing mice. Interestingly, tumor-bearing mice deposited CCL2 inside IVRs in the thymus. Moreover, tumor formation induced the accumulation of Sirp alpha(+) cDCs in IVRs under the control of CCR2-CCL2 axis and enhanced their capacity to take up antigens, resulting in the shift from Treg differentiation to negative selection. Finally, intrathymic negative selection similarly ensued in CCR2-competent mice once the tumor-specific antigen was secreted into bloodstream. Thus, we demonstrated that thymic Sirp alpha(+) cDCs crucially contribute to this novel process of intrathymic tumor immune tolerance.	[Baba, Tomohisa; Badr, Mohamed El Sherif; Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan; [Tomaru, Utano] Hokkaido Univ, Dept Pathol Pathophysiol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan	Kanazawa University; Hokkaido University; Hokkaido University	Baba, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan.	sergenti@staff.kanazawa-u.ac.jp	Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851	 [23790532]		This work was supported by Grant-in-aid for scientific research in Japan (23790532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Atibalentja DF, 2011, J IMMUNOL, V186, P1421, DOI 10.4049/jimmunol.1002587; Atibalentja DF, 2009, J IMMUNOL, V183, P7909, DOI 10.4049/jimmunol.0902632; Azakami H, 2005, J AGR FOOD CHEM, V53, P1254, DOI 10.1021/jf049325f; Baba T, 2009, J IMMUNOL, V183, P3053, DOI 10.4049/jimmunol.0900438; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; BOELAERT JR, 1989, PERITON DIALYSIS INT, V9, P95; Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Bubanovic IV, 2003, MED HYPOTHESES, V60, P315, DOI 10.1016/S0306-9877(02)00450-4; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; CORBETT TH, 1975, CANCER RES, V35, P2434; Corthay A, 2011, SCAND J IMMUNOL, V73, P527, DOI 10.1111/j.1365-3083.2011.02558.x; Corthay A, 2009, CANCER RES, V69, P5901, DOI 10.1158/0008-5472.CAN-08-4816; Croguennec T, 2007, J COLLOID INTERF SCI, V315, P627, DOI 10.1016/j.jcis.2007.07.041; Fujii H, 2011, ARTHRITIS RHEUM-US, V63, P96, DOI 10.1002/art.30106; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Kyewski B, CELL, V140, P24; Lauritzsen GF, 1998, INT J CANCER, V78, P216, DOI 10.1002/(SICI)1097-0215(19981005)78:2<216::AID-IJC16>3.3.CO;2-E; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Paessens LC, 2008, J PATHOL, V214, P96, DOI 10.1002/path.2260; Paessens LC, 2007, IMMUNOL LETT, V110, P65, DOI 10.1016/j.imlet.2007.03.005; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41154	10.1371/journal.pone.0041154	http://dx.doi.org/10.1371/journal.pone.0041154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815949	Green Submitted, Green Published, gold			2022-12-25	WOS:000306466100122
J	Oda, M; Kabura, M; Takagishi, T; Suzue, A; Tominaga, K; Urano, S; Nagahama, M; Kobayashi, K; Furukawa, K; Furukawa, K; Sakurai, J				Oda, Masataka; Kabura, Michiko; Takagishi, Teruhisa; Suzue, Ayaka; Tominaga, Kaori; Urano, Shiori; Nagahama, Masahiro; Kobayashi, Keiko; Furukawa, Keiko; Furukawa, Koichi; Sakurai, Jun			Clostridium perfringens Alpha-toxin Recognizes the GM1a-TrkA Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING SITES; PHOSPHOLIPASE-C; BOTULINUM NEUROTOXIN; BIOLOGICAL-ACTIVITIES; GANGLIOSIDE GM1; PC12 CELLS; SHEEP ERYTHROCYTES; NEURITE-OUTGROWTH; ENDOTHELIAL-CELLS; CHOLERA-TOXIN	Clostridium perfringens alpha-toxin is the major virulence factor in the pathogenesis of gas gangrene. Alpha-toxin is a 43-kDa protein with two structural domains; the N-domain contains the catalytic site and coordinates the divalent metal ions, and the C-domain is a membrane-binding site. The role of the exposed loop region (72-93 residues) in the N-domain, however, has been unclear. Here we show that this loop contains a ganglioside binding motif (H center dot center dot center dot SXWY center dot center dot center dot G) that is the same motif seen in botulinum neurotoxin and directly binds to a specific conformation of the ganglioside Neu5Ac alpha 2-3(Gal beta 1-3GalNAc beta 1-4)Gal beta 1-4Glc beta 1Cer (GM1a) through a carbohydrate moiety. Confocal microscopy analysis using fluorescently labeled BODIPY-GM1a revealed that the toxin colocalized with GM1a and induced clustering of GM1a on the cell membranes. Alpha-toxin was only slightly toxic in beta 1,4-N-acetylgalactosaminyltransferase knock-out mice, which lack the a-series gangliosides that contain GM1a, but was highly toxic in alpha 2,8-sialyltransferase knock-out mice, which lack both b-series and c-series gangliosides, similar to the control mice. Moreover, experiments with site-directed mutants indicated that Trp-84 and Tyr-85 in the exposed alpha-toxin loop play an important role in the interaction with GM1a and subsequent activation of TrkA. These results suggest that binding of alphatoxin to GM1a facilitates the activation of the TrkA receptor and induces a signal transduction cascade that promotes the release of chemokines. Therefore, we conclude that GM1a is the primary cellular receptor for alpha-toxin, which can be a potential target for drug developed against this pathogen.	[Oda, Masataka; Kabura, Michiko; Takagishi, Teruhisa; Suzue, Ayaka; Tominaga, Kaori; Urano, Shiori; Nagahama, Masahiro; Kobayashi, Keiko; Sakurai, Jun] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 7708514, Japan; [Furukawa, Keiko; Furukawa, Koichi] Nagoya Univ, Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 466, Japan	Tokushima Bunri University; Nagoya University	Oda, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 7708514, Japan.	masa@ph.bunri-u.ac.jp	Oda, Masataka/ABG-6047-2020		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government [21790431]; MEXT-supported Program for the Strategic Research Foundation at Private Universities [S0801078]; Grants-in-Aid for Scientific Research [23590526] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research 21790431 from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government and MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2008-2012 (S0801078).	Alape-Giron A, 2000, EUR J BIOCHEM, V267, P5191, DOI 10.1046/j.1432-1327.2000.01588.x; Arimitsu H, 2009, PROTEIN EXPRES PURIF, V67, P96, DOI 10.1016/j.pep.2009.04.011; Bryant AE, 1996, INFECT IMMUN, V64, P358, DOI 10.1128/IAI.64.1.358-362.1996; Bunting M, 1997, J CLIN INVEST, V100, P565, DOI 10.1172/JCI119566; Clark GC, 2003, J MOL BIOL, V333, P759, DOI 10.1016/j.jmb.2003.07.016; Duchemin AM, 2002, J NEUROCHEM, V81, P696, DOI 10.1046/j.1471-4159.2002.00831.x; Emsley P, 2000, J BIOL CHEM, V275, P8889, DOI 10.1074/jbc.275.12.8889; Flores-Diaz M, 2005, J BIOL CHEM, V280, P26680, DOI 10.1074/jbc.M500278200; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Holmgren J, 1980, Adv Exp Med Biol, V125, P453; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Jepson M, 2001, FEBS LETT, V495, P172, DOI 10.1016/S0014-5793(01)02385-7; Jepson M, 1999, INFECT IMMUN, V67, P3297, DOI 10.1128/IAI.67.7.3297-3301.1999; Karalewitz APA, 2010, BIOCHEMISTRY-US, V49, P8117, DOI 10.1021/bi100865f; Keyburn AL, 2006, INFECT IMMUN, V74, P6496, DOI 10.1128/IAI.00806-06; Kitamura M, 2005, BBA-MOL BASIS DIS, V1741, P1, DOI 10.1016/j.bbadis.2005.04.005; KITAMURA M, 1980, BIOCHIM BIOPHYS ACTA, V628, P328, DOI 10.1016/0304-4165(80)90382-7; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; Mutoh T, 2000, GLYCOCONJUGATE J, V17, P233, DOI 10.1023/A:1026597408790; Mutoh T, 1998, J BIOL CHEM, V273, P26001, DOI 10.1074/jbc.273.40.26001; NAGAHAMA M, 1995, J BACTERIOL, V177, P1179, DOI 10.1128/jb.177.5.1179-1185.1995; Nagahama M, 2002, MICROBIOL IMMUNOL, V46, P647, DOI 10.1111/j.1348-0421.2002.tb02748.x; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Ochi S, 2004, J BIOL CHEM, V279, P12181, DOI 10.1074/jbc.M307046200; Ochi S, 2002, MICROBIOL-SGM, V148, P237, DOI 10.1099/00221287-148-1-237; Oda M, 2006, INFECT IMMUN, V74, P2876, DOI 10.1128/IAI.74.5.2876-2886.2006; Oda M, 2008, J PHARMACOL EXP THER, V327, P934, DOI 10.1124/jpet.108.143677; Oda M, 2008, J LIPID RES, V49, P1039, DOI 10.1194/jlr.M700587-JLR200; Oda M, 2012, BBA-MOL BASIS DIS, V1822, P1581, DOI 10.1016/j.bbadis.2012.06.007; Oda M, 2011, BIOCHEM BIOPH RES CO, V411, P241, DOI 10.1016/j.bbrc.2011.06.103; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; Pitto M, 1998, FEBS LETT, V439, P93, DOI 10.1016/S0014-5793(98)01344-1; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Sakurai J, 2009, TOXINS, V1, P208, DOI 10.3390/toxins1020208; Shimizu K, 2002, P NATL ACAD SCI USA, V99, P9133, DOI 10.1073/pnas.142277999; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; Strotmeier J, 2010, BIOCHEM J, V431, P207, DOI 10.1042/BJ20101042; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Titball RV, 1999, ANAEROBE, V5, P51, DOI 10.1006/anae.1999.0191; Tsukamoto K, 2008, MICROB PATHOGENESIS, V44, P484, DOI 10.1016/j.micpath.2007.12.003; Urbina P, 2011, BBA-BIOMEMBRANES, V1808, P2618, DOI 10.1016/j.bbamem.2011.06.008; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Walker N, 2000, ARCH BIOCHEM BIOPHYS, V384, P24, DOI 10.1006/abbi.2000.2065; Yamazaki Y, 2007, BIOCHEM J, V407, P31, DOI 10.1042/BJ20070090	51	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33070	33079		10.1074/jbc.M112.393801	http://dx.doi.org/10.1074/jbc.M112.393801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22847002	Green Published, hybrid			2022-12-25	WOS:000309168300069
J	Watanabe, S; Morimoto, D; Fukumori, F; Shinomiya, H; Nishiwaki, H; Kawano-Kawada, M; Sasai, Y; Tozawa, Y; Watanabe, Y				Watanabe, Seiya; Morimoto, Daichi; Fukumori, Fumiyasu; Shinomiya, Hiroto; Nishiwaki, Hisashi; Kawano-Kawada, Miyuki; Sasai, Yuuki; Tozawa, Yuzuru; Watanabe, Yasuo			Identification and Characterization of D-Hydroxyproline Dehydrogenase and Delta(1)-Pyrroline-4-hydroxy-2-carboxylate Deaminase Involved in Novel L-Hydroxyproline Metabolism of Bacteria METABOLIC CONVERGENT EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-PROLINE DEHYDROGENASE; AMINO-ACID DEHYDROGENASE; CRYSTAL-STRUCTURE; ALTERNATIVE PATHWAY; D-GLUCARATE; GENE; PROTEINS; INSIGHT; OXIDASE; DEHYDRATASE	L-Hydroxyproline (4-hydroxyproline) mainly exists in collagen, and most bacteria cannot metabolize this hydroxyamino acid. Pseudomonas putida and Pseudomonas aeruginosa convert L-hydroxyproline to alpha-ketoglutarate via four hypothetical enzymatic steps different from known mammalian pathways, but the molecular background is rather unclear. Here, we identified and characterized for the first time two novel enzymes, D-hydroxyproline dehydrogenase and Delta(1)-pyrroline-4-hydroxy-2-carboxylate (Pyr4H2C) deaminase, involved in this hypothetical pathway. These genes were clustered together with genes encoding other catalytic enzymes on the bacterial genomes. D-Hydroxyproline dehydrogenases from P. putida and P. aeruginosa were completely different from known bacterial proline dehydrogenases and showed similar high specificity for substrate (D-hydroxyproline) and some artificial electron acceptor( s). On the other hand, the former is a homomeric enzyme only containing FAD as a prosthetic group, whereas the latter is a novel heterododecameric structure consisting of three different subunits (alpha(4)beta(4)gamma(4)), and two FADs, FMN, and [2Fe-2S] iron-sulfur cluster were contained in alpha beta gamma of the heterotrimeric unit. These results suggested that the L-hydroxyproline pathway clearly evolved convergently in P. putida and P. aeruginosa. Pyr4H2C deaminase is a unique member of the dihydrodipicolinate synthase/N-acetylneuraminate lyase protein family, and its activity was competitively inhibited by pyruvate, a common substrate for other dihydrodipicolinate synthase/N-acetylneuraminate lyase proteins. Furthermore, disruption of Pyr4H2C deaminase genes led to loss of growth on L-hydroxyproline (as well as D-hydroxyproline) but not L-and D-proline, indicating that this pathway is related only to L-hydroxyproline degradation, which is not linked to proline metabolism.	[Watanabe, Seiya; Morimoto, Daichi; Nishiwaki, Hisashi; Kawano-Kawada, Miyuki; Sasai, Yuuki; Watanabe, Yasuo] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Kawano-Kawada, Miyuki] Ehime Univ, Integrated Ctr Sci INCS, Matsuyama, Ehime 7908566, Japan; [Fukumori, Fumiyasu] Toyo Univ, Fac Life Sci, Itakura, Gunma 3740193, Japan; [Shinomiya, Hiroto] Ehime Prefectural Inst Publ Hlth & Environm Sci, Matsuyama, Ehime 7900003, Japan; [Tozawa, Yuzuru] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan	Ehime University; Ehime University; Toyo University; Ehime University	Watanabe, S (corresponding author), Ehime Univ, Fac Agr, 3-5-7 Tarumi, Matsuyama, Ehime 7908566, Japan.	irab@agr.ehime-u.ac.jp	Tozawa, Yuzuru/G-2657-2013; Tozawa, Yuzuru/AAM-9620-2020	Tozawa, Yuzuru/0000-0002-3885-1105; KAWANO-KAWADA, Miyuki/0000-0002-1168-9291	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18760592]; JGC-S Scholarship Foundation; Nippon Life Insurance Foundation; Asahi Glass Foundation; Takahashi Industrial and Economic Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JGC-S Scholarship Foundation; Nippon Life Insurance Foundation(Nippon Life Insurance Foundation); Asahi Glass Foundation; Takahashi Industrial and Economic Research Foundation	This work was supported in part by a Grant-in-aid for Young Scientists (B) 18760592 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. W.), a JGC-S Scholarship Foundation (to S. W.), the Nippon Life Insurance Foundation (to S. W.), the Asahi Glass Foundation (to S. W.), and the Takahashi Industrial and Economic Research Foundation (to S. W.).	ADAMS E, 1960, J BIOL CHEM, V235, P3499; Aghaie A, 2008, J BIOL CHEM, V283, P15638, DOI 10.1074/jbc.M800487200; BATER AJ, 1977, ARCH MICROBIOL, V112, P287, DOI 10.1007/BF00413094; Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; Cooper SK, 2008, J BIOL CHEM, V283, P10485, DOI 10.1074/jbc.M702181200; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; GRYDER RM, 1969, J BACTERIOL, V97, P292, DOI 10.1128/JB.97.1.292-306.1969; HEACOCK AM, 1975, J BIOL CHEM, V250, P2599; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kawakami R, 2005, FEBS J, V272, P4044, DOI 10.1111/j.1742-4658.2005.04810.x; Kawakami R, 2004, EXTREMOPHILES, V8, P99, DOI 10.1007/s00792-003-0368-x; Kobayashi Y, 2011, ENVIRON MICROBIOL, V13, P2007, DOI 10.1111/j.1462-2920.2010.02344.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manoharan H. T., 1980, J BIOSCIENCE, V2, P107; Pollegioni L, 2004, BIOTECHNOL PROGR, V20, P467, DOI 10.1021/bp034206q; Riedel TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026021; Sambrook J, 2001, MOL CLONING LAB MANU; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Satomura T, 2011, APPL MICROBIOL BIOT, V89, P1075, DOI 10.1007/s00253-010-2914-7; Shibasaki T, 1999, APPL ENVIRON MICROB, V65, P4028; SINGH RMM, 1965, J BIOL CHEM, V240, P4344; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; TA DT, 1992, J BIOL CHEM, V267, P11120; Tanigawa M, 2010, AMINO ACIDS, V38, P247, DOI 10.1007/s00726-009-0240-0; Tsuge H, 2005, J BIOL CHEM, V280, P31045, DOI 10.1074/jbc.C500234200; Watanabe S, 2007, J BIOL CHEM, V282, P6685, DOI 10.1074/jbc.M611057200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; White TA, 2007, J BIOL CHEM, V282, P14316, DOI 10.1074/jbc.M700912200; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z; YONEYA T, 1961, J BIOL CHEM, V236, P3272; ZANKER H, 1994, J BACTERIOL, V176, P4511, DOI 10.1128/JB.176.15.4511-4517.1994	39	31	32	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32674	32688		10.1074/jbc.M112.374272	http://dx.doi.org/10.1074/jbc.M112.374272			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22833679	Green Published, hybrid			2022-12-25	WOS:000309168300035
J	Zhou, LQ; Wu, J; Wang, WT; Yu, W; Zhao, GN; Zhang, P; Xiong, J; Li, M; Xue, Z; Wang, X; Xie, XM; Guo, ZC; Lv, X; Liu, DP				Zhou, Li-Quan; Wu, Jie; Wang, Wen-Tian; Yu, Wei; Zhao, Guang-Nian; Zhang, Peng; Xiong, Jian; Li, Man; Xue, Zheng; Wang, Xing; Xie, Xue-Min; Guo, Zhi-Chen; Lv, Xiang; Liu, De-Pei			The AT-rich DNA-binding Protein SATB2 Promotes Expression and Physical Association of Human (G)gamma- and (A)gamma-Globin Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN LOCUS; ERYTHROID-DIFFERENTIATION; ACTIVE CHROMATIN; NUCLEAR-MATRIX; GAMMA-PE; SITES; ORGANIZATION; INTERACTS; REQUIRES; ELEMENTS	Matrix attachment region (MAR)-binding protein (MARBP) has profound influence on gene transcriptional control by tethering genes to the nuclear scaffold. MARBP SATB2 is recently known as a versatile regulator functioning in the differentiation of multiple cell types including embryonic stem cells, osteoblasts and immunocytes. Roles of SATB2 in erythroid cells and its working mechanism in orchestrating target gene expression are largely unexplored. We show here that SATB2 is expressed in erythroid cells and activates gamma-globin genes by binding to MARs in their promoters and recruiting histone acetylase PCAF. Further analysis in higher-order chromatin structure shows that SATB2 affects physical proximity of human (G)gamma- and (A)gamma-globin promoters via self-association. We also found that SATB2 interacts with SATB1, which specifically activates epsilon-globin gene expression. Our results establish SATB2 as a novel gamma-globin gene regulator and provide a glimpse of the differential and cooperative roles of SATB family proteins in modulating clustered genes transcription and mediating higher-order chromatin structures.	[Zhou, Li-Quan; Wu, Jie; Wang, Wen-Tian; Yu, Wei; Zhao, Guang-Nian; Zhang, Peng; Xiong, Jian; Li, Man; Xue, Zheng; Wang, Xing; Xie, Xue-Min; Guo, Zhi-Chen; Lv, Xiang; Liu, De-Pei] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Zhou, Li-Quan; Wu, Jie; Wang, Wen-Tian; Yu, Wei; Zhao, Guang-Nian; Zhang, Peng; Xiong, Jian; Li, Man; Xue, Zheng; Wang, Xing; Xie, Xue-Min; Guo, Zhi-Chen; Lv, Xiang; Liu, De-Pei] Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lv, X (corresponding author), Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.	lvxiang99@yahoo.com.cn; liudp@pumc.edu.cn		Liu, De-Pei/0000-0002-2636-4297; Zhou, Li-quan/0000-0002-9332-9408	National Natural Science Foundation of China [31030026, 31021091]; National Basic Research Program [2011CB964803, 2011CB965203]; National Laboratory of Medical Molecular Biology [2060204]; Beijing municipal government [YB20081002301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Laboratory of Medical Molecular Biology; Beijing municipal government	This work was supported by the National Natural Science Foundation of China (Grant 31030026), the National Basic Research Program (Grants 2011CB964803 and 2011CB965203), the National Natural Science Foundation of China (Grant 31021091), the National Laboratory of Medical Molecular Biology (Grant 2060204), and Grant YB20081002301 from the Beijing municipal government.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Case SS, 1999, DNA CELL BIOL, V18, P805, DOI 10.1089/104454999314809; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gong H, 2009, BIOCHEM BIOPH RES CO, V383, P11, DOI 10.1016/j.bbrc.2009.03.122; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; JACKSON CE, 1995, J BIOL CHEM, V270, P28448; LLOYD JA, 1994, J BIOL CHEM, V269, P19385; Lopez RA, 2002, P NATL ACAD SCI USA, V99, P602, DOI 10.1073/pnas.022412699; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; SCHEUERMANN RH, 1989, GENE DEV, V3, P1255, DOI 10.1101/gad.3.8.1255; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004629; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Xue Z, 2012, NUCLEIC ACIDS RES, V40, P4804, DOI 10.1093/nar/gks064; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhao Q, 2004, J BIOL CHEM, V279, P41477, DOI 10.1074/jbc.M405129200; Zhou GL, 2006, MOL CELL BIOL, V26, P5096, DOI 10.1128/MCB.02454-05	37	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30641	30652		10.1074/jbc.M112.355271	http://dx.doi.org/10.1074/jbc.M112.355271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22825848	Green Published, hybrid			2022-12-25	WOS:000308579800054
J	Lenzen, H; Lunnemann, M; Bleich, A; Manns, MP; Seidler, U; Jorns, A				Lenzen, Henrike; Luennemann, Maria; Bleich, Andre; Manns, Michael P.; Seidler, Ursula; Joerns, Anne			Downregulation of the NHE3-Binding PDZ-Adaptor Protein PDZK1 Expression during Cytokine-Induced Inflammation in Interleukin-10-Deficient Mice	PLOS ONE			English	Article							INTESTINAL ION-TRANSPORT; TUMOR-NECROSIS-FACTOR; BOWEL-DISEASE; ULCERATIVE-COLITIS; NA+/H+ EXCHANGER; CROHNS-DISEASE; DEFICIENT MICE; KNOCKOUT MICE; NHE3; DIARRHEA	Background: Impaired salt and water absorption is an important feature in the pathogenesis of diarrhea in inflammatory bowel disease (IBD). We analyzed the expression of proinflammatory cytokines in the infiltrating immune cells and the function and expression of the Na+/H+ exchanger isoform 3 (NHE3) and its regulatory PDZ-adaptor proteins NHERF1, NHERF2, and PDZK1 in the colon of interleukin-10-deficient (IL-10(-/-)) mice. Methodology/Principal Findings: Gene and protein expression were analyzed by real-time reverse transcription polymerase chain reaction (qRT-PCR), in situ RT-PCR, and immunohistochemistry. NHE3 activity was measured fluorometrically in apical enterocytes within isolated colonic crypts. Mice developed chronic colitis characterized by a typical immune cell infiltration composed of T-lymphocytes and macrophages, with high levels of gene and protein expression of the proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha. In parallel, inducible nitric oxide synthase expression was increased while procaspase 3 expression was unaffected. Interferon-gamma expression remained low. Although acid-activated NHE3 activity was significantly decreased, the inflammatory process did not affect its gene and protein expression or its abundance and localization in the apical membrane. However, expression of the PDZ-adaptor proteins NHERF2 and PDZK1 was downregulated. NHERF1 expression was unchanged. In a comparative analysis we observed the PDZK1 downregulation also in the DSS (dextran sulphate sodium) model of colitis. Conclusions/Significance: The impairment of the absorptive function of the inflamed colon in the IL-10(-/-) mouse, in spite of unaltered NHE3 expression and localization, is accompanied by the downregulation of the NHE3-regulatory PDZ adaptors NHERF2 and PDZK1. We propose that the downregulation of PDZ-adaptor proteins may be an important factor leading to NHE3 dysfunction and diarrhea in the course of the cytokine-mediated inflammatory process in these animal models of IBD.	[Lenzen, Henrike; Luennemann, Maria; Manns, Michael P.; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Joerns, Anne] Hannover Med Sch, Inst Clin Biochem, D-3000 Hannover, Germany; [Joerns, Anne] Hannover Med Sch, Ctr Anat, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Lenzen, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany.	Lenzen.Henrike@mh-hannover.de	Seidler, Ursula/HII-8049-2022	Seidler, Ursula/0000-0002-9600-2769	Deutsche Forschungsgemeinschaft [Se460/9-5, S460/9-6, SFB621-C9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants Se460/9-5, S460/9-6 and SFB621-C9 from the Deutsche Forschungsgemeinschaft (to US). Publication charges for this article were supported by the Deutsche Forschungsgemeinschaft in the framework of the program "Open Access Publishing''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt T, 2009, DIABETOLOGIA, V52, P1381, DOI 10.1007/s00125-009-1348-1; Bachmann O, 2003, AM J PHYSIOL-GASTR L, V284, pG37, DOI 10.1152/ajpgi.00209.2002; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Broere N, 2009, PFLUG ARCH EUR J PHY, V457, P1079, DOI 10.1007/s00424-008-0579-1; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; Davidson NJ, 1998, J IMMUNOL, V161, P3143; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Gawenis LR, 2002, AM J PHYSIOL-GASTR L, V282, pG776, DOI 10.1152/ajpgi.00297.2001; Gratz R, 2002, DIGEST DIS SCI, V47, P1723, DOI 10.1023/A:1016476024293; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x; Jorns A, 2005, DIABETES, V54, P2041, DOI 10.2337/diabetes.54.7.2041; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Lohi H, 2002, AM J PHYSIOL-GASTR L, V283, pG567, DOI 10.1152/ajpgi.00356.2001; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Seidler U, 2006, ANN NY ACAD SCI, V1072, P262, DOI 10.1196/annals.1326.024; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Siddique I, 2009, SCAND J GASTROENTERO, V44, P56, DOI 10.1080/00365520802321253; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Uno S, 2007, DIABETOLOGIA, V50, P596, DOI 10.1007/s00125-006-0569-9; Yang HY, 1998, AM J PHYSIOL-GASTR L, V275, pG1445, DOI 10.1152/ajpgi.1998.275.6.G1445; Yeruva S, 2010, INFLAMM BOWEL DIS, V16, P1149, DOI 10.1002/ibd.21183; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	45	31	32	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40657	10.1371/journal.pone.0040657	http://dx.doi.org/10.1371/journal.pone.0040657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848392	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950200026
J	Sepulchre, JA; Merajver, SD; Ventura, AC				Sepulchre, Jacques-Alexandre; Merajver, Sofia D.; Ventura, Alejandra C.			Retroactive Signaling in Short Signaling Pathways	PLOS ONE			English	Article							COVALENT MODIFICATION; PROTEIN; MODEL; ULTRASENSITIVITY; CASCADES	In biochemical signaling pathways without explicit feedback connections, the core signal transduction is usually described as a one-way communication, going from upstream to downstream in a feedforward chain or network of covalent modification cycles. In this paper we explore the possibility of a new type of signaling called retroactive signaling, offered by the recently demonstrated property of retroactivity in signaling cascades. The possibility of retroactive signaling is analysed in the simplest case of the stationary states of a bicyclic cascade of signaling cycles. In this case, we work out the conditions for which variables of the upstream cycle are affected by a change of the total amount of protein in the downstream cycle, or by a variation of the phosphatase deactivating the same protein. Particularly, we predict the characteristic ranges of the downstream protein, or of the downstream phosphatase, for which a retroactive effect can be observed on the upstream cycle variables. Next, we extend the possibility of retroactive signaling in short but nonlinear signaling pathways involving a few covalent modification cycles.	[Sepulchre, Jacques-Alexandre] Univ Nice Sophia Antipolis, CNRS, UMR 7335, Inst Non Lineaire Nice, Valbonne, France; [Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Ventura, Alejandra C.] Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias, Buenos Aires, DF, Argentina; [Ventura, Alejandra C.] Univ Buenos Aires, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Sepulchre, JA (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 7335, Inst Non Lineaire Nice, Valbonne, France.	jacques-alexandre.sepulchre@inln.cnrs.fr			Department of Defense Breast Cancer Research Program; Center for Computational Medicine and Bioinformatics (University of Michigan); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); Breast Cancer Research Foundation; international program of scientific collaboration [PICS 05922]	Department of Defense Breast Cancer Research Program(United States Department of Defense); Center for Computational Medicine and Bioinformatics (University of Michigan)(University of Michigan System); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Breast Cancer Research Foundation; international program of scientific collaboration	ACV is a member of the Carrera del Investigador Cientifico (CONICET) and was supported by the Department of Defense Breast Cancer Research Program, the Center for Computational Medicine and Bioinformatics (University of Michigan), and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina). SDM receives funding from the Breast Cancer Research Foundation. The international program of scientific collaboration PICS 05922 between CNRS (France) and CONICET (Argentina) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe44; Anderson J, 2011, AUTOMATICA, V47, P1165, DOI 10.1016/j.automatica.2011.03.010; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Elion EA, 2005, SCIENCE, V307, P687, DOI 10.1126/science.1109500; Feliu E, 2012, B MATH BIOL, V74, P45, DOI 10.1007/s11538-011-9658-0; Franco E, 2009, IEEE DECIS CONTR P, P4584, DOI 10.1109/CDC.2009.5400523; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Jiang P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002152; Kim Y, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.121; Kim Y, 2010, CURR BIOL, V20, P446, DOI 10.1016/j.cub.2010.01.019; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; Nelson D.L., 2004, PRINCIPLES BIOCH, V4th; Ossareh HR, 2011, BIOPHYS J, V100, P1617, DOI 10.1016/j.bpj.2011.02.014; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Soyer OS, 2009, FEBS J, V276, P3290, DOI 10.1111/j.1742-4658.2009.07054.x; Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Wynn ML, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-156; Zumsande M, 2010, J THEOR BIOL, V265, P481, DOI 10.1016/j.jtbi.2010.04.025	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40806	10.1371/journal.pone.0040806	http://dx.doi.org/10.1371/journal.pone.0040806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848403	Green Published, Green Submitted, gold			2022-12-25	WOS:000309240600010
J	Wen, CY; Yan, ZF; Yang, XL; Guan, K; Xu, CZ; Song, T; Zheng, ZR; Wang, WJ; Wang, Y; Zhao, M; Zhang, YH; Xu, T; Dou, JP; Liu, JM; Xu, QB; He, X; Wei, C; Zhong, H				Wen, Chaoyang; Yan, Zhifeng; Yang, Xiaoli; Guan, Kai; Xu, Changzhi; Song, Ting; Zheng, Zirui; Wang, Wenjun; Wang, Ying; Zhao, Man; Zhang, Yanhong; Xu, Tao; Dou, Jianping; Liu, Jingmei; Xu, Quanbin; He, Xiang; Wei, Congwen; Zhong, Hui			Identification of Tyrosine-9 of MAVS as Critical Target for Inducible Phosphorylation That Determines Activation	PLOS ONE			English	Article							NF-KAPPA-B; ADAPTER PROTEIN; INNATE IMMUNITY; UBIQUITIN; VIRUS; NEMO; RESPONSES; BINDING; CARDIF; SITES	Background: Innate immunity to viruses involves receptors such as RIG-I, which senses viral RNA and triggers an IFN-beta signaling pathway involving the outer mitochondrial membrane protein MAVS. However, the functional status of MAVS phosphorylation remains elusive. Methodology/Principal Findings: Here we demonstrate for the first time that MAVS undergoes extensive tyrosine phosphorylation upon viral infection, indicating that MAVS phosphorylation might play an important role in MAVS function. A tyrosine-scanning mutational analysis revealed that MAVS tyrosine-9 (Y9) is a phosphorylation site that is required for IFN-beta signaling. Indeed, MAVS Y9F mutation severely impaired TRAF3/TRAF6 recruitment and displayed decreased tyrosine phosphorylation in response to VSV infection compared to wild type MAVS. Functionally, MAVS Y9 phosphorylation contributed to MAVS antiviral function without interfering with its apoptosis property. Conclusions/Significance: These experiments identify a novel residue of MAVS that is crucially involved in the recruitment of TRAF3/TRAF6 and in downstream propagation of MAVS signaling.	[Liu, Jingmei; He, Xiang] Beijing Inst Dis Control & Prevent, Beijing, Peoples R China; [Wen, Chaoyang; Yan, Zhifeng; Yang, Xiaoli; Xu, Tao; Dou, Jianping] Chinese PLA Gen Hosp Sanya City, Hainan Branch, Hainan, Peoples R China; [Wen, Chaoyang; Guan, Kai; Xu, Changzhi; Song, Ting; Zheng, Zirui; Wang, Wenjun; Wang, Ying; Zhao, Man; Zhang, Yanhong; Xu, Quanbin; Wei, Congwen; Zhong, Hui] Beijing Inst Biotechnol, Beijing, Peoples R China; [Yang, Xiaoli] Gen Hosp Peoples Armed Police Hosp, Beijing, Peoples R China		He, X (corresponding author), Beijing Inst Dis Control & Prevent, Beijing, Peoples R China.	hexiang_spring@yahoo.com; wency301@vip.sina.com; towall@yahoo.com	Xu, Quanbin/K-1904-2019	Xu, Quanbin/0000-0002-2833-9773	National Science Funding Committe(NSFC) [31170029];  [2012CB518900]	National Science Funding Committe(NSFC); 	This work was supported in part by 973 grant 2012CB518900 and National Science Funding Committe(NSFC) Grant 31170029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello MD, 2007, CELL HOST MICROBE, V2, P367, DOI 10.1016/j.chom.2007.11.005; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sebban-Benin H, 2007, HUM MOL GENET, V16, P2805, DOI 10.1093/hmg/ddm237; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	27	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41687	10.1371/journal.pone.0041687	http://dx.doi.org/10.1371/journal.pone.0041687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844514	Green Submitted, gold, Green Published			2022-12-25	WOS:000309240600041
J	Liu, AP; Yin, X; Shi, L; Li, P; Thornburg, KL; Wang, RK; Rugonyi, S				Liu, Aiping; Yin, Xin; Shi, Liang; Li, Peng; Thornburg, Kent L.; Wang, Ruikang; Rugonyi, Sandra			Biomechanics of the Chick Embryonic Heart Outflow Tract at HH18 Using 4D Optical Coherence Tomography Imaging and Computational Modeling	PLOS ONE			English	Article							BLOOD-FLOW; SECONDARY HEART; SHEAR-STRESS; STRAIN; WALL; MYOCARDIUM; PROLIFERATION; PATTERNS; VELOCITY; GROWTH	During developmental stages, biomechanical stimuli on cardiac cells modulate genetic programs, and deviations from normal stimuli can lead to cardiac defects. Therefore, it is important to characterize normal cardiac biomechanical stimuli during early developmental stages. Using the chicken embryo model of cardiac development, we focused on characterizing biomechanical stimuli on the Hamburger-Hamilton (HH) 18 chick cardiac outflow tract (OFT), the distal portion of the heart from which a large portion of defects observed in humans originate. To characterize biomechanical stimuli in the OFT, we used a combination of in vivo optical coherence tomography (OCT) imaging, physiological measurements and computational fluid dynamics (CFD) modeling. We found that, at HH18, the proximal portion of the OFT wall undergoes larger circumferential strains than its distal portion, while the distal portion of the OFT wall undergoes larger wall stresses. Maximal wall shear stresses were generally found on the surface of endocardial cushions, which are protrusions of extracellular matrix onto the OFT lumen that later during development give rise to cardiac septa and valves. The non-uniform spatial and temporal distributions of stresses and strains in the OFT walls provide biomechanical cues to cardiac cells that likely aid in the extensive differential growth and remodeling patterns observed during normal development.	[Liu, Aiping] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA; [Yin, Xin; Shi, Liang; Rugonyi, Sandra] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Li, Peng; Wang, Ruikang] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Thornburg, Kent L.] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97201 USA	University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; University of Washington; University of Washington Seattle; Oregon Health & Science University	Liu, AP (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA.	rugonyis@ohsu.edu	Rugonyi, Sandra/AAF-9269-2020; Wang, Ruikang/L-3889-2019; Li, Peng/H-7290-2017	Wang, Ruikang/0000-0001-5169-8822; Li, Peng/0000-0002-9652-2369	National Institutes of Health [HL094570]; National Science Foundation [DBI-1052688]; American Heart Association [0910093G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health HL094570 (SR), National Science Foundation DBI-1052688 (SR) and a predoctoral fellowship from American Heart Association 0910093G (AL). The content is solely the responsibility of the authors and does not necessarily represent the official views of grant giving bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartman T, 2005, DEV DYNAM, V233, P373, DOI 10.1002/dvdy.20367; Boppart SA, 2000, METH MOL B, V135, P217; Bruhn A, 2005, INT J COMPUT VISION, V61, P211, DOI 10.1023/B:VISI.0000045324.43199.43; Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684; Clark E B, 1978, Birth Defects Orig Artic Ser, V14, P431; CLARK EB, 1986, AM J PHYSIOL, V250, pH407, DOI 10.1152/ajpheart.1986.250.3.H407; COHEN LD, 1993, IEEE T PATTERN ANAL, V15, P1131, DOI 10.1109/34.244675; Damon BJ, 2009, DEV DYNAM, V238, P1535, DOI 10.1002/dvdy.21958; Dancu MB, 2004, ARTERIOSCL THROM VAS, V24, P2088, DOI 10.1161/01.ATV.0000143855.85343.0e; Filas BA, 2007, ANAT REC, V290, P1057, DOI 10.1002/ar.20575; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Garita B, 2011, AM J PHYSIOL-HEART C, V300, pH879, DOI 10.1152/ajpheart.00433.2010; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HU N, 1995, AM J PHYSIOL-HEART C, V269, pH1359, DOI 10.1152/ajpheart.1995.269.4.H1359; HU N, 1989, CIRC RES, V65, P1665, DOI 10.1161/01.RES.65.6.1665; ICARDO JM, 1989, ANAT REC, V225, P150, DOI 10.1002/ar.1092250210; Jenkins MW, 2007, OPT EXPRESS, V15, P6251, DOI 10.1364/OE.15.006251; Johnston PM, 1954, AM J PHYSIOL, V180, P361; KELLER BB, 1991, CIRC RES, V68, P226, DOI 10.1161/01.RES.68.1.226; LEATHERBURY L, 1991, PEDIATR RES, V30, P509, DOI 10.1203/00006450-199112000-00002; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; LIN IE, 1995, J BIOMECH ENG-T ASME, V117, P343, DOI 10.1115/1.2794190; Liu AP, 2011, COMPUT STRUCT, V89, P855, DOI 10.1016/j.compstruc.2011.03.003; Liu AP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3184462; Ma ZH, 2010, BIOMED OPT EXPRESS, V1, P798, DOI 10.1364/BOE.1.000798; Manner J, 2008, DEV DYNAM, V237, P953, DOI 10.1002/dvdy.21483; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; Martinsen BJ, 2005, DEV DYNAM, V233, P1217, DOI 10.1002/dvdy.20468; Miller CE, 2000, IN VITRO CELL DEV-AN, V36, P633; Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X; Oosterbaan AM, 2009, ULTRASOUND OBST GYN, V33, P638, DOI 10.1002/uog.6362; PATTEN BM, 1948, ANAT REC, V102, P299, DOI 10.1002/ar.1091020305; Pexieder T, 1970, J Fla Med Assoc, V57, P46; Poelma C, 2009, J R SOC INTERFACE; Poelmann RE, 2008, MED BIOL ENG COMPUT, V46, P479, DOI 10.1007/s11517-008-0304-4; Qayyum SR, 2001, ANAT RECORD, V264, P273, DOI 10.1002/ar.1162; Qiu YC, 2000, J VASC RES, V37, P147, DOI 10.1159/000025726; Rana MS, 2007, CIRC RES, V100, P1000, DOI 10.1161/01.RES.0000262688.14288.b8; Rothenberg Florence, 2003, Birth Defects Research, V69, P38, DOI 10.1002/bdrc.10007; Rugonyi S, 2008, PHYS MED BIOL, V53, P5077, DOI 10.1088/0031-9155/53/18/015; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; Sedmera D, 1997, ANAT RECORD, V248, P421; Sedmera D, 2011, DEV DYNAM, V240, P1322, DOI 10.1002/dvdy.22650; TABER LA, 1993, CIRC RES, V72, P455, DOI 10.1161/01.RES.72.2.455; Taber LA, 2001, J BIOMECH ENG-T ASME, V123, P528, DOI 10.1115/1.1412451; Taber LA, 2000, J ELASTICITY, V61, P165, DOI 10.1023/A:1011082712497; Van der Heiden K, 2006, DEV DYNAM, V235, P19, DOI 10.1002/dvdy.20557; Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Xu C, 2004, BIORHEOLOGY, V41, P113; YANG M, 1994, J BIOMECH ENG-T ASME, V116, P213, DOI 10.1115/1.2895722; ZHAO SM, 1995, ARTERIOSCL THROM VAS, V15, P1781, DOI 10.1161/01.ATV.15.10.1781	57	51	51	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40869	10.1371/journal.pone.0040869	http://dx.doi.org/10.1371/journal.pone.0040869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844414	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700020
J	Rabosky, ARD; Corl, A; Liwanag, HEM; Surget-Groba, Y; Sinervo, B				Rabosky, Alison R. Davis; Corl, Ammon; Liwanag, Heather E. M.; Surget-Groba, Yann; Sinervo, Barry			Direct Fitness Correlates and Thermal Consequences of Facultative Aggregation in a Desert Lizard	PLOS ONE			English	Article							CLIMATE-CHANGE; XANTUSIA-VIGILIS; SOCIAL-BEHAVIOR; LIFE-HISTORY; EVOLUTION; EUSOCIALITY; DISPERSAL; BENEFITS; RELATEDNESS; PHILOPATRY	Social aggregation is a common behavioral phenomenon thought to evolve through adaptive benefits to group living. Comparing fitness differences between aggregated and solitary individuals in nature - necessary to infer an evolutionary benefit to living in groups - has proven difficult because communally-living species tend to be obligately social and behaviorally complex. However, these differences and the mechanisms driving them are critical to understanding how solitary individuals transition to group living, as well as how and why nascent social systems change over time. Here we demonstrate that facultative aggregation in a reptile (the Desert Night Lizard, Xantusia vigilis) confers direct reproductive success and survival advantages and that thermal benefits of winter huddling disproportionately benefit small juveniles, which can favor delayed dispersal of offspring and the formation of kin groups. Using climate projection models, however, we estimate that future aggregation in night lizards could decline more than 50% due to warmer temperatures. Our results support the theory that transitions to group living arise from direct benefits to social individuals and offer a clear mechanism for the origin of kin groups through juvenile philopatry. The temperature dependence of aggregation in this and other taxa suggests that environmental variation may be a powerful but underappreciated force in the rapid transition between social and solitary behavior.	[Rabosky, Alison R. Davis; Corl, Ammon; Liwanag, Heather E. M.; Surget-Groba, Yann; Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Rabosky, Alison R. Davis] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Rabosky, Alison R. Davis] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Rabosky, Alison R. Davis] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Corl, Ammon] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Liwanag, Heather E. M.] Adelphi Univ, Dept Biol, Garden City, NY 11530 USA; [Surget-Groba, Yann] Xishuangbanna Trop Bot Garden, Ecol Evolut Grp, Mengla, Yunnan, Peoples R China	University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Uppsala University; Adelphi University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Rabosky, ARD (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	ardr@umich.edu	; Surget-Groba, Yann/K-4917-2012	Liwanag, Heather/0000-0003-3250-2542; Surget-Groba, Yann/0000-0001-7612-4892	American Museum of Natural History; American Society of Ichthyologists and Herpetologists; United States Department of Education; NSF [DBI-09060346]	American Museum of Natural History; American Society of Ichthyologists and Herpetologists; United States Department of Education(US Department of Education); NSF(National Science Foundation (NSF))	This research was funded by grants from the American Museum of Natural History, the American Society of Ichthyologists and Herpetologists, the United States Department of Education, and NSF (DBI-09060346) to ARDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; Agnarsson I, 2006, EVOLUTION, V60, P2342; Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; ARNOLD W, 1988, J COMP PHYSIOL B, V158, P151, DOI 10.1007/BF01075828; Aviles L, 2007, AM NAT, V170, P783, DOI 10.1086/521965; Berteaux D, 1996, OIKOS, V76, P330, DOI 10.2307/3546205; Cahan SH, 2002, OIKOS, V96, P206, DOI 10.1034/j.1600-0706.2002.960202.x; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Davis AR, 2012, BEHAV ECOL, V23, P18, DOI 10.1093/beheco/arr144; Davis AR, 2011, P ROY SOC B-BIOL SCI, V278, P1507, DOI 10.1098/rspb.2010.1703; Davis Alison R., 2007, Herpetological Review, V38, P402; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Eikenaar C, 2007, BEHAV ECOL, V18, P874, DOI 10.1093/beheco/arm047; Elfstrom BEO, 1999, J HERPETOL, V33, P240, DOI 10.2307/1565721; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Field J, 2010, CURR BIOL, V20, P2028, DOI 10.1016/j.cub.2010.10.020; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hatchwell BJ, 2009, PHILOS T R SOC B, V364, P3217, DOI 10.1098/rstb.2009.0109; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; HINES J E, 1989, U S Fish and Wildlife Service Fish and Wildlife Technical Report, P1; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Hunt JH, 1999, EVOLUTION, V53, P225, DOI 10.1111/j.1558-5646.1999.tb05348.x; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Jones TC, 2002, BEHAV ECOL, V13, P142, DOI 10.1093/beheco/13.1.142; KAUFMANN JS, 1989, PHYSIOL ZOOL, V62, P1047, DOI 10.1086/physzool.62.5.30156195; Krause J, 2002, LIVING GROUPS; MILLER MR, 1951, COPEIA, P114; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Okasha S, 2010, NATURE, V467, P653, DOI 10.1038/467653a; Rabosky DL, 2009, NATURE, V457, P183, DOI 10.1038/nature07435; Shah B, 2003, BEHAVIOUR, V140, P1039, DOI 10.1163/156853903322589632; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Voituron Y, 2002, J COMP PHYSIOL B, V172, P71; Wcislo WT, 1997, TRENDS ECOL EVOL, V12, P468, DOI 10.1016/S0169-5347(97)01198-1; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson E.O., 1975, P1; ZWEIFEL RICHARD G., 1966, AMER MUS NOVI TATES, V2247, P1	45	21	23	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40866	10.1371/journal.pone.0040866	http://dx.doi.org/10.1371/journal.pone.0040866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844413	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700019
J	Shange, RS; Ankumah, RO; Ibekwe, AM; Zabawa, R; Dowd, SE				Shange, Raymon S.; Ankumah, Ramble O.; Ibekwe, Abasiofiok M.; Zabawa, Robert; Dowd, Scot E.			Distinct Soil Bacterial Communities Revealed under a Diversely Managed Agroecosystem	PLOS ONE			English	Article							LAND-USE CHANGE; MICROBIAL DIVERSITY; FOREST; DISTURBANCE; ECOSYSTEMS; IMPACT	Land-use change and management practices are normally enacted to manipulate environments to improve conditions that relate to production, remediation, and accommodation. However, their effect on the soil microbial community and their subsequent influence on soil function is still difficult to quantify. Recent applications of molecular techniques to soil biology, especially the use of 16S rRNA, are helping to bridge this gap. In this study, the influence of three land-use systems within a demonstration farm were evaluated with a view to further understand how these practices may impact observed soil bacterial communities. Replicate soil samples collected from the three land-use systems (grazed pine forest, cultivated crop, and grazed pasture) on a single soil type. High throughput 16S rRNA gene pyrosequencing was used to generate sequence datasets. The different land use systems showed distinction in the structure of their bacterial communities with respect to the differences detected in cluster analysis as well as diversity indices. Specific taxa, particularly Actinobacteria, Acidobacteria, and classes of Proteobacteria, showed significant shifts across the land-use strata. Families belonging to these taxa broke with notions of copio- and oligotrphy at the class level, as many of the less abundant groups of families of Actinobacteria showed a propensity for soil environments with reduced carbon/nutrient availability. Orders Actinomycetales and Solirubrobacterales showed their highest abundance in the heavily disturbed cultivated system despite the lowest soil organic carbon (SOC) values across the site. Selected soil properties ([SOC], total nitrogen [TN], soil texture, phosphodiesterase [PD], alkaline phosphatase [APA], acid phosphatase [ACP] activity, and pH) also differed significantly across land-use regimes, with SOM, PD, and pH showing variation consistent with shifts in community structure and composition. These results suggest that use of pyrosequencing along with traditional analysis of soil physiochemical properties may provide insight into the ecology of descending taxonomic groups in bacterial communities.	[Shange, Raymon S.; Ankumah, Ramble O.] Tuskegee Univ, Dept Agr & Environm Sci, Tuskegee, AL 36088 USA; [Ibekwe, Abasiofiok M.] ARS, USDA, US Salin Lab, Riverside, CA USA; [Zabawa, Robert] Tuskegee Univ, George Washington Carver Agr Expt Stn, Tuskegee, AL 36088 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA	Tuskegee University; United States Department of Agriculture (USDA); Tuskegee University	Shange, RS (corresponding author), Tuskegee Univ, Dept Agr & Environm Sci, Tuskegee, AL 36088 USA.	rshange2946@mytu.tuskegee.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Ibekwe, Abasiofiok/0000-0003-3352-759X	United States Department of Agriculture-McIntyre-Stennis Forest Service Grant [ALX-MSFSW 0219038]; United States Department of Agriculture-National Institute of Food and Agriculture Grant [ALX-SWQ 0211874]	United States Department of Agriculture-McIntyre-Stennis Forest Service Grant; United States Department of Agriculture-National Institute of Food and Agriculture Grant	The work for this publication was funded by a United States Department of Agriculture-McIntyre-Stennis Forest Service Grant (ALX-MSFSW 0219038; http://www.csrees.usda.gov/about/offices/legis/mcintirestennis.html), and a United States Department of Agriculture-National Institute of Food and Agriculture Grant (ALX-SWQ 0211874; http://www.csrees.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Acosta-Martinez V, 2006, J ENVIRON QUAL, V35, P1309, DOI 10.2134/jeq2005.0470; Acosta-Martinez V., 2010, Diversity, V2, P910; Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Brye KR, 2003, SOIL SCI SOC AM J, V67, P1405, DOI 10.2136/sssaj2003.1405; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Burke RA, 2003, J ENVIRON QUAL, V32, P198, DOI 10.2134/jeq2003.0198; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; Chong CW, 2012, POLAR BIOL, V35, P387, DOI 10.1007/s00300-011-1084-0; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dupouey JL, 2002, ECOLOGY, V83, P2978, DOI 10.1890/0012-9658(2002)083[2978:IIOPLU]2.0.CO;2; Elsgaard L, 2002, SOIL BIOL BIOCHEM, V34, P79, DOI 10.1016/S0038-0717(01)00157-2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Hart SP, 2001, J DAIRY SCI S, V84, pE170; HENDRIX PF, 1990, SUSTAINABLE AGRICULTURAL SYSTEMS, P637; Hill P, 2011, MICROB ECOL, V61, P286, DOI 10.1007/s00248-010-9752-0; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Honnay O, 2003, LANDSCAPE URBAN PLAN, V63, P241, DOI 10.1016/S0169-2046(02)00194-9; Houghton RA, 2004, GEOPHYS MONOGR SER, V153, P85, DOI 10.1029/153GM08; Ibekwe AM, 2002, FEMS MICROBIOL ECOL, V39, P183, DOI 10.1111/j.1574-6941.2002.tb00921.x; Ishak HD, 2011, SCI REP-UK, V1, DOI 10.1038/srep00204; Jacobson M.G., 2002, SMALL SCALE FOREST E, V1, P71, DOI 10.1007/s11842-002-0006-y; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; KARCHESY JJ, 1980, J AGR FOOD CHEM, V28, P222, DOI 10.1021/jf60228a061; Keller JM, 2006, SOIL SCI SOC AM J, V70, P1094, DOI 10.2136/sssaj2005.0303N; Kennedy A.C., 2006, ANN ARID ZONE, V45, P287; Kohler F, 2005, PLANT SOIL, V278, P327, DOI 10.1007/s11104-005-8809-1; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lugo AE, 1997, FOREST ECOL MANAG, V99, P9, DOI 10.1016/S0378-1127(97)00191-6; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Neher DA, 1999, AGROFOREST SYST, V45, P159, DOI 10.1023/A:1006299100678; Osborne CA, 2011, FEMS MICROBIOL ECOL, V78, P70, DOI 10.1111/j.1574-6941.2011.01105.x; Page A.L, 1982, METHODS SOIL ANAL PA, Vsecond, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Parfitt RL, 2003, BIOGEOCHEMISTRY, V66, P203, DOI 10.1023/B:BIOG.0000005324.37711.63; Parham JA, 2003, BIOL FERT SOILS, V38, P209, DOI 10.1007/s00374-003-0657-7; Patra AK, 2005, ECOL MONOGR, V75, P65, DOI 10.1890/03-0837; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Saul-Tcherkas V, 2011, MICROB ECOL, V61, P64, DOI 10.1007/s00248-010-9763-x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Selvakumar G., 2007, Indian Journal of Microbiology, V47, P267, DOI 10.1007/s12088-007-0049-z; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Torsvik V, 1998, J BIOTECHNOL, V64, P53, DOI 10.1016/S0168-1656(98)00103-5; TSIOUVARAS CN, 1989, FOREST SCI, V35, P1125; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; WARDLE DA, 1995, PLANT SOIL, V170, P35, DOI 10.1007/BF02183053	60	97	97	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40338	10.1371/journal.pone.0040338	http://dx.doi.org/10.1371/journal.pone.0040338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844402	Green Published, gold			2022-12-25	WOS:000306687700011
J	Zarate, S; Jaita, G; Ferraris, J; Eijo, G; Magri, ML; Pisera, D; Seilicovich, A				Zarate, Sandra; Jaita, Gabriela; Ferraris, Jimena; Eijo, Guadalupe; Magri, Maria L.; Pisera, Daniel; Seilicovich, Adriana			Estrogens Induce Expression of Membrane-Associated Estrogen Receptor alpha Isoforms in Lactotropes	PLOS ONE			English	Article							PLASMA-MEMBRANE; PROLACTIN-RELEASE; GENE-EXPRESSION; PITUITARY-CELLS; ER-ALPHA; ESTRADIOL; 17-BETA-ESTRADIOL; PROGESTERONE; MECHANISM; APOPTOSIS	Estrogens are key to anterior pituitary function, stimulating hormone release and controlling cell fate to achieve pituitary dynamic adaptation to changing physiological conditions. In addition to their classical mechanism of action through intracellular estrogen receptors (ERs), estrogens exert rapid actions via cell membrane-localized ERs (mERs). We previously showed that E2 exerts a rapid pro-apoptotic action in anterior pituitary cells, especially in lactotropes and somatotropes, through activation of mERs. In the present study, we examined the involvement of mER alpha in the rapid pro-apoptotic action of estradiol by TUNEL in primary cultures of anterior pituitary cells from ovariectomized rats using a cell-impermeable E2 conjugate (E2-BSA) and an ER alpha selective antagonist (MPP dihydrochloride). We studied mER alpha expression during the estrous cycle and its regulation by gonadal steroids in vivo by flow cytometry. We identified ER alpha variants in the plasma membrane of anterior pituitary cells during the estrous cycle and studied E2 regulation of these mER alpha variants in vitro by surface biotinylation and Western Blot. E2-BSA-induced apoptosis was abrogated by MPP in total anterior pituitary cells and lactotropes. In cycling rats, we detected a higher number of lactotropes and a lower number of somatotropes expressing mER alpha at proestrus than at diestrus. Acute E2 treatment increased the percentage of mER alpha-expressing lactotropes whereas it decreased the percentage of mER alpha-expressing somatotropes. We detected three mER alpha isoforms of 66, 39 and 22 kDa. Expression of mER alpha 66 and mER alpha 39 was higher at proestrus than at diestrus, and short-term E2 incubation increased expression of these two mER alpha variants. Our results indicate that the rapid apoptotic action exerted by E2 in lactotropes depends on mER alpha, probably full-length ER alpha and/or a 39 kDa ER alpha variant. Expression and activation of mER alpha variants in lactotropes could be one of the mechanisms through which E2 participates in anterior pituitary cell renewal during the estrous cycle.	[Zarate, Sandra; Jaita, Gabriela; Ferraris, Jimena; Eijo, Guadalupe; Magri, Maria L.; Pisera, Daniel; Seilicovich, Adriana] Univ Buenos Aires, Fac Med, Inst Invest Biomed, Buenos Aires, DF, Argentina	University of Buenos Aires	Zarate, S (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed, Buenos Aires, DF, Argentina.	adyseili@fmed.uba.ar		Ferraris, Jimena/0000-0001-7472-0439; JAITA, GABRIELA/0000-0002-6513-0514	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2009-53]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 0159]; Universidad de Buenos Aires [UBACyT M067, M054]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This study was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2009-53), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 0159) and Universidad de Buenos Aires (UBACyT M067 and M054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Alyea RA, 2008, J NEUROCHEM, V106, P1525, DOI 10.1111/j.1471-4159.2008.05491.x; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009; BRANN DW, 1988, BIOL REPROD, V39, P1067, DOI 10.1095/biolreprod39.5.1067; Bulayeva NN, 2005, AM J PHYSIOL-ENDOC M, V288, pE388, DOI 10.1152/ajpendo.00349.2004; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; CARONTI B, 1993, TUMOR BIOL, V14, P59, DOI 10.1159/000217826; Castrique E, 2010, J ENDOCRINOL, V205, P49, DOI 10.1677/JOE-09-0414; Childs G. V., 2002, Archives of Physiology and Biochemistry, V110, P42, DOI 10.1076/apab.110.1.42.906; Childs GV, 2000, TRENDS ENDOCRIN MET, V11, P168, DOI 10.1016/S1043-2760(00)00252-6; Childs GV, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1483; CHO BN, 1993, MOL CELL ENDOCRINOL, V93, P47, DOI 10.1016/0303-7207(93)90138-A; Christian HC, 2002, J PHYSIOL-LONDON, V539, P557, DOI 10.1113/jphysiol.2001.012947; Davis TL, 2011, BIOL REPROD, V85, P770, DOI 10.1095/biolreprod.111.091926; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Dominguez R, 2010, J NEUROSCI, V30, P12589, DOI 10.1523/JNEUROSCI.1038-10.2010; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Gabriel L, 2009, JOVE, V34, DOI 10.3791/1669; GEFFROYROISNE S, 1992, ENDOCRINOLOGY, V131, P1503, DOI 10.1210/en.131.3.1503; Gonzalez M, 2008, GEN COMP ENDOCR, V155, P857, DOI 10.1016/j.ygcen.2007.10.007; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Gutierrez S, 2008, STEROIDS, V73, P515, DOI 10.1016/j.steroids.2008.01.002; Gutierrez S, 2012, MOL CELL ENDOCRINOL, V355, P169, DOI 10.1016/j.mce.2012.02.008; Hart SA, 2007, J NEUROSCI, V27, P2102, DOI 10.1523/JNEUROSCI.5436-06.2007; Heberden C, 2006, INT J BIOCHEM CELL B, V38, P376, DOI 10.1016/j.biocel.2005.09.006; Jaita G, 2011, ENDOCRINE, V39, P21, DOI 10.1007/s12020-010-9407-4; Jeng YJ, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-61; JENSEN EV, 1962, RECENT PROG HORM RES, V18, P387; Kawashima K, 2002, ENDOCRINOLOGY, V143, P2750, DOI 10.1210/en.143.7.2750; Kim KH, 2011, MOL BIOL CELL, V22, P4415, DOI 10.1091/mbc.E11-05-0416; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; McDevitta MA, 2008, MOL CELL ENDOCRINOL, V290, P24, DOI 10.1016/j.mce.2008.04.003; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Mitchner NA, 1998, ENDOCRINOLOGY, V139, P3976, DOI 10.1210/en.139.9.3976; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Muppidi J, 2004, CURRENT PROTOCOLS IM, P452; Norfleet AM, 2000, FASEB J, V14, P157, DOI 10.1096/fasebj.14.1.157; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Piroli GG, 1996, NEUROENDOCRINOLOGY, V63, P530, DOI 10.1159/000127082; Pisera D, 2004, AM J PHYSIOL-ENDOC M, V287, pE767, DOI 10.1152/ajpendo.00052.2004; Qiu J, 2006, J NEUROSCI, V26, P5649, DOI 10.1523/JNEUROSCI.0327-06.2006; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sanchez-Cardenas C, 2010, P NATL ACAD SCI USA, V107, P21878, DOI 10.1073/pnas.1010849107; Sarkar DK, 2006, FRONT HORM RES, V35, P32, DOI 10.1159/000094307; Schaeffer M, 2011, ENDOCRINOLOGY, V152, P4789, DOI 10.1210/en.2011-1430; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Shupnik MA, 2002, J NEUROENDOCRINOL, V14, P85, DOI 10.1046/j.0007-1331.2001.00744.x; Sosa LDV, 2012, AM J PHYSIOL-ENDOC M, V302, pE1189, DOI 10.1152/ajpendo.00408.2011; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Taylor SE, 2010, CANCER LETT, V288, P133, DOI 10.1016/j.canlet.2009.06.017; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Watson CS, 2008, FASEB J, V22, P3328, DOI 10.1096/fj.08-107672; Watson CS, 2002, STEROIDS, V67, P429, DOI 10.1016/S0039-128X(01)00172-6; Yin P, 2002, NEUROENDOCRINOLOGY, V76, P272, DOI 10.1159/000066626; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zarate S, 2010, FRONT HORM RES, V38, P25, DOI 10.1159/000318491; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR130, DOI 10.1186/bcr959	66	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41299	10.1371/journal.pone.0041299	http://dx.doi.org/10.1371/journal.pone.0041299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844453	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700065
J	Li, SY; Spooner, RA; Hampton, RY; Lord, JM; Roberts, LM				Li, Shuyu; Spooner, Robert A.; Hampton, Randolph Y.; Lord, J. Michael; Roberts, Lynne M.			Cytosolic Entry of Shiga-Like Toxin A Chain from the Yeast Endoplasmic Reticulum Requires Catalytically Active Hrd1p	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; PROTEIN DISULFIDE-ISOMERASE; RICIN A-CHAIN; O-MANNOSYLATION; CHOLERA-TOXIN; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; UBIQUITIN-LIGASE; A(1) DOMAIN; EUKARYOTIC RIBOSOMES	Background: Escherichia coli Shiga-like toxin 1 normally traffics to the endoplasmic reticulum (ER) in sensitive mammalian cells from where the catalytic A chain (SLTxA1) dislocates to the cytosol to inactivate ribosomes. Currently, no molecular details of the dislocation process are available. To investigate the mechanism of the dislocation step we expressed SLTxA1 in the ER of Saccharomyces cerevisiae. Methodology and Principal Findings: Using a combination of growth studies and biochemical tracking in yeast knock-out strains we show that SLTxA1 follows an ER-associated degradation (ERAD) pathway to enter the cytosol in a step mediated by the transmembrane Hrd1p ubiquitin ligase complex. ER-to-cytosol dislocation of the bulk population of SLTxA1 requires Cdc48p and its ubiquitin-handling co-factor Npl4p, and this population of toxin is terminally dispatched by proteasomal degradation. A small sub-population of SLTxA1 uncouples from this classical ERAD pathway and recovers catalytic activity in the cytosol. The pathway that leads to toxicity is also Hrd1p-dependent but, unlike that for the related ricin A chain toxin, SLTxA1 dislocation does require the catalytic cysteine of Hrd1p. However it does not depend on canonical ubiquitylation since toxin variants lacking endogenous lysyl residues also utilize this pathway, and furthermore there is no requirement for a number of Cdc48p co-factors. Conclusions and Significance: The fraction of SLTxA1 that disengages from the ERAD pathway thus does so upstream of Cdc48p interactions and downstream of Hrd1p interactions, in a step that possibly involves de-ubiquitylation. Mechanistically therefore, the dislocation of this toxin is quite distinct from that of conventional ERAD substrates that are normally degraded, and the toxins partially characterised to date that do not require the catalytic cysteine of the major Hrd1p component of the dislocation apparatus.	[Li, Shuyu; Spooner, Robert A.; Lord, J. Michael; Roberts, Lynne M.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Hampton, Randolph Y.] Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of Warwick; University of California System; University of California San Diego	Li, SY (corresponding author), Univ Dundee, Coll Life Sci, Dundee, Scotland.	Lynne.Roberts@warwick.ac.uk	Spooner, Robert/A-9870-2010	Spooner, Robert/0000-0001-9593-0195	Wellcome Trust [080566/Z/06/Z]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051996] Funding Source: NIH RePORTER; Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the Wellcome Trust (Program Grant number 080566/Z/06/Z) http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Aletrari MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022713; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Duriez M, 2008, J BIOL CHEM, V283, P32352, DOI 10.1074/jbc.M807178200; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; ENDO Y, 1987, J BIOL CHEM, V262, P5908; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Falguieres T, 2006, BIOL CELL, V98, P125, DOI 10.1042/BC20050001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; GARRED O, 1995, J BIOL CHEM, V270, P10817; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Goder V, 2008, FEBS LETT, V582, P1575, DOI 10.1016/j.febslet.2008.03.056; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; Menikh A, 1997, BIOCHEMISTRY-US, V36, P15865, DOI 10.1021/bi970944+; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Plemper RK, 1999, J CELL SCI, V112, P4123; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Redmann V, 2011, J BIOL CHEM, V286, P21231, DOI 10.1074/jbc.M111.234708; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Saleh MT, 1996, BIOCHEMISTRY-US, V35, P9325, DOI 10.1021/bi960177z; SANDVIG K, 1994, J CELL BIOL, V126, P53, DOI 10.1083/jcb.126.1.53; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Spooner RA, 2011, CURR TOP MICROBIOL I; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VOGEL JP, 1993, J BIOL CHEM, V268, P3040; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	81	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41119	10.1371/journal.pone.0041119	http://dx.doi.org/10.1371/journal.pone.0041119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829918	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300057
J	Pilosof, S; Dick, CW; Korine, C; Patterson, BD; Krasnov, BR				Pilosof, Shai; Dick, Carl W.; Korine, Carmi; Patterson, Bruce D.; Krasnov, Boris R.			Effects of Anthropogenic Disturbance and Climate on Patterns of Bat Fly Parasitism	PLOS ONE			English	Article							HIGH HOST-SPECIFICITY; FLIES DIPTERA; HABITAT FRAGMENTATION; NEOTROPICAL BATS; COUNT DATA; FOREST; ABUNDANCE; ECTOPARASITES; COMMUNITIES; ASSEMBLAGES	Environmental conditions, including anthropogenic disturbance, can significantly alter host and parasite communities. Yet, our current knowledge is based mainly on endoparasites, while ectoparasites remain little studied. We studied the indirect effects of anthropogenic disturbance (human population density) and climate (temperature, precipitation and elevation) on abundance of highly host-specific bat flies in four Neotropical bat species across 43 localities in Venezuela. We formulated a set of 11 a priori hypotheses that included a combination of the two effectors and host species. Statistically, each of these hypotheses was represented by a zero-inflated negative binomial mixture model, allowing us to control for excess zeros in the data. The best model was selected using Akaike's information criteria. Fly abundance was affected by anthropogenic disturbance in Artibeus planirostris, Carollia perspicillata and Pteronotus parnellii, but not Desmodus rotundus. Climate affected fly abundance in all bat species, suggesting mediation of these effects via the host or by direct effects on flies. We conclude that human disturbance may play a role in shaping bat-bat fly interactions. Different processes could determine fly abundance in the different bat species.	[Pilosof, Shai; Korine, Carmi; Krasnov, Boris R.] Ben Gurion Univ Negev, Albert Katz Int Sch Desert Studies, Swiss Inst Dryland Environm & Energy Res, Mitrani Dept Desert Ecol,Jacob Blaustein Inst Des, IL-84105 Beer Sheva, Israel; [Dick, Carl W.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Patterson, Bruce D.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA	Ben Gurion University; Western Kentucky University; Field Museum of Natural History (Chicago)	Pilosof, S (corresponding author), Ben Gurion Univ Negev, Albert Katz Int Sch Desert Studies, Swiss Inst Dryland Environm & Energy Res, Mitrani Dept Desert Ecol,Jacob Blaustein Inst Des, IL-84105 Beer Sheva, Israel.	spilosof@post.bgu.ac.il	Krasnov, Boris R./F-2234-2012; Dick, Carl/AAE-7154-2022; Patterson, Bruce D/O-5068-2019; Pilosof, Shai/AAX-8055-2020; Krasnov, Boris R./ABG-8403-2021	Krasnov, Boris R./0000-0002-0382-3331; Patterson, Bruce D/0000-0002-2249-7260; Pilosof, Shai/0000-0003-0430-5568; Krasnov, Boris R./0000-0002-0382-3331	Albert Katz International School for Desert Studies; Kreitman Fellowship for PhD students, Ben-Gurion University of the Negev	Albert Katz International School for Desert Studies; Kreitman Fellowship for PhD students, Ben-Gurion University of the Negev	SP was supported by a scholarship from the Albert Katz International School for Desert Studies and the Kreitman Fellowship for PhD students, Ben-Gurion University of the Negev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Beldomenico Pablo M, 2010, Trends Ecol Evol, V25, P21, DOI 10.1016/j.tree.2009.06.015; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Combes Claude., 2001, PARASITISM ECOLOGY E; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; Denwood MJ, 2008, PARASITOLOGY, V135, P1225, DOI 10.1017/S0031182008004708; Dick CW, 2007, ECOL ENTOMOL, V32, P446, DOI 10.1111/j.1365-2311.2007.00836.x; Dick CW, 2007, INT J PARASITOL, V37, P871, DOI 10.1016/j.ijpara.2007.02.004; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Handley C.O. Jr., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hyman G, 2000, LATIN AM POPULATION; Jackman S, 2011, PSCL CLASSES METHODS; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; King KC, 2007, PARASITOLOGY, V134, P2063, DOI 10.1017/S0031182007003277; Korallo-Vinarskaya NP, 2009, EVOL ECOL, V23, P329, DOI 10.1007/s10682-007-9229-x; Krasnov BR, 2007, OECOLOGIA, V154, P185, DOI 10.1007/s00442-007-0824-x; Krasnov BR, 2005, J BIOGEOGR, V32, P633, DOI 10.1111/j.1365-2699.2004.01206.x; Krasnov BR., 2010, BIOGEOGRAPHY HOST PA, P99; Kunz T.H., 1982, P1; Lafferty Kevin D., 2005, P113; LaVal RK, 2004, J MAMMAL, V85, P237, DOI 10.1644/BWG-016; Lebarbenchon C, 2006, ECOHEALTH, V3, P303, DOI 10.1007/s10393-006-0067-z; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Linares O., 1998, MAMIFEROS VENEZUELA; Loeys T, 2012, BRIT J MATH STAT PSY, V65, P163, DOI 10.1111/j.2044-8317.2011.02031.x; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Mbora DNM, 2009, J ANIM ECOL, V78, P210, DOI 10.1111/j.1365-2656.2008.01481.x; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Mello MAR, 2004, ACTA CHIROPTEROL, V6, P309, DOI 10.3161/001.006.0209; Merino S, 1996, ECOGRAPHY, V19, P107, DOI 10.1111/j.1600-0587.1996.tb00161.x; Munroe SEM, 2011, J PARASITOL, V97, P377, DOI 10.1645/GE-2592.1; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Patterson BD, 2008, PARASITOL RES, V103, P1091, DOI 10.1007/s00436-008-1097-y; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Patterson BD, 2009, ECOGRAPHY, V32, P481, DOI 10.1111/j.1600-0587.2008.05727.x; Poulin R, 2003, J BIOGEOGR, V30, P837, DOI 10.1046/j.1365-2699.2003.00868.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Russo D, 2010, BIODIVERS CONSERV, V19, P2501, DOI 10.1007/s10531-010-9856-3; Schulze MD, 2000, BIOTROPICA, V32, P174, DOI 10.1646/0006-3606(2000)032[0174:ACOTPB]2.0.CO;2; Stanko M, 2006, J ANIM ECOL, V75, P575, DOI 10.1111/j.1365-2656.2006.01080.x; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Taylor PD, 1996, LANDSCAPE ECOL, V11, P181, DOI 10.1007/BF02447516; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; Tinsley RC, 2011, PARASITOLOGY, V138, P1029, DOI 10.1017/S0031182011000461; Tobler W, 1997, Int J Popul Geogr, V3, P203; Valtonen ET, 2003, PARASITOLOGY, V126, pS43, DOI 10.1017/S0031182003003494; Wenzel R.L., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Willig MR, 2007, BIOTROPICA, V39, P737, DOI 10.1111/j.1744-7429.2007.00322.x; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	56	46	49	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41487	10.1371/journal.pone.0041487	http://dx.doi.org/10.1371/journal.pone.0041487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829953	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300093
J	Simoncini, D; Berenger, F; Shrestha, R; Zhang, KYJ				Simoncini, David; Berenger, Francois; Shrestha, Rojan; Zhang, Kam Y. J.			A Probabilistic Fragment-Based Protein Structure Prediction Algorithm	PLOS ONE			English	Article							MODELS; SOFTWARE; ROSETTA; SEARCH	Conformational sampling is one of the bottlenecks in fragment-based protein structure prediction approaches. They generally start with a coarse-grained optimization where mainchain atoms and centroids of side chains are considered, followed by a fine-grained optimization with an all-atom representation of proteins. It is during this coarse-grained phase that fragment-based methods sample intensely the conformational space. If the native-like region is sampled more, the accuracy of the final all-atom predictions may be improved accordingly. In this work we present EdaFold, a new method for fragment-based protein structure prediction based on an Estimation of Distribution Algorithm. Fragment-based approaches build protein models by assembling short fragments from known protein structures. Whereas the probability mass functions over the fragment libraries are uniform in the usual case, we propose an algorithm that learns from previously generated decoys and steers the search toward native-like regions. A comparison with Rosetta AbInitio protocol shows that EdaFold is able to generate models with lower energies and to enhance the percentage of near-native coarse-grained decoys on a benchmark of 20 proteins. The best coarse-grained models produced by both methods were refined into all-atom models and used in molecular replacement. All atom decoys produced out of EdaFold's decoy set reach high enough accuracy to solve the crystallographic phase problem by molecular replacement for some test proteins. EdaFold showed a higher success rate in molecular replacement when compared to Rosetta. Our study suggests that improving low resolution coarse-grained decoys allows computational methods to avoid subsequent sampling issues during all-atom refinement and to produce better all-atom models. EdaFold can be downloaded from http://www.riken.jp/zhangiru/software/.	[Simoncini, David; Berenger, Francois; Shrestha, Rojan; Zhang, Kam Y. J.] RIKEN, Zhang Initiat Res Unit, Adv Sci Inst, Wako, Saitama, Japan; [Shrestha, Rojan; Zhang, Kam Y. J.] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	RIKEN; University of Tokyo	Simoncini, D (corresponding author), RIKEN, Zhang Initiat Res Unit, Adv Sci Inst, Wako, Saitama, Japan.	kamzhang@riken.jp	Berenger, Francois/ABH-8997-2020; Simoncini, David/AAA-5204-2021; Zhang, Kam Y. J./B-3552-2012	Berenger, Francois/0000-0003-1377-944X; Simoncini, David/0000-0002-3772-5473; Zhang, Kam Y. J./0000-0002-9282-8045	Institute of Physical and Chemical Research (RIKEN)	Institute of Physical and Chemical Research (RIKEN)	This work was supported by the Initiative Research Program from The Institute of Physical and Chemical Research (RIKEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenger F, 2011, BIOINFORMATICS, V27, P939, DOI 10.1093/bioinformatics/btr072; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blum B, 2010, PROTEINS, V78, P1583, DOI 10.1002/prot.22677; Brunette TJ, 2005, BIOINFORMATICS, V21, pI66, DOI 10.1093/bioinformatics/bti1029; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; DANDEKAR T, 1992, PROTEIN ENG, V5, P637, DOI 10.1093/protein/5.7.637; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Das R, 2009, ACTA CRYSTALLOGR D, V65, P169, DOI 10.1107/S0907444908020039; Hamelryck T, 2006, PLOS COMPUT BIOL, V2, P1121, DOI 10.1371/journal.pcbi.0020131; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li SC, 2008, PROTEIN SCI, V17, P1925, DOI 10.1110/ps.036442.108; Lourenco HR, 2002, HDB METAHEURISTICS, P321, DOI DOI 10.1007/0-306-48056-5_11; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUHLENBEIN H, 1996, PARALLEL PROBLEM SOL, V4, P178, DOI DOI 10.1007/3-540-61723-X; Park Sung-Joon, 2005, Genome Inform, V16, P104; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sakae Y, 2011, J COMPUT CHEM, V32, P1353, DOI 10.1002/jcc.21716; Santana R, 2008, IEEE T EVOLUT COMPUT, V12, P418, DOI 10.1109/TEVC.2007.906095; Shmygelska A, 2009, P NATL ACAD SCI USA, V106, P1415, DOI 10.1073/pnas.0812510106; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Shrestha R, 2011, ACTA CRYSTALLOGR D, V67, P804, DOI 10.1107/S090744491102779X; Xu D, 2012, PROTEINS; Zhao F, 2008, PROTEINS, V73, P228, DOI 10.1002/prot.22057; Zhao F, 2010, BIOINFORMATICS, V26, pi310, DOI 10.1093/bioinformatics/btq193	26	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e38799	10.1371/journal.pone.0038799	http://dx.doi.org/10.1371/journal.pone.0038799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829868	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300006
J	Dinh, MH; Hirbod, T; Kigozi, G; Okocha, EA; Cianci, GC; Kong, XR; Prodger, JL; Broliden, K; Kaul, R; Serwadda, D; Wawer, MJ; Gray, RH; Hope, TJ				Dinh, Minh H.; Hirbod, Taha; Kigozi, Godfrey; Okocha, Eneniziaogochukwu A.; Cianci, Gianguido C.; Kong, Xiangrong; Prodger, Jessica L.; Broliden, Kristina; Kaul, Rupert; Serwadda, David; Wawer, Maria J.; Gray, Ronald H.; Hope, Thomas J.			No Difference in Keratin Thickness between Inner and Outer Foreskins from Elective Male Circumcisions in Rakai, Uganda	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADULT MALE FORESKIN; BARRIER FUNCTION; HIV PREVENTION; TARGET-CELLS; YOUNG MEN; TISSUE; SKIN; INFECTIONS; INVOLUCRIN	It has been hypothesized that increased HIV acquisition in uncircumcised men may relate to a more thinly keratinized inner foreskin. However, published data are contradictory and potentially confounded by medical indications for circumcision. We tested the hypothesis that the inner foreskin was more thinly keratinized than the outer foreskin using tissues from 19 healthy, HIV-uninfected men undergoing routine prophylactic circumcision in Rakai, Uganda. Sections from 3 foreskin anatomic sites (inner, outer, and frenar band) were snap-frozen separately. Two independent laboratories each separately stained, imaged, and measured keratin thicknesses in a blinded fashion. There was no significant difference in keratin thickness between the inner (mean = 14.67 +/- 7.48 mu m) and outer (mean = 13.30 +/- 8.49 mu m) foreskin, or between the inner foreskin and the frenar band (mean = 16.91 +/- 12.42 mu m). While the frenar band showed the greatest intra-individual heterogeneity in keratin thickness, there was substantial inter-individual variation seen in all regions. Measurements made by the two laboratories showed high correlation (r = 0.741, 95% CI, 0.533-0.864). We conclude that, despite inter-and intra-individual variability, keratin thickness was similar in the inner and outer foreskin of healthy Ugandan men, and that reduced keratin thickness is not likely to make the inner foreskin more susceptible to HIV acquisition.	[Dinh, Minh H.; Okocha, Eneniziaogochukwu A.; Cianci, Gianguido C.; Hope, Thomas J.] Northwestern Univ, Dept Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA; [Dinh, Minh H.; Okocha, Eneniziaogochukwu A.; Cianci, Gianguido C.; Hope, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Hirbod, Taha; Broliden, Kristina] Karolinska Inst, Dept Med Solna, Ctr Mol Med, Stockholm, Sweden; [Kigozi, Godfrey] Rakai Hlth Sci Program, Entebbe, Uganda; [Prodger, Jessica L.; Kaul, Rupert; Wawer, Maria J.; Gray, Ronald H.] Univ Toronto, Dept Med, Toronto, ON, Canada; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kong, Xiangrong; Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kong, Xiangrong; Serwadda, David] Makerere Univ, Sch Publ Hlth, Rakai, Uganda	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Karolinska Institutet; Rakai Health Sciences Program; University of Toronto; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Makerere University	Dinh, MH (corresponding author), Northwestern Univ, Dept Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA.	m-dinh@northwestern.edu		Kaul, Rupert/0000-0002-1586-4093; Prodger, Jessica/0000-0003-0805-4196	National Institutes of Health [5R33AI076968, 5K08HD060451-02, U01AI075115, R01AI087409]; Bill and Melinda Gates Foundation Grant [22006.03]; FIC AITRP and Pop Health, Anaerobes [D43TW01508, D43TW000010, PEPFAR USGPS000971]; Swedish Research Council; SIDA/SAREC; Canadian Institutes of Health Research [HBF-115704]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD060451] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001508, D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI076968, R01AI087409, U01AI075115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK096989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Grant(Bill & Melinda Gates Foundation); FIC AITRP and Pop Health, Anaerobes; Swedish Research Council(Swedish Research CouncilEuropean Commission); SIDA/SAREC; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by: National Institutes of Health 5R33AI076968 (TJH), 5K08HD060451-02 (MD), U01AI075115 (RG), and R01AI087409 (RG), Bill and Melinda Gates Foundation Grant 22006.03 (RG), FIC AITRP and Pop Health, Anaerobes D43TW01508 (RG), D43TW000010 (RG), and PEPFAR USGPS000971 (RG), the Swedish Research Council (KB, TH), SIDA/SAREC (KB, TH), and Canadian Institutes of Health Research HBF-115704 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SAS STAT 9 2 USERS G; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Dinh MH, 2011, BIOL REPROD; Dinh MH, 2010, AIDS, V24, P899, DOI 10.1097/QAD.0b013e3283367779; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; Ganor Yonatan, 2011, Am J Reprod Immunol, V65, P284, DOI 10.1111/j.1600-0897.2010.00933.x; Gray RH, 2010, AIDS, V24, P1381, DOI 10.1097/QAD.0b013e3283392555; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hirbod T, 2010, AM J PATHOL, V176, P2798, DOI 10.2353/ajpath.2010.090926; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; Johnson KE, 2009, AIDS, V23, P1807, DOI 10.1097/QAD.0b013e32832efdf1; Jordan GH, 2007, WEIN CAMPBELL WALSH; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Presland RB, 2004, J INVEST DERMATOL, V123, P603, DOI 10.1111/j.0022-202X.2004.23226.x; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Prodger JL, 2011, MUCOSAL IMMUNOL; Qin Q, 2009, INT UROL NEPHROL, V41, P747, DOI 10.1007/s11255-008-9521-x; Taylor SC, 2002, J AM ACAD DERMATOL, V46, pS41, DOI 10.1067/mjd.2002.120790; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Weiss HA, 2007, CURR OPIN INFECT DIS, V20, P66, DOI 10.1097/QCO.0b013e328011ab73	27	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41271	10.1371/journal.pone.0041271	http://dx.doi.org/10.1371/journal.pone.0041271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815984	gold, Green Published, Green Submitted			2022-12-25	WOS:000306548900104
J	Pommerenke, C; Wilk, E; Srivastava, B; Schulze, A; Novoselova, N; Geffers, R; Schughart, K				Pommerenke, Claudia; Wilk, Esther; Srivastava, Barkha; Schulze, Annika; Novoselova, Natalia; Geffers, Robert; Schughart, Klaus			Global Transcriptome Analysis in Influenza-Infected Mouse Lungs Reveals the Kinetics of Innate and Adaptive Host Immune Responses	PLOS ONE			English	Article							GENE-EXPRESSION; EPITHELIAL-CELLS; VIRUS; MICE; PATHOGENESIS; RECOGNITION; MACAQUES; DEATH	An infection represents a highly dynamic process involving complex biological responses of the host at many levels. To describe such processes at a global level, we recorded gene expression changes in mouse lungs after a non-lethal infection with influenza A virus over a period of 60 days. Global analysis of the large data set identified distinct phases of the host response. The increase in interferon genes and up-regulation of a defined NK-specific gene set revealed the initiation of the early innate immune response phase. Subsequently, infiltration and activation of T and B cells could be observed by an augmentation of T and B cell specific signature gene expression. The changes in B cell gene expression and preceding chemokine subsets were associated with the formation of bronchus-associated lymphoid tissue. In addition, we compared the gene expression profiles from wild type mice with Rag2 mutant mice. This analysis readily demonstrated that the deficiency in the T and B cell responses in Rag2 mutants could be detected by changes in the global gene expression patterns of the whole lung. In conclusion, our comprehensive gene expression study describes for the first time the entire host response and its kinetics to an acute influenza A infection at the transcriptome level.	[Pommerenke, Claudia; Wilk, Esther; Srivastava, Barkha; Schulze, Annika; Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Infect Genet, Braunschweig, Germany; [Pommerenke, Claudia; Wilk, Esther; Srivastava, Barkha; Schulze, Annika; Schughart, Klaus] Univ Vet Med Hannover, Braunschweig, Germany; [Novoselova, Natalia] Natl Acad Sci Belarus, United Inst Informat Problems, Minsk, BELARUS; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; National Academy of Sciences of Belarus (NASB); United Institute of Informatics Problems of the National Academy of Sciences of Belarus; Helmholtz Association; Helmholtz-Center for Infection Research	Pommerenke, C (corresponding author), Helmholtz Ctr Infect Res, Dept Infect Genet, Braunschweig, Germany.	klaus.schughart@helmholtz-hzi.de	Novoselova, Natalia/AAC-4216-2021	Schughart, Klaus/0000-0002-6824-7523	Helmholtz-Association (Program Infection and Immunity); German Ministry of Education and Research [01KI07137]	Helmholtz-Association (Program Infection and Immunity)(Helmholtz Association); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by intramural grants from the Helmholtz-Association (Program Infection and Immunity) and a research grant FluResearchNet (No. 01KI07137) from the German Ministry of Education and Research to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-61; Alberts R, 2010, MICROBES INFECT, V12, P309, DOI 10.1016/j.micinf.2010.01.008; Baskin CR, 2004, J VIROL, V78, P10420, DOI 10.1128/JVI.78.19.10420-10432.2004; Blazejewska P, 2011, VIROLOGY, V412, P36, DOI 10.1016/j.virol.2010.12.047; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Chung S., 2004, P ACM INT C INF KNOW, P150; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Dimitrakopoulou Konstantina, 2011, J Clin Bioinforma, V1, P27, DOI 10.1186/2043-9113-1-27; Ding M, 2008, GENES BRAIN BEHAV, V7, P173, DOI 10.1111/j.1601-183X.2007.00335.x; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Haller O, 2009, Verh K Acad Geneeskd Belg, V71, P73; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosseau S, 2007, IMMUNOLOGY, V120, P380, DOI 10.1111/j.1365-2567.2006.02514.x; Seki M, 2009, JPN J INFECT DIS, V62, P6; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Toapanta FR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-112; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van Iterson M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-439; Viemann D, 2010, J IMMUNOL; Wang J, 2011, AM J RESP CELL MOL B; Wu HY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-172; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang MS, 2004, IEEE T PATTERN ANAL, V26, P434, DOI 10.1109/TPAMI.2004.1265860; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zhang H, 2006, MICROBES INFECT, V8, P2172, DOI 10.1016/j.micinf.2006.04.018	51	83	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41169	10.1371/journal.pone.0041169	http://dx.doi.org/10.1371/journal.pone.0041169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815957	Green Published, Green Submitted, gold			2022-12-25	WOS:000306507000075
J	Alessandri, C; Barbati, C; Vacirca, D; Piscopo, P; Confaloni, A; Sanchez, M; Maselli, A; Colasanti, T; Conti, F; Truglia, S; Perl, A; Valesini, G; Malorni, W; Ortona, E; Pierdominici, M				Alessandri, Cristiano; Barbati, Cristiana; Vacirca, Davide; Piscopo, Paola; Confaloni, Annamaria; Sanchez, Massimo; Maselli, Angela; Colasanti, Tania; Conti, Fabrizio; Truglia, Simona; Perl, Andras; Valesini, Guido; Malorni, Walter; Ortona, Elena; Pierdominici, Marina			T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy	FASEB JOURNAL			English	Article						autoimmunity; cell fate; autoantibodies	GENOME-WIDE ASSOCIATION; CELL-ACTIVATION; APOPTOSIS; DEATH; AUTOIMMUNITY; DIFFERENTIATION; ABNORMALITIES; PATHOGENESIS; INHIBITION; IMMUNITY	Autophagy, the cytoprotection mechanism that takes place under metabolic impairment, has been implicated in the pathogenesis of autoimmunity. Here, we investigated the spontaneous and induced autophagic behavior of T lymphocytes from patients with systemic lupus erythematosus (SLE) compared with that of T lymphocytes from healthy donors by measuring the autophagy marker microtubule-associated protein 1 light chain 3 (LC3)-II. No significant differences in spontaneous autophagy were found between T lymphocytes from patients with SLE and from healthy donors, apart from CD4(+) naive T cells from patients with SLE in which constitutively higher levels of autophagy (P<0.001) were detected. At variance, whereas treatment of T lymphocytes from healthy donors with serum IgG from patients with SLE resulted in a 2-fold increase in LC3-II levels (P<0.001), T lymphocytes from SLE patients were resistant to autophagic induction and also displayed an up-regulation of genes negatively regulating autophagy, e.g., alpha-synuclein. These findings could open new perspectives in the search for pathogenetic determinants of SLE progression and in the development of therapeutic strategies aimed to recover T-cell compartment homeostasis by restoring autophagic susceptibility.-Alessandri, C., Barbati, C., Vacirca, D., Piscopo, P., Confaloni, A., Sanchez, M., Maselli, A., Colasanti, T., Conti, F., Truglia, S., Perl, A., Valesini, G., Malorni, W., Ortona, E., Pierdominici, M. T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J. 26, 4722-4732 (2012). www.fasebj.org	[Malorni, Walter] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Alessandri, Cristiano; Conti, Fabrizio; Truglia, Simona; Valesini, Guido] Sapienza Univ, Lupus Clin, Dipartimento Med Interna & Specialita Med, Rome, Italy; [Barbati, Cristiana; Vacirca, Davide; Piscopo, Paola; Confaloni, Annamaria; Sanchez, Massimo; Maselli, Angela; Colasanti, Tania; Ortona, Elena; Pierdominici, Marina] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Barbati, Cristiana; Colasanti, Tania; Malorni, Walter] San Raffaele Inst Sulmona, Laquila, Italy; [Perl, Andras] SUNY Syracuse, Dept Med, Div Rheumatol, Syracuse, NY 13210 USA; [Malorni, Walter] Ctr Integrated Metabol, Rome, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome; Istituto Superiore di Sanita (ISS); State University of New York (SUNY) System	Malorni, W (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	malorni@iss.it	Malorni, Walter/G-5874-2016; Sanchez, Massimo/AAD-1746-2021; COLASANTI, Tania/AFI-8434-2022; Piscopo, Paola/J-6504-2016; COLASANTI, Tania/AAF-4074-2022; Pierdominici, Marina/J-6436-2016; ortona, elena/J-6395-2016	Sanchez, Massimo/0000-0003-3696-7582; COLASANTI, Tania/0000-0002-4413-1817; Piscopo, Paola/0000-0002-0693-4969; COLASANTI, Tania/0000-0002-4413-1817; Confaloni, Annamaria/0000-0002-5390-8536; Pierdominici, Marina/0000-0002-6372-3754; , simona/0000-0001-9515-2135; malorni, walter/0000-0002-1223-7000; ortona, elena/0000-0001-9845-8105; Perl, Andras/0000-0002-5017-1348; Alessandri, Cristiano/0000-0003-4149-5321	Ministero della Salute; Associazione Italiana Ricerca Cancro (AIRC) [MCO-9998]; Programma di Ricerca di Rilevante Interesse Nazionale (PRIN); U.S. National Institutes of Health [AI048079, AI072648]; Alliance for Lupus Research; Central New York Community Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048079, R01AI048079] Funding Source: NIH RePORTER	Ministero della Salute(Ministry of Health, Italy); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Programma di Ricerca di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Central New York Community Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the Ministero della Salute (W.M. and E.O.), Associazione Italiana Ricerca Cancro (AIRC) MCO-9998 (W. M.), Programma di Ricerca di Rilevante Interesse Nazionale (PRIN) 2007 (G. V.), the U.S. National Institutes of Health (AI048079 and AI072648), the Alliance for Lupus Research, and the Central New York Community Foundation.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Balaburski GM, 2010, TRENDS CELL BIOL, V20, P363, DOI 10.1016/j.tcb.2010.02.007; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; EMLEN W, 1994, J IMMUNOL, V152, P3685; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Fernandez D, 2006, ARTHRITIS RHEUM-US, V54, P2983, DOI 10.1002/art.22085; Fernandez D, 2010, DISCOV MED, V9, P173; Fritsch RD, 2006, ARTHRITIS RHEUM, V54, P2184, DOI 10.1002/art.21943; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gerland LM, 2004, EXP GERONTOL, V39, P789, DOI 10.1016/j.exger.2004.01.013; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Gros F, 2012, AUTOPHAGY, V8, P1113, DOI 10.4161/auto.20275; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Harr MW, 2010, AUTOPHAGY, V6, P912, DOI 10.4161/auto.6.7.13290; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Ikeda T, 2010, J IMMUNOL, V185, P5259, DOI 10.4049/jimmunol.0902797; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; Kovacs B, 1996, CLIN IMMUNOL IMMUNOP, V81, P293, DOI 10.1006/clin.1996.0192; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Liao JJ, 2009, FASEB J, V23, P1786, DOI 10.1096/fj.08-124891; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lleo A, 2007, J AUTOIMMUN, V29, P61, DOI 10.1016/j.jaut.2007.06.003; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; MINOTA S, 1987, J IMMUNOL, V138, P1750; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mosca M, 2006, CLIN EXP RHEUMATOL, V24, pS100; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Perl A, 2010, AUTOIMMUNITY, V43, P32, DOI 10.3109/08916930903374774; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Pua HH, 2007, AUTOPHAGY, V3, P266, DOI 10.4161/auto.3908; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, CURR TOP MICROBIOL, V335, P85, DOI 10.1007/978-3-642-00302-8_4; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Spronk PE, 1996, CLIN EXP IMMUNOL, V104, P446, DOI 10.1046/j.1365-2249.1996.44754.x; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Towns R, 2005, AUTOPHAGY, V1, P163, DOI 10.4161/auto.1.3.2068; Tu SP, 2011, CANCER RES, V71, P4247, DOI 10.1158/0008-5472.CAN-10-4009; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; WEISSMANN G, 1964, LANCET, V2, P1373; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	60	107	117	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4722	4732		10.1096/fj.12-206060	http://dx.doi.org/10.1096/fj.12-206060			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22835828	Green Published			2022-12-25	WOS:000310574200032
J	Bijakowski, C; Vadon-Le Goff, S; Delolme, F; Bourhis, JM; Lecorche, P; Ruggiero, F; Becker-Pauly, C; Yiallouros, I; Stoocker, W; Dive, V; Hulmes, DJS; Moali, C				Bijakowski, Cecile; Vadon-Le Goff, Sandrine; Delolme, Frederic; Bourhis, Jean-Marie; Lecorche, Pascaline; Ruggiero, Florence; Becker-Pauly, Christoph; Yiallouros, Irene; Stoecker, Walter; Dive, Vincent; Hulmes, David J. S.; Moali, Catherine			Sizzled Is Unique among Secreted Frizzled-related Proteins for Its Ability to Specifically Inhibit Bone Morphogenetic Protein-1 (BMP-1)/Tolloid-like Proteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; NEGATIVE FEEDBACK REGULATOR; MAMMALIAN TOLLOID-LIKE; MYOCARDIAL-INFARCTION; ALPHA-SUBUNIT; LYSYL OXIDASE; BETA-SUBUNIT; CUB DOMAINS; METALLOPROTEINASES; ASTACIN	BMP-1/tolloid-like proteinases (BTPs) are major enzymes involved in extracellular matrix assembly and activation of bioactive molecules, both growth factors and anti-angiogenic molecules. Although the control of BTP activity by several enhancing molecules is well established, the possibility that regulation also occurs through endogenous inhibitors is still debated. Secreted frizzled-related proteins (sFRPs) have been studied as possible candidates, with highly contradictory results, after the demonstration that sizzled, a sFRP found in Xenopus and zebrafish, was a potent inhibitor of Xenopus and zebrafish tolloid-like proteases. In this study, we demonstrate that mammalian sFRP-1, -2, and -4 do not modify human BMP-1 activity on several of its known substrates including procollagen I, procollagen III, pN-collagen V, and prolysyl oxidase. In contrast, Xenopus sizzled appears as a tight binding inhibitor of human BMP-1, with aK(i) of 1.5 +/- 0.5 nM, and is shown to strongly inhibit other human tolloid isoforms mTLD and mTLL-1. Because sizzled is the most potent inhibitor of human tolloid-like proteinases known to date, we have studied its mechanism of action in detail and shown that the frizzled domain of sizzled is both necessary and sufficient for inhibitory activity and that it acts directly on the catalytic domain of BMP-1. Residues in sizzled required for inhibition include Asp-92, which is shared by sFRP-1 and -2, and also Phe-94, Ser-43, and Glu-44, which are specific to sizzled, thereby providing a rational basis for the absence of inhibitory activity of human sFRPs.	[Bijakowski, Cecile; Vadon-Le Goff, Sandrine; Delolme, Frederic; Bourhis, Jean-Marie; Hulmes, David J. S.; Moali, Catherine] Univ Lyon, CNRS, FRE3310, Inst Biol & Chim Prot,FR3302, F-69367 Lyon 7, France; [Lecorche, Pascaline; Dive, Vincent] CEA Saclay, SIMOPRO, F-91191 Gif Sur Yvette, France; [Ruggiero, Florence] Ecole Normale Super Lyon, CNRS, UMR 5242, Inst Genom Fonct Lyon, F-69364 Lyon 7, France; [Becker-Pauly, Christoph] Univ Kiel, Unit Degrad Protease Web, Inst Biochem, D-24118 Kiel, Germany; [Yiallouros, Irene; Stoecker, Walter] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, D-55128 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Kiel; Johannes Gutenberg University of Mainz	Moali, C (corresponding author), Univ Lyon, CNRS, FRE3310, Inst Biol & Chim Prot,FR3302, 7 Passage Vercors, F-69367 Lyon 7, France.	c.moali@ibcp.fr	le goff, sandrine/AAE-1990-2019; Stöcker, Walter/AAB-9704-2019; Becker-Pauly, Christoph/B-7569-2011	Stöcker, Walter/0000-0002-1515-6994; MOALI, Catherine/0000-0003-2479-4290; vadon-le goff, sandrine/0000-0002-4582-2273; RUGGIERO, Florence/0000-0003-2915-5359; Bourhis, Jean-Marie/0000-0002-3151-1546; Hulmes, David/0000-0002-0651-1317	Agence Nationale de la Recherche (project SCAR FREE); Agence Nationale de la Recherche (project TOLLREG); Fondation de France; CNRS; Universite Claude Bernard Lyon 1; Lyon Biopole; Deutsche Forschungsgemeinschaft [Sto185/3-2, SFB492, BE 4086/1-2, SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Agence Nationale de la Recherche (project SCAR FREE)(French National Research Agency (ANR)); Agence Nationale de la Recherche (project TOLLREG)(French National Research Agency (ANR)); Fondation de France(Fondation de France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; Lyon Biopole; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by the Agence Nationale de la Recherche (projects SCAR FREE and TOLLREG), the Fondation de France, the CNRS, the Universite Claude Bernard Lyon 1, the Lyon Biopole (to D. J. S. H. and C. M.), Deutsche Forschungsgemeinschaft Grants Sto185/3-2, SFB492 (to W. S. and I. Y.), BE 4086/1-2, SFB877, and the Cluster of Excellence "Inflammation at Interfaces" (to C. B.- P.).	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Berry R, 2010, FEBS LETT, V584, P657, DOI 10.1016/j.febslet.2009.12.050; Bhat RA, 2007, J CELL BIOCHEM, V102, P1519, DOI 10.1002/jcb.21372; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bradley L, 2000, DEV BIOL, V227, P118, DOI 10.1006/dbio.2000.9873; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2003, J SURG RES, V113, P208, DOI 10.1016/S0022-4804(03)00188-4; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Dabert-Gay AS, 2008, J BIOL CHEM, V283, P31058, DOI 10.1074/jbc.M805795200; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Ferguson M. W. J., 2008, International Patent, Patent No. 2008125869; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Gopalakrishnan B, 2004, J BIOL CHEM, V279, P30904, DOI 10.1074/jbc.M402252200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grgurevic L, 2011, J AM SOC NEPHROL, V22, P681, DOI 10.1681/ASN.2010070722; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Jasuja R, 2007, J BIOL CHEM, V282, P9053, DOI 10.1074/jbc.M610929200; Kessler E, 2001, J BIOL CHEM, V276, P27051, DOI 10.1074/jbc.M102921200; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HX, 2009, GENE DEV, V23, P2551, DOI 10.1101/gad.1839309; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Mac Sweeney A, 2008, J MOL BIOL, V384, P228, DOI 10.1016/j.jmb.2008.09.029; Martin R, 2000, ANAL BIOCHEM, V277, P276, DOI 10.1006/abio.1999.4395; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moali C, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P539; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Muir A, 2011, J BIOL CHEM, V286, P41905, DOI 10.1074/jbc.R111.299768; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Reyda S, 1999, BIOCHEM J, V344, P851, DOI 10.1042/0264-6021:3440851; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salic AN, 1997, DEVELOPMENT, V124, P4739; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Sun ZC, 2011, MOL CELL BIOCHEM, V352, P25, DOI 10.1007/s11010-011-0736-2; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; Takahara K, 1996, GENOMICS, V34, P157, DOI 10.1006/geno.1996.0260; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Wermter C, 2007, BIOL CHEM, V388, P513, DOI 10.1515/BC.2007.054; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3	71	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33581	33593		10.1074/jbc.M112.380816	http://dx.doi.org/10.1074/jbc.M112.380816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22825851	Green Published, hybrid			2022-12-25	WOS:000309602100043
J	Haidari, M; Zhang, W; Caivano, A; Chen, ZP; Ganjehei, L; Mortazavi, A; Stroud, C; Woodside, DG; Willerson, JT; Dixon, RAF				Haidari, Mehran; Zhang, Wei; Caivano, Amy; Chen, Zhenping; Ganjehei, Leila; Mortazavi, Ahmadreza; Stroud, Christopher; Woodside, Darren G.; Willerson, James T.; Dixon, Richard A. F.			Integrin alpha(2)beta(1) Mediates Tyrosine Phosphorylation of Vascular Endothelial Cadherin Induced by Invasive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; TRANSENDOTHELIAL MIGRATION; BARRIER FUNCTION; IN-VITRO; LEUKOCYTE TRANSMIGRATION; PREFERENTIAL ADHESION; SIGNALING PROMOTES; PROTEIN-KINASES; METASTASIS; ACTIVATION	The molecular mechanisms that regulate the endothelial response during transendothelial migration (TEM) of invasive cancer cells remain elusive. Tyrosine phosphorylation of vascular endothelial cadherin (VE-cad) has been implicated in the disruption of endothelial cell adherens junctions and in the diapedesis of metastatic cancer cells. We sought to determine the signaling mechanisms underlying the disruption of endothelial adherens junctions after the attachment of invasive breast cancer cells. Attachment of invasive breast cancer cells (MDA-MB-231) to human umbilical vein endothelial cells induced tyrosine phosphorylation of VE-cad, dissociation of beta-catenin from VE-cad, and retraction of endothelial cells. Breast cancer cell-induced tyrosine phosphorylation of VE-cad was mediated by activation of the H-Ras/Raf/MEK/ERK signaling cascade and depended on the phosphorylation of endothelial myosin light chain (MLC). The inhibition of H-Ras or MLC in endothelial cells inhibited TEM of MDA-MB-231 cells. VE-cad tyrosine phosphorylation in endothelial cells induced by the attachment of MDA-MB-231 cells was mediated by MDA-MB-231 alpha(2)beta(1) integrin. Compared with highly invasive MDA-MB-231 breast cancer cells, weakly invasive MCF-7 breast cancer cells expressed lower levels of alpha(2)beta(1) integrin. TEM of MCF-7 as well as induction of VE-cad tyrosine phosphorylation and dissociation of beta-catenin from the VE-cad complex by MCF-7 cells were lower than in MDA-MB-231 cells. These processes were restored when MCF-7 cells were treated with beta(1)-activating antibody. Moreover, the response of endothelial cells to the attachment of prostatic (PC-3) and ovarian (SKOV3) invasive cancer cells resembled the response to MDA-MB-231 cells. Our study showed that the MDA-MB-231 cell-induced disruption of endothelial adherens junction integrity is triggered by MDA-MB-231 cell alpha(2)beta(1) integrin and is mediated by H-Ras/MLC-induced tyrosine phosphorylation of VE-cad.	[Haidari, Mehran; Zhang, Wei; Caivano, Amy; Chen, Zhenping; Ganjehei, Leila; Mortazavi, Ahmadreza; Woodside, Darren G.; Willerson, James T.; Dixon, Richard A. F.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Stroud, Christopher; Willerson, James T.] Univ Texas Houston, Med Sch Houston, Dept Internal Med, Div Cardiol, Houston, TX 77030 USA	Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston	Haidari, M (corresponding author), St Lukes Episcopal Hosp, Texas Heart Inst, POB 20345,C1000, Houston, TX 77030 USA.	Mehran.Haidari@uth.tmc.edu			MacDonald General Research Fund [09RDM002]	MacDonald General Research Fund	This work was supported by MacDonald General Research Fund Grant 09RDM002 (to M. H.).	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181; BLISS RD, 1995, CLIN EXP METASTAS, V13, P173, DOI 10.1007/BF00132205; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; CHAN BMC, 1991, SCIENCE, V251, P1600, DOI 10.1126/science.2011740; Cooper CR, 2000, CLIN CANCER RES, V6, P4839; Di Ciano-Oliveira C, 2005, AM J PHYSIOL-CELL PH, V289, pC68, DOI 10.1152/ajpcell.00631.2004; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Haidari M, 2012, EXP CELL RES, V318, P1673, DOI 10.1016/j.yexcr.2012.05.009; Haidari M, 2011, CARDIOVASC RES, V92, P456, DOI 10.1093/cvr/cvr240; Haidari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021444; Hall CL, 2008, NEOPLASIA, V10, P797, DOI 10.1593/neo.08380; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; Heyder C, 2002, J CANCER RES CLIN, V128, P533, DOI 10.1007/s00432-002-0377-7; Ho WC, 1997, MOL BIOL CELL, V8, P1863, DOI 10.1091/mbc.8.10.1863; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; KUSAMA T, 1995, INT J CANCER, V63, P112, DOI 10.1002/ijc.2910630120; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Li YH, 1999, CLIN EXP METASTAS, V17, P423, DOI 10.1023/A:1006614232388; Lundstrom A, 1998, BIOCHEM BIOPH RES CO, V250, P735, DOI 10.1006/bbrc.1998.9389; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; NICOLSON GL, 1982, J HISTOCHEM CYTOCHEM, V30, P214, DOI 10.1177/30.3.7061823; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Ramirez N. E., J CLIN INVEST, V121, P226; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; van der Pluijm, 1997, LAB INVEST, V77, P665; Van Sluis GL, 2009, BLOOD, V114, P1968, DOI 10.1182/blood-2009-04-217679; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Wu M., CANCER, V116, P2768; Yang CQ, 2003, CANCER RES, V63, P8312; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315; YU DH, 1994, CANCER RES, V54, P3260	41	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32981	32992		10.1074/jbc.M112.395905	http://dx.doi.org/10.1074/jbc.M112.395905			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22833667	Green Published, hybrid			2022-12-25	WOS:000309168300061
J	Chen, KR; Chang, CH; Huang, CY; Lin, CY; Lin, WY; Lo, YC; Yang, CY; Hsing, EW; Chen, LF; Shih, SR; Shiau, AL; Lei, HY; Tan, TH; Ling, P				Chen, Kuan-Ru; Chang, Chun-Hung; Huang, Ching-Yu; Lin, Chun-Yang; Lin, Wan-Ying; Lo, Yin-Chiu; Yang, Chia-Yu; Hsing, En-Wei; Chen, Lin-Fang; Shih, Shin-Ru; Shiau, Ai-Li; Lei, Huan-Yao; Tan, Tse-Hua; Ling, Pin			TBK1-associated Protein in Endolysosomes (TAPE)/CC2D1A Is a Key Regulator Linking RIG-I-like Receptors to Antiviral Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAIN PROTEIN; CC2D1A; TRAFFICKING; RECOGNITION; DROSOPHILA; STIMULATOR; RESPONSES; PATHWAY; SENSOR; GENE	Retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) are key RNA viral sensors for triggering antiviral immunity. The underlying mechanisms for RLRs to trigger antiviral immunity have yet to be explored. Here we report the identification of TAPE (TBK1-associated protein in endolysosomes) as a novel regulator of the RLR pathways. TAPE functionally and physically interacts with RIG-I, MDA5, and IPS-1 to activate the IFN-beta promoter. TAPE knockdown impairs IFN-beta activation induced by RLRs but not IPS-1. TAPE-deficient cells are defective in cytokine production upon RLR ligand stimulation. During RNA virus infection, TAPE knockdown or deficiency diminishes cytokine production and antiviral responses. Our data demonstrate a critical role for TAPE in linking RLRs to antiviral immunity.	[Chen, Kuan-Ru; Shiau, Ai-Li; Lei, Huan-Yao; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chang, Chun-Hung; Lin, Chun-Yang; Lin, Wan-Ying; Lo, Yin-Chiu; Chen, Lin-Fang; Shiau, Ai-Li; Lei, Huan-Yao; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Shiau, Ai-Li; Lei, Huan-Yao; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Huang, Ching-Yu; Yang, Chia-Yu; Hsing, En-Wei; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Taiwan; [Hsing, En-Wei] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan; National Tsing Hua University; Baylor College of Medicine; Chang Gung University	Ling, P (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	lingpin@mail.ncku.edu.tw	Tan, Tse-Hua/ABD-7080-2021; Shih, Shin-Ru/M-9711-2016; Tan, Tse-Hua/E-3983-2010; shiau, A-Li/C-2885-2012; LING, PIN/C-6764-2009; Huang, Ching-Yu/E-3981-2010; Lin, Chun-Yang/AAH-1897-2020	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; shiau, A-Li/0000-0003-2449-8547; Lin, Chun-Yang/0000-0002-3064-0178; Huang, Ching-yu/0000-0002-5758-281X; Shih, Shin-Ru/0000-0003-4874-401X	National Science Council in Taiwan [NSC 97-2320-B-006-014-MY3, NSC 100-2320-B-006-013-MY3, NSC 100-2321-B-002-013]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council in Taiwan (Grants NSC 97-2320-B-006-014-MY3, NSC 100-2320-B-006-013-MY3, and NSC 100-2321-B-002-013).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chang CH, 2011, J BIOL CHEM, V286, P7043, DOI 10.1074/jbc.M110.164632; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Martinelli N, 2012, J MOL BIOL, V419, P75, DOI 10.1016/j.jmb.2012.02.044; Nakamura A, 2009, J CELL BIOL, V187, P607, DOI 10.1083/jcb.200906019; Ou XM, 2003, J NEUROSCI, V23, P7415; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Usami Y, 2012, J VIROL, V86, P3746, DOI 10.1128/JVI.06539-11; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhao M, 2011, J NEUROPHYSIOL, V105, P1506, DOI 10.1152/jn.00950.2010; Zhao M, 2010, J BIOL CHEM, V285, P24372, DOI 10.1074/jbc.M109.100057; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	22	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32216	32221		10.1074/jbc.C112.394346	http://dx.doi.org/10.1074/jbc.C112.394346			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833682	Green Published, hybrid			2022-12-25	WOS:000309059400058
J	Desplats, P; Spencer, B; Crews, L; Pathel, P; Morvinski-Friedmann, D; Kosberg, K; Roberts, S; Patrick, C; Winner, B; Winkler, J; Masliah, E				Desplats, Paula; Spencer, Brian; Crews, Leslie; Pathel, Pruthul; Morvinski-Friedmann, Dinorah; Kosberg, Kori; Roberts, Scott; Patrick, Christina; Winner, Beate; Winkler, Juergen; Masliah, Eliezer			alpha-Synuclein Induces Alterations in Adult Neurogenesis in Parkinson Disease Models via p53-mediated Repression of Notch1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; PROGENITOR CELLS; GENE-EXPRESSION; DENTATE GYRUS; P53; APOPTOSIS; NEURONS; ARREST; GROWTH; MICE	Parkinson disease is characterized by the loss of dopaminergic neurons mainly in the substantia nigra. Accumulation of alpha-synuclein and cell loss has been also reported in many other brain regions including the hippocampus, where it might impair adult neurogenesis, contributing to nonmotor symptoms. However, the molecular mechanisms of these alterations are still unknown. In this report we show that alpha-synuclein-accumulating adult rat hippocampus neural progenitors present aberrant neuronal differentiation, with reduction of Notch1 expression and downstream signaling targets. We characterized a Notch1 proximal promoter that contains p53 canonical response elements. In vivo binding of p53 represses the transcription of Notch1 in neurons. Moreover, we demonstrated that alpha-synuclein directly binds to the DNA at Notch1 promoter vicinity and also interacts with p53 protein, facilitating or increasing Notch1 signaling repression, which interferes with maturation and survival of neural progenitors cells. This study provides a molecular basis for alpha-synuclein-mediated disruption of adult neurogenesis in Parkinson disease.	[Desplats, Paula; Spencer, Brian; Crews, Leslie; Pathel, Pruthul; Kosberg, Kori; Roberts, Scott; Patrick, Christina; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Morvinski-Friedmann, Dinorah] Salk Inst Biol Studies, La Jolla, CA 92093 USA; [Winner, Beate] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Interdisciplinary Ctr Clin Res, Jr Res Grp 3, D-91054 Erlangen, Germany; [Winkler, Juergen] Univ Erlangen Nurnberg, Div Mol Neurol, D-91054 Erlangen, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Desplats, P (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, 9500 Gilman Dr,MTF 344, La Jolla, CA 92093 USA.	pdesplat@ucsd.edu	Winner, Beate/K-3730-2012; Winner, Beate/O-8213-2019; Desplats, Paula/AFW-5030-2022; Crews, Leslie/B-7584-2014	Winner, Beate/0000-0002-6909-0564; Winner, Beate/0000-0002-6909-0564; Crews, Leslie/0000-0003-0704-0067	National Institutes of Health [AG5131, AG18440, AG22074, AG3197, AG10435, NS057096]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R37AG018440, R01AG018440, P01AG022074, P01AG010435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG5131, AG18440, AG22074, AG3197, AG10435, and NS057096 (to E.M.).	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Amson R, 2000, P NATL ACAD SCI USA, V97, P5346, DOI 10.1073/pnas.97.10.5346; Boardman PE, 2003, NUCLEIC ACIDS RES, V31, P3572, DOI 10.1093/nar/gkg511; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buchen Elizabeth T., 2008, V52, P267; Crews L, 2008, J NEUROSCI, V28, P4250, DOI 10.1523/JNEUROSCI.0066-08.2008; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Desplats P, 2011, J BIOL CHEM, V286, P9031, DOI 10.1074/jbc.C110.212589; Desplats PA, 2008, NEUROBIOL DIS, V31, P298, DOI 10.1016/j.nbd.2008.05.005; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Elliott RC, 2001, NEUROSCIENCE, V106, P79, DOI 10.1016/S0306-4522(01)00198-1; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gorbatyuk OS, 2010, MOL THER, V18, P1450, DOI 10.1038/mt.2010.115; Greenberg DA, 2006, NAT MED, V12, P884, DOI 10.1038/nm0806-884; Harding AJ, 2002, ANN NEUROL, V51, P125, DOI 10.1002/ana.10071; Hegde ML, 2003, ARCH BIOCHEM BIOPHYS, V418, P169, DOI 10.1016/j.abb.2003.08.015; Hegde ML, 2007, ARCH BIOCHEM BIOPHYS, V464, P57, DOI 10.1016/j.abb.2007.03.042; Hegde ML, 2010, FRONT BIOSCI-LANDMRK, V15, P418, DOI 10.2741/3628; Hirsch EC, 1999, MOVEMENT DISORD, V14, P383, DOI 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F; Jimenez JS, 2010, J ALZHEIMERS DIS, V22, P375, DOI 10.3233/JAD-2010-100189; Johnson MA, 2009, BMB REP, V42, P245, DOI 10.5483/BMBRep.2009.42.5.245; Kawai T, 2005, NEUROSCI LETT, V380, P17, DOI 10.1016/j.neulet.2005.01.005; Kempermann Gerd, 2008, V52, P159; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; Medrano S, 2005, BIOCHEM BIOPH RES CO, V331, P828, DOI 10.1016/j.bbrc.2005.03.194; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Qi RZ, 2003, CANCER RES, V63, P8323; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, AM J PATHOL, V152, P367; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Winner B, 2004, J NEUROPATH EXP NEUR, V63, P1155, DOI 10.1093/jnen/63.11.1155; Winner B, 2008, NEUROBIOL AGING, V29, P913, DOI 10.1016/j.neurobiolaging.2006.12.016; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06	57	53	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31691	31702		10.1074/jbc.M112.354522	http://dx.doi.org/10.1074/jbc.M112.354522			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833673	Green Published, hybrid			2022-12-25	WOS:000309059400011
J	Martin, B; Chadwick, W; Cong, WN; Pantaleo, N; Daimon, CM; Golden, EJ; Becker, KG; Wood, WH; Carlson, OD; Egan, JM; Maudsley, S				Martin, Bronwen; Chadwick, Wayne; Cong, Wei-na; Pantaleo, Nick; Daimon, Caitlin M.; Golden, Erin J.; Becker, Kevin G.; Wood, William H., III; Carlson, Olga D.; Egan, Josephine M.; Maudsley, Stuart			Euglycemic Agent-mediated Hypothalamic Transcriptomic Manipulation in the N171-82Q Model of Huntington Disease Is Related to Their Physiological Efficacy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION-PROTEIN GENE; MOUSE MODEL; MUTATIONS; IDENTIFICATION; NEUROENDOCRINE; EXPRESSION; GHRELIN; BRAIN; HD	Our aim was to employ novel analytical methods to investigate the therapeutic treatment of the energy regulation dysfunction occurring in a Huntington disease (HD) mouse model. HD is a neurodegenerative disorder that is characterized by progressive motor impairment and cognitive alterations. Changes in neuroendocrine function, body weight, energy metabolism, euglycemia, appetite function, and gut function can also occur. It is likely that the locus of these alterations is the hypothalamus. We determined the effects of three different euglycemic agents on HD progression using standard physiological and transcriptomic signature analyses. N171-82Q HD mice were treated with insulin, Exendin-4, and the newly developed GLP-1-Tf to determine whether these agents could improve energy regulation and delay disease progression. Blood glucose, insulin, metabolic hormone levels, and pancreatic morphology were assessed. Hypothalamic gene transcription, motor coordination, and life span were also determined. The N171-82Q mice exhibited significant alterations in hypothalamic gene transcription signatures and energy metabolism that were ameliorated, to varying degrees, by the different euglycemic agents. Exendin-4 or GLP-1-Tf (but not insulin) treatment also improved pancreatic morphology, motor coordination, and increased life span. Using hypothalamic transcription signature analyses, we found that the physiological efficacy variation of the drugs was evident in the degree of reversal of the hypothalamic HD pathological signature. Euglycemic agents targeting hypothalamic and energy regulation dysfunction in HD could potentially alter disease progression and improve quality of life in HD.	[Martin, Bronwen; Cong, Wei-na; Daimon, Caitlin M.; Golden, Erin J.] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Chadwick, Wayne; Pantaleo, Nick; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Becker, Kevin G.; Wood, William H., III] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; [Carlson, Olga D.; Egan, Josephine M.] NIA, Diabet Sect, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, B (corresponding author), NIA, Metab Unit, NIH, 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Pantaleo, Nick/AAE-4452-2021; Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; Becker, Kevin/0000-0002-6794-6656; Martin, Bronwen/0000-0002-9185-6925	National Institutes of Health Intramural Research Program, NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000915, ZIAAG000319, ZIAAG000917, ZIAAG000905, ZIAAG000325, ZIAAG000916, ZIAAG000318, ZICAG000616] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NIA.	Altinova AE, 2007, ENDOCR J, V54, P221, DOI 10.1507/endocrj.K06-021; Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Barkalifa R, 2010, PHYSIOL GENOMICS, V42, P445, DOI 10.1152/physiolgenomics.00042.2010; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chen J, 2007, J NEUROSCI RES, V85, P1724, DOI 10.1002/jnr.21304; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Gaba AM, 2005, AM J CLIN NUTR, V81, P1335; Gossrau G, 2006, J NEURAL TRANSM, V113, P331, DOI 10.1007/s00702-005-0329-x; Head G. A., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P17, DOI 10.2174/187152506775268758; Hickey MA, 2012, MOL CELL NEUROSCI, V49, P149, DOI 10.1016/j.mcn.2011.10.007; Hong Y, 2009, NEUROTOXICOLOGY, V30, P538, DOI 10.1016/j.neuro.2009.04.011; Hult S, 2010, CURR DRUG TARGETS, V11, P1237, DOI 10.2174/1389450111007011237; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jankovic N, 2008, INT J NEUROSCI, V118, P391, DOI 10.1080/00207450701593103; Jarvis K, 2007, NEUROSCI LETT, V423, P184, DOI 10.1016/j.neulet.2007.06.058; Khan R. S., 2010, INT J PEPT, V2010; Kim BJ, 2010, J PHARMACOL EXP THER, V334, P682, DOI 10.1124/jpet.110.166470; Kim J, 2011, INT REV NEUROBIOL, V98, P419, DOI 10.1016/B978-0-12-381328-2.00016-X; Koop O, 2005, NEUROMUSCULAR DISORD, V15, P549, DOI 10.1016/j.nmd.2005.06.007; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Labudova O, 1998, BRAIN RES, V806, P55, DOI 10.1016/S0006-8993(98)00730-6; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee SB, 2010, J BIOL CHEM, V285, P29457, DOI 10.1074/jbc.M110.131367; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; MAZUREK MF, 1986, NEUROLOGY, V36, P1133, DOI 10.1212/WNL.36.8.1133; Mokhtari D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1067, DOI 10.1152/ajpendo.00212.2009; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Niu SN, 2011, FEBS LETT, V585, P85, DOI 10.1016/j.febslet.2010.11.059; Pan W, 2007, PEPTIDES, V28, P2411, DOI 10.1016/j.peptides.2007.10.006; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Perez-Tilve D, 2007, DIABETES, V56, P143, DOI 10.2337/db05-0996; Pers TH, 2011, GENET EPIDEMIOL, V35, P318, DOI 10.1002/gepi.20580; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schilling G, 2001, NEUROSCI LETT, V315, P149, DOI 10.1016/S0304-3940(01)02326-6; Schultz K, 2009, NEUROSCI LETT, V453, P104, DOI 10.1016/j.neulet.2009.02.008; Scuteri A, 2011, NEUROSCIENCE, V172, P12, DOI 10.1016/j.neuroscience.2010.10.065; Sutherland G, 2008, AM J MED GENET B, V147B, P495, DOI 10.1002/ajmg.b.30633; Timmers HJLM, 1996, BRAIN RES, V728, P141, DOI 10.1016/0006-8993(96)00080-7; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Wu LLY, 2010, J BIOL CHEM, V285, P5614, DOI 10.1074/jbc.M109.073197; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709	55	23	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31766	31782		10.1074/jbc.M112.387316	http://dx.doi.org/10.1074/jbc.M112.387316			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822065	Green Published, hybrid			2022-12-25	WOS:000309059400018
J	Zomot, E; Bahar, I				Zomot, Elia; Bahar, Ivet			A Conformational Switch in a Partially Unwound Helix Selectively Determines the Pathway for Substrate Release from the Carnitine/gamma-Butyrobetaine Antiporter CaiT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/BETAINE SYMPORTER BETP; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; NEUROTRANSMITTER TRANSPORTERS; GALACTOSE TRANSPORTER; MOLECULAR-DYNAMICS; STATE; NA+; METABOLISM; MECHANISM	CaiT is a homotrimeric antiporter that exchanges L-carnitine (CRN) with gamma-butyrobetaine(GBB) across the bacterial membrane. Three structures have been resolved to date for CaiT, all in the inward-facing state: CRN-bound (with four CRNs per subunit), GBB-bound (two GBBs per subunit), and apo. One of the reported binding sites is the counterpart of the primary site observed in structurally similar transporters. However, the mechanism and pathway(s) of CRN/GBB unbinding and translocation, or even the ability of the substrates to dislodge from the reported binding sites, are yet to be determined. To shed light on these issues, we performed a total of 1.3 mu s of molecular dynamics simulations and examined the dynamics of substrate-bound CaiT structures under different conditions. We find that both CRN and GBB are able to dissociate completely from their primary site into the cytoplasm. Substrate molecules initially located at the secondary sites dissociate even faster (within tens of nanoseconds) into the extra- or intra-cellular regions. Interestingly, the unbinding pathway from the primary site appears to be dictated by the geometry of the unwound part of the transmembrane (TM) helix 3, mostly around Thr(100) therein. Arg(262) on TM7, which apparently mimics the role of Na+ in CaiT structural homologues, plays a key role in triggering the dissociation of the substrate away from the primary site and guiding its release to the cytoplasm provided that the unwound part of TM3 switches from a shielding to a yielding pose.	[Zomot, Elia; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahar, I (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3058 Biomed Sci Tower 3,3501 5th Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020		National Science Foundation through resources provided by the Extreme Science and Engineering Discovery Environment (XSEDE) [TG-MCB100144, 3P41 RR006009 20S1]; National Institutes of Health from the NIGMS [R01 GM086238]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238] Funding Source: NIH RePORTER	National Science Foundation through resources provided by the Extreme Science and Engineering Discovery Environment (XSEDE); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the National Science Foundation through resources provided by the Extreme Science and Engineering Discovery Environment (XSEDE) (Grants TG-MCB100144 and 3P41 RR006009 20S1) and by National Institutes of Health Grant R01 GM086238 from the NIGMS (to I. B.).	Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FARWICK M, 1995, J BACTERIOL, V177, P4690, DOI 10.1128/jb.177.16.4690-4695.1995; FRITZ IB, 1964, AM J PHYSIOL, V206, P531, DOI 10.1152/ajplegacy.1964.206.3.531; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jung H, 2002, J BIOL CHEM, V277, P39251, DOI 10.1074/jbc.M206319200; JUNG K, 1987, J BASIC MICROB, V27, P131, DOI 10.1002/jobm.3620270303; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kleber HP, 1997, FEMS MICROBIOL LETT, V147, P1; Li J, 2012, BBA-BIOMEMBRANES, V1818, P263, DOI 10.1016/j.bbamem.2011.09.011; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; LINDSTED.G, 1967, BIOCHEMISTRY-US, V6, P1271, DOI 10.1021/bi00857a007; Nalecz Katarzyna A., 2004, Molecular Aspects of Medicine, V25, P551; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; TREEM WR, 1988, NEW ENGL J MED, V319, P1331, DOI 10.1056/NEJM198811173192006; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x; Zomot E, 2011, J BIOL CHEM, V286, P19693, DOI 10.1074/jbc.M110.202085; Zomot E, 2010, MOL BIOSYST, V6, P1040, DOI 10.1039/b927492h	28	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31823	31832		10.1074/jbc.M112.397364	http://dx.doi.org/10.1074/jbc.M112.397364			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843728	Green Published, hybrid			2022-12-25	WOS:000309059400023
J	Li, Y; Macdonald-Obermann, J; Westfall, C; Piwnica-Worms, D; Pike, LJ				Li, Yu; Macdonald-Obermann, Jennifer; Westfall, Corey; Piwnica-Worms, David; Pike, Linda J.			Quantitation of the Effect of ErbB2 on Epidermal Growth Factor Receptor Binding and Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; NEGATIVE COOPERATIVITY; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; KINASE ACTIVATION; DIMER FORMATION; LIGAND-BINDING; LIVING CELLS; DOMAIN; MEMBRANE	The epidermal growth factor (EGF) receptor is a member of the ErbB family of receptors that also includes ErbB2, ErbB3, and ErbB4. These receptors form homo- and heterodimers in response to ligand with ErbB2 being the preferred dimerization partner. Here we use I-125-EGF binding to quantitate the interaction of the EGF receptor with ErbB2. We show that the EGFR/ErbB2 heterodimer binds EGF with a 7-fold higher affinity than the EGFR homodimer. Because it cannot bind a second ligand, the EGFR/ErbB2 heterodimer is not subject to ligand-induced dissociation caused by the negatively cooperative binding of EGF to the second site on the EGFR homodimer. This increases the stability of the heterodimer relative to the homodimer and is associated with enhanced and prolonged EGF receptor autophosphorylation. These effects are independent of the kinase activity of ErbB2 but require back-to-back dimerization of the EGF receptor with ErbB2. Back-to-back dimerization is also required for phosphorylation of ErbB2. These findings provide a molecular explanation for the apparent preference of the EGF receptor for dimerizing with ErbB2 and suggest that the phosphorylation of ErbB2 occurs largely in the context of the EGFR/ErbB2 heterodimer, rather than through lateral phosphorylation of isolated ErbB2 subunits.	[Li, Yu; Macdonald-Obermann, Jennifer; Westfall, Corey; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu	Li, Yu/E-8600-2013		National Institutes of Health [R01GM82824, P50 CA94056]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM82824 (to L. J. P.) and P50 CA94056 (to D. P.-W.).	Adak S, 2011, J BIOL CHEM, V286, P45146, DOI 10.1074/jbc.M111.274175; Adak S, 2011, J BIOL CHEM, V286, P1545, DOI 10.1074/jbc.M110.182899; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; CONTRERAS MA, 1983, METHOD ENZYMOL, V92, P277; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; SARUP JC, 1991, GROWTH REGULAT, V1, P72; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yang KS, 2010, J BIOL CHEM, V285, P24014, DOI 10.1074/jbc.M110.103317; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	39	24	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31116	31125		10.1074/jbc.M112.373647	http://dx.doi.org/10.1074/jbc.M112.373647			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822073	Green Published, hybrid			2022-12-25	WOS:000308791300024
J	Liu, GH; Wang, SY; Huang, WY; Zhao, GH; Wei, SJ; Song, HQ; Xu, MJ; Lin, RQ; Zhou, DH; Zhu, XQ				Liu, Guo-Hua; Wang, Shu-Yan; Huang, Wei-Yi; Zhao, Guang-Hui; Wei, Shu-Jun; Song, Hui-Qun; Xu, Min-Jun; Lin, Rui-Qing; Zhou, Dong-Hui; Zhu, Xing-Quan			The Complete Mitochondrial Genome of Galba pervia (Gastropoda: Mollusca), an Intermediate Host Snail of Fasciola spp.	PLOS ONE			English	Article							TRANSFER-RNA GENES; COMPLETE SEQUENCE; DNA-SEQUENCE; EVOLUTION; REARRANGEMENTS; ORGANIZATION; ORDER; BASOMMATOPHORA; DUPLICATION; PHYLOGENIES	Complete mitochondrial (mt) genomes and the gene rearrangements are increasingly used as molecular markers for investigating phylogenetic relationships. Contributing to the complete mt genomes of Gastropoda, especially Pulmonata, we determined the mt genome of the freshwater snail Galba pervia, which is an important intermediate host for Fasciola spp. in China. The complete mt genome of G. pervia is 13,768 bp in length. Its genome is circular, and consists of 37 genes, including 13 genes for proteins, 2 genes for rRNA, 22 genes for tRNA. The mt gene order of G. pervia showed novel arrangement (tRNA-His, tRNA-Gly and tRNA-Tyr change positions and directions) when compared with mt genomes of Pulmonata species sequenced to date, indicating divergence among different species within the Pulmonata. A total of 3655 amino acids were deduced to encode 13 protein genes. The most frequently used amino acid is Leu (15.05%), followed by Phe (11.24%), Ser (10.76%) and IIe (8.346%). Phylogenetic analyses using the concatenated amino acid sequences of the 13 protein-coding genes, with three different computational algorithms (maximum parsimony, maximum likelihood and Bayesian analysis), all revealed that the families Lymnaeidae and Planorbidae are closely related two snail families, consistent with previous classifications based on morphological and molecular studies. The complete mt genome sequence of G. pervia showed a novel gene arrangement and it represents the first sequenced high quality mt genome of the family Lymnaeidae. These novel mtDNA data provide additional genetic markers for studying the epidemiology, population genetics and phylogeographics of freshwater snails, as well as for understanding interplay between the intermediate snail hosts and the intra-mollusca stages of Fasciola spp..	[Liu, Guo-Hua; Wang, Shu-Yan; Zhao, Guang-Hui; Song, Hui-Qun; Xu, Min-Jun; Zhou, Dong-Hui; Zhu, Xing-Quan] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China; [Liu, Guo-Hua; Zhu, Xing-Quan] Hunan Agr Univ, Coll Vet Med, Changsha, Hunan, Peoples R China; [Wang, Shu-Yan; Huang, Wei-Yi] Guangxi Univ, Coll Anim Sci & Technol, Nanning 530004, Guangxi Zhuang, Peoples R China; [Zhao, Guang-Hui] NW A&F Univ, Coll Vet Med, Yangling, Shaanxi Provinc, Peoples R China; [Wei, Shu-Jun] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Lin, Rui-Qing] S China Agr Univ, Coll Vet Med, Parasitol Lab, Guangzhou, Guangdong, Peoples R China; [Zhu, Xing-Quan] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan Province, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Hunan Agricultural University; Guangxi University; Northwest A&F University - China; Beijing Academy of Agriculture & Forestry; South China Agricultural University; Yunnan Agricultural University	Zhu, XQ (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China.	xingquanzhu1@hotmail.com	Wei, Shu-Jun/C-1109-2011	Wei, Shu-Jun/0000-0001-7398-0968	Open Funds of the State Key Laboratory of Veterinary Etiological Biology; Lanzhou Veterinary Research Institute; Chinese Academy of Agricultural Sciences [SKLVEB2011KFKT011, SKLVEB2010KFKT009, SKLVEB2009KFKT008, SKLVEB2011KFKT010, SKLVEB2011KFKT004]; Program for Outstanding Scientists in Agricultural Research; Yunnan Provincial Program for Introducing High-level Scientists [2009CI125]; Special Funds for Talents in Northwest A F University [Z109021107, 2010BSJJ015]	Open Funds of the State Key Laboratory of Veterinary Etiological Biology; Lanzhou Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Program for Outstanding Scientists in Agricultural Research; Yunnan Provincial Program for Introducing High-level Scientists; Special Funds for Talents in Northwest A F University	This work was supported by the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant Nos. SKLVEB2011KFKT011, SKLVEB2010KFKT009, SKLVEB2009KFKT008, SKLVEB2011KFKT010 and SKLVEB2011KFKT004), the Program for Outstanding Scientists in Agricultural Research, the Yunnan Provincial Program for Introducing High-level Scientists (Grant No. 2009CI125) and the Special Funds for Talents in Northwest A & F University (Z109021107 and 2010BSJJ015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ai L, 2011, VET PARASITOL, V181, P329, DOI 10.1016/j.vetpar.2011.03.057; Alasaad S, 2011, VET PARASITOL, V179, P266, DOI 10.1016/j.vetpar.2011.01.059; Bandyopadhyay PK, 2006, TOXICON, V48, P29, DOI 10.1016/j.toxicon.2006.04.013; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BOTTGER C., 1955, ZOOL ANZ, V18, P253; Cai XQ, 2012, PARASITOL RES, V110, P235, DOI 10.1007/s00436-011-2477-2; CANTATORE P, 1987, NATURE, V329, P853, DOI 10.1038/329853a0; Catanese G, 2010, GENE, V452, P35, DOI 10.1016/j.gene.2009.12.004; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Dayrat B, 2001, MOL PHYLOGENET EVOL, V19, P225, DOI 10.1006/mpev.2001.0926; Dayrat B, 2011, MOL PHYLOGENET EVOL, V59, P425, DOI 10.1016/j.ympev.2011.02.014; DeJong RJ, 2004, J PARASITOL, V90, P991, DOI 10.1645/GE-284R; Dowton M, 2003, J MOL EVOL, V56, P517, DOI 10.1007/s00239-002-2420-3; Fahrein K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-386; Feldmeyer B, 2010, MOL PHYLOGENET EVOL, V57, P1329, DOI 10.1016/j.ympev.2010.09.012; Grande C, 2004, MOL BIOL EVOL, V21, P303, DOI 10.1093/molbev/msh016; Grande C, 2002, MOL BIOL EVOL, V19, P1672, DOI 10.1093/oxfordjournals.molbev.a003990; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; HOFFMANN RJ, 1992, GENETICS, V131, P397; Kaset C, 2010, EXP PARASITOL, V126, P482, DOI 10.1016/j.exppara.2010.05.021; Ki JS, 2009, GENE, V435, P13, DOI 10.1016/j.gene.2009.01.005; Klussmann-Kolb A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-57; Knudsen B, 2006, MOL PHYLOGENET EVOL, V38, P459, DOI 10.1016/j.ympev.2005.08.017; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Lei RH, 2010, GENE, V464, P44, DOI 10.1016/j.gene.2010.06.001; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Lin RQ, 2007, PARASITOL RES, V101, P813, DOI 10.1007/s00436-007-0512-0; Lin RQ, 2011, GENE, V480, P28, DOI 10.1016/j.gene.2011.03.004; Liu GH, 2011, MOL BIOL REP, V38, P2249, DOI 10.1007/s11033-010-0355-0; Liu YY, 1965, B BIOL FR BELG, V3, P8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paraense WL, 2003, MEM I OSWALDO CRUZ, V98, P767, DOI 10.1590/S0074-02762003000600010; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Rawlings TA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-440; Relf V, 2011, VET PARASITOL, V175, P287, DOI 10.1016/j.vetpar.2010.10.010; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Spithill TW, 1998, PARASITOL TODAY, V14, P224, DOI 10.1016/S0169-4758(98)01245-9; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023008; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yamazaki N, 1997, GENETICS, V145, P749; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yasuda N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-17; Zhang HYKF., 1999, CHIN J VET PARASTIOL, V1, P1	62	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42172	10.1371/journal.pone.0042172	http://dx.doi.org/10.1371/journal.pone.0042172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844544	Green Published, gold, Green Submitted			2022-12-25	WOS:000309240600069
J	Zhang, Y; Li, WZ; Ou, LL; Wang, WW; Delyagina, E; Lux, C; Sorg, H; Riehemann, K; Steinhoff, G; Ma, N				Zhang, Yue; Li, Wenzhong; Ou, Lailiang; Wang, Weiwei; Delyagina, Evgenya; Lux, Cornelia; Sorg, Heiko; Riehemann, Kristina; Steinhoff, Gustav; Ma, Nan			Targeted Delivery of Human VEGF Gene via Complexes of Magnetic Nanoparticle-Adenoviral Vectors Enhanced Cardiac Regeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACUTE MYOCARDIAL-INFARCTION; MESENCHYMAL STEM-CELLS; THERAPY; HEART; ARTERIOGENESIS; ANGIOPOIETIN-1; INJECTION; KINASE; SWINE	This study assessed the concept of whether delivery of magnetic nanobeads (MNBs)/adenoviral vectors (Ad)-encoded hVEGF gene (Ad(hVEGF)) could regenerate ischaemically damaged hearts in a rat acute myocardial infarction model under the control of an external magnetic field. Adenoviral vectors were conjugated to MNBs with the Sulfo-NHS-LC-Biotin linker. In vitro transduction efficacy of MNBs/Ad-encoded luciferase gene (Ad(luc)) was compared with Ad(luc) alone in human umbilical vein endothelial cells (HUVECs) under magnetic field stimulation. In vivo, in a rat acute myocardial infarction (AMI) model, MNBs/Ad(hVEGF) complexes were injected intravenously and an epicardial magnet was employed to attract the circulating MNBs/Ad(hVEGF) complexes. In vitro, compared with Ad(luc) alone, MNBs/Ad(luc) complexes had a 50-fold higher transduction efficiency under the magnetic field. In vivo, epicardial magnet effectively attracted MNBs/Ad(hVEGF) complexes and resulted in strong therapeutic gene expression in the ischemic zone of the infarcted heart. When compared to other MI-treated groups, the MI-M+/Ad(hVEGF) group significantly improved left ventricular function (p<0.05) assessed by pressure-volume loops after 4 weeks. Also the MI-M+/Ad(hVEGF) group exhibited higher capillary and arteriole density and lower collagen deposition than other MI-treated groups (p<0.05). Magnetic targeting enhances transduction efficiency and improves heart function. This novel method to improve gene therapy outcomes in AMI treatment offers the potential into clinical applications.	[Zhang, Yue; Li, Wenzhong; Ou, Lailiang; Wang, Weiwei; Delyagina, Evgenya; Lux, Cornelia; Steinhoff, Gustav; Ma, Nan] Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, Rostock, Germany; [Li, Wenzhong; Wang, Weiwei; Ma, Nan] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Teltow, Germany; [Li, Wenzhong; Wang, Weiwei; Ma, Nan] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany; [Sorg, Heiko] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; [Riehemann, Kristina] Univ Munster, Ctr Nanotechnol, Munster, Germany; [Riehemann, Kristina] Univ Munster, Inst Phys, D-4400 Munster, Germany	University of Rostock; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Hannover Medical School; University of Munster; University of Munster	Li, WZ (corresponding author), Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, Rostock, Germany.	wenzhong.li@med.uni-rostock.de	Ma, Nan/L-1282-2013; Li, Wenzhong/I-2882-2014; Steinhoff, Gustav/AAB-1848-2020; ma, nan/AAF-6968-2020	Ma, Nan/0000-0003-4006-1003; ma, nan/0000-0003-4006-1003; Sorg, Heiko/0000-0001-6827-0857	German Federal Ministry of Education and Research, BioChancePlus program [0313191]; German Helmholtz Association, Mecklenburg-Vorpommern, German Federal Ministry of Education and Research, German Research Foundation (Nachwuchsgruppe Regenerative Medizin Regulation der Stammzellmigration) [0402710]; Forderkennzeichen (Ministry of Education (Germany, Berlin) [0312138 A]; Ministry of Economy (Mecklenburg-West Pommerania, Schwerin) [V220-630-08-TFMV-F/S-035]; Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-IRSES; Reference and Translation Center for Cardiac Stem Cell Therapy;  [Sonderforschungsbereich/Transregio 37];  [B5];  [B2];  [A4]	German Federal Ministry of Education and Research, BioChancePlus program(Federal Ministry of Education & Research (BMBF)); German Helmholtz Association, Mecklenburg-Vorpommern, German Federal Ministry of Education and Research, German Research Foundation (Nachwuchsgruppe Regenerative Medizin Regulation der Stammzellmigration); Forderkennzeichen (Ministry of Education (Germany, Berlin); Ministry of Economy (Mecklenburg-West Pommerania, Schwerin); Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-IRSES; Reference and Translation Center for Cardiac Stem Cell Therapy; ; ; ; 	This work was supported by Sonderforschungsbereich/Transregio 37 (B5, B2 and A4); German Federal Ministry of Education and Research, BioChancePlus program (0313191); The German Helmholtz Association, Mecklenburg-Vorpommern, German Federal Ministry of Education and Research, German Research Foundation (Nachwuchsgruppe Regenerative Medizin Regulation der Stammzellmigration 0402710); Forderkennzeichen 0312138 A (Ministry of Education (Germany, Berlin)); V220-630-08-TFMV-F/S-035 (Ministry of Economy (Mecklenburg-West Pommerania, Schwerin)); Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-2009-IRSES); and the Reference and Translation Center for Cardiac Stem Cell Therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; [Anonymous], 2004, J ADV NURSING, V48, P542; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Crottogini A, 2003, HUM GENE THER, V14, P1307, DOI 10.1089/104303403322319390; Curato C, 2010, J IMMUNOL, V185, P6286, DOI 10.4049/jimmunol.0903681; Delyagina E, 2011, NANOMEDICINE-UK, V6, P1593, DOI [10.2217/NNM.11.143, 10.2217/nnm.11.143]; Emmrich S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-61; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Forbes ZG, 2003, IEEE T MAGN, V39, P3372, DOI 10.1109/TMAG.2003.816260; Furlani D, 2008, TRANSPL P, V40, P962, DOI 10.1016/j.transproceed.2008.03.033; Gaebel R, 2011, BIOMATERIALS, V32, P9218, DOI 10.1016/j.biomaterials.2011.08.071; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Guerrero M, 2008, J INTERV CARDIOL, V21, P242, DOI 10.1111/j.1540-8183.2008.00358.x; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Hofmann A, 2009, P NATL ACAD SCI USA, V106, P44, DOI 10.1073/pnas.0803746106; Jacquier A, 2007, RADIOLOGY, V245, P196, DOI 10.1148/radiol.2451061077; Kastrati A, 2004, J AM COLL CARDIOL, V43, P734, DOI 10.1016/j.jacc.2003.07.054; Katare R, CIRC RES, V108, P1238; Laguens R, 2002, GENE THER, V9, P1676, DOI 10.1038/sj.gt.3301844; Li WZ, 2008, J GENE MED, V10, P897, DOI 10.1002/jgm.1208; Li WZ, 2007, J MAGN MAGN MATER, V311, P336, DOI 10.1016/j.jmmm.2006.11.201; Meloni M, 2012, DIABETES, V61, P229, DOI 10.2337/db11-0763; Mykhaylyk O, 2009, J BIOMED NANOTECHNOL, V5, P692, DOI 10.1166/jbn.2009.1086; Ou LL, 2011, J CELL MOL MED, V15, P1310, DOI 10.1111/j.1582-4934.2010.01086.x; Ou Lailiang, 2010, Open Cardiovasc Med J, V4, P231, DOI 10.2174/1874192401004010231; Pandori MW, 2002, VIROLOGY, V299, P204, DOI 10.1006/viro.2002.1510; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Saeed M, 2007, RADIOLOGY, V243, P451, DOI 10.1148/radiol.2432060928; Siddiqui AJ, 2003, BIOCHEM BIOPH RES CO, V310, P1002, DOI 10.1016/j.bbrc.2003.09.111; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Tamura K, 1999, JPN CIRC J, V63, P357, DOI 10.1253/jcj.63.357; Torchilin VP, 2000, EUR J PHARM SCI, V11, pS81, DOI 10.1016/S0928-0987(00)00166-4; Wang WW, 2011, J CELL MOL MED, V15, P1989, DOI 10.1111/j.1582-4934.2010.01130.x; Wang WW, 2010, J CELL MOL MED, V14, P392, DOI 10.1111/j.1582-4934.2008.00624.x; Wang WW, 2009, INT J ARTIF ORGANS, V32, P141, DOI 10.1177/039139880903200304; Wilchek M, 1999, BIOMOL ENG, V16, P1; Yang TC, 2007, MOL THER, V15, P997, DOI 10.1038/sj.mt.6300130; Yin Ruixing, 2000, Chinese Medical Sciences Journal, V15, P205; Yin Ruixing, 2000, Chinese Medical Sciences Journal, V15, P154; Zhou L, 2005, GENE THER, V12, P196, DOI 10.1038/sj.gt.3302416	41	50	51	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e39490	10.1371/journal.pone.0039490	http://dx.doi.org/10.1371/journal.pone.0039490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844395	gold, Green Submitted, Green Published			2022-12-25	WOS:000309240600003
J	Doukakis, P; Pikitch, EK; Rothschild, A; DeSalle, R; Amato, G; Kolokotronis, SO				Doukakis, Phaedra; Pikitch, Ellen K.; Rothschild, Anna; DeSalle, Rob; Amato, George; Kolokotronis, Sergios-Orestis			Testing the Effectiveness of an International Conservation Agreement: Marketplace Forensics and CITES Caviar Trade Regulation	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ACIPENSER-BAERII; RUSSIAN STURGEON; IDENTIFICATION; POLYMORPHISM; PADDLEFISH; MANAGEMENT; ALGORITHM; FISHERIES; RECOVERY	Background: The international wildlife trade is a key threat to biodiversity. Temporal genetic marketplace monitoring can determine if wildlife trade regulation efforts such as the Convention on International Trade in Endangered Species (CITES) are succeeding. Protected under CITES effective 1997, sturgeons and paddlefishes, the producers of black caviar, are flagship CITES species. Methodology/Principal Findings: We test whether CITES has limited the amount of fraudulent black caviar reaching the marketplace. Using mitochondrial DNA-based methods, we compare mislabeling in caviar and meat purchased in the New York City area pre and post CITES listing. Our recent sampling of this market reveals a decrease in mislabeled caviar (2006-2008; 10%; n = 90) compared to pre-CITES implementation (1995-1996; 19%; n = 95). Mislabeled caviar was found only in online purchase (n = 49 online/41 retail). Conclusions/Significance: Stricter controls on importing and exporting as per CITES policies may be having a positive conservation effect by limiting the amount of fraudulent caviar reaching the marketplace. Sturgeons and paddlefishes remain a conservation priority, however, due to continued overfishing and habitat degradation. Other marine and aquatic species stand to benefit from the international trade regulation that can result from CITES listing.	[Doukakis, Phaedra] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Doukakis, Phaedra; Pikitch, Ellen K.] SUNY Stony Brook, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA; [Doukakis, Phaedra; Rothschild, Anna; DeSalle, Rob; Amato, George; Kolokotronis, Sergios-Orestis] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Kolokotronis, Sergios-Orestis] Columbia Univ, Dept Biol, Barnard Coll, New York, NY USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; American Museum of Natural History (AMNH); Columbia University	Doukakis, P (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	pdoukakis@ucsd.edu	Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465	Alfred P. Sloan Foundation; Sackler Institute for Comparative Genomics at the American Museum of Natural History	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Sackler Institute for Comparative Genomics at the American Museum of Natural History	The authors thank the Pew Charitable Trusts, J.F. Thye, and P. R. Thye, and one anonymous contributor to the Institute for Ocean Conservation Science at Stony Brook University. Laboratory work was supported by the Alfred P. Sloan Foundation, and the Sackler Institute for Comparative Genomics at the American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CS, 2008, MOL ECOL, V17, P3985, DOI 10.1111/j.1365-294X.2008.03867.x; Bettoli PW, 2009, AM FISH S S, V66, P23; Birstein Vadim J., 2000, Conservation Genetics, V1, P81, DOI 10.1023/A:1010141906100; Birstein VJ, 1998, CONSERV BIOL, V12, P766, DOI 10.1046/j.1523-1739.1998.97081.x; Birstein VJ, 1999, J APPL ICHTHYOL, V15, P12, DOI 10.1111/j.1439-0426.1999.tb00197.x; Broad S, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P3; Bronzi P, 2011, J APPL ICHTHYOL, V27, P169, DOI 10.1111/j.1439-0426.2011.01757.x; C?lix M., 2018, EUROPEAN RED LIST SA; Congiu L, 2001, MOL ECOL, V10, P2355, DOI 10.1046/j.0962-1083.2001.01368.x; DeSalle R, 1996, NATURE, V381, P197, DOI 10.1038/381197a0; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Doukakis P, 2011, MITOCHONDR DNA, V22, P15, DOI 10.3109/19401736.2010.526112; Doukakis P, 2010, CONSERV BIOL, V24, P769, DOI 10.1111/j.1523-1739.2010.01458.x; Doukakis P, 2009, CONSERV BIOL, V23, P841, DOI 10.1111/j.1523-1739.2009.01281.x; Gessner J, 2002, J APPL ICHTHYOL, V18, P665, DOI 10.1046/j.1439-0426.2002.00366.x; Ginsberg J, 2002, CONSERV BIOL, V16, P1184, DOI 10.1046/j.1523-1739.2002.16504.x; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Jenneckens I, 2000, ECOL LETT, V3, P503, DOI 10.1046/j.1461-0248.2000.00179.x; Kottelat M, 2009, ACIPENSER NUDIVENTRI; Krieger J, 2008, J APPL ICHTHYOL, V24, P36, DOI 10.1111/j.1439-0426.2008.01088.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Ludwig A, 2008, J APPL ICHTHYOL, V24, P2, DOI 10.1111/j.1439-0426.2008.01085.x; Ludwig A, 2006, EUR J WILDLIFE RES, V52, P3, DOI 10.1007/s10344-005-0006-2; Ludwig A, 2009, BIOL INVASIONS, V11, P753, DOI 10.1007/s10530-008-9289-z; Mugue NS, 2008, RUSS J GENET+, V44, P793, DOI 10.1134/S1022795408070065; Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Uscamaita MR, 2010, ORYX, V44, P83, DOI 10.1017/S0030605309990196; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Ruban GI, 2011, J APPL ICHTHYOL, V27, P470, DOI 10.1111/j.1439-0426.2011.01668.x; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Simons AM, 2001, T AM FISH SOC, V130, P359, DOI 10.1577/1548-8659(2001)130&lt;0359:POSBOM&gt;2.0.CO;2; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stokstad E, 2010, SCIENCE, V328, P26, DOI 10.1126/science.328.5974.26-a; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Timoshkina NN, 2009, RUSS J GENET+, V45, P1098, DOI 10.1134/S1022795409090117; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wuertz S, 2009, AQUACULTURE, V298, P51, DOI 10.1016/j.aquaculture.2009.09.029; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	43	41	42	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40907	10.1371/journal.pone.0040907	http://dx.doi.org/10.1371/journal.pone.0040907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848410	gold, Green Published			2022-12-25	WOS:000306806600028
J	Kosem, A; van Wassenhove, V				Koesem, Anne; van Wassenhove, Virginie			Temporal Structure in Audiovisual Sensory Selection	PLOS ONE			English	Article							VISUAL-SEARCH; NEURONAL OSCILLATIONS; AUDITORY FLUTTER; ATTENTION; PERCEPTION; SYNCHRONY; PHASE; SOUND; TIME; SIGNALS	In natural environments, sensory information is embedded in temporally contiguous streams of events. This is typically the case when seeing and listening to a speaker or when engaged in scene analysis. In such contexts, two mechanisms are needed to single out and build a reliable representation of an event (or object): the temporal parsing of information and the selection of relevant information in the stream. It has previously been shown that rhythmic events naturally build temporal expectations that improve sensory processing at predictable points in time. Here, we asked to which extent temporal regularities can improve the detection and identification of events across sensory modalities. To do so, we used a dynamic visual conjunction search task accompanied by auditory cues synchronized or not with the color change of the target (horizontal or vertical bar). Sounds synchronized with the visual target improved search efficiency for temporal rates below 1.4 Hz but did not affect efficiency above that stimulation rate. Desynchronized auditory cues consistently impaired visual search below 3.3 Hz. Our results are interpreted in the context of the Dynamic Attending Theory: specifically, we suggest that a cognitive operation structures events in time irrespective of the sensory modality of input. Our results further support and specify recent neurophysiological findings by showing strong temporal selectivity for audiovisual integration in the auditory-driven improvement of visual search efficiency.	[Koesem, Anne; van Wassenhove, Virginie] INSERM, U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [Koesem, Anne; van Wassenhove, Virginie] CEA, DSV I2BM, NeuroSpin Ctr, Gif Sur Yvette, France; [Koesem, Anne; van Wassenhove, Virginie] Univ Paris Sud, Cognit Neuroimaging Unit, Gif Sur Yvette, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Kosem, A (corresponding author), INSERM, U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France.	Virginie.van-Wassenhove@cea.fr	Kosem, Anne/M-2344-2019; van Wassenhove, Virginie/F-4129-2010	Kosem, Anne/0000-0002-2692-9999; van Wassenhove, Virginie/0000-0002-2569-5502	Marie Curie [IRG-249222, ERC-StG-263584, ANRJCJC-1904]; Fondation Electricite De France (EDF); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)/Direction Generale des Armees (DGA) PhD fellowship	Marie Curie(European Commission); Fondation Electricite De France (EDF); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)/Direction Generale des Armees (DGA) PhD fellowship	This work was supported by Marie Curie IRG-249222, ERC-StG-263584, and ANRJCJC-1904 to VvW and Fondation Electricite De France (EDF) and Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)/Direction Generale des Armees (DGA) PhD fellowship to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsius A, 2011, EXP BRAIN RES, V213, P175, DOI 10.1007/s00221-011-2624-0; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Bates D. M., 2007, LME4 LINEAR MIXED EF; Benjamins JS, 2008, PERCEPTION, V37, P848, DOI 10.1068/p5783; Besle J, 2011, J NEUROSCI, V31, P3176, DOI 10.1523/JNEUROSCI.4518-10.2011; Blake Randolph, 2005, Behav Cogn Neurosci Rev, V4, P21, DOI 10.1177/1534582305276839; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Chen YC, 2008, PSYCHON B REV, V15, P404, DOI 10.3758/PBR.15.2.404; Chen YC, 2009, EXP BRAIN RES, V198, P209, DOI 10.1007/s00221-009-1831-4; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V54, P277, DOI 10.3758/BF03205262; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; FRENCHSTGEORGE M, 1989, PERCEPT PSYCHOPHYS, V46, P384; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2007, VISION RES, V47, P1075, DOI 10.1016/j.visres.2007.01.021; Fujisaki W, 2010, P ROY SOC B-BIOL SCI, V277, P2281, DOI 10.1098/rspb.2010.0243; Galambos R, 1981, P NATL ACAD SCI USA, V78, P2343; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; Gomez-Ramirez M, 2011, J NEUROSCI, V31, P18556, DOI 10.1523/JNEUROSCI.2164-11.2011; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Huang LQ, 2005, PERCEPT PSYCHOPHYS, V67, P150, DOI 10.3758/BF03195018; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jones MR, 2006, COGNITIVE PSYCHOL, V53, P59, DOI 10.1016/j.cogpsych.2006.01.003; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Kandil FI, 2001, EUR J NEUROSCI, V13, P2004, DOI 10.1046/j.0953-816x.2001.01573.x; KEELE SW, 1989, PSYCHOL RES-PSYCH FO, V50, P251, DOI 10.1007/BF00309261; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lee SH, 1999, SCIENCE, V284, P1165, DOI 10.1126/science.284.5417.1165; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000445; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; R Development Core Team, 2007, R LANG ENV STAT COMP; REGAN D, 1966, ELECTROEN CLIN NEURO, V20, P238, DOI 10.1016/0013-4694(66)90088-5; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Turgeon M, 2001, ANN NY ACAD SCI, V930, P375, DOI 10.1111/j.1749-6632.2001.tb05746.x; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010664; VanRullen R, 2006, J NEUROSCI, V26, P502, DOI 10.1523/JNEUROSCI.4654-05.2006; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; WELCH RB, 1986, PERCEPT PSYCHOPHYS, V39, P294, DOI 10.3758/BF03204939; Winfree A.T., 2000, GEOMETRY BIOL TIME; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zou H, 2012, J VISION, V12, DOI 10.1167/12.5.2	58	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40936	10.1371/journal.pone.0040936	http://dx.doi.org/10.1371/journal.pone.0040936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981GZ	22829899	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300037
J	Orr, BA; Haffner, MC; Nelson, WG; Yegnasubramanian, S; Eberhart, CG				Orr, Brent A.; Haffner, Michael C.; Nelson, William G.; Yegnasubramanian, Srinivasan; Eberhart, Charles G.			Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; ACTIVE DNA DEMETHYLATION; EMBRYONIC STEM-CELLS; IDH2 MUTATIONS; DIFFUSE GLIOMAS; MAMMALIAN DNA; HUMAN CANCERS; GLIOBLASTOMA; 5-METHYLCYTOSINE; DIFFERENTIATION	Epigenetic modification of DNA by cytosine methylation to produce 5-methylcytosine (5mC) has become well-recognized as an important epigenetic process in human health and disease. Recently, further modification of 5mC by the ten eleven translocated (TET) family of enzymes to produce 5-hydroxymethylcytosine (5hmC) has been described. In the present study, we used immunohistochemistry to evaluate the distribution of 5hmC in human brain during different periods of development and in a large series of gliomas (n = 225). We found that during development, 5hmC levels are high in more differentiated compartments like the fetal cortex, but low in the periventricular progenitor cell regions. In adults, we found 5hmC levels to be highest in the cortex, but present in all intrinsic cell types in the brain including stromal elements. In brain tumors, 5hmC levels were high in low grade tumors and reduced in malignant glioma, but did not exhibit any correlation with IDH1 mutation status. Additionally, we identified a significant relationship between low levels of 5hmC and reduced survival in malignant glioma. This observation was further supported by in silico analysis showing differential expression of genes involved in 5hmC homeostasis in aggressive subsets of glioblastoma. Finally, we show that several genes involved in regulating the levels of 5hmC are also prognostic in malignant glioma. These findings suggest that 5hmC regulation in malignant glioma may represent an important determinant of tumor differentiation and aggressive behavior, as well as a potential therapeutic target.	[Orr, Brent A.; Nelson, William G.; Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA; [Haffner, Michael C.; Nelson, William G.; Yegnasubramanian, Srinivasan] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Nelson, William G.] Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Orr, BA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	brentorr5@gmail.com; syegnasu@jhmi.edu		Orr, Brent/0000-0003-0997-4728	National Institutes of Health [T32CA067751, 5R01NS055089, 5R01CA070196]; Martin D. Abeloff V Scholar Award; NATIONAL CANCER INSTITUTE [R01CA070196, T32CA067751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martin D. Abeloff V Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially funded by National Institutes of Health postdoctoral fellowship (T32CA067751) to B.A.O., 5R01NS055089 to C.G.E., 5R01CA070196 and Martin D. Abeloff V Scholar Award to S.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Capper D, 2012, INT J CANCER, V131, P766, DOI 10.1002/ijc.26425; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Haffner MC, 2011, ONCOTARGET, V2, P627; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim YH, 2011, J CLIN PATHOL, V64, P850, DOI 10.1136/jclinpath-2011-200133; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kraus TF, 2012, INT J CANC IN PRESS; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Metellus P, 2011, ANN SURG ONCOL, V18, P2937, DOI 10.1245/s10434-011-1703-6; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; The WHO, 2020, CLASSIFICATION TUMOU; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	51	134	142	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41036	10.1371/journal.pone.0041036	http://dx.doi.org/10.1371/journal.pone.0041036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829908	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300046
J	Sabree, ZL; Hansen, AK; Moran, NA				Sabree, Zakee L.; Hansen, Allison K.; Moran, Nancy A.			Independent Studies Using Deep Sequencing Resolve the Same Set of Core Bacterial Species Dominating Gut Communities of Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA; MICROBIOTA; DIVERSITY; ORDERS	Starting in 2003, numerous studies using culture-independent methodologies to characterize the gut microbiota of honey bees have retrieved a consistent and distinctive set of eight bacterial species, based on near identity of the 16S rRNA gene sequences. A recent study [Mattila HR, Rios D, Walker-Sperling VE, Roeselers G, Newton ILG (2012) Characterization of the active microbiotas associated with honey bees reveals healthier and broader communities when colonies are genetically diverse. PLoS ONE 7(3): e32962], using pyrosequencing of the V1-V2 hypervariable region of the 16S rRNA gene, reported finding entirely novel bacterial species in honey bee guts, and used taxonomic assignments from these reads to predict metabolic activities based on known metabolisms of cultivable species. To better understand this discrepancy, we analyzed the Mattila et al. pyrotag dataset. In contrast to the conclusions of Mattila et al., we found that the large majority of pyrotag sequences belonged to clusters for which representative sequences were identical to sequences from previously identified core species of the bee microbiota. On average, they represent 95% of the bacteria in each worker bee in the Mattila et al. dataset, a slightly lower value than that found in other studies. Some colonies contain small proportions of other bacteria, mostly species of Enterobacteriaceae. Reanalysis of the Mattila et al. dataset also did not support a relationship between abundances of Bifidobacterium and of putative pathogens or a significant difference in gut communities between colonies from queens that were singly or multiply mated. Additionally, consistent with previous studies, the dataset supports the occurrence of considerable strain variation within core species, even within single colonies. The roles of these bacteria within bees, or the implications of the strain variation, are not yet clear.	[Sabree, Zakee L.; Hansen, Allison K.; Moran, Nancy A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Sabree, ZL (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	nancy.moran@yale.edu		Hansen, Allison/0000-0002-3066-5527	US National Science Foundation [DEB 1046153]; Yale University	US National Science Foundation(National Science Foundation (NSF)); Yale University	This work was supported by the US National Science Foundation (DEB 1046153) and by Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colwell R. K., 2006, ESTIMATES VERSION 8; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Dunn AK, 2005, APPL ENVIRON MICROB, V71, P8784, DOI 10.1128/AEM.71.12.8784-8794.2005; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2012, P NATL ACAD IN PRESS; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; GILLIAM M, 1976, J INVERTEBR PATHOL, V28, P275, DOI 10.1016/0022-2011(76)90137-3; Hansen AK, 2009, NORTHWEST SCI, V83, P348, DOI 10.3955/046.083.0406; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mather P. M., 1976, COMPUTATIONAL METHOD; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McCune B., 2011, PC ORD MULTIVARIATE; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Rosengaus RB, 2011, APPL ENVIRON MICROB, V77, P4303, DOI 10.1128/AEM.01886-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Volkmann M, 2010, INT J SYST EVOL MICR, V60, P2601, DOI 10.1099/ijs.0.019026-0	37	86	92	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41250	10.1371/journal.pone.0041250	http://dx.doi.org/10.1371/journal.pone.0041250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829932	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300071
J	Tarasov, AI; Semplici, F; Ravier, MA; Bellomo, EA; Pullen, TJ; Gilon, P; Sekler, I; Rizzuto, R; Rutter, GA				Tarasov, Andrei I.; Semplici, Francesca; Ravier, Magalie A.; Bellomo, Elisa A.; Pullen, Timothy J.; Gilon, Patrick; Sekler, Israel; Rizzuto, Rosario; Rutter, Guy A.			The Mitochondrial Ca2+ Uniporter MCU Is Essential for Glucose-Induced ATP Increases in Pancreatic beta-Cells	PLOS ONE			English	Article							SENSITIVE K+ CHANNEL; INSULIN-SECRETION; ESSENTIAL COMPONENT; CYTOPLASMIC CA2+; CYTOSOLIC CA2+; FATTY-ACIDS; CALCIUM; OSCILLATIONS; PROTEIN; EXOCYTOSIS	Glucose induces insulin release from pancreatic beta-cells by stimulating ATP synthesis, membrane depolarisation and Ca2+ influx. As well as activating ATP-consuming processes, cytosolic Ca2+ increases may also potentiate mitochondrial ATP synthesis. Until recently, the ability to study the role of mitochondrial Ca2+ transport in glucose-stimulated insulin secretion has been hindered by the absence of suitable approaches either to suppress Ca2+ uptake into these organelles, or to examine the impact on beta-cell excitability. Here, we have combined patch-clamp electrophysiology with simultaneous real-time imaging of compartmentalised changes in Ca2+ and ATP/ADP ratio in single primary mouse beta-cells, using recombinant targeted (Pericam or Perceval, respectively) as well as entrapped intracellular (Fura-Red), probes. Through shRNA-mediated silencing we show that the recently-identified mitochondrial Ca2+ uniporter, MCU, is required for depolarisation-induced mitochondrial Ca2+ increases, and for a sustained increase in cytosolic ATP/ADP ratio. By contrast, silencing of the mitochondrial Na+-Ca2+ exchanger NCLX affected the kinetics of glucose-induced changes in, but not steady state values of, cytosolic ATP/ADP. Exposure to gluco-lipotoxic conditions delayed both mitochondrial Ca2+ uptake and cytosolic ATP/ADP ratio increases without affecting the expression of either gene. Mitochondrial Ca2+ accumulation, mediated by MCU and modulated by NCLX, is thus required for normal glucose sensing by pancreatic beta-cells, and becomes defective in conditions mimicking the diabetic milieu.	[Tarasov, Andrei I.; Semplici, Francesca; Ravier, Magalie A.; Bellomo, Elisa A.; Pullen, Timothy J.; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol, Div Diabet Endocrinol & Metab, Dept Med, London, England; [Ravier, Magalie A.] Univ Montpellier I, Inst Genom Fonct, INSERM U661, CNRS UMR5203, Montpellier, France; [Ravier, Magalie A.] Univ Montpellier 2, Inst Genom Fonct, INSERM U661, CNRS UMR5203, Montpellier, France; [Gilon, Patrick] Catholic Univ Louvain, Fac Med, B-1200 Brussels, Belgium; [Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel; [Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, Padua, Italy	Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite Catholique Louvain; Ben Gurion University; University of Padua	Tarasov, AI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol, Div Diabet Endocrinol & Metab, Dept Med, London, England.	g.rutter@imperial.ac.uk	Ravier, Magalie/K-9911-2019; Pullen, Timothy J/H-2143-2011; Ravier, Magalie A/N-6934-2017; Tarasov, Andrei/I-6210-2012	Ravier, Magalie/0000-0001-6607-6559; Pullen, Timothy J/0000-0002-6853-5701; Ravier, Magalie A/0000-0001-6607-6559; Tarasov, Andrei/0000-0002-8883-176X; Rizzuto, Rosario/0000-0001-7044-5097; Rutter, Guy/0000-0001-6360-0343; Bellomo, Elisa/0000-0003-4823-2209	Wellcome Trust [081958/Z/07/Z]; JDRF; Telethon-Italy; Italian Ministry of Education (PRIN, FIRB); Cariparo Foundation; Royal Society; Italian Association for Cancer Research; European Research Council ("mitoCalcium"); Biotechnology and Biological Sciences Research Council [BB/J015873/1] Funding Source: researchfish; Medical Research Council [G0401641] Funding Source: researchfish; BBSRC [BB/J015873/1] Funding Source: UKRI; MRC [G0401641] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); JDRF(Juvenile Diabetes Research Foundation); Telethon-Italy(Fondazione Telethon); Italian Ministry of Education (PRIN, FIRB); Cariparo Foundation(Fondazione Cariparo); Royal Society(Royal Society of London); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); European Research Council ("mitoCalcium"); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Wellcome Trust (Programme Grant 081958/Z/07/Z to GAR, Value in People (VIP) award to TJP) and the JDRF (Postdoctoral Fellowship to AIT), Telethon-Italy, Italian Association for Cancer Research, the Italian Ministry of Education (PRIN, FIRB), the Cariparo Foundation and the European Research Council ("mitoCalcium") (for RR). PG is Research Director of the Fonds National de la Recherche Scientifique, Brussels. MAR is Charge de Recherches from INSERM, Paris. GAR is a Wellcome Trust Senior Investigator (WT098424AIA) and the holder of a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Ainscow EK, 2001, BIOCHEM J, V353, P175, DOI 10.1042/0264-6021:3530175; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Detimary P, 1998, BIOCHEM J, V333, P269, DOI 10.1042/bj3330269; Eliasson L, 1997, J PHYSIOL-LONDON, V503, P399, DOI 10.1111/j.1469-7793.1997.399bh.x; Eliasson L, 1996, SCIENCE, V271, P813, DOI 10.1126/science.271.5250.813; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Fink C, 1998, BIOPHYS J, V75, P1648, DOI 10.1016/S0006-3495(98)77607-6; Gilon P, 1999, J BIOL CHEM, V274, P20197, DOI 10.1074/jbc.274.29.20197; GILON P, 1992, J BIOL CHEM, V267, P20713; Gopel SO, 1999, J GEN PHYSIOL, V114, P759, DOI 10.1085/jgp.114.6.759; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; HORN R, 1992, METHOD ENZYMOL, V207, P149; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kohnke R, 2007, NUTR NEUROSCI, V10, P273, DOI 10.1080/10284150701745910; Lee B, 2003, DIABETES, V52, P965, DOI 10.2337/diabetes.52.4.965; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Nguyen KT, 2009, P NATL ACAD SCI USA, V106, P2007, DOI 10.1073/pnas.0810934106; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Parton LE, 2006, AM J PHYSIOL-ENDOC M, V291, pE982, DOI 10.1152/ajpendo.00067.2006; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rutter GA, 2004, DIABETOLOGIA, V47, P1861, DOI 10.1007/s00125-004-1541-1; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; RUTTER GA, 1990, INT J BIOCHEM, V22, P1081, DOI 10.1016/0020-711X(90)90105-C; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Tarasov AI, 2008, DIABETES, V57, P1595, DOI 10.2337/db07-1547; Tarasov AI, 2006, DIABETES, V55, P2446, DOI 10.2337/db06-0360; Tarasov AI, 2006, DIABETES, V55, P3075, DOI 10.2337/db06-0637; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914	49	126	130	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e39722	10.1371/journal.pone.0039722	http://dx.doi.org/10.1371/journal.pone.0039722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829870	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300008
J	Wolff, MJ; Leung, JM; Davenport, M; Poles, MA; Cho, I; Loke, P				Wolff, Martin J.; Leung, Jacqueline M.; Davenport, Michael; Poles, Michael A.; Cho, Ilseung; Loke, P'ng			T(H)17, T(H)22 and T-Reg Cells Are Enriched in the Healthy Human Cecum	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; INFLAMMATION; RESISTIN; GENE; APPENDECTOMY; PATHOGENESIS; POLYMORPHISM; MACROPHAGES; HOMEOSTASIS; EXPRESSION	There is increasing evidence that dysregulation of CD4(+) T cell populations leads to intestinal inflammation, but the regional distribution of these populations throughout the intestinal tract in healthy individuals remains unclear. Here, we show that T(H)17, T(H)22 and T-Reg cells are enriched in the healthy human cecum compared to the terminal ileum and sigmoid colon, whereas T(H)1 and T(H)2 cells do not significantly vary by location. Transcriptional profiling analysis of paired pinch biopsies from different regions of the intestine identified significant differences in the metabolic state of the terminal ileum, cecum, and sigmoid colon. An increased proportion of T(H)17 cells was positively associated with expression of resistin (RETN) and negatively associated with expression of trefoil factor 1 (TFF1). These results suggest that CD4(+) T helper cells that are important in maintaining mucosal barrier function may be enriched in the cecum as a result of metabolic differences of the surrounding microenvironment.	[Wolff, Martin J.; Poles, Michael A.; Cho, Ilseung] NYU, Sch Med, Dept Med, Div Gastroenterol, New York, NY 10003 USA; [Wolff, Martin J.; Leung, Jacqueline M.; Davenport, Michael; Loke, P'ng] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY USA; [Poles, Michael A.; Cho, Ilseung] Vet Affairs New York Harbor Healthcare Syst, Dept Med, Div Gastroenterol, New York, NY USA	New York University; New York University	Wolff, MJ (corresponding author), NYU, Sch Med, Dept Med, Div Gastroenterol, New York, NY 10003 USA.	Png.loke@nyumc.org	Loke, Png/X-2278-2019	Wolff, Martin/0000-0003-4391-2395; Leung, Jacqueline/0000-0002-1963-3380; Cho, Ilseung/0000-0002-7308-8707; Poles, Michael/0000-0002-7993-6156	New York University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093811] Funding Source: NIH RePORTER	New York University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by startup funds to Dr. P'ng Loke from the New York University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Bolin TD, 2009, AM J GASTROENTEROL, V104, P2476, DOI 10.1038/ajg.2009.388; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Cosnes J, 2002, GUT, V51, P803, DOI 10.1136/gut.51.6.803; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ehrhardt GRA, 2011, CURR TOP MICROBIOL, V350, P89, DOI 10.1007/82_2010_88; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Gardenbroek TJ, 2011, COLORECTAL DIS; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hartigan-O'Connor DJ, 2011, CURR OPIN HIV AIDS, V6, P221, DOI 10.1097/COH.0b013e32834577b3; Heitman SJ, 2009, CLIN GASTROENTEROL H, V7, P1272, DOI 10.1016/j.cgh.2009.05.032; Honda K, 2011, ANN REV IMMUNOL, V30; Hong PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025042; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Im GY, 2011, CLIN GASTROENTEROL H, V9, P1072, DOI 10.1016/j.cgh.2011.06.006; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Kyo K, 2001, J HUM GENET, V46, P5, DOI 10.1007/s100380170118; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matsushita M., 2007, Inflammopharmacology, V15, P154, DOI 10.1007/s10787-007-1563-7; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Palestrant D, 2004, ULTRASTRUCT PATHOL, V28, P23, DOI 10.1080/01913120490275196; Paski SC, 2007, AM J GASTROENTEROL, V102, P2294, DOI 10.1111/j.1572-0241.2007.01389.x; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; RIO MC, 1991, GASTROENTEROLOGY, V100, P375, DOI 10.1016/0016-5085(91)90205-Y; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Smith HF, 2009, J EVOLUTION BIOL, V22, P1984, DOI 10.1111/j.1420-9101.2009.01809.x; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Soutto M, 2011, J CLIN INVEST, V121, P1753, DOI 10.1172/JCI43922; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Swainson LA, 2010, J IMMUNOL, V184, P3639, DOI 10.4049/jimmunol.0903943; Tang X, 2009, TISSUE ANTIGENS, V74, P314, DOI 10.1111/j.1399-0039.2009.01335.x; Tiaka EK, 2011, CYTOKINE GROWTH F R, V22, P109, DOI 10.1016/j.cytogfr.2011.04.002; Trifari S, 2010, EUR J IMMUNOL, V40, P2369, DOI 10.1002/eji.201040848; Vestergaard EM, 2004, SCAND J CLIN LAB INV, V64, P146, DOI 10.1080/00365510410001176; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; Wolff D, 2010, CARIES RES, V44, P498, DOI 10.1159/000320161; Wolff MJ, 2012, TRENDS PARASITOL, V28, P187, DOI 10.1016/j.pt.2012.02.008; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	53	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41373	10.1371/journal.pone.0041373	http://dx.doi.org/10.1371/journal.pone.0041373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829946	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300085
J	Bill, A; Schmitz, A; Konig, K; Heukamp, LC; Hannam, JS; Famulok, M				Bill, Anke; Schmitz, Anton; Koenig, Katharina; Heukamp, Lukas C.; Hannam, Jeffrey S.; Famulok, Michael			Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; ACQUIRED-RESISTANCE; KINASE INHIBITORS; RNA INTERFERENCE; EGFR MUTATION; INSULIN; ACTIVATION; PATHWAY; ADENOCARCINOMAS; AMPLIFICATION	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), such as gefitinib, have been proven to efficiently inhibit the proliferation of a subset of non small-cell lung cancers (NSCLC). Unfortunately, the majority of NSCLC expressing wild type EGFR is primarily resistant to EGFR-TKI treatment. Here, we show that the proliferation of the gefitinib-resistant NSCLC cell lines H460 and A549 is reduced by the small molecule SecinH3 which indirectly attenuates EGFR activation by inhibition of cytohesins, a class of recently discovered cytoplasmic EGFR activators. SecinH3 and gefitinib showed a synergistic antiproliferative effect, which correlated with a profound inhibition of Akt activation and survivin expression. Treating mice bearing H460 xenografts with SecinH3 showed the antiproliferative and pro-apoptotic effect of SecinH3 in vivo. Our data suggest that targeting the EGFR indirectly by inhibiting its cytoplasmic activators, the cytohesins, has the potential to improve the treatment of primarily EGFR-TKI resistant lung cancers.	[Bill, Anke; Schmitz, Anton; Hannam, Jeffrey S.; Famulok, Michael] Univ Bonn, Chem Biol & Med Chem Unit, Life & Med Sci LIMES Inst, Bonn, Germany; [Koenig, Katharina; Heukamp, Lukas C.] Univ Cologne, Inst Pathol, Cologne, Germany	University of Bonn; University of Cologne	Bill, A (corresponding author), Univ Bonn, Chem Biol & Med Chem Unit, Life & Med Sci LIMES Inst, Bonn, Germany.	m.famulok@uni-bonn.de	Heukamp, Lukas C/A-8338-2013; Heukamp, Lukas/G-9967-2012	Hannam, Jeffrey/0000-0001-9827-3143; Bill, Anke/0000-0003-1244-7574; Heukamp, Lukas/0000-0002-3388-3482	Deutsche Forschungsgemeinschaft; Collaborative Reseach Center 645 [SFB 645]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Reseach Center 645	This work was funded by the Deutsche Forschungsgemeinschaft and the Collaborative Reseach Center 645 (SFB 645). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bi XH, 2008, ANGEW CHEM INT EDIT, V47, P9565, DOI 10.1002/anie.200803962; Bill A, 2011, J AM CHEM SOC, V133, P8372, DOI 10.1021/ja202513s; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Bodzin AS, 2012, J CELL PHYSIOL, V227, P2947, DOI 10.1002/jcp.23041; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Chakravarti A, 2002, CANCER RES, V62, P200; Chen G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-28; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fidler MJ, 2012, THER ADV MED ONCOL, V4, P51, DOI 10.1177/1758834011427576; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; GRECO WR, 1995, PHARMACOL REV, V47, P331; Habben K, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7584; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Li SD, 2008, MOL THER, V16, P163, DOI 10.1038/sj.mt.6300323; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Stumpfe D, 2010, ACS CHEM BIOL, V5, P839, DOI 10.1021/cb100171c; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Yamanaka S, 2008, PATHOBIOLOGY, V75, P2, DOI 10.1159/000113789; Zhang M, 2004, ACTA PHARMACOL SIN, V25, P61; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	36	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41179	10.1371/journal.pone.0041179	http://dx.doi.org/10.1371/journal.pone.0041179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815959	Green Submitted, Green Published, gold			2022-12-25	WOS:000306548900089
J	Patel, AS; Lin, L; Geyer, A; Haspel, JA; An, CH; Cao, JF; Rosas, IO; Morse, D				Patel, Avignat S.; Lin, Ling; Geyer, Alexander; Haspel, Jeffrey A.; An, Chang Hyeok; Cao, Jiaofei; Rosas, Ivan O.; Morse, Danielle			Autophagy in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GROWTH-FACTOR-BETA; OXIDATIVE STRESS; EPITHELIAL-CELLS; GENE-EXPRESSION; RAPAMYCIN; HYPOXIA; DISEASE; INFLAMMATION; TARGET	Background: Autophagy is a basic cellular homeostatic process important to cell fate decisions under conditions of stress. Dysregulation of autophagy impacts numerous human diseases including cancer and chronic obstructive lung disease. This study investigates the role of autophagy in idiopathic pulmonary fibrosis. Methods: Human lung tissues from patients with IPF were analyzed for autophagy markers and modulating proteins using western blotting, confocal microscopy and transmission electron microscopy. To study the effects of TGF-beta(1) on autophagy, human lung fibroblasts were monitored by fluorescence microscopy and western blotting. In vivo experiments were done using the bleomycin-induced fibrosis mouse model. Results: Lung tissues from IPF patients demonstrate evidence of decreased autophagic activity as assessed by LC3, p62 protein expression and immunofluorescence, and numbers of autophagosomes. TGF-beta(1) inhibits autophagy in fibroblasts in vitro at least in part via activation of mTORC1; expression of TIGAR is also increased in response to TGF-beta(1). In the bleomycin model of pulmonary fibrosis, rapamycin treatment is antifibrotic, and rapamycin also decreases expression of a-smooth muscle actin and fibronectin by fibroblasts in vitro. Inhibition of key regulators of autophagy, LC3 and beclin-1, leads to the opposite effect on fibroblast expression of a-smooth muscle actin and fibronectin. Conclusion: Autophagy is not induced in pulmonary fibrosis despite activation of pathways known to promote autophagy. Impairment of autophagy by TGF-beta(1) may represent a mechanism for the promotion of fibrogenesis in IPF.	[Patel, Avignat S.; Haspel, Jeffrey A.; An, Chang Hyeok; Cao, Jiaofei; Rosas, Ivan O.; Morse, Danielle] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Patel, Avignat S.; Haspel, Jeffrey A.; An, Chang Hyeok; Cao, Jiaofei; Rosas, Ivan O.; Morse, Danielle] Harvard Univ, Sch Med, Boston, MA USA; [Lin, Ling] Penn State Univ, Dept Med, Hershey, PA USA; [Geyer, Alexander] Mt Sinai Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY USA; [Rosas, Ivan O.] Lovelace Resp Res Inst, Albuquerque, NM USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Icahn School of Medicine at Mount Sinai; Lovelace Respiratory Research Institute	Patel, AS (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	edmorse@partners.org	Haspel, J./K-3563-2019	An, Chang Hyeok/0000-0001-9145-1322; Lin, Ling/0000-0001-5527-0575	NIH [5T32HL007633-25, K23 HL087030, R01HL087122-01]; National Institutes of Health (NIH) [5T32HL007633-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL087030, R01HL087122, T32HL007633] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A.S.P. is supported by NIH Grant 5T32HL007633-25. A.G. was supported by National Institutes of Health (NIH) Grant 5T32HL007633-24. I.O.R. is supported by NIH Grant K23 HL087030. D.M. is supported by NIH Grant R01HL087122-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Chang YP, 2010, J BIOL CHEM, V285, P28715, DOI 10.1074/jbc.M110.133355; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Fu LW, 2009, EUR J CELL BIOL, V88, P215, DOI 10.1016/j.ejcb.2008.11.003; Goc A, 2011, J CELL PHYSIOL, V226, P3004, DOI 10.1002/jcp.22648; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Kliment CR, 2010, FREE RADICAL BIO MED, V49, P707, DOI 10.1016/j.freeradbiomed.2010.04.036; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Korfhagen TR, 2009, AM J RESP CELL MOL, V41, P562, DOI 10.1165/rcmb.2008-0377OC; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Lin L, 2008, AM J PATHOL, V173, P337, DOI 10.2353/ajpath.2008.070915; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Poulalhon N, 2006, J BIOL CHEM, V281, P33045, DOI 10.1074/jbc.M606366200; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Simler NR, 2002, EUR RESPIR J, V19, P1124, DOI 10.1183/09031936.02.00281602; Tulek B, 2011, CLIN INVEST MED, V34, pE341; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshizaki A, 2010, ARTHRITIS RHEUM-US, V62, P2476, DOI 10.1002/art.27498; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HY, 1996, AM J PATHOL, V148, P527; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009	53	253	275	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41394	10.1371/journal.pone.0041394	http://dx.doi.org/10.1371/journal.pone.0041394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815997	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900115
J	Williams, AS; Kasahara, DI; Verbout, NG; Fedulov, AV; Zhu, M; Si, HQ; Wurmbrand, AP; Hug, C; Ranscht, B; Shore, SA				Williams, Alison S.; Kasahara, David I.; Verbout, Norah G.; Fedulov, Alexey V.; Zhu, Ming; Si, Huiqing; Wurmbrand, Allison P.; Hug, Christopher; Ranscht, Barbara; Shore, Stephanie A.			Role of the Adiponectin Binding Protein, T-Cadherin (Cdh13), in Allergic Airways Responses in Mice	PLOS ONE			English	Article							BODY-MASS INDEX; TARGETED DISRUPTION; DEFICIENT MICE; IN-VITRO; ASTHMA; INFLAMMATION; ASSOCIATION; OBESITY; HYPERRESPONSIVENESS; RISK	Adiponectin is an adipose derived hormone that declines in obesity. We have previously shown that exogenous administration of adiponectin reduces allergic airways responses in mice. T-cadherin (T-cad; Cdh13) is a binding protein for the high molecular weight isoforms of adiponectin. To determine whether the beneficial effects of adiponectin on allergic airways responses require T-cad, we sensitized wildtype (WT), T-cadherin deficient (T-cad(-/-)) and adiponectin and T-cad bideficient mice to ovalbumin (OVA) and challenged the mice with aerosolized OVA or PBS. Compared to WT, T-cad(-/-) mice were protected against OVA-induced airway hyperresponsiveness, increases in BAL inflammatory cells, and induction of IL-13, IL-17, and eotaxin expression. Histological analysis of the lungs of OVA-challenged T-cad(-/-) versus WT mice indicated reduced inflammation around the airways, and reduced mucous cell hyperplasia. Combined adiponectin and T-cad deficiency reversed the effects of T-cad deficiency alone, indicating that the observed effects of T-cad deficiency require adiponectin. Compared to WT, serum adiponectin was markedly increased in T-cad(-/-) mice, likely because adiponectin that is normally sequestered by endothelial T-cad remains free in the circulation. In conclusion, T-cad does not mediate the protective effects of adiponectin. Instead, mice lacking T-cad have reduced allergic airways disease, likely because elevated serum adiponectin levels act on other adiponectin signaling pathways.	[Williams, Alison S.; Kasahara, David I.; Verbout, Norah G.; Zhu, Ming; Si, Huiqing; Wurmbrand, Allison P.; Shore, Stephanie A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA; [Ranscht, Barbara] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Hug, Christopher] Childrens Hosp, Boston, MA 02115 USA; [Fedulov, Alexey V.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Williams, AS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA.	sshore@hsph.harvard.edu		Verbout, Norah/0000-0002-8170-9331	National Heart, Lung, and Blood Institute [HL-084044, HL102680]; National Institute of Environmental Health Sciences [ES-013307, ES-00002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084044, R21HL102680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R01ES013307] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Heart, Lung, and Blood Institute grant HL-084044 and HL102680, National Institute of Environmental Health Sciences grants ES-013307 and ES-00002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Arif AA, 2003, EUR RESPIR J, V21, P827, DOI 10.1183/09031936.03.00054103a; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Collington SJ, 2010, J IMMUNOL, V184, P6114, DOI 10.4049/jimmunol.0904177; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Fedulov AV, 2011, AM J RESP CELL MOL, V44, P285, DOI 10.1165/rcmb.2009-0400OC; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Folco EJ, 2009, J BIOL CHEM     1224; Gove ME, 2009, CYTOKINE, V47, P119, DOI 10.1016/j.cyto.2009.05.010; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ionescu LI, 2011, AM J RESP CELL MOL B; Ivanov D, 2004, CARDIOVASC RES, V64, P132, DOI 10.1016/j.cardiores.2004.06.010; Ivanov D, 2004, EXP CELL RES, V293, P207, DOI 10.1016/j.yexcr.2003.09.030; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Johnston RA, 2010, J APPL PHYSL; Joshi MB, 2005, FASEB J; Kasahara DI, 2012, J IMMUNOL, V188, P4558, DOI 10.4049/jimmunol.1102363; Kim S, 2003, ANN EPIDEMIOL, V13, P666, DOI 10.1016/S1047-2797(03)00054-1; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Litonjua AA, 2002, THORAX, V57, P581, DOI 10.1136/thorax.57.7.581; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Maillet I, 2011, AM J RESP CELL MOL, V45, P731, DOI 10.1165/rcmb.2010-0512OC; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Matsuzawa Y, 2005, ATHEROSCLEROSIS SUPP, V6, P7, DOI 10.1016/j.atherosclerosissup.2005.02.003; Medoff BD, 2009, AM J RESP CELL MOL B; Miller M, 2010, AM J PHYSIOL-LUNG C, V299, pL834, DOI 10.1152/ajplung.00326.2009; Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Pillow JJ, 2001, J APPL PHYSIOL, V91, P2730, DOI 10.1152/jappl.2001.91.6.2730; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; SALAZAR E, 1964, J APPL PHYSIOL, V19, P97, DOI 10.1152/jappl.1964.19.1.97; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Sood A, 2008, THORAX, V63, P877, DOI 10.1136/thx.2007.090803; Summer R, 2008, AM J PHYSIOL-LUNG C, V294, pL1035, DOI 10.1152/ajplung.00397.2007; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Takeuchi T, 2001, VIRCHOWS ARCH, V438, P370, DOI 10.1007/s004280000385; Tian L, 2011, ATHEROSCLEROSIS; Tian L, 2009, ATHEROSCLEROSIS, V202, P152, DOI 10.1016/j.atherosclerosis.2008.04.011; Tomioka S, 2002, J APPL PHYSIOL, V93, P263, DOI 10.1152/japplphysiol.01129.2001; Tsang JYS, 2011, INT IMMUNOP IN PRESS; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Wang Y, 2005, J BIOL CHEM     1224; Wilk S, 2011, EUR J IMMUNOL, V41, P2323, DOI 10.1002/eji.201041349; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhu M, 2009, AM J RESP CELL MOL B; Zhu M, 2011, EUROPEAN RESP J	61	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41088	10.1371/journal.pone.0041088	http://dx.doi.org/10.1371/journal.pone.0041088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815927	Green Published, gold, Green Submitted			2022-12-25	WOS:000306507000064
J	Gallardo, CM; Gunapala, KM; King, OD; Steele, AD				Gallardo, Christian M.; Gunapala, Keith M.; King, Oliver D.; Steele, Andrew D.			Daily Scheduled High Fat Meals Moderately Entrain Behavioral Anticipatory Activity, Body Temperature, and Hypothalamic c-Fos Activation	PLOS ONE			English	Article							AMYLOID-PRECURSOR PROTEIN; CIRCADIAN-RHYTHMS; PALATABLE MEAL; FEEDING SCHEDULES; LIMBIC FOREBRAIN; PERIOD2 PROTEIN; FOOD; RATS; EXPRESSION; MICE	When fed in restricted amounts, rodents show robust activity in the hours preceding expected meal delivery. This process, termed food anticipatory activity (FAA), is independent of the light-entrained clock, the suprachiasmatic nucleus, yet beyond this basic observation there is little agreement on the neuronal underpinnings of FAA. One complication in studying FAA using a calorie restriction model is that much of the brain is activated in response to this strong hunger signal. Thus, daily timed access to palatable meals in the presence of continuous access to standard chow has been employed as a model to study FAA in rats. In order to exploit the extensive genetic resources available in the murine system we extended this model to mice, which will anticipate rodent high fat diet but not chocolate or other sweet daily meals (Hsu, Patton, Mistlberger, and Steele; 2010, PLoS ONE e12903). In this study we test additional fatty meals, including peanut butter and cheese, both of which induced modest FAA. Measurement of core body temperature revealed a moderate preprandial increase in temperature in mice fed high fat diet but entrainment due to handling complicated interpretation of these results. Finally, we examined activation patterns of neurons by immunostaining for the immediate early gene c-Fos and observed a modest amount of entrainment of gene expression in the hypothalamus of mice fed a daily fatty palatable meal.	[Gallardo, Christian M.; Gunapala, Keith M.; Steele, Andrew D.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [King, Oliver D.] Boston Biomed Res Inst, Watertown, MA USA	California Institute of Technology; Boston Biomedical Research Institute	Gallardo, CM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	steelea@caltech.edu		Gallardo, Christian/0000-0001-5702-0852	Klarman Family Foundation	Klarman Family Foundation	Funding was provided by the Broad Fellows Program in Brain Circuitry at Caltech, an Ellison Medical Foundation New Scholar Award, and a Grants Program in Eating Disorders Research from the Klarman Family Foundation to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Angeles-Castellanos M, 2005, AM J PHYSIOL-REG I, V288, pR678, DOI 10.1152/ajpregu.00590.2004; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; BOLLES RC, 1974, BEHAV BIOL, V11, P365, DOI 10.1016/S0091-6773(74)90633-6; BOLLES RC, 1969, PHYSIOL BEHAV, V4, P87, DOI 10.1016/0031-9384(69)90018-3; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Challet E, 2010, CELL TISSUE RES, V341, P1, DOI 10.1007/s00441-010-1001-9; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Minana-Solis MD, 2011, NUTR NEUROSCI, V14, P72, DOI 10.1179/1476830511Y.0000000003; EIKELBOOM R, 1986, PHYSIOL BEHAV, V37, P649, DOI 10.1016/0031-9384(86)90299-4; Escobar C, 1998, AM J PHYSIOL-REG I, V274, pR1309, DOI 10.1152/ajpregu.1998.274.5.R1309; Escobar C, 2011, PHYSIOL BEHAV, V104, P555, DOI 10.1016/j.physbeh.2011.05.001; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Gunapala KM, 2010, PRION, V4, P302, DOI 10.4161/pri.4.4.13721; Hsu CT, 2010, PLOS ONE IN PRESS; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; Kalueff AV, 2005, BEHAV BRAIN RES, V160, P1, DOI 10.1016/j.bbr.2004.11.010; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; Lamont EW, 2007, NEUROSCIENCE, V144, P402, DOI 10.1016/j.neuroscience.2006.09.027; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; Merkestein M, 2012, OBESITY, V20, P963, DOI 10.1038/oby.2011.389; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; MISTLBERGER RE, 1992, BEHAV NEUROSCI, V106, P192, DOI 10.1037/0735-7044.106.1.192; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mohawk JA, 2011, TRENDS NEUROSCI; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Steele AD, 2008, P NATL ACAD SCI USA, V105, P13626, DOI 10.1073/pnas.0806319105; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Wolfer DP, 1997, BRAIN RES, V771, P1, DOI 10.1016/S0006-8993(97)00673-2	43	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41161	10.1371/journal.pone.0041161	http://dx.doi.org/10.1371/journal.pone.0041161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815954	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000306466100124
J	Shen, CJ; Jia, YH; Tian, RR; Ding, M; Zhang, CY; Wang, JH				Shen, Chan-Juan; Jia, Yan-Hui; Tian, Ren-Rong; Ding, Ming; Zhang, Chiyu; Wang, Jian-Hua			Translation of Pur-alpha is targeted by cellular miRNAs to modulate the differentiation-dependent susceptibility of monocytes to HIV-1 infection	FASEB JOURNAL			English	Article						host factor; microRNA	VIRUS TYPE-1 REPLICATION; BLOOD MONOCYTES; LATENT HIV-1; PROTEIN; RESTRICTION; TAT; SAMHD1; CELLS; ASSOCIATION; MACROPHAGES	The postentry restriction of HIV-1 replication in monocytes can be relieved when they differentiate to dendritic cells (DCs) or macrophages. Multiple mechanisms have been proposed to interpret the differentiation-dependent susceptibility of monocytes to HIV-1 infection, and the absence of host-cell-encoded essential factors for HIV-1 completing the life cycle may provide an explanation. We have analyzed the gene expression profile in monocytes by mRNA microarray and compared it with that of differentiated DCs. We demonstrated that purine-rich element binding protein alpha (Pur-alpha), a host-cell-encoded ubiquitous, sequence-specific DNA-and RNA-binding protein, showed inadequate expression in monocytes, and the translation of Pur-alpha mRNA was repressed by cell-expressed microRNA (miRNA). These Pur-alpha-targeted miRNAs modulated the differentiation-dependent susceptibility of monocytes/DCs to HIV-1 infection, because rescue of Pur-alpha expression by transfection of miRNA inhibitors relieved the restriction of HIV-1 infection in monocytes, and ectopic input of miRNA mimics significantly reduced HIV-1 infection of monocyte-derived DCs (MDDCs). Collectively, our data emphasized that inadequate host factors contribute to HIV-1 restriction in monocytes, and cellular miRNAs modulate differentiation-dependent susceptibility of host cells to HIV-1 infection. Elaboration of HIV-1 restriction in host cells facilitates our understanding of viral pathogenesis and the search for a new antiviral strategy.-Shen, C.-J., Jia, Y.-H., Tian, R.-R., Ding, M., Zhang, C., Wang, J.-H. Translation of Pur-alpha is targeted by cellular miRNAs to modulate the differentiation-dependent susceptibility of monocytes to HIV-1 infection. FASEB J. 26, 4755-4764 (2012). www.fasebj.org	[Shen, Chan-Juan; Jia, Yan-Hui; Tian, Ren-Rong; Zhang, Chiyu; Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Jia, Yan-Hui; Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Peoples R China; [Ding, Ming] Zhejiang Sci & Technol Univ, Lab Prote & Mol Enzymol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Jiangsu University; Zhejiang Sci-Tech University	Wang, JH (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai Inst Biol Sci, Hefei Rd 411, Shanghai 200025, Peoples R China.	jh_wang@sibs.ac.cn	DING, MING/E-6964-2015	DING, MING/0000-0002-9135-9275	100 Talent Program of the CAS [KSCX2-KW-BR-1]; National Basic Research Program of China (973 Program) [2012CB519004]; Knowledge Innovation Program of the CAS [KSCX2-YW-R210, KSCX2-EW-Q-2]; Natural Science Foundation of Shanghai [10ZR1435200]; Natural Science Foundation of China [81171567, 31100631]; 49th National Science Foundation for Postdoctoral Scientists of China [20110490076]; Sanofi-Aventis-SIBS Scholarship Program	100 Talent Program of the CAS; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Program of the CAS(Knowledge Innovation Program of the Chinese Academy of Sciences); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 49th National Science Foundation for Postdoctoral Scientists of China; Sanofi-Aventis-SIBS Scholarship Program	The authors thank Dr. Li Wu (The Ohio State University, Columbus, OH, USA), Dr. Vineet Kewal Ramani (National Cancer Institute, U. S. National Institutes of Health, Bethesda, MD, USA), and Dr. Ke Lan, Dr. Xian-Zhi Lin, Dr. De-Guang Liang, and Dr. Paul Zhou (Institute Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China) for the gifts of plasmids or cell lines. This work was supported by grants to J. H. W from the 100 Talent Program of the CAS (KSCX2-KW-BR-1), the National Basic Research Program of China (973 Program; 2012CB519004), the Knowledge Innovation Program of the CAS (KSCX2-YW-R210, KSCX2-EW-Q-2), the Natural Science Foundation of Shanghai (10ZR1435200), the Natural Science Foundation of China (81171567), and the Shanghai Rising-Star Program (A type; 11QA1407700). The work was also sponsored by grants to C. J. S. from the Natural Science Foundation of China (31100631) and the 49th National Science Foundation for Postdoctoral Scientists of China (20110490076). J. H. W. gratefully acknowledges the support of the Sanofi-Aventis-SIBS Scholarship Program.	Arfi V, 2008, J VIROL, V82, P6557, DOI 10.1128/JVI.02321-07; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Collini P, 2010, CURR MOL MED, V10, P727, DOI 10.2174/156652410793384141; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Daniel DC, 2001, J GEN VIROL, V82, P1543, DOI 10.1099/0022-1317-82-7-1543; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Gallia GL, 1999, P NATL ACAD SCI USA, V96, P11572, DOI 10.1073/pnas.96.20.11572; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Kok KH, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-78; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krachmarov CP, 1996, P NATL ACAD SCI USA, V93, P14112, DOI 10.1073/pnas.93.24.14112; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32; Leavy O, 2011, NAT REV IMMUNOL, V11, DOI 10.1038/nri3018; Lin XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016224; MCELRATH MJ, 1991, J CLIN INVEST, V87, P27, DOI 10.1172/JCI114981; MIKOVITS JA, 1992, J CLIN INVEST, V90, P1486, DOI 10.1172/JCI116016; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Neil S, 2001, J VIROL, V75, P5448, DOI 10.1128/JVI.75.12.5448-5456.2001; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Sonza S, 2001, AIDS, V15, P17, DOI 10.1097/00002030-200101050-00005; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; VALENTIN A, 1991, J ACQ IMMUN DEF SYND, V4, P751; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wortman MJ, 2000, J CELL BIOCHEM, V77, P65, DOI 10.1002/(SICI)1097-4644(20000401)77:1<65::AID-JCB7>3.0.CO;2-U; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhu T, 2002, J ANTIMICROB CHEMOTH, V50, P309, DOI 10.1093/jac/dkf143; Zhu TF, 2000, J LEUKOCYTE BIOL, V68, P338; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	43	45	48	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4755	4764		10.1096/fj.12-209023	http://dx.doi.org/10.1096/fj.12-209023			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22835829				2022-12-25	WOS:000310574200035
J	Breshears, LM; Schlievert, PM; Peterson, ML				Breshears, Laura M.; Schlievert, Patrick M.; Peterson, Marnie L.			A Disintegrin and Metalloproteinase 17 (ADAM17) and Epidermal Growth Factor Receptor (EGFR) Signaling Drive the Epithelial Response to Staphylococcus aureus Toxic Shock Syndrome Toxin-1 (TSST-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; NECROSIS-FACTOR-ALPHA; CELLS; ENTEROTOXINS; INFLAMMATION; PENETRATION; ACTIVATION; EXPRESSION; SYNDECANS; CLEAVAGE	Staphylococcal superantigens (SAgs), such as toxic shock syndrome toxin-1 (TSST-1), are the main cause of toxic shock syndrome (TSS). SAgs deregulate the host immune system after penetrating epithelial barriers such as the vaginal mucosa. In response to TSST-1, human vaginal epithelial cells (HVECs) produce cytokines and undergo morphological changes. The epithelial signaling mechanisms employed by SAgs remain largely unknown and are the focus of the work presented here. Analysis of published microarray data identified a network of genes up-regulated by HVECs in response to TSST-1 that includes the sheddase, a disintegrin and metalloproteinase 17 (ADAM17). Investigation revealed that the ADAM17 proteolytic targets, amphiregulin (AREG), transforming growth factor alpha (TGF alpha), syndecan-1 (SDC1), and tumor necrosis factor receptor 1 (TNFR1), are shed from HVECs in response to TSST-1. TAPI-1 (an ADAM inhibitor) completely abrogates all observed shedding and the production of the cytokine interleukin-8 (IL-8). Knock-down studies show that ADAM17, but not the closely related ADAM10, is required for AREG, TGF alpha, and TNFR1 shedding. Both ADAM10 and ADAM17 contribute to SDC1 shedding and IL-8 production by HVECs in response to TSST-1. EGFR signaling is critical for up-regulation of IL-8 at the transcriptional level in response to TSST-1 and is also necessary for AREG, TGF alpha, and TNFR1 shedding. A model is proposed describing the interactions of TSST-1, ADAMs, and the EGFR that lead to establishment of a proinflammatory positive feedback loop in epithelial cells and demonstrate a role for SAgs in the initial stages of disease.	[Peterson, Marnie L.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, McGuire Translat Res Facil, Minneapolis, MN 55455 USA; [Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Peterson, ML (corresponding author), Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, McGuire Translat Res Facil, Rm 4-212, Minneapolis, MN 55455 USA.	peter377@umn.edu		Breshears, Laura/0000-0002-0997-1140; Schlievert, Patrick/0000-0001-8314-9369	National Institutes of Health through the NIAID [R01AI073366-03, R01AI074283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073366, R01AI074283] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI073366-03 and R01AI074283 through the NIAID.	Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Aubert V, 2000, INFECT IMMUN, V68, P120, DOI 10.1128/IAI.68.1.120-124.2000; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Brosnahan AJ, 2008, BIOCHEMISTRY-US, V47, P12995, DOI 10.1021/bi801468w; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; Damm M, 2006, OTOLARYNG HEAD NECK, V134, P245, DOI 10.1016/j.otohns.2005.11.016; Davis CC, 2003, AM J OBSTET GYNECOL, V189, P1785, DOI 10.1016/S0002-9378(03)00873-1; Deghmane AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000405; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gotte Martin, 2003, ScientificWorldJournal, V3, P1327; Hayashida A, 2011, J BIOL CHEM, V286, P3288, DOI 10.1074/jbc.M110.185165; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; KUSHNARYOV VM, 1984, J INFECT DIS, V150, P535, DOI 10.1093/infdis/150.4.535; KUSHNARYOV VM, 1984, INFECT IMMUN, V45, P566, DOI 10.1128/IAI.45.3.566-571.1984; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Murray DL, 1996, INFECT IMMUN, V64, P371, DOI 10.1128/IAI.64.1.371-374.1996; O'Brien GJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-115; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Schaefers MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032813; Schlievert PM, 2000, INFECT IMMUN, V68, P3630, DOI 10.1128/IAI.68.6.3630-3634.2000; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Shupp JW, 2002, INFECT IMMUN, V70, P2178, DOI 10.1128/IAI.70.4.2178-2186.2002; Tanida S, 2004, GASTROENTEROLOGY, V127, P559, DOI 10.1053/j.gastro.2004.05.017; Uchiyama K, 2009, EUR J PHARM SCI, V38, P504, DOI 10.1016/j.ejps.2009.09.016; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107	44	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32578	32587		10.1074/jbc.M112.352534	http://dx.doi.org/10.1074/jbc.M112.352534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22833676	Green Published, hybrid			2022-12-25	WOS:000309168300027
J	Redeker, V; Pemberton, S; Bienvenut, W; Bousset, L; Melki, R				Redeker, Virginie; Pemberton, Samantha; Bienvenut, Willy; Bousset, Luc; Melki, Ronald			Identification of Protein Interfaces between alpha-Synuclein, the Principal Component of Lewy Bodies in Parkinson Disease, and the Molecular Chaperones Human Hsc70 and the Yeast Ssa1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CROSS-LINKING; LEVODOPA THERAPY; FIBRIL FORMATION; BINDING; DEATH; HSP70; TRANSMISSION; PEPTIDES; TOXICITY	Fibrillar alpha-synuclein (alpha-Syn) is the principal component of Lewy bodies, which are evident in individuals affected by Parkinson disease (PD). This neuropathologic form of alpha-Syn plays a central role in PD progression as it has been shown to propagate between neurons. Tools that interfere with alpha-Syn assembly or change the physicochemical properties of the fibrils have potential therapeutic properties as they may be sufficient to interfere with and/or halt cell-to-cell transmission and the systematic spread of alpha-Syn assemblies within the central nervous system. Vertebrate molecular chaperones from the constitutive/heat-inducible heat shock protein 70 (Hsc/p70) family have been shown to hinder the assembly of soluble alpha-Syn into fibrils and to bind to the fibrils and very significantly reduce their toxicity. To understand how Hsc70 family members sequester soluble alpha-Syn, we set up experiments to identify the molecular chaperone-alpha-Syn surface interfaces. We cross-linked human Hsc70 and its yeast homologue Ssa1p and alpha-Syn using a chemical cross-linker and mapped the Hsc70- and Ssa1p-alpha-Syn interface. We show that the client binding domain of Hsc70 and Ssa1p binds two regions within alpha-Syn similar to a tweezer, with the first spanning residues 10-45 and the second spanning residues 97-102. Our findings define what is necessary and sufficient for engineering Hsc70-and Ssa1p-derived polypeptide with minichaperone properties with a potential as therapeutic agents in Parkinson disease through their ability to affect alpha-Syn assembly and/or toxicity.	[Redeker, Virginie; Pemberton, Samantha; Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Bienvenut, Willy] CNRS, Ctr Rech Gif, FRC3115, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ave Terrasse, F-91198 Gif Sur Yvette, France.	melki@lebs.cnrs-gif.fr	Redeker, Virginie/L-8929-2018	Redeker, Virginie/0000-0003-2694-8388; bousset, luc/0000-0002-0433-4337; Bienvenut, Willy/0000-0003-4192-3920	French Ministry of Education, Research, and Technology; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale; Era-Net Neuron; Agence Nationale pour la Recherche [ANR-08-NEUR-001-01]; Fondation de France (Parkinson); Human Frontier Science Program	French Ministry of Education, Research, and Technology; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Era-Net Neuron; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de France (Parkinson); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the French Ministry of Education, Research, and Technology; the Centre National de la Recherche Scientifique (CNRS) and the Institut National de la Sante et de la Recherche Medicale, the Era-Net Neuron, the Agence Nationale pour la Recherche (ANR-08-NEUR-001-01), the Fondation de France (Parkinson), and the Human Frontier Science Program.	Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; COTZIAS GC, 1969, J AMER MED ASSOC, V207, P1353, DOI 10.1001/jama.1969.03150200119022; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linstrom F D, 1977, Ann Intern Med, V86, P298; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McClellan AJ, 2000, GENETICS, V156, P501; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; Nasstrom T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027230; Pemberton Samantha, 2012, Commun Integr Biol, V5, P94; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Redeker V, 2010, FEBS J, V277, P5112, DOI 10.1111/j.1742-4658.2010.07915.x; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Ross CA, 2007, PARKINSONISM RELAT D, V13, pS309, DOI 10.1016/S1353-8020(08)70022-1; Seebacher J, 2006, J PROTEOME RES, V5, P2270, DOI 10.1021/pr060154z; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TERRITO MC, 1973, JAMA-J AM MED ASSOC, V226, P1347, DOI 10.1001/jama.226.11.1347; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; WANAMAKER WM, 1976, JAMA-J AM MED ASSOC, V235, P2217, DOI 10.1001/jama.235.20.2217; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	40	37	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32630	32639		10.1074/jbc.M112.387530	http://dx.doi.org/10.1074/jbc.M112.387530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843682	Green Published, hybrid			2022-12-25	WOS:000309168300031
J	Gault, CR; Eblen, ST; Neumann, CA; Hannun, YA; Obeid, LM				Gault, Christopher R.; Eblen, Scott T.; Neumann, Carola A.; Hannun, Yusuf A.; Obeid, Lina M.			Oncogenic K-Ras Regulates Bioactive Sphingolipids in a Sphingosine Kinase 1-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; BREAST-CANCER CELLS; QUANTITATIVE-ANALYSIS; PLASMA-MEMBRANE; POOR SURVIVAL; SPHINGOSINE-1-PHOSPHATE; EXPRESSION; GROWTH; PHOSPHORYLATION; TRANSLOCATION	Sphingosine kinase 1 (SK1) is an important enzyme involved in the production of the bioactive lipid sphingosine 1-phosphate (S1P). SK1 is overexpressed in many forms of cancer, however, the contribution of SK1 to cancer progression is still unclear. One of the best characterized mutations found in several forms of human cancer is an activating point mutation in the Ras oncogene, which disrupts its GTPase activity and leads to stimulation of the MEK/ERK pathway. Because SK1 activity and subcellular localization have been shown to be regulated by ERK, we wished to investigate the effect of oncogenic Ras, a potent activator of the Raf/MEK/ERK pathway, on the activity of SK1 and sphingolipid metabolism. Using HEK293T cells transiently transfected with the K-RasG12V oncogene and both wild type and Sphk1(-/-) mouse embryonic fibroblasts stably infected with retroviral K-RasG12V, we found that K-RasG12V increases the production of S1P and decreases the production of ceramide in a SK1-dependent manner. In addition, we found that expression of the K-RasG12V oncogene leads to plasma membrane localization of SK1 and a reduction in cytosolic levels of SK1. This effect is likely mediated by the Raf/MEK/ERK pathway as constitutively active B-Raf or MEK1 are able to activate SK1, but constitutively active Akt1 is not. We believe this research has important implications for how sphingolipids may be contributing to oncogenic transformation and provide some of the first evidence for oncogenes inducing specific changes in sphingolipid metabolism through SK1 regulation.	[Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Gault, Christopher R.; Hannun, Yusuf A.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Eblen, Scott T.; Neumann, Carola A.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Obeid, LM (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu		Neumann, Carola/0000-0003-2801-9531; obeid, lina/0000-0002-0734-0847	National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR018823]; NCI [IPO1CA097132, P30 CA 138313, R01CA131-200, P01 CA0971321]; National Institutes of Health NCRR SC COBRE [P20 RR017677]; National Institutes of Health [NHLBI NRSA 5F30 HL093991, NIGMS R01 GM062887, NCI P01CA097132]; NIEHS [K22 ES012985-01]; MERIT Award from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Medical Center, Charleston, SC [1I0 BX000156 01A1]; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA131200, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL093991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health NCRR SC COBRE; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MERIT Award from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Medical Center, Charleston, SC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Marianne Dubard-Gault for help in generating the SK1 mutants and Kathy Wiita-Fisk for administrative assistance in preparing this manuscript. Measurement of sphingolipids was conducted by the Lipidomics Core of Medical University of South Carolina (MUSC) in a facility constructed with support from National Institutes of Health Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources. LC-MS/MS analysis of sphingolipids was performed by Lipidomics Shared Resource, MUSC(25) supported by NCI Grants IPO1CA097132 and P30 CA 138313 and National Institutes of Health NCRR SC COBRE Grant P20 RR017677. Laboratory space in the CRI building of MUSC was supported by National Institutes of Health Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources.; This work was supported, in whole or in part, by National Institutes of Health Grants NHLBI NRSA 5F30 HL093991 (to C. R. G.), NIGMS R01 GM062887 and NCI P01CA097132 (to Y. A. H.), R01CA131-200 from the NCI (to S. E.), K22 ES012985-01 from the NIEHS (to C. N.), P01 CA0971321 from the NCI (to L. M. O.), and by MERIT Award 1I0 BX000156 01A1) (to L. M. O.) from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Medical Center, Charleston, SC.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Henis YI, 2009, MOL MEMBR BIOL, V26, P80, DOI 10.1080/09687680802649582; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; KIM MY, 1991, J BIOL CHEM, V266, P484; Knapp P, 2010, PROSTAG OTH LIPID M, V92, P62, DOI 10.1016/j.prostaglandins.2010.03.002; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Sobue S, 2008, ONCOGENE, V27, P6023, DOI 10.1038/onc.2008.198; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; SPIEGEL S, 1994, BREAST CANCER RES TR, V31, P337, DOI 10.1007/BF00666166; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4	43	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31794	31803		10.1074/jbc.M112.385765	http://dx.doi.org/10.1074/jbc.M112.385765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833671	hybrid, Green Published			2022-12-25	WOS:000309059400020
J	Lehtinen, J; Raki, M; Bergstrom, KA; Uutela, P; Lehtinen, K; Hiltunen, A; Pikkarainen, J; Liang, HM; Pitkanen, S; Maatta, AM; Ketola, RA; Yliperttula, M; Wirth, T; Urtti, A				Lehtinen, Julia; Raki, Mari; Bergstrom, Kim A.; Uutela, Paivi; Lehtinen, Katariina; Hiltunen, Annukka; Pikkarainen, Jere; Liang, Huamin; Pitkanen, Sari; Maatta, Ann-Marie; Ketola, Raimo A.; Yliperttula, Marjo; Wirth, Thomas; Urtti, Arto			Pre-Targeting and Direct Immunotargeting of Liposomal Drug Carriers to Ovarian Carcinoma	PLOS ONE			English	Article							AVIDIN-BIOTIN TECHNOLOGY; PRETARGETED RADIOIMMUNOTHERAPY; IN-VITRO; MONOCLONAL-ANTIBODIES; PEGYLATED LIPOSOMES; COATED LIPOSOMES; ANTITUMOR DRUGS; SOLID TUMORS; MOUSE MODEL; CANCER	Background: Epidermal growth factor receptor (EGFR) is overexpressed in many solid tumor types, such as ovarian carcinoma. Immunoliposome based drug targeting has shown promising results in drug delivery to the tumors. However, the ratio of tumor-to-normal tissue concentrations should be increased to minimize the adverse effects of cytostatic drugs. Methodology/Principal Findings: We studied the EGFR-targeted doxorubicin immunoliposomes using pre-targeting and local intraperitoneal (i.p.) administration of the liposomes. This approach was used to increase drug delivery to tumors as compared to direct intravenous (i.v.) administration of liposomes. EGFR antibodies were attached on the surface of PEG coated liposomes using biotin-neutravidin binding. Receptor mediated cellular uptake and cytotoxic efficacy of EGFR-targeted liposomes were investigated in human ovarian adenocarcinoma (SKOV-3 and SKOV3.ip1) cells. In vivo distribution of the liposomes in mice was explored using direct and pre-targeting approaches and SPECT/CT imaging. Targeted liposomes showed efficient and specific receptor-mediated binding to ovarian carcinoma cells in vitro, but the difference in cytotoxicity between targeted and non-targeted liposomes remained small. The relatively low cytotoxic efficacy is probably due to insufficient doxorubicin release from the liposomes rather than lack of target binding. Tumor uptake of targeted liposomes in vivo was comparable to that of non-targeted liposomes after both direct and pre-targeting administration. For both EGFR-targeted and non-targeted liposomes, the i.p. administration increased liposome accumulation to the tumors compared to i.v. injections. Conclusions/Significance: Intraperitoneal administration of liposomes may be a beneficial approach to treat the tumors in the abdominal cavity. The i.p. pre-targeting method warrants further studies as a potential approach in cancer therapy.	[Lehtinen, Julia; Raki, Mari; Bergstrom, Kim A.; Uutela, Paivi; Ketola, Raimo A.; Urtti, Arto] Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland; [Lehtinen, Julia; Lehtinen, Katariina; Hiltunen, Annukka; Liang, Huamin; Yliperttula, Marjo] Univ Helsinki, Div Biopharm & Pharmacokinet, Fac Pharm, Helsinki, Finland; [Pikkarainen, Jere; Maatta, Ann-Marie] Ark Therapeut, Kuopio, Finland; [Pikkarainen, Jere; Wirth, Thomas] Univ Eastern Finland, Dept Biotechnol & Mol Med, Kuopio, Finland; [Pitkanen, Sari] Univ Eastern Finland, Dept Biosci, Kuopio, Finland	University of Helsinki; University of Helsinki; University of Eastern Finland; University of Eastern Finland	Lehtinen, J (corresponding author), Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland.	julia.lehtinen@helsinki.fi	Liang, Huamin/B-9909-2011	Liang, Huamin/0000-0001-8688-7404; Viitala, Sari/0000-0002-1401-3406; Kurkipuro, Jere/0000-0002-5239-6532	Ark Therapeutics (Kuopio, Finland); Finnish Funding Agency for Technology and Innovation (Helsinki, Finland); Finnish Cultural Foundation (Helsinki, Finland); TEKES	Ark Therapeutics (Kuopio, Finland); Finnish Funding Agency for Technology and Innovation (Helsinki, Finland)(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Cultural Foundation (Helsinki, Finland)(Finnish Cultural Foundation); TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	This research was funded by Ark Therapeutics (Kuopio, Finland; www.arktherapeutics.com), TEKES, the Finnish Funding Agency for Technology and Innovation (Helsinki, Finland; www.tekes.fi) and the Finnish Cultural Foundation (Helsinki, Finland; www.skr.fi). The public funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Company funder, Ark Therapeutics, participated in study design and performed one of the animal experiments.	Axworthy DB, 2000, P NATL ACAD SCI USA, V97, P1802, DOI 10.1073/pnas.97.4.1802; Boerman OC, 2003, J NUCL MED, V44, P400; Bolotin Elijah M., 1994, Journal of Liposome Research, V4, P455, DOI 10.3109/08982109409037057; Chen LC, 2007, NUCL MED BIOL, V34, P415, DOI 10.1016/j.nucmedbio.2007.02.003; Chuang KH, 2010, MOL CANCER THER, V9, P1903, DOI 10.1158/1535-7163.MCT-09-0899; DEJONG J, 1993, TRAC-TREND ANAL CHEM, V12, P422, DOI 10.1016/0165-9936(93)80006-6; Forero A, 2004, BLOOD, V104, P227, DOI 10.1182/blood-2003-09-3284; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 1999, BIOCONJUGATE CHEM, V10, P289, DOI 10.1021/bc9801124; Goins Beth A., 2003, P319; Hamblett KJ, 2005, BIOCONJUGATE CHEM, V16, P131, DOI 10.1021/bc034049g; Harding JA, 1997, BBA-BIOMEMBRANES, V1327, P181, DOI 10.1016/S0005-2736(97)00056-4; Hsieh YJ, 2008, INT J PHARM, V350, P265, DOI 10.1016/j.ijpharm.2007.09.002; Huhtala T, 2010, NUCL MED BIOL, V37, P957, DOI 10.1016/j.nucmedbio.2010.03.001; Ishida T, 2006, INT J PHARM, V309, P94, DOI 10.1016/j.ijpharm.2005.11.010; Kirchmeier MJ, 2001, J LIPOSOME RES, V11, P15, DOI 10.1081/LPR-100103167; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Kullberg M, 2009, J DRUG TARGET, V17, P98, DOI [10.1080/10611860802471562, 10.1080/10611860802471562 ]; Lee CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-255; Lehtinen J, 2008, J CONTROL RELEASE, V131, P145, DOI 10.1016/j.jconrel.2008.07.018; Lehtinen J, 2012, EUR J PHARM SCI, V46, P121, DOI 10.1016/j.ejps.2012.02.009; Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749; Lin YY, 2009, CANCER BIOTHER RADIO, V24, P453, DOI 10.1089/cbr.2008.0572; Mamot C, 2005, CANCER RES, V65, P11631, DOI 10.1158/0008-5472.CAN-05-1093; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; Mastrobattista E, 1999, ADV DRUG DELIVER REV, V40, P103, DOI 10.1016/S0169-409X(99)00043-5; Nobs L, 2006, BIOCONJUGATE CHEM, V17, P139, DOI 10.1021/bc050137k; Noske A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-294; Paasonen L, 2007, J CONTROL RELEASE, V122, P86, DOI 10.1016/j.jconrel.2007.06.009; Pan H, 2008, J CONTROL RELEASE, V125, P228, DOI 10.1016/j.jconrel.2007.10.016; Perez-Soler R, 2004, ONCOLOGIST, V9, P58, DOI 10.1634/theoncologist.9-1-58; Phelps SLB, 2008, GYNECOL ONCOL, V109, P411, DOI 10.1016/j.ygyno.2008.02.030; Pulkkinen M, 2008, EUR J PHARM BIOPHARM, V70, P66, DOI 10.1016/j.ejpb.2008.04.018; Sadzuka Y, 1997, CANCER LETT, V111, P77, DOI 10.1016/S0304-3835(96)04513-2; Sharkey RM, 2003, CANCER RES, V63, P354; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Xiao Z, 2002, J BIOTECHNOL, V94, P171, DOI 10.1016/S0168-1656(01)00424-2; YU DH, 1993, CANCER RES, V53, P891; YUAN F, 1995, CANCER RES, V55, P3752; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zavaleta CL, 2007, INT J PHARM, V337, P316, DOI 10.1016/j.ijpharm.2007.01.010	42	41	44	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41410	10.1371/journal.pone.0041410	http://dx.doi.org/10.1371/journal.pone.0041410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844475	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600026
J	Shen, L; Kim, SH; Chen, CY				Shen, Ling; Kim, Sung-Hoon; Chen, Chang Yan			Sensitization of Human Pancreatic Cancer Cells Harboring Mutated K-ras to Apoptosis	PLOS ONE			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; PHOSPHORYLATION; ADENOCARCINOMA; ISOFORMS; EPSILON; PATHWAY; DELTA; PKC	Pancreatic cancer is a devastating human malignancy and gain of functional mutations in K-ras oncogene is observed in 75%-90% of the patients. Studies have shown that oncogenic ras is not only able to promote cell growth or survival, but also apoptosis, depending upon circumstances. Using pancreatic cancer cell lines with or without expressing mutated K-ras, we demonstrated that the inhibition of endogenous PKC activity sensitized human pancreatic cancer cells (MIA and PANC-1) expressing mutated K-ras to apoptosis, which had no apoptotic effect on BxPC-3 pancreatic cancer cells that contain a normal Ras as well as human lung epithelial BAES-2B cells. In this apoptotic process, the level of ROS was increased and PUMA was upregulated in a p73-dependent fashion in MIA and PANC-1 cells. Subsequently, caspase-3 was cleaved. A full induction of apoptosis required the activation of both ROS- and p73-mediated pathways. The data suggest that PKC is a crucial factor that copes with aberrant K-ras to maintain the homeostasis of the pancreatic cancer cells harboring mutated K-ras. However, the suppression or loss of PKC disrupts the balance and initiates an apoptotic crisis, in which ROS and p73 appear the potential, key targets.	[Shen, Ling; Chen, Chang Yan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA; [Kim, Sung-Hoon] Kyung Hee Univ, Grad Sch EW Med Sci, Lab Angiogenesis & Chemoprevent, Seoul, South Korea	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyung Hee University	Shen, L (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA.	cchen6@bidmc.harvard.edu		kim, sunghoon/0000-0002-1570-3230	internal JCRT (Joint Center for Radiation Therapy, Harvard Medical School); National Institute of Health [1RO1CA100498]; NATIONAL CANCER INSTITUTE [R01CA100498] Funding Source: NIH RePORTER	internal JCRT (Joint Center for Radiation Therapy, Harvard Medical School); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was in part supported by an internal JCRT (Joint Center for Radiation Therapy, Harvard Medical School) and National Institute of Health 1RO1CA100498 awarded to Chang Yan Chen. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agami R, 1999, NATURE, V399, P809; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Aziz MH, 2006, CANCER RES, V66, P713, DOI 10.1158/0008-5472.CAN-05-2684; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Cappel WHDTN, 2003, CLIN CANCER RES, V9, P3598; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Cohenuram M, 2007, J PANCREAS, V8, P4; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Guo JJ, 2009, J CELL BIOCHEM, V107, P76, DOI 10.1002/jcb.22102; Jansen AP, 2001, CANCER RES, V61, P808; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; KALTHOFF H, 1993, ONCOGENE, V8, P289; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Kurinna S, 2006, LEUKEMIA, V20, P1316, DOI 10.1038/sj.leu.2404248; MANECKJEE R, 1994, CELL GROWTH DIFFER, V5, P1033; McCormic F, 1993, NATURE, V363, P5; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; PASTOR MI, 1995, CANCER SURV, V22, P75; Perletti GP, 1996, ONCOGENE, V12, P847; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Roberti MP, 2011, BREAST CANCER RES TR, V130, P465, DOI 10.1007/s10549-011-1360-2; Rusanescu G, 2001, MOL CELL BIOL, V21, P2650, DOI 10.1128/MCB.21.8.2650-2658.2001; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Schutte M, 1997, CANCER RES, V57, P3126; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Shama GD, 2007, EXP EYE RES, V85, P298; Shi X, 2001, PANCREATOLOGY, V1, P517, DOI 10.1159/000055854; Skowronski EW, 1996, CELL DEATH DIFFER, V3, P171; Tomaszewska Romana, 1998, Polish Journal of Pathology, V49, P83; Zhu T, 2010, ONCOGENE, V29, P1050, DOI 10.1038/onc.2009.344; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	44	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40435	10.1371/journal.pone.0040435	http://dx.doi.org/10.1371/journal.pone.0040435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848379	Green Published, gold, Green Submitted			2022-12-25	WOS:000306806600016
J	Fuentes, F; Zimmer, D; Atienza, M; Schottenfeld, J; Penkala, I; Bale, T; Bence, KK; Arregui, CO				Fuentes, Federico; Zimmer, Derek; Atienza, Marybless; Schottenfeld, Jamie; Penkala, Ian; Bale, Tracy; Bence, Kendra K.; Arregui, Carlos O.			Protein Tyrosine Phosphatase PTP1B Is Involved in Hippocampal Synapse Formation and Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE DEVELOPMENT; BETA-CATENIN; N-CADHERIN; ENDOPLASMIC-RETICULUM; STRUCTURAL PLASTICITY; ADHESION MOLECULES; MEDIATED ADHESION; GROWTH CONES; KINASE FER	ER-bound PTP1B is expressed in hippocampal neurons, and accumulates among neurite contacts. PTP1B dephosphorylates beta-catenin in N-cadherin complexes ensuring cell-cell adhesion. Here we show that endogenous PTP1B, as well as expressed GFP-PTP1B, are present in dendritic spines of hippocampal neurons in culture. GFP-PTP1B overexpression does not affect filopodial density or length. In contrast, impairment of PTP1B function or genetic PTP1B-deficiency leads to increased filopodia-like dendritic spines and a reduction in mushroom-like spines, while spine density is unaffected. These morphological alterations are accompanied by a disorganization of pre- and post-synapses, as judged by decreased clustering of synapsin-1 and PSD-95, and suggest a dynamic synaptic phenotype. Notably, levels of beta-catenin-Tyr-654 phosphorylation increased similar to 5-fold in the hippocampus of adult PTP1B(-/-) (KO) mice compared to wild type (WT) mice and this was accompanied by a reduction in the amount of beta-catenin associated with N-cadherin. To determine whether PTP1B-deficiency alters learning and memory, we generated mice lacking PTP1B in the hippocampus and cortex (PTP1B(fl/fl)-Emx1-Cre). PTP1B(fl/fl)-Emx1-Cre mice displayed improved performance in the Barnes maze (decreased time to find and enter target hole), utilized a more efficient strategy (cued), and had better recall compared to WT controls. Our results implicate PTP1B in structural plasticity within the hippocampus, likely through modulation of N-cadherin function by ensuring dephosphorylation of beta-catenin on Tyr-654. Disruption of hippocampal PTP1B function or expression leads to elongation of dendritic filopodia and improved learning and memory, demonstrating an exciting novel role for this phosphatase.	[Fuentes, Federico; Arregui, Carlos O.] Univ San Martin, CONICET, Inst Invest Biotecnol, Buenos Aires, DF, Argentina; [Zimmer, Derek; Atienza, Marybless; Schottenfeld, Jamie; Penkala, Ian; Bale, Tracy; Bence, Kendra K.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Pennsylvania	Fuentes, F (corresponding author), Univ Buenos Aires, Fac Exact & Nat Sci, Max Planck Lab Cellular Dynam, Ciudad Univ, Buenos Aires, DF, Argentina.	kbence@vet.upenn.edu; carregui@iib.unsam.edu.ar		Arregui, Carlos/0000-0003-0704-3321; Bence, Kendra/0000-0002-5879-4726; Penkala, Ian/0000-0002-4932-2970	NIH [DK082417]; Bunge y Born-Fulbright Scholarship;  [PICT 31939];  [PICT 332]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bunge y Born-Fulbright Scholarship; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	COA: PICT 31939 AND PICT 332, http://www.agencia.mincyt.gov.ar/spip.php?article28; KKB: NIH DK082417; FF: Bunge y Born-Fulbright Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arregui C, 2000, J CELL BIOL, V149, P1263, DOI 10.1083/jcb.149.6.1263; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Bult A, 1996, J NEUROSCI, V16, P7821; Chacon PJ, 2010, MOL CELL NEUROSCI, V43, P384, DOI 10.1016/j.mcn.2010.01.005; DAILEY ME, 1989, J NEUROSCI, V9, P1897; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fuentes F, 2009, MOL BIOL CELL, V20, P1878, DOI 10.1091/mbc.E08-07-0675; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Goetze B, 2004, J NEUROBIOL, V60, P517, DOI 10.1002/neu.20073; Gorski JA, 2002, J NEUROSCI, V22, P6309; Goslin K., 1991, CULTURING NERVE CELL, P251; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Gu Jiaping, 2009, Open Neurosci J, V3, P128; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; Hilfiker S, 1999, NAT NEUROSCI, V2, P104, DOI 10.1038/5659; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horn KE, 2012, J NEUROCHEM, V122, P147, DOI 10.1111/j.1471-4159.2012.07762.x; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pathre P, 2001, J NEUROSCI RES, V63, P143, DOI 10.1002/1097-4547(20010115)63:2<143::AID-JNR1006>3.0.CO;2-1; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Rhee J, 2001, J BIOL CHEM, V276, P6640, DOI 10.1074/jbc.M007656200; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Venkitaramani DV, 2011, EUR J NEUROSCI, V33, P2288, DOI 10.1111/j.1460-9568.2011.07687.x; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Xu G, 2002, J BIOL CHEM, V277, P49989, DOI 10.1074/jbc.M206454200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	81	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41536	10.1371/journal.pone.0041536	http://dx.doi.org/10.1371/journal.pone.0041536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844492	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700104
J	Guzman-Gutierrez, E; Westermeier, F; Salomon, C; Gonzalez, M; Pardo, F; Leiva, A; Sobrevia, L				Guzman-Gutierrez, Enrique; Westermeier, Francisco; Salomon, Carlos; Gonzalez, Marcelo; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis			Insulin-Increased L-Arginine Transport Requires A(2A) Adenosine Receptors Activation in Human Umbilical Vein Endothelium	PLOS ONE			English	Article							FACTOR-KAPPA-B; NITRIC-OXIDE; DIFFERENTIAL EXPRESSION; INTERNATIONAL UNION; CELLS; INHIBITION; GLUCOSE; CLASSIFICATION; NOMENCLATURE; PHARMACOLOGY	Adenosine causes vasodilation of human placenta vasculature by increasing the transport of arginine via cationic amino acid transporters 1 (hCAT-1). This process involves the activation of A(2A) adenosine receptors (A(2A)AR) in human umbilical vein endothelial cells (HUVECs). Insulin increases hCAT-1 activity and expression in HUVECs, and A(2A)AR stimulation increases insulin sensitivity in subjects with insulin resistance. However, whether A(2A)AR plays a role in insulin-mediated increase in L-arginine transport in HUVECs is unknown. To determine this, we first assayed the kinetics of saturable L-arginine transport (1 minute, 37 degrees C) in the absence or presence of nitrobenzylthioinosine (NBTI, 10 mu mol/L, adenosine transport inhibitor) and/or adenosine receptors agonist/antagonists. We also determined hCAT-1 protein and mRNA expression levels (Western blots and quantitative PCR), and SLC7A1 (for hCAT-1) reporter promoter activity. Insulin and NBTI increased the extracellular adenosine concentration, the maximal velocity for L-arginine transport without altering the apparent K-m for L-arginine transport, hCAT-1 protein and mRNA expression levels, and SLC7A1 transcriptional activity. An A2AAR antagonist ZM-241385 blocked these effects. ZM241385 inhibited SLC7A1 reporter transcriptional activity to the same extent in cells transfected with pGL3-hCAT-1(-1606) or pGL3-hCAT-1(-650) constructs in the presence of NBTI + insulin. However, SLC7A1 reporter activity was increased by NBTI only in cells transfected with pGL3-hCAT-1(-1606), and the ZM-241385 sensitive fraction of the NBTI response was similar in the absence or in the presence of insulin. Thus, insulin modulation of hCAT-1 expression and activity requires functional A(2A)AR in HUVECs, a mechanism that may be applicable to diseases associated with fetal insulin resistance, such as gestational diabetes.	[Guzman-Gutierrez, Enrique; Westermeier, Francisco; Salomon, Carlos; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, CMPL,Div Obstet & Gynaecol,Med Res Ctr CIM, Santiago, Chile; [Gonzalez, Marcelo] Univ Concepcion, Fac Biol Sci, Dept Physiol, Vasc Physiol Lab, Concepcion, Chile	Pontificia Universidad Catolica de Chile; Universidad de Concepcion	Guzman-Gutierrez, E (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Sch Med, CMPL,Div Obstet & Gynaecol,Med Res Ctr CIM, Alameda 340, Santiago, Chile.	sobrevia@med.puc.cl	Salomon, Carlos F/L-2167-2013; Sobrevia, Luis/H-9608-2016; Westermeier, Francisco/AAL-4145-2021; Gonzalez, Marcelo/O-4416-2016; Guzman-Gutierrez, Enrique/H-3536-2016	Salomon, Carlos F/0000-0003-4474-0046; Westermeier, Francisco/0000-0002-4476-4198; Gonzalez, Marcelo/0000-0002-0521-3633; Sobrevia, Luis/0000-0001-5802-2243; Guzman-Gutierrez, Enrique/0000-0001-6589-5667	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 1120928, 11110059, 11100192]; Comision Nacional de Investigacion en Ciencia y Tecnologia [CONICYT], Chile [PIA Anillos ACT-73, AT-24100210]; CONICYT-PhD (Chile) fellowships	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion en Ciencia y Tecnologia [CONICYT], Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT-PhD (Chile) fellowships	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 1120928, 11110059, 11100192]; Comision Nacional de Investigacion en Ciencia y Tecnologia [CONICYT, PIA Anillos ACT-73, AT-24100210], Chile. FP holds a postdoctoral position (CONICYT PIA Anillos ACT-73 postdoctoral research associate at CMPL, Pontificia Universidad Catolica de Chile). EG-G, FW and CS hold CONICYT-PhD (Chile) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljada A, 2001, J CLIN ENDOCR METAB, V86, P450, DOI 10.1210/jc.86.1.450; Casanello P, 2002, CIRC RES, V91, P127, DOI 10.1161/01.RES.0000027813.55750.E7; Ciaraldi TP, 1997, J CLIN ENDOCR METAB, V82, P1421, DOI 10.1210/jc.82.5.1421; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; da Silva CG, 2006, CIRC RES, V98, pE39, DOI 10.1161/01.RES.0000215436.92414.1d; Dong YL, 2004, AM J PHYSIOL-HEART C, V286, pH230, DOI 10.1152/ajpheart.00140.2003; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Escudero C, 2008, PLACENTA, V29, P816, DOI 10.1016/j.placenta.2008.06.014; Espinoza J, 2011, AM J OBSTET GYNECOL, V205, DOI DOI 10.1016/J.AJ0G.2011.06.034; Feoktistov I, 2002, CIRC RES, V90, P531, DOI 10.1161/01.RES.0000012203.21416.14; Fredholm BB, 1998, J NEUROCHEM, V70, P1210; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gonzalez M, 2011, J CELL PHYSIOL, V226, P2916, DOI 10.1002/jcp.22635; Guo D, 2012, BRIT J PHARMACOL, V166, P1846, DOI 10.1111/j.1476-5381.2012.01897.x; Guzman-Gutierrez E, 2011, CURR VASC PHARMACOL, V9, P750, DOI 10.2174/157016111797484062; Hammermann R, 2001, AMINO ACIDS, V21, P211, DOI 10.1007/s007260170029; KENIMER JG, 1981, MOL PHARMACOL, V20, P585; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Klotz KN, 1999, N-S ARCH PHARMACOL, V360, P103, DOI 10.1007/s002109900044; Lappas M, 2011, ANTIOXID REDOX SIGN, V15, P3061, DOI 10.1089/ars.2010.3765; Leiva A, 2011, EXP DIABETES RES, DOI 10.1155/2011/349286; Linden J, 1999, MOL PHARMACOL, V56, P705; Munoz G, 2006, J CELL PHYSIOL, V209, P826, DOI 10.1002/jcp.20769; Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326; Pandolfi A, 2010, CARDIOVASC RES, V86, P9, DOI 10.1093/cvr/cvq055; Ramkumar V, 2011, CURR NEUROPHARMACOL, V9, P342, DOI 10.2174/157015911795596559; READ MA, 1993, BRIT J PHARMACOL, V110, P454, DOI 10.1111/j.1476-5381.1993.tb13832.x; SALVATORE CA, 1993, P NATL ACAD SCI USA, V90, P10365, DOI 10.1073/pnas.90.21.10365; Sands WA, 2004, MOL PHARMACOL, V66, P1147, DOI 10.1124/mol.104.001107; Srinivasan M, 2005, J AM COLL CARDIOL, V46, P42, DOI 10.1016/j.jacc.2005.03.056; Steinberg HO, 2002, DIABETOLOGIA, V45, P623, DOI 10.1007/s00125-002-0800-2; Tsai PS, 2006, ANESTHESIOLOGY, V105, P1201, DOI 10.1097/00000542-200612000-00020; Vasquez G, 2004, J PHYSIOL-LONDON, V560, P111, DOI 10.1113/jphysiol.2004.068288; Vaquez R, 2007, J CELL PHYSIOL, V212, P626, DOI 10.1002/jcp.21057; Vega JL, 2009, CARDIOVASC RES, V82, P458, DOI 10.1093/cvr/cvp045; Visigalli R, 2007, BBA-BIOMEMBRANES, V1768, P1479, DOI 10.1016/j.bbamem.2007.02.016; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Wyatt AW, 2002, FASEB J, V16, P1584, DOI 10.1096/fasebj.16.12.1584; Zhang Wan-fu, 2010, Zhonghua Shao Shang Za Zhi, V26, P175	40	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41705	10.1371/journal.pone.0041705	http://dx.doi.org/10.1371/journal.pone.0041705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844517	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700143
J	Huang, TT; Ojcius, DM; Young, JD; Wu, YH; Ko, YF; Wong, TY; Wu, CY; Lu, CC; Lai, HC				Huang, Tsung-Teng; Ojcius, David M.; Young, John D.; Wu, Yi-Hui; Ko, Yun-Fei; Wong, Tsui-Yin; Wu, Cheng-Yeu; Lu, Chia-Chen; Lai, Hsin-Chih			The Anti-Tumorigenic Mushroom Agaricus blazei Murill Enhances IL-1 beta Production and Activates the NLRP3 Inflammasome in Human Macrophages	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; NALP3 INFLAMMASOME; P2X(7) RECEPTOR; CATHEPSIN-B; BETA-GLUCAN; IN-VITRO; MICE; EXTRACT; SECRETION; RELEASE	Agaricus blazei Murill (AbM) has been reported to possess immune activity against tumors and infections through stimulation of mononuclear phagocytes. Recently, AbM extract was shown to induce the production of the pro-inflammatory cytokine, interleukin-1 beta (IL-1 beta), in human monocytes. IL-1 beta is a key pro-inflammatory cytokine produced by activated macrophages and monocytes and its secretion is strictly controlled by the inflammasome. The purpose of this study is to investigate the effect of AbM water extracts on the regulation of IL-1 beta production and activation of the NLRP3 inflammasome in human THP-1 macrophages. The NLRP3 inflammasome consists of an NLRP3 receptor, an adaptor protein called ASC, and the inflammatory protease, caspase-1. Typically, stimulation of immune cells with microbial products results in production of pro-IL-1 beta, but a second stress-related signal activates the inflammasome and caspase-1, leading to processing and secretion of IL-1 beta. Our results show that AbM enhances transcription of IL-1 beta and triggers NLRP3 inflammasome-mediated IL-1 beta secretion in human THP-1 macrophages. AbM-mediated IL-1 beta secretion was markedly reduced in macrophages deficient in NLRP3 and ASC, demonstrating that the NLRP3 inflammasome is essential for AbM-induced IL-1 beta secretion. In addition, caspase-1 was activated and involved in proteolytic cleavage and secretion of IL-1 beta in AbM-treated macrophages. AbM-mediated IL-1 beta secretion also decreased in cells treated with cathepsin B inhibitor, suggesting that AbM can induce the release of cathepsin B. Furthermore, our data show that AbM-induced inflammasome activation requires the release of ATP, binding of extracellular ATP to the purinergic receptor P2X(7), the generation of reactive oxygen species, and efflux of potassium. Taken together, these findings reveal that AbM activates the NLRP3 inflammasome via multiple mechanisms, resulting in the secretion of IL-1 beta.	[Huang, Tsung-Teng; Ojcius, David M.; Young, John D.; Wong, Tsui-Yin; Wu, Cheng-Yeu; Lai, Hsin-Chih] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Young, John D.; Wong, Tsui-Yin; Wu, Cheng-Yeu] Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Wong, Tsui-Yin; Wu, Cheng-Yeu; Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Young, John D.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Young, John D.; Ko, Yun-Fei] Mingchi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan; [Wu, Yi-Hui] Natl Cheng Kung Univ Hosp, Canc Res Ctr, Tainan 70428, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; University of California System; University of California Merced; Rockefeller University; Ming Chi University of Technology; National Cheng Kung University; National Cheng Kung University Hospital; Fu Jen Catholic University	Huang, TT (corresponding author), Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan.	hclai@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council [NSC100-2321-B-002-009]; Chang Gung Memorial Hospital [CMRPD190302]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council (NSC100-2321-B-002-009) and Chang Gung Memorial Hospital (CMRPD190302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bernardshaw S, 2006, SHOCK, V25, P420, DOI 10.1097/01.shk.0000209526.58614.92; Bernardshaw S, 2005, SCAND J IMMUNOL, V62, P393, DOI 10.1111/j.1365-3083.2005.01667.x; Bernardshaw S, 2007, APMIS, V115, P719, DOI 10.1111/j.1600-0463.2007.apm_619.x; Bernardshaw S, 2005, INFLAMMATION, V29, P147, DOI 10.1007/s10753-006-9010-2; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ebina T, 1998, BIOTHERAPY, V11, P259, DOI 10.1023/A:1008054111445; Ellertsen LK, 2006, INT IMMUNOPHARMACOL, V6, P133, DOI 10.1016/j.intimp.2005.07.007; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Firenzuoli F, 2008, EVID-BASED COMPL ALT, V5, P3, DOI 10.1093/ecam/nem007; Forland DT, 2010, CYTOKINE, V49, P245, DOI 10.1016/j.cyto.2009.09.002; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Frlan R, 2006, CURR MED CHEM, V13, P2309, DOI 10.2174/092986706777935122; Fujimiya Y, 1998, CANCER IMMUNOL IMMUN, V46, P147, DOI 10.1007/s002620050473; Fujimiya Y, 1999, ANTICANCER RES, V19, P113; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hetland G, 2008, SCAND J IMMUNOL, V68, P363, DOI 10.1111/j.1365-3083.2008.02156.x; Hetland G, 2000, FEMS IMMUNOL MED MIC, V27, P111, DOI 10.1111/j.1574-695X.2000.tb01420.x; Hetland G, 1998, SCAND J IMMUNOL, V47, P548; Hetland G, 2002, FEMS IMMUNOL MED MIC, V33, P41, DOI 10.1111/j.1574-695X.2002.tb00570.x; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; ITOH H, 1994, JPN J PHARMACOL, V66, P265, DOI 10.1254/jjp.66.265; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; KAWAGISHI H, 1989, CARBOHYD RES, V186, P267, DOI 10.1016/0008-6215(89)84040-6; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mizuno M, 1999, BIOCHEM MOL BIOL INT, V47, P707; Nakajima A, 2002, INT IMMUNOPHARMACOL, V2, P1205, DOI 10.1016/S1567-5769(02)00056-5; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Said-Sadier N, 2012, CHANG GUNG MED J, V35, P297; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Smiderle FR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-58; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sorimachi K, 2001, CELL STRUCT FUNCT, V26, P103, DOI 10.1247/csf.26.103; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Takaku T, 2001, J NUTR, V131, P1409, DOI 10.1093/jn/131.5.1409; Vancompernolle K, 1998, FEBS LETT, V438, P150, DOI 10.1016/S0014-5793(98)01275-7; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	63	15	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41383	10.1371/journal.pone.0041383	http://dx.doi.org/10.1371/journal.pone.0041383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844468	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700079
J	Kneitel, JM				Kneitel, Jamie M.			Are Trade-Offs Among Species' Ecological Interactions Scale Dependent? A Test Using Pitcher-Plant Inquiline Species	PLOS ONE			English	Article							COMMUNITY STRUCTURE; FOOD WEBS; COMPETITION; COEXISTENCE; PREDATION; DISPERSAL; DIVERSITY; TRAITS; MECHANISMS; RICHNESS	Trade-offs among species' ecological interactions is a pervasive explanation for species coexistence. The traits associated with trade-offs are typically measured to mechanistically explain species coexistence at a single spatial scale. However, species potentially interact at multiple scales and this may be reflected in the traits among coexisting species. I quantified species' ecological traits associated with the trade-offs expected at both local (competitive ability and predator tolerance) and regional (competitive ability and colonization rate) community scales. The most common species (four protozoa and a rotifer) from the middle trophic level of a pitcher plant (Sarracenia purpurea) inquiline community were used to link species traits to previously observed patterns of species diversity and abundance. Traits associated with trade-offs (competitive ability, predator tolerance, and colonization rate) and other ecological traits (size, growth rate, and carrying capacity) were measured for each of the focal species. Traits were correlated with one another with a negative relationship indicative of a trade-off. Protozoan and rotifer species exhibited a negative relationship between competitive ability and predator tolerance, indicative of coexistence at the local community scale. There was no relationship between competitive ability and colonization rate. Size, growth rate, and carrying capacity were correlated with each other and the trade-off traits: Size was related to both competitive ability and predator tolerance, but growth rate and carrying capacity were correlated with predator tolerance. When partial correlations were conducted controlling for size, growth rate and carrying capacity, the trade-offs largely disappeared. These results imply that body size is the trait that provides the basis for ecological interactions and trade-offs. Altogether, this study showed that the examination of species' traits in the context of coexistence at different scales can contribute to our understanding of the mechanisms underlying community structure.	Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA	California State University System; California State University Sacramento	Kneitel, JM (corresponding author), Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA.	kneitel@csus.edu		Kneitel, Jamie/0000-0002-7841-1198	NSF [DEB-0083617, DEB-0091776]	NSF(National Science Foundation (NSF))	This project was funded by NSF grants DEB-0083617 and DEB-0091776 to T. E. Miller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; BALCIUNAS D, 1995, ECOLOGY, V76, P1327, DOI 10.2307/1940939; Bohannan BJM, 2002, ANTON LEEUW INT J G, V81, P107, DOI 10.1023/A:1020585711378; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; Brewer JS, 1998, OIKOS, V82, P347, DOI 10.2307/3546975; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Buckley HL, 2010, GLOBAL ECOL BIOGEOGR, V19, P711, DOI 10.1111/j.1466-8238.2010.00554.x; Buckley HL, 2003, ECOL LETT, V6, P825, DOI 10.1046/j.1461-0248.2003.00504.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; Cadotte MW, 2006, AM NAT, V168, P704, DOI 10.1086/508296; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; Coomes DA, 2002, OIKOS, V96, P421, DOI 10.1034/j.1600-0706.2002.960304.x; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Gudelj I, 2010, ECOL LETT, V13, P1073, DOI 10.1111/j.1461-0248.2010.01507.x; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; HARRISON S, 1995, AM NAT, V145, P546, DOI 10.1086/285755; Harvey E, 1996, OECOLOGIA, V108, P562, DOI 10.1007/BF00333734; HEARD SB, 1994, EVOL ECOL, V8, P493, DOI 10.1007/BF01238254; HilleRisLambers R, 2003, P ROY SOC B-BIOL SCI, V270, P2591, DOI 10.1098/rspb.2003.2532; Hoekman D, 2011, OECOLOGIA, V165, P1073, DOI 10.1007/s00442-010-1802-2; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Kneitel JM, 2004, ECOLOGY, V85, P2088, DOI 10.1890/03-3172; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; KURIHARA Y, 1990, ECOLOGY, V71, P645, DOI 10.2307/1940318; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; LUCKINBILL LS, 1979, AM NAT, V113, P427, DOI 10.1086/283400; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Maguire Jr B, 1971, ANNU REV ECOL SYST, V2, P439, DOI [DOI 10.1146/ANNUREV.ES.02.110171.002255, 10.1146/annurev.es.02.110171.002255]; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; MILLER T, 1994, AM MIDL NAT, V131, P136, DOI 10.2307/2426616; Miller TE, 2002, ECOLOGY, V83, P898, DOI 10.1890/0012-9658(2002)083[0898:EOCSOI]2.0.CO;2; Miller TE, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P122; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Shurin JB, 2001, AM NAT, V158, P624, DOI 10.1086/323589; Steiner CF, 2003, OIKOS, V101, P569, DOI 10.1034/j.1600-0706.2003.12309.x; Suding KN, 2003, ECOLOGY, V84, P1; terHorst CP, 2011, J EVOLUTION BIOL, V24, P36, DOI 10.1111/j.1420-9101.2010.02140.x; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Violle C, 2010, P NATL ACAD SCI USA, V107, P12925, DOI 10.1073/pnas.1000699107; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337	55	12	12	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41809	10.1371/journal.pone.0041809	http://dx.doi.org/10.1371/journal.pone.0041809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844526	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700153
J	Lass, U; Numann, A; von Eckardstein, K; Kiwit, J; Stockhammer, F; Horaczek, JA; Veelken, J; Herold-Mende, C; Jeuken, J; von Deimling, A; Mueller, W				Lass, Ulrike; Nuemann, Astrid; von Eckardstein, Kajetan; Kiwit, Juergen; Stockhammer, Florian; Horaczek, Joern A.; Veelken, Julian; Herold-Mende, Christel; Jeuken, Judith; von Deimling, Andreas; Mueller, Wolf			Clonal Analysis in Recurrent Astrocytic, Oligoastrocytic and Oligodendroglial Tumors Implicates IDH1- Mutation as Common Tumor Initiating Event	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; GLIOMATOSIS CEREBRI; GENETIC-ANALYSIS; NERVOUS-SYSTEM; 1P; RESISTANCE; SURVIVAL; 19Q; TEMOZOLOMIDE; ASSAY	Background: To investigate the dynamics of inter- and intratumoral molecular alterations during tumor progression in recurrent gliomas. Methodology/Principal Findings: To address intertumoral heterogeneity we investigated non-microdissected tumor tissue of 106 gliomas representing 51 recurrent tumors. To address intratumoral heterogeneity a set of 16 gliomas representing 7 tumor pairs with at least one recurrence, and 4 single mixed gliomas were investigated by microdissection of distinct oligodendroglial and astrocytic tumor components. All tumors and tumor components were analyzed for allelic loss of 1p/19q (LOH 1p/19q), for TP53-mutations and for R132 mutations in the IDH1 gene. The investigation of non-microdissected tumor tissue revealed clonality in 75% (38/51). Aberrant molecular alterations upon recurrence were detected in 25% (13/51). 64% (9/14) of these were novel and associated with tumor progression. Loss of previously detected alterations was observed in 36% (5/14). One tumor pair (1/14; 7%) was significant for both. Intratumoral clonality was detected in 57% (4/7) of the microdissected tumor pairs and in 75% (3/4) of single microdissected tumors. 43% (3/7) of tumor pairs and one single tumor (25%) revealed intratumoral heterogeneity. While intratumoral heterogeneity affected both the TP53-mutational status and the LOH1p/19q status, all tumors with intratumoral heterogeneity shared the R132 IDH1-mutation as a common feature in both their microdissected components. Conclusions/Significance: The majority of recurrent gliomas are of monoclonal origin. However, the detection of divertive tumor cell clones in morphological distinct tumor components sharing IDH1-mutations as early event may provide insight into the tumorigenesis of true mixed gliomas.	[Lass, Ulrike; von Deimling, Andreas] German Canc Ctr DKFZ, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [von Deimling, Andreas; Mueller, Wolf] Univ Heidelberg Hosp, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Nuemann, Astrid] Charite, Dept Neurol, D-13353 Berlin, Germany; [Kiwit, Juergen] HELIOS Klinikum Berlin Buch, Dept Neurosurg, Berlin, Germany; [von Eckardstein, Kajetan; Stockhammer, Florian] Univ Hosp Gottingen, Dept Neurosurg, Gottingen, Germany; [Horaczek, Joern A.; Veelken, Julian] Vivantes Klinikum Neukolln, Dept Neurosurg, Berlin, Germany; [Herold-Mende, Christel] Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Jeuken, Judith] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; University of Gottingen; VIivantes Klinikum Neukolln; Ruprecht Karls University Heidelberg; Radboud University Nijmegen	Lass, U (corresponding author), German Canc Ctr DKFZ, Clin Cooperat Unit Neuropathol, Heidelberg, Germany.	wolf.mueller@med.uni-heidelberg.de	von Deimling, Andreas/F-7774-2013	von Deimling, Andreas/0000-0002-5863-540X; Stockhammer, Florian/0000-0002-0525-5956	TUMORZENTRUM, Heidelberg - Mannheim [D.10026951]	TUMORZENTRUM, Heidelberg - Mannheim	The present study was supported by the TUMORZENTRUM, Heidelberg - Mannheim, project number D.10026951. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Cahill Daniel P, 2008, Clin Neurosurg, V55, P165; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dong ZQ, 2002, HUM PATHOL, V33, P528, DOI 10.1053/hupa.2002.124784; Felsberg J, 2004, BRAIN PATHOL, V14, P121, DOI 10.1111/j.1750-3639.2004.tb00044.x; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Hartmann C, 2005, J NEUROPATH EXP NEUR, V64, P10, DOI 10.1093/jnen/64.1.10; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Kattar MM, 1997, HUM PATHOL, V28, P1166, DOI 10.1016/S0046-8177(97)90255-0; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kokubo Y, 2005, BRIT J CANCER, V92, P1711, DOI 10.1038/sj.bjc.6602559; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Kros JM, 2002, J NEUROPATH EXP NEUR, V61, P806, DOI 10.1093/jnen/61.9.806; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; LOUIS DN, 1992, AM J PATHOL, V141, P777; Martinez R, 2005, J NEURO-ONCOL, V72, P95, DOI 10.1007/s11060-004-3347-x; Martinez R, 2007, J NEURO-ONCOL, V83, P91, DOI 10.1007/s11060-006-9292-0; Mawrin C, 2005, ACTA NEUROPATHOL, V110, P527, DOI 10.1007/s00401-005-1083-8; Mawrin C, 2003, HUM PATHOL, V34, P102, DOI 10.1053/hupa.2003.1; Mueller W, 2001, BRAIN PATHOL, V11, P39; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Ohgaki H., 2009, CANC SCI; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Piechocki MP, 2007, CANCER RES, V67, P6825, DOI 10.1158/0008-5472.CAN-07-0765; Qu MQ, 2007, ACTA NEUROPATHOL, V113, P129, DOI 10.1007/s00401-006-0142-0; Sahm F, 2012, ARCH NEUROL-CHICAGO, V69, P523, DOI 10.1001/archneurol.2011.2910; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Tada M, 1996, INT J CANCER, V67, P447, DOI 10.1002/(SICI)1097-0215(19960729)67:3<447::AID-IJC22>3.0.CO;2-3; The WHO, 2020, CLASSIFICATION TUMOU; van Dijk MC, 2005, DIAGN MOL PATHOL, V14, P9, DOI 10.1097/01.pas.0000146701.98954.47; VONDEIMLING A, 1993, NEUROPATH APPL NEURO, V19, P524; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Zhu JJ, 1997, AM J PATHOL, V151, P565; Zhuang Z, 2004, NEUROLOGY, V62, P2316, DOI 10.1212/WNL.62.12.2316	41	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41298	10.1371/journal.pone.0041298	http://dx.doi.org/10.1371/journal.pone.0041298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844452	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700064
J	Miaskowski, C; Cooper, BA; Dhruva, A; Dunn, LB; Langford, DJ; Cataldo, JK; Baggott, CR; Merriman, JD; Dodd, M; Lee, K; West, C; Paul, SM; Aouizerat, BE				Miaskowski, Christine; Cooper, Bruce A.; Dhruva, Anand; Dunn, Laura B.; Langford, Dale J.; Cataldo, Janine K.; Baggott, Christina R.; Merriman, John D.; Dodd, Marylin; Lee, Kathryn; West, Claudia; Paul, Steven M.; Aouizerat, Bradley E.			Evidence of Associations between Cytokine Genes and Subjective Reports of Sleep Disturbance in Oncology Patients and Their Family Caregivers	PLOS ONE			English	Article							QUALITY-OF-LIFE; NF-KAPPA-B; PSYCHOMETRIC EVALUATION; INTERLEUKIN-6 GENE; RADIATION-THERAPY; PROSTATE-CANCER; TRAIT ANXIETY; FATIGUE; BREAST; SYMPTOMS	The purposes of this study were to identify distinct latent classes of individuals based on subjective reports of sleep disturbance; to examine differences in demographic, clinical, and symptom characteristics between the latent classes; and to evaluate for variations in pro- and anti-inflammatory cytokine genes between the latent classes. Among 167 oncology outpatients with breast, prostate, lung, or brain cancer and 85 of their FCs, growth mixture modeling (GMM) was used to identify latent classes of individuals based on General Sleep Disturbance Scale (GSDS) obtained prior to, during, and for four months following completion of radiation therapy. Single nucleotide polymorphisms (SNPs) and haplotypes in candidate cytokine genes were interrogated for differences between the two latent classes. Multiple logistic regression was used to assess the effect of phenotypic and genotypic characteristics on GSDS group membership. Two latent classes were identified: lower sleep disturbance (88.5%) and higher sleep disturbance (11.5%). Participants who were younger and had a lower Karnofsky Performance status score were more likely to be in the higher sleep disturbance class. Variation in two cytokine genes (i.e., IL6, NFKB) predicted latent class membership. Evidence was found for latent classes with distinct sleep disturbance trajectories. Unique genetic markers in cytokine genes may partially explain the interindividual heterogeneity characterizing these trajectories.	[Miaskowski, Christine; Langford, Dale J.; Cataldo, Janine K.; Baggott, Christina R.; Merriman, John D.; Dodd, Marylin; West, Claudia; Paul, Steven M.; Aouizerat, Bradley E.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Cooper, Bruce A.] Univ Calif San Francisco, Dept Community Hlth Syst, San Francisco, CA 94143 USA; [Dhruva, Anand] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dunn, Laura B.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Lee, Kathryn] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miaskowski, C (corresponding author), Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA.	chris.miaskowski@nursing.ucsf.edu	Merriman, John/AAX-4055-2021; Paul, Steve/ABE-5400-2020; Merriman, John/AAX-4054-2021	Merriman, John/0000-0002-7113-5389; Merriman, John/0000-0002-7113-5389	National Institute of Nursing Research [NR04835]; University of California San Francisco(UCSF) Academic Senate grant; National Institutes of Health (NIH) Roadmap for Medical Research Grant [KL2 RR624130]; American Cancer Society (ACS); NIH Mentored Patient-Oriented Research Career Development Award [K23 AT005340]; Department of Defense Breast Cancer Research Program Postdoctoral Fellowship; NINR fellowship [F31 NR012604]; ACS Doctoral Degree Scholarship [DSCN-10-087]; Oncology Nursing Society Doctoral Scholarship; UCSF Nursing Alumni Association Scholarship; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K23AT005340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [F31NR012604, R01NR004835] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); University of California San Francisco(UCSF) Academic Senate grant; National Institutes of Health (NIH) Roadmap for Medical Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); NIH Mentored Patient-Oriented Research Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Postdoctoral Fellowship(United States Department of Defense); NINR fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); ACS Doctoral Degree Scholarship; Oncology Nursing Society Doctoral Scholarship; UCSF Nursing Alumni Association Scholarship; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by a grant from the National Institute of Nursing Research (NR04835) and partially supported by an University of California San Francisco(UCSF) Academic Senate grant to LBD and BEA. BEA was funded through the National Institutes of Health (NIH) Roadmap for Medical Research Grant (KL2 RR624130). CM is funded by the American Cancer Society (ACS) as a Clinical Research Professor. AD is funded through NIH Mentored Patient-Oriented Research Career Development Award (K23 AT005340). DJL is supported by a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship. JDM is supported by an NINR fellowship (F31 NR012604), an ACS Doctoral Degree Scholarship (DSCN-10-087), an Oncology Nursing Society Doctoral Scholarship, and a UCSF Nursing Alumni Association Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Aouizerat BE, 2009, BIOL RES NURS, V11, P27, DOI 10.1177/1099800409333871; Beck SL, 2004, J PAIN SYMPTOM MANAG, V27, P140, DOI 10.1016/j.jpainsymman.2003.12.002; Berger AM, 2009, SUPPORT CARE CANC; Berger AM, 2008, J PAIN SYMPTOM MANAG, V36, P191, DOI 10.1016/j.jpainsymman.2007.10.008; Berger AM, 2007, J PAIN SYMPTOM MANAG, V33, P398, DOI 10.1016/j.jpainsymman.2006.09.022; Berger Ann M, 2005, Oncol Nurs Forum, V32, pE98, DOI 10.1188/05.ONF.E98-E126; Berger AM, 2009, ONCOL NURS FORUM, V36, P401, DOI 10.1188/09.ONF.E165-E177; Bieling PJ, 1998, BEHAV RES THER, V36, P777, DOI 10.1016/S0005-7967(98)00023-0; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carney S, 2011, J CLIN ONCOL, V29, P1001, DOI 10.1200/JCO.2010.30.9104; Carpenter J S, 1998, Issues Ment Health Nurs, V19, P481; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Chen ML, 2008, LUNG CANCER, V62, P391, DOI 10.1016/j.lungcan.2008.03.016; Cho MH, 2006, J CANCER EDUC, V21, pS37, DOI 10.1207/s15430154jce2101s_8; Cimprich B, 2005, PSYCHO-ONCOLOGY, V14, P70, DOI 10.1002/pon.821; CIMPRICH B, 1992, RES NURS HEALTH, V15, P199, DOI 10.1002/nur.4770150306; Cimprich B, 2011, PSYCHO-ONCOLOGY, V20, P194, DOI 10.1002/pon.1729; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Davidson JR, 2002, SOC SCI MED, V54, P1309, DOI 10.1016/S0277-9536(01)00043-0; Dhruva A, 2012, CANCER NURS, V35, P70, DOI 10.1097/NCC.0b013e3182194a25; Dunn LB, 2012, EUR J ONCOL NURS, V16, P1, DOI 10.1016/j.ejon.2011.01.003; Enders C. K., 2008, IDENTIFYING CORRECT; Fletcher BS, 2008, J CLIN ONCOL, V26, P599, DOI 10.1200/JCO.2007.12.2838; Foley KA, 2010, BEHAV SLEEP MED, V8, P90, DOI 10.1080/15402001003622842; Fortner BV, 2002, J PAIN SYMPTOM MANAG, V24, P471, DOI 10.1016/S0885-3924(02)00500-6; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garrett K, 2011, J PAIN SYMPTOM MANAG, V42, P239, DOI 10.1016/j.jpainsymman.2010.11.010; Gay Caryl L, 2004, Biol Res Nurs, V5, P311, DOI 10.1177/1099800403262142; Gibbins J, 2009, J PAIN SYMPTOM MANAG, V38, P860, DOI 10.1016/j.jpainsymman.2009.04.025; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hearson B, 2007, INT J PALLIAT NURS, V13, P495, DOI 10.12968/ijpn.2007.13.10.27493; Heffner KL, 2011, CLIN J PAIN, V27, P35, DOI 10.1097/AJP.0b013e3181eef761; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hublin C, 2011, SLEEP, V34, P957, DOI 10.5665/SLEEP.1136; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kennedy BL, 2001, PSYCHIAT QUART, V72, P263, DOI 10.1023/A:1010305200087; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Larkin EK, 2010, CTS-CLIN TRANSL SCI, V3, P337, DOI 10.1111/j.1752-8062.2010.00236.x; Lee K A, 1999, J Obstet Gynecol Neonatal Nurs, V28, P193, DOI 10.1111/j.1552-6909.1999.tb01984.x; LEE KA, 1992, SLEEP, V15, P493, DOI 10.1093/sleep/15.6.493; LEE KA, 1992, BIRTH-ISS PERINAT C, V19, P208, DOI 10.1111/j.1523-536X.1992.tb00404.x; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Maurovich-Horvat E, 2008, Prague Med Rep, V109, P275; Miaskowski C, 1999, J PAIN SYMPTOM MANAG, V17, P320, DOI 10.1016/S0885-3924(99)00008-1; Miaskowski C, 2008, J PAIN SYMPTOM MANAG, V35, P632, DOI 10.1016/j.jpainsymman.2007.07.007; Miaskowski Christine, 2006, Oncol Nurs Forum, V33, pE79, DOI 10.1188/06.ONF.E79-E89; Miaskowski C, 2011, CANCER NURS, V34, P255, DOI 10.1097/NCC.0b013e3181f65d9b; Miaskowski C, 2010, J PAIN SYMPTOM MANAG, V40, P531, DOI 10.1016/j.jpainsymman.2009.12.006; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; Muthen B., 2004, SAGE HDB QUANTITATIV, P345, DOI DOI 10.4135/9781412986311.N19; Muthen B. O., 2002, BEHAVIORMETRIKA, V29, P81, DOI [DOI 10.2333/BHMK.29.81, 10.2333/bhmk.29.81]; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Osoba D, 1999, INT J CANCER, P132; Pollmacher T, 2002, BRAIN BEHAV IMMUN, V16, P525, DOI 10.1016/S0889-1591(02)00004-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pud D, 2008, J PAIN SYMPTOM MANAG, V35, P162, DOI 10.1016/j.jpainsymman.2007.03.010; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Savard J, 2009, J CLIN ONCOL, V27, P5233, DOI 10.1200/JCO.2008.21.6333; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; SHEEHAN TJ, 1995, J PERS ASSESS, V64, P507, DOI 10.1207/s15327752jpa6403_9; Spielberger C.G., 1983, MANUAL STATE ANXIETY; SPSS, 2010, IBM SPSS WIND VERS 1; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268	78	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40560	10.1371/journal.pone.0040560	http://dx.doi.org/10.1371/journal.pone.0040560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844404	Green Published, gold			2022-12-25	WOS:000306687700013
J	Lei, YF; Zouani, OF; Remy, M; Ayela, C; Durrieu, MC				Lei, Yifeng; Zouani, Omar F.; Remy, Murielle; Ayela, Cedric; Durrieu, Marie-Christine			Geometrical Microfeature Cues for Directing Tubulogenesis of Endothelial Cells	PLOS ONE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; CAPILLARY LUMEN FORMATION; ANGIOGENESIS IN-VITRO; PEPTIDE SVVYGLR; TUBE FORMATION; DIFFERENTIATION; OSTEOPONTIN; MORPHOGENESIS; GROWTH; VIVO	Angiogenesis, the formation of new blood vessels by sprouting from pre-existing ones, is critical for the establishment and maintenance of complex tissues. Angiogenesis is usually triggered by soluble growth factors such as VEGF. However, geometrical cues also play an important role in this process. Here we report the induction of angiogenesis solely by SVVYGLR peptide micropatterning on polymer surfaces. SVVYGLR peptide stripes were micropatterned onto polymer surfaces by photolithography to study their effects on endothelial cell (EC) behavior. Our results showed that the EC behaviors (cell spreading, orientation and migration) were significantly more guided and regulated on narrower SVVYGLR micropatterns (10 and 50 mm) than on larger stripes (100 mm). Also, EC morphogenesis into tube formation was switched on onto the smaller patterns. We illustrated that the central lumen of tubular structures can be formed by only one-to-four cells due to geometrical constraints on the micropatterns which mediated cell-substrate adhesion and generated a correct maturation of adherens junctions. In addition, sprouting of ECs and vascular networks were also induced by geometrical cues on surfaces micropatterned with SVVYGLR peptides. These micropatterned surfaces provide opportunities for mimicking angiogenesis by peptide modification instead of exogenous growth factors. The organization of ECs into tubular structures and the induction of sprouting angiogenesis are important towards the fabrication of vascularized tissues, and this work has great potential applications in tissue engineering and tissue regeneration.	[Lei, Yifeng; Zouani, Omar F.; Remy, Murielle; Durrieu, Marie-Christine] Univ Bordeaux 2, INSERM, U1026, F-33076 Bordeaux, France; [Lei, Yifeng; Zouani, Omar F.; Durrieu, Marie-Christine] Univ Bordeaux 1, CNRS, CBMN, UMR 5248, Pessac, France; [Ayela, Cedric] Univ Bordeaux, CNRS, IMS, UMR 5218, Talence, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite de Bordeaux	Lei, YF (corresponding author), Univ Bordeaux 2, INSERM, U1026, F-33076 Bordeaux, France.	yifeng.lei@inserm.fr; omar.zouani@inserm.fr	DURRIEU, Marie-Christine/I-4358-2016; lei, yifeng/GON-4920-2022	DURRIEU, Marie-Christine/0000-0003-0583-9289; Lei, Yifeng/0000-0002-3523-6887	"Region Aquitaine"; GIS "Advanced Materials in Aquitaine" (AMA); "Agence nationale pour la Recherche" (ANR) [ANR-09-ETEC-001-01]	"Region Aquitaine"(Region Nouvelle-Aquitaine); GIS "Advanced Materials in Aquitaine" (AMA); "Agence nationale pour la Recherche" (ANR)(French National Research Agency (ANR))	The work was financially supported by the "Region Aquitaine", the GIS "Advanced Materials in Aquitaine" (AMA) (www.ama-materials.com), and the "Agence nationale pour la Recherche" (ANR) (grant number ANR-09-ETEC-001-01) (www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Bayless KJ, 2002, J CELL SCI, V115, P1123; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chollet C, 2010, COLLOID SURFACE B, V75, P107, DOI 10.1016/j.colsurfb.2009.08.024; Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033; Co CC, 2005, J AM CHEM SOC, V127, P1598, DOI 10.1021/ja044382a; Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030; Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174; Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Green PM, 2001, FEBS LETT, V503, P75, DOI 10.1016/S0014-5793(01)02690-4; Hamada Y, 2004, DENT MATER J, V23, P650, DOI 10.4012/dmj.23.650; Hamada Y, 2003, BIOCHEM BIOPH RES CO, V310, P153, DOI 10.1016/j.bbrc.2003.09.001; Hamada Y, 2007, DENT MATER J, V26, P487, DOI 10.4012/dmj.26.487; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Li HY, 2010, AM J PHYSIOL-CELL PH, V299, pC422, DOI 10.1152/ajpcell.00562.2009; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Sukmana I, 2010, BIOMATERIALS, V31, P5091, DOI 10.1016/j.biomaterials.2010.02.076; Williams DF, 2011, BIOMATERIALS, V32, P4195, DOI 10.1016/j.biomaterials.2011.02.025; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229; Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042	56	39	40	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41163	10.1371/journal.pone.0041163	http://dx.doi.org/10.1371/journal.pone.0041163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829923	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300062
J	Lekawanvijit, S; Kompa, AR; Manabe, M; Wang, BH; Langham, RG; Nishijima, F; Kelly, DJ; Krum, H				Lekawanvijit, Suree; Kompa, Andrew R.; Manabe, Minako; Wang, Bing H.; Langham, Robyn G.; Nishijima, Fuyuhiko; Kelly, Darren J.; Krum, Henry			Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; NF-KAPPA-B; STAGE RENAL-DISEASE; ORAL ADSORBENT; INTERSTITIAL FIBROSIS; ARTERIAL STIFFNESS; GENE-EXPRESSION; HEART-FAILURE; LONG-TERM; AST-120	Cardiovascular death commonly occurs in patients with chronic kidney disease. Indoxyl sulfate (IS), a uremic toxin, has been demonstrated in vitro as a contributory factor in cardiac fibrosis, a typical pathological finding in uremic cardiomyopathy. This study aimed to determine if cardiac fibrosis is reversible by lowering serum IS levels using an oral charcoal adsorbent, AST-120. Subtotal-nephrectomized (5/6-STNx) Sprague-Dawley rats were randomized to receive either AST-120 (AST-120, n = 13) or no treatment (vehicle, n = 17) for 12 weeks. Sham operated rats (n = 12) were used as controls. Early left ventricular (LV) diastolic dysfunction was demonstrated by an increase in peak velocity of atrial filling [A and A' waves] and a decrease of E/A and E'/A' ratios obtained by echocardiography. This was accompanied by a 4.5-fold increase in serum IS (p<0.001) as well as elevated tail-cuff blood pressure (p<0.001) and heart weight (p<0.001). Increased LV fibrosis (p<0.001), gene expression of pro-fibrotic (TGF-beta, CTGF) and hypertrophic (ANP, beta-MHC and alpha-skeletal muscle actin) markers, as well as TGF-beta and phosphorylated NF-kappa B protein expression were observed in STNx + vehicle rats. Treatment with AST-120 reduced serum creatinine (by 54%, p<0.05) and urine total protein (by 27%, p<0.05) vs vehicle whilst having no effect on blood pressure (AST-120 = 227 +/- 11 vs vehicle = 224 +/- 8 mmHg, ns) and heart weight. The increase in serum IS was prevented with AST-120 (by 100%, p<0.001) which was accompanied by reduced LV fibrosis (68%, p<0.01) and TGF-beta and phosphorylated NF-kappa B protein expression (back to sham levels, p<0.05) despite no significant change in LV function. In conclusion, STNx resulted in increased cardiac fibrosis and circulating IS levels. Reduction of IS with AST-120 normalizes cardiac fibrosis, in a blood pressure independent manner.	[Lekawanvijit, Suree; Kompa, Andrew R.; Wang, Bing H.; Krum, Henry] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Kompa, Andrew R.; Langham, Robyn G.; Kelly, Darren J.] Univ Melbourne, Dept Med, St Vincents Hosp, Melbourne, Vic, Australia; [Manabe, Minako; Nishijima, Fuyuhiko] Kureha Corp, Dept Pharmaceut, Tokyo, Japan; [Langham, Robyn G.] St Vincents Hosp, Dept Nephrol, Melbourne, Vic, Australia	Monash University; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne	Lekawanvijit, S (corresponding author), Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	henry.krum@monash.edu		Kompa, Andrew/0000-0003-1002-2302; Kelly, Darren/0000-0003-4850-3929	National Health and Medical Research Council [334008, 546272]; Chiang Mai University, Thailand under the Royal Patronage of Her Royal Highness Princess Galyanivadhana	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Chiang Mai University, Thailand under the Royal Patronage of Her Royal Highness Princess Galyanivadhana	This work was supported by the National Health and Medical Research Council [Program Grant #334008 and #546272]. The URL of the funder's website is http://www.nhmrc.gov.au. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the technical support of Ms Mariana Pacheco and Ms Jemma Court for the animal studies, Ms Alison Cox for assistance with the Cobas assay, Dr Yuan Zhang for assistance with cardiac fibrosis analysis. S.L. is a recipient of a scholarship from the 'Prince Doctor' Fund, Chiang Mai University, Thailand, under the Royal Patronage of Her Royal Highness Princess Galyanivadhana.	Amann K, 2000, NEPHROL DIAL TRANSPL, V15, P964, DOI 10.1093/ndt/15.7.964; Aoyama I, 2002, NEPHRON, V92, P635, DOI 10.1159/000064108; Aoyama I, 2000, AM J NEPHROL, V20, P232, DOI 10.1159/000013594; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Campbell DJ, 2011, HYPERTENSION, V57, P186, DOI 10.1161/HYPERTENSIONAHA.110.165043; Cannella G, 1997, AM J KIDNEY DIS, V30, P659, DOI 10.1016/S0272-6386(97)90490-X; Cice G, 2003, J AM COLL CARDIOL, V41, P1438, DOI 10.1016/S0735-1097(03)00241-9; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Hampl H, 2005, AM J NEPHROL, V25, P211, DOI 10.1159/000085881; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Iida Shuji, 2006, Clin Exp Nephrol, V10, P262, DOI 10.1007/s10157-006-0441-8; Iyngkaran P., 2009, HEART LUNG CIRCUL, V18, pS250, DOI [10.1016/j.hlc.2009.05.618, DOI 10.1016/J.HLC.2009.05.618]; Kelly DJ, 1998, KIDNEY INT, V54, P343, DOI 10.1046/j.1523-1755.1998.00019.x; Kikuchi K, 2010, J CHROMATOGR B, V878, P2997, DOI 10.1016/j.jchromb.2010.09.006; Kobayashi N, 2002, NEPHRON, V91, P480, DOI 10.1159/000064291; Kompa AR, 2008, J PHARMACOL EXP THER, V325, P741, DOI 10.1124/jpet.107.133546; Kompa AR, 2010, PEPTIDES, V31, P1523, DOI 10.1016/j.peptides.2010.04.026; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; Maeda K, 2009, J INT MED RES, V37, P205, DOI 10.1177/147323000903700125; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Miyazaki T, 2000, NEPHROL DIAL TRANSPL, V15, P1773, DOI 10.1093/ndt/15.11.1773; Motojima M, 2003, KIDNEY INT, V63, P1671, DOI 10.1046/j.1523-1755.2003.00906.x; Nakai K, 2011, AM J NEPHROL, V33, P218, DOI 10.1159/000324354; Nakamura T, 2004, KIDNEY BLOOD PRESS R, V27, P121, DOI 10.1159/000077536; Nitta K, 2004, HYPERTENS RES, V27, P527, DOI 10.1291/hypres.27.527; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Niwa T, 1997, KIDNEY INT, V52, pS23; NIWA T, 1994, J LAB CLIN MED, V124, P96; Niwa T, 2010, NAGOYA J MED SCI, V72, P1; Owada S, 2008, AM J NEPHROL, V28, P446, DOI 10.1159/000112823; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Shibahara H, 2010, J NEPHROL, V23, P535; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; STANFEL LA, 1986, CLIN CHEM, V32, P938; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Tamada S, 2006, J PHARMACOL SCI, V100, P17, DOI 10.1254/jphs.FMJ05003X4; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Tran L, 2010, AM J PHYSIOL-HEART C, V298, pH608, DOI 10.1152/ajpheart.00942.2009; Ueda H, 2008, RENAL FAILURE, V30, P856, DOI 10.1080/08860220802356531; United States Renal Data Systems, USRDS 2007 ANN DAT R; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vlahakos DV, 1997, J AM SOC NEPHROL, V8, P1764; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zoccali C, 2002, HYPERTENSION, V40, P41, DOI 10.1161/01.HYP.0000022063.50739.60	51	121	131	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41281	10.1371/journal.pone.0041281	http://dx.doi.org/10.1371/journal.pone.0041281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829936	gold, Green Published			2022-12-25	WOS:000306956300075
J	Olson, KL; Mandl, KD				Olson, Karen L.; Mandl, Kenneth D.			Temporal Patterns of Medications Dispensed to Children and Adolescents in a National Insured Population	PLOS ONE			English	Article							PEDIATRIC POPULATION; CLAIMS DATA; DRUG-USE; TRENDS; PRESCRIPTIONS; LIMITATIONS; ADHERENCE; NORWAY; AGE	This study aimed to comprehensively describe prevalence and temporal dispensing patterns for medications prescribed to children and adolescents in the United States. Participants were 1.6 million children (49% female) under 18 years old enrolled in a nation-wide, employer-provided insurance plan. All medication claims from 1999-2006 were reviewed retrospectively. Drugs were assigned to 16 broad therapeutic categories. Effects of trend over time, seasonality, age and gender on overall and within category prevalence were examined. Results: Mean monthly prevalence for dispensed medications was 23.5% (range 19.4-27.5), with highest rates in winter and lowest in July. The age group with the highest prevalence was one-year-old children. On average each month, 17.1% of all children were dispensed a single drug and 6.4% were dispensed two or more. Over time, prevalence for two or more drugs did not change, but the proportion of children dispensed a single drug decreased (slope -.02%, p = .001). Overall, boys had higher monthly rates than girls (average difference 0.9%, p = .002). However, differences by gender were greatest during middle childhood, especially for respiratory and central nervous system agents. Contraceptives accounted for a large proportion of dispensed medication to older teenage girls. Rates for the drugs with the highest prevalence in this study were moderately correlated (average Pearson r.66) with those from a previously published national survey. Conclusion: On average, nearly one quarter of a population of insured children in the United States was dispensed medication each month. This rate decreased somewhat over time, primarily because proportionally fewer children were dispensed a single medication. The rate for two or more drugs dispensed simultaneously remained steady.	[Olson, Karen L.; Mandl, Kenneth D.] Childrens Hosp, Informat Program, Harvard MIT Hlth Sci & Technol, Div Emergency Med, Boston, MA 02115 USA; [Olson, Karen L.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Olson, KL (corresponding author), Childrens Hosp, Informat Program, Harvard MIT Hlth Sci & Technol, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	karen.olson@childrens.harvard.edu			National Library of Medicine, National Institutes of Health [R01 LM007677]; NATIONAL LIBRARY OF MEDICINE [R01LM007677] Funding Source: NIH RePORTER	National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by R01 LM007677 from the National Library of Medicine, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers R, 2009, ARCH DIS CHILD, V94, P443, DOI 10.1136/adc.2008.144386; Berg C, 2009, NORWEGIAN PRESCRIPTI; Blix HS, 2007, J ANTIMICROB CHEMOTH, V59, P971, DOI 10.1093/jac/dkm032; Christensen L, 2010, CURR MED RES OPIN, V26, P977, DOI 10.1185/03007991003673617; Clavenna A, 2009, EUR J PEDIATR, V168, P173, DOI 10.1007/s00431-008-0725-y; Clavenna A, 2009, EUR J CLIN PHARMACOL, V65, P749, DOI 10.1007/s00228-009-0679-7; Cox ER, 2008, PEDIATRICS, V122, pE1053, DOI 10.1542/peds.2008-0214; Crystal S, 2007, MED CARE, V45, pS58, DOI 10.1097/MLR.0b013e31805371bf; Ellis Alan R, 2010, N C Med J, V71, P9; Fredheim OMS, 2010, PEDIATR ANESTH, V20, P537, DOI 10.1111/j.1460-9592.2010.03310.x; Hameen-Anttila K, 2010, PHARMACOEPIDEM DR S, V19, P400, DOI 10.1002/pds.1887; Hassanin Hanan, 2010, Hawaii Med J, V69, P17; Jain R, 2011, J AM ACAD CHILD PSY, V50, P171, DOI 10.1016/j.jaac.2010.11.005; Karlstad O, 2010, EUR J CLIN PHARMACOL, V66, P399, DOI 10.1007/s00228-009-0749-x; Karve S, 2008, MED CARE, V46, P1125, DOI 10.1097/MLR.0b013e31817924d2; Lasky T, 2009, CLIN THER, V31, P436, DOI 10.1016/j.clinthera.2009.02.003; May DE, 2010, DRUGS, V70, P15, DOI 10.2165/11530540-000000000-00000; Olfson M, 2002, J AM ACAD CHILD PSY, V41, P514, DOI 10.1097/00004583-200205000-00008; Olfson M, 2010, J AM ACAD CHILD PSY, V49, P13, DOI 10.1016/j.jaac.2009.09.003; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Pathak P, 2010, PSYCHIAT SERV, V61, P123, DOI 10.1176/ps.2010.61.2.123; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Tournier M, 2010, PSYCHIAT RES, V179, P57, DOI 10.1016/j.psychres.2010.06.007; Vernacchio L, 2009, PEDIATRICS, V124, P446, DOI 10.1542/peds.2008-2869; Waxmonsky James G, 2005, Essent Psychopharmacol, V6, P262	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40991	10.1371/journal.pone.0040991	http://dx.doi.org/10.1371/journal.pone.0040991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829905	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300043
J	Yuan, XG; Zhang, JY; Yang, LY; Zhang, SL; Chen, BD; Geng, YJ; Wang, Y				Yuan, Xiguo; Zhang, Junying; Yang, Liying; Zhang, Shengli; Chen, Baodi; Geng, Yaojun; Wang, Yue			TAGCNA: A Method to Identify Significant Consensus Events of Copy Number Alterations in Cancer	PLOS ONE			English	Article							ARRAY CGH DATA; CIRCULAR BINARY SEGMENTATION; GENE-EXPRESSION; PROSTATE-CANCER; LUNG-CANCER; ABERRATIONS; TUMORS; IDENTIFICATION; CARCINOMAS; MUTATIONS	Somatic copy number alteration (CNA) is a common phenomenon in cancer genome. Distinguishing significant consensus events (SCEs) from random background CNAs in a set of subjects has been proven to be a valuable tool to study cancer. In order to identify SCEs with an acceptable type I error rate, better computational approaches should be developed based on reasonable statistics and null distributions. In this article, we propose a new approach named TAGCNA for identifying SCEs in somatic CNAs that may encompass cancer driver genes. TAGCNA employs a peel-off permutation scheme to generate a reasonable null distribution based on a prior step of selecting tag CNA markers from the genome being considered. We demonstrate the statistical power of TAGCNA on simulated ground truth data, and validate its applicability using two publicly available cancer datasets: lung and prostate adenocarcinoma. TAGCNA identifies SCEs that are known to be involved with proto-oncogenes (e.g. EGFR, CDK4) and tumor suppressor genes (e.g. CDKN2A, CDKN2B), and provides many additional SCEs with potential biological relevance in these data. TAGCNA can be used to analyze the significance of CNAs in various cancers. It is implemented in R and is freely available at http://tagcna.sourceforge.net/.	[Yuan, Xiguo; Zhang, Junying; Yang, Liying; Chen, Baodi; Geng, Yaojun] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Wang, Yue] Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp, Arlington, VA USA; [Zhang, Shengli] Xidian Univ, Dept Math, Xian, Peoples R China	Xidian University; Virginia Polytechnic Institute & State University; Xidian University	Yuan, XG (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	jyzhang@mail.xidian.edu.cn; yuewang@vt.edu			Natural Science Foundation of China [61070137, 91130006, 60933009]; US National Institutes of Health [CA160036, CA149147, GM085665]; Natural Science Basic Research Plan in Shaanxi Province of China [2012JQ8027]; Science and Technology Research Development Program in Shaanxi province of China [2009K01-56]; Fundamental Research Funds for the Central Universities [K50511030002]; NATIONAL CANCER INSTITUTE [U54CA149147, U24CA160036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM085665] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Basic Research Plan in Shaanxi Province of China; Science and Technology Research Development Program in Shaanxi province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Natural Science Foundation of China under Grants 61070137, 91130006, and 60933009; the US National Institutes of Health under Grants CA160036, CA149147, and GM085665; and the Project Supported by Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2012JQ8027); the Science and Technology Research Development Program in Shaanxi province of China (No. 2009K01-56), and the Fundamental Research Funds for the Central Universities (No. K50511030002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Choi HW, 2010, J COMPUT BIOL, V17, P121, DOI 10.1089/cmb.2009.0019; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Goransson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006057; Guttman M, 2007, PLOS GENET, V3, P1464, DOI 10.1371/journal.pgen.0030143; Houlden H, 2009, NEUROLOGY, V72, P617, DOI 10.1212/01.wnl.0000342463.35089.cc; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kim Jihoon, 2010, THESIS; Klijn C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1143; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nof E, 2007, CIRCULATION, V116, P463, DOI 10.1161/CIRCULATIONAHA.107.706887; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Outi S, 2006, GENE COPY NUMBER ALT; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Rose AE, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-70; Rueda OM, 2010, CURR BIOINFORM, V5, P1; Sawasaki T, 2004, TUMOR BIOL, V25, P141, DOI 10.1159/000079146; Shah SP, 2008, CYTOGENET GENOME RES, V123, P343, DOI 10.1159/000184726; Shah SP, 2007, BIOINFORMATICS, V23, pI450, DOI 10.1093/bioinformatics/btm221; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Treutlein J, 2009, SCHIZOPHR RES, V111, P123, DOI 10.1016/j.schres.2009.03.011; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vocke CD, 1996, CANCER RES, V56, P2411; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; Wattenhofer M, 2002, J MOL MED-JMM, V80, P124, DOI 10.1007/s00109-001-0310-6; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Yu GQ, 2011, BIOINFORMATICS, V27, P1473, DOI 10.1093/bioinformatics/btr183; Zhang QY, 2010, BIOINFORMATICS, V26, P464, DOI 10.1093/bioinformatics/btp708	34	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41082	10.1371/journal.pone.0041082	http://dx.doi.org/10.1371/journal.pone.0041082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815924	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900073
J	Forsythe, P; Wang, BX; Khambati, I; Kunze, WA				Forsythe, Paul; Wang, Binxiang; Khambati, Ibrahim; Kunze, Wolfgang A.			Systemic Effects of Ingested Lactobacillus Rhamnosus: Inhibition of Mast Cell Membrane Potassium (IKCa) Current and Degranulation	PLOS ONE			English	Article							K+ CHANNEL K(CA)3.1; PASSIVE CUTANEOUS ANAPHYLAXIS; ORAL TREATMENT; IMMUNOMODULATION; EXPRESSION; BACTERIA; REUTERI; MODEL; MICE; MIGRATION	Exposure of the intestine to certain strains lactobacillus can have systemic immune effects that include the attenuation of allergic responses. Despite the central role of mast cells in allergic disease little is known about the effect of lactobacilli on the function of these cells. To address this we assessed changes in rat mast cell activation following oral treatment with a strain of Lactobacillus known to attenuate allergic responses in animal models. Sprague Dawley rats were fed with L.rhamnosus JB-1 (1x10(9)) or vehicle control for 9 days. Mediator release from peritoneal mast cells (RPMC) was determined in response to a range of stimuli. Passive cutaneous anaphylaxis (PCA) was used to assess mast cell responses in vivo. The Ca2+ activated K+ channel (KCa3.1) current, identified as critical to mast cell degranulation, was monitored by whole cell patch-clamp. L.rhamnosus JB-1 treatment lead to significant inhibition of mast cell mediator release in response to a range of stimuli including IgE mediated activation. Furthermore, the PCA response was significantly reduced in treated rats. Patch-clamp studies revealed that RPMC from treated animals were much less responsive to the KCa3.1 opener, DCEBIO. These studies demonstrate that Ingestion of L. rhamnosus JB-1 leads to mast cell stabilization in rats and identify KCa3.1 as an immunomodulatory target for certain lactobacilli. Thus the systemic effects of certain candidate probiotics may include mast cell stabilization and such actions could contribute to the beneficial effect of these organisms in allergic and other inflammatory disorders.	[Forsythe, Paul; Wang, Binxiang; Khambati, Ibrahim; Kunze, Wolfgang A.] McMaster Univ, Brain Body Inst, Hamilton, ON, Canada; [Forsythe, Paul] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Kunze, Wolfgang A.] McMaster Univ, Dept Psychiat, Hamilton, ON, Canada; [Wang, Binxiang] McMaster Univ, Ctr Simulat Based Learning, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Forsythe, P (corresponding author), McMaster Univ, Brain Body Inst, Hamilton, ON, Canada.	forsytp@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada [371513-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada, grant number 371513-2009 (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba N, 2009, IMMUNOLOGY, V128, pe523, DOI 10.1111/j.1365-2567.2008.03022.x; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; BISSONNETTE EY, 1990, J IMMUNOL, V145, P3385; Bradding P, 2005, CHEM IMMUNOL ALLERGY, V87, P163, DOI 10.1159/000087643; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Duffy SM, 2008, EUR J IMMUNOL, V38, P2548, DOI 10.1002/eji.200738106; Duffy SM, 2007, EUR J IMMUNOL, V37, P1653, DOI 10.1002/eji.200637024; Duffy SM, 2005, FASEB J, V19, P1006, DOI 10.1096/fj.04-3439fje; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Eisenhut M, 2011, PFLUG ARCH EUR J PHY, V461, P401, DOI 10.1007/s00424-010-0917-y; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Forsythe P, 2010, IMMUNOL INVEST, V39, P429, DOI 10.3109/08820131003667978; Hille B, 1984, IONIC CHANNELS EXCIT; Hisbergues M, 2007, CLIN EXP ALLERGY, V37, P1286, DOI 10.1111/j.1365-2222.2007.02792.x; Inoue R, 2007, BRIT J DERMATOL, V156, P499, DOI 10.1111/j.1365-2133.2006.07695.x; Iwabuchi N, 2009, FEMS IMMUNOL MED MIC, V55, P324, DOI 10.1111/j.1574-695X.2008.00510.x; Kamiya T, 2006, GUT, V55, P191, DOI 10.1136/gut.2005.070987; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; KATAYAMA S, 1978, MICROBIOL IMMUNOL, V22, P89, DOI 10.1111/j.1348-0421.1978.tb00352.x; Kawase M, 2010, LETT APPL MICROBIOL, V51, P6, DOI 10.1111/j.1472-765X.2010.02849.x; Kim JY, 2008, J MICROBIOL BIOTECHN, V18, P1393; KNUDSEN T, 1995, DAN MED BULL, V42, P441; KODA A, 1990, INT ARCH ALLER A IMM, V92, P209, DOI 10.1159/000235179; Kunze WA, 2007, SCIENCE UNPUB; Kunze WA, 2009, J CELL MOL MED, V13, P2261, DOI 10.1111/j.1582-4934.2009.00686.x; Kwon HK, P NATL ACAD SCI US, V107, P2159; Lyons A, CLIN EXP ALLERGY, V40, P811; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; Magerl M, 2008, EXP DERMATOL, V17, P427, DOI 10.1111/j.1600-0625.2008.00704.x; Mao YK, 2006, J NEUROPHYSIOL, V96, P998, DOI 10.1152/jn.00204.2006; Maurer M, 2003, EXP DERMATOL, V12, P886, DOI 10.1111/j.0906-6705.2003.0109a.x; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; NEMETH A, 1990, AGENTS ACTIONS, V30, P143; Oksaharju A, 2011, WORLD J GASTROENTERO, V17, P750, DOI 10.3748/wjg.v17.i6.750; OSKERITZIAN C, 1993, INT ARCH ALLERGY IMM, V100, P56; Rivera J, 2008, CURR ALLERGY ASTHM R, V8, P14, DOI 10.1007/s11882-008-0004-z; Rugiero F, 2002, J PHYSIOL-LONDON, V538, P447, DOI 10.1113/jphysiol.2001.013051; Schiffer C, 2011, J IMMUNOL, V187, P2646, DOI 10.4049/jimmunol.1002415; SCHWARTZ LB, 1980, J INVEST DERMATOL, V74, P349, DOI 10.1111/1523-1747.ep12543620; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Vancanneyt M, 2006, APPL ENVIRON MICROB, V72, P5376, DOI 10.1128/AEM.00091-06; Vliagoftis H, 2005, IMMUNOL REV, V206, P190, DOI 10.1111/j.0105-2896.2005.00279.x; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640	48	29	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41234	10.1371/journal.pone.0041234	http://dx.doi.org/10.1371/journal.pone.0041234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815978	gold, Green Published, Green Submitted			2022-12-25	WOS:000306507000084
J	Blohm, G				Blohm, Gunnar			Simulating the Cortical 3D Visuomotor Transformation of Reach Depth	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; EYE-HAND COORDINATION; PRIMARY MOTOR CORTEX; CAT STRIATE CORTEX; INTERSTITIAL NUCLEUS; VISUAL-CORTEX; RETINAL DISPARITY; BINOCULAR VISION; REFERENCE FRAME; CYCLOPEAN EYE	We effortlessly perform reach movements to objects in different directions and depths. However, how networks of cortical neurons compute reach depth from binocular visual inputs remains largely unknown. To bridge the gap between behavior and neurophysiology, we trained a feed-forward artificial neural network to uncover potential mechanisms that might underlie the 3D transformation of reach depth. Our physiologically-inspired 4-layer network receives distributed 3D visual inputs (1st layer) along with eye, head and vergence signals. The desired motor plan was coded in a population (3rd layer) that we read out (4th layer) using an optimal linear estimator. After training, our network was able to reproduce all known single-unit recording evidence on depth coding in the parietal cortex. Network analyses predict the presence of eye/head and vergence changes of depth tuning, pointing towards a gain-modulation mechanism of depth transformation. In addition, reach depth was computed directly from eye-centered (relative) visual distances, without explicit absolute depth coding. We suggest that these effects should be observable in parietal and pre-motor areas.	Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada	Queens University - Canada	Blohm, G (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.	gunnar.blohm@queensu.ca		Blohm, Gunnar/0000-0002-2297-3271	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Ontario Research Fund (Canada); Botterell Foundation (Queen's University, Kingston, Ontario, Canada)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund (Canada); Botterell Foundation (Queen's University, Kingston, Ontario, Canada)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Foundation for Innovation, the Ontario Research Fund (Canada) and the Botterell Foundation (Queen's University, Kingston, Ontario, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2011, J NEUROSCI, V31, P10270, DOI 10.1523/JNEUROSCI.5956-10.2011; Baraduc P, 2001, CEREB CORTEX, V11, P906, DOI 10.1093/cercor/11.10.906; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Batista AP, 2007, J NEUROPHYSIOL; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Bhattacharyya R, 2009, J NEUROPHYSIOL, V102, P805, DOI 10.1152/jn.90359.2008; Blohm G, 2009, NEURON, V64, P598, DOI 10.1016/j.neuron.2009.11.022; Blohm G, 2007, J VISION, V7, DOI 10.1167/7.5.4; Blohm G, 2008, J VISION, V8, DOI 10.1167/8.16.3; Blohm G, 2009, CEREB CORTEX, V19, P1372, DOI 10.1093/cercor/bhn177; Bockisch CJ, 2001, VISION RES, V41, P2127, DOI 10.1016/S0042-6989(01)00094-3; Brotchie PR, 2003, NEUROIMAGE, V18, P178, DOI 10.1006/nimg.2002.1294; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2005, NEUROPSYCHOLOGIA; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; Burns JK, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00221; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; CRAWFORD JD, 1994, J NEUROSCI, V14, P6911; CRAWFORD JD, 1992, J NEUROPHYSIOL, V68, P432, DOI 10.1152/jn.1992.68.2.432; CRAWFORD JD, 1991, SCIENCE, V252, P1551, DOI 10.1126/science.2047862; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Ferraina S, 2009, J NEUROSCI, V29, P11461, DOI 10.1523/JNEUROSCI.1305-09.2009; Ferraina S, 2009, NEUROPSYCHOLOGIA, V47, P1409, DOI 10.1016/j.neuropsychologia.2008.12.028; Flash T, 2001, CURR OPIN NEUROBIOL, V11, P655, DOI 10.1016/S0959-4388(01)00265-3; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; FUKUSHIMA K, 1992, NEUROSCI RES, V13, P301, DOI 10.1016/0168-0102(92)90041-A; FUKUSHIMA K, 1990, EXP BRAIN RES, V79, P25; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; Genovesio A, 2007, J NEUROSCI, V27, P3268, DOI 10.1523/JNEUROSCI.5415-06.2007; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Gnadt JW, 1998, NEUROREPORT, V9, P233, DOI 10.1097/00001756-199801260-00011; Hadjidimitrakis K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023335; Hager WW, 2005, SIAM J OPTIMIZ, V16, P170, DOI 10.1137/030601880; HASLWANTER T, 1992, VISION RES, V32, P1341, DOI 10.1016/0042-6989(92)90226-9; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2003, EXP BRAIN RES, V152, P70, DOI 10.1007/s00221-003-1523-4; Henriques DYP, 2002, ANN NY ACAD SCI, V956, P515, DOI 10.1111/j.1749-6632.2002.tb02870.x; HEPP K, 1995, VISION RES, V35, P3237, DOI 10.1016/0042-6989(95)00104-M; Hermundstad AM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002063; Howard I. P., 2008, SEEING DEPTH; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Keith GP, 2007, J COMPUT NEUROSCI; Khokhotva M, 2005, VISION RES, V45, P2339, DOI 10.1016/j.visres.2005.04.007; KING WM, 1981, J NEUROPHYSIOL, V46, P549, DOI 10.1152/jn.1981.46.3.549; Krug K, 2011, J NEUROSCI, V31, P17892, DOI 10.1523/JNEUROSCI.2658-11.2011; LEHKY SR, 1990, PROC R SOC SER B-BIO, V240, P251, DOI 10.1098/rspb.1990.0037; MARSAGLIA G, 1972, ANN MATH STAT, V43, P645, DOI 10.1214/aoms/1177692644; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; Merriam ER, 2005, NEUROSCIENTIST, V11, P484, DOI 10.1177/1073858405276871; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; MULLER ME, 1959, COMMUN ACM, V2, P19, DOI 10.1145/377939.377946; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P556, DOI 10.1113/jphysiol.1966.sp008002; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Neri P, 2005, J NEUROPHYSIOL, V93, P1823, DOI 10.1152/jn.01068.2004; NIKARA T, 1968, EXP BRAIN RES, V6, P353; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; Ono H, 2002, VISION RES, V42, P1307, DOI 10.1016/S0042-6989(01)00281-4; ONO H, 1982, PERCEPT PSYCHOPHYS, V32, P201, DOI 10.3758/BF03206224; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P391; POGGIO GF, 1995, CEREB CORTEX, V5, P193, DOI 10.1093/cercor/5.3.193; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; POLAK E, 1969, REV FR INFORM RECH O, V3, P35; Polyak B.T., 1969, USSR COMP MATH MATH, V9, P94, DOI DOI 10.1016/0041-5553(69)90035-4; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; POUGET A, 1994, CEREB CORTEX, V4, P314, DOI 10.1093/cercor/4.3.314; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Read J, 2005, PROG BIOPHYS MOL BIO, V87, P77, DOI 10.1016/j.pbiomolbio.2004.06.005; Read JCA, 2006, J VISION, V6, P1323, DOI 10.1167/6.12.1; Roe AW, 2007, J NEUROSCI, V27, P11820, DOI 10.1523/JNEUROSCI.4164-07.2007; Rushworth MFS, 2006, NEUROPSYCHOLOGIA, V44, P2700, DOI 10.1016/j.neuropsychologia.2005.12.007; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SALINAS E, 1995, J NEUROSCI, V15, P6461; Salinas E, 2001, Prog Brain Res, V130, P175; Scott SH, 2003, CURR OPIN NEUROBIOL, V13, P671, DOI 10.1016/j.conb.2003.10.012; Scott SH, 2001, NAT NEUROSCI, V4, P969, DOI 10.1038/nn1001-969; Smith MA, 2005, J NEUROPHYSIOL, V93, P1742, DOI 10.1152/jn.00306.2004; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Soechting J F, 1990, J Cogn Neurosci, V2, P32, DOI 10.1162/jocn.1990.2.1.32; Somani RAB, 1998, VISION RES, V38, P911, DOI 10.1016/S0042-6989(97)00228-9; SUZUKI Y, 1995, EXP BRAIN RES, V106, P215; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tsutsui KI, 2005, NEUROSCI RES, V51, P221, DOI 10.1016/j.neures.2004.11.006; Tweed D, 1997, J NEUROPHYSIOL, V77, P654, DOI 10.1152/jn.1997.77.2.654; Uka T, 2002, CURR BIOL, V12, pR764, DOI 10.1016/S0960-9822(02)01287-3; VANRIJN LJ, 1993, VISION RES, V33, P691, DOI 10.1016/0042-6989(93)90189-4; Westheimer G, 2009, J PHYSIOL-LONDON, V587, P2807, DOI 10.1113/jphysiol.2009.170175; Wilcox LM, 2009, VISION RES, V49, P2653, DOI 10.1016/j.visres.2009.06.004; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Yang Y, 2011, J NEUROSCI, V31, P17905, DOI 10.1523/JNEUROSCI.4032-11.2011; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	103	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41241	10.1371/journal.pone.0041241	http://dx.doi.org/10.1371/journal.pone.0041241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815979	Green Submitted, gold, Green Published			2022-12-25	WOS:000306466100126
J	Ke, G; Liang, L; Yang, JM; Huang, X; Han, D; Huang, S; Zhao, Y; Zha, R; He, X; Wu, X				Ke, G.; Liang, L.; Yang, J. M.; Huang, X.; Han, D.; Huang, S.; Zhao, Y.; Zha, R.; He, X.; Wu, X.			MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene	ONCOGENE			English	Article						miR-181a; PRKCD; apoptosis; cervical cancer; radiation therapy	KINASE-C-DELTA; CASPASE ACTIVATION; MICRORNAS; CELLS	The purpose of this study was to define the roles of miR-181a in determining sensitivity of cervical cancer to radiation therapy, to explore the underlying mechanism and to evaluate the potential of miR-181a as a biomarker for predicting radio-sensitivity. Tumor specimens from 18 patients with a histological diagnosis of squamous cervical carcinoma (stage IIIB) were used in the micro-RNA profiling and comparison. These patients never received any chemotherapy before radiation therapy. Human cervical cancer cell lines, SiHa and Me180, were used in vitro (cell culture) and in vivo (animal) studies. Transfection of tumor cells with the mimic or inhibitor of miR-181a, and reporter gene assay, were performed to investigate the role of miR-181a in determining radio-sensitivity and the target gene. Higher expression of miR-181a was observed in human cervical cancer specimens and cell lines that were insensitive to radiation therapy, as compared with sensitive cancer specimens and the cell lines. We also found that miR-181a negatively regulated the expression of PRKCD, a pro-apoptotic protein kinase, via targeting its 3'-untranslated region (UTR), thereby inhibiting irradiation-induced apoptosis and decreasing G(2)/M block. The role of miR-181a in conferring cellular resistance to radiation treatment was validated both in cell culture models and in mouse tumor xenograft models. The effect of miR-181a on radio-resistance was mediated through targeting the 3'-UTR of PRKCD gene. Thus, the expression level of miR-181a in cervical cancer may serve as a biomarker for sensitivity to radiation therapy, and targeting miR-181a may represent a new approach to sensitizing cervical cancer to radiation treatment.	[Ke, G.; Huang, X.; Han, D.; Wu, X.] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200433, Peoples R China; [Ke, G.; Huang, X.; Han, D.; Wu, X.] Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Liang, L.; Huang, S.; Zhao, Y.; Zha, R.; He, X.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China; [Yang, J. M.] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; [Yang, J. M.] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA; [Yang, J. M.] Milton S Hershey Med Ctr, Hershey, PA USA	Fudan University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	He, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China.	xhhe@shsci.org; docwuxh@hotmail.com	liang, linhui/AAW-4176-2021; He, Xianghuo/I-1497-2014; Huang, Shenglin/N-9472-2018	He, Xianghuo/0000-0001-8872-668X; Huang, Shenglin/0000-0003-1279-0794	National Natural Science Foundation of China [81072128]; Science and Technology Commission of Shanghai Municipality (Academic leader foundation of Shanghai) [09XD1401100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (Academic leader foundation of Shanghai)	We are most grateful for the pWPXL, psPAX2 and pMD2.Glentivirus plasmids that were provided by Professor Didier Trono from the School of Life Sciences, EcolePoly technique Federale de Lausanne, 1015 Lausanne, Switzerland. This work was supported by National Natural Science Foundation of China (No. 81072128), and Science and Technology Commission of Shanghai Municipality (Academic leader foundation of Shanghai, 09XD1401100).	Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Denning MF, 1998, J BIOL CHEM, V273, P29995, DOI 10.1074/jbc.273.45.29995; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Gschwendt M, 1999, EUR J BIOCHEM, V259, P555, DOI 10.1046/j.1432-1327.1999.00120.x; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Hu X, 2001, CANCER RES, V70, P1441; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu ZM, 1997, MOL CELL BIOL, V17, P3418, DOI 10.1128/MCB.17.6.3418; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869	21	128	141	2	27	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2013	32	25					3019	3027		10.1038/onc.2012.323	http://dx.doi.org/10.1038/onc.2012.323			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22847611	Bronze			2022-12-25	WOS:000320705700002
J	Wang, P; Dong, Q; Zhang, C; Kuan, PF; Liu, Y; Jeck, WR; Andersen, JB; Jiang, W; Savich, GL; Tan, TX; Auman, JT; Hoskins, JM; Misher, AD; Moser, CD; Yourstone, SM; Kim, JW; Cibulskis, K; Getz, G; Hunt, HV; Thorgeirsson, SS; Roberts, LR; Ye, D; Guan, KL; Xiong, Y; Qin, LX; Chiang, DY				Wang, P.; Dong, Q.; Zhang, C.; Kuan, P-F; Liu, Y.; Jeck, W. R.; Andersen, J. B.; Jiang, W.; Savich, G. L.; Tan, T-X; Auman, J. T.; Hoskins, J. M.; Misher, A. D.; Moser, C. D.; Yourstone, S. M.; Kim, J. W.; Cibulskis, K.; Getz, G.; Hunt, H. V.; Thorgeirsson, S. S.; Roberts, L. R.; Ye, D.; Guan, K-L; Xiong, Y.; Qin, L-X; Chiang, D. Y.			Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas	ONCOGENE			English	Article						DNA methylation; epigenetics; tumor metabolism	CELL SELF-RENEWAL; IDH2 MUTATIONS; OLLIER DISEASE; TET PROTEINS; PHENOTYPE; DNA; 5-METHYLCYTOSINE; EXPRESSION; CONVERSION; EVENTS	Mutations in the genes encoding isocitrate dehydrogenase, IDH1 and IDH2, have been reported in gliomas, myeloid leukemias, chondrosarcomas and thyroid cancer. We discovered IDH1 and IDH2 mutations in 34 of 326 (10%) intrahepatic cholangiocarcinomas. Tumor with mutations in IDH1 or IDH2 had lower 5-hydroxymethylcytosine and higher 5-methylcytosine levels, as well as increased dimethylation of histone H3 lysine 79 (H3K79). Mutations in IDH1 or IDH2 were associated with longer overall survival (P = 0.028) and were independently associated with a longer time to tumor recurrence after intrahepatic cholangiocarcinoma resection in multivariate analysis (P = 0.021). IDH1 and IDH2 mutations were significantly associated with increased levels of p53 in intrahepatic cholangiocarcinomas, but no mutations in the p53 gene were found, suggesting that mutations in IDH1 and IDH2 may cause a stress that leads to p53 activation. We identified 2309 genes that were significantly hypermethylated in 19 cholangiocarcinomas with mutations in IDH1 or IDH2, compared with cholangiocarcinomas without these mutations. Hypermethylated CpG sites were significantly enriched in CpG shores and upstream of transcription start sites, suggesting a global regulation of transcriptional potential. Half of the hypermethylated genes overlapped with DNA hypermethylation in IDH1-mutant gliobastomas, suggesting the existence of a common set of genes whose expression may be affected by mutations in IDH1 or IDH2 in different types of tumors.	[Wang, P.; Jiang, W.; Guan, K-L; Xiong, Y.] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200032, Peoples R China; [Wang, P.; Jiang, W.; Ye, D.; Guan, K-L; Xiong, Y.] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Dong, Q.; Qin, L-X] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China; [Dong, Q.; Qin, L-X] Fudan Univ, Zhongshan Hosp, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Zhang, C.; Liu, Y.] Univ N Carolina, Carolina Ctr Genome Sci, Dept Stat & Operat Res, Chapel Hill, NC 27599 USA; [Kuan, P-F] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Kuan, P-F; Jeck, W. R.; Savich, G. L.; Tan, T-X; Auman, J. T.; Hoskins, J. M.; Misher, A. D.; Yourstone, S. M.; Xiong, Y.; Chiang, D. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Jeck, W. R.; Savich, G. L.; Tan, T-X; Yourstone, S. M.; Chiang, D. Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Andersen, J. B.; Thorgeirsson, S. S.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Auman, J. T.; Hoskins, J. M.; Misher, A. D.] Univ N Carolina, Inst Pharmacogen & Individualized Med, Chapel Hill, NC 27599 USA; [Moser, C. D.; Roberts, L. R.] Mayo Clin, Ctr Canc, Ctr Cell Signaling Gastroenterol, Div Gastroenterol & Hepatol, Rochester, MN USA; [Kim, J. W.] Wake Forest Univ, Baptist Med Ctr, Ctr Canc Genom, Winston Salem, NC 27109 USA; [Cibulskis, K.; Getz, G.] 7 Cambridge Ctr, Broad Inst, Genome Sequencing Anal Program & Platform, Cambridge, MA USA; [Hunt, H. V.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Guan, K-L] Fudan Univ, Shanghai Med Coll, Dept Biochem, Shanghai 200032, Peoples R China; [Guan, K-L] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, K-L] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Xiong, Y.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; University of North Carolina Chapel Hill; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295,450 West Dr, Chapel Hill, NC 27599 USA.	yxiong@email.unc.edu; qin.lunxiu@zs-hospital.sh.cn; chiang@med.unc.edu	Core, Mammalian Genotyping/AFU-1631-2022; Cibulskis, Kristian/AAC-7380-2019; , Pathology Services Core/CEZ-2246-2022; Chiang, Derek/L-6452-2019; Kuan, Pei Fen/GRX-4622-2022; Facility, Biospecimen Processing/AAC-7837-2022; Guan, Kun-Liang/ADK-7088-2022	Chiang, Derek/0000-0002-1131-6065; Tan, Ting Xu/0000-0002-7067-898X; Andersen, Jesper B/0000-0003-1760-5244; Roberts, Lewis/0000-0001-7885-8574; Kim, Johnny/0000-0002-5226-5460; Cibulskis, Kristian/0000-0003-1343-1582; Auman, James/0000-0002-9328-8829	985 Program from the Chinese Ministry of Education; MOST 973 [2009CB918401, 2011CB910600, 2012CB910300, 2012CB910101]; NSFC Program of International Cooperation and Exchanges [81120108016]; China National Key Projects for Infectious Disease [2008ZX10002-021, 2012ZX10002-012]; National Institutes of Health; James S McDonnell Foundation; Samuel Waxman Cancer Research Foundation; American Gastroenterological Association Foundation for Digestive Health and Nutrition; Alfred P Sloan Foundation; Nancy Stegman Cancer Research Fund; University Cancer Research Fund	985 Program from the Chinese Ministry of Education(Ministry of Education, China); MOST 973(National Basic Research Program of China); NSFC Program of International Cooperation and Exchanges; China National Key Projects for Infectious Disease; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S McDonnell Foundation; Samuel Waxman Cancer Research Foundation; American Gastroenterological Association Foundation for Digestive Health and Nutrition; Alfred P Sloan Foundation(Alfred P. Sloan Foundation); Nancy Stegman Cancer Research Fund; University Cancer Research Fund	The UNC Biospecimen Core Facility, Mammalian Genotyping Core Facility and Translational Pathology Laboratory provided technical assistance for this study. Funding for this research was provided by: the 985 Program from the Chinese Ministry of Education (KLG, YX), MOST 973 (No. 2009CB918401, No. 2011CB910600, No. 2012CB910300, No. 2012CB910101; DY, YX and KLG); the NSFC Program of International Cooperation and Exchanges (No. 81120108016; LXQ, YX) and the China National Key Projects for Infectious Disease (2008ZX10002-021, 2012ZX10002-012; LZQ), the National Institutes of Health (KLG, YX, SST, LRR), the James S McDonnell Foundation (YX), the Samuel Waxman Cancer Research Foundation (YX), the American Gastroenterological Association Foundation for Digestive Health and Nutrition (LRR), the Alfred P Sloan Foundation fellowship (DYC), the Nancy Stegman Cancer Research Fund (DYC) and the University Cancer Research Fund (DYC, YX).	Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Aishima S, 2006, HISTOPATHOLOGY, V49, P35, DOI 10.1111/j.1365-2559.2006.02414.x; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Andersen JB, 2012, GASTROENTEROLOGY, V142, P1021, DOI 10.1053/j.gastro.2011.12.005; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cardinale V, 2012, NAT REV GASTRO HEPAT, V9, P231, DOI 10.1038/nrgastro.2012.23; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kipp BR, 2012, HUM PATHOL; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shibata T, 2011, AM J PATHOL, V178, P1395, DOI 10.1016/j.ajpath.2010.12.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	46	262	291	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2013	32	25					3091	3100		10.1038/onc.2012.315	http://dx.doi.org/10.1038/onc.2012.315			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22824796	Green Accepted, Green Submitted			2022-12-25	WOS:000320705700009
J	Parazzoli, S; Harmon, JS; Vallerie, SN; Zhang, T; Zhou, HR; Robertson, RP				Parazzoli, Susan; Harmon, Jamie S.; Vallerie, Sara N.; Zhang, Tao; Zhou, Huarong; Robertson, R. Paul			Cyclooxygenase-2, Not Microsomal Prostaglandin E Synthase-1, Is the Mechanism for Interleukin-1 beta-induced Prostaglandin E-2 Production and Inhibition of Insulin Secretion in Pancreatic Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGE2 INHIBITION; MICE LACKING; ISOLATED RAT; IN-VIVO; EXPRESSION; IDENTIFICATION; GENE; PURIFICATION; IL-1-BETA; INDUCTION	Arachidonic acid is converted to prostaglandin E-2 (PGE(2)) by a sequential enzymatic reaction performed by two isoenzyme groups, cyclooxygenases (COX-1 and COX-2) and terminal prostaglandin E synthases (cPGES, mPGES-1, and mPGES-2). mPGES-1 is widely considered to be the final enzyme regulating COX-2-dependent PGE(2) synthesis. These generalizations have been based in most part on experiments utilizing gene expression analyses of cell lines and tumor tissue. To assess the relevance of these generalizations to a native mammalian tissue, we used isolated human and rodent pancreatic islets to examine interleukin (IL)-1 beta-induced PGE(2) production, because PGE(2) has been shown to mediate IL-1 beta inhibition of islet function. Rat islets constitutively expressed mRNAs of COX-1, COX-2, cPGES, and mPGES-1. As expected, IL-1 beta increased mRNA levels for COX-2 and mPGES-1, but not for COX-1 or cPGES. Basal protein levels of COX-1, cPGES, and mPGES-2 were readily detected in whole cell extracts but were not regulated by IL-1 beta. IL-1 beta increased protein levels of COX-2, but unexpectedly mPGES-1 protein levels were low and unaffected. In microsomal extracts, mPGES-1 protein was barely detectable in rat islets but clearly present in human islets; however, in neither case did IL-1 beta increase mPGES-1 protein levels. To further assess the importance of mPGES-1 to IL-1 beta regulation of an islet physiologic response, glucose-stimulated insulin secretion was examined in isolated islets of WT and mPGES-1-deficient mice. IL-1 beta inhibited glucose-stimulated insulin secretion equally in both WT and mPGES-1(-/-) islets, indicating that COX-2, not mPGES-1, mediates IL-1 beta-induced PGE(2) production and subsequent inhibition of insulin secretion.	[Robertson, R. Paul] Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA 98122 USA; [Robertson, R. Paul] Univ Washington, Div Metab Endocrinol & Nutr, Dept Pharmacol, Seattle, WA 98122 USA; [Robertson, R. Paul] Univ Washington, Pacific NW Diabet Res Inst, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pacific Northwest Diabetes Research Institute (PNDRI); University of Washington; University of Washington Seattle	Robertson, RP (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, 720 Broadway, Seattle, WA 98122 USA.	rpr@pnri.org	Roberston, R Paul/AAX-5613-2021		National Institutes of Health [NIDDK R01 38325]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health Grant NIDDK R01 38325 (to R. P. R.).	Asano K, 1996, AM J PHYSIOL-LUNG C, V271, pL126, DOI 10.1152/ajplung.1996.271.1.L126; Bage T, 2007, BBA-MOL CELL RES, V1773, P1589, DOI 10.1016/j.bbamcr.2007.07.008; Burke SJ, 2011, CELL IMMUNOL, V271, P379, DOI 10.1016/j.cellimm.2011.08.004; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; FU JY, 1990, J BIOL CHEM, V265, P16737; Guan YF, 2001, AM J PHYSIOL-RENAL, V281, pF1173, DOI 10.1152/ajprenal.0116.2001; Han R, 2002, J BIOL CHEM, V277, P36897, DOI 10.1074/jbc.M206949200; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Meng ZX, 2009, ENDOCRINOLOGY, V150, P5284, DOI 10.1210/en.2009-0671; METZ SA, 1981, DIABETES, V30, P551, DOI 10.2337/diabetes.30.7.551; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakatani Y, 2007, BIOCHEM BIOPH RES CO, V362, P387, DOI 10.1016/j.bbrc.2007.07.180; Oshima H, 2006, J BIOL CHEM, V281, P29330, DOI 10.1074/jbc.M602424200; Owyang AM, 2010, ENDOCRINOLOGY, V151, P2515, DOI 10.1210/en.2009-1124; PALMER JP, 1989, DIABETES, V38, P1211, DOI 10.2337/diabetes.38.10.1211; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Radilova H, 2009, MOL CELL BIOCHEM, V330, P131, DOI 10.1007/s11010-009-0126-1; ROBERTSON R P, 1986, Diabetes Metabolism Reviews, V2, P261; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; ROBERTSON RP, 1974, J CLIN INVEST, V54, P310, DOI 10.1172/JCI107766; ROBERTSON RP, 1977, J CLIN INVEST, V60, P747, DOI 10.1172/JCI108827; ROBERTSON RP, 1987, DIABETES, V36, P1047, DOI 10.2337/diabetes.36.9.1047; ROSEN GD, 1989, BIOCHEM BIOPH RES CO, V164, P1358, DOI 10.1016/0006-291X(89)91819-6; SEAQUIST ER, 1989, DIABETES, V38, P1439, DOI 10.2337/diabetes.38.11.1439; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; Subbaramaiah K, 2004, J BIOL CHEM, V279, P12647, DOI 10.1074/jbc.M312972200; Sweeney FJ, 2003, MOL CELL ENDOCRINOL, V205, P151, DOI 10.1016/S0303-7207(03)00091-1; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Watanabe K, 1999, BBA-MOL CELL BIOL L, V1439, P406, DOI 10.1016/S1388-1981(99)00084-0; WU KK, 1991, P NATL ACAD SCI USA, V88, P2384, DOI 10.1073/pnas.88.6.2384; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Zawalich WS, 2007, METABOLISM, V56, P12, DOI 10.1016/j.metabol.2006.08.016	45	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32246	32253		10.1074/jbc.M112.364612	http://dx.doi.org/10.1074/jbc.M112.364612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822059	Green Published, hybrid			2022-12-25	WOS:000309059400061
J	Bogel, G; Gujdar, A; Geiszt, M; Lanyi, A; Fekete, A; Sipeki, S; Downward, J; Buday, L				Boegel, Gabor; Gujdar, Annamaria; Geiszt, Miklos; Lanyi, Arpad; Fekete, Anna; Sipeki, Szabolcs; Downward, Julian; Buday, Laszlo			Frank-ter Haar Syndrome Protein Tks4 Regulates Epidermal Growth Factor-dependent Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADAPTER PROTEIN; PX-DOMAIN; PODOSOME FORMATION; RAS ACTIVATION; CANCER-CELLS; ACTIN; INVADOPODIA; CORTACTIN; RECEPTOR	Mutations in the SH3PXD2B gene coding for the Tks4 protein are responsible for the autosomal recessive Frank-ter Haar syndrome. Tks4, a substrate of Src tyrosine kinase, is implicated in the regulation of podosome formation. Here, we report a novel role for Tks4 in the EGF signaling pathway. In EGF-treated cells, Tks4 is tyrosine-phosphorylated and associated with the activated EGF receptor. This association is not direct but requires the presence of Src tyrosine kinase. In addition, treatment of cells with LY294002, an inhibitor of PI 3-kinase, or mutations of the PX domain reduces tyrosine phosphorylation and membrane translocation of Tks4. Furthermore, a PX domain mutant (R43W) Tks4 carrying a reported point mutation in a Frank-ter Haar syndrome patient showed aberrant intracellular expression and reduced phosphoinositide binding. Finally, silencing of Tks4 was shown to markedly inhibit HeLa cell migration in a Boyden chamber assay in response to EGF or serum. Our results therefore reveal a new function for Tks4 in the regulation of growth factor-dependent cell migration.	[Fekete, Anna; Buday, Laszlo] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, H-1113 Budapest, Hungary; [Boegel, Gabor; Gujdar, Annamaria; Sipeki, Szabolcs; Buday, Laszlo] Semmelweis Univ, Sch Med, Dept Med Chem, H-1094 Budapest, Hungary; [Geiszt, Miklos] Semmelweis Univ, Sch Med, Dept Physiol, H-1094 Budapest, Hungary; [Lanyi, Arpad] Univ Debrecen, Inst Immunol, H-4032 Debrecen, Hungary; [Downward, Julian] London Res Inst, Canc Res United Kingdom, London WC2A 3PX, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; Semmelweis University; University of Debrecen; Cancer Research UK; University of London; University College London	Buday, L (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Karolina St 29, H-1113 Budapest, Hungary.	buday@enzim.hu		Downward, Julian/0000-0002-2331-4729; Sipeki, Szabolcs/0000-0002-9678-6743	Hungarian Research Fund OTKA [K 83867, K 81676]; Hungarian Academy of Sciences; Social Reform Operative Program (TAMOP) [4.2.1/B-09/1/KONV/ 2010-007]; New Hungary Development Plan; European Social Fund; Cancer Research UK [15680] Funding Source: researchfish	Hungarian Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Social Reform Operative Program (TAMOP); New Hungary Development Plan; European Social Fund(European Social Fund (ESF)); Cancer Research UK(Cancer Research UK)	This work was supported by Hungarian Research Fund OTKA Grants K 83867 and K 81676 and by the "Lendulet" grants from the Hungarian Academy of Sciences (to L. B. and M. G.), by the Social Reform Operative Program (TAMOP) 4.2.1/B-09/1/KONV/ 2010-007 Project (to A. L.), and by the New Hungary Development Plan, co-financed by the European Social Fund.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Belsches A P, 1997, Front Biosci, V2, pd501; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; DIAKONOVA M, 1995, J CELL SCI, V108, P2499; Ellson CD, 2002, J CELL SCI, V115, P1099; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Gianni D, 2011, EUR J CELL BIOL, V90, P164, DOI 10.1016/j.ejcb.2010.05.007; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Gianni D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000370; Hishida T, 2008, FEBS J, V275, P5576, DOI 10.1111/j.1742-4658.2008.06682.x; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Lanyi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023653; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Mao M, 2009, MAMM GENOME, V20, P462, DOI 10.1007/s00335-009-9210-9; Murphy DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022499; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	36	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31321	31329		10.1074/jbc.M111.324897	http://dx.doi.org/10.1074/jbc.M111.324897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829589	Green Published, hybrid			2022-12-25	WOS:000308791300043
J	Zamora, R; Azhar, N; Namas, R; Metukuri, MR; Clermont, T; Gladstone, C; Namas, RA; Hermus, L; Megas, C; Constantine, G; Billiar, TR; Fink, MP; Vodovotz, Y				Zamora, Ruben; Azhar, Nabil; Namas, Rajaie; Metukuri, Mallikarjuna R.; Clermont, Thierry; Gladstone, Chase; Namas, Rami A.; Hermus, Linda; Megas, Cristina; Constantine, Gregory; Billiar, Timothy R.; Fink, Mitchell P.; Vodovotz, Yoram			Identification of a Novel Pathway of Transforming Growth Factor-beta 1 Regulation by Extracellular NAD(+) in Mouse Macrophages IN VITRO AND IN SILICO STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; GROWTH-FACTOR-BETA; CYCLIC ADP-RIBOSE; CYTOTOXIC T-CELLS; SPLITTING ENZYME; INTRACELLULAR CALCIUM; NITRIC-OXIDE; TGF-BETA; ACTIVATION; RIBOSYLATION	Extracellular beta-nicotinamide adenine dinucleotide (NAD(+)) is anti-inflammatory. We hypothesized that NAD(+) would modulate the anti-inflammatory cytokine Transforming Growth Factor (TGF)-beta 1. Indeed, NAD(+) led to increases in both active and latent cell-associated TGF-beta 1 in RAW 264.7 mouse macrophages as well as in primary peritoneal macrophages isolated from both C3H/HeJ (TLR4-mutant) and C3H/HeOuJ (wild-type controls for C3H/HeJ) mice. NAD(+) acts partially via cyclicADP-ribose (cADPR) and subsequent release of Ca2+. Treatment of macrophages with the cADPR analog 3-deaza-cADPR or Ca2+ ionophores recapitulated the effects of NAD(+) on TGF-beta 1, whereas the cADPR antagonist 8-Br-cADPR, Ca2+ chelation, and antagonism of L-type Ca2+ channels suppressed these effects. The time and dose effects of NAD(+) on TGF-beta 1 were complex and could be modeled both statistically and mathematically. Model-predicted levels of TGF-beta 1 protein and mRNA were largely confirmed experimentally but also suggested the presence of other mechanisms of regulation of TGF-beta 1 by NAD beta. Thus, in vitro and in silico evidence points to NAD(+) as a novel modulator of TGF-beta 1.	[Zamora, Ruben; Azhar, Nabil; Namas, Rajaie; Metukuri, Mallikarjuna R.; Clermont, Thierry; Gladstone, Chase; Namas, Rami A.; Hermus, Linda; Billiar, Timothy R.; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA; [Azhar, Nabil; Vodovotz, Yoram] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA; [Megas, Cristina; Constantine, Gregory] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15261 USA; [Constantine, Gregory; Billiar, Timothy R.; Fink, Mitchell P.; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15219 USA; [Fink, Mitchell P.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zamora, R (corresponding author), Univ Pittsburgh, Dept Surg, W943 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	zamorar@pitt.edu	Namas, Rami/AAD-5796-2020; Namas, Rami/AAD-5793-2020; Namas, Rajaie/U-2206-2019; Namas, Rami/GZK-4999-2022	Namas, Rami/0000-0002-8582-5321; Namas, Rami/0000-0002-8582-5321; Namas, Rajaie/0000-0003-0353-895X	National Institutes of Health Grants [R01-AI080799, P50-GM53789]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI080799 and P50-GM53789.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; ARTMAN M, 1979, ARCH BIOCHEM BIOPHYS, V195, P121, DOI 10.1016/0003-9861(79)90333-3; ARTMAN M, 1978, SCIENCE, V202, P1293, DOI 10.1126/science.214853; ARTMAN M, 1979, J RETICULOENDOTH SOC, V25, P479; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; BARCELLOSHOFF MH, 1995, AM J PATHOL, V147, P1228; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Chong HY, 1999, J CELL PHYSIOL, V178, P275, DOI 10.1002/(SICI)1097-4652(199903)178:3<275::AID-JCP1>3.3.CO;2-H; Ehrhart EJ, 1997, FASEB J, V11, P991, DOI 10.1096/fasebj.11.12.9337152; Fink MP, 2009, J LEUKOCYTE BIOL, V86, P203, DOI 10.1189/jlb.0309137; Franco L, 2001, J BIOL CHEM, V276, P21642, DOI 10.1074/jbc.M010536200; Franco L, 1998, FASEB J, V12, P1507; GRIMALDI JC, 1995, J IMMUNOL, V155, P811; Han XN, 2003, J PHARMACOL EXP THER, V307, P443, DOI 10.1124/jpet.103.056556; Hauschildt S, 1998, PROG CLIN BIOL RES, V397, P147; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Khan AU, 2002, AM J PHYSIOL-LUNG C, V282, pL1082, DOI 10.1152/ajplung.00358.2001; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Liu ZX, 2001, J IMMUNOL, V167, P4942, DOI 10.4049/jimmunol.167.9.4942; Looms DK, 2001, BIOCHEM J, V355, P87, DOI 10.1042/bj3550087; Luhrmann A, 1998, ANTIMICROB AGENTS CH, V42, P1911, DOI 10.1128/AAC.42.8.1911; MAEHAMA T, 1995, J BIOL CHEM, V270, P22747, DOI 10.1074/jbc.270.39.22747; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Metukuri MR, 2009, WOUND REPAIR REGEN, V17, P578, DOI 10.1111/j.1524-475X.2009.00509.x; Namazi MR, 2003, FASEB J, V17, P1377, DOI 10.1096/fj.03-0002hyp; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NOWICKI M, 1991, CELL IMMUNOL, V132, P115, DOI 10.1016/0008-8749(91)90011-Y; Okamoto S, 1998, J IMMUNOL, V160, P4190; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Ramakers BP, 2011, SHOCK, V36, P208, DOI 10.1097/SHK.0b013e318225aee4; Rigby MR, 1996, J IMMUNOL, V156, P4259; Romanello M, 2001, BIOCHEM BIOPH RES CO, V285, P1226, DOI 10.1006/bbrc.2001.5325; Sethi JK, 1997, J BIOL CHEM, V272, P16358, DOI 10.1074/jbc.272.26.16358; TWARDZIK DR, 1990, ANN NY ACAD SCI, V593, P276, DOI 10.1111/j.1749-6632.1990.tb16119.x; Vodovotz Y, 1999, CANCER RES, V59, P2142; Vodovotz Y, 2001, PROG INFLAM RES, P41; Wahl SM, 1999, MICROBES INFECT, V1, P1247, DOI 10.1016/S1286-4579(99)00261-0; Wang J, 1997, ADV EXP MED BIOL, V419, P191; Wang J, 1996, J IMMUNOL, V156, P2819; WANG J, 1994, J IMMUNOL, V153, P4048; Wong L, 1999, BBA-GEN SUBJECTS, V1472, P555, DOI 10.1016/S0304-4165(99)00161-0; Zamora R, 2005, CRIT CARE MED, V33, pS478, DOI 10.1097/01.CCM.0000191725.59611.14	45	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31003	31014		10.1074/jbc.M112.344309	http://dx.doi.org/10.1074/jbc.M112.344309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829588	Green Published, hybrid			2022-12-25	WOS:000308791300014
J	Love, RP; Xu, HX; Chelico, L				Love, Robin P.; Xu, Huixin; Chelico, Linda			Biochemical Analysis of Hypermutation by the Deoxycytidine Deaminase APOBEC3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HUMAN-IMMUNODEFICIENCY-VIRUS; INDUCED CYTIDINE DEAMINASE; SOMATIC HYPERMUTATION; VIF PROTEIN; HIV-1 VIF; REVERSE-TRANSCRIPTASE; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; HUMAN-CELLS	APOBEC3A belongs to a family of single-stranded DNA (ssDNA) DNA cytosine deaminases that are known for restriction of HIV through deamination-induced mutational inactivation, e. g. APOBEC3G, or initiation of somatic hypermutation and class switch recombination (activation-induced cytidine deaminase). APOBEC3A, which is localized to both the cytoplasm and nucleus, not only restricts HIV but can also initiate catabolism of cellular DNA. Despite being ascribed these roles, there is a paucity of data available on the biochemical mechanism by which APOBEC3A deaminates ssDNA. Here we assessed APOBEC3A deamination activity on ssDNA and in dynamic systems modeling HIV replication (cytoplasmic event) and DNA transcription (nuclear event). We find that APOBEC3A, unlike the highly processive APOBEC3G, exhibits low or no processivity when deaminating synthetic ssDNA substrates with two cytosines located 5-63 nucleotides apart, likely because of an apparent K-d in the micromolar range (9.1 mu M). APOBEC3A was able to deaminate nascently synthesized (-) DNA in an in vitro model HIV replication assay but induced fewer mutations overall in comparison to APOBEC3G. However, the data indicate that the target deamination motif (5'-TC for APOBEC3A and 5'-CC for APOBEC3G) and not the number of mutations best predicted the ability to mutationally inactivate HIV. We further assessed APOBEC3A for the ability to deaminate dsDNA undergoing transcription, which could allow for collateral deaminations to occur in genomic DNA similar to the action of activation-induced cytidine deaminase. That APOBEC3A was able to deaminate dsDNA undergoing transcription suggests a genomic cost of a deamination-based retroviral restriction system.	[Love, Robin P.; Xu, Huixin; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	linda.chelico@usask.ca		Love, Robin/0000-0002-2509-706X; Chelico, Linda/0000-0003-4673-8978	Natural Sciences and Engineering Research Council of Canada; Saskatchewan Health Research Foundation; Canadian Foundation for Innovation; National Institutes of Health [ISI0RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Health Research Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada, a new investigator establishment grant from the Saskatchewan Health Research Foundation, and The Canadian Foundation for Innovation.; DNA substrates for deamination assays were obtained through the Tri-Link Biotechnologies Research Rewards Program. The SEC-LX/UV/RI instrumentation was supported by National Institutes of Health Award ISI0RR023748-01. We thank Madison Adolph for assistance with preparation of plasmids for DNA sequencing and Yuqing Feng and Anjuman Ara for critical discussion of the manuscript.	An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Betts MJ, 2003, AMINO ACID PROPERTIE, P289; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; COFFIN JM, 1997, RETROVIRUSES, P121; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Creighton S, 1995, METHOD ENZYMOL, V262, P232; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hu CL, 2010, J VIROL, V84, P11981, DOI 10.1128/JVI.00723-10; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Marin M, 2008, J VIROL, V82, P987, DOI 10.1128/JVI.01078-07; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; Miyagi E, 2010, J VIROL, V84, P11067, DOI 10.1128/JVI.01249-10; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	72	60	61	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30812	30822		10.1074/jbc.M112.393181	http://dx.doi.org/10.1074/jbc.M112.393181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22822074	hybrid, Green Published			2022-12-25	WOS:000308579800069
J	Tachibana, Y; Fukushima, A; Saito, H; Yoneyama, S; Ushida, K; Yoneyama, S; Kawashima, R				Tachibana, Yoshiyuki; Fukushima, Ai; Saito, Hitomi; Yoneyama, Satoshi; Ushida, Kazuo; Yoneyama, Susumu; Kawashima, Ryuta			A New Mother-Child Play Activity Program to Decrease Parenting Stress and Improve Child Cognitive Abilities: A Cluster Randomized Controlled Trial	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; FLUID INTELLIGENCE; PREFRONTAL CORTEX; SELF-REGULATION; WORKING-MEMORY; ATTACHMENT; INTERVENTIONS; SENSITIVITY; FAMILIES; ANXIETY	Background: We propose a new play activity intervention program for mothers and children. Our interdisciplinary program integrates four fields of child-related sciences: neuroscience, preschool pedagogy, developmental psychology, and child and maternal psychiatry. To determine the effect of this intervention on child and mother psychosocial problems related to parenting stress and on the children's cognitive abilities, we performed a cluster randomized controlled trial. Methodology/Principal Findings: Participants were 238 pairs of mothers and typically developing preschool children (ages 4-6 years old) from Wakakusa kindergarten in Japan. The pairs were asked to play at home for about 10 min a day, 5 days a week for 3 months. Participants were randomly assigned to the intervention or control group by class unit. The Parenting Stress Index (PSI) (for mothers), the Goodenough Draw-a-Man intelligence test (DAM), and the new S-S intelligence test (NSSIT) (for children) PSI (for maternal psychosocial problems related to parenting stress), and the score on the DAM (for child cognitive abilities). The results of the PSI suggested that the program may reduce parenting stress. The results of the cognitive tests suggested that the program may improve the children's fluid intelligence, working memory, and processing speed. Conclusions/Significance: Our intervention program may ameliorate the children's psychosocial problems related to parenting stress and increase their cognitive abilities.	[Tachibana, Yoshiyuki] Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Div Maternal Child Psychiat, Tokyo, Japan; [Tachibana, Yoshiyuki; Kawashima, Ryuta] Tohoku Univ, Smart Aging Int Res Ctr, IDAC, Dept Appl Brain Sci, Sendai, Miyagi 980, Japan; [Fukushima, Ai; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, IDAC, Sendai, Miyagi 980, Japan; [Saito, Hitomi; Yoneyama, Satoshi; Ushida, Kazuo; Yoneyama, Susumu] Wakakusa Kindergarten, Sendai, Miyagi, Japan	National Center for Child Health & Development - Japan; Tohoku University; Tohoku University	Tachibana, Y (corresponding author), Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Div Maternal Child Psychiat, Tokyo, Japan.	tatibana@idac.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the promotion scheme "Researches for improvement of children's life style'' by the Ministry of Education, Culture, Sports, Science and Technology entitled "The research and practice of the play program for enhancing parent-child attachment and child cognitive abilities''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin R. R., 2012, PARENTING STRESS IND; Abidin RR., 1995, PSYCHOL ASSESSMENT R; Abidin RR, 1995, PARENTING STRESS IND, V75; Anthony LG, 2005, INFANT CHILD DEV, V14, P133, DOI 10.1002/icd.385; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Barnett DW, 2002, DESIGNING PRESCHOOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk L.E., 1995, SCAFFOLDING CHILDREN; Bierman KL, 2008, DEV PSYCHOPATHOL, V20, P821, DOI 10.1017/S0954579408000394; Blair C, 2008, DEV PSYCHOPATHOL, V20, P899, DOI 10.1017/S0954579408000436; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Booth P. B., 1999, THERAPLAY HELPING PA; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; BOWLBY J, 1977, BRIT J PSYCHIAT, V130, P201, DOI 10.1192/bjp.130.3.201; Bowlby J., 1988, SECURE BASE; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Campbell MJ, 2000, STAT METHODS MED RES, V9, P81, DOI 10.1191/096228000676246354; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Colom R, 2007, J BIOSOC SCI, V39, P79, DOI 10.1017/S0021932005001173; Creasey G, 2003, PLAY CHILDREN ATTACH, P133; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deater-Deckard K., 2004, PARENTING STRESS; Dehn MJ, 2008, WORKING MEMORY ACAD; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Dudoit S., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1040; Edwards CP, 2000, CROSS-CULT RES, V34, P318, DOI 10.1177/106939710003400402; Fagan J, 1999, EARLY CHILD RES Q, V14, P243, DOI 10.1016/S0885-2006(99)00008-3; Fivush R, 2006, ATTACH HUM DEV, V8, P283, DOI 10.1080/08912960600858935; Fonagy P., 2002, AFFECT REGULATION ME; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Goodenough FL., 1926, MEASUREMENT INTELLIG; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Greenberg MT, 2006, ANN NY ACAD SCI, V1094, P139, DOI 10.1196/annals.1376.013; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Judge S, 2003, FAM RELAT, V52, P241, DOI 10.1111/j.1741-3729.2003.00241.x; Juffer F., 2008, PROMOTING POSITIVE P; Kazui M, 2005, ATTACHMENT; Kerr M, 1998, STRATEGIES MANAGING; Khatena J, 1967, GIFTED CHILD Q, V11, P227; Killip S, 2004, ANN FAM MED, V2, P204, DOI 10.1370/afm.141; Kobayashi S, 1967, P YAMAGATA U ED SCI, V5, P131; Love JM., 2002, MAKING DIFFERENCE LI, VI; LOYD BH, 1985, J PEDIATR PSYCHOL, V10, P169, DOI 10.1093/jpepsy/10.2.169; Magill-Evans J, 2006, J ADV NURS, V55, P248, DOI 10.1111/j.1365-2648.2006.03896.x; McBride BA, 1991, EARLY CHILD DEV CARE, V67, P73, DOI DOI 10.1080/0300443910670107; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monk CS, 2008, DEV PSYCHOPATHOL, V20, P1231, DOI 10.1017/S095457940800059X; MOUTON PY, 1988, J CLIN CHILD PSYCHOL, V17, P217, DOI 10.1207/s15374424jccp1703_4; Narama M., 1999, SHOUNI HOKEN KENKYU, V58, P610; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Raven J.C., 1958, GUIDE USING COLOURED; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Rohde TE, 2007, INTELLIGENCE, V35, P83, DOI 10.1016/j.intell.2006.05.004; Russ HG, 1988, EFFECTS ADOPTION PRE; Seifer R, 1995, MONOGR SOC RES CHILD, V60, P146, DOI 10.2307/1166176; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; Swanson HL, 2006, J EDUC PSYCHOL, V98, P17; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Thompson RA, 2000, CHILD DEV, V71, P145, DOI 10.1111/1467-8624.00128; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI DOI 10.3310/HTA3050; van Ijzendoorn MH, 1992, MULTIPLE CARETAKER P; Ana B, 2007, PSYCHON B REV, V14, P320, DOI 10.3758/BF03194071; Vygotsky L. S., 1978, MIND SOC DEV HIGHER, P52; Vygotsky LS, 1960, GENESIS HIGHER MENTA, P61; Warren SL, 1997, J AM ACAD CHILD PSY, V36, P637, DOI 10.1097/00004583-199705000-00014; Wechsler D, 1991, WISC 3 WECHSLER INTE; WEINER A, 1994, FAM PROCESS, V33, P441, DOI 10.1111/j.1545-5300.1994.00441.x; West BT, 2007, LINEAR MIXED MODELS, p[98, 268, 333]; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x; Yamane K, 1977, MANUAL NEW S S INTEL	80	15	15	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e38238	10.1371/journal.pone.0038238	http://dx.doi.org/10.1371/journal.pone.0038238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848340	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200002
J	Hoflehner, E; Binder, M; Hemmer, W; Mahler, V; Panzani, RC; Jarisch, R; Wiedermann, U; Duchene, M				Hoflehner, Elisabeth; Binder, Marina; Hemmer, Wolfgang; Mahler, Vera; Panzani, Raphael C.; Jarisch, Reinhart; Wiedermann, Ursula; Duchene, Michael			Thioredoxin from the Indianmeal Moth Plodia interpunctella: Cloning and Test of the Allergenic Potential in Mice	PLOS ONE			English	Article							HOUSE-DUST; CROSS-REACTIVITY; ARGININE KINASE; IGE ANTIBODIES; BAKERS ASTHMA; PAN-ALLERGEN; FAMILY; INSECTS; WHEAT; RESPONSES	Background/Objective: The Indianmeal moth Plodia interpunctella is a highly prevalent food pest in human dwellings, and has been shown to contain a number of allergens. So far, only one of these, the arginine kinase (Plo i 1) has been identified. Objective: The aim of this study was to identify further allergens and characterise these in comparison to Plo i 1. Method: A cDNA library from whole adult P. interpunctella was screened with the serum of a patient with indoor allergy and IgE to moths, and thioredoxin was identified as an IgE-binding protein. Recombinant thioredoxin was generated in E. coli, and tested together with Plo i 1 and whole moth extracts in IgE immunoblots against a large panel of indoor allergic patients' sera. BALB/c mice were immunised with recombinant thioredoxin and Plo i 1, and antibody production, mediator release from RBL cells, T-cell proliferation and cytokine production were measured. Result: For the first time a thioredoxin from an animal species was identified as allergen. About 8% of the sera from patients with IgE against moth extracts reacted with recombinant P. interpunctella thioredoxin, compared to 25% reacting with recombinant Plo i 1. In immunised BALB/c mice, the recombinant allergens both induced classical Th2-biased immune responses such as induction IgE and IgG1 antibodies, upregulation of IL-5 and IL-4 and basophil degranulation. Conclusion: Thioredoxin from moths like Plo i 1 acts like a classical Type I allergen as do the thioredoxins from wheat or corn. This clearly supports the pan-allergen nature of thioredoxin. The designation Plo i 2 is suggested for the new P. interpunctella allergen.	[Hoflehner, Elisabeth; Binder, Marina; Wiedermann, Ursula; Duchene, Michael] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Hemmer, Wolfgang; Jarisch, Reinhart] Floridsdorfer Allergiezentrum, Vienna, Austria; [Mahler, Vera] Univ Erlangen Nurnberg, Dept Dermatol, Erlangen, Germany; [Panzani, Raphael C.] Ctr Rech Allergol, Marseille, France	Medical University of Vienna; University of Erlangen Nuremberg	Duchene, M (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	michael.duchene@meduniwien.ac.at	Duchêne, Michael/G-6659-2019	Duchêne, Michael/0000-0003-1232-3600; Wiedermann, Ursula/0000-0002-1302-3223	"Jubilaumsstiftung der Osterreichischen Nationalbank'', Vienna, Austria [8643]; "Hochschuljubilaumsstiftung der Stadt Wien'', Vienna, Austria [H-1760/2006]	"Jubilaumsstiftung der Osterreichischen Nationalbank'', Vienna, Austria; "Hochschuljubilaumsstiftung der Stadt Wien'', Vienna, Austria	This study was supported by Grant 8643 from the "Jubilaumsstiftung der Osterreichischen Nationalbank'', and by Grant H-1760/2006 from the "Hochschuljubilaumsstiftung der Stadt Wien'', Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRUDA LK, 1995, INT ARCH ALLERGY IMM, V107, P295, DOI 10.1159/000237006; BALDO BA, 1988, INT ARCH ALLER A IMM, V85, P278, DOI 10.1159/000234518; Binder M, 2001, J IMMUNOL, V167, P5470, DOI 10.4049/jimmunol.167.9.5470; Buchanan BB, 1997, P NATL ACAD SCI USA, V94, P5372, DOI 10.1073/pnas.94.10.5372; Buchanan BB, 2007, J ALLERGY CLIN IMMUN, V119, P513, DOI 10.1016/j.jaci.2006.08.039; Chu KH, 2005, ADV BIOCHEM ENG BIOT, V97, P205, DOI 10.1007/b135827; Chuang CY, 2009, INHAL TOXICOL, V21, P153, DOI [10.1080/08958370802368730, 10.1080/08958370802368730 ]; del Val G, 1999, J ALLERGY CLIN IMMUN, V103, P690, DOI 10.1016/S0091-6749(99)70244-7; Fu CX, 2009, MOL CELL PROTEOMICS, V8, P1674, DOI 10.1074/mcp.M800580-MCP200; Glaser AG, 2008, ALLERGY, V63, P1617, DOI 10.1111/j.1398-9995.2008.01777.x; Hales BJ, 2007, CLIN EXP ALLERGY, V37, P1357, DOI 10.1111/j.1365-2222.2007.02786.x; Hoffman DR, 2008, CURR OPIN ALLERGY CL, V8, P338, DOI 10.1097/ACI.0b013e3283036a7d; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; Komase Y, 1997, ALLERGY, V52, P75, DOI 10.1111/j.1398-9995.1997.tb02548.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Limacher A, 2007, J IMMUNOL, V178, P389, DOI 10.4049/jimmunol.178.1.389; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sander I, 2011, ALLERGY, V66, P1208, DOI 10.1111/j.1398-9995.2011.02636.x; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Son A, 2006, CELL RES, V16, P230, DOI 10.1038/sj.cr.7310031; STEVENSON DD, 1967, J ALLERGY, V39, P274, DOI 10.1016/0021-8707(67)90091-3; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Uda K, 2006, COMP BIOCHEM PHYS D, V1, P209, DOI 10.1016/j.cbd.2005.10.007; URBACH ERIC, 1941, JOUR ALLERGY, V12, P485, DOI 10.1016/S0021-8707(41)90227-7; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; vanWijnen JH, 1997, ALLERGY, V52, P460, DOI 10.1111/j.1398-9995.1997.tb01030.x; Vaughan WT, 1928, J LAB CLIN MED, V13, P955; Weichel M, 2006, J ALLERGY CLIN IMMUN, V117, P676, DOI 10.1016/j.jaci.2005.11.040; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Wittich FW, 1940, J LANCET, P418; Yu CJ, 2003, J IMMUNOL, V170, P445, DOI 10.4049/jimmunol.170.1.445	33	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42026	10.1371/journal.pone.0042026	http://dx.doi.org/10.1371/journal.pone.0042026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844539	Green Submitted, Green Published, gold			2022-12-25	WOS:000309240600062
J	Ngui, R; Lim, YAL; Chua, KH				Ngui, Romano; Lim, Yvonne A. L.; Chua, Kek Heng			Rapid Detection and Identification of Human Hookworm Infections through High Resolution Melting (HRM) Analysis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; ANCYLOSTOMA-DUODENALE; NECATOR-AMERICANUS; ASSAY; POLYMORPHISM; DIAGNOSIS; WORLD; EGGS; GENE	Background: Hookworm infections are still endemic in low and middle income tropical countries with greater impact on the socioeconomic and public health of the bottom billion of the world's poorest people. In this study, a real-time polymerase chain reaction (PCR) coupled with high resolution melting-curve (HRM) analysis was evaluated for an accurate, rapid and sensitive tool for species identification focusing on the five human hookworm species. Methods: Real-time PCR coupled with HRM analysis targeting the second internal transcribed spacer (ITS-2) of nuclear ribosomal DNA as the genetic marker was used to identify and distinguish hookworm species in human samples. Unique and distinct characteristics of HRM patterns were produced for each of the five hookworm species. The melting curves were characterized by peaks of 79.24 +/- 0.05 degrees C and 83.00 +/- 0.04 degrees C for Necator americanus, 79.12 +/- 0.10 degrees C for Ancylostoma duodenale, 79.40 +/- 0.10 degrees C for Ancylostoma ceylanicum, 79.63 +/- 0.05 degrees C for Ancylostoma caninum and 79.70 +/- 0.14 degrees C for Ancylostoma braziliense. An evaluation of the method's sensitivity and specificity revealed that this assay was able to detect as low as 0.01 ng/mu l hookworm DNA and amplification was only recorded for hookworm positive samples. Conclusion: The HRM assay developed in this study is a rapid and straightforward method for the diagnosis, identification and discrimination of five human hookworms. This assay is simple compared to other probe-based genotyping methods as it does not require multiplexing, DNA sequencing or post-PCR processing. Therefore, this method offers a new alternative for rapid detection of human hookworm species.	[Chua, Kek Heng] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Ngui, Romano; Lim, Yvonne A. L.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chua, KH (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	khchua@um.edu.my	LIM, YVONNE AL/B-5276-2010; Ngui, Romano/H-9645-2015; CHUA, KEK HENG/B-5261-2010	LIM, YVONNE AL/0000-0003-4050-6332; Ngui, Romano/0000-0002-3520-579X; CHUA, KEK HENG/0000-0002-0452-9994	University of Malaya High Impact Research Grant (UM/MoHE HIR Grant) [E000044-20001]; University of Malaya Student Research Grant [PV024/2011B]; E-Science Grant from the Ministry of Science, Technology and Innovative (MOSTI), Malaysia	University of Malaya High Impact Research Grant (UM/MoHE HIR Grant); University of Malaya Student Research Grant; E-Science Grant from the Ministry of Science, Technology and Innovative (MOSTI), Malaysia	This study was supported by the University of Malaya High Impact Research Grant (UM/MoHE HIR Grant E000044-20001), University of Malaya Student Research Grant (PV024/2011B) and the E-Science Grant from the Ministry of Science, Technology and Innovative (MOSTI), Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 1999, ADV PARASIT, V42, P277, DOI 10.1016/S0065-308X(08)60151-7; Andriantsoanirina V, 2009, J MICROBIOL METH, V78, P165, DOI 10.1016/j.mimet.2009.05.013; Areekit Supatra, 2009, J Med Assoc Thai, V92 Suppl 3, pS24; Basuni M, 2011, AM J TROP MED HYG, V84, P338, DOI 10.4269/ajtmh.2011.10-0499; Bienz M, 2001, PARASITOL RES, V87, P1011; Brooker S, 2008, ADV PARASIT, V58, P197; Crompton DWT, 2000, PARASITOLOGY, V121, pS39, DOI 10.1017/S0031182000006454; de Gruijter JM, 2005, TROP MED INT HEALTH, V10, P574, DOI 10.1111/j.1365-3156.2005.01440.x; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Gasser RB, 1997, MOL CELL PROBE, V11, P201, DOI 10.1006/mcpr.1997.0106; GASSER RB, 1993, NUCLEIC ACIDS RES, V21, P2525, DOI 10.1093/nar/21.10.2525; Gasser RB, 1998, MOL BIOCHEM PARASIT, V92, P303, DOI 10.1016/S0166-6851(98)00008-5; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000405; Hussein EM, 2009, PARASITOL RES, V105, P1053, DOI 10.1007/s00436-009-1515-9; Jiraanankul V, 2011, AM J TROP MED HYG, V84, P594, DOI 10.4269/ajtmh.2011.10-0189; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Ng ZX, 2012, BRIT J OPHTHALMOL, V96, P289, DOI 10.1136/bjophthalmol-2011-300658; Ngui R, 2012, AM J TROP MED HYG, V86, P837, DOI 10.4269/ajtmh.2012.11-0446; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001522; Pangasa A, 2009, MOL CELL PROBE, V23, P10, DOI 10.1016/j.mcp.2008.10.003; Poulson MD, 2007, BIOTECHNIQUES, V43, P87, DOI 10.2144/000112459; Radvansky J, 2011, PARASITOL RES, V108, P201, DOI 10.1007/s00436-010-2057-x; Radvansky J, 2010, ANAL BIOCHEM, V398, P126, DOI 10.1016/j.ab.2009.11.005; Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Robinson BS, 2006, APPL ENVIRON MICROB, V72, P5857, DOI 10.1128/AEM.00113-06; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Sato M, 2010, T ROY SOC TROP MED H, V104, P617, DOI 10.1016/j.trstmh.2010.06.006; Stanley KK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni182; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153, DOI 10.1093/ajcn/65.1.153; Talmi-Frank D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000581; Teh CSJ, 2010, J APPL MICROBIOL, V108, P1940, DOI 10.1111/j.1365-2672.2009.04599.x; Thong KL, 2011, TROP BIOMED, V28, P21; Traub RJ, 2004, VET PARASITOL, V123, P245, DOI 10.1016/j.vetpar.2004.05.026; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Zhou L, 2004, TISSUE ANTIGENS, V64, P156, DOI 10.1111/j.1399-0039.2004.00248.x	41	41	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41996	10.1371/journal.pone.0041996	http://dx.doi.org/10.1371/journal.pone.0041996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22844538	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000309240600061
J	Robertson, T; Batty, GD; Der, G; Green, MJ; McGlynn, LM; McIntyre, A; Shiels, PG; Benzeval, M				Robertson, Tony; Batty, G. David; Der, Geoff; Green, Michael J.; McGlynn, Liane M.; McIntyre, Alan; Shiels, Paul G.; Benzeval, Michaela			Is Telomere Length Socially Patterned? Evidence from the West of Scotland Twenty-07 Study	PLOS ONE			English	Article							FETUIN-A LEVELS; SOCIOECONOMIC-STATUS; PULSE PRESSURE; PATERNAL AGE; BLOOD-CELLS; OLDER MEN; ASSOCIATION; HEALTH; MORTALITY; INDICATOR	Lower socioeconomic status (SES) is strongly associated with an increased risk of morbidity and premature mortality, but it is not known if the same is true for telomere length, a marker often used to assess biological ageing. The West of Scotland Twenty-07 Study was used to investigate this and consists of three cohorts aged approximately 35 (N = 775), 55 (N = 866) and 75 years (N = 544) at the time of telomere length measurement. Four sets of measurements of SES were investigated: those collected contemporaneously with telomere length assessment, educational markers, SES in childhood and SES over the preceding twenty years. We found mixed evidence for an association between SES and telomere length. In 35-year-olds, many of the education and childhood SES measures were associated with telomere length, i.e. those in poorer circumstances had shorter telomeres, as was intergenerational social mobility, but not accumulated disadvantage. A crude estimate showed that, at the same chronological age, social renters, for example, were nine years (biologically) older than home owners. No consistent associations were apparent in those aged 55 or 75. There is evidence of an association between SES and telomere length, but only in younger adults and most strongly using education and childhood SES measures. These results may reflect that childhood is a sensitive period for telomere attrition. The cohort differences are possibly the result of survival bias suppressing the SES-telomere association; cohort effects with regard different experiences of SES; or telomere possibly being a less effective marker of biological ageing at older ages.	[Robertson, Tony; Batty, G. David; Der, Geoff; Green, Michael J.; Benzeval, Michaela] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [McGlynn, Liane M.; McIntyre, Alan; Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, MVLS, Glasgow, Lanark, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; University College London	Robertson, T (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	t.robertson@sphsu.mrc.ac.uk	Benzeval, Michaela/J-3163-2015; Batty, GD/Y-4401-2018; Robertson, Tony/L-5062-2015	Benzeval, Michaela/0000-0002-0372-2098; Batty, GD/0000-0003-1822-5753; Robertson, Tony/0000-0002-1962-5874; Shiels, Paul/0000-0002-7577-9843; Der, Geoff/0000-0002-8677-073X; Green, Michael/0000-0003-3193-2452	UK Medical Research Council (MRC) [MC_US_A540_0080]; MRC [MC_US_A540_0056]; Medical Research Council [MC_U130059823, MC_UP_A540_1021, MC_U130059821] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [MC_U130059821, MC_UP_A540_1021, MC_U130059823] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The West of Scotland Twenty-07 Study is funded by the UK Medical Research Council (MRC) (MC_US_A540_0080) and the data were originally collected by the MRC/CSO Social and Public Health Sciences Unit. T. Robertson, M. Green, G. Der and M. Benzeval are funded by the MRC (MC_US_A540_0056). G. D. Batty is a Wellcome Trust Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2007, AGING CELL, V6, P125, DOI 10.1111/j.1474-9726.2006.00258.x; Adams JM, 2004, EUR J PUBLIC HEALTH, V14, P331, DOI 10.1093/eurpub/14.3.331; Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P839, DOI 10.1136/jech.2009.088427; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Carstairs V., 1991, DEPRIVATION HLTH SCO; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan R, 2010, BRIT J NUTR, V103, P107, DOI 10.1017/S0007114509991383; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; Deroo LA, 2009, AM J EPIDEMIOL, V169, pS88; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fernandez-Egea E, 2009, SCHIZOPHRENIA BULL, V35, P437, DOI 10.1093/schbul/sbn169; Geronimus AT, 2010, HUM NATURE-INT BIOS, V21, P19, DOI 10.1007/s12110-010-9078-0; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Harris SE, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.013; Hou LF, 2009, CANCER EPIDEM BIOMAR, V18, P3103, DOI 10.1158/1055-9965.EPI-09-0347; Janicki-Deverts D, 2009, PSYCHOSOM MED, V71, P541, DOI 10.1097/PSY.0b013e31819e7526; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kuh D, 2006, AGING CELL, V5, P579, DOI 10.1111/j.1474-9726.2006.00250.x; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Lorimer K, 2010, 20078 MRCCSO SOC PUB; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.2307/3180803; Macintyre S, 1989, READINGS NEW PUBLIC, P56; Marmot M, 2010, MARMOT REV FAIR SOC; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Mather KA, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-62; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Maxwell F, 2011, CLIN CANCER RES, V17, P5573, DOI 10.1158/1078-0432.CCR-10-3271; McLoone P., 2004, CARSTAIRS SCORES SCO; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nordfjall K, 2008, SCAND J PUBLIC HEALT, V36, P744, DOI 10.1177/1403494808090634; OPCS (Office of Population Censuses and Surveys), 1980, CLASS OCC 1980; Parks CG, 2011, OCCUP ENVIRON MED, V68, P582, DOI 10.1136/oem.2010.063214; Risques RA, 2010, J AM GERIATR SOC, V58, P1289, DOI 10.1111/j.1532-5415.2010.02948.x; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Seaman S, 2011, 27 MRCCSO SOC PUBL H; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Shiels PG, 2010, J GERONTOL A-BIOL, V65, P789, DOI 10.1093/gerona/glq095; Sies H., 1991, OXIDATIVE STRESS OXI; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Walsh D., 2008, AFTERSHOCK DEINDUSTR; Woo J, 2009, AGE AGEING, V38, P553, DOI 10.1093/ageing/afp098; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006; Zheng YL, 2010, BREAST CANCER RES TR, V120, P769, DOI 10.1007/s10549-009-0440-z	60	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41805	10.1371/journal.pone.0041805	http://dx.doi.org/10.1371/journal.pone.0041805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22844525	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700152
J	Tang, K; Jiao, NZ; Liu, KS; Zhang, Y; Li, SH				Tang, Kai; Jiao, Nianzhi; Liu, Keshao; Zhang, Yao; Li, Shuhui			Distribution and Functions of TonB-Dependent Transporters in Marine Bacteria and Environments: Implications for Dissolved Organic Matter Utilization	PLOS ONE			English	Article							ACETYLGLUCOSAMINE UTILIZATION PATHWAY; OUTER-MEMBRANE; CAULOBACTER-CRESCENTUS; COMPARATIVE GENOMICS; PROTEOMIC ANALYSIS; ACTIVE-TRANSPORT; PROTEIN; OCEAN; DATABASE; CARBON	Background: Bacteria play critical roles in marine nutrient cycles by incorporating and redistributing dissolved organic matter (DOM) and inorganic nutrients in the ocean. TonB-dependent transporter (TBDT) proteins allow Gram-negative bacteria to take up scarce resources from nutrient-limiting environments as well as siderophores, heme, vitamin B12, and recently identified carbohydrates. Thus, the characterization of TBDT distribution and functions is essential to better understand the contribution TBDT to DOM assimilation and its consequences on nutrient cycling in the environment. Methodology/Principal Findings: This study presents the distribution of encoded known and putative TBDT proteins in the genomes of microorganisms and from the Global Ocean Survey data. Using a Lek clustering algorithm and substrate specificities, the TBDT sequences were mainly classified into the following three groups: (1) DOM transporters; (2) Siderophores/Vitamins transporters; and (3) Heme/Hemophores/Iron(heme)-binding protein transporters. Diverse TBDTs were found in the genomes of oligotroph Citromicrobium bathyomarinum JL354 and Citromicrobium sp JLT1363 and were highly expressed in the stationary phase of bacterial growth. The results show that the Gammaproteobacteria and the Cytophaga-Flavobacterium-Bacteroides (CFB) group bacteria accounted for the majority of the TBDT gene pool in marine surface waters. Conclusions/Significance: The results of this study confirm the ecological importance of TBDTs in DOM assimilation for bacteria in marine environments owing to a wide range of substrate utilization potential in the ubiquitous Gammaproteobacteria and CFB group bacteria.	[Tang, Kai; Jiao, Nianzhi; Liu, Keshao; Zhang, Yao; Li, Shuhui] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Xiamen University	Tang, K (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	tangkai@xmu.edu.cn; jiao@xmu.edu			NSFC (Natural Science Foundation of China) [40906079]; National Basic Research Program of China [2011CB808800]; NSFC [91028001]; Public Science and Technology Research Funds Projects of Ccean [201105021]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China	NSFC (Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ccean; Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by NSFC (Natural Science Foundation of China) 40906079, National Basic Research Program of China 2011CB808800, key NSFC 91028001, Public Science and Technology Research Funds Projects of Ccean 201105021 and the Scientific Research Foundation for Returned Scholars, Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aluwihare LI, 1999, MAR ECOL PROG SER, V186, P105, DOI 10.3354/meps186105; Babbette B, 2004, J BACTERIOL, V186, P374, DOI 10.1128/JB.186.2.374-382.2004; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Biers EJ, 2007, APPL ENVIRON MICROB, V75, P2221; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boulanger A, 2010, J BACTERIOL, V192, P1487, DOI 10.1128/JB.01418-09; Chen JL, 1997, FEMS MICROBIOL LETT, V156, P61, DOI 10.1016/S0378-1097(97)00396-0; Christie-Oleza JA, 2012, ISME J, V6, P124, DOI 10.1038/ismej.2011.86; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunliffe M, 2009, ISME J, V3, P1001, DOI 10.1038/ismej.2009.69; Dafher EV, 2002, J ENVIRON MONITOR, V4, P55, DOI 10.1039/b107279j; Dai J, 2005, ANAL CHEM, V77, P5793, DOI 10.1021/ac050251w; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Eddy Sean R, 2009, Genome Inform, V23, P205; Edwards JL, 2010, GENES-BASEL, V1, P371, DOI 10.3390/genes1030371; Eisenbeis S, 2008, J BACTERIOL, V190, P5230, DOI 10.1128/JB.00194-08; Eppler T., 2001, MICROBIAL TRANSPORT, P77; Erni B, 2001, MICROBIAL TRANSPORT, P115; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; He JS, 2008, FEMS MICROBIOL LETT, V288, P221, DOI 10.1111/j.1574-6968.2008.01354.x; Hopkinson BM, 2012, ENVIRON MICROBIOL, V14, P114, DOI 10.1111/j.1462-2920.2011.02539.x; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Jiao NZ, 2011, APPL ENVIRON MICROB, V77, P7439, DOI 10.1128/AEM.05640-11; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jiao NZ, 2010, J BACTERIOL, V192, P1169, DOI 10.1128/JB.01504-09; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lim BL, 2010, MICROBES ENVIRON, V25, P67, DOI 10.1264/jsme2.ME10102; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCarthy M, 1996, MAR CHEM, V55, P281, DOI 10.1016/S0304-4203(96)00041-2; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller TR, 2010, J BACTERIOL, V192, P6101, DOI 10.1128/JB.01030-10; Milton H, 2001, MICROBIAL TRANSPORT, P1; Mirus O, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-68; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Obernosterer I., 2007, BIOGEOSCIENCES DISCU, V4, P2809, DOI [10.5194/bgd-4-2809-2007, DOI 10.5194/BGD-4-2809-2007]; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Sowell SM, 2011, ISME J, V5, P856, DOI 10.1038/ismej.2010.168; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Suzumura M, 1995, LIMNOL OCEANOGR, V40, P1254, DOI 10.4319/lo.1995.40.7.1254; Tang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011604; Tang K, 2010, CURR MICROBIOL, V60, P124, DOI 10.1007/s00284-009-9515-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Wilmes B, 2011, APPL ENVIRON MICROB, V77, P1276, DOI 10.1128/AEM.01750-10; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zheng QA, 2011, J BACTERIOL, V193, P2074, DOI 10.1128/JB.00121-11	69	75	76	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41204	10.1371/journal.pone.0041204	http://dx.doi.org/10.1371/journal.pone.0041204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829928	Green Submitted, Green Published, gold			2022-12-25	WOS:000306956300067
J	Fajardo, T; Rosas, MF; Sobrino, F; Martinez-Salas, E				Fajardo, Teodoro, Jr.; Flora Rosas, Maria; Sobrino, Francisco; Martinez-Salas, Encarnacion			Exploring IRES Region Accessibility by Interference of Foot-and-Mouth Disease Virus Infectivity	PLOS ONE			English	Article							RIBOSOME-ENTRY SITE; TRANSLATION INITIATION-FACTORS; INTERNAL INITIATION; IN-VIVO; L-PROTEASE; HETEROTYPIC INHIBITION; MORPHOLINO OLIGOMERS; FUNCTIONAL-ANALYSIS; NONCODING REGIONS; STABLE EXPRESSION	Translation initiation of picornavirus RNA is driven by an internal ribosome entry site (IRES) element located upstream of the initiator codon. RNA structure organization as well as RNA-protein interaction plays a fundamental role in internal initiation. IRES activity has been mainly analyzed in the context of reporter genes, lacking regions of the viral genome potentially affecting translation efficiency. With the aim to understand the vulnerability of the IRES and translation start region to small molecules in the context of the viral genome, we designed a set of customized RNase-resistant 2'O-methyl antisense oligoribonucleotides (2'OMe AONs) based on RNA structure data. These AONs were then used to monitor their capacity to interfere viral RNA translation, and thus, to inhibit virus yield. Foot-and-mouth disease virus (FMDV) RNA translation can be initiated at two in-frame AUG codons. We show here that a 2'OMe AON complementary to AUG2 inhibited viral multiplication more efficiently than the one that targeted AUG1. Furthermore, the response of the viral RNA to AONs targeting the IRES region denoted important differences between tissue culture cells and cell-free systems, reinforcing the need to analyze viral RNA response in living cells. Importantly, we have identified four specific motifs within the IRES element that are targets for viral inhibitors both in tissue culture cells and in cell-free systems. The identified targets define accessible regions to small molecules, which disturb either the RNA structural organization or the RNA-protein interactions needed to initiate translation in FMDV RNA.	[Fajardo, Teodoro, Jr.; Flora Rosas, Maria; Sobrino, Francisco; Martinez-Salas, Encarnacion] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Fajardo, T (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain.	emartinez@cbm.uam.es	; Martinez-Salas, Encarna/J-5733-2014	Sobrino, Francisco/0000-0003-4968-8291; Martinez-Salas, Encarna/0000-0002-8432-5587	Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-02159, CSD2009-00080, BFU2011-25437]; Fundacion Ramon Areces; MICINN [BIO2011-24351]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by grants BFU2008-02159, CSD2009-00080, BFU2011-25437 from Ministerio de Ciencia e Innovacion (MICINN) and by an Institutional Grant from Fundacion Ramon Areces. Work at FS laboratory was supported by grant BIO2011-24351 from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev DE, 2007, RNA, V13, P1366, DOI 10.1261/rna.469707; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; BELSHAM GJ, 1992, EMBO J, V11, P1105, DOI 10.1002/j.1460-2075.1992.tb05150.x; BELSHAM GJ, 1990, J VIROL, V64, P5389, DOI 10.1128/JVI.64.11.5389-5395.1990; Bigeriego P, 1999, ANTIVIR RES, V44, P133, DOI 10.1016/S0166-3542(99)00057-1; CAO XM, 1995, J VIROL, V69, P560, DOI 10.1128/JVI.69.1.560-563.1995; de los Santos T, 2006, J VIROL, V80, P1906, DOI 10.1128/JVI.80.4.1906-1914.2006; de Quinto SL, 1998, GENE, V217, P51; de Quinto SL, 1999, VIROLOGY, V255, P324, DOI 10.1006/viro.1999.9598; De Quinto SL, 2000, RNA, V6, P1380, DOI 10.1017/S1355838200000753; de Quinto SL, 2002, NUCLEIC ACIDS RES, V30, P4398, DOI 10.1093/nar/gkf569; De Quinto SL, 2001, RNA, V7, P1213, DOI 10.1017/S1355838201010433; Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005; deQuinto SL, 1997, J VIROL, V71, P4171; Fernandez N, 2011, NUCLEIC ACIDS RES, V39, P8572, DOI 10.1093/nar/gkr560; Fernandez N, 2011, VIROLOGY, V409, P251, DOI 10.1016/j.virol.2010.10.013; Fernandez-Miragall O, 2006, RNA, V12, P223, DOI 10.1261/rna.2153206; Fernandez-Miragall O, 2003, RNA, V9, P1333, DOI 10.1261/rna.5950603; Fernandez-Miragall O, 2007, J GEN VIROL, V88, P3053, DOI 10.1099/vir.0.83218-0; FORSS S, 1984, NUCLEIC ACIDS RES, V12, P6587, DOI 10.1093/nar/12.16.6587; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005; Gonzalez-Carmona MA, 2011, J HEPATOL, V55, P19, DOI 10.1016/j.jhep.2010.11.010; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; GUTIERREZ A, 1993, ANTIVIR RES, V22, P1, DOI 10.1016/0166-3542(93)90082-T; GUTIERREZ A, 1994, J VIROL, V68, P7426; Haraguchi T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1317; HOKE GD, 1991, NUCLEIC ACIDS RES, V19, P5743, DOI 10.1093/nar/19.20.5743; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; INOUE H, 1987, FEBS LETT, V215, P327, DOI 10.1016/0014-5793(87)80171-0; KING AMQ, 1980, J VIROL, V34, P627, DOI 10.1128/JVI.34.3.627-634.1980; Kinney RM, 2005, J VIROL, V79, P5116, DOI 10.1128/JVI.79.8.5116-5128.2005; Knox C, 2005, J GEN VIROL, V86, P687, DOI 10.1099/vir.0.80208-0; KUHN R, 1990, J VIROL, V64, P4625; Lawrence P, 2012, VIROLOGY, V425, P40, DOI 10.1016/j.virol.2011.12.019; Laxton C, 2011, ANTIMICROB AGENTS CH, V55, P3105, DOI 10.1128/AAC.00222-11; LUZ N, 1991, J VIROL, V65, P6486, DOI 10.1128/JVI.65.12.6486-6494.1991; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; Martinez-Salas E, 2010, PICORNAVIRUSES, P141; Martinez-Salas E, 2008, TRENDS MICROBIOL, V16, P230, DOI 10.1016/j.tim.2008.01.013; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MartinezSalas E, 1996, J VIROL, V70, P992; MARTINEZSALAS E, 1993, J VIROL, V67, P3748; Mason PW, 2002, J VIROL, V76, P9686, DOI 10.1128/JVI.76.19.9686-9694.2002; Monaghan P, 2004, J GEN VIROL, V85, P933, DOI 10.1099/vir.0.19408-0; Neuman BW, 2005, J VIROL, V79, P9665, DOI 10.1128/JVI.79.15.9665-9676.2005; O'Donnell V, 2011, VIROLOGY, V410, P142, DOI 10.1016/j.virol.2010.10.042; Pacheco A, 2008, PROTEOMICS, V8, P4782, DOI 10.1002/pmic.200800338; Pacheco A, 2009, NUCLEIC ACIDS RES, V37, P582, DOI 10.1093/nar/gkn979; Piccone ME, 2009, J VIROL, V83, P6681, DOI 10.1128/JVI.01729-08; Pilipenko EV, 2000, GENE DEV, V14, P2028; Pineiro D, 2012, NUCLEIC ACIDS RES, V40, P4942, DOI 10.1093/nar/gks172; Pulido MR, 2007, VIROLOGY, V364, P466, DOI 10.1016/j.virol.2007.03.013; Rodriguez-Pulido M, 2011, J VIROL, V85, P6492, DOI 10.1128/JVI.00599-11; Rosas MF, 2008, VIROLOGY, V380, P34, DOI 10.1016/j.virol.2008.06.040; Rosas MF, 2003, J GEN VIROL, V84, P393, DOI 10.1099/vir.0.18668-0; Saiz M, 2001, J GEN VIROL, V82, P93, DOI 10.1099/0022-1317-82-1-93; Santos TDL, 2005, VIROLOGY, V335, P222, DOI 10.1016/j.virol.2005.03.001; Serrano P, 2006, J GEN VIROL, V87, P3013, DOI 10.1099/vir.0.82059-0; Serrano P, 2009, VIROLOGY, V388, P221, DOI 10.1016/j.virol.2009.03.021; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; Stone JK, 2008, ANTIMICROB AGENTS CH, V52, P1970, DOI 10.1128/AAC.00011-08; Vagnozzi A, 2007, J VIROL, V81, P11669, DOI 10.1128/JVI.00557-07; Wakita T, 1999, J MED VIROL, V57, P217, DOI 10.1002/(SICI)1096-9071(199903)57:3<217::AID-JMV1>3.3.CO;2-O; Yu YP, 2011, NUCLEIC ACIDS RES, V39, P4851, DOI 10.1093/nar/gkr045	67	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41382	10.1371/journal.pone.0041382	http://dx.doi.org/10.1371/journal.pone.0041382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815996	Green Published, Green Submitted, gold			2022-12-25	WOS:000306548900114
J	Sugimoto, M; Watanabe, T; Sugimoto, Y				Sugimoto, Mayumi; Watanabe, Toshio; Sugimoto, Yoshikazu			The Molecular Effects of a Polymorphism in the 5 ' UTR of Solute Carrier Family 44, Member 5 that Is Associated with Birth Weight in Holsteins	PLOS ONE			English	Article							CHOLINE TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; EMBRYONIC-DEVELOPMENT; EXPRESSION; IDENTIFICATION; FERTILITY; EFFLUX; GROWTH; CATTLE; CELLS	Dystocia is a major problem for the dairy cattle industry, and the observed high rates of this condition stem from genetic selection to increase subsequent milk production of the calving female. Because smaller birth size does not adversely affect subsequent milk production, selecting for cows with a smaller birth size would reduce dystocia rates and be beneficial for both the cattle and the farmers. To identify genes that regulate birth weight, we conducted a genome-wide association study using 1151 microsatellite markers and identified a single nucleotide polymorphism (SNP) associated with birth weight: A-326G in the 59 untranslated region (UTR) of solute carrier family 44, member 5 (SLC44A5). Cows with higher birth weights carried the A polymorphism in the SLC44A5 59 UTR, and the presence of the A polymorphism correlated with a high rate of dystocia. Luciferase assays and quantitative polymerase chain reaction (QPCR) assays revealed that SLC44A5 transcripts with the A polymorphism are expressed at lower levels than those carrying the G polymorphism. SLC44A5 encodes a choline transporter-like protein, and choline is a component of the major phospholipids of cell membranes. Uptake studies in HeLa cells demonstrated that SLC44A5 knockdown reduces choline efflux, whereas SLC44A5 overexpression resulted in the opposite effect. Furthermore, cell viability assays indicated that SLC44A5 knockdown increased cell proliferation, whereas SLC44A5 overexpression repressed proliferation. Taken together, our results suggest that calves with reduced SLC44A5 expression are larger due to enhanced cell proliferation. This study provides novel insights into the molecular mechanisms that control birth weight in Holsteins and suggests that SLC44A5 may serve as a potential target for preventing dystocia.	[Sugimoto, Mayumi] Natl Livestock Breeding Ctr, Nishigo, Japan; [Watanabe, Toshio; Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Nishigo, Japan		Sugimoto, M (corresponding author), Natl Livestock Breeding Ctr, Nishigo, Japan.	m0komats@nlbc.go.jp			Japan Racing and Livestock Promotion Foundation	Japan Racing and Livestock Promotion Foundation	This work was supported by the Japan Racing and Livestock Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardalan M, 2010, J ANIM PHYSIOL AN N, V94, pE259, DOI 10.1111/j.1439-0396.2009.00966.x; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Cheng KR, 2008, AM J PHYSIOL-GASTR L, V295, pG591, DOI 10.1152/ajpgi.00055.2008; Coffey MP, 2006, J DAIRY SCI, V89, P322, DOI 10.3168/jds.S0022-0302(06)72097-5; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; Dematawewa CMB, 1997, J DAIRY SCI, V80, P754, DOI 10.3168/jds.S0022-0302(97)75995-2; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Kouji H, 2009, ARCH BIOCHEM BIOPHYS, V483, P90, DOI 10.1016/j.abb.2008.12.008; Li YL, 1997, J CLIN INVEST, V100, P2873, DOI 10.1172/JCI119836; Maltecca C, 2009, ANIM GENET, V40, P27, DOI 10.1111/j.1365-2052.2008.01793.x; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Mee I, 2008, VET J, V176, P93, DOI 10.1016/j.tvjl.2007.12.032; Miakotina OL, 2005, AM J PHYSIOL-LUNG C, V288, pL93, DOI 10.1152/ajplung.00184.2004; Michel V, 2006, EXP BIOL MED, V231, P490; Pritchard JK, 2000, GENETICS, V155, P945; Sanchez X, 1998, J IMMUNOL, V160, P906; Sugimoto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013817; Swali A, 2006, THERIOGENOLOGY, V66, P1173, DOI 10.1016/j.theriogenology.2006.03.028; Thomasen JR, 2008, J DAIRY SCI, V91, P2098, DOI 10.3168/jds.2007-0602; Tominaga K, 2005, MOL CELL BIOL, V25, P2924, DOI 10.1128/MCB.25.8.2924-2937.2005; Uchida Y, 2009, J PHARMACOL SCI, V109, P102, DOI 10.1254/jphs.08291FP; Wang T, 2007, ACTA BIOCH BIOPH SIN, V39, P668, DOI 10.1111/j.1745-7270.2007.00323.x; Watanabe T, 2008, ANIM GENET, V39, P374, DOI 10.1111/j.1365-2052.2008.01742.x; WONG TY, 1982, NEUROSCI LETT, V29, P293, DOI 10.1016/0304-3940(82)90332-9; YAVIN E, 1976, J BIOL CHEM, V251, P1392; Yuan ZF, 2004, GENE, V341, P305, DOI 10.1016/j.gene.2004.07.042; ZEISEL SH, 1992, J AM COLL NUTR, V11, P473; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zufferey R, 2004, NEUROCHEM RES, V29, P461, DOI 10.1023/B:NERE.0000013752.43906.e5	36	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41267	10.1371/journal.pone.0041267	http://dx.doi.org/10.1371/journal.pone.0041267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815983	Green Submitted, Green Published, gold			2022-12-25	WOS:000306548900103
J	Chander, H; Truesdell, P; Meens, J; Craig, AWB				Chander, H.; Truesdell, P.; Meens, J.; Craig, A. W. B.			Transducer of Cdc42-dependent actin assembly promotes breast cancer invasion and metastasis	ONCOGENE			English	Article						breast cancer; metastasis; invadopodia; F-BAR adaptor Toca-1	CDC42-INTERACTING PROTEIN 4; GROWTH-FACTOR-RECEPTOR; INVADOPODIA FORMATION; TUMOR-CELLS; N-WASP; CARCINOMA CELLS; PCH PROTEINS; BAR; CORTACTIN; SRC	Metastatic breast adenocarcinomas display activation signatures for signaling pathways that trigger cell motility and tissue invasion. Here, we report that the adaptor protein transducer of Cdc42-dependent actin assembly-1 (Toca-1) is expressed in highly invasive breast cancers and regulates their metastatic phenotypes. We show that Toca-1 localizes to the filamentous actin-rich core of invadopodial protrusions actively degrading the extracellular matrix (ECM). Toca-1 colocalizes with Cortactin, and we show that this interaction is mediated by the SH3 domain of Toca-1. Stable knockdown (KD) of Toca-1 expression in MDA-MB-231 cells led to a significant defect in epidermal growth factor (EGF)-induced cell migration and invasion. Toca-1 KD cells also showed significant defects in EGF- and Src-induced ECM digestion and formation of invadopodial membrane protrusions. To test the role of Toca-1 in metastasis, we achieved stable Toca-1 KD in both human and rat metastatic breast adenocarcinoma cell lines. Orthotopic tumor xenografting of control and Toca-1 KD cells in natural-killer /B-/T-cell-deficient mice revealed a significant defect in spontaneous lung metastases with Toca-1 silencing in vivo. In contrast, no defects in primary tumor growth or lung seeding following tail vein injection of Toca-1 KD cells was observed, suggesting that Toca-1 functions at an early step in the dissemination of metastatic breast tumor cells. Taken together, our results identify Toca-1 as a proinvasive protein in breast adenocarcinoma and a potential therapeutic target to limit tumor metastasis.	[Chander, H.; Truesdell, P.; Meens, J.; Craig, A. W. B.] Queens Canc Res Inst, Canc Biol & Genet Div, Kingston, ON, Canada; [Craig, A. W. B.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Craig, AWB (corresponding author), Queens Univ, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	andrew.craig@queensu.ca	Craig, Andrew/AAC-6923-2019; Craig, Andrew/G-2312-2017	Craig, Andrew/0000-0002-2039-2393; Craig, Andrew/0000-0002-2039-2393	Canadian Breast Cancer Foundation (Ontario, Canada)	Canadian Breast Cancer Foundation (Ontario, Canada)	We greatfully acknowledge Stephanie Everingham, Jinghui Hu and Alka Mukhopadhyay for help in preparing key reagents, and Chandra Tayade for providing mice. Thanks to Sohail Ahmed, Phillipe Chavrier and Alan Mak for providing plasmids, and Leda Raptis and Doris Germain for providing cell lines. This research is supported by a grant from Canadian Breast Cancer Foundation (Ontario, Canada) to AWBC.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Aspenstrom P, 2010, BBA-MOL CELL RES, V1803, P174, DOI 10.1016/j.bbamcr.2009.06.002; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Campellone KG, 2012, J BIOL CHEM, V287, P20613, DOI 10.1074/jbc.M112.363473; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Eckert MA, 2011, ONCOTARGET, V2, P562; Fricke Robert, 2010, Commun Integr Biol, V3, P89; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hu JH, 2011, J CELL SCI, V124, P1739, DOI 10.1242/jcs.078014; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Le Devedec SE, 2009, CLIN EXP METASTAS, V26, P673, DOI 10.1007/s10585-009-9267-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; Rakha EA, 2009, BREAST CANCER RES TR, V113, P411, DOI 10.1007/s10549-008-9952-1; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rucci N, 2006, J PHARMACOL EXP THER, V318, P161, DOI 10.1124/jpet.106.102004; Shimada A, 2010, FEBS LETT, V584, P1111, DOI 10.1016/j.febslet.2010.02.058; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Suetsugu S, 2009, FEBS LETT, V583, P3401, DOI 10.1016/j.febslet.2009.10.019; Sun XL, 2009, CARCINOGENESIS, V30, P2109, DOI 10.1093/carcin/bgp251; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Valsecchi ME, 2012, CANCER-AM CANCER SOC, V118, P3484, DOI 10.1002/cncr.26661; Van Trappen PO, 2002, LANCET ONCOL, V3, P44, DOI 10.1016/S1470-2045(01)00621-0; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Wang WG, 2007, CANCER RES, V67, P3505, DOI 10.1158/0008-5472.CAN-06-3714; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Webb BA, 2006, EXP CELL RES, V312, P760, DOI 10.1016/j.yexcr.2005.11.032; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamamoto H, 2011, J UROLOGY, V185, P1930, DOI 10.1016/j.juro.2010.12.027	56	28	31	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2013	32	25					3080	3090		10.1038/onc.2012.317	http://dx.doi.org/10.1038/onc.2012.317			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22824798				2022-12-25	WOS:000320705700008
J	Bergeret, F; Gavalda, S; Chalut, C; Malaga, W; Quemard, A; Pedelacq, JD; Daffe, M; Guilhot, C; Mourey, L; Bon, C				Bergeret, Fabien; Gavalda, Sabine; Chalut, Christian; Malaga, Wladimir; Quemard, Annaik; Pedelacq, Jean-Denis; Daffe, Mamadou; Guilhot, Christophe; Mourey, Lionel; Bon, Cecile			Biochemical and Structural Study of the Atypical Acyltransferase Domain from the Mycobacterial Polyketide Synthase Pks13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; ACYL CARRIER PROTEIN; CRYSTAL-STRUCTURE; MALONYL-COA; TRANSACYLASE; TUBERCULOSIS; IDENTIFICATION; BIOSYNTHESIS; ARCHITECTURE; SITE	Pks13 is a type I polyketide synthase involved in the final biosynthesis step of mycolic acids, virulence factors, and essential components of the Mycobacterium tuberculosis envelope. Here, we report the biochemical and structural characterization of a 52-kDa fragment containing the acyl-transferase domain of Pks13. This fragment retains the ability to load atypical extender units, unusually long chain acyl-CoA with a predilection for carboxylated substrates. High resolution crystal structures were determined for the apo, palmitoylated, and carboxypalmitoylated forms. Structural conservation with type I polyketide synthases and related fatty-acid synthases also extends to the interdomain connections. Subtle changes could be identified both in the active site and in the upstream and downstream linkers in line with the organization displayed by this singular polyketide synthase. More importantly, the crystallographic analysis illustrated for the first time how a long saturated chain can fit in the core structure of an acyltransferase domain through a dedicated channel. The structures also revealed the unexpected binding of a 12-mer peptide that might provide insight into domain-domain interaction.	[Mourey, Lionel; Bon, Cecile] Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse 4, France; Univ Toulouse, Univ Toulouse 3, IPBS, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Mourey, L (corresponding author), Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, 205 Route Narbonne,BP 64182, F-31077 Toulouse 4, France.	lionel.mourey@ipbs.fr; cecile.bon@ipbs.fr	BON, cecile C/F-9231-2018; Pedelacq, Jean-Denis/C-6053-2011; Mourey, Lionel/B-5662-2009	Mourey, Lionel/0000-0002-8259-1259; PEDELACQ, Jean-Denis/0000-0002-3202-2517; Quemard, Annaik/0000-0002-5545-3424; Bon, Cecile/0000-0002-3700-2646; Chalut, Christian/0000-0002-4849-1369	European Commission Grant [LSHP-CT-2006037217]; "Vaincre la Mucoviscidose" (France) [IC0716]; French "Agence Nationale de la Recherche" Grant [09-BLAN-0298-01]; "Region Midi-Pyrenees" Grant [09005193]; European Regional Development Fund Grant [34249]	European Commission Grant(European CommissionEuropean Commission Joint Research Centre); "Vaincre la Mucoviscidose" (France); French "Agence Nationale de la Recherche" Grant(French National Research Agency (ANR)); "Region Midi-Pyrenees" Grant(Region Occitanie); European Regional Development Fund Grant	This work was supported by European Commission Grant LSHP-CT-2006037217, "Vaincre la Mucoviscidose" (France) Grant IC0716, French "Agence Nationale de la Recherche" Grant 09-BLAN-0298-01, "Region Midi-Pyrenees" Grant 09005193, and European Regional Development Fund Grant 34249.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Bunkoczi G, 2009, CHEM BIOL, V16, P667, DOI 10.1016/j.chembiol.2009.04.011; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEREWENDA ZS, 1991, BIOCHEM CELL BIOL, V69, P842, DOI 10.1139/o91-125; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Khosla C, 2009, J ORG CHEM, V74, P6416, DOI 10.1021/jo9012089; Koppisch AT, 2003, BIOCHEMISTRY-US, V42, P11057, DOI 10.1021/bi0349672; Kwan DH, 2011, MOLECULES, V16, P6092, DOI 10.3390/molecules16076092; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liou GF, 2003, CURR OPIN CHEM BIOL, V7, P279, DOI 10.1016/S1367-5931(03)00016-4; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Maier T, 2010, Q REV BIOPHYS, V43, P373, DOI 10.1017/S0033583510000156; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pappenberger G, 2010, J MOL BIOL, V397, P508, DOI 10.1016/j.jmb.2010.01.066; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; RUCH FE, 1973, J BIOL CHEM, V248, P8095; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schneider TR, 2004, ACTA CRYSTALLOGR D, V60, P2269, DOI 10.1107/S0907444904023492; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Zhang L, 2007, PROTEIN SCI, V16, P1184, DOI 10.1110/ps.072757307	59	29	30	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33675	33690		10.1074/jbc.M111.325639	http://dx.doi.org/10.1074/jbc.M111.325639			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22825853	hybrid, Green Published			2022-12-25	WOS:000309602100051
J	Ou, YW; Ma, L; Dong, LJ; Ma, LY; Zhao, ZT; Ma, L; Zhou, W; Fan, J; Wu, CY; Yu, CJ; Zhan, QM; Song, YM				Ou, Yunwei; Ma, Ling; Dong, Lijia; Ma, Liying; Zhao, Zitong; Ma, Li; Zhou, Wei; Fan, Jing; Wu, Chuanyue; Yu, Chunjiang; Zhan, Qimin; Song, Yongmei			Migfilin Protein Promotes Migration and Invasion in Human Glioma through Epidermal Growth Factor Receptor-mediated Phospholipase C-gamma and STAT3 Protein Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMAS; PROGNOSTIC-SIGNIFICANCE; EGF RECEPTOR; BIOLOGY; CALCIUM; GLIOBLASTOMA; ASSOCIATION; DEGRADATION; PLC-GAMMA-1; METHYLATION	Migfilin is critical for cell shape and motile regulation. However, its pathological role in glioma is unknown. Using an immunohistochemical staining assay, we demonstrate that there is a significant correlation between expression of Migfilin and pathological tumor grade in 217 clinical glioma samples. High Migfilin expression is associated with poor prognosis for patients with glioma. Investigation of the molecular mechanism shows that Migfilin promotes migration and invasion in glioma cells. Moreover, Migfilin positively modulates the expression and activity of epidermal growth factor receptor, and Migfilin-mediated migration and invasion depend on epidermal growth factor receptor-induced PLC-gamma and STAT3-signaling pathways. Our results may provide significant clinical application, including use of Migfilin as a molecular marker in glioma for early diagnosis and as an indicator of prognosis.	[Ou, Yunwei; Yu, Chunjiang] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China; [Ou, Yunwei; Dong, Lijia; Ma, Liying; Zhao, Zitong; Ma, Li; Zhou, Wei; Fan, Jing; Zhan, Qimin; Song, Yongmei] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Ou, Yunwei; Dong, Lijia; Ma, Liying; Zhao, Zitong; Ma, Li; Zhou, Wei; Fan, Jing; Zhan, Qimin; Song, Yongmei] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Ou, Yunwei; Dong, Lijia; Ma, Liying; Zhao, Zitong; Ma, Li; Zhou, Wei; Fan, Jing; Zhan, Qimin; Song, Yongmei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Ling] Capital Med Univ, Fu Xing Hosp, Dept Intens Care Unit, Beijing 100045, Peoples R China; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, CJ (corresponding author), Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China.	cjyu1955@sina.com; zhanqimin@pumc.edu.cn; ymsong.2008@gmail.com		song, yongmei/0000-0002-7789-0158	973 National Key Fundamental Research Program of China [2011CB911004, 2011CB910801]; National Natural Science Foundation of China [81071633]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 National Key Fundamental Research Program of China Grants 2011CB911004 and 2011CB910801 and National Natural Science Foundation of China Grant 81071633.	Afra D, 2002, LANCET, V359, P1011; Akazawa H, 2004, J CELL BIOL, V164, P395, DOI 10.1083/jcb.200309159; Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Fine HA, 2007, CANCER J, V13, P349, DOI 10.1097/PPO.0b013e31815b18db; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; He H, 2012, MOL CANCER RES, V10, P273, DOI 10.1158/1541-7786.MCR-11-0419; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Kim MJ, 2000, EXP MOL MED, V32, P101, DOI 10.1038/emm.2000.18; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Papachristou DJ, 2007, HISTOPATHOLOGY, V51, P499, DOI 10.1111/j.1365-2559.2007.02791.x; Poot DHJ, 2010, LECT NOTES COMPUT SC, V6361, P615; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Sun L, 1998, ONCOGENE, V16, P2095, DOI 10.1038/sj.onc.1201731; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; van der Zee E, 1998, J PERIODONTAL RES, V33, P65; Wang XJ, 2001, EXP CELL RES, V267, P28, DOI 10.1006/excr.2001.5241; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2009, NEURO-ONCOLOGY, V11, P69, DOI 10.1215/15228517-2008-078; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Yang Liu, 2003, Cancer Control, V10, P138; Zhang P, 2011, MOL CANCER RES, V9, P1418, DOI 10.1158/1541-7786.MCR-11-0147	41	26	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32394	32405		10.1074/jbc.M112.393900	http://dx.doi.org/10.1074/jbc.M112.393900			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843679	hybrid, Green Published			2022-12-25	WOS:000309168300010
J	Levitt, PS; Papp-Wallace, KM; Taracila, MA; Hujer, AM; Winkler, ML; Smith, KM; Xu, Y; Harris, ME; Bonomo, RA				Levitt, Peter S.; Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Hujer, Andrea M.; Winkler, Marisa L.; Smith, Kerri M.; Xu, Yan; Harris, Michael E.; Bonomo, Robert A.			Exploring the Role of a Conserved Class A Residue in the Omega-Loop of KPC-2 beta-Lactamase A MECHANISM FOR CEFTAZIDIME HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; SUBSTRATE PROFILE; CRYSTAL-STRUCTURE; K. PNEUMONIAE; CARBAPENEMASE; MUTANT; SUBSTITUTIONS; RESOLUTION	Gram-negative bacteria harboring KPC-2, a class A beta-lactamase, are resistant to all beta-lactam antibiotics and pose a major public health threat. Arg-164 is a conserved residue in all class A beta-lactamases and is located in the solvent-exposed Omega-loop of KPC-2. To probe the role of this amino acid in KPC-2, we performed site-saturation mutagenesis. When compared with wild type, 11 of 19 variants at position Arg-164 in KPC-2 conferred increased resistance to the oxyimino-cephalosporin, ceftazidime (minimum inhibitory concentration; 32 -> 128 mg/liter) when expressed in Escherichia coli. Using the R164S variant of KPC-2 as a representative beta-lactamase for more detailed analysis, we observed only a modest 25% increase in k(cat)/K-m for ceftazidime (0.015 -> 0.019 mu M-1 s(-1)). Employing pre-steady-state kinetics and mass spectrometry, we determined that acylation is rate-limiting for ceftazidime hydrolysis by KPC-2, whereas deacylation is rate-limiting in the R164S variant, leading to accumulation of acyl-enzyme at steady-state. CD spectroscopy revealed that a conformational change occurred in the turnover of ceftazidime by KPC-2, but not the R164S variant, providing evidence for a different form of the enzyme at steady state. Molecular models constructed to explain these findings suggest that ceftazidime adopts a unique conformation, despite preservation of Omega-loop structure. We propose that the R164S substitution in KPC-2 enhances ceftazidime resistance by proceeding through "covalent trapping" of the substrate by a deacylation impaired enzyme with a lower K-m. Future antibiotic design must consider the distinctive behavior of the Omega-loop of KPC-2.	[Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Hujer, Andrea M.; Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Harris, Michael E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Winkler, Marisa L.; Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Papp-Wallace, Krisztina M.; Hujer, Andrea M.; Winkler, Marisa L.; Bonomo, Robert A.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept Vet, Res Serv, Cleveland, OH 44106 USA; [Smith, Kerri M.; Xu, Yan] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University System of Ohio; Cleveland State University	Bonomo, RA (corresponding author), 10701 East Blvd, Cleveland, OH 44106 USA.	robert.bonomo@med.va.gov	Smith, Kerri M/D-9878-2011; Smith, Kerri/P-4609-2019; Papp-Wallace, Krisztina/L-2923-2019; Xu, Yan/AAW-4085-2021	Papp-Wallace, Krisztina/0000-0002-9976-7898; Smith, Kerri/0000-0001-5161-3278	National Institutes of Health [1R01-A1063517]; Medical Scientist Training Program Training Grant from Case Western Reserve University [T32 GM07250]; Veterans Affairs Career Development Program; Veterans Affairs Merit Review Program; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM096000] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program Training Grant from Case Western Reserve University; Veterans Affairs Career Development Program; Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-A1063517 (to R. A. B.).; Supported by Medical Scientist Training Program Training Grant T32 GM07250 from Case Western Reserve University.; Supported by the Veterans Affairs Career Development Program.; Supported by the Veterans Affairs Merit Review Program. To whom correspondence should be addressed: 10701 East Blvd., Cleveland, OH 44106. Tel.: 216-791-3800, Ext. 4399; Fax: 216-231-3482; E-mail: robert.bonomo@med.va.gov.	Alba J, 2005, ANTIMICROB AGENTS CH, V49, P4760, DOI 10.1128/AAC.49.11.4760-4762.2005; Antunes NT, 2011, BIOCHEMISTRY-US, V50, P6387, DOI 10.1021/bi200403e; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; Bergamasco MD, 2012, TRANSPL INFECT DIS, V14, P198, DOI 10.1111/j.1399-3062.2011.00688.x; Bos F, 2008, ANTIMICROB AGENTS CH, V52, P1072, DOI 10.1128/AAC.01035-07; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; CLSI (Clinical and Laboratory Standards Institute), 2017, M100 PERF STAND ANT; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; HERZBERG O, 1991, BIOCHEMISTRY-US, V30, P9503, DOI 10.1021/bi00103a017; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; Kontopoulou K, 2010, J HOSP INFECT, V76, P70, DOI 10.1016/j.jhin.2010.03.021; KUZIN AP, 1995, BIOCHEMISTRY-US, V34, P9532, DOI 10.1021/bi00029a030; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Papp-Wallace KM, 2012, ANTIMICROB AGENTS CH, V56, P4428, DOI 10.1128/AAC.05769-11; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Papp-Wallace KM, 2010, PROTEIN SCI, V19, P1714, DOI 10.1002/pro.454; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P2867, DOI 10.1128/AAC.00197-10; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; Sampson JM, 2011, ANTIMICROB AGENTS CH, V55, P2303, DOI 10.1128/AAC.01360-10; Sougakoff W, 2002, ACTA CRYSTALLOGR D, V58, P267, DOI 10.1107/S0907444901019606; SOUGAKOFF W, 1989, GENE, V78, P339, DOI 10.1016/0378-1119(89)90236-9; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Swaren P, 1998, J BIOL CHEM, V273, P26714, DOI 10.1074/jbc.273.41.26714; TaibiTronche P, 1996, J AM CHEM SOC, V118, P7441, DOI 10.1021/ja9529753; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P1553, DOI 10.1128/AAC.01405-06; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; WEBER DA, 1990, J INFECT DIS, V162, P460, DOI 10.1093/infdis/162.2.460; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zawadzke LE, 1996, BIOCHEMISTRY-US, V35, P16475, DOI 10.1021/bi962242a	41	60	61	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31783	31793		10.1074/jbc.M112.348540	http://dx.doi.org/10.1074/jbc.M112.348540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843686	Green Published, hybrid			2022-12-25	WOS:000309059400019
J	Chen, Y; Gou, XC; Ke, X; Cui, HY; Chen, Z				Chen, Yanke; Gou, Xingchun; Ke, Xia; Cui, Hongyong; Chen, Zhinan			Human Tumor Cells Induce Angiogenesis through Positive Feedback between CD147 and Insulin-Like Growth Factor-I	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INDUCER; ENDOTHELIAL-CELLS; SURFACE EXPRESSION; UP-REGULATION; CANCER CELLS; FACTOR VEGF; EMMPRIN; HAB18G/CD147; INVASION; MODELS	Tumor angiogenesis is a complex process based upon a sequence of interactions between tumor cells and endothelial cells. Previous studies have shown that CD147 was correlated with tumor angiogenesis through increasing tumor cell secretion of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). In this study, we made a three-dimensional (3D) tumor angiogenesis model using a co-culture system of human hepatocellular carcinoma cells SMMC-7721 and humanumbilical vein endothelial cells (HUVECs) in vitro. We found that CD147-expressing cancer cells could promote HUVECs to form net-like structures resembling the neo-vasculature, whereas the ability of proliferation, migration and tube formation of HUVECs was significantly decreased in tumor conditioned medium (TCM) of SMMC-7721 cells transfected with specific CD147-siRNA. Furthermore, by assaying the change of pro-angiogenic factors in TCM, we found that the inhibition of CD147 expression led to significant decrease of VEGF and insulin-like growth factor-I (IGF-I) secretion. Interestingly, we also found that IGF-I up-regulated the expression of CD147 in both tumor cells and HUVECs. These findings suggest that there is a positive feedback between CD147 and IGF-I at the tumor-endothelial interface and CD147 initiates the formation of an angiogenesis niche.	[Chen, Yanke] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Gou, Xingchun; Ke, Xia; Cui, Hongyong; Chen, Zhinan] Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China; [Chen, Yanke; Ke, Xia; Cui, Hongyong; Chen, Zhinan] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Peoples R China; [Ke, Xia; Cui, Hongyong; Chen, Zhinan] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Gou, Xingchun] Xian Med Univ, Lab Cell Biol & Translat Med, Xian, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Medical University	Chen, Y (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	yankechen@126.com; Zhinanchen@fmmu.edu.cn			National Basic Research Program of China [2009CB521704]; National Natural Science Foundation of China [81101744]; Shaanxi Provincial Education Department;  [2010JK801]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Education Department; 	This work was supported by Grant 2009CB521704 from the National Basic Research Program of China, Grant No. 81101744 from National Natural Science Foundation of China and Grant No. 2010JK801 from the Scientific Research Program Funded by Shaanxi Provincial Education Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner I, 1998, VASA-J VASCULAR DIS, V27, P201; BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Caudroy S, 2002, CLIN EXP METASTAS, V19, P697, DOI 10.1023/A:1021350718226; Chen YK, 2009, CANCER LETT, V278, P113, DOI 10.1016/j.canlet.2009.01.004; Clark D E, 1998, Angiogenesis, V2, P309, DOI 10.1023/A:1009200824934; Dai L, 2011, INT J CANC; Folkman J, 1997, EXS, V79, P1; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Han MD, 2006, DEV DYNAM, V235, P124, DOI 10.1002/dvdy.20531; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holly J, 2004, LANCET, V364, P325, DOI 10.1016/S0140-6736(04)16708-1; Horiuchi A, 2002, ANTICANCER RES, V22, P2697; Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Li RS, 2001, J CELL PHYSIOL, V186, P371, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1042>3.0.CO;2-8; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Menashi S, 2003, CANCER RES, V63, P7575; Millimaggi D, 2007, NEOPLASIA, V9, P349, DOI 10.1593/neo.07133; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Pushkarsky T, 2005, J BIOL CHEM, V280, P27866, DOI 10.1074/jbc.M503770200; Qin ZQ, 2010, CANCER RES, V70, P3884, DOI 10.1158/0008-5472.CAN-09-4663; Riethdorf S, 2006, INT J CANCER, V119, P1800, DOI 10.1002/ijc.22062; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI13374; Shi YH, 2007, PATHOLOGY, V39, P396, DOI 10.1080/00313020701444549; Shigematsu S, 1999, ENDOCR J, V46, pS59; Sun JX, 2001, CANCER RES, V61, P2276; Tang Y, 2004, MOL CANCER RES, V2, P73; Tang Y, 2006, MOL CANCER RES, V4, P371, DOI 10.1158/1541-7786.MCR-06-0042; Turner KJ, 2002, BRIT J CANCER, V86, P1276, DOI 10.1038/sj.bjc.6600215; Voigt H, 2009, CANCER INVEST, V27, P329, DOI 10.1080/07357900802392675; Wellmann S, 2001, CLIN CHEM, V47, P654; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Yang XJ, 2010, ORAL ONCOL, V46, P755, DOI 10.1016/j.oraloncology.2010.08.008; Yurchenko V, 2005, J BIOL CHEM, V280, P17013, DOI 10.1074/jbc.M412851200; Zheng HC, 2006, BRIT J CANCER, V95, P1371, DOI 10.1038/sj.bjc.6603425; Zhu W, 2008, NEUROCHEM INT, V52, P1086, DOI 10.1016/j.neuint.2007.11.005; Zigrino P, 2005, BIOCHIMIE, V87, P321, DOI 10.1016/j.biochi.2004.10.025	42	25	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40965	10.1371/journal.pone.0040965	http://dx.doi.org/10.1371/journal.pone.0040965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844419	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700029
J	Chen, Y; Sjolinder, M; Wang, X; Altenbacher, G; Hagner, M; Berglund, P; Gao, YM; Lu, T; Jonsson, AB; Sjolinder, H				Chen, Yao; Sjolinder, Mikael; Wang, Xiao; Altenbacher, Georg; Hagner, Matthias; Berglund, Pernilla; Gao, Yumin; Lu, Ting; Jonsson, Ann-Beth; Sjolinder, Hong			Thyroid Hormone Enhances Nitric Oxide-Mediated Bacterial Clearance and Promotes Survival after Meningococcal Infection	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EUTHYROID SICK SYNDROME; NEISSERIA-GONORRHOEAE; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; SEPTIC SHOCK; CELL-SURFACE; ACID DITPA; IN-VITRO; RECEPTOR	Euthyroid sick syndrome characterized by reduced levels of thyroid hormones (THs) is observed in patients with meningococcal shock. It has been found that the level of THs reflects disease severity and is predictive for mortality. The present study was conducted to investigate the impact of THs on host defense during meningococcal infection. We found that supplementation of thyroxine to mice infected with Neisseria meningitidis enhanced bacterial clearance, attenuated the inflammatory responses and promoted survival. In vitro studies with macrophages revealed that THs enhanced bacteria-cell interaction and intracellular killing of meningococci by stimulating inducible nitric oxide synthase (iNos)-mediated NO production. TH treatment did not activate expression of TH receptors in macrophages. Instead, the observed TH-directed actions were mediated through nongenomic pathways involving the protein kinases PI3K and ERK1/2 and initiated at the membrane receptor integrin alpha v beta 3. Inhibition of nongenomic TH signaling prevented iNos induction, NO production and subsequent intracellular bacterial killing by macrophages. These data demonstrate a beneficial role of THs in macrophage-mediated N. meningitidis clearance. TH replacement might be a novel option to control meningococcal septicemia.	[Chen, Yao; Sjolinder, Mikael; Wang, Xiao; Altenbacher, Georg; Hagner, Matthias; Berglund, Pernilla; Gao, Yumin; Lu, Ting; Jonsson, Ann-Beth; Sjolinder, Hong] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Stockholm University	Chen, Y (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	hong.sjolinder@gmt.su.se			Swedish Research Council [2008-2572, 2008-3367]; Swedish Society of Medicine; Magnus Bergvalls Foundation; Harald Jeanssons Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Magnus Bergvalls Foundation; Harald Jeanssons Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	This work was supported by the Swedish Research Council (Grant no. 2008-2572, 2008-3367, www.vr.se), the Swedish Society of Medicine (www.sls.se), the Magnus Bergvalls Foundation (http://www.magnbergvallsstiftelse.nu), the Harald Jeanssons Foundation (http://www.jeanssonsstiftelser.se), the Tore Nilsons Foundation (http://www.torenilsonsstiftelse.nu), and the Ake Wiberg Foundation (http://www.ake-wiberg.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abed Y, 2011, P NATL ACAD SCI USA, V108, P8224, DOI 10.1073/pnas.1017624108; Anjum MF, 2002, J BACTERIOL, V184, P2987, DOI 10.1128/JB.184.11.2987-2993.2002; Annane D., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002243.pub2, DOI 10.1002/14651858.CD002243.PUB2]; Arcos MLB, 2006, AM J PHYSIOL-CELL PH, V291, pC327, DOI 10.1152/ajpcell.00316.2005; Astier AL, 2008, IMMUNOLOGY, V124, P149, DOI 10.1111/j.1365-2567.2008.02821.x; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Carrillo-Sepulveda MA, 2010, CARDIOVASC RES, V85, P560, DOI 10.1093/cvr/cvp304; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; den Brinker M, 2005, J CLIN ENDOCR METAB, V90, P5613, DOI 10.1210/jc.2005-0888; den Brinker M, 2005, INTENS CARE MED, V31, P970, DOI 10.1007/s00134-005-2671-8; Farwell AP, 2005, DEV BRAIN RES, V154, P121, DOI 10.1016/j.devbrainres.2004.07.016; Fernandez V, 1997, NITRIC OXIDE-BIOL CH, V1, P463, DOI 10.1006/niox.1997.0149; Flamant F, 2007, MOL ENDOCRINOL, V21, P321, DOI 10.1210/me.2006-0035; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Inan M, 2003, SURG TODAY, V33, P24, DOI 10.1007/s005950300004; Jack DL, 2005, J LEUKOCYTE BIOL, V77, P328, DOI 10.1189/jlb.0604342; Johansson L, 2005, J IMMUNOL, V175, P433, DOI 10.4049/jimmunol.175.1.433; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Kallstrom H, 2001, CELL MICROBIOL, V3, P133, DOI 10.1046/j.1462-5822.2001.00095.x; Karanikas G, 2004, THYROID, V14, P488, DOI 10.1089/1050725041517002; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Kelly G S, 2000, Altern Med Rev, V5, P306; Kirchner M, 2005, MOL MICROBIOL, V56, P945, DOI 10.1111/j.1365-2958.2005.04600.x; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; KLEBANOFF SJ, 1967, J EXP MED, V126, P1063, DOI 10.1084/jem.126.6.1063; Kuzman JA, 2007, CAN J PHYSIOL PHARM, V85, P311, DOI 10.1139/Y07-011; Leonard JL, 1997, THYROID, V7, P147, DOI 10.1089/thy.1997.7.147; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; LITTLE JS, 1985, ENDOCRINOLOGY, V117, P1431, DOI 10.1210/endo-117-4-1431; Mascanfroni ID, 2010, J BIOL CHEM, V285, P9569, DOI 10.1074/jbc.M109.071241; May RC, 2001, J CELL SCI, V114, P1061; McIver B, 1997, THYROID, V7, P125, DOI 10.1089/thy.1997.7.125; Mezosi E, 2005, J ENDOCRINOL, V185, P121, DOI 10.1677/joe.1.05968; Mitchell FE, 2010, J THROID RES, V2010, DOI 10.4061/2010/726098; Mousa SA, 2006, ENDOCRINOLOGY, V147, P1602, DOI 10.1210/en.2005-1390; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; Novitzky D, 1989, Eur J Cardiothorac Surg, V3, P140, DOI 10.1016/1010-7940(89)90092-4; NOVITZKY D, 1987, TRANSPLANT P, V19, P2037; Patel DM, 2011, J CELL SCI, V124, P578, DOI 10.1242/jcs.076208; Persson BD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001122; ROTHWELL PM, 1995, CRIT CARE MED, V23, P78, DOI 10.1097/00003246-199501000-00015; Russell W, 2008, J CLIN ENDOCR METAB, V93, P2300, DOI 10.1210/jc.2007-2674; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2004, ENDOCRINOLOGY, V145, P2357, DOI 10.1210/en.2003-1696; Salman H, 2000, CRYOBIOLOGY, V41, P66, DOI 10.1006/cryo.2000.2267; Schlenker EH, 2008, AM J PHYSIOL-REG I, V294, pR1504, DOI 10.1152/ajpregu.00027.2008; SCHOENFELD PS, 1995, SOUTHERN MED J, V88, P347, DOI 10.1097/00007611-199503000-00019; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; SIEGEL E, 1964, J CLIN ENDOCR METAB, V24, P313, DOI 10.1210/jcem-24-4-313; Sjolinder H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000241; SLAG MF, 1981, JAMA-J AM MED ASSOC, V245, P43, DOI 10.1001/jama.245.1.43; Tomanek RJ, 1998, J MOL CELL CARDIOL, V30, P923, DOI 10.1006/jmcc.1998.0671; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006; Williams JM, 1998, MOL MICROBIOL, V27, P171, DOI 10.1046/j.1365-2958.1998.00670.x; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yildizdas D, 2004, J PEDIATR ENDOCR MET, V17, P1435	62	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41445	10.1371/journal.pone.0041445	http://dx.doi.org/10.1371/journal.pone.0041445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844479	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700091
J	He, YL; Zhang, CL; Gao, XF; Yao, JJ; Hu, CL; Mei, YA				He, Yan-Lin; Zhang, Chun-Lei; Gao, Xiao-Fei; Yao, Jin-Jing; Hu, Chang-Long; Mei, Yan-Ai			Cyproheptadine Enhances the I-K of Mouse Cortical Neurons through Sigma-1 Receptor-Mediated Intracellular Signal Pathway	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; POTASSIUM CHANNELS; CAMP/PROTEIN-KINASE; C-TERMINALS; KV2.1; PHOSPHORYLATION; LOCALIZATION; MODULATION; INHIBITION; SUBUNIT	Cyproheptadine (CPH) is a histamine- and serotonin-receptor antagonist, and its effects are observed recently in the modulation of multiple intracellular signals. In this study, we used cortical neurons and HEK-293 cells transfected with Kv2.1 alpha-subunit to address whether CPH modify neural voltage-gated K+ channels by a mechanism independent of its serotonergic and histaminergic properties. Our results demonstrate that intracellularly delivered CPH increased the I-K by reducing the activity of protein kinas A (PKA). Inhibition of G(i) eliminated the CPH-induced effect on both the I-K and PKA. Blocking of 5-HT-, M-, D-2-, H-1- or H-2-type GPCR receptors with relevant antagonists did not eliminate the CPH-induced effect on the I-K. Antagonists of the sigma-1 receptor, however, blocked the effect of CPH. Moreover, the inhibition of sigma-1 by siRNA knockdown significantly reduced the CPH-induced effect on the I-K. On the contrary, sigma-1 receptor agonist mimicked the effects of CPH on the induction of I-K. A ligand-receptor binding assay indicated that CPH bound to the sigma-1 receptor. Similar effect of CPH were obtained from HEK-293 cells transfected with the alpha-subunit of Kv2.1. In overall, we reveal for the first time that CPH enhances the I-K by modulating activity of PKA, and that the associated activation of the sigma-1 receptor/G(i)-protein pathway might be involved. Our findings illustrate an uncharacterized effect of CPH on neuron excitability through the I-K, which is independent of histamine H-1 and serotonin receptors.	[He, Yan-Lin] Fudan Univ, Sch Life Sci, Inst Brain Sci, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	He, YL (corresponding author), Fudan Univ, Sch Life Sci, Inst Brain Sci, Shanghai 200433, Peoples R China.	yamei@fudan.edu.cn	Hu, Changlong/AAQ-8348-2020	Hu, Changlong/0000-0002-8609-8947; Zhang, Chun-Lei/0000-0003-1296-1370; He, Yanlin/0000-0002-5471-9016	National Basic Research Program of China [2007CB512303, 2011CB503703]; Shanghai Leading Academic Discipline Project [B111]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The study was supported by a grant from the National Basic Research Program of China (2007CB512303 and 2011CB503703) and the Shanghai Leading Academic Discipline Project [B111]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Cerda O, 2011, J BIOL CHEM, V286, P28738, DOI 10.1074/jbc.M111.251942; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CLINESCHMIDT BV, 1976, ARCH INT PHARMACOD T, V223, P287; Codd EE, 2010, TOXICOL SCI, V117, P493, DOI 10.1093/toxsci/kfq200; Droogmans S, 2009, AM J PHYSIOL-HEART C, V296, pH1940, DOI 10.1152/ajpheart.01177.2008; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Goudie AJ, 2007, J PSYCHOPHARMACOL, V21, P179, DOI 10.1177/0269881107067076; GOUELI BS, 1995, ANAL BIOCHEM, V225, P10, DOI 10.1006/abio.1995.1100; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hawkins BS, 2004, TOXICOL SCI, V79, P258, DOI 10.1093/toxsci/kfh113; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; He YL, 2010, J PHARMACOL EXP THER, V332, P437, DOI 10.1124/jpet.109.159160; Holl Ralph, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P220; Jiao S, 2007, J NEUROCHEM, V100, P979, DOI 10.1111/j.1471-4159.2006.04261.x; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Klouz A, 2002, BRIT J PHARMACOL, V135, P1607, DOI 10.1038/sj.bjp.0704626; KOTAKE H, 1987, EUR J PHARMACOL, V139, P307; Levitt ES, 2011, MOL PHARMACOL, V79, P461, DOI 10.1124/mol.110.064816; Liao Z, 2007, TOXICON, V50, P135, DOI 10.1016/j.toxicon.2007.03.006; Liu LY, 2007, J NEUROCHEM, V102, P333, DOI 10.1111/j.1471-4159.2007.04669.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao XL, 2008, BLOOD, V112, P760, DOI 10.1182/blood-2008-02-142687; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Mavlyutov TA, 2012, NEUROSCIENCE, V206, P60, DOI 10.1016/j.neuroscience.2011.12.040; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Melishchuk A, 1998, BIOPHYS J, V75, P1828, DOI 10.1016/S0006-3495(98)77624-6; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; REMY DC, 1977, J MED CHEM, V20, P836, DOI 10.1021/jm00216a020; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; Rueff Laura, 2008, Rev Neurol Dis, V5, P65; Soriani O, 1999, J PHARMACOL EXP THER, V289, P321; Spangler DL, 2006, SOUTH MED J, V99, P593, DOI 10.1097/01.smj.0000221631.98056.87; Stahl SM, 2005, CNS SPECTRUMS, V10, P319, DOI 10.1017/S1092852900022641; Suh HW, 1999, NEUROPEPTIDES, V33, P121, DOI 10.1054/npep.1999.0006; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; WALKER JM, 1990, PHARMACOL REV, V42, P355; WOOLTORTON JRA, 1995, BRIT J PHARMACOL, V116, P2191, DOI 10.1111/j.1476-5381.1995.tb15053.x; Wu YJ, 2005, CURR MED CHEM, V12, P453, DOI 10.2174/0929867053363045; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41303	10.1371/journal.pone.0041303	http://dx.doi.org/10.1371/journal.pone.0041303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844454	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700067
J	Swett, R; Cisneros, GA; Feig, AL				Swett, Rebecca; Cisneros, G. Andres; Feig, Andrew L.			Conformational Analysis of Clostridium difficile Toxin B and Its Implications for Substrate Recognition	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; PARTICLE MESH EWALD; CHARGE FORCE-FIELD; STRUCTURAL DETERMINANTS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; HINGE PREDICTION; PORE FORMATION; AMINO-ACIDS; PROTEINS	Clostridium difficile (C. difficile) is an opportunistic pathogen that can cause potentially lethal hospital-acquired infections. The cellular damage that it causes is the result of two large clostridial cytotoxins: TcdA and TcdB which act by glucosylating cytosolic G-proteins, mis-regulation of which induces apoptosis. TcdB is a large flexible protein that appears to undergo significant structural rearrangement upon accommodation of its substrates: UDP-glucose and a Rho-family GTPase. To characterize the conformational space of TcdB, we applied normal mode and hinge-region analysis, followed by long-timescale unbiased molecular dynamics. In order to examine the TcdB and RhoA interaction, macromolecular docking and simulation of the TcdB/RhoA complex was performed. Generalized Masked Delaunay analysis of the simulations determined the extent of significant motions. This combination of methods elucidated a wide range of motions within TcdB that are reiterated in both the low-cost normal mode analysis and the extensive MD simulation. Of particular interest are the coupled motions between a peripheral 4-helix bundle and a small loop in the active site that must rearrange to allow RhoA entry to the catalytic site. These extensive coupled motions are indicative of TcdB using a conformational capture mechanism for substrate accommodation.	[Swett, Rebecca; Cisneros, G. Andres; Feig, Andrew L.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Wayne State University	Swett, R (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	afeig@chem.wayne.edu	Cisneros, G. Andres/H-5197-2017	Cisneros, G. Andres/0000-0001-6629-3430; Feig, Andrew/0000-0002-5783-1097	Wayne State University; Wayne State University C&IT (Computer and Information Technology group)	Wayne State University; Wayne State University C&IT (Computer and Information Technology group)	This work was supported by Wayne State University. The authors wish to acknowledge support from the Wayne State University C&IT (Computer and Information Technology group) group that oversees the TeraGrid facilities on campus and other high performance computing infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen SJ, 2010, ACS CHEM BIOL, V5, P1097, DOI 10.1021/cb100209b; [Anonymous], 2010, MATH ED VERS 8 0; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cookson B, 2007, POSTGRAD MED J, V83, P291, DOI 10.1136/pgmj.2006.056143; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawson LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025754; DEBRUNNER PG, 1982, ANNU REV PHYS CHEM, V33, P283, DOI 10.1146/annurev.pc.33.100182.001435; Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P332, DOI 10.1086/596604; Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P57, DOI 10.1086/592981; Egerer M, 2008, N-S ARCH PHARMACOL, V377, P11; Egerer M, 2007, N-S ARCH PHARMACOL, V375, P93; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Flores SC, 2008, PROTEINS, V73, P299, DOI 10.1002/prot.22060; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Giesemann T, 2006, N-S ARCH PHARMACOL, V372, P125; Grant BJ, 2010, BIOPHYS J, V99, pL87, DOI 10.1016/j.bpj.2010.10.020; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivarsson M. E., 2012, ANGEW CHEM, V124, P4098; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jank T, 2006, N-S ARCH PHARMACOL, V372, P55; Jank T, 2005, J BIOL CHEM, V280, P37833, DOI 10.1074/jbc.M506836200; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jank T, 2006, J BIOL CHEM, V281, P19527, DOI 10.1074/jbc.M600863200; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kaiser E, 2011, INFECT IMMUN, V79, P3913, DOI 10.1128/IAI.05372-11; Keating KS, 2009, PROTEIN SCI, V18, P359, DOI 10.1002/pro.38; Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Lanis JM, 2012, MOL MICROBIOL, V84, P66, DOI 10.1111/j.1365-2958.2012.08009.x; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Mathieu R, 2003, J BIOMOL NMR, V25, P83, DOI 10.1023/A:1021990314599; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McGlone SM, 2011, CLIN MICROBIOL INFEC; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Muller S, 1999, EUR J BIOCHEM, V266, P1073, DOI 10.1046/j.1432-1327.1999.00951.x; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077; Patel S, 2004, J COMPUT CHEM, V25, P1, DOI 10.1002/jcc.10355; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; PETSKO GA, 1984, ANNU REV BIOPHYS BIO, V13, P331; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Ritchie DW, 2005, J APPL CRYSTALLOGR, V38, P808, DOI 10.1107/S002188980502474X; Sapay N, 2011, J COMPUT CHEM, V32, P1400, DOI 10.1002/jcc.21726; Shen A, 2011, NAT STRUCT MOL BIOL, V18, P364, DOI 10.1038/nsmb.1990; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Wang H, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3446812; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wriggers W, 2009, J CHEM THEORY COMPUT, V5, P2595, DOI 10.1021/ct900229u	62	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41518	10.1371/journal.pone.0041518	http://dx.doi.org/10.1371/journal.pone.0041518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844485	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700097
J	Bertels, F; Merker, H; Kost, C				Bertels, Felix; Merker, Holger; Kost, Christian			Design and Characterization of Auxotrophy-Based Amino Acid Biosensors	PLOS ONE			English	Article							ESCHERICHIA-COLI; MICROBIOLOGICAL ASSAY; AVAILABLE LYSINE; BIOAVAILABILITY; QUANTIFICATION; TN7	Efficient and inexpensive methods are required for the high-throughput quantification of amino acids in physiological fluids or microbial cell cultures. Here we develop an array of Escherichia coli biosensors to sensitively quantify eleven different amino acids. By using online databases, genes involved in amino acid biosynthesis were identified that - upon deletion should render the corresponding mutant auxotrophic for one particular amino acid. This rational design strategy suggested genes involved in the biosynthesis of arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, threonine, tryptophan, and tyrosine as potential genetic targets. A detailed phenotypic characterization of the corresponding single-gene deletion mutants indeed confirmed that these strains could neither grow on a minimal medium lacking amino acids nor transform any other proteinogenic amino acid into the focal one. Site-specific integration of the egfp gene into the chromosome of each biosensor decreased the detection limit of the GFP-labeled cells by 30% relative to turbidometric measurements. Finally, using the biosensors to determine the amino acid concentration in the supernatants of two amino acid overproducing E. coli strains (i.e. DhisL and DtdcC) both turbidometrically and via GFP fluorescence emission and comparing the results to conventional HPLC measurements confirmed the utility of the developed biosensor system. Taken together, our study provides not only a genotypically and phenotypically well-characterized set of publicly available amino acid biosensors, but also demonstrates the feasibility of the rational design strategy used.	[Bertels, Felix; Merker, Holger; Kost, Christian] Max Planck Inst Chem Ecol, Res Grp Expt Ecol & Evolut, Jena, Germany	Max Planck Society	Bertels, F (corresponding author), Max Planck Inst Chem Ecol, Res Grp Expt Ecol & Evolut, Jena, Germany.	christiankost@gmail.com	Kost, Christian/N-1553-2014	Kost, Christian/0000-0002-7870-7343	Volkswagen Foundation; Jena School for Microbial Communication	Volkswagen Foundation(Volkswagen); Jena School for Microbial Communication	Funding by the Volkswagen Foundation (CK) and the Jena School for Microbial Communication (HM, CK) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLACKMOR.JA, 1972, J CLIN PATHOL, V25, P171, DOI 10.1136/jcp.25.2.171; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Chalova VI, 2007, APPL MICROBIOL BIOT, V76, P91, DOI 10.1007/s00253-007-0989-6; Chalova VI, 2008, WORLD J MICROB BIOT, V24, P353, DOI 10.1007/s11274-007-9479-3; Chalova VI, 2009, SENSORS-BASEL, V9, P7038, DOI 10.3390/s90907038; DeAngelis KM, 2005, APPL ENVIRON MICROB, V71, P8537, DOI 10.1128/AEM.71.12.8537-8547.2005; EFRON ML, 1964, NEW ENGL J MED, V270, P1378, DOI 10.1056/NEJM196406252702602; Erickson AM, 2000, J MICROBIOL METH, V40, P207, DOI 10.1016/S0167-7012(00)00121-4; Froelich CA, 2005, J RAPID METH AUT MIC, V13, P1, DOI 10.1111/j.1745-4581.2005.00001.x; FURST P, 1990, J CHROMATOGR, V499, P557, DOI 10.1016/S0021-9673(00)97000-6; GUILBAULT GG, 1974, ANAL CHIM ACTA, V69, P183, DOI 10.1016/0003-2670(74)80021-8; Hansen LH, 2001, MICROBIAL ECOL, V42, P483, DOI 10.1007/s00248-001-0025-9; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Herbert P, 2000, J FOOD SCI, V65, P1130, DOI 10.1111/j.1365-2621.2000.tb10251.x; HITCHINS AD, 1989, PLANT FOOD HUM NUTR, V39, P109, DOI 10.1007/BF01092407; KACANIKLIC V, 1994, ELECTROANAL, V6, P381, DOI 10.1002/elan.1140060505; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaspar H, 2008, J CHROMATOGR B, V870, P222, DOI 10.1016/j.jchromb.2008.06.018; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kim MI, 2010, ANAL CHEM, V82, P4072, DOI 10.1021/ac100087r; Kwan RCH, 2002, BIOTECHNOL LETT, V24, P1203, DOI 10.1023/A:1016163315804; LANZER M, 1988, P NATL ACAD SCI USA, V85, P8973, DOI 10.1073/pnas.85.23.8973; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Li X, 2003, LETT APPL MICROBIOL, V37, P458, DOI 10.1046/j.1472-765X.2003.01425.x; LICHTENSTEIN C, 1982, NATURE, V297, P601, DOI 10.1038/297601a0; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; NEWTON WA, 1965, J BACTERIOL, V89, P355, DOI 10.1128/JB.89.2.355-364.1965; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; PFEIFFER D, 1990, ELECTROANAL, V2, P517, DOI 10.1002/elan.1140020704; Seki A, 2003, SENSOR ACTUAT B-CHEM, V94, P253, DOI 10.1016/S0925-4005(03)00381-2; Simova E, 2006, INT J FOOD MICROBIOL, V107, P112, DOI 10.1016/j.ijfoodmicro.2005.08.020; STOTT JA, 1966, BRIT J NUTR, V20, P663, DOI 10.1079/BJN19660069; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Tepper N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016274; Tessaro MJ, 2012, APPL ENVIRON MICROB, V78, P604, DOI 10.1128/AEM.05261-11; TUFFNELL JM, 1985, J APPL BACTERIOL, V58, P333, DOI 10.1111/j.1365-2672.1985.tb01469.x; VANSTOCKEM M, 1987, APPL ENVIRON MICROB, V53, P410, DOI 10.1128/AEM.53.2.410-415.1987; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003; ZLATKIS A, 1960, ANAL CHEM, V32, P162, DOI 10.1021/ac60158a006	43	31	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41349	10.1371/journal.pone.0041349	http://dx.doi.org/10.1371/journal.pone.0041349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829942	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300081
J	Guo, JP; Wu, XY; Too, CL; Yin, FR; Lu, XL; He, J; Li, R; Liu, X; Murad, S; Padyukov, L; Li, ZG				Guo, Jianping; Wu, Xinyu; Too, Chun Lai; Yin, Fangrui; Lu, Xiaolan; He, Jing; Li, Ru; Liu, Xu; Murad, Shahnaz; Padyukov, Leonid; Li, Zhanguo			A Replication Study Confirms the Association of Dendritic Cell Immunoreceptor (DCIR) Polymorphisms with ACPA - Negative RA in a Large Asian Cohort	PLOS ONE			English	Article							HLA-DRB1 SHARED EPITOPE; RHEUMATOID-ARTHRITIS; RECEPTOR COMPLEX; AUTOIMMUNITY; ANTIBODIES; DISEASES; SMOKING; PTPN22; GENE	Objectives: Dendritic cell immunoreceptor (DCIR) has been implicated in development of autoimmune disorders in rodent and DCIR polymorphisms were associated with anti-citrullinated proteins antibodies (ACPA)-negative rheumatoid arthritis (RA) in Swedish Caucasians. This study was undertaken to further investigate whether DCIR polymorphisms are also risk factors for the development of RA in four Asian populations originated from China and Malaysia. Methods: We genotyped two DCIR SNPs rs2377422 and rs10840759 in Han Chinese population (1,193 cases, 1,278 controls), to assess their association with RA. Subsequently, rs2377422 was further genotyped in three independent cohorts of Malaysian-Chinese subjects (MY_Chinese, 254 cases, 206 controls), Malay subjects (MY_Malay, 515 cases, 986 controls), and Malaysian-Indian subjects (MY_Indian, 378 cases, 285 controls), to seek confirmation of association in various ethnic groups. Meta-analysis was preformed to evaluate the contribution of rs2377422 polymorphisms to the development of ACPA-negative RA in distinct ethnic groups. Finally, we carried out association analysis of rs2377422 polymorphisms with DCIR mRNA expression levels. Results: DCIR rs2377422 was found to be significantly associated with ACPA -negative RA in Han Chinese (OR 1.92, 95% CI 1.27-2.90, P = 0.0020). Meta-analysis confirms DCIR rs2377422 as a risk factor for ACPA-negative RA across distinct ethnic groups (ORoverall = 1.17, 95% CI 1.06-1.30, P = 0.003). The SNP rs2377422 polymorphism showed significant association with DCIR mRNA expression level, i.e. RA-risk CC genotype exhibit a significant increase in the expression of DCIR (P = 0.0023, Kruskal-Wallis). Conclusions: Our data provide evidence for association between DCIR rs2377422 and RA in non-Caucasian populations and confirm the influence of DCIR polymorphisms on RA susceptibility, especially on ACPA-negative RA.	[Guo, Jianping; Wu, Xinyu; He, Jing; Li, Ru; Liu, Xu; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China; [Too, Chun Lai; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Too, Chun Lai; Murad, Shahnaz] Inst Med Res, Kuala Lumpur 50588, Malaysia; [Yin, Fangrui] Baotou Med Coll, Affiliated Hosp 1, Dept Rheumatol, Baotou, Peoples R China; [Lu, Xiaolan] Xuanwu Hosp, Dept Rheumatol, Beijing, Peoples R China	Peking University; Karolinska Institutet; Kementerian Kesihatan Malaysia; Baotou Medical College; Capital Medical University	Guo, JP (corresponding author), Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China.	leonid.padyukov@ki.se; jpguo99@gmail.com	lu, xl/HDO-8340-2022; Too, Chun Lai/AAW-8967-2021; Chun-Lai, Too/AAI-1878-2020; Padyukov, Leonid/A-4890-2009	Too, Chun Lai/0000-0002-4079-8454; Padyukov, Leonid/0000-0003-2950-5670	National Basic Research Program of China (973 Program) [2010CB529100]; Program of International Science & Technology Cooperation from MOST [S2011ZR0260]; Major International Joint Research Project from NSFC [81120108020]; Doctoral Fund of Ministry of Education of China [20110001110045]; Ministry of Health (MOH), Malaysia [MRG 7/2005, JPP-IMR 08-012 (NMRR-08-820-1975)]; Swedish Medical Research Council; Swedish Combined program	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program of International Science & Technology Cooperation from MOST; Major International Joint Research Project from NSFC; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Ministry of Health (MOH), Malaysia; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Combined program	This study was financially supported by National Basic Research Program of China (973 Program) (No. 2010CB529100, http://www.973.gov.cn/ AreaAppl.aspx), Program of International Science & Technology Cooperation from MOST (No: S2011ZR0260, http://www.most.gov.cn/), Major International Joint Research Project from NSFC (No: 81120108020 http://www.nsfc.gov.cn/Portal0/default152.htm) and the Doctoral Fund of Ministry of Education of China (No: 20110001110045, http://www.cutech.edu.cn/cn/index.htm). MyEIRA study was financially supported by the Ministry of Health (MOH), Malaysia: MRG 7/2005 and JPP-IMR 08-012 (NMRR-08-820-1975), and by the Swedish Medical Research Council and the Swedish Combined program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bax M, 2011, IMMUNOGENETICS, V63, P459, DOI 10.1007/s00251-011-0528-6; Chun-Lai T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021069; Eklow C, 2008, ANN RHEUM DIS, V67, P1742, DOI 10.1136/ard.2007.076976; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Guo JP, 2009, GENES IMMUN, V10, P227, DOI 10.1038/gene.2009.4; Guo JP, 2008, ARTHRITIS RHEUM, V58, P1343, DOI 10.1002/art.23434; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Kochi Y, 2009, J AUTOIMMUN, V32, P158, DOI 10.1016/j.jaut.2009.02.020; Kokkonen H, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2214; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Ronninger M, 2008, GENES IMMUN, V9, P412, DOI 10.1038/gene.2008.32; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015	20	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41228	10.1371/journal.pone.0041228	http://dx.doi.org/10.1371/journal.pone.0041228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829930	Green Submitted, gold, Green Published			2022-12-25	WOS:000306956300069
J	Li, CY; Chiang, CS; Cheng, WC; Wang, SC; Cheng, HT; Chen, CR; Shu, WY; Tsai, ML; Hseu, RS; Chang, CW; Huang, CY; Fang, SH; Hsu, IC				Li, Chia-Yang; Chiang, Chi-Shiun; Cheng, Wei-Chung; Wang, Shu-Chi; Cheng, Hung-Tsu; Chen, Chaang-Ray; Shu, Wun-Yi; Tsai, Min-Lung; Hseu, Ruey-Shyang; Chang, Cheng-Wei; Huang, Chao-Ying; Fang, Shih-Hua; Hsu, Ian C.			Gene Expression Profiling of Dendritic Cells in Different Physiological Stages under Cordyceps sinensis Treatment	PLOS ONE			English	Article							MICROARRAY DATA-ANALYSIS; TRADITIONAL CHINESE MEDICINE; SCIENTIFIC REDISCOVERY; CDNA MICROARRAYS; HERBAL MEDICINE; EXTRACTS; DESIGN; POLYSACCHARIDES; FUNDAMENTALS; INFLAMMATION	Cordyceps sinensis (CS) has been commonly used as herbal medicine and a health supplement in China for over two thousand years. Although previous studies have demonstrated that CS has benefits in immunoregulation and anti-inflammation, the precise mechanism by which CS affects immunomodulation is still unclear. In this study, we exploited duplicate sets of loop-design microarray experiments to examine two different batches of CS and analyze the effects of CS on dendritic cells (DCs), in different physiology stages: naive stage and inflammatory stage. Immature DCs were treated with CS, lipopolysaccharide (LPS), or LPS plus CS (LPS/CS) for two days, and the gene expression profiles were examined using cDNA microarrays. The results of two loop-design microarray experiments showed good intersection rates. The expression level of common genes found in both loop-design microarray experiments was consistent, and the correlation coefficients (Rs), were higher than 0.96. Through intersection analysis of microarray results, we identified 295 intersecting significantly differentially expressed (SDE) genes of the three different treatments (CS, LPS, and LPS/CS), which participated mainly in the adjustment of immune response and the regulation of cell proliferation and death. Genes regulated uniquely by CS treatment were significantly involved in the regulation of focal adhesion pathway, ECM-receptor interaction pathway, and hematopoietic cell lineage pathway. Unique LPS regulated genes were significantly involved in the regulation of Toll-like receptor signaling pathway, systemic lupus erythematosus pathway, and complement and coagulation cascades pathway. Unique LPS/CS regulated genes were significantly involved in the regulation of oxidative phosphorylation pathway. These results could provide useful information in further study of the pharmacological mechanisms of CS. This study also demonstrates that with a rigorous experimental design, the biological effects of a complex compound can be reliably studied by a complex system like cDNA microarray.	[Li, Chia-Yang; Chiang, Chi-Shiun; Cheng, Wei-Chung; Wang, Shu-Chi; Chen, Chaang-Ray; Tsai, Min-Lung; Chang, Cheng-Wei; Huang, Chao-Ying; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Li, Chia-Yang] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Cheng, Wei-Chung] Taipei Vet Gen Hosp, Div Pediat Neurosurg, Neurol Inst, Taipei, Taiwan; [Cheng, Hung-Tsu] Natl Tsing Hua Univ, Inst Nanoengineerin & Microsyst, Hsinchu, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Hseu, Ruey-Shyang] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Fang, Shih-Hua] Natl Taiwan Sport Univ, Inst Athlet, Taichung, Taiwan	National Tsing Hua University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Taipei Veterans General Hospital; National Tsing Hua University; National Tsing Hua University; National Taiwan University	Li, CY (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008; Hsiao, Wei-Hung/B-9931-2013	Chiang, Chi-Shiun/0000-0002-2581-4129; Cheng, Wei-Chung/0000-0002-1229-4857; LI, CHIA-YANG/0000-0001-5689-9850; Chen, Chaang-Ray/0000-0003-2106-8699	Committee on Chinese Medicine and Pharmacy of the Department of Health (Taiwan) [CCMP93-RD-051, CCMP-94-RD-049]	Committee on Chinese Medicine and Pharmacy of the Department of Health (Taiwan)	This study was funded by the Committee on Chinese Medicine and Pharmacy of the Department of Health (Taiwan) under contract numbers CCMP93-RD-051 and CCMP-94-RD-049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ahn SK, 2003, INT J MOL MED, V12, P231; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benoit YD, 2009, BIOL CELL, V101, P695, DOI 10.1042/BC20090060; Birerdinc A, 2010, J VIRAL HEPATITIS, V17, P730, DOI 10.1111/j.1365-2893.2009.01235.x; Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chen CR, 2012, COMPUT BIOL MED, V42, P228, DOI 10.1016/j.compbiomed.2011.11.012; Chen YJ, 1997, LIFE SCI, V60, P2349, DOI 10.1016/S0024-3205(97)00291-9; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clark TA, 2007, MOL ECOL, V16, P2613, DOI 10.1111/j.1365-294X.2007.03354.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kuo MC, 2007, APPL MICROBIOL BIOT, V75, P769, DOI 10.1007/s00253-007-0880-5; KUO YC, 1994, CANCER INVEST, V12, P611, DOI 10.3109/07357909409023046; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Leung YF, 2003, TRENDS GENET, V19, P649, DOI 10.1016/j.tig.2003.09.015; Li CY, 2009, J LEUKOCYTE BIOL, V85, P987, DOI 10.1189/jlb.0908573; Li SP, 2006, J PHARMACEUT BIOMED, V41, P1571, DOI 10.1016/j.jpba.2006.01.046; Liu WC, 2008, EXP BIOL MED, V233, P447, DOI 10.3181/0708-RM-230; Liu WC, 2006, RADIAT RES, V166, P900, DOI 10.1667/RR0670.1; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Opal SM, 2002, CRIT CARE, V6, P125; Perseghin P, 2009, TRANSFUS APHER SCI, V41, P33, DOI 10.1016/j.transci.2009.05.011; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Schuchhardt J, 2000, Nucleic Acids Res, V28, pE47, DOI 10.1093/nar/28.10.e47; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Siu KM, 2004, LIFE SCI, V76, P385, DOI 10.1016/j.lfs.2004.07.014; Tempelman RJ, 2005, VET IMMUNOL IMMUNOP, V105, P175, DOI 10.1016/j.vetimm.2005.02.002; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Tsai CH, 2001, J AGR FOOD CHEM, V49, P2137, DOI 10.1021/jf001071k; Tsai ML, 2009, RADIAT RES, V171, P716, DOI 10.1667/RR1625.1; Vinciotti V, 2005, BIOINFORMATICS, V21, P492, DOI 10.1093/bioinformatics/bti022; Yamaguchi Y, 2000, PHYTOTHER RES, V14, P647, DOI 10.1002/1099-1573(200012)14:8&lt;647::AID-PTR670&gt;3.0.CO;2-W; Zhao BT, 2001, AM J PHYSIOL-CELL PH, V281, pC1587, DOI 10.1152/ajpcell.2001.281.5.C1587; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P429, DOI 10.1089/acm.1998.4.429	49	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40824	10.1371/journal.pone.0040824	http://dx.doi.org/10.1371/journal.pone.0040824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829888	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300026
J	Dong, P; Karaayvaz, M; Jia, N; Kaneuchi, M; Hamada, J; Watari, H; Sudo, S; Ju, J; Sakuragi, N				Dong, P.; Karaayvaz, M.; Jia, N.; Kaneuchi, M.; Hamada, J.; Watari, H.; Sudo, S.; Ju, J.; Sakuragi, N.			Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis	ONCOGENE			English	Article						EMT; cancer; gain-of-function; miRNA; p53 mutation	ENDOMETRIAL CANCER-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; SUPPRESSES METASTASIS; MICRORNA EXPRESSION; DNA-BINDING; PROMOTES; ZEB1; CONTRIBUTES; REPRESSION	The tumor suppressor gene p53 has been implicated in the regulation of epithelial-mesenchymal transition (EMT) and tumor metastasis by regulating microRNA (miRNA) expression. Here, we report that mutant p53 exerts oncogenic functions and promotes EMT in endometrial cancer (EC) by directly binding to the promoter of miR-130b (a negative regulator of ZEB1) and inhibiting its transcription. We transduced p53 mutants into p53- null EC cells, profiled the miRNA expression by miRNA microarray and identified miR-130b as a potential target of mutant p53. Ectopic expression of p53 mutants repressed the expression of miR-130b and triggered ZEB1-dependent EMT and cancer cell invasion. Loss of an endogenous p53 mutation increased the expression of miR-130b, which resulted in reduced ZEB1 expression and attenuation of the EMT phenotype. Furthermore, re-expression of miR-130b suppressed mutant p53- induced EMT and ZEB1 expression. Importantly, the expression of miR-130 was significantly reduced in EC tissues, and patients with higher expression levels of miR-130b survived longer. These data provide a novel understanding of the roles of p53 gain-of-function mutations in accelerating tumor progression and metastasis through modulation of the miR-130b-ZEB1 axis.	[Dong, P.; Kaneuchi, M.; Watari, H.; Sudo, S.; Sakuragi, N.] Hokkaido Univ, Sch Med, Dept Gynecol, Sapporo, Hokkaido 0608638, Japan; [Karaayvaz, M.; Ju, J.] SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA; [Jia, N.] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Hamada, J.] Hokkaido Univ, Inst Med Genet, Div Canc Related Genes, Sapporo, Hokkaido 0608638, Japan	Hokkaido University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Shanghai Jiao Tong University; Hokkaido University	Dong, P (corresponding author), Hokkaido Univ, Sch Med, Dept Gynecol, Sapporo, Hokkaido 0608638, Japan.	dongpeix@yahoo.co.jp; Jingfang.Ju@stonybrookmedicine.edu	Dong, Peixin/M-5592-2015	Dong, Peixin/0000-0002-2335-1394; Ju, Jingfang/0000-0002-4821-7458	Women's Health Educational System; Ministry of Health, Labour and Welfare of Japan; Shanghai Municipal Natural Science Foundation [11ZR1430500]; Stony Brook University Translational Research Laboratory Start-up fund [R01CA155019, R33CA147966]; NATIONAL CANCER INSTITUTE [R33CA147966] Funding Source: NIH RePORTER	Women's Health Educational System; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Shanghai Municipal Natural Science Foundation; Stony Brook University Translational Research Laboratory Start-up fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate the critical review by Ms Sonya R Lorrain. This work was funded by a grant from Women's Health Educational System, a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan, Shanghai Municipal Natural Science Foundation (11ZR1430500) and by Stony Brook University Translational Research Laboratory Start-up fund (J Ju), R01CA155019 (J Ju) and R33CA147966 (J Ju). We thank Dr Zhujie Xu for his technical assistance.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chicas A, 2000, BIOCHEM BIOPH RES CO, V279, P383, DOI 10.1006/bbrc.2000.3965; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Dong PX, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-103; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Fujisawa T, 2003, Hum Cell, V16, P47, DOI 10.1111/j.1749-0774.2003.tb00128.x; GUALBERTO A, 1995, J BIOL CHEM, V270, P19680, DOI 10.1074/jbc.270.34.19680; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; McLure KG, 1999, EMBO J, V18, P763, DOI 10.1093/emboj/18.3.763; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Scian MJ, 2004, ONCOGENE, V23, P4430, DOI 10.1038/sj.onc.1207553; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh M, 2008, MODERN PATHOL, V21, P912, DOI 10.1038/modpathol.2008.82; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Sun YB, 2000, J BIOL CHEM, V275, P11327, DOI 10.1074/jbc.275.15.11327; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Yang C, 2012, GYNECOL ONCOL, V124, P325, DOI 10.1016/j.ygyno.2011.10.013; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Zalcenstein A, 2006, ONCOGENE, V25, P359, DOI 10.1038/sj.onc.1209061; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; ZHANG W, 1993, ONCOGENE, V8, P2555	49	216	227	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2013	32	27					3286	3295		10.1038/onc.2012.334	http://dx.doi.org/10.1038/onc.2012.334			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	22847613	Green Published, hybrid			2022-12-25	WOS:000321301600008
J	Wu, HY; Wang, TY; Li, LY; Correia, K; Morgan, JI				Wu, Hui-Yuan; Wang, Taiyu; Li, Leyi; Correia, Kristen; Morgan, James I.			A structural and functional analysis of Nna1 in Purkinje cell degeneration (pcd) mice	FASEB JOURNAL			English	Article						CCP; enzyme kinetics; neurodegeneration; transgenic rescue; deglutamylation	CARBOXYPEPTIDASE-A; ALPHA-TUBULIN; BETA-TUBULIN; HUMAN ASPARTOACYLASE; SUBSTRATE-BINDING; GLUTAMIC-ACID; MUTANT MOUSE; BRAIN; SITE; METALLOCARBOXYPEPTIDASES	The axotomy-inducible enzyme Nna1 defines a subfamily of M14 metallocarboxypeptidases, and its mutation underlies the Purkinje cell degeneration (pcd) mouse. However, the relationship among its catalytic activity, substrate specificities, and the critical processes of neurodegeneration/axon regeneration is incompletely understood. Here we used a transgenic rescue strategy targeting expression of modified forms of Nna1 to Purkinje cells in pcd mice to determine structure-activity relationships for neuronal survival and in parallel characterized the enzymatic properties of purified recombinant Nna1. The Nna1 subfamily uniquely shares conserved substrate-determining residues with aspartoacylase that, when mutated, cause Canavan disease. Homologous mutations (D1007E and R1078E) inactivate Nna1 in vivo, as does mutation of its catalytic glutamate (E1094A), which implies that metabolism of acidic substrates is essential for neuronal survival. Consistent with reports that Nna1 is a tubulin glutamylase, recombinant Nna1-but not the catalytic mutants-removes glutamate from tubulin. Recombinant Nna1 metabolizes synthetic substrates with 2 or more C-terminal glutamate (but not aspartate) residues (V-max for 3 glutamates is similar to 7-fold higher than 2 glutamates although K-M is similar). Catalysis is not ATP/GTP dependent, and mutating the ATP/GTP binding site of Nna1 has no effect in vivo. Nna1 is a monomeric enzyme essential for neuronal survival through hydrolysis of polyglutamate-containing substrates.Wu, H.-Y., Wang, T., Li, L., Correia, K., Morgan, J. I. A structural and functional analysis of Nna1 in Purkinje cell degeneration (pcd) mice. FASEB J. 26, 4468-4480 (2012). www.fasebj.org	[Wu, Hui-Yuan; Wang, Taiyu; Li, Leyi; Correia, Kristen; Morgan, James I.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Morgan, JI (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl,Rm D2025,MS 323, Memphis, TN 38105 USA.	jim.morgan@stjude.org	Morgan, James/GRO-2905-2022; Morgan, James/N-8104-2018; Wu, Huiyuan/C-1575-2013	Morgan, James/0000-0002-8920-1065; 	U.S. National Cancer Institute [CA 21765]; U.S. National Institutes of Health [NS051537]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051537] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Drs. Jaeki Min and Fangyi Zhu (Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital) and Drs. Parmil Bansal, Roberto Pattarini, and Hong Guo (Department of Developmental Neurobiology, St. Jude Children's Research Hospital) for assistance with chemical synthesis, mass spectrometry, and FPLC analysis, as well as the Hartwell Center for Bioinformatics and Biotechnology and Protein Production Facility (St. Jude Children's Research Hospital) for molecular biology and proteomics support. This work was supported in part by U.S. National Cancer Institute cancer center support grant CA 21765, U.S. National Institutes of Health grant NS051537 to J.I.M., and American Lebanese Syrian Associated Charities (ALSAC). The authors declare no conflicts of interest.	ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Berezniuk I, 2010, AUTOPHAGY, V6, P558, DOI 10.4161/auto.6.4.11813; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104; BLANKS JC, 1992, EXP EYE RES, V54, P637, DOI 10.1016/0014-4835(92)90019-O; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Cho JH, 2001, BIOCHEMISTRY-US, V40, P10197, DOI 10.1021/bi010807j; CHRISTIANSON DW, 1986, P NATL ACAD SCI USA, V83, P7568, DOI 10.1073/pnas.83.20.7568; CHRISTIANSON DW, 1986, J AM CHEM SOC, V108, P545, DOI 10.1021/ja00263a052; COOMBS TL, 1962, BIOCHEMISTRY-US, V1, P899, DOI 10.1021/bi00911a024; Cullen DA, 2004, NEUROSCI LETT, V357, P175, DOI 10.1016/j.neulet.2003.12.055; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; EATON DL, 1991, J BIOL CHEM, V266, P21833; EDDE B, 1992, BIOCHEMISTRY-US, V31, P403, DOI 10.1021/bi00117a014; Edge M, 1998, PROTEIN ENG, V11, P1229, DOI 10.1093/protein/11.12.1229; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Gagnon C, 1996, J CELL SCI, V109, P1545; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; GARDELL SJ, 1985, NATURE, V317, P551, DOI 10.1038/317551a0; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; HIROSE J, 1987, BIOCHEMISTRY-US, V26, P6561, DOI 10.1021/bi00394a041; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Le Coq J, 2006, BIOCHEMISTRY-US, V45, P5878, DOI 10.1021/bi052608w; LIPSCOMB WN, 1980, P NATL ACAD SCI-BIOL, V77, P3875, DOI 10.1073/pnas.77.7.3875; Lyons PJ, 2011, J BIOL CHEM, V286, P39023, DOI 10.1074/jbc.M111.265819; Makarova KS, 1999, J MOL BIOL, V292, P11, DOI 10.1006/jmbi.1999.3059; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; Mathews C. K., 2000, BIOCHEMISTRY-US, P375; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OGORMAN S, 1985, J COMP NEUROL, V234, P277, DOI 10.1002/cne.902340302; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; REES DC, 1981, P NATL ACAD SCI-BIOL, V78, P5455, DOI 10.1073/pnas.78.9.5455; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rong YQ, 2004, MOL BRAIN RES, V132, P128, DOI 10.1016/j.molbrainres.2004.10.015; ROZEN F, 1989, MOL CELL BIOL, V9, P4061, DOI 10.1128/MCB.9.9.4061; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; Skidgel RA, 2007, INT IMMUNOPHARMACOL, V7, P1888, DOI 10.1016/j.intimp.2007.07.014; SMITH EL, 1949, P NATL ACAD SCI USA, V35, P80, DOI 10.1073/pnas.35.2.80; VALLEE BL, 1955, J BIOL CHEM, V217, P253; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; Vendrell J., 2004, HDB METALLOPROTEINS, P167; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; ZHANG FM, 1991, J BIOL CHEM, V266, P24606	60	19	20	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4468	4480		10.1096/fj.12-205047	http://dx.doi.org/10.1096/fj.12-205047			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22835831	Green Published			2022-12-25	WOS:000310574200010
J	Priyadarzini, TRK; Selvin, JFA; Gromiha, MM; Fukui, K; Veluraja, K				Priyadarzini, Thanu R. K.; Selvin, Jeyasigamani F. A.; Gromiha, M. Michael; Fukui, Kazuhiko; Veluraja, Kasinadar			Theoretical Investigation on the Binding Specificity of Sialyldisaccharides with Hemagglutinins of Influenza A Virus by Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLNEURAMINIC ACID; SIALIC-ACID; RECEPTOR SPECIFICITY; AMINO-ACID; SUGAR CHAINS; HOST-CELL; C-VIRUS; ORIGIN; EVOLUTION; SUBSTITUTIONS	Recognition of cell-surface sialyldisaccharides by influenza A hemagglutinin (HA) triggers the infection process of influenza. The changes in glycosidic torsional linkage and the receptor conformations may alter the binding specificity of HAs to the sialylglycans. In this study, 10-ns molecular dynamics simulations were carried out to examine the structural and dynamic behavior of the HAs bound with sialyldisaccharides Neu5Ac alpha(2-3) Gal (N23G) and Neu5Ac alpha(2-6) Gal (N26G). The analysis of the glycosidic torsional angles and the pair interaction energy between the receptor and the interacting residues of the binding site reveal that N23G has two binding modes for H1 and H5 and a single binding mode for H3 and H9. For N26G, H1 and H3 has two binding modes, and H5 and H9 has a single binding mode. The direct and water-mediated hydrogen bonding interactions between the receptors and HAs play dominant roles in the structural stabilization of the complexes. It is concluded from pair interaction energy and Molecular Mechanic-Poisson-Boltz-mann Surface Area calculations that N26G is a better receptor for H1 when compared with N23G. N23G is a better receptor for H5 when compared with N26G. However, H3 and H9 can recognize N23G and N26G in equal binding specificity due to the marginal energy difference (approximate to 2.5 kcal/mol). The order of binding specificity of N23G is H3 > H5 > H9 > H1 and N26G is H1 > H3 > H5 > H9, respectively. The proposed conformational models will be helpful in designing inhibitors for influenza virus.	[Priyadarzini, Thanu R. K.; Selvin, Jeyasigamani F. A.; Veluraja, Kasinadar] Manonmaniam Sundaranar Univ, Dept Phys, Tirunelveli 627012, Tamil Nadu, India; [Gromiha, M. Michael] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Fukui, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo 1350064, Japan	Manonmaniam Sundaranar University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; National Institute of Advanced Industrial Science & Technology (AIST)	Veluraja, K (corresponding author), Manonmaniam Sundaranar Univ, Dept Phys, Tirunelveli 627012, Tamil Nadu, India.	veluraja@msuniv.ac.in	veluraja, kasinadar/R-3089-2019; Gromiha, Michael/H-8493-2019	Michael, Gromiha/0000-0002-1776-4096	Department of Biotechnology [BT/PR4251/BID/07/2003, BT/BI/25/001/2006]; Department of Science and Technology [SR/S0/BB-53/2003]; Council of Scientific and Industrial Research; Department of Biotechnology, India; National Institute of Advanced Industrial Science and Technology, Japan [BT/BI/14/028/2007]	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Institute of Advanced Industrial Science and Technology, Japan	Recipient of Department of Biotechnology Grant BT/PR4251/BID/07/2003.; Recipient of Department of Science and Technology Grant SR/S0/BB-53/2003 and a grant from Council of Scientific and Industrial Research.; Supported by the Department of Biotechnology, India, and National Institute of Advanced Industrial Science and Technology, Japan Collaborative Project BT/BI/14/028/2007.; We acknowledge the use of the Bioinformatics Center at the Department of Physics, Manonmaniam Sundaranar University, which is funded by Department of Biotechnology Grant BT/BI/25/001/2006.	ARNOTT S, 1972, J CHEM SOC PERK T 2, P324, DOI 10.1039/p29720000324; BAUM LG, 1990, ACTA HISTOCHEM, P35; BROSSMER R, 1993, FEBS LETT, V323, P96, DOI 10.1016/0014-5793(93)81456-A; Case D.A., 2006, AMBER VERSION 9, V9; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Dawson ED, 2007, ANAL CHEM, V79, P378, DOI 10.1021/ac061920o; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; FLIPPEN JL, 1973, ACTA CRYSTALLOGR B, V29, P1881, DOI 10.1107/S0567740873005698; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Gottschalk A, 1959, VIRUSES, V3, P51; GUNTHER I, 1993, VIRUS RES, V27, P147, DOI 10.1016/0168-1702(93)90078-2; Guo CT, 2007, GLYCOBIOLOGY, V17, P713, DOI 10.1093/glycob/cwm038; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo SK, 2007, VIRUS RES, V129, P64, DOI 10.1016/j.virusres.2007.05.005; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lau LT, 2004, BIOCHEM BIOPH RES CO, V313, P336, DOI 10.1016/j.bbrc.2003.11.131; Ledesma J, 2011, J CLIN VIROL, V51, P75, DOI 10.1016/j.jcv.2011.01.020; Lekcharoensuk P, 2010, VET MICROBIOL, V145, P230, DOI 10.1016/j.vetmic.2010.04.008; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nadtanet N., 2010, MONATSH CHEM, V141, P801; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nunthaboot N, 2010, J CHEM INF MODEL, V50, P1410, DOI 10.1021/ci100038g; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Priyadarzini TRK, 2012, CARBOHYD RES, V351, P93, DOI 10.1016/j.carres.2012.01.015; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Schwahn AB, 2009, ANAL CHEM, V81, P3500, DOI 10.1021/ac900026f; SKEHEL JJ, 1995, AM J RESP CRIT CARE, V152, pS13, DOI 10.1164/ajrccm/152.4_Pt_2.S13; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Suzuki Y, 2001, INT CONGR SER, V1219, P521, DOI 10.1016/S0531-5131(01)00630-6; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tobita K, 1997, Nihon Rinsho, V55, P2512; Vasudevan SV, 2002, BIOPOLYMERS, V63, P168, DOI 10.1002/bip.10019; Veluraja K, 2008, J THEOR BIOL, V252, P15, DOI 10.1016/j.jtbi.2007.12.024; VELURAJA K, 1980, BIOCHIM BIOPHYS ACTA, V630, P442, DOI 10.1016/0304-4165(80)90293-7; Veluraja K, 2010, CARBOHYD RES, V345, P2030, DOI 10.1016/j.carres.2010.06.021; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang RX, 2008, VIROLOGY, V375, P182, DOI 10.1016/j.virol.2008.01.041; Wang ZY, 2004, VIRUS RES, V99, P177, DOI 10.1016/j.virusres.2003.11.010; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97; ZIMMER G, 1992, EUR J BIOCHEM, V204, P209, DOI 10.1111/j.1432-1033.1992.tb16626.x	58	26	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34547	34557		10.1074/jbc.M112.357061	http://dx.doi.org/10.1074/jbc.M112.357061			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22846994	Green Published, hybrid			2022-12-25	WOS:000309654200058
J	Robertson, AB; Matson, SW				Robertson, Adam B.; Matson, Steven W.			Reconstitution of the Very Short Patch Repair Pathway from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH-REPAIR; ENDONUCLEASE VSR PROTEIN; DEOXYRIBONUCLEIC-ACID; FUNCTIONAL INTERACTIONS; CYTOSINE METHYLATION; GENE-PRODUCT; HYDROLYTIC DEAMINATION; REPLICATION FIDELITY; N-GLYCOSIDASE; POLYMERASE-I	The Escherichia coli very short patch (VSP) repair pathway corrects thymidine-guanine mismatches that result from spontaneous hydrolytic deamination damage of 5-methyl cytosine. The VSP repair pathway requires the Vsr endonuclease, DNA polymerase I, a DNA ligase, MutS, and MutL to function at peak efficiency. The biochemical roles of most of these proteins in the VSP repair pathway have been studied extensively. However, these proteins have not been studied together in the context of VSP repair in an in vitro system. Using purified components of the VSP repair system in a reconstitution reaction, we have begun to develop an understanding of the role played by each of these proteins in the VSP repair pathway and have gained insights into their interactions. In this report we demonstrate an in vitro reconstitution of the VSP repair pathway using a plasmid DNA substrate. Surprisingly, the repair track length can be modulated by the concentration of DNA ligase. We propose roles for MutL and MutS in coordination of this repair pathway.	[Robertson, Adam B.; Matson, Steven W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Matson, Steven W.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matson, SW (corresponding author), Univ N Carolina, Dept Biol, CB 3280,Coker Hall, Chapel Hill, NC 27599 USA.	smatson@bio.unc.edu			National Institutes of Health [GM 33476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 33476 (to S. W. M.).	AU KG, 1992, J BIOL CHEM, V267, P12142; BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BHAGWAT AS, 1986, J BACTERIOL, V166, P751, DOI 10.1128/jb.166.3.751-755.1986; BHAGWAT AS, 1988, GENE, V74, P155; Bhagwat AS, 2002, MOL MICROBIOL, V44, P1421, DOI 10.1046/j.1365-2958.2002.02989.x; Drotschmann K, 1998, NUCLEIC ACIDS RES, V26, P948, DOI 10.1093/nar/26.4.948; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; DZIDIC S, 1989, MOL GEN GENET, V217, P254, DOI 10.1007/BF02464889; Elliott SL, 2005, J MOL BIOL, V353, P692, DOI 10.1016/j.jmb.2005.08.048; FRIEDBERG EC, 1975, J VIROL, V16, P315, DOI 10.1128/JVI.16.2.315-321.1975; Gonzalez-Nicieza R, 2001, J MOL BIOL, V310, P501, DOI 10.1006/jmbi.2001.4799; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Heinze RJ, 2009, NUCLEIC ACIDS RES, V37, P4453, DOI 10.1093/nar/gkp380; HENNECKE F, 1991, NATURE, V353, P776, DOI 10.1038/353776a0; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; JIRICNY J, 1988, NUCLEIC ACIDS RES, V16, P7843, DOI 10.1093/nar/16.16.7843; JONES M, 1987, CELL, V50, P621, DOI 10.1016/0092-8674(87)90035-3; KARRAN P, 1980, BIOCHEMISTRY-US, V19, P6005, DOI 10.1021/bi00567a010; Kornberg A., 1992, DNA REPLICATION; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LANGLEROUAULT F, 1987, EMBO J, V6, P1121, DOI 10.1002/j.1460-2075.1987.tb04867.x; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; Lieb M, 1996, MOL MICROBIOL, V20, P467, DOI 10.1046/j.1365-2958.1996.5291066.x; LIEB M, 1991, GENETICS, V128, P23; LIEB M, 1987, J BACTERIOL, V169, P5241, DOI 10.1128/jb.169.11.5241-5246.1987; LIEB M, 1995, J BACTERIOL, V177, P660, DOI 10.1128/jb.177.3.660-666.1995; LIEB M, 1986, GENETICS, V114, P1041; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; Lutsenko E, 1999, MUTAT RES-REV MUTAT, V437, P11, DOI 10.1016/S1383-5742(99)00065-4; Macintyre G, 1997, J BACTERIOL, V179, P6048, DOI 10.1128/jb.179.19.6048-6052.1997; Mansour CA, 2001, MUTAT RES-DNA REPAIR, V485, P331, DOI 10.1016/S0921-8777(01)00071-4; MODRICH P, 1973, J BIOL CHEM, V248, P7495; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Monastiriakos SK, 2004, DNA REPAIR, V3, P639, DOI 10.1016/j.dnarep.2004.02.008; Polosina YY, 2010, MUTAT RES-REV MUTAT, V705, P228, DOI 10.1016/j.mrrev.2010.07.002; Polosina YY, 2010, BIOESSAYS, V32, P51, DOI 10.1002/bies.200900089; Polosina YY, 2009, J BACTERIOL, V191, P4041, DOI 10.1128/JB.00066-09; Robertson A, 2006, J BIOL CHEM, V281, P8399, DOI 10.1074/jbc.M509184200; Robertson AB, 2006, J BIOL CHEM, V281, P19949, DOI 10.1074/jbc.M601604200; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SOHAIL A, 1990, J BACTERIOL, V172, P4214, DOI 10.1128/jb.172.8.4214-4221.1990; Sriskanda V, 2001, NUCLEIC ACIDS RES, V29, P4930, DOI 10.1093/nar/29.24.4930; SU SS, 1988, J BIOL CHEM, V263, P6829; Tsutakawa SE, 1999, MOL CELL, V3, P621, DOI 10.1016/S1097-2765(00)80355-X; Turner DP, 2000, J MOL BIOL, V304, P765, DOI 10.1006/jmbi.2000.4248; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; WELSH KM, 1987, J BIOL CHEM, V262, P15624; YAO M, 1995, J BIOL CHEM, V270, P28609, DOI 10.1074/jbc.270.48.28609; YAO M, 1994, J BIOL CHEM, V269, P16260; ZELL R, 1987, EMBO J, V6, P1809, DOI 10.1002/j.1460-2075.1987.tb02435.x	57	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32953	32966		10.1074/jbc.M112.384321	http://dx.doi.org/10.1074/jbc.M112.384321			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846989	Green Published, hybrid			2022-12-25	WOS:000309168300059
J	Daleke, MH; van der Woude, AD; Parret, AHA; Ummels, R; de Groot, AM; Watson, D; Piersma, SR; Jimenez, CR; Luirink, J; Bitter, W; Houben, ENG				Daleke, Maria H.; van der Woude, Aniek D.; Parret, Annabel H. A.; Ummels, Roy; de Groot, A. Marit; Watson, David; Piersma, Sander R.; Jimenez, Connie R.; Luirink, Joen; Bitter, Wilbert; Houben, Edith N. G.			Specific Chaperones for the Type VII Protein Secretion Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE; SYSTEM; PPE; MYCOBACTERIA; SURFACE; SIGNAL; RD1; PE	Mycobacteria use the dedicated type VII protein secretion systems ESX-1 and ESX-5 to secrete virulence factors across their highly hydrophobic cell envelope. The substrates of these systems include the large mycobacterial PE and PPE protein families, which are named after their characteristic Pro-Glu and Pro-Pro-Glu motifs. Pathogenic mycobacteria secrete large numbers of PE/PPE proteins via the major export pathway, ESX-5. In addition, a few PE/PPE proteins have been shown to be exported by ESX-1. It is not known how ESX-1 and ESX-5 recognize their cognate PE/PPE substrates. In this work, we investigated the function of the cytosolic protein EspG(5), which is essential for ESX-5-mediated secretion in Mycobacterium marinum, but for which the role in secretion is not known. By performing protein co-purifications, we show that EspG(5) interacts with several PPE proteins and a PE/PPE complex that is secreted by ESX-5, but not with the unrelated ESX-5 substrate EsxN or with PE/PPE proteins secreted by ESX-1. Conversely, the ESX-1 paralogue EspG(1) interacted with a PE/PPE couple secreted by ESX-1, but not with PE/PPE substrates of ESX-5. Furthermore, structural analysis of the complex formed by EspG(5) and PE/PPE indicates that these proteins interact in a 1:1:1 ratio. In conclusion, our study shows that EspG(5) and EspG(1) interact specifically with PE/PPE proteins that are secreted via their own ESX systems and suggests that EspG proteins are specific chaperones for the type VII pathway.	[Daleke, Maria H.; van der Woude, Aniek D.; Ummels, Roy; Bitter, Wilbert; Houben, Edith N. G.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, NL-1081 BT Amsterdam, Netherlands; [Daleke, Maria H.; van der Woude, Aniek D.; de Groot, A. Marit; Watson, David; Luirink, Joen; Bitter, Wilbert; Houben, Edith N. G.] Vrije Univ Amsterdam, Dept Mol Cell Biol, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Parret, Annabel H. A.] Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany; [Piersma, Sander R.; Jimenez, Connie R.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, OncoProte Lab, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; European Molecular Biology Laboratory (EMBL); Vrije Universiteit Amsterdam	Houben, ENG (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	e.houben@vumc.nl	Bitter, Wilbert/ABG-3726-2020; Luirink, Joen/AAB-8658-2021; Bitter, Wilbert/AAA-6872-2019; Jimenez, Connie/AAI-3763-2020; Houben, Edith N.G./B-2110-2015; Bitter, W/CAJ-5778-2022	Bitter, Wilbert/0000-0001-8347-6511; Houben, Edith N.G./0000-0002-8805-2002; Parret, Annabel/0000-0003-0635-8890; Jimenez, Connie R/0000-0002-3103-4508; van der Woude, Aniek/0000-0002-7786-9893	Netherlands Organization for Scientific Research; European Community [201762]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This work was supported by funding from an Earth and Life Sciences (ALW) Open Program grant (to M. H. D.) and an Excellent CHemical Research (ECHO) grant (to A. D. v. d. W.), both from The Netherlands Organization for Scientific Research, and by the European Community Seventh Framework Programme (FP7/2007-2013) under Grant 201762 (to W. B.).	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Bottai D, 2011, J INFECT DIS, V203, P1155, DOI 10.1093/infdis/jiq089; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Hayward CMM, 1999, VACCINE, V17, P1272, DOI 10.1016/S0264-410X(98)00350-8; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Puttinaowarat S., 2000, Fish Veterinary Journal, P6; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van der Woude AD, 2012, J BIOL CHEM, V287, P20417, DOI 10.1074/jbc.M111.336461; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003	30	62	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31939	31947		10.1074/jbc.M112.397596	http://dx.doi.org/10.1074/jbc.M112.397596			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843727	hybrid, Green Published			2022-12-25	WOS:000309059400033
J	Kim, HG; Kim, DJ; Li, SQ; Lee, KY; Li, X; Bode, AM; Dong, ZG				Kim, Hong-Gyum; Kim, Dong Joon; Li, Shengqing; Lee, Kun Yeong; Li, Xiang; Bode, Ann M.; Dong, Zigang			Polycomb (PcG) Proteins, BMI1 and SUZ12, Regulate Arsenic-induced Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MALIGNANT-TRANSFORMATION; HUMAN KERATINOCYTE TRANSFORMATION; TRITHORAX GROUP PROTEINS; TUMOR-SUPPRESSOR LOCUS; EPITHELIAL-CELLS; LUNG-CANCER; MEDIATED REPRESSION; DNA METHYLATION; GENE; P16(INK4A)	Inorganic arsenic is a well-documented human carcinogen associated with cancers of the skin, lung, liver, and bladder. However, the underlying mechanisms explaining the tumorigenic role of arsenic are not well understood. The present study explored a potential mechanism of cell transformation induced by arsenic exposure. Exposure to a low dose (0.5 mu M) of arsenic trioxide (As2O3) caused transformation of BALB/c 3T3 cells. In addition, in a xenograft mouse model, tumor growth of the arsenic-induced transformed cells was dramatically increased. In arsenic-induced transformed cells, polycomb group (PcG) proteins, including BMI1 and SUZ12, were activated resulting in enhanced histone H3K27 tri-methylation levels. On the other hand, tumor suppressor p16(INK4a) and p19(ARF) mRNA and protein expression were dramatically suppressed. Introduction of small hairpin (sh) RNA-BMI1 or -SUZ12 into BALB/c 3T3 cells resulted in suppression of arsenic-induced transformation. Histone H3K27 tri-methylation returned to normal in BMI1- or SUZ12-knockdown BALB/c 3T3 cells compared with BMI1- or SUZ12-wildtype cells after arsenic exposure. As a consequence, the expression of p16(INK4a) and p19(ARF) was recovered in arsenic-treated BMI1- or SUZ12-knockdown cells. Thus, arsenic-induced cell transformation was blocked by inhibition of PcG function. Taken together, these results strongly suggest that the polycomb proteins, BMI1 and SUZ12 are required for cell transformation induced by organic arsenic exposure.	[Kim, Hong-Gyum; Kim, Dong Joon; Li, Shengqing; Lee, Kun Yeong; Li, Xiang; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Kim, Dong Joon/AAL-8967-2020		Hormel Foundation; National Institutes of Health [ES016548, R37 CA081064, CA120388, CA077646]; NATIONAL CANCER INSTITUTE [R01CA077646, R37CA081064, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation and National Institutes of Health Grants ES016548, R37 CA081064, CA120388, and CA077646.	Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Benbrahim-Tallaa L, 2005, TOXICOL APPL PHARM, V206, P288, DOI 10.1016/j.taap.2004.11.017; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P243, DOI 10.1289/ehp.9630; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cui X, 2006, HUM PATHOL, V37, P298, DOI 10.1016/j.humpath.2005.10.013; Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159; Gebel TW, 1999, SCIENCE, V283, P1458; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Huang CS, 1999, J BIOL CHEM, V274, P14595, DOI 10.1074/jbc.274.21.14595; Huang YL, 2008, CANCER RES, V68, P9131, DOI 10.1158/0008-5472.CAN-08-3025; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; KAKUNAGA T, 1973, INT J CANCER, V12, P463, DOI 10.1002/ijc.2910120217; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Lee MO, 2011, J THORAC ONCOL, V6, P423, DOI 10.1097/JTO.0b013e3182018ace; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li YA, 2010, TOXICOL SCI, V116, P174, DOI 10.1093/toxsci/kfq109; Liu J, 2006, TOXICOL APPL PHARM, V216, P407, DOI 10.1016/j.taap.2006.06.006; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Muramatsu D, 2009, MUTAT RES-GEN TOX EN, V675, P66, DOI 10.1016/j.mrgentox.2009.02.008; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Ouyang WM, 2008, ENVIRON HEALTH PERSP, V116, P1, DOI 10.1289/ehp.10403; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pi JB, 2008, FREE RADICAL BIO MED, V45, P651, DOI 10.1016/j.freeradbiomed.2008.05.020; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Pizzatti L, 2010, GENE CHROMOSOME CANC, V49, P107, DOI 10.1002/gcc.20722; Reichard JF, 2010, EPIGENOMICS-UK, V2, P87, DOI [10.2217/epi.09.45, 10.2217/EPI.09.45]; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Srivastav RK, 2011, BIOCHEM J, V438, P495, DOI 10.1042/BJ20110035; Tie F, 2001, DEVELOPMENT, V128, P275; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wen GY, 2008, MOL MED, V14, P2, DOI 10.2119/2007-00090.Wen; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063	46	26	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31920	31928		10.1074/jbc.M112.360362	http://dx.doi.org/10.1074/jbc.M112.360362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843710	Green Published, hybrid			2022-12-25	WOS:000309059400031
J	Cronin, KR; Mangan, TP; Carew, JA				Cronin, Katherine R.; Mangan, Thomas P.; Carew, Josephine A.			Upregulation of the Coagulation Factor VII Gene during Glucose Deprivation Is Mediated by Activating Transcription Factor 4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; ASPARAGINE SYNTHETASE GENE; FACTOR PROCOAGULANT ACTIVITY; FACTOR-BINDING PROTEIN-1; AMINO-ACID LIMITATION; TISSUE FACTOR; ER STRESS; MESSENGER-RNA; C/EBP-BETA	Background: Constitutive production of blood coagulation proteins by hepatocytes is necessary for hemostasis. Stressful conditions trigger adaptive cellular responses and delay processing of most proteins, potentially affecting plasma levels of proteins secreted exclusively by hepatocytes. We examined the effect of glucose deprivation on expression of coagulation proteins by the human hepatoma cell line, HepG2. Methodology/Principal Findings: Expression of coagulation factor VII, which is required for initiation of blood coagulation, was elevated by glucose deprivation, while expression of other coagulation proteins decreased. Realtime PCR and ELISA demonstrated that the relative percentage expression +/- SD of steady-state F7 mRNA and secreted factor VII antigen were significantly increased (from 100+/-15% to 188+/-27% and 100+/-8.8% to 176.3+/-17.3% respectively, p < 0.001) at 24 hr of treatment. The integrated stress response was induced, as indicated by upregulation of transcription factor ATF4 and of additional stress-responsive genes. Small interfering RNAs directed against ATF4 potently reduced basal F7 expression, and prevented F7 upregulation by glucose deprivation. The response of the endogenous F7 gene was replicated in reporter gene assays, which further indicated that ATF4 effects were mediated via interaction with an amino acid response element in the F7 promoter. Conclusions/Significance: Our data indicated that glucose deprivation enhanced F7 expression in a mechanism reliant on prior ATF4 upregulation primarily due to increased transcription from the ATF4 gene. Of five coagulation protein genes examined, only F7 was upregulated, suggesting that its functions may be important in a systemic response to glucose deprivation stress.	[Cronin, Katherine R.; Mangan, Thomas P.; Carew, Josephine A.] VA Boston Healthcare Syst, Dept Res, W Roxbury, MA USA; [Carew, Josephine A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School	Cronin, KR (corresponding author), VA Boston Healthcare Syst, Dept Res, W Roxbury, MA USA.	josephine_carew@hms.harvard.edu			Department of Veteran's Affairs of the United States government	Department of Veteran's Affairs of the United States government	This work was funded by a Merit-1 research award (to JAC) by the Department of Veteran's Affairs of the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Arbini AA, 1997, BLOOD, V89, P176, DOI 10.1182/blood.V89.1.176.176_176_182; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boden G, 2011, OBESITY, V19, P1366, DOI 10.1038/oby.2011.71; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carew JA, 1998, BLOOD, V92, P1639, DOI 10.1182/blood.V92.5.1639.417k10_1639_1645; Carew JA, 2000, BLOOD, V96, P4370; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Connelly S, 1999, THROMB HAEMOSTASIS, V81, P234, DOI 10.1055/s-0037-1614449; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dietzen DJ, 2004, BLOOD, V103, P3038, DOI 10.1182/blood-2003-07-2399; ESTES SD, 1995, EXP CELL RES, V220, P47, DOI 10.1006/excr.1995.1290; FAIR DS, 1983, J LAB CLIN MED, V101, P372; Gombart AF, 2007, J LEUKOCYTE BIOL, V81, P1535, DOI 10.1189/jlb.0806516; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heeb MJ, 2008, EXPERT REV HEMATOL, V1, P9, DOI 10.1586/17474086.1.1.9; Hinnebusch AG, 2005, NAT STRUCT MOL BIOL, V12, P835, DOI 10.1038/nsmb1005-835; Hoffman M, 2007, J THROMB HAEMOST, V5, P1403, DOI 10.1111/j.1538-7836.2007.02576.x; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Huang CC, 2010, BIOCHEM J, V429, P215, DOI 10.1042/BJ20100286; Jackson AA, 2007, J BIOL CHEM, V282, P31156, DOI 10.1074/jbc.M704694200; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Kavlie A, 2003, THROMB HAEMOSTASIS, V90, P194, DOI 10.1160/TH02-09-0050; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Mackman N, 2006, BLOOD CELL MOL DIS, V36, P104, DOI 10.1016/j.bcmd.2005.12.008; Mackman N, 2005, ARTERIOSCL THROM VAS, V25, P2273, DOI 10.1161/01.ATV.0000183884.06371.52; Malabanan KP, 2010, J MOL MED, V88, P545, DOI 10.1007/s00109-010-0615-4; Marchand A, 2006, J BIOL CHEM, V281, P19124, DOI 10.1074/jbc.M602157200; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Moneva MH, 2002, CURR DRUG TARGETS, V3, P203, DOI 10.2174/1389450023347803; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Muth H, 2005, THROMB HAEMOSTASIS, V94, P1028, DOI 10.1160/TH05-01-0002; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; Romisch J, 1999, BLOOD COAGUL FIBRIN, V10, P471; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosen ED, 2005, THROMB HAEMOSTASIS, V94, P493, DOI 10.1160/TH05-05-0337; Rosen ED, 1997, NATURE, V390, P290, DOI 10.1038/36862; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selvaraj SR, 2012, J THROMB HAEMOST, V10, P107, DOI 10.1111/j.1538-7836.2011.04545.x; Shinagawa K, 2009, AM J PHYSIOL-LUNG C, V296, pL763, DOI 10.1152/ajplung.90638.2008; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Toomey JR, 1996, BLOOD, V88, P1583; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wolberg AS, 1999, BLOOD COAGUL FIBRIN, V10, P201, DOI 10.1097/00001721-199906000-00007; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Xu H, 2006, J PATHOL, V210, P488, DOI 10.1002/path.2073; Xu H, 2009, J PATHOL, V217, P362, DOI 10.1002/path.2454; Xu Z, 2010, MOL MED, V16, P167, DOI 10.2119/molmed.2009.00171; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zheng XW, 2011, BLOOD COAGUL FIBRIN, V22, P624, DOI 10.1097/MBC.0b013e3283497699	96	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40994	10.1371/journal.pone.0040994	http://dx.doi.org/10.1371/journal.pone.0040994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848420	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950200037
J	Zeeberg, BR; Kohn, KW; Kahn, A; Larionov, V; Weinstein, JN; Reinhold, W; Pommier, Y				Zeeberg, Barry R.; Kohn, Kurt W.; Kahn, Ari; Larionov, Vladimir; Weinstein, John N.; Reinhold, William; Pommier, Yves			Concordance of Gene Expression and Functional Correlation Patterns across the NCl-60 Cell Lines and the Cancer Genome Atlas Glioblastoma Samples	PLOS ONE			English	Article							TOOL	Background: The NCl-60 is a panel of 60 diverse human cancer cell lines used by the U. S. National Cancer Institute to screen compounds for anticancer activity. We recently clustered genes based on correlation of expression profiles across the NCl-60. Many of the resulting clusters were characterized by cancer-associated biological functions. The set of curated glioblastoma (GBM) gene expression data from the Cancer Genome Atlas (TCGA) initiative has recently become available. Thus, we are now able to determine which of the processes are robustly shared by both the immortalized cell lines and clinical cancers. Results: Our central observation is that some sets of highly correlated genes in the NCl-60 expression data are also highly correlated in the GBM expression data. Furthermore, a "double fishing'' strategy identified many sets of genes that show Pearson correlation >= 0.60 in both the NCl-60 and the GBM data sets relative to a given "bait'' gene. The number of such gene sets far exceeds the number expected by chance. Conclusion: Many of the gene-gene correlations found in the NCl-60 do not reflect just the conditions of cell lines in culture; rather, they reflect processes and gene networks that also function in vivo. A number of gene network correlations co-occur in the NCl-60 and GBM data sets, but there are others that occur only in NCl-60 or only in GBM. In sum, this analysis provides an additional perspective on both the utility and the limitations of the NCl-60 in furthering our understanding of cancers in vivo.	[Zeeberg, Barry R.; Kohn, Kurt W.; Larionov, Vladimir; Reinhold, William; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kahn, Ari] SRA Int Inc, Fairfax, VA USA; [Weinstein, John N.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Comp Biol & Syst Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); SRA International; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Zeeberg, BR (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	zeebergb@mail.nih.gov	zeeberg, barry/AAO-1246-2020; Reinhold, William/J-6704-2017	Weinstein, John/0000-0001-9401-6908; Reinhold, William/0000-0001-5513-9323	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Cancer Institute (UT-MD Anderson TCGA Genome Data Analysis Center) [U24CA143883]; Michael & Susan Dell Foundation; NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006192, U24CA143883] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (UT-MD Anderson TCGA Genome Data Analysis Center); Michael & Susan Dell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The work of JNW was supported in part by Grant Number U24CA143883 from the National Cancer Institute (UT-MD Anderson TCGA Genome Data Analysis Center), by a gift from the H.A. & Mary K. Chapman Foundation, and by a grant from the Michael & Susan Dell Foundation honoring Lorraine Dell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Kohn KW, 2012, PLOS ONE, V7; Reinhold WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025991; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WEINSTEIN JN, 1994, STEM CELLS, V12, P13, DOI 10.1002/stem.5530120106; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Weinstein JN, 2006, MOL CANCER THER, V5, P2601, DOI 10.1158/1535-7163.MCT-06-0640; Zeeberg BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030317; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zoppoli G, 2011, ONCOGENE, V31, P535	14	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e40062	10.1371/journal.pone.0040062	http://dx.doi.org/10.1371/journal.pone.0040062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848369	Green Published, Green Submitted, gold			2022-12-25	WOS:000309240600005
J	Landry, GJ; Opiol, H; Marchant, EG; Pavlovski, I; Mear, RJ; Hamson, DK; Mistlberger, RE				Landry, Glenn J.; Opiol, Hanna; Marchant, Elliott G.; Pavlovski, Ilya; Mear, Rhiannon J.; Hamson, Dwayne K.; Mistlberger, Ralph E.			Scheduled Daily Mating Induces Circadian Anticipatory Activity Rhythms in the Male Rat	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; FEEDING SCHEDULES; GENE-EXPRESSION; SYRIAN-HAMSTERS; DRUG REWARD; DAILY MEAL; FOOD; CLOCK; ENTRAINMENT; ACCESS	Daily schedules of limited access to food, palatable high calorie snacks, water and salt can induce circadian rhythms of anticipatory locomotor activity in rats and mice. All of these stimuli are rewarding, but whether anticipation can be induced by neural correlates of reward independent of metabolic perturbations associated with manipulations of food and hydration is unclear. Three experiments were conducted to determine whether mating, a non-ingestive behavior that is potently rewarding, can induce circadian anticipatory activity rhythms in male rats provided scheduled daily access to steroid-primed estrous female rats. In Experiment 1, rats anticipated access to estrous females in the mid-light period, but also exhibited post-coital eating and running. In Experiment 2, post-coital eating and running were prevented and only a minority of rats exhibited anticipation. Rats allowed to see and smell estrous females showed no anticipation. In both experiments, all rats exhibited sustained behavioral arousal and multiple mounts and intromissions during every session, but ejaculated only every 2-3 days. In Experiment 3, the rats were given more time with individual females, late at night for 28 days, and then in the midday for 28 days. Ejaculation rates increased and anticipation was robust to night sessions and significant although weaker to day sessions. The anticipation rhythm persisted during 3 days of constant dark without mating. During anticipation of nocturnal mating, the rats exhibited a significant preference for a tube to the mating cage over a tube to a locked cage with mating cage litter. This apparent place preference was absent during anticipation of midday mating, which may reflect a daily rhythm of sexual reward. The results establish mating as a reward stimulus capable of inducing circadian rhythms of anticipatory behavior in the male rat, and reveal a critical role for ejaculation, a modulatory role for time of day, and a potential confound role for uncontrolled food intake.	[Landry, Glenn J.; Opiol, Hanna; Marchant, Elliott G.; Pavlovski, Ilya; Mear, Rhiannon J.; Hamson, Dwayne K.; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Landry, GJ (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Landry, Glenn J/L-2133-2015; Hamson, Dwayne/AAA-6914-2020	Landry, Glenn J/0000-0002-6946-3914; 	Natural Science and Engineering Research Council of Canada; PGSD scholarship; USRA	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); PGSD scholarship; USRA	This work was funded by the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), in the form of an operating grant to REM, a PGSD scholarship to GJL, and a USRA scholarship to HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1992, AM J PHYSIOL, V263, pR116, DOI 10.1152/ajpregu.1992.263.1.R116; Agmo A, 1997, BRAIN RES PROTOC, V1, P203, DOI 10.1016/S1385-299X(96)00036-0; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; ASCHOFF J, 1986, MONIT ZOOL ITAL, V20, P195; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Challet E, 2010, CELL TISSUE RES, V341, P1, DOI 10.1007/s00441-010-1001-9; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DAMSMA G, 1992, BEHAV NEUROSCI, V106, P181, DOI 10.1037/0735-7044.106.1.181; Davidson AJ, 2005, METHOD ENZYMOL, V393, P509, DOI 10.1016/S0076-6879(05)93026-7; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Davis BA, 2007, BEHAV NEUROSCI, V121, P1012, DOI 10.1037/0735-7044.121.5.1012; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; ERSKINE MS, 1980, J ENDOCRINOL, V86, P127, DOI 10.1677/joe.0.0860127; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Honma K, 2009, EUR J NEUROSCI, V30, P1707, DOI 10.1111/j.1460-9568.2009.06976.x; Hood S, 2011, NEUROSCIENCE, V186, P65, DOI 10.1016/j.neuroscience.2011.04.045; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Hsu, 2010, PLOS ONE, V5; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012903; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Iijima M, 2002, EUR J NEUROSCI, V16, P921, DOI 10.1046/j.1460-9568.2002.02140.x; Jansen HT, 2012, CHRONOBIOL INT; Kosobud AEK, 1998, NEUROSCI LETT, V250, P99, DOI 10.1016/S0304-3940(98)00439-X; KOSOBUD AEK, 1994, J NEUROSCI, V14, P7117; Lopez HH, 1999, HORM BEHAV, V36, P176, DOI 10.1006/hbeh.1999.1535; Marchant EG, 1996, PHYSIOL BEHAV, V60, P657, DOI 10.1016/S0031-9384(96)80045-X; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1991, J BIOL RHYTHM, V6, P71, DOI 10.1177/074873049100600108; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; MISTLBERGER RE, 1995, BEHAV NEUROSCI, V109, P790, DOI 10.1037/0735-7044.109.4.790; MISTLBERGER RE, 1992, J BIOL RHYTHM, V7, P149, DOI 10.1177/074873049200700206; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; Paul MJ, 2007, COLD SH Q B, V72, P615, DOI 10.1101/sqb.2007.72.042; Pecoraro N, 2002, BEHAV NEUROSCI, V116, P757, DOI 10.1037//0735-7044.116.5.757; ROSENWASSER AM, 1988, ANIM LEARN BEHAV, V16, P324, DOI 10.3758/BF03209084; Sinclair SV, 1997, BEHAV BRAIN RES, V87, P127, DOI 10.1016/S0166-4328(96)02274-7; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tenk CM, 2009, HORM BEHAV, V55, P93, DOI 10.1016/j.yhbeh.2008.08.012; TERMAN M, 1984, ANN NY ACAD SCI, V423, P470, DOI 10.1111/j.1749-6632.1984.tb23454.x; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Webb IC, 2009, J BIOL RHYTHM, V24, P465, DOI 10.1177/0748730409346657; Webb IC, 2009, EUR J NEUROSCI, V30, P1739, DOI 10.1111/j.1460-9568.2009.06966.x; WHALEN RE, 1961, J COMP PHYSIOL PSYCH, V54, P409, DOI 10.1037/h0046385	59	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e40895	10.1371/journal.pone.0040895	http://dx.doi.org/10.1371/journal.pone.0040895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848408	Green Published, Green Submitted, gold			2022-12-25	WOS:000306806600027
J	Daddaoua, A; Fillet, S; Fernandez, M; Udaondo, Z; Krell, T; Ramos, JL				Daddaoua, Abdelali; Fillet, Sandy; Fernandez, Matilde; Udaondo, Zulema; Krell, Tino; Ramos, Juan L.			Genes for Carbon Metabolism and the ToxA Virulence Factor in Pseudomonas aeruginosa Are Regulated through Molecular Interactions of PtxR and PtxS	PLOS ONE			English	Article							FERRIC UPTAKE REGULATOR; GLUCOSE-METABOLISM; SIGMA-FACTOR; EXOTOXIN-A; PUTIDA; PROMOTERS; REGA; EXPRESSION; PATHWAYS; QUANTIFICATION	Homologs of the transcriptional regulator PtxS are omnipresent in Pseudomonas, whereas PtxR homologues are exclusively found in human pathogenic Pseudomonas species. In all Pseudomonas sp., PtxS with 2-ketogluconate is the regulator of the gluconate degradation pathway and controls expression from its own promoter and also from the P-gad and P-kgu for the catabolic operons. There is evidence that PtxS and PtxR play a central role in the regulation of exotoxin A expression, a relevant primary virulence factor of Pseudomonas aeruginosa. We show using DNaseI-footprint analysis that in P. aeruginosa PtxR binds to the -35 region of the P-toxA promoter in front of the exotoxin A gene, whereas PtxS does not bind to this promoter. Bioinformatic and DNaseI-footprint analysis identified a PtxR binding site in the P-kgu and P-gad promoters that overlaps the -35 region, while the PtxS operator site is located 50 bp downstream from the PtxR site. In vitro, PtxS recognises PtxR with nanomolar affinity, but this interaction does not occur in the presence of 2-ketogluconate, the specific effector of PtxS. DNAaseI footprint assays of P-kgu and P-gad promoters with PtxS and PtxR showed a strong region of hyper-reactivity between both regulator binding sites, indicative of DNA distortion when both proteins are bound; however in the presence of 2-ketogluconate no protection was observed. We conclude that PtxS modulates PtxR activity in response to 2-ketogluconate by complex formation in solution in the case of the P-toxA promoter, or via the formation of a DNA loop as in the regulation of gluconate catabolic genes. Data suggest two different mechanisms of control exerted by the same regulator.	[Daddaoua, Abdelali; Fillet, Sandy; Udaondo, Zulema; Krell, Tino; Ramos, Juan L.] CSIC EEZ, Environm Protect Dept, Granada, Spain; [Fernandez, Matilde] Poligono Juncaril, Bioiliberis R&D, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Daddaoua, A (corresponding author), CSIC EEZ, Environm Protect Dept, Granada, Spain.	juanluis.ramos@eez.csic.es	Fernandez, Matilde/F-5980-2013; Krell, Tino/G-7296-2015; Daddaoua, Abdelali/D-6930-2014; Udaondo, Zulema/ABI-7810-2020	Fernandez, Matilde/0000-0002-7064-670X; Krell, Tino/0000-0002-9040-3166; Daddaoua, Abdelali/0000-0002-7348-6393; Udaondo, Zulema/0000-0003-3445-6842; Ramos, Juan L./0000-0002-8731-7435; Fernandez, Matilde/0000-0002-5832-5161	European Research Area Network (ERANET) programme Pathogenomics within the ADHERS [BIO2008-04419-E]; Fondos Europeos para El Desarrollo (FEDER) [BIO-2006-05668, BIO2010-17227, CVI-3010]	European Research Area Network (ERANET) programme Pathogenomics within the ADHERS; Fondos Europeos para El Desarrollo (FEDER)	This study was supported by the European Research Area Network (ERANET) programme Pathogenomics within the ADHERS BIO2008-04419-E/project. We also received Fondos Europeos para El Desarrollo (FEDER) grants BIO-2006-05668, BIO2010-17227 and CVI-3010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; Barton HA, 1996, MOL MICROBIOL, V21, P1001, DOI 10.1046/j.1365-2958.1996.381426.x; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Chastre J, 2002, J BACTERIOL, V192, P4357; Colmer JA, 2001, CAN J MICROBIOL, V47, P820, DOI 10.1139/cjm-47-9-820; Colmer JA, 1998, MOL GEN GENET, V258, P250, DOI 10.1007/s004380050729; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; Daddaoua A, 2010, J BACTERIOL, V192, P4357, DOI 10.1128/JB.00520-10; Daniels C, 2010, J BIOL CHEM, V285, P21372, DOI 10.1074/jbc.M110.113282; Davinic M, 2009, MICROBIOL-SGM, V155, P2265, DOI 10.1099/mic.0.028373-0; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; del Castillo T, 2007, J BACTERIOL, V189, P6602, DOI 10.1128/JB.00679-07; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; Dohar JE, 2005, LARYNGOSCOPE, V115, P1469, DOI 10.1097/01.mlg.0000172036.82897.d4; ENTNER N, 1952, J BIOL CHEM, V196, P853; FENNER C, 1975, ANAL BIOCHEM, V63, P595, DOI 10.1016/0003-2697(75)90386-3; Ferrell E, 2008, MICROBIOL-SGM, V154, P431, DOI 10.1099/mic.0.2007/011577-0; Fillet S, 2009, J BACTERIOL, V191, P1901, DOI 10.1128/JB.01504-08; FRANK DW, 1988, J BACTERIOL, V170, P4477, DOI 10.1128/jb.170.10.4477-4483.1988; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Gaines JM, 2007, MICROBIOL-SGM, V153, P4219, DOI 10.1099/mic.0.2007/011338-0; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Hamood AN, 1996, MOL MICROBIOL, V21, P97, DOI 10.1046/j.1365-2958.1996.6251337.x; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; HEDSTROM RC, 1986, INFECT IMMUN, V51, P37, DOI 10.1128/IAI.51.1.37-42.1986; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; MARQUES S, 1993, BIOCHIM BIOPHYS ACTA, V1216, P227, DOI 10.1016/0167-4781(93)90149-8; Miller J.H., 1972, EXPT MOL GENETICS; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ochsner UA, 1996, MOL MICROBIOL, V21, P1019, DOI 10.1046/j.1365-2958.1996.481425.x; Sainsbury S, 2009, NUCLEIC ACIDS RES, V37, P4545, DOI 10.1093/nar/gkp445; Sasse J, 2004, CURR PROTOC IMMUNOL, V8, P89; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; STOREY DG, 1990, MOL MICROBIOL, V4, P499, DOI 10.1111/j.1365-2958.1990.tb00616.x; Swanson BL, 2000, J BACTERIOL, V182, P4366, DOI 10.1128/JB.182.15.4366-4371.2000; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; WEST SEH, 1994, INFECT IMMUN, V62, P897, DOI 10.1128/IAI.62.3.897-903.1994	42	25	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e39390	10.1371/journal.pone.0039390	http://dx.doi.org/10.1371/journal.pone.0039390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844393	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700004
J	Guo, CJ; Yang, LS; Zhang, YF; Wu, YY; Weng, SP; Yu, XQ; He, JG				Guo, Chang-Jun; Yang, Li-Shi; Zhang, Ying-Fen; Wu, Yan-Yan; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			A Novel Viral SOCS from Infectious Spleen and Kidney Necrosis Virus: Interacts with Jak1 and Inhibits IFN-alpha Induced Stat1/3 Activation	PLOS ONE			English	Article							JANUS TYROSINE KINASE; SIGNALING PATHWAY; MOLECULAR EPIDEMIOLOGY; GENE-EXPRESSION; PROTEIN; FISH; SUPPRESSION; IDENTIFICATION; IRIDOVIRUS; BINDING	Interferon (IFN)-induced Janus kinase (Jak)/signal transducer and activator of transcription (Stat) pathway is important in controlling immune responses and is negatively response-regulated by the suppressor of cytokine signaling (SOCS) proteins. However, several viruses have developed various strategies to inhibit this pathway to circumvent the anti-viral immunity of the host. The infectious spleen and kidney necrosis virus (ISKNV) is the type species of the genus Megalocytivirus in the family Iridoviridae and a causative agent of epizootics in fish. ISKNV ORF103R encodes a predicted viral SOCS (vSOCS) with high homology to the vertebrate SOCS1, but lacks a SOCS-box domain. Interestingly, vSOCS only exists in the genus Megalocytivirus. ISKNV-vSOCS can block the IFN-alpha-induced Jak/Stat pathway in HepG2 cells. Over-expression of ISKNV-vSOCS inhibited the activities of IFN-stimulated response element (ISRE) promoter; however, the inhibitions by ISKNV-vSOCS were dose-dependent. ISKNV-vSOCS interacted with Jak1 protein and inhibited its tyrosine kinase activity in vitro. ISKNV-vSOCS also impaired the phosphorylation of Stat1 and Stat3 proteins and suppressed their activations. The point mutations (F18D, S66A, S85A, and R64K) of ISKNV-vSOCS significantly impaired the inhibition of IFN-alpha-induced ISRE-promoter activation. In conclusion, vSOCS inhibits IFN-alpha-induced Stat1/Stat3 signaling, suggesting that Megalocytivirus has developed a novel strategy to evade IFN anti-viral immunity via vSOCS protein.	[Guo, Chang-Jun; He, Jian-Guo] Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Chang-Jun; Yang, Li-Shi; Zhang, Ying-Fen; Wu, Yan-Yan; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Div Cell Biol & Biophys, Sch Biol Sci, Kansas City, MO 64110 USA	Sun Yat Sen University; Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	Guo, CJ (corresponding author), Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn	YU, XiaoQiang/GRJ-1077-2022; YU, XIAO-QIANG/AAL-1797-2021	YU, XIAO-QIANG/0000-0003-1419-9009	National Natural Science Foundation of China [U0631008, 31001123]; National Basic Research Program of China [2006CB101802]; National High Technology Research and Development Program of China (863 Program) [2006AA09Z445, 2006AA100309]; Priming Scientific Research Foundation for Junior Teachers in Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Priming Scientific Research Foundation for Junior Teachers in Sun Yat-sen University	This work was supported by the National Natural Science Foundation of China, under Grant Nos. U0631008 and 31001123; the National Basic Research Program of China, under Grant No. 2006CB101802; the National High Technology Research and Development Program of China (863 Program), under Grant Nos. 2006AA09Z445 and 2006AA100309; and the Priming Scientific Research Foundation for Junior Teachers in Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2006, VIROLOGY, V355, P213, DOI 10.1016/j.virol.2006.07.004; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Baetz A, 2008, FASEB J, V22, P4296, DOI 10.1096/fj.08-116079; Banes AK, 2004, AM J PHYSIOL-RENAL, V286, pF653, DOI 10.1152/ajprenal.00163.2003; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chinchar V.G., 2005, VIRUS TAXONOMY CLASS, P145; De Sepulveda P, 1999, EMBO J, V18, P904; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; Federici M, 2002, J IMMUNOL, V169, P434, DOI 10.4049/jimmunol.169.1.434; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Go J, 2006, MOL CELL PROBE, V20, P212, DOI 10.1016/j.mcp.2005.12.002; Guo CJ, 2009, FISH SHELLFISH IMMUN, V27, P349, DOI 10.1016/j.fsi.2009.06.001; Haan S, 2008, J IMMUNOL, V180, P998, DOI 10.4049/jimmunol.180.2.998; Harcourt BH, 1999, J VIROL, V73, P3491, DOI 10.1128/JVI.73.4.3491-3496.1999; He JG, 2001, VIROLOGY, V291, P126, DOI 10.1006/viro.2001.1208; He Jianguo, 1998, Acta Scientiarum Naturalium Universitatis Sunyatseni, V37, P74; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Hirano T, 2006, DEV CELL, V10, P542, DOI 10.1016/j.devcel.2006.04.011; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Jin HJ, 2008, MOL IMMUNOL, V45, P1258, DOI 10.1016/j.molimm.2007.09.015; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; KALVAKOLANU DVR, 1991, P NATL ACAD SCI USA, V88, P7459, DOI 10.1073/pnas.88.17.7459; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kim TJ, 2007, J FISH DIS, V30, P691, DOI 10.1111/j.1365-2761.2007.00856.x; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Li SY, 1999, ONCOGENE, V18, P5727, DOI 10.1038/sj.onc.1202960; Limnander A, 2004, MOL CELL, V15, P329, DOI 10.1016/j.molcel.2004.06.041; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Lu L, 2005, VIROLOGY, V339, P81, DOI 10.1016/j.virol.2005.05.021; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200; PAZDRAK K, 1995, J IMMUNOL, V155, P397; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sun BJ, 2007, VET IMMUNOL IMMUNOP, V116, P26, DOI 10.1016/j.vetimm.2007.01.001; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Terstegen L, 2001, J IMMUNOL, V167, P5209, DOI 10.4049/jimmunol.167.9.5209; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vidy A, 2005, J VIROL, V79, P14411, DOI 10.1128/JVI.79.22.14411-14420.2005; Wang YQ, 2007, ARCH VIROL, V152, P763, DOI 10.1007/s00705-006-0870-4; Williams T, 1996, ADV VIRUS RES, V46, P345, DOI 10.1016/S0065-3527(08)60076-7; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yeh TC, 1999, CELL MOL LIFE SCI, V55, P1523, DOI 10.1007/s000180050392; Yokota S, 2003, VIROLOGY, V306, P135, DOI 10.1016/S0042-6822(02)00026-0; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	62	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41092	10.1371/journal.pone.0041092	http://dx.doi.org/10.1371/journal.pone.0041092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844427	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700041
J	Muramatsu, D; Iwai, A; Aoki, S; Uchiyama, H; Kawata, K; Nakayama, Y; Nikawa, Y; Kusano, K; Okabe, M; Miyazaki, T				Muramatsu, Daisuke; Iwai, Atsushi; Aoki, Shiho; Uchiyama, Hirohumi; Kawata, Koji; Nakayama, Yosuke; Nikawa, Yasuhiro; Kusano, Kisato; Okabe, Mitsuyasu; Miyazaki, Tadaaki			beta-Glucan Derived from Aureobasidium pullulans Is Effective for the Prevention of Influenza in Mice	PLOS ONE			English	Article							A-VIRUS-INFECTION; COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; STRAIN BLACK YEAST; TOLL-LIKE RECEPTOR; ALVEOLAR MACROPHAGES; RIG-I; RNA VIRUSES; IMMUNE-RESPONSES; INTERFERON-ALPHA	beta-(1 -> 3)-D-glucans with beta-(1 -> 6)-glycosidic linked branches produced by mushrooms, yeast and fungi are known to be an immune activation agent, and are used in anti-cancer drugs or health-promoting foods. In this report, we demonstrate that oral administration of Aureobasidium pullulans-cultured fluid (AP-CF) enriched with the beta-(1 -> 3),(1 -> 6)-D-glucan exhibits efficacy to protect mice infected with a lethal titer of the A/Puerto Rico/8/34 (PR8; H1N1) strain of influenza virus. The survival rate of the mice significantly increased by AP-CF administration after sublethal infection of PR8 virus. The virus titer in the mouse lung homogenates was significantly decreased by AP-CF administration. No significant difference in the mRNA expression of inflammatory cytokines, and in the population of lymphocytes was observed in the lungs of mice administered with AP-CF. Interestingly, expression level for the mRNA of virus sensors, RIG-I (retinoic acid-inducible gene-I) and MDA5 (melanoma differentiation-associated protein 5) strongly increased at 5 hours after the stimulation of A. pullulans-produced purified beta-(1 -> 3),(1 -> 6)-D-glucan (AP-BG) in murine macrophage-derived RAW264.7 cells. Furthermore, the replication of PR8 virus was significantly repressed by pre-treatment of AP-BG. These findings suggest the increased expression of virus sensors is effective for the prevention of influenza by the inhibition of viral replication with the administration of AP-CF.	[Muramatsu, Daisuke; Aoki, Shiho; Nikawa, Yasuhiro] Aureo Sci Co Ltd, Sapporo, Hokkaido, Japan; [Iwai, Atsushi; Uchiyama, Hirohumi; Kawata, Koji; Nikawa, Yasuhiro; Kusano, Kisato; Okabe, Mitsuyasu] Aureo Co Ltd, Chiba, Japan; [Muramatsu, Daisuke; Iwai, Atsushi; Aoki, Shiho; Uchiyama, Hirohumi; Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Sapporo, Hokkaido, Japan; [Miyazaki, Tadaaki] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan; [Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Inst Med Genet, Res Sect Probiot Immunol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Muramatsu, D (corresponding author), Aureo Sci Co Ltd, Sapporo, Hokkaido, Japan.	miyazaki@pop.med.hokudai.ac.jp	Iwai, Atsushi/I-6469-2019	Iwai, Atsushi/0000-0002-1491-4693	Aureo Co., Ltd.; Aureo-Science Co., Ltd.; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases; Global COE Program Establishment of International Collaboration Centers for Zoonosis Control from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	Aureo Co., Ltd.; Aureo-Science Co., Ltd.; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program Establishment of International Collaboration Centers for Zoonosis Control from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was funded by by Aureo Co., Ltd., and Aureo-Science Co., Ltd. This work was supported, in part, by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases and Global COE Program Establishment of International Collaboration Centers for Zoonosis Control from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akramiene D, 2007, MEDICINA-LITHUANIA, V43, P597, DOI 10.3390/medicina43080076; Boyd M, 2006, MED J AUSTRALIA, V185, pS44; BROWN RG, 1967, ACTA CHEM SCAND, V21, P2383, DOI 10.3891/acta.chem.scand.21-2383; BROWN RG, 1967, ACTA CHEM SCAND, V21, P2379, DOI 10.3891/acta.chem.scand.21-2379; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Chaung HC, 2009, VET IMMUNOL IMMUNOP, V131, P147, DOI 10.1016/j.vetimm.2009.04.004; CHIHARA G, 1970, CANCER RES, V30, P2776; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Conti L, 2008, IMMUNOBIOLOGY, V213, P859, DOI 10.1016/j.imbio.2008.07.017; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Hamada N, 2000, BIOSCI BIOTECH BIOCH, V64, P1801, DOI 10.1271/bbb.64.1801; HASHIMOTO K, 1991, INT J IMMUNOPHARMACO, V13, P437, DOI 10.1016/0192-0561(91)90014-X; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Husser L, 2011, VIRUS RES, V159, P9, DOI 10.1016/j.virusres.2011.04.005; Ikewaki N, 2007, MICROBIOL IMMUNOL, V51, P861, DOI 10.1111/j.1348-0421.2007.tb03982.x; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; KATAOKASHIRASUGI N, 1994, BIOSCI BIOTECH BIOCH, V58, P2145, DOI 10.1271/bbb.58.2145; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Kimura Y, 2007, J PHARM PHARMACOL, V59, P1137, DOI 10.1211/jpp.59.8.0012; Kimura Y, 2007, INT IMMUNOPHARMACOL, V7, P963, DOI 10.1016/j.intimp.2007.03.003; Kimura Y, 2006, ANTICANCER RES, V26, P4131; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Liu JJ, 2009, RECENT PAT ANTI-CANC, V4, P101, DOI 10.2174/157489209788452858; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lynch JP, 2007, SEMIN RESP CRIT CARE, V28, P144, DOI 10.1055/s-2007-976487; MASHIBA H, 1979, GANN, V70, P687; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; McCaughey Conall, 2010, Ulster Med J, V79, P46; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Mok KP, 2009, J INFECT DIS, V200, P1104, DOI 10.1086/605606; Novak M., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P67; OHHASHI F, 1978, GANN, V69, P255; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Queiroz LS, 2010, INT IMMUNOPHARMACOL, V10, P34, DOI 10.1016/j.intimp.2009.09.015; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; SAKURAI T, 1992, INT J IMMUNOPHARMACO, V14, P821, DOI 10.1016/0192-0561(92)90080-5; Shimizu K, 2009, HEPATO-GASTROENTEROL, V56, P240; Sugiyama A, 2010, J VET MED SCI, V72, P755, DOI 10.1292/jvms.09-0526; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Uchiyama Hirofumi, 2012, BMC Res Notes, V5, P189, DOI 10.1186/1756-0500-5-189; Van Reeth K, 1998, J INFECT DIS, V177, P1076, DOI 10.1086/517398; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; YAMAMOTO T, 1981, Invasion and Metastasis, V1, P71; Yatawara L, 2009, KOREAN J PARASITOL, V47, P345, DOI 10.3347/kjp.2009.47.4.345; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, ADV DRUG DELIVER REV, V60, P841, DOI 10.1016/j.addr.2007.12.001; Yoon HS, 2010, J MICROBIOL BIOTECHN, V20, P438, DOI 10.4014/jmb.0905.05058; Zhou LD, 2009, INT IMMUNOPHARMACOL, V9, P455, DOI 10.1016/j.intimp.2009.01.010	60	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41399	10.1371/journal.pone.0041399	http://dx.doi.org/10.1371/journal.pone.0041399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844473	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700084
J	Ureshino, H; Murakami, Y; Watari, K; Izumi, H; Kawahara, A; Kage, M; Arao, T; Nishio, K; Yanagihara, K; Kinoshita, H; Kuwano, M; Ono, M				Ureshino, Hiroki; Murakami, Yuichi; Watari, Kosuke; Izumi, Hiroto; Kawahara, Akihiko; Kage, Masayoshi; Arao, Tokuzo; Nishio, Kazuto; Yanagihara, Kazuyoshi; Kinoshita, Hisafumi; Kuwano, Michihiko; Ono, Mayumi			N-myc Downstream Regulated Gene 1 (NDRG1) Promotes Metastasis of Human Scirrhous Gastric Cancer Cells through Epithelial Mesenchymal Transition	PLOS ONE			English	Article							PANCREATIC-CANCER; STOMACH-CANCER; TUMOR-GROWTH; EXPRESSION; PROGRESSION; SUPPRESSOR; FAMILY; ANGIOGENESIS; MICROARRAY; INHIBITOR	Our recent study demonstrated that higher expression of N-myc downregulated gene 1 (NDRG1) is closely correlated with poor prognosis in gastric cancer patients. In this study, we asked whether NDRG1 has pivotal roles in malignant progression including metastasis of gastric cancer cells. By gene expression microarray analysis expression of NDRG1 showed the higher increase among a total of 3691 up-regulated genes in a highly metastatic gastric cancer cell line (58As1) than their parental low metastatic counterpart (HSC-58). The highly metastatic cell lines showed decreased expression of E-cadherin, together with enhanced expression of vimentin and Snail. This decreased expression of E-cadherin was restored by Snail knockdown in highly metastatic cell lines. We next established stable NDRG1 knockdown cell lines (As1/Sic50 and As1/Sic54) from the highly metastatic cell line, and both of these cell lines showed enhanced expression of E-cadherin and decreased expression of vimentin and Snail. And also, E-cadherin promoter-driven luciferase activity was found to be increased by NDRG1 knockdown in the highly metastatic cell line. NDRG1 knockdown in gastric cancer cell showed suppressed invasion of cancer cells into surround tissues, suppressed metastasis to the peritoneum and decreased ascites accumulation in mice with significantly improved survival rates. This is the first study to demonstrate that NDRG1 plays its pivotal role in the malignant progression of gastric cancer through epithelial mesenchymal transition.	[Ureshino, Hiroki; Murakami, Yuichi; Watari, Kosuke; Ono, Mayumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 807, Japan; [Kawahara, Akihiko; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan; [Arao, Tokuzo; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Ureshino, Hiroki; Kinoshita, Hisafumi] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan; [Kuwano, Michihiko] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut, Lab Mol Canc Biol, Fukuoka 812, Japan	Kyushu University; University of Occupational & Environmental Health - Japan; Kurume University; Kindai University (Kinki University); National Cancer Center - Japan; Kurume University; Kyushu University	Ureshino, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan.	mono@phar.kyushu-u.ac.jp		Watari, Kosuke/0000-0003-0260-2323	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23300350] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Dr. Ono), and by the 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan (Dr. Kuwano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aomatsu K, 2012, INVEST OPHTH VIS SCI, V53, P751, DOI 10.1167/iovs.11-8222; Azuma K, 2012, J THORAC ON IN PRESS; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Chan ACO, 2003, J CLIN ONCOL, V21, P2288, DOI 10.1200/JCO.2003.08.078; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Hasegawa S, 2002, CANCER RES, V62, P7012; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Inagaki Y, 2009, DIGEST LIVER DIS, V41, P96, DOI 10.1016/j.dld.2008.04.003; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kawahara A, 2011, EXP THER MED, V2, P471, DOI 10.3892/etm.2011.222; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Masuda K, 2003, INT J CANCER, V105, P803, DOI 10.1002/ijc.11152; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Oliveira C, 2009, HUM MOL GENET, V18, P1545, DOI 10.1093/hmg/ddp046; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; Strumane K, 2004, HANDB EXP PHARM, V165, P69, DOI 10.1007/978-3-540-68170-0_4; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yanagihara K, 2006, CANCER RES, V66, P7532, DOI 10.1158/0008-5472.CAN-05-3259; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	35	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41312	10.1371/journal.pone.0041312	http://dx.doi.org/10.1371/journal.pone.0041312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844455	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700068
J	Wan, ZX; Ritchie, I; Beaudoin, MS; Castellani, L; Chan, CB; Wright, DC				Wan, Zhongxiao; Ritchie, Ian; Beaudoin, Marie-Soleil; Castellani, Laura; Chan, Catherine B.; Wright, David C.			IL-6 Indirectly Modulates the Induction of Glyceroneogenic Enzymes in Adipose Tissue during Exercise	PLOS ONE			English	Article							MUSCLE-DERIVED INTERLEUKIN-6; ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; MESSENGER-RNA; ADIPOCYTES; LIPOLYSIS; THIAZOLIDINEDIONES	Background: Glyceroneogenesis is an important step in the control of fatty acid re-esterification with PEPCK and PDK4 being identified as key enzymes in this process. We have previously shown that glyceroneogenic enzymes such as PDK4 are rapidly induced in white adipose tissue during exercise. Recent studies have suggested that IL-6 regulates adipose tissue metabolism and gene expression during exercise. Interestingly, IL-6 has been reported to directly decrease PEPCK expression. The purpose of this investigation was to determine the role of IL-6 in modulating the effects of exercise on the expression of glyceroneogenic enzymes in mouse adipose tissue. We hypothesized that the exercise-mediated induction of PDK4 and PEPCK would be greater in adipose tissue from IL-6 deficient mice compared to wild type controls. Methodology and Principle Findings: Treatment of cultured epididymal adipose tissue (eWAT) with IL-6 (150 ng/ml) increased the phosphorylation of AMPK, ACC and STAT3 and induced SOCS3 mRNA levels while decreasing PEPCK and PDK4 mRNA. AICAR decreased the expression of PDK4 and PEPCK. The activation of AMPK by IL-6 was independent of increases in lipolysis. An acute bout of treadmill running (15 meters/minute, 5% incline, 90 minutes) did not induce SOCS3 or increase phosphorylation of STAT3 in eWAT, indicating that IL-6 signalling was not activated. Exercise-induced increases in PEPCK and PDK4 mRNA expression were attenuated in eWAT from IL-6(-/-) mice in parallel with a greater relative increase in AMPK phosphorylation compared to exercised WT mice. These changes occurred independent of alterations in beta-adrenergic signalling in adipose tissue from IL-6(-/-) mice. Conclusions and Significance: Our findings question the role of IL-6 signalling in adipose tissue during exercise and suggest an indirect effect of this cytokine in the regulation of adipose tissue gene expression during exercise.	[Wan, Zhongxiao; Chan, Catherine B.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Ritchie, Ian; Beaudoin, Marie-Soleil; Castellani, Laura; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Alberta; University of Guelph	Wan, ZX (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	dcwright@uoguelph.ca	Chan, Catherine/C-1162-2011	Chan, Catherine/0000-0003-3882-0592; Wright, David/0000-0003-3867-8901	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This project was funded by a grant from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ian Ritchie was supported by a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship. Marie-Soleil Beaudoin received stipend support from an Ontario Graduate Scholarship. David C. Wright is a Canadian Diabetes Association Scholar and Tier II Canada Research Chair in Lipids, Metabolism and Health.	Brandt C, 2011, ACTA PHYSL OXF; Cadoudal T, 2007, DIABETOLOGIA, V50, P666, DOI 10.1007/s00125-006-0560-5; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Feingold KR, 2011, INNATE IMMUN; FranckhauserVogel S, 1997, J CELL BIOCHEM, V66, P386, DOI 10.1002/(SICI)1097-4644(19970901)66:3<386::AID-JCB10>3.0.CO;2-D; Fried S K, 2001, Methods Mol Biol, V155, P197; Fritsche L, 2010, DIABETOLOGIA, V53, P1732, DOI 10.1007/s00125-010-1754-4; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ji C, 2011, J BIOENERG BIOMEMBR; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Leroyer S, 2011, J LIPID RES, V52, P207, DOI 10.1194/jlr.M000869; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Nielsen NB, 2009, REGUL PEPTIDES, V155, P39, DOI 10.1016/j.regpep.2009.04.010; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen L, 2012, AM J PHYSIOL-ENDOC M, V302, pE831, DOI 10.1152/ajpendo.00339.2011; Pedersen L, 2011, J PHYSIOL-LONDON, V589, P1409, DOI 10.1113/jphysiol.2010.200733; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RESHEFF L, 1970, J BIOL CHEM, V245, P5979; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; ROGNSTAD R, 1966, P NATL ACAD SCI USA, V55, P1148, DOI 10.1073/pnas.55.5.1148; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Tchivileva IE, 2009, MOL IMMUNOL, V46, P2256, DOI 10.1016/j.molimm.2009.04.008; Thomson DM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1572, DOI 10.1152/ajpendo.00371.2007; Thonberg H, 2002, BIOCHEM J, V364, P73, DOI 10.1042/bj3640073; Wan Z, 2011, OBESITY SILVER SPRIN; Wan ZX, 2010, AM J PHYSIOL-CELL PH, V299, pC1162, DOI 10.1152/ajpcell.00188.2010; Wang T, 2003, OBES RES, V11, P880, DOI 10.1038/oby.2003.121; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang YQ, 2010, BIOCHEM CELL BIOL, V88, P853, DOI [10.1139/O10-116, 10.1139/o10-116]; Zhang J, 2011, ENDOCRINOLOGY, V152, P1829, DOI 10.1210/en.2010-0828	38	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41719	10.1371/journal.pone.0041719	http://dx.doi.org/10.1371/journal.pone.0041719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844518	gold, Green Published			2022-12-25	WOS:000306687700144
J	Gomes, CC; Diniz, MG; Orsine, LA; Duarte, AP; Fonseca-Silva, T; Conn, BI; De Marco, L; Pereira, CM; Gomez, RS				Gomes, Carolina Cavalieri; Diniz, Marina Goncalves; Orsine, Lissur Azevedo; Duarte, Alessandra Pires; Fonseca-Silva, Thiago; Conn, Brendan I.; De Marco, Luiz; Pereira, Claudia Maria; Gomez, Ricardo Santiago			Assessment of TP53 Mutations in Benign and Malignant Salivary Gland Neoplasms	PLOS ONE			English	Article							EX-PLEOMORPHIC ADENOMA; TUMOR-SUPPRESSOR GENE; PROTEIN ACCUMULATION; BCL-2 EXPRESSION; BREAST-TISSUE; P53 MUTATIONS; CANCER; CARCINOMAS; HEAD; SUSCEPTIBILITY	Despite advances in the understanding of the pathogenesis of salivary gland neoplasms (SGN), the molecular pathways associated with enhanced tumor growth and cell survival remain to be established. The aim of the present study was to investigate whether TP53 mutations are relevant to SGN pathogenesis and if they impact on p53 protein expression. The study included 18 benign and 18 malignant SGN samples. Two polymorphic microsatellite markers at the TP53 genetic locus were chosen to assess loss of heterozygosity (LOH) in the samples that had matched normal DNA. The TP53 exons 2-11 were amplified by PCR, and all of the products were sequenced. Reverse transcription-PCR of the TP53 open reading frame (ORF) was carried out in the samples that had fresh tissue available, and immunohistochemistry for the p53 protein was performed in all samples. TP53 LOH was only found in two pleomorphic adenomas. We found two missense mutations in exon 7 (one in a pleomorphic adenoma and the other in a polymorphous low grade adenocarcinoma), another in exon 8 (in a carcinoma ex pleomorphic adenoma) and a fourth missense mutation in exon 10 (in a mucoepidermoid carcinoma). In addition, a nonsense mutation was found in exon 8 of an adenoid cystic carcinoma. Several intronic and exonic SNPs were detected. Although almost all of the malignant samples were immunopositive for p53, approximately 37% of the benign samples were positive, including the sample harboring the missense mutation and one of the samples that showed LOH. The complete TP53 ORF could be amplified in all samples analyzed, including the IHC negative samples, the samples showing LOH and one sample displaying a missense mutation. In summary, our results show that TP53 mutations are not a frequent event in SGN and that p53 immunopositivity might not be associated with sequence mutations in SGN.	[Gomes, Carolina Cavalieri] Univ Fed Minas Gerais, Inst Biol Sci, Dept Pathol, Belo Horizonte, MG, Brazil; [Diniz, Marina Goncalves; Orsine, Lissur Azevedo; Duarte, Alessandra Pires; Fonseca-Silva, Thiago; Pereira, Claudia Maria; Gomez, Ricardo Santiago] Univ Fed Minas Gerais, Dept Oral Surg & Pathol, Sch Dent, Belo Horizonte, MG, Brazil; [Conn, Brendan I.] Royal Infirm Edinburgh NHS Trust, Dept Pathol, Edinburgh, Midlothian, Scotland; [De Marco, Luiz] Univ Fed Minas Gerais, Dept Surg, Sch Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Royal Infirmary of Edinburgh; University of Edinburgh; Universidade Federal de Minas Gerais	Gomes, CC (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Pathol, Belo Horizonte, MG, Brazil.	carolinacgomes@ufmg.br	Pereira, Claudia/J-4359-2014; Gomes, Carolilna C/D-1807-2018; Gomez, Ricardo Santiago/G-1976-2012; GOMES, CAROLINA/C-9072-2015	Gomez, Ricardo Santiago/0000-0001-8770-8009; Goncalves Diniz, Marina/0000-0002-4212-1172; GOMES, CAROLINA/0000-0003-1580-4995	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein DJ, 2011, CURR OPIN ONCOL, V23, P249, DOI 10.1097/CCO.0b013e328344f59c; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Andrews GA, 2004, HEAD NECK-J SCI SPEC, V26, P870, DOI 10.1002/hed.20029; Augello C, 2006, J CELL PHYSIOL, V207, P654, DOI 10.1002/jcp.20601; Ben-Izhak O, 2009, CANCER BIOMARK, V5, P23, DOI 10.3233/CBM-2009-0567; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Castillo-Davis CI, 2005, TRENDS GENET, V21, P533, DOI 10.1016/j.tig.2005.08.001; de Oliveira FA, 2009, HEAD NECK PATHOL, V3, P271, DOI 10.1007/s12105-009-0139-9; Debaere D, 2011, B-ENT, V7, P1; El-Naggar AK, 2000, GENE CHROMOSOME CANC, V27, P162, DOI 10.1002/(SICI)1098-2264(200002)27:2<162::AID-GCC7>3.0.CO;2-9; Eveson JW, 2005, WORLD HLTH ORG CLASS, P212; Fowler MH, 2006, MODERN PATHOL, V19, P350, DOI 10.1038/modpathol.3800533; Gedlicka C, 2010, J SURG ONCOL, V101, P127, DOI 10.1002/jso.21444; Giefing M, 2008, NEOPLASMA, V55, P55; Gomes CC, 2011, ORAL DIS, V17, P564, DOI 10.1111/j.1601-0825.2011.01802.x; Hrstka R, 2009, J CELL MOL MED, V13, P440, DOI 10.1111/j.1582-4934.2008.00634.x; Ito FA, 2005, INT J ORAL MAX SURG, V34, P533, DOI 10.1016/j.ijom.2005.02.005; Johns MM, 1996, CANCER RES, V56, P1151; Kandel R, 2000, INT J CANCER, V87, P73, DOI 10.1002/1097-0215(20000701)87:1<73::AID-IJC11>3.0.CO;2-U; Karja VJ, 1997, J ORAL PATHOL MED, V26, P217, DOI 10.1111/j.1600-0714.1997.tb01227.x; Kishi M, 2005, ORAL ONCOL, V41, P161, DOI 10.1016/j.oraloncology.2004.08.004; Kiyoshima T, 2001, ORAL ONCOL, V37, P315, DOI 10.1016/S1368-8375(00)00083-X; Kontogeorgos G, 1999, Pituitary, V1, P207, DOI 10.1023/A:1009929704018; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lamolle G, 2006, MUTAT RES-FUND MOL M, V600, P102, DOI 10.1016/j.mrfmmm.2006.03.004; Leedham SJ, 2009, GASTROENTEROLOGY, V136, P542, DOI 10.1053/j.gastro.2008.10.086; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Matizonkas-Antonio Luciana Fasanella, 2005, Braz. Dent. J., V16, P162, DOI 10.1590/S0103-64402005000200014; Moore D, 1998, HISTOPATHOLOGY, V32, P35; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Renehan AG, 1999, BRIT J CANCER, V80, P1296, DOI 10.1038/sj.bjc.6690501; Rohan TE, 2006, CANCER EPIDEM BIOMAR, V15, P1316, DOI 10.1158/1055-9965.EPI-06-0195; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Ueno T, 2012, CANCER SCI, V103, P131, DOI 10.1111/j.1349-7006.2011.02105.x; van Houten VMM, 2000, CLIN CANCER RES, V6, P3803; Weber A, 2002, VIRCHOWS ARCH, V441, P428, DOI 10.1007/s00428-002-0705-y; Yamamoto Y, 1996, HUM PATHOL, V27, P782, DOI 10.1016/S0046-8177(96)90449-9; Yoshimoto T, 1998, J ENDOCRINOL, V159, P247, DOI 10.1677/joe.0.1590247	38	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41261	10.1371/journal.pone.0041261	http://dx.doi.org/10.1371/journal.pone.0041261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829934	gold, Green Published, Green Submitted			2022-12-25	WOS:000306956300073
J	Pound, LD; Sarkar, SA; Ustione, A; Dadi, PK; Shadoan, MK; Lee, CE; Walters, JA; Shiota, M; McGuinness, OP; Jacobson, DA; Piston, DW; Hutton, JC; Powell, DR; O'Brien, RM				Pound, Lynley D.; Sarkar, Suparna A.; Ustione, Alessandro; Dadi, Prasanna K.; Shadoan, Melanie K.; Lee, Catherine E.; Walters, Jay A.; Shiota, Masakazu; McGuinness, Owen P.; Jacobson, David A.; Piston, David W.; Hutton, John C.; Powell, David R.; O'Brien, Richard M.			The Physiological Effects of Deleting the Mouse Slc30a8 Gene Encoding Zinc Transporter-8 Are Influenced by Gender and Genetic Background	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELL; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; IN-VIVO; RISK LOCI; MICE; ZNT8; EXPRESSION; VARIANTS	Objective: The SLC30A8 gene encodes the islet-specific transporter ZnT-8, which is hypothesized to provide zinc for insulin-crystal formation. A polymorphic variant in SLC30A8 is associated with altered susceptibility to type 2 diabetes. Several groups have examined the effect of global Slc30a8 gene deletion but the results have been highly variable, perhaps due to the mixed 129SvEv/C57BL/6J genetic background of the mice studied. We therefore sought to remove the conflicting effect of 129SvEv-specific modifier genes. Methods: The impact of Slc30a8 deletion was examined in the context of the pure C57BL/6J genetic background. Results: Male C57BL/6J Slc30a8 knockout (KO) mice had normal fasting insulin levels and no change in glucose-stimulated insulin secretion (GSIS) from isolated islets in marked contrast to the similar to 50% and similar to 35% decrease, respectively, in both parameters observed in male mixed genetic background Slc30a8 KO mice. This observation suggests that 129SvEv-specific modifier genes modulate the impact of Slc30a8 deletion. In contrast, female C57BL/6J Slc30a8 KO mice had reduced (similar to 20%) fasting insulin levels, though this was not associated with a change in fasting blood glucose (FBG), or GSIS from isolated islets. This observation indicates that gender also modulates the impact of Slc30a8 deletion, though the physiological explanation as to why impaired insulin secretion is not accompanied by elevated FBG is unclear. Neither male nor female C57BL/6J Slc30a8 KO mice showed impaired glucose tolerance. Conclusions: Our data suggest that, despite a marked reduction in islet zinc content, the absence of ZnT-8 does not have a substantial impact on mouse physiology.	[Pound, Lynley D.; Ustione, Alessandro; Dadi, Prasanna K.; Shiota, Masakazu; McGuinness, Owen P.; Jacobson, David A.; Piston, David W.; O'Brien, Richard M.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Shadoan, Melanie K.; Powell, David R.] Lexicon Pharmaceut Inc, The Woodlands, TX USA; [Sarkar, Suparna A.; Lee, Catherine E.; Walters, Jay A.; Hutton, John C.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Hlth Sci Ctr, Aurora, CO USA	Vanderbilt University; Lexicon Pharmaceuticals; University of Colorado System; University of Colorado Anschutz Medical Campus	Pound, LD (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	richard.obrien@vanderbilt.edu		Jacobson, David A./0000-0003-1816-5375	National Institutes of Health (NIH) [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126, DK92589, DK052068, DK085064, DK043748, DK078188, DK080193, P60 DK20593]; American Diabetes Association [9901-116]; Juvenile Diabetes Research Association [4-2007-1056]; Barbara Davis Center Diabetes and Endocrinology Research Center [P30 DK57516]; JDRF [1-2008-1021]; Vanderbilt Molecular Endocrinology Training Program [5T32 DK07563];  [K01 DK081666]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, K01DK080193, P30DK057516, K01DK081666, R01DK043748, R01DK092589, R56DK043748, R01DK078188, R56DK052068, P30DK020593, U24DK059637, R01DK085064, U2CDK059637, R01DK052068, T32DK007563, P30DK058404, R29DK043748] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Association; Barbara Davis Center Diabetes and Endocrinology Research Center; JDRF(Juvenile Diabetes Research Foundation); Vanderbilt Molecular Endocrinology Training Program; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Vanderbilt Hormone Assay & Analytical Services Core and the Vanderbilt Islet Procurement and Analysis Core are both supported by National Institutes of Health (NIH) grants DK20593, to the Vanderbilt Diabetes Research Training Center (VDRTC), and DK59637, to the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC). The authors also thank personnel in the MMPC for advice on performing glucose tolerance tests and Mary Dawes for performing electron microscopy. The electron microscopy core is part of the VUMC Cell Imaging Shared Resource, which is supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126. Research in the laboratory of RO was supported by NIH grant DK92589. Research in the laboratory of JCH was supported by the American Diabetes Association (9901-116), NIH grant DK052068, Juvenile Diabetes Research Association grant 4-2007-1056 and the Barbara Davis Center Diabetes and Endocrinology Research Center (P30 DK57516). Research in the laboratory of DWP was supported by NIH grant DK085064. Research in the laboratory of DAJ was supported by K01 DK081666. Research in the laboratory of OPM was supported by NIH grants DK043748 and DK078188. SAS was supported by NIH grant DK080193 and JDRF grant 1-2008-1021. The Vanderbilt Hormone Assay & Analytical Services Core, the Vanderbilt Islet Procurement and Analysis Core and the Vanderbilt Cell Imaging Shared Resource are all supported by NIH grant P60 DK20593, to the Vanderbilt Diabetes Research Training Center (VDRTC). LDP was supported by the Vanderbilt Molecular Endocrinology Training Program grant 5T32 DK07563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; CIARALDI TP, 1990, HORM METAB RES, V22, P283, DOI 10.1055/s-2007-1004903; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; HAVU N, 1977, ACTA ENDOCRINOL-COP, V86, P570, DOI 10.1530/acta.0.0860570; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Klempt M, 2006, MAMM GENOME, V17, P93, DOI 10.1007/s00335-005-0119-7; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Pound LD, 2011, BIOCHEM J, V433, P95, DOI 10.1042/BJ20101488; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Rutter GA, 2010, ISLETS, V2, P49, DOI 10.4161/isl.2.1.10259; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Talchai C, 2009, DIABETES OBES METAB, V11, P38, DOI 10.1111/j.1463-1326.2009.01115.x; van de Bunt M, 2010, CURR DIABETES REP, V10, P452, DOI 10.1007/s11892-010-0150-2; Wenzlau JM, 2008, DIABETES, V57, P2693, DOI 10.2337/db08-0522; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Xu KF, 2011, DIABETES RES CLIN PR, V91, P195, DOI 10.1016/j.diabres.2010.11.012; Young GS, 2007, APPL PHYSIOL NUTR ME, V32, P161, DOI 10.1139/H06-082; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou HR, 2007, DIABETES, V56, P1107, DOI 10.2337/db06-1454	42	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40972	10.1371/journal.pone.0040972	http://dx.doi.org/10.1371/journal.pone.0040972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22829903	Green Published, gold, Green Submitted			2022-12-25	WOS:000306956300041
J	Lagergren, J; Mattson, F				Lagergren, Jesper; Mattson, Fredrik			Diverging Trends in Recent Population-Based Survival Rates in Oesophageal and Gastric Cancer	PLOS ONE			English	Article							CARDIA CANCER; ADENOCARCINOMAS; SWEDEN; SEX	Background: Survival trends in oesophageal and gastric cancer need to be updated. A nationwide Swedish population-based study in 1961-2009 was based on registry data. Methodology/Principal Findings: Relative survival rate, i.e. the ratio of the observed to the expected survival, adjusted for age, sex, and calendar period, and presented with 95% confidence intervals (CI), was the main outcome measure. The expected survival was calculated using the corresponding Swedish general population with no exclusions. The relative survival rates in oesophageal and gastric cardia adenocarcinoma have improved since the 1990s (p for trend <0.001), but not in oesophageal squamous cell carcinoma or gastric non-cardia adenocarcinoma. The relative 5-year survival rates during the two recent periods 1990-1999 and 2000-2008 were 12.5% (95% CI 10.1%-14.9%) and 10.3% (95% CI 8.5-12.0%) for oesophageal squamous cell carcinoma, 12.5% (95% CI 10.1%-14.9%) and 14.6% (95% CI 12.6-16.6%) for oesophageal adenocarcinoma, 11.1% (95% CI 9.6%-12.6%) and 14.3% (95% CI 12.3-16.3%) for gastric cardia adenocarcinoma, and 20.2% (95% CI 19.2%-21.1%) and 19.0% (95% CI 17.7-20.2%) for gastric non-cardia adenocarcinoma. The 3-year survival in tumour stage III in 2004-2008 was about 25% for all four tumour types. Conclusions/Significance: The survival in oesophageal and cardia adenocarcinoma is increasing, but the lack of such increase in oesophageal squamous cell carcinoma and gastric non-cardia adenocarcinoma is a concern.	[Lagergren, Jesper; Mattson, Fredrik] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London, England	Karolinska Institutet; University of London; King's College London	Lagergren, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	jesper.lagergren@ki.se		Lagergren, Jesper/0000-0002-5143-5448	Swedish Research Council [80749601]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Swedish Research Council (ID 80749601), (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Crane SJ, 2008, MAYO CLIN PROC, V83, P1087, DOI 10.4065/83.10.1087; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; Davies AR, 2006, DIS ESOPHAGUS, V19, P496, DOI 10.1111/j.1442-2050.2006.00629.x; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114; Lagergren J, 2011, INT J CANCER, V129, P513, DOI 10.1002/ijc.25701; Lindblad M, 2006, ANN SURG, V243, P479, DOI 10.1097/01.sla.0000205825.34452.43; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Stitzenberg KB, 2010, ANN SURG ONCOL, V17, P2824, DOI 10.1245/s10434-010-1159-0; Sundelof M, 2002, INT J CANCER, V99, P751, DOI 10.1002/ijc.10420; Sundelof M, 2008, EUR J CANCER, V44, P1566, DOI 10.1016/j.ejca.2008.04.002; Whitson BA, 2010, J THORAC CARDIOV SUR, V139, P43, DOI 10.1016/j.jtcvs.2009.04.011; Wouters MWJM, 2009, ANN SURG ONCOL, V16, P1789, DOI 10.1245/s10434-009-0458-9	17	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41352	10.1371/journal.pone.0041352	http://dx.doi.org/10.1371/journal.pone.0041352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815994	Green Submitted, Green Published, gold			2022-12-25	WOS:000306548900112
J	Tambor, V; Kacerovsky, M; Andrys, C; Musilova, I; Hornychova, H; Pliskova, L; Link, M; Stulik, J; Lenco, J				Tambor, Vojtech; Kacerovsky, Marian; Andrys, Ctirad; Musilova, Ivana; Hornychova, Helena; Pliskova, Lenka; Link, Marek; Stulik, Jiri; Lenco, Juraj			Amniotic Fluid Cathelicidin in PPROM Pregnancies: From Proteomic Discovery to Assessing Its Potential in Inflammatory Complications Diagnosis	PLOS ONE			English	Article							PRETERM PREMATURE RUPTURE; ANTIMICROBIAL PEPTIDE LL-37; VITAMIN-D; INTRAAMNIOTIC INFECTION; 1ST YEAR; MEMBRANES; RISK; EXPRESSION; MANAGEMENT; CELLS	Background: Preterm prelabor rupture of membranes (PPROM) complicated by microbial invasion of the amniotic cavity (MIAC) leading to histological chorioamnionitis (HCA) significantly impacts perinatal morbidity. Unfortunately, no well-established tool for identifying PPROM patients threatened by these disorders is available. Methodology/Principal Findings: We performed an unbiased exploratory analysis of amniotic fluid proteome changes due to MIAC and HCA. From among the top five proteins that showed the most profound and significant change, we sought to confirm results concerning cathelicidin (P49913, CAMP_HUMAN), since an ELISA kit was readily available for this protein. In our exploratory proteomic study, cathelicidin showed a similar to 6-fold higher concentration in PPROM patients with confirmed MIAC and HCA. We verified significantly higher levels of cathelicidin in exploratory samples (women without both MIAC and HCA: median 1.4 ng/ml; women with both conditions confirmed: median 3.6 ng/ml; p = 0.0003). A prospective replication cohort was used for independent validation and for assessment of cathelicidin potential to stratify women with MIAC leading to HCA from women in whom at least one of these conditions was ruled out. We confirmed the association of higher amniotic fluid cathelicidin levels with MIAC leading to HCA (the presence of both MIAC and HCA: median 3.1 ng/ml; other women: median 1.4 ng/ml; p < 0.0001). A cathelicidin concentration of 4.0 ng/ml was found to be the best cut-off point for identifying PPROM women with both MIAC and HCA. When tested on the validation cohort, a sensitivity of 48%, a specificity of 90%, a likelihood ratio of 5.0, and an area under receiver-operating characteristic curve of 71% were achieved for identification of women with MIAC leading to HCA. Conclusions: Our multi-stage study suggests cathelicidin as a candidate marker that should be considered for a panel of amniotic fluid proteins permitting identification of PPROM women with MIAC leading to HCA.	[Tambor, Vojtech; Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Kacerovsky, Marian; Musilova, Ivana] Charles Univ Prague, Fac Med Hradec Kralove, Dept Obstet & Gynecol, Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Andrys, Ctirad] Charles Univ Prague, Fac Med Hradec Kralove, Dept Allergy & Clin Immunol, Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Musilova, Ivana] Pardubice Univ, Hosp Pardubice, Dept Obstet & Gynecol, Fac Hlth Studies, Pardubice, Czech Republic; [Hornychova, Helena] Charles Univ Prague, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Fingerlands Dept Pathol, Hradec Kralove, Czech Republic; [Pliskova, Lenka] Charles Univ Prague, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Link, Marek; Stulik, Jiri; Lenco, Juraj] Univ Def, Fac Mil Hlth Sci, Inst Mol Pathol, Hradec Kralove, Czech Republic	University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University of Pardubice; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University of Defence - Czech Republic	Tambor, V (corresponding author), Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic.	lenco@pmfhk.cz	Lenčo, Juraj/AAL-4281-2020; Kacerovsky, Marian/ABE-3437-2020; Hornychová, Helena/M-9470-2017; Musilová, Ivana Kacerovská/I-6204-2017; Kacerovsky, Marian/A-7586-2011	Hornychová, Helena/0000-0002-2487-1754; Musilová, Ivana Kacerovská/0000-0002-6960-8319; Kacerovsky, Marian/0000-0001-9858-7900; Lenco, Juraj/0000-0002-8526-9249; Stulik, Jiri/0000-0002-4790-2365; Andrys, Ctirad/0000-0001-6489-8786; Link, Marek/0000-0003-4601-4523	Ministry of Health of the Czech Republic [NS 10382-3/2009]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was fully supported by a grant received from the Ministry of Health of the Czech Republic (NS 10382-3/2009, http://www.mzcr.cz/Odbornik/obsah/veda-a-vyzkum_977_3.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Amatngalim GD, 2011, INFLAMMATION, V34, P412, DOI 10.1007/s10753-010-9248-6; Ananth C V, 1996, Obstet Gynecol Surv, V51, P324, DOI 10.1097/00006254-199605000-00024; Arora Chander P., 2010, Biopolymers and Cell, V26, P97; Been JV, 2009, ARCH DIS CHILD-FETAL, V94, pF218, DOI 10.1136/adc.2008.150458; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7; Doyle LW, 2012, CURR OPIN PEDIATR, V24, P154, DOI 10.1097/MOP.0b013e3283504da1; Edmondson N, 2009, PEDIATR DEVEL PATHOL, V12, P16, DOI 10.2350/07-04-0270.1; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gopalani S, 2004, AM J PERINAT, V21, P183, DOI 10.1055/s-2004-828609; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Hase K, 2003, GASTROENTEROLOGY, V125, P1613, DOI 10.1053/j.gastro.2003.08.028; Havelka AM, 2010, ACTA PAEDIATR, V99, P836, DOI 10.1111/j.1651-2227.2010.01726.x; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; Klaffenbach D, 2011, PLACENTA, V32, P830, DOI 10.1016/j.placenta.2011.08.004; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; Mercer BM, 2000, AM J OBSTET GYNECOL, V183, P738, DOI 10.1067/mob.2000.106766; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Porreco RP, 2008, J MATERN-FETAL NEO M, V21, P573, DOI 10.1080/14767050802178011; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Reeves SA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.014; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P661, DOI 10.1016/S0002-9378(88)80030-9; Romero R, 2010, J MATERN-FETAL NEO M, V23, P261, DOI 10.3109/14767050903067386; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Shand AW, 2010, BJOG-INT J OBSTET GY, V117, P1593, DOI 10.1111/j.1471-0528.2010.02742.x; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simhan HN, 2005, BJOG-INT J OBSTET GY, V112, P32, DOI 10.1111/j.1471-0528.2005.00582.x; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Tambor V, 2010, PHYSIOL RES, V59, P471, DOI 10.33549/physiolres.931758; Tambor V, 2012, J PROTEOMICS, V75, P857, DOI 10.1016/j.jprot.2011.09.027; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; The czech society of obstetrics and gynecology, 2007, CLIN GUID OBST; Tjabringa GS, 2006, INT ARCH ALLERGY IMM, V140, P103, DOI 10.1159/000092305; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang YH, 2003, LEUKEMIA RES, V27, P947, DOI 10.1016/S0145-2126(03)00020-1; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; Zanardo V, 2008, PEDIATR DEVEL PATHOL, V11, P350, DOI 10.2350/07-08-0324.1; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17	56	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41164	10.1371/journal.pone.0041164	http://dx.doi.org/10.1371/journal.pone.0041164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815956	Green Submitted, Green Published, gold			2022-12-25	WOS:000306548900088
J	Kohler, PL; Greenwood, SD; Nookala, S; Kotb, M; Kranz, DM; Schlievert, PM				Kohler, Petra L.; Greenwood, Seth D.; Nookala, Suba; Kotb, Malak; Kranz, David M.; Schlievert, Patrick M.			Staphylococcus aureus Isolates Encode Variant Staphylococcal Enterotoxin B Proteins That Are Diverse in Superantigenicity and Lethality	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; 3-DIMENSIONAL STRUCTURE; METHICILLIN-RESISTANT; ATOPIC-DERMATITIS; CRYSTAL-STRUCTURE; MINNESOTA; EXOTOXIN; SITE; C2	Staphylococcus aureus produces superantigens (SAgs) that bind and cross-link T cells and APCs, leading to activation and proliferation of immune cells. SAgs bind to variable regions of the beta-chains of T cell receptors (V beta-TCRs), and each SAg binds a unique subset of V beta-TCRs. This binding leads to massive cytokine production and can result in toxic shock syndrome (TSS). The most abundantly produced staphylococcal SAgs and the most common causes of staphylococcal TSS are TSS toxin-1 (TSST-1), and staphylococcal enterotoxins B and C (SEB and SEC, respectively). There are several characterized variants of humans SECs, designated SEC1-4, but only one variant of SEB has been described. Sequencing the seb genes from over 20 S. aureus isolates show there are at least five different alleles of seb, encoding forms of SEB with predicted amino acid substitutions outside of the predicted immune-cell binding regions of the SAgs. Examination of purified, variant SEBs indicates that these amino acid substitutions cause differences in proliferation of rabbit splenocytes in vitro. Additionally, the SEBs varied in lethality in a rabbit model of TSS. The SEBs were diverse in their abilities to cause proliferation of human peripheral blood mononuclear cells, and differed in their activation of subsets of T cells. A soluble, high-affinity V beta-TCR, designed to neutralize the previously characterized variant of SEB (SEB1), was able to neutralize the variant SEBs, indicating that this high-affinity peptide may be useful in treating a variety of SEB-mediated illnesses.	[Kohler, Petra L.; Greenwood, Seth D.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Nookala, Suba; Kotb, Malak] Univ Cincinnati, Sch Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA; [Kranz, David M.] Univ Illinois, Dept Biochem, Sch Mol & Cellular Biol, Urbana, IL 61801 USA; [Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa	Kohler, PL (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	patrick-schlievert@uiowa.edu		Schlievert, Patrick/0000-0001-8314-9369	United States Public Health Service from Great Lakes Regional Center of Excellence [R01-AI074283, U54-AI57153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI074283] Funding Source: NIH RePORTER	United States Public Health Service from Great Lakes Regional Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service grants R01-AI074283 awarded to PMS, and U54-AI57153 awarded to PMS and DMK from the Great Lakes Regional Center of Excellence of which PMS and DMK are members. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MD, 2002, J BIOL CHEM, V277, P2756, DOI 10.1074/jbc.M109369200; BERGDOLL MS, 1981, LANCET, V1, P1017; Briggs C, 1997, IMMUNOLOGY, V90, P169, DOI 10.1046/j.1365-2567.1997.00151.x; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Buonpane RA, 2007, NAT MED, V13, P725, DOI 10.1038/nm1584; Chi YI, 2002, J BIOL CHEM, V277, P22839, DOI 10.1074/jbc.M201932200; CRASS BA, 1986, J CLIN MICROBIOL, V23, P1138, DOI 10.1128/JCM.23.6.1138-1139.1986; Garcia C, 1998, IMMUNOLOGY, V94, P160, DOI 10.1046/j.1365-2567.1998.00493.x; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; KOMISAR JL, 1994, INFECT IMMUN, V62, P4775, DOI 10.1128/IAI.62.11.4775-4780.1994; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; LEE PK, 1992, J INFECT DIS, V165, P1056, DOI 10.1093/infdis/165.6.1056; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; MARRACK P, 1990, SCIENCE, V248, P1066; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Neill RJ, 1996, INFECT IMMUN, V64, P3007, DOI 10.1128/IAI.64.8.3007-3015.1996; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; POINDEXTER NJ, 1985, J INFECT DIS, V151, P65, DOI 10.1093/infdis/151.1.65; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schlievert PM, 2008, CLIN INFECT DIS, V46, P1562, DOI 10.1086/586746; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; SCHLIEVERT PM, 1986, LANCET, V1, P1149; Schlievert PM, 2004, J CLIN MICROBIOL, V42, P2875, DOI 10.1128/JCM.42.6.2875-2876.2004; Thomas D, 2009, INFECT IMMUN, V77, P2043, DOI 10.1128/IAI.01388-08; Wang XG, 2009, MICROBIOL-SGM, V155, P680, DOI 10.1099/mic.0.025254-0; Yarwood JM, 2002, J BIOL CHEM, V277, P13138, DOI 10.1074/jbc.M111661200	33	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41157	10.1371/journal.pone.0041157	http://dx.doi.org/10.1371/journal.pone.0041157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815951	Green Published, gold, Green Submitted			2022-12-25	WOS:000306466100123
J	Xu, Q; Ma, PQ; Hu, CF; Chen, LC; Xue, LY; Wang, ZZ; Liu, M; Zhu, HX; Xu, NZ; Lu, N				Xu, Qing; Ma, Peiqing; Hu, Chenfei; Chen, Lechuang; Xue, Liyan; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi; Lu, Ning			Overexpression of the DEC1 Protein Induces Senescence In Vitro and Is Related to Better Survival in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTION FACTOR; EXPRESSION; STRA13; CANCER; BARRIER; P21(WAF1/CIP1); GENE; DIFFERENTIATION; TUMORIGENESIS	Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related death in China and has limited effective therapeutic options except for early surgery, since the underlying molecular mechanism driving its precursor lesions towards invasive ESCC is not fully understood. Cellular senescence is the state of the permanent growth arrest of a cell, and is considered as the initial barrier of tumor development. Human differentiated embryo chondrocyte expressed gene 1 (Dec1) is an important transcription factor that related to senescence. In this study, DEC1 immunohistochemical analysis was performed on tissue microarray blocks constructed from ESCC combined with adjacent precursor tissues of 241 patients. Compared with normal epithelia, DEC1 expression was significantly increased in intraepithelial neoplasia and DEC1 expression was significantly decreased in ESCC in comparison with intraepithelial neoplasia. In vitro, DEC1 overexpression induced cellular senescence, and it inhibited cell growth and colony formation in ESCC cell line EC9706. Fresh esophagectomy tissue sections from five ESCC patients were detected by immunohistochemistry of DEC1 and senescence-associated beta-galactosidase (SA-beta-Gal) activity, and strongly positive expression of DEC1 was correlated to more senescent cells in these fresh tissue sections. Kaplan - Meier method analysis of the 241 patients revealed that DEC1 expression levels were significantly correlated with the survival of ESCC patients after surgery. The expression levels of DEC1 were also correlated with age, tumor embolus, depth of invasion of ESCC, lymph metastasis status and pTNMs. These results suggest that DEC1 overexpression in precursor lesions of ESCC is a protective mechanism by inducing cellular senescence in ESCC initiation, and DEC1 may be a potential prognostic marker of ESCC.	[Xu, Qing; Hu, Chenfei; Chen, Lechuang; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [Xu, Qing; Hu, Chenfei; Chen, Lechuang; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Xu, Qing; Ma, Peiqing; Hu, Chenfei; Chen, Lechuang; Xue, Liyan; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi; Lu, Ning] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Peiqing; Xue, Liyan; Lu, Ning] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xu, Q (corresponding author), Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	ningzhi.xu@gmail.com; nlu03@126.com	Chen, Lechuang/AAF-8351-2020; Wang, Chengshu/A-1656-2011; Xiao, Guohua/G-3083-2013	Wang, Chengshu/0000-0003-1477-1466; Xiao, Guohua/0000-0003-3407-2734	National Natural Science Foundation [81021061, 31171322, 30770973, 39925020]; 863 Project grant [2006AA02A403]; Basic Research Program of CICAMS [JK2011B26]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 863 Project grant; Basic Research Program of CICAMS	This work was funded by National Natural Science Foundation (81021061, 31171322, 30770973, 39925020) (http://www.nsfc.gov.cn/), 863 Project grant (2006AA02A403) (http://www.863.gov.cn/), Basic Research Program of CICAMS (JK2011B26) (http://www.cicams.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campo-Trapero J, 2008, ACTA ONCOL, V47, P1464, DOI 10.1080/02841860802183612; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Chandeck C, 2010, ADV ANAT PATHOL, V17, P42, DOI 10.1097/PAP.0b013e3181c66f4e; Chang MS, 2005, PATHOL RES PRACT, V201, P417, DOI 10.1016/j.prp.2005.04.005; Chen X, 2002, CELL RES, V12, P229, DOI 10.1038/sj.cr.7290129; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cohen DJ, 2011, EXPERT OPIN PHARMACO, V12, P225, DOI 10.1517/14656566.2010.517748; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Decottignies A, 2011, SEMIN CANCER BIOL, V21, P360, DOI 10.1016/j.semcancer.2011.09.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Guillaumond F, 2008, BIOCHEM BIOPH RES CO, V369, P1184, DOI 10.1016/j.bbrc.2008.03.009; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; OGASAWARA S, 1995, CANCER RES, V55, P891; Ohbu M, 2001, HISTOPATHOLOGY, V39, P589, DOI 10.1046/j.1365-2559.2001.01279.x; Ohtani N, 2012, EXP DERMATOL, V21, P1, DOI 10.1111/j.1600-0625.2012.01493.x; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Sakai N, 2010, DIS ESOPHAGUS, V23, P415, DOI 10.1111/j.1442-2050.2009.01026.x; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shi XH, 2011, WORLD J GASTROENTERO, V17, P2037, DOI 10.3748/wjg.v17.i15.2037; Shirakawa Y, 2000, CLIN CANCER RES, V6, P541; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Tsai MH, 2011, ANN SURG ONCOL, V18, P2662, DOI 10.1245/s10434-011-1603-9; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vallbohmer D, 2006, DIS ESOPHAGUS, V19, P425, DOI 10.1111/j.1442-2050.2006.00622.x; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Wang WB, 2010, BIOCHEM BIOPH RES CO, V401, P422, DOI 10.1016/j.bbrc.2010.09.070; Xue L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-296; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	57	34	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41862	10.1371/journal.pone.0041862	http://dx.doi.org/10.1371/journal.pone.0041862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22937093	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700160
J	Chen, JB; Yang, YH; Lee, WC; Liou, CW; Lin, TK; Chung, YH; Chuang, LY; Yang, CH; Chang, HW				Chen, Jin-Bor; Yang, Yi-Hsin; Lee, Wen-Chin; Liou, Chia-Wei; Lin, Tsu-Kung; Chung, Yueh-Hua; Chuang, Li-Yeh; Yang, Cheng-Hong; Chang, Hsueh-Wei			Sequence-Based Polymorphisms in the Mitochondrial D-Loop and Potential SNP Predictors for Chronic Dialysis	PLOS ONE			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; STAGE RENAL-DISEASE; DNA MUTATIONS; BREAST-CANCER; CONTROL REGION; OXIDATIVE STRESS; POINT MUTATIONS; PROSTATE-CANCER; ORAL-CANCER; COMBINATIONAL POLYMORPHISMS	Background: The mitochondrial (mt) displacement loop (D-loop) is known to accumulate structural alterations and mutations. The aim of this study was to investigate the prevalence of single nucleotide polymorphisms (SNPs) within the D-loop among chronic dialysis patients and healthy controls. Methodology and Principal Findings: We enrolled 193 chronic dialysis patients and 704 healthy controls. SNPs were identified by large scale D-loop sequencing and bioinformatic analysis. Chronic dialysis patients had lower body mass index, blood thiols, and cholesterol levels than controls. A total of 77 SNPs matched with the positions in reference of the Revised Cambridge Reference Sequence (CRS) were found in the study population. Chronic dialysis patients had a significantly higher incidence of 9 SNPs compared to controls. These include SNP5 (16108Y), SNP17 (16172Y), SNP21 (16223Y), SNP34 (16274R), SNP35 (16278Y), SNP55 (16463R), SNP56 (16519Y), SNP64 (185R), and SNP65 (189R) in D-loop of CRS. Among these SNPs with genotypes, SNP55-G, SNP56-C, and SNP64-A were 4.78, 1.47, and 5.15 times more frequent in dialysis patients compared to controls (P<0.05), respectively. When adjusting the covariates of demographics and comorbidities, SNP64-A was 5.13 times more frequent in dialysis patients compared to controls (P<0.01). Furthermore, SNP64-A was found to be 35.80, 3.48, 4.69, 5,55, and 4.67 times higher in female patients and in patients without diabetes, coronary artery disease, smoking, and hypertension in an independent significance manner (P<0.05), respectively. In patients older than 50 years or with hypertension, SNP34-A and SNP17-C were found to be 7.97 and 3.71 times more frequent (P<0.05) compared to patients younger than 50 years or those without hypertension, respectively. Conclusions and Significance: The results of large-scale sequencing suggest that specific SNPs in the mtDNA D-loop are significantly associated with chronic dialysis. These SNPs can be considered as potential predictors for chronic dialysis.	[Chen, Jin-Bor; Lee, Wen-Chin] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Nephrol,Dept Internal Med,Mitochondrial Res U, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Liou, Chia-Wei; Lin, Tsu-Kung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Liou, Chia-Wei; Lin, Tsu-Kung] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chung, Yueh-Hua] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Yang, Cheng-Hong] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Ctr Excellence Environm Med, Ctr Canc, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chang Gung University; Chang Gung Memorial Hospital; National Sun Yat Sen University; I Shou University; I Shou University; National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, JB (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Nephrol,Dept Internal Med,Mitochondrial Res U, Kaohsiung, Taiwan.	chyang@cc.kuas.edu.tw; changhw@kmu.edu.tw	Yang, Cheng-Hong/K-2438-2019; Yang, Yi-Hsin/D-6471-2012; Chang, Hsueh-Wei/C-9654-2009; LEE, Wen-Chin/AAQ-8466-2021; Yang, Cheng-Hong/M-7984-2013	Yang, Yi-Hsin/0000-0002-9581-2778; Chang, Hsueh-Wei/0000-0003-0068-2366; LEE, Wen-Chin/0000-0001-6172-1483; Yang, Cheng-Hong/0000-0002-2741-0072; Arcelus, Jon/0000-0002-3805-0180; Guo, Boliang/0000-0002-1844-705X	Kaohsiung Chang Gung Memorial Hospital [CMRPG850271, CMRPG850272, CMRPG850242, CMRPG850252]; Department of Health, Executive Yuan, Republic of China [DOH101-TD-C-111-002]; Kaohsiung Medical University Research Foundation [KMUER014, KMU-M110001]; National Sun Yat-sen University-KMU Joint Research Project [NSYSUKMU 101-006]	Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Department of Health, Executive Yuan, Republic of China; Kaohsiung Medical University Research Foundation; National Sun Yat-sen University-KMU Joint Research Project	This study was partly supported by grants from Kaohsiung Chang Gung Memorial Hospital under contract nos. CMRPG850271, CMRPG850272, CMRPG850242, and CMRPG850252, the Department of Health, Executive Yuan, Republic of China (DOH101-TD-C-111-002), and the Kaohsiung Medical University Research Foundation (KMUER014 and KMU-M110001) and the National Sun Yat-sen University-KMU Joint Research Project (#NSYSUKMU 101-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022332; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Boles RG, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01305.x; Bostrom MA, 2011, AM J KIDNEY IN PRESS; Briollais L, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-22; Chen JB, 2008, AM J NEPHROL, V28, P853, DOI 10.1159/000139638; Chen JB, 2009, J NEGAT RESULTS BIOM, V8, DOI 10.1186/1477-5751-8-10; Chuang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037018; Chuang LY, 2012, EUR J CANCER PREV, V21, P336, DOI 10.1097/CEJ.0b013e32834e31f6; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Marinho AND, 2011, GENET MOL BIOL, V34, P31, DOI 10.1590/S1415-47572010005000106; Ebner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027192; Goia-Rusanu Cristina D, 2011, Roum Arch Microbiol Immunol, V70, P5; Ha PK, 2002, CLIN CANCER RES, V8, P2260; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Kalousova M, 2008, ANN NY ACAD SCI, V1126, P268, DOI 10.1196/annals.1433.012; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kim W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002211; Lenz O, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-30; Lievre A, 2005, J CLIN ONCOL, V23, P3517, DOI 10.1200/JCO.2005.07.044; Lin GT, 2008, CHINESE J PHYSIOL, V51, P32; Lin GT, 2009, OMICS, V13, P165, DOI 10.1089/omi.2008.0050; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Liu SA, 2011, EUR ARCH OT IN PRESS; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Nagy A, 2003, J PATHOL, V199, P237, DOI 10.1002/path.1273; Nomoto S, 2002, CLIN CANCER RES, V8, P481; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parrella P, 2001, CANCER RES, V61, P7623; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Reiner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014359; Rose G, 2002, INT J BIOCHEM CELL B, V34, P1449, DOI 10.1016/S1357-2725(02)00042-0; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sigrist MK, 2008, NEPHRON CLIN PRACT, V108, pC121, DOI 10.1159/000114202; Sotgia F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-62; Sperati CJ, 2009, AM J KIDNEY DIS, V53, P845, DOI 10.1053/j.ajkd.2008.12.025; Suzuki M, 2003, CLIN CANCER RES, V9, P5636; Tan DJ, 2003, GENE CHROMOSOME CANC, V37, P186, DOI 10.1002/gcc.10217; Wada T, 2006, ANTICANCER RES, V26, P3403; Wang CJ, 2011, BIOCHEM BIOPH RES CO, V406, P493, DOI 10.1016/j.bbrc.2011.02.088; Wang QX, 2006, MITOCHONDRION, V6, P37, DOI 10.1016/j.mito.2005.11.002; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Wang YC, 2011, J NEPHROL, V24, P351, DOI 10.5301/JN.2010.5816; Wetmore JB, 2006, HUM GENET, V120, P201, DOI 10.1007/s00439-006-0191-4; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yang CH, 2012, KAOHSIUNG J MED SCI, V28, P362, DOI 10.1016/j.kjms.2012.02.002; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yao Li, 2009, BMC Proc, V3 Suppl 7, pS83; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Zaki E A, 2009, Cephalalgia, V29, P719, DOI 10.1111/j.1468-2982.2008.01793.x; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng ZL, 2009, NEPHRON CLIN PRACT, V113, pC104, DOI 10.1159/000228542	62	166	171	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41125	10.1371/journal.pone.0041125	http://dx.doi.org/10.1371/journal.pone.0041125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815937	gold, Green Submitted, Green Published			2022-12-25	WOS:000306548900077
J	Hosseinzadeh, F; Ebrahimi, M; Goliaei, B; Shamabadi, N				Hosseinzadeh, Faezeh; Ebrahimi, Mansour; Goliaei, Bahram; Shamabadi, Narges			Classification of Lung Cancer Tumors Based on Structural and Physicochemical Properties of Proteins by Bioinformatics Models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; ARTIFICIAL NEURAL-NETWORKS; GENE-EXPRESSION DATA; AMINO-ACID-SEQUENCE; SUBCELLULAR-LOCALIZATION; PREDICTION; HYDROPHOBICITY; MICROARRAY; FEATURES; FAMILY	Rapid distinction between small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) tumors is very important in diagnosis of this disease. Furthermore sequence-derived structural and physicochemical descriptors are very useful for machine learning prediction of protein structural and functional classes, classifying proteins and the prediction performance. Herein, in this study is the classification of lung tumors based on 1497 attributes derived from structural and physicochemical properties of protein sequences (based on genes defined by microarray analysis) investigated through a combination of attribute weighting, supervised and unsupervised clustering algorithms. Eighty percent of the weighting methods selected features such as autocorrelation, dipeptide composition and distribution of hydrophobicity as the most important protein attributes in classification of SCLC, NSCLC and COMMON classes of lung tumors. The same results were observed by most tree induction algorithms while descriptors of hydrophobicity distribution were high in protein sequences COMMON in both groups and distribution of charge in these proteins was very low; showing COMMON proteins were very hydrophobic. Furthermore, compositions of polar dipeptide in SCLC proteins were higher than NSCLC proteins. Some clustering models (alone or in combination with attribute weighting algorithms) were able to nearly classify SCLC and NSCLC proteins. Random Forest tree induction algorithm, calculated on leaves one-out and 10-fold cross validation) shows more than 86% accuracy in clustering and predicting three different lung cancer tumors. Here for the first time the application of data mining tools to effectively classify three classes of lung cancer tumors regarding the importance of dipeptide composition, autocorrelation and distribution descriptor has been reported.	[Hosseinzadeh, Faezeh] Univ Tehran, Lab Biophys & Mol Biol, Inst Biochem & Biophys, Tehran, Iran; [Ebrahimi, Mansour] Univ Qom, Dept Biol, Basic Sci Sch, Qom, Iran; [Ebrahimi, Mansour; Shamabadi, Narges] Univ Qom, Bioinformat Res Grp, Green Res Ctr, Qom, Iran; [Goliaei, Bahram] Iran Univ Med Sci, Dept Med Phys, Tehran, Iran	University of Tehran; Iran University of Medical Sciences	Hosseinzadeh, F (corresponding author), Univ Tehran, Lab Biophys & Mol Biol, Inst Biochem & Biophys, Tehran, Iran.	mebrahimi14@gmail.com	ebrahimi, mansour/D-9950-2011; hosseinzadeh, faezeh/GNH-2600-2022; Ebrahimi, Mansour/AAO-9096-2021; Ebrahimie, Esmaeil/AAN-2611-2020	Ebrahimi, Mansour/0000-0001-7011-2567; Ebrahimie, Esmaeil/0000-0002-4431-2861; Shamabadi, Narges Sadat/0000-0003-0906-9445; Hosseinzadeh, Faezeh/0000-0002-7990-3805				Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Alvarez-Chaver P, 2007, INT J BIOCHEM CELL B, V39, P529, DOI 10.1016/j.biocel.2006.10.001; Anagnostou VK, 2011, CANCER; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Balasubramanian D, 2007, P ANN INT IEEE EMBS, P2134, DOI 10.1109/IEMBS.2007.4352744; Barash O, 2011, NANOMEDICINE; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Bhaskaran, 1988, INT J PEPT PROTEIN R; BIGELOW CC, 1967, J THEOR BIOL, V16, P187, DOI 10.1016/0022-5193(67)90004-5; Bock JR, 2003, BIOINFORMATICS, V19, P125, DOI 10.1093/bioinformatics/19.1.125; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; BROTO P, 1984, EUR J MED CHEM, V19, P71; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Caballero J, 2007, J MOL GRAPH MODEL, V26, P166, DOI 10.1016/j.jmgm.2006.11.002; Cai CZ, 2004, PROTEINS, V55, P66, DOI 10.1002/prot.20045; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Chan EC, 2005, CANCER GENET CYTOGEN, V162, P10, DOI 10.1016/j.cancergencyto.2005.03.008; CHARTON M, 1981, J THEOR BIOL, V91, P115, DOI 10.1016/0022-5193(81)90377-5; CHARTON M, 1982, J THEOR BIOL, V99, P629, DOI 10.1016/0022-5193(82)90191-6; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 2006, J PROTEOME RES, V5, P316, DOI 10.1021/pr050331g; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Chou KC, 2006, BIOCHEM BIOPH RES CO, V347, P150, DOI 10.1016/j.bbrc.2006.06.059; CID H, 1992, PROTEIN ENG, V5, P373, DOI 10.1093/protein/5.5.373; Crimins F, 2003, CAMDA 03; Cui J, 2007, MOL IMMUNOL, V44, P866, DOI 10.1016/j.molimm.2006.04.001; Dayhoff H, 1987, ATLAS PROTEIN SEQUEN, P363; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Fu XJ, 2003, IEEE T SYST MAN CY B, V33, P399, DOI 10.1109/TSMCB.2003.810911; Furney SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-3; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gromiha MM, 2008, PROTEINS, V70, P1274, DOI 10.1002/prot.21616; Guan P, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-103; Guan PP, 2005, J MED CHEM, V48, P7418, DOI 10.1021/jm0505258; Guo J, 2006, BIOINFORMATICS, V22, P1784, DOI 10.1093/bioinformatics/btl180; Han LY, 2004, NUCLEIC ACIDS RES, V32, P6437, DOI 10.1093/nar/gkh984; Han LY, 2004, RNA, V10, P355, DOI 10.1261/rna.5890304; Hjertman M, 2001, BIOCHEM BIOPH RES CO, V288, P736, DOI 10.1006/bbrc.2001.5830; HORNE DS, 1988, BIOPOLYMERS, V27, P451, DOI 10.1002/bip.360270308; Hu YC, 2002, ONCOGENE, V21, P7289, DOI 10.1038/sj.onc.1205805; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kligerman S, 2010, AM J ROENTGENOL, V194, P562, DOI 10.2214/AJR.09.3354; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Lo SL, 2005, PROTEOMICS, V5, P876, DOI 10.1002/pmic.200401118; Marchevsky AM, 2004, J MOL DIAGN, V6, P28, DOI 10.1016/S1525-1578(10)60488-6; Markey MK, 2003, PROTEOMICS, V3, P1678, DOI 10.1002/pmic.200300521; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Nevins Joseph R, 2011, Proc Am Thorac Soc, V8, P180, DOI 10.1513/pats.201006-040MS; Nguyen AN, 2010, J AM MED INFORM ASSN, V17, P440, DOI 10.1136/jamia.2010.003707; Nie Guang-jin, 2009, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V27, P257; Nitta N, 1998, TISSUE ELASTICITY IM; Ong SAK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-300; Raj V, 2011, CURR PROBL DIAGN RAD, V40, P85, DOI 10.1067/j.cpradiol.2010.02.002; Rustici G. R., 2008, CURR PROTOC BIOINFOR; SCHNEIDER G, 1994, BIOPHYS J, V66, P335, DOI 10.1016/S0006-3495(94)80782-9; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Tanney A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-20; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; Travis WD, 2011, SEMIN ROENTGENOL, V46, P178, DOI 10.1053/j.ro.2011.02.003; van Rijt SH, 2010, J MED CHEM, V53, P840, DOI 10.1021/jm901556u; Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223; Wrona Anna, 2010, Pneumonol Alergol Pol, V78, P407; Xi LL, 2010, J THEOR BIOL, V264, P1159, DOI 10.1016/j.jtbi.2010.03.042; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yanagawa N, 2007, LUNG CANCER, V58, P131, DOI 10.1016/j.lungcan.2007.05.011; Yang Yan, 2008, Zhonghua Zhongliu Zazhi, V30, P616	76	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e40017	10.1371/journal.pone.0040017	http://dx.doi.org/10.1371/journal.pone.0040017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	29161736	Green Published, Green Submitted, gold			2022-12-25	WOS:000306956300010
J	Ou, JJ; Luan, W; Deng, J; Sa, R; Liang, HJ				Ou, Juanjuan; Luan, Wei; Deng, Jia; Sa, Rina; Liang, Houjie			alpha V Integrin Induces Multicellular Radioresistance in Human Nasopharyngeal Carcinoma via Activating SAPK/JNK Pathway	PLOS ONE			English	Article							CELL; INTEGRIN-ALPHA(V)BETA(3); RESISTANCE; APOPTOSIS; INVASION; THERAPY; STRESS; NECTIN; MATRIX; JNK	Background: Tumor cells acquire the capacity of resistance to chemotherapy or radiotherapy via cell-matrix and cell-cell crosstalk. Integrins are the most important cell adhesion molecules, in which alpha V integrin mainly mediating the tight contact between tumor cells. Methodology/Principal Findings: To investigate the role of alpha V integrin in multi-cellular radioresistance (MCR) of human nasopharyngeal carcinoma (NPC), we performed immunohistochemistry and Western blotting to find that the expression of alpha V integrin in the tumor tissue of radioresistant patients is much higher than that in radiosensitive patients. In vitro, we cultured human NPC cell line CNE-2 cells as multi-cellular spheroids (MCSs) or as monolayer cells (MCs), and found that the expression of alpha V integrin in MCSs is significantly higher than that in MCs. MTT, flow cytometry and clonogenic suvival assays showed that MCSs are less sensitive to X-ray irradiation than MCs while blocking of alpha V integrin in MCSs dramatically reversed their radioresistance. Furthermore, as detected by Western blotting, MCSs displayed sustained activation of the stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) pathway in presence of irradiation. Blocking of alpha V integrin in MCSs decreased the expression of phosphorylated JNK. Additionally, blocking of SAPK/JNK signaling pathway synergistically induced apoptosis of MCSs exposed to irradiation by increasing the expression of cleaved caspase-3. In vivo, we found that irradiation combined with alpha V integrin blocking treatment significantly enhanced the radiosensitivity of NPC xenografts. Conclusions: Our results indicate a novel role of alpha V integrin in multi-cellular radioresistance of NPCs.	[Ou, Juanjuan] Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Ou, JJ (corresponding author), Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China.	lianghoujie@sina.com	Liu, Juxiu/B-3400-2009; Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [81000965]; 973 Program, National Basic Research Program of China [2010cb529403]; Div Of Biological Infrastructure [0933958] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program, National Basic Research Program of China(National Basic Research Program of China); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grant number 81000965 from the National Natural Science Foundation of China, and by 973 Program No. 2010cb529403 from the National Basic Research Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Chen QM, 2007, CLIN CANCER RES, V13, P3689, DOI 10.1158/1078-0432.CCR-07-0026; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; He JM, 2009, CANCER LETT, V284, P182, DOI 10.1016/j.canlet.2009.04.023; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hwang R, 2004, HEMATOL ONCOL CLIN N, V18, P991, DOI 10.1016/j.hoc.2004.09.010; Jean C, 2011, ONCOGENE, V30, P2697, DOI 10.1038/onc.2011.27; Le Tourneau C, 2010, B CANCER, V97, P1453, DOI 10.1684/bdc.2010.1226; Leclerc D, 2008, J BIOL CHEM, V283, P3151, DOI 10.1074/jbc.M708598200; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Pauwels B, 2010, FUTURE ONCOL, V6, P1485, DOI 10.2217/FON.10.104; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Sakamoto Y, 2008, J BIOL CHEM, V283, P496, DOI 10.1074/jbc.M704195200; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sandfort V, 2007, INT J RADIAT BIOL, V83, P727, DOI 10.1080/09553000701694335; Stulic M, 2007, CYTOKINE, V37, P163, DOI 10.1016/j.cyto.2007.03.010; Sun HY, 2011, EXP BIOL MED, V236, P352, DOI 10.1258/ebm.2010.010106; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vellon L, 2006, MOL CARCINOGEN, V45, P795, DOI 10.1002/mc.20242; Zhang SY, 2004, CARCINOGENESIS, V25, P2191, DOI 10.1093/carcin/bgh234	31	90	102	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38737	10.1371/journal.pone.0038737	http://dx.doi.org/10.1371/journal.pone.0038737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22844484	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900045
J	Deng, Q; Hui, DF; Zhang, DQ; Zhou, GY; Liu, JX; Liu, SZ; Chu, GW; Li, J				Deng, Qi; Hui, Dafeng; Zhang, Deqiang; Zhou, Guoyi; Liu, Juxiu; Liu, Shizhong; Chu, Guowei; Li, Jiong			Effects of Precipitation Increase on Soil Respiration: A Three-Year Field Experiment in Subtropical Forests in China	PLOS ONE			English	Article							CO2 EFFLUX; CARBON-DIOXIDE; TERRESTRIAL ECOSYSTEMS; EXPERIMENTAL DROUGHT; GRASSLAND ECOSYSTEM; ORGANIC-CARBON; TEMPERATURE; RESPONSES; VARIABILITY; DEPENDENCE	Background: The aim of this study was to determine response patterns and mechanisms of soil respiration to precipitation increases in subtropical regions. Methodology/Principal Findings: Field plots in three typical forests [i.e. pine forest (PF), broadleaf forest (BF), and pine and broadleaf mixed forest (MF)] in subtropical China were exposed under either Double Precipitation (DP) treatment or Ambient Precipitation (AP). Soil respiration, soil temperature, soil moisture, soil microbial biomass and fine root biomass were measured over three years. We tested whether precipitation treatments influenced the relationship of soil respiration rate (R) with soil temperature (T) and soil moisture (M) using R=(a+cM)exp(bT), where a is a parameter related to basal soil respiration; b and c are parameters related to the soil temperature and moisture sensitivities of soil respiration, respectively. We found that the DP treatment only slightly increased mean annual soil respiration in the PF (15.4%) and did not significantly change soil respiration in the MF and the BF. In the BF, the increase in soil respiration was related to the enhancements of both soil fine root biomass and microbial biomass. The DP treatment did not change model parameters, but increased soil moisture, resulting in a slight increase in soil respiration. In the MF and the BF, the DP treatment decreased soil temperature sensitivity b but increased basal soil respiration a, resulting in no significant change in soil respiration. Conclusion/Significance: Our results indicate that precipitation increasing in subtropical regions in China may have limited effects on soil respiration.	[Deng, Qi; Zhang, Deqiang; Zhou, Guoyi; Liu, Juxiu; Liu, Shizhong; Chu, Guowei; Li, Jiong] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Deng, Qi] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Tennessee State University	Deng, Q (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	dhui@tnstate.edu	Liu, Juxiu/B-3400-2009; Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	National Basic Research Program of China [2009CB42110x]; Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences [XDA05050205]; Dinghushan Forest Ecosystem Research Station; National Science Foundation [0933958]; Div Of Biological Infrastructure [0933958] Funding Source: National Science Foundation	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences; Dinghushan Forest Ecosystem Research Station; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was financially supported by National Basic Research Program of China (2009CB42110x), Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences (XDA05050205), Dinghushan Forest Ecosystem Research Station, and the National Science Foundation (0933958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2006, GLOBAL CHANGE BIOL, V12, P177, DOI 10.1111/j.1365-2486.2005.001058.x; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Chen Xiao-mei, 2010, Yingyong Shengtai Xuebao, V21, P1210; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Deng Q, 2010, BIOGEOSCIENCES, V7, P315, DOI 10.5194/bg-7-315-2010; Deng Q, 2011, ENVIRON MANAGE, V48, P1182, DOI 10.1007/s00267-011-9732-2; Ding M. M., 2001, IITF17 USDA FOR SERV; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; [方运霆 Fang Yun], 2003, [生态学报, Acta Ecologica Sinica], V23, P1685; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; He C., 1982, TROPICAL SUBTROPICAL, V1, P25; Hui D., 1996, PRACTICAL SAS USAGE; Hui DF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002297; Hui DF, 2003, TREE PHYSIOL, V23, P433, DOI 10.1093/treephys/23.7.433; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; Jackson RB, 2009, ECOLOGY, V90, P3352, DOI 10.1890/08-1609.1; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jenerette GD, 2008, FUNCT ECOL, V22, P924, DOI 10.1111/j.1365-2435.2008.01450.x; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Liu JX, 2008, BIOGEOSCIENCES, V5, P1783, DOI 10.5194/bg-5-1783-2008; [刘申 LIU Shen], 2007, [生态科学, Ecologic Science], V26, P387; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Luo Y., 2006, SOIL RESP ENV, P35, DOI [10.1016/B978-012088782-8/50003-6, DOI 10.1016/B978-012088782-8/50003-6]; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Misson L, 2010, GLOBAL CHANGE BIOL, V16, P2461, DOI 10.1111/j.1365-2486.2009.02121.x; Noormets A, 2008, AGR FOREST METEOROL, V148, P216, DOI 10.1016/j.agrformet.2007.08.002; Palmroth S, 2005, GLOBAL CHANGE BIOL, V11, P421, DOI 10.1111/j.1365-2486.2005.00915.x; Peng Shao-Lin, 1995, Chinese Journal of Botany, V7, P75; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Schaefer K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001928; Schwendenmann L, 2005, ECOSYSTEMS, V8, P339, DOI 10.1007/s10021-003-0088-1; Scotta ED, 2007, GLOBAL CHANGE BIOL, V13, P546; Shen CD, 2001, RADIOCARBON, V43, P671; Shen WJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000685; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowerby A, 2008, GLOBAL CHANGE BIOL, V14, P2388, DOI 10.1111/j.1365-2486.2008.01643.x; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; van Straaten O, 2010, BIOGEOSCIENCES, V7, P1223, DOI 10.5194/bg-7-1223-2010; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang B. S., 1982, Tropical and Subtropical Forest Ecosystem, Ding Hu Shan Forest Ecosystem Reserve, China, P142; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yan J. H., 2009, SOIL BIOL BIOCHEM, V9, P1, DOI DOI 10.1016/J.S0ILBI0.2008.12.018; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zhang DQ, 2006, SCI CHINA SER D, V49, P139, DOI 10.1007/s11430-006-8139-z; Zhou T, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000850; Zhou XH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002526	61	90	102	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41493	10.1371/journal.pone.0041493	http://dx.doi.org/10.1371/journal.pone.0041493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844484	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700095
J	Kim, SJ; Peshkin, L; Mitchison, TJ				Kim, Sujeong; Peshkin, Leonid; Mitchison, Timothy J.			Vascular Disrupting Agent Drug Classes Differ in Effects on the Cytoskeleton	PLOS ONE			English	Article							5,6-DIMETHYLXANTHENONE-4-ACETIC ACID DMXAA; COMBRETASTATIN A4 PHOSPHATE; TUMOR-NECROSIS-FACTOR; FLAVONE ACETIC-ACID; MICROTUBULE DYNAMICS; ANTITUMOR-ACTIVITY; KNOCKOUT MICE; IN-VIVO; CANCER; CELLS	Vascular disrupting agents (VDAs), anti-cancer drugs that target established tumor blood vessels, fall into two main classes: microtubule targeting drugs, exemplified by combretastatin A4 (CA4), and flavonoids, exemplified by 5,6-dimethylxanthe-none-4-acetic acid (DMXAA). Both classes increase permeability of tumor vasculature in mouse models, and DMXAA in particular can cause massive tumor necrosis. The molecular target of CA4 is clearly microtubules. The molecular target(s) of DMXAA remains unclear. It is thought to promote inflammatory signaling in leukocytes, and has been assumed to not target microtubules, though it is not clear from the literature how carefully this assumption has been tested. An earlier flavone analog, flavone acetic acid, was reported to promote mitotic arrest suggesting flavones might possess anti-microtubule activity, and endothelial cells are sensitive to even mild disruption of microtubules. We carefully investigated whether DMXAA directly affects the microtubule or actin cytoskeletons of endothelial cells by comparing effects of CA4 and DMXAA on human umbilical vein endothelial cells (HUVEC) using time-lapse imaging and assays for cytoskeleton integrity. CA4 caused retraction of the cell margin, mitotic arrest and microtubule depolymerization, while DMXAA, up to 500 mu M, showed none of these effects. DMXAA also had no effect on pure tubulin nucleation and polymerization, unlike CA4. We conclude that DMXAA exhibits no direct anti-microtubule action and thus cleanly differs from CA4 in its mechanism of action at the molecular level.	[Kim, Sujeong; Peshkin, Leonid; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kim, SJ (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Sujeong_Kim@hms.harvard.edu		Mond, Jonathan/0000-0002-0410-091X; Hay, Phillipa/0000-0003-0296-6856; Peshkin, Leonid/0000-0002-6420-848X; MITCHISON, DEBORAH/0000-0002-6736-7937; Giannakakou, Paraskevi/0000-0001-7378-262X	Korea Research Foundation; Korean Government [KRF-2008-357-C00112];  [CA139980]; NATIONAL CANCER INSTITUTE [P01CA139980] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Korea Research Foundation Grant funded by the Korean Government [KRF-2008-357-C00112] and New Initiative Grant CA139980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley BC, 2003, LANCET ONCOL, V4, P141, DOI 10.1016/S1470-2045(03)01018-0; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; Ching LM, 1999, CANCER RES, V59, P3304; CUSHMAN M, 1991, J MED CHEM, V34, P2579, DOI 10.1021/jm00112a036; Dark GG, 1997, CANCER RES, V57, P1829; Eichhorn ME, 2007, LANGENBECK ARCH SURG, V392, P371, DOI 10.1007/s00423-007-0150-0; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Galbraith SM, 2001, ANTICANCER RES, V21, P93; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1; Head M, 2010, EXPERT OPIN INV DRUG, V19, P295, DOI 10.1517/13543780903540214; JORDAN MA, 1992, J CELL SCI, V102, P401; Kanthou C, 2002, BLOOD, V99, P2060, DOI 10.1182/blood.V99.6.2060; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Nam NH, 2003, CURR MED CHEM, V10, P1697, DOI 10.2174/0929867033457151; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Panaro NJ, 1999, BRIT J CANCER, V80, P1905, DOI 10.1038/sj.bjc.6690619; PLOWMAN J, 1986, CANCER TREAT REP, V70, P631; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Vincent L, 2005, J CLIN INVEST, V115, P2992, DOI 10.1172/JCI24586; Wang LCS, 2004, BIOCHEM PHARMACOL, V67, P937, DOI 10.1016/j.bcp.2003.10.023; Wu Q, 2012, J PHARMACOL EXP THER; Zhao L, 2002, BRIT J CANCER, V87, P465, DOI 10.1038/sj.bjc.6600479; Zweifel M, 2011, ANN ONCOL, V22, P2036, DOI 10.1093/annonc/mdq708; ZWI LJ, 1994, ONCOL RES, V6, P79	31	58	58	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40177	10.1371/journal.pone.0040177	http://dx.doi.org/10.1371/journal.pone.0040177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848372	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300007
J	Wang, HK; Yan, YH; Wang, JM; Zhang, HP; Qi, W				Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Zhang, HePing; Qi, Wei			Production and Characterization of Antifungal Compounds Produced by Lactobacillus plantarum IMAU10014	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTIBIOTICS; SPOILAGE; BREAD; FOOD	Lactobacillus plantarum IMAU10014 was isolated from koumiss that produces a broad spectrum of antifungal compounds, all of which were active against plant pathogenic fungi in an agar plate assay. Two major antifungal compounds were extracted from the cell-free supernatant broth of L. plantarum IMAU10014. 3-phenyllactic acid and Benzeneacetic acid, 2-propenyl ester were carried out by HPLC, LC-MS, GC-MS, NMR analysis. It is the first report that lactic acid bacteria produce antifungal Benzeneacetic acid, 2-propenyl ester. Of these, the antifungal products also have a broad spectrum of antifungal activity, namely against Botrytis cinerea, Glomerella cingulate, Phytophthora drechsleri Tucker, Penicillium citrinum, Penicillium digitatum and Fusarium oxysporum, which was identified by the overlay and well-diffusion assay. F. oxysporum, P. citrinum and P. drechsleri Tucker were the most sensitive among molds.	[Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Qi, Wei] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China; [Zhang, HePing] Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Minist Educ, Hohhot, Peoples R China	Tianjin University Science & Technology; Inner Mongolia Agricultural University	Wang, HK (corresponding author), Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China.	haikuanwangcn@yahoo.com.cn; hepingdd@vip.sina.com	Zhang, He/GXN-0028-2022		National Natural Science Foundation of China [30900961, 20876116]; Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	This work was supported by the National Natural Science Foundation of China (No. 30900961 and No. 20876116), the Key Laboratory of Dairy Biotechnology, the Engineering, Ministry of Education, the Inner Mongolia Agricultural University for helpful contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2008, LETT APPL MICROBIOL, V47, P180, DOI 10.1111/j.1472-765X.2008.02412.x; Coloretti F, 2007, FEMS MICROBIOL LETT, V271, P245, DOI 10.1111/j.1574-6968.2007.00723.x; Dal Bello F, 2007, J CEREAL SCI, V45, P309, DOI 10.1016/j.jcs.2006.09.004; Dalie DKD, 2010, FOOD CONTROL, V21, P370, DOI 10.1016/j.foodcont.2009.07.011; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V87, P149; Gerez CL, 2009, FOOD CONTROL, V20, P144, DOI 10.1016/j.foodcont.2008.03.005; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; MATSUDA T, 1994, J JPN SOC FOOD SCI, V41, P687; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Niku-Paavola ML, 1999, J APPL MICROBIOL, V86, P29, DOI 10.1046/j.1365-2672.1999.00632.x; Prema P, 2010, FOOD BIOPROCESS TECH, V3, P379, DOI 10.1007/s11947-008-0127-1; Rouse S, 2008, J APPL MICROBIOL, V104, P915, DOI 10.1111/j.1365-2672.2007.03619.x; Schnurer J, 2005, TRENDS FOOD SCI TECH, V16, P70, DOI 10.1016/j.tifs.2004.02.014; Schwenninger SM, 2008, J FOOD PROTECT, V71, P2481, DOI 10.4315/0362-028X-71.12.2481; Sjogren J, 2003, APPL ENVIRON MICROB, V69, P7554, DOI 10.1128/AEM.69.12.7554-7557.2003; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; Sun TS, 2009, EUR FOOD RES TECHNOL, V228, P607, DOI 10.1007/s00217-008-0969-9; Vermeulen N, 2006, J AGR FOOD CHEM, V54, P3832, DOI 10.1021/jf052733e; Wang HK, 2011, ANN MICROBIOL, V61, P879, DOI 10.1007/s13213-011-0209-6; Yang LP, 2008, WORLD J MICROB BIOT, V24, P909, DOI 10.1007/s11274-007-9626-x	22	374	401	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29452	10.1371/journal.pone.0029452	http://dx.doi.org/10.1371/journal.pone.0029452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22844460	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200014
J	Chen, L; Huang, LZ; Min, DH; Phillips, A; Wang, SQ; Madgwick, PJ; Parry, MAJ; Hu, YG				Chen, Liang; Huang, Linzhou; Min, Donghong; Phillips, Andy; Wang, Shiqiang; Madgwick, Pippa J.; Parry, Martin A. J.; Hu, Yin-Gang			Development and Characterization of a New TILLING Population of Common Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; DETECT INDUCED MUTATIONS; GENE-FUNCTION; INSERTIONAL MUTAGENESIS; FUNCTIONAL GENOMICS; POINT MUTATIONS; INDUCED MUTANTS; DISCOVERY; RESOURCE; RICE	Mutagenesis is an important tool in crop improvement. However, the hexaploid genome of wheat (Triticum aestivum L.) presents problems in identifying desirable genetic changes based on phenotypic screening due to gene redundancy. TILLING (Targeting Induced Local Lesions IN Genomes), a powerful reverse genetic strategy that allows the detection of induced point mutations in individuals of the mutagenized populations, can address the major challenge of linking sequence information to the biological function of genes and can also identify novel variation for crop breeding. Wheat is especially well-suited for TILLING due to the high mutation densities tolerated by polyploids. However, only a few wheat TILLING populations are currently available in the world, which is far from satisfying the requirement of researchers and breeders in different growing environments. In addition, current TILLING screening protocols require costly fluorescence detection systems, limiting their use, especially in developing countries. We developed a new TILLING resource comprising 2610 M-2 mutants in a common wheat cultivar 'Jinmai 47'. Numerous phenotypes with altered morphological and agronomic traits were observed from the M-2 and M-3 lines in the field. To simplify the procedure and decrease costs, we use unlabeled primers and either non-denaturing polyacrylamide gels or agarose gels for mutation detection. The value of this new resource was tested using PCR with RAPD and Intron-spliced junction (ISJ) primers, and also TILLING in three selected candidate genes, in 300 and 512 mutant lines, revealing high mutation densities of 1/34 kb by RAPD/ISJ analysis and 1/47 kb by TILLING. In total, 31 novel alleles were identified in the 3 targeted genes and confirmed by sequencing. The results indicate that this mutant population represents a useful resource for the wheat research community. We hope that the use of this reverse genetics resource will provide novel allelic diversity for wheat improvement and functional genomics.	[Chen, Liang; Huang, Linzhou; Min, Donghong; Wang, Shiqiang; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andy; Madgwick, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Ctr Crop Genet Improvement, Harpenden, Herts, England; NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	Ministry of Science and Technology [2006AA100201, 2006AA100223, 2006CB708208]; 111 Program of Introducing Talents of Discipline to Universities P. R. China [111-2-16]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 Program of Introducing Talents of Discipline to Universities P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223), the pre-phase project of the 973 Program (2006CB708208) of the Ministry of Science and Technology, and the 111 Program of Introducing Talents of Discipline to Universities (111-2-16), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 1993, PLANT MOL BIOL REP, V11, P128, DOI DOI 10.1007/BF02670471; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bentley A, 2000, GENETICS, V156, P1169; Bibi S, 2009, PAK J BOT, V41, P1022; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chua NH, 2006, CURR OPIN BIOTECH, V17, P103, DOI 10.1016/j.copbio.2006.03.002; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Eversole K, 2009, ANN WHEAT N IN PRESS, P55; Fox JL, 2004, NAT BIOTECHNOL, V22, P1062, DOI 10.1038/nbt0904-1062; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HALLORAN GM, 1982, ANN BOT-LONDON, V49, P115, DOI 10.1093/oxfordjournals.aob.a086220; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Muth J, 2008, PLANT BIOTECHNOL J, V6, P576, DOI 10.1111/j.1467-7652.2008.00340.x; Naghavi Mohammad Reza, 2004, Iranian Journal of Biotechnology, V2, P195; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Przetakiewicz J, 2002, CELL MOL BIOL LETT, V7, P671; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rothe N, 2010, THESIS KANSASS STATE; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SONG WN, 1995, GENET RESOUR CROP EV, V42, P273, DOI 10.1007/BF02431262; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till B. J., 2007, GENOMICS ASSISTED CR, P333; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103	53	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41570	10.1371/journal.pone.0041570	http://dx.doi.org/10.1371/journal.pone.0041570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844501	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700113
J	Chen, L; Ma, YL; Kim, EY; Yu, W; Schwartz, RJ; Qian, L; Wang, J				Chen, Li; Ma, Yanlin; Kim, Eun Young; Yu, Wei; Schwartz, Robert J.; Qian, Ling; Wang, Jun			Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; NOTCH ACTIVATION; GENE-EXPRESSION; OUTFLOW-TRACT; BHLH FACTORS; CELL FATE; METHYLATION	Ezh2 is a histone trimethyltransferase that silences genes mainly via catalyzing trimethylation of histone 3 lysine 27 (H3K27Me3). The role of Ezh2 as a regulator of gene silencing and cell proliferation in cancer development has been extensively investigated; however, its function in heart development during embryonic cardiogenesis has not been well studied. In the present study, we used a genetically modified mouse system in which Ezh2 was specifically ablated in the mouse heart. We identified a wide spectrum of cardiovascular malformations in the Ezh2 mutant mice, which collectively led to perinatal death. In the Ezh2 mutant heart, the endocardial cushions (ECs) were hypoplastic and the endothelial-to-mesenchymal transition (EMT) process was impaired. The hearts of Ezh2 mutant mice also exhibited decreased cardiomyocyte proliferation and increased apoptosis. We further identified that the Hey2 gene, which is important for cardiomyocyte proliferation and cardiac morphogenesis, is a downstream target of Ezh2. The regulation of Hey2 expression by Ezh2 may be independent of Notch signaling activity. Our work defines an indispensible role of the chromatin remodeling factor Ezh2 in normal cardiovascular development.	[Chen, Li; Kim, Eun Young; Qian, Ling; Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Ma, Yanlin] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Yu, Wei; Schwartz, Robert J.] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA	Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Chen, L (corresponding author), Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA.	junwang@heart.thi.tmc.edu	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	American Heart Association; National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	American Heart Association(American Heart Association); National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the American Heart Association to JW. JW is also supported by a P30 grant from the National Health Institute as a Newly Independent Investigator (NII). LC is supported by a Postdoctoral Fellowship from the American Heart Association Southern Central Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Gordadze AV, 2001, J VIROL, V75, P5899, DOI 10.1128/JVI.75.13.5899-5912.2001; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu JC, 2004, CURR PROB CARDIOLOGY, V29, P641, DOI 10.1016/j.cpcardiol.2004.04.003; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180	61	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31005	10.1371/journal.pone.0031005	http://dx.doi.org/10.1371/journal.pone.0031005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22844501	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500025
J	Chen, LC; Hsu, C; Chiueh, CC; Lee, WS				Chen, Li-Ching; Hsu, Chin; Chiueh, Chuang Chin; Lee, Wen-Sen			Ferrous Citrate Up-Regulates the NOS2 through Nuclear Translocation of NF kappa B Induced by Free Radicals Generation in Mouse Cerebral Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; BRAIN-INJURY; PUTATIVE ROLE; IRON; ACTIVATION; EXPRESSION; FERRITIN	Previous studies indicate that the inducible nitric oxide synthase 2 (NOS2) of the brain vascular tissue in experimental subarachnoid hemorrhage (SAH) rats is a critical factor for inducing cerebral vasospasm. However, the underlying molecular mechanisms remain to be elucidated. Here, we applied ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cell (CEC) to mimic the SAH conditions and to address the issue how SAH-induced NOS2 up-regulation. Using immunocytochemical staining technique, we demonstrated that NOS2 was expressed in the cultured CEC. Treatment of the CEC with FC induced increases of the intracellular level of ROS, nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) nuclear translocation as well as NF kappa B binding onto the NOS promoter, and the levels of NOS2 mRNA and protein. These effects were abolished by pre-treatment of the cell with N-Acetyl-Cysteine (NAC), a reactive oxygen species (ROS) scavenger. In the present study, two previously predicted NFkB binding sites were confirmed in the NOS2 promoter within the range of -1529 bp to -1516 bp and -1224 bp to -1210 bp. Interestingly, both NF kappa B binding sites are involved in the FC-activated NOS2 transcriptional activity; the binding site located at -1529 bp to -1516 bp played a greater role than the other binding site located at -1224 bp to -1210 bp in the mouse CEC. These findings highlight the molecular mechanism underlying FC-induced up-regulation of NOS2 in the mouse CEC.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chiueh, Chuang Chin] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Sch Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	National Science Council of Taiwan [NSC-101-2320-B-038-005, NSC-101-2629-B-037-001, NSC-95-2320-B-037-032-MY2, NSC97-2314-B-037-039-MY2, NSC-95-2320-B-038-027-MY2]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the National Science Council of Taiwan (NSC-101-2320-B-038-005 and NSC-101-2629-B-037-001 to W. S. L.; NSC-95-2320-B-037-032-MY2 and NSC97-2314-B-037-039-MY2 to C. H.; NSC-95-2320-B-038-027-MY2 to C. C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Berra L V, 2007, J Neurosurg Sci, V51, P1; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Chiueh CC, 2000, NEUROTOX RES, V2, P293, DOI 10.1007/BF03033799; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Du WL, 2005, CHEST, V128, p556S, DOI 10.1378/chest.128.6_suppl.556S; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Taylor BS, 2001, PROG INFLAM RES, P1; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wong J M, 1995, Adv Pharmacol, V34, P155; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46239	10.1371/journal.pone.0046239	http://dx.doi.org/10.1371/journal.pone.0046239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	22844501	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900115
J	Wang, LH; Lv, XJ; Zhai, YG; Fu, SH; Wang, D; Rayner, S; Tang, Q; Liang, GD				Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Wang, David; Rayner, Simon; Tang, Qing; Liang, Guodong			Genomic Characterization of a Novel Virus of the Family Tymoviridae Isolated from Mosquitoes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-MOSAIC-VIRUS; MINUS-STRAND SYNTHESIS; RNA; GENUS; ORGANIZATION; INITIATION; MEMBER; LINE	Background: The family Tymoviridae comprises three plant virus genera, including Tymovirus, Marafivirus, and Maculavirus, which are found in most parts of the world and cause severe agricultural losses. We describe a putatively novel member of the family Tymoviridae, which is isolated from mosquitoes (Culex spp.), referred to as CuTLV. Methods and Results: The CuTLV was isolated by cell culture, which replicates and causes cytopathic effects in Aedes albopictus C6/36 cells, but not in mammalian BHK-21 or Vero cells. The complete 6471 nucleotide sequence of CuTLV was determined. The genome of CuTLV is predicted to contain three open reading frames (ORFs). The largest ORF1 is 5307 nucleotides (nt) in length and encodes a putative polypeptide of 1769 amino acids (aa), which contains the conserved motifs for the methyltransferase (MTR), Tymovirus endopeptidase (PRO), helicase (HEL), and RNA-dependent RNA polymerase (RdRp) of the replication-associated proteins (RPs) of positive-stranded RNA viruses. In contrast, the ORF1 sequence does not contain the so-called "tymobox'' or "marafibox'', the conserved subgenomic RNA promoter present in all tymoviruses or marafiviruses, respectively. ORF2 and ORF3 putatively encode a 248-aa coat protein (CP) and a proline-rich 149-aa polypeptide. The whole genomic nucleotide identity of CuTLV with other members of family Tymoviridae ranged from 46.2% (ChiYMV) to 52.4% (GFkV). Phylogenetic analysis based on the putative RP and CP genes of CuTLV demonstrated that the virus is most closely related to viruses in the genus Maculavirus. Conclusions: The CuTLV is a novel virus related to members of the family Tymoviridae, with molecular characters that are distinct from those of tymoviruses, marafiviruses, and other maculaviruses or macula-like viruses. This is the first report of the isolation of a Tymoviridae-like virus from mosquitoes. Further investigations are required to clarify the origin, replication strategy, and the public health or agricultural importance of the CuTLV.	[Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, David] Washington Univ, St Louis, MO USA; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Beijing 100864, Hubei, Peoples R China	Chinese Center for Disease Control & Prevention; Washington University (WUSTL); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, LH (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	Ministry of Science and Technology, People's Republic of China [2003BA712A08-01, 2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	Funding was provided by the Ministry of Science and Technology, People's Republic of China (no. 2003BA712A08-01 and 2011CB504702); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdullah A, 2010, VIRUS RES, V152, P10, DOI 10.1016/j.virusres.2010.05.010; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; DING S, 1990, NUCLEIC ACIDS RES, V18, P1181, DOI 10.1093/nar/18.5.1181; Dreher TW, 2004, MOL PLANT PATHOL, V5, P367, DOI 10.1111/j.1364-3703.2004.00236.X; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Hellendoorn K, 1996, NUCLEIC ACIDS RES, V24, P4910, DOI 10.1093/nar/24.24.4910; Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Izadpanah K, 2002, VIRUS GENES, V24, P131, DOI 10.1023/A:1014516515454; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; King AMQ, 2011, 9 INT COMM TAX VIR, P944; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Martelli GP, 2002, ARCH VIROL, V147, P1847, DOI 10.1007/s007050200046; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Sabanadzovic S, 2001, J GEN VIROL, V82, P2009, DOI 10.1099/0022-1317-82-8-2009; Sabanadzovic S, 2009, ARCH VIROL, V154, P1729, DOI 10.1007/s00705-009-0510-x; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Stephan D, 2008, VIRUS GENES, V36, P231, DOI 10.1007/s11262-007-0181-1; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39845	10.1371/journal.pone.0039845	http://dx.doi.org/10.1371/journal.pone.0039845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	23272162	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200014
J	Wang, L; Si, WN; Yao, YF; Tian, DC; Araki, H; Yang, SH				Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai			Genome-Wide Survey of Pseudogenes in 80 Fully Resequenced Arabidopsis thaliana Accessions	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; GENETIC DIVERSITY; DNA; ASSOCIATION; POLYMORPHISMS; EVOLUTIONARY; ANNOTATION; MECHANISMS; RESISTANCE; PATTERNS	Pseudogenes (Psi s), including processed and non-processed Psi s, are ubiquitous genetic elements derived from originally functional genes in all studied genomes within the three kingdoms of life. However, systematic surveys of non-processed Psi s utilizing genomic information from multiple samples within a species are still rare. Here a systematic comparative analysis was conducted of Psi s within 80 fully re-sequenced Arabidopsis thaliana accessions, and 7546 genes, representing similar to 28% of the genomic annotated open reading frames (ORFs), were found with disruptive mutations in at least one accession. The distribution of these Psi s on chromosomes showed a significantly negative correlation between Psi s/ORFs and their local gene densities, suggesting a higher proportion of Psi s in gene desert regions, e. g. near centromeres. On the other hand, compared with the non-Psi loci, even the intact coding sequences (CDSs) in the Psi loci were found to have shorter CDS length, fewer exon number and lower GC content. In addition, a significant functional bias against the null hypothesis was detected in the Psi s mainly involved in responses to environmental stimuli and biotic stress as reported, suggesting that they are likely important for adaptive evolution to rapidly changing environments by pseudogenization to accumulate successive mutations.	[Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Araki, Hitoshi] Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland	Nanjing University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Araki, H (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	Hitoshi.Araki@eawag.ch; sihaiyang@nju.edu.cn	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	National Natural Science Foundation of China [30970198, J1103512]; NSFC of Jiangsu province [BK2011015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC of Jiangsu province	This work was supported by National Natural Science Foundation of China (30970198 and J1103512) and NSFC of Jiangsu province (BK2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benovoy D, 2006, J MOL EVOL, V62, P511, DOI 10.1007/s00239-005-0045-z; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Du JC, 2008, GENE, V426, P1, DOI 10.1016/j.gene.2008.09.003; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Khachane AN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-38; Lafontaine I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-260; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sen K, 2010, FEBS LETT, V584, P4015, DOI 10.1016/j.febslet.2010.08.012; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yang S, 2012, P NATL ACAD SCI USA; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zhang YL, 2009, J MOL EVOL, V68, P393, DOI 10.1007/s00239-009-9217-6; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	43	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51769	10.1371/journal.pone.0051769	http://dx.doi.org/10.1371/journal.pone.0051769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272162	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600039
